PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eto, A; Saido, TC; Fukushima, K; Tomioka, S; Imai, S; Nisizawa, T; Hanada, N				Eto, A; Saido, TC; Fukushima, K; Tomioka, S; Imai, S; Nisizawa, T; Hanada, N			Inhibitory effect of a self-derived peptide on glucosyltransferase of Streptococcus mutans - Possible novel anticaries measures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-ANALYSIS; ALPHA-AMYLASE; NUCLEOTIDE-SEQUENCE; OPTICAL BIOSENSOR; GLUCAN SYNTHESIS; GTF GENES; SOBRINUS; BINDING; SITE; DOMAIN	Glucosyltransferase (GTF) plays an important role in the development of dental caries. We examined the possible presence of self-inhibitory segments within the enzyme molecule for the purpose of developing anticaries measures through GTF inhibition. Twenty-two synthetic peptides derived from various regions presumably responsible for insoluble-glucan synthesis were studied with respect to their effects on catalytic activity. One of them, which is identical in amino acid sequence to residues 1176-1194, significantly and specifically inhibited both sucrose hydrolysis and glucosyl transfer to glucan by GTF-I, Double-reciprocal analysis revealed that the inhibition is noncompetitive. Scramble peptides, composed of the identical amino acids in randomized sequence, had no effect on GTF-I activity. Furthermore, the peptide is tightly bound to the enzyme once complexed, even in the presence of sodium dodecyl sulfate (SDS). Kinetic analysis using an optical evanescent resonant mirror cuvette system demonstrated that the enzyme-peptide interaction was biphasic. These results indicate that the peptide directly interacts with the enzyme with high affinity and inhibits its activity in a sequence-specific manner. This peptide itself could possibly be an effective agent for prevention of dental caries, although its effectiveness may be improved by further modification.	Natl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, Tokyo 1628640, Japan; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Nihon Univ, Sch Dent, Dept Microbiol, Matsudo, Chiba 2718587, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138657, Japan	National Institute of Infectious Diseases (NIID); RIKEN; Nihon University; University of Tokyo	Hanada, N (corresponding author), Natl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.		Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021; Hanada, Nobuhiro/C-5308-2011	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; 				AOKI H, 1986, INFECT IMMUN, V53, P587, DOI 10.1128/IAI.53.3.587-594.1986; Edwards PR, 1997, ANAL BIOCHEM, V246, P1, DOI 10.1006/abio.1996.9922; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; ETO A, 1995, J BIOL CHEM, V270, P25115, DOI 10.1074/jbc.270.42.25115; FERRETTI JJ, 1987, J BACTERIOL, V169, P4271, DOI 10.1128/jb.169.9.4271-4278.1987; FUKUSHIMA K, 1992, INFECT IMMUN, V60, P2815, DOI 10.1128/IAI.60.7.2815-2822.1992; Hall DR, 1997, ANAL BIOCHEM, V253, P145, DOI 10.1006/abio.1997.2358; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HANADA N, 1989, INFECT IMMUN, V57, P2079, DOI 10.1128/IAI.57.7.2079-2085.1989; HANADA N, 1988, INFECT IMMUN, V56, P1999, DOI 10.1128/IAI.56.8.1999-2005.1988; HANADA N, 1993, INFECT IMMUN, V61, P2096, DOI 10.1128/IAI.61.5.2096-2103.1993; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KATO C, 1991, FEMS MICROBIOL LETT, V79, P153, DOI 10.1111/j.1574-6968.1991.tb04521.x; KATO C, 1992, BIOCHEM BIOPH RES CO, V189, P1184, DOI 10.1016/0006-291X(92)92329-V; KATO C, 1990, FEMS MICROBIOL LETT, V72, P299, DOI 10.1111/j.1574-6968.1990.tb03906.x; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOOSER G, 1991, J BIOL CHEM, V266, P8916; MOOSER G, 1988, INFECT IMMUN, V56, P880, DOI 10.1128/IAI.56.4.880-884.1988; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; ROGERS JC, 1983, J BIOL CHEM, V258, P8169; Russell R. R., 1990, ARCH ORAL BIOL, V35, P53; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SHIROZA T, 1987, J BACTERIOL, V169, P4263, DOI 10.1128/jb.169.9.4263-4270.1987; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; VERTESY L, 1984, EUR J BIOCHEM, V141, P505, DOI 10.1111/j.1432-1033.1984.tb08221.x; WIEGAND G, 1995, J MOL BIOL, V247, P99, DOI 10.1006/jmbi.1994.0125; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; YAMASHITA Y, 1989, J BACTERIOL, V171, P6265, DOI 10.1128/jb.171.11.6265-6270.1989	33	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15797	15802		10.1074/jbc.274.22.15797	http://dx.doi.org/10.1074/jbc.274.22.15797			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336482	hybrid			2022-12-27	WOS:000080560100071
J	Hamada, K; Kumazaki, T; Satoh, S				Hamada, K; Kumazaki, T; Satoh, S			Effect of transforming RNA on the synthesis of a protein with a secretory signal sequence in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; 7SL RNA; MESSENGER-RNA; MALIGNANT TRANSFORMATION; TRANSLATION INITIATION; POLY(A) TAIL; SECONDARY STRUCTURE; ELONGATION ARREST	U5 small nuclear RNA itself can act as a clastogenic and transforming agent when transfected into cells. In the previous work, the 3' half of the U5 small nuclear RNA first stem structure (designated RNA3S) was capable of driving normal cells into tumorigenic cells when expressed with a poly(A) tail (RNA3S(+)). This transformation critically depended upon the polypurine sequence GGAGAGGAA in RNA3S(+), In this work, we first examined the pre-beta-lactamase and luciferase (model secretory and nonsecretory proteins) translation with the in vitro synthesized RNA3S in rabbit reticulocyte lysate, The capped RNA3S with a poly(A) tail suppressed the translation. In addition, the polypurine sequence played a crucial role in affecting the secretory protein synthesis, indicating a primary action of RNA3S(+). Further studies revealed that the oligodeoxynucleotides, corresponding to the polypurine and its antisense sequences, directly contacted 28 S rRNA in ribosome and 7SL RNA in signal recognition particle, respectively, and differentially affected the nascent chain elongation of secretory protein synthesis. These results suggest that RNA3S(+) blocks a physiological regulatory function played by signal recognition particle and the ribosome in the secretory protein synthesis and support the idea that the transformation might result from a repressed cellular activity.	Hiroshima Univ, Res Inst Radiat Biol & Med, Div Cell Biol, Minami Ku, Hiroshima 7340037, Japan; Inst Bioregulat Co Ltd, Naka Ku, Yokohama, Kanagawa 2310013, Japan	Hiroshima University	Hamada, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Div Cell Biol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7340037, Japan.							ANDREAZZOLI M, 1991, EMBO J, V10, P767, DOI 10.1002/j.1460-2075.1991.tb08008.x; ANDREWS DW, 1987, EMBO J, V6, P3471, DOI 10.1002/j.1460-2075.1987.tb02671.x; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BRANLANT C, 1983, NUCLEIC ACIDS RES, V11, P8359, DOI 10.1093/nar/11.23.8359; Bridges BA, 1997, BIOESSAYS, V19, P347, DOI 10.1002/bies.950190412; Cairns J, 1998, GENETICS, V148, P1433; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FARBER E, 1991, CANCER RES, V51, P2751; FARBER E, 1987, LAB INVEST, V56, P4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; HALL BG, 1990, GENETICS, V126, P5; HALL BG, 1995, P NATL ACAD SCI USA, V92, P5669, DOI 10.1073/pnas.92.12.5669; HAMADA K, 1989, MOL CELL BIOL, V9, P4345, DOI 10.1128/MCB.9.10.4345; Hamada K, 1997, MOL CARCINOGEN, V20, P175; HAMADA K, 1992, MUTAT RES, V267, P97, DOI 10.1016/0027-5107(92)90114-H; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HYNES RO, 1976, BIOCHIM BIOPHYS ACTA, V458, P73, DOI 10.1016/0304-419X(76)90015-9; ISFORT RJ, 1994, CARCINOGENESIS, V15, P1203, DOI 10.1093/carcin/15.6.1203; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; MADER S, 1995, MOL CELL BIOL, V15, P4990; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; MULLER M, 1982, J BIOL CHEM, V257, P1860; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SAMBROOK J, 1989, MOL CLONING LAB MANU, P207; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; Schwab ED, 1996, MED HYPOTHESES, V47, P235, DOI 10.1016/S0306-9877(96)90086-9; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; STRAUSS BS, 1992, CANCER RES, V52, P249; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9; VAHERI A, 1978, BIOCHIM BIOPHYS ACTA, V516, P1, DOI 10.1016/0304-419X(78)90002-1; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; WEINBERG RA, 1989, CANCER RES, V49, P3713; WIECH H, 1991, FEBS LETT, V285, P182, DOI 10.1016/0014-5793(91)80800-I; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; WOOD KV, 1984, BIOCHEM BIOPH RES CO, V124, P592, DOI 10.1016/0006-291X(84)91595-X; ZWIEB C, 1989, PROG NUCLEIC ACID RE, V37, P207; ZWIEB C, 1985, NUCLEIC ACIDS RES, V13, P6105, DOI 10.1093/nar/13.17.6105	58	2	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15786	15796		10.1074/jbc.274.22.15786	http://dx.doi.org/10.1074/jbc.274.22.15786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336481	hybrid			2022-12-27	WOS:000080560100070
J	Andersson, H; Kappeler, F; Hauri, HP				Andersson, H; Kappeler, F; Hauri, HP			Protein targeting to endoplasmic reticulum by dilysine signals involves direct retention in addition to retrieval	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; GOLGI-APPARATUS; TRANSMEMBRANE PROTEINS; CIS-GOLGI; BETA-COP; ERGIC-53; TRANSPORT; COATOMER; ER; COMPARTMENT	Dilysine signals confer localization of type I membrane proteins to the endoplasmic reticulum (ER). According to the prevailing model these signals target proteins to the ER by COP I-mediated retrieval from post-ER compartments, whereas the actual retention mechanism in the ER is unknown. We expressed chimeric membrane proteins with a C-terminal -Lys-Lys-Ala-Ala (KKAA) or -Lys-Lys-Phe-Phe (KKFF) dilysine signal in Lec-1 cells. Unlike KKFF constructs, which had access to post-ER compartments, the KKAA chimeras were localized to the ER by confocal microscopy and mere neither processed by cis-Golgi-specific enzymes in vivo nor included into ER-derived transport vesicles in an in vitro budding assay, suggesting that KKAA-bearing proteins are permanently retained in the ER. The ER localization was nonsaturable and exclusively mediated by the dilysine signal because mutating the lysines to alanines led to cell surface expression of the chimeras. Although the KKAA signal avidly binds COP I in vitro, the ER retention by this signal does not depend on intact COP I in vivo because it was not affected in an epsilon-COP-deficient cell line. me propose that dilysine ER targeting signals can mediate ER retention in addition to retrieval.	Univ Basel, Bioctr, Dept Pharmacol, CH-4056 Basel, Switzerland	University of Basel	Hauri, HP (corresponding author), Univ Basel, Bioctr, Dept Pharmacol, Klingelbergstr 70, CH-4056 Basel, Switzerland.							CARRERA AC, 1987, EUR J IMMUNOL, V17, P179, DOI 10.1002/eji.1830170205; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DAHLLOF B, 1991, J BIOL CHEM, V266, P1804; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; HAURI H-P, 1992, Current Opinion in Cell Biology, V4, P600, DOI 10.1016/0955-0674(92)90078-Q; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KAPPELER F, 1994, J BIOL CHEM, V269, P6279; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Klumperman J, 1998, J CELL SCI, V111, P3411; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49; ORCI L, 1994, P NATL ACAD SCI USA, V91, P11924, DOI 10.1073/pnas.91.25.11924; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; ROWE T, 1995, METHOD ENZYMOL, V257, P49; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SCHWEIZER A, 1991, J CELL BIOL, V113, P45, DOI 10.1083/jcb.113.1.45; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P121; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0	36	106	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15080	15084		10.1074/jbc.274.21.15080	http://dx.doi.org/10.1074/jbc.274.21.15080			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329713	hybrid			2022-12-27	WOS:000081965200078
J	Gegout, V; Schlegl, J; Schlager, B; Hentze, MW; Reinbolt, J; Ehresmann, B; Ehresmann, C; Romby, P				Gegout, V; Schlegl, J; Schlager, B; Hentze, MW; Reinbolt, J; Ehresmann, B; Ehresmann, C; Romby, P			Ligand-induced structural alterations in human iron regulatory protein-1 revealed by protein footprinting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FERRITIN MESSENGER-RNA; FE-S CLUSTER; RESPONSIVE-ELEMENT; TRANSFERRIN RECEPTOR; SULFUR CLUSTER; TRANSLATIONAL REGULATION; CYTOSOLIC ACONITASE; IRE-BP; EXPRESSION	Human iron regulatory protein-1 (IRP-1) is a bifunctional protein that regulates iron metabolism by binding to mRNAs encoding proteins involved in iron uptake, storage, and utilization. Intracellular iron accumulation regulates IRP-1 function by promoting the assembly of an iron-sulfur cluster, conferring aconitase activity to IRP-1, and hindering RNA binding. Using protein footprinting, we have studied the structure of the two functional forms of IRP-1 and have mapped the surface of the iron-responsive element (IRE) binding site. Binding of the ferritin IRE or of the minimal regulatory region of transferrin receptor mRNA induced strong protections against proteolysis in the region spanning amino acids 80 to 187, which are located in the putative cleft thought to be involved in RNA binding. In addition, IRE-induced protections were also found in the C-terminal domain at Arg-721 and Arg-728. These data implicate a bipartite IRE binding site located in the putative cleft of IRP-1. The aconitase form of IRP-1 adopts a more compact structure because strong reductions of cleavage were detected in two defined areas encompassing residues 149 to 187 and 721 to 735. Thus both ligands of apo-IRP-1, the IRE and the 4Fe-4S cluster, induce distinct but overlapping alterations in protease accessibility. These data provide evidences for structural changes in IRP-1 upon cluster formation that affect the accessibility of residues constituting the RNA binding site.	CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9002, F-67084 Strasbourg, France; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL)	Romby, P (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	romby@ibmc.u-strasbg.fr	Hentze, Matthias W/V-3980-2017; ROMBY, Pascale/AGP-3328-2022	Hentze, Matthias W/0000-0002-4023-7876; 				AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BARTON HA, 1990, J BIOL CHEM, V265, P7000; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CONSTABLE A, 1992, P NATL ACAD SCI USA, V89, P4554, DOI 10.1073/pnas.89.10.4554; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; EMERYGOODMAN A, 1993, NUCLEIC ACIDS RES, V21, P1457, DOI 10.1093/nar/21.6.1457; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Harford JB, 1998, COLD SPRING HARBOR M, P575; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; HEYDUK E, 1994, BIOCHEMISTRY-US, V33, P9643, DOI 10.1021/bi00198a033; HIRLING H, 1992, NUCLEIC ACIDS RES, V20, P33, DOI 10.1093/nar/20.1.33; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; JENSEN TH, 1995, J BIOL CHEM, V270, P13777, DOI 10.1074/jbc.270.23.13777; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; LEIBOLD EA, 1990, NUCLEIC ACIDS RES, V18, P1819, DOI 10.1093/nar/18.7.1819; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; Maniatis T., 1982, MOL CLONING; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; NEUPERT B, 1995, NUCLEIC ACIDS RES, V23, P2579, DOI 10.1093/nar/23.14.2579; Paraskeva E, 1996, FEBS LETT, V389, P40, DOI 10.1016/0014-5793(96)00574-1; PATINO MM, 1992, J BIOL CHEM, V267, P19011; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; PHILPOTT CC, 1991, NUCLEIC ACIDS RES, V19, P6333, DOI 10.1093/nar/19.22.6333; Rabinowitz J, 1972, Methods Enzymol, V24, P431; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; ROSE IA, 1967, J BIOL CHEM, V242, P1870; ROUAULT TA, 1992, BIOMETALS, V5, P131, DOI 10.1007/BF01061319; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; Saitoh Y, 1993, CHROMOSOME RES, V1, P239, DOI 10.1007/BF00710129; Schalinske KL, 1997, BIOCHEMISTRY-US, V36, P3950, DOI 10.1021/bi9624447; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schlegl J, 1997, RNA, V3, P1159; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; SWENSON GR, 1994, NUCLEIC ACIDS RES, V22, P2627, DOI 10.1093/nar/22.13.2627; THEIL EC, 1994, BIOCHEM J, V304, P1; YU Y, 1992, J BIOL CHEM, V267, P19005; ZHENG LM, 1990, J BIOL CHEM, V265, P2814	59	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15052	15058		10.1074/jbc.274.21.15052	http://dx.doi.org/10.1074/jbc.274.21.15052			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329709	hybrid			2022-12-27	WOS:000081965200074
J	Schmidt, M; Voss, M; Weernink, PAO; Wetzel, J; Amano, M; Kaibuchi, K; Jakobs, KH				Schmidt, M; Voss, M; Weernink, PAO; Wetzel, J; Amano, M; Kaibuchi, K; Jakobs, KH			A role for rho-kinase in rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION-FACTOR; GTP-BINDING PROTEIN; DIFFICILE TOXIN-B; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RAT-BRAIN; TYROSINE PHOSPHORYLATION; SERINE/THREONINE KINASE; AGONIST STIMULATION; D DEFINES; ACTIVATION	Stimulation of phospholipase D (PLD) by membrane receptors is now recognized as a major signal transduction pathway involved in diverse cellular functions. Rho proteins control receptor signaling to PLD, and these GTPases have been shown to directly stimulate purified recombinant PLD1 enzymes in vitro. Here we report that stimulation of PLD activity, measured in the presence of phosphatidylinositol 4,5-bisphosphate, by RhoA in membranes of HEK-293 cells expressing the m3 muscarinic acetylcholine receptor (mAChR) is phosphorylation-dependent. Therefore, the possible involvement of the RhoA-stimulated serine/threonine kinase, Rho-kinase, was investigated. Overexpression of Rho-kinase and constitutively active Rho-kinase (Rho-kinase-CAT) but not of kinase-deficient Rho-kinase-CAT markedly increased m3 mAChR-mediated but not protein kinase C-mediated PLD stimulation, similar to overexpression of RhoA Expression of the Rho-inactivating C3 transferase abrogated the stimulatory effect of wild-type Rho-kinase, but not of Rho-kinase-CAT. Recombinant Rho-kinase CAT mimicked the phosphorylation-dependent PLD stimulation by RhoA in HEK-293 cell membranes. Finally, the Rho-kinase inhibitor HA-1077 largely inhibited RhoA-induced PLD stimulation in membranes as well as PLD stimulation by the m3 mAChR but not by protein kinase C in intact HEK-293 cells. me conclude that Rho-kinase is involved in Rho-dependent PLD stimulation by the G protein-coupled m3 mAChR in HEK-293 cells. Thus, our findings identify Rho-kinase as a novel player in the receptor-controlled PLD signaling pathway.	Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany; Nara Inst Sci & Technol, Div Signal Transduct, Nara 63001, Japan	University of Duisburg Essen; Nara Institute of Science & Technology	Schmidt, M (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Pharmakol, Hufelandstr 55, D-45122 Essen, Germany.		Schmidt, Martina/C-5339-2018; Amano, Mutsuki/M-4820-2014	Schmidt, Martina/0000-0003-3075-0630; Amano, Mutsuki/0000-0002-0662-1524				AKTORIES K, 1993, GTPASES BIOL, V1, P87; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Asano T, 1998, CARDIOVASC DRUG REV, V16, P76, DOI 10.1111/j.1527-3466.1998.tb00346.x; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; COCKCROFT S, 1997, PROG LIPID RES, V35, P345; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Fensome A, 1996, CURR BIOL, V6, P730, DOI 10.1016/S0960-9822(09)00454-0; Fensome A, 1998, J BIOL CHEM, V273, P13157, DOI 10.1074/jbc.273.21.13157; GENY B, 1995, EUR J BIOCHEM, V231, P31, DOI 10.1111/j.1432-1033.1995.tb20666.x; GOSH S, 1996, J BIOL CHEM, V271, P8472; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hess JA, 1997, J BIOL CHEM, V272, P1615, DOI 10.1074/jbc.272.3.1615; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Keller J, 1997, FEBS LETT, V403, P299, DOI 10.1016/S0014-5793(97)00067-7; Kim JH, 1996, J BIOL CHEM, V271, P25213, DOI 10.1074/jbc.271.41.25213; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Malcolm KC, 1996, J BIOL CHEM, V271, P13135, DOI 10.1074/jbc.271.22.13135; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Min DS, 1998, J BIOL CHEM, V273, P7044, DOI 10.1074/jbc.273.12.7044; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Morris AJ, 1996, TRENDS PHARMACOL SCI, V17, P182, DOI 10.1016/0165-6147(96)10016-X; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; PERTILE P, 1995, J BIOL CHEM, V270, P5130, DOI 10.1074/jbc.270.10.5130; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rumenapp U, 1997, EUR J BIOCHEM, V248, P407, DOI 10.1111/j.1432-1033.1997.00407.x; RUMENAPP U, 1995, EUR J BIOCHEM, V234, P240, DOI 10.1111/j.1432-1033.1995.240_c.x; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; Schmidt M, 1998, J BIOL CHEM, V273, P7413, DOI 10.1074/jbc.273.13.7413; Schmidt M, 1996, EUR J BIOCHEM, V240, P707, DOI 10.1111/j.1432-1033.1996.0707h.x; Schmidt M, 1996, N-S ARCH PHARMACOL, V354, P87, DOI 10.1007/BF00178707; SCHMIDT M, 1994, EUR J BIOCHEM, V225, P667, DOI 10.1111/j.1432-1033.1994.00667.x; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vinggaard AM, 1997, CELL SIGNAL, V9, P189, DOI 10.1016/S0898-6568(96)00140-4; Winstel R, 1996, P NATL ACAD SCI USA, V93, P2105, DOI 10.1073/pnas.93.5.2105	55	79	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14648	14654		10.1074/jbc.274.21.14648	http://dx.doi.org/10.1074/jbc.274.21.14648			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329658	hybrid			2022-12-27	WOS:000081965200023
J	Vidugiriene, J; Sharma, DK; Smith, TK; Baumann, NA; Menon, AK				Vidugiriene, J; Sharma, DK; Smith, TK; Baumann, NA; Menon, AK			Segregation of glycosylphosphatidylinositol biosynthetic reactions in a subcompartment of the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYL-PHOSPHATIDYLINOSITOL ANCHOR; VARIANT SURFACE GLYCOPROTEIN; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; GPI-ANCHOR; RAT-LIVER; GLUCOSAMINYL PHOSPHATIDYLINOSITOL; GLYCOPHOSPHATIDYLINOSITOL ANCHORS; STRUCTURAL CHARACTERIZATION; INTRACELLULAR-TRANSPORT	Glycosylphosphatidylinositols (GPIs) are synthesized in the endoplasmic reticulum (ER) via the sequential addition of monosaccharides, fatty acid, and phosphoethanolamine(s) to phosphatidylinositol (PI), While attempting to establish a mammalian cell-free system for GPI biosynthesis, we found that the assembly of mannosylated GPI species was impaired when purified ER preparations were substituted for unfractionated cell lysates as the enzyme source. To explore this problem we analyzed the distribution of the various GPI biosynthetic reactions in subcellular fractions prepared from homogenates of mammalian cells. The results indicate the following: (i) the initial reaction of GPI assembly, i.e, the transfer of GlcNAc to PI to form GlcNAc-PI, is uniformly distributed in the ER; (ii) the second step of the pathway, i.e. de-N-acetylation of GlcNAc-PI to yield GlcN-PI, is largely confined to a subcompartment of the ER that appears to be associated with mitochondria; (iii) the mitochondria-associated ER subcompartment is enriched in enzymatic activities involved in the conversion of GlcN-PI to H5 (a singly mannosylated GPI structure containing one phosphoethanolamine side chain; and (iv) the mitochondria-associated ER subcompartment, unlike bulk ER, is capable of the de novo synthesis of H5 from UDP-GlcNAc and PI. The confinement of these GPI biosynthetic reactions to a domain of the ER provides another example of the compositional and functional heterogeneity of the ER, The implications of these findings for GPI assembly are discussed.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland	University of Wisconsin System; University of Wisconsin Madison; University of Dundee	Menon, AK (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.			Menon, Anant Kumar/0000-0001-6924-2698	NIGMS NIH HHS [GM5427] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1990, J BIOL CHEM, V265, P14691; ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; AMTHAUER R, 1992, P NATL ACAD SCI USA, V89, P6124, DOI 10.1073/pnas.89.13.6124; ARDAIL D, 1993, J BIOL CHEM, V268, P25985; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; CUI Z, 1993, J BIOL CHEM, V268, P16655; DELUCA AW, 1994, GLYCOBIOLOGY, V4, P909, DOI 10.1093/glycob/4.6.909; DOERING TL, 1989, J BIOL CHEM, V264, P11168; Doerrler WT, 1996, J BIOL CHEM, V271, P27031, DOI 10.1074/jbc.271.43.27031; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Field M. C., 1992, LIPID MODIFICATION P, P155; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Graham John M., 1993, V19, P1; HIROSE S, 1992, J BIOL CHEM, V267, P16968; HIROSE S, 1992, P NATL ACAD SCI USA, V89, P6025, DOI 10.1073/pnas.89.13.6025; KAMITANI T, 1992, J BIOL CHEM, V267, P24611; KATZ J, 1983, BIOCHEM J, V214, P795, DOI 10.1042/bj2140795; KODUKULA K, 1991, J BIOL CHEM, V266, P4464; LOW MG, 1986, TRENDS BIOCHEM SCI, V11, P212, DOI 10.1016/0968-0004(86)90009-5; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MEIER PJ, 1981, BIOCHIM BIOPHYS ACTA, V646, P283, DOI 10.1016/0005-2736(81)90335-7; MENON A, 1995, TRENDS CELL BIOL, V5, P355, DOI 10.1016/S0962-8924(00)89069-8; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; Menon AK, 1997, BIOCHEM SOC T, V25, P861, DOI 10.1042/bst0250861; MENON AK, 1998, GPI ANCH BIOM; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; PICKETT CB, 1980, EXP CELL RES, V128, P343, DOI 10.1016/0014-4827(80)90070-1; PUOTI A, 1993, J BIOL CHEM, V268, P7215; PUOTI A, 1991, J BIOL CHEM, V266, P21051; PUOTI A, 1992, J BIOL CHEM, V267, P22673; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rooney E, 1996, J BIOL CHEM, V271, P29304, DOI 10.1074/jbc.271.46.29304; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Saito K, 1996, FEBS LETT, V395, P262, DOI 10.1016/0014-5793(96)01049-6; Sharma DK, 1997, BIOCHEM J, V328, P171; SHARMA DK, 1997, THESIS U DUNDEE DUND; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; SHORE GC, 1977, J CELL BIOL, V72, P714, DOI 10.1083/jcb.72.3.714; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; Smith TK, 1996, J BIOL CHEM, V271, P6476, DOI 10.1074/jbc.271.11.6476; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STEVENS VL, 1995, BIOCHEM J, V310, P361, DOI 10.1042/bj3100361; STEVENS VL, 1994, J BIOL CHEM, V269, P31397; Stevens VL, 1996, BIOCHEM J, V313, P253, DOI 10.1042/bj3130253; Takahashi M, 1996, EMBO J, V15, P4254, DOI 10.1002/j.1460-2075.1996.tb00800.x; TAKEDA J, 1995, TRENDS BIOCHEM SCI, V20, P367, DOI 10.1016/S0968-0004(00)89078-7; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; UEDA E, 1993, J BIOL CHEM, V268, P9998; URAKAZE M, 1992, J BIOL CHEM, V267, P6459; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vertel B M, 1992, Semin Cell Biol, V3, P325, DOI 10.1016/1043-4682(92)90019-R; VIDUGIRIENE J, 1995, EMBO J, V14, P4686, DOI 10.1002/j.1460-2075.1995.tb00150.x; VIDUGIRIENE J, 1995, METHOD ENZYMOL, V250, P513; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; VIDUGIRIENE J, 1994, J CELL BIOL, V127, P333, DOI 10.1083/jcb.127.2.333; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; VOELKER DR, 1993, J BIOL CHEM, V268, P7069; WASSLER M, 1993, J CELL BIOL, V123, P285, DOI 10.1083/jcb.123.2.285	64	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15203	15212		10.1074/jbc.274.21.15203	http://dx.doi.org/10.1074/jbc.274.21.15203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329729	hybrid			2022-12-27	WOS:000081965200094
J	Bab, I; Smith, E; Gavish, H; Attar-Namdar, M; Chorev, M; Chen, YC; Muhlrad, A; Birnbaum, MJ; Stein, G; Frenkel, B				Bab, I; Smith, E; Gavish, H; Attar-Namdar, M; Chorev, M; Chen, YC; Muhlrad, A; Birnbaum, MJ; Stein, G; Frenkel, B			Biosynthesis of osteogenic growth peptide via alternative translational initiation at AUG(85) of histone H4 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; EUKARYOTIC RIBOSOMES; MAMMALIAN-CELLS; MESSENGER-RNA; EXPRESSION; GENE; SEQUENCE; RAT; UPSTREAM; DNA	The osteogenic growth peptide (OGP) is an extracellular mitogen identical to the histone H4 (H4) COOH-terminal residues 90-103, which regulates osteogenesis and hematopoiesis, By Northern analysis, OGP mRNA is indistinguishable from H4 mRNA. Indeed, cells transfected with a construct encoding [His(102)]H4 secreted the corresponding [His(13)]OGP. These results suggest production of OGP from H4 genes. Cells transfected with H4-chloramphenicol acetyltransferase (CAT) fusion genes expressed both "long" and "short" CAT proteins. The short CAT was retained following an ATG --> TTG mutation of the H4 ATG initiation codon, but not following mutation of the in-frame internal ATG(85) codon, which, unlike ATG(1), resides within a perfect context for translational initiation. These results suggest that a PreOGP is translated starting at AUG(85). The translational initiation at AUG(85) could be inhibited by optimizing the nucleotide sequence surrounding ATG(1) to maximally support upstream translational initiation, thus implicating leaky ribosomal scanning in usage of the internal AUG. Conversion of the predicted PreOGP to OGP was shown in a cell lysate system using synthetic [His(102)]H4-(85-103) as substrate. Together, our results demonstrate that H4 gene expression diverges at the translational level into the simultaneous parallel production of both H4, a nuclear structural protein, and OGP, an extracellular regulatory peptide.	Univ So Calif, Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; Hebrew Univ Jerusalem, Fac Med Dent, Bone Lab, IL-91120 Jerusalem, Israel; Univ So Calif, Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Biochem, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Mol Biol, Los Angeles, CA 90033 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Bone & Mineral Metab, Boston, MA 02215 USA; Merrimack Coll, Dept Biol, N Andover, MA 01845 USA; Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA	University of Southern California; Hebrew University of Jerusalem; University of Southern California; University of Southern California; University of Southern California; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Merrimack College; University of Massachusetts System; University of Massachusetts Worcester	Frenkel, B (corresponding author), Univ So Calif, Sch Med, Inst Med Genet, 2250 Alcazar St,CSC-IGM240, Los Angeles, CA 90033 USA.		Bab, Itai A/C-2613-2009					Akhmanova A, 1996, FEBS LETT, V388, P219, DOI 10.1016/0014-5793(96)00551-0; BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x; BARANY G, 1979, PEPTIDES, V1, P1; Brinkmeier ML, 1998, MOL ENDOCRINOL, V12, P622, DOI 10.1210/me.12.5.622; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Class R, 1996, AM J CLIN ONCOL-CANC, V19, P522, DOI 10.1097/00000421-199610000-00019; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; Frenkel B, 1996, ENDOCRINOLOGY, V137, P1080, DOI 10.1210/en.137.3.1080; Gan WN, 1998, J BIOL CHEM, V273, P5006, DOI 10.1074/jbc.273.9.5006; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Greenberg Z, 1997, J CELL BIOCHEM, V65, P359, DOI 10.1002/(SICI)1097-4644(19970601)65:3<359::AID-JCB6>3.0.CO;2-R; GREENBERG Z, 1995, J CLIN ENDOCR METAB, V80, P2330, DOI 10.1210/jc.80.8.2330; Gurevitch O, 1996, BLOOD, V88, P4719, DOI 10.1182/blood.V88.12.4719.bloodjournal88124719; KHARCHENKO E P, 1987, Byulleten' Eksperimental'noi Biologii i Meditsiny, V103, P418; Kim HS, 1996, BIOCHEM BIOPH RES CO, V229, P381, DOI 10.1006/bbrc.1996.1814; Kogerman P, 1998, CLIN EXP METASTAS, V16, P83; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; Louters LL, 1996, BIOCHIMIE, V78, P39, DOI 10.1016/0300-9084(96)81327-7; Maiyar AC, 1996, J BIOL CHEM, V271, P12414, DOI 10.1074/jbc.271.21.12414; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; MEIER VS, 1989, NUCLEIC ACIDS RES, V17, P795, DOI 10.1093/nar/17.2.795; Merrick WC., 1996, TRANSLATION CONTROL, P31; MULTIGNER L, 1992, NATURE, V360, P33, DOI 10.1038/360033a0; PAULI U, 1987, SCIENCE, V236, P1308, DOI 10.1126/science.3035717; ROBINSON D, 1995, J BONE MINER RES, V10, P690; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Watabe Y, 1996, J BIOL CHEM, V271, P25126, DOI 10.1074/jbc.271.41.25126; Wells D., 1989, Nucleic Acids Research, V17, P311; WOLFE SA, 1989, BIOCHIM BIOPHYS ACTA, V1007, P140, DOI 10.1016/0167-4781(89)90032-8	35	44	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14474	14481		10.1074/jbc.274.20.14474	http://dx.doi.org/10.1074/jbc.274.20.14474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318873	hybrid			2022-12-27	WOS:000080322200102
J	Hirsch, RE; Juszczak, LJ; Fataliev, NA; Friedman, JM; Nagel, RL				Hirsch, RE; Juszczak, LJ; Fataliev, NA; Friedman, JM; Nagel, RL			Solution-active structural alterations in liganded hemoglobins C (beta 6 Glu -> Lys) and S (beta 6 Glu -> Val)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; REFINED CRYSTAL-STRUCTURE; SIDE-CHAIN CONFORMATION; DEOXYHEMOGLOBIN-S; CENTRAL CAVITY; FLUORESCENCE; ERYTHROCYTE; BINDING; RESOLUTION; MEMBRANES	Based upon existing crystallographic evidence, HbS, HbC, and HbA have essentially the same molecular structure. However, important areas of the molecule are not well defined crystallographically (e.g. the N-terminal nonhelical portion of the alpha and beta chains), and conformational constraints differ in solution and in the crystalline state. Over the years, our laboratory and others have provided evidence of conformational changes in HbS and, more recently, in HbC. We now present data based upon allosteric perturbation monitored by front-face fluorescence, ultraviolet resonance Raman spectroscopy, circular dichroism, and oxygen equilibrium studies that confirm and significantly expand previous findings suggesting solution-active structural differences in liganded forms of HbS and HbC distal to the site of mutation and involving the 2,3-diphosphoglycerate binding pocket. The liganded forms of these hemoglobins are of significant interest because HbC crystallizes in the erythrocyte in the oxy form, and oxy HbS exhibits increased mechanical precipitability and a high propensity to oxidize. Specific findings are as follows: 1) differences in the intrinsic fluorescence indicate that the Trp microenvironments are more hydrophobic for HbS > HbC > HbA,2) ultraviolet resonance Raman spectroscopy detects alterations in Tyr hydrogen bonding, in Trp hydrophobicity at the (alpha(1)beta(2) interface (beta 37), and in the A-helix ((alpha 14/beta 15) of both chains, 3) displacement by inositol hexaphosphate of the Hb-bound 8-hydroxy-1,3,6-pyrenetrisulfonate (the fluorescent 2,3-diphosphoglycerate analog) follows the order HbA > HbS > HbC, and 4) oxygen equilibria measurements indicate a differential allosteric effect by inositol hexaphosphate for HbC similar to HbS > HbA.	Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hirsch, RE (corresponding author), Albert Einstein Coll Med, Dept Med, Div Hematol, Ullmann 925,1300 Morris Pk Ave, Bronx, NY 10461 USA.				NHLBI NIH HHS [HL 38655, HL 58247, P01HL51804] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL038655, R01HL058247] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASAKURA T, 1973, NATURE, V244, P437, DOI 10.1038/244437a0; ASAKURA T, 1974, BIOCHEM BIOPH RES CO, V270, P780; Austin J. C., 1993, BIOMOLECULAR SPECT A, P55; BUNN HF, 1972, HEMOGLOBIN RED CELL, P41; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; DeYoung A, 1981, Methods Enzymol, V76, P792; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; ELBAUM D, 1976, BIOCHIM BIOPHYS ACTA, V427, P57, DOI 10.1016/0005-2795(76)90285-3; ELBAUM D, 1981, MOL BASIS MUTANT HEM, V1, P253; FRONTICELLI C, 1976, J BIOL CHEM, V251, P4968; FRONTICELLI C, 1978, J BIOL CHEM, V253, P2288; FRONTICELLI C, 1978, BIOCH CLIN ASPECTS H; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P3424, DOI 10.1021/bi00686a021; Geraci G, 1981, Methods Enzymol, V76, P262; Gottfried DS, 1997, J BIOL CHEM, V272, P1571, DOI 10.1074/jbc.272.3.1571; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; Harrington JP, 1998, COMP BIOCHEM PHYS B, V119, P305, DOI 10.1016/S0305-0491(97)00330-1; HEBBEL RP, 1990, SEMIN HEMATOL, V27, P51; HIRSCH R E, 1992, Biophysical Journal, V61, pA57; Hirsch RE, 1997, BRIT J HAEMATOL, V98, P583, DOI 10.1046/j.1365-2141.1997.2483062.x; HIRSCH RE, 1994, METHOD ENZYMOL, V232, P231; HIRSCH RE, 1980, J COLLOID INTERF SCI, V78, P212, DOI 10.1016/0021-9797(80)90510-X; HIRSCH RE, 1980, BIOCHEM BIOPH RES CO, V93, P432, DOI 10.1016/0006-291X(80)91096-7; Hirsch RE, 1996, J BIOL CHEM, V271, P372, DOI 10.1074/jbc.271.1.372; HIRSCH RE, 1991, BLOOD S1, V78, pA199; Hu XH, 1997, BIOCHEMISTRY-US, V36, P15701, DOI 10.1021/bi971136l; HUANG J, 1999, IN PRESS BIOCH; Huang SC, 1997, BIOCHEMISTRY-US, V36, P6197, DOI 10.1021/bi970018v; IP SHC, 1976, BIOCHEMISTRY-US, V15, P654, DOI 10.1021/bi00648a032; JAYARAMAN V, 1995, SCIENCE, V269, P1843, DOI 10.1126/science.7569921; Juszczak LJ, 1998, J RAMAN SPECTROSC, V29, P963, DOI 10.1002/(SICI)1097-4555(199810/11)29:10/11<963::AID-JRS332>3.0.CO;2-4; Kirby E.P., 1971, EXCITED STATES PROTE; KLIPSTEIN FA, 1960, J CLIN INVEST, V39, P1894, DOI 10.1172/JCI104213; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LIN M L, 1991, Biophysical Journal, V59, p290A; MACQUARRIE R, 1971, J BIOL CHEM, V246, P5832; MACQUARRIE R, 1972, J BIOL CHEM, V247, P5686; MARUYAMA T, 1995, J RAMAN SPECTROSC, V26, P319, DOI 10.1002/jrs.1250260411; MELKI G, 1971, BIOCH BIOPHYS ACT, V263, P226; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; OKONJO K, 1980, J BIOL CHEM, V255, P3274; PADLAN EA, 1985, J BIOL CHEM, V260, P8272; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; PENNELLY RR, 1978, BIOCH CLIN ASPECTS H; REISS GH, 1982, J CLIN INVEST, V70, P946, DOI 10.1172/JCI110706; RODGERS KR, 1994, SCIENCE, V265, P1697, DOI 10.1126/science.8085153; ROTH EF, 1975, BLOOD, V45, P377; RUSSU IM, 1982, BIOCHEMISTRY-US, V21, P5044, DOI 10.1021/bi00263a030; SCOTT TW, 1983, FEBS LETT, V158, P68, DOI 10.1016/0014-5793(83)80678-4; SCOTT TW, 1985, J AM CHEM SOC, V107, P3702, DOI 10.1021/ja00298a047; SHAKLAI N, 1981, P NATL ACAD SCI-BIOL, V78, P65, DOI 10.1073/pnas.78.1.65; SHAKLAI N, 1977, BIOCHEMISTRY-US, V16, P5585, DOI 10.1021/bi00644a031; Sheng K, 1998, BLOOD, V91, P3467, DOI 10.1182/blood.V91.9.3467.3467_3467_3470; Sokolov L, 1998, J PHYS CHEM B, V102, P8314, DOI 10.1021/jp982099q; SU C, 1989, J AM CHEM SOC, V111, P3457, DOI 10.1021/ja00191a068; UEDA Y, 1978, BIOCHEM BIOPH RES CO, V85, P526, DOI 10.1016/0006-291X(78)91195-6; WALDER JA, 1984, J BIOL CHEM, V259, P238; Wang DJ, 1998, BIOCHEMISTRY-US, V37, P9940, DOI 10.1021/bi980295h; ZENTZ C, 1994, METHOD ENZYMOL, V232, P247	59	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13777	13782		10.1074/jbc.274.20.13777	http://dx.doi.org/10.1074/jbc.274.20.13777			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318781	hybrid			2022-12-27	WOS:000080322200010
J	Rivkees, SA; Chen, M; Kulkarni, J; Browne, J; Zhao, ZY				Rivkees, SA; Chen, M; Kulkarni, J; Browne, J; Zhao, ZY			Characterization of the murine A1 adenosine receptor promoter, potent regulation by GATA-4 and Nkx2.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-4; POLYMERASE CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; DNA-BINDING TARGETS; EXPRESSION; GENE; NKX-2.5; LOCALIZATION; HOMEOBOX; ELEMENTS	Adenosine acts via A1 adenosine receptors (A1ARs) in the heart and brain to potently influence mammalian physiology. A1ARs are expressed very early in embryonic development, and A1ARs are among the earliest expressed G protein coupled receptors in the heart and brain, To understand the biologic basis of A1AR expression, a genomic fragment containing the murine A1AR promoter was cloned. Reporter assay studies using DDT1 MF2 cells that express A1ARs revealed that 500 base pairs of the proximal A1AR promoter contained essential elements for A1AR gene expression. Transgenic mice with A1AR proximal promoter coupled with the beta-galactosidase reporter gene had heavy labeling of the brain and atria, consistent with normal patterns of A1AR expression. Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression. These observations suggest that embryonic A1AR expression involves activation of the A1AR promoter by GATA-4 and Nkx2.5.	Yale Univ, Sch Med, Div Pediat Endocrinol, New Haven, CT 06520 USA	Yale University	Rivkees, SA (corresponding author), Yale Pediat, POB 208081, New Haven, CT 06520 USA.			Zhao, Zhiyong/0000-0002-6145-7464	NHLBI NIH HHS [R01-HL58442] Funding Source: Medline; NINDS NIH HHS [R01-NS33539] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033539] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHRINGER RR, 1993, DEVELOPMENT, V117, P823; Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; CHESKIS B, 1995, MOL ENDOCRINOL, V9, P1814, DOI 10.1210/me.9.12.1814; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; ENGELAND K, 1995, J BIOL CHEM, V270, P24572, DOI 10.1074/jbc.270.41.24572; Fenton SE, 1996, J BIOL CHEM, V271, P30870, DOI 10.1074/jbc.271.48.30870; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; GUTKOWSKA J, 1993, ENDOCRINOLOGY, V132, P693, DOI 10.1210/en.132.2.693; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; HIGGINS MJ, 1994, PHARM WORLD SCI, V16, P62, DOI 10.1007/BF01880657; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofman PL, 1997, AM J PHYSIOL-REG I, V273, pR1374, DOI 10.1152/ajpregu.1997.273.4.R1374; HOYLE GW, 1994, J NEUROSCI, V14, P2455; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KRIANGKUM J, 1992, NUCLEIC ACIDS RES, V20, P3793, DOI 10.1093/nar/20.14.3793; LINDEN J, 1991, FASEB J, V5, P2668, DOI 10.1096/fasebj.5.12.1916091; LINTS TJ, 1993, DEVELOPMENT, V119, P969; LINTS TJ, 1993, DEVELOPMENT, V119, P419; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MULLICK J, 1995, BIOCHEMISTRY-US, V34, P13729, DOI 10.1021/bi00042a003; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; RAMKUMAR V, 1991, MOL PHARMACOL, V40, P639; REN HZ, 1994, P NATL ACAD SCI USA, V91, P4864, DOI 10.1073/pnas.91.11.4864; Ren HZ, 1995, MOL PHARMACOL, V48, P975; Ren HZ, 1998, MOL PHARMACOL, V53, P43, DOI 10.1124/mol.53.1.43; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Scott V, 1994, Methods Mol Biol, V31, P339; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7	32	42	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14204	14209		10.1074/jbc.274.20.14204	http://dx.doi.org/10.1074/jbc.274.20.14204			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318839	hybrid			2022-12-27	WOS:000080322200068
J	Sokolov, M; Lu, L; Tucker, W; Gao, F; Gegenheimer, PA; Richter, ML				Sokolov, M; Lu, L; Tucker, W; Gao, F; Gegenheimer, PA; Richter, ML			The 20 C-terminal amino acid residues of the chloroplast ATP synthase gamma subunit are not essential for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR-I; BINDING CHANGE MECHANISM; ESCHERICHIA-COLI; EPSILON-SUBUNIT; F1-ATPASE; STOICHIOMETRY; MITOCHONDRIA; RESOLUTION; EXPRESSION; CATALYSIS	It has been suggested that the last seven to nine amino acid residues at the C terminus of the gamma subunit of the ATP synthase act as a spindle for relation of the gamma subunit with respect to the c alpha beta subunits during catalysis (Abrahams, J. P,, Leslie, A. G. W., Lutter, R,, and Walker, J, E, (1994) Nature 370, 621-628), To test this hypothesis we selectively deleted C-terminal residues from the chloroplast gamma subunit, two at a time starting at the sixth residue from the end and finishing at the 20th residue from. the end. The mutant gamma genes were overexpressed in Escherichia coli and assembled with a native alpha(3)beta(3) complex, All the mutant forms of gamma assembled as effectively as the wild-type gamma. Deletion of the terminal 6 residues of gamma resulted in a significant increase (>50%) in the Ca-dependent ATPase activity when compared with the wildtype assembly. The increased activity persisted even after deletion of the C-terminal 14 residues, well beyond the seven residues proposed to form the spindle. Further deletions resulted in a decreased activity to similar to 19% of that of the wild-type enzyme after deleting all 20 C-terminal residues. The results indicate that the tip of the gamma C terminus is not essential for catalysis and raise questions about the role of the C terminus as a spindle for rotation.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Richter, ML (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	markl@kuhub.cc.ukans.edu	Gegenheimer, Peter Albert/E-2271-2013	Gegenheimer, Peter Albert/0000-0001-9863-1545				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ANTHON GE, 1986, BIOCHIM BIOPHYS ACTA, V848, P92, DOI 10.1016/0005-2728(86)90164-7; Averboukh L, 1996, BIOTECHNIQUES, V20, P918; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN ZG, 1995, J BIOL CHEM, V270, P17124, DOI 10.1074/jbc.270.29.17124; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; GAO F, 1995, J BIOL CHEM, V270, P9763, DOI 10.1074/jbc.270.17.9763; GUERRERO KJ, 1990, J BIOL CHEM, V265, P16280; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HU NM, 1993, J BIOL CHEM, V268, P8536; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MORONEY JV, 1979, J BIOL CHEM, V254, P8951; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; RICHTER ML, 1985, BIOCHEMISTRY-US, V24, P5755, DOI 10.1021/bi00342a011; RICHTER ML, 1996, ADV PHOTOSYNTH, V4, P453; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambrook J., 2002, MOL CLONING LAB MANU; SOTEROPOULOS P, 1992, J BIOL CHEM, V267, P10348; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4	30	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13824	13829		10.1074/jbc.274.20.13824	http://dx.doi.org/10.1074/jbc.274.20.13824			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318787	hybrid			2022-12-27	WOS:000080322200016
J	Jimenez-Lara, AM; Aranda, A				Jimenez-Lara, AM; Aranda, A			Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; THYROID-HORMONE RECEPTOR; ACTIVATION FUNCTION AF-2; NUCLEAR-RECEPTOR; BINDING DOMAIN; HISTONE ACETYLTRANSFERASE; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; CONSERVED REGION; ACID RECEPTORS	Mutant R246A in the predicted helix 3 of the ligand-binding domain, as well as mutants L417S and E420Q in helix 12, which contains the core ligand-dependent transcriptional activation domain (AF-2), were generated to examine AF-2 activity of the vitamin D receptor (VDR), These mutations abolished vitamin D-dependent transactivation. In addition, VDR mediates a ligand-dependent repression of the response of the retinoic acid receptor beta 2 promoter to retinoic acid, and the helix 3 and helix 12 mutants were unable to mediate transrepression. Furthermore, the VDR mutants, but not the native receptor, enhanced phorbol ester induction of the activator protein-1-containing collagenase promoter. The helix 3 and helix 12 mutations strikingly reduced the ability of VDR to interact with the coactivators steroid receptor coactivator-1, ACTR, and the CREB-binding protein. As a consequence, overexpression of steroid receptor coactivator-1 increased vitamin D-dependent transactivation by VDR but not by the K246A mutant. These results indicate that the lysine 246 participates, together with residues in helix 12, in the recruitment of coactivators and that AF-2 activity is involved both in ligand dependent transactivation and in transrepression by VDR.	CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; Univ Autonoma Madrid, E-28029 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Aranda, A (corresponding author), CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.		Aranda, Ana/ABG-8820-2020; Jiménez-Lara, Ana-María/ABF-5639-2020	Aranda, Ana/0000-0002-8338-9589; Jiménez-Lara, Ana-María/0000-0001-6471-9741				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; GarciaVillalba P, 1996, MOL CELL BIOL, V16, P318; Gill RK, 1998, MOL ENDOCRINOL, V12, P57, DOI 10.1210/mend.12.1.0048; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Helmer EB, 1996, ENDOCRINOLOGY, V137, P390, DOI 10.1210/en.137.2.390; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; JIMENEZLARA AM, 1999, IN PRESS ENDOCRINOLO; Jin CH, 1996, MOL ENDOCRINOL, V10, P945, DOI 10.1210/me.10.8.945; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; MILBURN MV, 1997, EMBO WORKSH STRUCT F; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; ODONNELL AL, 1990, MOL ENDOCRINOL, V4, P715, DOI 10.1210/mend-4-5-715; ONATE SA, 1995, SCIENCE, V270, P1354; Palomino T, 1998, J BIOL CHEM, V273, P27541, DOI 10.1074/jbc.273.42.27541; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; SCHONTHAL A, 1989, ONCOGENE, V4, P629; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; SONE T, 1991, J BIOL CHEM, V266, P23296; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; WAYS DK, 1993, MOL ENDOCRINOL, V7, P1112, DOI 10.1210/me.7.9.1112; WHITFIELD GK, 1995, MOL ENDOCRINOL, V9, P1166, DOI 10.1210/me.9.9.1166; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; ZHAO LJ, 1993, METHOD ENZYMOL, V217, P218	49	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13503	13510		10.1074/jbc.274.19.13503	http://dx.doi.org/10.1074/jbc.274.19.13503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224118	Green Published, hybrid			2022-12-27	WOS:000080200400080
J	Richardson, TP; Trinkaus-Randall, V; Nugent, MA				Richardson, TP; Trinkaus-Randall, V; Nugent, MA			Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; FACTOR RECEPTOR; ENDOTHELIAL-CELLS; CORNEAL SCARS; PROTEOGLYCANS; RELEASE; MYOFIBROBLASTS; MITOGENESIS; DEGRADATION; MECHANISM	The role of cell density in modulating basic fibroblast growth factor binding and activity was investigated. A primary corneal stromal fibroblast cell culture system was used, since these cells do not constitutively express heparan sulfate proteoglycans in vivo except after injury. A 3-5-fold reduction in bFGF binding per cell was observed as cell density increased from 1000 to 35,000 cells/cm(2). The cell density-dependent change in bFGF binding was not the result of altered FGFR expression as determined by equilibrium binding experiments and by immunoblot analysis. However, bFGF-cell surface receptor binding affinities were measured to be 10-20-fold higher at low cell densities than at intermediate and high cell density. bFGF-induced cell proliferation was also cell density-dependent, with maximal stimulation of proliferation 190-280% greater at intermediate densities (15,000 cells/cm(2)) than at other cell densities. This effect was specific to bFGF as serum, epidermal growth factor, and transforming growth factor-beta did not exhibit the same density-dependent profile. Further, heparan sulfate proteoglycans and, specifically, syndecan-4 were implicated as the modulator of bFGF binding and activity. Pretreatment of cell cultures with heparinase resulted in reduced bFGF binding to the cells and abrogated bFGF induced proliferation. These data suggest a mechanism by which cell density regulates heparan sulfate proteoglycan expression and modulates the cellular response to bFGF. Modulation of heparan sulfate proteoglycan expression might be an important aspect of the regulation of stromal cell migration and proliferation during wound healing.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University; Boston University	Nugent, MA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.			Trinkaus-Randall, Vickery/0000-0002-8573-9108; Nugent, Matthew/0000-0002-8630-4712	NEI NIH HHS [EY110004] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; BROWN CT, 1995, J CELL BIOCHEM, V59, P57, DOI 10.1002/jcb.240590108; Brown CT, 1999, J BIOL CHEM, V274, P7111, DOI 10.1074/jbc.274.11.7111; CINTRON C, 1990, INVEST OPHTH VIS SCI, V31, P1975; CIZMECISMITH G, 1993, J BIOL CHEM, V268, P18740; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; FLAUMENHAFT R, 1992, MOL BIOL CELL, V3, P1057, DOI 10.1091/mbc.3.10.1057; Forsten KE, 1997, J CELL PHYSIOL, V172, P209, DOI 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S; Guillonneau X, 1998, MOL BIOL CELL, V9, P2785, DOI 10.1091/mbc.9.10.2785; HANNEKEN A, 1995, INVEST OPHTH VIS SCI, V36, P1192; HANNEKEN A, 1995, J CELL BIOL, V128, P1221, DOI 10.1083/jcb.128.6.1221; HASSELL JR, 1983, ARCH BIOCHEM BIOPHYS, V222, P362, DOI 10.1016/0003-9861(83)90532-5; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MCKEEHAN WL, 1994, MOL REPROD DEV, V39, P69, DOI 10.1002/mrd.1080390112; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; RAO RC, 1992, J OCUL PHARMACOL, V8, P77, DOI 10.1089/jop.1992.8.77; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rich CB, 1996, J BIOL CHEM, V271, P23043, DOI 10.1074/jbc.271.38.23043; Safaiyan F, 1998, EUR J BIOCHEM, V252, P576, DOI 10.1046/j.1432-1327.1998.2520576.x; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SCHMIDT A, 1990, EUR J CELL BIOL, V52, P229; SkaletzRorowski A, 1996, ARTERIOSCL THROM VAS, V16, P1063, DOI 10.1161/01.ATV.16.8.1063; Spanakis SG, 1998, INVEST OPHTH VIS SCI, V39, P1320; TRINKAUSRANDALL V, 1990, INVEST OPHTH VIS SCI, V31, P1321; TRIPATHI RC, 1992, EXP EYE RES, V54, P447, DOI 10.1016/0014-4835(92)90056-X; TURNBULL JE, 1993, BIOCHEM SOC T, V21, P477, DOI 10.1042/bst0210477; WATSKY MA, 1995, INVEST OPHTH VIS SCI, V36, P2568; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	40	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13534	13540		10.1074/jbc.274.19.13534	http://dx.doi.org/10.1074/jbc.274.19.13534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224122	hybrid			2022-12-27	WOS:000080200400084
J	Howard, OMZ; Shirakawa, AK; Turpin, JA; Maynard, A; Tobin, GJ; Carrington, M; Oppenheim, JJ; Dean, M				Howard, OMZ; Shirakawa, AK; Turpin, JA; Maynard, A; Tobin, GJ; Carrington, M; Oppenheim, JJ; Dean, M			Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE-RECEPTOR; ENVELOPE GLYCOPROTEINS; DISEASE PROGRESSION; ENTRY; INFECTION; CORECEPTOR; ASSOCIATION; INHIBITION; MACROPHAGE	Analysis of CCR5 variants in human immunodeficiency virus, type 1 (HIV-1), high risk cohorts led to the identification of multiple single amino acid substitutions in the amino-terminal third of the HIV-1 co-receptor CCR5 suggesting the possibility of protective and permissive genotypes; unfortunately, the low frequency of these mutations did not led to correlation with function. Therefore, we used analytical methods to assess the functional and structural significance of six of these variant receptors in vitro. These studies showed three categories of effects on CCR5 function. 1) Mutations in the first extracellular domain of CCR5 severely reduce specific ligand binding and chemokine-induced chemotaxis. 2) An extracellular domain variant, A29S, when co-expressed with CD4, supported HIV-1 infection whereas the others do not. 3) The transmembrane region variants of CCR5 support monotropic HIV-1 infection that is blocked by addition of some receptor agonists, Mutations in the first and second transmembrane domains increase RANTES (regulated on activation normal T-cell expressed) binding affinity but did not affect MIP1 beta binding affinity presumably based on differences in ligand-receptor interaction sites. Furthermore, the CCR5 transmembrane mutants do not respond to RANTES with the classical bell-shaped chemotactic response curve, suggesting that they are resistant to RANTES-induced desensitization. These data demonstrate that single amino acid changes in the extracellular domains of CCR5 can have profound effects on both HIV-1 coreceptor and specific ligand-induced functions, whereas mutations in the transmembrane domain only affect the response to chemokine ligands.	NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NCI, Mol Immunoregulat Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Div Basic Sci, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; SW Res Inst, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Howard, OMZ (corresponding author), POB B, Frederick, MD 21702 USA.		Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Howard, O M Zack/B-6117-2012	Dean, Michael C/0000-0003-2234-0631; Howard, O M Zack/0000-0002-0505-7052	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009369, Z01BC005652] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Alkhatib G, 1997, J BIOL CHEM, V272, P20420, DOI 10.1074/jbc.272.33.20420; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Bazan HA, 1998, J VIROL, V72, P4485, DOI 10.1128/JVI.72.5.4485-4491.1998; Bieniasz Paul D., 1998, Frontiers in Bioscience, V3, pD44; Bjorndal A, 1997, J VIROL, V71, P7478; Bohm SK, 1997, BIOCHEM J, V322, P1; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Elsner J, 1997, EUR J IMMUNOL, V27, P2892, DOI 10.1002/eji.1830271122; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Garred P, 1998, J RHEUMATOL, V25, P1462; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Grimm MC, 1998, J EXP MED, V188, P317, DOI 10.1084/jem.188.2.317; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Hill CM, 1998, VIROLOGY, V248, P357, DOI 10.1006/viro.1998.9283; Horuk R, 1998, J BIOL CHEM, V273, P386, DOI 10.1074/jbc.273.1.386; Howard OMZ, 1998, J MED CHEM, V41, P2184, DOI 10.1021/jm9801253; Howard OMZ, 1998, J LEUKOCYTE BIOL, V64, P6, DOI 10.1002/jlb.64.1.6; HOWARD OMZ, 1995, BIOCHEM J, V306, P217, DOI 10.1042/bj3060217; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; Kuhmann SE, 1997, J VIROL, V71, P8642, DOI 10.1128/JVI.71.11.8642-8656.1997; LEONARD EJ, 1995, CURRENT PROTOCOLS IM, V13; LUI R, 1996, CELL, V86, P367; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Shieh JTC, 1998, J VIROL, V72, P4243, DOI 10.1128/JVI.72.5.4243-4249.1998; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sozzani S, 1997, J LEUKOCYTE BIOL, V62, P30, DOI 10.1002/jlb.62.1.30; Tournamille C, 1997, J BIOL CHEM, V272, P16274, DOI 10.1074/jbc.272.26.16274; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou YH, 1998, J IMMUNOL, V160, P4018	47	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16228	16234		10.1074/jbc.274.23.16228	http://dx.doi.org/10.1074/jbc.274.23.16228			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347178	hybrid			2022-12-27	WOS:000080668600038
J	Riethmuller, C; Gorren, ACF; Pitters, E; Hemmens, B; Habisch, HJ; Heales, SJR; Schmidt, K; Werner, ER; Mayer, B				Riethmuller, C; Gorren, ACF; Pitters, E; Hemmens, B; Habisch, HJ; Heales, SJR; Schmidt, K; Werner, ER; Mayer, B			Activation of neuronal nitric-oxide synthase by the 5-methyl analog of tetrahydrobiopterin - Functional, evidence against reductive oxygen activation by the pterin cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARGININE; SUBUNIT DIMERIZATION; ELECTRON-TRANSFER; INSECT CELLS; BINDING; HEME; ENZYME; DIMER; SUBSTRATE; INTERMEDIATE	Tetrahydrobiopterin ((6R) -5,6,7,8-tetrahydro-L-biopterin (H(4)biopterin)) is an essential cofactor of nitric-oxide synthases (NOSs), but its role in enzyme function is not known. Binding of the pterin affects the electronic structure of the prosthetic heme group in the oxygenase domain and results in a pronounced stabilization of the active homodimeric structure of the protein. However, these allosteric effects are also produced by the potent pterin antagonist of NOS, 4-amino-H(4)biopterin, suggesting that the natural cofactor has an additional, as yet unknown catalytic function. Here we show that the 5-methyl analog of H(4)biopterin, which does not react with O(2), is a functionally active pterin cofactor of neuronal NOS. Activation of the H(4)biopterin-free enzyme occurred in a biphasic manner with half-maximally effective concentrations of approximately 0.2 mu M and 10 mM 5-methyl-H(4)biopterin. Thus, the affinity of the 5-methyl compound was 3 orders of magnitude lower than that of the natural cofactor, allowing the direct demonstration of the functional anticooperativity of the two pterin binding sites of dimeric NOS. In contrast to H(4)biopterin, which inactivates nitric oxide (NO) through nonenzymatic superoxide formation, up to 1 mM of the 5-methyl derivative did not consume O(2) and had no effect on NO steady-state concentrations measured electrochemically with a Clark-type NO electrode. Therefore, reconstitution with 5-methyl-H(4)biopterin allowed, for the first time, the detection of enzymatic NO formation in the absence of superoxide or NO scavengers. These results unequivocally identify free NO as a NOS product and indicate that reductive O(2) activation by the pterin cofactor is not essential to NO biosynthesis.	Graz Univ, Inst Pharmakol & Toxikol, A-8010 Graz, Austria; UCL Natl Hosp Neurol & Neurosurg, Dept Clin Biochem, London WC1N 3BG, England; Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria	University of Graz; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Innsbruck	Mayer, B (corresponding author), Graz Univ, Inst Pharmakol & Toxikol, Univ Pl 2, A-8010 Graz, Austria.	mayer@kfunigraz.ac.at	Mayer, Bernd/B-9391-2008	Habisch, Hansjorg/0000-0001-5537-506X; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Werner, Ernst R./0000-0003-1948-3391; Mayer, Bernd/0000-0002-2921-3494				BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; Gorren ACF, 1996, BIOCHEMISTRY-US, V35, P16735, DOI 10.1021/bi961931j; HARTENECK C, 1994, BIOCHEM J, V304, P683, DOI 10.1042/bj3040683; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; HEVEL JM, 1992, BIOCHEMISTRY-US, V31, P7160, DOI 10.1021/bi00146a019; HYLAND K, 1985, J CHROMATOGR, V343, P35, DOI 10.1016/S0378-4347(00)84565-X; KLATT P, 1994, J BIOL CHEM, V269, P13861; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; KLATT P, 1993, J BIOL CHEM, V268, P14781; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; KUKOVETZ WR, 1989, J CARDIOVASC PHARM, V14, pS40, DOI 10.1097/00005344-198914110-00008; List BM, 1996, BIOCHEM J, V315, P57, DOI 10.1042/bj3150057; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MAYER B, 1995, N-S ARCH PHARMACOL, V351, P453; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; MAYER B, 1994, NEUROPHARMACOLOGY, V33, P1253, DOI 10.1016/0028-3908(94)90024-8; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Mayer B, 1997, BIOCHEMISTRY-US, V36, P8422, DOI 10.1021/bi970144z; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; Perry JM, 1998, P NATL ACAD SCI USA, V95, P11101, DOI 10.1073/pnas.95.19.11101; Pfeiffer S, 1997, BIOCHEM J, V328, P349, DOI 10.1042/bj3280349; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; WERNER ER, 1994, BIOCHEM J, V304, P189, DOI 10.1042/bj3040189; Werner ER, 1996, BIOCHEM J, V320, P193, DOI 10.1042/bj3200193; Xia Y, 1997, P NATL ACAD SCI USA, V94, P12705, DOI 10.1073/pnas.94.23.12705	39	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16047	16051		10.1074/jbc.274.23.16047	http://dx.doi.org/10.1074/jbc.274.23.16047			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347155	hybrid			2022-12-27	WOS:000080668600015
J	Diderich, JA; Schepper, M; van Hoek, P; Luttik, MAH; van Dijken, JP; Pronk, JT; Klaassen, P; Boelens, HFM; de Mattos, RJT; van Dam, K; Kruckeberg, AL				Diderich, JA; Schepper, M; van Hoek, P; Luttik, MAH; van Dijken, JP; Pronk, JT; Klaassen, P; Boelens, HFM; de Mattos, RJT; van Dam, K; Kruckeberg, AL			Glucose uptake kinetics and transcription of HXT genes chemostat cultures of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDIVIDUAL HEXOSE TRANSPORTERS; ESCHERICHIA-COLI; PHYSIOLOGICAL CHARACTERIZATION; SUGAR-TRANSPORT; YEAST; EXPRESSION; AFFINITY; REPRESSION; PROTEIN; GROWTH	The kinetics of glucose transport and the transcription of all 20 members of the HXT hexose transporter gene family were studied in relation to the steady state in situ carbon metabolism of Saccharomyces cerevisiae CEN.PK113-7D grown in chemostat cultures. Cells were cultivated at a dilution rate of 0.10 h(-1) under various nutrient-limited conditions (anaerobically glucose- or nitrogen-limited or aerobically glucose-, galactose-, fructose-, ethanol-, or nitrogen-limited), or at dilution rates ranging between 0.05 and 0.38 h(-1) in aerobic glucose-limited cultures. Transcription of HXT1-HXT7 was correlated with the extracellular glucose concentration in the cultures. Transcription of GAL2, encoding the galactose transporter, was only detected in galactose-limited cultures. SNF3 and RGT2, two members of the HXT family that encode glucose sensors, were transcribed at low levels. HXT8-HXT17 transcripts were detected at very low levels. A consistent relationship was observed between the expression of individual HXT genes and the glucose transport kinetics determined from zero-trans influx of C-14-glucose during 5 s, This relationship was in broad agreement with the transport kinetics of Hxt1-Hxt7 and Gal2 deduced in previous studies on single-HXT strains. At lower dilution rates the glucose transport capacity estimated from zero-trans influx experiments and the residual glucose concentration exceeded the measured in situ glucose consumption rate. At high dilution rates, however, the estimated glucose transport capacity was too low to account for the in situ glucose consumption rate.	Univ Amsterdam, EC Slater Inst, NL-1018 TV Amsterdam, Netherlands; Delft Univ Technol, Kluyver Lab Biotechnol, NL-2628 BC Delft, Netherlands; Gist Brocades BV, NL-2600 MA Delft, Netherlands; Univ Amsterdam, Dept Chem Engn, NL-1018 WV Amsterdam, Netherlands	University of Amsterdam; Delft University of Technology; University of Amsterdam	Kruckeberg, AL (corresponding author), Free Univ Amsterdam, Fac Biol, Dept Mol Cell Physiol, de Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.		Diderich, Jasper/AAH-3373-2019	Luttik, Marijke/0000-0002-9798-8072; Diderich, Jasper/0000-0003-2675-9712; Pronk, Jack/0000-0002-5617-4611				ADAMS J, 1985, GENETICS, V110, P173; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; BISSON LF, 1988, J BACTERIOL, V170, P4838, DOI 10.1128/jb.170.10.4838-4845.1988; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; CELENZA JL, 1988, P NATL ACAD SCI USA, V85, P2130, DOI 10.1073/pnas.85.7.2130; CIRIACY M, 1997, YEAST SUGAR METABOLI, P45; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; HELLING RB, 1987, GENETICS, V116, P349; HUIBREGTSE JM, 1993, J BIOL CHEM, V268, P22219; KOU SC, 1970, J BACTERIOL, V103, P671, DOI 10.1128/JB.103.3.671-678.1970; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; LAGUNAS R, 1993, FEMS MICROBIOL LETT, V104, P229, DOI 10.1016/0378-1097(93)90598-V; LEWIS DA, 1991, MOL CELL BIOL, V11, P3804, DOI 10.1128/MCB.11.7.3804; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1982, MOL CLONING LABORATO, P199; Mathias LJ, 1997, TRENDS POLYM SCI, V5, P2; MEIJER M, 1998, THESIS U UTRECHT; Meijer MMC, 1996, BBA-BIOENERGETICS, V1277, P209, DOI 10.1016/S0005-2728(96)00098-9; NEIGEBORN L, 1986, MOL CELL BIOL, V6, P3569, DOI 10.1128/MCB.6.11.3569; NOORMAN HJ, 1991, J GEN MICROBIOL, V137, P2171, DOI 10.1099/00221287-137-9-2171; Ozcan S, 1996, MOL CELL BIOL, V16, P5536; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; OZCAN S, 1994, EUR J BIOCHEM, V224, P605, DOI 10.1111/j.1432-1033.1994.00605.x; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; PIRT SJ, 1975, PRINCIPLES MICROBE C, P29; POSTMA E, 1989, YEAST, V5, P159, DOI 10.1002/yea.320050305; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHULZE U, 1995, THESIS U TU DENMARK; SEBER GAF, 1989, NONLINEAR REGRESSION, P683; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Smits HP, 1996, YEAST, V12, P439, DOI 10.1002/(SICI)1097-0061(199604)12:5<439::AID-YEA925>3.3.CO;2-N; Teusink B, 1998, J BACTERIOL, V180, P556, DOI 10.1128/JB.180.3.556-562.1998; THEODORIS G, 1994, GENETICS, V137, P957; Travisano M, 1996, GENETICS, V143, P15; TSCHOPP JF, 1986, J BACTERIOL, V166, P313, DOI 10.1128/jb.166.1.313-318.1986; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P2133; VANURK H, 1988, YEAST, V4, P283, DOI 10.1002/yea.320040406; VERDUYN C, 1990, J GEN MICROBIOL, V136, P395, DOI 10.1099/00221287-136-3-395; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; VERDUYN C, 1984, J MICROBIOL METH, V2, P15, DOI 10.1016/0167-7012(84)90027-7; WALSH MC, 1994, J BACTERIOL, V176, P953, DOI 10.1128/JB.176.4.953-958.1994; Weikert C, 1997, MICROBIOL-UK, V143, P1567, DOI 10.1099/00221287-143-5-1567; WENDELL DL, 1993, J BACTERIOL, V175, P7689, DOI 10.1128/JB.175.23.7689-7696.1993; WENZEL TJ, 1995, NUCLEIC ACIDS RES, V23, P883, DOI 10.1093/nar/23.5.883; WEUSTHUIS RA, 1994, MICROBIOL REV, V58, P616, DOI 10.1128/MMBR.58.4.616-630.1994; WEUSTHUIS RA, 1994, MICROBIOL-UK, V140, P1723, DOI 10.1099/13500872-140-7-1723	53	169	173	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15350	15359		10.1074/jbc.274.22.15350	http://dx.doi.org/10.1074/jbc.274.22.15350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336421	hybrid			2022-12-27	WOS:000080560100010
J	Navarre, WW; Ton-That, H; Faull, KF; Schneewind, O				Navarre, WW; Ton-That, H; Faull, KF; Schneewind, O			Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi 11 - Identification of a D-alanyl-glycine endopeptidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; BETA-LYTIC PROTEASE; L-ALANINE AMIDASE; CELL-WALL; SURFACE-PROTEINS; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; ACHROMOBACTER-LYTICUS; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING	Bacteriophage muralytic enzymes degrade the cell wall envelope of staphylococci to release phage particles from the bacterial cytoplasm, Murein hydrolases of staphylococcal phages phi 11, 80 alpha, 187, Twort, and phi PVL harbor a central domain that displays sequence homology to known N-acetylmuramyl-L-alanyl amidases; however, their precise cleavage sites on the staphylococcal peptidoglycan have thus far not been determined, Here we examined the properties of the phi 11 enzyme to hydrolyze either the staphylococcal cell wall or purified cell wall anchor structures attached to surface protein. Our results show that the phi 11 enzyme has D-alanyl-glycyl endopeptidase as well as N-acetylmuramyl-L-alanyl amidase activity. Analysis of a deletion mutant lacking the amidase homologous sequence, phi 11(Delta 181-381), revealed that the D-alanyl-glycyl endopeptidase activity is contained within the N-terminal 180 amino acid residues of the polypeptide chain. Sequences similar to this N-terminal domain are found in the murein hydrolases of staphylococcal phages but not in those of phages that infect other Gram-positive bacteria such as Listeria or Bacillus.	Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schneewind, O (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	olafs@ucla.edu	Ton-That, Hung/AAB-6155-2020	Navarre, William/0000-0002-9293-9220; Ton-That, Hung/0000-0003-1611-0469	NIAID NIH HHS [AI 38897, AI 33985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033985, R01AI038897] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ackermann H. W., 1987, VIRUSES PROKARYOTES, V2; Baba T, 1996, EMBO J, V15, P4789, DOI 10.1002/j.1460-2075.1996.tb00859.x; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Bon J, 1997, CAN J MICROBIOL, V43, P612, DOI 10.1139/m97-087; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; Creighton T. E., 1993, PROTEINS STRUCTURES; DAWSON IM, 1949, NATURE BACTERIAL SUR, P119; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DIAZ E, 1992, J BACTERIOL, V174, P5516; DIAZ E, 1991, J BIOL CHEM, V266, P5464; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; GARCIA JL, 1994, J BACTERIOL, V176, P4066, DOI 10.1128/JB.176.13.4066-4072.1994; GHUYSEN J. M., 1965, BIOCHEMISTRY, V4, P2245, DOI 10.1021/bi00886a043; GHUYSEN J. M., 1965, BIOCHEMISTRY, V4, P2237, DOI 10.1021/bi00886a042; Ghuysen J-M., 1966, METHOD ENZYMOL, P685, DOI DOI 10.1016/0076-6879(66)08124-2; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1110, DOI 10.1021/bi00905a035; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1119, DOI 10.1021/bi00905a036; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; GHUYSEN JM, 1994, BACTERIA CELL ALL; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gupta S K, 1995, J Comput Biol, V2, P459, DOI 10.1089/cmb.1995.2.459; HIGASHI Y, 1970, J BIOL CHEM, V245, P3683; HIGASHI Y, 1970, J BIOL CHEM, V245, P3697; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; HOLTJE JV, 1975, J BIOL CHEM, V250, P6072; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332, DOI 10.1093/oxfordjournals.jbchem.a022116; Li SL, 1997, J BIOCHEM-TOKYO, V122, P772; LI SL, 1990, J BACTERIOL, V172, P6506, DOI 10.1128/jb.172.11.6506-6511.1990; Loessner MJ, 1997, J BACTERIOL, V179, P2845, DOI 10.1128/jb.179.9.2845-2851.1997; Loessner MJ, 1998, FEMS MICROBIOL LETT, V162, P265, DOI 10.1016/S0378-1097(98)00131-1; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; MUNOZ E, 1966, BIOCHEMISTRY-US, V5, P3748, DOI 10.1021/bi00876a004; NAKAGAWA J, 1984, J BIOL CHEM, V259, P3937; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; PETIT JF, 1966, BIOCHEMISTRY-US, V5, P2764, DOI 10.1021/bi00872a037; Quintela JC, 1999, J BACTERIOL, V181, P334, DOI 10.1128/JB.181.1.334-337.1999; QUINTELA JC, 1995, J BACTERIOL, V177, P4947, DOI 10.1128/jb.177.17.4947-4962.1995; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; ROMERO A, 1990, J BACTERIOL, V172, P5064, DOI 10.1128/jb.172.9.5064-5070.1990; SANCHEZPUELLES JM, 1990, GENE, V89, P69, DOI 10.1016/0378-1119(90)90207-8; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Shockman GD., 1994, BACTERIAL CELL WALL, P131, DOI 10.1016/S0167-7306(08)60410-X; SLOAN GL, 1977, BIOCHEM J, V167, P293, DOI 10.1042/bj1670293; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; TIPPER DJ, 1969, BIOCHEMISTRY-US, V8, P2183, DOI 10.1021/bi00833a060; TIPPER DJ, 1967, BIOCHEMISTRY-US, V6, P906, DOI 10.1021/bi00855a035; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TIPPER DJ, 1965, BIOCHEMISTRY-US, V4, P468, DOI 10.1021/bi00879a015; TIPPER DJ, 1969, J BACTERIOL, V97, P837, DOI 10.1128/JB.97.2.837-847.1969; TIPPER DJ, 1969, BIOCHEMISTRY-US, V8, P2192, DOI 10.1021/bi00833a061; TIPPER DJ, 1968, J BIOL CHEM, V243, P3169; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; WANG X, 1991, GENE, V102, P105; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	66	137	158	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15847	15856		10.1074/jbc.274.22.15847	http://dx.doi.org/10.1074/jbc.274.22.15847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336488	hybrid			2022-12-27	WOS:000080560100077
J	Shinde, U; Fu, X; Inouye, M				Shinde, U; Fu, X; Inouye, M			A pathway for conformational diversity in proteins mediated by intramolecular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN BPN'; PRO-SEQUENCE; ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; PROPEPTIDE; PEPTIDE; REQUIREMENT; SPECIFICITY; MECHANISM; CATALYSIS	Conformational diversity within unique amino acid sequences is observed in diseases like scrapie and Alzheimer's disease. The molecular basis of such diversity is unknown. Similar phenomena occur in subtilisin, a serine protease homologous with eukaryotic pro-hormone convertases, The subtilisin propeptide functions as an intramolecular chaperone (IMC) that imparts steric information during folding but is not required for enzymatic activity. Point mutations within IMCs alter folding, resulting in structural conformers that specifically interact with their cognate IMCs in a process termed "protein memory." Here, we show a mechanism that mediates conformational diversity in subtilisin. During maturation, while the IMC is autocleaved and subsequently degraded by the active site of subtilisin, enzymatic properties of this site differ significantly before and after cleavage. Although subtilisin folded by Ile(-48) --> Thr IMC (IMCI-48T) acquires an "altered" enzymatically active conformation (SUb(I-48T)) significantly different from wild-type subtilisin (Sub(WT)), both precursors undergo autocleavage at similar rates. IMC cleavage initiates conformational changes during which the IMC continues its chaperoning function subsequent to its cleavage from subtilisin. Structural imprinting resulting in conformational diversity originates during this reorganization stage and is a late folding event catalyzed by autocleavage of the IMC.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.	inouye@rwja.umdnj.edu						ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BRYAN P, 1992, BIOCHEMISTRY-US, V31, P4937, DOI 10.1021/bi00136a003; CHANG SC, 1994, J BIOL CHEM, V269, P3548; CLARK JL, 1969, P NATL ACAD SCI USA, V62, P278, DOI 10.1073/pnas.62.1.278; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; EDER J, 1995, INTRAMOLECULAR CHAPE, P35; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; KOBAYASHI T, 1992, J MOL BIOL, V226, P931, DOI 10.1016/0022-2836(92)91042-N; LI YY, 1994, J BIOL CHEM, V269, P4169; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MAHONEY WC, 1980, J BIOL CHEM, V255, P1199; Miranker AD, 1996, CURR OPIN STRUC BIOL, V6, P31, DOI 10.1016/S0959-440X(96)80092-3; OLAITAN SA, 1968, J BIOL CHEM, V243, P5296; PHILIPP M, 1983, MOL CELL BIOCHEM, V51, P5, DOI 10.1007/BF00215583; PHILO JS, 1993, BIOCHEMISTRY-US, V32, P10812, DOI 10.1021/bi00091a036; POLGAR L, 1967, BIOCHEMISTRY-US, V6, P610, DOI 10.1021/bi00854a032; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; RUSSELL AJ, 1987, NATURE, V328, P496, DOI 10.1038/328496a0; RUSSELL AJ, 1987, J MOL BIOL, V193, P803, DOI 10.1016/0022-2836(87)90360-3; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; SHINDE U, 1995, J MOL BIOL, V252, P25, DOI 10.1006/jmbi.1995.0472; SHINDE U, 1995, J MOL BIOL, V247, P390, DOI 10.1006/jmbi.1994.0147; SHINDE U, 1997, MOL CHAPERONES PROTE, P467; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SMITH SM, 1989, J BIOL CHEM, V264, P20487; SOHL JL, 1995, INTRAMOLECULAR CHAPE, P61; SORENSEN P, 1993, BIOCHEMISTRY-US, V32, P12160; SUTER U, 1992, J NEUROSCI, V12, P306; VANDENHAZEL HB, 1995, J BIOL CHEM, V270, P8602, DOI 10.1074/jbc.270.15.8602; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; Weiner M, 1995, MOL BIOL CURRENT INN; WELLS JA, 1988, TRENDS BIOCHEM SCI, V13, P291, DOI 10.1016/0968-0004(88)90121-1; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; ZHU X, 1992, BIOCH LIFE SCI ADV, V11, P35; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	48	66	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15615	15621		10.1074/jbc.274.22.15615	http://dx.doi.org/10.1074/jbc.274.22.15615			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336458	hybrid			2022-12-27	WOS:000080560100047
J	Yu, R; Hinkle, PM				Yu, R; Hinkle, PM			Signal transduction and hormone-dependent internalization of the thyrotropin-releasing hormone receptor in cells lacking G(q) and G(11)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C INHIBITOR; BETA-ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; ARRESTIN/CLATHRIN INTERACTION; BETA(2)-ADRENERGIC RECEPTOR; STIMULATED INTERNALIZATION; NUCLEOTIDE-BINDING; CARBOXYL-TERMINUS; XENOPUS OOCYTES; ARRESTIN	The thyrotropin-releasing hormone (TRH) receptor was expressed in embryonic fibroblasts from mice lacking the a subunits of G(q) and G(11) (Fq/11 cells) to determine whether G protein coupling is necessary for agonist-dependent receptor internalization. Neither TRH nor agonists acting on endogenous receptors increased intracellular calcium unless the cells were co-transfected with the alpha subunit of G(q). In contrast, temperature-dependent internalization of [H-3]MeTRH in Fq/11 cells was the same whether G(q)alpha was expressed or not. A rhodamine-labeled TRH analog and fluorescein-labeled transferrin co-localized in endocytic vesicles in Fq/11 cells, indicating that endocytosis took place via the normal clathrin pathway. Cotransfection with beta-arrestin or V53D beta-arrestin increased TRH-dependent receptor sequestration. Fq/11 cells were co-transfected with the TRH receptor and a green fluorescent protein (GFP)-beta-arrestin conjugate. GFP-beta-arrestin was uniformly distributed in the cytoplasm of untreated cells and quickly translocated to the periphery of the cells when TRH was added. A truncated TRH receptor that lacks potential phosphorylation sites in the cytoplasmic carboxyl terminus signaled but did not internalize or cause membrane localization of GFP-beta-arrestin. These results prove that calcium signaling by the TRH receptor requires coupling to a G protein in the G(q) family, but TRH-dependent binding of beta-arrestin and sequestration do not.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Ctr Canc, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER; NCI NIH HHS [CA 11098] Funding Source: Medline; NIDDK NIH HHS [DK19974] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHWORTH R, 1995, P NATL ACAD SCI USA, V92, P512, DOI 10.1073/pnas.92.2.512; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BENYA RV, 1994, MOL PHARMACOL, V46, P495; Bhowmick N, 1998, ENDOCRINOLOGY, V139, P3185, DOI 10.1210/en.139.7.3185; Bohm SK, 1997, BIOCHEM J, V322, P1; CLARK RB, 1985, J CYCLIC NUCL PROT, V10, P97; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DELAPENA P, 1995, J BIOL CHEM, V270, P3554, DOI 10.1074/jbc.270.8.3554; Drmota T, 1998, J BIOL CHEM, V273, P24000, DOI 10.1074/jbc.273.37.24000; Drmota T, 1998, J BIOL CHEM, V273, P21699, DOI 10.1074/jbc.273.34.21699; FALCKPEDERSEN E, 1994, MOL PHARMACOL, V45, P684; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; GOLLASCH M, 1993, P NATL ACAD SCI USA, V90, P6265, DOI 10.1073/pnas.90.13.6265; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hildebrandt JP, 1997, BRIT J PHARMACOL, V120, P841, DOI 10.1038/sj.bjp.0700991; HINKLE PM, 1989, MOL ENDOCRINOL, V3, P1337, DOI 10.1210/mend-3-9-1337; Hipkin RW, 1997, J BIOL CHEM, V272, P13869, DOI 10.1074/jbc.272.21.13869; Jan CR, 1998, LIFE SCI, V63, P895, DOI 10.1016/S0024-3205(98)00346-4; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; LI PZ, 1992, MOL ENDOCRINOL, V6, P1393, DOI 10.1210/me.6.9.1393; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P129, DOI 10.1073/pnas.82.1.129; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Muto Y, 1997, J PHARMACOL EXP THER, V282, P1379; NELSON EJ, 1994, ENDOCRINOLOGY, V135, P1084, DOI 10.1210/en.135.3.1084; NUSSENZVEIG DR, 1993, MOL ENDOCRINOL, V7, P1105, DOI 10.1210/me.7.9.1105; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Petrou C, 1997, J BIOL CHEM, V272, P2326; QUICK MW, 1994, J BIOL CHEM, V269, P30164; Roettger BF, 1997, MOL PHARMACOL, V51, P357; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Yu R, 1997, J BIOL CHEM, V272, P28301, DOI 10.1074/jbc.272.45.28301; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785	40	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15745	15750		10.1074/jbc.274.22.15745	http://dx.doi.org/10.1074/jbc.274.22.15745			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336475	hybrid			2022-12-27	WOS:000080560100064
J	Bae, SH; Lee, JN; Fitzky, BU; Seong, JY; Paik, YK				Bae, SH; Lee, JN; Fitzky, BU; Seong, JY; Paik, YK			Cholesterol biosynthesis from lanosterol - Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; SONIC-HEDGEHOG; STEROL DELTA(7)-REDUCTASE; DELTA-7-STEROL REDUCTASE; SACCHAROMYCES-CEREVISIAE; MICROSOMAL-ENZYMES; ASSAY-METHOD; KINASE-C; GENE; PURIFICATION	The cDNA encoding the 471-amino acid rat 7-dehydrocholesterol reductase (DHCR), an enzyme that has been implicated in both cholesterol biosynthesis and developmental abnormalities (e.g. Smith-Lemli-Opitz syndrome) in mammals, has been cloned and sequenced, and the primary structure of the enzyme has been deduced. The DHCR gene was mapped to chromosome 8q2.1 by fluorescence in situ hybridization, Rat DHCR, calculated molecular mass of 54.15-kDa polypeptide, shares a close amino acid identity with mouse and human DHCRs (96 and 87%, respectively) as compared with its other related proteins (e.g. fungal sterol Delta(14)-reductase) and exhibits high hydrophobicity (>68%) with 9 transmembrane domains. Five putative sterol-sensing domains were predicted to be localized in transmembrane domains 4-8, which are highly homologous to those found in 3-hydroxymethylglutaryl-CoA reductase, sterol regulatory element-binding protein cleavage-activating protein, and patched protein. The polypeptide encoded by DHCR cDNA was expressed in yeast as a 55.45-kDa myc-tagged fusion protein, which was recognized with anti-myc monoclonal antibody 9E10 and shown to possess full DHCR activity with respect to dependence on NADPH and sensitivity to DHCR inhibitors. Northern blot analysis indicates that the highest expression of DHCR mRNA was detected in liver, followed by kidney and brain. In rat brains, the highest level of mRNA encoding DHCR was detected in the midbrain, followed by the spinal cord and medulla, Feeding fats 5% cholestyramine plus 0.1% lovastatin in chow resulted in both approximately a 3-fold induction of DHCR mRNA and a 5-fold increase of the enzymic activity in the liver. When rats were fed 0.1% (w/w) AY-9944 (in chow) for 14-days, a complete inhibition of DHCR activity and a significant reduction in serum total cholesterol level mere observed. However, the level of hepatic DHCR mRNA fell only slightly, suggesting that AY-9944 may act more rapidly at the protein level than at the level of transcription of the DHCR gene under these conditions.	Yonsei Univ, Med Res Ctr, Dept Biochem, Sudaemoon Ku, Seoul 120749, South Korea; Inst Biochem Pharmakol, A-6020 Innsbruck, Austria; Dept Biochem, A-6020 Innsbruck, Austria; Bioprod Res Ctr, A-6020 Innsbruck, Austria	Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Med Res Ctr, Dept Biochem, Sudaemoon Ku, 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@bubble.yonsei.ac.kr	Bae, Sung-Ho/AAK-7350-2020	Seong, Je Kyung/0000-0003-1177-6958				ALLEY TL, 1995, AM J HUM GENET, V56, P1411; Anderson AJ, 1998, AM J MED GENET, V78, P413, DOI 10.1002/(SICI)1096-8628(19980806)78:5<413::AID-AJMG4>3.0.CO;2-M; Bae SH, 1997, BIOCHEM J, V326, P609, DOI 10.1042/bj3260609; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chambers CM, 1997, AM J MED GENET, V68, P322, DOI 10.1002/(SICI)1096-8628(19970131)68:3<322::AID-AJMG14>3.0.CO;2-V; CHEN WN, 1991, YEAST, V7, P305, DOI 10.1002/yea.320070313; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cho SY, 1998, MOL CELLS, V8, P233; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DVORNIK D, 1968, J LIPID RES, V9, P587; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GAYLOR JL, 1981, BIOCH ISOPRENOIDS, V1, P482; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; GRAND RJA, 1989, BIOCHEM J, V258, P625, DOI 10.1042/bj2580625; Honda A, 1998, J LIPID RES, V39, P44; HUNTER T, 1982, J BIOL CHEM, V257, P4843; IRONS M, 1994, AM J MED GENET, V50, P347, DOI 10.1002/ajmg.1320500409; KANG MK, 1995, J BIOCHEM-TOKYO, V117, P819, DOI 10.1093/oxfordjournals.jbchem.a124781; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; KIM CK, 1995, BBA-LIPID LIPID MET, V1259, P39, DOI 10.1016/0005-2760(95)00128-Y; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; Kolf-Clauw M, 1998, J LAB CLIN MED, V131, P222, DOI 10.1016/S0022-2143(98)90093-2; KolfClauw M, 1997, TERATOLOGY, V56, P188, DOI 10.1002/(SICI)1096-9926(199709)56:3<188::AID-TERA2>3.0.CO;2-Y; KolfClauw M, 1996, TERATOLOGY, V54, P115, DOI 10.1002/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI MH, 1994, GENE, V140, P41; Lanoue L, 1997, AM J MED GENET, V73, P24; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; Lee EY, 1999, BIOCHEM PHARMACOL, V57, P579, DOI 10.1016/S0006-2952(98)00321-9; Lee JN, 1997, J BIOCHEM MOL BIOL, V30, P370; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; MACKNESS MI, 1992, LIPOPROTEIN ANAL PRA, P1; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; PAIK YK, 1986, J BIOL CHEM, V261, P6470; PAIK YK, 1984, J BIOL CHEM, V259, P3413; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROUX C, 1980, J NUTR, V110, P2310, DOI 10.1093/jn/110.11.2310; SAMBROOK J, 1989, MOL CLONING LAB MANA; Shefer S, 1997, METABOLISM, V46, P844, DOI 10.1016/S0026-0495(97)90133-5; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; TINT GS, 1995, J LIPID RES, V36, P89; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; Xu GR, 1998, METABOLISM, V47, P878, DOI 10.1016/S0026-0495(98)90130-5	60	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14624	14631		10.1074/jbc.274.21.14624	http://dx.doi.org/10.1074/jbc.274.21.14624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329655	hybrid			2022-12-27	WOS:000081965200020
J	Leng, XH; Nishi, T; Forgac, M				Leng, XH; Nishi, T; Forgac, M			Transmembrane topography of the 100-kDa a subunit (Vph1p) of the yeast vacuolar proton translocating ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLE (H+)-ATPASE; SITE-DIRECTED MUTAGENESIS; H+-ATPASE; ESCHERICHIA-COLI; ALPHA-SUBUNIT; SACCHAROMYCES-CEREVISIAE; STRUCTURAL-CHANGES; MEMBRANE TOPOLOGY; CDNA SEQUENCE; GENE ENCODES	The membrane topography of the yeast vacuolar proton-translocating ATPase a subunit (Vph1p) has been investigated using cysteine scanning mutagenesis. A Cys-less form of Vph1p lacking the seven endogenous cysteines was constructed and shown to have 80% of wild type activity. Single cysteine residues were introduced at 13 sites within the Cys-less mutant, with 12 mutants showing greater than 70% of wild type activity. To evaluate their disposition with respect to the membrane, vacuoles were treated in the presence or absence of the impermeant sulfhydryl reagent 4-acetamido-4'-maleimidylstilbene-2,2'-disulfonic acid (AMS) followed by the membrane permeable sulfhydryl reagent 3-(N-maleimidylpropionyl) biocytin (MPB). Three of the 12 active cysteine mutants were not labeled by MPB. The mutants E3C, D89C, T161C, S266C, N447C, K450C, and S703C were labeled by MPB in an AMS-protectable manner, suggesting a cytoplasmic orientation, whereas G602C and S840C showed minimal protection by AMS, suggesting a lumenal orientation. Factor Xa cleavage sites were introduced at His-499, Leu-560, and Pro-606. Cleavage at 560 was observed in the absence of detergent, suggesting a cytoplasmic orientation for this site. Based on these results, we propose a model of the a subunit containing nine transmembrane segments, with the amino terminus facing the cytoplasm and the carboxyl terminus facing the lumen.	Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, 136 Harrison Ave, Boston, MA 02111 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM34478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P960; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1988, J BIOL CHEM, V263, P8796; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CAIN BD, 1986, J BIOL CHEM, V261, P43; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Capaldi RA, 1996, J BIOENERG BIOMEMBR, V28, P397, DOI 10.1007/BF02113980; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 1997, J EXP BIOL, V200, P217; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P341, DOI 10.1007/BF00762527; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P13; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PERIN MS, 1991, J BIOL CHEM, V266, P3877; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; VIK SB, 1994, J BIOL CHEM, V269, P30364; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	49	87	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14655	14661		10.1074/jbc.274.21.14655	http://dx.doi.org/10.1074/jbc.274.21.14655			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329659	hybrid			2022-12-27	WOS:000081965200024
J	Mizzen, CA; Dou, YL; Liu, YG; Cook, RG; Gorovsky, MA; Allis, CD				Mizzen, CA; Dou, YL; Liu, YG; Cook, RG; Gorovsky, MA; Allis, CD			Identification and mutation of phosphorylation sites in a linker histone - Phosphorylation of macronuclear H1 is not essential for viability in tetrahymena	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; TRANSCRIPTION IN-VIVO; RNA POLYMERASE-II; AMITOTIC MACRONUCLEUS; CHROMATIN STRUCTURE; SEQUENCE; GENE; CONDENSATION; ACETYLATION; PYRIFORMIS	Linker histone phosphorylation has been suggested to play roles in both chromosome condensation and transcriptional regulation, In the ciliated protozoan Tetrahymena, in contrast to many eukaryotes, histone H1 of macronuclei is highly phosphorylated during interphase. Macronuclei divide amitotically without overt chromosome condensation in this organism, suggesting that requirements for phosphorylation of macronuclear H1 may be limited to transcriptional regulation. Here we report the major sites of phosphorylation of macronuclear H1 in Tetrahymena thermophila. Five phosphorylation sites, present in a single cluster, were identified by sequencing P-32-labeled peptides isolated from tryptic peptide maps. Phosphothreonine was detected within two TPVK motifs and one TPTK motif that resemble established p34(cdc2) kinase consensus sequences. Phosphoserine was detected at two non-proline-directed sites that do not resemble known kinase consensus sequences. Phosphorylation at the two noncanonical sites appears to be hierarchical because it was observed only when a nearby p34cdc2 Site was also phosphorylated. Cells expressing macronuclear H1 containing alanine substitutions at all five of these phosphorylation sites were viable even though macronuclear H1 phosphorylation was abolished. These data suggest that the five sites identified comprise the entire collection of sites utilized by Tetrahymena and demonstrate that phosphorylation of macronuclear H1, like the protein itself, is not essential for viability in Tetrahymena.	Univ Virginia, Hlth Sci Ctr, Dept Mol Genet & Biochem, Charlottesville, VA 22908 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA	University of Virginia; University of Rochester; Baylor College of Medicine	Allis, CD (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Mol Genet & Biochem, Box 440, Charlottesville, VA 22908 USA.	allis@virginia.edu			NIGMS NIH HHS [GM40922, GM21793] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021793, R01GM040922] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; Balhorn R, 1975, Methods Enzymol, V40, P138; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; BRADBURY EM, 1992, BIOESSAYS, V14, P9; CALZONE FJ, 1983, J BIOL CHEM, V258, P6899; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GLOVER CVC, 1981, CELL, V23, P73, DOI 10.1016/0092-8674(81)90271-3; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; GOROVSKY MA, 1974, J CELL BIOL, V61, P134, DOI 10.1083/jcb.61.1.134; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HAYASHI T, 1987, J BIOCHEM-TOKYO, V102, P369, DOI 10.1093/oxfordjournals.jbchem.a122063; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; LENNOX RW, 1989, METHOD ENZYMOL, V170, P532; LU MJ, 1994, CHROMOSOMA, V103, P111; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; PAULSON JR, 1980, EUR J BIOCHEM, V111, P189; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; ROTH SY, 1988, J CELL BIOL, V107, P2473, DOI 10.1083/jcb.107.6.2473; ROTH SY, 1991, EMBO J, V10, P2069, DOI 10.1002/j.1460-2075.1991.tb07738.x; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sweet MT, 1997, J BIOL CHEM, V272, P916, DOI 10.1074/jbc.272.2.916; van Holde KE, 1989, CHROMATIN, P69; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302; Wolffe A, 1998, CHROMATIN - STRUCTURE AND FUNCTION, 3RD EDITION, P1, DOI 10.1016/B978-012761914-9/50003-9; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; WU M, 1994, MOL CELL BIOL, V14, P10, DOI 10.1128/MCB.14.1.10; WU M, 1986, P NATL ACAD SCI USA, V83, P8674, DOI 10.1073/pnas.83.22.8674; Zlatanova J, 1996, PROG NUCLEIC ACID RE, V52, P217, DOI 10.1016/S0079-6603(08)60968-X	36	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14533	14536		10.1074/jbc.274.21.14533	http://dx.doi.org/10.1074/jbc.274.21.14533			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329641	hybrid			2022-12-27	WOS:000081965200006
J	Walmsley, AR; Batten, MR; Lad, U; Bulleid, NJ				Walmsley, AR; Batten, MR; Lad, U; Bulleid, NJ			Intracellular retention of procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; CARBOXYL-TERMINAL PROPEPTIDE; MOLECULAR CHAPERONE; III PROCOLLAGEN; OSTEOGENESIS IMPERFECTA; I PROCOLLAGEN; HELICAL PROCOLLAGEN; CIS-HYDROXYPROLINE; QUALITY-CONTROL; CHICK-EMBRYOS	The correct folding and assembly of proteins within the endoplasmic reticulum (ER) are prerequisites for subsequent transport from this organelle to the Gels apparatus. The mechanisms underlying the ability of the cell to recognize and retain unassembled or mal-folded proteins generally require binding to molecular chaperones within the ER. One classic example of this process occurs during the biosynthesis of procollagen. Here partially folded intermediates are retained and prevented from secretion, leading to a build up of unfolded chains within the cell. The accumulation of these partially folded intermediates occurs during vitamin C deficiency due to incomplete proline hydroxylation, as vitamin C is an essential co-factor of the enzyme prolyl 4-hydroxylase. in this report we show that this retention is tightly regulated with little or no secretion occurring under conditions preventing proline hydroxylation. me studied the molecular mechanism underlying retention by determining which proteins associate with partially folded procollagen intermediates within the ER. By using a combination of cross-linking and sucrose gradient analysis, we show that the major protein binding to procollagen during its biosynthesis is prolyl 4-hydroxylase, and no binding to other ER resident proteins including Hsp47 was detected. This binding is regulated by the folding status rather than the extent of hydroxylation of the chains demonstrating that this enzyme can recognize and retain unfolded procollagen chains and can release these chains for further transport once they have folded correctly.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg, Manchester M13 9PT, Lancs, England.			Bulleid, Neil/0000-0002-9839-5279				Allen S, 1997, BIOCHEM J, V328, P113, DOI 10.1042/bj3280113; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; CHEAH KSE, 1979, BIOCHEM J, V182, P81, DOI 10.1042/bj1820081; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031; FESSLER LI, 1981, J BIOL CHEM, V256, P2531; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hosokawa N, 1998, J BIOCHEM-TOKYO, V124, P654, DOI 10.1093/oxfordjournals.jbchem.a022162; JAIN N, 1994, BIOCHEM J, V304, P61, DOI 10.1042/bj3040061; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; JUVA K, 1969, J BIOL CHEM, V244, P6486; KAO WWY, 1979, J BIOL CHEM, V254, P2234; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LANE JM, 1971, BIOCHIM BIOPHYS ACTA, V236, P517, DOI 10.1016/0005-2795(71)90235-2; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908; McLaughlin SH, 1998, BIOCHEM J, V331, P793, DOI 10.1042/bj3310793; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1989, AM J MED GENET, V34, P60, DOI 10.1002/ajmg.1320340112; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; TUDERMAN L, 1975, EUR J BIOCHEM, V52, P9, DOI 10.1111/j.1432-1033.1975.tb03967.x; UITTO J, 1975, SCIENCE, V190, P1202, DOI 10.1126/science.1198105; UITTO J, 1972, BIOCHIM BIOPHYS ACTA, V278, P601, DOI 10.1016/0005-2795(72)90023-2; UITTO J, 1974, EUR J BIOCHEM, V43, P221, DOI 10.1111/j.1432-1033.1974.tb03403.x; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; WALLIS GA, 1989, J BIOL CHEM, V265, P18628; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637	44	79	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14884	14892		10.1074/jbc.274.21.14884	http://dx.doi.org/10.1074/jbc.274.21.14884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329688	hybrid			2022-12-27	WOS:000081965200053
J	Veillette, A; Soussou, D; Latour, S; Davidson, D; Gervais, FG				Veillette, A; Soussou, D; Latour, S; Davidson, D; Gervais, FG			Interactions of CD45-associated protein with the antigen receptor signaling machinery in T-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE CD45; AMINO-TERMINAL DOMAIN; KINASE P56LCK; CELL RESPONSIVENESS; SH3 DOMAINS; ASSOCIATION; EXPRESSION; P56(LCK); ZAP-70; LCK	CD45 is a transmembrane protein tyrosine phosphatase playing an essential role during T-cell activation This function relates to the ability of CD45 to regulate p56(lck), a cytoplasmic protein tyrosine kinase necessary for T-cell antigen receptor (TCR) signaling. Previous studies have demonstrated that CD45 is constitutively associated in T-lymphocytes with a transmembrane molecule termed CD45-AP (or lymphocyte phosphatase-associated phosphoprotein), Even though the exact role of this polypeptide is unclear, recent analyses of mice lacking CD45-AP have indicated that its expression is also required for optimal T-cell activation. Herein, we wished to understand better the function of CD45-AP. The results of our studies showed that in T-cells, CD45-AP is part of a multimolecular complex that includes not only CD45, but also TCR, the CD4 and CD8 coreceptors, and p56(lck). The association of CD45-AP with TCR, CD4, and CD8 seemed to occur via the shared ability of these molecules to bind CD45. However, binding of CD45-AP to p56(lck) could take place in the absence of other lymphoid-specific components, suggesting that it can be direct, Structure-function analyses demonstrated that such an interaction was mediated by an acidic segment in the cytoplasmic region of CD45-AP and by the kinase domain of p56(lck). Interestingly, the ability of CD45-AP to interact with Lck in the absence of other lymphoid-specific molecules was proportional to the degree of catalytic activation of p56(lck). Together, these findings suggest that CD45-AP is an adaptor molecule involved in orchestrating interactions among components of the antigen, receptor signaling machinery. Moreover, they raise the possibility that one of the functions of CD45-AP is to recognize activated Lck molecules and bring them into the vicinity of CD45.	McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; Montreal Gen Hosp, Dept Med, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Dept Oncol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Veillette, A (corresponding author), McGill Univ, McGill Canc Ctr, Rm 715,McIntyre Med Sci Bldg,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391				ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Bonnard M, 1997, CELL IMMUNOL, V175, P1, DOI 10.1006/cimm.1996.1044; Bruyns E, 1995, J BIOL CHEM, V270, P31372; BURNS CM, 1994, J BIOL CHEM, V269, P13594; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chow L M, 1995, Semin Immunol, V7, P207, DOI 10.1006/smim.1995.0026; CHOW LML, 1994, ONCOGENE, V9, P3437; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; Doro U, 1996, MOL CELL BIOL, V16, P4996; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gervais FG, 1997, J BIOL CHEM, V272, P12754, DOI 10.1074/jbc.272.19.12754; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; GERVAIS FG, 1995, MOL CELL BIOL, V15, P2393; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Kitamura K, 1997, EUR J IMMUNOL, V27, P383, DOI 10.1002/eji.1830270207; KITAMURA K, 1995, J BIOL CHEM, V270, P21151, DOI 10.1074/jbc.270.36.21151; KORETZKY GA, 1993, J BIOL CHEM, V268, P8958; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; Matsuda A, 1998, J EXP MED, V187, P1863, DOI 10.1084/jem.187.11.1863; MCFARLAND EDC, 1995, J BIOL CHEM, V270, P28103; McFarland EDC, 1997, BIOCHEMISTRY-US, V36, P7169, DOI 10.1021/bi970013y; Ng DHW, 1996, J BIOL CHEM, V271, P1295, DOI 10.1074/jbc.271.3.1295; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RESKEKUNZ AB, 1985, EUR J IMMUNOL, V15, P1048, DOI 10.1002/eji.1830151017; REYNOLDS PJ, 1992, ONCOGENE, V7, P1949; ROSS SE, 1994, BIOCHEM BIOPH RES CO, V198, P88, DOI 10.1006/bbrc.1994.1013; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; SCHRAVEN B, 1994, J BIOL CHEM, V269, P29102; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; SCHRAVEN B, 1992, EUR J IMMUNOL, V22, P1857, DOI 10.1002/eji.1830220727; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Shimizu Y, 1997, AM J HEMATOL, V54, P1, DOI 10.1002/(SICI)1096-8652(199701)54:1<1::AID-AJH1>3.0.CO;2-1; TAKEDA A, 1994, J BIOL CHEM, V269, P2357; Thomas M L, 1995, Semin Immunol, V7, P279, DOI 10.1006/smim.1995.0032; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1992, ONCOGENE, V7, P971; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VOLAREVIC S, 1990, P NATL ACAD SCI USA, V87, P7085, DOI 10.1073/pnas.87.18.7085; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEAVER CT, 1991, MOL CELL BIOL, V11, P4415, DOI 10.1128/MCB.11.9.4415; WEIL R, 1995, J BIOL CHEM, V270, P2791, DOI 10.1074/jbc.270.6.2791; Weiss A, 1995, ANN NY ACAD SCI, V766, P149, DOI 10.1111/j.1749-6632.1995.tb26658.x	57	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14392	14399		10.1074/jbc.274.20.14392	http://dx.doi.org/10.1074/jbc.274.20.14392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318863	hybrid			2022-12-27	WOS:000080322200092
J	Bai, XM; Wei, G; Sinha, A; Esko, JD				Bai, XM; Wei, G; Sinha, A; Esko, JD			Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; HUMAN SKIN FIBROBLASTS; HERPES-SIMPLEX VIRUS; N-DEACETYLASE/N-SULFOTRANSFERASE; HEPARAN-SULFATE PROTEOGLYCANS; SWARM RAT CHONDROSARCOMA; SAPORIN FUSION PROTEIN; CORE-LIKE MOLECULE; CHONDROITIN SULFATE; GOLGI-APPARATUS	The proteoglycans of animal cells typically contain one or more heparan sulfate or chondroitin sulfate chains. These glycosaminoglycans assemble on a tetrasaccharide primer, -GlcA beta 1,3Gal beta 1,3Gal beta 1,4Xyl beta-O-, attached to specific serine residues in the core protein. Studies of Chinese hamster ovary cell mutants defective in the first or second enzymes of the pathway (xylosyl-transferase and galactosyltransferase I) show that the assembly of the primer occurs by sequential transfer of single monosaccharide residues from the corresponding high energy nucleotide sugar donor to the non-reducing end of the growing chain. In order to study the other reactions involved in linkage tetrasaccharide assembly, we have devised a powerful selection method based on induced resistance to a mitotoxin composed of basic fibroblast growth factor-saporin. One class of mutants does not incorporate (SO4)-S-35 and [6-H-3]GlcN into glycosaminoglycan chains. Incubation of these cells with naphthol-beta-D-xyloside (Xyl beta-O-Np) resulted in accumulation of linkage region intermediates containing 1 or 2 mol of galactose (Gal beta 1, 4Xyl beta-O-Np and Gal beta 1, 3Gal beta 1, 4Xyl beta-O-Np) and sialic acid (Sia alpha 2,3Gal beta 1, 3Gal beta 1, 4Xyl beta-O-Np) but not any GlcA-containing oligosaccharides. Extracts of the mutants completely lacked UDP-glucluronic acid:Gal beta 1,3Gal-R glucuronosyltransferase (GlcAT-I) activity, as measured by the transfer of GlcA from UDP-GlcA to Gal beta 1,3Gal beta-O- naphthalenemethanol (<0.2 versus 3.6 pmol/min/mg). The mutation most likely lies in the structural gene encoding GlcAT-I since transfection of the mutant with a cDNA for GlcAT-I completely restored enzyme activity and glycosaminoglycan synthesis. These findings suggest that a single GlcAT effects the biosynthesis of common linkage region of both heparan sulfate and chondroitin sulfate in Chinese hamster ovary cells.	Univ Calif San Diego, Dept Med, Div Cellular & Mol Med, Glycobiol Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Dept Med, Div Cellular & Mol Med, Glycobiol Program, 9500 Gilman Dr,CMM E 1055, La Jolla, CA 92093 USA.	jesko@ucsd.edu						Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAKER JR, 1972, J BIOL CHEM, V247, P3838; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cheng F, 1996, J BIOL CHEM, V271, P28572, DOI 10.1074/jbc.271.45.28572; COLLIECJOUAULT S, 1994, J BIOL CHEM, V269, P24953; Conrad H. E., 1998, HEPARIN BINDING PROT; DEAGOSTINI AL, 1990, P NATL ACAD SCI USA, V87, P9784, DOI 10.1073/pnas.87.24.9784; DeBeer T, 1996, EUR J BIOCHEM, V240, P789; Dietrich CP, 1998, CELL MOL BIOL, V44, P417; DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; ELGAVISH A, 1988, J BIOL CHEM, V263, P18607; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1986, J BIOL CHEM, V261, P5725; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1989, METHOD CELL BIOL, V32, P387; ESKO JD, 1996, CURRENT PROTOCOLS MO; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GLOSSL J, 1986, J BIOL CHEM, V261, P1920; GREVE H, 1988, GLYCOCONJUGATE J, V5, P175, DOI 10.1007/BF01061206; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; IZUMI J, 1994, J BIOCHEM-TOKYO, V116, P524, DOI 10.1093/oxfordjournals.jbchem.a124556; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JOHN KV, 1977, J BIOL CHEM, V252, P6707; KATO M, 1994, J BIOL CHEM, V269, P18881; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P1175, DOI 10.1093/glycob/7.8.1175; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; LAPPI DA, 1994, J BIOL CHEM, V269, P12552; Lidholt K, 1997, GLYCOCONJUGATE J, V14, P737, DOI 10.1023/A:1018525602197; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MANZI A, 1995, J BIOL CHEM, V270, P9154, DOI 10.1074/jbc.270.16.9154; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MILLA ME, 1992, J BIOL CHEM, V267, P103; Miura Y, 1998, GLYCOBIOLOGY, V8, P813, DOI 10.1093/glycob/8.8.813; Moses J, 1997, EUR J BIOCHEM, V248, P521, DOI 10.1111/j.1432-1033.1997.00521.x; NAKAMURA T, 1994, BIOCHEM J, V304, P731, DOI 10.1042/bj3040731; NUWAYHID N, 1986, J BIOL CHEM, V261, P2936; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PRIETO I, 1991, ANN NY ACAD SCI, V638, P434, DOI 10.1111/j.1749-6632.1991.tb49062.x; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; ROHRMANN K, 1985, EUR J BIOCHEM, V148, P463, DOI 10.1111/j.1432-1033.1985.tb08862.x; ROUX L, 1988, J BIOL CHEM, V263, P8879; SALIMATH PV, 1995, J BIOL CHEM, V270, P9164, DOI 10.1074/jbc.270.16.9164; SHIBATA S, 1995, J BIOL CHEM, V270, P13794, DOI 10.1074/jbc.270.23.13794; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; SPEAR PG, 1992, ADV EXP MED BIOL, V313, P341; STOOLMILLER AC, 1972, J BIOL CHEM, V247, P3525; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; TAKAGAKI K, 1991, J BIOCHEM-TOKYO, V109, P514, DOI 10.1093/oxfordjournals.jbchem.a123413; Takagaki K, 1996, J BIOCHEM-TOKYO, V119, P697; TEKOTTE H, 1994, J NEUROCHEM, V62, P1126; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Wei G, 1999, J BIOL CHEM, V274, P7857, DOI 10.1074/jbc.274.12.7857; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; YAMADA S, 1995, EUR J BIOCHEM, V233, P687, DOI 10.1111/j.1432-1033.1995.687_2.x; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	86	89	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13017	13024		10.1074/jbc.274.19.13017	http://dx.doi.org/10.1074/jbc.274.19.13017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224052	hybrid			2022-12-27	WOS:000080200400014
J	Chan, D; Freddi, S; Weng, YM; Bateman, JF				Chan, D; Freddi, S; Weng, YM; Bateman, JF			Interaction of collagen alpha 1(X) containing engineered NC1 mutations with normal alpha 1(X) in vitro - Implications for the molecular basis of schmid metaphyseal chondrodysplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL NONCOLLAGENOUS DOMAIN; X COLLAGEN; IN-VITRO; OSTEOGENESIS IMPERFECTA; NONSENSE CODONS; MESSENGER-RNA; GENE; SEQUENCE; CHAIN; CARTILAGE	Collagen X is a short-chain homotrimeric collagen expressed in the hypertrophic zone of calcifying cartilage. The clustering of mutations in the carboxyl-terminal nonhelical NC1 domain in Schmid metaphyseal chondrodysplasia (SMCD) suggests a critical role for NCI in collagen X structure and function. In vitro collagen X DNA expression, using T7-driven coupled transcription and translation, demonstrated that although alpha 1(X) containing normal NC1 domains can form electrophoretically stable trimers, engineered SMCD NC1 missense or premature termination mutations prevented the formation of electrophoretically stable homotrimers or heterotrimers when co-expressed with normal alpha 1(X), To allow the detection of more subtle interactions that may interfere with assembly but not produce SDS-stable final products, we have developed a competition-based in vitro co-expression and assembly approach. Our studies show that alpha 1(X) chains containing SMCD mutations reduce the efficiency of normal al(X) trimer assembly, indicating that interactions do occur between mutant and normal NC1 domains, which can impact on the formation of normal trimers, This finding has important implications for the molecular pathology of collagen X mutations in SMCD, Although we have previously demonstrated haploinsufficiency as one in vivo mechanism (Chan, D,, Weng, Y, M,, Hocking, A. M., Golub, S., McQuillan, D, J,, and Bateman, J, F, (1998) J, Clin. Invest, 101, 1490-1499), the current study suggests dominant interference is also possible if the mutant protein is expressed in vivo. Furthermore, we establish that a conserved 13-amino acid aromatic motif (amino acids 589-601) is critical for the interaction between the NCI domains, suggesting that this region may initiate assembly and the other NC1 mutations interfered with secondary interactions important in folding or in stabilizing the assembly process.	Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Orthopaed Mol Biol Res Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne	Bateman, JF (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Orthopaed Mol Biol Res Unit, Parkville, Vic 3052, Australia.		Chan, Danny/C-4203-2009	Chan, Danny/0000-0003-3824-5778; Bateman, John/0000-0001-8542-0730				APTE SS, 1993, MATRIX, V13, P165, DOI 10.1016/S0934-8832(11)80075-2; Barber RE, 1996, BIOCHEM J, V320, P479, DOI 10.1042/bj3200479; Bateman J F, 1988, Ann N Y Acad Sci, V543, P95, DOI 10.1111/j.1749-6632.1988.tb55321.x; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BATEMAN JF, 1996, EXTRACELLULAR MATRIX, P23; BRASS A, 1992, FEBS LETT, V303, P126, DOI 10.1016/0014-5793(92)80503-9; Byers Peter H., 1993, P317; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; CHAN D, 1995, J BIOL CHEM, V270, P4558, DOI 10.1074/jbc.270.9.4558; Chan D, 1996, J BIOL CHEM, V271, P13566, DOI 10.1074/jbc.271.23.13566; Chan D, 1998, J CLIN INVEST, V101, P1490, DOI 10.1172/JCI1976; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kielty Cay M., 1993, P103; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908; MAQUAT LE, 1995, RNA, V1, P453; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MCINTOSH I, 1995, HUM MUTAT, V5, P121, DOI 10.1002/humu.1380050204; MCINTOSH I, 1994, HUM MOL GENET, V3, P303, DOI 10.1093/hmg/3.2.303; McLaughlin SH, 1998, BIOCHEM J, V331, P793, DOI 10.1042/bj3310793; MIDDLETON RB, 1993, BIOCHEM J, V296, P511, DOI 10.1042/bj2960511; NERLICH AG, 1992, HISTOCHEMISTRY, V98, P275, DOI 10.1007/BF00270010; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; Wallis GA, 1996, J MED GENET, V33, P450, DOI 10.1136/jmg.33.6.450; Willing MC, 1996, AM J HUM GENET, V59, P799; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139	34	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13091	13097		10.1074/jbc.274.19.13091	http://dx.doi.org/10.1074/jbc.274.19.13091			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224061	hybrid			2022-12-27	WOS:000080200400023
J	Gebhardt, F; Zanker, KS; Brandt, B				Gebhardt, F; Zanker, KS; Brandt, B			Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTO-ONCOGENE; CELLS; EGFR; DNA; EXPRESSION; SEQUENCES; REGION; SITE; PCR	The influence of a highly polymorphic CA dinucleotide repeat in the epidermal growth factor receptor (EGFR) gene on transcription was examined with a quantitative nuclear run-off method. We could demonstrate that transcription of the EG;FR gene is inhibited by approximately 80% in alleles with 21 CA repeats. In experiments with polymerase chain reaction products that spanned a region of more than 4,000 base pairs and contained the promoter, two enhancers, and the polymorphic region in the first intron of the gene, we found that transcription activity declines with increasing numbers of CA dinucleotides. In vivo pre-mRNA expression data from cultured cell, lines support these findings, although other regulation mechanisms can outweigh this effect. In addition, we showed that under our experimental conditions RNA elongation terminates at a site closely downstream of the simple sequence repeat and that there are two separate major transcription start sites. Our results provide new insights in individually different EGFR gene expression and the role of the CA repeat in transcription of this proto-oncogene.	Univ Munster, Inst Klin Chem & Lab Med, D-48149 Munster, Germany; Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany	University of Munster; Witten Herdecke University	Brandt, B (corresponding author), Univ Munster, Inst Klin Chem & Lab Med, D-48149 Munster, Germany.			Brandt, Burkhard/0000-0003-3681-3049				ADAMSON ED, 1981, MOL CELL BIOCHEM, V34, P129, DOI 10.1007/BF02359619; BORNSTEIN P, 1988, MOL CELL BIOL, V8, P4851, DOI 10.1128/MCB.8.11.4851; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CELI FS, 1993, NUCLEIC ACIDS RES, V21, P1047, DOI 10.1093/nar/21.4.1047; Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135; CHRYSOGELOS SA, 1993, NUCLEIC ACIDS RES, V21, P5736, DOI 10.1093/nar/21.24.5736; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRANKLIN GC, 1991, EMBO J, V10, P1365, DOI 10.1002/j.1460-2075.1991.tb07656.x; Gabrielian A, 1996, FEBS LETT, V393, P65, DOI 10.1016/0014-5793(96)00855-1; Gabrielian A, 1996, FEBS LETT, V393, P124, DOI 10.1016/0014-5793(96)00837-X; HALEY JD, 1991, J BIOL CHEM, V266, P1746; HOU XY, 1994, J BIOL CHEM, V269, P4307; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; MAEKAWA T, 1989, J BIOL CHEM, V264, P5488; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; Roetger A, 1997, DNA CELL BIOL, V16, P443, DOI 10.1089/dna.1997.16.443; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SHEN WH, 1992, TRENDS GENET, V8, P227; SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740; TAE HJ, 1994, J BIOL CHEM, V269, P10475; TRAVERS AA, 1990, DNA TOPOLOGY ITS BIO; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308	24	318	331	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13176	13180		10.1074/jbc.274.19.13176	http://dx.doi.org/10.1074/jbc.274.19.13176			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224073	hybrid			2022-12-27	WOS:000080200400035
J	Brewer, G				Brewer, G			Evidence for a 3 '-5 ' decay pathway for c-myc mRNA in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; CODING REGION; DEGRADATION; PURIFICATION; TURNOVER; PROTEIN; INVITRO; YEAST; EXORIBONUCLEASE; EXOSOME	Many mBNAs in mammalian cells decay via a sequential pathway involving rapid conversion of polyadenylated molecules to a poly(A)-deficient state followed by rapid degradation of the poly(A)-deficient molecules. However, the rapidity of this latter step(s) has precluded further analyses of the decay pathways involved. Decay intermediates derived from degradation of poly(A)-deficient molecules could offer clues regarding decay pathways, but these intermediates have not been readily detected. Cell-free mRNA decay systems have proven useful in analyses of decay pathways because decay intermediates are rather stable in vitro. Cell-free systems indicate that many mRNAs decay by a sequential 3'-5' pathway because 3'-terminal decay intermediates form following deadenylation. However, if 3'-terminal, in vitro decay intermediates reflect a biologically significant aspect of mRNA turnover, then similar intermediates should be present in cells. Here, I have compared the in vivo and in vitro decay of mRNA encoded by the c-myc proto-oncogene. Its decay both in vivo and in vitro occurs by rapid removal of the poly(A) tract and generation of a 3'-terminal decay intermediate. These data strongly suggest that a 3'-5' pathway contributes to turnover of c-myc mRNA in cells. It is likely that 3'-5' decay represents a major turnover pathway in mammalian cells.	Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA	Wake Forest University	Brewer, G (corresponding author), Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.				NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER; NCI NIH HHS [CA52443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BREWER G, 1990, METHOD ENZYMOL, V181, P202; Brewer G, 1998, J BIOL CHEM, V273, P34770, DOI 10.1074/jbc.273.52.34770; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; BREWER G, 1992, PROMEGA NOTES, V40, P11; CARUCCIO N, 1994, J BIOL CHEM, V269, P31814; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; DEAN A, 1983, P NATL ACAD SCI-BIOL, V80, P5515, DOI 10.1073/pnas.80.18.5515; DEMARIA CT, 1997, PROGR MOL SUBCELLULA, P65; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lee CH, 1998, J BIOL CHEM, V273, P25261, DOI 10.1074/jbc.273.39.25261; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; ROSS J, 1986, MOL CELL BIOL, V6, P4362, DOI 10.1128/MCB.6.12.4362; ROSS J, 1995, MICROBIOL REV, V59, P16; ROSS J, 1993, CONTROL MESSENGER RN, P417; RuizEchevarria MJ, 1996, TRENDS BIOCHEM SCI, V21, P433, DOI 10.1016/S0968-0004(96)10055-4; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; SWARTWOUT SG, 1989, MOL CELL BIOL, V9, P288, DOI 10.1128/MCB.9.1.288	31	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16174	16179		10.1074/jbc.274.23.16174	http://dx.doi.org/10.1074/jbc.274.23.16174			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347171	hybrid			2022-12-27	WOS:000080668600031
J	Fang, N; Koretzky, GA				Fang, N; Koretzky, GA			SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CELL ANTIGEN RECEPTOR; ACCESSORY MOLECULE CD28; ACTIVATED T-CELLS; SIGNAL-TRANSDUCTION; PROTOONCOGENE PRODUCT; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NUCLEAR FACTOR; IL-2 PROMOTER	SLP-76 and Vav, two hematopoietic cell specific molecules, are critical for T cell development and activation. Following T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76, Furthermore, SLP-76 and Vav have a synergistic effect on interleukin (IL)-2 promoter activity in T cells. In this report, we show that two tyrosines, Tyr-113 and Tyr-128, of SLP-76 are required for its binding to Vav, both in vitro and in intact cells. Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 gene expression. Overexpression of SLP-76 in the Jurkat T cell line potentiates the activities of both nuclear factor of activated T cells and AP-1 transcription factors, In contrast, overexpression of Vav leads to enhanced nuclear factor of activated T cells activity without affecting AP-1, Additionally, overexpression of Vav, but not SLP-76, augments CD28-induced IL-2 promoter activity. These findings suggest that the synergy between SLP-76 and Vav in regulating IL-2 gene expression reflects the cooperation between different signaling pathways.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Koretzky, GA (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, 540 EMRB, Iowa City, IA 52242 USA.		Koretzky, Gary/AAU-5381-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053256] Funding Source: NIH RePORTER; NIGMS NIH HHS [R0IGM53256] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON JP, 1995, SCIENCE, V270, P932, DOI 10.1126/science.270.5238.932; ALTMAN A, 1990, CRIT REV IMMUNOL, V10, P347; BOGUSKI MS, 1992, NATURE, V358, P113, DOI 10.1038/358113a0; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Cantrell D, 1998, TRENDS CELL BIOL, V8, P180, DOI 10.1016/S0962-8924(98)01264-1; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Fang N, 1996, J IMMUNOL, V157, P3769; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; JAIN J, 1992, J IMMUNOL, V148, P1240; Kabelitz D, 1995, Curr Top Microbiol Immunol, V200, P1; Kalli K, 1998, MOL CELL BIOL, V18, P3140, DOI 10.1128/MCB.18.6.3140; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Klasen S, 1998, INT IMMUNOL, V10, P481, DOI 10.1093/intimm/10.4.481; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Maggirwar SB, 1997, MOL CELL BIOL, V17, P2605, DOI 10.1128/MCB.17.5.2605; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Musci MA, 1997, J IMMUNOL, V159, P1639; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; PASTOR MI, 1995, CANCER SURV, V22, P75; PASTOR MI, 1995, IMMUNOL TODAY, V16, P159, DOI 10.1016/0167-5699(95)80134-0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; RAMOSMORALES F, 1994, ONCOGENE, V9, P1917; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROBEY E, 1995, IMMUNOL TODAY, V16, P306, DOI 10.1016/0167-5699(95)80140-5; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; VONBOEHMER H, 1995, CLIN IMMUNOL IMMUNOP, V76, pS145, DOI 10.1016/S0090-1229(95)90018-7; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WEISS A, 1992, COLD SPRING HARB SYM, V57, P107, DOI 10.1101/SQB.1992.057.01.014; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	59	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16206	16212		10.1074/jbc.274.23.16206	http://dx.doi.org/10.1074/jbc.274.23.16206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347175	hybrid			2022-12-27	WOS:000080668600035
J	Boix, E; Nikolovski, Z; Moiseyev, GP; Rosenberg, HF; Cuchillo, CM; Nogues, MV				Boix, E; Nikolovski, Z; Moiseyev, GP; Rosenberg, HF; Cuchillo, CM; Nogues, MV			Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PANCREATIC RIBONUCLEASE; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; CATALYTIC PROPERTIES; SECONDARY STRUCTURE; MASS-SPECTROMETRY; MOLECULAR-CLONING; GRANULE PROTEINS; BINDING SUBSITES; NEUROTOXIN	With the use of a high yield prokaryotic expression system, large amounts of human eosinophil cationic protein (ECP) have been obtained. This has allowed a thorough kinetic study of the ribonuclease activity of this protein. The catalytic efficiencies for oligouridylic acids of the type (Up)(n)U>p, mononucleotides U>p and C>p, and dinucleoside monophosphates CpA, UpA, and UpG have been interpreted by the specific subsites distribution in ECP, The distribution of products derived from digestion of high molecular mass substrates, such as poly(U) and poly(C), by ECP was compared with that of RNase A The characteristic cleavage pattern of polynucleotides by ECP suggests that an exonuclease-like mechanism is predominantly favored in comparison to the endonuclease catalytic mechanism of RNase A. Comparative molecular modeling with bovine pancreatic RNase A-substrate analog crystal complexes revealed important differences in the subsite structure, whereas the secondary phosphate-binding site (p(2)) is lacking, the secondary base subsite (B-2) is severely impaired, and there are new interactions at the p(o), B-o, and p(-1) sites, located upstream of the P-O-5' cleavable phosphodiester bond, that are not found in RNase A. The differences in the multisubsites structure could explain the reduced catalytic efficiency of ECP and the shift from an endonuclease to an exonuclease-type mechanism.	Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Ciencies, Bellaterra 08193, Spain; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Autonomous University of Barcelona; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nogues, MV (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Ciencies, Bellaterra 08193, Spain.		Boix, Ester/B-9038-2012; Nogues, M. Victoria/H-6100-2015	Boix, Ester/0000-0003-1790-2142; Nogues, M. Victoria/0000-0002-7104-0961	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000649] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Ackerman Steven J., 1993, P33; ALONSO J, 1986, ARCH BIOCHEM BIOPHYS, V246, P681, DOI 10.1016/0003-9861(86)90324-3; ARNOTT S, 1976, J MOL BIOL, V106, P735, DOI 10.1016/0022-2836(76)90262-X; BEINTEMA JJ, 1988, BIOCHEMISTRY-US, V27, P4530, DOI 10.1021/bi00412a046; BIRDSALL DL, 1992, J BIOL CHEM, V267, P22230; BOIX E, 1994, J BIOL CHEM, V269, P2529; Boix E, 1996, J MOL BIOL, V257, P992, DOI 10.1006/jmbi.1996.0218; BRAVO J, 1994, ANAL BIOCHEM, V219, P82, DOI 10.1006/abio.1994.1234; Cuchillo C. M., 1997, RIBONUCLEASES STRUCT, P272; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; DELCARDAYRE SB, 1994, BIOCHEMISTRY-US, V33, P6031, DOI 10.1021/bi00186a001; DELLORENS R, 1989, PROTEIN ENG, V2, P417, DOI 10.1093/protein/2.6.417; DELROSAR.EJ, 1969, BIOCHEMISTRY-US, V8, P1884, DOI 10.1021/bi00833a017; Domachowske JB, 1997, J LEUKOCYTE BIOL, V62, P363, DOI 10.1002/jlb.62.3.363; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; FOLLMANN H., 1967, EUR J BIOCHEM, V1, P243, DOI 10.1111/j.1432-1033.1967.tb00068.x; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; GILLILAND GL, 1994, PROTEIN PEPTIDE LETT, V1, P60; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; Grantham R., 1981, NUCLEIC ACIDS RES, V9, P43; GULLBERG U, 1986, BIOCHEM BIOPH RES CO, V139, P1239, DOI 10.1016/S0006-291X(86)80310-2; Hahner S, 1997, NUCLEIC ACIDS RES, V25, P1957, DOI 10.1093/nar/25.10.1957; HAMANN KJ, 1990, GENOMICS, V7, P535, DOI 10.1016/0888-7543(90)90197-3; IMAZAWA M, 1968, J BIOCHEM-TOKYO, V64, P595, DOI 10.1093/oxfordjournals.jbchem.a128936; IRIE M, 1984, J BIOCHEM-TOKYO, V96, P89, DOI 10.1093/oxfordjournals.jbchem.a134833; KOLBANOVSKAYA EY, 1993, MOL BIOL+, V27, P821; LEHRER RI, 1989, J IMMUNOL, V142, P4428; LI JRT, 1974, ARCH BIOCHEM BIOPHYS, V161, P227, DOI 10.1016/0003-9861(74)90255-0; LIBONATI M, 1992, MOL CELL BIOCHEM, V117, P139; MCPHERSON A, 1986, J MOL BIOL, V189, P305, DOI 10.1016/0022-2836(86)90512-7; MITSUI Y, 1978, BIOCHIM BIOPHYS ACTA, V535, P299, DOI 10.1016/0005-2795(78)90096-X; MOISEEV GP, 1982, BIOORG KHIM+, V8, P1197; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; Mosimann SC, 1996, J MOL BIOL, V260, P540, DOI 10.1006/jmbi.1996.0420; Moussaoui M, 1996, J BIOL CHEM, V271, P4687; Moussaoui M, 1998, J BIOL CHEM, V273, P25565, DOI 10.1074/jbc.273.40.25565; NEWTON DL, 1994, J NEUROSCI, V14, P538; NOGUES MV, 1995, BBA-PROTEIN STRUCT M, V1253, P16, DOI 10.1016/0167-4838(95)00138-K; Nogues MV, 1998, CELL MOL LIFE SCI, V54, P766, DOI 10.1007/s000180050205; OLSSON I, 1977, LAB INVEST, V36, P493; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; Sambrook J., 2002, MOL CLONING LAB MANU; SHAPIRO R, 1991, BIOCHEMISTRY-US, V30, P2246, DOI 10.1021/bi00222a030; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; SNYDER MR, 1997, RIBONUCLEASES STRUCT, P425; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; SORRENTINO S, 1991, FEBS LETT, V288, P23, DOI 10.1016/0014-5793(91)80994-E; SORRENTINO S, 1992, J BIOL CHEM, V267, P14859; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Spry CJ, 1988, EOSINOPHILS COMPREHE; STEYAERT J, 1994, PROTEINS, V18, P318, DOI 10.1002/prot.340180403; TARRAGONAFIOL A, 1993, PROTEIN ENG, V6, P901, DOI 10.1093/protein/6.8.901; Trulson A, 1997, BRIT J HAEMATOL, V98, P312, DOI 10.1046/j.1365-2141.1997.2203035.x; VICENTINI AM, 1990, BIOCHEMISTRY-US, V29, P8827, DOI 10.1021/bi00489a046; WANG BH, 1994, ANAL CHEM, V66, P1918, DOI 10.1021/ac00083a023; Yakovlev G, 1997, J BIOMOL STRUCT DYN, V15, P243, DOI 10.1080/07391102.1997.10508189; YAKOVLEV GI, 1985, FEBS LETT, V179, P217, DOI 10.1016/0014-5793(85)80521-4; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; YOUNG PR, 1978, J MOL BIOL, V126, P467, DOI 10.1016/0022-2836(78)90053-0; ZEGERS I, 1994, PROTEIN SCI, V3, P2322, DOI 10.1002/pro.5560031217; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	68	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15605	15614		10.1074/jbc.274.22.15605	http://dx.doi.org/10.1074/jbc.274.22.15605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336457	hybrid			2022-12-27	WOS:000080560100046
J	Li, QJ; Vaingankar, SM; Green, HM; Martins-Green, M				Li, QJ; Vaingankar, SM; Green, HM; Martins-Green, M			Activation of the 9E3/cCAF chemokine by phorbol esters occurs via multiple signal transduction pathways that converge to MEK1/ERK2 and activate the Elk1 transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ROUS-SARCOMA VIRUS; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; MAP KINASE; PLATELET PROTEIN; TUMOR PROMOTERS; DOWN-REGULATION; SKIN TUMORS; GENE	Using primary fibroblasts in culture, we have investigated the signal transduction mechanisms by which phorbol esters, a class of tumor promoters, activate the 9E3 gene and its chemokine product the chicken chemotactic and angiogenic factor. This gene is highly stimulated by phorbol 12,13-dibutyrate (PDBu) via three pathways: (i) a small contribution through protein kinase C (the commonly recognized pathway for these tumor promoters), (ii) a contribution involving tyrosine kinases, and (iii) a larger contribution via pathways that can be interrupted by dexamethasone, All three of these pathways converge into the mitogen-activated protein kinases, MEK1/ERK2, Using a luciferase reporter system, we show that although both the AP-1 and PDRIIkB (a NF kappa B-like factor in chickens) response elements are capable of activation in these normal cells, regions of the 9E3 promoter containing them are unresponsive to PDBu stimulation. In contrast, we show for the first time that activation by PDBu occurs through a segment of the promoter containing Elk1 response elements; deletion and mutation of these elements abrogates 9E3/ chicken chemotactic and angiogenic factor expression. Electrophoretic mobility shift assays and functional studies using PathDetect systems show that stimulation of the cells by phorbol esters leads to activation of the Elk1 transcription factor, which binds to its element in the 9E3 promoter.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Martins-Green, M (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mmgreen@ucrac1.ucr.edu			NIGMS NIH HHS [GM48436] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048436] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ATKINS KB, 1995, CELL GROWTH DIFFER, V6, P713; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BARKER K, 1990, MOL CELL BIOL, V10, P3813, DOI 10.1128/MCB.10.7.3813; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BEDARD PA, 1987, P NATL ACAD SCI USA, V84, P6715, DOI 10.1073/pnas.84.19.6715; BISSELL MJ, 1979, P NATL ACAD SCI USA, V76, P348, DOI 10.1073/pnas.76.1.348; BISSELL MJ, 1977, J SUPRAMOL STR CELL, V6, P1, DOI 10.1002/jss.400060102; BLOBEL GA, 1991, P NATL ACAD SCI USA, V88, P1162, DOI 10.1073/pnas.88.4.1162; BLUMBERG PM, 1980, CRC CR REV TOXICOL, V8, P153, DOI 10.3109/10408448009037493; Cabannes E, 1997, ONCOGENE, V15, P29, DOI 10.1038/sj.onc.1201162; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cannon RE, 1997, MOL CARCINOGEN, V20, P108, DOI 10.1002/(SICI)1098-2744(199709)20:1<108::AID-MC12>3.0.CO;2-5; CHAO TSO, 1994, J BIOL CHEM, V269, P7337; Cobb M H, 1996, Adv Pharmacol, V36, P49, DOI 10.1016/S1054-3589(08)60576-1; Cohen RA, 1996, NEUROCASE, V2, P93; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DEHBI M, 1992, MOL CELL BIOL, V12, P1490, DOI 10.1128/MCB.12.4.1490; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; DIGIOVANNI J, 1993, CARCINOGENESIS, V14, P319, DOI 10.1093/carcin/14.2.319; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Farina AR, 1997, CELL GROWTH DIFFER, V8, P789; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; FOURNIER A, 1989, BIOCHEM BIOPH RES CO, V161, P556, DOI 10.1016/0006-291X(89)92635-1; Gatti A, 1997, EUR J BIOCHEM, V249, P92, DOI 10.1111/j.1432-1033.1997.t01-1-00092.x; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; GULBINS E, 1994, MOL CELL BIOL, V14, P4749, DOI 10.1128/MCB.14.7.4749; Gutkind JS, 1997, LIFE SCI, V60, P999; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; HORUK R, 1996, CHEMOATTRACTANT LIGA; Howard OMZ, 1996, TRENDS BIOTECHNOL, V14, P46, DOI 10.1016/0167-7799(96)80920-6; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Iversen Olav Hilmar, 1995, Critical Reviews in Oncogenesis, V6, P357; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jenkins TD, 1997, J BIOL CHEM, V272, P24433, DOI 10.1074/jbc.272.39.24433; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; KLIGMAN AM, 1994, CANCER LETT, V87, P171, DOI 10.1016/0304-3835(94)90219-4; Knoepp SM, 1996, J BIOL CHEM, V271, P1678, DOI 10.1074/jbc.271.3.1678; KRANE SM, 1993, BRIT J RHEUMATOL, V32, P3; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kujoth GC, 1998, CELL GROWTH DIFFER, V9, P523; LACEY M, 1986, NATURE, V322, P609, DOI 10.1038/322609a0; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Liu YZ, 1997, BIOCHEM J, V322, P155, DOI 10.1042/bj3220155; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Martins-Green M., 1997, Cytokine and Growth Factor Reviews, V8, P221, DOI 10.1016/S1359-6101(97)00016-6; Martins-Green M, 1998, CYTOKINE, V10, P522, DOI 10.1006/cyto.1997.0311; Martins-Green M, 1998, CYTOKINE, V10, P819, DOI 10.1006/cyto.1998.0383; MARTINSGREEN M, 1994, CANCER RES, V54, P4334; MartinsGreen M, 1996, CYTOKINE, V8, P448, DOI 10.1006/cyto.1996.0061; MARTINSGREEN M, 1990, J CELL BIOL, V110, P581, DOI 10.1083/jcb.110.3.581; MARTINSGREEN M, 1992, J CELL SCI, V101, P701; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Mukaida N, 1992, Cytokines, V4, P41; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Puceat M, 1996, MOL CELL BIOCHEM, V157, P65; RICHMOND A, 1996, CHEMOATTRACTANT LIGA, P87; Rider LG, 1996, J IMMUNOL, V157, P2374; Sanders JL, 1996, J BONE MINER RES, V11, P1862; Schwachtgen JL, 1998, BLOOD, V92, P1247, DOI 10.1182/blood.V92.4.1247.416k08_1247_1258; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SIEWEKE MH, 1994, CRIT REV ONCOGENESIS, V5, P297, DOI 10.1615/CritRevOncog.v5.i2-3.90; SIEWEKE MH, 1989, CANCER RES, V49, P6419; STALKER A, 1991, AM J ANAT, V190, P19, DOI 10.1002/aja.1001900104; SUGANO S, 1987, CELL, V49, P321, DOI 10.1016/0092-8674(87)90284-4; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; Vaingankar SM, 1998, J BIOL CHEM, V273, P5226, DOI 10.1074/jbc.273.9.5226; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Wu GD, 1997, J BIOL CHEM, V272, P2396; XIAN WJ, 1995, CELL GROWTH DIFFER, V6, P1447; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710	81	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15454	15465		10.1074/jbc.274.22.15454	http://dx.doi.org/10.1074/jbc.274.22.15454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336436	hybrid			2022-12-27	WOS:000080560100025
J	Tanabe, K; Nakanish, H; Maeda, H; Nishioku, T; Hashimoto, K; Liou, SY; Akamine, A; Yamamoto, K				Tanabe, K; Nakanish, H; Maeda, H; Nishioku, T; Hashimoto, K; Liou, SY; Akamine, A; Yamamoto, K			A predominant apoptotic death pathway of neuronal PC12 cells induced by activated microglia is displaced by a non-apoptotic death pathway following blockage of caspase-3-dependent cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; N-ACETYLCYSTEINE; CYTOCHROME-C; CATHEPSIN-D; CULTURED MICROGLIA; INTERFERON-GAMMA; BCL-2; INHIBITION; PROTEASES; RECEPTOR	Activated microglia have been implicated in the regulation of neuronal cell death, However, the biochemical mechanism for neuronal death triggered by activated microglia is still unclear, When treated with activated microglia, neuronal PC12 cells undergo apoptosis accompanied by caspase-3-like protease activation and DNA fragmentation, Apoptotic bodies formed were subsequently phagocytosed by neighboring activated microglia. Pretreatment of the cells with the caspase-3-like protease inhibitor N-acetyl-Asp-Glu-Val-Asp-aldehyde did not reverse this cell death. Although Bcl-2 overexpression in the cells caused the inhibition of caspase-3-like protease activity and DNA fragmentation and the effective interference of apoptosis induced by deprivation of trophic factors, it could not suppress the activated microglia-induced neuronal death, At the electron microscopic level, degenerating cells with high levels of Bcl-2 were characterized by slightly condensed chromatins forming irregular-shaped masses, severely disintegrated perikarya, and marked vacuolation. Various protease inhibitors tested did not inhibit this cell death, whereas the radical oxygen species scavenger N-acetyl-L-cysteine significantly suppressed this death. Altogether, our study provides an alternative death pathway for the activated microglia-induced neuronal death by blockage of the caspase-3 protease cascade.	Kyushu Univ, Fac Dent, Dept Pharmacol, Fukuoka 8128582, Japan; Kyushu Univ, Fac Dent, Dept Conservat Dent 2, Fukuoka 8128582, Japan; Nippon Glaxo Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3004247, Japan	Kyushu University; Kyushu University; Eisai Co Ltd; GlaxoSmithKline	Yamamoto, K (corresponding author), Kyushu Univ, Fac Dent, Dept Pharmacol, Fukuoka 8128582, Japan.							ALBRECHT H, 1994, FEBS LETT, V351, P45, DOI 10.1016/0014-5793(94)00817-5; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Atabay C, 1996, J NEUROSCI RES, V43, P465; BATISTATOU A, 1993, J NEUROSCI, V13, P4422; BETZCORRADIN S, 1993, GLIA, V7, P255; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Borner C, 1996, J BIOL CHEM, V271, P12695, DOI 10.1074/jbc.271.22.12695; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; COLTON CA, 1994, ANN NY ACAD SCI, V738, P54; COSSARIZZA A, 1995, EXP CELL RES, V220, P232, DOI 10.1006/excr.1995.1311; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; FERRARI G, 1995, J NEUROSCI, V15, P2857; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Islam KN, 1997, FREE RADICAL BIO MED, V22, P1007, DOI 10.1016/S0891-5849(96)00493-5; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lafon C, 1996, CELL GROWTH DIFFER, V7, P1095; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nakanishi H, 1997, J NEUROCHEM, V68, P739; Navikas V, 1996, J NEUROSCI RES, V45, P322, DOI 10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B; Nuovo GJ, 1996, MOL MED, V2, P358, DOI 10.1007/BF03401633; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PIETENPOL JA, 1994, CANCER RES, V54, P3714; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; SARIN A, 1993, J EXP MED, V178, P1693, DOI 10.1084/jem.178.5.1693; Sastradipura DF, 1998, J NEUROCHEM, V70, P2045; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; Shimizu S, 1996, ONCOGENE, V13, P21; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SLATER AFG, 1995, BBA-MOL BASIS DIS, V1271, P59, DOI 10.1016/0925-4439(95)00010-2; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Stefanis L, 1996, J BIOL CHEM, V271, P30663, DOI 10.1074/jbc.271.48.30663; Takai N, 1998, J NEUROSCI RES, V54, P214, DOI 10.1002/(SICI)1097-4547(19981015)54:2<214::AID-JNR9>3.0.CO;2-H; Tanabe H, 1997, EUR J NEUROSCI, V9, P848, DOI 10.1111/j.1460-9568.1997.tb01434.x; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; Uhlmann EJ, 1996, CANCER RES, V56, P2506; Vairo G, 1996, ONCOGENE, V13, P1511; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533; ZIELASEK J, 1992, CELL IMMUNOL, V141, P111, DOI 10.1016/0008-8749(92)90131-8	58	39	39	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15725	15731		10.1074/jbc.274.22.15725	http://dx.doi.org/10.1074/jbc.274.22.15725			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336472	hybrid			2022-12-27	WOS:000080560100061
J	Gonen, H; Bercovich, B; Orian, A; Carrano, A; Takizawa, C; Yamanaka, K; Pagano, M; Iwai, K; Ciechanover, A				Gonen, H; Bercovich, B; Orian, A; Carrano, A; Takizawa, C; Yamanaka, K; Pagano, M; Iwai, K; Ciechanover, A			Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of I kappa B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE GENE; KINASE COMPLEX; PROTEASOME PATHWAY; SCAFFOLD PROTEIN; ENZYMES; PHOSPHORYLATION; ACTIVATION; YEAST; PROTEOLYSIS; LIGASE	The last step in the activation of the transcription factor NF-kappa B is signal-induced, ubiquitin- and proteasome-mediated degradation of the inhibitor I kappa B alpha. Although most of the components involved in the activation and degradation pathways have been identified, the ubiquitin carrier proteins (E2) have remained elusive. Here we show that the two highly homologous members of the UBCH5 family, UBCH5b and UBCH5c, and CDC34/UBC3, the mammalian homolog of yeast Cdc34/Ubc3, are the E2 enzymes involved in the process. The conjugation reaction they catalyze in vitro is specific, as they do not recognize the S32A,S36A mutant species of I kappa B alpha that cannot be phosphorylated and conjugated following an extracellular signal. Furthermore, the reaction is specifically inhibited by a doubly phosphorylated peptide that spans the ubiquitin ligase recognition domain of the inhibitor. Cys-to-Ala mutant species of the enzymes that cannot bind ubiquitin inhibit tumor necrosis factor a-induced degradation of the inhibitor in vivo. Not surprisingly, they have a similar effect in a cell-free system as well. Although it is clear that the E2 enzymes are not entirely specific to I kappa B alpha, they are also not involved in the conjugation and degradation of the bulk of cellular proteins, thus exhibiting some degree of specificity that is mediated probably via their association with a defined subset of ubiquitin-protein ligases. The mechanisms that underlie the involvement of two different E2 species in I kappa B alpha conjugation are not clear at present. It is possible that different conjugating machineries operate under different physiological conditions or in different cells.	Technion Israel Inst Technol, Fac Med, Dept Biochem, IL-31096 Haifa, Israel; Bruce Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; Bruce Rappaport Fac Med, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; NYU, Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sankyo Ku, Kyoto 6068501, Japan	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; New York University; New York University; Kyoto University	Ciechanover, A (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Biochem, Efron St,Bat Galim,POB 9649, IL-31096 Haifa, Israel.		Yamanaka, Koji/ABD-1034-2020; Yamanaka, Koji/H-5806-2011; IWAI, KAZUHIRO/GSN-7385-2022; Ciechanover, Aaron J/C-9166-2017	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Iwai, Kazuhiro/0000-0001-5620-5951; pagano, michele/0000-0003-3210-2442				Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BLUMENFELD N, 1994, J BIOL CHEM, V269, P9574; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Coux O, 1998, J BIOL CHEM, V273, P8820, DOI 10.1074/jbc.273.15.8820; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Gonen H, 1996, J BIOL CHEM, V271, P302, DOI 10.1074/jbc.271.1.302; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GROPPER R, 1991, J BIOL CHEM, V266, P3602; GUAN JL, 1984, CELL, V37, P779, DOI 10.1016/0092-8674(84)90413-6; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; KAISER P, 1994, J BIOL CHEM, V269, P8797; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; PETERS JM, 1998, UBIQUITIN BIOL CELL, P1; PLON SE, 1993, P NATL ACAD SCI USA, V90, P10484, DOI 10.1073/pnas.90.22.10484; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; TABOR S, 1990, CURRENT PROTOCOLS MO; Tashiro K, 1997, P NATL ACAD SCI USA, V94, P7862, DOI 10.1073/pnas.94.15.7862; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wing SS, 1996, MOL CELL BIOL, V16, P4064; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	50	97	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14823	14830		10.1074/jbc.274.21.14823	http://dx.doi.org/10.1074/jbc.274.21.14823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329681	hybrid			2022-12-27	WOS:000081965200046
J	Illana, B; Lazaro, JM; Gutierrez, C; Meijer, WJJ; Blanco, L; Salas, M				Illana, B; Lazaro, JM; Gutierrez, C; Meijer, WJJ; Blanco, L; Salas, M			Phage phi 29 terminal protein residues Asn(80) and Tyr(82) are recognition elements of the replication origins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMED DNA-REPLICATION; BACILLUS-SUBTILIS; BACTERIOPHAGE PHI-29; SECONDARY-STRUCTURE; INITIATION; INVITRO; PHAGE-PHI-29; COMPLEX; POLYMERASE; TEMPLATE	Initiation of phage phi 29 DNA replication starts with the recognition of the origin of replication, located at both ends of the linear DNA, by a heterodimer formed by the phi 29 terminal protein (TP) and the phi 29 DNA polymerase. The parental TP, covalently linked to the DNA ends, is one of the main components of the replication origin. Here we provide evidence that recognition of the origin is mediated through interactions between the TP of the TP/DNA polymerase heterodimer, called primer TP, and the parental TP, Based on amino acid sequence comparisons, various phi 29 TP mutants were generated at conserved amino acid residues from positions 61 to 87, In vitro phi 29 DNA amplification analysis revealed that residues Asn(80) and Tyr(82) are essential for functional interaction between primer and parental TP required for recognition of the origin of replication. Although these mutant TPs can form functional heterodimers with phi 29 DNA polymerase that are able to recognize the origin of replication, these heterodimers are not able to recognize an origin containing a mutant TP.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cientif, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cientif, E-28049 Madrid, Spain.	msalas@cbm.uam.es	Gutierrez, Crisanto/ABH-8782-2020; Salas, Margarita/J-9873-2014; Blanco, Luis/I-1848-2015	Salas, Margarita/0000-0001-5939-3441; Meijer, Wilfried/0000-0003-1842-0049; Gutierrez, Crisanto/0000-0001-8905-8222	NIGMS NIH HHS [5RO1 GM27242-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BJORNSTI MA, 1982, J VIROL, V41, P508, DOI 10.1128/JVI.41.2.508-517.1982; BLANCO L, 1987, J VIROL, V61, P3983, DOI 10.1128/JVI.61.12.3983-3991.1987; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; BLANCO L, 1994, P NATL ACAD SCI USA, V91, P12198, DOI 10.1073/pnas.91.25.12198; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUNSWORTHBROWNE M, 1980, NUCLEIC ACIDS RES, V8, P543, DOI 10.1093/nar/8.3.543; GARCIA JA, 1984, P NATL ACAD SCI-BIOL, V81, P80, DOI 10.1073/pnas.81.1.80; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRIMES S, 1989, J MOL BIOL, V209, P101, DOI 10.1016/0022-2836(89)90173-3; GUTIERREZ C, 1991, J MOL BIOL, V222, P983, DOI 10.1016/0022-2836(91)90589-X; GUTIERREZ C, 1994, EMBO J, V13, P269, DOI 10.1002/j.1460-2075.1994.tb06257.x; GUTIERREZ J, 1986, VIROLOGY, V155, P474, DOI 10.1016/0042-6822(86)90209-6; HAY RT, 1996, REPLICATION EUKARYOT, P699; HERMOSO JM, 1985, NUCLEIC ACIDS RES, V13, P7715, DOI 10.1093/nar/13.21.7715; HIROKAWA H, 1972, P NATL ACAD SCI USA, V69, P1555, DOI 10.1073/pnas.69.6.1555; INCIARTE MR, 1980, J VIROL, V34, P187, DOI 10.1128/JVI.34.1.187-199.1980; KORNBERG A, 1992, DNA REPLICATION, P103; Mendez J, 1997, EMBO J, V16, P2519, DOI 10.1093/emboj/16.9.2519; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; PRONK R, 1992, CHROMOSOMA, V102, pS39, DOI 10.1007/BF02451784; RONDA C, 1983, J VIROL, V48, P721, DOI 10.1128/JVI.48.3.721-730.1983; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SALAS M, 1978, J MOL BIOL, V119, P269, DOI 10.1016/0022-2836(78)90438-2; SALAS M, 1996, REPLICATION EUKARYOT, P131; SALAS M, 1983, MECHANISMS DNA REPLI, P203; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAACK J, 1990, GENE DEV, V4, P1197, DOI 10.1101/gad.4.7.1197; SERRANO M, 1990, SCIENCE, V248, P1012, DOI 10.1126/science.2111580; SOGO JM, 1989, METHOD ENZYMOL, V170, P142; SOGO JM, 1982, VIROLOGY, V116, P1, DOI 10.1016/0042-6822(82)90398-1; SOGO JM, 1987, ELECTRON MICROS, P61; VANDERVLIET PC, 1996, REPLICATION EUKARYOT, P87; VLCEK C, 1986, GENE, V46, P215, DOI 10.1016/0378-1119(86)90406-3; ZABALLOS A, 1989, GENE, V83, P187, DOI 10.1016/0378-1119(89)90104-2; ZABALLOS A, 1987, GENE, V58, P67, DOI 10.1016/0378-1119(87)90030-8	38	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15073	15079		10.1074/jbc.274.21.15073	http://dx.doi.org/10.1074/jbc.274.21.15073			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329712	hybrid			2022-12-27	WOS:000081965200077
J	Inohara, N; Koseki, T; del Peso, L; Hu, YM; Yee, C; Chen, S; Carrio, R; Merino, J; Liu, D; Ni, J; Nunez, G				Inohara, N; Koseki, T; del Peso, L; Hu, YM; Yee, C; Chen, S; Carrio, R; Merino, J; Liu, D; Ni, J; Nunez, G			Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEATS; CELL-DEATH; CYTOCHROME-C; DISEASE RESISTANCE; CED-3 ACTIVATION; PROTEIN-KINASE; APOPTOSIS; RECEPTOR; COMPLEX; FAMILY	Ced-4 and Apaf-1 belong to a major class of apoptosis regulators that contain caspase-recruitment (CARD) and nucleotide-binding oligomerization domains. Nod1, a protein with an NH2-terminal CARD-linked to a nucleotide-binding domain and a COOH-terminal segment with multiple leucine-rich repeats, was identified. Nod-1 was found to bind to multiple caspases with long prodomains, but specifically activated caspase-9 and promoted caspase-9-induced apoptosis. As reported for Apaf-1, Nod1 required both the CARD and P-loop for function. Unlike Apaf-1, Nod1 induced activation of nuclear factor-kappa-B (NF-kappa B) and bound RICK, a CARD-containing kinase that also induces NF-KB activation. Nod1 mutants inhibited NF-KB activity induced by RICK, but not that resulting from tumor necrosis factor-cu stimulation. Thus, Nod1 is a leucine-rich repeat-containing Apaf-1-like molecule that can regulate both apoptosis and NF-kappa B activation pathways.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Cantabria, Dept Biol Mol, Unidad Inmunol, Santander 39011, Spain; Human Genome Sci, Rockville, MD 20850 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidad de Cantabria; GlaxoSmithKline; Human Genome Sciences Inc	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Nuñez, Gabriel/A-7160-2014; del Peso, Luis/K-9391-2014	del Peso, Luis/0000-0003-4014-5688; Carrio, Roberto/0000-0001-5527-8403	NATIONAL CANCER INSTITUTE [R01CA064556, K04CA064421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA64556, K04 CA64421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chaudhary D, 1998, J BIOL CHEM, V273, P17708, DOI 10.1074/jbc.273.28.17708; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Chinnaiyan AM, 1997, NATURE, V388, P728, DOI 10.1038/41913; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Peter ME, 1997, P NATL ACAD SCI USA, V94, P12736, DOI 10.1073/pnas.94.24.12736; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; SAKSELA K, 1993, MOL CELL BIOL, V13, P3698, DOI 10.1128/MCB.13.6.3698; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Verma IM, 1997, P NATL ACAD SCI USA, V94, P11758, DOI 10.1073/pnas.94.22.11758; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	55	595	639	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14560	14567		10.1074/jbc.274.21.14560	http://dx.doi.org/10.1074/jbc.274.21.14560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329646	hybrid			2022-12-27	WOS:000081965200011
J	Gatto, C; Lutsenko, S; Shin, JM; Sachs, G; Kaplan, JH				Gatto, C; Lutsenko, S; Shin, JM; Sachs, G; Kaplan, JH			Stabilization of the H,K-ATPase M5M6 membrane hairpin by K+ ions - Mechanistic significance for P-2-type ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; IN-VITRO TRANSLATION; ESCHERICHIA-COLI; CYTOPLASMIC LOOP; ATP-BINDING; IDENTIFICATION; CA2+-ATPASE; TOPOLOGY; PROTEINS; NA+,K+-ATPASE	The integral membrane protein, the gastric H,K-ATPase, is an alpha-beta heterodimer, with 10 putative transmembrane segments in the alpha-subunit and one such segment in the beta-subunit, All transmembrane segments remain within the membrane domain following trypsinization of the intact gastric H,K-ATPase in the presence of K+ ions, identified as M1M2, M3M4, M5M6, and M7, M8, M9, and M10, Removal of K+ ions from this digested preparation results in the selective loss of the M5M6 hairpin from the membrane. The release of the M5M6 fragment is directed to the extracellular phase as evidenced by the accumulation of the released M5M6 hairpin inside the sealed inside out vesicles. The stabilization of the M5M6 hairpin in the membrane phase by the transported cation as well as loss to the aqueous phase in the absence of the transported cation has been previously observed for another P-2-type ATPase, the Na,K-ATPase (Lutsenko, S., Anderko, R., and Kaplan, J. H. (1995) Proc. Natl, Acad. Sci. U. S. A. 92, 7936-7940). Thus, the effects of the counter-transported cation on retention of the M5M6 segment in the membrane as compared with the other membrane pairs may be a general feature of P-2-ATPase ion pumps, reflecting a flexibility of this region that relates to the mechanism of transport.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; W Los Angeles Vet Affairs Med Ctr, Ctr Ulcer Res, Los Angeles, CA 90073 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Kaplan, JH (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	kaplanj@ohsu.edu		Kaplan, Jack/0000-0002-7048-6574	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030315, F32HL009972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039500] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30315, HL09972] Funding Source: Medline; NIGMS NIH HHS [GM39500] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BAYLE D, 1995, J BIOL CHEM, V270, P25678, DOI 10.1074/jbc.270.43.25678; Beggah AT, 1999, J BIOL CHEM, V274, P8217, DOI 10.1074/jbc.274.12.8217; Beguin P, 1997, ANN NY ACAD SCI, V834, P540, DOI 10.1111/j.1749-6632.1997.tb52312.x; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; Besancon M, 1997, J BIOL CHEM, V272, P22438, DOI 10.1074/jbc.272.36.22438; BROTHERUS JR, 1981, BIOCHEM BIOPH RES CO, V100, P146, DOI 10.1016/S0006-291X(81)80075-7; CAPIEAUX E, 1993, J BIOL CHEM, V268, P21895; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Gatto C, 1999, BIOPHYS J, V76, pA450; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; Kaplan JH, 1997, ANN NY ACAD SCI, V834, P45, DOI 10.1111/j.1749-6632.1997.tb52224.x; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; Lingrel JB, 1997, ANN NY ACAD SCI, V834, P194, DOI 10.1111/j.1749-6632.1997.tb52251.x; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; RABON EC, 1993, J BIOL CHEM, V268, P8012; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; SACHS G, 1993, ALIMENT PHARM THER, V7, P4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIN JM, 1994, J BIOL CHEM, V269, P8642; Shin JM, 1997, ANN NY ACAD SCI, V834, P65, DOI 10.1111/j.1749-6632.1997.tb52226.x; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Xie YH, 1996, J BIOL CHEM, V271, P2563, DOI 10.1074/jbc.271.5.2563	35	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13737	13740		10.1074/jbc.274.20.13737	http://dx.doi.org/10.1074/jbc.274.20.13737			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318774	hybrid			2022-12-27	WOS:000080322200003
J	Pan, CJ; Lin, BC; Chou, JY				Pan, CJ; Lin, BC; Chou, JY			Transmembrane topology of human glucose 6-phosphate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-STORAGE-DISEASE; PUTATIVE GLUCOSE-6-PHOSPHATE TRANSLOCASE; ASPARAGINE-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; CHROMOSOME 11Q23; GENE; PROTEIN; IB; PHOSPHATE	Glycogen storage disease type 1b is caused by a deficiency in a glucose 6-phosphate transporter (G6PT) that translocates glucose 6-phosphate from the cytoplasm to the endoplasmic reticulum lumen where the active site of glucose 6-phosphatase is situated. Using amino- and carboxyl-terminal tagged G6PT, we demonstrate that proteolytic digestion of intact microsomes resulted in the cleavage of both tags, indicating that both termini of G6PT face the cytoplasm. This is consistent with ten and twelve transmembrane domain models for G6PT predicted by hydropathy analyses. A region of G6PT corresponding to amino acid residues 50-71, which constitute a transmembrane segment in the twelve-domain model, are situated in a 51-residue luminal loop in the ten-domain model. To determine which of these two models is correct, we generated two G6PT mutants, T53N and S55N, that created a potential Asn-linked glycosylation site at residues 53-55 ((NSS)-S-53) Or 55-57 (N(55)QS), respectively. (NSS)-S-53 Or N(55)QS would be glycosylated only if it is situated in a luminal loop larger than 33 residues as predicted by the ten-domain model. Whereas wild-type G6PT is not a glycoprotein, both T53N and S55N mutants are glycosylated, strongly supporting the ten-helical model for G6PT.	NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chou, JY (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Bldg 10,Rm 9S241, Bethesda, MD 20892 USA.	chou@helix.nih.gov	Lin, Baochuan/A-8390-2009	Lin, Baochuan/0000-0002-9484-0785				Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Arion W J, 1976, J Biol Chem, V251, P4891; ARION WJ, 1980, J BIOL CHEM, V255, P396; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; Chen Y-T, 1995, METABOLIC MOL BASES, P935; GERINI, 1997, FEBS LETT, V419, P235; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; GUTZEMANN R, 1993, EUR J PEDIATR S1, V152, pS33; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; HOFFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Kure S, 1998, BIOCHEM BIOPH RES CO, V248, P426, DOI 10.1006/bbrc.1998.8985; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lin BC, 1998, J BIOL CHEM, V273, P31656, DOI 10.1074/jbc.273.48.31656; LLOYD AD, 1990, J BACTERIOL, V172, P1688, DOI 10.1128/jb.172.4.1688-1693.1990; Marcolongo P, 1998, FEBS LETT, V436, P247, DOI 10.1016/S0014-5793(98)01129-6; NARISAWA K, 1978, BIOCHEM BIOPH RES CO, V83, P1360, DOI 10.1016/0006-291X(78)91371-2; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, V2, P349; Pan CJ, 1998, J BIOL CHEM, V273, P21658, DOI 10.1074/jbc.273.34.21658; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; STRUCK DK, 1977, J BIOL CHEM, V252, P1007; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Veiga-da-Cunha M, 1998, AM J HUM GENET, V63, P976, DOI 10.1086/302068; WESSELS HP, 1991, METHOD CELL BIOL, V34, P287; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590	29	62	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13865	13869		10.1074/jbc.274.20.13865	http://dx.doi.org/10.1074/jbc.274.20.13865			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318794	hybrid			2022-12-27	WOS:000080322200023
J	Perini, G; Oetjen, E; Green, MR				Perini, G; Oetjen, E; Green, MR			The hepatitis B pX protein promotes dimerization and DNA binding of cellular basic region leucine zipper proteins by targeting the conserved basic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X-PROTEIN; HTLV-I-TAX; LONG TERMINAL REPEAT; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BZIP PROTEINS; HBX PROTEIN; HEPATOCELLULAR-CARCINOMA; SEQUENCE REQUIREMENTS; TRANSACTIVATOR TAX	The hepatitis B virus pX protein is a potent transcriptional activator of viral and cellular genes whose mechanism of action is poorly understood. Here we show that pX dramatically stimulates in vitro DNA binding of a variety of cellular proteins that contain basic region/leucine zipper (bZIP) DNA binding domains. The basis for increased DNA binding is a direct interaction be tween pX and the conserved bZIP basic region, which promotes bZIP dimerization and the increased concentration of the bZIP homodimer then drives the DNA binding reaction. Unexpectedly, we found that the DNA binding specificity of various pX-bZIP complexes differs from one another and from that of the bZIP itself. Thus, through recognition of the conserved basic region, pX promotes dimerization, increases DNA binding, and alters DNA recognition. These properties-of pX are remarkably similar to those of the human T-cell lymphotrophic virus type I Tax protein. Although Tax and pX are not homologous, we show that the regions of the two proteins that stimulate bZIP binding contain apparent metal binding. sites. Finally, consistent with this in vitro activity, we provide evidence that both Tax and pX activate transcription in vivo, at least in part, by facilitating occupancy of bZIPs on target promoters.	Univ Massachusetts, Med Ctr, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Med Ctr, Howard Hughes Med Inst, Program Mol Med, 373 Plantat St,Suite 309, Worcester, MA 01605 USA.							ABDELHAFIZ HAM, 1993, ONCOGENE, V8, P1161; ARII M, 1992, ONCOGENE, V7, P397; ARMSTRONG AP, 1993, P NATL ACAD SCI USA, V90, P7303, DOI 10.1073/pnas.90.15.7303; AUFIERO B, 1990, EMBO J, V9, P497, DOI 10.1002/j.1460-2075.1990.tb08136.x; BARANGER AM, 1995, NATURE, V376, P606, DOI 10.1038/376606a0; Barnabas S, 1997, J BIOL CHEM, V272, P20684, DOI 10.1074/jbc.272.33.20684; BEIMLING P, 1992, ONCOGENE, V7, P257; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BLATTER EE, 1992, NATURE, V359, P650, DOI 10.1038/359650a0; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; DEMEDINA T, 1994, VIROLOGY, V202, P401, DOI 10.1006/viro.1994.1356; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FAKTOR O, 1990, ONCOGENE, V5, P867; FEUER G, 1992, BIOCHIM BIOPHYS ACTA, V1114, P223, DOI 10.1016/0304-419X(92)90017-S; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GOREN I, 1995, J VIROL, V69, P5806, DOI 10.1128/JVI.69.9.5806-5811.1995; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Henkler F, 1996, J VIRAL HEPATITIS, V3, P109, DOI 10.1111/j.1365-2893.1996.tb00001.x; HOHNE M, 1990, EMBO J, V9, P1137, DOI 10.1002/j.1460-2075.1990.tb08220.x; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; HU KQ, 1990, P NATL ACAD SCI USA, V87, P7140, DOI 10.1073/pnas.87.18.7140; HU KQ, 1992, P NATL ACAD SCI USA, V89, P11441, DOI 10.1073/pnas.89.23.11441; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; KIDDLJUNGGREN K, 1995, J GEN VIROL, V76, P2119, DOI 10.1099/0022-1317-76-9-2119; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; KOIKE K, 1989, MOL BIOL MED, V6, P151; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; LOPEZCABRERA M, 1991, VIROLOGY, V183, P825, DOI 10.1016/0042-6822(91)91019-D; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Marriott SJ, 1996, VIROLOGY, V224, P206, DOI 10.1006/viro.1996.0522; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; NATOLI G, 1994, MOL CELL BIOL, V14, P989, DOI 10.1128/MCB.14.2.989; NATOLI G, 1994, ONCOGENE, V9, P2837; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Palmer CR, 1997, BIOCHEMISTRY-US, V36, P15349, DOI 10.1021/bi972076m; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; PERINI G, 1995, NATURE, V376, P602, DOI 10.1038/376602a0; RENNER M, 1995, J HEPATOL, V23, P53, DOI 10.1016/0168-8278(95)80311-4; ROBINSON WS, 1994, ANNU REV MED, V45, P297; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; SEMMES OJ, 1992, VIROLOGY, V188, P754, DOI 10.1016/0042-6822(92)90530-3; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; SHERKER AH, 1991, ANNU REV MICROBIOL, V45, P475; SHIRAKATA Y, 1989, JPN J CANCER RES, V80, P617, DOI 10.1111/j.1349-7006.1989.tb01686.x; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SPANDAU DF, 1988, J VIROL, V62, P427, DOI 10.1128/JVI.62.2.427-434.1988; TAKADA S, 1994, ONCOGENE, V9, P341; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; TWU JS, 1989, P NATL ACAD SCI USA, V86, P5168, DOI 10.1073/pnas.86.13.5168; UNGER T, 1990, EMBO J, V9, P1889, DOI 10.1002/j.1460-2075.1990.tb08315.x; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; WU JY, 1990, CELL, V63, P687, DOI 10.1016/0092-8674(90)90135-2; Xu X, 1996, VIROLOGY, V218, P362, DOI 10.1006/viro.1996.0205; Yoshida M, 1993, Trends Microbiol, V1, P131, DOI 10.1016/0966-842X(93)90127-D; ZAHM P, 1988, ONCOGENE, V3, P169; ZHOU DX, 1990, J VIROL, V64, P4025, DOI 10.1128/JVI.64.8.4025-4028.1990; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	75	27	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13970	13977		10.1074/jbc.274.20.13970	http://dx.doi.org/10.1074/jbc.274.20.13970			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318808	hybrid			2022-12-27	WOS:000080322200037
J	Basran, J; Jang, MH; Sutcliffe, MJ; Hille, R; Scrutton, NS				Basran, J; Jang, MH; Sutcliffe, MJ; Hille, R; Scrutton, NS			The role of Tyr-169 of trimethylamine dehydrogenase in substrate oxidation and magnetic interaction between FMN cofactor and the 4Fe/4S center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; COVALENTLY BOUND COENZYME; WILD-TYPE; DIMETHYLAMINE DEHYDROGENASE; METHYLOTROPHIC BACTERIUM; PROSTHETIC GROUPS; C30A MUTANT; FLAVOPROTEIN; KINETICS; FLAVIN	Tyr-169 in trimethylamine dehydrogenase is one component of a triad also comprising residues His-172 and Asp-267. Its role in catalysis and in mediating the magnetic interaction between FMN cofactor and the 4Fe/4S center have been investigated by stopped-flow and EPR spectroscopy of a Tyr-169 to Phe (Y169F) mutant of the enzyme. Tyr-169 is shown to play an important role in catalysis (mutation to phenylalanine reduces the limiting rate constant for bleaching of the active site flavin by about 100-fold) but does not serve as a general base in the course of catalysis. In addition, we are able to resolve two kinetically influential ionizations involved in both the reaction of free enzyme with free substrate (as reflected in k(lim)/K-d) and in the breakdown of the E-ox.S complex (as reflected in k(lim)). In EPR studies of the Y169F mutant, it is found that the ability of the Y169F enzyme to form the spin-interacting state between flavin semiquinone and reduced 4Fe/4S center characteristic of wild-type enzyme is significantly compromised. The present results are consistent with Tyr-169 representing the ionizable group of pK(a) similar to 9.5, previously identified in pH-jump studies of electron transfer, whose deprotonation must occur for the spin-interacting state to be established.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; Ohio State Univ, Dept Med Biochem, Columbus, OH 43210 USA	University of Leicester; University of Leicester; University System of Ohio; Ohio State University	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.			Sutcliffe, Mike/0000-0003-0414-1700				Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; BOYD G, 1992, FEBS LETT, V308, P271, DOI 10.1016/0014-5793(92)81291-S; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Falzon L, 1996, BIOCHEMISTRY-US, V35, P2445, DOI 10.1021/bi951550q; HILL CL, 1977, P NATL ACAD SCI USA, V74, P547, DOI 10.1073/pnas.74.2.547; Huang LX, 1996, J BIOL CHEM, V271, P13401, DOI 10.1074/jbc.271.23.13401; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; KASPRZAK AA, 1983, BIOCHEM J, V211, P535, DOI 10.1042/bj2110535; LIM LW, 1986, J BIOL CHEM, V261, P5140; Mewies M, 1996, BIOCHEM J, V317, P267, DOI 10.1042/bj3170267; Mewies M, 1997, BIOCHEMISTRY-US, V36, P7162, DOI 10.1021/bi970621d; PACKMAN LC, 1995, J BIOL CHEM, V270, P13186, DOI 10.1074/jbc.270.22.13186; ROHLFS RJ, 1994, J BIOL CHEM, V269, P30869; ROHLFS RJ, 1995, J BIOL CHEM, V270, P22196, DOI 10.1074/jbc.270.38.22196; ROHLFS RJ, 1991, J BIOL CHEM, V266, P15244; Sambrook J., 2002, MOL CLONING LAB MANU; SCRUTTON NS, 1994, J BIOL CHEM, V269, P13942; SINGER TP, 1980, FLAVINS FLAVOPROTEIN, P277; STEENKAMP DJ, 1982, BIOCHEM J, V207, P233, DOI 10.1042/bj2070233; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; STEENKAMP DJ, 1978, BIOCHEM J, V169, P361, DOI 10.1042/bj1690361; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2812; STEENKAMP DJ, 1976, BIOCHIM BIOPHYS ACTA, V429, P705, DOI 10.1016/0005-2744(76)90319-3; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P4086; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; STEENKAMP DJ, 1978, MECHANISMS OXIDIZING, P127; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; WILSON EK, 1995, BIOCHEMISTRY-US, V34, P2584, DOI 10.1021/bi00008a024; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q	30	18	18	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13155	13161		10.1074/jbc.274.19.13155	http://dx.doi.org/10.1074/jbc.274.19.13155			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224070	hybrid			2022-12-27	WOS:000080200400032
J	Burmester, T				Burmester, T			Identification, molecular cloning, and phylogenetic analysis of a non-respiratory pseudo-hemocyanin of Homarus americanus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANULIRUS-INTERRUPTUS HEMOCYANIN; ARTHROPOD HEMOCYANINS; PHENOL OXIDASE; EVOLUTION; PROTEIN; SUBUNIT; SEQUENCE; CDNA; ARYLPHORIN; ELECTROPHORESIS	Copper-containing hemocyanins serve to transport oxygen in many arthropod species. Here I describe the identification and cDNA cloning of a structurally closely related non-respiratory pseudo-hemocyanin (PHc) of the American lobster, Homarus americanus, This protein has lost the ability to bind copper and, therefore, oxygen because a histidine residue in copper-binding site A is replaced by tyrosine, Like many arthropod hemocyanins, PHc forms a hexamer, It consists of two different subunit types of 660 and 661 amino acids, respectively, that share a 94.4% sequence identity. Whereas Homarus hemocyanin is produced in the hepatopancreas, PHc is synthesized by the ovaries and the heart tissue. Because different levels of PHc were observed in distinct individuals, I propose an association of the synthesis of this protein with the molting or reproduction cycle, similar to the hexamerins, insect storage proteins that are also related to the hemocyanins, However, phylogenetic analyses show that PHc derived independently from crustacean hemocyanins. Therefore, Homarus PHc is a member of a new class within the growing hemocyanin protein superfamily.	Univ Mainz, Inst Zool, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Univ Mainz, Inst Zool, D-55099 Mainz, Germany.		Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863				BAK HJ, 1987, FEBS LETT, V204, P141; BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493; Burmester T, 1998, J MOL EVOL, V47, P93, DOI 10.1007/PL00006366; Burmester T, 1996, J MOL EVOL, V42, P713, DOI 10.1007/BF02338804; DAYHOFF MO, 1979, ATLAS PROTEIN SEQ S3, V5; DEPLEDGE MH, 1989, HELGOLANDER MEERESUN, V43, P207, DOI 10.1007/BF02367900; Durstewitz G, 1997, MOL BIOL EVOL, V14, P266, DOI 10.1093/oxfordjournals.molbev.a025762; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; FUJIMOTO K, 1995, P NATL ACAD SCI USA, V92, P7769, DOI 10.1073/pnas.92.17.7769; GAYKEMA WPJ, 1984, NATURE, V309, P23, DOI 10.1038/309023a0; HARRIS JR, 1970, J ULTRA MOL STRUCT R, V33, P219, DOI 10.1016/S0022-5320(70)90017-1; Jekel PA, 1996, COMP BIOCHEM PHYS B, V115, P243, DOI 10.1016/0305-0491(96)00119-8; JEKEL PA, 1988, EUR J BIOCHEM, V178, P403, DOI 10.1111/j.1432-1033.1988.tb14464.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINZEN B, 1985, SCIENCE, V229, P519, DOI 10.1126/science.4023698; MANGUM CP, 1983, BIOL CRUSTACEA, V5, P373; MARKL J, 1979, J COMP PHYSIOL, V130, P283, DOI 10.1007/BF00689845; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; MARKL J, 1986, BIOL BULL, V171, P90, DOI 10.2307/1541909; MARKL J, 1992, J COMP PHYSIOL B, V162, P665, DOI 10.1007/BF00301616; MARKL J, 1979, J COMP PHYSL, V133, P67; NEUTEBOOM B, 1992, EUR J BIOCHEM, V206, P243, DOI 10.1111/j.1432-1033.1992.tb16922.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez D, 1998, MOL BIOL EVOL, V15, P415, DOI 10.1093/oxfordjournals.molbev.a025938; SCHELLER K, 1977, J INSECT PHYSIOL, V23, P285, DOI 10.1016/0022-1910(77)90043-9; Sellos D, 1997, FEBS LETT, V407, P153, DOI 10.1016/S0014-5793(97)00350-5; SENKBEIL EG, 1981, COMP BIOCHEM PHYS B, V68, P163, DOI 10.1016/0305-0491(81)90198-X; STOCKER W, 1988, J COMP PHYSIOL B, V158, P271, DOI 10.1007/BF00695326; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Terwilliger NB, 1999, P NATL ACAD SCI USA, V96, P2013, DOI 10.1073/pnas.96.5.2013; TURBEVILLE JM, 1991, MOL BIOL EVOL, V8, P669; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; WILLOTT E, 1989, J BIOL CHEM, V264, P19052	36	50	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13217	13222		10.1074/jbc.274.19.13217	http://dx.doi.org/10.1074/jbc.274.19.13217			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224079	hybrid			2022-12-27	WOS:000080200400041
J	Ardehali, H; Printz, RL; Whitesell, RR; May, JM; Granner, DK				Ardehali, H; Printz, RL; Whitesell, RR; May, JM; Granner, DK			Functional interaction between the N- and C-terminal halves of human hexokinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN HEXOKINASE; DEPENDENT DIABETES-MELLITUS; RATE-LIMITING STEP; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; MAMMALIAN HEXOKINASES; CRYSTAL-STRUCTURE; REGULATORY SITE; BINDING-SITE; INSULIN	Mammalian hexokinases (HKs) I-III are composed of two highly homologous similar to 50-kDa halves. Studies of HKI indicate that the C-terminal half of the molecule is active and is sensitive to inhibition by glucose B-phosphate (G6P), whereas the N-terminal half binds G6P but is devoid of catalytic activity. In contrast, both the N- and C-terminal halves of HKII (N-HKII and C-HKII, respectively) are catalytically active, and when expressed as discrete proteins both are inhibited by G6P, However, C-HKII has a significantly higher K-i for G6P (K-iG6P) than N-HKII. We here address the question of whether the high K-iG6P of the C-terminal half (C-half) of HKII is decreased by interaction with the N-terminal half (N-half) in the context of the intact enzyme. A chimeric protein consisting of the N-half of HKI and the C-half of HKII was prepared. Because the N-half of HKI is unable to phosphorylate glucose, the catalytic activity of this chimeric enzyme depends entirely on the C-HKII component. The K-iG6P of this chimeric enzyme is similar to that of HKI and is significantly lower than that of C-HKII. When a conserved amino acid (Asp(209)) required for glucose binding is mutated in the N-half of this chimeric protein, a significantly higher K-iG6P (similar to that of C-HKII) is observed. However, mutation of a second conserved amino acid (Ser(155)), also involved in catalysis but not required for glucose binding, does not increase the K-iG6P of the chimeric enzyme. This resembles the behavior of HKII, in which a D209A mutation results in an increase in the K-iG6P of the enzyme, whereas a S155A mutation does not. These results suggest an interaction in which glucose binding by the N-half causes the activity of the C-half to be regulated by significantly lower concentrations of G6P.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Granner, DK (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, 707 Light Hall, Nashville, TN 37232 USA.				NIDDK NIH HHS [DK20593, DK46867] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK046867, P60DK020593] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleshin AE, 1998, FEBS LETT, V434, P42, DOI 10.1016/S0014-5793(98)00952-1; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; ANDERSON CM, 1978, J MOL BIOL, V123, P207, DOI 10.1016/0022-2836(78)90321-2; ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; ARORA KK, 1993, J BIOL CHEM, V268, P18259; ARORA KK, 1991, J BIOL CHEM, V266, P5359; BAIJAL M, 1992, ARCH BIOCHEM BIOPHYS, V298, P271, DOI 10.1016/0003-9861(92)90123-E; Baque S, 1998, DIABETES, V47, P1392, DOI 10.2337/diabetes.47.9.1392; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Beechem JM., 2002, TOPICS FLUORESCENCE, P241, DOI DOI 10.1007/0-306-47058-6_5; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; Bonadonna RC, 1996, DIABETES, V45, P915, DOI 10.2337/diabetes.45.7.915; CROFFORD OB, 1965, J BIOL CHEM, V240, P3237; CROFFORD OB, 1965, J BIOL CHEM, V240, P14; Fang TY, 1998, J BIOL CHEM, V273, P19548, DOI 10.1074/jbc.273.31.19548; GARFINKEL D, 1984, AM J PHYSIOL, V247, pR527, DOI 10.1152/ajpregu.1984.247.3.R527; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; KATZ A, 1988, AM J PHYSIOL, V255, pE942, DOI 10.1152/ajpendo.1988.255.6.E942; Kelley DE, 1996, J CLIN INVEST, V97, P2705, DOI 10.1172/JCI118724; KIPNIS DM, 1959, J BIOL CHEM, V234, P165; Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107; KUBO K, 1986, AM J PHYSIOL, V250, pE100, DOI 10.1152/ajpendo.1986.250.1.E100; LANGE AJ, 1991, BIOCHEM J, V277, P159, DOI 10.1042/bj2770159; MEHTA A, 1988, J BIOL CHEM, V263, P15492; MORGAN HE, 1961, J BIOL CHEM, V236, P253; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; STEITZ TA, 1977, J BIOL CHEM, V252, P4494; Tsai HJ, 1996, ARCH BIOCHEM BIOPHYS, V329, P17, DOI 10.1006/abbi.1996.0186; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; WHITE TK, 1987, ARCH BIOCHEM BIOPHYS, V259, P402, DOI 10.1016/0003-9861(87)90506-6; WHITESELL RR, 1995, J CEREBR BLOOD F MET, V15, P814, DOI 10.1038/jcbfm.1995.102; WHITESELL RR, 1993, J CELL PHYSIOL, V157, P509, DOI 10.1002/jcp.1041570310; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776	39	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15986	15989		10.1074/jbc.274.23.15986	http://dx.doi.org/10.1074/jbc.274.23.15986			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347146	hybrid			2022-12-27	WOS:000080668600006
J	Lopez-Coronado, JM; Belles, JM; Lesage, F; Serrano, R; Rodriguez, PL				Lopez-Coronado, JM; Belles, JM; Lesage, F; Serrano, R; Rodriguez, PL			A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3 '-phosphoadenosine 5 '-phosphate phosphatase and inositol-polyphosphate 1-phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE; SALT TOLERANCE; YEAST; GENE; SULFOTRANSFERASE; INHIBITION; TOXICITY; FAMILY; PAPS	We report the molecular cloning in Rattus norvegicus of a novel mammalian enzyme (RnPIP), which shows both 3'-phosphoadenosine 5'-phosphate (PAP) phosphatase and inositol-polyphosphate l-phosphatase activities. This enzyme is the first PAP phosphatase characterized at the molecular level in mammals, and it represents the first member of a novel family of dual specificity enzymes. The phosphatase activity is strictly dependent on Mg2+, and it is inhibited by Ca2+ and Li+ ions. Lithium chloride inhibits the hydrolysis of both PAP and inositol-1,4-bisphosphate at submillimolar concentration; therefore, it is possible that the inhibition of the human homologue of RnPIP by lithium ions is related to the pharmacological action of lithium. We propose that the PAP phosphatase activity of RnPIP is crucial for the function of enzymes sensitive to inhibition by PAP, such as sulfotransferase and RNA processing enzymes. Finally, an unexpected connection between PAP and inositol-1,4-bisphosphate metabolism emerges from this work.	Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain; Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, F-06560 Valbonne, France	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Rodriguez, PL (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain.		Bellés, José María/H-4734-2015; Lesage, Florian/D-5097-2011; Lesage, Florian/P-9780-2019; Rodriguez, Pedro L./K-4605-2014	Bellés, José María/0000-0003-0362-9616; Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; Rodriguez, Pedro L./0000-0002-5886-9425				BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BRUNNGRABER EG, 1958, J BIOL CHEM, V233, P472; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Jenkinson S, 1995, Methods Mol Biol, V41, P151; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; LESAGE F, 1994, NUCLEIC ACIDS RES, V22, P3685, DOI 10.1093/nar/22.18.3685; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MARCUS F, 1980, J BIOL CHEM, V255, P2481; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; RAMASWAMY SG, 1987, J BIOL CHEM, V262, P10044; RENSDOMIANO SS, 1987, J NEUROCHEM, V48, P1411, DOI 10.1111/j.1471-4159.1987.tb05679.x; Roth J. A., 1982, SULFATE METABOLISM S, P107; SCHWENN JD, 1988, ARCH MICROBIOL, V150, P313, DOI 10.1007/BF00408300; Thomas W., 1992, Human Molecular Genetics, V1, P138, DOI 10.1093/hmg/1.2.138-a; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149	23	56	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16034	16039		10.1074/jbc.274.23.16034	http://dx.doi.org/10.1074/jbc.274.23.16034			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347153	hybrid			2022-12-27	WOS:000080668600013
J	Berneburg, M; Grether-Beck, S; Kurten, V; Ruzicka, T; Briviba, K; Sies, H; Krutmann, J				Berneburg, M; Grether-Beck, S; Kurten, V; Ruzicka, T; Briviba, K; Sies, H; Krutmann, J			Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-SCALE DELETIONS; OXIDATIVE DAMAGE; HUMAN SKIN; DNA-DAMAGE; STRAND BREAKS; EXPRESSION; CELLS; COLLAGENASE; RADIATION; MUTATIONS	Mutations of mitochondrial (mt) DNA accumulate during normal aging. The most frequent mutation is a 4,977-base pair deletion also called the common deletion, which is increased in photoaged skin. Oxidative stress may play a major role in the generation of large scale mtDNA deletions, but direct proof for this has been elusive. We therefore assessed whether the common deletion can be generated in vitro through UV irradiation and whether reactive oxygen species are involved in this process, Normal human fibroblasts were repetitively exposed to sublethal doses of UVA radiation and assayed for the common deletion employing a semiquantitative polymerase chain reaction technique. There was a time/dose-dependent generation of the common deletion, attributable to the generation of singlet oxygen, since the common deletion was diminished when irradiating in the presence of singlet oxygen quenchers, but increased when enhancing singlet oxygen half-life by deuterium oxide. The induction of the common deletion by UVA irradiation was mimicked by treatment of unirradiated cells with singlet oxygen produced by the thermodecomposition of an endoperoxide. These studies provide evidence for the involvement of reactive oxygen species in the generation of aging-associated mtDNA lesions in human cells and indicate a previously unrecognized role of singlet oxygen in photoaging of human skin.	Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Physiol Chem 1, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Krutmann, J (corresponding author), Univ Dusseldorf, Dept Dermatol, Moorenstr 5, D-40225 Dusseldorf, Germany.		Sies, Helmut/B-7266-2008; Sies, Helmut/ABE-7355-2020	Sies, Helmut/0000-0002-1000-3198; Briviba, Karlis/0000-0003-3338-7515				AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arkin MR, 1997, CHEM BIOL, V4, P389, DOI 10.1016/S1074-5521(97)90129-0; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x; BOURGERON T, 1993, J BIOL CHEM, V268, P19369; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; DEVASAGAYAM TPA, 1991, BIOCHEMISTRY-US, V30, P6283, DOI 10.1021/bi00239a029; DI MASCIO P, 1989, J AM CHEM SOC, V111, P2909, DOI 10.1021/ja00190a027; DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042; FLOYD RA, 1989, ARCH BIOCHEM BIOPHYS, V273, P106, DOI 10.1016/0003-9861(89)90167-7; Frederick JE, 1992, BIOL RESPONSES ULTRA, P7; GATTERMANN N, 1995, LEUKEMIA, V9, P1704; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576; HENNINGER HP, 1993, BIOL CHEM H-S, V374, P625, DOI 10.1515/bchm3.1993.374.7-12.625; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; Ito K, 1997, BIOL CHEM, V378, P1307; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MODAK SB, 1993, CANCER RES, V53, P4505; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; SCHARFFETTERKOCHANEK K, 1993, FEBS LETT, V331, P304, DOI 10.1016/0014-5793(93)80357-Z; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Sies H, 1996, J PHOTOCH PHOTOBIO B, V32, P97, DOI 10.1016/1011-1344(95)07192-X; WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023; Wei Yau-Huei, 1998, Proceedings of the National Science Council Republic of China Part B Life Sciences, V22, P55; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; WLASCHEK M, 1995, J INVEST DERMATOL, V104, P194, DOI 10.1111/1523-1747.ep12612751; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YANG JH, 1995, ARCH DERMATOL RES, V287, P641; YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	42	282	299	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15345	15349		10.1074/jbc.274.22.15345	http://dx.doi.org/10.1074/jbc.274.22.15345			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336420	hybrid			2022-12-27	WOS:000080560100009
J	Klatt, P; Molina, EP; Lamas, S				Klatt, P; Molina, EP; Lamas, S			Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; REDOX REGULATION; NITROSATIVE STRESS; SERUM-ALBUMIN; SULFENIC ACID; IN-VITRO; THIOLS; AP-1; NITROSOGLUTATHIONE; TRANSCRIPTION	This study addresses potential molecular mechanisms underlying the inhibition of the transcription factor c-Jun by nitric oxide. We show that in the presence of the physiological sulfhydryl glutathione nitric oxide modifies the two cysteine residues contained in the DNA binding module of c-Jun in a selective and distinct way. Although nitric oxide induced the formation of an intermolecular disulfide bridge between cysteine residues in the leucine zipper site of c-Jun monomers, this same radical directed the covalent incorporation of stoichiometric amounts of glutathione to a single conserved cysteine residue in the DNA-binding site of the protein. We found that covalent dimerization of c-Jun apparently did not affect its DNA binding activity, whereas the formation of a mixed disulfide with glutathione correlated well with the inhibition of transcription factor binding to DNA. Furthermore, we provide experimental evidence that nitric oxide-induced S-glutathionylation and inhibition of c-Jun involves the formation of S-nitrosoglutathione. In conclusion, our results support the reversible formation of a mixed disulfide between glutathione and c-Jun as a potential mechanism by which nitrosative stress may be transduced into a functional response at the level of transcription.	CSIC, Ctr Invest Biol, Dept Estructura & Func Proteinas, Inst Reina Sofia Invest Nefrol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Lamas, S (corresponding author), CSIC, Ctr Invest Biol, Dept Estructura & Func Proteinas, Inst Reina Sofia Invest Nefrol, Calle Velazquez 144, E-28006 Madrid, Spain.	pklatt@cib.csic.es; slamas@cib.csic.es	Lamas, Santiago/G-7308-2015; Pineda-Molina, Estela/K-9969-2014	Lamas, Santiago/0000-0001-5166-4155; Pineda-Molina, Estela/0000-0002-4266-0192				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BANNISTER AJ, 1991, ONCOGENE, V6, P1243; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brendeford EM, 1998, FEBS LETT, V425, P52, DOI 10.1016/S0014-5793(98)00196-3; Chandra A, 1997, BIOCHEMISTRY-US, V36, P15801, DOI 10.1021/bi9714722; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Conant K, 1998, J NEUROIMMUNOL, V88, P39, DOI 10.1016/S0165-5728(98)00069-1; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; DEMASTER EG, 1995, BIOCHEMISTRY-US, V34, P11494, DOI 10.1021/bi00036a023; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; FURCHGOTT RF, 1995, ANNU REV PHARMACOL, V35, P1; Galter Dagmar, 1994, European Journal of Biochemistry, V221, P639; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gorren ACF, 1996, ARCH BIOCHEM BIOPHYS, V330, P219, DOI 10.1006/abbi.1996.0247; GREEN LC, 1982, ANAL BIOCHEM, V162, P156; Hardison R, 1978, Methods Cell Biol, V17, P235, DOI 10.1016/S0091-679X(08)61146-2; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Liu ZG, 1998, J PHARMACOL EXP THER, V284, P526; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEYER DJ, 1994, FEBS LETT, V345, P177, DOI 10.1016/0014-5793(94)00429-3; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; Nikitovic D, 1998, BIOCHEM BIOPH RES CO, V242, P109, DOI 10.1006/bbrc.1997.7930; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; OEHLER T, 1993, ONCOGENE, V8, P1141; Oliveira L, 1999, J BIOL CHEM, V274, P516, DOI 10.1074/jbc.274.1.516; Padgett CM, 1998, ARCH BIOCHEM BIOPHYS, V358, P232, DOI 10.1006/abbi.1998.0859; PARK EM, 1988, BIOCHIM BIOPHYS ACTA, V964, P151, DOI 10.1016/0304-4165(88)90161-4; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; SCHARFSTEIN JS, 1994, J CLIN INVEST, V94, P1432, DOI 10.1172/JCI117480; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; Schmidt K, 1997, N-S ARCH PHARMACOL, V355, P457, DOI 10.1007/PL00004969; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; SIES H, 1975, EUR J BIOCHEM, V57, P503, DOI 10.1111/j.1432-1033.1975.tb02325.x; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tabuchi A, 1996, J BIOL CHEM, V271, P31061, DOI 10.1074/jbc.271.49.31061; TABUCHI A, 1994, FEBS LETT, V351, P123, DOI 10.1016/0014-5793(94)00839-6; THOMAS JA, 1994, METHOD ENZYMOL, V233, P385; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wink DA, 1997, J BIOL CHEM, V272, P11147; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1994, METHOD ENZYMOL, V234, P163; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	60	137	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15857	15864		10.1074/jbc.274.22.15857	http://dx.doi.org/10.1074/jbc.274.22.15857			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336489	hybrid, Green Published			2022-12-27	WOS:000080560100078
J	Wood, WM; Dowding, JM; Gordon, DF; Ridgway, EC				Wood, WM; Dowding, JM; Gordon, DF; Ridgway, EC			An upstream regulator of the glycoprotein hormone cu-subunit gene mediates pituitary cell type activation and repression by different mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC ENHANCER; ALPHA-SUBUNIT; GROWTH-HORMONE; TRANSCRIPTION FACTOR; PROMOTER ACTIVITY; HOMEODOMAIN PROTEINS; EXPRESSION; PIT-1; ELEMENTS; LIM	Targeting of alpha-subunit gene expression within the pituitary is influenced by an upstream regulatory region that directs high level expression to thyrotropes and gonadotropes of transgenic mice. The same region also enhanced the activity of the proximal promoter in transfections of pituitary-derived alpha-TSH and alpha-T3 cells. We have localized the activating sequences to a 125-bp region that contains consensus sites for factors that also play a role in proximal promoter activity. Proteins present in alpha-TSH and alpha-T3 cells as well as those from GH3 somatotrope-derived cells interact with this region. The upstream area inhibited proximal alpha-promoter activity by 80% when transfected into GH3 cells. Repression in GH3 cells was mediated through a different mechanism than enhancement, as supported by the following evidence. Reversing the orientation of the area resulted in a loss of proximal promoter activation in alpha-TSH and alpha-T3 cells but did not relieve repression in GH3 cells. Mutation of proximal sites shown to be important for activation had no effect on repression. Finally, bidirectional deletional analysis revealed that multiple elements are involved in activation and repression and, together with the DNA binding studies, suggests that these processes may be mediated through closely juxtaposed or even overlapping elements, thus perhaps defining a new class of bifunctional gene regulatory sequence.	Univ Colorado, Hlth Sci Ctr, Dept Med Endocrinol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol Diabet & Metab, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Wood, WM (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med Endocrinol, B-151,4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047407] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47407, DK 36842] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; ANDERSEN B, 1990, J BIOL CHEM, V265, P21874; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; BARNHART KM, 1994, MOL ENDOCRINOL, V8, P878, DOI 10.1210/me.8.7.878; BOKAR JA, 1989, MOL CELL BIOL, V9, P5113, DOI 10.1128/MCB.9.11.5113; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; Brinkmeier ML, 1998, MOL ENDOCRINOL, V12, P622, DOI 10.1210/me.12.5.622; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; GORDON DF, 1993, MOL CELL ENDOCRINOL, V96, P75, DOI 10.1016/0303-7207(93)90097-4; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; HAMERNIK DL, 1992, MOL ENDOCRINOL, V6, P1745, DOI 10.1210/me.6.10.1745; HAUGEN BR, 1994, MOL ENDOCRINOL, V8, P1574, DOI 10.1210/me.8.11.1574; HECKERT LL, 1995, J BIOL CHEM, V270, P26497, DOI 10.1074/jbc.270.44.26497; HORN F, 1992, MOL CELL BIOL, V12, P2143, DOI 10.1128/MCB.12.5.2143; HOWARD PW, 1995, J BIOL CHEM, V270, P20930, DOI 10.1074/jbc.270.36.20930; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHIBASHI M, 1987, J CLIN ENDOCR METAB, V64, P1187, DOI 10.1210/jcem-64-6-1187; JACKSON SM, 1995, MOL ENDOCRINOL, V9, P278, DOI 10.1210/me.9.3.278; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; REN SC, 1993, BLOOD, V81, P1058; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Sarapura VD, 1998, MOL CELL ENDOCRINOL, V146, P77, DOI 10.1016/S0303-7207(98)00195-6; SARAPURA VD, 1992, THYROID, V2, P31, DOI 10.1089/thy.1992.2.31; SARAPURA VD, 1990, ENDOCRINOLOGY, V127, P1352, DOI 10.1210/endo-127-3-1352; SCHAUFELE F, 1990, J BIOL CHEM, V265, P17189; SCHODERBEK WE, 1992, MOL ENDOCRINOL, V6, P893, DOI 10.1210/me.6.6.893; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; SEIDAH NG, 1994, DNA CELL BIOL, V13, P1163, DOI 10.1089/dna.1994.13.1163; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; STEGER DJ, 1991, MOL ENDOCRINOL, V5, P243, DOI 10.1210/mend-5-2-243; SWANSON LW, 1992, PROG BRAIN RES, V92, P97, DOI 10.1016/S0079-6123(08)61167-X; TANSEY WP, 1991, J BIOL CHEM, V266, P9805; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; WALDMAN IA, 1997, EMBO J, V16, P3145; WHITE MC, 1986, CLIN ENDOCRINOL, V25, P173, DOI 10.1111/j.1365-2265.1986.tb01679.x; Wood WM, 1998, MOL CELL ENDOCRINOL, V142, P141, DOI 10.1016/S0303-7207(98)00110-5; WOOD WM, 1989, J BIOL CHEM, V264, P14840; Wood WM, 1996, J BIOL CHEM, V271, P24213, DOI 10.1074/jbc.271.39.24213	45	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15526	15532		10.1074/jbc.274.22.15526	http://dx.doi.org/10.1074/jbc.274.22.15526			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336446	hybrid			2022-12-27	WOS:000080560100035
J	McAbee, DD; Jiang, X				McAbee, DD; Jiang, X			Copper and zinc ions differentially block asialoglycoprotein receptor-mediated endocytosis in isolated rat hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSYL RECEPTORS; MOLECULAR-BIOLOGY; HOLO-LACTOFERRIN; APO-LACTOFERRIN; FATTY ACYLATION; BINDING; IRON; CELLS; SUBPOPULATION; INACTIVATION	Asialoglycoprotein receptors on hepatocytes lose endocytic and ligand binding activity when hepatocytes are exposed to iron ions. Here, we report the effects of zinc and copper ions on the endocytic and ligand binding activity of asialoglycoprotein receptors on isolated rat hepatocytes. Treatment of cells at 37 degrees C for 2 h with ZnCl2 (0-220 mu M) or CuCl2 (0-225 mu M) reversibly blocked sustained endocytosis of I-125-asialoorosomucoid by up to 93% (t(1/2) = 62 min) and 99% (t(1/2) = 54 min), respectively. Cells remained viable during such treatments. Zinc- and copper-treated cells lost similar to 50% of their surface asialoglycoprotein receptor ligand binding activity; zinc-treated cells accumulated inactive asialoglycoprotein receptors intracellularly, whereas copper-treated cells accumulated inactive receptors on their surfaces. Cells treated at 4 degrees C with metal did not lose surface asialoglycoprotein receptor activity. Exposure of cells to copper ions, but not to zinc ions, blocked internalization of prebound 125I-asialoorosomucoid, but degradation of internalized ligand and pinocytosis of the fluid-phase marker Lucifer Yellow were not blocked by metal treatment. Zinc ions reduced diferric transferrin binding and endocytosis on hepatocytes by similar to 33%; copper ions had no inhibitory effects. These findings are the first demonstration of a specific inhibition of receptor-mediated endocytosis by non-iron transition metals.	Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	McAbee, DD (corresponding author), Calif State Univ Long Beach, Dept Chem & Biochem, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043355] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43355] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennatt DJ, 1997, BIOCHEMISTRY-US, V36, P8359, DOI 10.1021/bi963078u; Bennatt DJ, 1997, BIOCHEMISTRY-US, V36, P8367, DOI 10.1021/bi963079m; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; Eide D, 1997, CURR OPIN CELL BIOL, V9, P573, DOI 10.1016/S0955-0674(97)80036-1; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Mason A. Z., 1995, METAL SPECIATION BIO, P479; MCABEE DD, 1991, J CELL BIOCHEM, V45, P59, DOI 10.1002/jcb.240450113; MCABEE DD, 1988, BIOCHEMISTRY-US, V27, P2061, DOI 10.1021/bi00406a037; MCABEE DD, 1993, BIOCHEMISTRY-US, V32, P13749, DOI 10.1021/bi00212a046; MCABEE DD, 1991, J BIOL CHEM, V266, P23624; MCABEE DD, 1987, J BIOL CHEM, V262, P1942; McAbee DD, 1998, BIOCHEM J, V331, P719, DOI 10.1042/bj3310719; McAbee DD, 1997, J CELL PHYSIOL, V171, P75; OKA JA, 1989, J BIOL CHEM, V264, P12016; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; QIAN YC, 1995, AM J PHYSIOL-CELL PH, V269, pC892, DOI 10.1152/ajpcell.1995.269.4.C892; SCHACHTE.H, 1970, J BIOL CHEM, V245, P1090; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; TROWBRIDGE IS, 1992, J INORG BIOCHEM, V47, P209, DOI 10.1016/0162-0134(92)84066-V; Weigel P H, 1993, Subcell Biochem, V19, P125; WEIGEL PH, 1983, ANAL BIOCHEM, V133, P437, DOI 10.1016/0003-2697(83)90106-9; WEIGEL PH, 1994, MOL BIOL CELL, V5, P227, DOI 10.1091/mbc.5.2.227; Weigel PH, 1998, BIOCHEM BIOPH RES CO, V246, P563, DOI 10.1006/bbrc.1998.8491; Zeng FY, 1996, J BIOL CHEM, V271, P32454, DOI 10.1074/jbc.271.50.32454; ZENG FY, 1995, J BIOL CHEM, V270, P21382, DOI 10.1074/jbc.270.36.21382	29	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14750	14758		10.1074/jbc.274.21.14750	http://dx.doi.org/10.1074/jbc.274.21.14750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329671	hybrid			2022-12-27	WOS:000081965200036
J	Steenhuis, JJ; Hutchison, RS; Barry, BA				Steenhuis, JJ; Hutchison, RS; Barry, BA			Alterations in carboxylate ligation at the active site of photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC OXYGEN EVOLUTION; DIFFERENCE FT-IR; EVOLVING MANGANESE CLUSTER; TEMPERATURE-DEPENDENCE; CRYSTAL-STRUCTURES; ELECTRON-TRANSFER; AB-INITIO; COMPLEX; OXIDATION; PROTEIN	Photosystem II (PSII) is the photosynthetic enzyme catalyzing the oxidation of water and reduction of plastoquinone (Q). This reaction occurs at a catalytic site containing four manganese atoms and cycling among five oxidation states, the S-n states, where n refers to the number of oxidizing equivalents stored. Biochemical and spectroscopic techniques have been used previously to conclude that aspartate 170 in the D1 subunit influences the structure and function of the PSII active site (Boerner, R. J., Nguyen, A. P., Barry, B. A., and Debus, R, J. (1992) Biochemistry 31, 6660-6672). Substitution of glutamate for aspartate 170 resulted in an assembled manganese cluster, which was capable of enzymatic turnover, but at lower steady-state oxygen evolution rates. Here, we obtained the difference (light-minus-dark) Fourier transform IR spectrum associated with the S(2)Q(-)-minus-S(1)Q transition by illumination of oxygen-evolving wild-type and DE170D1 PSII preparations at 200 K. These spectra are known to be dominated by contributions from carboxylic acid and carboxylate residues that are close to or ligating the manganese cluster. Substitution of glutamate for aspartate 170 results in alterations in the S(2)Q(-)-minus-S(1)Q spectrum; the alterations are consistent with a change in carboxylate coordination to manganese or calcium. In particular, the spectra are consistent with a shift from bridging/bidentate carboxylates in wild-type PSII to unidentate carboxylate ligation in DE170D1 PSII.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Barry, BA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 1479 Gortner Ave, St Paul, MN 55108 USA.							AASA R, 1987, FEBS LETT, V221, P245, DOI 10.1016/0014-5793(87)80934-1; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BELLAMY LJ, 1980, INFRARED SPECTRA COM, P183; BERNARD MT, 1995, J BIOL CHEM, V270, P1589, DOI 10.1074/jbc.270.4.1589; BOERNER RJ, 1992, BIOCHEMISTRY-US, V31, P6660, DOI 10.1021/bi00144a005; BRITT RD, 1996, ADV PHOTOSYNTH, V4, P137; BUTLER WF, 1984, BIOPHYS J, V45, P947, DOI 10.1016/S0006-3495(84)84241-1; CASEY JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P21, DOI 10.1016/0005-2728(84)90075-6; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEERFIELD DW, 1995, PROTEINS, V21, P244, DOI 10.1002/prot.340210307; DEPAULA JC, 1986, BIOCHEMISTRY-US, V25, P6487, DOI 10.1021/bi00369a022; DEPAULA JC, 1985, BIOCHEMISTRY-US, V24, P8114, DOI 10.1021/bi00348a042; Diner BA, 1991, CURR OPIN STRUC BIOL, V1, P546, DOI 10.1016/S0959-440X(05)80076-4; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; FLETT MS, 1962, SPECTROCHIM ACTA, V18, P1537, DOI 10.1016/S0371-1951(62)80282-3; Ghirardi ML, 1998, BIOCHEMISTRY-US, V37, P13559, DOI 10.1021/bi980358w; Kim S, 1998, BBA-BIOENERGETICS, V1366, P330, DOI 10.1016/S0005-2728(98)00134-0; Kim SY, 1998, BIOPHYS J, V74, P2588, DOI 10.1016/S0006-3495(98)77965-2; LIBSON AM, 1994, BIOCHEMISTRY-US, V33, P8007, DOI 10.1021/bi00192a004; MACDONALD GM, 1995, J BIOL CHEM, V270, P8420, DOI 10.1074/jbc.270.15.8420; MACDONALD GM, 1992, BIOCHEMISTRY-US, V31, P9848, DOI 10.1021/bi00155a043; MACDONALD GM, 1994, BIOCHEMISTRY-US, V33, P4393, DOI 10.1021/bi00180a037; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; Nakamoto K., 1986, INFRARED RAMAN SPECT, P191; Nara M, 1996, J PHYS CHEM-US, V100, P19812, DOI 10.1021/jp9615924; NAVERRETE JTL, 1994, BIOPOLYMERS, V34, P1065; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; NOREN GH, 1991, BIOCHEMISTRY-US, V30, P3943, DOI 10.1021/bi00230a020; PAKRASI HB, 1992, PHOTOSYSTEMS STRUCTU, P231; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; PECORARO VL, 1988, PHOTOCHEM PHOTOBIOL, V48, P249; RAMIREZ FJ, 1995, SPECTROCHIM ACTA A, V51, P293, DOI 10.1016/0584-8539(94)00188-H; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; SAUER K, 1992, MANGANESE REDOX ENZY, P141; Smith JC, 1997, INORG CHIM ACTA, V255, P99, DOI 10.1016/S0020-1693(96)05350-9; Steenhuis JJ, 1996, J AM CHEM SOC, V118, P11927, DOI 10.1021/ja961691v; Steenhuis JJ, 1998, J PHYS CHEM B, V102, P4, DOI 10.1021/jp9730609; Steenhuis JJ, 1997, J PHYS CHEM B, V101, P6652, DOI 10.1021/jp971260e; STYRING S, 1988, BIOCHIM BIOPHYS ACTA, V933, P378, DOI 10.1016/0005-2728(88)90046-1; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; WIEGHARDT K, 1988, J AM CHEM SOC, V110, P7398, DOI 10.1021/ja00230a021; YACHANDRA VK, 1993, SCIENCE, V260, P675, DOI 10.1126/science.8480177; YOCUM CF, 1992, MANGANESE REDOX ENZY, P71	46	21	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14609	14616		10.1074/jbc.274.21.14609	http://dx.doi.org/10.1074/jbc.274.21.14609			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329653	hybrid			2022-12-27	WOS:000081965200018
J	Wang, LH; Kalb, RG; Strittmatter, SM				Wang, LH; Kalb, RG; Strittmatter, SM			A PDZ protein regulates the distribution of the transmembrane semaphorin, M-SemF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE GUIDANCE; PERIPHERAL-NERVE PROJECTION; NITRIC-OXIDE SYNTHASE; C-TERMINUS; GUANYLATE KINASES; FASCICLIN-II; FAMILY; DOMAIN; RECEPTOR; MOLECULES	M-SemF is a membrane-associated, neurally enriched member of the semaphorin family of axon guidance signals. We considered whether the cytoplasmic domain of M-SemF might possess a signaling function and/or might control the distribution of M-SemF on the cell surface. We identify a PDZ-containing neural protein as an M-SemF cytoplasmic domain-associated protein (SEMCAP-1), SEMCAP-2 is a closely related nonneuronal protein. SEMCAP-1 has recently also been identified as GIPC, by virtue of its interaction with the RGS protein GAIP in vitro (De Vries, L., Lou, X., Zhao, G., Zheng, B., and Farquhar, M.G. (1998) Proc. Natl, Acad, Sci, U. S. A, 95, 12340-12345), Expression studies support the notion that SEMCAP-1(GIPC) interacts with M-SemF, but not GAIP, in brain. Lung SEMCAP-2 and SEMCAP-1(GIPC) are potential partners for both GAIP and M-SemF. The protein interaction requires the single PDZ domain of SEMCAP-1(GIPC) and the carboxyl-terminal four residues of M-SemF, ESSV, While SEMCAP-1(GIPC) also interacts with SemC, it does not interact with other proteins containing a class I PDZ binding motif, nor does M-SemF interact with other class I PDZ proteins. Coexpression of SEMCAP-1(G;IPC) induces the redistribution of dispersed M-SemF into detergent-resistant aggregates in HEK293 cells. Thus, SEMCAP-1(GIPC) appears to regulate the subcellular distribution of M-SemF in brain, and SEMCAPs could link M-SemF to G protein signal transduction pathways.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018,333 Cedar St, New Haven, CT 06520 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	NINDS NIH HHS [NS33020, NS29837] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033020, R01NS029837, R37NS033020] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chiba A, 1996, DEV BIOL, V180, P424, DOI 10.1006/dbio.1996.0316; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Elhabazi A, 1997, J BIOL CHEM, V272, P23515, DOI 10.1074/jbc.272.38.23515; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jin Z, 1997, J NEUROSCI, V17, P6256; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Takahashi T, 1997, J NEUROSCI, V17, P9183; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	51	105	116	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14137	14146		10.1074/jbc.274.20.14137	http://dx.doi.org/10.1074/jbc.274.20.14137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318831	hybrid			2022-12-27	WOS:000080322200060
J	Nyitrai, M; Hild, G; Belagyi, J; Somogyi, B				Nyitrai, M; Hild, G; Belagyi, J; Somogyi, B			The flexibility of actin filaments as revealed by fluorescence resonance energy transfer - The influence of divalent cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; X-RAY-DIFFRACTION; LABELED F-ACTIN; CONFORMATIONAL CHANGE; ROTATIONAL-DYNAMICS; STRUCTURAL-CHANGES; HEAVY-MEROMYOSIN; MYOSIN-FILAMENTS; VARIABLE TWIST; CONTRACTION	The temperature profile of the fluorescence resonance energy transfer efficiency normalized by the fluorescence quantum yield of the donor in the presence of acceptor, f, was measured in a way allowing the independent investigation of (i) the strength of interaction between the adjacent protomers (intermonomer flexibility) and (ii) the flexibility of the protein matrix within actin protomers (intramonomer flexibility). In both cases the relative increase as a function of temperature in f is larger in calcium-F-actin than in magnesium-F-actin in the range of 5-40 degrees C, which indicates that both the intramonomer and the intermonomer flexibility of the actin filaments are larger in calcium-F-actin than those in magnesium-F-actin. The intermonomer flexibility was proved to be larger than the intramonomer one in both the calcium-F-actin and the magnesium-F-actin, The distance between Gln(41) and Cys(374) residues was found to be cation-independent and did not change during polymerization at 21 degrees C, The steady-state fluorescence anisotropy data of fluorophores attached to the Gln(41) or Cys(374) residues suggest that the microenvironments around these regions are more rigid in the magnesium-loaded actin filament than in the calcium-loaded form.	Univ Pecs, Sch Med, Hungarian Acad Sci, Res Grp, H-7601 Pecs, Hungary; Univ Pecs, Sch Med, Dept Biophys, H-7601 Pecs, Hungary; Univ Pecs, Sch Med, Cent Res Lab, H-7601 Pecs, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Pecs; University of Pecs; University of Pecs	Somogyi, B (corresponding author), Univ Pecs, Sch Med, Hungarian Acad Sci, Res Grp, POB 99, H-7601 Pecs, Hungary.			Nyitrai, Miklos/0000-0002-6229-4337				BADLEY RA, 1969, J MOL BIOL, V44, P71, DOI 10.1016/0022-2836(69)90405-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER B, 1987, BASIC RES CARDIOLO S; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; EGELMAN EH, 1995, CURR OPIN STRUC BIOL, V5, P172, DOI 10.1016/0959-440X(95)80072-7; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; GALAZKIEWICZ B, 1989, EUR J BIOCHEM, V186, P233, DOI 10.1111/j.1432-1033.1989.tb15200.x; GEEVES MA, 1991, BIOCHEM J, V274, P1; GENNIS RB, 1972, BIOCHEMISTRY-US, V11, P2509, DOI 10.1021/bi00763a020; Heintz D, 1996, BIOCHEMISTRY-US, V35, P12686, DOI 10.1021/bi961159k; Hild G, 1998, BIOPHYS J, V75, P3015, DOI 10.1016/S0006-3495(98)77742-2; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; JANMEY PA, 1990, NATURE, V347, P95, DOI 10.1038/347095a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; KOUYAMA T, 1985, BIOPHYS J, V47, P43, DOI 10.1016/S0006-3495(85)83875-3; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P43; LORAND L, 1983, ANAL BIOCHEM, V131, P419, DOI 10.1016/0003-2697(83)90193-8; Maeda Y, 1988, Adv Exp Med Biol, V226, P381; MIKI M, 1982, BIOPHYS CHEM, V16, P165, DOI 10.1016/0301-4622(82)85019-9; MIKI M, 1991, BIOCHEMISTRY-US, V30, P10878, DOI 10.1021/bi00109a011; MIKI M, 1987, EUR J BIOCHEM, V168, P339, DOI 10.1111/j.1432-1033.1987.tb13425.x; MOSSAKOWSKA M, 1988, EUR J BIOCHEM, V175, P557, DOI 10.1111/j.1432-1033.1988.tb14228.x; Nyitrai M, 1998, BIOPHYS J, V74, P2474, DOI 10.1016/S0006-3495(98)77955-X; OOSAWA F, 1977, BIORHEOLOGY, V14, P11; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663; SCHARF RE, 1995, BBA-PROTEIN STRUCT M, V1253, P129, DOI 10.1016/0167-4838(95)00186-5; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SCHUTT CE, 1995, BIOPHYS J, V68, pS12; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEIN LA, 1979, BIOCHEMISTRY-US, V18, P3895, DOI 10.1021/bi00585a009; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; STOKES DL, 1987, J CELL BIOL, V104, P1005, DOI 10.1083/jcb.104.4.1005; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; SUZUKI S, 1983, J GEN PHYSIOL, V81, P531, DOI 10.1085/jgp.81.4.531; TAKASHI R, 1979, BIOCHEMISTRY-US, V18, P5164, DOI 10.1021/bi00590a021; TAKASHI R, 1988, BIOCHEMISTRY-US, V27, P938, DOI 10.1021/bi00403a015; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; THOMAS DD, 1995, BIOPHYS J, V68, pS135; WAKABAYASHI K, 1993, ADV EXP MED BIOL, V332, P451; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; YAGI N, 1989, J MOL BIOL, V208, P359, DOI 10.1016/0022-2836(89)90396-3; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; ZIMMERLE CT, 1987, BIOCHEMISTRY-US, V26, P6545, DOI 10.1021/bi00394a039	54	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12996	13001		10.1074/jbc.274.19.12996	http://dx.doi.org/10.1074/jbc.274.19.12996			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224049	hybrid			2022-12-27	WOS:000080200400011
J	Ohtani, K; Suzuki, Y; Eda, S; Kawai, T; Kase, T; Yamazaki, H; Shimada, T; Keshi, H; Sakai, Y; Fukuoh, A; Sakamoto, T; Wakamiya, N				Ohtani, K; Suzuki, Y; Eda, S; Kawai, T; Kase, T; Yamazaki, H; Shimada, T; Keshi, H; Sakai, Y; Fukuoh, A; Sakamoto, T; Wakamiya, N			Molecular cloning of a novel human collectin from liver (CL-L1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; INFLUENZA-A-VIRUS; CARBOHYDRATE-RECOGNITION DOMAINS; PULMONARY SURFACTANT APOPROTEIN; BOVINE CONGLUTININ; INHIBIT HEMAGGLUTINATION; BACTERICIDAL ACTIVITY; LECTINS; CDNA; PURIFICATION	Collectins are a C-lectin family with collagen-like sequences and carbohydrate recognition domains. These proteins can bind to carbohydrate antigens of microorganisms and inhibit their infection by direct neutralization and agglutination, the activation of complement through the lectin pathway, and opsonization by collectin receptors, Here we report the cloning of a cDNA encoding human collectin from liver (CL-L1 (collectin liver 1)) that has typical collectin structural characteristics, consisting of an N-terminal cysteine-rich domain, a collagen-like domain, a neck domain, and a carbohydrate recognition domain. The cDNA has an insert of 831 base pairs coding for a protein of 277 amino acid residues. The deduced amino acid sequence shows that this collectin has a unique repeat of four lysine residues in its C-terminal area. Northern blot, Western blot, and reverse tp anscription-polymerase chain reaction analyses showed that CL-L1 is present mainly in liver as a cytosolic protein and at low levels in placenta. More sensitive analyses by reverse transcription-polymerase chain reactions showed that most tissues (except skeletal muscle) have CL-L1 mRNA Zoo-blot analysis indicated that CL-L1 is limited to mammals and birds. A chromosomal localization study indicated that the CL-L1 gene localizes to chromosome 8q23-q24.1, different from chromosome 10 of other human collectin genes. Expression studies of fusion proteins lacking the collagen and N-terminal domains produced in Escherichia coli affirmed that CL-L1 binds mannose weakly. CL-L1 and recombinant CL-L1 fusion proteins do not bind to mannan columns. Analysis of the phylogenetic tree of CL-LI and other collectins indicated that CL-L1 belongs to a fourth subfamily of collectins following the mannan-binding protein, surfactant protein A, and surfactant protein D subfamilies including bovine conglutinin and collectin-43 (CL-43), These findings indicate that CL-LI may be involved in different biological functions.	Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; Osaka Prefectural Inst Publ Hlth, Dept Pathol, Osaka 537, Japan; Osaka Prefectural Inst Publ Hlth, Dept Food Microbiol, Osaka 537, Japan; Osaka Prefectural Inst Publ Hlth, Dept Virol, Osaka 537, Japan; Osaka Prefectural Inst Publ Hlth, Dept Pharmaceut Affairs, Osaka 537, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan	Osaka University; Osaka Prefectural Institute of Public Health; Osaka Prefectural Institute of Public Health; Osaka Prefectural Institute of Public Health; Osaka Prefectural Institute of Public Health; Osaka University	Wakamiya, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	wakamiya@biken.osaka-u.ac.jp	Yamazaki, Hiroshi/A-6081-2011; Suzuki, Yasuhiko/F-6890-2012	Yamazaki, Hiroshi/0000-0002-1068-4261; Shimada, Tsutomu/0000-0003-2552-4348				DAVIS AE, 1984, BIOCHEMISTRY-US, V23, P2139, DOI 10.1021/bi00305a006; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Eda S, 1996, BIOCHEM J, V316, P43, DOI 10.1042/bj3160043; Eda S, 1997, BIOCHEM J, V323, P393, DOI 10.1042/bj3230393; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; HARTLEY CA, 1992, J VIROL, V66, P4358, DOI 10.1128/JVI.66.7.4358-4363.1992; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HOLMSKOV U, 1993, J BIOL CHEM, V268, P10120; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Kamemura K, 1998, ANAL BIOCHEM, V258, P305, DOI 10.1006/abio.1998.2585; Kawai T, 1997, GENE, V186, P161, DOI 10.1016/S0378-1119(96)00664-6; Kawai T, 1998, GLYCOBIOLOGY, V8, P237, DOI 10.1093/glycob/8.3.237; KAWASAKI N, 1989, J BIOCHEM-TOKYO, V106, P483, DOI 10.1093/oxfordjournals.jbchem.a122878; Kodama T, 1996, CURR OPIN LIPIDOL, V7, P287, DOI 10.1097/00041433-199610000-00005; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; LIM BL, 1994, J BIOL CHEM, V269, P11820; LIM BL, 1993, IMMUNOLOGY, V78, P159; Mogues T, 1996, GLYCOBIOLOGY, V6, P543, DOI 10.1093/glycob/6.5.543; PERSSON A, 1989, BIOCHEMISTRY-US, V28, P6361, DOI 10.1021/bi00441a031; PIKAAR JC, 1995, J INFECT DIS, V172, P481, DOI 10.1093/infdis/172.2.481; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SASTRY K, 1991, J IMMUNOL, V147, P692; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; SHIMAMOTO A, 1997, SEIKAGAKU, V69, P574; SHIMIZU H, 1992, J BIOL CHEM, V267, P1853; SUZUKI Y, 1993, BIOCHEM BIOPH RES CO, V191, P335, DOI 10.1006/bbrc.1993.1222; vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1; VANIWAARDEN JF, 1992, J BIOL CHEM, V267, P25039; WAKAMIYA N, 1992, BIOCHEM BIOPH RES CO, V187, P1270, DOI 10.1016/0006-291X(92)90440-V; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0	37	114	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13681	13689		10.1074/jbc.274.19.13681	http://dx.doi.org/10.1074/jbc.274.19.13681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224141	hybrid			2022-12-27	WOS:000080200400103
J	Barrientos, A; Moraes, CT				Barrientos, A; Moraes, CT			Titrating the effects of mitochondrial complex I impairment in the cell physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; RESPIRATORY NADH DEHYDROGENASE; DEPENDENT LIPID-PEROXIDATION; DNA-ENCODED SUBUNITS; PERMEABILITY TRANSITION; XENOMITOCHONDRIAL CYBRIDS; SUPEROXIDE FORMATION; HEART-MITOCHONDRIA; FLUORESCENT-PROBE; SKIN FIBROBLASTS	The mitochondrial oxidative phosphorylation system consists of five multimeric enzymes (complexes I-V). NADH dehydrogenase or complex I (CI) is affected in most of the mitochondrial diseases and in some neuro degenerative disorders. We have studied the physiological consequences of a partial CI inhibition at the cellular level. We used a genetic model (40% CI-inhibited human-ape xenomitochondrial cybrids) and a drug-induced model (0-100% CI-inhibited cells using different concentrations of rotenone). We observed a quantitative correlation between the level of CI impairment and cell respiration, cell growth, free radical production, lipid peroxidation, mitochondrial membrane potential, and apoptosis. We showed that cell death was quantitatively associated with free radical production rather than with a decrease in respiratory chain function. The results obtained with human xenomitochondrial cybrid cells were compatible with those observed in rotenone-induced 40% CI-inhibited cells. At high concentrations (5-6-fold higher than the concentration necessary for 100% CI inhibition), rotenone showed a second toxic effect at the level of microtubule assembly, which also led to apoptosis, The correlation found among all the parameters studied helped clarify the physiological consequences of partial CI inhibitions at the cellular level.	Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	University of Miami; University of Miami	Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1501 NW 9th Ave, Miami, FL 33136 USA.		Moraes, Carlos/AAT-3818-2021		NEI NIH HHS [EY10804] Funding Source: Medline; NIGMS NIH HHS [GM55766] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; BEYER RE, 1992, BIOCHEM CELL BIOL, V70, P390, DOI 10.1139/o92-061; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRINKLEY BR, 1974, EXP CELL RES, V85, P41, DOI 10.1016/0014-4827(74)90210-9; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; CHANCE B, 1963, J BIOL CHEM, V238, P418; CHIUEH CC, 1984, PSYCHOPHARMACOL BULL, V20, P548; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x; DYKENS JA, 1994, J NEUROCHEM, V63, P584; FIGUERAS MJ, 1973, EUR J CANCER, V9, P529, DOI 10.1016/0014-2964(73)90140-0; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; IMBERTI R, 1992, RES COMMUN CHEM PATH, V78, P27; Jun AS, 1996, MOL CELL BIOL, V16, P771; Kenyon L, 1997, P NATL ACAD SCI USA, V94, P9131, DOI 10.1073/pnas.94.17.9131; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUYPERS FA, 1987, BIOCHIM BIOPHYS ACTA, V921, P266, DOI 10.1016/0005-2760(87)90027-0; LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481; Marchetti P, 1996, CANCER RES, V56, P2033; MARGULIS L, 1973, INT REV CYTOL, V34, P333, DOI 10.1016/S0074-7696(08)61939-7; Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267; MEISNER HM, 1966, EXP CELL RES, V42, P291, DOI 10.1016/0014-4827(66)90292-8; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; PRYOR WA, 1982, ANN NY ACAD SCI, V393, P1, DOI 10.1111/j.1749-6632.1982.tb31228.x; RAMSAY RR, 1992, BIOCHEM BIOPH RES CO, V189, P47, DOI 10.1016/0006-291X(92)91523-S; RICHTER C, 1988, FREE RADICAL BIO MED, V4, P365, DOI 10.1016/0891-5849(88)90088-3; ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8; ROBINSON BH, 1985, AM J HUM GENET, V37, P938; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SCOTT ID, 1980, BIOCHEM J, V192, P873, DOI 10.1042/bj1920873; Seaton TA, 1997, BRAIN RES, V777, P110; Seaton TA, 1998, BRAIN RES, V809, P12, DOI 10.1016/S0006-8993(98)00790-2; SHAPIRA AHV, 1989, LANCET, V1, P1269; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; SINGER TP, 1994, BBA-BIOENERGETICS, V1187, P198, DOI 10.1016/0005-2728(94)90110-4; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; TAKAYANAGI R, 1980, BIOCHEM J, V192, P853, DOI 10.1042/bj1920853; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3	64	302	307	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16188	16197		10.1074/jbc.274.23.16188	http://dx.doi.org/10.1074/jbc.274.23.16188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347173	hybrid			2022-12-27	WOS:000080668600033
J	Bayliss, MT; Osborne, D; Woodhouse, S; Davidson, C				Bayliss, MT; Osborne, D; Woodhouse, S; Davidson, C			Sulfation of chondroitin sulfate in human articular cartilage - The effect of age, topographical position, and zone of cartilage on tissue composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; DERMATAN SULFATE; JOINT FLUID; PROTEOGLYCAN; DISEASE; OSTEOARTHRITIS; AGGRECAN	The chondroitin ABC lyase digestion products of normal human femoral condyle articular cartilage and of purified aggrecan were analyzed for their mono- and nonsulfated disaccharide composition, Changes in the total tissue chemistry were most pronounced during the period from birth to 20 years of age, when the -[GlcA beta,3GalNAc6]- disaccharide content increased from approximately 50% to 85% of the total disaccharide content and there was a concomitant decrease in the content of the 4-sulfated disaccharide, In general, the disaccharide content of the deeper layers of immature cartilage were richer in the 4-sulfated residue than the upper regions of the tissue. As the tissue aged and decreased in thickness, the disaccharide composition became more evenly 6-sulfated. The newly synthesized chondroitin sulfate chains had a similar composition to the endogenous chains and also underwent the same age and zonal changes, The monoclonal antisera 3B3(+) and 2B6(+) were used to immunolocalize the unsaturated 6- and 4-sulfated residues generated at the reducing termini of the chondroitin sulfate chains by digestion with chondroitin ABC lyase, and these analyses indicated that the sulfation pattern at this position did not necessarily reflect the internal disaccharide composition of the chains. In summary, the sulfation pattern of chondroitin sulfate disaccharides from human normal articular cartilage varies with the age of the specimen, the position (topography) on the joint surface, and the zone of cartilage analyzed, Furthermore, these changes in composition are a consequence of both extracellular, post-translational processing of the core protein of aggrecan and changes in the sulfotransferase activity of the chondrocyte.	Univ London Royal Vet Coll, London NW1 0TU, England; Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England	University of London; University of London Royal Veterinary College; Eli Lilly; University of Cambridge	Bayliss, MT (corresponding author), Univ London Royal Vet Coll, Royal Coll St, London NW1 0TU, England.							ALI SY, 1981, SEMIN ARTHRITIS RHEU, V11, P56, DOI 10.1016/0049-0172(81)90039-1; BAYLISS MT, 1985, BIOCHEM J, V232, P111, DOI 10.1042/bj2320111; BAYLISS MT, 1990, BIOCHEM SOC T, V18, P799, DOI 10.1042/bst0180799; BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013; Brown MP, 1998, AM J VET RES, V59, P786; CARNEY SL, 1986, ANAL BIOCHEM, V156, P38, DOI 10.1016/0003-2697(86)90150-8; CATERSON B, 1990, J CELL SCI, V97, P411; CHRISTNER JE, 1980, J BIOL CHEM, V255, P7102; DEUTSCH W, 1994, SPRACHE KOGNIT, V13, P230; Dudhia J, 1996, BIOCHEM J, V313, P933, DOI 10.1042/bj3130933; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; HARDINGHAM T, 1990, SEMIN ARTHRITIS RHEU, V20, P12, DOI 10.1016/0049-0172(90)90044-G; HASCALL VC, 1970, J BIOL CHEM, V245, P4920; HAZELL PK, 1995, ARTHRITIS RHEUM, V38, P953, DOI 10.1002/art.1780380711; LEMPERG R, 1974, CALC TISS RES, V15, P237, DOI 10.1007/BF02059060; LEWIS S, 1995, ACTA ORTHOP SCA S266, V66, P142; LOHMANDER S, 1977, ARCH BIOCHEM BIOPHYS, V180, P93, DOI 10.1016/0003-9861(77)90012-1; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Maroudas A., 1979, ADULT ARTICULAR CART; MICHELACCI YM, 1979, CONNECT TISSUE RES, V7, P29, DOI 10.3109/03008207909152350; MORALES TI, 1991, ARCH BIOCHEM BIOPHYS, V286, P99, DOI 10.1016/0003-9861(91)90013-9; MOURAO PAS, 1976, BIOCHIM BIOPHYS ACTA, V428, P19, DOI 10.1016/0304-4165(76)90104-5; MURATA K, 1979, J BIOCHEM-TOKYO, V86, P371, DOI 10.1093/oxfordjournals.jbchem.a132535; MURATA K, 1997, CONNECT TISSUE RES, V5, P109; Plaas AHK, 1998, J BIOL CHEM, V273, P12642, DOI 10.1074/jbc.273.20.12642; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Platt D, 1998, EQUINE VET J, V30, P43, DOI 10.1111/j.2042-3306.1998.tb04087.x; ROSENBERG LC, 1985, J BIOL CHEM, V260, P6304; ROUGHLEY PJ, 1980, J BIOL CHEM, V255, P217; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SHINMEI M, 1992, ARTHRITIS RHEUM, V35, P1304, DOI 10.1002/art.1780351110; SLATER RR, 1995, ARTHRITIS RHEUM-US, V38, P655, DOI 10.1002/art.1780380513	33	160	163	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15892	15900		10.1074/jbc.274.22.15892	http://dx.doi.org/10.1074/jbc.274.22.15892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336494	hybrid			2022-12-27	WOS:000080560100083
J	Habura, A; Tikhonenko, I; Chisholm, RL; Koonce, MP				Habura, A; Tikhonenko, I; Chisholm, RL; Koonce, MP			Interaction mapping of a dynein heavy chain - Identification of dimerization and intermediate-chain binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-ARM DYNEIN; CYTOPLASMIC DYNEIN; MOLECULAR ANALYSIS; MOTOR PROTEINS; SEQUENCE-ANALYSIS; ALPHA-DYNEIN; DICTYOSTELIUM; DYNACTIN; COMPLEX; GENES	Cytoplasmic dynein is a multisubunit microtubule-based motor protein that is involved in several eukaryotic cell motilities, Two dynein heavy chains each form a motor domain that connects to a common cargo-binding tail. Although this tail domain is composed of multiple polypeptides, subunit organization within this region is poorly understood. Here we present an in vitro dissection of the tail-forming region of the dynein heavy chain from Dictyostelium. Our work identifies a sequence important for dimerization and for binding the dynein intermediate chain. The core of this motif localizes within an similar to 150-amino acid region that is strongly conserved among other cytoplasmic dyneins, This level of conservation does not extend to the axonemal dynein heavy chains, suggesting functional differences between the two. Dimerization appears to occur through a different mechanism than the heavy chain-intermediate chain interaction. We corroborate the in vitro interactions with in vivo expression of heavy chain fragments in Dictyostelium. Fragments lacking the interaction domain express well, without an obvious phenotype. On the other hand, the region crucial for both interactions appears to be lethal when overexpressed.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Albany, NY 12201 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Koonce, MP (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Empire State Plaza,POB 509, Albany, NY 12201 USA.	Michael.Koonce@wadsworth.org	Chisholm, Rex L/B-3418-2009	Chisholm, Rex L/0000-0002-5638-3990	NIGMS NIH HHS [GM51532] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051532, R29GM051532] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775; Efimov VP, 1998, GENETICS, V149, P101; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; HUGHES SM, 1995, J CELL SCI, V108, P17; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; KING SM, 1991, J BIOL CHEM, V266, P8401; KOONCE MP, 1992, J CELL BIOL, V119, P1597, DOI 10.1083/jcb.119.6.1597; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Koonce MP, 1998, CELL MOTIL CYTOSKEL, V39, P63, DOI 10.1002/(SICI)1097-0169(1998)39:1<63::AID-CM6>3.0.CO;2-H; KOONCE MP, 1990, CELL MOTIL CYTOSKEL, V15, P51, DOI 10.1002/cm.970150108; LIN KH, 1991, BIOTECHNIQUES, V11, P748; Mazumdar M, 1996, P NATL ACAD SCI USA, V93, P6552, DOI 10.1073/pnas.93.13.6552; Milisav I, 1998, CELL MOTIL CYTOSKEL, V39, P261, DOI 10.1002/(SICI)1097-0169(1998)39:4<261::AID-CM2>3.0.CO;2-6; MITCHELL DR, 1994, J CELL SCI, V107, P635; Mitchell DR, 1997, CELL MOTIL CYTOSKEL, V37, P120, DOI 10.1002/(SICI)1097-0169(1997)37:2<120::AID-CM4>3.3.CO;2-G; MOCZ G, 1993, BIOCHEMISTRY-US, V32, P3456, DOI 10.1021/bi00064a032; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; Sambrook J., 1989, MOL CLONING, pA1; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; SCHLIWA M, 1981, J CELL BIOL, V90, P222, DOI 10.1083/jcb.90.1.222; SCHROER TA, 1994, CURR OPIN CELL BIOL, V6, P69, DOI 10.1016/0955-0674(94)90118-X; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; Steffen W, 1996, J STRUCT BIOL, V117, P227, DOI 10.1006/jsbi.1996.0087; Sweeney HL, 1996, ANNU REV PHYSIOL, V58, P751, DOI 10.1146/annurev.ph.58.030196.003535; Trivinos-Lagos L., 1993, Molecular Biology of the Cell, V4, p47A; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WILKERSON CG, 1994, J CELL SCI, V107, P497; WITMAN G B, 1992, Current Opinion in Cell Biology, V4, P74	39	61	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15447	15453		10.1074/jbc.274.22.15447	http://dx.doi.org/10.1074/jbc.274.22.15447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336435	hybrid			2022-12-27	WOS:000080560100024
J	Lu, PJ; Sundquist, K; Baeckstrom, D; Poulsom, R; Hanby, A; Meier-Ewert, S; Jones, T; Mitchell, M; Pitha-Rowe, P; Freemont, P; Taylor-Papadimitriou, J				Lu, PJ; Sundquist, K; Baeckstrom, D; Poulsom, R; Hanby, A; Meier-Ewert, S; Jones, T; Mitchell, M; Pitha-Rowe, P; Freemont, P; Taylor-Papadimitriou, J			A novel gene (PLU-1) containing highly conserved putative DNA chromatin binding motifs is specifically up-regulated in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; ESCAPES X-INACTIVATION; MONOCLONAL-ANTIBODY; NUCLEAR RECEPTOR; PROTEINS; MORPHOGENESIS; HYBRIDIZATION; EXPRESSION; SEQUENCE; COACTIVATORS	A novel human gene (PLU-1) has been identified which shows a highly restricted expression in normal adult tissues but which is consistently expressed in breast cancers, A fragment of the PLU-1 cDNA was identified by differentially screening a fetal brain library with cDNAs prepared from ce-1 cells (a human mammary epithelial cell line overexpressing c-ErbB2) treated or untreated with the antibody 4D5, which inhibits c-ErbB2 phosphorylation. Clones covering the full cDNA sequence of 6.4 kilobases were isolated from a breast cancer cDNA library. Although expression of PLU-1 in ce-1 cells is regulated by signaling from c-ErbB2, the gene is expressed in all the breast cancer cell lines examined, in cells cultured from primary breast cancers, and in the invasive and in situ components of primary breast cancers. Translation of the open reading frame predicts a protein of 1544 amino acids, which contains three PHD/LAP motifs, a specific DNA-binding domain found in a Drosophila protein (dri) and novel domains showing extensive homology with other human and non human gene products. Transient transfection of cell lines with MYC-tagged PLU-1 showed the protein to be localized in the nucleus and associated with discrete foci. The presence of the dri motif and PHD/LAP fingers together with the clear nuclear localization and consistent expression in breast cancers, suggest a role for PLU-1 in regulating gene expression in breast cancers.	Johns Hopkins Univ, Oncol Grp, Baltimore, MD 21231 USA; Imperial Canc Res Fund, Lab Epithelial Cell Biol, London WC2A 3PX, England; Imperial Canc Res Fund, Lab Situ Hybridizat & Histopathol, London WC2A 3PX, England; Imperial Canc Res Fund, Genome Anal Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Lab Mol Struct & Funct, London WC2A 3PX, England; Imperial Canc Res Fund, Lab Human Cytogenet, London WC2A 3PX, England; Imperial Canc Res Fund, Lab Computat Genome Anal, London WC2A 3PX, England; Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England	Johns Hopkins University; Cancer Research UK; Cancer Research UK; Cancer Research UK; The Genome Analysis Centre (TGAC); Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust	Taylor-Papadimitriou, J (corresponding author), Guys Hosp, Imperial Canc Res Fund, Breast Canc Biol Grp, 3rd Floor,Thomas Guy House,St Thomas St, London SE1 9RT, England.		Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011	Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Freemont, Paul/0000-0002-5658-8486	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049043] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49043] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; ALIMANDI M, 1995, ONCOGENE, V10, P1813; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DSOUZA B, 1993, ONCOGENE, V8, P1797; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Gregory SL, 1996, MOL CELL BIOL, V16, P792; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KUMAR R, 1991, MOL CELL BIOL, V11, P979, DOI 10.1128/MCB.11.2.979; LU PJ, 1995, J CELL BIOL, V129, P1363, DOI 10.1083/jcb.129.5.1363; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SEGATTO O, 1990, New Biologist, V2, P187; SENIOR PV, 1988, DEVELOPMENT, V104, P431; SHEARER M, 1992, INT J CANCER, V51, P602, DOI 10.1002/ijc.2910510417; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAKEUCHI T, 1995, GENE DEV, V9, P211; TAYLORPAPADIMITRIOU J, 1993, CANCER SURV, V16, P59; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang LM, 1998, P NATL ACAD SCI USA, V95, P6809, DOI 10.1073/pnas.95.12.6809; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WU JS, 1994, HUM MOL GENET, V3, P153, DOI 10.1093/hmg/3.1.153	37	186	216	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15633	15645		10.1074/jbc.274.22.15633	http://dx.doi.org/10.1074/jbc.274.22.15633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336460	hybrid			2022-12-27	WOS:000080560100049
J	Saba, RI; Ruysschaert, JM; Herchuelz, A; Goormaghtigh, E				Saba, RI; Ruysschaert, JM; Herchuelz, A; Goormaghtigh, E			Fourier transform infrared spectroscopy study of the secondary and tertiary structure of the reconstituted Na+/Ca2+ exchanger 70-kDa polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; MEMBRANE H+-ATPASE; NA-CA EXCHANGE; LOW-DENSITY-LIPOPROTEIN; PLASMA-MEMBRANE; PARTIAL-PURIFICATION; NA+-CA-2+ EXCHANGE; NEUROSPORA-CRASSA; P-GLYCOPROTEIN; CONFORMATIONAL-CHANGES	The secondary structure of the purified 70-kDa protein Na+/Ca2+ exchanger, functionally reconstituted into asolectin lipid vesicles, was examined by Fourier transform infrared attenuated total reflection spectroscopy. Fourier transform infrared attenuated total reflection spectroscopy provided evidence that the protein is composed of 44% alpha-helices, 25% beta-sheets, 16% beta-turns, and 15% random structures, notably the proportion of alpha-helices is greater than that corresponding to the transmembrane domains predicted by exchanger hydropathy profile. Polarized infrared spectroscopy showed that the orientation of helices is almost perpendicular to the membrane. Tertiary structure modifications, induced by addition of Ca2+, were evaluated by deuterium/hydrogen exchange kinetic measurements for the reconstituted exchanger. This approach was previously proven as a useful tool for detection of tertiary structure modifications induced by an interaction between a protein and its specific ligand, Deuterium/hydrogen exchange kinetic measurements indicated that, in the absence of Ca2+, a large fraction of the protein (40%) is inaccessible to solvent. Addition of Ca2+ increased to 55% the inaccessibility to solvent, representing a major conformational change characterized by the shielding of at least 93 amino acids.	Free Univ Brussels, Fac Med, Lab Pharmacodynamie & Therapeut, B-1070 Brussels, Belgium; Free Univ Brussels, Fac Sci, Chim Phys Macromol Interfaces Lab, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Saba, RI (corresponding author), Free Univ Brussels, Fac Med, Lab Pharmacodynamie & Therapeut, CP 617,Route Lennik 808,Bat GE, B-1070 Brussels, Belgium.			Goormaghtigh, Erik/0000-0002-2071-2262				ACETO JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P553, DOI 10.1016/0003-9861(92)90449-7; ADDISON R, 1986, J BIOL CHEM, V261, P4896; ADDISON R, 1982, J BIOL CHEM, V257, P421; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Barth A, 1997, J BIOL CHEM, V272, P25507, DOI 10.1074/jbc.272.41.25507; BARZILAI A, 1984, P NATL ACAD SCI-BIOL, V81, P6521, DOI 10.1073/pnas.81.20.6521; BERS DM, 1989, CIRC RES, V65, P334, DOI 10.1161/01.RES.65.2.334; CABIAUX V, 1989, J BIOL CHEM, V264, P4928; CHALLOU N, 1994, BIOCHEMISTRY-US, V33, P3902; CHEON J, 1988, J BIOL CHEM, V263, P2309; DEJONGH HHJ, 1995, BIOCHEMISTRY-US, V34, P172, DOI 10.1021/bi00001a021; DIPOLO R, 1987, BIOCHIM BIOPHYS ACTA, V897, P347, DOI 10.1016/0005-2736(87)90432-9; DIPOLO R, 1986, BIOCHIM BIOPHYS ACTA, V854, P298, DOI 10.1016/0005-2736(86)90123-9; DIPOLO R, 1979, J GEN PHYSIOL, V73, P91, DOI 10.1085/jgp.73.1.91; DURKIN JT, 1991, ARCH BIOCHEM BIOPHYS, V290, P369, DOI 10.1016/0003-9861(91)90553-U; FISCHBARG J, 1993, P NATL ACAD SCI USA, V90, P11658, DOI 10.1073/pnas.90.24.11658; GOORMAGHTIGH E, 1993, BIOCHEMISTRY-US, V32, P6104, DOI 10.1021/bi00074a023; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; GOORMAGHTIGH E, 1991, EUR J BIOCHEM, V195, P421, DOI 10.1111/j.1432-1033.1991.tb15721.x; GOORMAGHTIGH E, 1990, MOL DESCRIPTION BIOL, P285; GORNETSCHELNOKOW U, 1994, EMBO J, V13, P338, DOI 10.1002/j.1460-2075.1994.tb06266.x; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; Hale CC, 1997, BIOCHEM BIOPH RES CO, V236, P113, DOI 10.1006/bbrc.1997.6912; HALE CC, 1984, P NATL ACAD SCI-BIOL, V81, P6569, DOI 10.1073/pnas.81.21.6569; Harrick N.J., 1967, INTERNAL REFLEXION S; Heimburg T, 1997, J BIOL CHEM, V272, P25685, DOI 10.1074/jbc.272.41.25685; HILGEMANN DW, 1986, J GEN PHYSIOL, V87, P675, DOI 10.1085/jgp.87.5.675; HILGEMANN DW, 1991, ANN NY ACAD SCI, V639, P126, DOI 10.1111/j.1749-6632.1991.tb17296.x; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; KHANANSHVILI D, 1991, J BIOL CHEM, V266, P13764; MILANICK MA, 1991, AM J PHYSIOL, V261, pC185, DOI 10.1152/ajpcell.1991.261.1.C185; MIYAMOTO H, 1980, J BIOL CHEM, V255, P2656; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Philipson K D, 1993, Int Rev Cytol, V137C, P199; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; PHILIPSON KD, 1987, BIOCHIM BIOPHYS ACTA, V897, P152, DOI 10.1016/0005-2736(87)90323-3; PHILIPSON KD, 1987, BIOCHIM BIOPHYS ACTA, V899, P60; Raussens V, 1997, J BIOL CHEM, V272, P262; RAUSSENS V, 1997, THESIS U LIBRE BRUXE; REEVES JP, 1990, INTRACELLULAR CALCIU, P305; Saba RI, 1999, BIOCHEM J, V338, P139, DOI 10.1042/0264-6021:3380139; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SOLDATI L, 1985, J BIOL CHEM, V260, P3321; Sonveaux N, 1996, J BIOL CHEM, V271, P24617, DOI 10.1074/jbc.271.40.24617; STREHLER EE, 1991, J MEMBRANE BIOL, V120, P1, DOI 10.1007/BF01868586; SUSI H, 1967, J BIOL CHEM, V242, P5460; SWEADNER KJ, 1992, ANN NY ACAD SCI, V671, P217, DOI 10.1111/j.1749-6632.1992.tb43798.x; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VERMURI R, 1988, BIOCHIM BIOPHYS ACTA, V937, P258; VIGNERON L, 1995, J BIOL CHEM, V270, P17685, DOI 10.1074/jbc.270.30.17685; WAKABAYASHI S, 1982, BIOCHIM BIOPHYS ACTA, V693, P125, DOI 10.1016/0005-2736(82)90478-3; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2	59	21	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15510	15518		10.1074/jbc.274.22.15510	http://dx.doi.org/10.1074/jbc.274.22.15510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336444	hybrid			2022-12-27	WOS:000080560100033
J	Shih, SC; Mullen, A; Abrams, K; Mukhopadhyay, D; Claffey, KP				Shih, SC; Mullen, A; Abrams, K; Mukhopadhyay, D; Claffey, KP			Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; SELECTIVE INHIBITOR; GLUCOSE-TRANSPORT; ZETA-ISOFORM; KAPPA-B; ACTIVATION; POTENT; GENE	Aberrant expression of the potent angiogenic cytokine, vascular endothelial growth factor (VEGF), has been demonstrated to be associated with most human solid tumors. Both transcriptional and post-transcriptional mechanisms have been shown to modulate VEGF expression in a multitude of cell types. Here we report that when protein kinase C (PKC) pathways were activated in human glioblastoma U373 cells by phorbol 12-myristate 13-acetate (PMA), VEGF mRNA expression was up-regulated via a post-transcriptional mRNA stabilization mechanism. PMA treatment exhibited no increase in VEGF-specific transcriptional activation as determined by run-off transcription assays and VEGF promoter-luciferase reporter assays. However, PMA increased VEGF mRNA half-life from 0.8 to 3.6 h which was blocked by PKC inhibitors but not by protein kinase A or cyclic nucleotide-dependent protein kinase inhibitors. When U373 cells were transfected with antisense oligonucleotide sequences to the translation start sites of PKC-alpha, -beta, -gamma, -delta, -epsilon, or -zeta isoforms, both PKC-alpha and -zeta antisense oligonucleotides showed substantial inhibition of PMA-induced VEGF mRNA. In addition, overexpression of PKC-zeta resulted in a strong constitutive up-regulation of VEGF mRNA expression. This study demonstrates for the first time that specific PKC isoforms regulate VEGF mRNA expression through post-transcriptional mechanisms.	Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06030 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA	University of Connecticut; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Claffey, KP (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, 263 Farmington Ave, Farmington, CT 06030 USA.				NCI NIH HHS [CA64436] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064436, R29CA064436] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; BOULIS NM, 1990, BRAIN RES, V525, P198, DOI 10.1016/0006-8993(90)90864-8; Casabona G, 1997, PROG NEURO-PSYCHOPH, V21, P407, DOI 10.1016/S0278-5846(97)00011-0; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Claffey KP, 1996, CANCER METAST REV, V15, P165, DOI 10.1007/BF00437469; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Huang CS, 1997, J BIOL CHEM, V272, P4187, DOI 10.1074/jbc.272.7.4187; IJICHI A, 1995, GLIA, V14, P87, DOI 10.1002/glia.440140203; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; JONES KT, 1994, J CELL PHYSIOL, V159, P324, DOI 10.1002/jcp.1041590215; KIESER A, 1994, ONCOGENE, V9, P963; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V237, P336, DOI 10.1006/bbrc.1997.7061; LOZANO J, 1994, J BIOL CHEM, V269, P19200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Nave BT, 1996, BIOCHEM J, V318, P203, DOI 10.1042/bj3180203; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; TAMAOKI T, 1990, BIO-TECHNOL, V8, P732, DOI 10.1038/nbt0890-732; TISCHER E, 1991, J BIOL CHEM, V266, P11947; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; USHMOROV AG, 1994, CARCINOGENESIS, V15, P2739, DOI 10.1093/carcin/15.12.2739; vanDijk MCM, 1997, BIOCHEM J, V323, P693, DOI 10.1042/bj3230693; VISNJIC D, 1995, BIOCHEM J, V310, P163, DOI 10.1042/bj3100163; WAYS DK, 1992, J BIOL CHEM, V267, P4799	33	87	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15407	15414		10.1074/jbc.274.22.15407	http://dx.doi.org/10.1074/jbc.274.22.15407			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336429	hybrid			2022-12-27	WOS:000080560100018
J	Zhou, ZM; Peng, SB; Crider, BP; Andersen, P; Xie, XS; Stone, DK				Zhou, ZM; Peng, SB; Crider, BP; Andersen, P; Xie, XS; Stone, DK			Recombinant SFD isoforms activate vacuolar proton pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED VESICLES; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; TRANSLOCATING COMPLEX; RECONSTITUTION; SUBUNIT; ATPASE; (H+)-ATPASE; EXPRESSION; PROTEINS	The vacuolar proton pump of clathrin-coated vesicles is composed of two general sectors, a cytosolic, ATP hydrolytic domain (V-1) and an intramembranous proton channel, V-0. V-1 is comprised of 8-9 subunits including polypeptides of 50 and 57 kDa, termed SFD (Sub Fifty-eight-kDa Doublet). Although SFD is essential to the activation of ATPase and proton pumping activities catalyzed by holoenzyme, its constituent polypeptides have not been separated to determine their respective roles in ATPase functions. Recent molecular characterization of these subunits revealed that they are isoforms that arise through an alternative splicing mechanism (Zhou,., Peng, S.-B., Crider, B.P., Slaughter, C., Xie, X.S., and Stone, D.K. (1998) J. Biol. Chem. 273, 5878-5884). To determine the functional characteristics of the 57-kDa (SFD alpha)(1) and 50-kDa (SFD beta) isoforms, we expressed these proteins in Escherichia coli. We determined that purified recombinant proteins, rSFD alpha and rSFD beta, when reassembled with SFD-depleted holoenzyme, are functionally interchangeable in restoration of ATPase and proton pumping activities. In addition, we determined that the V-pump of chromaffin granules has only the SFDa isoform in its native state and that rSFD alpha and rSFD beta are equally effective in restoring ATPase and proton pumping activities to SFD-depleted enzyme. Finally, we found that SFD alpha and SFD beta structurally interact not only with V-1, but also with V-0, indicating that these activator subunits may play both structural and functional roles in coupling ATP hydrolysis to proton flow.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Mol Transport, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stone, DK (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Mol Transport, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NIDDK NIH HHS [R01DK-33627] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Boekema EJ, 1997, P NATL ACAD SCI USA, V94, P14291, DOI 10.1073/pnas.94.26.14291; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; Crider BP, 1997, J BIOL CHEM, V272, P10721; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Harvey WR, 1997, J EXP BIOL, V200, P203; HO MN, 1993, J BIOL CHEM, V268, P18286; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KANE PM, 1995, J BIOL CHEM, V270, P17025; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU Q, 1994, J BIOL CHEM, V269, P31592; MATTSSON JP, 1994, J BIOL CHEM, V269, P24979; MEYERS M, 1993, J BIOL CHEM, V268, P9184; NANDI PK, 1982, P NATL ACAD SCI-BIOL, V79, P5881, DOI 10.1073/pnas.79.19.5881; Peng SB, 1999, J BIOL CHEM, V274, P2549, DOI 10.1074/jbc.274.4.2549; PENG SB, 1995, J BIOL CHEM, V270, P16926; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STONE DK, 1984, J BIOL CHEM, V259, P2701; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THURIEAU C, 1988, DNA-J MOLEC CELL BIO, V7, P663, DOI 10.1089/dna.1988.7.663; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1989, J BIOL CHEM, V264, P18870; XIE XS, 1994, J BIOL CHEM, V269, P25809; XIE XS, 1986, P NATL ACAD SCI USA, V83, P8913, DOI 10.1073/pnas.83.23.8913; XIE XS, 1993, J BIOL CHEM, V268, P25063; ZANG K, 1992, J BIOL CHEM, V267, P9701; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	30	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15913	15919		10.1074/jbc.274.22.15913	http://dx.doi.org/10.1074/jbc.274.22.15913			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336497	hybrid			2022-12-27	WOS:000080560100086
J	Mizuno, T; Nakata, M; Naiki, H; Michikawa, M; Wang, R; Haass, C; Yanagisawa, K				Mizuno, T; Nakata, M; Naiki, H; Michikawa, M; Wang, R; Haass, C; Yanagisawa, K			Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; SCRAPIE ISOFORM; PRION PROTEIN; MDCK CELLS; IN-VITRO; FIBRIL FORMATION; CAVEOLAE; PEPTIDE; GANGLIOSIDES	Deposition of aggregated amyloid beta-protein (A beta), a proteolytic cleavage product of the amyloid precursor protein (1), is a critical step in the development of Alzheimer's disease (2). However, we are far from understanding the molecular mechanisms underlying the initiation of A beta polymerization in vivo. Here, we report that a seeding A beta, which catalyzes the fibrillogenesis of soluble A beta, is generated from the apically missorted amyloid precursor protein in cultured epithelial cells. Furthermore, the generation of this A beta depends exclusively on the presence of cholesterol in the cells. Taken together with mass spectrometric analysis of this novel A beta and our recent study (3), it is suggested that a conformationally altered form of A beta, which acts as a "seed" for amyloid fibril formation, is generated in intracellular cholesterol-rich microdomains.	Natl Inst Longev Sci, Dept Dementia Res, Obu 4748522, Japan; Peptide Inst Inc, Prot Res Fdn, Osaka 562, Japan; Fukui Med Univ, Dept Pathol, Fukui 9101193, Japan; Rockefeller Univ, Lab Mass Spectrometry, New York, NY 10021 USA; Cent Inst Mental Hlth, Dept Mol Biol, D-68159 Mannheim, Germany	University of Fukui; Rockefeller University; Central Institute of Mental Health	Yanagisawa, K (corresponding author), Natl Inst Longev Sci, Dept Dementia Res, Gengo 36-3, Obu 4748522, Japan.		Wang, Rong/A-8721-2009; Naiki, Hironobu/G-5599-2014					Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Mizuno T, 1998, BBA-BIOMEMBRANES, V1373, P119, DOI 10.1016/S0005-2736(98)00097-2; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Naiki H, 1996, LAB INVEST, V74, P374; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SUZUKI N, 1994, AM J PATHOL, V145, P452; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; VAN A, 1995, FEBS LETT, V369, P18; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062	31	101	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15110	15114		10.1074/jbc.274.21.15110	http://dx.doi.org/10.1074/jbc.274.21.15110			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329717	hybrid			2022-12-27	WOS:000081965200082
J	Nardini, M; Ridder, IS; Rozeboom, HJ; Kalk, KH; Rink, R; Janssen, DB; Dijkstra, BW				Nardini, M; Ridder, IS; Rozeboom, HJ; Kalk, KH; Rink, R; Janssen, DB; Dijkstra, BW			The X-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1 - An enzyme to detoxify harmful epoxides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOALKANE DEHALOGENASE; CATALYTIC MECHANISM; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; DIFFRACTION DATA; PROGRAM PACKAGE; MOLSCRIPT; LIPASE; ERRORS; FOLD	Epoxide hydrolases catalyze the cofactor-independent hydrolysis of reactive and toxic epoxides, They play an essential role in the detoxification of various xenobiotics in higher organisms and in the bacterial degradation of several environmental pollutants. The first x-ray structure of one of these, from Agrobacterium radiobacter AD1, has been determined by isomorphous replacement at 2.1-Angstrom resolution. The enzyme shows a two domain structure with the core having the alpha/beta hydrolase-fold topology. The catalytic residues, Asp(107) and His(275), are located in a predominantly hydrophobic environment between the two domains. A tunnel connects the back of the active-site cavity with the surface of the enzyme and provides access to the active site for the catalytic water molecule, which in the crystal structure, has been found at hydrogen bond distance to His275. Because of a crystallographic contact, the active site has become accessible for the Gln(134) side chain, which occupies a position mimicking a bound substrate. The structure suggests Tyr(152)/Tyr(215) as the residues involved in substrate binding, stabilization of the transition state, and possibly protonation of the epoxide oxygen.	Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; Univ Groningen, BIOSON Res Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Dept Chem, Biochem Lab, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.		Dijkstra, Bauke W./H-4308-2019; Nardini, Marco/B-7842-2017	Dijkstra, Bauke W./0000-0001-9731-6586; Nardini, Marco/0000-0002-3718-2165; Ridder, Ivo Steven/0000-0002-1669-4161; Rozeboom, Henriette/0000-0002-1656-6477				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ARAND M, 1994, FEBS LETT, V338, P251, DOI 10.1016/0014-5793(94)80278-5; Archelas A, 1998, TRENDS BIOTECHNOL, V16, P108, DOI 10.1016/S0167-7799(97)01161-X; BELL PA, 1993, J BIOL CHEM, V268, P14011; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; HECHT HJ, 1994, NAT STRUCT BIOL, V1, P532, DOI 10.1038/nsb0894-532; HERANDEZ O, 1982, METABOLIC BASIS DETO, P207; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JACOBS MHJ, 1991, EUR J BIOCHEM, V202, P1217, DOI 10.1111/j.1432-1033.1991.tb16493.x; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KERR BM, 1990, DRUG METAB DISPOS, V18, P540; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KLEYWEGT GJ, 1995, STRUCTURE, V15, P535; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krooshof GH, 1997, BIOCHEMISTRY-US, V36, P9571, DOI 10.1021/bi971014t; LACOURCIERE GM, 1994, CHEM RES TOXICOL, V7, P121, DOI 10.1021/tx00038a001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Misawa E, 1998, EUR J BIOCHEM, V253, P173, DOI 10.1046/j.1432-1327.1998.2530173.x; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMAKRISHNAN C, 1965, J MOL BIOL, V7, P95; Rink R, 1997, J BIOL CHEM, V272, P14650, DOI 10.1074/jbc.272.23.14650; Spelberg JHL, 1998, TETRAHEDRON-ASYMMETR, V9, P459, DOI 10.1016/S0957-4166(98)00003-2; VERSCHUEREN KHG, 1993, J MOL BIOL, V232, P856, DOI 10.1006/jmbi.1993.1436; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0	39	146	154	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14579	14586		10.1074/jbc.274.21.14579	http://dx.doi.org/10.1074/jbc.274.21.14579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329649	hybrid, Green Published			2022-12-27	WOS:000081965200014
J	Bowler, WB; Dixon, CJ; Halleux, C; Maier, R; Bilbe, G; Fraser, WD; Gallagher, JA; Hipskind, RA				Bowler, WB; Dixon, CJ; Halleux, C; Maier, R; Bilbe, G; Fraser, WD; Gallagher, JA; Hipskind, RA			Signaling in human osteoblasts by extracellular nucleotides - Their weak induction of the c-fos proto-oncogene via Ca2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMOOTH-MUSCLE CELLS; GROWTH-FACTOR; GENE-TRANSCRIPTION; OSTEOSARCOMA CELLS; MAP KINASE; PURINERGIC RECEPTORS; CALCIUM INFLUX; IN-VIVO; ATP	Extracellular nucleotides acting through specific P2 receptors activate intracellular signaling cascades. Consistent with the expression of G protein-coupled P2Y receptors in skeletal tissue, the human osteosarcoma cell line SaOS-2 and primary osteoblasts express P2Y(1) and P2Y(2) receptors, respectively. Their activation by nucleotide agonists (ADP and ATP for P2Y(1); ATP and UTP for P2Y(2)) elevates [Ca2+](i) and moderately induces expression of the c-fos proto-oncogene. A synergistic effect on c-fos induction is observed by combining ATP and parathyroid hormone, a key bone cell regulator. Parathyroid hormone elevates intracellular cAMP levels and correspondingly activates a stably integrated reporter gene driven by the Ca2+/cAMP-responsive element of the human c-fos promoter. Nucleotides have little effect on either cAMP levels or this reporter, instead activating luciferase controlled by the full c-fos promoter. This induction is reproduced by a stably integrated serum response element reporter independently of mitogen-activated protein kinase activation and ternary complex factor phosphorylation. This novel example of synergy between the cAMP-dependent protein kinase/CaCRE signaling module and a non-mitogen-activated protein kinase/ternary complex factor pathway that targets the serum response element shows that extracellular ATP, via P2Y receptors, can potentiate strong responses to ubiquitous growth and differentiative factors.	Univ Liverpool, Human Bone Cell Res Grp, Liverpool L69 3GE, Merseyside, England; Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England; Univ Liverpool, Dept Clin Chem, Liverpool L69 3GE, Merseyside, England; Novartis Pharma AG, CH-4002 Basel, Switzerland; Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34293 Montpellier 5, France	University of Liverpool; University of Liverpool; University of Liverpool; Novartis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Bowler, WB (corresponding author), Univ Liverpool, Human Bone Cell Res Grp, Liverpool L69 3GE, Merseyside, England.	wbb@liv.ac.uk						ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BOWLER WB, 1995, J BONE MINER RES, V10, P1137; Bowler WB, 1998, BONE, V22, P195, DOI 10.1016/S8756-3282(97)00280-9; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dixon CJ, 1997, BRIT J PHARMACOL, V120, P777; DUBYAK G R, 1990, Comprehensive Therapy, V16, P57; ENDHO H, 1997, BIOCHEM BIOPH RES CO, V235, P99; Evans DB, 1996, J BONE MINER RES, V11, P1066; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; GALLAGHER JA, 1996, METHODS MOL MED, V1, P233; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; HARDEN TK, 1995, ANNU REV PHARMACOL, V35, P541, DOI 10.1146/annurev.pharmtox.35.1.541; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583; HIPSKIND RA, 1994, GENE DEV, V8, P1803, DOI 10.1101/gad.8.15.1803; HIPSKIND RA, 1998, FRONT BIOSCI, V3, P804, DOI DOI 10.2741/A323; HUANG NN, 1989, P NATL ACAD SCI USA, V86, P7904, DOI 10.1073/pnas.86.20.7904; Hurley MM, 1996, J BONE MINER RES, V11, P1256; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; KUMAGAI H, 1991, J BONE MINER RES, V6, P697; LEE G, 1994, MOL CELL BIOL, V14, P4579, DOI 10.1128/MCB.14.7.4579; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; MACDONALD BR, 1986, ENDOCRINOLOGY, V118, P2445, DOI 10.1210/endo-118-6-2445; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Neary JT, 1998, NEUROSCI LETT, V242, P159, DOI 10.1016/S0304-3940(98)00067-6; OREILLY DS, 1986, J ENDOCRINOL, V111, P501, DOI 10.1677/joe.0.1110501; Patel V, 1996, BIOCHEM J, V320, P221, DOI 10.1042/bj3200221; Post SR, 1998, J BIOL CHEM, V273, P23093, DOI 10.1074/jbc.273.36.23093; RAISZ LG, 1963, NATURE, V197, P1015, DOI 10.1038/1971015a0; REIMER WJ, 1992, AM J PHYSIOL, V263, pC1040, DOI 10.1152/ajpcell.1992.263.5.C1040; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; RODAN SB, 1987, CANCER RES, V47, P4961; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHOFL C, 1991, BIOCHEM J, V274, P15, DOI 10.1042/bj2740015; SCHOFL C, 1992, J BONE MINER RES, V6, P697; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; THOMAS AP, 1992, TECHNIQUES CALCIUM R, P1; Tornquist K, 1996, J CELL PHYSIOL, V166, P241; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VERHEIJEN MHG, 1995, ENDOCRINOLOGY, V136, P3331, DOI 10.1210/en.136.8.3331; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WANG DJ, 1992, J CELL PHYSIOL, V153, P221, DOI 10.1002/jcp.1041530202; Wang Y, 1996, MOL CELL BIOL, V16, P5915; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Wu LW, 1997, J CLIN ENDOCR METAB, V82, P1126, DOI 10.1210/jc.82.4.1126; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yu SM, 1996, MOL PHARMACOL, V50, P1000	70	95	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14315	14324		10.1074/jbc.274.20.14315	http://dx.doi.org/10.1074/jbc.274.20.14315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318853	hybrid			2022-12-27	WOS:000080322200082
J	Della Rocca, GJ; Maudsley, S; Daaka, Y; Lefkowitz, RJ; Luttrell, LM				Della Rocca, GJ; Maudsley, S; Daaka, Y; Lefkowitz, RJ; Luttrell, LM			Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade - Role of focal adhesions and receptor tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE CELLS; MAP KINASE; ANGIOTENSIN-II; EGF RECEPTOR; C-SRC; THROMBIN-RECEPTOR; DISTINCT PATHWAYS; ION-CHANNEL; PHOSPHORYLATION	G protein-coupled receptors (GPCRs)initiate Ras-dependent activation of the Erk 1/2 mitogen-activated protein kinase cascade by stimulating recruitment of Ras guanine nucleotide exchange factors to the plasma membrane. Both integrin-based focal adhesion complexes and receptor tyrosine kinases have been proposed as scaffolds upon which the GPCR-induced Ras activation complex may assemble. Using specific inhibitors of focal adhesion complex assembly and receptor tyrosine kinase activation, we have determined the relative contribution of each to activation of the Erk 1/2 cascade following stimulation of endogenous GPCRs in three different cell types. The tetrapeptide RGDS, which inhibits integrin dimerization, and cytochalasin D, which depolymerizes the actin cytoskeleton, disrupt the assembly of focal adhesions. In PC12 rat pheochromocytoma cells, both agents block lysophosphatidic acid (LPA)- and bradykinin-stimulated Erk 1/2 phosphorylation, suggesting that intact focal adhesion complexes are required for GPCR-induced mitogen-activated protein kinase activation in these cells, In Rat 1 fibroblasts, Erk 1/2 activation via LPA and thrombin receptors is completely insensitive to both agents. Conversely, the epidermal growth factor receptor-specific tyrphostin AG1478 inhibits GPCR-mediated Erk 1/2 activation in Rat 1 cells but has no effect in PC12 cells. In HEH-293 human embryonic kidney cells, LPA and thrombin receptor-mediated Erk 1/2 activation is partially sensitive to both the RGDS peptide and tyrphostin AG1478, suggesting that both focal adhesion and receptor tyrosine kinase scaffolds are employed in these cells. The dependence of GPCR-mediated Erk 1/2 activation on intact focal adhesions correlates with expression of the calcium-regulated focal adhesion kinase, Pyk2, In all three cell types, GPCR-stimulated Erk 1/2 activation is significantly inhibited by the Src kinase inhibitors, herbimycin A and 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyra-zolo-D-3,4-pyrimidine (PP1), suggesting that Src family nonreceptor tyrosine kinases represent a point of convergence for signals originating from either scaffold.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.		Della Rocca, Gregory/AAM-5281-2021; Lefkowitz, Robert/AAW-2649-2021; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Luttrell, Louis/0000-0003-2805-6949	NHLBI NIH HHS [HL16037] Funding Source: Medline; NIDDK NIH HHS [DK02352, DK55524] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, K08DK002352, R56DK055524] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN YH, 1994, J BIOL CHEM, V269, P27372; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Slack BE, 1998, P NATL ACAD SCI USA, V95, P7281, DOI 10.1073/pnas.95.13.7281; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	36	223	224	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13978	13984		10.1074/jbc.274.20.13978	http://dx.doi.org/10.1074/jbc.274.20.13978			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318809	hybrid			2022-12-27	WOS:000080322200038
J	Sekiya, F; Bae, YS; Jhon, DY; Hwang, SC; Rhee, SG				Sekiya, F; Bae, YS; Jhon, DY; Hwang, SC; Rhee, SG			AHNAK, a protein that binds and activates phospholipase C-gamma 1 in the presence of arachidonic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GENE AHNAK; STIMULATES PHOSPHOINOSITIDE HYDROLYSIS; PLACENTAL-LACTOGEN RELEASE; C-GAMMA; TAU-PROTEIN; PLASMA-MEMBRANE; KINASE-C; IN-SITU; CA-2+; CELLS	We have recently shown that phospholipase C-gamma (PLC-gamma) is activated by tau, a neuronal cell-specific microtubule-associated protein, in the presence of arachidonic acid, We now report that non-neuronal tissues also contain a protein that can activate PLC-gamma in the presence of arachidonic acid. Purification of this activator from bovine lung cytosol yielded several proteins with apparent molecular sizes of 70-130 kDa. They were identified as fragments derived from an unusually large protein (similar to 700 kDa) named AHNAK, which comprises about 30 repeated motifs each 128 amino acids in length. Two AHNAK fragments containing one and four of the repeated motifs, respectively, were expressed as glutathione S-transferase fusion proteins. Both recombinant proteins activated PLC-gamma 1 at nanomolar concentrations in the presence of arachidonic acid, suggesting that an intact AHNAK molecule contains multiple sites for PLC-gamma activation. The role of arachidonic acid was to promote a physical interaction between AHNAK and PLC-gamma 1, and the activation by AHNAK and arachidonic acid was mainly attributable to reduction in the enzyme's apparent K-m toward the substrate phosphatidylinositol 4,5-bisphosphate. Our results suggest that arachidonic acid liberated by phospholipase A(2) can act as an additional trigger for PLC-gamma activation, constituting an alternative mechanism that is independent of tyrosine phosphorylation.	NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), NHLBI, Lab Cell Signaling, NIH, Bldg 3,Rm 122, Bethesda, MD 20892 USA.	sgrhee@nih.gov		Hwang, Sung Chul/0000-0003-2401-619X				Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CHOW SC, 1990, J BIOL CHEM, V265, P902; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Flanagan LA, 1997, BIOPHYS J, V73, P1440, DOI 10.1016/S0006-3495(97)78176-1; GERZER R, 1986, BIOCHIM BIOPHYS ACTA, V886, P383, DOI 10.1016/0167-4889(86)90173-4; Glick J, 1996, J BIOL CHEM, V271, P2949, DOI 10.1074/jbc.271.6.2949; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; HASHIMOTO T, 1993, J CELL SCI, V105, P275; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; HIEDA Y, 1989, J CELL BIOL, V109, P1511, DOI 10.1083/jcb.109.4.1511; Hwang SC, 1996, J BIOL CHEM, V271, P18342, DOI 10.1074/jbc.271.31.18342; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; JONES GA, 1993, J BIOL CHEM, V268, P20845; KUDOH J, 1995, CYTOGENET CELL GENET, V70, P218, DOI 10.1159/000134037; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LYNCH MA, 1990, J NEUROCHEM, V55, P215, DOI 10.1111/j.1471-4159.1990.tb08841.x; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; NEGISHI M, 1990, BIOCHEM BIOPH RES CO, V169, P773, DOI 10.1016/0006-291X(90)90398-7; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PARK D, 1992, J BIOL CHEM, V267, P16048; PIOMELLI D, 1989, P NATL ACAD SCI USA, V86, P8550, DOI 10.1073/pnas.86.21.8550; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; SUH PG, 1988, J BIOL CHEM, V263, P14497; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; WAHL MI, 1992, J BIOL CHEM, V267, P10447; Wilson DM, 1997, AM J PATHOL, V150, P2181; WOLF BA, 1986, J BIOL CHEM, V261, P3501; ZEITLER P, 1985, MOL PHARMACOL, V28, P549; ZEITLER P, 1991, LIFE SCI, V48, P2089, DOI 10.1016/0024-3205(91)90166-9	39	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13900	13907		10.1074/jbc.274.20.13900	http://dx.doi.org/10.1074/jbc.274.20.13900			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318799	hybrid			2022-12-27	WOS:000080322200028
J	Standaert, ML; Bandyopadhyay, G; Sajan, MP; Cong, L; Quon, MJ; Farese, RV				Standaert, ML; Bandyopadhyay, G; Sajan, MP; Cong, L; Quon, MJ; Farese, RV			Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes - An apparent requirement for activation of GLUT4 translocation and glucose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-STIMULATED GLUCOSE; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; POTENTIAL ROLE; AKT; CELLS; ZETA; ALPHA; PDK1	Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, is known to provoke insulin-like effects on GLUT4 translocation and glucose transport, but the underlying mechanism is obscure. Presently, we found in both rat adipocytes and 3T3/L1 adipocytes that okadaic acid provoked partial insulin-like increases in glucose transport, which were inhibited by phosphatidylinositol (PI) 3-kinase inhibitors, wortmannin and LY294002, and inhibitors of atypical protein kinase C (PKC) isoforms, zeta and lambda. Moreover, in both cell types, okadaic acid provoked increases in the activity of immunoprecipitable PRC-zeta/lambda by a PI 3-kinase-dependent mechanism. In keeping with apparent PI 3-kinase dependence of stimulatory effects of okadaic acid on glucose transport and PKC-zeta/lambda activity, okadaic acid provoked insulin-like increases in membrane PI 3-kinase activity in rat adipocytes; the mechanism for PI 3-kinase activation was uncertain, however, because it was not apparent in phosphotyrosine immunoprecipitates. Of further note, okadaic acid provoked partial insulin-like increases in the translocation of hemagglutinin antigen-tagged GLUT4 to the plasma membrane in transiently transfected rat adipocytes, and these stimulatory effects on hemagglutinin antigen-tagged GLUT4 translocation were inhibited by eo-expression of kinase;inactive forms of PRC-zeta and PKC-lambda. but not by a double mutant (T308A, 5473A), activation-resistant form of protein kinase B, Our findings suggest that, as with insulin, PI 3-kinase-dependent atypical PKCs, zeta and lambda, are required for okadaic acid-induced increases in GLUT4 translocation and glucose transport in rat adipocytes and 3T3/L1 adipocytes.	Univ S Florida, Coll Med, Dept Internal Med, Tampa, FL 33612 USA; NHLBI, Hypertens Endocrine Branch, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Farese, RV (corresponding author), JA Haley VA Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Quon, Michael/B-1970-2008; Farese, Robert/B-3605-2015	QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL003608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065969, R01DK038079] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK065969, 2R01DK38079-09A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; JULLIEN D, 1993, J BIOL CHEM, V268, P15246; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEMARCHANDBRUSTEL Y, 1995, ENDOCRINOLOGY, V136, P3564, DOI 10.1210/en.136.8.3564; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Rondinone CM, 1996, J BIOL CHEM, V271, P18148, DOI 10.1074/jbc.271.30.18148; Standaert M, 1998, J BIOL CHEM, V273, P7470, DOI 10.1074/jbc.273.13.7470; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335	20	59	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14074	14078		10.1074/jbc.274.20.14074	http://dx.doi.org/10.1074/jbc.274.20.14074			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318822	hybrid			2022-12-27	WOS:000080322200051
J	Varlamov, O; Wu, F; Shields, D; Fricker, LD				Varlamov, O; Wu, F; Shields, D; Fricker, LD			Biosynthesis and packaging of carboxypeptidase D into nascent secretory vesicles in pituitary cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; KEX2-LIKE PROCESSING ENDOPROTEASE; OBESE FAT/FAT MICE; ATT-20 CELLS; INTRACELLULAR TRAFFICKING; METALLOCARBOXYPEPTIDASE-D; PROPROTEIN CONVERTASE; PERMEABILIZED CELLS; TISSUE DISTRIBUTION; BOVINE PITUITARY	Metallocarboxypeptidase D (CPD) is a membrane-bound trans-Golgi network (TGN) protein. In AtT-20 cells, CPD is initially produced as a 170-kDa endoglycosidase H-sensitive glycoprotein. Within 30 min of chase, the CPD increases to 180 kDa and is resistant to endoglycosidase H as a result of carbohydrate maturation. CPD also undergoes an activation step required for binding to a substrate affinity resin. Blocking the protein exit from the endoplasmic reticulum inhibits the increase in molecular mass but not the step required for affinity column binding, suggesting that enzyme activation precedes carbohydrate maturation and that these reactions occur in distinct intracellular compartments. Only the higher molecular weight mature CPD enters nascent secretory vesicles, which bud from the TGN of permeabilized AtT-20 and GH(3) cells. The budding efficiency of CPD into vesicles is 2-3-fold lower than that of endogenous proopiomelanocortin in AtT-20 cells or prolactin in GH(3) cells. In contrast, the packaging of a truncated form of CPD, which lacks the cytoplasmic tail and transmembrane domain, was similar to that of proopiomelanocortin, Taken together, the results support the proposal that CPD functions in the TGN in the processing of proteins that transit the secretory pathway and that the C-terminal region plays a major role in TGN retention.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NIDA NIH HHS [K02 DA-00194] Funding Source: Medline; NIDDK NIH HHS [R37 DK21860, R01 DK-51271] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271, R37DK021860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000194] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Austin CD, 1996, J CELL BIOL, V135, P1471, DOI 10.1083/jcb.135.6.1471; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; EIPPER BA, 1987, MOL ENDOCRINOL, V1, P777, DOI 10.1210/mend-1-11-777; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; Fricker LD, 1996, J BIOL CHEM, V271, P30619, DOI 10.1074/jbc.271.48.30619; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1993, J NEUROCHEM, V61, P1404, DOI 10.1111/j.1471-4159.1993.tb13634.x; FRICKER LD, 1993, INNOVATIONS PROTEASE, P259; FRICKER LD, 1991, PEPTIDE BIOSYNTHESIS, P199; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KLEIN RS, 1992, J NEUROCHEM, V58, P2011, DOI 10.1111/j.1471-4159.1992.tb10941.x; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; Ling WLW, 1998, METHODS, V16, P141, DOI 10.1006/meth.1998.0661; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MITRA A, 1994, J BIOL CHEM, V269, P19876; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; PARKINSON D, 1990, J BIOL CHEM, V265, P17101; Rovere C, 1996, ENDOCRINOLOGY, V137, P2954, DOI 10.1210/en.137.7.2954; RUSSELL JT, 1984, J BIOL CHEM, V259, P9496; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Song LX, 1996, J BIOL CHEM, V271, P28884, DOI 10.1074/jbc.271.46.28884; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Varlamov O, 1998, J CELL SCI, V111, P877; Varlamov O, 1996, J BIOL CHEM, V271, P13981, DOI 10.1074/jbc.271.24.13981; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Xin XN, 1997, DNA CELL BIOL, V16, P897, DOI 10.1089/dna.1997.16.897; XU HX, 1993, J CELL BIOL, V122, P1169, DOI 10.1083/jcb.122.6.1169	44	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14040	14045		10.1074/jbc.274.20.14040	http://dx.doi.org/10.1074/jbc.274.20.14040			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318817	hybrid			2022-12-27	WOS:000080322200046
J	Scheele, JS; Bruner, E; Kharitonov, VG; Martasek, P; Roman, LJ; Masters, BSS; Sharma, VS; Magde, D				Scheele, JS; Bruner, E; Kharitonov, VG; Martasek, P; Roman, LJ; Masters, BSS; Sharma, VS; Magde, D			Kinetics of NO ligation with nitric-oxide synthase by flash photolysis and stopped-flow spectrophotometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; L-ARGININE; HEME-PROTEINS; SPECTRAL CHARACTERIZATION; DISSOCIATION; HEMOGLOBIN; MECHANISM; BINDING; CO; TETRAHYDROBIOPTERIN	Nitric-oxide synthase (NOS) catalyzes conversion of L-arginine to nitric oxide, which subsequently stimulates a host of physiological processes. Prior work suggests that NOS is inhibited by NO, providing opportunities for autoregulation, This contribution reports that NO reacts rapidly (k(a) congruent to 2 x 10(7) M-1 s(-1)) with neuronal NOS in both its ferric and ferrous oxidation states. Association kinetics are almost unaffected by L-arginine or the cofactor tetrahydrobiopterin, There is no evidence for the distinct two phases previously reported for association kinetics of CO. Small amounts of geminate recombination of NO trapped in a protein pocket can be observed over nanoseconds, and a much larger amount is inferred to take place at picosecond time scales. Dissociation rates are also very fast from the ferric form, in the neighborhood of 50 s(-1), when measured by extrapolating association rates to the zero NO concentration limit. Scavenging experiments give dissociation rate constants more than an order of magnitude slower: still quite fast. For the ferrous species, extrapolation is not distinguishable from zero, while scavenging experiments give a dissociation rate constant near 10(-4) s(-1). Implications of these results for interactions near the heme binding site are discussed.	Univ Calif San Diego, Dept Biochem & Chem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Health San Antonio	Magde, D (corresponding author), Univ Calif San Diego, Dept Biochem & Chem, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Martasek, Pavel/G-6622-2017	Martasek, Pavel/0000-0001-6165-4444	NHLBI NIH HHS [HL40818] Funding Source: Medline; NIDDK NIH HHS [2T32DK07233] Funding Source: Medline; NIGMS NIH HHS [GM52419] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Soud HM, 1998, BIOCHEMISTRY-US, V37, P3777, DOI 10.1021/bi972398q; BUGA GM, 1993, CIRC RES, V73, P808, DOI 10.1161/01.RES.73.5.808; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; EICH RF, 1997, REACTIONS NITRIC OXI; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; GRISCAVAGE JM, 1994, J BIOL CHEM, V269, P21644; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; JONGEWARD KA, 1988, J AM CHEM SOC, V110, P380, DOI 10.1021/ja00210a011; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; KHARITONOV VG, 1996, METHODS NITRIC OXIDE, P39; KLATT P, 1992, BIOCHEM J, V288, P15, DOI 10.1042/bj2880015; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MASTERS BSS, 1994, ANNU REV NUTR, V14, P131, DOI 10.1146/annurev.nu.14.070194.001023; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Scheele JS, 1997, J BIOL CHEM, V272, P12523, DOI 10.1074/jbc.272.19.12523; SHARMA VS, 1983, BIOCHEMISTRY-US, V22, P3897, DOI 10.1021/bi00285a026; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tierney DL, 1998, J AM CHEM SOC, V120, P2983, DOI 10.1021/ja973648t; TSAI AL, 1994, FEBS LETT, V341, P141, DOI 10.1016/0014-5793(94)80445-1; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001	33	49	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13105	13110		10.1074/jbc.274.19.13105	http://dx.doi.org/10.1074/jbc.274.19.13105			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224063	hybrid			2022-12-27	WOS:000080200400025
J	Czaplewski, LG; McKeating, J; Craven, CJ; Higgins, LD; Appay, V; Brown, A; Dudgeon, T; Howard, LA; Meyers, T; Owen, J; Palan, SR; Tan, P; Wilson, G; Woods, NR; Heyworth, CM; Lord, BI; Brotherton, D; Christison, R; Craig, S; Cribbes, S; Edwards, RM; Evans, SJ; Gilbert, R; Morgan, P; Randle, E; Schofield, N; Varley, PG; Fisher, J; Waltho, JP; Hunter, MG				Czaplewski, LG; McKeating, J; Craven, CJ; Higgins, LD; Appay, V; Brown, A; Dudgeon, T; Howard, LA; Meyers, T; Owen, J; Palan, SR; Tan, P; Wilson, G; Woods, NR; Heyworth, CM; Lord, BI; Brotherton, D; Christison, R; Craig, S; Cribbes, S; Edwards, RM; Evans, SJ; Gilbert, R; Morgan, P; Randle, E; Schofield, N; Varley, PG; Fisher, J; Waltho, JP; Hunter, MG			Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES - Characterization of active disaggregated chemokine variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETICALLY-ENGINEERED VARIANT; RANDOMIZED PHASE-II; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL EXPRESSION; HEMATOPOIETIC-CELLS; NMR-SPECTROSCOPY; BREAST-CANCER; STEM-CELLS; PROTEIN-1-ALPHA; MIP-1-ALPHA	Human CC chemokines macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES (regulated on activation normal T cell expressed) self-associate to form high-molecular mass aggregates. To explore the biological significance of chemokine aggregation, nonaggregating variants were sought. The phenotypes of 105 hMIP-1 alpha variants generated by systematic mutagenesis and expression in yeast were determined, hMIP-1 alpha residues Asp(26) and Glu(66) were critical to the self-association process. Substitution at either residue resulted in the formation of essentially homogenous tetramers at 0.5 mg/ml. Substitution of identical or analogous residues in homologous positions in both hMIP-1 beta and RANTES demonstrated that they were also critical to aggregation. Our analysis suggests that a single charged residue at either position 26 or 66 is insufficient to support extensive aggregation and that two charged residues must be present. Solution of the three-dimensional NMR structure of hMIP-1 alpha has enabled comparison of these residues in hMIP-1 beta and RANTES. Aggregated and disaggregated forms of hMIP-1 alpha, hMIP-1 beta, and RANTES generally have equivalent G-protein-coupled receptor-mediated biological potencies. We have therefore generated novel reagents to evaluate the role of hMIP-1 alpha, hMIP-1 beta, and RANTES aggregation in vitro and in vivo. The disaggregated chemokines retained their human immunodeficiency virus (HIV) inhibitory activities. Surprisingly, high concentrations of RANTES, but not disaggregated RANTES variants, enhanced infection of cells by both M- and T-tropic HIV isolates/strains. This observation has important implications for potential therapeutic uses of chemokines implying that disaggregated forms may be necessary for safe clinical investigation.	British Biotech Pharmaceut Ltd, Oxford OX4 5LY, England; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC, Dept Expt Haematol, Manchester M20 9BX, Lancs, England; Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Reading; University of Sheffield; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Leeds	Czaplewski, LG (corresponding author), British Biotech Pharmaceut Ltd, Watlington Rd, Oxford OX4 5LY, England.		Appay, Victor/M-4830-2017; Appay, Victor/AAM-7701-2021	Appay, Victor/0000-0001-5434-3963; McKeating, Jane/0000-0002-7229-5886				ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; AVALOS BR, 1994, BLOOD, V84, P1790, DOI 10.1182/blood.V84.6.1790.bloodjournal8461790; Bernstein SH, 1997, BRIT J HAEMATOL, V99, P888, DOI 10.1046/j.1365-2141.1997.4913294.x; BILLETER M, 1992, J BIOMOL NMR, V2, P257, DOI 10.1007/BF01875320; Buckle AM, 1997, METHOD ENZYMOL, V287, P127; CANQUE B, 1994, BLOOD, V84, pA480; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLEMENTS JM, 1992, CYTOKINE, V4, P76, DOI 10.1016/1043-4666(92)90040-X; Clemons MJ, 1998, BLOOD, V92, P1532, DOI 10.1182/blood.V92.5.1532.417k18_1532_1540; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; CONNOR RI, 1994, AIDS RES HUM RETROV, V10, P321, DOI 10.1089/aid.1994.10.321; CRAIG S, 1993, Patent No. 13206; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; GEITZ D, 1992, NUCLEIC ACIDS RES, V20, P1425; GRAHAM GJ, 1994, J BIOL CHEM, V269, P4974; HUNTER MG, 1995, BLOOD, V86, P4400, DOI 10.1182/blood.V86.12.4400.bloodjournal86124400; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAROCHE Y, 1994, BIO-TECHNOL, V12, P1119, DOI 10.1038/nbt1194-1119; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; LORD BI, 1992, BLOOD, V79, P2605; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MANTEL C, 1993, P NATL ACAD SCI USA, V90, P2232, DOI 10.1073/pnas.90.6.2232; Marshall E, 1998, EUR J CANCER, V34, P1023, DOI 10.1016/S0959-8049(97)10141-1; Meunier S, 1997, BIOCHEMISTRY-US, V36, P4412, DOI 10.1021/bi9627929; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; PARKINSON EK, 1993, J INVEST DERMATOL, V101, P113, DOI 10.1111/1523-1747.ep12363603; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PATEL SR, 1993, BIOCHEMISTRY-US, V32, P5466, DOI 10.1021/bi00071a024; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Sherman F., 1986, METHODS YEAST GENETI; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; STCHARLES R, 1989, J BIOL CHEM, V264, P2092; Varley PG, 1997, EUR BIOPHYS J BIOPHY, V25, P437, DOI 10.1007/s002490050058; VERFAILLIE CM, 1994, J EXP MED, V179, P643, DOI 10.1084/jem.179.2.643; vonLuettichau I, 1996, CYTOKINE, V8, P89, DOI 10.1006/cyto.1996.0012; Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457; Whitehead Brian, 1997, V60, P29; Williams SL, 1997, CYTOKINES CELL MOL T, V3, P41; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851	55	139	144	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16077	16084		10.1074/jbc.274.23.16077	http://dx.doi.org/10.1074/jbc.274.23.16077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347159	hybrid			2022-12-27	WOS:000080668600019
J	Bhattacharya, M; Peri, K; Ribeiro-da-Silva, A; Almazan, G; Shichi, H; Hou, X; Varma, DR; Chemtob, S				Bhattacharya, M; Peri, K; Ribeiro-da-Silva, A; Almazan, G; Shichi, H; Hou, X; Varma, DR; Chemtob, S			Localization of functional prostaglandin E-2 receptors EP3 and EP4 in the nuclear envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RAT-LIVER; ENDOPLASMIC-RETICULUM; PROSTANOID RECEPTOR; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; CELLS; EXPRESSION; ACTIVATION; SUBTYPES	The effects of prostaglandin E-2 are thought to be mediated via G protein-coupled plasma membrane receptors, termed EP. However recent data implied that prostanoids may also act intracellularly. We investigated if the ubiquitous EP3 and the EP4 receptors are localized in nuclear membranes. Radioligand binding studies on isolated nuclear membrane fractions of neonatal porcine brain and adult rat liver revealed the presence of EP3 and EP4. A perinuclear localization of EP3 alpha and EP4 receptors was visualized by indirect immunocytofluorescence and confocal microscopy in porcine cerebral microvascular endothelial cells and in transfected HEK 293 cells that stably overexpress these receptors. Immunoelectron microscopy clearly revealed EP3 alpha and EP4 receptors localization in the nuclear envelope of endothelial cells; this is the first demonstration of the nuclear localization of these receptors. Data also reveal that nuclear EP receptors are functional as they affect transcription of genes such as inducible nitric-oxide synthase and intranuclear calcium transients; this appears to involve pertussis toxin-sensitive G proteins. These results define a possible molecular mechanism of action of nuclear EP3 receptors.	Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA; Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Dept Ophthalmol, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Dept Pharmacol, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; McGill University; Wayne State University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Chemtob, S (corresponding author), Univ Montreal, Hop St Justine, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.		Ribeiro-da-Silva, Alfredo/K-4783-2012	Ribeiro-da-Silva, Alfredo/0000-0002-4125-0255				ADACHI H, 1993, EUR J BIOCHEM, V217, P37, DOI 10.1111/j.1432-1033.1993.tb18215.x; ADAM M, 1994, FEBS LETT, V338, P170, DOI 10.1016/0014-5793(94)80358-7; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; BARSONY J, 1990, P NATL ACAD SCI USA, V87, P1188, DOI 10.1073/pnas.87.3.1188; BASTIEN L, 1994, J BIOL CHEM, V269, P11873; Baylink TM, 1996, J BONE MINER RES, V11, P1413; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BOOZ GW, 1992, ENDOCRINOLOGY, V130, P3641, DOI 10.1210/en.130.6.3641; Chemtob S, 1996, ACTA PAEDIATR, V85, P517, DOI 10.1111/j.1651-2227.1996.tb14077.x; Coffey RJ, 1997, P NATL ACAD SCI USA, V94, P657, DOI 10.1073/pnas.94.2.657; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; DALE B, 1994, P ROY SOC B-BIOL SCI, V255, P119, DOI 10.1098/rspb.1994.0017; DiRosa M, 1996, PROSTAG LEUKOTR ESS, V54, P229, DOI 10.1016/S0952-3278(96)90053-8; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Doke A., 1996, Pediatric Research, V39, p205A; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dumont I, 1998, AM J PHYSIOL-REG I, V275, pR1812, DOI 10.1152/ajpregu.1998.275.6.R1812; FIGUEIREDO BC, 1993, MOL BRAIN RES, V17, P258, DOI 10.1016/0169-328X(93)90010-M; Gerasimenko OV, 1996, PFLUG ARCH EUR J PHY, V432, P1, DOI 10.1007/s004240050098; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; HESCHELER J, 1988, EMBO J, V7, P613; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LAHAIE I, 1998, AM J PHYSIOL, V274, P1406; LEFFLER CW, 1985, PROSTAGLANDINS, V30, P811, DOI 10.1016/0090-6980(85)90009-7; LEPRETRE N, 1994, J BIOL CHEM, V269, P29546; LI DY, 1994, BRIT J PHARMACOL, V112, P59, DOI 10.1111/j.1476-5381.1994.tb13029.x; LIND GJ, 1993, INVEST OPHTH VIS SCI, V34, P2943; Lu D, 1998, ENDOCRINOLOGY, V139, P365, DOI 10.1210/en.139.1.365; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; NeuschaferRube F, 1997, FEBS LETT, V401, P185, DOI 10.1016/S0014-5793(96)01468-8; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; NOORDLIE RC, 1966, METHOD ENZYMOL, V9, P619; PERI KG, 1995, J BIOL CHEM, V270, P24615, DOI 10.1074/jbc.270.41.24615; PICKEL V, 1993, IMMUNOHISTOCHEMISTRY; RIBEIRODASILVA A, 1993, IMMUNOHISTOCHEMISTRY; RUBIN BS, 1986, BRAIN RES, V383, P60, DOI 10.1016/0006-8993(86)90008-9; SAFFITZ JE, 1994, FASEB J, V8, P252, DOI 10.1096/fasebj.8.2.8119495; Sambrook J., 2002, MOL CLONING LAB MANU; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SIMONSON MS, 1994, EXP CELL RES, V215, P137, DOI 10.1006/excr.1994.1325; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; TAKAGI H, 1994, NITRIC OXIDE ROLES N, P44; TAKEI Y, 1994, J BIOCHEM-TOKYO, V115, P578, DOI 10.1093/oxfordjournals.jbchem.a124378; VIRGOLINI I, 1988, PROSTAGLANDINS, V36, P807, DOI 10.1016/0090-6980(88)90058-5; Yano T, 1997, BIOCHEM PHARMACOL, V53, P1757, DOI 10.1016/S0006-2952(96)00869-6; ZHAO C, 1995, J OCUL PHARMACOL TH, V11, P421, DOI 10.1089/jop.1995.11.421	54	208	211	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15719	15724		10.1074/jbc.274.22.15719	http://dx.doi.org/10.1074/jbc.274.22.15719			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336471	hybrid			2022-12-27	WOS:000080560100060
J	Fay, PJ; Koshibu, K; Mastri, M				Fay, PJ; Koshibu, K; Mastri, M			The A1 and A2 subunits of factor VIIIa synergistically stimulate factor IXa catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; COAGULATION FACTOR-VIII; LIGHT-CHAIN; COFACTOR ACTIVITY; INTERACTIVE SITE; BINDING-SITE; CLEAVAGE; PROTEOLYSIS; IDENTIFICATION	Factor VIIIa, the protein cofactor for factor IXa, is comprised of A1, A2, and A3-C1-C2 subunits. Recently, we showed that isolated A2 subunit enhanced the k(cat) for factor IXa-catalyzed activation of factor X by similar to 100-fold (similar to 1 min(-1)), whereas isolated A1 or A3-C1-C2 subunits showed no effect on this rate (Fay, P. J., and Koshibu, K. J. (1998) J, Biol, Chem, 273, 19049-19054), However, A1 subunit increased the A2-dependent stimulation by similar to 10-fold. The K-m for factor X in the presence of A2 subunit was unaffected by A1 subunit, whereas the k(cat) observed in the presence of saturating A1 and A2 subunits (similar to 15 min(-1)) represented 5-10% of the value observed for native factor VIIIa (similar to 200 min(-1)). An anti-A1 subunit antibody that blocks the association of A2 eliminated the A1-dependent contribution to factor IXa activity, Inclusion of both A1 and A2 subunits resulted in greater increases in the fluorescence anisotropy of fluorescein-Phe-Phe-Arg factor IXa than that observed for A2 subunit alone and approached values obtained with factor VIIIa, These results indicate that A1 subunit alters the A2 subunit-dependent modulation of the active site of factor IXa to synergistically increase cofactor activity, yielding an overall increase in k(cat) of over 1000-fold compared with factor IXa alone.	Univ Rochester, Med Ctr, Vasc Med Unit, Sch Med & Dent,Dept Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Med Ctr, Vasc Med Unit, Sch Med & Dent,Dept Med, POB 610,601 Elmwood Ave, Rochester, NY 14642 USA.			Koshibu, Kyoko/0000-0002-9809-0299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, P01HL030616] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30616, HL 38199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASILLAS G, 1971, COAGULATION, V4, P107; CURTIS JE, 1994, J BIOL CHEM, V269, P6246; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FOSTER PA, 1990, BLOOD, V75, P1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; OBrien LM, 1997, BLOOD, V90, P3943, DOI 10.1182/blood.V90.10.3943; OBRIEN LM, 1995, J BIOL CHEM, V270, P27087, DOI 10.1074/jbc.270.45.27087; PERSSON E, 1995, BIOCHEMISTRY-US, V34, P12775, DOI 10.1021/bi00039a038; PITTMAN DD, 1992, BLOOD, V79, P389; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Regan LM, 1996, J BIOL CHEM, V271, P3982; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Sudhakar K, 1996, J BIOL CHEM, V271, P23015, DOI 10.1074/jbc.271.38.23015; Sudhakar K, 1998, BIOCHEMISTRY-US, V37, P6874, DOI 10.1021/bi980084c	31	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15401	15406		10.1074/jbc.274.22.15401	http://dx.doi.org/10.1074/jbc.274.22.15401			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336428	hybrid			2022-12-27	WOS:000080560100017
J	Kim, DG; Chi, SS; Lee, KH; Rhee, SY; Kwon, YH; Chung, CH; Kwon, HM; Kang, MS				Kim, DG; Chi, SS; Lee, KH; Rhee, SY; Kwon, YH; Chung, CH; Kwon, HM; Kang, MS			Neuregulin stimulates myogenic differentiation in an autocrine manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK EMBRYONIC MYOBLASTS; MAMMARY EPITHELIAL-CELLS; SKELETAL-MUSCLE; MEMBRANE-FUSION; ERBB3 RECEPTORS; PRECURSOR CELLS; EXPRESSION; GROWTH; HEREGULIN; MYOD	During myogenesis, mononucleated myoblasts form multinucleated myotubes by membrane fusion. Efficiency of this intercellular process can be maximized by a simultaneous progress, with a time window, of other neighboring myoblasts in the differentiation program. This phenomenon has been described as the community effect. It proposes the existence of a molecule that acts as a differentiation-inducing signal to a group of identical cells. Here,we show that neuregulin is a strong candidate for this molecule in myoblast differentiation. The expression of neuregulin increased rapidly but transiently at early stage of differentiation of rat L6 cells. Neuregulin showed a potent differentiation-promoting activity in membrane fusion and expression of myosin heavy chain. The antibodies raised against neuregulin and its cognate receptor ErbB3, which were capable of neutralizing the signal pathway, inhibited myotube formation and expression of myosin heavy chain in both L6 cells and primary rat myoblasts. The progress of differentiation was mostly halted after the expression of myogenin and cell cycle arrest. These results suggest that the activation of an autocrine signaling of neuregulin may provide a basic mechanism for the community effect observed in the differentiation of the embryonic muscle cells.	Dankook Univ, Dept Mol Biol, Yongsan Gu, Seoul 140714, South Korea; Seoul Natl Univ, Dept Mol Biol, Seoul 151742, South Korea; Seoul Natl Univ, Res Ctr Cell Differentiat, Seoul 151742, South Korea; Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea	Dankook University; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University	Kwon, HM (corresponding author), Dankook Univ, Dept Mol Biol, Yongsan Gu, 8 Hannam Dong, Seoul 140714, South Korea.							ALBERTS B, 1994, MOL BIOL CELL, P724; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; BAEK HJ, 1994, DEV BIOL, V165, P178, DOI 10.1006/dbio.1994.1244; BENBARUCH N, 1994, P SOC EXP BIOL MED, V206, P221; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; COSSU G, 1995, P NATL ACAD SCI USA, V92, P2254, DOI 10.1073/pnas.92.6.2254; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Florini JR, 1996, J BIOL CHEM, V271, P12699, DOI 10.1074/jbc.271.22.12699; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; FRANK D, 1991, DEVELOPMENT, V113, P1387; GOODEARL ADJ, 1995, J CELL BIOL, V130, P1423, DOI 10.1083/jcb.130.6.1423; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V; GURDON JB, 1993, CURR BIOL, V3, P1, DOI 10.1016/0960-9822(93)90139-F; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hannon K, 1996, J CELL BIOL, V132, P1151, DOI 10.1083/jcb.132.6.1151; HOLT CE, 1994, P NATL ACAD SCI USA, V91, P10844, DOI 10.1073/pnas.91.23.10844; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee KH, 1997, BIOCHEM J, V324, P237, DOI 10.1042/bj3240237; LU HS, 1995, J BIOL CHEM, V270, P4784, DOI 10.1074/jbc.270.9.4784; MARTE BM, 1995, MOL ENDOCRINOL, V9, P14, DOI 10.1210/me.9.1.14; MARTE BM, 1995, ONCOGENE, V10, P167; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; OTT MO, 1991, DEVELOPMENT, V111, P1097; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Velasco JA, 1998, MOL CARCINOGEN, V21, P156, DOI 10.1002/(SICI)1098-2744(199803)21:3<156::AID-MC2>3.0.CO;2-K	43	60	62	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15395	15400		10.1074/jbc.274.22.15395	http://dx.doi.org/10.1074/jbc.274.22.15395			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336427	hybrid			2022-12-27	WOS:000080560100016
J	He, XY; Merz, G; Mehta, P; Schulz, H; Yang, SY				He, XY; Merz, G; Mehta, P; Schulz, H; Yang, SY			Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme - Characterization of a novel 17 beta-hydroxysteroid dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BINDING PROTEIN; AMYLOID-BETA PEPTIDE; EXPRESSION CLONING; STRUCTURAL ORGANIZATION; ALZHEIMERS-DISEASE; MOLECULAR-CLONING; A DEHYDROGENASE; CELLS; REDUCTASE; RAT	Human brain short chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) was found to catalyze the oxidation of 17 beta-estradiol and dihydroandrosterone as well as alcohols. Mitochondria have been demonstrated to be the proper location of this NAD(+)-dependent dehydrogenase in cells, although its primary structure is identical to an amyloid beta-peptide binding protein reportedly associated with the endoplasmic reticulum (ERAB). This fatty acid beta-oxidation enzyme was identified as a novel 17 beta-hydroxysteroid dehydrogenase responsible for the inactivation of sex steroid hormones. The catalytic rate constant of the purified enzyme was estimated to be 0.66 min(-1) with apparent K-m values of 43 and 50 mu M for 17 beta-estradiol and NAD(+), respectively. The catalytic efficiency of this enzyme for the oxidation of 17 beta-estradiol was comparable with that of peroxisomal 17 beta-hydroxysteroid dehydrogenase type 4, As a result, the human SCHAD gene product, a single-domain multifunctional enzyme, appears to function in two different pathways of lipid metabolism. Because the catalytic functions of human brain short chain L-3-hydroxyacyl-CoA dehydrogenase could weaken the protective effects of estrogen and generate aldehydes in neurons, it is proposed that a high concentration of this enzyme in brain is a potential risk factor for Alzheimer's disease.	New York State Inst Basic Res Dev Disabil, Dept Pharmacol, Staten Isl, NY 10314 USA; New York State Inst Basic Res Dev Disabil, Dept Pathol Neurobiol, Staten Isl, NY 10314 USA; New York State Inst Basic Res Dev Disabil, Dept Immunol, Staten Isl, NY 10314 USA; CUNY City Coll, Dept Chem, New York, NY 10031 USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; City College of New York (CUNY)	Yang, SY (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Pharmacol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047392] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30847] Funding Source: Medline; NIDDK NIH HHS [DK47392] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Beyreuther K, 1997, NATURE, V389, P677, DOI 10.1038/39479; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DIENAIDENOUBHAN.M, 1996, EUR J BIOCHEM, V240, P660; Fomitcheva J, 1998, J BIOL CHEM, V273, P22664, DOI 10.1074/jbc.273.35.22664; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Goodman YD, 1996, J NEUROCHEM, V66, P1836; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; He XY, 1998, BBA-LIPID LIPID MET, V1392, P119, DOI 10.1016/S0005-2760(98)00031-9; He XY, 1999, BBA-MOL CELL BIOL L, V1437, P119, DOI 10.1016/S1388-1981(98)00005-5; Henderson Victor W., 1997, American Journal of Medicine, V103, p11S, DOI 10.1016/S0002-9343(97)00261-1; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kawata M, 1995, NEUROSCI RES, V24, P1, DOI 10.1016/0168-0102(96)81278-8; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Leenders F, 1996, J BIOL CHEM, V271, P5438, DOI 10.1074/jbc.271.10.5438; LIN SX, 1992, J BIOL CHEM, V267, P16182; Nokelainen P, 1998, MOL ENDOCRINOL, V12, P1048, DOI 10.1210/me.12.7.1048; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Pelletier G, 1995, BRAIN RES, V704, P233, DOI 10.1016/0006-8993(95)01119-6; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; SCHIEBER A, 1992, EUR J BIOCHEM, V206, P491, DOI 10.1111/j.1432-1033.1992.tb16952.x; Segel IH, 1975, ENZYME KINETICS BEHA; Suzuki K, 1998, J BIOCHEM-TOKYO, V123, P353; Torroja L, 1998, J CELL BIOL, V141, P1009, DOI 10.1083/jcb.141.4.1009; Vredendaal PJCM, 1998, MAMM GENOME, V9, P763, DOI 10.1007/s003359900860; Woolley CS, 1997, J NEUROSCI, V17, P1848; WU L, 1993, J BIOL CHEM, V268, P12964; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yan SD, 1997, NATURE, V389, P689	39	110	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15014	15019		10.1074/jbc.274.21.15014	http://dx.doi.org/10.1074/jbc.274.21.15014			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329704	hybrid			2022-12-27	WOS:000081965200069
J	Luan, P; Balch, WE; Emr, SD; Burd, CG				Luan, P; Balch, WE; Emr, SD; Burd, CG			Molecular dissection of guanine nucleotide dissociation inhibitor function in vivo - Rab-independent binding to membranes and role of Rab recycling factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; GDP/GTP EXCHANGE; GOLGI TRANSPORT; YEAST HOMOLOG; BOVINE BRAIN; GDP; PROTEIN; GTP; GTPASES	Guanine nucleotide dissociation inhibitor (GDI) is an essential protein required for the recycling of Rab GTPases mediating the targeting and fusion of vesicles in the exocytic and endocytic pathways. Using site-directed mutagenesis of yeast GDI1, we demonstrate that amino acid residues required for Rab recognition in vitro are critical for function in vivo in Saccharomyces cerevisiae. Analysis of the effects of Rab-binding mutants on function in vivo reveals that only a small pool of recycling Rab protein is essential for growth, and that the rates of recycling of distinct Rabs are differentially sensitive to GDI. Furthermore, we find that membrane association of Gdi1p is Rab-independent. Mutant Gdi1 proteins unable to bind Rabs were able to associate with cellular membranes as efficiently as wild-type Gdi1p, yet caused a striking loss of the endogenous cytosolic Gdi1p-Rab pools leading to dominant inhibition of growth when expressed at levels of the normal, endogenous pool. These results demonstrate a potential role for a new recycling factor in the retrieval of Rab-GDP from membranes, and illustrate the importance of multiple effecters in regulating GDI function in Rab delivery and retrieval from membranes.	Scripps Res Inst, Dept Cell Biol IMM 11, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol IMM 11, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Div Cellular & Mol Med, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol IMM 11, La Jolla, CA 92037 USA.	webalch@scripps.edu		Burd, Christopher/0000-0003-1831-8706	NCI NIH HHS [CA 58689] Funding Source: Medline; NIGMS NIH HHS [GM33301] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Collins RN, 1997, J BIOL CHEM, V272, P18281, DOI 10.1074/jbc.272.29.18281; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; OSSIG R, 1995, EMBO J, V14, P3645, DOI 10.1002/j.1460-2075.1995.tb00034.x; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; SCHALK IJ, 1994, J MOL BIOL, V244, P469, DOI 10.1006/jmbi.1994.1744; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Sherman F, 1979, METHODS YEAST GENETI; SHISHEVA A, 1994, J BIOL CHEM, V269, P23865; SHISHEVA A, 1995, EUR J CELL BIOL, V68, P143; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; WALDHERR M, 1993, NAT GENET, V3, P193, DOI 10.1038/ng0393-193; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Wu SK, 1998, J BIOL CHEM, V273, P26931, DOI 10.1074/jbc.273.41.26931; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; YANG CZ, 1994, J BIOL CHEM, V269, P31891	47	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14806	14817		10.1074/jbc.274.21.14806	http://dx.doi.org/10.1074/jbc.274.21.14806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329679	hybrid			2022-12-27	WOS:000081965200044
J	Perisic, O; Paterson, HF; Mosedale, G; Lara-Gonzalez, S; Williams, RL				Perisic, O; Paterson, HF; Mosedale, G; Lara-Gonzalez, S; Williams, RL			Mapping the phospholipid-binding surface and translocation determinants of the C2 domain from cytosolic phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GREEN FLUORESCENT PROTEIN; ARACHIDONIC-ACID; CRYSTAL-STRUCTURE; MEMBRANE PENETRATION; NUCLEAR-ENVELOPE; CALCIUM; SYNAPTOTAGMIN; SPECIFICITY; CELLS	Cytosolic phospholipase A(2) (cPLA(2)) plays a key role in the generation of arachidonic acid, a precursor of potent inflammatory mediators, Intact cPLA(2) is known to translocate in a calcium-dependent manner from the cytosol to the nuclear envelope and endoplasmic reticulum, We show here that the C2 domain of cPLA(2) alone is sufficient for this calcium-dependent translocation in living cells, We have identified sets of exposed hydrophobic residues in loops known as calcium-binding region (CBR) 1 and CBR3, which surround the C2 domain calcium-binding sites, whose mutation dramatically decreased phospholipid binding in vitro without significantly affecting calcium binding. Mutation of a residue that binds calcium ions (D43N) also eliminated phospholipid binding. The same mutations that prevent phospholipid binding of the isolated C2 domain in vitro abolished the calcium-dependent translocation of cPLA(2) to internal membranes in vivo, suggesting that the membrane targeting is driven largely by direct interactions with the phospholipid bilayer, Using fluorescence quenching by spin-labeled phospholipids for a series of mutants containing a single tryptophan residue at various positions in the cPLA(2) C2 domain, we show that two of the calcium-binding loops, CBR1 and CBR3, penetrate in a calcium-dependent manner into the hydrophobic core of the phospholipid bilayer, establishing an anchor for docking the domain onto the membrane.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Inst Canc Res, Chester Beatty Labs, Canc Res Campaign, Ctr Cell & Mol Biol, London SW3 6JB, England	MRC Laboratory Molecular Biology; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rlw@mrc-lmb.cam.ac.uk		Lara-Gonzalez, Samuel/0000-0002-3313-0165; Perisic, Olga/0000-0002-3842-2896; Williams, Roger/0000-0001-7754-4207	MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Fujimoto K, 1996, J CELL SCI, V109, P2453; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Irvine R, 1998, CURR BIOL, V8, pR557, DOI 10.1016/S0960-9822(07)00360-0; KRAMER RM, 1997, FEBS LETT, V210, P19; KRAMER RM, 1994, SIGNAL ACTIVATED PHO, P13; LESLIE CC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P261, DOI 10.1016/0005-2760(90)90129-L; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; PEARSON RH, 1979, NATURE, V281, P499, DOI 10.1038/281499a0; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Ponting CP, 1996, PROTEIN SCI, V5, P162; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; REGIER MK, 1993, ARCH BIOCHEM BIOPHYS, V301, P439, DOI 10.1006/abbi.1993.1168; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; SierraHonigmann R, 1996, LAB INVEST, V74, P684; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874	51	113	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14979	14987		10.1074/jbc.274.21.14979	http://dx.doi.org/10.1074/jbc.274.21.14979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329700	hybrid			2022-12-27	WOS:000081965200065
J	Craig, AG; Norberg, T; Griffin, D; Hoeger, C; Akhtar, M; Schmidt, K; Low, W; Dykert, J; Richelson, E; Navarro, V; Mazella, J; Watkins, M; Hillyard, D; Imperial, J; Cruz, LJ; Olivera, BM				Craig, AG; Norberg, T; Griffin, D; Hoeger, C; Akhtar, M; Schmidt, K; Low, W; Dykert, J; Richelson, E; Navarro, V; Mazella, J; Watkins, M; Hillyard, D; Imperial, J; Cruz, LJ; Olivera, BM			Contulakin-G, an O-glycosylated invertebrate neurotensin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONUS-GEOGRAPHUS VENOM; MASS-SPECTROMETRY; GAMMA-CARBOXYGLUTAMATE; BINDING-PROPERTIES; PEPTIDE; RECEPTOR; IDENTIFICATION; EXPRESSION; TRYPTOPHAN; BROMINATION	We have purified contulakin-G, a 16-amino acid O-linked glycopeptide (pGlu-Ser-Glu-Glu-Gly-Gly-Ser-Asn-Ala-Thr-Lys-Lys-Pro-Tyr-Ile-Leu-OH, pGlu is pyroglutamate) from Conus geographus venom. The major glycosylated form of contulakin-G was found to incorporate the disaccharide beta-D-Galp-(1-->3)-alpha-D-GalpNAc-(1-->) attached to Thr(10). The C-terminal sequence of contulakin-G shows a high degree of similarity to the neurotensin family of peptides. Synthetic peptide replicates of Gal(beta-->3) GalNAc(alpha-->)Thr(10) contulakin-G and its nonglycosylated analog were prepared using an Fmoc (9-fluorenylmethoxycarbonyl) protected solid phase synthesis strategy. The synthetic glycosylated contulakin-G, when administered intracerebroventricular into mice, was found to result in motor control-associated dysfunction observed for the native peptide, Contulakin-G was found to be active at 10-fold lower doses than the nonglycosylated Thr(10) contulakin-G analog. The binding affinities of contulakin-G and the nonglycosylated Thr(10) contulakin-G for a number of neurotensin receptor types including the human neurotensin type 1 receptor (hNTR1), the rat neurotensin type 1 and type 2 receptors, and the mouse neurotensin type 3 receptor were determined. The binding affinity of the nonglycosylated Thr(10) contulakin-G was approximately an order of magnitude lower than that of neurotensin,,, for all the receptor types tested. In contrast, the glycosylated form of contulakin-G exhibited significantly weaker binding affinity for all of the receptors tested. However, both contulakin-G and nonglycosylated Thr(10) contulakin-G were found to be potent agonists of rat neurotensin receptor type 1. Based on these results, we conclude that O-linked glycosylation appears to be a highly unusual strategy for increasing the efficacy of toxins directed against neurotransmitter receptors.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Swedish Univ Agr Sci, Dept Chem, S-75007 Uppsala, Sweden; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines	Utah System of Higher Education; University of Utah; Salk Institute; Swedish University of Agricultural Sciences; Mayo Clinic; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Utah System of Higher Education; University of Utah; University of the Philippines System; University of the Philippines Diliman	Olivera, BM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.		Richelson, Elliott/A-9407-2012; Mazella, Jean/A-6767-2012		NIGMS NIH HHS [GM 48677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAKI K, 1973, CHEM PHARM BULL, V21, P2801; BAENZIGER JU, 1994, FASEB J, V8, P1019, DOI 10.1096/fasebj.8.13.7926366; BARBER M, 1982, ANAL CHEM, V54, pA645; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CHABRY J, 1994, J NEUROCHEM, V63, P19; COLLEDGE CJ, 1992, TOXICON, V30, P1111, DOI 10.1016/0041-0101(92)90056-B; COTTER RJ, 1989, BIOMED ENVIRON MASS, V18, P513, DOI 10.1002/bms.1200180803; CRAIG AG, 1994, BIOL MASS SPECTROM, V23, P519, DOI 10.1002/bms.1200230810; CRAIG AG, 1993, BIOL MASS SPECTROM, V22, P31, DOI 10.1002/bms.1200220105; Craig AG, 1998, BIOCHEMISTRY-US, V37, P16019, DOI 10.1021/bi981690a; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; CUSACK B, 1991, EUR J PHARM-MOLEC PH, V206, P339, DOI 10.1016/0922-4106(91)90119-3; CUSACK B, 1993, J RECEPTOR RES, V13, P123, DOI 10.3109/10799899309073650; FEURLE GE, 1992, J BIOL CHEM, V267, P22305; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; GRAY WR, 1981, J BIOL CHEM, V256, P4734; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; Jimenez EC, 1997, BIOCHEMISTRY-US, V36, P989, DOI 10.1021/bi962840p; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; LENGUYEN D, 1986, INT J PEPT PROT RES, V27, P285; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; LUNING B, 1989, GLYCOCONJUGATE J, V6, P5, DOI 10.1007/BF01047886; MAZELLA J, 1988, J BIOL CHEM, V263, P144; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; MCLUCKEY SA, 1991, ANAL CHEM, V63, P375, DOI 10.1021/ac00004a015; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; MONJE VD, 1993, NEUROPHARMACOLOGY, V32, P1141, DOI 10.1016/0028-3908(93)90008-Q; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NORBERG T, 1994, METHOD ENZYMOL, V247, P87; OLIVERA BM, 1985, TOXICON, V23, P277, DOI 10.1016/0041-0101(85)90150-3; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; SADOUL JL, 1984, BIOCHEM BIOPH RES CO, V120, P812, DOI 10.1016/S0006-291X(84)80179-5; SPENGLER B, 1992, RAPID COMMUN MASS SP, V6, P105, DOI 10.1002/rcm.1290060207; Stewart J. M., 1984, SOLID PHASE PEPTIDE, P176; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Tyler BM, 1998, BRAIN RES, V792, P246, DOI 10.1016/S0006-8993(98)00150-4; VANRENTERGHEM C, 1988, BIOCHEM BIOPH RES CO, V157, P977, DOI 10.1016/S0006-291X(88)80970-7; YOSHIDA H, 1976, BIOCHEMISTRY-US, V15, P61, DOI 10.1021/bi00646a010	46	172	178	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13752	13759		10.1074/jbc.274.20.13752	http://dx.doi.org/10.1074/jbc.274.20.13752			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318778	hybrid			2022-12-27	WOS:000080322200007
J	Odell, M; Shuman, S				Odell, M; Shuman, S			Footprinting of Chlorella virus DNA ligase bound at a nick in duplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; ESCHERICHIA-COLI; ENZYME; SPECIFICITY; FIDELITY; DOMAIN; GENE; SITE	The 298-amino acid ATP-dependent DNA ligase of Chlorella virus PBCV-1 is the smallest eukaryotic DNA ligase known. The enzyme has intrinsic specificity for binding to nicked duplex DNA. To delineate the ligase-DNA interface, we have footprinted the enzyme binding site on DNA and the DNA binding site on Ligase, The size of the exonuclease III footprint of ligase bound a single nick in duplex DNA is 19-21 nucleotides. The footprint is asymmetric, extending 8-9 nucleotides on the 3'-OH side of the nick and 11-12 nucleotides on the 5'-phosphate side. The 5'-phosphate moiety is essential for the binding of Chlorella virus ligase to nicked DNA. Here we show that the 3'-OH moiety is not required for nick recognition. The Chlorella virus ligase binds to a nicked Ligand containing 2',3'-dideoxy and 5'-phosphate termini, but cannot catalyze adenylation of the 5'-end. Hence, the 3'-OH is important for step 2 chemistry even though it is not itself chemically transformed during DNA-adenylate formation. A 2'-OH cannot substitute for the essential 3'-OH in adenylation at a nick or even in strand closure at a preadenylated nick. The protein side of the ligase-DNA interface was probed by limited proteolysis of ligase with trypsin and chymotrypsin in the presence and absence of nicked DNA. Protease accessible sites are clustered within a short segment from amino acids 210-225 located distal to conserved motif V. The ligase is protected from proteolysis by nicked DNA. Protease cleavage of the native enzyme prior to DNA addition results in loss of DNA binding. These results suggest a bipartite domain structure in which the interdomain segment either comprises part of the DNA binding site or undergoes a conformational change upon DNA binding. The domain structure of Chlorella virus ligase inferred from the solution experiments is consistent with the structure of T7 DNA ligase determined by x-ray crystallography.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.							DOHERTY AJ, 1996, NUCLEIC ACIDS RES, V24, P2282; Engler M.J., 1982, ENZYMES, V15, P3, DOI [10.1016/S1874-6047(08)60273-5, DOI 10.1016/S1874-6047(08)60273-5]; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; KLETZIN A, 1992, NUCLEIC ACIDS RES, V20, P5389, DOI 10.1093/nar/20.20.5389; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LEHMAN IR, 1974, SCIENCE, V186, P790; MODRICH P, 1973, J BIOL CHEM, V248, P7502; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Sekiguchi J, 1997, NUCLEIC ACIDS RES, V25, P727, DOI 10.1093/nar/25.4.727; Shuman S, 1996, STRUCTURE, V4, P653, DOI 10.1016/S0969-2126(96)00070-6; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; SHUMAN S, 1995, VIROLOGY, V211, P73, DOI 10.1006/viro.1995.1380; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; YANG SW, 1992, J BIOL CHEM, V267, P8117	22	54	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14032	14039		10.1074/jbc.274.20.14032	http://dx.doi.org/10.1074/jbc.274.20.14032			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318816	hybrid			2022-12-27	WOS:000080322200045
J	Ramanadham, S; Hsu, FF; Bohrer, A; Ma, ZM; Turk, J				Ramanadham, S; Hsu, FF; Bohrer, A; Ma, ZM; Turk, J			Studies of the role of group VI phospholipase A(2) in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-inducecd arachidonic acid release in pancreatic islets and insulinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; MASS-SPECTROMETRIC CHARACTERIZATION; OXIDE-DEPENDENT MECHANISM; MACROPHAGE-LIKE CELLS; PROTEIN-KINASE-C; P388D(1) MACROPHAGES; PHOSPHATIDATE PHOSPHOHYDROLASE; BETA-CELLS; MEMBRANE PHOSPHOLIPIDS; SUBCELLULAR MEMBRANES	An 84-kDa group VI phospholipase A(2) (iPLA(2)) that does not require Ca2+ for catalysis has been cloned from Chinese hamster ovary cells, murine P388D1 cells, and pancreatic islet beta-cells, A housekeeping role for iPLA(2) in generating lysophosphatidylcholine (LPC) accepters for arachidonic acid incorporation into phosphatidylcholine (PC) has been proposed because iPLA(2) inhibition reduces LPC levels and suppresses arachidonate incorporation and phospholipid remodeling in P388D1 cells. Because islet beta-cell phospholipids are enriched in arachidonate, we have examined the role of iPLA(2) in arachidonate incorporation into islets and INS-1 insulinoma cells. Inhibition of iPLA(2) with a bromoenol lactone (BEL) suicide substrate did not suppress and generally enhanced [H-3]arachidonate incorporation into these cells in the presence or absence of extracellular calcium at varied time points and EEL concentrations. Arachidonate incorporation into islet phospholipids involved deacylation-reacylation and not de novo synthesis, as indicated by experiments with varied extracellular glucose concentrations and by examining [C-14]glucose incorporation into phospholipids. EEL also inhibited islet cytosolic phosphatidate phosphohydrolase (PAPH), but the PAPH inhibitor propranolol did not affect arachidonate incorporation into islet or INS-1 cell phospholipids. Inhibition of islet iPLA(2) did not alter the phospholipid head-group classes into which [H-3]arachidonate was initially incorporated or its subsequent transfer from PC to other lipids. Electrospray ionization mass spectrometric measurements indicated that inhibition of INS-1 cell iPLA(2) accelerated arachidonate incorporation into PC and that inhibition of islet iPLA(2) reduced LPC levels by 25%, suggesting that LPC mass does not limit arachidonate incorporation into islet PC. Gas chromatography/mass spectrometry measurements indicated that EEL but not propranolol suppressed insulin secretagogue-induced hydrolysis of arachidonate from islet phospholipids. In islets and INS-1 cells, iPLA(2) is thus not required for arachidonate incorporation or phospholipid remodeling and may play other roles in these cells.	Washington Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 660 S Euclid Ave,Box 8127, St Louis, MO 63110 USA.			Hsu, Fong-Fu/0000-0001-5368-0183	NIDDK NIH HHS [R37-DK-34388] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; ASMIS R, 1994, ANN NY ACAD SCI, V744, P1, DOI 10.1111/j.1749-6632.1994.tb52718.x; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; BALBOA MA, 1995, J BIOL CHEM, V270, P11738, DOI 10.1074/jbc.270.20.11738; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1996, EUR J BIOCHEM, V235, P480, DOI 10.1111/j.1432-1033.1996.00480.x; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BLANK ML, 1992, BIOCHIM BIOPHYS ACTA, V1124, P262, DOI 10.1016/0005-2760(92)90138-L; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Branch AD, 1998, TRENDS BIOCHEM SCI, V23, P45, DOI 10.1016/S0968-0004(97)01155-9; CASELLI A, 1994, J BIOL CHEM, V269, P24878; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; CHILTON FH, 1987, BIOCHIM BIOPHYS ACTA, V917, P48, DOI 10.1016/0005-2760(87)90282-7; CORBETT JA, 1992, BIOCHEM J, V287, P220; Crooke ST, 1996, ANTISENSE NUCLEIC A, V6, P145, DOI 10.1089/oli.1.1996.6.145; DAVIS LG, 1994, BASIC METHODS MOL BI, P335; DAY CP, 1992, BIOCHIM BIOPHYS ACTA, V1127, P87, DOI 10.1016/0005-2760(92)90205-A; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DENNIS EA, 1992, METHOD ENZYMOL, V209, P1; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dillon DA, 1997, J BIOL CHEM, V272, P10361; DUNLOP M, 1985, FEBS LETT, V193, P231, DOI 10.1016/0014-5793(85)80158-7; EDDLESTONE GT, 1995, AM J PHYSIOL-CELL PH, V268, pC181, DOI 10.1152/ajpcell.1995.268.1.C181; FARESE RV, 1983, METABOLISM, V32, P628, DOI 10.1016/0026-0495(83)90035-5; Forsell PKAL, 1998, FEBS LETT, V434, P295, DOI 10.1016/S0014-5793(98)00999-5; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; GUBITOSIKLUG RA, 1995, J BIOL CHEM, V270, P2885, DOI 10.1074/jbc.270.7.2885; Han XL, 1998, BBA-BIOMEMBRANES, V1414, P95, DOI 10.1016/S0005-2736(98)00154-0; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HILL EE, 1968, J BIOL CHEM, V243, P4440; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; KENNEDY C, 1994, BBA-LIPID LIPID MET, V1211, P326, DOI 10.1016/0005-2760(94)90157-0; KRONER EE, 1981, J BIOL CHEM, V256, P3690; KUWAE T, 1987, BIOCHEM BIOPH RES CO, V142, P86, DOI 10.1016/0006-291X(87)90454-2; KUWAE T, 1990, J BIOL CHEM, V265, P5002; Kuwae T, 1997, BBA-LIPID LIPID MET, V1344, P74, DOI 10.1016/S0005-2760(96)00135-X; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Ma ZM, 1998, BBA-LIPID LIPID MET, V1391, P384, DOI 10.1016/S0005-2760(98)00027-7; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Ma ZM, 1997, J BIOL CHEM, V272, P17827, DOI 10.1074/jbc.272.28.17827; Ma ZM, 1996, J BIOL CHEM, V271, P1029, DOI 10.1074/jbc.271.2.1029; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P82; MESSINEO FC, 1984, J BIOL CHEM, V259, P1336; METZ SA, 1991, BIOCHEM PHARMACOL, V41, pR1, DOI 10.1016/0006-2952(91)90470-P; METZ SA, 1988, DIABETES, V37, P1453, DOI 10.2337/diabetes.37.11.1453; METZ SA, 1987, BIOCHEM BIOPH RES CO, V142, P251, DOI 10.1016/0006-291X(87)90478-5; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; PATTON GM, 1982, J LIPID RES, V23, P190; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; Ramanadham S, 1998, BBA-LIPID LIPID MET, V1390, P301, DOI 10.1016/S0005-2760(97)00189-6; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; SCHMID PC, 1991, J BIOL CHEM, V266, P13690; SCHMID PC, 1995, ARCH BIOCHEM BIOPHYS, V319, P168, DOI 10.1006/abbi.1995.1279; SCOTT WA, 1980, J EXP MED, V152, P324, DOI 10.1084/jem.152.2.324; Sekine N, 1997, DIABETES, V46, P1424, DOI 10.2337/diabetes.46.9.1424; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; SUGIURA T, 1995, BBA-LIPID LIPID MET, V1255, P167, DOI 10.1016/0005-2760(94)00237-S; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; TURK J, 1986, BIOCHIM BIOPHYS ACTA, V879, P399, DOI 10.1016/0005-2760(86)90232-8; TURK J, 1984, BIOCHIM BIOPHYS ACTA, V794, P125, DOI 10.1016/0005-2760(84)90305-9; WEIS MT, 1986, CIRC RES, V59, P694, DOI 10.1161/01.RES.59.6.694; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLF BA, 1989, BIOCHEMISTRY-US, V28, P4291, DOI 10.1021/bi00436a026; WOLF BA, 1986, J BIOL CHEM, V261, P3501; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; WU S, 1997, AM J PHYSIOL, V273, pL331; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	88	96	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13915	13927		10.1074/jbc.274.20.13915	http://dx.doi.org/10.1074/jbc.274.20.13915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318801	hybrid			2022-12-27	WOS:000080322200030
J	Schoenwaelder, SM; Burridge, K				Schoenwaelder, SM; Burridge, K			Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho - A novel role for the calpain inhibitor calpeptin in the inhibition of protein-tyrosine phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STRESS FIBER FORMATION; SWISS 3T3 CELLS; INTEGRIN-MEDIATED ADHESION; TUMOR-SUPPRESSOR PTEN; ACTIN CYTOSKELETON; INTRACELLULAR CAMP; BINDING PROTEIN; MESANGIAL CELLS; HUMAN PLATELETS	Activation of the thiol protease calpain results in proteolysis of focal adhesion-associated proteins and severing of cytoskeletal-integrin links. We employed a commonly used inhibitor of calpain, calpeptin, to examine a role for this protease in the reorganization of the cytoskeleton under a variety of conditions. Calpeptin induced stress fiber formation in both forskolin-treated REF-52 fibroblasts and serum-starved Swiss 3T3 fibroblasts. Surprisingly, calpeptin was the only calpain inhibitor of several tested with the ability to induce these effects, suggesting that calpeptin may act on targets besides calpain. Here we show that calpeptin inhibits tyrosine phosphatases, enhancing tyrosine phosphorylation particularly of paxillin, Calpeptin preferentially inhibits membrane-associated phosphatase activity. Consistent with this observation, in vitro phosphatase assays using purified glutathione S-transferase fusion proteins demonstrated a preference for the transmembrane protein-tyrosine phosphatase-alpha over the cytosolic protein-tyrosine phosphatase-1B. Furthermore, unlike wide spectrum inhibitors of tyrosine phosphatases such as pervanadate, calpeptin appeared to inhibit a subset of phosphatases. Calpeptin-induced assembly of stress fibers was inhibited by botulinum toxin C3, indicating that calpeptin is acting on a phosphatase upstream of the small GTPase Rho, a protein that controls stress fiber and focal adhesion assembly. Not only does this work reveal that calpeptin is an inhibitor of protein-tyrosine phosphatases, but it suggests that calpeptin will be a valuable tool to identify the phosphatase activity upstream of Rho.	Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Schoenwaelder, SM (corresponding author), Univ N Carolina, Dept Cell Biol & Anat, 108 Taylor Hall, CB 7090, Chapel Hill, NC 27599 USA.	drsms@med.unc.edu	Schoenwaelder, Simone/E-9506-2011; Jackson, Shaun P/E-9633-2011	Schoenwaelder, Simone/0000-0003-0465-5840	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45100] Funding Source: Medline; NIGMS NIH HHS [GM29860] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; BARRY ST, 1994, J CELL SCI, V107, P2033; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; DEFILIPPI P, 1995, EXP CELL RES, V221, P141, DOI 10.1006/excr.1995.1361; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Flinn HM, 1996, J CELL SCI, V109, P1133; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FOX JEB, 1995, THROMB HAEMOSTASIS, V73, P987; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; GLASS WF, 1993, J CELL PHYSIOL, V157, P296; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gu MX, 1996, J BIOL CHEM, V271, P27751, DOI 10.1074/jbc.271.44.27751; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211; Hopkin K, 1998, SCIENCE, V282, P1027, DOI 10.1126/science.282.5391.1027; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; KISHIMOTO A, 1983, J BIOL CHEM, V258, P1156; Koyama Y, 1996, BIOCHEM BIOPH RES CO, V218, P331, DOI 10.1006/bbrc.1996.0058; KREISBERG JI, 1985, AM J PHYSIOL, V249, pF227, DOI 10.1152/ajprenal.1985.249.2.F227; Kreisberg JI, 1997, AM J PHYSIOL-RENAL, V273, pF283, DOI 10.1152/ajprenal.1997.273.2.F283; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; LAMPUGNANI MG, 1990, LAB INVEST, V63, P521; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Li JP, 1996, BBA-MOL CELL RES, V1312, P223, DOI 10.1016/0167-4889(96)00038-9; Liu F, 1998, CURR BIOL, V8, P173, DOI 10.1016/S0960-9822(98)70066-1; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; NOBES CD, 1995, J CELL SCI, V108, P225; ODA A, 1993, J BIOL CHEM, V268, P12603; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; RANKIN S, 1994, FEBS LETT, V354, P315, DOI 10.1016/0014-5793(94)01148-6; Retta SF, 1996, EXP CELL RES, V229, P307, DOI 10.1006/excr.1996.0376; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schneider GB, 1998, CELL ADHES COMMUN, V5, P207, DOI 10.3109/15419069809040292; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P24876, DOI 10.1074/jbc.272.40.24876; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Troyer DA, 1996, J AM SOC NEPHROL, V7, P415; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; TURNER CE, 1989, J BIOL CHEM, V264, P11938; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; WANG YL, 1990, ACTA PHARMACOL SIN, V11, P39; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yuan YP, 1996, J BIOL CHEM, V271, P27090, DOI 10.1074/jbc.271.43.27090; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	69	94	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14359	14367		10.1074/jbc.274.20.14359	http://dx.doi.org/10.1074/jbc.274.20.14359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318859	hybrid			2022-12-27	WOS:000080322200088
J	Rothery, RA; Trieber, CA; Weiner, JH				Rothery, RA; Trieber, CA; Weiner, JH			Interactions between the molybdenum cofactor and iron-sulfur clusters of Escherichia coli dimethylsulfoxide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; ELECTRON-PARAMAGNETIC-RESONANCE; FORMATE DEHYDROGENASE-H; SITE-DIRECTED MUTAGENESIS; ENGINEERED 3FE-4S CLUSTER; NITRATE REDUCTASE; CRYSTAL-STRUCTURE; DMSO REDUCTASE; RHODOBACTER-SPHAEROIDES; EPR SPECTROSCOPY	We have used site-directed mutagenesis to study the interactions between the molybdo-bis(molybdopterin guanine dinucleotide) cofactor (Mo-bisMGD) and the other prosthetic groups of Escherichia coli Me2SO reductase (DmsABC), In redox-poised preparations, there is a significant spin-spin interaction between the reduced E-m,E-7 = -120 mV [4Fe-4S] cluster of DmsB and the Mo(V) of the Mo-bisMGD of DmsA, This interaction is significantly modified in a DmsA-C38S mutant that contains a [3Fe-4S] cluster in DmsA, suggesting that the [3Fe-4S] cluster is in close juxtaposition to the vector connecting the Mo(V) and the E-m,E-7 = -120 mV cluster of DmsB, In a DmsA-R77S mutant, the interaction is eliminated, indicating the importance of this residue in defining the interaction pathway. In ferricyanide-oxidized glycerol-inhibited DmsA(C38S)BC, there is no detectable interaction between the oxidized [3Fe-4S] cluster and the Mo-bisMGD, except for a minor broadening of the Mo(V) spectrum. In a double mutant, DmsA(S176A)B(C102S)C, which contains an engineered [3Fe-4S] cluster in DmsB, no significant paramagnetic interaction is detected between the oxidized [3Fe-4S] cluster and the Mo(V), These results have important implications for (i) understanding the magnetic interactions between the Mo(V) and other paramagnetic centers and (ii) delineating the electron transfer pathway from the [4Fe-4S] clusters of DmsB to the Mo-bisMGD of DmsA.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, MRC Grp Mol Biol Membranes, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.			Rothery, Richard/0000-0003-3265-1783; Trieber, Catharine/0000-0002-1336-1126				BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1648, DOI 10.1021/bi00536a027; BERG BL, 1991, J BIOL CHEM, V266, P22380; BERTRAND P, 1994, J AM CHEM SOC, V116, P3078, DOI 10.1021/ja00086a042; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; BLASCO F, 1990, MOL GEN GENET, V222, P104, DOI 10.1007/BF00283030; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; BRAY RC, 1991, BIOCHEM J, V280, P817, DOI 10.1042/bj2800817; BRETON J, 1994, FEBS LETT, V345, P76, DOI 10.1016/0014-5793(94)00445-5; CAMMACK R, 1994, BIOCHEM SOC T, V22, P721, DOI 10.1042/bst0220721; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; CONDON C, 1988, MOL MICROBIOL, V2, P43, DOI 10.1111/j.1365-2958.1988.tb00005.x; FINNEGAN MG, 1993, INORG CHEM, V32, P2616, DOI 10.1021/ic00064a005; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P7708, DOI 10.1073/pnas.91.16.7708; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; INNES JB, 1989, BIOCHEMISTRY-US, V28, P1116, DOI 10.1021/bi00429a028; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KRAFFT T, 1992, EUR J BIOCHEM, V206, P5456; LOWE DJ, 1978, BIOCHEM J, V169, P471, DOI 10.1042/bj1690471; LOWE DJ, 1972, BIOCHEM J, V130, P239, DOI 10.1042/bj1300239; Magalon A, 1997, J BACTERIOL, V179, P5037, DOI 10.1128/jb.179.16.5037-5045.1997; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; MATHEWS R, 1974, J BIOL CHEM, V249, P4326; Moulis JM, 1996, PROTEIN SCI, V5, P1765, DOI 10.1002/pro.5560050902; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; PRINCE RC, 1987, J BIOL CHEM, V262, P5125; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; ROTHERY RA, 1995, J BACTERIOL, V177, P2057, DOI 10.1128/jb.177.8.2057-2063.1995; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; ROTHERY RA, 1993, BIOCHEMISTRY-US, V32, P5855, DOI 10.1021/bi00073a019; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; SAMBASIVARAO D, 1991, J BACTERIOL, V173, P5935, DOI 10.1128/jb.173.19.5935-5943.1991; SAMBASIVARAO D, 1990, J BACTERIOL, V172, P5938, DOI 10.1128/jb.172.10.5938-5948.1990; Sambrook J., 2002, MOL CLONING LAB MANU; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Trieber CA, 1996, J BIOL CHEM, V271, P27339, DOI 10.1074/jbc.271.44.27339; Trieber CA, 1996, J BIOL CHEM, V271, P4620; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; Turner RJ, 1997, PROTEIN ENG, V10, P285, DOI 10.1093/protein/10.3.285; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; WEINER JH, 1993, J BIOL CHEM, V268, P3238; Zhao ZW, 1998, J BIOL CHEM, V273, P20758, DOI 10.1074/jbc.273.33.20758	49	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13002	13009		10.1074/jbc.274.19.13002	http://dx.doi.org/10.1074/jbc.274.19.13002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224050	hybrid			2022-12-27	WOS:000080200400012
J	Shi, XM; Yang, XL; Chen, D; Chang, ZJ; Cao, X				Shi, XM; Yang, XL; Chen, D; Chang, ZJ; Cao, X			Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOX GENES; DIFFERENTIATION; EXPRESSION; TRANSCRIPTION; PROMOTER; FORELIMB; CELLS; MSX-1; BMP-4; LIMB	Bone morphogenetic proteins (BMP) transduce their signals into the cell through a family of mediator proteins known as Smads. Upon phosphorylation by the BMP receptors, Smad1 interacts with Smad4 and translocates into the nucleus where the complex recruits DNA-binding protein(s) to activate specific gene transcription. However, the DNA-binding protein(s) involved in BMP signaling has not been identified. Using a yeast two-hybrid approach, we found that Smad1 interacts with Hoxc-8, a homeodomain transcription factor. The interaction between Smad1 and Hoxc-8 was confined by a "pull-down" assay and a co-immunoprecipitation experiment in COS-l cells. Interestingly, purified Smad1 inhibited Hoxc-8 binding to the osteopontin Hoxc-8 site in a concentration-dependent manner. Transient transfection studies showed that native osteopontin promoter activity was elevated upon BMP stimulation. Consistent with the gel shift assay, overexpression of Hoxc-8 abolished the BMP stimulation. When a wild type or mutant Hoxc-8 binding element was linked to an SV40 promoter-driven reporter gene, the wild type but not the mutant Hoxc-8 binding site responded to BMP stimulation. Again, overexpression of Hoxc-8 suppressed the BMP-induced activity of the wild type reporter construct. Our findings suggest that Smad1 interaction with Hoxc-8 dislodges Hoxc-8 from its DNA binding element, resulting in the induction of gene expression.	Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Cao, X (corresponding author), 1670 Univ Blvd,BH G002, Birmingham, AL 35294 USA.	Cao@path.uab.edu	Chang, Zhijie/AAH-8109-2019	Elefteriou, Xiangli/0000-0002-2333-8747; Chang, Zhijie/0000-0003-1567-3227	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053757] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53757] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; BACHILLER D, 1994, EMBO J, V13, P1930, DOI 10.1002/j.1460-2075.1994.tb06462.x; CAO X, 1993, J BIOL CHEM, V268, P27371; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; CATRON KM, 1995, MOL CELL BIOL, V15, P861; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; CRAIG AM, 1991, GENE, V100, P163, DOI 10.1016/0378-1119(91)90362-F; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Izon DJ, 1998, BLOOD, V92, P383, DOI 10.1182/blood.V92.2.383.414k41_383_393; JOWETT AK, 1993, DEVELOPMENT, V117, P461; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Ladher R, 1996, DEVELOPMENT, V122, P2385; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LEMOUELLIC H, 1988, GENE DEV, V2, P125, DOI 10.1101/gad.2.1.125; Lu HC, 1997, DEVELOPMENT, V124, P1643; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Mead PE, 1996, NATURE, V382, P357, DOI 10.1038/382357a0; MOUELLIC HL, 1992, CELL, V69, P251; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Phippard DJ, 1996, DEVELOPMENT, V122, P2729; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Shimamoto T, 1999, J EXP ZOOL, V283, P186; SIMEONE A, 1987, P NATL ACAD SCI USA, V84, P4914, DOI 10.1073/pnas.84.14.4914; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; STERNER JM, 1995, J BIOL CHEM, V270, P9281, DOI 10.1074/jbc.270.16.9281; Tang SJ, 1998, DEVELOPMENT, V125, P1877; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P614, DOI 10.1210/me.8.5.614; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; ZHANG N, 1993, ONCOGENE, V8, P3265; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	37	148	157	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13711	13717		10.1074/jbc.274.19.13711	http://dx.doi.org/10.1074/jbc.274.19.13711			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224145	hybrid			2022-12-27	WOS:000080200400107
J	Greene, B; King, J				Greene, B; King, J			In vitro unfolding refolding of wild type phage P22 scaffolding protein reveals capsid-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; BACTERIOPHAGE P22; IN-VITRO; COAT PROTEIN; AMINO-ACIDS; PROCAPSIDS; SUBUNITS; HEAD; PURIFICATION; PRECURSOR	The scaffolding proteins of double-stranded DNA viruses are required for the polymerization of capsid subunits into properly sized closed shells but are absent from the mature virions, Phage P22 scaffolding subunits are elongated 33-kDa molecules that copolymerize with coat subunits into icosahedral precursor shells and subsequently exit from the precursor shell through channels in the procapsid lattice to participate in further rounds of polymerization and dissociation. Purified scaffolding subunits could be refolded in vitro after denaturation by high temperature or guanidine hydrochloride solutions. The lack of coincidence of fluorescence and circular dichroism signals indicated the presence of at least one partially folded intermediate, suggesting that the protein consisted of multiple domains. Proteolytic fragments containing the C terminus were competent for copolymerization with capsid subunits into procapsid shells in vitro, whereas the N terminus was not needed for this function. Proteolysis of partially denatured scaffolding subunits indicated that it was the capsid-binding C-terminal domain that unfolded at low temperatures and guanidinium concentrations. The minimal stability of the coat-binding domain may reflect its role in the conformational switching needed for icosahedral shell assembly.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Greene, B (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA.				NIGMS NIH HHS [GM17890] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM017890] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAZINET C, 1990, J MOL BIOL, V216, P701, DOI 10.1016/0022-2836(90)90393-Z; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; BeaudetMiller M, 1996, J VIROL, V70, P8081, DOI 10.1128/JVI.70.11.8081-8088.1996; BOND JS, 1993, PROTEOLYTIC ENZYMES; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; CASIENS S, 1988, BACTERIOPHAGES, V1, P15; CASJENS S, 1985, J VIROL, V53, P174, DOI 10.1128/JVI.53.1.174-179.1985; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CREIGHTON TE, 1987, PROTEIN ENG, P83; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; FULLER MT, 1982, J MOL BIOL, V156, P633, DOI 10.1016/0022-2836(82)90270-4; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; Greene B, 1996, VIROLOGY, V225, P82, DOI 10.1006/viro.1996.0577; Greene B, 1999, J BIOL CHEM, V274, P16141, DOI 10.1074/jbc.274.23.16141; GREENE B, 1994, VIROLOGY, V205, P188, DOI 10.1006/viro.1994.1634; GUO PX, 1991, VIROLOGY, V183, P366, DOI 10.1016/0042-6822(91)90149-6; HARRISON SC, 1984, TRENDS BIOCHEM SCI, V9, P345, DOI 10.1016/0968-0004(84)90057-4; Hong Z, 1996, J VIROL, V70, P533, DOI 10.1128/JVI.70.1.533-540.1996; HORWITZ M S, 1991, P771; KING J, 1978, CELL, V15, P551, DOI 10.1016/0092-8674(78)90023-5; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; KING J, 1996, STRUCTURAL BIOL VIRU, P288; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; LEE CS, 1995, J VIROL, V69, P5024, DOI 10.1128/JVI.69.8.5024-5032.1995; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATUSICKKUMAR L, 1995, J VIROL, V69, P4347, DOI 10.1128/JVI.69.7.4347-4356.1995; MITRAKI A, 1993, J BIOL CHEM, V268, P20071; MURIALDO H, 1978, MICROBIOL REV, V42, P529, DOI 10.1128/MMBR.42.3.529-576.1978; Parker MH, 1997, PROTEIN SCI, V6, P1583, DOI 10.1002/pro.5560060722; Parker MH, 1998, J MOL BIOL, V281, P69, DOI 10.1006/jmbi.1998.1917; Parker MH, 1997, J MOL BIOL, V268, P655, DOI 10.1006/jmbi.1997.0995; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; Preston VG, 1997, J GEN VIROL, V78, P1633, DOI 10.1099/0022-1317-78-7-1633; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; RIXON FJ, 1993, SEMIN VIROL, V4, P135, DOI 10.1006/smvy.1993.1009; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SPEED MA, 1995, PROTEIN SCI, V4, P900; TESCHKE CM, 1995, BIOCHEMISTRY-US, V34, P6815, DOI 10.1021/bi00020a028; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10658, DOI 10.1021/bi00091a016; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; THOMAS GJ, 1982, BIOCHEMISTRY-US, V21, P3866, DOI 10.1021/bi00259a023; THOMSEN DR, 1995, J VIROL, V69, P3690, DOI 10.1128/JVI.69.6.3690-3703.1995; Thuman-Commike PA, 1998, BIOPHYS J, V74, P559, DOI 10.1016/S0006-3495(98)77814-2; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; TRAUB F, 1984, J VIROL, V49, P892, DOI 10.1128/JVI.49.3.892-901.1984; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; VANDRIEL R, 1980, J MOL BIOL, V138, P27, DOI 10.1016/S0022-2836(80)80003-9; VOTER WA, 1982, J ULTRA MOL STRUCT R, V80, P374, DOI 10.1016/S0022-5320(82)80051-8; Wood LJ, 1997, J VIROL, V71, P179, DOI 10.1128/JVI.71.1.179-190.1997; WYCKOFF E, 1985, J VIROL, V53, P192, DOI 10.1128/JVI.53.1.192-197.1985; ZIEGELHOFFER T, 1992, J BIOL CHEM, V267, P455	61	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16135	16140		10.1074/jbc.274.23.16135	http://dx.doi.org/10.1074/jbc.274.23.16135			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347165	hybrid			2022-12-27	WOS:000080668600025
J	Heinlein, CA; Ting, HJ; Yeh, SY; Chang, CS				Heinlein, CA; Ting, HJ; Yeh, SY; Chang, CS			Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; PPAR-GAMMA; NUCLEAR RECEPTOR; INDEPENDENT ACTIVATION; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; GENE-EXPRESSION; DIFFERENTIATION; INSULIN; BINDING	In an effort to understand transcriptional regulation by the peroxisome proliferator-activated receptor gamma (PPAR gamma), we have investigated its potential interaction with coregulators and have identified ARA70 as a ligand-enhanced coactivator. ARA70 was initially described as a coactivator for the androgen receptor (AR) and is expressed in a range of tissues including adipose tissue (Yeh, S., and Chang, C. (1996) Proc. Natl. Acad. Sci. U.S. A. 93, 5517-5521), Here we show that ARA70 and PPAR gamma specifically interact by coimmunoprecipitation and in a mammalian two-hybrid assay. PPAR gamma and ARA70 interact in the absence of the PPAR gamma ligand 15-deoxy-Delta 12,14-prostaglandin J2, although the addition of exogenous ligand enhances this interaction. Similarly, in transient transfection of DU145 cells, cotransfection of PPAR gamma and ARA70 induces transcription from re porter constructs driven by either three copies of an isolated PPAR response element or the natural promoter of the adipocyte fatty acid-binding protein 2 in the absence of exogenous 15-deoxy-Delta 12,14-prostaglandin J2. However, this PPAR gamma-ARA70 transactivation is enhanced by the addition of ligand. Thus, ARA70 can function as a ligand-enhanced coactivator of PPAR gamma. Finally, we show that AR can squelch PPAR gamma-ARA70 transactivation, which suggests that cross-talk may occur between PPAR gamma- and AR-mediated responses in adipocytes.	Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Box 626,601 Elmwood Ave, Rochester, NY 14642 USA.			Ting, Huei-Ju/0000-0003-3709-5755	NATIONAL CANCER INSTITUTE [R01CA077532] Funding Source: NIH RePORTER; NCI NIH HHS [CA77532, CA55638, CA68568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bai WL, 1997, J BIOL CHEM, V272, P10457; Bjorntorp Per, 1997, Human Reproduction (Oxford), V12, P21; Brodie AE, 1996, BIOCHEM BIOPH RES CO, V228, P655, DOI 10.1006/bbrc.1996.1713; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHALWA A, 1994, ENDOCRINOLOGY, V135, P798; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Chu RY, 1996, J BIOL CHEM, V271, P27670, DOI 10.1074/jbc.271.44.27670; DiRenzo J, 1997, MOL CELL BIOL, V17, P2166, DOI 10.1128/MCB.17.4.2166; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; DUNAIF A, 1995, AM J MED S1A, V98, P33; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; HAUG A, 1986, ACTA ENDOCRINOL-COP, V113, P133, DOI 10.1530/acta.0.1130133; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLMANG A, 1990, AM J PHYSIOL, V259, pE555, DOI 10.1152/ajpendo.1990.259.4.E555; JOW L, 1995, J BIOL CHEM, V270, P3836, DOI 10.1074/jbc.270.8.3836; KIMURA N, 1993, J HISTOCHEM CYTOCHEM, V41, P671, DOI 10.1177/41.5.8468448; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kopelman PG, 1997, BRIT MED BULL, V53, P322, DOI 10.1093/oxfordjournals.bmb.a011616; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Mizukami J, 1997, BIOCHEM BIOPH RES CO, V240, P61, DOI 10.1006/bbrc.1997.7602; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qi JS, 1997, MOL CELL BIOL, V17, P7195, DOI 10.1128/MCB.17.12.7195; REBUFFESCRIVE M, 1991, INT J OBESITY, V15, P791; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schoonjans K, 1996, J LIPID RES, V37, P907; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	52	111	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16147	16152		10.1074/jbc.274.23.16147	http://dx.doi.org/10.1074/jbc.274.23.16147			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347167	hybrid			2022-12-27	WOS:000080668600027
J	Blanchoin, L; Pollard, TD				Blanchoin, L; Pollard, TD			Mechanism of interaction of Acanthamoeba actophorin (ADF/cofilin) with actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR COFILIN; F-ACTIN; ADP-ACTIN; INORGANIC-PHOSPHATE; PHALLOIDIN BINDING; NUCLEOTIDE-BINDING; KINETIC-ANALYSIS; ARP2/3 COMPLEX; RATE CONSTANTS; YEAST COFILIN	We characterized the interaction of Acanthamoeba actophorin, a member of ADF/cofilin family, with filaments of amoeba and rabbit skeletal muscle actin. The affinity is about 10 times higher for muscle actin filaments (K-d = 0.5 mu M) than amoeba actin filaments (K-d = 5 mu M) even though the affinity for muscle and amoeba Mg-ADP-actin monomers (K-d = 0.1 mu M) is the same (Blanchoin, L., and Pollard, T. D. (1998) J, Biol, Chem. 273, 25106-25111), Actophorin binds slowly (k(+) = 0.03 mu M-1 s(-1)) to and dissociates from amoeba actin filaments in a simple bimolecular reaction, but binding to muscle actin filaments is cooperative. Actophorin severs filaments in a concentration-dependent fashion. Phosphate or BeF3 bound to ADP-actin filaments inhibit actophorin binding. Actophorin increases the rate of phosphate release from actin filaments more than 10-fold. The time course of the interaction of actophorin with filaments measured by quenching of the fluorescence of pyrenyl-actin or fluorescence anisotropy of rhodamine-actophorin is complicated, because severing, depolymerization, and repolymerization follows binding. The 50-fold higher affinity of actophorin for Mg-ADP-actin monomers (K-d = 0.1 mu M) than ADP-actin filaments provides the thermodynamic basis for driving disassembly of filaments that have hydrolyzed ATP and dissociated gamma-phosphate.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				PHS HHS [NIH 26388] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AIZAWA H, 1995, J BIOL CHEM, V270, P10923, DOI 10.1074/jbc.270.18.10923; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Blanchoin L, 1996, J BIOL CHEM, V271, P12380, DOI 10.1074/jbc.271.21.12380; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COOPER JA, 1986, J BIOL CHEM, V261, P477; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; Kinosian HJ, 1996, BIOCHEMISTRY-US, V35, P16550, DOI 10.1021/bi961891j; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KUHLMAN PA, 1994, FEBS LETT, V339, P297, DOI 10.1016/0014-5793(94)80434-6; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MAEKAWA S, 1984, J BIOCH, V95, P337; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MORIYAMA K, 1990, J BIOL CHEM, V265, P5768; Mossakowska M, 1996, J MUSCLE RES CELL M, V17, P383, DOI 10.1007/BF00123355; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NISHIDA E, 1984, J BIOCHEM-TOKYO, V95, P387, DOI 10.1093/oxfordjournals.jbchem.a134619; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; QUIRK S, 1993, BIOCHEMISTRY-US, V32, P8525, DOI 10.1021/bi00084a019; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wriggers W, 1997, BIOPHYS J, V73, P624, DOI 10.1016/S0006-3495(97)78098-6; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410	51	226	234	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15538	15546		10.1074/jbc.274.22.15538	http://dx.doi.org/10.1074/jbc.274.22.15538			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336448	hybrid			2022-12-27	WOS:000080560100037
J	Chu, ZL; Shin, YA; Yang, JM; DiDonato, JA; Ballard, DW				Chu, ZL; Shin, YA; Yang, JM; DiDonato, JA; Ballard, DW			IKK gamma mediates the interaction of cellular I kappa B kinases with the tax transforming protein of human T cell leukemia virus type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I; TRANSCRIPTIONAL ACTIVATOR; SIGNAL-TRANSDUCTION; COMPLEX; ALPHA; LINE; IDENTIFICATION; EXPRESSION; PATHWAYS; BINDING	The Tax oncoprotein of human T cell leukemia virus type 1 constitutively activates transcription factor NF-kappa B by a mechanism involving Tax-induced phosphorylation of I kappa B alpha, a labile cytoplasmic inhibitor of NF-kappa B. To trigger this signaling cascade, Tax associates stably with and persistently activates a cellular I kappa B kinase (IKK) containing both catalytic (IKK alpha and IKK beta) and noncatalytic (IKK gamma) subunits. We now demonstrate that IKK gamma enables Tax to dock with the IKK beta catalytic subunit, resulting in chronic I kappa B kinase activation. Mutations in either IKK gamma or Tax that prevent formation of these higher order Tax.IKK complexes also interfere with the ability of Tax to induce IKK beta catalytic function in vivo. Deletion mapping studies indicate that amino acids 1-100 of IKK gamma are required for this Tax targeting function. Together, these findings identify IKK gamma as an adaptor protein that directs the stable formation of pathologic Tax.IKK complexes in virally infected T cells.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; Cleveland Clinic Foundation	Ballard, DW (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 802 Rudolph Light Hall, Nashville, TN 37232 USA.		Hazen, Stanley L/ABD-5845-2021		NCI NIH HHS [T32 CA09385] Funding Source: Medline; NIAID NIH HHS [R01AI33839] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033839] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Baumann B, 1998, J BIOL CHEM, V273, P11448, DOI 10.1074/jbc.273.19.11448; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KITAJIMA I, 1992, SCIENCE, V258, P1792, DOI 10.1126/science.1299224; KOEFFLER HP, 1984, BLOOD, V64, P482; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	30	154	160	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15297	15300		10.1074/jbc.274.22.15297	http://dx.doi.org/10.1074/jbc.274.22.15297			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336413	hybrid			2022-12-27	WOS:000080560100002
J	Smith, TJ; Jennings, TA; Sciaky, D; Cao, HJ				Smith, TJ; Jennings, TA; Sciaky, D; Cao, HJ			Prostaglandin-endoperoxide H synthase-2 expression in human thyroid epithelium - Evidence for constitutive expression in vivo and in cultured KAT-50 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; HUMAN ORBITAL FIBROBLASTS; HUMAN-SKIN FIBROBLASTS; NF-KAPPA-B; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; GLYCOSAMINOGLYCAN SYNTHESIS; INDUCIBLE CYCLOOXYGENASE; LEUKOREGULIN INDUCTION; PANCREATIC-ISLET	zProstaglandin-endoperoxide H synthase (PGHS) (EC 1.14.99.1) expression was examined in human thyroid tissue and in KAT-50, a well differentiated human thyroid epithelial cell line. PGHS-1 is found constitutively expressed in most healthy tissues, whereas PGHS-2 is highly inducible and currently thought to be expressed, with few exceptions, only in diseased tissues. Surprisingly, PGHS-2 mRNA and protein were easily detected in normal thyroid tissue. KAT-50 cells express high levels of constitutive PGHS-2 mRNA and protein under basal culture conditions, Compounds usually associated with PGHS-8 induction, including interleukin-1 beta (IL-beta), phorbol la-myristate 13-acetate, and serum transiently down-regulated PGHS-2 expression. Human PGHS-2 promoter constructs (-1840/+123 and -831/+123) fused to a luciferase reporter and transfected into untreated KAT-50 cells exhibited substantial activity. NS-398, a highly selective inhibitor of PGHS-2 could inhibit substantial basal prostaglandin E-2 production, Exogenous IL-1 receptor antagonist or IL-1 alpha neutralizing antibodies could attenuate constitutive PGHS-2 expression in KAT-50 cells, suggesting that endogenous IL-1 alpha synthesis was driving PGHS-2 expression, Our findings suggest that normal thyroid epithelium expresses high constitutive levels of PGHS-2 in situ and in vitro and this enzyme is active in the generation of prostaglandin E-2. Thus, unprovoked PGHS-2 expression might be considerably more widespread in healthy tissues than is currently believed.	Albany Med Coll, Dept Med, Div Mol & Cellular Med, Albany, NY 12208 USA; Albany Med Coll, Dept Biochem & Mol Biol, Albany, NY 12208 USA; Albany Med Coll, Dept Pathol, Albany, NY 12208 USA; Samuel S Stratton Vet Affairs Med Ctr, Albany, NY 12208 USA	Albany Medical College; Albany Medical College; Albany Medical College	Smith, TJ (corresponding author), Albany Med Coll, Dept Med, Div Mol & Cellular Med, A-175,47 New Scotland Ave, Albany, NY 12208 USA.		Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	NATIONAL EYE INSTITUTE [R01EY008976, R01EY011708] Funding Source: NIH RePORTER; NEI NIH HHS [EY11708, EY08976] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Asano K, 1996, AM J PHYSIOL-LUNG C, V271, pL126, DOI 10.1152/ajplung.1996.271.1.L126; Atwa MA, 1996, EUR J ENDOCRINOL, V135, P322, DOI 10.1530/eje.0.1350322; BETZ M, 1991, J IMMUNOL, V146, P108; CAO CY, 1995, BRAIN RES, V697, P187, DOI 10.1016/0006-8993(95)00839-I; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; DARGENIO DZ, 1992, ADAPT 2 PROGRAM SIMU; Davies Terry F., 1996, P525; DICERBO A, 1992, J CLIN ENDOCR METAB, V74, P585, DOI 10.1210/jc.74.3.585; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DiPaola R, 1997, J CLIN ENDOCR METAB, V82, P670, DOI 10.1210/jc.82.2.670; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; FOX BS, 1993, IMMUNOMETHODS, V2, P255; FUNK CD, 1991, FASEB J, V5, P2304, DOI 10.1096/fasebj.5.9.1907252; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hla T, 1996, PROSTAG OTH LIPID M, V51, P81, DOI 10.1016/0090-6980(95)00158-1; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HU ZQ, 1995, J IMMUNOL, V155, P2134; Huff R., 1995, Inflammation Research, V44, pS145, DOI 10.1007/BF01778304; KARGMAN SL, 1995, CANCER RES, V55, P2556; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Kwon G, 1998, DIABETES, V47, P583, DOI 10.2337/diabetes.47.4.583; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Liu XH, 1996, CANCER RES, V56, P5125; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Narko K, 1997, ENDOCRINOLOGY, V138, P3638, DOI 10.1210/en.138.9.3638; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; OBANION MK, 1991, J BIOL CHEM, V266, P23261; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Parker J, 1997, EXP CELL RES, V236, P321, DOI 10.1006/excr.1997.3741; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; RANKIN JHG, 1976, AM J PHYSIOL, V231, P754, DOI 10.1152/ajplegacy.1976.231.3.754; RAPOPORT B, 1978, ENDOCRINOLOGY, V102, P175, DOI 10.1210/endo-102-1-175; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; ROBERTSON RP, 1974, J CLIN INVEST, V54, P310, DOI 10.1172/JCI107766; ROPER RL, 1990, J IMMUNOL, V145, P2644; SCHREY MP, 1995, BRIT J CANCER, V72, P1412, DOI 10.1038/bjc.1995.523; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Smith RS, 1997, AM J PATHOL, V151, P317; Smith TJ, 1998, RHEUM DIS CLIN N AM, V24, P501, DOI 10.1016/S0889-857X(05)70023-5; Smith TJ, 1997, ENDOCRINOLOGY, V138, P5576, DOI 10.1210/en.138.12.5576; SMITH TJ, 1994, P NATL ACAD SCI USA, V91, P5094, DOI 10.1073/pnas.91.11.5094; SMITH TJ, 1984, J CLIN INVEST, V74, P2157, DOI 10.1172/JCI111642; SMITH TJ, 1988, METABOLISM, V37, P179, DOI 10.1016/S0026-0495(98)90015-4; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; TAHARA K, 1991, J BIOL CHEM, V266, P440; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Venkataraman GM, 1998, THYROID, V8, P63, DOI 10.1089/thy.1998.8.63; WANG HS, 1995, J CLIN ENDOCR METAB, V80, P3553, DOI 10.1210/jc.80.12.3553; Wang HS, 1996, J BIOL CHEM, V271, P22718, DOI 10.1074/jbc.271.37.22718; Williams CS, 1997, J CLIN INVEST, V100, P1325, DOI 10.1172/JCI119651; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yang XH, 1997, BBA-GENE STRUCT EXPR, V1350, P287, DOI 10.1016/S0167-4781(96)00225-4; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X; Young DA, 1998, P NATL ACAD SCI USA, V95, P8904, DOI 10.1073/pnas.95.15.8904	70	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15622	15632		10.1074/jbc.274.22.15622	http://dx.doi.org/10.1074/jbc.274.22.15622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336459	hybrid			2022-12-27	WOS:000080560100048
J	Ehrnsperger, M; Lilie, H; Gaestel, M; Buchner, J				Ehrnsperger, M; Lilie, H; Gaestel, M; Buchner, J			The dynamics of Hsp25 quaternary structure - Structure and function of different oligomeric species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; EHRLICH ASCITES TUMOR; A-CRYSTALLIN; ACTIN POLYMERIZATION; STRESS PROTEINS; EXPRESSION; AGGREGATION; CELLS; PHOSPHORYLATION	Small heat shock proteins (sHsps), including alpha-crystallin, represent a conserved and ubiquitous family of proteins. They form large oligomers, ranging in size from 140 to more than 800 kDa, which seem to be important for the interaction with non-native proteins as molecular chaperones. Here we analyzed the stability and oligomeric structure of murine Hsp25 and its correlation with function. Upon unfolding, the tertiary and quaternary structure of Hsp25 is rapidly lost, whereas the secondary structure remains remarkably stable. Unfolding is completely reversible, leading to native hexadecameric structures. These oligomers are in a concentration-dependent equilibrium with tetramers and dimers, indicating that tetramers assembled from dimers represent the basic building blocks of Hsp25 oligomers. At high temperatures, the Hsp25 complexes increase in molecular mass, consistent with the appearance of "heat shock granules" in vivo after heat treatment. This high molecular mass "heat shock form" of Hsp25 is in a slow equilibrium with hexadecameric Hsp25. Thus, it does not represent an off-pathway reaction. Interestingly, the heat shock form exhibits unchanged chaperone activity even after incubation at 80 degrees C. We conclude that Hsp25 is a dynamic tetramer of tetramers with a unique ability to refold and reassemble into its active quaternary structure after denaturation. So-called heat shock granules, which have been reported to appear in response to stress, seem to represent a novel functional species of Hsp25.	Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; Univ Halle Wittenberg, Inst Biotechnol, D-06120 Halle, Germany; Univ Halle Wittenberg, Innovationskolleg Zellspezialisieriung, D-06120 Halle, Germany	University of Regensburg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Buchner, J (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93040 Regensburg, Germany.	johannes.buchner@ch.tum.de	Buchner, Johannes/A-2651-2010; Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Buchner, Johannes/0000-0003-1282-7737				Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664; ARRIGO AP, 1987, DEV BIOL, V122, P39, DOI 10.1016/0012-1606(87)90330-7; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; Bassi FA, 1995, BIOPHYS J, V69, P2720, DOI 10.1016/S0006-3495(95)80143-8; BEHLKE J, 1991, FEBS LETT, V288, P119, DOI 10.1016/0014-5793(91)81016-2; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; CHIESA R, 1990, FEBS LETT, V268, P222, DOI 10.1016/0014-5793(90)81013-E; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; COLLIER NC, 1988, J CELL BIOL, V106, P1131, DOI 10.1083/jcb.106.4.1131; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DUDICH IV, 1995, BBA-PROTEIN STRUCT M, V1253, P163, DOI 10.1016/0167-4838(95)00135-X; Ehrnsperger M, 1998, ANAL BIOCHEM, V259, P218, DOI 10.1006/abio.1998.2630; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; EHRNSPERGER M, 1997, MOL CHAPERONES LIFE, P533; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; Gesierich U, 1996, FEBS LETT, V393, P151, DOI 10.1016/0014-5793(96)00867-8; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KAMPINGA HH, 1994, BIOCHEM BIOPH RES CO, V204, P1170, DOI 10.1006/bbrc.1994.2586; KANTOROW M, 1995, J BIOL CHEM, V270, P17215, DOI 10.1074/jbc.270.29.17215; KATO K, 1992, J BIOL CHEM, V267, P7718; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; KNAUF U, 1992, FEBS LETT, V309, P297, DOI 10.1016/0014-5793(92)80793-G; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; MEHLEN P, 1994, EUR J BIOCHEM, V221, P327, DOI 10.1111/j.1432-1033.1994.tb18744.x; MERCK KB, 1992, BIOCHIM BIOPHYS ACTA, V1130, P267, DOI 10.1016/0167-4781(92)90439-7; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; OSTERYOUNG KW, 1994, J BIOL CHEM, V269, P28676; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; ROSSI JM, 1989, J CELL BIOL, V108, P425, DOI 10.1083/jcb.108.2.425; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STEGE GJJ, 1995, J CELL PHYSIOL, V164, P579, DOI 10.1002/jcp.1041640316; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; SUREWICZ WK, 1995, BIOCHEMISTRY-US, V34, P9655, DOI 10.1021/bi00030a001; VIERLING E, 1997, GUIDBOOK MOL CHAPERO, P277; WANG KY, 1995, INVEST OPHTH VIS SCI, V36, P311; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; WISTOW G, 1993, EXP EYE RES, V56, P729, DOI 10.1006/exer.1993.1090; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936	55	145	148	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14867	14874		10.1074/jbc.274.21.14867	http://dx.doi.org/10.1074/jbc.274.21.14867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329686	hybrid			2022-12-27	WOS:000081965200051
J	Fortini, P; Parlanti, E; Sidorkina, OM; Laval, J; Dogliotti, E				Fortini, P; Parlanti, E; Sidorkina, OM; Laval, J; Dogliotti, E			The type of DNA glycosylase determines the base excision repair pathway in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APURINIC APYRIMIDINIC SITES; COLI FPG PROTEIN; ESCHERICHIA-COLI; POLYMERASE-BETA; NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; PURIFIED PROTEINS; HUMAN HOMOLOG; FREE-RADICALS; ABASIC SITES	The base excision repair (BER) of modified nucleotides is initiated by damage-specific DNA glycosylases. The repair of the resulting apurinic/apyrimidinic site involves the replacement of either a single nucleotide (short patch BER) or of several nucleotides (long patch BER). The mechanism that controls the selection of either BER pathway is unknown. We tested the hypothesis that the type of base damage present on DNA, by determining the specific DNA glycosylase in charge of its excision, drives the repair of the resulting abasic site intermediate to either BER branch. In mammalian cells hypoxanthine (HX) and 1,N-6-ethenoadenine (epsilon A) are both substrates for the monofunctional 3-methyladenine DNA glycosylase, the ANPG protein, whereas 7,8-dihydro-8-oxoguanine (8-oxoG) is removed by the bifunctional DNA glycosylase/beta-lyase 8-oxoG-DNA glycosylase (OGG1). Circular plasmid molecules containing a single HX, EA, Or 8-oxoG were constructed. In vitro repair assays with HeLa cell extracts revealed that EX and epsilon A are repaired via both short and long patch BER, whereas 8-oxoG is repaired mainly via the short patch pathway The preferential repair of 8-oxoG by short patch BER was confirmed by the low efficiency of repair of this lesion by DNA polymerase beta-deficient mouse cells as compared with their wild-type counterpart. These data fit into a model where the intrinsic properties of the DNA glycosylase that recognizes the lesion selects the branch of BER that will restore the intact DNA template.	Ist Super Sanita, Comparat Toxicol & Ecotoxicol Lab, I-00161 Rome, Italy; Inst Gustave Roussy, CNRS, UMR 1772, Grp Reparat ADN, F-94805 Villejuif, France	Istituto Superiore di Sanita (ISS); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Dogliotti, E (corresponding author), Ist Super Sanita, Comparat Toxicol & Ecotoxicol Lab, Viale Regina Elena 299, I-00161 Rome, Italy.		Fortini, Paola/K-1197-2018; Parlanti, Eleonora/AAC-5978-2021	Fortini, Paola/0000-0001-6206-8498; 				Aburatani H, 1997, CANCER RES, V57, P2151; Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139; BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; CZECZOT H, 1991, J BACTERIOL, V173, P3419, DOI 10.1128/jb.173.11.3419-3424.1991; Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; DOGLIOTTI E, 1997, BASE EXCISION REPAIR, P81; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; FROSINA G, 1994, BIOCHEM J, V304, P699, DOI 10.1042/bj3040699; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Jaiswal M, 1998, NUCLEIC ACIDS RES, V26, P2184, DOI 10.1093/nar/26.9.2184; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; ROTHWELL DG, 1997, BASE EXCISION REPAIR, P67; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	38	189	194	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15230	15236		10.1074/jbc.274.21.15230	http://dx.doi.org/10.1074/jbc.274.21.15230			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329732	hybrid			2022-12-27	WOS:000081965200097
J	Kudo, N; Taoka, H; Toda, T; Yoshida, M; Horinouchi, S				Kudo, N; Taoka, H; Toda, T; Yoshida, M; Horinouchi, S			A novel nuclear export signal sensitive to oxidative stress in the fission yeast transcription factor Pap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORDER CHROMOSOME STRUCTURE; BREFELDIN-A RESISTANCE; REV ACTIVATION DOMAIN; SCHIZOSACCHAROMYCES-POMBE; LEPTOMYCIN-B; SACCHAROMYCES-CEREVISIAE; MAP KINASE; CELL-CYCLE; NUCLEOCYTOPLASMIC TRANSPORT; MUTATIONAL ANALYSIS	Pap1, a fission yeast AP-l-like transcription factor, is negatively regulated by CRM1/exportin 1, the nuclear export factor. Pap1 was localized normally in the cytoplasm but was accumulated in the nucleus when Crm1 was inactivated by a temperature sensitive mutation or by treatment with leptomycin B, a specific export inhibitor. Deletion of the C-terminal cysteine-rich domain (CRD) resulted in nuclear accumulation of Pap1, while a glutathione S-transferase-green fluorescent protein-CRD fusion protein was localized in the cytoplasm in a Crm1-dependent manner. Deletion and mutational analyses identified several important amino acids in a 19-amino acid region in the CRD as a nuclear export signal (NES), Strikingly, a cysteine residue (Cys-532), in addition to two leucines and an isoleucine, was important for the NES function and the presence of at least one of the two cysteine residues was essential. Unlike classical NESs such as the human immunodeficiency virus Rev NES, the Pap1 NES lost the function upon treatment with oxidants such as diethyl maleate. The oxidative stress response is conserved through evolution, as green fluorescent protein-fused proteins bearing the Pap1 NES expressed in mammalian cells responded to diethyl maleate. These results show that the hydrophobic amino acid-rich region containing two important cysteines in Pap1 serves as a novel NES, which is sensitive to oxidative stress.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 113, Japan; Imperial Canc Res Fund, Lab Cell Regulat, London WC2A 3PX, England	University of Tokyo; Cancer Research UK	Yoshida, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 113, Japan.	ayoshida@hongo.ecc.u-tokyo.ac.jp	Kudo, Nobuaki/AAU-7196-2021; Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674; Kudo, Nobuaki/0000-0001-8134-1242				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Alfa C., 1993, EXPT FISSION YEAST L, P133; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Casso D, 1996, MOL GEN GENET, V252, P518, DOI 10.1007/BF02172398; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; HIRATA D, 1994, MOL GEN GENET, V242, P250, DOI 10.1007/BF00280413; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Kumada K, 1996, MOL GEN GENET, V250, P59, DOI 10.1007/s004380050051; Lee J, 1997, J BIOL CHEM, V272, P23042, DOI 10.1074/jbc.272.37.23042; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; NAKAGAWA CW, 1995, J BIOCHEM-TOKYO, V118, P109, DOI 10.1093/oxfordjournals.jbchem.a124864; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHI K, 1994, J BIOL CHEM, V269, P6320; NISHI K, 1992, MOL MICROBIOL, V6, P761, DOI 10.1111/j.1365-2958.1992.tb01526.x; NUNOSHIBA T, 1994, NUCLEIC ACIDS RES, V22, P2958, DOI 10.1093/nar/22.15.2958; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Takeuchi T, 1997, FEBS LETT, V416, P339, DOI 10.1016/S0014-5793(97)01233-7; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; TODA T, 1992, MOL CELL BIOL, V12, P5474, DOI 10.1128/MCB.12.12.5474; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; TURI TG, 1995, BIOCHEM BIOPH RES CO, V213, P410, DOI 10.1006/bbrc.1995.2147; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; WEMMIE A, 1994, J BIOL CHEM, V269, P14690; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; WU AL, 1993, J BIOL CHEM, V268, P18850; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X	61	117	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15151	15158		10.1074/jbc.274.21.15151	http://dx.doi.org/10.1074/jbc.274.21.15151			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329722	hybrid			2022-12-27	WOS:000081965200087
J	Gereben, B; Bartha, T; Tu, HM; Harney, JW; Rudas, P; Larsen, PR				Gereben, B; Bartha, T; Tu, HM; Harney, JW; Rudas, P; Larsen, PR			Cloning and expression of the chicken type 2 iodothyronine 5 '-deiodinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC SECIS ELEMENTS; DEIODINASE MESSENGER-RNA; RAT CEREBRAL-CORTEX; THYROID-HORMONE; SELENOCYSTEINE INCORPORATION; 5'-IODOTHYRONINE DEIODINASE; FUNCTIONAL-CHARACTERIZATION; RANA-CATESBEIANA; SELENOPROTEIN; RECEPTOR	The type 2 iodothyronine deiodinase (D2) is critical for the intracellular production of 3,5,3'-triiodothyronine from thyroxine. The D2 mRNA of higher vertebrates is over 6 kilobases (kb), and no complete cDNA clones have been reported. Using 5'- and 3'-rapid amplification of cDNA ends and two cDNA libraries, we have cloned the 6094-base pair fall-length chicken D2 cDNA. The deduced protein is similar to 31 kDa and contains two in-frame UGA codons presumably encoding selenocysteine. One of these is in the highly conserved active catalytic center; the other is near the carboxyl terminus. Unusual features of the cDNA include a selenocysteine insertion sequence element similar to 4.8 kb 3' to the UGA codon in the active center and three short open reading frames in the 5'-untranslated region. The K-m of D2 is similar to 1.0 nM for thyroxine, and the reaction is insensitive to inhibition by 6-n-propylthiouracil. Chicken D2 is expressed as a single transcript of similar to 6 kb in different brain regions and in the thyroid and lung. Hypothyroidism increases D2 mRNA in the telencephalon, Unlike in mammals, D2 mRNA and activity are expressed in the liver of the chicken, suggesting a role for D2 in the generation of plasma 3,5,3'-triiodothyronine in this species.	Brigham & Womens Hosp, Dept Med, Div Thyroid, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Vet Sci Budapest, Dept Physiol & Biochem, H-1400 Budapest, Hungary	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Veterinary Medicine Budapest	Larsen, PR (corresponding author), Harvard Inst Med, Div Thyroid, Rm 560, Boston, MA 02115 USA.				NIDDK NIH HHS [DK-36256, DK-07529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529, R01DK036256] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUID J, 1973, J CLIN INVEST, V52, P1195, DOI 10.1172/JCI107286; Becker KB, 1997, ENDOCRINOLOGY, V138, P2989, DOI 10.1210/en.138.7.2989; BERRY MJ, 1990, MOL ENDOCRINOL, V4, P743, DOI 10.1210/mend-4-5-743; BERRY MJ, 1991, ENDOCRINOLOGY, V129, P550, DOI 10.1210/endo-129-1-550; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BRENT GA, 1989, J BIOL CHEM, V264, P178; Buettner C, 1998, J BIOL CHEM, V273, P33374, DOI 10.1074/jbc.273.50.33374; Burmeister LA, 1997, ENDOCRINOLOGY, V138, P5231, DOI 10.1210/en.138.12.5231; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1995, CURRENT PROTOCOLS MO; Cogburn LA, 1997, BIOCHEM BIOPH RES CO, V241, P459, DOI 10.1006/bbrc.1997.7834; CRANTZ FR, 1982, ENDOCRINOLOGY, V110, P367, DOI 10.1210/endo-110-2-367; Croteau W, 1998, J BIOL CHEM, V273, P25230, DOI 10.1074/jbc.273.39.25230; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Darras VM, 1998, ANN NY ACAD SCI, V839, P80, DOI 10.1111/j.1749-6632.1998.tb10736.x; DAVEY JC, 1995, J BIOL CHEM, V270, P26786, DOI 10.1074/jbc.270.45.26786; Davey JC, 1999, ENDOCRINOLOGY, V140, P1022, DOI 10.1210/endo.140.2.6678; DECUYPERE E, 1979, GEN COMP ENDOCR, V37, P264, DOI 10.1016/0016-6480(79)90115-1; DECUYPERE E, 1982, GEN COMP ENDOCR, V47, P15, DOI 10.1016/0016-6480(82)90077-6; Decuypere E., 1990, Avian incubation., P239; GALTON VA, 1988, ENDOCRINOLOGY, V122, P1746; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HUGHES TE, 1986, J EXP ZOOL, V238, P393, DOI 10.1002/jez.1402380312; Jackson RJ, 1997, CURR OPIN GENET DEV, V7, P233, DOI 10.1016/S0959-437X(97)80133-5; Kim SW, 1998, ENDOCRINOLOGY, V139, P4895, DOI 10.1210/en.139.12.4895; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; Martin GW, 1998, RNA, V4, P65; Martin GW, 1996, RNA, V2, P171; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; MCNABB FMA, 1986, COMP BIOCHEM PHYS A, V85, P249, DOI 10.1016/0300-9629(86)90247-1; RUDAS P, 1986, GEN COMP ENDOCR, V63, P400, DOI 10.1016/0016-6480(86)90139-5; RUDAS P, 1993, ACTA VET HUNG, V41, P381; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; SALVATORE D, 1998, BIOCHIMIE PARIS, V81, P1; Sanders JP, 1997, ENDOCRINOLOGY, V138, P5153, DOI 10.1210/en.138.12.5153; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SILVA JE, 1977, SCIENCE, V198, P617, DOI 10.1126/science.199941; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; Sun BC, 1997, ENDOCRINOLOGY, V138, P5452, DOI 10.1210/en.138.12.5452; Sun YM, 1998, ENDOCRINOLOGY, V139, P3390, DOI 10.1210/en.139.8.3390; TOYODA N, 1995, J BIOL CHEM, V270, P12310, DOI 10.1074/jbc.270.20.12310; ValverdeR C, 1997, ENDOCRINOLOGY, V138, P642, DOI 10.1210/en.138.2.642; VanderGeyten S, 1997, ENDOCRINOLOGY, V138, P5144, DOI 10.1210/en.138.12.5144; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	50	70	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13768	13776		10.1074/jbc.274.20.13768	http://dx.doi.org/10.1074/jbc.274.20.13768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318780	hybrid			2022-12-27	WOS:000080322200009
J	Gonciarz-Swiatek, M; Wawrzynow, A; Um, SJ; Learn, BA; McMacken, R; Kelley, WL; Georgopoulos, C; Sliekers, O; Zylicz, M				Gonciarz-Swiatek, M; Wawrzynow, A; Um, SJ; Learn, BA; McMacken, R; Kelley, WL; Georgopoulos, C; Sliekers, O; Zylicz, M			Recognition, targeting, and hydrolysis of the lambda O replication protein by the ClpP ClpX protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-MU TRANSPOSASE; SINGLE-STRANDED-DNA; HEAT-SHOCK PROTEIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; SPECIFICITY COMPONENT; MUTATIONAL ANALYSIS; ATP HYDROLYSIS; BINDING SITES; HSP104	It has previously been established that sequences at the C termini of polypeptide substrates are critical for efficient hydrolysis by the ClpP/ClpX ATP-dependent protease, We report for the bacteriophage lambda O replication protein, however, that N-terminal sequences play the most critical role in facilitating proteolysis by ClpP/ClpX The N-terminal portion of lambda O is degraded at a rate comparable with that of wild type O protein, whereas the C-terminal domain of O is hydrolyzed at least 10-fold more slowly. Consistent with these results, deletion of the first 18 amino acids of lambda O blocks degradation of the N-terminal domain, whereas proteolysis of the O C-terminal domain is only slightly diminished as a result of deletion of the C-terminal 15 amino acids. We demonstrate that ClpX retains its capacity to bind to the N-terminal domain following removal of the first 18 amino acids of O, However, ClpX cannot efficiently promote the ATP-dependent binding of this truncated O polypeptide to ClpP, the catalytic subunit of the ClpP/ClpX protease, Based on our results with lambda O protein, we suggest that two distinct structural elements may be required in substrate polypeptides to enable efficient hydrolysis by the ClpP/ClpX protease: (i) a ClpX-binding site, which may be located remotely from substrate termini, and (ii) a proper N- or C-terminal sequence, whose exposure on the substrate surface may be induced by the binding of ClpX.	Univ Gdansk, Fac Biotechnol, Dept Mol & Cellular Biol, PL-80822 Gdansk, Poland; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA; Ctr Med Univ Geneva, Dept Biochim Med, CH-1211 Geneva 4, Switzerland	Fahrenheit Universities; University of Gdansk; Johns Hopkins University; University of Geneva	Zylicz, M (corresponding author), Univ Gdansk, Fac Biotechnol, Dept Mol & Cellular Biol, Kladki 24, PL-80822 Gdansk, Poland.	zylicz@biotech.univ.gda.pl		Sliekers, Olav/0000-0002-8109-2431; Zylicz, Alicja/0000-0003-4174-3073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036526, R01GM032253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32253, GM36526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEJARANO I, 1993, J BACTERIOL, V175, P7720, DOI 10.1128/JB.175.23.7720-7723.1993; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Jones JM, 1998, J BIOL CHEM, V273, P459, DOI 10.1074/jbc.273.1.459; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Konieczny I, 1997, P NATL ACAD SCI USA, V94, P14378, DOI 10.1073/pnas.94.26.14378; Kruklitis R, 1996, EMBO J, V15, P935, DOI 10.1002/j.1460-2075.1996.tb00428.x; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Laachouch JE, 1996, EMBO J, V15, P437, DOI 10.1002/j.1460-2075.1996.tb00374.x; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; LEBOWITZ JH, 1984, NUCLEIC ACIDS RES, V12, P3069, DOI 10.1093/nar/12.7.3069; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, CELL, V91, P939, DOI 10.1016/S0092-8674(00)80485-7; LIPINSKA B, 1980, BIOCHEM BIOPH RES CO, V92, P120, DOI 10.1016/0006-291X(80)91528-4; MCMACKEN R, 1983, MECHANISMS DNA REPLI, P819; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MILMAN G, 1987, METHOD ENZYMOL, V153, P482; NAKAI H, 1995, J BIOL CHEM, V270, P19591, DOI 10.1074/jbc.270.33.19591; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; ROBERTS JD, 1983, NUCLEIC ACIDS RES, V11, P7435, DOI 10.1093/nar/11.21.7435; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; SEOL JH, 1995, BIOCHEM BIOPH RES CO, V217, P41, DOI 10.1006/bbrc.1995.2743; SINGH SK, 1994, J BIOL CHEM, V269, P29537; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; UM SJ, 1993, THESIS J HOPKINS U; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; WEGRZYN G, 1992, J MOL BIOL, V226, P675; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P6176, DOI 10.1073/pnas.79.20.6176; WYATT WM, 1974, VIROLOGY, V58, P313, DOI 10.1016/0042-6822(74)90168-8; Zylicz M, 1998, P NATL ACAD SCI USA, V95, P15259, DOI 10.1073/pnas.95.26.15259	53	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13999	14005		10.1074/jbc.274.20.13999	http://dx.doi.org/10.1074/jbc.274.20.13999			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318812	hybrid			2022-12-27	WOS:000080322200041
J	McCarthy, JJ; Vyas, DR; Tsika, GL; Tsika, RW				McCarthy, JJ; Vyas, DR; Tsika, GL; Tsika, RW			Segregated regulatory elements direct beta-myosin heavy chain expression in response to altered muscle activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING-PROTEIN; DEVELOPMENTAL REGULATION; GENE-EXPRESSION; CARDIAC-MUSCLE; REGION; CELLS; DNA; TRANSCRIPTION; REPRESSOR; SEQUENCES	Our previous transgenic analyses revealed that a 600-base pair beta-myosin heavy chain (beta MyHC) promoter conferred mechanical overload (MOV) and non-weightbearing (NWB) responsiveness to a chloramphenicol acetyltransferase reporter gene. Whether the same DNA regulatory element(s) direct beta MyHC expression following MOV or NWB activity in vivo remains unknown. We now show that a 293-base pair beta MyHC promoter fused to chloramphenicol acetyltransferase (beta 293) responds to MOV, but not NWB activity, indicating a segregation of these two diverse elements. Inclusion of the beta MyHC negative regulatory element (-332 to -300; beta NRE) within transgene beta 350 repressed expression in all transgenic lines. Electrophoretic mobility shift assays showed highly enriched binding activity only in NWB soleus nuclear extracts that was specific to the distal region of the beta NRE sense strand (d beta NRE-S; -332 to -311). Supershift electrophoretic mobility shift assay revealed that the binding at the distal region of the beta NRE sense strand was antigenically distinct from cellular nucleic acid-binding protein and Y-box-binding factor 1, two proteins shown to bind this element, Two-dimensional UV cross-linking and shift Southwestern blotting analyses detected two proteins (50 and 52 kDa) that bind to this element. These in vivo results demonstrate that segregated beta MyHC promoter elements transcriptionally regulate beta MyHC transgene expression in response to two diverse modes of neuromuscular activity.	Univ Missouri, Dept Vet Biomed Sci, Sch Vet Med, Columbia, MO 65211 USA; Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; Univ Missouri, Sch Med, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tsika, RW (corresponding author), Univ Missouri, Dept Vet Biomed Sci, Sch Vet Med, 1600 E Rollins Ave,W112 VET Med Bldg, Columbia, MO 65211 USA.	tsikar@missouri.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041464, F32AR008412] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR41464, F32 AR08412] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; EDWARDS JG, 1992, BIOCHEM BIOPH RES CO, V189, P504, DOI 10.1016/0006-291X(92)91586-F; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; FLINK IL, 1995, J BIOL CHEM, V270, P6959, DOI 10.1074/jbc.270.12.6959; FLINK IL, 1992, J BIOL CHEM, V267, P9917; GORE MT, 1993, CIRCULATION, V88, P236; GRAY T A, 1990, Technique (Philadelphia), V2, P147; Hasegawa K, 1997, CIRCULATION, V96, P3943; Kelm RJ, 1996, J BIOL CHEM, V271, P24278, DOI 10.1074/jbc.271.39.24278; Kingsley PD, 1996, DEV GROWTH DIFFER, V38, P697; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; McCarthy JJ, 1997, AM J PHYSIOL-REG I, V272, pR1552, DOI 10.1152/ajpregu.1997.272.5.R1552; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; RINDT H, 1993, J BIOL CHEM, V268, P5332; RUIZLOZANO P, 1994, GENE, V14, P243; Sapru MK, 1996, J BIOL CHEM, V271, P7203, DOI 10.1074/jbc.271.12.7203; SHIMIZU N, 1992, NUCLEIC ACIDS RES, V20, P1793, DOI 10.1093/nar/20.7.1793; SHIMIZU N, 1992, MOL CELL BIOL, V12, P619, DOI 10.1128/MCB.12.2.619; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; Tsika GL, 1996, AM J PHYSIOL-CELL PH, V271, pC690, DOI 10.1152/ajpcell.1996.271.2.C690; Tsika R W, 1994, Exerc Sport Sci Rev, V22, P361; TSIKA RW, 1995, AM J PHYSIOL-CELL PH, V269, pC665, DOI 10.1152/ajpcell.1995.269.3.C665; WARDEN CH, 1994, GENOMICS, V24, P14, DOI 10.1006/geno.1994.1576; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; ZOU YM, 1995, MOL CELL BIOL, V15, P2972	35	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14270	14279		10.1074/jbc.274.20.14270	http://dx.doi.org/10.1074/jbc.274.20.14270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318848	hybrid			2022-12-27	WOS:000080322200077
J	Arakaki, N; Kajihara, T; Arakaki, R; Ohnishi, T; Kazi, JA; Nakashima, H; Daikuhara, Y				Arakaki, N; Kajihara, T; Arakaki, R; Ohnishi, T; Kazi, JA; Nakashima, H; Daikuhara, Y			Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor scatter factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FULMINANT HEPATIC-FAILURE; NECROSIS-FACTOR-ALPHA; C-MET RECEPTOR; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; HYDROGEN-PEROXIDE; HUMAN-FIBROBLASTS; RELAXING FACTOR	In this study, we show that N-acetylcysteine (NAC), a precursor of glutathione and an intracellular free radical scavenger, almost completely prevented hepatocyte growth factor (HGF)-suppressed growth of Sarcoma 180 and Meth A cells, and HGF-induced apoptosis, assessed by DNA fragmentation, and increase in caspase-3 activity, in Sarcoma 180 cells. The reduced form of glutathione also prevented HGF-suppressed growth of the cells as effective as NAG. Ascorbic acid partially prevented the effect of HGF, but other antioxidants such as superoxide dismutase, catalase, and vitamin E, and the free radical spin traps N-t-butyl-alpha-phenylnitrone and 3,3,5,5-tetramethyl-1-pyrroline-1-oxide did not have protective effects. HGF caused morphological changes of the cells, many cells showing condensation and rounding, and enhanced the generation of intracellular reactive oxygen species (ROS) as judged by flow cytometric analysis using 2',7'-dichlorofluorescein diacetate. NAC completely prevented both HGF-induced morphological changes and the enhancement of ROS generation in the cells. However, NAC did not prevent the HGF-induced scattering of Madin-Darby canine kidney cells. To our knowledge, this is the first report that HGF stimulates the production of ROS, and our results suggest the involvement of oxidative stress in the mechanism by which HGF induces growth suppression of tumor cells.	Kagoshima Univ, Sch Dent, Dept Biochem, Kagoshima 8908544, Japan; Kagoshima Univ, Sch Dent, Dept Immunol & Microbiol, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University	Daikuhara, Y (corresponding author), Kagoshima Univ, Sch Dent, Dept Biochem, 35-1 Sakuragaoka 8, Kagoshima 8908544, Japan.		Jamil, Kazi Ahsan/B-1057-2009	Jamil, Kazi Ahsan/0000-0001-5605-2211				Arakaki N, 1995, HEPATOLOGY, V22, P1728, DOI 10.1016/0270-9139(95)90198-1; Arakaki N, 1998, BIOCHEM BIOPH RES CO, V245, P211, DOI 10.1006/bbrc.1998.8397; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUROW S, 1987, EUR J CELL BIOL, V43, P128; BUSS JE, 1982, P NATL ACAD SCI-BIOL, V79, P2574, DOI 10.1073/pnas.79.8.2574; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Gohda E, 1998, BIOCHEM BIOPH RES CO, V245, P278, DOI 10.1006/bbrc.1998.8416; GOHDA E, 1991, DIGEST DIS SCI, V36, P785, DOI 10.1007/BF01311238; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HENNET T, 1993, BIOCHEM J, V289, P587, DOI 10.1042/bj2890587; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KAYANOKI Y, 1994, J BIOL CHEM, V269, P15488; KYLE ME, 1988, J BIOL CHEM, V263, P3784; KYLE ME, 1987, BIOCHEM BIOPH RES CO, V149, P889, DOI 10.1016/0006-291X(87)90491-8; LASTER SM, 1988, J IMMUNOL, V141, P2629; LIU ML, 1995, CARCINOGENESIS, V16, P841, DOI 10.1093/carcin/16.4.841; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NALDINI L, 1991, ONCOGENE, V6, P501; Offen D, 1996, EXP NEUROL, V141, P32, DOI 10.1006/exnr.1996.0136; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rahimi N, 1996, J BIOL CHEM, V271, P24850, DOI 10.1074/jbc.271.40.24850; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; SantoniRugiu E, 1996, P NATL ACAD SCI USA, V93, P9577, DOI 10.1073/pnas.93.18.9577; SARAFIAN TA, 1994, FREE RADICAL RES, V21, P1, DOI 10.3109/10715769409056549; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SHIMA N, 1991, CELL BIOL INT REP, V15, P397, DOI 10.1016/0309-1651(91)90128-6; SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; Snedecor G.W., 1967, STAT METHODS, V6th, P1; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; TAJIMA H, 1991, FEBS LETT, V291, P229, DOI 10.1016/0014-5793(91)81291-F; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Wu DF, 1996, J BIOL CHEM, V271, P23914, DOI 10.1074/jbc.271.39.23914; Yoshie Y, 1997, CARCINOGENESIS, V18, P1359, DOI 10.1093/carcin/18.7.1359; YOSHIYAMA Y, 1991, BIOCHEM BIOPH RES CO, V175, P660, DOI 10.1016/0006-291X(91)91616-K; Zamora R, 1997, EUR J PHARMACOL, V321, P87, DOI 10.1016/S0014-2999(96)00918-1	65	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13541	13546		10.1074/jbc.274.19.13541	http://dx.doi.org/10.1074/jbc.274.19.13541			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224123	hybrid			2022-12-27	WOS:000080200400085
J	Kazlauskas, A; Poellinger, L; Pongratz, I				Kazlauskas, A; Poellinger, L; Pongratz, I			Evidence that the Co-chaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; NUCLEAR TRANSLOCATOR PROTEIN; DNA-BINDING ACTIVITY; AH-RECEPTOR; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; PROGESTERONE-RECEPTOR; PAS DOMAIN; IN-VIVO; HSP90	The dioxin (aryl hydrocarbon) receptor is a ligand-dependent transcription factor that induces expression of a number of genes encoding drug metabolizing enzymes, In the absence of ligand the dioxin receptor is present in the cytoplasmic compartment of the cell associated with the molecular chaperone hsp90, which has been implicated in regulating the correct folding of the ligand binding domain of the receptor. In this study we have examined a potential role of the hsp90-associated p23 protein in the activation process of the dioxin receptor to a DNA binding form. In an in vitro model we show that addition of ligand alone to the dioxin receptor fails to induce release of hsp90 from the dioxin receptor. In the presence of ligand, this release was, however, induced upon addition of purified preparations of Arnt. Interestingly, p23 was also found to be associated with the nonactivated form of the dioxin receptor. Following fractionation on sucrose gradients p23 was dissociated from the receptor-hsp90 complex generating a receptor form, which showed ligand-independent release of hsp90 by Arnt and, consequently, ligand-independent activation of the DNA binding activity of the dioxin receptor. Ligand dependence was reconstituted in the presence of molybdate, a transition metal ion known to stabilize the interaction between the molecular chaperone hsp90 and p23, Taken together these experiments suggest a role of p23 in modulating ligand responsiveness in the activation process of the dioxin receptor.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Pongratz, I (corresponding author), Karolinska Inst, Dept Cellular & Mol Biol, S-17177 Stockholm, Sweden.	ingemar.pongratz@cmb.ki.se						BODINE PV, 1990, MOL CELL ENDOCRINOL, V74, pC77, DOI 10.1016/0303-7207(90)90199-I; BODINE PV, 1988, J BIOL CHEM, V263, P3501; BODINE PV, 1988, P NATL ACAD SCI USA, V85, P1462, DOI 10.1073/pnas.85.5.1462; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CARVER LA, 1994, J BIOL CHEM, V269, P30109; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; CUTHILL S, 1991, MOL CELL BIOL, V11, P401, DOI 10.1128/MCB.11.1.401; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; GRADIN K, 1993, J BIOL CHEM, V268, P4061; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; HAPGOOD J, 1989, P NATL ACAD SCI USA, V86, P60, DOI 10.1073/pnas.86.1.60; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HUTCHISON KA, 1995, J BIOL CHEM, V270, P18841, DOI 10.1074/jbc.270.32.18841; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; LEGRAVEREND C, 1982, J BIOL CHEM, V257, P6402; Ma Q, 1997, J BIOL CHEM, V272, P8878; MASON GGF, 1994, J BIOL CHEM, V269, P4438; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; NEMOTO T, 1990, J BIOL CHEM, V265, P2269; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; POELLINGER L, 1993, PHARM SKIN, V5, P103; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; Pongratz I, 1998, MOL CELL BIOL, V18, P4079, DOI 10.1128/MCB.18.7.4079; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt William B., 1994, Seminars in Cell Biology, V5, P83; PROBST MR, 1993, MOL PHARMACOL, V44, P511; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Sassone-Corsi P, 1998, NATURE, V392, P871, DOI 10.1038/31821; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Wang G L, 1996, Curr Opin Hematol, V3, P156; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WHITELAW M, 1993, MOL CELL BIOL, V13, P2504, DOI 10.1128/MCB.13.4.2504; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x	47	205	211	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13519	13524		10.1074/jbc.274.19.13519	http://dx.doi.org/10.1074/jbc.274.19.13519			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224120	hybrid			2022-12-27	WOS:000080200400082
J	Lee, KY; Chang, WT; Qiu, DM; Kao, PN; Rosen, GD				Lee, KY; Chang, WT; Qiu, DM; Kao, PN; Rosen, GD			PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRIPTERYGIUM-WILFORDII; TRANSCRIPTION; PHOSPHORYLATION; ACTIVATION; P65; INHIBITION; C-IAP2; DEATH	Progress in the treatment of solid tumors has been slow and sporadic. The efficacy of conventional chemotherapy in solid tumors is limited because tumors frequently have mutations in the p53 gene. Also, chemotherapy only kills rapidly dividing cells. Members of the tumor necrosis factor (TNF) family, however, induce apoptosis regardless of the p53 phenotype. Unfortunately, the cytotoxicity of TNF-alpha is limited by its activation of NF-kappa B and activation of NF-kappa B is proinflammatory, We have identified a compound called PG490, that is composed of purified triptolide, which induces apoptosis in tumor cells and sensitizes tumor cells to TNF-alpha-induced apoptosis, PG490 potently inhibited TNF-alpha-induced activation of NF-kappa B, PG490 also blocked TNF-alpha-mediated induction of c-IAP2 (hiap-1) and c-IAP1 (hiap-2), members of the inhibitor of apoptosis (IAP) family, interestingly, PG490 did not block DNA binding of NF-kappa B, but it blocked transactivation of NF-kappa B, Our identification of a compound that blocks TNF-alpha-induced activation of NP-kappa B may enhance the cytotoxicity of TNF-alpha on tumors in vivo and limit its proinflammatory effects.	Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA	Stanford University	Rosen, GD (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, 300 Pasteur Dr, Stanford, CA 94305 USA.							Bauerle PA, 1996, CELL, V87, P13; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Burow ME, 1998, CANCER RES, V58, P4940; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gu WZ, 1998, INT J IMMUNOPHARMACO, V20, P389, DOI 10.1016/S0192-0561(98)00035-6; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; KUPCHAN SM, 1974, SCIENCE, V185, P791, DOI 10.1126/science.185.4153.791; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; Tao XL, 1998, ARTHRITIS RHEUM-US, V41, P130, DOI 10.1002/1529-0131(199801)41:1<130::AID-ART16>3.3.CO;2-W; Tao XL, 1996, J PHARMACOL EXP THER, V276, P316; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Wen LP, 1997, AM J PHYSIOL-LUNG C, V273, pL921, DOI 10.1152/ajplung.1997.273.5.L921; YANG SX, 1994, INT J IMMUNOPHARMACO, V16, P895, DOI 10.1016/0192-0561(94)90044-2; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	23	171	191	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13451	13455		10.1074/jbc.274.19.13451	http://dx.doi.org/10.1074/jbc.274.19.13451			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224110	hybrid			2022-12-27	WOS:000080200400072
J	Rodrigue, A; Chanal, A; Beck, K; Muller, M; Wu, LF				Rodrigue, A; Chanal, A; Beck, K; Muller, M; Wu, LF			Co-translocation of a periplasmic enzyme complex by a hitchhiker mechanism through the bacterial Tat pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN EXPORT; PLASMA-MEMBRANE; NICKEL; SYSTEM; GENES; HYDROGENASE-2; COMPONENTS; PRECURSOR; SEQUENCES	Bacterial periplasmic nickel-containing hydrogenases are composed of a small subunit containing a twin-arginine signal sequence and a large subunit devoid of an export signal. To understand how the large subunit is translocated into the periplasm, we cloned the hyb operon encoding the hydrogenase 2 of Escherichia coli constructed a deletion mutant, and studied the mechanism of translocation of hydrogenase 2, The small subunit (HybO) or the large subunit (HybC) accumulated in the cytoplasm as a precursor when either of them was expressed in the absence of the other subunit, Therefore, contrary to most classical secretory proteins, the signal sequence of the small subunit itself is not sufficient for membrane targeting and translocation if the large subunit is missing. On the other hand, the small subunit was required not only for membrane targeting of the large subunit, but also for the acquisition of nickel by the large subunit, Most interestingly, the signal sequence of the small subunit determines whether the large subunit follows the Sec or the twin-arginine translocation pathway. Taken together, these results provide for the first time compelling evidence for a naturally occurring hitchhiker co-translocation mechanism in bacteria.	UPR9043 CNRS, Inst Biol Struct & Microbiol, Chim Bacterienne Lab, F-13402 Marseille 20, France; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Wu, LF (corresponding author), UPR9043 CNRS, Inst Biol Struct & Microbiol, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.		Rodrigue, Agnès/AAD-5987-2020	Rodrigue, Agnes/0000-0002-8473-8103				BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BARDONNET N, 1992, FEMS MICROBIOL LETT, V93, P243, DOI 10.1111/j.1574-6968.1992.tb05105.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Binder U, 1996, ARCH MICROBIOL, V165, P69, DOI 10.1007/s002030050299; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bouveret E, 1997, MOL MICROBIOL, V23, P909, DOI 10.1046/j.1365-2958.1997.2751640.x; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Chanal A, 1998, MOL MICROBIOL, V30, P674, DOI 10.1046/j.1365-2958.1998.01095.x; Harlow E, 1998, ANTIBODIES LAB MANUA; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; MANEEWANNAKUL S, 1994, PLASMID, V31, P300, DOI 10.1006/plas.1994.1032; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; Robinson C, 1997, TRENDS PLANT SCI, V2, P431, DOI 10.1016/S1360-1385(97)90027-3; Rodrigue A, 1996, FEBS LETT, V392, P81, DOI 10.1016/0014-5793(96)00788-0; Rodrigue A, 1996, J BACTERIOL, V178, P4453, DOI 10.1128/jb.178.15.4453-4460.1996; RUSSELL CB, 1989, J BACTERIOL, V171, P2609, DOI 10.1128/jb.171.5.2609-2613.1989; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VOORDOUW G, 1992, ADV INORG CHEM, V38, P397, DOI 10.1016/S0898-8838(08)60069-0; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; WU LF, 1993, FEMS MICROBIOL LETT, V104, P243; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2	32	216	221	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13223	13228		10.1074/jbc.274.19.13223	http://dx.doi.org/10.1074/jbc.274.19.13223			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224080	hybrid, Green Published			2022-12-27	WOS:000080200400042
J	Lee, J; Godon, C; Lagniel, G; Spector, D; Garin, J; Labarre, J; Toledano, MB				Lee, J; Godon, C; Lagniel, G; Spector, D; Garin, J; Labarre, J; Toledano, MB			Yap1 and Skn7 control two specialized oxidative stress response regulons in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-SPECIFIC ANTIOXIDANT; PENTOSE-PHOSPHATE PATHWAY; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; BUDDING YEAST; SUPEROXIDE-DISMUTASE; METAL RESISTANCE; BZIP PROTEINS; TARGET GENE	Yap1 and Skn7 are two yeast transcriptional regulators that co-operate to activate thioredoxin (TRX2) and thioredoxin reductase (TRR1) in response to redox stress signals. Although they are both important for re sistance to H2O2, only Yap1 is important for cadmium resistance, whereas Skn7 has a negative effect upon this response. The respective roles of Yap1 and Skn7 in the induction of defense genes by H2O2 were analyzed by two-dimensional gel electrophoresis. Yap1 controls a large oxidative stress response regulon of at least 32 proteins. Fifteen of these proteins also require the presence of Skn7 for their induction by H2O2. Although about half of the Yap1 target genes do not contain a consensus Yap1 recognition motif, the control of one such gene, TSA1, involves the binding of Yap1 and Skn7 to its promoter in vitro. The co-operative control of the oxidative stress response by Yap1 and Skn7 delineates two gene subsets. Remarkably, these two gene subsets separate antioxidant scavenging enzymes from the metabolic pathways regenerating the main cellular reducing power, glutathione and NADPH. Such a specialization may explain, at least in part, the dissociated function of Yap1 and Skn7 in H2O2 and cadmium resistance.	CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France; Rutgers State Univ, Coll Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08855 USA; CEA, Dept Biol Mol & Struct, F-38054 Grenoble, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Rutgers State University New Brunswick; CEA	Toledano, MB (corresponding author), CEA Saclay, Serv Biochim & Genet Mol, Batiment 142, F-91191 Gif Sur Yvette, France.							BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Brennan RJ, 1996, MUTAT RES-FUND MOL M, V356, P171, DOI 10.1016/0027-5107(96)00051-6; BROWN JL, 1993, J BACTERIOL, V175, P6908, DOI 10.1128/jb.175.21.6908-6915.1993; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, BIOFACTORS, V4, P177; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P182; HALLIWELL B, 1994, NUTR REV, V52, P253; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HIRATA D, 1994, MOL GEN GENET, V242, P250, DOI 10.1007/BF00280413; IZAWA S, 1995, FEBS LETT, V368, P73, DOI 10.1016/0014-5793(95)00603-7; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Ketela T, 1998, MOL GEN GENET, V259, P372, DOI 10.1007/s004380050824; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; KULLIK I, 1994, REDOX REPORT, V1, P1; KWON SJ, 1994, BIOCHEM BIOPH RES CO, V201, P8, DOI 10.1006/bbrc.1994.1662; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; MORGAN BA, 1995, EMBO J, V14, P5679, DOI 10.1002/j.1460-2075.1995.tb00255.x; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAAFFGERSTENSCHLAGER I, 1993, CURR GENET, V24, P373, DOI 10.1007/BF00351843; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGHAL RK, 1987, FASEB J, V1, P220, DOI 10.1096/fasebj.1.3.2887478; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Stephen DWS, 1996, FEMS MICROBIOL LETT, V141, P207, DOI 10.1111/j.1574-6968.1996.tb08386.x; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; WU AL, 1993, J BIOL CHEM, V268, P18850; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	56	453	469	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16040	16046		10.1074/jbc.274.23.16040	http://dx.doi.org/10.1074/jbc.274.23.16040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347154	hybrid			2022-12-27	WOS:000080668600014
J	Taniura, H; Matsumoto, K; Yoshikawa, K				Taniura, H; Matsumoto, K; Yoshikawa, K			Physical and functional interactions of neuronal growth suppressor necdin with p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; EMBRYONAL CARCINOMA-CELLS; NUCLEAR-PROTEIN; P53-MEDIATED APOPTOSIS; TUMOR SUPPRESSION; GENE; EXPRESSION; MOUSE; ONCOPROTEIN; REGION	Necdin is expressed in virtually all postmitotic neurons, and ectopic expression of this protein suppresses cell proliferation. Necdin, like the retinoblastoma protein, interacts with cell cycle promoting proteins such as simian virus 40 large T antigen, adenovirus E1A, and the transcription factor E2F1. Here we demonstrate that necdin interacts with the tumor suppressor protein p53 as well. The yeast two-hybrid and in vitro binding analyses revealed that necdin bound to a narrow region (amino acids 35-62) located between the MDM2-binding site and the proline-rich region in the amino-terminal domain of p53, The electrophoretic mobility shift assay showed that necdin supershifted a complex between p53 and its binding DNA, implying that the p53-necdin complex is competent for DNA binding. In p53-deficient osteosarcoma SAOS-2 cells, necdin markedly suppressed p53-dependent activation of the p21/WAF promoter. Necdin and p53 inhibited cell growth in an additive manner as assessed by the colony formation of SAOS-2 cells, suggesting that necdin does not affect p53-mediated growth suppression. On the other hand, necdin inhibited p53-induced apoptosis of osteosarcoma U2OS cells. Thus, necdin can be a growth suppressor that targets p53 and modulates its biological functions in postmitotic neurons.	Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Osaka 5650871, Japan	Osaka University	Taniura, H (corresponding author), Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Yamadaoka 3-2, Osaka 5650871, Japan.	hideo@protein.osaka-u.ac.jp						ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BROWN DR, 1993, MOL CELL BIOL, V13, P6849, DOI 10.1128/MCB.13.11.6849; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAUPT Y, 1995, ONCOGENE, V10, P1563; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jordan J, 1997, J NEUROSCI, V17, P1397; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MAHESWARAN S, 1995, GENE DEV, V9, P2143, DOI 10.1101/gad.9.17.2143; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakada Y, 1998, GENE, V213, P65, DOI 10.1016/S0378-1119(98)00206-6; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SLACK RS, 1993, ONCOGENE, V8, P1585; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiang H, 1998, J NEUROSCI, V18, P1363	40	121	132	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16242	16248		10.1074/jbc.274.23.16242	http://dx.doi.org/10.1074/jbc.274.23.16242			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347180	hybrid			2022-12-27	WOS:000080668600040
J	Bae, H; Cabrera-Vera, TM; Depree, KM; Graber, SG; Hamm, HE				Bae, H; Cabrera-Vera, TM; Depree, KM; Graber, SG; Hamm, HE			Two amino acids within the alpha 4 helix of G alpha(i1) mediate coupling with 5-hydroxytryptamine(1B) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GAMMA-SUBUNIT; GUANINE-NUCLEOTIDE-BINDING; HETEROTRIMERIC G-PROTEINS; A1 ADENOSINE RECEPTORS; RECOMBINANT G-PROTEINS; TRIMERIC G-PROTEINS; BETA-GAMMA; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; PROTEOLYTIC DIGESTION	We previously reported that residues 299-318 in Ga-i1 participate in the selective interaction between Ga-i1 and the 5-hydroxytryptamine(1B) (5-HT1B) receptor (Bae, H., Anderson, K., Flood, L. A., Skiba, N. P., Hamm, H. E., and Graber, S. G. (1997) J. Biol. Chem. 272, 32071-32077). The present study more precisely defines which residues within this domain are critical for 5-HT1B receptor-mediated G protein activation. A series of Ga-i1/G alpha(t) chimeras and point mutations were reconstituted with G beta gamma and Sf9 cell membranes containing the 5-HT1B receptor. Functional coupling to 5-HT1B receptors was assessed by 1) [S-35]GTP gamma S binding and 2) agonist affinity shift assays. Replacement of the alpha 4 helix of Ga-i1 (residues 299-308) with the corresponding sequence from G alpha(t) produced a chimera (Chi22) that only weakly coupled to the 5-HT1B receptor. In contrast, substitution of residues within the alpha 4-beta 6 loop region of Ga-i1 (residues 309-318) with the corresponding sequence in G alpha(t) either permitted full 5-HT1B receptor coupling to the chimera (Chi24) or only minimally reduced coupling to the chimeric protein (Chi25), Two mutations within the alpha 4 helix of Ga-i1 (Q304K and E308L) reduced agonist-stimulated [S-35]GTP gamma S binding, and the effects of these mutations were additive. The opposite substitutions within Chi22 (K300Q and L304E) restored Ga-i1 receptor coupling, and again the effects of the two mutations were additive. Mutations of other residues within the alpha 4 helix of Ga-i1 had minimal to no effect on 5-HT1B coupling behavior. These data provide evidence that alpha 4 helix residues in G alpha(i) participate in directing specific receptor interactions and suggest that Gln(304) and Glu(308) of Ga-i1 act in concert to mediate the ability of the 5-HT1B receptor to couple specifically to inhibitory G proteins.	Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; W Virginia Univ, Dept Pharmacol & Toxicol, Morgantown, WV 26506 USA	Northwestern University; West Virginia University	Hamm, HE (corresponding author), Northwestern Univ, Inst Neurosci, 320 E Super,Searle Bldg,Rm 5-555, Chicago, IL 60611 USA.		Hamm, Heidi E/G-2374-2014; Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582	NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010291] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA70085-02] Funding Source: Medline; NEI NIH HHS [EY10291] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASANO T, 1985, J BIOL CHEM, V260, P2653; Bae H, 1997, J BIOL CHEM, V272, P32071, DOI 10.1074/jbc.272.51.32071; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOYER JL, 1994, J BIOL CHEM, V269, P2814; Clawges HM, 1997, BIOCHEMISTRY-US, V36, P12930, DOI 10.1021/bi970112b; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; ENGEL G, 1986, N-S ARCH PHARMACOL, V332, P1, DOI 10.1007/BF00633189; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Figler RA, 1996, MOL PHARMACOL, V50, P1587; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; Goadsby PJ, 1998, CLIN NEUROSCI, V5, P18; GRABER SG, 1992, J BIOL CHEM, V267, P1271; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KUBOTA A, 1994, BIOCHEM BIOPH RES CO, V204, P176, DOI 10.1006/bbrc.1994.2442; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LAUGWITZ KL, 1993, NEURON, V10, P233, DOI 10.1016/0896-6273(93)90314-H; LEE CH, 1995, MOL PHARMACOL, V47, P218; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; MIDDLEMISS DN, 1988, EUR J PHARMACOL, V157, P101, DOI 10.1016/0014-2999(88)90476-1; MIGEON JC, 1994, J BIOL CHEM, V269, P9767; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; POBINER BF, 1991, MOL PHARMACOL, V40, P156; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; RAYMOND JR, 1993, BIOCHEMISTRY-US, V32, P11064, DOI 10.1021/bi00092a016; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Taylor JM, 1996, J BIOL CHEM, V271, P3336; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yasuda H, 1996, J BIOL CHEM, V271, P18588, DOI 10.1074/jbc.271.31.18588	51	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14963	14971		10.1074/jbc.274.21.14963	http://dx.doi.org/10.1074/jbc.274.21.14963			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329698	Green Published, hybrid			2022-12-27	WOS:000081965200063
J	Johnsson, E; Areschoug, T; Mestecky, J; Lindahl, G				Johnsson, E; Areschoug, T; Mestecky, J; Lindahl, G			An IgA-binding peptide derived from a streptococcal surface protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCI; GROUP-A STREPTOCOCCI; IMMUNOGLOBULIN-A; MOLECULAR CHARACTERIZATION; BETA-ANTIGEN; COILED COILS; FC-RECEPTORS; IDENTIFICATION; PYOGENES; REGION	Surface proteins that bind to the Fc part of human IgA are expressed by many strains of Streptococcus pyogenes, a major human pathogen. Studies of these proteins have been complicated by their size and by their ability to bind human plasma proteins other than IgA. Here, we describe a synthetic 50-residue peptide, derived from streptococcal protein Sir22, that binds human IgA but not any of the other plasma proteins known to bind to Sir22. The peptide binds serum IgA and secretory IgA and binds IgA of both subclasses. Evidence is presented that the peptide folds correctly both in solution and when it is immobilized and that it readily renatures after denaturation, Together, these data indicate that the peptide corresponds to a protein domain that binds IgA with high specificity. This is the first report of an IgA-binding domain that retains its properties in isolated form.	Univ Lund, Dept Lab Med, S-22362 Lund, Sweden; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	Lund University; University of Alabama System; University of Alabama Birmingham	Lindahl, G (corresponding author), Univ Lund, Dept Lab Med, Solvegatan 23, S-22362 Lund, Sweden.							AKERSTROM B, 1994, MOL IMMUNOL, V31, P393, DOI 10.1016/0161-5890(94)90117-1; AKERSTROM B, 1992, J IMMUNOL, V148, P3238; BESSEN DE, 1994, INFECT IMMUN, V62, P1968, DOI 10.1128/IAI.62.5.1968-1974.1994; BESSEN DE, 1992, INFECT IMMUN, V60, P124, DOI 10.1128/IAI.60.1.124-135.1992; Carayannopoulos L, 1996, J EXP MED, V183, P1579, DOI 10.1084/jem.183.4.1579; CEDERVALL T, 1995, SCAND J IMMUNOL, V42, P433, DOI 10.1111/j.1365-3083.1995.tb03677.x; FRICK IM, 1994, MOL MICROBIOL, V12, P143, DOI 10.1111/j.1365-2958.1994.tb01003.x; FRITHZ E, 1989, MOL MICROBIOL, V3, P1111, DOI 10.1111/j.1365-2958.1989.tb00261.x; HEDEN LO, 1991, EUR J IMMUNOL, V21, P1481, DOI 10.1002/eji.1830210623; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; Jerlstrom PG, 1996, INFECT IMMUN, V64, P2787; JOHNSSON E, 1994, J IMMUNOL, V153, P3557; Johnsson E, 1998, J IMMUNOL, V161, P4894; Johnsson E, 1996, J IMMUNOL, V157, P3021; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; LINDAHL G, 1989, MOL MICROBIOL, V3, P239, DOI 10.1111/j.1365-2958.1989.tb01813.x; LINDAHL G, 1990, EUR J IMMUNOL, V20, P2241, DOI 10.1002/eji.1830201013; MESTECKY J, 1985, METHOD ENZYMOL, V116, P37; Morton HC, 1996, CRIT REV IMMUNOL, V16, P423; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; RUSSELLJONES GJ, 1984, J EXP MED, V160, P1467, DOI 10.1084/jem.160.5.1467; SCHALEN C, 1980, ACTA PATH MICRO IM C, V88, P271; STENBERG L, 1994, J BIOL CHEM, V269, P13458; SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032; Thern A, 1998, J IMMUNOL, V160, P860; THERN A, 1995, J IMMUNOL, V154, P375	26	27	28	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14521	14524		10.1074/jbc.274.21.14521	http://dx.doi.org/10.1074/jbc.274.21.14521			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329638	hybrid			2022-12-27	WOS:000081965200003
J	Mikkola, I; Bruun, JA; Bjorkoy, G; Holm, T; Johansen, T				Mikkola, I; Bruun, JA; Bjorkoy, G; Holm, T; Johansen, T			Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX-CONTAINING GENE; HYDROLYZING PHOSPHOLIPASE-C; NIH 3T3 CELLS; MAP KINASE; PAIRED-DOMAIN; TRANSCRIPTION FACTOR; DNA-BINDING; EYE DEVELOPMENT; MEDIATED PHOSPHORYLATION; TRANSDUCTION PATHWAY	The transcription factor Pax6 is required for normal development of the central nervous system, the eyes, nose, and pancreas. Here we show that the transactivation domain (TAD) of zebrafish Pax6 is phosphorylated in vitro by the mitogen-activated protein kinases (MAPKs) extracellular-signal regulated kinase (ERK) and p38 kinase but not by Jun N-terminal kinase (JNK). Three of four putative proline-dependent kinase phosphorylation sites are phosphorylated in vitro. Of these sites, the serine 413 (Ser(413)) is evolutionary conserved from sea urchin to man. Ser(413) is also phosphorylated in vivo upon activation of ERK or p38 kinase. Substitution of Ser(413) with alanine strongly decreased the transactivation potential of the Pax6 TAD whereas substitution with glutamate increased the transactivation. Reporter gene assays with wild-type and mutant Pax6 revealed that transactivation by the full-length Pax6 protein from paired domain-binding sites was strongly enhanced (le-fold) following co-transfection with activated p38 kinase. This enhancement was largely dependent on the Ser(413) site. ERK activation, however, produced a 3-fold increase in transactivation which was partly independent of the Ser(413) site. These findings provide a starting point for further studies aimed at elucidating a post-translational regulation of Pax6 following activation of MAPK signaling pathways.	Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway.	terjej@fagmed.uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Bruun, Jack-Ansgar/0000-0003-0614-2790; Mikkola, Ingvild/0000-0001-6442-7626				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bennicelli JL, 1996, P NATL ACAD SCI USA, V93, P5455, DOI 10.1073/pnas.93.11.5455; Bjorkoy G, 1997, J BIOL CHEM, V272, P11557; BJORKOY G, 1995, J BIOL CHEM, V270, P21299; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fortin AS, 1997, HUM MOL GENET, V6, P1781, DOI 10.1093/hmg/6.11.1781; Glardon S, 1997, DEVELOPMENT, V124, P817; Glardon S, 1998, DEVELOPMENT, V125, P2701; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; GUPTA S, 1994, FEBS LETT, V353, P281, DOI 10.1016/0014-5793(94)01052-8; HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Kurozumi K, 1998, GENES CELLS, V3, P257, DOI 10.1046/j.1365-2443.1998.00186.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Loosli F, 1996, P NATL ACAD SCI USA, V93, P2658, DOI 10.1073/pnas.93.7.2658; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Mao C, 1996, ONCOGENE, V12, P863; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MARTIN P, 1992, ONCOGENE, V7, P1721; MIKKOLA I, 1992, J NEUROBIOL, V23, P933, DOI 10.1002/neu.480230802; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Sjottem E, 1996, J VIROL, V70, P188; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; UNDERHILL DA, 1995, P NATL ACAD SCI USA, V92, P3692, DOI 10.1073/pnas.92.9.3692; Underhill DA, 1997, J BIOL CHEM, V272, P14175, DOI 10.1074/jbc.272.22.14175; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WESTWICK JK, 1995, METHOD ENZYMOL, V255, P342; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	76	93	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15115	15126		10.1074/jbc.274.21.15115	http://dx.doi.org/10.1074/jbc.274.21.15115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329718	hybrid			2022-12-27	WOS:000081965200083
J	Portnoy, ME; Rosenzweig, AC; Rae, T; Huffman, DL; O'Halloran, TV; Culotta, VC				Portnoy, ME; Rosenzweig, AC; Rae, T; Huffman, DL; O'Halloran, TV; Culotta, VC			Structure-function analyses of the ATX1 metallochaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; CEREVISIAE LYS7 GENE; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; PHYSIOLOGICAL-ROLE; WILSON-DISEASE; IRON TRANSPORT; YEAST; PROTEIN; HOMEOSTASIS	Saccharomyces cerevisiae Atx1p represents a member of the family of metallochaperone molecules that escort copper to distinct intracellular targets, Atx1p specifically delivers copper to the Ccc2p copper transporter in the Golgi. Additionally, when overproduced, Atx1p substitutes for superoxide dismutase 1 in preventing oxidative damage; however the mechanistic overlap between these functions is unresolved. The crystal structure of Atx1p has been solved recently, By examining a surface electrostatic potential distribution, multiple conserved lysines are revealed on one face of Atx1p. An additional conserved lysine (Lys(65)) lies in close proximity to the metal binding site. Through site-directed mutagenesis, residues in the metal binding region including Lys65 were found to be necessary for both copper delivery to Ccc2p and for Atx1p antioxidant activity. Copper trafficking to Ccc2p also relied on the lysine rich face of Atx1p. Surprisingly however, elimination of these lysines did not inhibit the antioxidant activity of Atx1p, We provide evidence that Atx1p does not suppress oxidative damage by a metallochaperone mechanism but may directly consume superoxide. Purified Cu-Atx1p reacts noncatalytically with superoxide anion in vitro. We conclude that the copper-trafficking and antioxidant functions of Atx1p arise from chemically and structurally distinct attributes of this metallochaperone.	Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Johns Hopkins University; Johns Hopkins University; Northwestern University; Northwestern University	Culotta, VC (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Rm 7023, Baltimore, MD 21205 USA.		O'Halloran, Thomas/ABE-6125-2021	O'Halloran, Thomas/0000-0001-8732-5059	NCI NIH HHS [T32CA 09110] Funding Source: Medline; NIEHS NIH HHS [ES 08996] Funding Source: Medline; NIGMS NIH HHS [R01 GM054111, GM54111] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; FRIDOVICH I, 1985, CRC HDB METHODS OXYG, P213; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Gamonet F, 1998, EUR J BIOCHEM, V251, P716, DOI 10.1046/j.1432-1327.1998.2510716.x; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Himelblau E, 1998, PLANT PHYSIOL, V117, P1227, DOI 10.1104/pp.117.4.1227; HORECKA J, 1995, GENE, V162, P87, DOI 10.1016/0378-1119(95)00325-Z; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LIN SJ, 1997, THESIS J HOPKINS U; Linder M. C., 1991, BIOCH COPPER, V1-13; LIU XF, 1992, J BIOL CHEM, V267, P18298; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishihara E, 1998, NEUROREPORT, V9, P3259, DOI 10.1097/00001756-199810050-00023; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; ROSENZWEIG AC, 1999, IN PRESS STRUCTURE L; Sherman F., 1978, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Steele RA, 1997, BIOCHEMISTRY-US, V36, P6885, DOI 10.1021/bi9631632; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	37	120	121	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15041	15045		10.1074/jbc.274.21.15041	http://dx.doi.org/10.1074/jbc.274.21.15041			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329707	hybrid			2022-12-27	WOS:000081965200072
J	Hopf, A; Schreiber, R; Mall, M; Greger, R; Kunzelmann, K				Hopf, A; Schreiber, R; Mall, M; Greger, R; Kunzelmann, K			Cystic fibrosis transmembrane conductance regulator inhibits epithelial Na+ channels carrying Liddle's syndrome mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; XENOPUS OOCYTES; CYTOSOLIC NA+; DUCT CELLS; PROTEIN; CFTR; EXPRESSION; SEQUENCE; SUBUNIT; ENAC	Epithelial Na+ channels (ENaC) are inhibited by the cystic fibrosis transmembrane conductance regulator (CFTR) upon activation by protein kinase A. It is, however, still unclear how CFTR regulates the activity of ENaC. In the present study we examined whether CFTR interacts with ENaC by interfering with the Nedd4- and ubiquitin-mediated endocytosis of ENaC. Various C-terminal mutations were introduced into the three alpha-, beta-, and gamma-subunits of the rat epithelial Na+ channel, thereby eliminating PY motifs, which are important binding domains for the ubiquitin ligase Nedd4. When expressed in Xenopus oocytes, most of the ENaC stop (alpha-H647X, beta-P565X, gamma-S608X) or point (alpha-P671A, beta-Y618A, gamma-P(624-626)A) mutations induced enhanced Na+ currents when compared with wild type alpha,beta,gamma-rENaC. However, ENaC currents formed by either of the mutant alpha-, beta-, or gamma-subunits were inhibited during activation of CFTR by forskolin (10 mu mol/l) and 3-isobutyl-1-methylxanthine (1 mmol/l), Antibodies to dynamin or ubiquitin enhanced alpha,beta,gamma-rENaC whole cell Na+ conductance but did not interfere with inhibition of ENaC by CFTR. Another mutant, beta-T592M,T593A-ENac, also showed enhanced Na+ currents, which were down-regulated by CFTR. Moreover, activation of ENaC by extracellular proteases and xCAP1 does not disturb CFTR-dependent inhibition of ENaC. We conclude that regulation of ENaC by CFTR is distal to other regulatory limbs and does not involve Nedd4-dependent ubiquitination.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Kunzelmann, K (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Kottgen, Anna/D-2920-2012; Mall, Marcus A./AAA-1498-2022; Schreiber, Robert/Q-7550-2019	Mall, Marcus A./0000-0002-4057-2199; Kunzelmann, Karl/0000-0002-4583-7037				Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; Cui Y, 1997, P NATL ACAD SCI USA, V94, P9962, DOI 10.1073/pnas.94.18.9962; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DINUDOM A, 1993, J MEMBRANE BIOL, V135, P289; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; STUTTS MJ, 1998, PEDIATR PULM, V17, P217; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5	25	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13894	13899		10.1074/jbc.274.20.13894	http://dx.doi.org/10.1074/jbc.274.20.13894			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318798	hybrid			2022-12-27	WOS:000080322200027
J	Arizmendi, C; Liu, S; Croniger, C; Poli, V; Friedman, JE				Arizmendi, C; Liu, S; Croniger, C; Poli, V; Friedman, JE			The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-1-ACID GLYCOPROTEIN GENE; LEUCINE-ZIPPER PROTEINS; GLUCOCORTICOID RECEPTOR; C/EBP-BETA; TARGETED DISRUPTION; ADIPOCYTE DIFFERENTIATION; 3T3-L1 PREADIPOCYTES; SIGNAL-TRANSDUCTION; ENERGY HOMEOSTASIS; CELL-PROLIFERATION	CCAAT/enhancer-binding protein (C/EBP) beta and C/EBP alpha are members of the c/ebp gene family and are highly expressed in mammalian liver and adipose tissue. C/EBP alpha is essential for adipogenesis and neonatal gluconeogenesis, as shown by the C/EBP alpha knockout mouse. C/EBP beta binds to several sequences of the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter with high affinity, and C/EBP beta protein is increased 200% in the livers of streptozotocin-diabetic mice, concurrent with increased PEPCK mRNA. To elucidate the role of C/EBP beta in the control of gluconeogenesis during diabetes, we studied the levels of plasma metabolites and hormones related to energy metabolism during diabetes in adult mice heterozygous and homozygous for a null mutation of the gene for C/EBP beta. We also examined the expression of PEPCK and glucose 6-phosphatase mRNAs and regulation of blood glucose, including the contribution of gluconeogenesis to blood glucose in c/ebp beta(-/-) mice. C/EBP beta was not essential to basal PEPCK mRNA levels. However, C/EBP beta deletion affected streptozotocin-diabetic response by: (a) delaying hyperglycemia, (b) preventing the increase of plasma free fatty acids, (c) limiting the full induction of PEPCK and glucose 6-phosphatase genes, and (d) preventing the increase in gluconeogenesis rate. Gel supershifts of transcription factor C/EBP alpha, bound to CRE, P3I, and AF-2 sites of the PEPCK promoter, was not increased in diabetic c/ebp beta(-/-) mouse liver nuclei, suggesting that C/EBP alpha does not substitute for C/EBP beta in the diabetic response of liver gene transcription. These results ling C/EBP beta to the metabolic and gene regulatory responses to diabetes and implicate C/EBP beta as an essential factor underlying glucocorticoid-dependent activation of PEPCK gene transcription in the intact animal.	Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; Univ Salamanca, Sch Med, Dept Biochem & Mol Biol, E-37007 Salamanca, Spain; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland	Case Western Reserve University; Case Western Reserve University; University of Salamanca; University of Dundee	Friedman, JE (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025541, R29DK050272] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-50272, DK-25541, DK-07319] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; ALAM T, 1993, J BIOL CHEM, V268, P15681; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; BOSCH F, 1995, DIABETES, V44, P267, DOI 10.2337/diabetes.44.3.267; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Croniger C, 1997, J BIOL CHEM, V272, P26306, DOI 10.1074/jbc.272.42.26306; Crosson SM, 1997, DIABETOLOGIA, V40, P1117, DOI 10.1007/s001250050796; CRYER PE, 1998, WILLIAMS TXB ENDOCRI, P939; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; FRIEDMAN JE, 1993, J BIOL CHEM, V268, P12952; GARLATTI M, 1993, J BIOL CHEM, V268, P6567; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HETENYI G, 1974, FED PROC, V33, pS44; Houssay BA, 1942, ENDOCRINOLOGY, V30, P884, DOI 10.1210/endo-30-6-884; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; KADISH AH, 1968, CLIN CHEM, V14, P116; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Long CNH, 1936, J EXP MED, V63, P465, DOI 10.1084/jem.63.4.465; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; NITSCH D, 1993, MOL CELL BIOL, V13, P4494, DOI 10.1128/MCB.13.8.4494; Nizielski SE, 1996, AM J PHYSIOL-REG I, V270, pR1005, DOI 10.1152/ajpregu.1996.270.5.R1005; OBRIEN RM, 1994, J BIOL CHEM, V269, P30419; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PARK EA, 1993, J BIOL CHEM, V268, P613; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; UMEK RM, 1991, SCIENCE, V251, P283; Velho G, 1998, EUR J ENDOCRINOL, V138, P233, DOI 10.1530/eje.0.1380233; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Yang DW, 1998, ANAL BIOCHEM, V258, P315, DOI 10.1006/abio.1998.2632; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	66	67	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13033	13040		10.1074/jbc.274.19.13033	http://dx.doi.org/10.1074/jbc.274.19.13033			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224054	hybrid			2022-12-27	WOS:000080200400016
J	Drachman, JG; Millett, KM; Kaushansky, K				Drachman, JG; Millett, KM; Kaushansky, K			Thrombopoietin signal transduction requires functional JAK2, not TYK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; MPL CYTOPLASMIC DOMAIN; C-MPL; CYTOKINE RECEPTOR; SHC PHOSPHORYLATION; GROWTH-FACTOR; DIFFERENTIATION; ACTIVATION; PATHWAY; CELLS	The Janus family of tyrosine kinases (JAKs) plays a critical role in signal transduction by members of the cytokine receptor superfamily. In response to ligand-receptor interaction, these nonreceptor tyrosine kinases are rapidly phosphorylated and activated, triggering tyrosine phosphorylation and activation of downstream signaling intermediates. Upon binding to its receptor, the product of the proto-oncogene c-mpl, thrombopoietin (TPO) activates both JAK2 and TYK2 in multiple cell lines as well as megakaryocytes and platelets. To study whether one or both of these kinases are essential for TPO signal transduction, we engineered a parental human sarcoma cell line (2C4) as well as sarcoma cell lines that are deficient in JAK2 expression (gamma 2A) or TYK2 expression (U1A) to express the wild-type Mpl receptor. The ability of TPO to induce tyrosine phosphorylation of Mpl and multiple intracellular substrates in each cell line was then examined. Our results demonstrate that JAK2-deficient cells (gamma 2A-Mpl) are unable to initiate TPO-mediated signaling. In contrast, cells that are TYK2-deficient (U1A-Mpl) are able to induce tyrosine phosphorylation of Mpl, JAK2, STAT3, and Shc as efficiently as parental cells (2C4-Mpl). These data indicate that JAK2 is an essential component of Mpl signaling and that, in the absence of JAK2, TYK2 is incapable of initiating TPO-induced tyrosine phosphorylation.	Puget Sound Blood Ctr & Program, Div Res, Seattle, WA 98104 USA; Univ Washington, Div Hematol, Seattle, WA 98195 USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle	Drachman, JG (corresponding author), Puget Sound Blood Ctr & Program, Div Res, 921 Terry Ave, Seattle, WA 98104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003498] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL03498-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Alexander WS, 1996, EMBO J, V15, P6531, DOI 10.1002/j.1460-2075.1996.tb01044.x; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Broudy VC, 1996, BLOOD, V88, P2026, DOI 10.1182/blood.V88.6.2026.bloodjournal8862026; COURTOIS G, 1995, J VIROL, V69, P2794, DOI 10.1128/JVI.69.5.2794-2800.1995; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dorsch M, 1997, J EXP MED, V186, P1947, DOI 10.1084/jem.186.12.1947; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; EZUMI Y, 1995, FEBS LETT, V374, P48, DOI 10.1016/0014-5793(95)01072-M; GURNEY AL, 1995, P NATL ACAD SCI USA, V92, P5292, DOI 10.1073/pnas.92.12.5292; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hill RJ, 1996, CELL GROWTH DIFFER, V7, P1125; Ihle JN, 1996, PHILOS T R SOC B, V351, P159, DOI 10.1098/rstb.1996.0012; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jin LQ, 1998, P NATL ACAD SCI USA, V95, P8093, DOI 10.1073/pnas.95.14.8093; KAUSHANSKY K, 1995, P NATL ACAD SCI USA, V92, P3234, DOI 10.1073/pnas.92.8.3234; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; MORELLA KK, 1995, BLOOD, V86, P557, DOI 10.1182/blood.V86.2.557.bloodjournal862557; Morita H, 1996, FEBS LETT, V395, P228, DOI 10.1016/0014-5793(96)01047-2; MU SX, 1995, BLOOD, V86, P4532, DOI 10.1182/blood.V86.12.4532.bloodjournal86124532; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Porteu F, 1996, MOL CELL BIOL, V16, P2473; SATTLER M, 1995, EXP HEMATOL, V23, P1040; SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x; TORTOLANI PJ, 1995, BLOOD, V85, P3444, DOI 10.1182/blood.V85.12.3444.bloodjournal85123444; TWEARDY DJ, 1995, BLOOD, V86, P4409, DOI 10.1182/blood.V86.12.4409.bloodjournal86124409; Yamashita Y, 1997, EXP HEMATOL, V25, P211	30	98	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13480	13484		10.1074/jbc.274.19.13480	http://dx.doi.org/10.1074/jbc.274.19.13480			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224114	hybrid			2022-12-27	WOS:000080200400076
J	Ji, SN; Guan, R; Frank, SJ; Messina, JL				Ji, SN; Guan, R; Frank, SJ; Messina, JL			Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; RAT HEPATOMA-CELLS; RECEPTOR GENE-EXPRESSION; JAK2 TYROSINE KINASE; BINDING-PROTEIN; FACTOR-I; GH RECEPTOR; ERYTHROPOIETIN RECEPTOR; MESSENGER-RNA; IGF-I	Insulin is important for maintaining the responsive ness of the liver to growth hormone (GH). Insulin deficiency results in a decrease in liver GH receptor (GHR) expression, which can be reversed by insulin administration. In osteoblasts, continuous insulin treatment decreases the fraction of cellular GHR localized to the plasma membrane. Thus, it is not clear whether hyperinsulinemia results in an enhancement or inhibition of GH action. We asked whether continuous insulin stimulation, similar to what occurs in hyperinsulinemic states, results in GH resistance. Our present studies suggest that insulin treatment of hepatoma cells results in a time-dependent inhibition of acute GH-induced phosphorylation of STAT5B. Whereas total protein levels of JAK2 were not reduced after insulin pretreatment for 16 h, GH-induced JAK2 phosphorylation was inhibited. There was a concomitant decrease in GH binding and a reduction in immunoreactive GHR levels following pretreatment with insulin for 8-24 h. In summary, continuous insulin treatment in rat H4 hepatoma cells reduces GH binding, immunoreactive GHR, GH-induced phosphorylation of JAK2, and GH-induced tyrosine phosphorylation of STAT5B. These findings suggest that hepatic GH resistance may develop when a patient exhibits chronic hyperinsulinemia, a condition often observed in patients with obesity and in the early stage of Type 2 diabetes.	Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Endocrinol & Metab, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Birmingham Vet Adm Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Messina, JL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Volker Hall,G019,1670 Univ Blvd, Birmingham, AL 35294 USA.	messina@vh.path.uab.edu			NIDDK NIH HHS [DK40456, DK46395] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046395, R01DK040456, R29DK046395, R56DK046395] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Angulo M, 1996, J PEDIATR ENDOCR MET, V9, P393; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; ASAKAWA K, 1986, BIOCHEM J, V238, P379, DOI 10.1042/bj2380379; BAUMANN G, 1995, EXP CLIN ENDOCR DIAB, V103, P2, DOI 10.1055/s-0029-1211322; BAXTER RC, 1980, ENDOCRINOLOGY, V107, P1176, DOI 10.1210/endo-107-4-1176; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; BEREKET A, 1995, J CLIN ENDOCR METAB, V80, P1312, DOI 10.1210/jc.80.4.1312; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Bjorntorp Per, 1997, Human Reproduction (Oxford), V12, P21; BLACKARD WG, 1970, DIABETES, V19, P302, DOI 10.2337/diab.19.5.302; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Cerasi E, 1970, Horm Metab Res, V2, P302; Chen J, 1997, P NATL ACAD SCI USA, V94, P2295, DOI 10.1073/pnas.94.6.2295; Chen NY, 1997, ENDOCRINOLOGY, V138, P1988, DOI 10.1210/en.138.5.1988; CLAYTON KL, 1994, CLIN ENDOCRINOL, V41, P517, DOI 10.1111/j.1365-2265.1994.tb02584.x; Cuneo RC, 1998, J CLIN ENDOCR METAB, V83, P107, DOI 10.1210/jc.83.1.107; DUSANTERFOURT I, 1994, EMBO J, V13, P2583, DOI 10.1002/j.1460-2075.1994.tb06548.x; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P148, DOI 10.1210/en.135.1.148; FRANK SJ, 1995, J BIOL CHEM, V270, P14776, DOI 10.1074/jbc.270.24.14776; Frick GP, 1998, ENDOCRINOLOGY, V139, P2824, DOI 10.1210/en.139.6.2824; GAVIN JR, 1982, ENDOCRINOLOGY, V110, P637, DOI 10.1210/endo-110-2-637; HanaireBroutin H, 1996, DIABETOLOGIA, V39, P1498, DOI 10.1007/s001250050604; HanaireBroutin H, 1996, DIABETES METAB, V22, P245; HO KK, 1996, ENDOCR J, V43, P63; Jiang J, 1998, BIOCHEM BIOPH RES CO, V253, P774, DOI 10.1006/bbrc.1998.9793; Kratzsch J, 1996, CLIN ENDOCRINOL, V44, P673, DOI 10.1046/j.1365-2265.1996.672494.x; KRETT NL, 1987, ENDOCRINOLOGY, V120, P401, DOI 10.1210/endo-120-1-401; LARON Z, 1995, J CLIN ENDOCR METAB, V80, P1526, DOI 10.1210/jc.80.5.1526; Leung KC, 1997, P NATL ACAD SCI USA, V94, P11381, DOI 10.1073/pnas.94.21.11381; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LOBIE PE, 1994, J BIOL CHEM, V269, P21330; LUGER A, 1990, EXP CLIN ENDOCRINOL, V95, P339, DOI 10.1055/s-0029-1210974; MAES M, 1983, DIABETES, V32, P1060, DOI 10.2337/diabetes.32.11.1060; Maheshwari H, 1996, J CLIN ENDOCR METAB, V81, P995, DOI 10.1210/jc.81.3.995; MALHERBE C, 1970, J CLIN ENDOCR METAB, V30, P535, DOI 10.1210/jcem-30-4-535; Martini JF, 1997, J BIOL CHEM, V272, P18951, DOI 10.1074/jbc.272.30.18951; MASSAGUE J, 1982, J BIOL CHEM, V257, P3958; MENON RK, 1992, J CLIN ENDOCR METAB, V74, P934, DOI 10.1210/jc.74.4.934; MENON RK, 1994, J ENDOCRINOL, V142, P453, DOI 10.1677/joe.0.1420453; MERCADO M, 1992, DIABETES, V41, P605, DOI 10.2337/diabetes.41.5.605; MESSINA JL, 1985, AM J PHYSIOL, V249, pE56, DOI 10.1152/ajpendo.1985.249.1.E56; MESSINA JL, 1989, ENDOCRINOLOGY, V124, P754, DOI 10.1210/endo-124-2-754; MESSINA JL, 1985, J BIOL CHEM, V260, P6418; Mullis PE, 1997, MOL CELL ENDOCRINOL, V131, P89, DOI 10.1016/S0303-7207(97)00096-8; Ochoa R, 1995, ARCH MED RES, V26, pS17; Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997; PITOT H, 1963, NATL CANCER I MONOGR, V13, P229; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; SawkaVerhelle D, 1997, EUR J BIOCHEM, V250, P411, DOI 10.1111/j.1432-1033.1997.0411a.x; TOLLET P, 1990, MOL ENDOCRINOL, V4, P1934, DOI 10.1210/mend-4-12-1934; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	57	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13434	13442		10.1074/jbc.274.19.13434	http://dx.doi.org/10.1074/jbc.274.19.13434			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224108	hybrid			2022-12-27	WOS:000080200400070
J	MacNicol, MC; MacNicol, AM				MacNicol, MC; MacNicol, AM			Nerve growth factor-stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES MAP KINASE; NIH 3T3 CELLS; CYCLIC-AMP; PC12 CELLS; ADENOSINE-MONOPHOSPHATE; SUSTAINED ACTIVATION; SIGNAL-TRANSDUCTION; REGULATORY DOMAIN; GENE-EXPRESSION; PHOSPHORYLATION	The cAMP-dependent protein kinase (PKA) exhibits both inhibitory and stimulatory effects upon growth factor signaling mediated by the mitogen-activated protein kinase signaling pathway. PKA has been demonstrated to inhibit Raf-l-mediated cellular proliferation. PKA can both prevent Res-dependent Raf-l activation and directly inhibit Raf-l catalytic activity. In contrast to the inhibitory effect of PKA on Raf-l-dependent processes, PKA potentiates nerve growth factor-stimulated PC12 cell differentiation, a B-Raf mediated process. This potentiation, rather than inhibition, of PC12 cell differentiation is curious in light of the ability of PKA to inhibit Raf-l catalytic activity. The kinase domains of Raf-l and B-Raf are highly conserved, and it has been predicted that B-Raf catalytic activity would also be inhibited by PKA. In this study we examined the ability of PRA to regulate the kinase activity of the B-raf protooncogene, We report that nerve growth factor-stimulated B-Raf activity is not inhibited by PKA. By contrast, an N-terminally truncated, constitutively active form of B-Raf is inhibited by PKA both in vitro and in transfected PC12 cells. These results suggest that the N-terminal regulatory domain interferes with the ability of PRA to modulate B-Raf catalytic activity and provide an explanation for the observed resistance of B-Raf-dependent processes to PKA inhibition.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	MacNicol, AM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	amacnico@medicine.bsd.uchicago.edu			NCI NIH HHS [CA70846] Funding Source: Medline; NIDDK NIH HHS [P60 DK20595-18] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLY S, 1989, CANCER RES, V49, P5650; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; EYCHENE A, 1992, ONCOGENE, V7, P1315; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GARDNER AM, 1994, METHOD ENZYMOL, V238, P258; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; HEIDECKER G, 1992, ADV CANCER RES, V58, P53, DOI 10.1016/S0065-230X(08)60290-0; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; HORDIJK PL, 1994, J BIOL CHEM, V269, P3534; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; MacNicol MC, 1997, GENE, V196, P25, DOI 10.1016/S0378-1119(97)00171-6; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; PERALDI P, 1995, FEBS LETT, V357, P290, DOI 10.1016/0014-5793(94)01376-C; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; PURUSHOTHAM KR, 1994, BIOCHEM BIOPH RES CO, V202, P743, DOI 10.1006/bbrc.1994.1993; RAPP UR, 1991, ONCOGENE, V6, P495; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; RUSSELL M, 1994, MOL CELL BIOL, V14, P2343, DOI 10.1128/MCB.14.4.2343; SCHRAMM K, 1994, BIOCHEM BIOPH RES CO, V201, P740, DOI 10.1006/bbrc.1994.1763; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; STORM SM, 1990, ONCOGENE, V5, P345; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Weissinger EM, 1997, MOL CELL BIOL, V17, P3229, DOI 10.1128/MCB.17.6.3229; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; YOUNG SW, 1994, FEBS LETT, V338, P212, DOI 10.1016/0014-5793(94)80367-6; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	47	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13193	13197		10.1074/jbc.274.19.13193	http://dx.doi.org/10.1074/jbc.274.19.13193			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224075	hybrid			2022-12-27	WOS:000080200400037
J	Tomlinson, MG; Kurosaki, T; Berson, AE; Fujii, GH; Johnston, JK; Bolen, JB				Tomlinson, MG; Kurosaki, T; Berson, AE; Fujii, GH; Johnston, JK; Bolen, JB			Reconstitution of Btk signaling by the atypical Tec family tyrosine kinases Bmx and Txk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE C-GAMMA-2; PREDOMINANT EXPRESSION; MEDIATED ACTIVATION; REGULATED KINASE; GENE; DOMAIN; PHOSPHORYLATION; IDENTIFICATION	Bruton's tyrosine kinase (Btk) is mutated in X-linked agammaglobulinemia patients and plays an essential role in B cell receptor signal transduction, Btk is a member of the Tec family of nonreceptor protein-tyrosine kinases that includes Bmx, Itk, Tec, and Txk. Cell lines deficient for Btk are impaired in phospholipase C-gamma 2 (PLC gamma 2)-dependent signaling. Itk and Tec have recently been shown to reconstitute PLC gamma 2-dependent signaling in Btk-deficient human cells, but it is not knows whether the atypical Tec family members, Bmx and Txk, can reconstitute function. Here we reconstitute Btk-deficient DT40 B cells with Bmx and Txk to compare their function with other Tec kinases, We show that in common with Itk and Tee, Bmx reconstituted PLC gamma 2-dependent responses including calcium mobilization, extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) activation, and apoptosis, Txk also restored PLC gamma 2/calcium signaling but, unlike other Tec kinases, functioned in a phosphatidylinositol 3-kinase-independent manner and failed to reconstitute apoptosis. These results are consistent with a common role for Tec kinases as amplifiers of PLC gamma 2-dependent signal transduction, but suggest that the pleckstrin homology domain of Tec kinases, absent in Txk, is essential for apoptosis.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Cell Signaling, Palo Alto, CA 94304 USA; Kansai Med Univ, Dept Mol Genet, Moriguchi, Osaka 570, Japan	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Kansai Medical University	Tomlinson, MG (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Cell Signaling, 901 Calif Ave, Palo Alto, CA 94304 USA.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Tomlinson, Michael/0000-0002-1189-0091				Afar DEH, 1996, MOL CELL BIOL, V16, P3465; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BURKHARDT AL, 1993, CURRENT PROTOCOLS IM, P1; Debnath J, 1999, MOL CELL BIOL, V19, P1498; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lu YL, 1998, J IMMUNOL, V161, P5404; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MANO H, 1995, BLOOD, V85, P343; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Satterthwaite AB, 1997, P NATL ACAD SCI USA, V94, P13152, DOI 10.1073/pnas.94.24.13152; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SOMMERS CL, 1995, ONCOGENE, V11, P245; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; TANG B, 1994, MOL CELL BIOL, V14, P8432, DOI 10.1128/MCB.14.12.8432; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604	47	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13577	13585		10.1074/jbc.274.19.13577	http://dx.doi.org/10.1074/jbc.274.19.13577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224128	hybrid			2022-12-27	WOS:000080200400090
J	Yanagi, Y; Suzawa, M; Kawabata, M; Miyazono, K; Yanagisawa, J; Kato, S				Yanagi, Y; Suzawa, M; Kawabata, M; Miyazono, K; Yanagisawa, J; Kato, S			Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through Smad proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TUMOR-SUPPRESSOR; MAD PROTEINS; NUCLEAR RECEPTOR; MESSENGER-RNA; ACTIVATION; INDUCTION; CELLS; TRANSCRIPTION; SUPERFAMILY	Several lines of experiments demonstrated the interplay between the transforming growth factor-beta (TGF-beta) and vitamin D signaling pathways. Recently, we found that Smad3, a downstream component of the TGF-beta signaling pathway, potentiates ligand-induced transactivation of vitamin D receptor (VDR) as a coactivator of VDR (Yanagisawa, J,, Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., and Kato, S. (1999) Science 283, 1317-1321). Here, we investigated the roles of inhibitory Smads, Smad6 and Smad7, which are negative regulators of the TGF-beta/bone morphogenetic protein signaling pathway, on the Smad3-mediated potentiation of VDR function. We found that Smad7, but not Smad6, abrogates the Smad3-mediated VDR potentiation. Interaction studies in vivo and in vitro showed that Smad7 inhibited the formation of the VDR-Smad3 complex, whereas Smad6 had no effect. Taken together, our results strongly suggest that the interplay between the TGF-beta and vitamin D signaling pathways is, at least in part, mediated by the two classes of Smad proteins, which modulate VDR transactivation function both positively and negatively.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130034, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 332, Japan; Japanese Fdn Canc Res, Toshima Ku, Tokyo 1708455, Japan; Japan Soc Promot Sci, Res Future Program, Toshima Ku, Tokyo 1708455, Japan; Inst Canc, Dept Biochem, Tokyo 1708455, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Japan Society for the Promotion of Science	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130034, Japan.		Yanagi, Yasuo/AAF-2670-2020					Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; KALEHOVEN E, 1998, EMBO J, V17, P232; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MANGELSDORF DJ, 1998, EMBO J, V17, P507; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Staal A, 1996, ENDOCRINOLOGY, V137, P2001, DOI 10.1210/en.137.5.2001; STAAL A, 1994, BONE MINER, V26, P27, DOI 10.1016/S0169-6009(08)80160-2; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; Takeshita A, 1998, J BIOL CHEM, V273, P14738, DOI 10.1074/jbc.273.24.14738; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; TRORCHIA J, 1997, NATURE, V387, P677; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	32	90	93	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12971	12974		10.1074/jbc.274.19.12971	http://dx.doi.org/10.1074/jbc.274.19.12971			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224044	hybrid			2022-12-27	WOS:000080200400006
J	Chen, CY; Faller, DV				Chen, CY; Faller, DV			Selective inhibition of protein kinase C isozymes by Fas ligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; KAPPA-B ACTIVATION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; RECEPTOR SUPERFAMILY; MOLECULAR-CLONING; SURFACE ANTIGEN; DEATH DOMAIN; CERAMIDE; LYMPHOCYTES	Activation of protein kinase C (PKC) can protect cells from apoptosis induced by various agents, including Fas ligation. To elucidate a possible interaction between Fas-mediated apoptotic signals and activation-related protective signals, we investigated the impact of Fas ligation on PKC activity. We demonstrate that engagement of Fas on human lymphoid Jurkat cells triggered apoptosis, and Fas ligation resulted in partial blockade of cellular PKC activity. The phorbol 12-myristate 13-acetate-mediated translocation of PKC theta from the cytoplasm to the membrane was inhibited by treatment with anti-Fas antibody, whereas the translocation of PKC alpha or epsilon was not affected. In vitro kinase assay of PKC alpha or epsilon phosphotransferase activity demonstrated that Fas ligation inhibited the ability of PKC alpha to phosphorylate histone H1 as substrate but did not inhibit epsilon isozyme activity. This inhibition of PKC alpha activity mediated by Fas ligation was reversed by okadaic acid, a phosphatase inhibitor, suggesting the involvement of a member of the protein phosphatase 2A subfamily in this component of Fas signaling, Identical patterns of PKC isozyme inhibition were obtained using mouse thymoma cells over-expressing the fog gene (LF(+)), These results suggest that the selective inhibition of a potentially protective, PKC-mediated pathway by Fas activation may, to some extent, contribute to Fas-induced apoptotic signaling.	Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Faller, DV (corresponding author), Boston Univ, Sch Med, Canc Res Ctr, 80 E Concord St K-701, Boston, MA 02118 USA.				NATIONAL CANCER INSTITUTE [R01CA050459] Funding Source: NIH RePORTER; NCI NIH HHS [CA50459] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; CHEN CY, 1995, ONCOGENE, V11, P1487; Chen CY, 1998, J BIOL CHEM, V273, P16700, DOI 10.1074/jbc.273.27.16700; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COWLING GJ, 1994, PHILOS T ROY SOC B, V345, P257, DOI 10.1098/rstb.1994.0103; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; EASTMAN A, 1994, CANCER RES, V54, P2812; Emoto Y, 1996, BLOOD, V87, P1990; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Gamard CJ, 1997, J BIOL CHEM, V272, P16474, DOI 10.1074/jbc.272.26.16474; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Gubina E, 1998, BLOOD, V91, P823, DOI 10.1182/blood.V91.3.823.823_823_829; Gulbins E, 1998, J LEUKOCYTE BIOL, V63, P253, DOI 10.1002/jlb.63.2.253; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JONES MJ, 1995, J BIOL CHEM, V270, P5007, DOI 10.1074/jbc.270.10.5007; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KIM MY, 1991, J BIOL CHEM, V266, P484; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; KOVACS B, 1995, J IMMUNOL, V155, P5543; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; Meller N, 1996, MOL CELL BIOL, V16, P5782; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; RAJOTTE D, 1992, J BIOL CHEM, V267, P9980; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Sawai H, 1997, J BIOL CHEM, V272, P2452; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith BL, 1996, J BIOL CHEM, V271, P16753, DOI 10.1074/jbc.271.28.16753; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TOMEI LD, 1988, BIOCHEM BIOPH RES CO, V155, P324, DOI 10.1016/S0006-291X(88)81088-X; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WHELAN RD, ONCOGENE, V16, P1939; WOLFF RA, 1994, J BIOL CHEM, V269, P19605	60	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15320	15328		10.1074/jbc.274.22.15320	http://dx.doi.org/10.1074/jbc.274.22.15320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336417	hybrid			2022-12-27	WOS:000080560100006
J	Lopes, LR; Hoyal, CR; Knaus, UG; Babior, BM				Lopes, LR; Hoyal, CR; Knaus, UG; Babior, BM			Activation of the leukocyte NADPH oxidase by protein kinase C in a partially recombinant cell-free system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; CHRONIC GRANULOMATOUS-DISEASE; DEPENDENT SUPEROXIDE PRODUCTION; SODIUM DODECYL-SULFATE; GTP-BINDING PROTEIN; HUMAN-NEUTROPHILS; ANIONIC AMPHIPHILE; PHOSPHORYLATION; TRANSLOCATION; COMPONENTS	The leukocyte NADPH oxidase is an enzyme present in phagocytes and B lymphocytes that when activated catalyzes the production of O-2(radical anion) from oxygen at the expense of NADPH. A correlation between the activation of the oxidase and the phosphorylation of p47(PHOX), a cytosolic oxidase component, is well recognized in whole cells, and direct evidence for a relationship between the phosphorylation of this oxidase component and the activation of the oxidase has been obtained in a number of cell-free systems containing neutrophil membrane and cytosol. Using superoxide dismutase-inhibitable cytochrome c reduction to quantify O-2(radical anion) production, we now show that p47(PHOX) phosphorylated by protein kinase C activates the NADPH oxidase not only in a cell-free system containing neutrophil membrane and cytosol, but also in a system in which the cytosol is replaced by the recombinant proteins p67(PHOX), Rac2, and phosphorylated p47(PHOX), suggesting that neutrophil plasma membrane plus those three cytosolic proteins are both necessary and sufficient for oxidase activation. In both the cytosol-containing and recombinant cell-free systems, however, activation by SDS yielded greater rates of O-2(radical anion) production than activation by protein kinase C-phosphorylated p47PHOX, indicating that a system that employs protein kinase C-phosphorylated p47PHOX as the sole activating agent, although more physiological than the SDS-activated system, is nevertheless incomplete.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Lopes, LR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.		Lopes, Lucia R/B-9063-2012	Lopes, Lucia R/0000-0003-0530-7805	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028479, R37AI024227, R01AI024227] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00833] Funding Source: Medline; NIAID NIH HHS [AI-24227, AI-28479] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1992, J BIOL CHEM, V267, P16767; BABIOR BM, 1984, CLIN RES, V32, pA550; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; BROMBERG Y, 1994, J BIOL CHEM, V269, P7055; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; ElBenna J, 1995, BLOOD CELL MOL DIS, V21, P201, DOI 10.1006/bcmd.1995.0023; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HAYAKAWA T, 1986, J BIOL CHEM, V261, P9109; HEYWORTH PG, 1990, BIOCHIM BIOPHYS ACTA, V1052, P299, DOI 10.1016/0167-4889(90)90225-3; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; IYER SS, 1994, J BIOL CHEM, V269, P22405; KLEINBERG ME, 1990, J BIOL CHEM, V265, P15577; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1991, J BIOL CHEM, V266, P19812; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MCPHAIL LC, 1995, P NATL ACAD SCI USA, V92, P7931, DOI 10.1073/pnas.92.17.7931; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; PARK JW, 1994, BIOCHEMISTRY-US, V33, P2907, DOI 10.1021/bi00176a021; PARK JW, 1992, J BIOL CHEM, V267, P17327; Park JW, 1997, J BIOL CHEM, V272, P11035; QUINN MT, 1993, J BIOL CHEM, V268, P20983; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMEYA A, 1993, FEBS LETT, V330, P215, DOI 10.1016/0014-5793(93)80276-Z; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; TOUBIN HT, 1979, P NATL ACAD SCI USA, V76, P4350; Tsunawaki S, 1996, J EXP MED, V184, P893, DOI 10.1084/jem.184.3.893; TYAGI SR, 1992, BIOCHEMISTRY-US, V31, P2765, DOI 10.1021/bi00125a017	37	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15533	15537		10.1074/jbc.274.22.15533	http://dx.doi.org/10.1074/jbc.274.22.15533			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336447	hybrid			2022-12-27	WOS:000080560100036
J	Rulli, SJ; Horiba, MN; Skripnikova, E; Rabon, EC				Rulli, SJ; Horiba, MN; Skripnikova, E; Rabon, EC			Glu-857 moderates K+-dependent stimulation and SCH 28080-dependent inhibition of the gastric H,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCE; CATION-BINDING-SITE; SARCOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; TRANSMEMBRANE DOMAIN; MEMBRANE TOPOLOGY; H+/K+-ATPASE	The rabbit H,K-ATPase alpha- and beta-subunits were transiently expressed in HEK293 T cells. The co-expression of the H,K-ATPase alpha- and P-subunits was essential for the functional H,K-ATPase. The K+-stimulated H,K-ATPase activity of 0.82 +/- 0.2 mu mol/mg/h saturated with a K-0.5 (KCI) of 0.6 +/- 0.1 mM, whereas the 2-methyl-8-(phenylmethoxy)imidazo[1,2a]pyridine-3-acetonitrile (SCH 28080)-inhibited ATPase of 0.62 +/- 0.07 mu mol/mg/h saturated with a K-i (SCH 28080) of 1.0 +/- 0.3 mu M. Site mutations were introduced at the N,N-dicyclohexylcarbodiimide-reactive residue, Glu-857, to evaluate the role of this residue in ATPase function, Variations in the side chain size and charge of this residue did not inhibit the specific activity of the H,K-ATPase, but reversal of the side chain charge by substitution of Lys or Arg for Glu produced a reciprocal change in the sensitivity of the H,K-ATPase to K+ and SCH 28080. The K-0.5 for K+ stimulated ATPase was decreased to 0.2 +/- .05 and 0.2 +/- .03 mM, respectively, in Lys-857 and Arg-857 site mutants, whereas the K-i for SCH 28080-dependent inhibition was increased to 6.5 +/- 1.4 and 5.9 +/- 1.5 mu M, respectively. The H,K-ATPase kinetics were unaffected by the introduction of Ala at this site, but Leu produced a modest reciprocal effect. These data indicate that Glu-857 is not an essential residue for cation dependent activity but that the residue influences the kinetics of both K+ and SCH 28080-mediated functions. This finding suggests a possible role of this residue in the conformational equilibrium of the H,K-ATPase.	Tulane Univ, Med Ctr, Dept Physiol, New Orleans, LA 70112 USA; Dept Vet Affairs, New Orleans, LA 70112 USA	Tulane University	Rabon, EC (corresponding author), Tulane Univ, Med Ctr, Dept Physiol, SL39,1430 Tulane Ave, New Orleans, LA 70112 USA.							ARGUELLO JM, 1991, J BIOL CHEM, V266, P14627; ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; ARGUELLO JM, 1995, J BIOL CHEM, V270, P22764, DOI 10.1074/jbc.270.39.22764; Arguello JM, 1996, J BIOL CHEM, V271, P24610, DOI 10.1074/jbc.271.40.24610; Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; BAMBERG K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P69, DOI 10.1016/0167-4781(92)90100-E; BAYLE D, 1995, J BIOL CHEM, V270, P25678, DOI 10.1074/jbc.270.43.25678; Bayle D, 1997, J RECEPT SIGNAL TR R, V17, P29, DOI 10.3109/10799899709036593; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beggah AT, 1997, J BIOL CHEM, V272, P10318; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CROWSON MS, 1992, J BIOL CHEM, V267, P13740; DEANCOS JG, 1988, BIOCHEMISTRY-US, V27, P1793; FENG JN, 1995, CELL MOL BIOL RES, V41, P29; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; GOLDSHLEGER R, 1992, P NATL ACAD SCI USA, V89, P6911, DOI 10.1073/pnas.89.15.6911; GORGA FR, 1985, BIOCHEMISTRY-US, V24, P6783, DOI 10.1021/bi00345a009; GRISHIN AV, 1994, FEBS LETT, V349, P144, DOI 10.1016/0014-5793(94)00655-5; HALL K, 1991, BIOCHIM BIOPHYS ACTA, V1077, P173, DOI 10.1016/0167-4838(91)90055-5; JAISSER F, 1993, J CELL BIOL, V123, P1421, DOI 10.1083/jcb.123.6.1421; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; Klaassen CHW, 1997, BIOCHEM J, V321, P419, DOI 10.1042/bj3210419; Klaassen CHW, 1997, ANN NY ACAD SCI, V834, P101, DOI 10.1111/j.1749-6632.1997.tb52230.x; Kone BC, 1998, J BIOL CHEM, V273, P2543, DOI 10.1074/jbc.273.5.2543; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE HC, 1978, BIOCHIM BIOPHYS ACTA, V508, P339, DOI 10.1016/0005-2736(78)90336-X; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; MERCIER F, 1991, FASEB J, V5, pA749; NEWMAN PR, 1990, DNA CELL BIOL, V9, P749, DOI 10.1089/dna.1990.9.749; OKAMOTO CT, 1990, BIOCHIM BIOPHYS ACTA, V1037, P360, DOI 10.1016/0167-4838(90)90038-H; PEDEMONTE CH, 1986, J BIOL CHEM, V261, P6660; PICK U, 1979, BIOCHEMISTRY-US, V18, P108, DOI 10.1021/bi00568a017; RABON EC, 1993, J BIOL CHEM, V268, P8012; Rabon EC, 1996, J BIOL CHEM, V271, P32137, DOI 10.1074/jbc.271.50.32137; RABON EC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P277, DOI 10.1016/0167-4838(90)90260-M; RABON EC, 1990, J BIOL CHEM, V265, P1594; SACHS G, 1976, J BIOL CHEM, V251, P7690; SHAINSKAYA A, 1994, J BIOL CHEM, V269, P10780; Shainskaya A, 1998, J BIOL CHEM, V273, P7311, DOI 10.1074/jbc.273.13.7311; SHIN JM, 1994, J BIOL CHEM, V269, P22533; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; VANHUYSSE JW, 1993, BIOCHEMISTRY-US, V32, P819, DOI 10.1021/bi00054a012; VANHUYSSE JW, 1993, CELL MOL BIOL RES, V39, P497; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	58	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15245	15250		10.1074/jbc.274.21.15245	http://dx.doi.org/10.1074/jbc.274.21.15245			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329734	hybrid			2022-12-27	WOS:000081965200099
J	Rumbaugh, JA; Henricksen, LA; DeMott, MS; Bambara, RA				Rumbaugh, JA; Henricksen, LA; DeMott, MS; Bambara, RA			Cleavage of substrates with mismatched nucleotides by flap endonuclease-1 - Implications for mammalian Okazaki fragment processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 DNA-REPLICATION; BASE EXCISION-REPAIR; SINGLE-STRANDED-DNA; CALF RTH-1 NUCLEASE; SIMIAN VIRUS-40 DNA; 3' EXONUCLEASE; SCHIZOSACCHAROMYCES-POMBE; PURIFIED PROTEINS; POLYMERASE-ALPHA; YEAST	Flap endonuclease-l (FEN1) is proposed to participate in removal of the initiator RNA of mammalian Okazaki fragments by two pathways. In one pathway, RNase HI removes most of the RNA, leaving a single ribonucleotide adjacent to the DNA FEN1 removes this ribonucleotide exonucleolytically. In the other pathway, FEN1 removes the entire primer endonucleolytically after displacement of the 5'-end region of the Okazaki fragment. Cleavage would occur beyond the RNA, a short distance into the DNA, The initiator RNA and an adjacent short region of DNA are synthesized by DNA polymerase alpha/primase. Because the fidelity of DNA polymerase a is lower than that of the DNA polymerases that complete DNA extension, mismatches occur relatively frequently near the 5'-ends of Okazaki fragments. We have examined the ability of FEN1 to repair such errors. Results show that mismatched bases up to 15 nucleotides from the 5'-end of an annealed DNA strand change the pattern of FEN1 cleavage. Instead of removing terminal nucleotides sequentially, FEN1 appears to cleave a portion of the mismatched strand endonucleolytically. We propose that a mismatch destabilizes the helical structure over a nearby area. This allows FEN1 to cleave more efficiently, facilitating removal of the mismatch. If mismatches were not introduced during synthesis of the Okazaki fragment, helical disruption would not occur, nor would unnecessary degradation of the 5'-end of the fragment.	Univ Rochester, Sch Med & Dent, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Med Ctr, Dept Biochem & Biophys, Box 712,601 Elmwood Ave, Rochester, NY 14642 USA.				NCI NIH HHS [CA11198] Funding Source: Medline; NIGMS NIH HHS [GM24441, GM18961] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA011198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Frank P, 1998, FEBS LETT, V421, P23, DOI 10.1016/S0014-5793(97)01528-7; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; FRIEDBERG EC, 1996, DNA REPLICATION EUKA; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HIRAOKA LR, 1995, GENOMICS, V25, P220, DOI 10.1016/0888-7543(95)80129-A; Huang L, 1996, BIOCHEMISTRY-US, V35, P9266, DOI 10.1021/bi9603074; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; Lehmann AR, 1996, MUTAT RES-DNA REPAIR, V363, P147, DOI 10.1016/0921-8777(96)00017-1; LINDAHL T, 1995, PHILOS T ROY SOC B, V347, P57, DOI 10.1098/rstb.1995.0009; LONGLEY MJ, 1990, NUCLEIC ACIDS RES, V18, P7317, DOI 10.1093/nar/18.24.7317; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; NETHANEL T, 1992, J VIROL, V66, P6634, DOI 10.1128/JVI.66.11.6634-6640.1992; PERRINO FW, 1990, BIOCHEMISTRY-US, V29, P5526; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; ROBERTS JD, 1991, P NATL ACAD SCI USA, V88, P3465, DOI 10.1073/pnas.88.8.3465; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Sambrook J., 2002, MOL CLONING LAB MANU; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TURCHI JJ, 1993, J BIOL CHEM, V268, P15136; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, J BIOL CHEM, V269, P10923; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	44	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14602	14608		10.1074/jbc.274.21.14602	http://dx.doi.org/10.1074/jbc.274.21.14602			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329652	hybrid			2022-12-27	WOS:000081965200017
J	Krichevsky, AM; Metzer, E; Rosen, H				Krichevsky, AM; Metzer, E; Rosen, H			Translational control of specific genes during differentiation of HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; MESSENGER-RNA; RIBOSOMAL-RNA; 7SL RNA; EXPRESSION; PROTEIN; SEQUENCES; REPRESSION; FERRITIN; DOMAIN	Eukaryotic gene expression can be regulated through selective translation of specific mRNA species. Nevertheless, the limited number of known examples hampers the identification of common mechanisms that regulate translation of specific groups of genes in mammalian cells. We developed a method to identify translationally regulated genes. This method was used to examine the regulation of protein synthesis in HL-60 cells undergoing monocytic differentiation. A partial screening of cellular mRNAs identified five mRNAs whose translation was specifically inhibited and five others that were activated as was indicated by their mobilization onto polysomes, The specifically inhibited mRNAs encoded ribosomal proteins, identified as members of the 5'-terminal oligopyrimidine tract mRNA family. Most of the activated transcripts represented uncharacterized genes. The most actively mobilized transcript (termed TA-40) was an untranslated 1.3-kilobase polyadenylated RNA with unusual structural features, including two Alu-like elements. Following differentiation, a significant change in the cytoplasmic distribution of Alu-containing mRNAs was observed, namely, the enhancement of Alu-containing mRNAs in the polysomes. Our findings support the notion that protein synthesis is regulated during differentiation of HL-60 cells by both global and gene-specific mechanisms and that Alu-like sequences within cytoplasmic mRNAs are involved in such specific regulation.	Hebrew Univ Jerusalem, Fac Med, Dept Mol Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Rosen, H (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Mol Virol, POB 12272, IL-91120 Jerusalem, Israel.	hrose@md2.huji.ac.il		Krichevsky, Anna/0000-0002-5080-5507				AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; BERNSTEIN J, 1995, J BIOL CHEM, V270, P10559, DOI 10.1074/jbc.270.18.10559; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Chang DY, 1997, NUCLEIC ACIDS RES, V25, P1117, DOI 10.1093/nar/25.6.1117; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOU CC, 1986, MOL CELL BIOL, V6, P566, DOI 10.1128/MCB.6.2.566; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Fan XHC, 1997, GENE DEV, V11, P2557, DOI 10.1101/gad.11.19.2557; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HOFFMANLIEBERMANN B, 1981, DEV BIOL, V81, P255, DOI 10.1016/0012-1606(81)90289-X; HOWARD B H, 1990, New Biologist, V2, P759; IMATAKA H, 1994, J BIOL CHEM, V269, P20668; Jackson RJ, 1991, TRANSLATION EUKARYOT, P193; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIANG P, 1995, CURRENT PROTOCOLS MO; LORENI F, 1992, NUCLEIC ACIDS RES, V20, P1859, DOI 10.1093/nar/20.8.1859; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; MATTIA E, 1986, J BIOL CHEM, V261, P4587; MATTIA E, 1989, P NATL ACAD SCI USA, V86, P1801, DOI 10.1073/pnas.86.6.1801; MELEFORS O, 1993, BIOESSAYS, V15, P85, DOI 10.1002/bies.950150203; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MEYUHAS O, 1987, MOL CELL BIOL, V7, P2691, DOI 10.1128/MCB.7.8.2691; Meyuhas Oded, 1996, V30, P363; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; ROSEN H, 1989, DEV BRAIN RES, V46, P123, DOI 10.1016/0165-3806(89)90149-1; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ryoo HM, 1997, J CELL BIOCHEM, V64, P106, DOI 10.1002/(SICI)1097-4644(199701)64:1<106::AID-JCB13>3.0.CO;2-J; SAKAMOTO K, 1991, J BIOL CHEM, V266, P3031; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Spahn CMT, 1996, J BIOL CHEM, V271, P32857, DOI 10.1074/jbc.271.51.32857; STRAUSS WM, 1995, CURRENT PROTOCOLS MO; THOMAS G, 1986, J CELL BIOL, V103, P2137, DOI 10.1083/jcb.103.6.2137; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Tranque P, 1998, P NATL ACAD SCI USA, V95, P12238, DOI 10.1073/pnas.95.21.12238; TSIFTSOGLOU AS, 1985, INT J CELL CLONING, V3, P349, DOI 10.1002/stem.5530030602; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; VIDAL F, 1993, P NATL ACAD SCI USA, V90, P208, DOI 10.1073/pnas.90.1.208; WICKERS M, 1996, TRANSLATIONAL CONTRO, P433; WINZEN R, 1992, J IMMUNOL, V148, P3454; YENOFSKY R, 1982, BIOCHEMISTRY-US, V21, P3909, DOI 10.1021/bi00260a001; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090	51	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14295	14305		10.1074/jbc.274.20.14295	http://dx.doi.org/10.1074/jbc.274.20.14295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318851	hybrid			2022-12-27	WOS:000080322200080
J	Zhou, TQ; Rosen, BP				Zhou, TQ; Rosen, BP			Asp(45) is a Mg2+ ligand in the ArsA ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-TRANSLOCATING ATPASE; NUCLEOTIDE-BINDING SITE; AZOTOBACTER-VINELANDII; CATALYTIC SUBUNIT; GTP-BINDING; PROTEIN; COMPLEX; PUMP; COORDINATION; MUTAGENESIS	The ATPase activity of ArsA, the catalytic subunit of the plasmid-encoded, ATP-dependent extrusion pump for arsenicals and antimonials in Escherichia coli, is allosterically activated by arsenite or antimonite. Magnesium is essential for ATPase activity. To examine the role of Asp(45) mutants were constructed in which Asp(45) was changed to Glu, Asn, or Ale. Cells expressing these mutated arsA genes lost arsenite resistance to varying degrees. Purified D45A and D45N enzymes were inactive, The purified D45E enzyme exhibited approximately 5% of the wild type activity with about a 5-fold decrease in affinity for Mg2+. Intrinsic tryptophan fluorescence was used to probe Mg2+ binding. ArsA containing only Trp(159) exhibited fluorescence enhancement upon the addition of MgATP, which was absent in D45N and D45A. As another measure of conformation, limited trypsin digestion was used to estimate the surface accessibility of residues in ArsA. ATP and Sb(III) synergistically protected wild type ArsA from trypsin digestion. Subsequent addition of Mg2+ increased trypsin sensitivity. D45N and D45A remained protected by ATP and Sb(III) but lost the Mg2+ effect. D45E exhibited an intermediate Mg2+ response. These results indicate that Asp(45) is a Mg2+-responsive residue, consistent with its function as a Mg2+ ligand.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.		Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Rosen, Barry P./0000-0002-5230-4271	NIGMS NIH HHS [GM55424] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN CM, 1986, J BIOL CHEM, V261, P5030; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; DEY S, 1994, ARCH BIOCHEM BIOPHYS, V311, P418, DOI 10.1006/abbi.1994.1256; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HARMARK K, 1992, BIOCHEMISTRY-US, V31, P7367, DOI 10.1021/bi00147a022; HSU CM, 1989, J BIOL CHEM, V264, P17349; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KAUR P, 1992, J BIOL CHEM, V267, P19272; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Li JX, 1996, J BIOL CHEM, V271, P25247, DOI 10.1074/jbc.271.41.25247; Miller J.H., 1992, SHORT COURSE BACTERI, P150; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Sambrook J., 2002, MOL CLONING LAB MANU; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weber J, 1998, BIOCHEMISTRY-US, V37, P608, DOI 10.1021/bi972370e; Xu C, 1998, J BIOCHEM-TOKYO, V123, P16; ZHOU TQ, 1995, BIOCHEMISTRY-US, V34, P13622, DOI 10.1021/bi00041a042; Zhou TQ, 1997, J BIOL CHEM, V272, P19731, DOI 10.1074/jbc.272.32.19731	23	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13854	13858		10.1074/jbc.274.20.13854	http://dx.doi.org/10.1074/jbc.274.20.13854			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318792	hybrid			2022-12-27	WOS:000080322200021
J	Brower, CS; Shilatifard, A; Mather, T; Kamura, T; Takagi, Y; Haque, D; Treharne, A; Foundling, SI; Conaway, JW; Conaway, RC				Brower, CS; Shilatifard, A; Mather, T; Kamura, T; Takagi, Y; Haque, D; Treharne, A; Foundling, SI; Conaway, JW; Conaway, RC			The Elongin B ubiquitin homology domain - Identification of Elongin B sequences important for interaction with Elongin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTION FACTOR-SIII; NUCLEAR-PORE COMPLEX; MOLECULAR-CLONING; FACTOR-EPSILON; ELONGATION; BINDING; GENE; DEGRADATION	Mammalian Elongin B is a 118-amino acid protein composed of an 84-amino acid amino-terminal ubiquitin-like domain and a 34-amino acid carboxyl-terminal tail. Elongin B is found in cells as a subunit of the heterodimeric Elongin BC complex, which was originally identified as a positive regulator of RNA polymerase II elongation factor Elongin A and subsequently as a component of the multiprotein von Hippel-Lindau tumor suppressor and suppressor of cytokine signaling complexes, As part of our effort to understand how the Elongin BC complex regulates the activity of Elongin A, we are characterizing Elongin B functional domains, In this report, we show that the Elongin B ubiquitin-like domain is necessary and sufficient for interaction with Elongin C and for positive regulation of Elongin A transcriptional activity. In addition, by site-directed mutagenesis of the Elongin B ubiquitin-like domain, we identify a short Elongin B region that is important for its interaction with Elongin C, Finally, we observe that both the ubiquitin-like domain and carboxyl-terminal tail are conserved in Drosophila melanogaster and Caenorhabditis elegans Elongin B homologs that efficiently substitute for mammalian Elongin B in reconstitution of the transcriptionally active Elongin ABC complex, suggesting that the carboxyl-terminal tail performs an additional function not detected in our assays.	Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63104 USA; Oklahoma Med Res Fdn, Program Cardiovasc Biol, Oklahoma City, OK 73104 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Saint Louis University; Oklahoma Medical Research Foundation; Stanford University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Conaway, RC (corresponding author), Oklahoma Med Res Fdn, Program Mol & Cell Biol, 825 Ne 13Th St, Oklahoma City, OK 73104 USA.			Conaway, Joan/0000-0002-2786-0663	NIGMS NIH HHS [GM41628] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 1997, BIOCHEM BIOPH RES CO, V241, P334, DOI 10.1006/bbrc.1997.7819; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; CONAWAY JW, 1992, J BIOL CHEM, V267, P10142; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; PETERSON MG, 1991, NATURE, V354, P369; Rao-Naik C, 1998, J BIOL CHEM, V273, P34976, DOI 10.1074/jbc.273.52.34976; Sambrook J., 2002, MOL CLONING LAB MANU; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562; TAN SY, 1994, BIOTECHNIQUES, V16, P824; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	36	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13629	13636		10.1074/jbc.274.19.13629	http://dx.doi.org/10.1074/jbc.274.19.13629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224134	hybrid			2022-12-27	WOS:000080200400096
J	De la Cerda, B; Diaz-Quintana, A; Navarro, JA; Hervas, M; De la Rosa, MA				De la Cerda, B; Diaz-Quintana, A; Navarro, JA; Hervas, M; De la Rosa, MA			Site-directed mutagenesis of cytochrome c(6) from Synechocystis sp. PCC6803 - The heme protein possesses a negatively charged area that may be isofunctional with the acidic patch of plastocyanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; PHOTOSYSTEM-I; SPINACH PLASTOCYANIN; REACTION-MECHANISM; CRYSTAL-STRUCTURE; FLASH-PHOTOLYSIS; CYANOBACTERIUM; PCC-6803; MUTANT	This paper reports the first site-directed mutagenesis analysis of any cytochrome c(6), a heme protein that performs the same function as the copper-protein plastocyanin in the electron transport chain of photosynthetic organisms. Photosystem I reduction by the mutants of cytochrome c(6) from the cyanobacterium Synechocystis sp, PCC 6803 has been studied by laser flash absorption spectroscopy. Their kinetic efficiency and thermodynamic properties have been compared with those of plastocyanin mutants from the same organism. Such a comparative study reveals that aspartates at positions 70 and 72 in cytochrome c(6) are located in an acidic patch that may be isofunctional with the well known "south-east" patch of plastocyanin, Calculations of surface electrostatic potential distribution in the mutants of cytochrome c(6) and plastocyanin indicate that the changes in protein reactivity depend on the surface electrostatic potential pattern rather than on the net charge modification induced by mutagenesis, Phe-64, which is close to the heme group and may be the counterpart of Tyr-83 in plastocyanin, does not appear to be involved in the electron transfer to photosystem I, In contrast, Arg-67, which is at the edge of the cytochrome c(6) acidic area, seems to be crucial for the interaction with the reaction center.	Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Ctr Isla Cartuja, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC)	De la Rosa, MA (corresponding author), Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Amer Vespucio S-N, Seville 41092, Spain.		Hervas, Manuel/K-9279-2014; De la Rosa, Miguel/B-2545-2014; Díaz-Quintana, Antonio/A-1946-2011; navarro, jose a/B-6354-2015; De la cerda, Berta/L-7039-2014	Hervas, Manuel/0000-0003-4523-8891; De la Rosa, Miguel/0000-0003-1187-5737; Díaz-Quintana, Antonio/0000-0001-8973-8009; navarro, jose a/0000-0002-0536-6074; De la cerda, Berta/0000-0001-5603-6473				CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; DelaCerda B, 1997, BIOCHEMISTRY-US, V36, P10125, DOI 10.1021/bi9708601; DIAZ A, 1994, EUR J BIOCHEM, V222, P1001, DOI 10.1111/j.1432-1033.1994.tb18951.x; FRAZAO C, 1995, STRUCTURE, V3, P1159, DOI 10.1016/S0969-2126(01)00252-0; GIAMMONA DA, 1984, THESIS U CALIFORNIA; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P4947, DOI 10.1093/nar/18.16.4947; HAEHNEL W, 1994, EMBO J, V13, P1028, DOI 10.1002/j.1460-2075.1994.tb06351.x; HERVAS M, 1994, BBA-BIOENERGETICS, V1184, P235, DOI 10.1016/0005-2728(94)90228-3; Hervas M, 1996, BIOCHEMISTRY-US, V35, P2693, DOI 10.1021/bi951876z; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; HERVAS M, 1993, FEBS LETT, V319, P257, DOI 10.1016/0014-5793(93)80558-C; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Kannt A, 1996, BBA-BIOENERGETICS, V1277, P115, DOI 10.1016/S0005-2728(96)00090-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MODI S, 1992, BIOCHIM BIOPHYS ACTA, V1102, P85, DOI 10.1016/0005-2728(92)90068-D; MODI S, 1992, BIOCHIM BIOPHYS ACTA, V1101, P64, DOI 10.1016/0167-4838(92)90467-R; Navarro JA, 1997, J BIOL INORG CHEM, V2, P11, DOI 10.1007/s007750050101; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NORDLING M, 1991, FEBS LETT, V291, P327, DOI 10.1016/0014-5793(91)81313-W; PEARLMAN PA, 1995, AMBER 4 1; Romero A, 1998, J MOL BIOL, V275, P327, DOI 10.1006/jmbi.1997.1455; Sebban-Kreuzer C, 1998, BIOCHEMISTRY-US, V37, P8331, DOI 10.1021/bi980142u; Sigfridsson K, 1996, BIOCHEMISTRY-US, V35, P1249, DOI 10.1021/bi9520141; Ullmann GM, 1997, BIOCHEMISTRY-US, V36, P16187, DOI 10.1021/bi971241v; Ullmann GM, 1997, J AM CHEM SOC, V119, P42, DOI 10.1021/ja962237u; WATKINS JA, 1994, PROTEIN SCI, V3, P2104, DOI 10.1002/pro.5560031124	27	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13292	13297		10.1074/jbc.274.19.13292	http://dx.doi.org/10.1074/jbc.274.19.13292			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224089	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000080200400051
J	Kachnic, LA; Wu, B; Wunsch, H; Mekeel, KL; DeFrank, JS; Tang, W; Powell, SN				Kachnic, LA; Wu, B; Wunsch, H; Mekeel, KL; DeFrank, JS; Tang, W; Powell, SN			The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; V(D)J RECOMBINATION; IONIZING-RADIATION; ATAXIA-TELANGIECTASIA; CHECKPOINT PATHWAY; KU-AUTOANTIGEN; G(1) ARREST; KINASE; MUTATION	scid mouse embryonic fibroblasts are deficient in DNA-dependent protein kinase activity due to a mutation in the C-terminal domain of the catalytic subunit (DNA-PKcs). when exposed to ionizing radiation, the increase in levels of p53 was the same as in normal mouse embryonic fibroblasts. However, the rise in p21(WAF1/cip1) and mdma was found to be delayed and attenuated, which ;correlated in time with delayed onset of G(1)/S arrest by now cytometric analysis. The p53-dependent G(1) checkpoint was not eliminated: inactivation of p53 by the E6 protein in scid cells resulted in the complete loss of detectable G(1)/S arrest after DNA damage, Immunofluorescence analysis of normal cells revealed p53 to be localized predominantly within the cytoplasm prior to irradiation and then translocate to the nucleus after irradiation. In contrast, scid cells show abnormal accumulation of p53 in the nucleus independent of irradiation, which was confirmed by immunoblot analysis of nuclear lysates. Taken together, these data suggest that loss of DNA-PK activity appears to attenuate the kinetics of p53 to activate downstream genes, implying that DNA-PK plays a role in post-translational modification of p53, without affecting the increase in levels of p53 in response to DNA damage.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Lab Mol & Cellular Radiat Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Powell, SN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Lab Mol & Cellular Radiat Biol, Cox 302,100 Blossom St, Boston, MA 02114 USA.				NCI NIH HHS [CA58985] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058985] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BUDACH W, 1992, CANCER RES, V52, P6292; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chernov MV, 1998, P NATL ACAD SCI USA, V95, P2284, DOI 10.1073/pnas.95.5.2284; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Danska JS, 1996, MOL CELL BIOL, V16, P5507; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCELLA M, 1993, ONCOGENE, V8, P1519; FRIED LM, 1996, P NATL ACAD SCI USA, V93, P17382; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GANNON JV, 1991, NATURE, V349, P802; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Gurley KE, 1996, CARCINOGENESIS, V17, P2537, DOI 10.1093/carcin/17.12.2537; Haapajarvi T, 1997, MOL CELL BIOL, V17, P3074, DOI 10.1128/MCB.17.6.3074; HARPER JW, 1993, CELL, V75, P805; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; Huang LC, 1996, CANCER RES, V56, P2940; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Isaacs JS, 1997, CANCER RES, V57, P2986; Jackson SP, 1997, INT J BIOCHEM CELL B, V29, P935, DOI 10.1016/S1357-2725(97)00006-X; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Jongmans W, 1996, ONCOGENE, V13, P1133; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1993, ENVIRON HEALTH PERSP, V101, P55, DOI 10.2307/3431842; KASTAN MB, 1991, CANCER RES, V51, P6304; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LITTLE JB, 1968, NATURE, V218, P1064, DOI 10.1038/2181064a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Mayo LD, 1997, CANCER RES, V57, P5013; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; MILLER RD, 1995, P NATL ACAD SCI USA, V92, P10790; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; OLSON DC, 1993, ONCOGENE, V8, P2353; POWELL SN, 1995, CANCER RES, V55, P1643; PRICE BD, 1993, ONCOGENE, V8, P3055; Rathmell WK, 1997, CANCER RES, V57, P68; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; ZHAN QM, 1994, CANCER RES, V54, P2755	66	51	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13111	13117		10.1074/jbc.274.19.13111	http://dx.doi.org/10.1074/jbc.274.19.13111			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224064	hybrid			2022-12-27	WOS:000080200400026
J	Ribeiro, SMF; Poczatek, M; Schultz-Cherry, S; Villain, M; Murphy-Ullrich, JE				Ribeiro, SMF; Poczatek, M; Schultz-Cherry, S; Villain, M; Murphy-Ullrich, JE			The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPATHIC COMPLEMENTARITY APPROACH; MOLECULAR-WEIGHT COMPLEX; BETA-1-LATENCY-ASSOCIATED PEPTIDE; MESSENGER-RNA; STRUCTURAL CHARACTERIZATION; EXTRACELLULAR-MATRIX; HUMAN-PLATELETS; TGF-BETA; BINDING; CELLS	One of the primary points of regulation of transforming growth factor-beta (TGF-beta) activity is control of its conversion from the latent precursor to the biologically active form. We have identified thrombospondin-l as a major physiological regulator of latent TGF-beta activation. Activation is dependent on the interaction of a specific sequence in thrombospondin-l ((KRFK415)-R-412) with the latent TGF-beta complex. Platelet thrombospondin-1 has TGF-beta activity and immunoreactive mature TGF-beta associated with it. We now report that the latency-associated peptide (LAP) of the latent TGF-beta complex also interacts with thrombospondin-l as part of a biologically active complex. Thrombospondin LAP complex formation involves the activation sequence of thrombospondin-l (KRFK) and a sequence (LSKL) near the amino terminus of LAP that is conserved in TGF-beta(1-5). The interactions of LAP with thrombospondin-l through the LSKL and KRFK sequences are important for thrombospondin-mediated activation of latent TGF-beta since LSKL peptides can competitively inhibit latent TGF-beta activation by thrombospondin or KRFK-containing peptides. In addition, the association of LAP with thrombospondin-1 may function to prevent the reformation of an inactive LAP TGF-beta complex since thrombospondin-bound LAP no longer confers latency on active TGF-beta. The mechanism of TGF-beta activation by thrombospondin-1 appears to be conserved among TGF-beta isoforms as latent TGF-beta(2) can also be activated by thrombospondin-1 or KRFK peptides in a manner that is sensitive to inhibition by LSKL peptides.	Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ribeiro, SMF (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Volker Hall,G038,1670 Univ Blvd, Birmingham, AL 35294 USA.	ribeiro@path.uab.edu	Schultz-Cherry, Stacey/N-2506-2018		NHLBI NIH HHS [R01 HL050061, HL50061] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050061] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; Bailly S, 1997, J BIOL CHEM, V272, P16329, DOI 10.1074/jbc.272.26.16329; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BLALOCK JE, 1995, NAT MED, V1, P876, DOI 10.1038/nm0995-876; BORNSTEIN P, 1994, METHOD ENZYMOL, V245, P62; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; BRENTANI RR, 1988, P NATL ACAD SCI USA, V85, P364, DOI 10.1073/pnas.85.2.364; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; BURT DW, 1992, MOL ENDOCRINOL, V6, P989, DOI 10.1210/me.6.6.989; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; DERYNCK R, 1997, NUCLEIC ACIDS RES, V15, P3188; FASSINA G, 1994, GROWTH FACTORS, V10, P99, DOI 10.3109/08977199409010983; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; HENNESSY SW, 1989, J CELL BIOL, V108, P729, DOI 10.1083/jcb.108.2.729; KONDAIAH P, 1990, J BIOL CHEM, V265, P1089; LAHAV J, 1993, BIOCHIM BIOPHYS ACTA, V1182, P1, DOI 10.1016/0925-4439(93)90146-R; LAU LF, 1991, MOL ASPECTS CELLULAR, V6, P257; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; LIOUBIN MN, 1991, J CELL BIOCHEM, V45, P112, DOI 10.1002/jcb.240450118; Maier C C, 1994, Immunomethods, V5, P107, DOI 10.1006/immu.1994.1044; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; MIANO JM, 1993, ARTERIOSCLER THROMB, V13, P211, DOI 10.1161/01.ATV.13.2.211; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1108, DOI 10.1210/mend-3-7-1108; MILLER DM, 1992, MOL ENDOCRINOL, V6, P694, DOI 10.1210/me.6.5.694; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MOSHER DF, 1990, ANNU REV MED, V41, P85; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; PASQUALINI R, 1989, J BIOL CHEM, V264, P14566; QIAN SW, 1990, NUCLEIC ACIDS RES, V18, P3059, DOI 10.1093/nar/18.10.3059; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; SLATER M, 1995, EXPERIENTIA, V51, P235, DOI 10.1007/BF01931104; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Yang YB, 1997, BIOCHEMISTRY-US, V36, P11923, DOI 10.1021/bi9710479	45	285	303	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13586	13593		10.1074/jbc.274.19.13586	http://dx.doi.org/10.1074/jbc.274.19.13586			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224129	hybrid			2022-12-27	WOS:000080200400091
J	Kanaya, E; Nakajima, N; Morikawa, K; Okada, K; Shimura, Y				Kanaya, E; Nakajima, N; Morikawa, K; Okada, K; Shimura, Y			Characterization of the transcriptional activator CBF1 from Arabidopsis thaliana - Evidence for cold denaturation in regions outside of the dna binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLENE-RESPONSIVE ELEMENT; HOMEOTIC GENE APETALA2; CIS-ACTING ELEMENT; ABSCISIC-ACID; LOW-TEMPERATURE; PROTEIN INTERACTS; AP2 DOMAIN; EXPRESSION; DROUGHT; AINTEGUMENTA	A transcriptional activator, CBF1, from Arabidopsis thaliana, which has the AP2 domain for DNA binding and regulates the cold acclimation response, was overexpressed in Escherichia coli, purified, and characterized, Analyses of the interaction between CBF1 and the C-repeat/dehydration-responsive element by fluorescence measurement showed that CBF1 binds to C-repeat/dehydration-responsive element as a monomer irrespective of the temperature. CD spectra of the intact and truncated CBF1 proteins (1-213, 41-213, 41-157, and 41-146) were measured to examine the temperature-dependent changes of the secondary structure of CBF1. The results suggested that the CBF1 protein has regions exhibiting reversible cold denaturation in the range between 30 and -5 degrees C and also has a region exhibiting thermal denaturation between 40 and 60 degrees C. This cold denaturation occurred in both the N-terminal and acidic regions. The thermal denaturation occurred in the region encompassing the AP2 domain. The difference between the retention time of CBF1 at 4 degrees C and that at 25 degrees C in gel filtration, and the decrease of the sedimentation coefficient, s(20,w), caused by the temperature change from 25 to 3 degrees C, strongly suggested that the cold denaturation was accompanied by the extension of the molecule. The possible cold denaturation observed here might be a physiologically important structural response of CBF1 to cold stress.	Biomed Engn Res Inst, Osaka 5650874, Japan; Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	Kyoto University	Kanaya, E (corresponding author), Biomed Engn Res Inst, 6-2-3 Furuedai, Osaka 5650874, Japan.							ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; GOSTI F, 1995, MOL GEN GENET, V246, P10, DOI 10.1007/BF00290128; Greenblatt J, 1996, METHOD ENZYMOL, V274, P120; GROVES WE, 1968, ANAL BIOCHEM, V22, P195, DOI 10.1016/0003-2697(68)90307-2; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; HOPKINS F. GOWLAND, 1930, NATURE [LONDON], V126, P383, DOI 10.1038/126383a0; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KELLY RC, 1976, J BIOL CHEM, V251, P7240; KITAKUNI E, 1994, PROTEIN SCI, V3, P831; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T., 1993, ANAL ULTRACENTRIFUGA, P90; Leblanc B, 1994, Methods Mol Biol, V30, P1; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MAHAPATRA SS, 1989, PLANT PHYSIOL, V89, P375; MARCOTTE WR, 1988, NATURE, V335, P454, DOI 10.1038/335454a0; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; Maxam A M, 1980, Methods Enzymol, V65, P499; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Miller J. H., 1972, EXPT MOL GENETICS, P433; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; NORDIN K, 1991, PLANT MOL BIOL, V16, P1061, DOI 10.1007/BF00016077; OHARE P, 1988, EMBO J, V7, P4231, DOI 10.1002/j.1460-2075.1988.tb03320.x; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; ROBEN SM, 1992, MOL CELL BIOL, V12, P444; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; TRUANT R, 1993, J BIOL CHEM, V268, P2284; VANHOLDE KE, 1985, PHYSICAL BIOCH, P225; WAXMAN E, 1993, BIOCHEMISTRY-US, V32, P3005, DOI 10.1021/bi00063a011; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	56	20	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16068	16076		10.1074/jbc.274.23.16068	http://dx.doi.org/10.1074/jbc.274.23.16068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347158	hybrid			2022-12-27	WOS:000080668600018
J	Dmitriev, O; Jones, PC; Jiang, WP; Fillingame, RH				Dmitriev, O; Jones, PC; Jiang, WP; Fillingame, RH			Structure of the membrane domain of subunit b of the Escherichia coli F0F1 ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING H+ TRANSPORT; MOLECULAR MACHINE; CROSS-LINKING; ALPHA-SUBUNIT; GAMMA-SUBUNIT; F-0 SECTOR; 2ND STALK; F1-ATPASE; F1; PROTEINS	The structure of the N-terminal transmembrane domain (residues 1-34) of subunit b of the Escherichia coli F0F1-ATP synthase has been solved by two-dimensional H-1 NMR in a membrane mimetic solvent mixture of chloroform/methanol/H2O (4:4:1), Residues 4-22 form an cu-helix, which is likely to span the hydrophobic domain of the lipid bilayer to anchor the largely hydrophilic subunit b in the membrane. The helical structure is interrupted by a rigid bend in the region of residues 23-26 with cu-helical structure resuming at Pro-27 at an angle offset by 20 degrees from the transmembrane helix. In native subunit b, the hinge region and C-terminal alpha-helical segment would connect the transmembrane helix to the cytoplasmic domain. The transmembrane domains of the two subunit b in F-0 were shown to be close to each other by cross-linking experiments in which single Cys were substituted for residues 2-21 of the native subunit and b-b dimer formation tested after oxidation with Cu(II) (phenanthroline)(2). Cys residues that formed disulfide cross-links were found with a periodicity indicative of one face of an alpha-helix, over the span of residues 2-18, where Cys at positions 2, 6, and 10 formed dimers in highest yield. A model for the dimer is presented based upon the NMR structure and distance constraints from the cross-linking data. The transmembrane Lu-helices are positioned at a 23 degrees angle to each other with the side chains of Thr 6, Gln-10, Phe-14, and Phe-17 at the interface between subunits, The change in direction of helical packing at the hinge region may be important in the functional interaction of the cytoplasmic domains.	Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	filingam@macc.wisc.edu	Dmitriev, Oleg/AAB-7830-2019		NCRR NIH HHS [RR02301] Funding Source: Medline; NIGMS NIH HHS [GM23105] Funding Source: Medline; PHS HHS [R02301] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BIRKENHAGER R, 1995, EUR J BIOCHEM, V230, P58, DOI 10.1111/j.1432-1033.1995.tb20534.x; Bottcher B, 1998, J MOL BIOL, V281, P757, DOI 10.1006/jmbi.1998.1957; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Boyer PD, 1998, ANGEW CHEM INT EDIT, V37, P2297, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO;2-W; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; DMITRIEV OY, 1995, EUR J BIOCHEM, V233, P478, DOI 10.1111/j.1432-1033.1995.478_2.x; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1992, J BIOL CHEM, V267, P7630; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Engelbrecht S, 1997, FEBS LETT, V414, P485, DOI 10.1016/S0014-5793(97)00997-6; Fillingame RH, 1997, J EXP BIOL, V200, P217; Fillingame RH, 1998, BBA-BIOENERGETICS, V1365, P135, DOI 10.1016/S0005-2728(98)00053-X; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOPPE J, 1983, J BIOL CHEM, V258, P2882; HOPPE J, 1984, BIOCHEMISTRY-US, V23, P5610, DOI 10.1021/bi00318a035; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JANS DA, 1984, J BACTERIOL, V160, P764, DOI 10.1128/JB.160.2.764-770.1984; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PERLIN DS, 1985, ARCH BIOCHEM BIOPHYS, V236, P603, DOI 10.1016/0003-9861(85)90664-2; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; Rodgers AJW, 1998, J BIOL CHEM, V273, P29406, DOI 10.1074/jbc.273.45.29406; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Singh S, 1996, FEBS LETT, V397, P30, DOI 10.1016/S0014-5793(96)01127-1; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; Takeyasu K, 1996, FEBS LETT, V392, P110, DOI 10.1016/0014-5793(96)00796-X; TITMAN JJ, 1990, J MAGN RESON, V89, P640, DOI 10.1016/0022-2364(90)90351-9; VIK SB, 1994, J BIOL CHEM, V269, P30364; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; WALLINE, 1995, PROTEIN SCI, V6, P808; WARREN WS, 1993, SCIENCE, V262, P2005, DOI 10.1126/science.8266096; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609	56	121	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15598	15604		10.1074/jbc.274.22.15598	http://dx.doi.org/10.1074/jbc.274.22.15598			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336456	hybrid			2022-12-27	WOS:000080560100045
J	Fasshauer, D; Antonin, W; Margittai, M; Pabst, S; Jahn, R				Fasshauer, D; Antonin, W; Margittai, M; Pabst, S; Jahn, R			Mixed and non-cognate SNARE complexes - Characterization of assembly and biophysical properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE DOCKING; N-TERMINAL DOMAIN; MEMBRANE-FUSION; CLOSTRIDIAL NEUROTOXINS; PROTEIN INTERACTIONS; STRUCTURAL-CHANGES; LIGHT-SCATTERING; SYNTAXIN; SYNAPTOBREVIN; TRANSPORT	Assembly of soluble N-ethylmaleimide-sensitive fusion attachment protein receptor (SNARE) proteins between two opposing membranes is thought to be the key event that initiates membrane fusion. Many new SNARE proteins have recently been localized to distinct intracellular compartments, supporting the view that sets of specific SNAREs are specialized for distinct trafficking steps. We have now investigated whether other SNAREs can form complexes with components of the synaptic SNARE complex including synaptobrevin/VAMP 2, SNAP-25, and syntaxin 1, When the Q-SNAREs syntaxin 2, 3, and 4, and the R-SNARE endobrevin/VAMP 8 were used in various combinations, heat-resistant complexes were formed. Limited proteolysis revealed that these complexes contained a protease-resistant core similar to that of the synaptic complex. All complexes were disassembled by the ATPase N-ethylmaleimide-sensitive fusion protein and its cofactor alpha-SNAP. Circular dichroism spectroscopy showed that major conformational changes occur during assembly, which are associated with induction of structure from unstructured monomers, Furthermore, no preference for synaptobrevin was observed during the assembly of the synaptic complex when endobrevin/VAMP 8 was present in equal concentrations. We conclude that cognate and non-cognate SNARE complexes are very similar with respect to biophysical properties, assembly, and disassembly, suggesting that specificity of membrane fusion in intracellular membrane traffic is not due to intrinsic specificity of SNARE pairing.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Margittai, Martin/D-5039-2014; Fasshauer, Dirk/B-1563-2013; Antonin, Wolfram/A-8656-2014; Antonin, Wolfram/P-3648-2019	Margittai, Martin/0000-0003-1903-5927; Fasshauer, Dirk/0000-0002-1040-4282; Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; Jahn, Reinhard/0000-0003-1542-3498				Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Gotte M, 1998, TRENDS CELL BIOL, V8, P215, DOI 10.1016/S0962-8924(98)01272-0; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Katz L, 1998, EMBO J, V17, P6200, DOI 10.1093/emboj/17.21.6200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Rizo J, 1998, NAT STRUCT BIOL, V5, P839, DOI 10.1038/2280; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Weis WI, 1998, NATURE, V395, P328, DOI 10.1038/26354; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	47	243	260	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15440	15446		10.1074/jbc.274.22.15440	http://dx.doi.org/10.1074/jbc.274.22.15440			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336434	hybrid			2022-12-27	WOS:000080560100023
J	Nishida, CR; de Montellano, PRO				Nishida, CR; de Montellano, PRO			Autoinhibition of endothelial nitric-oxide synthase - Identification of an electron transfer control element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR-CLONING; REDUCTASE-ACTIVITY; HUMAN-LIVER; CALMODULIN; EXPRESSION; PURIFICATION; BINDING; CDNA; FLAVOPROTEIN	The primary sequences of the three mammalian nitric- oxide synthase (NOS) isoforms differ by the insertion of a 52-55-amino acid loop into the reductase domains of the endothelial (eNOS) and neuronal (nNOS), but not inducible (iNOS). On the basis of studies of peptide derivatives as inhibitors of (NO)-N-. formation and calmodulin (CaM) binding (Salerno, J. C., Harris, D. E., Irizarry, K., Patel, B., Morales, A. J., Smith, S. M., Martasek, P., Roman, L. J., Masters, B. S., Jones, C. L., Weissman, B. A., Lane, P., Liu, Q., and Gross, S. S. (1997) J. Biol, Chem. 272, 29769-29777), the insert has been proposed to be an autoinhibitory element. We have examined the role of the insert in its native protein context by deleting the insert from both wild-type eNOS and fi om chimeras obtained by swapping the reductase domains of the three NOS isoforms. The Ca2+ concentrations required to activate the enzymes decrease significantly when the insert is deleted, consistent with suppression of autoinhibition. Furthermore, removal of the insert greatly enhances the maximal activity of mild-type eNOS, the least active of the three isoform. Despite the correlation between reductase and overall enzymatic activity for the wild-type and chimeric NOS proteins, the loop-free eNOS still requires CaM to synthesize (NO)-N-.. However, the reductive activity of the CaM-free, loop-deleted eNOS is enhanced significantly over that of CaM-free wild-type eNOS and approaches the same level as that of CaM-bound wild-type eNOS. Thus, the inhibitory effect of the loop on both the eNOS reductase and (NO)-N-.-synthesizing activities may have an origin distinct from the loop's inhibitory effects on the binding of CaM and the concomitant activation of the reductase and (NO)-N-.-synthesizing activities. The eNOS insert not only inhibits activation of the enzyme by CaM but also contributes to the relatively low overall activity of this NOS isoform.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ortiz@cgl.ucsf.edu			NIGMS NIH HHS [GM25515] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen PF, 1997, J BIOL CHEM, V272, P6114, DOI 10.1074/jbc.272.10.6114; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Fossetta JD, 1996, FEBS LETT, V379, P135, DOI 10.1016/0014-5793(95)01496-9; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Gerber NC, 1997, ARCH BIOCHEM BIOPHYS, V343, P249, DOI 10.1006/abbi.1997.0187; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Grabowski PS, 1996, PORTL PR P, V10, P48; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; HANIU M, 1989, BIOCHEMISTRY-US, V28, P8639, DOI 10.1021/bi00447a054; HARTENECK C, 1994, BIOCHEM J, V304, P683, DOI 10.1042/bj3040683; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; HEVEL JM, 1994, METHOD ENZYMOL, V233, P250; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Huhmer AFR, 1997, CHEM RES TOXICOL, V10, P618, DOI 10.1021/tx960188t; JANSSENS SP, 1992, J BIOL CHEM, V267, P22694; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLATT P, 1992, J BIOL CHEM, V267, P11374; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Lin AW, 1996, J BIOL CHEM, V271, P11911, DOI 10.1074/jbc.271.20.11911; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; MASTERS BSS, 1994, ANNU REV NUTR, V14, P131, DOI 10.1146/annurev.nu.14.070194.001023; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; NAKANE M, 1993, FEBS LETT, V316, P175, DOI 10.1016/0014-5793(93)81210-Q; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rafferty S, 1996, BIOCHEM BIOPH RES CO, V220, P1002, DOI 10.1006/bbrc.1996.0522; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; RIVEROSMORENO V, 1995, EUR J BIOCHEM, V230, P52; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Ruan J, 1996, J BIOL CHEM, V271, P22679, DOI 10.1074/jbc.271.37.22679; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Schrammel A, 1998, BBA-PROTEIN STRUCT M, V1387, P257, DOI 10.1016/S0167-4838(98)00138-1; SESSA WC, 1994, J VASC RES, V31, P131, DOI 10.1159/000159039; SESSA WC, 1992, J BIOL CHEM, V267, P15274; SHERMAN PA, 1993, BIOCHEMISTRY-US, V32, P11600, DOI 10.1021/bi00094a017; Shirato M, 1998, BIOCHEM J, V333, P795, DOI 10.1042/bj3330795; Strobel Henry W., 1995, P225; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tao Bernard Y., 1994, P69; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; VERMILION JL, 1974, BIOCHEM BIOPH RES CO, V60, P1315, DOI 10.1016/0006-291X(74)90341-6; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yuda M, 1996, EUR J BIOCHEM, V242, P807, DOI 10.1111/j.1432-1033.1996.0807r.x	59	94	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14692	14698		10.1074/jbc.274.21.14692	http://dx.doi.org/10.1074/jbc.274.21.14692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329664	hybrid			2022-12-27	WOS:000081965200029
J	Hajnoczky, G; Hager, R; Thomas, AP				Hajnoczky, G; Hager, R; Thomas, AP			Mitochondria suppress local feedback activation of inositol 1,4,5-trisphosphate receptors by Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; RAT-LIVER; CALCIUM OSCILLATIONS; PURKINJE-CELLS; RELEASE; TRISPHOSPHATE; MOBILIZATION; CEREBELLUM; METABOLISM; FRACTIONS	The concerted action of inositol 1,4,5-trisphosphate (IP3) and Ca2+ on the IP3 receptor Ca2+ release channel (IP3R) is a fundamental step in the generation of cytosolic Ca2+ oscillations and waves, which underlie Ca2+ signaling in many cells. Mitochondria appear in close association with regions of endoplasmic reticulum (ER) enriched in IP3R and are particularly responsive to IP3-induced increases of cytosolic Ca2+ ([Ca2+](c)). To determine whether feedback regulation of the IP3R by released Ca2+ is modulated by mitochondrial Ca2+ uptake, the interactions between ER and mitochondrial Ca2+ pools were examined by fluorescence imaging of compartmentalized Ca2+ indicators in permeabilized hepatocytes, IP3 decreased luminal ER Ca2+ ([Ca2+](ER)), and this was paralleled by an increase in mitochondrial matrix Ca2+ ([Ca2+](m)) and activation of Ca2+-sensitive mitochondrial metabolism. Remarkably, the decrease in [Ca2+](ER) evoked by submaximal IP3 was enhanced when mitochondrial Ca2+ uptake was blocked with ruthenium red or uncoupler. Moreover, subcellular regions that were relatively deficient in mitochondria demonstrated greater sensitivity to IP3 than regions of the cell with a high density of mitochondria. These data demonstrate that Ca2+ uptake by the mitochondria suppresses the local positive feedback effects of Ca2+ on the IP3R, giving rise to subcellular heterogeneity in IP3 sensitivity and IP3R excitability. Thus, mitochondria can play an important role in setting the threshold for activation and establishing the subcellular pattern of IP3-dependent [Ca2+](c) signaling.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Jefferson University	Thomas, AP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,Univ Hts, Newark, NJ 07103 USA.	thomasap@umdnj.edu	Thomas, Andrew/C-6755-2013	Thomas, Andrew/0000-0002-9026-7467	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038422, R29DK038422, R01DK051526, R29DK051526] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38422, DK51526] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Budd SL, 1996, J NEUROCHEM, V67, P2282; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; DAWSON AP, 1984, BIOCHEM BIOPH RES CO, V120, P858, DOI 10.1016/S0006-291X(84)80186-2; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Haugland RP, 1996, HDB FLUORESCENT PROB, P266; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LUKACS GL, 1987, BIOCHIM BIOPHYS ACTA, V931, P251, DOI 10.1016/0167-4889(87)90213-8; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MARSHALL ICB, 1993, J BIOL CHEM, V268, P13214; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Michikawa T, 1996, CRIT REV NEUROBIOL, V10, P39, DOI 10.1615/CritRevNeurobiol.v10.i1.20; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; RICHARDSON A, 1993, J BIOL CHEM, V268, P11528; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SHORE GC, 1977, J CELL BIOL, V72, P714, DOI 10.1083/jcb.72.3.714; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296	35	219	222	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14157	14162		10.1074/jbc.274.20.14157	http://dx.doi.org/10.1074/jbc.274.20.14157			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318833	hybrid			2022-12-27	WOS:000080322200062
J	Huang, W; Dolmer, K; Gettins, PGW				Huang, W; Dolmer, K; Gettins, PGW			NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH REPEAT; TRIPLE-RESONANCE NMR; 3-DIMENSIONAL STRUCTURE; LIGAND-BINDING; CHEMICAL-SHIFTS; CALCIUM; DOMAIN; SENSITIVITY; DYNAMICS; SITE	The low density lipoprotein receptor-related protein is a member of the low density lipoprotein receptor family and contains clusters of cysteine-rich complement-like repeats of about 42 residues that are present in all members of this family of receptors, These clusters are thought to be the principal binding sites for protein ligands. We have expressed one complement-like repeat, CR8, from the cluster in lipoprotein receptor-related protein that binds certain proteinase inhibitor-proteinase complexes and used three-dimensional NMR on the C-13/N-15-labeled protein to determine the structure in solution of the calcium-hound form. The structure is very similar in overall fold to repeat 5 from the low density Lipoprotein receptor (LB5), with backbone root mean square deviation of 1.5 Angstrom. The calcium-binding. site also appears to be homologous, with four carboxyl and two backbone carbonyl ligands, However, differences in primary structure are such that equivalent surfaces that might represent the binding interfaces are very different from one another, indicating that different domains will have very different ligand specificities.	Univ Illinois, Dept Biochem & Mol Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Biol, Coll Med, M-C 536,1853 W Polk St, Chicago, IL 60612 USA.		Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54414] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017; CASE DA, 1997, AMBER 5; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; [No title captured]	24	69	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14130	14136		10.1074/jbc.274.20.14130	http://dx.doi.org/10.1074/jbc.274.20.14130			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318830	hybrid			2022-12-27	WOS:000080322200059
J	Saura, CA; Tomita, T; Davenport, F; Harris, CL; Iwatsubo, T; Thinakaran, G				Saura, CA; Tomita, T; Davenport, F; Harris, CL; Iwatsubo, T; Thinakaran, G			Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; IN-VIVO; TRANSFECTED CELLS; MISSENSE MUTATIONS; SENILE PLAQUES; APP MUTATIONS; WILD-TYPE; COMPLEX; GENE	Mutations in genes encoding presenilins (PS1 and PS2) cosegregate with the majority of early onset cases of familial. Alzheimer's disease. PS1 and PS2 are polytopic membrane proteins that undergo endoproteolytic cleavage to generate stable NH2- and COOH-terminal derivatives (NTF and CTF, respectively). Several lines of evidence suggest that the endoproteolytic derivatives are likely the functional units of PS in vivo. In the present report, we examine the disposition of PS NTF and CTF assemblies in stable mouse N2a neuroblastoma cell lines expressing human PS polypeptides. We show that exogenous expression of PS1 NTFs neither assemble with endogenous CTF nor exhibit dominant negative inhibitory effects on the endogenous PS1 cleavage and the accumulation of derivatives; In cells co-expressing PSI and PS2, PS1- and PS2-derived fragments do not form mixed assemblies. In contrast, cells expressing a chimeric PS1/PS2 polypeptide form stable PS1 NTF-PS2 CTF assemblies. Moreover, expression of chimeric PS1/ PS2 polypeptides harboring a familial early onset AD-linked mutation (M146L) elevates the production of A beta 42 peptides, Our results provide evidence that assembly of structural domains contained within NH2- and COOH-terminal regions of PS occur prior to endoproteolytic cleavage.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan	Johns Hopkins University; Johns Hopkins University; University of Tokyo	Thinakaran, G (corresponding author), Univ Chicago, Knapp Res Ctr, Dept Neurobiol Pharmacol & Physiol, 924 E 57th St, Chicago, IL 60637 USA.		Saura, Carlos A/D-2727-2011; Saura, Carlos A/AFM-9239-2022; Tomita, Taisuke/L-5427-2015	Saura, Carlos A/0000-0003-3692-5657; Tomita, Taisuke/0000-0002-0075-5943	NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [1PO1 AG14248] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Busfield Frances, 1995, P59, DOI 10.1016/B978-012286965-5/50006-6; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kim TW, 1997, J BIOL CHEM, V272, P11006; Lah JJ, 1997, J NEUROSCI, V17, P1971; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; Mercken M, 1996, FEBS LETT, V389, P297, DOI 10.1016/0014-5793(96)00608-4; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; PEREZTUR J, 1995, NEUROREPORT, V7, P291; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; TOMITA T, 1983, J BIOL CHEM, V273, P2115; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; Wisniewski HM, 1973, PROGR NEUROPATHOLOGY, V2, P1; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	43	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13818	13823		10.1074/jbc.274.20.13818	http://dx.doi.org/10.1074/jbc.274.20.13818			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318786	hybrid			2022-12-27	WOS:000080322200015
J	Benard, V; Bohl, BP; Bokoch, GM				Benard, V; Bohl, BP; Bokoch, GM			Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; NADPH OXIDASE ACTIVITY; RESPIRATORY BURST OXIDASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; HL-60 CELLS; PHOSPHOLIPASE-D; RHO-GTPASES; KINASE; INHIBITION	A major function of Rac2 in neutrophils is the regulation of oxidant production important in bacterial killing. Rac and the related GTPase Cdc42 also regulate the dynamics of the actin cytoskeleton, necessary for leukocyte chemotaxis and phagocytosis of microorganisms. Although these GTPases appear to be critical down stream components of chemoattractant receptor signaling in human neutrophils, the pathways involved in direct control of Rac/Cdc4a activation remain to be determined. We describe an assay that measures the formation of Rac-GTP and Cdc42-GTP based on their specific binding to the pal-binding domain of p21-activated kinase 1. A pal-binding domain glutathione S-transferase fusion protein specifically binds Rac and Cdc42 in their GTP-bound forms both in vitro and in cell samples. Binding is selective for Rac and Cdc42 versus RhoA. Using this assay, we investigated Rac and Cdc42 activation in neutrophils and differentiated HL-60 cells. The chemoattractant fMet-Leu-Phe and the phorbol ester phorbol myristate acetate stimulate formation of Rac-GTP and Cdc42-GTP with distinct time courses that parallel cell activation. We also show that the signaling pathways leading to Rac and Cdc42 activation in HL-60 cells involve G proteins sensitive to pertussis toxin, as well as tyrosine kinase and phosphatidylinositol 3-kinase activities.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Planat-Benard, Valerie/0000-0002-0712-4220	NCRR NIH HHS [MO1 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM39434, GM44428] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039434, R01GM044428] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BADWEY JA, 1982, BIOCHEM BIOPH RES CO, V106, P170, DOI 10.1016/0006-291X(82)92073-3; BAGGIOLINI M, 1987, EXP CELL RES, V169, P408, DOI 10.1016/0014-4827(87)90201-1; BOKOCH GM, 1984, CELL, V39, P301, DOI 10.1016/0092-8674(84)90008-4; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; BOKOCH GM, 1992, J CLIN INVEST, V89, P402, DOI 10.1172/JCI115599; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CHUANG TH, 1993, J BIOL CHEM, V268, P775; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; FREEMAN JLR, 1994, BIOCHEMISTRY-US, V33, P13431, DOI 10.1021/bi00249a031; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P1217, DOI 10.1091/mbc.4.11.1217; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Houle MG, 1996, BIOCHEM CELL BIOL, V74, P459, DOI 10.1139/o96-050; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Leonard DA, 1997, BIOCHEMISTRY-US, V36, P1173, DOI 10.1021/bi9622837; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; OKADA T, 1994, J BIOL CHEM, V269, P3563; PROSSNITZ ER, 1993, J IMMUNOL, V151, P5704; Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; QUINN MT, 1993, J BIOL CHEM, V268, P20983; QUINN MT, 1995, J LEUKOCYTE BIOL, V58, P263, DOI 10.1002/jlb.58.3.263; SIDDIQI AR, 1995, J BIOL CHEM, V270, P8466, DOI 10.1074/jbc.270.15.8466; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	51	669	679	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13198	13204		10.1074/jbc.274.19.13198	http://dx.doi.org/10.1074/jbc.274.19.13198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224076	hybrid			2022-12-27	WOS:000080200400038
J	Hong, YL; Sarge, KD				Hong, YL; Sarge, KD			Regulation of protein phosphatase 2A activity by heat shock transcription factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; TUMOR-ANTIGENS; A-SUBUNIT; GENE-TRANSCRIPTION; CATALYTIC SUBUNIT; EXPRESSION; IDENTIFICATION; TYPE-2A; ACTIVATION; RABBIT	Heat shock transcription factor (HSF) mediates the stress-induced expression of heat shock protein genes (hsp), However, HSF is required for normal cell function even in the absence of stress and is important for cell cycle progression, but the mechanism that mediates these effects of HSF is unknown. Here, it is shown that a member of the HSF family, HSF2, interacts with the PR65 (A) subunit of protein phosphatase 2A (PP2A), HSF1 binding to PR65 blocks its interaction with the catalytic subunit, due to competition between HSF2 and catalytic subunit for the same binding site in PR65. In addition, overexpression of HSF2 stimulates PP2A activity in cells, indicating the relevance of HSF2 as a regulator of PP2A in vivo, These results identify HSF2 as a dual function protein, capable of regulating both hsp expression and PP2A activity. This could function as a mechanism by which hsp expression is integrated with the control of cell division or other PP2A-regulated pathways.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, Lexington, KY 40536 USA.	kdsarge@pop.uku.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD032008] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32008] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; CHEN SC, 1989, J BIOL CHEM, V264, P7267; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COHEN P, 1988, METHOD ENZYMOL, V159, P390; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GALLO GJ, 1993, MOL CELL BIOL, V13, P749, DOI 10.1128/MCB.13.2.749; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P7330; James P, 1996, GENETICS, V144, P1425; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; KAMIBAYASHI C, 1992, J BIOL CHEM, V267, P21864; KINGSTON RE, 1991, HORMONAL CONTROL GEN, P377; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; Morimoto R I, 1996, EXS, V77, P139; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; PALLAS DC, 1992, J VIROL, V66, P886, DOI 10.1128/JVI.66.2.886-893.1992; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; WERA S, 1995, J BIOL CHEM, V270, P21374, DOI 10.1074/jbc.270.36.21374; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Zolnierowicz S, 1996, BIOCHEM J, V317, P187, DOI 10.1042/bj3170187	45	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12967	12970		10.1074/jbc.274.19.12967	http://dx.doi.org/10.1074/jbc.274.19.12967			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224043	hybrid			2022-12-27	WOS:000080200400005
J	Stock, SD; Hama, H; DeWald, DB; Takemoto, JY				Stock, SD; Hama, H; DeWald, DB; Takemoto, JY			SEC14-dependent secretion in Saccharomyces cerevisiae - Nondependence on sphingolipid synthesis-coupled diacylglycerol production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; YEAST GOLGI-COMPLEX; VESICLE FORMATION; LIPID-SYNTHESIS; GENE; INOSITOL; TRANSPORT; 3-KINASE; IDENTIFICATION	The SEC14 gene in Saccharomyces cerevisiae encodes a phosphatidylinositol transfer protein required for secretory protein movement from the Golgi, Mutation of SAC1, a gene of unknown function, restores secretory now in sec14-1(ts) strains. The existing model for the bypass of the sec14-1(ts) defect by sac1-22 involves stimulation of sphingolipid biosynthesis and, in particular, the synthesis of mannosyl-diinositolphosphoryl-ceramide with concomitant increases in Golgi diacylglycerol levels. To test this model, we disrupted IPT1, the mannosyl-diinositolphosphoryl ceramide synthase of S, cerevisiae, Disruption of the IPT1 gene had no effect on the ability of sac1-22 to bypass sec14-1(ts). Furthermore, sphingolipid analysis of sec14-1(ts) and sec14-1(ts) sac1-22 strains showed that mannosyl-diinositolphosphoryl-ceramide synthesis was not stimulated in the bypass mutant. However, the sec14-1(ts) strain had elevated mannosyl-monoinositolphosphoryl-ceramide levels, and the sec14-1(ts) sac1-22 strain showed an 8-fold increase in phosphatidylinositol 4-phosphate along with a decrease in phosphatidylinositol 4,5-bisphosphate, Cellular diacylglycerol levels, measured by [C-14]acetate incorporation, did not differ between the sec14-1(ts) and the sec14-1 sac1-22 bypass strains, although disruption of IPT1 in the bypass strain resulted in reduced levels. These data indicate that phosphatidylinositol 4-phosphate, rather than mannosyl-diinositolphosphoryl-ceramide, accumulates in the sec14-1(ts) sac1-22 bypass strain, and that Golgi diacylglycerol accumulation is not required for bypass of the sec14-1(ts) growth and secretory phenotypes.	Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Takemoto, JY (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	jon@biology.usu	Takemoto, Jon/A-5309-2011	Takemoto, Jon/0000-0001-9919-9168				BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BUTTKE TM, 1982, J BACTERIOL, V152, P747; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Cunningham E, 1996, P NATL ACAD SCI USA, V93, P6589, DOI 10.1073/pnas.93.13.6589; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; Kaiser C., 1994, METHODS YEAST GENETI; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; Panaretou C, 1997, J BIOL CHEM, V272, P2477; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; SMITH SW, 1974, J BIOL CHEM, V249, P3395; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Westphal V, 1996, J BIOL CHEM, V271, P11865, DOI 10.1074/jbc.271.20.11865; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	32	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12979	12983		10.1074/jbc.274.19.12979	http://dx.doi.org/10.1074/jbc.274.19.12979			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224046	hybrid			2022-12-27	WOS:000080200400008
J	Zhang, N; Zhong, R; Deuel, TF				Zhang, N; Zhong, R; Deuel, TF			Domain structure of pleiotrophin required for transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING BRAIN; EXPRESSION; PROTEIN; CLONING; MIDKINE; CELLS	The pleiotrophin (PTN) gene (Ptn) is a potent proto-oncogene that is highly expressed in many primary human tumors and constitutively expressed in cell lines derived from these tumors. The product of the Ptn gene is a secreted 136-amino acid heparin binding cytokine with distinct lysine-rich clusters within both the N- and C-terminal domains. To seek domains of PTN functionally important in neoplastic transformation, we constructed a series of mutants and tested their transforming potential by four independent criteria. Our data establish that a domain within PTN residues 41 to 64 and either but not both the N- or C-terminal domains are required for transformation; deletion of both the N- and C termini abolishes the transformation potential of PTN. Furthermore, deletion of two internal 5-amino acid residue repeats enhances the transformation potency of PTN a-fold. Our data indicate that PTN residues 41-64 contain an essential domain for transformation and suggest the hypothesis that this domain requires an additional interaction of the highly basic clusters of the N or C terminus of PTN with a negatively charged "docking" site to enable the transforming domain itself to engage and initiate PTN signaling through its cognate receptor.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Growth Regulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Deuel, TF (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Growth Regulat, 330 Brookline Ave, Boston, MA 02215 USA.							CERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; FANG WJ, 1992, J BIOL CHEM, V267, P25889; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; TSUTSUI J, 1993, CANCER RES, V53, P1281; WALKER A, 1994, J BIOL CHEM, V269, P931; ZHANG N, 1997, J BIOL CHEM, V272, P16730	15	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12959	12962		10.1074/jbc.274.19.12959	http://dx.doi.org/10.1074/jbc.274.19.12959			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224041	hybrid			2022-12-27	WOS:000080200400003
J	Bafico, A; Gazit, A; Pramila, T; Finch, PW; Yaniv, A; Aaronson, SA				Bafico, A; Gazit, A; Pramila, T; Finch, PW; Yaniv, A; Aaronson, SA			Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; SECRETED PROTEINS; CELL-LINES; FAMILY; TRANSFORMATION; EXPRESSION; MEMBER; GENE	Frizzled related proteins (FRPs) comprise a family of secreted molecules that contain an N-terminal cysteine-rich domain (CRD) highly similar to the CRDs of the frizzled family of membrane-anchored Wnt receptors. FRPs have been shown to interact with Wnt proteins and antagonize Wnt signaling in a Xenopus developmental model. Fire demonstrated that FRP antagonizes the Wnt-induced increase in uncomplexed beta-catenin in both transient cotransfection and stable transformation models, where Wnt-induced morphological alterations are inhibited as well. We showed further that FRP inhibits Wnt signaling in a paracrine mode using a T-cell factor luciferase reporter to measure Wnt function. Investigation of the mechanisms responsible for FRP inhibition revealed that FRP forms complexes with WNT-1 or WNT-2 through its CRD domain. Transfection analysis with FRPs containing different tags revealed that FRP itself forms complexes and that this ability is conferred by its CRD domain. Finally, we demonstrated by cotransfection that FRP forms complexes with a prototype frizzled. AU of these findings are consistent with a model by which FRP inhibits Wnt signaling through interactions with Wnt and/or formation of nonfunctional complexes with the frizzled receptor.	CUNY, Mt Sinai Med Ctr, David H Ruttenberg Canc Ctr, New York, NY 10029 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, IL-69978 Tel Aviv, Israel	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Sackler Faculty of Medicine	Aaronson, SA (corresponding author), CUNY, Mt Sinai Med Ctr, David H Ruttenberg Canc Ctr, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.							ALIMANDI M, 1995, ONCOGENE, V10, P1813; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; CHAN AML, 1994, P NATL ACAD SCI USA, V91, P7558, DOI 10.1073/pnas.91.16.7558; Dale TC, 1996, CANCER RES, V56, P4320; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HEIDARAN MA, 1991, J BIOL CHEM, V266, P20232; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HUGUET EL, 1994, CANCER RES, V54, P2615; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LAROCHELLE WJ, 1995, J CELL BIOL, V129, P357, DOI 10.1083/jcb.129.2.357; LAROCHELLE WJ, 1989, MOL CELL BIOL, V9, P3538, DOI 10.1128/MCB.9.8.3538; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; LIN TP, 1992, CANCER RES, V52, P4413; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Xu QH, 1998, DEVELOPMENT, V125, P4767; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	34	286	319	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16180	16187		10.1074/jbc.274.23.16180	http://dx.doi.org/10.1074/jbc.274.23.16180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347172	hybrid			2022-12-27	WOS:000080668600032
J	Adams, CM; Snyder, PM; Welsh, MJ				Adams, CM; Snyder, PM; Welsh, MJ			Paradoxical stimulation of a DEG ENaC channel by amiloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; MUTATIONS CAUSING NEURODEGENERATION; SENSITIVE NA+ CHANNEL; ION CHANNELS; CAENORHABDITIS-ELEGANS; ALPHA-SUBUNIT; CATION CHANNELS; C-ELEGANS; FAMILY; EXPRESSION	Extracellular amiloride inhibits all known DEG/ENaC ion channels, including BNC1, a proton-activated human neuronal cation channel. Earlier studies showed that protons cause a conformational change that activates BNC1 and exposes residue 430 to the extracellular solution, Here we demonstrate that, in addition to blocking BNC1, amiloride also exposes residue 430, This result suggested that, like protons, amiloride might be capable of activating the channel. To test this hypothesis, we introduced a mutation in the BNC1 pore that reduces amiloride block, and found that amiloride stimulated these channels. Amiloride inhibition was voltage-dependent, suggesting block within the pore, whereas stimulation was not, suggesting binding to an extracellular site. These data show that amiloride can have two distinct effects on BNC1, and they suggest two different interaction sites. The results suggest that extracellular amiloride binding may have a stimulatory effect similar to that of protons in BNC1 or extracellular ligands in other DEG/ENaC channels.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, 500 EMRB, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Adams, Christopher/0000-0002-5795-7212				Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Adams CM, 1999, BIOPHYS J, V76, P1377, DOI 10.1016/S0006-3495(99)77299-1; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Fuller CM, 1997, BIOPHYS J, V72, P1622, DOI 10.1016/S0006-3495(97)78808-8; Fyfe GK, 1998, SEMIN NEPHROL, V18, P138; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; LI XJ, 1995, MOL PHARMACOL, V47, P1133; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WALDMANN R, 1995, J BIOL CHEM, V270, P11735, DOI 10.1074/jbc.270.20.11735	27	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15500	15504		10.1074/jbc.274.22.15500	http://dx.doi.org/10.1074/jbc.274.22.15500			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336442	hybrid			2022-12-27	WOS:000080560100031
J	Hanakahi, LA; Sun, H; Maizels, N				Hanakahi, LA; Sun, H; Maizels, N			High affinity interactions of nucleolin with G-G-paired rDNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING DOMAINS; PRE-RIBOSOMAL-RNA; TELOMERIC DNA; CRYSTAL-STRUCTURE; PROTEIN-KINASE; CDNA SEQUENCE; CELLS; LOCALIZATION; ORGANIZATION; RECOGNITION	Nucleolin is a very abundant eukaryotic protein that localizes to the nucleolus, where the rDNA undergoes transcription, replication, and recombination and where rRNA processing occurs. The top (non-template) strand of the rDNA is very guanine-rich and has considerable potential to form structures stabilized by G-G pairing, We have assayed binding of endogenous and recombinant nucleolin to synthetic oligonucleotides in which G-rich regions have formed intermolecular G-G pairs to produce either two-stranded G2 or four-stranded G4 DNA. We report that nucleolin binds G-G-paired DNA with very high affinity; the dissociation constant for interaction with G4 DNA is K-D = 1 nM. TWO separate domains of nucleolin can interact with G-G-paired DNA, the four RNA binding domains and the C-terminal Arg-Gly-Gly repeats. Both domains bind G4 DNA with high specificity and recognize G4 DNA structure independent of sequence context. The high affinity of the nucleolin/G4 DNA interaction identifies G-G-paired structures as natural binding targets of nucleolin in the nucleolus, The ability of two independent domains of nucleolin to bind G-G-paired structures suggests that nucleolin can function as an architectural factor in rDNA transcription, replication, or recombination.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University	Maizels, N (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06510 USA.	nancy.maizels@yale.edu			NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA16038] Funding Source: Medline; NIGMS NIH HHS [R01 GM39799, R01 GM039799] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; BELENGUER P, 1990, MOL CELL BIOL, V10, P3607, DOI 10.1128/MCB.10.7.3607; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; BOURBON HM, 1990, GENE, V88, P187, DOI 10.1016/0378-1119(90)90031-L; BOURBON HM, 1988, J MOL BIOL, V200, P627, DOI 10.1016/0022-2836(88)90476-7; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; CAIZERGUESFERRER M, 1987, BIOCHEMISTRY-US, V26, P7876, DOI 10.1021/bi00398a051; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Fakan S, 1980, Int Rev Cytol, V65, P255; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gerbi SA, 1995, BIOCHEM CELL BIOL, V73, P845, DOI 10.1139/o95-092; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; HEINE MA, 1993, MOL BIOL CELL, V4, P1189, DOI 10.1091/mbc.4.11.1189; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KIM J, 1991, NATURE, V351, P331, DOI 10.1038/351331a0; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; MARIDOR G, 1990, NUCLEIC ACIDS RES, V18, P1286, DOI 10.1093/nar/18.5.1286; Maxam A M, 1980, Methods Enzymol, V65, P499; Osheim YN, 1996, J CELL BIOL, V133, P943, DOI 10.1083/jcb.133.5.943; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; PuvionDutilleul F, 1997, CHROMOSOMA, V105, P496, DOI 10.1007/s004120050211; PUVIONDUTILLEUL F, 1991, CHROMOSOMA, V100, P395, DOI 10.1007/BF00337518; RANKIN ML, 1993, NUCLEIC ACIDS RES, V21, P169, DOI 10.1093/nar/21.1.169; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; SRIVASTAVA M, 1990, J BIOL CHEM, V265, P14922; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7	50	190	201	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15908	15912		10.1074/jbc.274.22.15908	http://dx.doi.org/10.1074/jbc.274.22.15908			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336496	hybrid			2022-12-27	WOS:000080560100085
J	Hussain, NK; Yamabhai, M; Ramjaun, AR; Guy, AM; Baranes, D; O'Bryan, JP; Der, CJ; Kay, BK; McPherson, PS				Hussain, NK; Yamabhai, M; Ramjaun, AR; Guy, AM; Baranes, D; O'Bryan, JP; Der, CJ; Kay, BK; McPherson, PS			Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DOMAIN-CONTAINING PROTEIN; HIPPOCAMPAL MOSSY FIBER; KINASE SUBSTRATE EPS15; AMPHIPHYSIN SH3 DOMAIN; ACTIN CYTOSKELETON; EH-DOMAIN; BINDING-SITE; ARRESTIN/CLATHRIN INTERACTION; SACCHAROMYCES-CEREVISIAE	We recently identified and cloned intersectin, a protein containing two Eps15 homology (EH) domains and five Src homology 3 (SH3) domains. Using a newly developed intersectin antibody, we demonstrate that endogenous COS-7 cell intersectin localizes to clathrin-coated pits, and transfection studies suggest that the EH domains may direct this localization. Through alternative splicing in a stop codon, a long form of intersectin is generated with a C-terminal extension containing Dbl homology (DH), pleckstrin homology (PH), and C2 domains. Western blots reveal that the long form of intersectin is expressed specifically in neurons, whereas the short isoform is expressed at lower levels in glia and other nonneuronal cells. Immunofluorescence analysis of cultured hippocampal neurons reveals that intersectin is found at the plasma membrane where it is colocalized with clathrin. Ibp2, a protein identified based on its interactions with the EH domains of intersectin, binds to clathrin through the N terminus of the heavy chain, suggesting a mechanism for the localization of intersectin at clathrin-coated pits. Ibp2 also binds to the clathrin adaptor AP2, and antibodies against intersectin co-immunoprecipitate clathrin, AP2, and dynamin from brain extracts, These data suggest that the long and short forms of intersectin are components of the endocytic machinery in neurons and nonneuronal cells.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B4, Canada; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill	Kay, BK (corresponding author), Univ Wisconsin, Dept Pharmacol, 3795 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.			O'Bryan, John/0000-0001-5386-1080; Der, Channing/0000-0002-7751-2747	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090091] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cupers P, 1998, J BIOL CHEM, V273, P1847, DOI 10.1074/jbc.273.4.1847; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; GOSSLIN K, 1990, CULTURING NERVE CELL, P251; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARLAN JE, 1995, BIOCHEMISTRY-US, V34, P9859, DOI 10.1021/bi00031a006; INNOLO G, 1997, CANCER RES, V57, P240; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Mazzoni IE, 1996, BRAIN RES, V707, P88, DOI 10.1016/0006-8993(95)01225-7; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1999, CELL SIGNAL, V11, P229, DOI 10.1016/S0898-6568(98)00059-X; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ramjaun AR, 1996, J BIOL CHEM, V271, P24856, DOI 10.1074/jbc.271.40.24856; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sambrook J., 2002, MOL CLONING LAB MANU; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; SHARP AH, 1993, J NEUROSCI, V13, P3051; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Tang HY, 1997, MOL CELL BIOL, V17, P4294, DOI 10.1128/MCB.17.8.4294; Tang HY, 1996, MOL CELL BIOL, V16, P4897; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401	62	144	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15671	15677		10.1074/jbc.274.22.15671	http://dx.doi.org/10.1074/jbc.274.22.15671			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336464	hybrid			2022-12-27	WOS:000080560100053
J	Mera, A; Suga, M; Ando, M; Suda, T; Yamaguchi, N				Mera, A; Suga, M; Ando, M; Suda, T; Yamaguchi, N			Induction of cell shape changes through activation of the interleukin-3 common beta chain receptor by the RON receptor-type tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-STIMULATING PROTEIN; HEPATOCYTE GROWTH-FACTOR; SIGNAL-TRANSDUCTION; GM-CSF; GENE-PRODUCT; DOMAINS; SUBUNIT; FAMILY; STK; IDENTIFICATION	The RON receptor-type tyrosine kinase, a member of the hepatocyte growth factor receptor family, is a receptor for macrophage-stimulating protein (MSP), Recently, we observed that MSP induces morphological changes in interleukin (IL)-3-dependent Ba/F3 cells ectopically expressing RON. We show here that stimulation of those cells with either MSP or IL-3 increases tyrosine phosphorylation of proteins of 130, 110, 90, 62, and 58 kDa and induces similar morphological changes, accompanied by unique nuclear shape and redistribution of F-actin, A tyrosine kinase inhibitor, genistein, blocked both the increase in tyrosine phosphorylation and morphological changes. Upon stimulation with either MSP or IL-3, prominent tyrosine-phosphorylated pp90 was similarly co-immunoprecipitated with the common beta chain of IL-3 receptor (beta(c)). Unlike IL-3, stimulation with MSP increased tyrosine phosphorylation of beta(c) without activation of JAK2, resulting in morphological changes with modest cell growth. Confocal immunofluorescence analyses showed colocalization of RON, beta(c), and tyrosine-phosphorylated proteins. In vitro kinase assays revealed that autophosphorylated RON phosphorylated beta(c), These results suggest that the signaling pathway for morphological changes through beta(c) and its associated protein pp90 is distinct from the pathway for cell growth in the IL-3 signal transduction system.	Kumamoto Univ, Sch Med, Dept Internal Med 1, Kumamoto 8600811, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto 8600811, Japan	Kumamoto University; Kumamoto University	Mera, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Radiobiochem, Yada 52-1, Shizuoka 4228526, Japan.		Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771				Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; GAUGINO G, 1994, EMBO J, V13, P3524; HAN S, 1991, BIOCHEMISTRY-US, V30, P9768, DOI 10.1021/bi00104a029; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hirao A, 1998, J BIOL CHEM, V273, P10004, DOI 10.1074/jbc.273.16.10004; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; HUFF JL, 1993, P NATL ACAD SCI USA, V90, P6140, DOI 10.1073/pnas.90.13.6140; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; IWAMA A, 1994, BLOOD, V83, P3160, DOI 10.1182/blood.V83.11.3160.bloodjournal83113160; IWAMA A, 1995, BLOOD, V86, P3394, DOI 10.1182/blood.V86.9.3394.bloodjournal8693394; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; LEONARD EJ, 1976, EXP CELL RES, V102, P434, DOI 10.1016/0014-4827(76)90065-3; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; RONSIN C, 1993, ONCOGENE, V8, P1195; SABE H, 1991, INT IMMUNOL, V3, P1137, DOI 10.1093/intimm/3.11.1137; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Sakamoto O, 1997, J CLIN INVEST, V99, P701, DOI 10.1172/JCI119214; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHIMAMOTO A, 1993, FEBS LETT, V333, P61, DOI 10.1016/0014-5793(93)80375-5; SKEEL A, 1991, J EXP MED, V173, P1227, DOI 10.1084/jem.173.5.1227; SKEEL A, 1994, J IMMUNOL, V152, P4618; TADA J, 1999, IN PRESS BLOOD; TAKAKI S, 1991, EMBO J, V10, P2833, DOI 10.1002/j.1460-2075.1991.tb07832.x; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Wang MH, 1996, EXP CELL RES, V226, P39, DOI 10.1006/excr.1996.0200; WANG MH, 1994, J BIOL CHEM, V269, P14027; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WARRINGA RAJ, 1991, BLOOD, V77, P2694; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YOSHIMURA T, 1993, J BIOL CHEM, V268, P15461	43	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15766	15774		10.1074/jbc.274.22.15766	http://dx.doi.org/10.1074/jbc.274.22.15766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336478	hybrid			2022-12-27	WOS:000080560100067
J	Perletti, L; Dantonel, JC; Davidson, I				Perletti, L; Dantonel, JC; Davidson, I			The TATA-binding protein and its associated factors are differentially expressed in adult mouse tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE-LIKE TAFS; TRANSCRIPTIONAL ACTIVATION; PROMOTER SELECTIVITY; ACETYLASE COMPLEX; TFIID COMPLEX; CYCLIN GENES; DISTINCT; YEAST; CELLS	We have investigated the expression levels of the TATA-binding protein (TBP) and several TBP-associated factors (TAF(II)s) in differentiated adult mouse tissues. Immunoblots performed using monoclonal antibodies show that there are considerable variations in the levels of TBP and many TAF(II) proteins present in various tissues. Consequently, the relative levels of TAF(II)s and TBP vary significantly from one tissue to another. TBP and several TAF(II)s are overexpressed in both testis and small intestine, while in marked contrast, many of these proteins, including TBP itself, were substantially down-regulated in nervous tissues and in the heart. These tissues do, however, show a high expression level of the TBP-like factor, which thus may represent an alternative factor for the specialized transcription program in some differentiated tissues. While there are significant variations in the levels of TAF(II)28 protein, reverse transcription-coupled polymerase chain reaction shows similar expression of the TAF(II)28 mRNA in different tissues. The variations in TAF(II)28 protein levels therefore result from post-transcriptional regulatory events.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Davidson, I (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163-67404, Strasbourg, France.			Davidson, Irwin/0000-0001-5533-1171				Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; CHOMCZYNSKI P, 1986, BIOCHEM BIOPH RES CO, V134, P812, DOI 10.1016/S0006-291X(86)80493-4; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Lavigne AC, 1996, J BIOL CHEM, V271, P19774, DOI 10.1074/jbc.271.33.19774; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; May M, 1996, EMBO J, V15, P3093, DOI 10.1002/j.1460-2075.1996.tb00672.x; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Purrello M, 1998, ONCOGENE, V16, P1633, DOI 10.1038/sj.onc.1201673; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; SuzukiYagawa Y, 1997, MOL CELL BIOL, V17, P3284, DOI 10.1128/MCB.17.6.3284; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X; Wang EH, 1997, GENE DEV, V11, P2658, DOI 10.1101/gad.11.20.2658; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	36	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15301	15304		10.1074/jbc.274.22.15301	http://dx.doi.org/10.1074/jbc.274.22.15301			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336414	hybrid			2022-12-27	WOS:000080560100003
J	Fadel, MP; Dziak, E; Lo, CM; Ferrier, J; Mesaeli, N; Michalak, M; Opas, M				Fadel, MP; Dziak, E; Lo, CM; Ferrier, J; Mesaeli, N; Michalak, M; Opas, M			Calreticulin affects focal contact-dependent but not close contact-dependent cell-substratum adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; STRESS FIBER FORMATION; SWISS 3T3 FIBROBLASTS; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; INTERFERENCE-REFLECTION; SARCOPLASMIC-RETICULUM; SPHINGOSINE DERIVATIVES; INTRACELLULAR CALCIUM; CULTURED FIBROBLASTS	We used two cell lines expressing fast (RPEfast) and slow (RPEslow) attachment kinetics to investigate mechanisms of cell-substratum adhesion. We show that the abundance of a cytoskeletal protein, vinculin, is dramatically decreased in RPEfast cells. This coincides with the diminished expression level of an endoplasmic reticulum chaperone, calreticulin. Both protein and mRNA levels for calreticulin and vinculin were decreased in RPEfast cells. After RPEfast cells were transfected with cDNA encoding calreticulin, both the expression of endoplasmic reticulum-resident calreticulin and cytoplasmic vinculin increased. The abundance of other adhesion-related proteins was not affected. RPEfast cells underexpressing calreticulin displayed a dramatic increase in the abundance of total cellular phosphotyrosine suggesting that the effects of calreticulin on cell adhesiveness may involve modulation of the activities of protein tyrosine kinases or phosphatases which may affect the stability of focal contacts. The calreticulin and vinculin underexpressing RPEfast cells lacked extensive focal contacts and adhered weakly but attached fast to the substratum. In contrast, the RPEslow cells that expressed calreticulin and vinculin abundantly developed numerous and prominent focal contacts slowly, but adhered strongly, Thus, while the calreticulin overexpressing RPEslow cells "grip" the substratum with focal contacts, calreticulin underexpressing RPEfast cells use close contacts to "stick" to it.	Univ Toronto, Dept Cell Biol & Anat, Toronto, ON M5S 1A8, Canada; Univ Toronto, MRC, Periodontal Physiol Grp, Toronto, ON M5S 1A8, Canada; Univ Alberta, Dept Biochem, MRC, Grp Mol Biol Membranes, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Toronto; University of Alberta	Fadel, MP (corresponding author), Univ Toronto, Dept Cell Biol & Anat, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	m.opas@utoronto.ca		Mesaeli, Nasrin/0000-0003-1456-4643; Lo, Chun-Min/0000-0003-4382-4512				Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; BADLEY RA, 1980, J CELL SCI, V43, P379; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BEREITERHAHN J, 1979, J CELL BIOL, V82, P767, DOI 10.1083/jcb.82.3.767; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205; CHEN WT, 1985, J CELL BIOL, V100, P1103, DOI 10.1083/jcb.100.4.1103; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; COTTLERFOX M, 1979, EXP CELL RES, V118, P414, DOI 10.1016/0014-4827(79)90169-1; COUCHMAN JR, 1979, CELL BIOL INT REP, V3, P431, DOI 10.1016/0309-1651(79)90004-3; COUCHMAN JR, 1979, J CELL SCI, V39, P149; COUTU MD, 1988, P NATL ACAD SCI USA, V85, P8535, DOI 10.1073/pnas.85.22.8535; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; DANOWSKI BA, 1989, J CELL SCI, V93, P255; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; DESAI NN, 1993, J CELL BIOL, V121, P1385, DOI 10.1083/jcb.121.6.1385; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fasolato C, 1998, MOL BIOL CELL, V9, P1513, DOI 10.1091/mbc.9.6.1513; FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FLIEGEL L, 1989, BIOCHIM BIOPHYS ACTA, V982, P1, DOI 10.1016/0005-2736(89)90166-1; GEIGER B, 1983, BIOCHIM BIOPHYS ACTA, V737, P305, DOI 10.1016/0304-4157(83)90005-9; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HEATH JP, 1978, J CELL SCI, V29, P197; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; HERTL W, 1984, IN VITRO CELL DEV B, V20, P796; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ilic D, 1997, J CELL SCI, V110, P401; IZZARD CS, 1976, J CELL SCI, V21, P129; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Katoh K, 1996, CELL STRUCT FUNCT, V21, P27, DOI 10.1247/csf.21.27; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; LIU NG, 1994, J BIOL CHEM, V269, P28635; Lo CM, 1998, EUR BIOPHYS J BIOPHY, V27, P9, DOI 10.1007/s002490050105; Lo CM, 1998, PHYS REV E, V57, P6982, DOI 10.1103/PhysRevE.57.6982; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; MICHALAK M, 1980, J BIOL CHEM, V255, P1327; Michalak M, 1996, J BIOL CHEM, V271, P29436, DOI 10.1074/jbc.271.46.29436; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Moore DD, 1995, GLOB MOB SURV; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; NABI IR, 1993, J CELL SCI, V104, P37; NORTON EK, 1982, EXP CELL RES, V139, P463, DOI 10.1016/0014-4827(82)90282-8; Opas M, 1995, BIOCHEM CELL BIOL, V73, P311, DOI 10.1139/o95-039; OPAS M, 1986, INVEST OPHTH VIS SCI, V27, P1622; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; OPAS M, 1984, EUR J CELL BIOL, V33, P60; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; Pletjushkina OJ, 1998, CELL ADHES COMMUN, V5, P121, DOI 10.3109/15419069809040286; REES DA, 1977, NATURE, V267, P124, DOI 10.1038/267124a0; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; Shago M, 1997, EXP CELL RES, V230, P50, DOI 10.1006/excr.1996.3408; Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TORNQUIST K, 1994, BIOCHEM J, V299, P213, DOI 10.1042/bj2990213; VIRTANEN I, 1980, J CELL BIOL, V85, P429, DOI 10.1083/jcb.85.2.429; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5; WARD MD, 1994, J MATH BIOL, V32, P677, DOI 10.1007/BF00163022; WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432; WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Xu WM, 1998, DEVELOPMENT, V125, P327; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	86	65	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15085	15094		10.1074/jbc.274.21.15085	http://dx.doi.org/10.1074/jbc.274.21.15085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329714	hybrid			2022-12-27	WOS:000081965200079
J	Mingot, JM; Penalva, MA; Fernandez-Canon, JM				Mingot, JM; Penalva, MA; Fernandez-Canon, JM			Disruption of phacA, an Aspergillus nidulans gene encoding a novel cytochrome P450 monooxygenase catalyzing phenylacetate 2-hydroxylation, results in penicillin overproduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA U; MOLECULAR CHARACTERIZATION; HOMOGENTISATE DIOXYGENASE; IDENTIFICATION; SUPERFAMILY; EXPRESSION; REDUCTASE	Aspergillus nidulans utilizes phenylacetate as a carbon source via homogentisate, which is degraded to fumarate and acetoacetate. Mutational evidence strongly suggested that phenylacetate is converted to homogentisate through two sequential hydroxylating reactions in positions 2 and 5 of the aromatic ring. Using cDNA substraction techniques, we have characterized a gene, denoted phacA, whose transcription is strongly induced by phenylacetate and which putatively encodes a cytochrome P450 protein. A disrupted phacA strain does not grow on phenylacetate but grows on 2-hydroxy- or 2,5-dihydroxyphenylacetate. Microsomal extracts of the disrupted strain are deficient in the NADPH-dependent conversion of phenylacetate to 2-hydroxyphenylacetate. We conclude that PhacA catalyzes the ortho-hydroxylation of phenylacetate, the first step of A. nidulans phenylacetate catabolism, The involvement of a P450 enzyme in the ortho-hydroxylation of a monoaromatic compound has no precedent, In addition, PhacA shows substantial sequence divergence with known cytochromes P450 and defines a new family of these enzymes, suggesting that saprophytic fungi may represent a source of novel cytochromes P450, Phenylacetate is a precursor for benzylpenicillin production, phacA disruption increases penicillin production 3-5-fold, indicating that catabolism competes with antibiotic biosynthesis for phenylacetate and strongly suggesting strategies for Penicillium chrysogenum strain improvement by reverse genetics.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, Velazquez 144, E-28006 Madrid, Spain.		Fernandez-canon, Jose/ADI-4196-2022; Fernández-Cañón, José Manuel/AAO-6088-2020; Penalva, Miguel A/G-2295-2015; Fernández-Cañón, José Manuel/AAO-5607-2020	Fernández-Cañón, José Manuel/0000-0002-8092-2181; Penalva, Miguel A/0000-0002-3102-2806; 				ANDERSON JJ, 1980, J BACTERIOL, V141, P534, DOI 10.1128/JB.141.2.534-543.1980; APIRION D, 1965, GENET RES, V6, P317, DOI 10.1017/S0016672300004213; BENVENISTE I, 1989, BIOCHEM J, V259, P847, DOI 10.1042/bj2590847; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; CLUTTERBUCK AJ, 1993, GENETIC MAPS LOCUS M; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; ESPESO EA, 1992, MOL MICROBIOL, V6, P1457, DOI 10.1111/j.1365-2958.1992.tb00866.x; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FERNANDEZCANON JM, 1995, P NATL ACAD SCI USA, V92, P9132, DOI 10.1073/pnas.92.20.9132; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; Harayama Shigeaki, 1992, V28, P99; HOCKENHULL DJD, 1951, BIOCHEMISTRY-US, V50, P605; Lein J., 1986, OVERPRODUCTION MICRO, P105; LUENGO JM, 1994, ASPERGILLUS 50 YEARS, P603; Minambres B, 1996, J BIOL CHEM, V271, P33531, DOI 10.1074/jbc.271.52.33531; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Strobel H W, 1978, Methods Enzymol, V52, P89; SUGUMARAN M, 1979, FEMS MICROBIOL LETT, V5, P427, DOI 10.1111/j.1574-6968.1979.tb03373.x; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; VANGORCOM RFM, 1990, MOL GEN GENET, V223, P192, DOI 10.1007/BF00265053; VERMILION JL, 1978, J BIOL CHEM, V253, P8812; WHITED GM, 1991, J BACTERIOL, V173, P3010, DOI 10.1128/JB.173.9.3010-3016.1991	28	59	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14545	14550		10.1074/jbc.274.21.14545	http://dx.doi.org/10.1074/jbc.274.21.14545			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329644	Green Published, hybrid			2022-12-27	WOS:000081965200009
J	van de Poel, RHL; Meijers, JCM; Bouma, BN				van de Poel, RHL; Meijers, JCM; Bouma, BN			Interaction between protein S and complement C4b-binding protein (C4BP) - Affinity studies using chimeras containing C4BP beta-chain short consensus repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C4-BINDING PROTEIN; COAGULATION FACTOR-XI; BINDING-SITE; COFACTOR ACTIVITY; CLASSICAL PATHWAY; ENDOTHELIAL-CELLS; ALPHA-CHAIN; PLASMA; PROTEOLYSIS; SYSTEM	Human C4b-binding protein (C4BP) is a regulator of the complement system and plays an important role in the regulation of the anticoagulant protein C pathway. C4BP can bind anticoagulant protein S, resulting in a decreased cofactor function of protein S for activated protein C, C4BP is a multimeric protein containing several identical alpha chains and a single beta-chain (C4BP beta), each chain being composed of short consensus repeats (SCRs), Previous studies have localized the protein S binding site to the NH2-terminal SCR (SCR-1) of C4BP beta. To further localize the protein S binding site, we constructed chimeras containing C4BP beta SCR-1, SCR-2, SCR-3, SCR-1+2, SCR-1+3, and SCR-2+3 fused to tissue-type plasminogen activator. Binding assays of protein S with these chimeras indicated that SCR-S contributes to the interaction of protein S with SCR-1, since the affinity of protein S for SCR-1+2 was up to B-fold higher compared with SCR-1 and SCR-1+3. Using an assay that measures protein S cofactor activity, we showed that cofactor activity was decreased due to binding to constructs that contain SCR-1. SCR-1+2 inhibited more potently than SCR-1 and SCR-1+3. SCR-3 had no additional effect on SCR-1, and therefore the effect of SCR-S was specific. In conclusion, beta-chain SCR-2 contributes to the interaction of C4BP with protein S.	Univ Utrecht, Med Ctr, Dept Haematol, Thrombosis & Haemostasis Lab, NL-3508 GA Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	van de Poel, RHL (corresponding author), Univ Utrecht, Med Ctr, Dept Haematol, Thrombosis & Haemostasis Lab, POB 85500, NL-3508 GA Utrecht, Netherlands.		Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780				BERTINA RM, 1985, THROMB HAEMOSTASIS, V53, P268; CHANG CTG, 1994, THROMB HAEMOSTASIS, V71, P461; CHUNG LP, 1985, BIOCHEM J, V230, P133, DOI 10.1042/bj2300133; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; DAHA MR, 1980, J IMMUNOL, V125, P2051; DAHLBACK B, 1984, J BIOL CHEM, V259, P1631; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1986, J BIOL CHEM, V261, P2022; DAHLBACK B, 1983, P NATL ACAD SCI-BIOL, V80, P3461, DOI 10.1073/pnas.80.11.3461; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DAHLBACK B, 1990, J BIOL CHEM, V265, P16082; DE FRUTOS PG, 1994, BLOOD, V84, P815; FERNANDEZ JA, 1993, J BIOL CHEM, V268, P16788; FERNANDEZ JA, 1994, J BIOL CHEM, V269, P2535; FERNANDEZ JA, 1994, BIOCHEMISTRY-US, V33, P11073, DOI 10.1021/bi00203a003; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; FUJITA T, 1983, J EXP MED, V157, P1239, DOI 10.1084/jem.157.4.1239; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GRIFFIN JH, 1992, BLOOD, V79, P3203; HACKENG TM, 1993, J BIOL CHEM, V268, P3993; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Hardig Y, 1996, J BIOL CHEM, V271, P20861, DOI 10.1074/jbc.271.34.20861; HARDIG Y, 1993, J BIOL CHEM, V268, P3033; Herwald H, 1996, J BIOL CHEM, V271, P13061, DOI 10.1074/jbc.271.22.13061; HESSING M, 1991, EUR J IMMUNOL, V21, P2077, DOI 10.1002/eji.1830210916; HESSING M, 1990, THROMB HAEMOSTASIS, V64, P245; HILLARP A, 1993, J BIOL CHEM, V268, P15017; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; HILLARP A, 1988, J BIOL CHEM, V263, P12759; JOHANNESSEN M, 1990, THROMB HAEMOSTASIS, V63, P54; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; Linse S, 1997, J BIOL CHEM, V272, P14658, DOI 10.1074/jbc.272.23.14658; MEIJERS JCM, 1992, BLOOD, V79, P1435; MEIJERS JCM, 1992, BIOCHEMISTRY-US, V31, P4680, DOI 10.1021/bi00134a021; NELSON RM, 1992, J BIOL CHEM, V267, P8140; NISHIOKA J, 1990, J BIOL CHEM, V265, P9072; NUSSENZWEIG V, 1981, METHOD ENZYMOL, V80, P124; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207; SUZUKI K, 1988, J BIOL CHEM, V263, P17034; Villoutreix BO, 1995, PROTEIN ENG, V8, P1253, DOI 10.1093/protein/8.12.1253; WALKER FJ, 1989, J BIOL CHEM, V264, P17645; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	47	24	24	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15144	15150		10.1074/jbc.274.21.15144	http://dx.doi.org/10.1074/jbc.274.21.15144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329721	hybrid			2022-12-27	WOS:000081965200086
J	Yan, SF; Lu, JS; Zou, YS; Soh-Won, J; Cohen, DM; Buttrick, PM; Cooper, DR; Steinberg, SF; Mackman, N; Pinsky, DJ; Stern, DM				Yan, SF; Lu, JS; Zou, YS; Soh-Won, J; Cohen, DM; Buttrick, PM; Cooper, DR; Steinberg, SF; Mackman, N; Pinsky, DJ; Stern, DM			Hypoxia-associated induction of early growth response-1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; VASCULAR ENDOTHELIAL-CELLS; TYROSINE-HYDROXYLASE GENE; RAT VENTRICULAR MYOCYTES; TERNARY COMPLEX FACTORS; TISSUE FACTOR GENE; FIBRIN DEPOSITION; TRANSCRIPTIONAL REGULATION; OXYGEN DEPRIVATION	The paradigm for the response to hypoxia is erythropoietin gene expression; activation of hypoxia-inducible factor-1 (HIF-1) results in erythropoietin production. Previously, we found that oxygen deprivation induced tissue factor, especially in mononuclear phagocytes, by an early growth response (Egr-1)-dependent pathway without involvement of HIF-1 (Yan, S.-F., Zou, Y.-S., Gao, Y., Zhai, C., Mackman, N., Lee, S., Milbrandt, J., Pinsky, D., Kisiel, TY., and Stern, D. (1998) Proc. Natl. Acad Sci. U.S.A. 95, 8298-8303). Now, we show that cultured monocytes subjected to hypoxia (pO(2) approximate to 12 torr) displayed increased Egr-1 expression because of de novo biosynthesis, with a approximate to 10-fold increased rate of transcription. Transfection of monocytes with Egr-1 promoter-luciferase constructs localized elements responsible for hypoxia-enhanced expression to -424/-65, a region including EBS (ets binding site)-SRE (serum response element)-EBS and SRE-EBS-SRE sites. Further studies with each of these regions Ligated to the basal thymidine kinase promoter and luciferase demonstrated that EBS sites in the element spanning -424/-375 were critical for hypoxia-enhanceable gene expression. These data suggested that an activated ets factor, such as Elk-1, in complex with serum response factor, was the likely proximal trigger of Egr-1 transcription. Indeed, hypoxia induced activation of Elk-1, and suppression of Elk-1 blocked up-regulation of Egr-1 transcription. The signaling cascade preceding Elk-1 activation in response to oxygen deprivation was traced to activation of protein kinase C-beta II, Raf, mitogen-activated protein kinase/extracellular signal-regulated protein kinase kinase and mitogen-activated protein kinases. Comparable hypoxia-mediated Egr-1 induction and activation were observed in cultured hepatoma-derived cells deficient in HIF-1 beta and wild-type hepatoma cells, indicating that the HIF-1 and Egr-1 pathways are initiated independently in response to oxygen deprivation. me propose that activation of Egr-1 in response to hypoxia induces a different facet of the adaptive response than HIF-1, one component of which causes expression of tissue factor, resulting in fibrin deposition.	Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Oregon Hlth Sci Univ, Dept Med, Div Nephrol, Portland, OR 97201 USA; Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60612 USA; Univ S Florida, James A Haley Vet Hosp, Tampa, FL 33711 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Oregon Health & Science University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Scripps Research Institute; Scripps Research Institute	Yan, SF (corresponding author), Columbia Univ Coll Phys & Surg, Dept Surg, 630 W 168th St,P&S 11-420, New York, NY 10032 USA.				NHLBI NIH HHS [HL42507, HL59488, HL55397] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059488, R01HL055397, R01HL042507] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; BRAND T, 1992, CIRC RES, V71, P1351, DOI 10.1161/01.RES.71.6.1351; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; CARDELL M, 1993, J NEUROCHEM, V61, P1308, DOI 10.1111/j.1471-4159.1993.tb13623.x; Chalfant CE, 1996, MOL ENDOCRINOL, V10, P1273, DOI 10.1210/me.10.10.1273; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; CONRAD R, 1994, J BIOL CHEM, V269, P32051; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Danis RP, 1998, INVEST OPHTH VIS SCI, V39, P171; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Folkman J, 1996, NAT MED, V2, P167, DOI 10.1038/nm0296-167; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goldberg M, 1997, J CLIN INVEST, V99, P55, DOI 10.1172/JCI119133; Gozal E, 1998, J APPL PHYSIOL, V85, P372, DOI 10.1152/jappl.1998.85.1.372; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang TR, 1996, CIRC RES, V78, P553, DOI 10.1161/01.RES.78.4.553; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Khachigian LM, 1997, CIRC RES, V81, P457, DOI 10.1161/01.RES.81.4.457; KILEY SC, 1995, J CELL SCI, V108, P1003; KOONG AC, 1994, CANCER RES, V54, P1425; KORTENJANN M, 1995, ONCOGENE, V11, P2105; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LI YW, 1995, AM J PHYSIOL-HEART C, V268, pH426, DOI 10.1152/ajpheart.1995.268.1.H426; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mishra RR, 1998, MOL BRAIN RES, V59, P74, DOI 10.1016/S0169-328X(98)00139-9; MITCHELL FE, 1989, BIOCHEM J, V261, P131, DOI 10.1042/bj2610131; Muller JM, 1997, EUR J BIOCHEM, V244, P45, DOI 10.1111/j.1432-1033.1997.00045.x; Muller JN, 1997, J BIOL CHEM, V272, P23435, DOI 10.1074/jbc.272.37.23435; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; OUELLETTE AJ, 1990, J CLIN INVEST, V85, P766, DOI 10.1172/JCI114502; Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307; ROBERTSON M, 1998, MOL CELL BIOL, V15, P3531; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schwachtgen JL, 1998, J CLIN INVEST, V101, P2540, DOI 10.1172/JCI1404; Semenza GL, 1996, TRENDS CARDIOVAS MED, V6, P151, DOI 10.1016/1050-1738(96)00039-4; Sieber FE, 1998, STROKE, V29, P1445, DOI 10.1161/01.STR.29.7.1445; Soh JW, 1999, MOL CELL BIOL, V19, P1313; SPEECHLYDICK ME, 1994, CIRC RES, V75, P586, DOI 10.1161/01.RES.75.3.586; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yan SF, 1997, J BIOL CHEM, V272, P4287, DOI 10.1074/jbc.272.7.4287; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; YAN SF, 1995, J BIOL CHEM, V270, P11463, DOI 10.1074/jbc.270.19.11463; YAO KS, 1994, MOL CELL BIOL, V14, P5997, DOI 10.1128/MCB.14.9.5997; Zhang YM, 1996, J CLIN INVEST, V97, P2213, DOI 10.1172/JCI118662	59	213	226	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15030	15040		10.1074/jbc.274.21.15030	http://dx.doi.org/10.1074/jbc.274.21.15030			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329706	hybrid			2022-12-27	WOS:000081965200071
J	Beullens, M; Van Eynde, A; Vulsteke, V; Connor, J; Shenolikar, S; Stalmans, W; Bollen, M				Beullens, M; Van Eynde, A; Vulsteke, V; Connor, J; Shenolikar, S; Stalmans, W; Bollen, M			Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; INHIBITORY POLYPEPTIDES; PHOSPHORYLATION; BINDING; IDENTIFICATION; EXPRESSION; MECHANISM; GLYCOGEN; PEPTIDES; CLONING	NIPP-1 is a subunit of the major nuclear protein phosphatase-l (PP-1) in mammalian cells and potently inhibits PP-1 activity in vitro, Using yeast two-hybrid and co-sedimentation assays, we mapped a PP-1-binding site and the inhibition function to the central one-third domain of NIPP-1, Full-length NIPP-1 (351 residues) and the central domain, NIPP-1(143-217), were equally potent PP-1 inhibitors (IC50 = 0.3 mu M). Synthetic peptides spanning the central domain of NIPP-1 further narrowed the PP-1 inhibitory function to residues 191-200, A second, noninhibitory PP-1-binding site was identified by far-Western assays with digoxygenin-conjugated catalytic subunit (PP-1(C)) and included a consensus RVXF motif (residues 200-203) found in many other PP-1-binding proteins. The substitutions, V201A and/or F203A, in the RVXF motif, or phosphorylation of Ser(199) or Ser(204), which are established phosphorylation sites for protein kinase A and protein kinase CK2, respectively, prevented PP-1(C)-binding by NIPP-1(191-210) in the far-Western assay. NIPP-1(191-210) competed for PP-1 inhibition by full-length NIPP-1(1-351), inhibitor-1 and inhibitor-2, and dissociated PP-1(C) from inhibitor-1- and NIPP-1(143-217)-Sepharose but not from full-length NIPP-1(1-351)-Sepharose. Together, these data identified some of the key elements in the central domain of NIPP-1 that regulate PP-1 activity and suggested that the flanking sequences stabilize the association of NIPP-1 with PP-1(C).	Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochim, B-3000 Louvain, Belgium; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	KU Leuven; Duke University	Bollen, M (corresponding author), Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochim, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.ac.be		Connor, John/0000-0002-8867-7256	NIDDK NIH HHS [DK52044] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK052044] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; ANTONIW JF, 1977, BIOCHEM J, V162, P423, DOI 10.1042/bj1620423; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 1998, METH MOL B, V93, P145; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIAND JP, 1985, J IMMUNOL METHODS, V78, P59, DOI 10.1016/0022-1759(85)90329-1; Connor JH, 1998, J BIOL CHEM, V273, P27716, DOI 10.1074/jbc.273.42.27716; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Endo S, 1997, BIOCHEMISTRY-US, V36, P6986, DOI 10.1021/bi970418i; FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Jagiello I, 1997, J BIOL CHEM, V272, P22067, DOI 10.1074/jbc.272.35.22067; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Johnson DF, 1996, EUR J BIOCHEM, V239, P317, DOI 10.1111/j.1432-1033.1996.0317u.x; Kreivi JP, 1997, FEBS LETT, V420, P57, DOI 10.1016/S0014-5793(97)01485-3; Krtolica A, 1998, ONCOGENE, V17, P2295, DOI 10.1038/sj.onc.1202159; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; PARK IK, 1994, J BIOL CHEM, V269, P944; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Yang J, 1998, FASEB J, V12, pA1407; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	35	73	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14053	14061		10.1074/jbc.274.20.14053	http://dx.doi.org/10.1074/jbc.274.20.14053			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318819	hybrid			2022-12-27	WOS:000080322200048
J	Lewis, AL; Xia, Y; Datta, SK; McMillin, J; Kellems, RE				Lewis, AL; Xia, Y; Datta, SK; McMillin, J; Kellems, RE			Combinatorial interactions regulate cardiac expression of the murine adenylosuccinate synthetase 1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE GENE; HEAVY-CHAIN GENE; POSITION-INDEPENDENT EXPRESSION; DNA-BINDING TARGETS; TRANSGENIC MICE; DEVELOPMENTAL REGULATION; SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; UPSTREAM ELEMENTS; TRANSCRIPTION	The mammalian heart begins contracting at the linear tube stage during embryogenesis and continuously pumps, nonstop, throughout the entire lifetime of the animal. Therefore, the cardiac energy metabolizing pathways must be properly established and efficiently functioning. While the biochemistry of these pathways is well defined, limited information regarding the regulation of cardiac metabolic genes is available. Previously, we reported that 1.9 kilobase pairs of murine adenylosuccinate synthetase 1 gene (Adss1) 5'-flanking DNA directs high levels of reporter expression to the adult transgenic heart, In this report, we define the 1.9-kilobase pair fragment as a cardiac-specific enhancer that controls correct spatiotemporal expression of a reporter similar to the endogenous Adss1 gene. A 700-base pair fragment within this region activates a heterologous promoter specifically in adult transgenic hearts. Proteins present in a cardiac nuclear extract interact with potential transcription factor binding sites of this region and these cia-acting sites play important regulatory roles in the cardiac expression of this reporter. Finally, we report that several different cardiac transcription factors trans-activate the 1.9HSCAT construct through these sites and that combinations result in enhanced reporter expression. Adss1 appears to be one of the first target genes identified for the bHLH factors Hand1 and Hand2.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas System; Baylor College of Medicine	Kellems, RE (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.							ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1989, MOL CELL BIOL, V9, P2513, DOI 10.1128/MCB.9.6.2513; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Colbert MC, 1997, J CLIN INVEST, V100, P1958, DOI 10.1172/JCI119727; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U; FabreSuver C, 1996, J BIOL CHEM, V271, P4646, DOI 10.1074/jbc.271.9.4646; Fishman MC, 1997, DEVELOPMENT, V124, P2099; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GUICHERIT OM, 1991, J BIOL CHEM, V266, P22582; Gulick J, 1997, CIRC RES, V80, P655, DOI 10.1161/01.RES.80.5.655; Higgs DR, 1998, CELL, V95, P299, DOI 10.1016/S0092-8674(00)81761-4; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; KELLER A, 1992, MECH DEVELOP, V38, P41, DOI 10.1016/0925-4773(92)90037-K; KNOTTS S, 1995, NUCLEIC ACIDS RES, V23, P3301, DOI 10.1093/nar/23.16.3301; KRNACIK MJ, 1995, J BIOL CHEM, V270, P11119, DOI 10.1074/jbc.270.19.11119; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LEE KJ, 1994, MOL CELL BIOL, V14, P1220, DOI 10.1128/MCB.14.2.1220; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Lee Y, 1997, MOL CELL BIOL, V17, P2745, DOI 10.1128/MCB.17.5.2745; Lewis AL, 1996, J BIOL CHEM, V271, P22647, DOI 10.1074/jbc.271.37.22647; LYONS GE, 1991, DEVELOPMENT, V113, P1017; MAHNKEZIZELMAN DK, 1992, J BIOL CHEM, V267, P20866; McGrew MJ, 1996, MOL CELL BIOL, V16, P4524; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; RINDT H, 1995, P NATL ACAD SCI USA, V92, P1540, DOI 10.1073/pnas.92.5.1540; Sambrook J., 2002, MOL CLONING LAB MANU; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shi DQ, 1997, J BIOL CHEM, V272, P2334, DOI 10.1074/jbc.272.4.2334; Shi DQ, 1998, J BIOL CHEM, V273, P27331, DOI 10.1074/jbc.273.42.27331; Shield MA, 1996, MOL CELL BIOL, V16, P5058; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P1; WINSTON JH, 1992, J BIOL CHEM, V267, P13472; Xia Y, 1996, J BIOL CHEM, V271, P12082, DOI 10.1074/jbc.271.20.12082; Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399; Xu PA, 1999, J BIOL CHEM, V274, P10316, DOI 10.1074/jbc.274.15.10316	46	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14188	14197		10.1074/jbc.274.20.14188	http://dx.doi.org/10.1074/jbc.274.20.14188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318837	hybrid			2022-12-27	WOS:000080322200066
J	Missiaen, L; Parys, JB; Weidema, AF; Sipma, H; Vanlingen, S; De Smet, P; Callewaert, G; De Smedt, H				Missiaen, L; Parys, JB; Weidema, AF; Sipma, H; Vanlingen, S; De Smet, P; Callewaert, G; De Smedt, H			The bell-shaped Ca2+ dependence of the inositol 1,4,5-trisphosphate-induced Ca2+ release is modulated by Ca2+/calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; CYTOSOLIC CA2+; CA2+-INDEPENDENT INHIBITION; TRISPHOSPHATE RECEPTORS; LUMINAL CA2+; CALCIUM; CALMODULIN; MOBILIZATION; CEREBELLUM	Calmodulin inhibits inositol 1,4,5-trisphosphate (IP3) binding to the IP3 receptor in both a Ca2+-dependent and a Ca2+-independent way. Because there are no functional data on the modulation of the IP3-induced Ca2+ release by calmodulin at various Ca2+ concentrations, we have studied how cytosolic Ca2+ and Sr2+ interfere with the effects of calmodulin on the IP3-induced Ca2+ release in permeabilized A7r5 cells, We now report that calmodulin inhibited Ca2+ release through the IP3 receptor with an IC50 of 4.6 mu M if the cytosolic Ca2+ concentration was 0.3 mu M or higher. This inhibition was particularly pronounced at low IP3 concentrations. In contrast, calmodulin did not affect IP3-induced Ca2+ release if the cytosolic Ca2+ concentration was below 0.3 mu M. Calmodulin also inhibited Ca2+ release through the IP3 receptor in the presence of at least 10 mu M Sr2+. We conclude that cytosolic Ca2+ or Sr2+ are absolutely required for the calmodulin-induced inhibition of the IP,induced Ca2+ release and that this dependence represents the formation of the Ca2+/calmodulin or Sr2+/ calmodulin complex.	Catholic Univ Louvain, Fysiol Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain	Missiaen, L (corresponding author), Catholic Univ Louvain, Fysiol Lab, Campus Gasthuisberg O-N,Herestr 49, B-3000 Louvain, Belgium.			Parys, Jan/0000-0002-3591-4967				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BOOTMAN MD, 1995, BIOCHEM J, V306, P445, DOI 10.1042/bj3060445; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; COMBETTES L, 1994, J BIOL CHEM, V269, P17561; COX JA, 1981, J BIOL CHEM, V256, P3218; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; HORNE JH, 1995, BIOCHEMISTRY-US, V34, P12738, DOI 10.1021/bi00039a033; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MARSHALL ICB, 1994, BIOCHEM J, V301, P591, DOI 10.1042/bj3010591; Martell AE, 1989, CRITICAL STABILITY C; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; RICHARDSON A, 1993, J BIOL CHEM, V268, P11528; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SIPMA H, 1999, IN PRESS J BIOL CHEM, V274; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; ZHANG BX, 1993, J BIOL CHEM, V268, P10997	24	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13748	13751		10.1074/jbc.274.20.13748	http://dx.doi.org/10.1074/jbc.274.20.13748			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318777	hybrid			2022-12-27	WOS:000080322200006
J	Plager, DA; Loegering, DA; Weiler, DA; Checkel, JL; Wagner, JM; Clarke, NJ; Naylor, S; Page, SM; Thomas, LL; Akerblom, I; Cocks, B; Stuart, S; Gleich, GJ				Plager, DA; Loegering, DA; Weiler, DA; Checkel, JL; Wagner, JM; Clarke, NJ; Naylor, S; Page, SM; Thomas, LL; Akerblom, I; Cocks, B; Stuart, S; Gleich, GJ			A novel and highly divergent homolog of human eosinophil granule major basic protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SEQUENCE-ANALYSIS; CATIONIC PROTEIN; MESSENGER-RNA; AMINO-ACID; CELLS; RIBONUCLEASE; NEUROTOXIN; ACTIVATION; MECHANISM	Eosinophils are important effector cells in defense against helminth infection and in allergic diseases. To identify novel eosinophil proteins, large scale sequencing of a cDNA library prepared from interleukin-5-stimulated umbilical cord precursor cells was performed, and the major genes expressed by maturing eosinophils were determined. This resulted in the identification of a cDNA with 64% identity to human prepro-major basic protein (hprepro-MBP). This cDNA was designated hprepro-MBP homolog (hprepro-MBPH). Interestingly, the calculated pI values for hMBPH and hMBP differed by > 100-fold, with pI values of 8.7 and 11.4, respectively, Given this pronounced basicity difference, the homolog transcript's abundance (1.1%), and MBP's critical role in eosinophil biological activity, we further characterized the homolog. Reverse transcription-polymerase chain reaction detected transcription of hprepro-MBPH in bone marrow only, and this result was confirmed by analysis of a large cDNA data base (electronic Northern). hMBPH was isolated from human eosinophil granule lysates, and its identity was verified by amino acid sequencing and by mass spectrometry. Analyses of the biological activities showed that hMBPH had effects similar to hMBP in cell killing and neutrophil (superoxide anion production and interleukin-8 release) and basophil (histamine and leukotriene C-4 release) stimulation assays, but usually with reduced potency. Overall, this novel homolog's unique physical properties indicated that the high net positive charge of hMBP is important but not essential for biological activity.	Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Biol, Rochester, MN 55905 USA; Incyte Pharmaceut, Palo Alto, CA 94304 USA; Rush Presbyterian St Lukes Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Incyte; Rush University	Plager, DA (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	plager.douglas@mayo.edu			NIAID NIH HHS [AI 34577, AI 32041, AI 09728] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009728, R37AI009728, R01AI032041, U19AI034577, U01AI034577] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABUGHAZALEH RI, 1992, J MEMBRANE BIOL, V128, P153; ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; AOKI I, 1991, FEBS LETT, V282, P56, DOI 10.1016/0014-5793(91)80443-7; Bains W, 1996, NAT BIOTECHNOL, V14, P711, DOI 10.1038/nbt0696-711; BARKER RL, 1990, GENE, V86, P285, DOI 10.1016/0378-1119(90)90292-Y; BONNO M, 1994, LAB INVEST, V70, P234; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Fasman G.D., 1989, PRACTICAL HDB BIOCH, P196; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GLEICH GJ, 1988, J ALLERGY CLIN IMMUN, V81, P776, DOI 10.1016/0091-6749(88)90931-1; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; GLEICH GJ, 1976, J CLIN INVEST, V57, P633, DOI 10.1172/JCI108319; GLEICH GJ, 1992, INFLAMMATION BASIC P, P663; GRUART V, 1992, BLOOD, V79, P2592; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; HARLOW E, 1988, ANTIBODIES LABORATOR, P207; HASKELL MD, 1995, BLOOD, V86, P4627, DOI 10.1182/blood.V86.12.4627.bloodjournal86124627; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; KINGSTON RE, 1997, CURRENT PROTOCOLS MO, V1, pCH4; KITA H, 1995, J IMMUNOL, V154, P4749; KITA H, 1998, ALLERGY PRINCIPLES P, V1, P242; KROEGEL C, 1987, LANCET, V1, P1380; LARSON KA, 1995, J IMMUNOL, V155, P3002; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LODISH H, 1995, MOL CELL BIOL, P694; LODISH H, 1995, MOL CELL BIOL, P1139; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MADDOX DE, 1984, J EXP MED, V160, P29, DOI 10.1084/jem.160.1.29; MCCONAHEY P, 1980, IMMUNOCHEMICAL TEC A, V70, P210; MCGROGAN M, 1988, J EXP MED, V168, P2295, DOI 10.1084/jem.168.6.2295; MOY JN, 1990, J IMMUNOL, V145, P2626; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OXVIG C, 1994, FEBS LETT, V341, P213, DOI 10.1016/0014-5793(94)80459-1; OXVIG C, 1994, BIOCHEM MOL BIOL INT, V33, P329; OXVIG C, 1993, J BIOL CHEM, V268, P12243; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; POPKENHARRIS P, 1995, J IMMUNOL, V155, P1472; ROCHESTER CL, 1995, CHEST, V107, pS117, DOI 10.1378/chest.107.3_Supplement.117S; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; SAITO H, 1988, P NATL ACAD SCI USA, V85, P2288, DOI 10.1073/pnas.85.7.2288; SARMIENTO EU, 1995, J IMMUNOL, V155, P2211; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sivaraman T, 1997, J PROTEIN CHEM, V16, P291, DOI 10.1023/A:1026357009886; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; SPRY CJF, 1983, Q J MED, V52, P1; TAI PC, 1987, LANCET, V1, P643; TEN RM, 1991, CYTOKINE, V3, P350, DOI 10.1016/1043-4666(91)90505-8; TEN RM, 1989, J EXP MED, V169, P1757, DOI 10.1084/jem.169.5.1757; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; WAGNER JM, 1993, PLACENTA, V14, P671, DOI 10.1016/S0143-4004(05)80384-4; WASMOEN TL, 1988, J BIOL CHEM, V263, P12559; Yamaguchi Y, 1998, BLOOD, V91, P3447, DOI 10.1182/blood.V91.9.3447.3447_3447_3458; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	62	58	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14464	14473		10.1074/jbc.274.20.14464	http://dx.doi.org/10.1074/jbc.274.20.14464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318872	hybrid			2022-12-27	WOS:000080322200101
J	Trevino, RJ; Gliubich, F; Berni, R; Cianci, M; Chirgwin, JM; Zanotti, G; Horowitz, PM				Trevino, RJ; Gliubich, F; Berni, R; Cianci, M; Chirgwin, JM; Zanotti, G; Horowitz, PM			NH2-terminal sequence truncation decreases the stability of bovine rhodanese, minimally perturbs its crystal structure, and enhances interaction with GroEL under native conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER RHODANESE; PROTEIN; ENZYME; RESOLUTION; SITE	The NH2-terminal sequence of rhodanese influences many of its properties, ranging from mitochondrial import to folding. Rhodanese truncated by >9 residues is degraded in Escherichia coli. Mutant enzymes with lesser truncations are recoverable and active, but they show altered active site reactivities (Trevino, R. J., Tsalkova, T., Dramer, G., Hardesty, B., Chirgwin, J. M., and Horowitz, P. M, (1998) J. Biol. Chem. 273, 27841-27847), suggesting that the NH2-terminal sequence stabilizes the overall structure. We tested aspects of the conformations of these shortened species. Intrinsic and probe fluorescence showed that truncation decreased stability and increased hydrophobic exposure, while near UV CD suggested altered tertiary structure. Under native conditions, truncated rhodanese bound to GroEL and was released and reactivated by adding ATP and GroES, suggesting equilibrium between native and nonnative conformers. Furthermore, GroEL assisted folding of denatured mutants to the same extent as wild type, although at a reduced rate. X-ray crystallography showed that Delta 1-7 crystallized isomorphously with wild type in polyethyleneglycol, and the structure was highly conserved. Thus, the missing NH2-terminal residues that contribute to global stability of the native structure in solution do not significantly alter contacts at the atomic level of the crystallized protein. The two-domain structure of rhodanese was not significantly altered by drastically different crystallization conditions or crystal packing suggesting rigidity of the native rhodanese domains and the stabilization of the interdomain interactions by the crystal environment. The results support a model in which loss of interactions near the rhodanese NH2 terminus does not distort the folded native structure but does facilitate the transition in solution to a molten globule state, which among other things, can interact with molecular chaperone.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Med Endocrinol, San Antonio, TX 78284 USA; Univ Padua, Dept Organ Chem, I-35131 Padua, Italy; CNR, Biopolymer Res Ctr, I-35131 Padua, Italy; Univ Milan, Inst Pharmaceut Chem, I-20135 Milan, Italy; Univ Parma, Inst Biochem Sci, I-43100 Parma, Italy	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Parma	Horowitz, PM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.	horowitz@bioc02.uthscsa.edu	Cianci, Michele/I-5577-2012; Cianci, Michele/AAD-7581-2019	Cianci, Michele/0000-0001-5607-6061; Cianci, Michele/0000-0001-5607-6061; Zanotti, Giuseppe/0000-0002-0945-6501; Berni, Rodolfo/0000-0002-1839-0479	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOGGARAM V, 1985, BIOCHEM BIOPH RES CO, V130, P407, DOI 10.1016/0006-291X(85)90431-0; BOLEN DW, 1974, ARCH BIOCHEM BIOPHYS, V161, P435, DOI 10.1016/0003-9861(74)90325-7; CHOW SF, 1985, J BIOL CHEM, V260, P9593; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Fenton WA, 1997, PROTEIN SCI, V6, P743; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Gliubich F, 1998, ACTA CRYSTALLOGR D, V54, P481, DOI 10.1107/S090744499701216X; Gorovits BM, 1998, BBA-PROTEIN STRUCT M, V1382, P120, DOI 10.1016/S0167-4838(97)00158-1; GUIDO K, 1976, BIOCHIM BIOPHYS ACTA, V427, P600, DOI 10.1016/0005-2795(76)90203-8; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOROWITZ PM, 1993, ACS SYM SER, V516, P167; Kahn P C, 1979, Methods Enzymol, V61, P339; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; LAKOWICZ JR, 1986, PRINCIPLES FLUORESCE, P342; LIJK LJ, 1984, EUR J BIOCHEM, V142, P399, DOI 10.1111/j.1432-1033.1984.tb08301.x; LUO GX, 1993, J BIOL CHEM, V268, P10246; LUO GX, 1995, BBA-PROTEIN STRUCT M, V1252, P165, DOI 10.1016/0167-4838(95)00131-D; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Pace C N, 1986, Methods Enzymol, V131, P266; PLOEGMAN JH, 1979, J MOL BIOL, V127, P149, DOI 10.1016/0022-2836(79)90236-5; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; Trevino RJ, 1998, J BIOL CHEM, V273, P27841, DOI 10.1074/jbc.273.43.27841; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VOLINI M, 1967, J BIOL CHEM, V242, P5220; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; Westley J, 1981, Methods Enzymol, V77, P285	32	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13938	13947		10.1074/jbc.274.20.13938	http://dx.doi.org/10.1074/jbc.274.20.13938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318804	hybrid			2022-12-27	WOS:000080322200033
J	Zhao, JM; Furukawa, K; Fukumoto, S; Okada, M; Furugen, R; Miyazaki, H; Takamiya, K; Aizawa, S; Shiku, H; Matsuyama, T; Furukawa, K				Zhao, JM; Furukawa, K; Fukumoto, S; Okada, M; Furugen, R; Miyazaki, H; Takamiya, K; Aizawa, S; Shiku, H; Matsuyama, T; Furukawa, K			Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LYMPHOCYTE SUBPOPULATIONS; VIRUS TYPE-I; SYNTHASE GENE; T-LYMPHOCYTES; ASIALO GM1; C-MYC; ACTIVATION; EXPRESSION; PROLIFERATION; ASSOCIATION	T cell development and function in complex ganglioside-lacking (GM2/GD2 synthase gene-disrupted) mice were analyzed, GM1, asialo-GM1, and GD1b were representative gangliosides expressed on T cells of the wild type mice and completely deleted on those of the mutant mice. The sizes and cell numbers of the mutant mice spleen and thymus were significantly reduced, Spleen cells from the mutant mice showed clearly reduced proliferation compared with the wild type when stimulated by interleukin 2 (IL-2) but not when treated with concanavalin A or anti-CD3 cross-linking Expression levels of IL-2 receptor alpha, beta, and gamma were almost equivalent, and up-regulation of a chain after T cell activation was also similar between the mutant and wild type mice. Activation of JAK1, JAK3, and SAT5 after IL-2 treatment was reduced, and c-fos expression was delayed and reduced in the mutant spleen cells, suggesting that the IL-2 signal was attenuated in the mutant mice probably due to the modulation of IL-2 receptors by the lack of complex gangliosides.	Nagoya Univ, Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan; Nagasaki Univ, Sch Dent, Dept Pediat Dent, Nagasaki 8528102, Japan; Nagasaki Univ, Sch Dent, Dept Prevent Dent, Nagasaki 8528102, Japan; Nagasaki Univ, Sch Med, Dept Oncol, Nagasaki 8528102, Japan; Nagasaki Univ, Sch Med, Dept Pediat, Nagasaki 8528102, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Lab Morphogenesis, Kumamoto 8600811, Japan; Mie Univ, Sch Med, Dept Internal Med, Tsu, Mie 5140001, Japan	Nagoya University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Kumamoto University; Mie University	Furukawa, K (corresponding author), Nagoya Univ, Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp		Shiku, Hiroshi/0000-0002-0362-755X; Zhao, Jinmin/0000-0002-1047-8820; Fukumoto, Satoshi/0000-0002-5046-6891; Takamiya, Kogo/0000-0001-7240-6307				BARLOZZARI T, 1983, J IMMUNOL, V131, P1024; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; FLOUTSIS G, 1989, INT J CANCER, V43, P6, DOI 10.1002/ijc.2910430103; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; FURUKAWA K, 1993, P NATL ACAD SCI USA, V90, P1972, DOI 10.1073/pnas.90.5.1972; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; KAWAHARA A, 1995, P NATL ACAD SCI USA, V92, P8724, DOI 10.1073/pnas.92.19.8724; Ledeen RW, 1998, ANN NY ACAD SCI, V845, P161, DOI 10.1111/j.1749-6632.1998.tb09669.x; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; NAKAMURA K, 1988, J BIOCHEM-TOKYO, V103, P201, DOI 10.1093/oxfordjournals.jbchem.a122232; OFFNER H, 1987, J IMMUNOL, V139, P3295; Okada M, 1996, CANCER RES, V56, P2844; PARKER J, 1984, FEBS LETT, V170, P391, DOI 10.1016/0014-5793(84)81351-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P4638; ROBB RJ, 1986, J IMMUNOL, V136, P971; SCHWARTING GA, 1983, J BIOL CHEM, V258, P5893; STEINDOUGLAS KE, 1976, J EXP MED, V143, P822, DOI 10.1084/jem.143.4.822; SUTTLES J, 1987, J IMMUNOL, V138, P364; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; TING CC, 1986, J IMMUNOL, V137, P2100; WELTE K, 1987, J IMMUNOL, V139, P1763; WHISLER RL, 1980, J IMMUNOL, V125, P2106; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	33	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13744	13747		10.1074/jbc.274.20.13744	http://dx.doi.org/10.1074/jbc.274.20.13744			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318776	hybrid			2022-12-27	WOS:000080322200005
J	Ellis, CA; Malik, AB; Gilchrist, A; Hamm, H; Sandoval, R; Voyno-Yasenetskaya, T; Tiruppathi, C				Ellis, CA; Malik, AB; Gilchrist, A; Hamm, H; Sandoval, R; Voyno-Yasenetskaya, T; Tiruppathi, C			Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of G(i)-linked Ras/mitogen-activated protein kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; MESSENGER-RNA EXPRESSION; BETA-GAMMA-SUBUNITS; COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; TYROSINE KINASES; COS-7 CELLS; MAP KINASE; MECHANISM	We addressed the mechanisms of restoration of cell surface proteinase-activated receptor-1 (PAR-1) by investigating thrombin-activated signaling pathways involved in PAR-1 re-expression in endothelial cells. Exposure of endothelial cells transfected with PAR-I promoter-luciferase reporter construct to either thrombin or PAR-I activating peptide increased the steady-state PAR-1 mRNA and reporter activity, respectively. Pretreatment of reporter-transfected endothelial cells with pertussis toxin or co-expression of a minigene encoding Il-amino acid sequence of COOH-terminal Ga; prevented the thrombin-induced increase in reporter activity. Pertussis toxin treatment also prevented thrombin-induced MAPK phosphorylation, indicating a role of G alpha(i) in activating the downstream MAPK pathway. Expression of constitutively active G alpha(i2) mutant or G beta 1 gamma 2 subunits increased reporter activity 3-4-fold in the absence of thrombin stimulation. Go-expression of dominant negative mutants of either Ras or MEK1 with the reporter construct inhibited the thrombin-induced PAR-1 expression, whereas constitutively active forms of either Ras or MEK1 activated PAR-1 expression in the absence of thrombin stimulation. Expression of dominant negative Src kinase or inhibitors of phosphoinositide 3-kinase also prevented the MAPK activation and PAR-1 expression. We conclude that thrombin-induced activation of PAR-1 mediates PAR-1 expression by signaling through G(i1/2) coupled to Src and phosphoinositide 3-kinase, and thereby activating the downstream Ras/MAPK cascade.	Univ Illinois, Coll Med, Dept Pharmacol MC 868, Chicago, IL 60612 USA; Northwestern Univ, Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Tiruppathi, C (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC 868, 835 S Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu	voyno-yasenetskaya, tatyana/A-3171-2008; Hamm, Heidi E/G-2374-2014; Gilchrist, Annette/I-4465-2014	Gilchrist, Annette/0000-0003-2386-7646; Malik, Asrar/0000-0002-8205-7128	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL027016, R01HL045638, R37HL027016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45638, HL27016] Funding Source: Medline; NIGMS NIH HHS [GM58531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; BAHOU WF, 1993, J CLIN INVEST, V91, P1405, DOI 10.1172/JCI116344; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Ellis CA, 1999, AM J PHYSIOL-CELL PH, V276, pC38, DOI 10.1152/ajpcell.1999.276.1.C38; FAURE M, 1994, J BIOL CHEM, V269, P7851; GARCIA JGN, 1993, J CELL PHYSIOL, V156, P541, DOI 10.1002/jcp.1041560313; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; GRAVES JD, 1994, ANN REV N Y ACAD SCI, V320; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; HEIN L, 1994, J BIOL CHEM, V269, P27719; HORVAT R, 1995, J CELL SCI, V108, P1155; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; Igishi T, 1998, BIOCHEM BIOPH RES CO, V244, P5, DOI 10.1006/bbrc.1998.8208; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Li FZ, 1996, J BIOL CHEM, V271, P26320, DOI 10.1074/jbc.271.42.26320; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mirza H, 1996, J CLIN INVEST, V97, P1705, DOI 10.1172/JCI118597; Molino M, 1997, J BIOL CHEM, V272, P11133; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; QURESHI SA, 1992, J BIOL CHEM, V267, P17635; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rubio I, 1997, BIOCHEM J, V326, P891, DOI 10.1042/bj3260891; Schmidt VA, 1998, J BIOL CHEM, V273, P15061, DOI 10.1074/jbc.273.24.15061; Schmidt VA, 1996, J BIOL CHEM, V271, P9307, DOI 10.1074/jbc.271.16.9307; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; THOLANIKUNNEL BG, 1995, J BIOL CHEM, V270, P12787, DOI 10.1074/jbc.270.21.12787; TIRUPPATHI C, 1992, AM J PHYSIOL, V263, pL595, DOI 10.1152/ajplung.1992.263.5.L595; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WOOLKALIS MJ, 1995, J BIOL CHEM, V270, P9868, DOI 10.1074/jbc.270.17.9868; ZACHARIAS U, 1995, J BIOL CHEM, V270, P545, DOI 10.1074/jbc.270.2.545	53	105	109	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13718	13727		10.1074/jbc.274.19.13718	http://dx.doi.org/10.1074/jbc.274.19.13718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224146	hybrid			2022-12-27	WOS:000080200400108
J	English, MA; Licht, JD				English, MA; Licht, JD			Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENYS-DRASH SYNDROME; SUPPRESSOR GENE WT1; I RECEPTOR GENE; WILMS-TUMOR; PROTEIN WT1; DNA-BINDING; SUBNUCLEAR LOCALIZATION; UROGENITAL DEVELOPMENT; KIDNEY DEVELOPMENT; PROMOTER ACTIVITY	The WT1 gene encodes a zinc finger DNA binding transcription factor and is mutated in up to 15% of Wilms tumor cases. The WT1 protein binds to the promoters of many genes through GC- or TC-rich sequences and can function both as a transcriptional repressor and an activator in co-transfection assays depending on the cell type, the structure of the test promoter, and even the expression vectors used. Engineered expression of WT1 can lead to growth suppression by both cell cycle arrest and induction of apoptosis. However, the transcriptional activity of WT1 that is required for growth control was not defined. We found that three N-terminal tumor-associated missense mutations of WT1 were defective for activation of both a synthetic reporter containing WT1-binding sites as well as the promoter of a WT1 responsive gene, p21. These mutants failed to inhibit cell growth but still retain their ability to repress several putative WT1 target promoters. These results indicate that activation and not repression by WT1 is the critical transcriptional activity of the protein responsible for its growth suppressing properties.	Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Licht, JD (corresponding author), Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, Box 1130,1 Gustave L Levy Pl, New York, NY 10029 USA.		Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369	NCI NIH HHS [R01 CA59998] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA059998] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301; BAIRD PN, 1992, ONCOGENE, V7, P2141; Beckwith JB, 1997, CANCER INVEST, V15, P153, DOI 10.3109/07357909709115768; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; Cook DM, 1996, ONCOGENE, V13, P1789; COPPES MJ, 1992, CANCER RES, V52, P6125; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; DEY BR, 1994, MOL ENDOCRINOL, V8, P595, DOI 10.1210/me.8.5.595; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Englert C, 1997, CANCER RES, V57, P1429; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GOODYER P, 1995, ONCOGENE, V10, P1125; Guan LS, 1998, J BIOL CHEM, V273, P27047, DOI 10.1074/jbc.273.42.27047; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; HASTIE ND, 1994, ANNU REV GENET, V28, P523; Heckman C, 1997, J BIOL CHEM, V272, P19609, DOI 10.1074/jbc.272.31.19609; Hosono S, 1999, ONCOGENE, V18, P417, DOI 10.1038/sj.onc.1202311; HUFF V, 1993, BIOCHIM BIOPHYS ACTA, V1155, P295, DOI 10.1016/0304-419X(93)90011-Z; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Johnstone RW, 1998, J BIOL CHEM, V273, P10880, DOI 10.1074/jbc.273.18.10880; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KUDOH T, 1995, P NATL ACAD SCI USA, V92, P4517, DOI 10.1073/pnas.92.10.4517; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; LICHT JD, 1993, P NATL ACAD SCI USA, V90, P11361, DOI 10.1073/pnas.90.23.11361; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; LITTLE MH, 1993, HUM MOL GENET, V2, P259, DOI 10.1093/hmg/2.3.259; LUO XN, 1995, ONCOGENE, V11, P743; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Maheswaran S, 1998, GENE DEV, V12, P1108, DOI 10.1101/gad.12.8.1108; MAHESWARAN S, 1995, GENE DEV, V9, P2143, DOI 10.1101/gad.9.17.2143; MALIK KTA, 1994, FEBS LETT, V349, P75, DOI 10.1016/0014-5793(94)00642-3; Martinerie C, 1996, ONCOGENE, V12, P1479; MATSUNAGA E, 1981, HUM GENET, V57, P231; MCCANN S, 1995, J BIOL CHEM, V270, P23785, DOI 10.1074/jbc.270.40.23785; McConnell MJ, 1997, ONCOGENE, V14, P2689, DOI 10.1038/sj.onc.1201114; Menke AL, 1997, CANCER RES, V57, P1353; MOFFETT P, 1995, P NATL ACAD SCI USA, V92, P11105, DOI 10.1073/pnas.92.24.11105; Moshier JA, 1996, NUCLEIC ACIDS RES, V24, P1149, DOI 10.1093/nar/24.6.1149; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; OGAWA O, 1993, HUM MOL GENET, V2, P203, DOI 10.1093/hmg/2.2.203; PARK S, 1993, CANCER RES, V53, P4757; PARK S, 1993, NAT GENET, V5, P363, DOI 10.1038/ng1293-363; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PRITCHARDJONES K, 1991, ONCOGENE, V6, P2211; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; REDDY JC, 1995, J BIOL CHEM, V270, P29976; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; RYAN G, 1995, DEVELOPMENT, V121, P867; SHARMA PM, 1994, P NATL ACAD SCI USA, V91, P9931, DOI 10.1073/pnas.91.21.9931; Thate C, 1998, ONCOGENE, V17, P1287, DOI 10.1038/sj.onc.1202055; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896; WANG ZY, 1993, J BIOL CHEM, V268, P9172; WANG ZY, 1995, ONCOGENE, V10, P1243; Wang ZY, 1996, J BIOL CHEM, V271, P24811, DOI 10.1074/jbc.271.40.24811; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; WERNER H, 1995, INT J BIOCHEM CELL B, V27, P987, DOI 10.1016/1357-2725(95)00074-Y; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315	72	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13258	13263		10.1074/jbc.274.19.13258	http://dx.doi.org/10.1074/jbc.274.19.13258			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224085	hybrid			2022-12-27	WOS:000080200400047
J	Piecha, D; Muratoglu, S; Morgelin, M; Hauser, N; Studer, D; Kiss, I; Paulsson, M; Deak, F				Piecha, D; Muratoglu, S; Morgelin, M; Hauser, N; Studer, D; Kiss, I; Paulsson, M; Deak, F			Matrilin-2, a large, oligomeric matrix protein, is expressed by a great variety of cells and forms fibrillar networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; HELICAL COILED-COIL; C-TERMINAL DOMAIN; ENDOTHELIAL-CELLS; CARTILAGE; MOUSE; MUSCLE; LINE; ASSEMBLES; LAMININ	Matrilin-2 is a member of the protein superfamily with von Willebrand factor type A-like modules. Mouse matrilin-2 cDNA fragments were expressed in 293-EBNA cells, and the protein was purified, characterized, and used to immunize rabbits. The affinity-purified antiserum detects matrilin-2 in dense and loose connective tissue structures, subepithelial connective tissue of the skin and digestive tract, specialized cartilages, and blood vessel walls. In situ hybridization of S-35-labeled riboprobes localizes the matrilin-2 mRNA to fibroblasts of dermis, tendon, ligaments, perichondrium, and periosteum; connective tissue elements in the heart; smooth muscle cells; and epithelia and loose connective tissue cells of the alimentary canal and respiratory tract. RNA blot hybridization and immunoblotting revealed both matrilin-2 mRNA and protein in cultures of a variety of cell types, confirming the tissue distribution. Alternative splicing affects a module unique for matrilin-2 in all of the above RNA sources. SDS-polyacrylamide gel electrophoresis and electron microscopy reveals matrilin-2 from tissue extracts and cell line cultures as a mixture of mono-, di-, tri-, and tetramers, Matrilin-2 is substituted with N-linked oligosaccharides but not with glycosaminoglycans, Because of other, yet unidentified, cell-type dependent posttranslational modifications, the monomer is heterogeneous in size. Immunofluorescence showed that matrilin-2 functions by forming an extracellular, filamentous network.	Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; Univ Cologne, Fac Med, Inst Biochem, D-50931 Cologne, Germany; Univ Lund, Dept Cell & Mol Biol, S-22100 Lund, Sweden; ME Muller Inst Biomech, CH-3010 Bern, Switzerland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Cologne; Lund University	Deak, F (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, POB 521, H-6701 Szeged, Hungary.		Studer, Daniel/F-8581-2012	Muratoglu Catania, Selen/0000-0002-1804-4875				AKITA M, 1993, PATHOBIOLOGY, V61, P98, DOI 10.1159/000163769; Beck K, 1996, J MOL BIOL, V256, P909, DOI 10.1006/jmbi.1996.0137; Beck K, 1997, EMBO J, V16, P3767, DOI 10.1093/emboj/16.13.3767; Belluoccio D, 1997, FEBS LETT, V415, P212, DOI 10.1016/S0014-5793(97)01126-5; BLANK RS, 1995, CIRC RES, V76, P742, DOI 10.1161/01.RES.76.5.742; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Deak F, 1997, J BIOL CHEM, V272, P9268; DEAK F, 1999, IN PRESS MATRIX BIOL, V18; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FOWLER WE, 1989, COAGULATION BLEEDING, P181; FUSENIG NE, 1978, B CANCER, V65, P271; HAUSER N, 1994, J BIOL CHEM, V269, P25747; HOFSTETTER W, 1992, P NATL ACAD SCI USA, V89, P9637, DOI 10.1073/pnas.89.20.9637; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Pan OH, 1998, J BIOL CHEM, V273, P14205, DOI 10.1074/jbc.273.23.14205; PFEIFFER SE, 1972, P NATL ACAD SCI USA, V69, P2885, DOI 10.1073/pnas.69.10.2885; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	29	73	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13353	13361		10.1074/jbc.274.19.13353	http://dx.doi.org/10.1074/jbc.274.19.13353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224097	hybrid			2022-12-27	WOS:000080200400059
J	Walmsley, AR; Zhou, TQ; Borges-Walmsley, MI; Rosen, BP				Walmsley, AR; Zhou, TQ; Borges-Walmsley, MI; Rosen, BP			The ATPase mechanism of ArsA, the catalytic subunit of the arsenite pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-TRANSLOCATING ATPASE; NUCLEOTIDE-BINDING SITE; MUTAGENESIS; RESISTANCE; DOMAIN	The ArsA ATPase is the catalytic subunit of a novel arsenite pump, with two nucleotide-binding consensus sequences in the N- and C-terminal halves of the protein. The single tryptophan-containing Trp(159) ArsA was used to elucidate the elementary steps of the ATPase mechanism by fluorescence stopped-flow experiments. The binding and hydrolysis of MgATP is a multistep process with a minimal kinetic mechanism (Mechanism 1). A notable feature of the reaction is that MgATP binding induces a slow transient increase in fluorescence of ArsA, which is independent of the ATP concentration, indicative of the build-up of a pre-steady state intermediate, This finding, coupled with a phosphate burst, implies that the steady-state intermediate builds up subsequent to product release. We propose that the rate-limiting step is an isomerization between different conformational forms of ArsA. k(cat) is faster than the phosphate burst, indicating that both nucleotide binding sites of ArsA are catalytic, Consistent with this interpretation, approximately 2 mol of phosphate are released per mole of ArsA during the phosphate burst. [GRAPHICS] ion is enhanced by the addition of ligand. Thus, ARA70 can function as a ligand-enhanced coactivator of PPAR gamma. Finally, we show that AR can squelch PPAR gamma-ARA70 transactivation, which suggests that cross-talk may occur between PPAR gamma- and AR-mediated responses in adipocytes.	Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	University of Glasgow; Wayne State University	Walmsley, AR (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.	A.Walmsley@bio.gla.ac.uk	Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055425, R01GM055425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken Alastair, 1996, P3, DOI 10.1007/978-1-60327-259-9_1; CHEN CM, 1986, J BIOL CHEM, V261, P5030; DEY S, 1994, ARCH BIOCHEM BIOPHYS, V311, P418, DOI 10.1006/abbi.1994.1256; DEY S, 1995, DRUG TRANSPORT ANTIM, P103; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KAUR P, 1993, J BACTERIOL, V175, P351, DOI 10.1128/JB.175.2.351-357.1993; KAUR P, 1992, J BIOL CHEM, V267, P19272; KAUR P, 1994, BIOCHEMISTRY-US, V33, P6456, DOI 10.1021/bi00187a010; KAUR P, 1998, ADV MOL CEL A&B, V23, P455; Li JX, 1996, J BIOL CHEM, V271, P25247, DOI 10.1074/jbc.271.41.25247; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13233, DOI 10.1021/bi00040a039; Ramaswamy S, 1998, J BIOL CHEM, V273, P9243, DOI 10.1074/jbc.273.15.9243; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; ZHOU TQ, 1995, BIOCHEMISTRY-US, V34, P13622, DOI 10.1021/bi00041a042; Zhou TQ, 1997, J BIOL CHEM, V272, P19731, DOI 10.1074/jbc.272.32.19731	18	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16153	16161		10.1074/jbc.274.23.16153	http://dx.doi.org/10.1074/jbc.274.23.16153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347168	hybrid			2022-12-27	WOS:000080668600028
J	Xie, XS; Lu, HP				Xie, XS; Lu, HP			Single-molecule enzymology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FLUORESCENCE CORRELATION SPECTROSCOPY; ENZYME; KINETICS; DYNAMICS; FLUCTUATIONS; PROTEINS; DIAGNOSTICS; MICROSCOPY; CATALYSIS; BEHAVIOR		Pacific NW Natl Lab, William R Wiley Environm Mol Sci Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu						AGMON N, 1983, J CHEM PHYS, V78, P6947, DOI 10.1063/1.444643; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; BROOKS CL, 1998, PROTEINS THEORETICAL, V71; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; Craig DB, 1996, J AM CHEM SOC, V118, P5245, DOI 10.1021/ja9540839; Dapprich J., 1995, Experimental Technique of Physics, V41, P259; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; FEHER G, 1973, P NATL ACAD SCI USA, V70, P870, DOI 10.1073/pnas.70.3.870; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Geva E, 1998, CHEM PHYS LETT, V288, P225, DOI 10.1016/S0009-2614(98)00322-4; HA MT, 1996, PHSY REV LETT, V77, P3979; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hagen SJ, 1996, J CHEM PHYS, V104, P3395, DOI 10.1063/1.471044; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Jia YW, 1997, P NATL ACAD SCI USA, V94, P7932, DOI 10.1073/pnas.94.15.7932; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; LIPSCOMB WN, 1982, ACCOUNTS CHEM RES, V15, P232, DOI 10.1021/ar00080a001; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; McCammon JA., 1987, DYNAMICS PROTEINS NU; MCCAMMON JA, 1999, SIMPLICITY COMPLEXIT, P189; Neet K E, 1980, Methods Enzymol, V64, P192; Neria E, 1997, CHEM PHYS LETT, V267, P23, DOI 10.1016/S0009-2614(97)00068-7; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Palmer T, 1991, UNDERSTANDING ENZYME; PERKINS TT, 1994, SCIENCE, V264, P822, DOI 10.1126/science.8171336; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; REES WA, 1993, SCIENCE, V260, P1646, DOI 10.1126/science.8503010; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Sakmann B., 1995, SINGLE CHANNEL RECOR; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vasudevan PT, 1996, APPL BIOCHEM BIOTECH, V60, P63, DOI 10.1007/BF02788060; WANG J, 1995, PHYS REV LETT, V74, P4317, DOI 10.1103/PhysRevLett.74.4317; Wennmalm S, 1997, P NATL ACAD SCI USA, V94, P10641, DOI 10.1073/pnas.94.20.10641; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	51	228	253	4	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15967	15970		10.1074/jbc.274.23.15967	http://dx.doi.org/10.1074/jbc.274.23.15967			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347141	hybrid			2022-12-27	WOS:000080668600001
J	Yu, H; Olshevskaya, E; Duda, T; Seno, K; Hayashi, F; Sharma, RK; Dizhoor, AM; Yamazaki, A				Yu, H; Olshevskaya, E; Duda, T; Seno, K; Hayashi, F; Sharma, RK; Dizhoor, AM; Yamazaki, A			Activation of retinal guanylyl cyclase-1 by Ca2+-binding proteins involves its dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE ROD PHOTORECEPTORS; GTP-BINDING PROTEIN; OUTER SEGMENTS; FUNCTIONAL-CHARACTERIZATION; CGMP-PHOSPHODIESTERASE; MOLECULAR-CLONING; CALCIUM; PURIFICATION; EXPRESSION; PHOTOTRANSDUCTION	Retinal guanylyl cyclase-1 (retGC-1), a key enzyme in phototransduction, is activated by guanylyl cyclase-activating proteins (GCAPs) if [Ca2+] is less than 300 nM. The activation is believed to be essential for the recovery of photoreceptors to the dark state; however, the molecular mechanism of the activation is unknown. Here, we report that dimerization of retGC-1 is involved in its activation by GCAPs, The GC activity and the formation of a 210-kDa cross-linked product of retGC-1 were monitored in bovine rod outer segment homogenates, GCAPs-free bovine rod outer segment membranes and recombinant bovine retGC-1 expressed in COS-7 cells. In addition to recombinant bovine GCAPs, constitutively active mutants of GCAPs that activate retGC-1 in a [Ca2+]-independent manner and bovine brain S100b that activates retGC-1 in the presence of similar to 10 mu M [Ca2+] were used to investigate whether these activations take place through a similar mechanism, and whether [Ca2+] is directly involved in the dimerization. We found that a monomeric form of retGC-1 (similar to 110 kDa) was mainly observed whenever GC activity was at basal or low levels. However, the 210-kDa product was increased whenever the GC activity was stimulated by any Ca2+-binding proteins used. We also found that [Ca2+] did not directly regulate the formation of the 210-kDa product. The 210-kDa product was detected in a purified GC preparation and did not contain GCAPs even when the formation of the 210-kDa product was stimulated by GCAPs, These data strongly suggest that the 210-kDa cross-linked product is a homodimer of retGC-1. We conclude that inactive retGC-1 is predominantly a monomeric form, and that dimerization of retGC-1 may be an essential step for its activation by active forms of GCAPs.	Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Univ Med & Dent New Jersey, Unit Regulatory & Mol Biol, Dept Cell Biol, Stratford, NJ 08084 USA; Univ Med & Dent New Jersey, Unit Regulatory & Mol Biol, Dept Ophthalmol, Stratford, NJ 08084 USA; Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan	Wayne State University; Wayne State University; Wayne State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kobe University	Yamazaki, A (corresponding author), Wayne State Univ, Sch Med, Kresge Eye Inst, 4717 St Antoine St, Detroit, MI 48201 USA.	akio_yamazaki@wayne.edu		Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [EY09631, EY11522, EY07546] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011522, R01EY009631, R01EY007546] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; APARICIO JG, 1995, PROTEIN EXPRES PURIF, V6, P501, DOI 10.1006/prep.1995.1067; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cooper N, 1995, J MOL NEUROSCI, V6, P211, DOI 10.1007/BF02736766; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; Duda T, 1998, BIOCHEM BIOPH RES CO, V242, P118, DOI 10.1006/bbrc.1997.7921; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Goraczniak R, 1997, BIOCHEM BIOPH RES CO, V234, P666, DOI 10.1006/bbrc.1997.6579; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; Goraczniak RM, 1998, BIOCHEM BIOPH RES CO, V245, P447, DOI 10.1006/bbrc.1998.8455; GORCZYCA WA, 1994, BIOCHEMISTRY-US, V33, P3217, DOI 10.1021/bi00177a011; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; Hallett MA, 1996, J CELL SCI, V109, P1803; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P73; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Li N, 1998, EUR J BIOCHEM, V252, P591, DOI 10.1046/j.1432-1327.1998.2520591.x; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Margulis A, 1996, BIOCHEM BIOPH RES CO, V218, P243, DOI 10.1006/bbrc.1996.0043; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; POZDNYAKOV N, 1995, BIOCHEMISTRY-US, V34, P14279, DOI 10.1021/bi00044a002; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Seno K, 1998, J BIOL CHEM, V273, P22169, DOI 10.1074/jbc.273.35.22169; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SITARAMAYYA A, 1991, BIOCHEMISTRY-US, V30, P6742, DOI 10.1021/bi00241a016; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Tucker CL, 1997, BIOCHEMISTRY-US, V36, P11995, DOI 10.1021/bi971212k; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Wolbring G, 1996, BIOCHEMISTRY-US, V35, P11013, DOI 10.1021/bi960699e; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702; YAMAZAKI A, 1987, J BIOL CHEM, V262, P9316; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	55	60	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15547	15555		10.1074/jbc.274.22.15547	http://dx.doi.org/10.1074/jbc.274.22.15547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336449	hybrid			2022-12-27	WOS:000080560100038
J	Jaworowski, A; Wilson, NJ; Christy, E; Byrne, R; Hamilton, JA				Jaworowski, A; Wilson, NJ; Christy, E; Byrne, R; Hamilton, JA			Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC EXPRESSION; GROWTH-FACTOR; CELL-CYCLE; FACTOR-I; ANTIPROLIFERATIVE AGENTS; MONONUCLEAR PHAGOCYTES; CYTOKINE BIOSYNTHESIS; SIGNALING PATHWAYS; APOPTOSIS; CSF-1	Colony stimulating factor-1 (CSF-1) (or macrophage CSF) is involved in the survival, proliferation, differentiation, and activation of cells of the monocyte/macrophage lineage. Because the mitogen-activated protein kinase family members extracellular signal-regulated kinases (ERKs), p38, and c-Jun N-terminal kinase are widely implicated in such cellular functions, we measured their activity in growing and growth-arrested cultures of bone marrow-derived macrophages (BMM), as well as their stimulation by saturating concentrations of CSF-1, ERK activity was approximately a-fold higher in cycling BMM compared with growth-arrested BMM; in addition, CSF-l-stimulated BMM DNA synthesis was partially inhibited by PD98059, a specific inhibitor of MEK activation, suggesting a role for a mitogen-activated protein-ERK kinase (MEK)/ERK pathway in the control of DNA synthesis but surprisingly not in the control of cyclin D1 mRNA or c-myc mRNA expression. The suppression of BMM apoptosis by CSF-1, i.e, enhanced survival, was not reversed by PD98059, suggesting that a MEK/ERK pathway is not involved in this process. Using a quantitative kinase assay, it was found that CSF-1 gave a slight increase in BMM p38 activity, supporting prior data that CSF-1 is a relatively weak stimulator of inflammatory cytokine production in monocytes/macrophages, Relatively high concentrations of the p38 inhibitor, SKB202190, suppressed CSF-l-stimulated BMM DNA synthesis. No evidence could be obtained for the involvement of p38 activity in BMM apoptosis following CSF-1 withdrawal. We were not able to show that CSF-1 enhanced BMM JNK-1 activity to a significant extent; again, no role could be found for JNK-1 activity in the BMM apoptosis occurring after CSF-1 removal.	Univ Melbourne, Royal Melbourne Hosp, Inflammat Res Ctr, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne	Jaworowski, A (corresponding author), Macfarlane Burnet Ctr Med Res, POB 254, Fairfield, Vic 3078, Australia.			jaworowski, anthony/0000-0002-3844-805X; Hamilton, John A/0000-0002-9493-9224				Aziz N, 1999, MOL CELL BIOL, V19, P1101; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; COCKS BG, 1992, J BIOL CHEM, V267, P12307; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; Dello Sbarba P, 1991, Growth Factors, V5, P75; Ding AH, 1996, J EXP MED, V183, P1899, DOI 10.1084/jem.183.4.1899; EVANS R, 1989, J LEUKOCYTE BIOL, V46, P428, DOI 10.1002/jlb.46.5.428; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HAMILTON JA, 1993, IMMUNOL TODAY, V14, P18, DOI 10.1016/0167-5699(93)90319-G; HAMILTON JA, 1993, J LEUKOCYTE BIOL, V53, P707, DOI 10.1002/jlb.53.6.707; HART B, 1967, J MOL BIOL, V26, P365; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jaworowski A, 1996, BIOCHEM J, V320, P1011, DOI 10.1042/bj3201011; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; L'Allemain Gilles, 1994, Progress in Growth Factor Research, V5, P291, DOI 10.1016/0955-2235(94)90011-6; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; LEE JC, 1993, ANN NY ACAD SCI, V696, P149; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Messina A, 1996, J COMP NEUROL, V372, P544, DOI 10.1002/(SICI)1096-9861(19960902)372:4<544::AID-CNE4>3.0.CO;2-4; MOORE RN, 1980, J IMMUNOL, V125, P1302; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; OSTER W, 1992, BLOOD, V79, P1260; POLLARD JW, 1991, P NATL ACAD SCI USA, V88, P1474, DOI 10.1073/pnas.88.4.1474; ROCK CO, 1992, MOL CELL BIOL, V12, P2351, DOI 10.1128/MCB.12.5.2351; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; Salmon RA, 1997, J IMMUNOL, V159, P5309; TUSHINSKI RJ, 1983, J CELL PHYSIOL, V116, P67, DOI 10.1002/jcp.1041160111; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Vadiveloo PK, 1996, ONCOGENE, V13, P599; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; VAIRO G, 1990, J BIOL CHEM, V265, P2692; VAIRO G, 1995, ONCOGENE, V10, P1969; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Wilson NJ, 1998, BIOCHEM BIOPH RES CO, V244, P475, DOI 10.1006/bbrc.1998.8290; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zornig M, 1996, CURR BIOL, V6, P1553, DOI 10.1016/S0960-9822(02)70769-0	45	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15127	15133		10.1074/jbc.274.21.15127	http://dx.doi.org/10.1074/jbc.274.21.15127			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329719	hybrid			2022-12-27	WOS:000081965200084
J	Lin, JH; Makris, A; McMahon, C; Bear, SE; Patriotis, C; Prasad, VR; Brent, R; Golemis, EA; Tsichlis, PN				Lin, JH; Makris, A; McMahon, C; Bear, SE; Patriotis, C; Prasad, VR; Brent, R; Golemis, EA; Tsichlis, PN			The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DISTINCT BINDING DOMAINS; KINASE-KINASE; IN-VITRO; PLASMA-MEMBRANE; ACTIVATES RAF-1; RAS; PHOSPHORYLATION; C-RAF-1; ACID	Tvl-1 is a 269-amino acid ankyrin repeat protein ex pressed primarily in thymus, lung, and testes that was identified by screening a murine T-cell two-hybrid cDNA library for proteins that associate with the serine-threonine kinase Raf-1. The interaction of Tvl-1 with Raf-1 was confirmed by co-immunoprecipitation of the two proteins from COS-1 cells transiently transfected with Tvl-1 and Raf-1 expression constructs as well as by co-immunoprecipitation of the endogenous proteins from CV-1 and NB2 cells. Tvl-1 interacts with Raf-1 via its carboxyl-terminal ankyrin repeat domain, The same domain also mediates Tvl-1 homodimerization, Tvl-1 was detected by immunofluorescence in both the cytoplasm and the nucleus suggesting that in addition to Raf-1 it may also interact with nuclear proteins. Activated Raf-1 phosphorylates Tvl-1 both in vitro and in vivo. In baculovirus-infected Sf9 insect cells, Tvl-1 potentiates the activation of Raf-1 by Src and Ras while in COS-1 cells it potentiates the activation of Raf-1 by EGF. These data suggest that Tvl-1 is both a target as well as a regulator of Raf-1. The human homologue of Tvl-1 maps to chromosome 19p12, upstream of MEF2B with the two genes in a head to head arrangement.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Albert Einstein Coll Med, New York, NY USA; Inst Mol Sci, Berkeley, CA 94704 USA	Jefferson University; Fox Chase Cancer Center; Yeshiva University; The Molecular Sciences Institute	Tsichlis, PN (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 10th St, Philadelphia, PA 19107 USA.	P_Tsichlis@lac.jci.tju.edu	Prasad, Vinayaka R./A-1029-2011	Prasad, Vinayaka/0000-0002-9461-0189; Golemis, Erica/0000-0003-3618-3673	NATIONAL CANCER INSTITUTE [P30CA006927, T32CA009683] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927, T32-CA09683, R01-CA38147] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DENT P, 1995, MOL CELL BIOL, V15, P4125; Dent P, 1996, J BIOL CHEM, V271, P3119, DOI 10.1074/jbc.271.6.3119; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; GHOSH S, 1994, J BIOL CHEM, V269, P30785; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Golemis E A, 1997, Methods Mol Biol, V63, P197; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; HOBSON GM, 1995, GENOMICS, V29, P704, DOI 10.1006/geno.1995.9007; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; MORRISON DK, 1995, METHOD ENZYMOL, V255, P301; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Park RK, 1996, J BIOL CHEM, V271, P13342, DOI 10.1074/jbc.271.23.13342; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; Popik W, 1996, MOL CELL BIOL, V16, P6532; RAPP UR, 1991, ONCOGENE, V6, P495; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	58	32	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14706	14715		10.1074/jbc.274.21.14706	http://dx.doi.org/10.1074/jbc.274.21.14706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329666	hybrid			2022-12-27	WOS:000081965200031
J	Maamra, M; Finidori, J; Von Laue, S; Simon, S; Justice, S; Webster, J; Dower, S; Ross, R				Maamra, M; Finidori, J; Von Laue, S; Simon, S; Justice, S; Webster, J; Dower, S; Ross, R			Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GH-BINDING PROTEIN; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED INTERNALIZATION; LIVING CELLS; LIGAND; VISUALIZATION; TRANSLOCATION; TRAFFICKING; ACTIVATION	We have investigated trafficking of two negative regulators of growth hormone receptor (GHR) signaling: a human, truncated receptor, GHR1-279, and a GH antagonist, B2036, Fluorescent-labeled growth hormone (GH) was rapidly internalized by the full-length GHR, with >80% of the hormone internalized within 5 min of exposure to GH, In contrast, <5% of labeled GH was internalized by cells expressing truncated GHR1-279, Using another truncated receptor, GHR1-317 fused to enhanced green fluorescent protein (EGFP), we have exploited fluorescence energy transfer to monitor the trafficking of ligand-receptor complexes. The data confirmed that internalization of this truncated receptor is very inefficient, It was possible to visualize the truncated GHR1-317-EGFP packaged in the endoplasmic reticulum, its rapid movement in membrane bound vesicles to the Golgi apparatus, and subsequent transport to the cell membrane, The GH antagonist, B2036, blocked Jak2-Stat5-mediated GHR signaling but was internalized with a similar time course to native GH, The results: 1) demonstrate the rapid internalization of GH when studied under physiological conditions; 2) confirm the hypothesis that internalization of cytoplasmic domain truncated human GHRs is very inefficient, which explains their dominant negative action; and 3) show that the antagonist action of B2036 is independent of receptor internalization.	Univ Sheffield, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England; Univ Sheffield, Div Med & Mol Genet, Sheffield S5 7AU, S Yorkshire, England; Fac Med Necker, INSERM U344, F-75730 Paris, France	University of Sheffield; University of Sheffield; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ross, R (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.		Ross, Richard/B-2672-2012	Ross, Richard/0000-0001-9222-9678; dower, steve/0000-0002-4675-4225; von Laue, Sigward/0000-0002-5229-4712				ALLEVATO G, 1995, J BIOL CHEM, V270, P17210, DOI 10.1074/jbc.270.29.17210; Amit T, 1997, J CLIN ENDOCR METAB, V82, P3813, DOI 10.1210/jc.82.11.3813; Ayling RM, 1997, NAT GENET, V16, P13, DOI 10.1038/ng0597-13; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Dastot F, 1996, P NATL ACAD SCI USA, V93, P10723, DOI 10.1073/pnas.93.20.10723; FINIDORI J, 1995, J ENDOCRINOL, V147, P11, DOI 10.1677/joe.0.1470011; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GOUJON L, 1994, P NATL ACAD SCI USA, V91, P957, DOI 10.1073/pnas.91.3.957; Govers P, 1998, J BIOL CHEM, V273, P16426, DOI 10.1074/jbc.273.26.16426; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Iida K, 1998, J CLIN ENDOCR METAB, V83, P531, DOI 10.1210/jc.83.2.531; ILONDO MM, 1991, ENDOCRINOLOGY, V128, P1597, DOI 10.1210/endo-128-3-1597; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Leung KC, 1997, P NATL ACAD SCI USA, V94, P11381, DOI 10.1073/pnas.94.21.11381; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; Mellado M, 1997, J BIOL CHEM, V272, P9189; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; SILVA CM, 1993, ENDOCRINOLOGY, V132, P101, DOI 10.1210/en.132.1.101; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; THORNER MO, 1998, ENDOCRINE SOC 1998, P57; VANDERLELY AJ, 1998, ENDOCRINE SOC 1998, P57; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; Wojcik R, 1998, J CLIN ENDOCR METAB, V83, P4481, DOI 10.1210/jc.83.12.4481	26	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14791	14798		10.1074/jbc.274.21.14791	http://dx.doi.org/10.1074/jbc.274.21.14791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329677	hybrid			2022-12-27	WOS:000081965200042
J	Neumann, GM; Bach, LA				Neumann, GM; Bach, LA			The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-LABILE SUBUNIT; CELL-LINE; FACTOR-II; IGF-II; MOLECULAR-CLONING; DOMAIN; SITES; PURIFICATION; COMPLEXES; SEQUENCE	The actions of insulin-like growth factors (IGFs) are modulated by a family of six high affinity binding proteins (IGFBPs 1-6), IGFBP-6 differs from other IGFBPs in having the highest affinity for IGF-II and in binding IGF-I with 20-100-fold lower affinity. IGFBPs 1-5 contain 18 conserved cysteines, but human IGFBP-6 lacks 2 of the 12 N-terminal cysteines, The complete disulfide linkages of IGFBP-6 were determined using electrospray ionization mass spectrometry of purified tryptic peptide complexes digested with combinations of chymotrypsin, thermolysin, and endoproteinase Glu-C. Numbering IGFBP-6 cysteines sequentially from the N terminus, the first three disulfide linkages are Cys(1)-Cys(2), Cys(3)-Cys(4), and Cys(5)-Cys(6). The next two linkages are Cys(7)-Cys(9) and Cys(8)-Cys(10), which are analogous to those previously determined for IGFBP-3 and IGFBP-5, The C-terminal linkages are Cys(11)-Cys(12), Cys(13)-Cys(14), and Cys(15)-Cys(16), analogous to those previously determined for IGFBP-2, Disulfide linkages of IGFBP-1 were partially determined and show that Cys(1) is not linked to Cys(2) and Cys(3) is not linked to Cys(4), Analogous with IGFBP-3, IGFBP-5, and IGFBP-6, Cys(9)-Cys(11) and Cys(10)-Cys(12) of IGFBP-1 are also disulfide-linked, The N-terminal linkages of IGFBP-6 differ significantly from those of IGFBP-1 (and, by implication, the other IGFBPs), which could contribute to the distinctive IGF binding properties of IGFBP-6.	Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Heidelberg, Vic 3084, Australia; La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; La Trobe University	Bach, LA (corresponding author), Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Austin Campus, Heidelberg, Vic 3084, Australia.			Bach, Leon/0000-0002-9062-1518				BACH LA, 1993, ENDOCRINOLOGY, V133, P990, DOI 10.1210/en.133.3.990; BACH LA, 1992, BIOCHEM BIOPH RES CO, V186, P301, DOI 10.1016/S0006-291X(05)80807-1; BACH LA, 1993, J BIOL CHEM, V268, P9246; BACH LA, 1994, ENDOCRINOLOGY, V135, P2168, DOI 10.1210/en.135.5.2168; Bach LA, 1995, DIABETES REV, V3, P38; BEAN MF, 1992, ANAL BIOCHEM, V201, P216, DOI 10.1016/0003-2697(92)90331-Z; BOISCLAIR YR, 1994, GROWTH REGULAT, V4, P136; FORBES B, 1990, J ENDOCRINOL, V126, P497, DOI 10.1677/joe.0.1260497; Forbes BE, 1998, J BIOL CHEM, V273, P4647, DOI 10.1074/jbc.273.8.4647; Hashimoto R, 1997, J BIOL CHEM, V272, P27936, DOI 10.1074/jbc.272.44.27936; Ho PJ, 1997, ENDOCRINOLOGY, V138, P3811, DOI 10.1210/en.138.9.3811; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kalus W, 1998, EMBO J, V17, P6558, DOI 10.1093/emboj/17.22.6558; KATO M, 1995, J BIOL CHEM, V270, P12373, DOI 10.1074/jbc.270.21.12373; Lalou C, 1996, ENDOCRINOLOGY, V137, P3206, DOI 10.1210/en.137.8.3206; MARTIN JL, 1990, J BIOL CHEM, V265, P4124; Neumann GM, 1998, BIOCHEMISTRY-US, V37, P6572, DOI 10.1021/bi972894e; Neumann GM, 1996, BBA-PROTEIN STRUCT M, V1298, P223, DOI 10.1016/S0167-4838(96)00133-1; Qin XZ, 1998, J BIOL CHEM, V273, P23509, DOI 10.1074/jbc.273.36.23509; ROGHANI M, 1991, J CLIN ENDOCR METAB, V73, P658, DOI 10.1210/jcem-73-3-658; SHIMASAKI S, 1991, MOL ENDOCRINOL, V5, P938, DOI 10.1210/mend-5-7-938; SMITH RD, 1990, ANAL CHEM, V62, P882, DOI 10.1021/ac00208a002; Spencer E. Martin, 1995, Progress in Growth Factor Research, V6, P209; Twigg SM, 1998, J BIOL CHEM, V273, P28791, DOI 10.1074/jbc.273.44.28791; WANG JF, 1988, BIOCHEM BIOPH RES CO, V157, P718, DOI 10.1016/S0006-291X(88)80309-7; ZAPF J, 1990, J BIOL CHEM, V265, P14892; ZHANG RM, 1989, J BIOL CHEM, V264, P18472	27	59	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14587	14594		10.1074/jbc.274.21.14587	http://dx.doi.org/10.1074/jbc.274.21.14587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329650	hybrid			2022-12-27	WOS:000081965200015
J	Barbier, AJ; Poppleton, HM; Yigzaw, Y; Mullenix, JB; Wiepz, GJ; Bertics, PJ; Patel, TB				Barbier, AJ; Poppleton, HM; Yigzaw, Y; Mullenix, JB; Wiepz, GJ; Bertics, PJ; Patel, TB			Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEIN; CARDIAC ADENYLATE-CYCLASE; EGF RECEPTOR; TYROSINE KINASE; AUTOPHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; PC12 CELLS; PHOSPHORYLATION; CAMP	Binding of epidermal growth factor (EGF) to its receptor (EGFR) augments the tyrosine kinase activity of the receptor and autophosphorylation. Exposure of some tissues and cells to EGF also stimulates adenylyl cyclase activity and results in an increase in cyclic AMP (cAMP) levels. Because cAMP activates the cAMP-dependent protein kinase A (PKA), we investigated the effect of PKA on the EGFR, The purified catalytic subunit of PKA (PKAc) stoichiometrically phosphorylated the purified full-length wild type (WT) and kinase negative (K721M) forms of the EGFR. PKAc phosphorylated both WT-EGFR as well as a mutant truncated form of EGFR (Delta 1022-1186) exclusively on serine residues. Moreover, PKAc also phosphorylated the cytosolic domain of the EGFR (EGFRKD). Phosphorylation of the purified WT as well as EGFR Delta 1022-1186 and EGFRKD was accompanied by decreased autophosphorylation and diminished tyrosine kinase activity. Pretreatment of REF-52 cells with the nonhydrolyzable cAMP analog, 8-(4-chlorophenylthio)-cAMP, decreased EGF-induced tyrosine phosphorylation of cellular proteins as well as activation of the WT-EGFR. Similar effects were also observed in B82L cells transfected to express the Delta 1022-1186 form of EGFR. Furthermore, activation of PKAc in intact cells resulted in serine phosphorylation of the EGFR, The decreased phosphorylation of cellular proteins and diminished activation of the EGFR in cells treated with the cAMP analog was not the result of altered binding of EGF to its receptors or changes in receptor internalization. Therefore, we conclude that PKA phosphorylates the EGFR on Ser residues and decreases its tyrosine kinase activity and signal transduction both in vitro and in vivo.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison	Patel, TB (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053271] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 48308] Funding Source: Medline; NIGMS NIH HHS [GM 53271] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUDNIK LT, 1991, J BIOL CHEM, V266, P13908; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GHOSHDASTIDAR P, 1984, J BIOL CHEM, V259, P3864; GILL GN, 1985, GROWTH FACTORS TRANS, P11; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HONNEGGER A, 1988, EMBO J, V7, P3045; HSUEH YP, 1995, J BIOL CHEM, V270, P18094, DOI 10.1074/jbc.270.30.18094; HUBLER L, 1992, BIOCHEM J, V281, P107, DOI 10.1042/bj2810107; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; KUPPUSWAMY D, 1993, J BIOL CHEM, V268, P19134; LIEBERMAN MD, 1996, SURGERY, V120, P345; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; NAIR BG, 1990, J BIOL CHEM, V265, P21317; NAIR BG, 1993, BIOCHEM PHARMACOL, V46, P1239, DOI 10.1016/0006-2952(93)90473-A; NAIR BG, 1993, GROWTH FACTORS, V8, P41, DOI 10.3109/08977199309029133; NAIR BG, 1989, BIOCHEM J, V264, P563, DOI 10.1042/bj2640563; NAKAGAWA Y, 1991, BIOCHEM PHARMACOL, V42, P2333, DOI 10.1016/0006-2952(91)90238-Z; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Poppleton H, 1996, J BIOL CHEM, V271, P6947, DOI 10.1074/jbc.271.12.6947; RACKOFF WR, 1984, MOL CELL ENDOCRINOL, V34, P113, DOI 10.1016/0303-7207(84)90062-5; RASHED SM, 1991, EUR J BIOCHEM, V197, P805, DOI 10.1111/j.1432-1033.1991.tb15975.x; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; ROTH RA, 1987, DIABETES, V36, P123, DOI 10.2337/diabetes.36.1.123; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; STADTMAUER L, 1986, J BIOL CHEM, V261, P3402; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; STRYJEKKAMINSKA D, 1995, AM J PHYSIOL-GASTR L, V269, pG676, DOI 10.1152/ajpgi.1995.269.5.G676; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; WALTON GM, 1990, J BIOL CHEM, V265, P1750; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	42	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14067	14073		10.1074/jbc.274.20.14067	http://dx.doi.org/10.1074/jbc.274.20.14067			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318821	hybrid			2022-12-27	WOS:000080322200050
J	El Hadj, NB; Popoff, MR; Marvaud, JC; Payrastre, B; Boquet, P; Geny, B				El Hadj, NB; Popoff, MR; Marvaud, JC; Payrastre, B; Boquet, P; Geny, B			G-protein-stimulated phospholipase D activity is inhibited by lethal toxin from Clostridium sordellii in HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEINS; PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; KINASE-C; D ACTIVATION; ACTIN-FILAMENTS; STREPTOLYSIN-O; RHO-PROTEINS; D DEFINES; V-SRC	Lethal toxin (LT) from Clostridium sordellii has been shown in HeLa cells to glucosylate and inactivate Has and Rac and, hence, to disorganize the actin cytoskeleton. In the present work, we demonstrate that LT treatment provokes the same effects in HL-60 cells. We show that guanosine 5'-O-(3-thiotriphosphate)-stimulated phospholipase D (PLD) activity is inhibited in a time- and dose-dependent manner after an overnight treatment with LT, A similar dose response to the toxin was found when PLD activity was stimulated by phorbol la-myristate 13-acetate via the protein kinase C pathway. The toxin effect on actin organization seemed unlikely to account directly for PLD inhibition as cytochalasin D and iota toxin from Clostridium perfringens E disorganize the actin cytoskeleton without modifying PLD activity. However, the enzyme inhibition and actin cytoskeleton disorganization could both be related to a major decrease observed in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). Likely in a relationship with this decrease, recombinant ADP-ribosylation factor, RhoA, Rac, and RalA were not able to reconstitute PLD activity in LT-treated cells permeabilized and depleted of cytosol. Studies of phosphoinositide kinase activities did not allow us to attribute the decrease in PtdIns(4,5)P-2 to inactivation of PtdIns4P 5-kinase. LT was also found to provoke a major inhibition in phosphatidylinositol 3-kinase that could not account for the inhibition of PLD activity because wortmannin, at doses that fully inhibit phosphatidylinositol 3-kinase, had no effect on the phospholipase activity. Among the three small G-proteins, Ras, Rac, and RalA, inactivated by LT and involved in PLD regulation, inactivation of Ral proteins appeared to be responsible for PLD inhibition as LT toxin (strain 9048) unable to glucosylate Ral proteins did not modify PLD activity. In HL-60 cells, LT treatment appeared also to modify cytosol components in relationship with PLD inhibition as a cytosol prepared from LT-treated cells was less efficient than one from control HL-60 cells in stimulating PLD activity. Phosphatidylinositol transfer proteins involved in the regulation of polyphosphoinositides and ADP-ribosylation factor, a major cytosolic PLD activator in HL-60 cells, were unchanged, whereas the level of cytosolic protein kinase C alpha was decreased after LT treatment, We conclude that in HL-60 cells, lethal toxin from C. sordellii, in inactivating small G-proteins involved in PLD regulation, provokes major modifications at the membrane and the cytosol levels that participate in the inhibition of PLD activity. Although Ral appeared to play an essential role in PLD activity, we discuss the role of other small G-proteins inactivated by LT in the different modifications observed in HL-60 cells.	Inst Cochin Genet Mol, INSERM, U332, F-75014 Paris, France; Inst Pasteur, Unite Toxines Microbiennes, F-75724 Paris 15, France; Hop Purpan, INSERM, U326, F-31059 Toulouse, France; Fac Med Nice, INSERM, U452, F-06107 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Geny, B (corresponding author), Inst Cochin Genet Mol, INSERM, U332, 22 Rue Mechain, F-75014 Paris, France.			, Bernard/0000-0002-8693-0190				AKTORIES K, 1994, MOL CELL BIOCHEM, V138, P167, DOI 10.1007/BF00928459; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Choudhury S, 1996, CANCER LETT, V109, P149, DOI 10.1016/S0304-3835(96)04439-4; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DAWSON RMC, 1967, BIOCHEM J, V102, P76, DOI 10.1042/bj1020076; DEVRIES KJ, 1995, BIOCHEM J, V310, P643, DOI 10.1042/bj3100643; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; GENY B, 1993, EUR J BIOCHEM, V215, P389, DOI 10.1111/j.1432-1033.1993.tb18045.x; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hofmann F, 1996, BIOCHEM BIOPH RES CO, V227, P77, DOI 10.1006/bbrc.1996.1470; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; JIANG H, 1995, J BIOL CHEM, V270, P6006, DOI 10.1074/jbc.270.11.6006; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lee CH, 1997, J BIOL CHEM, V272, P15986, DOI 10.1074/jbc.272.25.15986; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; LOPEZ I, 1995, J BIOL CHEM, V270, P19465, DOI 10.1074/jbc.270.33.19465; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Lukowski S, 1996, J BIOL CHEM, V271, P24164, DOI 10.1074/jbc.271.39.24164; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MARTINEZ RD, 1992, J MED MICROBIOL, V36, P30, DOI 10.1099/00222615-36-1-30; MORRIS JDH, 1989, ONCOGENE, V4, P27; Ohguchi K, 1996, INFECT IMMUN, V64, P4433, DOI 10.1128/IAI.64.11.4433-4437.1996; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; POLVERINO AJ, 1990, BIOCHEM J, V271, P309, DOI 10.1042/bj2710309; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; Schmidt M, 1998, J BIOL CHEM, V273, P7413, DOI 10.1074/jbc.273.13.7413; Schmidt M, 1996, EUR J BIOCHEM, V240, P707, DOI 10.1111/j.1432-1033.1996.0707h.x; Singer WD, 1996, J BIOL CHEM, V271, P4504; Steed PM, 1998, FASEB J, V12, P1309, DOI 10.1096/fasebj.12.13.1309; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8	56	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14021	14031		10.1074/jbc.274.20.14021	http://dx.doi.org/10.1074/jbc.274.20.14021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318815	hybrid			2022-12-27	WOS:000080322200044
J	Ericsson, J; Usheva, A; Edwards, PA				Ericsson, J; Usheva, A; Edwards, PA			YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-Y; SYNTHASE GENE; DIFFERENTIATION FACTOR-1; ADIPOCYTE DETERMINATION; SYNERGISTIC ACTIVATION; PROMOTER ACTIVITY; NF-Y; REPRESSION; EXPRESSION; TRANSACTIVATION	Ying Yang 1 (YY1) is shown to bind to the proximal promoters of the genes encoding 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase, farnesyl diphosphate (FPP) synthase, and the low density lipoprotein (LDL) receptor. To investigate the potential effect of YY1 on the expression of SREBP-responsive genes, HepG2 cells were transiently transfected with luciferase reporter constructs under the control of promoters derived from either HMG-CoA synthase, FPP synthase, or the LDL receptor genes, The luciferase activity of each construct increased when HepG2 cells were incubated in lipid-depleted media or when the cells were contransfected with a plasmid encoding mature sterol regulatory element-binding protein (SREBP)-1a. In each case, the increase in luciferase activity was attenuated by coexpression of wild-type YY1 but not by coexpression of mutant YY1 proteins that are known to be defective in either DNA binding or in modulating transcription of other known YY1-responsive genes. In contrast, incubation of cells in lipid-depleted media resulted in induction of an HMG-CoA reductase promoter-luciferase construct by a process that was unaffected by coexpression of wild-type YY1. Electromobility shift assays were used to demonstrate that the proximal promoters of the HMG-CoA synthase, FPP synthase, and the LDL receptor contain YY1 binding sites and that YY1 displaced nuclear factor Y from the promoter of the HMG-CoA synthase gene. We conclude that YY1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter. We hypothesize that YY1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes.	Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School	Edwards, PA (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, CHS 33-257, Los Angeles, CA 90095 USA.		Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30568] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Edwards PA, 1998, CURR OPIN LIPIDOL, V9, P433, DOI 10.1097/00041433-199810000-00007; Ericsson J, 1998, J BIOL CHEM, V273, P17865, DOI 10.1074/jbc.273.28.17865; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Guan GM, 1997, J BIOL CHEM, V272, P10295; Guo B, 1997, P NATL ACAD SCI USA, V94, P121, DOI 10.1073/pnas.94.1.121; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Jackson SM, 1998, J LIPID RES, V39, P767; JACKSON SM, 1995, J BIOL CHEM, V270, P21445, DOI 10.1074/jbc.270.37.21445; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; LU SY, 1994, MOL CELL BIOL, V14, P6253, DOI 10.1128/MCB.14.9.6253; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Seelan RS, 1997, J BIOL CHEM, V272, P10175, DOI 10.1074/jbc.272.15.10175; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Ye JP, 1996, MOL CELL BIOL, V16, P157; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102	41	48	51	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14508	14513		10.1074/jbc.274.20.14508	http://dx.doi.org/10.1074/jbc.274.20.14508			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318878	hybrid			2022-12-27	WOS:000080322200107
J	Bearer, CF; Swick, AR; O'Riordan, MA; Cheng, GH				Bearer, CF; Swick, AR; O'Riordan, MA; Cheng, GH			Ethanol inhibits L1-mediated neurite outgrowth in postnatal rat cerebellar granule cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE L1; ACTIVATED PROTEIN-KINASES; FETAL-ALCOHOL-SYNDROME; N-CADHERIN; HIPPOCAMPAL-NEURONS; L1-LIKE MOLECULE; GROWTH; FGF; PHOSPHORYLATION; MIGRATION	The neuropathology of the effects of ethanol on the developing central nervous system are similar to those of patients with mutations in L1, a neural cell adhesion molecule. This observation suggests that inhibition of L1 plays a role in the pathogenesis of alcohol-related neurodevelopmental disorders. Here we examine the effects of ethanol on L1 hemophilic binding and on L1 mediated neurite outgrowth. Ethanol had no effect on cell adhesion or aggregation in a myeloma cell line expressing full-length human L1. In contrast, the rate of L1-mediated neurite outgrowth of rat postnatal day 6 cerebellar granule cells grown on a substratum of Ng-CAM, the chick homologue of L1, was inhibited by 48.6% in the presence of ethanol with a half-maximal concentration of 4.7 mM, The same effect was found with soluble L1-Fc, thus showing that the inhibitory effect is not dependent on cell adhesion. In contrast, neither laminin nor N-cadherin-mediated neurite outgrowth was inhibited by physiologic concentrations of ethanol. We conclude that one mechanism of ethanol's toxicity to the developing central nervous system may be the inhibition of L1-mediated neurite outgrowth.	Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Bearer, CF (corresponding author), Rainbow Babies & Childrens Hosp, Dept Pediat, 11100 Euclid Ave,Suite 8100, Cleveland, OH 44106 USA.	cfb3@po.cwru.edu		Bearer, Cynthia/0000-0003-4809-2250	NATIONAL EYE INSTITUTE [R01EY005285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011839] Funding Source: NIH RePORTER; NEI NIH HHS [EY5285, R01 EY005285] Funding Source: Medline; NIAAA NIH HHS [R01 AA011839] Funding Source: Medline; NINDS NIH HHS [NS34252] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel E. L., 1990, FETAL ALCOHOL SYNDRO; ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; BEATTIE CE, 1993, J NEUROSCI, V13, P1784; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; CHARNESS ME, 1994, J BIOL CHEM, V269, P9304; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Dow K E, 1990, Neuroreport, V1, P111, DOI 10.1097/00001756-199010000-00007; DOW KE, 1985, SCIENCE, V228, P591, DOI 10.1126/science.3983644; DOW KE, 1990, BRAIN RES, V508, P40, DOI 10.1016/0006-8993(90)91114-V; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; HEATON MB, 1994, J NEUROSCI RES, V39, P305, DOI 10.1002/jnr.490390308; HEATON MB, 1995, DEV BRAIN RES, V89, P270, DOI 10.1016/0165-3806(95)00131-V; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; HUNDLE B, 1995, J BIOL CHEM, V270, P30134; *I MED, 1996, FET ALC SYNDR DIAGN; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; JONES KL, 1973, LANCET, V1, P1267; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kim JA, 1996, DEV BRAIN RES, V96, P1; Kunz S, 1996, J CELL BIOL, V135, P253, DOI 10.1083/jcb.135.1.253; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LEMMON V, 1986, J NEUROSCI, V6, P2987; Lemoine P., 1968, OUEST MED, V25, P476; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Matsuzawa M, 1996, INT J DEV NEUROSCI, V14, P283, DOI 10.1016/0736-5748(96)00014-7; MESSER A, 1977, BRAIN RES, V130, P13, DOI 10.1016/0006-8993(77)90839-3; MESSER A, 1977, BRAIN RES, V130, P1, DOI 10.1016/0006-8993(77)90838-1; MESSING RO, 1991, BRAIN RES, V565, P301, DOI 10.1016/0006-8993(91)91662-K; MESSING RO, 1991, J BIOL CHEM, V266, P23428; MIURA M, 1992, J BIOL CHEM, V267, P10752; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; ROIVAINEN R, 1995, P NATL ACAD SCI USA, V92, P1891, DOI 10.1073/pnas.92.6.1891; ROSENBERG A, 1994, ALCOHOL, V11, P565, DOI 10.1016/0741-8329(94)90084-1; STANESCU GL, 1991, J CLIN LAB ANAL, V5, P206, DOI 10.1002/jcla.1860050310; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; TRAUNECKER A, 1991, EMBO J, V10, P3655, DOI 10.1002/j.1460-2075.1991.tb04932.x; Vallejo Y, 1997, J BIOL CHEM, V272, P12244, DOI 10.1074/jbc.272.18.12244; WILKEMEYER MF, 1997, ALCOHOL CLIN EXP RES, V21, P85; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WILLIAMS EJ, 1995, J CELL SCI, V108, P3523; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1995, NEUROSCI LETT, V200, P155, DOI 10.1016/0304-3940(95)12100-I; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; ZOU JY, 1993, DEV BRAIN RES, V72, P75, DOI 10.1016/0165-3806(93)90161-3	54	104	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13264	13270		10.1074/jbc.274.19.13264	http://dx.doi.org/10.1074/jbc.274.19.13264			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224086	hybrid, Green Accepted			2022-12-27	WOS:000080200400048
J	Hulett, MD; Brinkworth, RI; McKenzie, IFC; Hogarth, PM				Hulett, MD; Brinkworth, RI; McKenzie, IFC; Hogarth, PM			Fine structure analysis of interaction of Fc epsilon RI with IgE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-BINDING REGIONS; EPIDERMAL LANGERHANS CELLS; GAMMA-RII; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODIES; FUNCTIONAL DOMAINS; MOLECULAR-CLONING; IDENTIFICATION; CHAIN	The high affinity receptor for IgE (Fc epsilon RI) plays an integral role in triggering IgE-mediated hypersensitivity reactions. The IgE-interactive site of human Fc epsilon RI has previously been broadly mapped to several large regions in the second extracellular domain (D2) of the a-subunit (Fc epsilon RI alpha). In this study, the IgE binding site of human FceRIa has been further localized to subregions of D2, and key residues putatively involved in the interaction with IgE have been identified. Chimeric receptors generated between Fc epsilon RI alpha and the functionally distinct but structurally homologous low affinity receptor for IgG (Fc gamma RIIa) have been used to localize two IgE binding regions of Fc epsilon RI alpha to amino acid segments Tyr(129)-His(134) and Lys(154)-Glu(161). Both regions were capable of independently binding IgE upon placement into Fc gamma RIIa, Molecular modeling of the three-dimensional structure of Fc epsilon RI alpha-D2 has suggested that these binding regions correspond to the "exposed" C'-E and F-G loop regions at the membrane distal portion of the domain. A systematic site-directed mutagenesis strategy, whereby each residue in the Tyr(129)-His(134) and Lys(154)-Glu(161) regions of Fc epsilon RI alpha was replaced with alanine, has identified key residues putatively involved in the interaction with IgE, Substitution of Tyr(131), Glu(132), Val(155) and Asp(159) decreased the binding of IgE, whereas substitution of Trp(130), Trp(156) Tyr(160), and Glu(161) increased binding. In addition, mutagenesis of residues Trp(113), Val(115), and Tyr(116) in the B-C loop region, which lies adjacent to the C'-E and F-G loops, has suggested Trp(113) also contributes to IgE binding, since the substitution of this residue with alanine dramatically reduces binding. This information should prove valuable in the design of strategies to intervene in the Fc epsilon RI alpha-IgE interaction for the possible treatment of IgE-mediated allergic disease.	Austin Hosp, Austin Res Inst, Heidelberg, Vic 3084, Australia; Univ Queensland, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Queensland	Hogarth, PM (corresponding author), Austin Hosp, Austin Res Inst, Studley Rd, Heidelberg, Vic 3084, Australia.		Hulett, Mark D/C-4160-2012	Hogarth, Mark/0000-0002-0360-7890; Hulett, Mark/0000-0003-2072-5968				BENHAMOU M, 1996, IGE RECEPTOR FCERI F, P32; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; GAVIN AL, 1995, IMMUNOLOGY, V86, P392; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; HAAKFRENDSCHO M, 1993, J IMMUNOL, V151, P351; HARLOW E, 1988, ANTIBODIES LABORATOR, P328; Helm BA, 1996, J BIOL CHEM, V271, P7494, DOI 10.1074/jbc.271.13.7494; HIBBS ML, 1988, P NATL ACAD SCI USA, V85, P2240, DOI 10.1073/pnas.85.7.2240; HIBBS ML, 1994, J IMMUNOL, V152, P4466; HOGARTH PM, 1992, IMMUNOL REV, V125, P21, DOI 10.1111/j.1600-065X.1992.tb00623.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; HULETT MD, 1993, EUR J IMMUNOL, V23, P640, DOI 10.1002/eji.1830230310; HULETT MD, 1994, J BIOL CHEM, V269, P15287; HULETT MD, 1991, J IMMUNOL, V147, P1863; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; IERINO FL, 1993, J IMMUNOL, V150, P1794; LOPEZ AF, 1983, IMMUNOLOGY, V48, P503; MALLAMACI MA, 1993, J BIOL CHEM, V268, P22076; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; McDonnell JM, 1996, NAT STRUCT BIOL, V3, P419, DOI 10.1038/nsb0596-419; NISSIM A, 1993, J IMMUNOL, V150, P1365; PARISH CR, 1974, PROC R SOC SER B-BIO, V187, P47, DOI 10.1098/rspb.1974.0060; PRESTA L, 1994, J BIOL CHEM, V269, P26368; RA C, 1993, INT IMMUNOL, V5, P47, DOI 10.1093/intimm/5.1.47; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RIGBY AJ, 1996, IGE RECEPTOR FCERI F, P7; RISKE F, 1991, J BIOL CHEM, V266, P11245; ROBERTSON MW, 1993, J BIOL CHEM, V268, P12736; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Tamm A, 1996, J BIOL CHEM, V271, P3659; VANDOREN K, 1984, J VIROL, V50, P606, DOI 10.1128/JVI.50.2.606-614.1984; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0	40	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13345	13352		10.1074/jbc.274.19.13345	http://dx.doi.org/10.1074/jbc.274.19.13345			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224096	hybrid			2022-12-27	WOS:000080200400058
J	Roychowdhury, S; Panda, D; Wilson, L; Rasenick, MM				Roychowdhury, S; Panda, D; Wilson, L; Rasenick, MM			G protein alpha subunits activate tubulin GTPase and modulate microtubule polymerization dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SIGNAL-TRANSDUCTION; BINDING REGULATORY PROTEIN; ADENYLATE-CYCLASE; TRANSITION FREQUENCIES; KINETIC STABILIZATION; MITOTIC SPINDLE; LIVING CELLS; INTACT-CELLS; GROWTH CONES; INSTABILITY	G proteins serve many functions involving the transfer of signals from cell. surface receptors to intracellular effector molecules. Considerable evidence suggests that there is an interaction between G proteins and the cytoskeleton. In this report, G protein alpha subunits G(i1)alpha, G(B)alpha, and G(o)alpha are shown to activate the GTPase activity of tubulin, inhibit microtubule assembly, and accelerate microtubule dynamics. G(i)alpha inhibited polymerization of tubulin-GTP into microtubules by 80-90% in the absence of exogenous GTP, Addition of exogenous GTP, but not guanylylimidodiphosphate, which is resistant to hydrolysis, overcame the inhibition. Analysis of the dynamics of individual microtubules by video microscopy demonstrated that G(i1)alpha increases the catastrophe frequency, the frequency of transition from growth to shortening. Thus, G alpha may play a role in modulating microtubule dynamic instability, providing a mechanism for the modification of the cytoskeleton by extracellular signals.	Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Santa Barbara	Rasenick, MM (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, MC 901,835 S Wolcott Ave, Chicago, IL 60612 USA.	raz@uic.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015482] Funding Source: NIH RePORTER; NIA NIH HHS [AG 15482] Funding Source: Medline; NIMH NIH HHS [MH 39595] Funding Source: Medline; NINDS NIH HHS [NS13560] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CARLIER MF, 1989, INT REV CYTOL, V115, P139; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHENG N, 1988, J BIOL CHEM, V263, P3935; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cote M, 1997, ENDOCRINOLOGY, V138, P69, DOI 10.1210/en.138.1.69; Crouch MF, 1997, FASEB J, V11, P189, DOI 10.1096/fasebj.11.2.9039962; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; LEE E, 1994, METHOD ENZYMOL, V237, P146; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LEWIS JM, 1991, CELL REGUL, V2, P1097, DOI 10.1091/mbc.2.12.1097; LIN CT, 1992, LAB INVEST, V67, P770; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Popova JS, 1997, J BIOL CHEM, V272, P6760, DOI 10.1074/jbc.272.10.6760; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; RASENICK MM, 1988, J NEUROCHEM, V51, P300, DOI 10.1111/j.1471-4159.1988.tb04870.x; RASENICK MM, 1981, NATURE, V294, P560, DOI 10.1038/294560a0; RASENICK MM, 1984, J NEUROCHEM, V43, P1447, DOI 10.1111/j.1471-4159.1984.tb05407.x; Ravindra R, 1996, J CELL BIOCHEM, V61, P392, DOI 10.1002/(SICI)1097-4644(19960601)61:3<392::AID-JCB6>3.3.CO;2-M; ROYCHOWDHURY S, 1994, BIOCHEMISTRY-US, V33, P9800, DOI 10.1021/bi00198a052; ROYCHOWDHURY S, 1993, BIOCHEMISTRY-US, V32, P4955, DOI 10.1021/bi00069a034; ROYCHOWDHURY S, 1986, BIOCHEMISTRY-US, V25, P7847, DOI 10.1021/bi00372a010; Roychowdhury S, 1997, J BIOL CHEM, V272, P31576, DOI 10.1074/jbc.272.50.31576; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WANG N, 1991, BIOCHEMISTRY-US, V30, P10957, DOI 10.1021/bi00109a021; WANG N, 1990, J BIOL CHEM, V265, P1239; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WU HC, 1994, LAB INVEST, V71, P175	55	92	110	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13485	13490		10.1074/jbc.274.19.13485	http://dx.doi.org/10.1074/jbc.274.19.13485			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224115	hybrid			2022-12-27	WOS:000080200400077
J	Thual, C; Komar, AA; Bousset, L; Fernandez-Bellot, E; Cullin, C; Melki, R				Thual, C; Komar, AA; Bousset, L; Fernandez-Bellot, E; Cullin, C; Melki, R			Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; YEAST; BINDING; CONFORMATIONS; TRANSLATION; PROPAGATION; SYSTEM; DOMAIN; SUP35; GENE	Sacchromyces cerevisiae prion-like protein Urea was expressed in Escherichia coli and was purified to homogeneity, We show here that Ure2p is a soluble protein that can assemble into fibers that are similar to the fibers observed in the case of PrP in its scrapie prion filaments form or that form on Sup35 self-assembly. Ure2p self-assembly is a cooperative process where one can distinguish a lag phase followed by an elongation phase preceding a plateau. A combination of size exclusion chromatography, sedimentation velocity, and electron microscopy demonstrates that the soluble form of Ure2p consists at least of three forms of the protein as follows: a monomeric, dimeric, and tetrameric form whose abundance is concentration-dependent. By the use of limited proteolysis, intrinsic fluorescence, and circular dichroism measurements, we bring strong evidence for the existence of at least two structural domains in Ure2p molecules. Indeed, Ure2p NH2-terminal region is found poorly structured, whereas its COOH-terminal domain appears to be compactly folded. Finally, we show that only slight conformational changes accompany Ure2p assembly into insoluble high molecular weight oligomers, These changes essentially affect the COOH-terminal part of the molecule. The properties of Ure2p are compared in the discussion to that of other prion-like proteins such as Sup35 and mammalian prion protein PrP.	CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.		cullin, christophe/AAM-2179-2020	cullin, christophe/0000-0003-4110-4677; Komar, Anton/0000-0003-4188-0633				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fernandez-Bellot E, 1999, BIOCHEM J, V338, P403, DOI 10.1042/0264-6021:3380403; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; JOHN ME, 1995, PLANT PHYSIOL, V108, P669, DOI 10.1104/pp.108.2.669; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512; Komar AA, 1997, FEBS LETT, V415, P6, DOI 10.1016/S0014-5793(97)01082-X; KOMAR AA, 1995, FEBS LETT, V376, P195, DOI 10.1016/0014-5793(95)01275-0; Komar AA, 1998, BIOL CHEM, V379, P1295; KUNTZ ID, 1971, J AM CHEM SOC, V93, P516, DOI 10.1021/ja00731a037; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIN TH, 1991, J BIOL CHEM, V266, P1635; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Melki R, 1996, BIOCHEMISTRY-US, V35, P10422, DOI 10.1021/bi960788r; Mihara H, 1998, BIOPOLYMERS, V47, P83, DOI 10.1002/(SICI)1097-0282(1998)47:1<83::AID-BIP9>3.0.CO;2-T; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIPE JD, 1994, CRIT REV CLIN LAB SC, V31, P352; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; [No title captured]	40	115	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13666	13674		10.1074/jbc.274.19.13666	http://dx.doi.org/10.1074/jbc.274.19.13666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224139	hybrid			2022-12-27	WOS:000080200400101
J	Vande Weghe, JG; Ow, DW				Vande Weghe, JG; Ow, DW			A fission yeast gene for mitochondrial sulfide oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURPLE PHOTOTROPHIC BACTERIUM; SCHIZOSACCHAROMYCES-POMBE; QUINONE REDUCTASE; FLAVOCYTOCHROME-C; RHODOBACTER-CAPSULATUS; CYTOCHROME REDUCTION; TOLERANCE; DEHYDROGENASE; DETOXIFICATION; PURIFICATION	A cadmium-hypersensitive mutant of the fission yeast Schizosaccharomyces pombe was found to accumulate abnormally high levels of sulfide. The gene required for normal regulation of sulfide levels, hmt2(+), was cloned by complementation of the cadmium-hypersensitive phenotype of the mutant. Cell fractionation and immunocytochemistry indicated that HMT2 protein is localized to mitochondria, Sequence analysis revealed homology between HMT2 and sulfide dehydrogenases from photosynthetic bacteria. HMT2 protein, produced in and purified from Escherichia coli, was soluble, bound FAD, and catalyzed the reduction of quinone (coenzyme Q(2)) by sulfide. HMT2 activity was also detected in isolated fission yeast mitochondria. We propose that HMT2 functions as a sulfide:quinone oxidoreductase. Homologous enzymes may be widespread in higher organisms, as sulfide-oxidizing activities have been described previously in animal mitochondria, and genes of unknown function, but with similarity to hmt2(+), are present in the genomes of flies, worms, rats, mice, and humans.	USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley	Ow, DW (corresponding author), USDA ARS, Ctr Plant Gene Express, 800 Buchanan St, Albany, CA 94710 USA.							ALFA C, 1993, EXPT FISSION YEAST L, P134; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARIELI B, 1994, J BIOL CHEM, V269, P5705; BAGARINAO T, 1990, J COMP PHYSIOL B, V160, P519; BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; BAXTER CI, 1958, BIOCHIM BIOPHYS ACTA, V27, P584, DOI 10.1016/0006-3002(58)90390-1; BEACH D, 1981, NATURE, V290, P140, DOI 10.1038/290140a0; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P452; BRUNE DC, 1986, ARCH MICROBIOL, V145, P295, DOI 10.1007/BF00443662; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; DAUM G, 1982, J BIOL CHEM, V257, P3028; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; JAULT JM, 1994, J BIOENERG BIOMEMBR, V26, P447, DOI 10.1007/BF00762785; Johnson B.F, 1989, MOL BIOL FISSION YEA, P243; Lee RW, 1996, BIOL BULL, V191, P421, DOI 10.2307/1543015; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MEYER TE, 1991, BIOCHEMISTRY-US, V30, P8840, DOI 10.1021/bi00100a016; MOORE AL, 1992, YEAST, V8, P923, DOI 10.1002/yea.320081103; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; National Research Council Division of Medical Science subcommittee on Hydrogen Sulfide, 1979, HYDR SULF; OESCHGER R, 1992, MAR ECOL PROG SER, V86, P167, DOI 10.3354/meps086167; OESCHGER R, 1994, OPHELIA, V40, P147, DOI 10.1080/00785326.1994.10430581; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Perego P, 1997, MOL PHARMACOL, V51, P12, DOI 10.1124/mol.51.1.12; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; ROST B, 1995, 3 INT C INT SYST MOL, P314; SCHNEPPENHEIM R, 1991, ELECTROPHORESIS, V12, P367, DOI 10.1002/elps.1150120508; Schutz M, 1997, J BIOL CHEM, V272, P9890; SHAHAK Y, 1994, PHOTOSYNTH RES, V39, P175, DOI 10.1007/BF00029384; SHAHAK Y, 1992, FEBS LETT, V299, P127, DOI 10.1016/0014-5793(92)80230-E; SPEISER DM, 1992, MOL CELL BIOL, V12, P5301, DOI 10.1128/MCB.12.12.5301; VANBEEUMEN J, 1990, J BIOL CHEM, V265, P9793; VanDriessche G, 1996, PROTEIN SCI, V5, P1753; Voelkel Susanne, 1996, European Journal of Biochemistry, V235, P231; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750	36	89	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13250	13257		10.1074/jbc.274.19.13250	http://dx.doi.org/10.1074/jbc.274.19.13250			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224084	hybrid			2022-12-27	WOS:000080200400046
J	Warnecke, D; Erdmannn, R; Fahl, A; Hube, B; Muller, F; Zank, T; Zahringer, U; Heinz, E				Warnecke, D; Erdmannn, R; Fahl, A; Hube, B; Muller, F; Zank, T; Zahringer, U; Heinz, E			Cloning and functional expression of UGT genes encoding sterol glucosyltransferases from Saccharomyces cerevisiae, Candida albicans, Pichia pastoris, and Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-GLUCOSYLTRANSFERASE; TRUE SLIME-MOLD; UDP-GLUCOSE; PHYSARUM-POLYCEPHALUM; PLASMA-MEMBRANE; PLANT STEROLS; ENDOPLASMIC-RETICULUM; STRUCTURAL-ANALYSIS; ESCHERICHIA-COLI; SINAPIS-ALBA	Sterol glucosides, typical membrane-bound lipids of many eukaryotes, are biosynthesized by a UDP-glucose: sterol glucosyltransferase (EC 2.4.1.173), We cloned genes from three different yeasts and from Dictyostelium discoideum, the deduced amino acid sequences of which all showed similarities with plant sterol glucosyltransferases (Ugt80A1, Ugt80A2), These genes from Sac charomyces cerevisiae (UGT51 = YLR189C), Pichia pas toris (UGT51B1), Candida albicans (UGT51C1), and Dictyostelium discoideum (ugt52) were expressed in Escherichia coli. In vitro enzyme assays with cell-free extracts of the transgenic E, coli strains showed that the genes encode UDP-glucose:sterol glucosyltransferases which can use different sterols such as cholesterol, sitosterol, and ergosterol as sugar accepters. An S. cerevisiae null mutant of UGT51 had lost its ability to synthesize sterol glucoside but exhibited normal growth under various culture conditions. Expression of either UGT51 or UGT51B1 in this null mutant under the control of a galactose-induced promoter restored sterol glucoside synthesis in vitro, Lipid extracts of these cells contained a novel glycolipid, This lipid was purified and identified as ergosterol-beta-D-glucopyranoside by nuclear magnetic resonance spectroscopy. These data prove that the cloned genes encode sterol-beta-D-glucosyltransferases and that sterol glucoside synthesis is an inherent feature of eukaryotic microorganisms.	Univ Hamburg, Inst Allgemeine Bot, D-22609 Hamburg, Germany; Free Univ Berlin, Inst Biochem, D-12203 Berlin, Germany; Forschungszentrum Borstel, D-23845 Borstel, Germany	University of Hamburg; Free University of Berlin; Forschungszentrum Borstel	Warnecke, D (corresponding author), Univ Hamburg, Inst Allgemeine Bot, Ohnhorststr 18, D-22609 Hamburg, Germany.	warnecke@botanik.uni-hamburg.de		Hube, Bernhard/0000-0002-6028-0425				ABRAHAM W, 1987, J LIPID RES, V28, P446; ALTSCHUL SF, 1990, J MOL BIOL, V215, P408; Ausubel FM, 1988, MOL REPROD DEV; Bach TJ, 1997, PROG LIPID RES, V36, P197, DOI 10.1016/S0163-7827(97)00009-X; BARAUD J, 1970, B SOC CHIM BIOL, V52, P421; BOUVIERNAVE P, 1995, PLANT SCI, V110, P11, DOI 10.1016/0168-9452(95)04181-S; BouvierNave P, 1997, EUR J BIOCHEM, V246, P518, DOI 10.1111/j.1432-1033.1997.t01-1-00518.x; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; DUPERON R, 1980, BIOGENESIS FUNCTION, P445; ERDMANN R, 1994, YEAST, V10, P935, DOI 10.1002/yea.320100708; ESDERS TW, 1972, J BIOL CHEM, V247, P248; GHANNOUM MA, 1986, J GEN MICROBIOL, V132, P2367; GHANNOUM MA, 1990, J MED VET MYCOL, V28, P103; GRUNWALD C, 1971, PLANT PHYSIOL, V48, P653, DOI 10.1104/pp.48.5.653; Haque M, 1996, J BACTERIOL, V178, P2065, DOI 10.1128/jb.178.7.2065-2070.1996; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; HASE A, 1981, ARCH BIOCHEM BIOPHYS, V210, P280, DOI 10.1016/0003-9861(81)90191-0; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; HUNGUND BL, 1994, CHEM PHYS LIPIDS, V69, P167, DOI 10.1016/0009-3084(94)90038-8; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; KALINOWSKA M, 1986, Phytochemistry (Oxford), V25, P45, DOI 10.1016/S0031-9422(00)94498-4; KASTELICSUHADOLC T, 1980, BIOCHIM BIOPHYS ACTA, V620, P322, DOI 10.1016/0005-2760(80)90213-1; KIMMEL AR, 1985, MOL CELL BIOL, V5, P2123, DOI 10.1128/MCB.5.8.2123; KIMMEL AR, 1979, CELL, V16, P787, DOI 10.1016/0092-8674(79)90094-1; KIRK DN, 1990, J CHEM SOC PERK T 2, P1567, DOI 10.1039/p29900001567; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEHLE L, 1980, EUR J BIOCHEM, V109, P589, DOI 10.1111/j.1432-1033.1980.tb04832.x; LENART U, 1995, ACTA BIOCHIM POL, V42, P269; LIU H, 1995, J BIOL CHEM, V270, P10940, DOI 10.1074/jbc.270.18.10940; LIVERMORE BP, 1978, INFECT IMMUN, V20, P215, DOI 10.1128/IAI.20.1.215-220.1978; LORCH Y, 1985, J MOL BIOL, V186, P821, DOI 10.1016/0022-2836(85)90400-0; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MAYBERRY WR, 1983, BIOCHIM BIOPHYS ACTA, V752, P434, DOI 10.1016/0005-2760(83)90273-4; MCKERSIE BD, 1979, PLANT PHYSIOL, V63, P802, DOI 10.1104/pp.63.5.802; MCMORRIS TC, 1977, BIOCHIM BIOPHYS ACTA, V486, P308, DOI 10.1016/0005-2760(77)90026-1; Moehs CP, 1997, PLANT J, V11, P227, DOI 10.1046/j.1365-313X.1997.11020227.x; MUDD JB, 1980, PLANT PHYSIOL, V65, P78, DOI 10.1104/pp.65.1.78; MUHIUDEEN IA, 1984, J LIPID RES, V25, P1117; MURAKAMIMUROFUSHI K, 1987, J BIOL CHEM, V262, P16719; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; MURAKAMIMUROFUSHI K, 1989, BIOCHIM BIOPHYS ACTA, V992, P412, DOI 10.1016/0304-4165(89)90108-6; Ness F, 1998, J BACTERIOL, V180, P1913, DOI 10.1128/JB.180.7.1913-1919.1998; OEKERS P, 1998, J BIOL CHEM, V273, P26765; Palermo LM, 1997, CURR GENET, V32, P93, DOI 10.1007/s002940050252; PARKS LW, 1978, LIPIDS, V13, P730, DOI 10.1007/BF02533753; PARODI AJ, 1976, ACTA PHYSIOL LAT AM, V26, P430; PATEL KR, 1978, J BACTERIOL, V136, P829, DOI 10.1128/JB.136.2.829-831.1978; Rahier A, 1997, BIOCHEM BIOPH RES CO, V236, P434, DOI 10.1006/bbrc.1997.6974; Schaller H, 1998, PLANT PHYSIOL, V118, P461, DOI 10.1104/pp.118.2.461; Schroeder F, 1996, P SOC EXP BIOL MED, V213, P150, DOI 10.3181/00379727-213-44047; SHAW DR, 1989, MOL GEN GENET, V218, P453, DOI 10.1007/BF00332409; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH PF, 1971, J BACTERIOL, V108, P986, DOI 10.1128/JB.108.3.986-991.1971; SMITH WB, 1977, ORG MAGN RESONANCE, V9, P644, DOI 10.1002/mrc.1270091108; Sweigard JA, 1998, MOL PLANT MICROBE IN, V11, P404, DOI 10.1094/MPMI.1998.11.5.404; Tomeo ME, 1997, YEAST, V13, P449; TYORINOJA K, 1974, BIOCHEM J, V141, P133; ULLMANN P, 1993, BIOCHIMIE, V75, P713, DOI 10.1016/0300-9084(93)90102-X; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Veron B, 1996, LIPIDS, V31, P989, DOI 10.1007/BF02522694; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Warnecke DC, 1997, PLANT MOL BIOL, V35, P597, DOI 10.1023/A:1005806119807; WARNECKE DC, 1994, PLANT PHYSIOL, V105, P1067, DOI 10.1104/pp.105.4.1067; WEBB MS, 1995, BBA-BIOMEMBRANES, V1239, P226, DOI 10.1016/0005-2736(95)00147-U; WERTZ PW, 1986, J LIPID RES, V27, P427; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; WOJCIECHOWSKI ZA, 1979, BIOCHIM BIOPHYS ACTA, V570, P363, DOI 10.1016/0005-2744(79)90156-6; WOJCIECHOWSKI ZA, 1979, PHYTOCHEMISTRY, V18, P39, DOI 10.1016/S0031-9422(00)90911-7; WOJCIECHOWSKI ZA, 1991, PHYSL BIOCH STEROLS; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	78	102	114	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13048	13059		10.1074/jbc.274.19.13048	http://dx.doi.org/10.1074/jbc.274.19.13048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224056	hybrid			2022-12-27	WOS:000080200400018
J	Yen, FT; Masson, M; Clossais-Besnard, N; Andre, P; Grosset, JM; Bougueleret, L; Dumas, JB; Guerassimenko, O; Bihain, BE				Yen, FT; Masson, M; Clossais-Besnard, N; Andre, P; Grosset, JM; Bougueleret, L; Dumas, JB; Guerassimenko, O; Bihain, BE			Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; DI-LEUCINE MOTIF; CHYLOMICRON REMNANTS; LDL RECEPTOR; APOLIPOPROTEIN-E; DOWN-REGULATION; PATHWAY; GENE; PROTEIN; METABOLISM	The lipolysis-stimulated receptor (LSR) is a lipoprotein receptor primarily expressed in the liver and activated by free fatty acids. Antibodies inhibiting LSR functions showed that the receptor is a heterotrimer or tetramer consisting of 68-kDa (alpha) and 56-kDa (beta) sub units associated through disulfide bridges. Screening of expression libraries with these antibodies led to identification of mRNAs derived by alternate splicing from a single gene and coding for proteins with molecular masses matching that of LSR alpha and beta, Antibodies directed against a synthetic peptide of LSR alpha and beta putative ligand binding domains inhibited LSR activity. Western blotting identified two liver proteins with the same apparent molecular mass as that of LSR alpha and beta. Transient transfections of LSR alpha alone in Chinese hamster ovary cells increased oleate-induced binding and uptake of lipoproteins, while cotransfection of both LSR alpha and beta increased oleate-induced proteolytic degradation of the particles. The ligand specificity of LSR expressed in cotransfected Chinese hamster ovary cells closely matched that previously described using fibroblasts from subjects lacking the low density lipoprotein receptor. LSR affinity is highest for the triglyceride-rich lipoproteins, chylomicrons, and very low density lipoprotein. We speculate that LSR is a rate-limiting step for the clearance of dietary triglycerides and plays a role in determining their partitioning between the liver and peripheral tissues.	INSERM U391, F-35043 Rennes, France; Genset SA, F-75000 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bihain, BE (corresponding author), Genset Corp, 875 Prospect St,Suite 206, La Jolla, CA 92037 USA.		André, Patrice/M-8139-2014; Yen, Frances T/G-9175-2014	André, Patrice/0000-0002-5834-7395; Yen, Frances T/0000-0001-8740-4304				ATTIE AD, 1982, HEPATOLOGY, V2, P269; BARTLES JR, 1990, METHOD ENZYMOL, V191, P825; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; BIHAIN BE, 1992, BIOCHEMISTRY-US, V31, P4628, DOI 10.1021/bi00134a013; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Cooper AD, 1997, J LIPID RES, V38, P2173; DEARIA E, 1996, J LIPID RES, V37, P197; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; HOEG JM, 1986, BIOCHIM BIOPHYS ACTA, V876, P13, DOI 10.1016/0005-2760(86)90312-7; HUETTINGER M, 1988, CLIN BIOCHEM, V21, P87, DOI 10.1016/S0009-9120(88)80093-6; HUYNH TV, 1984, DNA CLONING TECHNIQU; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; KHALLOU J, 1996, CIRCULATION S, V94, P37; KOSAK M, 1990, P NATL ACAD SCI USA, V87, P8301; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; MAHLEY RW, 1989, ARTERIOSCLER, V9, P114; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MANN CJ, 1995, BIOCHEMISTRY-US, V34, P10421, DOI 10.1021/bi00033a014; Oukka M, 1997, EUR J IMMUNOL, V27, P855, DOI 10.1002/eji.1830270408; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; Sambrook J., 2002, MOL CLONING LAB MANU; Shepherd J, 1986, Methods Enzymol, V129, P566; SHIN JY, 1991, J BIOL CHEM, V266, P10658; TROUSSARD AA, 1995, J BIOL CHEM, V270, P17068, DOI 10.1074/jbc.270.29.17068; Via D P, 1986, Methods Enzymol, V129, P848; VILARO S, 1988, BIOCHIM BIOPHYS ACTA, V959, P106, DOI 10.1016/0005-2760(88)90021-5; VILARO S, 1988, AM J PHYSIOL, V254, pG711, DOI 10.1152/ajpgi.1988.254.5.G711; Ware Carl F., 1998, P549; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	39	57	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13390	13398		10.1074/jbc.274.19.13390	http://dx.doi.org/10.1074/jbc.274.19.13390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224102	hybrid			2022-12-27	WOS:000080200400064
J	Xue, HH; Sakaguchi, T; Fujie, M; Ogawa, H; Ichiyama, A				Xue, HH; Sakaguchi, T; Fujie, M; Ogawa, H; Ichiyama, A			Flux of the L-serine metabolism in rabbit, human, and dog livers - Substantial contributions of both mitochondrial and peroxisomal serine : pyruvate/alanine : glyoxylate aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-DISTRIBUTION; HEPATIC ALANINE; RAT-LIVER; GLYCINE; COMPARTMENTATION; BINDING	L-Serine metabolism in rabbit, dog, and human livers was investigated, focusing on the relative contributions of the three pathways, one initiated by serine dehydratase, another by serine:pyruvate/alanine:glyoxylate aminotransferase (SPT/AGT), and the other involving serine hydroxymethyltransferase and the mitochondrial glycine cleavage enzyme system (GCS), Under quasi-physiological in vitro conditions (1 mM L-serine and 0.25 mar pyruvate), flux through serine dehydratase accounted for only traces, and that through SPT/AGT substantially contributed no matter whether the enzyme was located in peroxisomes (rabbit and human) or largely in mitochondria (dog), As for flux through serine hydroxymethyltransferase and GCS, the conversion of serine to glycine occurred fairly rapidly, followed by GCS-mediated slow decarboxylation of the accumulated glycine, The flux through GCS was relatively high in the dog and low in the rabbit, and only in the dog was it comparable with that through SPT/AGT, An in vivo experiment with L-[3-(3)H,(14)C]serine as the substrate indicated that in rabbit liver, gluconeogenesis from Lserine proceeds mainly via hydroxypyruvate, Because an important role in the conversion of glyoxylate to glycine has been assigned to peroxisomal SPT/AGT from the studies on primary hyperoxaluria type I, these results suggest that SPT/AGT in this organelle plays dual roles in the metabolism of glyoxylate and serine.	Hamamatsu Univ Sch Med, Dept Biochem 1, Shizuoka 4313192, Japan; Hamamatsu Univ Sch Med, Dept Surg 2, Shizuoka 4313192, Japan; Hamamatsu Univ Sch Med, Equipment Ctr, Shizuoka 4313192, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Biochem, Toyama 9300194, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Toyama	Ichiyama, A (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, 3600 Handa Cho, Shizuoka 4313192, Japan.			Xue, Hai-Hui/0000-0002-9163-7669				APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BELIVEAU GP, 1982, COMP BIOCHEM PHYS B, V71, P13, DOI 10.1016/0305-0491(82)90168-7; BLOXAM DL, 1972, BRIT J NUTR, V27, P233, DOI 10.1079/BJN19720090; DANPURE CJ, 1990, J CELL SCI, V97, P669; DANPURE CJ, 1995, METABOLIC MOL BASES, V2, P2385; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; GELLER AM, 1989, ANAL BIOCHEM, V180, P120, DOI 10.1016/0003-2697(89)90098-5; HARRIS KS, 1980, INVEST UROL, V18, P106; ISHIKAWA E, 1965, J BIOCHEM, V57, P506, DOI 10.1093/oxfordjournals.jbchem.a128109; Ishikawa K, 1996, J BIOCHEM, V119, P970; JOIS M, 1990, J BIOL CHEM, V265, P1246; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; MAITRA U, 1964, J BIOL CHEM, V237, P1485; NOGUCHI T, 1978, J BIOL CHEM, V253, P7593; ODA T, 1990, J BIOL CHEM, V265, P7513; PANDE SV, 1978, J BIOL CHEM, V253, P1565; ROWSELL EV, 1979, COMP BIOCHEM PHYS B, V63, P543, DOI 10.1016/0305-0491(79)90061-0; ROWSELL EV, 1972, BIOCHEM J, V127, P155, DOI 10.1042/bj1270155; RYAN WL, 1966, NATURE, V212, P292, DOI 10.1038/212292a0; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; TAKADA Y, 1982, COMP BIOCHEM PHYS B, V72, P597, DOI 10.1016/0305-0491(82)90512-0; Wagner C, 1996, J NUTR, V126, pS1228, DOI 10.1093/jn/126.suppl_4.1228S; Xue HH, 1999, J BIOL CHEM, V274, P16020, DOI 10.1074/jbc.274.23.16020; YANAGISAWA M, 1983, BIOCH METABOLIC PROC, P413	25	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16028	16033		10.1074/jbc.274.23.16028	http://dx.doi.org/10.1074/jbc.274.23.16028			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347152	hybrid, Green Submitted			2022-12-27	WOS:000080668600012
J	Johnson, KJ; Sage, H; Briscoe, G; Erickson, HP				Johnson, KJ; Sage, H; Briscoe, G; Erickson, HP			The compact conformation of fibronectin is determined by intramolecular ionic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; RESONANCE SPIN-LABEL; CIRCULAR-DICHROISM; ELECTRON-MICROSCOPY; SELF-ASSOCIATION; HEPARIN-BINDING; CELLS; STABILITY; FRAGMENTS; STRENGTH	Fibronectin exists in a compact or extended conformation, depending upon environmental pH and salt concentration. Using recombinant fragments expressed in bacteria and baculovirus, we determined the domains responsible for producing fibronectin's compact conformation. Our velocity and equilibrium sedimentation data show that FN2-14 (a protein containing FN-III domains 2 through 14) forms dimers in low salt. Experiments with smaller fragments indicates that the compact conformation is produced by binding of FN12-14 of one subunit to FN2-3 of the other subunit in the dimer, The binding is weakened at higher salt concentrations, implying an electrostatic interaction. Furthermore, segment FN7-14+A, which contains the alternatively spliced A domain between FN11 and 12, forms dimers, whereas FN7-14 without A does not. Segment FN12-14+A also forms dimers, but the isolated A domain does not. These data imply an association of domain A with FN12-14, and the presence of A may favor an open conformation by competing with FN2-3 for binding to FN12-14.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, 365 Sands Bldg,Box 3011, Durham, NC 27710 USA.			Johnson, Kamin/0000-0003-4550-5566	NATIONAL CANCER INSTITUTE [R37CA047056, R01CA047056] Funding Source: NIH RePORTER; NCI NIH HHS [CA47056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256; ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501; ANKEL EG, 1986, ARCH BIOCHEM BIOPHYS, V244, P50, DOI 10.1016/0003-9861(86)90093-7; AOTA S, 1994, J BIOL CHEM, V269, P24756; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; BUSBY TF, 1995, J BIOL CHEM, V270, P18558, DOI 10.1074/jbc.270.31.18558; Carnemolla B, 1996, BIOCHEM CELL BIOL, V74, P745, DOI 10.1139/o96-081; CASTELLANI P, 1986, J CELL BIOL, V103, P1671, DOI 10.1083/jcb.103.5.1671; EHRISMANN R, 1982, J BIOL CHEM, V257, P7381; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159; HAYASHI M, 1983, J BIOL CHEM, V258, P3332; Hino K, 1996, ARTHRITIS RHEUM, V39, P1685, DOI 10.1002/art.1780391011; HOMANDBERG GA, 1986, BIOCHEMISTRY-US, V25, P6917, DOI 10.1021/bi00370a027; HORMANN H, 1982, KLIN WOCHENSCHR, V60, P1265, DOI 10.1007/BF01727483; Hynes RO, 1990, FIBRONECTINS; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174; LAI CS, 1984, BIOCHEMISTRY-US, V23, P6393, DOI 10.1021/bi00321a017; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; MARKOVIC Z, 1983, H-S Z PHYSIOL CHEM, V364, P1795, DOI 10.1515/bchm2.1983.364.2.1795; ODERMATT E, 1982, J MOL BIOL, V159, P109, DOI 10.1016/0022-2836(82)90034-1; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; ROCCO M, 1983, J BIOL CHEM, V258, P4545; ROCCO M, 1984, FEBS LETT, V178, P327, DOI 10.1016/0014-5793(84)80627-4; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWARZBAUER JE, 1987, EMBO J, V6, P2673; SEKIGUCHI K, 1986, BIOCHEMISTRY-US, V25, P4936, DOI 10.1021/bi00365a032; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	34	155	156	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15473	15479		10.1074/jbc.274.22.15473	http://dx.doi.org/10.1074/jbc.274.22.15473			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336438	hybrid			2022-12-27	WOS:000080560100027
J	Oh, HJ; Easton, D; Murawski, M; Kaneko, Y; Subjeck, JR				Oh, HJ; Easton, D; Murawski, M; Kaneko, Y; Subjeck, JR			The chaperoning activity of hsp110 - Identification of functional domains by use of targeted deletions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SECONDARY STRUCTURE PREDICTION; REGULATED STRESS PROTEIN; PEPTIDE-BINDING DOMAIN; AMINO-ACID-ANALOGS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; NONNATIVE PROTEIN; SUBSTRATE-BINDING; LARGE HSP70-LIKE	hsp110 is one of major heat shock proteins of eukaryotic cells and is a diverged relative of the hsp70 family. It has been previously shown that hsp110 maintains heat-denatured luciferase in a soluble, folding competent state and also confers cellular heat resistance in vivo. In the present study the functional domains of hsp110 that are responsible for its chaperoning activity are identified by targeted deletion mutagenesis using the DnaK structure as the model. The chaperoning activity of mutants is assessed based on their ability to solubilize heat-denatured luciferase as well as to refold luciferase in the presence of rabbit reticulocyte lysate. It is shown that these functions require only an internal region of hsp110 that includes the predicted peptide binding domain and two immediately adjacent C-terminal domains. It is also shown that although hsp110 binds ATP, binding can be blocked by its C-terminal region.	Roswell Pk Canc Inst, Dept Mol & Cellular Biophys, Buffalo, NY 14263 USA; SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; Buffalo State College	Subjeck, JR (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biophys, Buffalo, NY 14263 USA.		Easton, Douglas/A-9359-2009; Easton, Douglas/AAU-4216-2020	Easton, Douglas/0000-0003-4288-0774; Easton, Douglas/0000-0003-4288-0774; Oh, Kelly/0000-0001-8203-5247	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045994] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boice JA, 1997, J BIOL CHEM, V272, P24825, DOI 10.1074/jbc.272.40.24825; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen X, 1996, FEBS LETT, V380, P68, DOI 10.1016/0014-5793(96)00011-7; Chung KS, 1998, GENE, V210, P143, DOI 10.1016/S0378-1119(98)00061-4; CRAIG EA, 1985, MOL CELL BIOL, V5, P3517, DOI 10.1128/MCB.5.12.3517; Craven RA, 1997, TRENDS CELL BIOL, V7, P277, DOI 10.1016/S0962-8924(97)01079-9; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; Dierks T, 1996, EMBO J, V15, P6931, DOI 10.1002/j.1460-2075.1996.tb01085.x; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FOLTZ KR, 1993, SCIENCE, V259, P1421, DOI 10.1126/science.8383878; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; GAO BC, 1991, J BIOL CHEM, V266, P19565; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; Kaneko Y, 1997, J BIOL CHEM, V272, P2640, DOI 10.1074/jbc.272.5.2640; Kaneko Y, 1997, GENE, V189, P19, DOI 10.1016/S0378-1119(96)00807-4; Kojima R, 1996, J BIOL CHEM, V271, P12327, DOI 10.1074/jbc.271.21.12327; LANDRY J, 1982, CANCER RES, V42, P2457; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; LEVINSON W, 1980, BIOCHIM BIOPHYS ACTA, V606, P170, DOI 10.1016/0005-2787(80)90108-2; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; LI GC, 1985, J CELL PHYSIOL, V122, P91, DOI 10.1002/jcp.1041220114; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Mauk R, 1997, DEV BIOL, V184, P31, DOI 10.1006/dbio.1997.8512; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; MOROZOV A, 1995, FEBS LETT, V371, P214, DOI 10.1016/0014-5793(95)00884-C; MUKAI H, 1993, GENE, V132, P57; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; Storozhenko S, 1996, FEBS LETT, V390, P113, DOI 10.1016/0014-5793(96)00640-0; SUBJECK JR, 1982, HEAT SHOCK BACTERIA, P405; TOMASOVIC SP, 1983, RADIAT RES, V95, P399, DOI 10.2307/3576265; TSAI MY, 1994, J BIOL CHEM, V269, P5958; WANG TF, 1993, J BIOL CHEM, V268, P26049; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	44	112	115	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15712	15718		10.1074/jbc.274.22.15712	http://dx.doi.org/10.1074/jbc.274.22.15712			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336470	hybrid			2022-12-27	WOS:000080560100059
J	Hirohashi, T; Suzuki, H; Sugiyama, Y				Hirohashi, T; Suzuki, H; Sugiyama, Y			Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC-ANION TRANSPORTER; CONJUGATE EXPORT PUMP; EISAI HYPERBILIRUBINEMIC RATS; PRIMARY ACTIVE-TRANSPORT; DUBIN-JOHNSON-SYNDROME; CANCER CELL-LINES; CANALICULAR MEMBRANE; DEPENDENT TRANSPORT; BILIARY-EXCRETION; LEUKOTRIENE C-4	We have previously cloned rat MRP3 as an inducible transporter in the liver (Hirohashi, T,, Suzuki, H., Ito, K,, Ogawa, K,, Kume, K,, Shimizu, T,, and Sugiyama, Y, (1998) Mol. Pharmacol, 53, 1068-1075), In the present study, the function of rat MRP3 was investigated using membrane vesicles isolated from LLC-PK1 and HeLa cell population transfected with corresponding cDNA, The ATP-dependent uptake of both 17 beta estradiol 17-beta-D-glucuronide ([H-3]E(2)17 beta G) and glucuronide of [C-14] 6-hydroxy-5,7- dimethyl-2-methylamino-4- (3-pyridylmethyl) benzothiazole (E3040), but not that of [H-3]leukotriene C-4 and [H-3]2,4-dinitrophenyl-S-glutathione, was markedly stimulated by MRP3 transfection in both cell lines. The K-m and V-max values for the uptake of [H-3]E(2)17 beta G were 67 +/- 14 mu M and 415 +/- 73 pmol/min/mg of protein, respectively, for MRP3-expressing membrane vesicles and 3.0 +/- 0.7 mu M and 3.4 +/- 0.4 pmol/min/mg of protein, respectively, for the endogenous transporter expressed on HeLa cells. [H-3]E(2)17 beta G had also a similar K-m value for MRP3 when LLC-PK1 cells were used as the host. All glucuronide conjugates examined (E3040 glucuronide, 4-methylumbelliferone glucuronide, and naphthyl glucuronide) and methotrexate inhibited MRP3-mediated [H-3]E(2)17 beta G transport in LLC-PK1 cells, Moreover, [H-3]methotrexate was transported via MRP3, The inhibitory effect of estrone sulfate, [H-3]2,4-dinitrophenyl-S-glutathione, and [H-3]leukotriene C-4 was moderate or minimal, whereas N-acetyl-2,4-dinitrophenylcysteine had no effect on the uptake of [H-3]E(2)17 beta G. The uptake of [H-3]E(2)17 beta G was enhanced by E3040 sulfate and 4-methylumbelliferone sulfate. Thus we were able to demonstrate that several kinds of organic anions are transported via MRP3, although the substrate specificity of MRP3 differs from that of MRP1 and cMOAT/MRP2 in that glutathione conjugates are poor substrates for MRP3.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Suzuki, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.							Buchler M, 1996, J BIOL CHEM, V271, P15091; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; DEVRIES MH, 1989, N-S ARCH PHARMACOL, V340, P588, DOI 10.1007/BF00260615; DEVRIES MH, 1989, N-S ARCH PHARMACOL, V340, P239, DOI 10.1007/BF00168975; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; HINCHMAN CA, 1991, J BIOL CHEM, V266, P22179; Hirohashi T, 1998, MOL PHARMACOL, V53, P1068; Hirohashi Tomoko, 1997, Pharmaceutical Research (New York), V14, pS458; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; Ishikawa T, 1997, BIOSCIENCE REP, V17, P189, DOI 10.1023/A:1027385513483; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16, DOI 10.1152/ajpgi.1997.272.1.G16; Ito K, 1998, J BIOL CHEM, V273, P1684, DOI 10.1074/jbc.273.3.1684; Jedlitschky G, 1996, CANCER RES, V56, P988; Keppler D, 1997, FASEB J, V11, P509, DOI 10.1096/fasebj.11.7.9212074; Kiuchi Y, 1998, FEBS LETT, V433, P149, DOI 10.1016/S0014-5793(98)00899-0; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; Koike K, 1997, CANCER RES, V57, P5475; Kool M, 1997, CANCER RES, V57, P3537; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Madon J, 1997, FEBS LETT, V406, P75, DOI 10.1016/S0014-5793(97)00245-7; Masuda M, 1997, CANCER RES, V57, P3506; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Niinuma K, 1997, J PHARMACOL EXP THER, V282, P866; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Saxena M, 1996, BIOCHEM J, V320, P273, DOI 10.1042/bj3200273; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHWENK M, 1982, ARCH PHARM, V321, P223; Stride BD, 1996, MOL PHARMACOL, V49, P962; TAKENAKA O, 1995, J PHARMACOL EXP THER, V274, P1362; Taniguchi K, 1996, CANCER RES, V56, P4124; van Aubel RAMH, 1998, MOL PHARMACOL, V53, P1062; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; Yamazaki M, 1996, PHARMACEUT RES, V13, P497, DOI 10.1023/A:1016077517241	38	298	306	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15181	15185		10.1074/jbc.274.21.15181	http://dx.doi.org/10.1074/jbc.274.21.15181			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329726	hybrid			2022-12-27	WOS:000081965200091
J	Arrizubieta, MJ; Bandman, E				Arrizubieta, MJ; Bandman, E			Regulation of alpha-helical coiled-coil dimerization in chicken skeletal muscle light meromyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN4 LEUCINE-ZIPPER; INTERHELICAL IONIC INTERACTIONS; HEAVY-CHAIN FAMILY; MYOSIN HEAVY; AMINO-ACIDS; STABILITY; HETERODIMER; ISOFORMS; SPECIFICITY; PROTEINS	The dimerization specificity of the light meromyosin (LMM) domain of chicken neonatal and adult myosin isoforms was analyzed by metal chelation chromatography. Our results show that neonatal and adult LMMs associate preferentially, although not exclusively, as homodimeric coiled-coils. Using chimeric LMM constructs combining neonatal and adult sequences, we observed that a stretch of 183 amino acids of sequence identity at the N terminus of the LMM was sufficient to allow the adult LMM to dimerize in a non-selective manner. In contrast, sequence identity in the remaining C-terminal 465 amino acids had only a modest effect on the dimerization selectivity of the adult isoform. Sequence identity at the N terminus also promoted dimerization of the neonatal LMM to a greater degree than sequence identity at the C terminus. However, the N terminus had only a partial effect on the dimerization specificity of the neonatal sequence, and residues distributed throughout the LMM were capable of affecting dimerization selectivity of this isoform. These results indicated that dimerization preference of the neonatal and adult isoforms was affected to a different extent by sequence identity at a given region of the LMM.	Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis	Bandman, E (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.							Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Arrizubieta MJ, 1998, BIOCHEM BIOPH RES CO, V244, P588, DOI 10.1006/bbrc.1998.8105; BANDMAN E, 1982, DEV BIOL, V93, P508, DOI 10.1016/0012-1606(82)90138-5; BANDMAN E, 1985, INT REV CYTOL, V97, P97, DOI 10.1016/S0074-7696(08)62349-9; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; GAUTHIER GF, 1990, J CELL BIOL, V110, P693, DOI 10.1083/jcb.110.3.693; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P510, DOI 10.1038/nsb0696-510; GORDON DA, 1992, J MUSCLE RES CELL M, V13, P654, DOI 10.1007/BF01738255; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HOFFMAN S, 1988, FEBS LETT, V238, P245; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; Jaenicke R, 1989, PROTEIN STRUCTURE PR, P191; JOHN M, 1994, J BIOL CHEM, V269, P16247; KERWIN B, 1991, J CELL BIOL, V113, P311, DOI 10.1083/jcb.113.2.311; KOHN WD, 1995, J BIOL CHEM, V270, P25495, DOI 10.1074/jbc.270.43.25495; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; LEHRER SS, 1991, BIOCHEMISTRY-US, V30, P5682, DOI 10.1021/bi00237a007; LEHRER SS, 1989, SCIENCE, V246, P926, DOI 10.1126/science.2814515; LOWEY S, 1991, J CELL BIOL, V113, P303, DOI 10.1083/jcb.113.2.303; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; MOLINA MI, 1987, J BIOL CHEM, V262, P6478; MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010; MOORE LA, 1992, J MOL BIOL, V225, P1143, DOI 10.1016/0022-2836(92)90114-Y; MOORE LA, 1992, J MOL BIOL, V223, P383, DOI 10.1016/0022-2836(92)90741-2; Nozaki Y, 1972, Methods Enzymol, V26, P43; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; PU WT, 1993, NUCLEIC ACIDS RES, V21, P4348, DOI 10.1093/nar/21.18.4348; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; ROBBINS J, 1986, J BIOL CHEM, V261, P6606; SCHUERMANN M, 1991, NUCLEIC ACIDS RES, V19, P734; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAYLOR LD, 1989, J CELL BIOL, V108, P533, DOI 10.1083/jcb.108.2.533; Tidyman WE, 1997, DEV DYNAM, V208, P491; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; WALLER GS, 1985, J BIOL CHEM, V260, P4368; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365; ZHU BY, 1993, PROTEIN SCI, V2, P383	44	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13847	13853		10.1074/jbc.274.20.13847	http://dx.doi.org/10.1074/jbc.274.20.13847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318791	hybrid			2022-12-27	WOS:000080322200020
J	Ivanov, VN; Ronai, Z				Ivanov, VN; Ronai, Z			Down-regulation of tumor necrosis factor alpha expression by activating transcription factor 2 increases UVC-induced apoptosis of late-stage melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FAS LIGAND EXPRESSION; C-JUN; TNF-ALPHA; SIGNAL-TRANSDUCTION; MALIGNANT-MELANOMA; T-CELLS; NEGATIVE REGULATION; RESPONSE ELEMENT; BINDING PROTEIN	To identify mechanisms whereby activating transcription factor 2 (ATF2) alters the radiation resistance of human melanoma cells, we examined the possible role of ATF2 in WC-induced apoptosis. Forced expression of full-length or truncated (Delta 1-195 amino acids) forms of ATF2 in LU1205, a late-stage human melanoma cell line, elevated the levels of UVC-induced apoptosis. At the same time, either truncated or full-length forms of ATF2 reduced UVC-induced activation of the tumor necrosis factor-alpha (TNF alpha) promoter and decreased expression of TNF alpha. Forced expression of c-Jun in ATF2-expressing melanoma cells restored TNF alpha expression, suggesting that both forms of ATF2 sequestered transcription factors that positively regulate TNF alpha expression in response to UV irradiation. Antagonistic antibodies to Fas, but not to TNFR1, efficiently suppressed UVC-induced apoptosis, suggesting that the Fas pathway mediates the primary apoptotic signal in melanoma cells whereas the TNFR1 pathway elicits a survival signal. Indeed, treatment of melanoma cells with TNF alpha before UVC irradiation partially suppressed WC-induced apoptosis, further supporting the protective role of TNF alpha in UVC-treated melanoma cells. Taken together, our findings suggest that ATF2 contributes to UVC-induced apoptosis through transcriptional silencing of TNF alpha, which balances Fas-mediated cell death in melanoma.	Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ronai, Z (corresponding author), Mt Sinai Sch Med, Ruttenberg Canc Ctr, 1425 Madison Ave,Rm 15-20, New York, NY 10029 USA.	ronaiz01@doc.mmsm.edu	Ivanov, Vladimir N/A-3081-2008	Ivanov, Vladimir N/0000-0003-3091-9774; RONAI, ZEEV/0000-0002-3859-0400	NCI NIH HHS [CA 51995] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA051995, R01CA051995] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; Caricchio R, 1998, J IMMUNOL, V161, P241; CHATTON B, 1994, ONCOGENE, V9, P375; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Choi CY, 1997, J BIOL CHEM, V272, P16934, DOI 10.1074/jbc.272.27.16934; Cubillos S, 1997, ANTICANCER RES, V17, P2207; DECESARE D, 1995, ONCOGENE, V11, P365; DENG G, 1993, P NATL ACAD SCI USA, V90, P2189, DOI 10.1073/pnas.90.6.2189; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FUCHS SY, 1999, IN PRESS MOL CELL BI, V19; GEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747, DOI 10.1128/MCB.12.2.747; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hakansson A, 1997, MELANOMA RES, V7, P139, DOI 10.1097/00008390-199704000-00008; Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; KHOURY E, 1994, BLOOD, V84, P2506; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Krasilnikov M, 1999, MOL CARCINOGEN, V24, P64, DOI 10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2; Latinis KM, 1997, J IMMUNOL, V158, P4602; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; LEMAIGRE FP, 1993, NUCLEIC ACIDS RES, V21, P2907, DOI 10.1093/nar/21.12.2907; Leverkus M, 1997, EXP CELL RES, V232, P255, DOI 10.1006/excr.1997.3514; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NARAYAN S, 1995, BIOCHEMISTRY-US, V34, P73, DOI 10.1021/bi00001a009; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; NEWELL CL, 1994, J LEUKOCYTE BIOL, V56, P27, DOI 10.1002/jlb.56.1.27; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OROSZ P, 1995, INT J CANCER, V60, P867, DOI 10.1002/ijc.2910600624; OROSZ P, 1993, J EXP MED, V177, P1391, DOI 10.1084/jem.177.5.1391; Osborne BA, 1996, CURR OPIN IMMUNOL, V8, P245, DOI 10.1016/S0952-7915(96)80063-X; QIN ZH, 1993, J EXP MED, V178, P355, DOI 10.1084/jem.178.1.355; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Rehemtulla A, 1997, J BIOL CHEM, V272, P25783, DOI 10.1074/jbc.272.41.25783; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Ronai Z, 1998, ONCOGENE, V16, P523, DOI 10.1038/sj.onc.1201566; RUSTEN LS, 1994, J CLIN INVEST, V94, P165, DOI 10.1172/JCI117303; RUTBERG SE, 1994, MOL CARCINOGEN, V10, P82, DOI 10.1002/mc.2940100205; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; Stoelcker B, 1996, J INFLAMM, V46, P155; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsai EY, 1996, MOL CELL BIOL, V16, P459; van Dam H, 1998, GENE DEV, V12, P1227, DOI 10.1101/gad.12.8.1227; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WU S, 1993, CANCER RES, V53, P1939; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yang YM, 1996, ONCOGENE, V12, P2223; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	88	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14079	14089		10.1074/jbc.274.20.14079	http://dx.doi.org/10.1074/jbc.274.20.14079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318823	Green Published, hybrid			2022-12-27	WOS:000080322200052
J	Olsson, C; Riebeck, K; Dohlsten, M; Michaelsson, E				Olsson, C; Riebeck, K; Dohlsten, M; Michaelsson, E			CTLA-4 ligation suppresses CD28-induced NF-kappa B and AP-1 activity in mouse T cell blasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTORS; IN-VIVO; CD28; ACTIVATION; RECEPTOR; BINDING; COSTIMULATION; PROTEINS; ALPHA	The effects of cytotoxic lymphocyte antigen 4 (CTLA-4) on CD3/CD28 monoclonal antibody (mAb) activation of CD4(+)/CTLA-4(+) blastoid T cells were studied in an in vitro model system. As previously reported, coligation of CTLA-4 mAb results in suppression of T cell proliferation and cytokine production. The proliferation but not the interleukin 2 (IL-2) production could be restored by addition of exogenous IL-2, suggesting that the inhibitory effect occurred at the level of IL-2 production rather than at the regulation of the IL-2 receptor pathway. To study the effects on nuclear factors critical for T cell activation, we analyzed the levels of the transcription factors NF-kappa B and AP-1. These were potently induced in CD3/CD28 mAb-restimulated T cells. In contrast, CTLA-4 ligation strongly suppressed the induction of both transcription factors. The compositions of NF-kappa B and AP-1 family members were similar, irrespective of stimulation conditions. Analyses of the NF-kappa B regulator I kappa B-alpha revealed similar levels of I kappa B-alpha protein in the preparations. However, a reduced phosphorylation of I kappa B-alpha in CTLA-4 coengaged T cell blasts compared with T cells ligated with CD3/CD28 was-found. Previous studies have concluded that CTLA-4 ligation regulates T cell activation by inhibiting the T cell receptor-mediated signals, However, the present findings propose that the major impact of CTLA-4 ligation is inhibition of signals mediated by CD28.	Act Biotech Res AB, SE-22007 Lund, Sweden; Malmo Univ Hosp, Dept Med Microbiol, SE-22007 Lund, Sweden; Univ Lund, Dept Cell & Mol Biol, Sect Tumor Immunol, Wallenberg Lab, SE-22007 Lund, Sweden	Lund University; Skane University Hospital; Lund University	Olsson, C (corresponding author), Act Biotech Res AB, POB 724, SE-22007 Lund, Sweden.			Riesbeck, Kristian/0000-0001-6274-6965; Michaelsson, Erik/0000-0001-8643-2821				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Cefai D, 1998, J IMMUNOL, V160, P2223; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Finn PW, 1997, J IMMUNOL, V158, P4074; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Greene JAL, 1996, J BIOL CHEM, V271, P26762, DOI 10.1074/jbc.271.43.26762; Hutchcroft JE, 1996, J IMMUNOL, V156, P4071; HUTCHCROFT JE, 1995, P NATL ACAD SCI USA, V92, P8808, DOI 10.1073/pnas.92.19.8808; JAIN JN, 1993, J IMMUNOL, V151, P837; Kariv I, 1996, J IMMUNOL, V157, P29; Krummel MF, 1996, INT IMMUNOL, V8, P519, DOI 10.1093/intimm/8.4.519; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Olsson C, 1998, INT IMMUNOL, V10, P499, DOI 10.1093/intimm/10.4.499; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Perkins D, 1996, J IMMUNOL, V156, P4154; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327	38	59	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14400	14405		10.1074/jbc.274.20.14400	http://dx.doi.org/10.1074/jbc.274.20.14400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318864	hybrid			2022-12-27	WOS:000080322200093
J	Nakamura, K; Yahagi, S; Yamazaki, T; Yamane, K				Nakamura, K; Yahagi, S; Yamazaki, T; Yamane, K			Bacillus subtilis histone-like protein, HBsu, is an integral component of a SRP-like particle that can bind the Alu domain of small cytoplasmic RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; METHIONINE-RICH DOMAIN; COLI 4.5S RNA; ESCHERICHIA-COLI; 7S RNA; 54-KD PROTEIN; CDNA CLONE; SEQUENCE; SUBUNIT; HOMOLOG	Small cytoplasmic RNA (scRNA) is metabolically stable and abundant in Bacillus subtilis cells. Consisting of 271 nucleotides, it is structurally homologous to mammalian signal recognition particle RNA. In contrast to 4.5 S RNA of Escherichia coli, B. subtilis scRNA contains an Alu domain in addition to the evolutionarily conserved S domain. In this study, we show that a 10-kDa protein in B, subtilis cell extracts has scRNA binding activity at the Abu domain. The in vitro binding selectivity of the 10-kDa protein shows that it recognizes the higher structure of the Alu domain of scRNA caused by five consecutive complementary sequences in the two loops. Purification and subsequent analyses demonstrated that the 10-kDa protein is HBsu, which was originally identified as a member of the histone-like protein family. By constructing a HBsu-deficient B, subtilis mutant, we showed that HBsu is essential for normal growth. Immunoprecipitating cell lysates using anti-HBsu antibody yielded scRNA. Moreover, the eo-precipitation of HBsu with (His)(6)-tagged Ffh depended on the presence of scRNA, suggesting that HBsu, Ffh, and scRNA make a ternary complex and that scRNA serves as a functional unit for binding. These results demonstrated that HBsu is the third component of a signal recognition particle-like particle in B, subtilis that can bind the Alu domain of scRNA.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan	University of Tsukuba	Nakamura, K (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan.	nakamura.kouji@nifty.ne.jp						BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; BIEKER KL, 1990, TRENDS GENET, V6, P329, DOI 10.1016/0168-9525(90)90254-4; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; BOTT KF, 1967, J BACTERIOL, V94, P562, DOI 10.1128/JB.94.3.562-570.1967; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; Bunai K, 1996, BIOCHEM BIOPH RES CO, V227, P762, DOI 10.1006/bbrc.1996.1582; Bunai K, 1999, J BIOCHEM, V125, P151, DOI 10.1093/oxfordjournals.jbchem.a022252; Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165; DANESE PN, 1995, J BACTERIOL, V177, P4969, DOI 10.1128/jb.177.17.4969-4973.1995; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; GARDEL C, 1990, EMBO J, V9, P4205, DOI 10.1002/j.1460-2075.1990.tb07645.x; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENNER DJ, 1990, METHOD ENZYMOL, V185, P223; HERZ J, 1990, FEBS LETT, V276, P103, DOI 10.1016/0014-5793(90)80518-N; HIGH S, 1991, J CELL BIOL, V113, P229, DOI 10.1083/jcb.113.2.229; HONDA K, 1993, J BACTERIOL, V175, P4885, DOI 10.1128/JB.175.15.4885-4894.1993; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; Kohler P, 1997, J BACTERIOL, V179, P2060; LARSEN N, 1991, NUCLEIC ACIDS RES, V19, P209, DOI 10.1093/nar/19.2.209; LINGELBACH K, 1988, NUCLEIC ACIDS RES, V16, P9431, DOI 10.1093/nar/16.20.9431; LUTCKE H, 1993, J CELL BIOL, V121, P977, DOI 10.1083/jcb.121.5.977; MICKA B, 1992, BIOCHIMIE, V74, P641, DOI 10.1016/0300-9084(92)90136-3; MICKA B, 1991, J BACTERIOL, V173, P3191, DOI 10.1128/JB.173.10.3191-3198.1991; NAKAMURA K, 1992, J BACTERIOL, V174, P2185, DOI 10.1128/JB.174.7.2185-2192.1992; NAKAMURA K, 1995, MICROBIOL-SGM, V141, P2965, DOI 10.1099/13500872-141-11-2965; NAKAMURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1394, DOI 10.1006/bbrc.1994.1385; NISHIGUCHI M, 1994, J BACTERIOL, V176, P157, DOI 10.1128/JB.176.1.157-165.1994; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; Oguro A, 1996, GENE, V172, P17, DOI 10.1016/0378-1119(96)00181-3; Oguro A, 1998, J BIOL CHEM, V273, P19542, DOI 10.1074/jbc.273.31.19542; PORITZ MA, 1988, CELL, V55, P4, DOI 10.1016/0092-8674(88)90003-7; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; Shibata T, 1996, J BIOL CHEM, V271, P13162, DOI 10.1074/jbc.271.22.13162; SIEGEL V, 1988, TRENDS BIOCHEM SCI, V13, P314, DOI 10.1016/0968-0004(88)90127-2; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STRUB K, 1989, P NATL ACAD SCI USA, V86, P9747, DOI 10.1073/pnas.86.24.9747; STRUCK JCR, 1989, MOL GEN GENET, V215, P478, DOI 10.1007/BF00427046; STRUCK JCR, 1988, NUCLEIC ACIDS RES, V16, P2719, DOI 10.1093/nar/16.6.2719; Takamatsu H, 1997, EUR J BIOCHEM, V248, P575, DOI 10.1111/j.1432-1033.1997.00575.x; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	49	75	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13569	13576		10.1074/jbc.274.19.13569	http://dx.doi.org/10.1074/jbc.274.19.13569			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224127	hybrid			2022-12-27	WOS:000080200400089
J	Reinhard, M; Zumbrunn, J; Jaquemar, D; Kuhn, M; Walter, U; Trueb, B				Reinhard, M; Zumbrunn, J; Jaquemar, D; Kuhn, M; Walter, U; Trueb, B			An alpha-actinin binding site of zyxin is essential for subcellular zyxin localization and alpha-actinin recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROFILAMENT PROTEIN VASP; LISTERIA-MONOCYTOGENES; CYTOPLASMIC DOMAIN; FOCAL ADHESION; LIM DOMAIN; CYTOSKELETAL PROTEINS; ACTA PROTEIN; CELLS; PURIFICATION; LIGAND	The LIM domain protein zyxin is a component of adherens type junctions, stress fibers, and highly dynamic membrane areas and appears to be involved in microfilament organization. Chicken zyxin and its human counterpart display less than 60% sequence identity, raising concern about their functional identity. Here, we demonstrate that human zyxin, like the avian protein, specifically interacts with alpha-actinin. Furthermore, we map the interaction site to a motif of approximately 22 amino acids, present in the N-terminal domain of human zyxin, This motif is both necessary and sufficient for alpha-actinin binding, whereas a downstream region, which is related in sequence, appears to be dispensable. A synthetic peptide comprising human zyxin residues 21-42 specifically binds to alpha-actinin in solid phase binding assays. In contrast to full-length zyxin, constructs lacking this motif do not interact with alpha-actinin in blot overlays and fail to recruit alpha-actinin in living cells. When zyxin lacking the alpha actinin binding site is expressed as a fusion protein with green fluorescent protein, association of the recombinant protein with stress fibers is abolished, and targeting to focal adhesions is grossly impaired. Our results suggest a crucial role for the alpha-actinin-zyxin interaction in subcellular zyxin localization and microfilament organization.	Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97078 Wurzburg, Germany; Univ Bern, ME Muller Inst Biomech, CH-3010 Bern, Switzerland	University of Wurzburg; University of Bern	Reinhard, M (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Versbacher Str 5, D-97078 Wurzburg, Germany.		Reinhard, Martin/A-1006-2008; Walter, ulrich/W-2478-2017; Trueb, Beat/AAL-9621-2020	Reinhard, Martin/0000-0002-7833-6175; Walter, ulrich/0000-0001-6784-2307; Trueb, Beat/0000-0001-8684-6856				ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; Balzar M, 1998, MOL CELL BIOL, V18, P4833, DOI 10.1128/MCB.18.8.4833; Bubeck P, 1997, J CELL SCI, V110, P1361; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; CRITCHLEY DR, 1999, IN PRESS GUIDEBOOK C; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Golsteyn RM, 1997, J CELL SCI, V110, P1893; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Hobert O, 1996, ONCOGENE, V12, P1577; KOLLER E, 1991, NUCLEIC ACIDS RES, V19, P485, DOI 10.1093/nar/19.3.485; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; PAVALKO FM, 1995, EXP CELL RES, V217, P534, DOI 10.1006/excr.1995.1119; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schmeichel KL, 1998, BIOCHEM J, V331, P885, DOI 10.1042/bj3310885; SCHULZE H, 1989, EMBO J, V8, P3587, DOI 10.1002/j.1460-2075.1989.tb08531.x; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Zigmond SH, 1998, CURR BIOL, V8, pR654, DOI 10.1016/S0960-9822(07)00415-0; Zumbrunn J, 1996, EUR J BIOCHEM, V241, P657, DOI 10.1111/j.1432-1033.1996.00657.x	44	85	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13410	13418		10.1074/jbc.274.19.13410	http://dx.doi.org/10.1074/jbc.274.19.13410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224105	hybrid			2022-12-27	WOS:000080200400067
J	Smith, JJ; Rucknagel, KP; Schierhorn, A; Tang, J; Nemeth, A; Linder, M; Herschman, HR; Wahle, E				Smith, JJ; Rucknagel, KP; Schierhorn, A; Tang, J; Nemeth, A; Linder, M; Herschman, HR; Wahle, E			Unusual sites of arginine methylation in poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; RNA-BINDING PROTEINS; SUBSTRATE-SPECIFICITY; N-METHYLTRANSFERASE; MESSENGER-RNA; ENZYMATIC METHYLATION; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; MOLECULAR-WEIGHT; HNRNP PROTEINS	Arginine methylation is a post-translational modification found mostly in RNA-binding proteins. Poly(A) binding protein II from calf thymus was shown by mass spectrometry and sequencing to contain N-G-N-G-dimethylarginine at 13 positions in its amino acid sequence. Two additional arginine residues were partially methylated. Almost all of the modified residues were found in Arg-Xaa-Arg clusters in the C terminus of the protein. These motifs are distinct from Arg-Gly-Gly motifs that have been previously described as sites and specificity determinants for asymmetric arginine dimethylation. Poly(A)-binding protein II and deletion mutants expressed in Escherichia coli were in vitro substrates for two mammalian protein arginine methyltransferases, PRMT1 and PRMT3, with S-adenosyl-L-methionine as the methyl group donor. Both PRMT1 and PRMT3 specifically methylated arginines in the C-terminal domain corresponding to the naturally modified sites.	Univ Halle Wittenberg, Inst Biochem, D-06120 Halle, Germany; Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; Max Planck Forschungsstelle Enzymol Prot, D-06120 Halle, Germany; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Giessen, Inst Biochem, D-35392 Giessen, Germany	Martin Luther University Halle Wittenberg; Justus Liebig University Giessen; Max Planck Society; University of California System; University of California Los Angeles; Justus Liebig University Giessen	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Wahle, Elmar/0000-0003-2504-0677	NIAID NIH HHS [AI34567] Funding Source: Medline; NIGMS NIH HHS [GM24797] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034567, U19AI034567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024797] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbdulMana N, 1996, BIOCHEMISTRY-US, V35, P3545, DOI 10.1021/bi952298p; Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Bagni C, 1998, J BIOL CHEM, V273, P10868, DOI 10.1074/jbc.273.18.10868; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BURGESS WH, 1991, CELL REGUL, V2, P87, DOI 10.1091/mbc.2.2.87; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; GHOSH SK, 1990, BIOCHIM BIOPHYS ACTA, V1039, P142, DOI 10.1016/0167-4838(90)90179-J; Henry MF, 1996, MOL CELL BIOL, V16, P3668; KAJITA Y, 1995, J BIOL CHEM, V270, P22167, DOI 10.1074/jbc.270.38.22167; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; LEE TD, 1990, METHOD ENZYMOL, V193, P361, DOI 10.1016/0076-6879(90)93427-M; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LISCHWE MA, 1982, J BIOL CHEM, V257, P4600; LISCHWE MA, 1985, J BIOL CHEM, V260, P14304; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; RAJPUROHIT R, 1994, J BIOL CHEM, V269, P1075; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; RAWAL N, 1995, BBA-PROTEIN STRUCT M, V1248, P11, DOI 10.1016/0167-4838(94)00213-Z; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; SHAMOO Y, 1994, BIOCHEMISTRY-US, V33, P8272, DOI 10.1021/bi00193a014; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; SOMMER A, 1989, BIOCHEM BIOPH RES CO, V160, P1267, DOI 10.1016/S0006-291X(89)80140-8; Stutz F, 1998, GENE DEV, V12, P3303, DOI 10.1101/gad.12.21.3303; SUZUKI K, 1991, J BIOL CHEM, V266, P20007; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6	48	121	124	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13229	13234		10.1074/jbc.274.19.13229	http://dx.doi.org/10.1074/jbc.274.19.13229			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224081	hybrid			2022-12-27	WOS:000080200400043
J	Sallmann, FR; Baveye-Descamps, S; Pattus, F; Salmon, V; Branza, N; Spik, G; Legrand, D				Sallmann, FR; Baveye-Descamps, S; Pattus, F; Salmon, V; Branza, N; Spik, G; Legrand, D			Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin - Binding characteristics and biological effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HUMAN LACTOTRANSFERRIN; OUTER-MEMBRANE; ANTIBACTERIAL ACTIVITY; BOVINE LACTOFERRIN; HUMAN TRANSFERRINS; LOOP REGION; PROTEIN; RECEPTOR; LIPOPOLYSACCHARIDE	The binding of lactoferrin, an iron-binding glycoprotein found in secretions and leukocytes, to the outer membrane of Gram-negative bacteria is a prerequisite to exert its bactericidal activity. It was proposed that porins, in addition to lipopolysaccharides, are responsible for this binding. We studied the interactions of human lactoferrin with the three major porins of Escherichia coli OmpC, OmpF, and PhoE. Binding experiments were performed on both purified porins and porin-deficient E. coli K12 isogenic mutants. We determined that lactoferrin binds to the purified native OmpC or PhoE trimer with molar ratios of 1.9 +/- 0.4 and 1.8 +/- 0.5 and K-d values of 39 +/- 18 and 103 +/- 15 mM, respectively, but not to OmpF, Furthermore, preferential binding of lactoferrin was observed on strains that express either OmpC or PhoE, It was also demonstrated that residues 1-5, 28-34, and 39-42 of lactoferrin interact with porins, Eased on sequence comparisons, the involvement of lactoferrin amino acid residues and porin loops in the interactions is discussed. The relationships between binding and antibacterial activity of the protein were studied using E. coli mutants and planar Lipid bilayers. Electrophysiological studies revealed that lactoferrin can act as a blocking agent for OmpC but not for PhoE or OmpF. However, a total inhibition of the growth was only observed for the PhoE-expressing strain (minimal inhibitory concentration of lactoferrin was 2.4 mg/ml). These data support the proposal that the antibacterial activity of lactoferrin may depend, at least in part, on its ability to bind to porins, thus modifying the stability and/or the permeability of the bacterial outer membrane.	Univ Sci & Technol Lille, Chim Biol Lab, F-59655 Villeneuve Dascq, France; Univ Sci & Technol Lille, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; Ecole Super Biotechnol Strasbourg, CNRS, Unite Propre Rech 9050, Dept Recepteurs & Prot Membranaires, F-67400 Illkirch, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS)	Legrand, D (corresponding author), Univ Sci & Technol Lille, Chim Biol Lab, F-59655 Villeneuve Dascq, France.		Legrand, Dominique/AAT-5715-2021	LEGRAND, Dominique/0000-0002-0814-221X				APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; BELLAMY WR, 1993, J APPL BACTERIOL, V75, P478; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; Chapple DS, 1998, INFECT IMMUN, V66, P2434, DOI 10.1128/IAI.66.6.2434-2440.1998; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; ELLISON RT, 1990, J GEN MICROBIOL, V136, P1437, DOI 10.1099/00221287-136-7-1437; ERDEI J, 1994, INFECT IMMUN, V62, P1236, DOI 10.1128/IAI.62.4.1236-1240.1994; FOUREL D, 1993, J BACTERIOL, V175, P2754, DOI 10.1128/JB.175.9.2754-2757.1993; HUETTINGER M, 1992, J BIOL CHEM, V267, P18551; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; JEANTEUR D, 1991, MOL MICROBIOL, V5, P2153, DOI 10.1111/j.1365-2958.1991.tb02145.x; Kang JH, 1996, INT J PEPT PROT RES, V48, P357; KORTELAND J, 1982, BIOCHIM BIOPHYS ACTA, V690, P282, DOI 10.1016/0005-2736(82)90332-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKEY JH, 1989, EUR J BIOCHEM, V186, P303, DOI 10.1111/j.1432-1033.1989.tb15209.x; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; LEGRAND D, 1984, BIOCHIM BIOPHYS ACTA, V787, P90, DOI 10.1016/0167-4838(84)90111-0; LEGRAND D, 1992, BIOCHEMISTRY-US, V31, P9243, DOI 10.1021/bi00153a018; Legrand D, 1997, BIOCHEM J, V327, P841, DOI 10.1042/bj3270841; LEGRAND D, 1995, FEBS LETT, V365, P57, DOI 10.1016/0014-5793(95)00441-B; LEVYTOLEDANO S, 1995, THROMB HAEMOSTASIS, V73, P857; MACGILLIVRAY RTA, 1982, P NATL ACAD SCI-BIOL, V79, P2504, DOI 10.1073/pnas.79.8.2504; MANN DM, 1994, J BIOL CHEM, V269, P23661; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; MAZURIER J, 1983, BIOCHIM BIOPHYS ACTA, V745, P44, DOI 10.1016/0167-4838(83)90168-1; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; MONTREUIL J, 1960, BIOCHIM BIOPHYS ACTA, V45, P413, DOI 10.1016/0006-3002(60)91478-5; MORONA R, 1985, EUR J BIOCHEM, V150, P161, DOI 10.1111/j.1432-1033.1985.tb09002.x; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NAIDU SS, 1993, ANTIMICROB AGENTS CH, V37, P240, DOI 10.1128/AAC.37.2.240; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Odell EW, 1996, FEBS LETT, V382, P175, DOI 10.1016/0014-5793(96)00168-8; ORAM JD, 1968, BIOCHIM BIOPHYS ACTA, V170, P351, DOI 10.1016/0304-4165(68)90015-9; PIERCE A, 1991, EUR J BIOCHEM, V196, P177, DOI 10.1111/j.1432-1033.1991.tb15801.x; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; REY MW, 1990, NUCLEIC ACIDS RES, V18, P5288, DOI 10.1093/nar/18.17.5288; Salmon V, 1997, PROTEIN EXPRES PURIF, V9, P203, DOI 10.1006/prep.1996.0687; Sambrook J., 2002, MOL CLONING LAB MANU; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751; SCHINDLER H, 1980, FEBS LETT, V122, P77, DOI 10.1016/0014-5793(80)80405-4; SCHINDLER M, 1979, BIOCHEMISTRY-US, V18, P4425, DOI 10.1021/bi00587a024; Shimazaki K, 1998, J DAIRY SCI, V81, P2841, DOI 10.3168/jds.S0022-0302(98)75843-6; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; STEPHENS S, 1980, IMMUNOLOGY, V41, P597; TIGYL Z, 1992, INFECT IMMUN, V60, P2619, DOI 10.1128/IAI.60.7.2619-2626.1992; TOMMASSEN J, 1985, EMBO J, V4, P1583, DOI 10.1002/j.1460-2075.1985.tb03820.x; TUCKER AD, 1991, J MOL BIOL, V222, P881, DOI 10.1016/0022-2836(91)90582-Q; vanBerkel PHC, 1997, BIOCHEM J, V328, P145, DOI 10.1042/bj3280145; VISCA P, 1990, MED MICROBIOL IMMUN, V179, P323; WU HF, 1995, ARCH BIOCHEM BIOPHYS, V317, P85, DOI 10.1006/abbi.1995.1139; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993; Ziere GJ, 1996, BIOCHEM J, V313, P289, DOI 10.1042/bj3130289; ZIERE GJ, 1993, J BIOL CHEM, V268, P27069	58	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16107	16114		10.1074/jbc.274.23.16107	http://dx.doi.org/10.1074/jbc.274.23.16107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347162	hybrid			2022-12-27	WOS:000080668600022
J	Chen, NY; Ma, WY; Huang, CS; Dong, ZG				Chen, NY; Ma, WY; Huang, CS; Dong, ZG			Translocation of protein kinase C epsilon and protein kinase C delta to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED AP-1 ACTIVATION; GROWTH-FACTOR; UV IRRADIATION; PHORBOL ESTER; SIGNAL; INHIBITION; CELLS; P53; PHOSPHORYLATION; RECEPTOR	UV-induced signal transduction may be involved in tumor promotion and induction of apoptosis, The role of protein kinase C (PKC) in UVB-induced signal transduction is not well understood. This study showed that UVB markedly induced translocation of membrane-associated PKC epsilon and PKC delta, but not PKC alpha, from cytosol to membrane. Dominant negative mutant (DNM) PKC epsilon or PKC delta inhibited UVB-induced translocation of PKC epsilon and PKC delta, respectively, UVB-induced activation of extracellular signal-regulated protein kinases (Erks) and c-Jun NH2-terminal kinases (JNKs) was strongly inhibited by DNM PKC epsilon and PKC delta, whereas the DNM of PKC alpha was less effective on the UVB-induced phosphorylation of Erks and JNKs, Among the PKC inhibitors used only rottlerin, a selective inhibitor of PKC delta, markedly inhibited the UVB-induced activation of Erks and JNKs, but not p38 kinases, Safingol, a selective inhibitor for PKC alpha, did not show any inhibitory effect on UVB-induced mitogen-activated protein kinase activation. GF109203X is a stronger inhibitor of classical PKC than novel PKC, Lower concentrations of GF109203X (<10 mu M) had no effect on UVB-induced activation of Erks or JNKs, However, at higher concentrations (over 20 mu M), GF109203X inhibited UVB-induced activation of JNKs, Erks, and even p38 kinases. Meanwhile, rottlerin and GF109203X markedly inhibited UVB-induced apoptosis of JB6 cells, whereas safingol had little inhibitory effect. DNM-Erk2 cells and PD98059, a selective inhibitor for mitogen-activated protein kinase/extracellular signal-regulated kinase 1 that directly activates Erks, inhibited UVB-induced apoptosis. DNM-JNK1 cells also blocked UVB-induced apoptosis, whereas SB202190, a specific inhibitor for p38 kinases, did not produce the inhibitory effect. These data demonstrate that PKC delta and PKC epsilon, but not PKC alpha, mediate UVB-induced signal transduction and apoptosis in JB6 cells through activation of Erks and JNKs.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16Th Ave NE, Austin, MN 55912 USA.			Huang, Chuanshu/0000-0003-4133-5096	NATIONAL CANCER INSTITUTE [R29CA074916] Funding Source: NIH RePORTER; NCI NIH HHS [CA74916] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; Adler V, 1996, J BIOL CHEM, V271, P23304, DOI 10.1074/jbc.271.38.23304; ANGEL P, 1995, INDUCIBLE GENE EXPRE, P62; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; Boutwell R K, 1974, CRC Crit Rev Toxicol, V2, P419; CHAN TM, 1986, BIOCHEM BIOPH RES CO, V139, P439, DOI 10.1016/S0006-291X(86)80010-9; CUNNINGHAM M L, 1985, Journal of Free Radicals in Biology and Medicine, V1, P381, DOI 10.1016/0748-5514(85)90150-3; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; Dong ZG, 1997, J BIOL CHEM, V272, P9962; Dong ZG, 1998, ONCOGENE, V17, P1845, DOI 10.1038/sj.onc.1202084; EPSTEIN JH, 1983, J AM ACAD DERMATOL, V9, P487, DOI 10.1016/S0190-9622(83)70160-X; Findlay GM, 1928, LANCET, V2, P1070; FITZPATRICK TB, 1976, RES PHOTOBIOLOGY, P485; FORBES PD, 1976, RES PHOTOBIOLOGY, P469; Fry R J, 1989, Carcinog Compr Surv, V11, P321; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HAYES GR, 1987, P NATL ACAD SCI USA, V84, P8115, DOI 10.1073/pnas.84.22.8115; Huang CS, 1998, CANCER RES, V58, P4102; Huang CS, 1998, CELL SIGNAL, V10, P185, DOI 10.1016/S0898-6568(97)00098-3; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1997, ONCOGENE, V14, P1945, DOI 10.1038/sj.onc.1201056; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029, DOI 10.1152/ajplung.1997.273.5.L1029; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIU M, 1994, CARCINOGENESIS, V15, P1089, DOI 10.1093/carcin/15.6.1089; MATSUI MS, 1995, SKIN CANC MECH HUMAN, P21; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; OLAH Z, 1994, ANAL BIOCHEM, V221, P94, DOI 10.1006/abio.1994.1384; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; PETERSEN M, 1995, PHOTOCHEM PHOTOBIOL, V62, P444, DOI 10.1111/j.1751-1097.1995.tb02366.x; PUNNONEN K, 1992, J INVEST DERMATOL, V99, P221, DOI 10.1111/1523-1747.ep12650445; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; RUNNEBAUM IB, 1994, ANTICANCER RES, V14, P1137; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; STRICKLAND PT, 1986, J INVEST DERMATOL, V86, P37, DOI 10.1111/1523-1747.ep12283779; Sun Y, 1997, ONCOGENE, V14, P385, DOI 10.1038/sj.onc.1200834; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WILLIS I, 1981, J INVEST DERMATOL, V76, P404, DOI 10.1111/1523-1747.ep12520945	49	124	126	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15389	15394		10.1074/jbc.274.22.15389	http://dx.doi.org/10.1074/jbc.274.22.15389			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336426	hybrid			2022-12-27	WOS:000080560100015
J	Abnet, CC; Tanguay, RL; Hahn, ME; Heideman, W; Peterson, RE				Abnet, CC; Tanguay, RL; Hahn, ME; Heideman, W; Peterson, RE			Two forms of aryl hydrocarbon receptor type 2 in rainbow trout (Oncorhynchus mykiss) - Evidence for differential expression and enhancer specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-STAGE DEVELOPMENT; DIBENZO-P-DIOXIN; AH-RECEPTOR; NUCLEAR TRANSLOCATOR; MESSENGER-RNA; BIPHENYL CONGENERS; BINDING ACTIVITIES; DNA RECOGNITION; ATLANTIC TOMCOD; DOWN-REGULATION	Two aryl hydrocarbon receptors (AhRs), rtAhR2 alpha and rtAhR2 beta, were cloned from rainbow trout (rt) cDNA libraries. The distribution of sequence differences, genomic Southern blot analysis, and the presence of both transcripts in all individual rainbow trout examined suggest that the two forms of rtAhR2 are derived from separate genes. The two rtAhR2s have significant sequence similarity with AhRs cloned from mammalian species, especially in the basic helix-loop-helix and PAS functional domains located in the amino-terminal 400 amino acids of the protein. In contrast, the Gin-rich transactivation domain found in the carboxyl-terminal half of mammalian AhRs is absent from both rtAhR2s. Both clones were expressed by in vitro transcription/translation and proteins of approximately 125 kDa were produced. These proteins bind 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and are able to bind dioxin response elements in gel shift assays, rtAhR2 alpha and rtAhR2 beta are expressed in a tissue-specific manner with the highest expression of rtAhR2 beta in the heart. Expression of rtAhR2 alpha and rtAhR2 beta mRNAs is positively regulated by TCDD. Both rtAhR2 alpha and rtAhR2 beta produced TCDD-dependent activation of a reporter gene driven by dioxin response elements. Surprisingly, the two receptors showed distinct preferences for different enhancer sequences. These results suggest that the two receptor forms may regulate different sets of genes, and may play different roles in the toxic responses produced by AhR agonists such as TCDD.	Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Univ Wisconsin, Ctr Environm Toxicol, Madison, WI 53706 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Woods Hole Oceanographic Institution	Peterson, RE (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.		Hahn, Mark/AAV-7516-2020; Abnet, Christian C/C-4111-2015	Hahn, Mark/0000-0003-4358-2082; Abnet, Christian C/0000-0002-3008-7843	NIEHS NIH HHS [F32 ES05786-01, R29 ES06272, F32 ES005786-02, F32 ES005786, R01 ES006272, R01 ES006272-08] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES005786, R01ES006272, R29ES006272] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABBOTT BD, 1994, TOXICOL APPL PHARM, V126, P16, DOI 10.1006/taap.1994.1085; ABNET CC, 1998, TOXICOL SCI, V42, P385; Allendorf F.W., 1984, P1; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V1; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; BERNDTSON AK, 1994, ARCH BIOCHEM BIOPHYS, V310, P187, DOI 10.1006/abbi.1994.1156; CARVAN MJ, 1998, TOXICOL SCI, V42, P359; CHEUNG MO, 1981, TOXICOL APPL PHARM, V61, P197, DOI 10.1016/0041-008X(81)90409-9; Cook PM, 1997, SETAC TECH PUBLICAT, P9; COOMBS DH, 1985, ANAL BIOCHEM, V148, P254, DOI 10.1016/0003-2697(85)90654-2; DENISON MS, 1988, J BIOL CHEM, V263, P17221; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; DOTTAVIOMARTIN D, 1978, ANAL BIOCHEM, V87, P562, DOI 10.1016/0003-2697(78)90706-6; Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319; EMA M, 1994, J BIOL CHEM, V269, P27337; Ferguson M.M., 1991, Biochemistry and Molecular Biology of Fishes, V1, P25; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; GASIEWICZ TA, 1979, TOXICOL APPL PHARM, V51, P329, DOI 10.1016/0041-008X(79)90475-7; Giannone JV, 1998, BIOCHEM PHARMACOL, V55, P489, DOI 10.1016/S0006-2952(97)00493-0; HAHN ME, 1995, BIOCHEM J, V310, P383, DOI 10.1042/bj3100383; HAHN ME, 1994, ARCH BIOCHEM BIOPHYS, V310, P218, DOI 10.1006/abbi.1994.1160; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; JAIN S, 1994, J BIOL CHEM, V269, P31518; KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710; Li SY, 1997, ARCH BIOCHEM BIOPHYS, V340, P73, DOI 10.1006/abbi.1997.9905; LORENZEN A, 1990, TOXICOL APPL PHARM, V106, P53, DOI 10.1016/0041-008X(90)90105-4; MA Q, 1995, J BIOL CHEM, V270, P12697, DOI 10.1074/jbc.270.21.12697; Ma Q, 1997, J BIOL CHEM, V272, P8878; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Pollenz RS, 1996, J BIOL CHEM, V271, P30886, DOI 10.1074/jbc.271.48.30886; Pollenz RS, 1996, MOL PHARMACOL, V49, P391; PROKIPCAK RD, 1991, CAN J PHYSIOL PHARM, V69, P1204, DOI 10.1139/y91-176; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Roman BL, 1998, TOXICOL APPL PHARM, V150, P228, DOI 10.1006/taap.1998.8388; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Roy NK, 1997, ARCH BIOCHEM BIOPHYS, V344, P373, DOI 10.1006/abbi.1997.0238; ROY NK, 1995, ARCH BIOCHEM BIOPHYS, V322, P204, DOI 10.1006/abbi.1995.1453; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; SWANSON HI, 1991, TOXICOL LETT, V58, P85, DOI 10.1016/0378-4274(91)90194-B; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; TSUI HW, 1981, CAN J PHYSIOL PHARM, V59, P927, DOI 10.1139/y81-143; Walker Mary K., 1994, P347; WALKER MK, 1991, CAN J FISH AQUAT SCI, V48, P875, DOI 10.1139/f91-104; Walker MK, 1997, TOXICOL APPL PHARM, V143, P407, DOI 10.1006/taap.1996.8068; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; Zabel EW, 1996, ENVIRON TOXICOL CHEM, V15, P2310, DOI 10.1002/etc.5620151229; ZABEL EW, 1995, TOXICOL APPL PHARM, V134, P204, DOI 10.1006/taap.1995.1185	51	98	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15159	15166		10.1074/jbc.274.21.15159	http://dx.doi.org/10.1074/jbc.274.21.15159			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329723	Green Accepted, hybrid			2022-12-27	WOS:000081965200088
J	Faulkner, A; Chen, XM; Rush, J; Horazdovsky, B; Waechter, CJ; Carman, GM; Sternweis, PC				Faulkner, A; Chen, XM; Rush, J; Horazdovsky, B; Waechter, CJ; Carman, GM; Sternweis, PC			The LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; RAT-LIVER MICROSOMES; DOLICHYL-PHOSPHATE; ESCHERICHIA-COLI; ACID PHOSPHATASE; PLASMA-MEMBRANES; YEAST; PROTEIN; PURIFICATION; PHOSPHOHYDROLASE	Two genes in Saccharomyces cerevisiae, LPP1 and DPP1, with homology to a mammalian phosphatidic acid (PA) phosphatase were identified and disrupted. Neither single nor combined deletions resulted in growth or secretion phenotypes. As observed previously (Toke, D. A., Bennett, W. L., Dillon, D. A., Wu, W.-I., Chen, X., Ostrander, D. B., Oshiro, J., Cremesti, A., Voelker, D. R., Fischl, A. S., and Carman, G. M. (1998) J. Biol. Chem. 273, 3278-3284; Toke, D. A., Bennett, W. L., Oshiro, J., Wu, W.-I., Voelker, D. R., and Carman, G. M. (1998) J. Biol. Chem. 273, 14331-14338), the disruption of DPP1 and LPP1 produced profound losses of Mg2+-independent PA phosphatase activity. The coincident attenuation of hydrolytic activity against diacylglycerol pyrophosphate prompted an examination of the effects of these disruptions on hydrolysis of isoprenoid pyrophosphates. Disruption of either LPP1 or DPP1 caused respective decreases of about 25 and 75% in Mg2+-independent hydrolysis of several isoprenoid phosphates by particulate fractions isolated from these cells. The particulate and cytosolic fractions from the double disruption (lpp1 Delta dpp1 Delta) showed essentially complete loss of Mg2+-independent hydrolytic activity toward dolichyl phosphate (dolichyl-P), dolichyl pyrophosphate (dolichyl-P-P), farnesyl pyrophosphate (farnesyl-P-P), and geranylgeranyl pyrophosphate (geranylgeranyl-P-P). However, a modest Mg2+-stimulated activity toward PA and dolichyl-P was retained in cytosol from lpp1 Delta dpp1 Delta cells. The action of Dpp1p on isoprenyl pyrophosphates was confirmed by characterization of the hydrolysis of geranylgeranyl-P-P by the purified protein. These results indicate that LPP1 and DPP1 account for most of the hydrolytic activities toward dolichyl-P-P, dolichyl-P, farnesyl-P-P, and geranylgeranyl-P-P but also suggest that yeast contain other enzymes capable of dephosphorylating these essential isoprenoid intermediates.	Univ Texas, SW Med Sch, Dept Pharmacol, Dallas, TX 75235 USA; Univ Texas, SW Med Sch, Dept Biochem, Dallas, TX 75235 USA; Rutgers State Univ, Cook Coll, Dept Food Sci, New Brunswick, NJ 08901 USA; Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, Coll Med, Lexington, KY 40536 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Rutgers State University New Brunswick; University of Kentucky	Sternweis, PC (corresponding author), Univ Texas, SW Med Sch, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	sternwei@UTSW.swmed.edu	Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499	NIGMS NIH HHS [GM36065, GM31954, GM28140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R01GM031954, R37GM028140, R01GM036065] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANSAL VS, 1994, ARCH BIOCHEM BIOPHYS, V315, P393, DOI 10.1006/abbi.1994.1516; BELOCOPITOW E, 1982, EUR J BIOCHEM, V125, P167, DOI 10.1111/j.1432-1033.1982.tb06664.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BURTON WA, 1981, ARCH BIOCHEM BIOPHYS, V208, P409, DOI 10.1016/0003-9861(81)90526-9; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1992, METHOD ENZYMOL, V209, P219; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Frank DW, 1998, J BIOL CHEM, V273, P11791, DOI 10.1074/jbc.273.19.11791; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P102; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; ORLEAN P, 1992, BIOCHEM CELL BIOL, V70, P438, DOI 10.1139/o92-067; RIP JW, 1981, J BIOL CHEM, V256, P1929; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROSSIGNOL DP, 1983, J BIOL CHEM, V258, P9122; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHER MG, 1985, J BIOL CHEM, V260, P3742; SCHER MG, 1985, METHOD ENZYMOL, V111, P547; Sherman F, 1979, METHODS YEAST GENETI; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; Stukey J, 1997, PROTEIN SCI, V6, P469; SUMBILLA C, 1985, METHOD ENZYMOL, V111, P471; Szkopinska A, 1997, J LIPID RES, V38, P962; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WAECHTER CJ, 1981, RES METHODS NEUROCHE, P201; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; WAGGONER DW, 1995, J BIOL CHEM, V270, P19422, DOI 10.1074/jbc.270.33.19422; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	52	106	113	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14831	14837		10.1074/jbc.274.21.14831	http://dx.doi.org/10.1074/jbc.274.21.14831			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329682	hybrid			2022-12-27	WOS:000081965200047
J	Lee, L; Abe, A; Shayman, JA				Lee, L; Abe, A; Shayman, JA			Improved inhibitors of glucosylceramide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCEREBROSIDE SYNTHETASE; CERAMIDE	Previous work has led to the identification of inhibitors of glucosylceramide synthase, the enzyme catalyzing the first glycosylation step in the synthesis of glucosylceramide-based glycosphingolipids. These inhibitors have two identified sites of action: the inhibition of glucosylceramide synthase, resulting in the depletion of cellular glycosphingolipids, and the inhibition of 1-O-acylceramide synthase, resulting in the elevation of cell ceramide levels. A new series of glucosylceramide synthase inhibitors based on substitutions in the phenyl ring of a parent compound, 1-phenyl-2-palmitoylamino3-pyrrolidino-1-propanol (P4), was made. For substitutions of single functional groups, the potency of these inhibitors in blocking glucosylceramide synthase was primarily dependent upon the hydrophobic and electronic properties of the substituents, An exponential relationship was found between the IC50 of each inhibitor and the sum of derived hydrophobic (pi) and electronic (sigma) parameters. This relationship demonstrated that substitutions that increased the electron-donating characteristics and decreased the lipophilic characteristics of the homologues enhanced the potency of these compounds in blocking glucosylceramide formation. A novel compound was subsequently designed and observed to be even more active in blocking glucosylceramide formation. This compound, D-threo-4'-hydroxy-P4, inhibited glucosylceramide synthase at an IC50 of 90 nM In addition, a series of dioxane substitutions was designed and tested. These included 3',4'-methylenedioxyphenyl-, 3',4'-ethylenedioxyphenyl-, and 3'4'-trimethylenedioxyphenyl substituted homologues. D-threo-3',4'-Ethylenedioxy-P4-inhibited glucosylceramide synthase was comparably active to the p-hydroxy homologue. 4'-Hydroxy-P4 and ethylenedioxy-P4 blocked glucosylceramide synthase activity at concentrations that had little effect on 1-O-acylceramide synthase activity. These novel inhibitors resulted in the inhibition of glycosphingolipid synthesis in cultured cells at concentrations that did not significantly raise intracellular ceramide levels or inhibit cell growth.	Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shayman, JA (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, POB 0676,Rm 1560 MSRBII,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.				NIDDK NIH HHS [R01 DK41487] Funding Source: Medline; PHS HHS [R0139255] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041487] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; ABE A, 1995, J LIPID RES, V36, P611; Abe A, 1996, J BIOL CHEM, V271, P14383, DOI 10.1074/jbc.271.24.14383; Abe A, 1998, J BIOL CHEM, V273, P8467, DOI 10.1074/jbc.273.14.8467; ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; ABE A, 1996, BIOCH BIOCH ACTA, V1299, P331; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; HAKOMORI S, 1993, ADV LIPID RES, V23, P147; HAMMETT LP, 1940, PHYSICAL ORGANIC CHE; HOGBERG T, 1991, TXB DRUG DESIGN DEV, P55; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; PREISS J, 1986, J BIOL CHEM, V261, P8597; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; SHAYMAN JA, 1990, J BIOL CHEM, V265, P12135; SHUKLA GS, 1991, BIOCHIM BIOPHYS ACTA, V1083, P101, DOI 10.1016/0005-2760(91)90130-A; TUTE MS, 1970, ADV DRUG RES, V6, P1; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265	18	189	224	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14662	14669		10.1074/jbc.274.21.14662	http://dx.doi.org/10.1074/jbc.274.21.14662			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329660	hybrid			2022-12-27	WOS:000081965200025
J	Sahni, A; Sporn, LA; Francis, CW				Sahni, A; Sporn, LA; Francis, CW			Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR PRODUCTION; DNA-SYNTHESIS; BETA-CHAIN; EXTRACELLULAR-MATRIX; VONWILLEBRAND-FACTOR; AFFINITY RECEPTORS; FIBRIN; EXPRESSION; HEPARIN; PROTEIN	Endothelial cell growth is stimulated by fibroblast growth factor-2 (FGF-2), and both adhesion and proliferation are modulated by interactions with fibrinogen and fibrin. Previous evidence indicates that FGF-2 binds specifically and with high affinity to fibrinogen and fibrin, suggesting that their effects on endothelial cells may be coordinated. In this study, we have, therefore, investigated the ability of FGF-2 bound to fibrinogen and fibrin to stimulate proliferation of endothelial cells. Human umbilical vein endothelial cells were cultured in the presence of FGF-2 with or without fibrinogen, and proliferation was assessed by microscopic examination of cultures, incorporation of [H-3]thymidine and by cell counting. Cells cultured in the presence of both FGF-2 and fibrinogen proliferated more rapidly than those with FGF-2 alone and exhibited a decreased population doubling time. At concentrations of FGF-2 up to 150 ng/ml, there was greater endothelial cell proliferation in the presence of fibrinogen than in its absence with the most pronounced effect below 1 ng/ml. The maximum effect of fibrinogen was observed at a molar ratio of fibrinogen to FGF-2 of 2:1, corresponding to the maximum molar binding ratio. Endothelial cells proliferated when plated on fibrin or surface-immobilized fibrinogen with FGF-2, indicating that FGF-2 bound to surface-associated fibrin(ogen) retained activity. We conclude that fibrinogen- or fibrin-bound FGF-2 is able to support endothelial cell proliferation and that fibrinogen potentiates the proliferative capacity of FGF-2.	Univ Rochester, Med Ctr, Dept Med, Vasc Med Unit,Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Francis, CW (corresponding author), Univ Rochester, Med Ctr, Dept Med, Vasc Med Unit,Sch Med & Dent, Box 610,601 Elmwood Ave, Rochester, NY 14642 USA.	charles_francis@URMC.rochester.edu			NHLBI NIH HHS [HL-07152, HL-30616] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030616] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARAKI S, 1990, BIOCHEM BIOPH RES CO, V168, P1194, DOI 10.1016/0006-291X(90)91155-L; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; BARBIERI B, 1981, P SOC EXP BIOL MED, V168, P204; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663; CASSCELLS W, 1992, P NATL ACAD SCI USA, V89, P7159, DOI 10.1073/pnas.89.15.7159; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; ERBAN JK, 1992, J BIOL CHEM, V267, P2451; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; FUKAO H, 1990, THROMB RES, P11; FUKAO H, 1995, LIFE SCI, V57, P1267, DOI 10.1016/0024-3205(95)02083-U; GORCZYCA W, 1993, CANCER RES, V53, P1945; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; GUALANDRIS A, 1995, J CELL PHYSIOL, V162, P400, DOI 10.1002/jcp.1041620312; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; HUGHES SE, 1993, CARDIOVASC RES, V27, P1199, DOI 10.1093/cvr/27.7.1199; KAPLAN KL, 1989, ARTERIOSCLEROSIS, V9, P43, DOI 10.1161/01.ATV.9.1.43; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KLEIN S, 1993, MOL BIOL CELL, V4, P973, DOI 10.1091/mbc.4.10.973; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; MIGNATTI P, 1991, J CELL BIOL, V113, P1193, DOI 10.1083/jcb.113.5.1193; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; Pepper MS, 1997, ARTERIOSCL THROM VAS, V17, P605, DOI 10.1161/01.ATV.17.4.605; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; PRESTA M, 1986, MOL CELL BIOL, V6, P4060, DOI 10.1128/MCB.6.11.4060; QI JF, 1995, J IMMUNOL, V155, P867; RAMSBY ML, 1993, INVEST OPHTH VIS SCI, V34, P3207; RIBES JA, 1987, J CLIN INVEST, V79, P117, DOI 10.1172/JCI112771; RIBES JA, 1989, J CLIN INVEST, V84, P435, DOI 10.1172/JCI114184; ROSENGART TK, 1988, BIOCHEM BIOPH RES CO, V152, P432, DOI 10.1016/S0006-291X(88)80732-0; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SCHLEEF RR, 1982, TISSUE CELL, V14, P629, DOI 10.1016/0040-8166(82)90053-2; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPORN LA, 1995, BLOOD, V86, P1802, DOI 10.1182/blood.V86.5.1802.bloodjournal8651802; Suehiro K, 1997, J BIOL CHEM, V272, P5360, DOI 10.1074/jbc.272.8.5360; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; TSAI JC, 1995, J NEUROSURG, V82, P864, DOI 10.3171/jns.1995.82.5.0864; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355	49	70	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14936	14941		10.1074/jbc.274.21.14936	http://dx.doi.org/10.1074/jbc.274.21.14936			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329694	hybrid			2022-12-27	WOS:000081965200059
J	Schullery, DS; Ostrowski, J; Denisenko, ON; Stempka, L; Shnyreva, M; Suzuki, H; Gschwendt, M; Bomsztyk, K				Schullery, DS; Ostrowski, J; Denisenko, ON; Stempka, L; Shnyreva, M; Suzuki, H; Gschwendt, M; Bomsztyk, K			Regulated interaction of protein kinase C delta with the heterogeneous nuclear ribonucleoprotein K protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAV PROTOONCOGENE PRODUCT; HNRNP-K; TYROSINE PHOSPHORYLATION; RNA-BINDING; TRANSCRIPTIONAL REPRESSOR; IN-VITRO; DNA; PURIFICATION; DOMAIN; IDENTIFICATION	The heterogeneous nuclear ribonucleoprotein (hnRNP) K protein recruits a diversity of molecular partners that are involved in signal transduction, transcription, RNA processing, and translation. K protein is phosphorylated in vivo and in vitro by inducible kinase(s) and contains several potential sites for protein kinase C (PKC) phosphorylation, In this study we show that K protein is phosphorylated in vitro by PKC delta and by other PKCs, Deletion analysis and site-directed mutagenesis revealed that Ser(302) is a major K protein site phosphorylated by PKC delta in vitro, This residue is located in the middle of a short amino acid fragment that divides the two clusters of SH3-binding domains. Mutation of Ser(302) decreased the level of phosphorylation of exogenously expressed K protein in phorbol la-myristate 13-acetate-treated COS cells, suggesting that Ser(302) is also a site for PKC-mediated phosphorylation in vivo. In vitro, PKC delta binds K protein via the highly interactive KI domain, an interaction that is blocked by poly(C) RNA. Mutation of Ser(302) did not alter the K protein-PKG delta interaction in vitro, suggesting that phosphorylation of this residue alone is not sufficient to alter this interaction. Instead, binding of PKC delta to K protein in vitro and in vivo was greatly increased by K protein phosphorylation on tyrosine residues. The ability of PKC delta to bind and phosphorylate K protein may serve not only to alter the activity of K protein itself, but K protein may also bridge PKC delta to other K protein molecular partners and thus facilitate molecular cross-talk. The regulated nature of the PKC delta-K protein interaction may serve to meet cellular needs at sites of active transcription, RNA processing and translation in response to changing extracellular environment.	Univ Washington, Dept Med, Seattle, WA 98195 USA; German Canc Res Ctr, D-69120 Heidelberg, Germany; Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, PL-02781 Warsaw, Poland; Inst Oncol, PL-02781 Warsaw, Poland	University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Bomsztyk, K (corresponding author), Univ Washington, Dept Med, Box 356521, Seattle, WA 98195 USA.				NIDDK NIH HHS [DK45978] Funding Source: Medline; NIGMS NIH HHS [GM45134] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045978, R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; ITO K, 1994, NUCLEIC ACIDS RES, V22, P53, DOI 10.1093/nar/22.1.53; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 1996, J BIOL CHEM, V271, P3420; LEIBERSPERGER H, 1990, J BIOL CHEM, V265, P16108; LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; MUNICIO MM, 1995, J BIOL CHEM, V270, P15884, DOI 10.1074/jbc.270.26.15884; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; OSTROWSKI J, 1993, NUCLEIC ACIDS RES, V21, P1045, DOI 10.1093/nar/21.4.1045; ROSENBERGER U, 1995, BIOCHEM J, V305, P269, DOI 10.1042/bj3050269; ROSENBERGER U, 1996, EUR J CELL BIOL S42, V69, P288; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; VANSEUNINGEN I, 1995, BIOCHEMISTRY-US, V34, P5644, DOI 10.1021/bi00016a040; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZANG R, 1994, BIOCHEM J, V304, P641, DOI 10.1042/bj3040641; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	44	87	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15101	15109		10.1074/jbc.274.21.15101	http://dx.doi.org/10.1074/jbc.274.21.15101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329716	hybrid			2022-12-27	WOS:000081965200081
J	van Holde, KE				van Holde, KE			Biochemistry at the single-molecule level: Minireview series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	van Holde, KE (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	vanholde@asbmb.faseb.org							0	6	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14515	14515		10.1074/jbc.274.21.14515	http://dx.doi.org/10.1074/jbc.274.21.14515			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329636	hybrid			2022-12-27	WOS:000081965200001
J	Boesen-de Cock, JGR; Tepper, AD; de Vries, E; van Blitterswijk, WJ; Borst, J				Boesen-de Cock, JGR; Tepper, AD; de Vries, E; van Blitterswijk, WJ; Borst, J			Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APO-1/FAS RECEPTOR/LIGAND SYSTEM; DAUNORUBICIN-INDUCED APOPTOSIS; FAS/FAS LIGAND INTERACTIONS; DRUG-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; INDUCED CELL-DEATH; ACID SPHINGOMYELINASE; CERAMIDE FORMATION; LYMPHOID-CELLS; COMPLEX DISC	The death receptor CD95 (APO-1/Fas), the anticancer drug etoposide, and gamma-radiation induce apoptosis in the human T cell line Jurkat. Variant clones selected for resistance to CD95-induced apoptosis proved cross-resistant to etoposide- and radiation-induced apoptosis, suggesting that the apoptosis pathways induced by these distinct stimuli have critical component(s) in common. The pathways do not converge at the level of CD95 ligation or caspase-8 signaling. Whereas caspase-8 function was required for CD95-mediated cytochrome c release, effector caspase activation, and apoptosis, these responses were unaffected in etoposide-treated and irradiated cells when caspase-8 was inhibited by FLIPL. Both effector caspase processing and cytochrome c release were inhibited in the resistant variant cells as well as in Bcl-2 transfectants, suggesting that, in Jurkat cells, the apoptosis signaling pathways activated by CD95, etoposide, and gamma-radiation are under common mitochondrial control. All three stimuli induced ceramide production in wild-type cells, but not in resistant variant cells. Exogenous ceramide bypassed apoptosis resistance in the variant cells, but not in Bcl-2-transfected cells, suggesting that apoptosis signaling induced by CD95, etoposide, and gamma-radiation is subject to common regulation at a level different from that targeted by Bcl-2.	Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst, Div Cellular Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	jborst@nki.nl		Borst, Jannie/0000-0002-8043-5009				Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brady HJM, 1996, EMBO J, V15, P1221, DOI 10.1002/j.1460-2075.1996.tb00463.x; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Chmura SJ, 1997, CANCER RES, V57, P1270; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; Cock JGRBD, 1998, APOPTOSIS, V3, P17, DOI 10.1023/A:1009603001888; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Datta R, 1997, J BIOL CHEM, V272, P1965, DOI 10.1074/jbc.272.3.1965; DEJONG D, 1994, CANCER RES, V54, P256; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; Hu SM, 1997, J BIOL CHEM, V272, P9621; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JAATTELA M, 1995, ONCOGENE, V10, P2297; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Michael JM, 1997, CANCER RES, V57, P3600; MIYASHITA T, 1995, CELL, V80, P293; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Tepper AD, 1997, J BIOL CHEM, V272, P24308, DOI 10.1074/jbc.272.39.24308; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	57	101	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14255	14261		10.1074/jbc.274.20.14255	http://dx.doi.org/10.1074/jbc.274.20.14255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318846	hybrid			2022-12-27	WOS:000080322200075
J	Corbin, JD; Francis, SH				Corbin, JD; Francis, SH			Cyclic GMP phosphodiesterase-5: Target of sildenafil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CGMP-SPECIFIC PHOSPHODIESTERASE; DEPENDENT PROTEIN-KINASES; MALE ERECTILE DYSFUNCTION; NUCLEOTIDE PHOSPHODIESTERASES; CAMP-PHOSPHODIESTERASE; BINDING-PROTEIN; NITRIC-OXIDE; GUANYLYL CYCLASE; CATALYTIC DOMAIN; SMOOTH-MUSCLE		Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Corbin, JD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall,21st & Garland Ave, Nashville, TN 37232 USA.	jackie.corbin@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041269] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40029] Funding Source: Medline; NIGMS NIH HHS [GM41269] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bakre MM, 1997, FEBS LETT, V408, P345, DOI 10.1016/S0014-5793(97)00458-4; Ballard SA, 1998, J UROLOGY, V159, P2164, DOI 10.1016/S0022-5347(01)63299-3; BEAVO JA, 1994, MOL PHARMACOL, V46, P399; BERTHET J, 1957, J BIOL CHEM, V229, P351; BOLGER GB, 1994, CELL SIGNAL, V6, P851, DOI 10.1016/0898-6568(94)90018-3; BURGERS PMJ, 1979, J BIOL CHEM, V254, P9959; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; BURNS F, 1992, BIOCHEM J, V283, P487, DOI 10.1042/bj2830487; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Charbonneau H., 1990, CYCLIC NUCLEOTIDE PH, P267; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; DAVIS CW, 1977, J BIOL CHEM, V252, P4078; Degerman E, 1997, J BIOL CHEM, V272, P6823, DOI 10.1074/jbc.272.11.6823; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; FLORIO VA, 1994, BIOCHEMISTRY-US, V33, P8948, DOI 10.1021/bi00196a012; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Francis SH, 1998, METHODS, V14, P81, DOI 10.1006/meth.1997.0567; FRANCIS SH, 1988, METHOD ENZYMOL, V159, P722; FRANCIS SH, 1990, CYCLIC NUCLEOTIDE PH, P117; FRANCIS SH, 1993, CYCLIC GMP SYNTHESIS, P115; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GETTYS TW, 1987, J BIOL CHEM, V262, P333; GOLDBERG ND, 1980, J BIOL CHEM, V255, P344; HAMET P, 1978, J CYCLIC NUCL PROT, V4, P281; HOFMANN F, 1992, BIOCHIM BIOPHYS ACTA, V1135, P51, DOI 10.1016/0167-4889(92)90165-8; HOUSLAY MD, 1995, ADV ENZYME REGUL, V35, P303, DOI 10.1016/0065-2571(94)00012-R; Jeremy JY, 1997, BRIT J UROL, V79, P958, DOI 10.1046/j.1464-410X.1997.00206.x; JIANG H, 1992, J BIOL CHEM, V267, P1015; JIN SLC, 1992, J BIOL CHEM, V267, P18929; Kotera J, 1997, EUR J BIOCHEM, V249, P434, DOI 10.1111/j.1432-1033.1997.t01-1-00434.x; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Lochhead A, 1997, J BIOL CHEM, V272, P18397, DOI 10.1074/jbc.272.29.18397; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Loughney K, 1998, GENE, V216, P139, DOI 10.1016/S0378-1119(98)00303-5; MANGANIELLO VC, 1960, CYCLIC NUCL PHOSPHOD, P61; McAllisterLucas LM, 1995, J BIOL CHEM, V270, P30671, DOI 10.1074/jbc.270.51.30671; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; MICHAELI T, 1993, J BIOL CHEM, V268, P12925; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Park K, 1998, BIOCHEM BIOPH RES CO, V249, P612, DOI 10.1006/bbrc.1998.9206; Percival MD, 1997, BIOCHEM BIOPH RES CO, V241, P175, DOI 10.1006/bbrc.1997.7542; RALL TW, 1958, J BIOL CHEM, V232, P1065; Sanchez LS, 1998, PEDIATR RES, V43, P163, DOI 10.1203/00006450-199802000-00002; SCHULTZ KD, 1977, NATURE, V265, P750, DOI 10.1038/265750a0; SEKHAR KR, 1996, PHOSPHODIESTERASE IN, P135; Sheth SB, 1997, THROMB HAEMOSTASIS, V77, P155; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Sonnenburg WK, 1995, J BIOL CHEM, V270, P30989, DOI 10.1074/jbc.270.52.30989; SRIVASTAVA D, 1995, BIOCHEM J, V308, P653, DOI 10.1042/bj3080653; Terrett NK, 1996, BIOORG MED CHEM LETT, V6, P1819, DOI 10.1016/0960-894X(96)00323-X; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; THOMPSON WJ, 1992, ADV SEC MESS PHOSPH, V25, P165; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; UNDERWOOD DC, 1994, J PHARMACOL EXP THER, V270, P250; Wagner G, 1998, BMJ-BRIT MED J, V316, P678, DOI 10.1136/bmj.316.7132.678; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; YAMAZAKI A, 1984, ADV CYCLIC NUCL PROT, V16, P381; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Yanaka N, 1998, EUR J BIOCHEM, V255, P391, DOI 10.1046/j.1432-1327.1998.2550391.x	69	402	415	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13729	13732		10.1074/jbc.274.20.13729	http://dx.doi.org/10.1074/jbc.274.20.13729			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318772	hybrid			2022-12-27	WOS:000080322200001
J	Egawa, K; Sharma, PM; Nakashima, N; Huang, Y; Huver, E; Boss, GR; Olefsky, JM				Egawa, K; Sharma, PM; Nakashima, N; Huang, Y; Huver, E; Boss, GR; Olefsky, JM			Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; GLUCOSE-TRANSPORT ACTIVITY; RECEPTOR SUBSTRATE FAMILY; 3T3-L1 ADIPOCYTES; GLUT4 TRANSLOCATION; DNA-SYNTHESIS; 1-PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOTYROSINE PROTEIN	Phosphatidylinositol (PI) 3-kinase plays an important role in various insulin-stimulated biological responses including glucose transport, glycogen synthesis, and protein synthesis. However, the molecular link between PI 3-kinase and these biological responses is still unclear. We have investigated whether targeting of the catalytic p110 subunit of PI 3-kinase to cellular membranes is sufficient and necessary to induce PI 3-kinase dependent signaling responses, characteristic of insulin action. We overexpressed Myc-tagged, membrane-targeted p110 (p110(CAAX)), and wild-type p110 (p110(WT)) in 3T3-L1 adipocytes by adenovirus-mediated gene transfer. Overexpressed p110(CAAX) exhibited similar to 2-fold increase in basal kinase activity in p110 immunoprecipitates, that further increased to similar to 4-fold with insulin. Even at this submaximal PI 3-kinase activity, p110(CAAX) fully stimulated p70 S6 kinase, Akt, 2-deoxyglucose uptake, and Ras, whereas, p110(WT) had little or no effect on these downstream effects, Interestingly p110(CAAX) did not activate MAP kinase, despite its stimulation of p21(ras). Surprisingly, p110(CAAX) did not increase basal glycogen synthase activity, and inhibited insulin stimulated activity, indicative of cellular resistance to this action of insulin, p110(CAAX) also inhibited insulin stimulated, but not platelet-derived growth factor-stimulated mitogen-activated protein kinase phosphorylation, demonstrating that the p110(CAAX) induced inhibition of mitogen-activated protein kinase and insulin signaling is specific, and not due to some toxic or nonspecific effect on the cells. Moreover, p110(CAAX) stimulated IRS-1 Ser/Thr phosphorylation, and inhibited IRS-1 associated PI 3-kinase activity, without affecting insulin receptor tyrosine phosphorylation, suggesting that it may play an important role as a negative regulator for insulin signaling. In conclusion, our studies show that membrane-targeted PI S-kinase can mimic a number of biologic effects normally induced by insulin. In addition, the persistent activation of PI 3-kinase induced by p110(CAAX) expression leads to desensitization of specific signaling pathways. Interestingly, the state of cellular insulin resistance is not global, in that some of insulin's actions are inhibited, whereas others are intact.	Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Whittier Diabet Inst, La Jolla, CA 92093 USA; Vet Adm Res Serv, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Boss, Gerry/0000-0002-9758-8714	NIDDK NIH HHS [R01 DK 36651] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENJAMIN WB, 1994, BIOCHEM J, V300, P477, DOI 10.1042/bj3000477; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Brownell HL, 1997, DNA CELL BIOL, V16, P103, DOI 10.1089/dna.1997.16.103; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; GLUZMAN Y, 1982, VIRAL VECTORS, P187; GOULD GW, 1994, CELL SIGNAL, V6, P313, DOI 10.1016/0898-6568(94)90036-1; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; HERBST JJ, 1995, J BIOL CHEM, V270, P26000, DOI 10.1074/jbc.270.43.26000; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; JHUN BH, 1994, MOL CELL BIOL, V14, P7466, DOI 10.1128/MCB.14.11.7466; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; LAM K, 1994, J BIOL CHEM, V269, P20648; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; OKADA T, 1994, J BIOL CHEM, V269, P3568; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAKAUE M, 1995, MOL CELL BIOL, V15, P379, DOI 10.1128/MCB.15.1.379; SCHEELE JS, 1995, P NATL ACAD SCI USA, V92, P1097, DOI 10.1073/pnas.92.4.1097; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Sharma PM, 1997, MOL CELL BIOL, V17, P7386, DOI 10.1128/MCB.17.12.7386; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; SJOLANDER A, 1991, P NATL ACAD SCI USA, V88, P7908, DOI 10.1073/pnas.88.18.7908; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; TANTI JF, 1994, BIOCHEM J, V304, P17, DOI 10.1042/bj3040017; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; ZHANG WW, 1995, BIOTECHNIQUES, V18, P444	58	87	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14306	14314		10.1074/jbc.274.20.14306	http://dx.doi.org/10.1074/jbc.274.20.14306			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318852	hybrid			2022-12-27	WOS:000080322200081
J	Hew, Y; Grzelczak, Z; Lau, C; Keeley, FW				Hew, Y; Grzelczak, Z; Lau, C; Keeley, FW			Identification of a large region of secondary structure in the 3 '-untranslated region of chicken elastin mRNA with implications for the regulation of mRNA stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; NECROSIS-FACTOR-ALPHA; DNA-POLYMERASE; POSTTRANSCRIPTIONAL REGULATION; TROPOELASTIN EXPRESSION; DELETION MUTAGENESIS; GENE-EXPRESSION; DOWN-REGULATION; CIS-ELEMENT; PROTEIN	Synthesis of aortic elastin peaks in the perinatal period and then is strongly down-regulated with postnatal vascular development. Our laboratory has previously shown that changes in elastin mRNA stability contribute to this developmental decrease in elastin production. Here we identify a large region of stable secondary structure in the 3'-untranslated region (3'-UTR) of chicken elastin mRNA. Reverse transcriptase polymerase chain reaction or polymerase chain reaction amplification of the 3'-UTR consistently resulted in products with an similar to 328-bp deletion from the central region of the 3'-UTR, suggesting the presence of secondary structure. The presence of this structure was confirmed by probing the 3'-UTR with RNases with selectivity for single- or double-stranded RNA. Gel migration shift assays using cytosolic extracts from 2-day old chicken aorta demonstrate specific binding of a cytosolic protein to riboprobes containing the 3'-UTR of elastin but not to riboprobes either corresponding to other areas of the message or containing the 3'-UTR but lacking the region of secondary structure. Binding of cytosolic protein was particularly prominent in aortic extracts from 2-day old chickens, a time when elastin message is stable, as compared with 8- and 15-week old chickens, when the elastin message is relatively unstable, suggesting that this region of secondary structure may play a role in developmental regulation of stability of elastin mRNA.	Hosp Sick Children, Div Cardiovasc Res, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Keeley, FW (corresponding author), Hosp Sick Children, Div Cardiovasc Res, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; AMARA FM, 1995, NUCLEIC ACIDS RES, V23, P1461, DOI 10.1093/nar/23.9.1461; BAULE VJ, 1988, BIOCHEM BIOPH RES CO, V154, P1054, DOI 10.1016/0006-291X(88)90247-1; BRESSAN GM, 1987, BIOCHEMISTRY-US, V26, P1497, DOI 10.1021/bi00380a001; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; CARIELLO NF, 1991, GENE, V99, P105, DOI 10.1016/0378-1119(91)90040-I; CzyzykKrzeska MF, 1997, KIDNEY INT, V51, P585, DOI 10.1038/ki.1997.84; DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Ford LP, 1997, MOL CELL BIOL, V17, P398, DOI 10.1128/MCB.17.1.398; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; Gluick TC, 1997, BIOCHEMISTRY-US, V36, P16173, DOI 10.1021/bi971362v; Gluick TC, 1997, J MOL BIOL, V270, P451, DOI 10.1006/jmbi.1997.1119; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107; KAHARI VM, 1992, LAB INVEST, V66, P580; KEELEY FW, 1990, ARCH BIOCHEM BIOPHYS, V282, P226, DOI 10.1016/0003-9861(90)90109-C; Kucich U, 1997, AM J RESP CELL MOL, V17, P10, DOI 10.1165/ajrcmb.17.1.2816; LAING LG, 1994, J MOL BIOL, V237, P577, DOI 10.1006/jmbi.1994.1256; LEFEVRE M, 1980, BIOCHIM BIOPHYS ACTA, V630, P519, DOI 10.1016/0304-4165(80)90006-9; Long SD, 1996, BIOCHEM BIOPH RES CO, V220, P949, DOI 10.1006/bbrc.1996.0512; McGowan KM, 1997, J BIOL CHEM, V272, P1331, DOI 10.1074/jbc.272.2.1331; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; PARKS WC, 1992, BIOCHEMISTRY-US, V31, P6639, DOI 10.1021/bi00144a003; Peng SSY, 1996, MOL CELL BIOL, V16, P1490; PIERCE RA, 1992, J BIOL CHEM, V267, P11593; ROBSON P, 1993, J BIOL CHEM, V268, P1440; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schlegl J, 1997, RNA, V3, P1159; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; TOKIMITSU I, 1987, ARCH BIOCHEM BIOPHYS, V256, P455, DOI 10.1016/0003-9861(87)90602-3; WANG XM, 1995, MOL CELL BIOL, V15, P1769; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	36	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14415	14421		10.1074/jbc.274.20.14415	http://dx.doi.org/10.1074/jbc.274.20.14415			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318866	hybrid			2022-12-27	WOS:000080322200095
J	Kaspar, P; Dvorakova, M; Kralova, J; Pajer, P; Kozmik, Z; Dvorak, M				Kaspar, P; Dvorakova, M; Kralova, J; Pajer, P; Kozmik, Z; Dvorak, M			Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; V-MYB; LEUCINE-ZIPPER; NUCLEOTIDE-SEQUENCE; CELLULAR PROGENITOR; MAMMALIAN-CELLS; GENE-EXPRESSION; BINDING PROTEIN; ONCOGENE; TRANSACTIVATION	Using the yeast two-hybrid system, the transcription factor ATBF1 was identified as v-Myb- and c-Myb-binding protein. Deletion mutagenesis revealed amino acids 2484-2520 in human ATBF1 and 279-300 in v-Myb as regions required for in vitro binding of both proteins. Further experiments identified leucines Leu(325) and Leu(332) of the Myb leucine zipper motif as additional amino acid residues important for efficient ATBF1-Myb interaction in vitro, In co-transfection experiments, the full-length ATBF1 was found to form in vivo complexes with v-Myb and inhibit v-Myb transcriptional activity. Both ATBF1 2484-2520 and Myb 279-300 regions were required for the inhibitory effect. Finally, the chicken ATBF1 was identified, showing high degree of amino acid sequence homology with human and murine proteins. Our data reveal Myb proteins as the first ATBF1 partners detected so far and identify amino acids 279-300 in v-Myb as a novel protein-protein interaction interface through which Myb transcriptional activity can he regulated.	Acad Sci Czech Republ, Inst Mol Genet, Prague 16637 6, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Dvorak, M (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Flemingovo 2, Prague 16637 6, Czech Republic.	mdvorak@img.cas.cz	Kozmik, Zbynek/I-8807-2014; Kozmik, Zbynek/G-3581-2014; Kralova, Jarmila/G-3834-2014; Kaspar, Petr/G-5864-2014; Pajer, Petr/G-5869-2014; Kaspar, Petr/J-1705-2014; Dvořák, Michal/I-9939-2014; Dvorak, Michal/G-5861-2014	Kralova, Jarmila/0000-0002-4735-8857; Kozmik, Zbynek/0000-0002-5850-2105				ARSURA M, 1995, MOL CELL BIOL, V15, P6702; Bartunek P, 1997, ONCOGENE, V15, P2939, DOI 10.1038/sj.onc.1201457; BARTUNEK P, 1992, VIROLOGY, V190, P882, DOI 10.1016/0042-6822(92)90930-N; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; DVORAK M, 1989, NUCLEIC ACIDS RES, V17, P5651; FAVIER D, 1994, ONCOGENE, V9, P305; Gonda TJ, 1996, CURR TOP MICROBIOL, V211, P99; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; GRASSER FA, 1991, MOL CELL BIOL, V11, P3987; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; INTRONA M, 1994, SEMIN CANCER BIOL, V5, P113; KALKBRENNER F, 1990, ONCOGENE, V5, P657; KaneiIshii C, 1997, SCIENCE, V277, P246, DOI 10.1126/science.277.5323.246; KANEIISHII C, 1992, P NATL ACAD SCI USA, V89, P3088, DOI 10.1073/pnas.89.7.3088; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; LANE T, 1990, MOL CELL BIOL, V10, P2591, DOI 10.1128/MCB.10.6.2591; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Lipsick JS, 1996, ONCOGENE, V13, P223; LIPSICK JS, 1986, J VIROL, V59, P267, DOI 10.1128/JVI.59.2.267-275.1986; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MAHESWARAN S, 1994, MOL CELL BIOL, V14, P1147, DOI 10.1128/MCB.14.2.1147; Mink S, 1996, MOL CELL BIOL, V16, P1316; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Ness SA, 1996, BBA-REV CANCER, V1288, pF123, DOI 10.1016/S0304-419X(96)00027-3; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Pfitzner E, 1998, P NATL ACAD SCI USA, V95, P5539, DOI 10.1073/pnas.95.10.5539; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SENECA S, 1993, ONCOGENE, V8, P2335; VRANOVSKY K, 1992, GENE, V117, P233; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395	38	51	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14422	14428		10.1074/jbc.274.20.14422	http://dx.doi.org/10.1074/jbc.274.20.14422			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318867	hybrid			2022-12-27	WOS:000080322200096
J	Kim, HS; Maeda, N; Oh, GT; Fernandez, LG; Gomez, RA; Smithies, O				Kim, HS; Maeda, N; Oh, GT; Fernandez, LG; Gomez, RA; Smithies, O			Homeostasis in mice with genetically decreased angiotensinogen is primarily by an increased number of renin-producing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE CHAIN-REACTION; CONVERTING ENZYME; BLOOD-PRESSURE; NUCLEOTIDE-SEQUENCE; EXPRESSING CELLS; GENE DUPLICATION; MESSENGER-RNA; MOUSE; KIDNEY; HYPERTENSION	Here we investigate the biochemical, molecular, and cellular changes directed toward blood pressure homeostasis that occur in the endocrine branch of the renin-angiotensin system of mice having one angiotensinogen gene inactivated. No compensatory up-regulation of the remaining normal allele occurs in tbe liver, the main tissue of angiotensinogen synthesis. No significant changes occur in expression of the genes coding for the angiotensin converting enzyme or the major pressor-mediating receptor for angiotensin, but plasma renin concentration in the mice having only one copy of the angiotensinogen gene is greater than twice wild-type, This increase is mediated primarily by a modest increase in the proportion of renal glomeruli producing renin in their juxtaglomerular apparatus and by four times wild-type numbers of renin-producing cells along afferent arterioles of the glomeruli rather than by upregulating renin production in cells already committed to its synthesis.	Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ Virginia, Hlth Sci Ctr, Dept Pediat, Charlottesville, VA 22908 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Virginia	Kim, HS (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.		Oh, Goo Taeg/AAQ-9995-2021		NHLBI NIH HHS [HL49277] Funding Source: Medline; NIGMS NIH HHS [GM20069] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020069, R37GM020069] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; AZROLAN N, 1990, J LIPID RES, V31, P1141; BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945; BURT DW, 1989, GENE, V84, P91, DOI 10.1016/0378-1119(89)90143-1; CANTIN M, 1977, AM J PATHOL, V87, P581; CASELLAS D, 1993, AM J PHYSIOL, V265, pF151, DOI 10.1152/ajprenal.1993.265.1.F151; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLOUSTON W M, 1988, Genomics, V2, P240, DOI 10.1016/0888-7543(88)90008-0; DICKINSON DP, 1984, GENETICS, V108, P651; DZAU VJ, 1988, AM J PHYSIOL, V255, pF563, DOI 10.1152/ajprenal.1988.255.4.F563; EPSTEIN CJ, 1986, CONSEQUENCES CHROMOS, P65; FABIAN JR, 1989, J BIOL CHEM, V264, P17589; FIELD LJ, 1985, P NATL ACAD SCI USA, V82, P6196, DOI 10.1073/pnas.82.18.6196; GERBER H, 1987, ENDOCRINOLOGY, V120, P91, DOI 10.1210/endo-120-1-91; GOMEZ RA, 1990, AM J PHYSIOL, V259, pF660, DOI 10.1152/ajprenal.1990.259.4.F660; GOMEZ RA, 1988, AM J PHYSIOL, V254, pF900, DOI 10.1152/ajprenal.1988.254.6.F900; HERMANN K, 1988, CLIN CHEM, V34, P1046; Hilgers KF, 1997, HYPERTENSION, V29, P216, DOI 10.1161/01.HYP.29.1.216; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; KIM WS, 1989, NUCLEIC ACIDS RES, V17, P9480, DOI 10.1093/nar/17.22.9279; KOHARA K, 1991, PEPTIDES, V12, P1135, DOI 10.1016/0196-9781(91)90070-6; Krege JH, 1997, HYPERTENSION, V29, P150, DOI 10.1161/01.HYP.29.1.150; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; LIN CT, 1986, ENDOCRINOLOGY, V118, P538, DOI 10.1210/endo-118-2-538; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; NARUSE K, 1981, P NATL ACAD SCI-BIOL, V78, P7579, DOI 10.1073/pnas.78.12.7579; NASJLETTI A, 1971, CAN J PHYSIOL PHARM, V49, P931, DOI 10.1139/y71-129; NG KKF, 1967, NATURE, V216, P762, DOI 10.1038/216762a0; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; PICCINI N, 1982, CELL, V30, P205, DOI 10.1016/0092-8674(82)90026-5; Reddi V, 1998, J AM SOC NEPHROL, V9, P63; ROMANO LA, 1994, HYPERTENSION, V23, P889, DOI 10.1161/01.HYP.23.6.889; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Sealey J E, 1980, Endocr Rev, V1, P365; SEALEY JE, 1991, CLIN CHEM, V37, P1811; SEALEY JE, 1989, AM J HYPERTENS, V2, P358, DOI 10.1093/ajh/2.5.358; SIGMUND CD, 1991, HYPERTENSION, V18, P446, DOI 10.1161/01.HYP.18.4.446; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SMITHIES O, 1994, P NATL ACAD SCI USA, V91, P3612, DOI 10.1073/pnas.91.9.3612; TAUGNER R, 1982, KLIN WOCHENSCHR, V60, P1218, DOI 10.1007/BF01716726; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WHITEBREAD S, 1989, BIOCHEM BIOPH RES CO, V163, P284, DOI 10.1016/0006-291X(89)92133-5	53	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14210	14217		10.1074/jbc.274.20.14210	http://dx.doi.org/10.1074/jbc.274.20.14210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318840	hybrid, Green Published			2022-12-27	WOS:000080322200069
J	Liu, XS; Zou, H; Widlak, P; Garrard, W; Wang, XD				Liu, XS; Zou, H; Widlak, P; Garrard, W; Wang, XD			Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) - Oligomerization and direct interaction with histone H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN CONDENSATION; FRAGMENTATION; INHIBITOR; SPECIFICITIES; PROTEASES; CLEAVAGE; FAMILY	DNA fragmentation factor (DFF) is a heterodimeric protein composed of 45-kDa (DFF45) and 40-kDa (DFF40) subunits, a protein that mediates regulated DNA fragmentation and chromatin condensation in response to apoptotic signals. DFF45 is a specific molecular chaperone and an inhibitor for the nuclease activity of DFF40. Previous studies have shown that upon cleavage of DFF45 by caspase-3, the nuclease activity of DFF40 is relieved of inhibition. Here we further investigate the mechanism of DFF40 activation. We demonstrate that DFF45 can also be cleaved and inactivated by caspase-7 but not by caspase-6 and caspase-8. The cleaved DFF45 fragments dissociate from DFF40, allowing DFF40 to oligomerize to form a large functional complex that cleaves DNA by introducing double strand breaks. Histone H1 directly interacts with DFF, confers DNA binding ability to DFF, and stimulates the nuclease activity of DFF40 by increasing its K-cat, and decreasing its K-m.	Univ Texas, SW Med Ctr, Dept Biochem, HHMI, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75235 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, HHMI, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Widlak, Piotr/AAL-8075-2021	Widlak, Piotr/0000-0001-5099-4726; Wang, Xiaodong/0000-0001-9885-356X	NIGMS NIH HHS [GMRO1-29935, GMRO1-55942, GMRO1-51585] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029935, R01GM051585] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CAMPBELL VW, 1980, J BIOL CHEM, V255, P3726; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 1998, EXP CELL RES, V243, P453, DOI 10.1006/excr.1998.4212; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Toh SY, 1998, BIOCHEM BIOPH RES CO, V250, P598, DOI 10.1006/bbrc.1998.9369; VANHOLDE KE, 1989, CHROMATIN, P198; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	18	156	165	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13836	13840		10.1074/jbc.274.20.13836	http://dx.doi.org/10.1074/jbc.274.20.13836			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318789	hybrid			2022-12-27	WOS:000080322200018
J	Mziaut, H; Korza, G; Hand, AR; Gerard, C; Ozols, J				Mziaut, H; Korza, G; Hand, AR; Gerard, C; Ozols, J			Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11 beta-hydroxysteroid dehydrogenase and the 50-kDa esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; GREEN FLUORESCENT PROTEIN; NADH-CYTOCHROME-B5 REDUCTASE; MEMBRANE-PROTEINS; HEMAGGLUTININ-NEURAMINIDASE; INTRACELLULAR-TRANSPORT; MICROSOMAL MEMBRANE; GOLGI LOCALIZATION; COVALENT STRUCTURE; SIMIAN VIRUS-5	Previous studies identified two intrinsic endoplasmic reticulum (EB) proteins, 11 beta-hydroxysteroid dehydrogenase, isozyme 1 (11 beta-HSD) and the 50-kDa esterase (E3), sharing some amino acid sequence motifs in their N-terminal transmembrane (TM) domains. Both are type II membrane proteins with the C terminus projecting into the lumen of the ER, This finding implied that the N-terminal TM domains of 11 beta-HSD and E3 may constitute a lumenal targeting signal (LTS). To investigate this hypothesis we created chimeric fusions using the putative targeting sequences and the reporter gene, Aequorea victoria green fluorescent protein, Transfected COS cells expressing LTS-green fluorescent protein chimeras were examined by fluorescent microscopy and electron microscopic immunogold labeling The orientation of expressed chimeras was established by immunocytofluorescent staining of selectively permeabilized COS cells. In addition, protease protection assays of membranes in the presence and absence of detergents was used to confirm lumenal or the cytosolic orientation of the constructed chimeras. To investigate the general applicability of the proposed LTS, we fused the N terminus of E3 to the N terminus of the NADH-cytochrome b5 reductase lacking the myristoyl group and N-terminal 30-residue membrane anchor. The orientation of the cytochrome b5 reductase was reversed, from cytosolic to lumenal projection of the active domain. These observations establish that an amino acid sequence consisting of short basic or neutral residues at the N terminus, followed by a specific array of hydrophobic residues terminating with acidic residues, is sufficient for lumenal targeting of single-pass proteins that are structurally and functionally unrelated.	Univ Connecticut, Ctr Hlth, Sch Med, Dept Electron Microscopy, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Sch Med, Dept Biochem, Farmington, CT 06030 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA	University of Connecticut; University of Connecticut; Harvard University; Boston Children's Hospital; Harvard Medical School	Ozols, J (corresponding author), Univ Connecticut, Ctr Hlth, Sch Med, Dept Biochem, Farmington, CT 06030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026351] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-26351] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOS TJ, 1984, P NATL ACAD SCI-BIOL, V81, P2327, DOI 10.1073/pnas.81.8.2327; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; DAHDAL RY, 1993, J BIOL CHEM, V268, P26310; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Hand Arthur R., 1995, P205, DOI 10.1016/B978-012286230-4/50006-7; Haynes RL, 1997, J BIOL CHEM, V272, P17126, DOI 10.1074/jbc.272.27.17126; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; HEIN WR, 1993, EMBO J, V12, P715, DOI 10.1002/j.1460-2075.1993.tb05705.x; HEINEMANN FS, 1982, J BIOL CHEM, V257, P4988; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; HEINEMANN FS, 1984, J BIOL CHEM, V259, P797; HIEBERT SW, 1985, J VIROL, V54, P1; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KUMAR V, 1994, J BIOL CHEM, V269, P13451; MALLABIABARRENA A, 1995, EMBO J, V14, P2257, DOI 10.1002/j.1460-2075.1995.tb07220.x; MORI M, 1981, P NATL ACAD SCI-BIOL, V78, P6056, DOI 10.1073/pnas.78.10.6056; MUNRO S, 1995, BIOCHEM SOC T, V23, P527, DOI 10.1042/bst0230527; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; OTTO JC, 1994, J BIOL CHEM, V269, P19868; OZOLS J, 1986, J BIOL CHEM, V261, P3965; Ozols J, 1998, BIOCHEMISTRY-US, V37, P10336, DOI 10.1021/bi9807916; OZOLS J, 1995, J BIOL CHEM, V270, P2305, DOI 10.1074/jbc.270.5.2305; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; OZOLS J, 1993, P NATL ACAD SCI USA, V90, P5302, DOI 10.1073/pnas.90.11.5302; OZOLS J, 1985, J BIOL CHEM, V260, P5427; OZOLS J, 1977, P NATL ACAD SCI USA, V74, P3725, DOI 10.1073/pnas.74.9.3725; OZOLS J, 1994, BIOCHEMISTRY-US, V33, P3751, DOI 10.1021/bi00178a035; OZOLS J, 1989, J BIOL CHEM, V264, P12533; OZOLS J, 1985, J BIOL CHEM, V260, P1953; OZOLS J, 1984, J BIOL CHEM, V259, P3349; Parks GD, 1996, J BIOL CHEM, V271, P7187, DOI 10.1074/jbc.271.12.7187; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; STRITTMATTER P, 1992, J BIOL CHEM, V267, P2519; THIEDE MA, 1986, J BIOL CHEM, V261, P3230; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459	45	33	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14122	14129		10.1074/jbc.274.20.14122	http://dx.doi.org/10.1074/jbc.274.20.14122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318829	hybrid			2022-12-27	WOS:000080322200058
J	Santamaria, I; Velasco, G; Pendas, AM; Paz, A; Lopez-Otin, C				Santamaria, I; Velasco, G; Pendas, AM; Paz, A; Lopez-Otin, C			Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCES; HUMAN BLEOMYCIN HYDROLASE; CHROMOSOMAL LOCALIZATION; PROCATHEPSIN-L; GENE CHARACTERIZATION; EXPRESSION ANALYSIS; TISSUE DISTRIBUTION; GENOMIC STRUCTURE; PROTEASES; BREAST	A cDNA encoding a new cysteine proteinase belonging to the papain family and called cathepsin F has been cloned from a human prostate cDNA library. This cDNA encodes a polypeptide of 484 amino acids, with the same domain organization as other cysteine proteinases, in; eluding a hydrophobic signal sequence, a prodomain, and a catalytic region. However, this propeptide domain is unusually long and distinguishes cathepsin F from other proteinases of the papain family. Cathepsin F also shows all structural motifs characteristic of these proteinases, including the essential cysteine residue of the active site. Consistent with these structural features, cathepsin F produced in Escherichia coli as a fusion protein with glutathione S-transferase degrades the synthetic peptide benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin, a substrate commonly used for functional characterization of cysteine proteinases, Furthermore, this proteolytic activity is blocked by transepoxysuccinyl-L-leucylamido-(4-guanidino an inhibitor of cysteine proteinases. The gene encoding cathepsin F maps to chromosome 11q13, close to that encoding cathepsin W, Cathepsin F is widely expressed in human tissues, suggesting a role in normal protein catabolism. Northern blot analysis also revealed a significant level of expression in some cancer cell lines opening the possibility that this enzyme could be involved in degradative processes occurring during tumor progression.	Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.		Pendas, Alberto M/L-1017-2014; Velasco, Gloria/AAS-5842-2021; Santamaria, Inigo/H-6727-2015; López-Otín, Carlos/AAB-2106-2020	Velasco, Gloria/0000-0001-8032-5056; Santamaria, Inigo/0000-0001-8718-5359; López-Otín, Carlos/0000-0001-6964-1904; Paz-Aparicio, Ana/0000-0001-5112-7333; Pendas, Alberto M/0000-0001-9264-3721				BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; CHAUHAN SS, 1993, J BIOL CHEM, V268, P1039; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Chuaqui RF, 1997, AM J PATHOL, V150, P297; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; CUOZZO JW, 1995, J BIOL CHEM, V270, P15611, DOI 10.1074/jbc.270.26.15611; DELAISSE JM, 1991, BIOCHEM J, V279, P167, DOI 10.1042/bj2790167; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Ferrando AA, 1997, J BIOL CHEM, V272, P33298, DOI 10.1074/jbc.272.52.33298; Ferrando AA, 1996, CANCER RES, V56, P1746; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; FUCHS R, 1988, BIOL CHEM H-S, V369, P469, DOI 10.1515/bchm3.1988.369.1.469; GAL S, 1988, BIOCHEM J, V253, P303, DOI 10.1042/bj2530303; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GONG QM, 1993, DNA CELL BIOL, V12, P299, DOI 10.1089/dna.1993.12.299; HESITERKAMP N, 1982, NATURE, V299, P747; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; JOSEPH LJ, 1988, J CLIN INVEST, V81, P1621, DOI 10.1172/JCI113497; KAMPHUIS IG, 1985, J MOL BIOL, V182, P317, DOI 10.1016/0022-2836(85)90348-1; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KRIEGER TJ, 1991, J BIOL CHEM, V266, P8376; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Linnevers C, 1997, FEBS LETT, V405, P253, DOI 10.1016/S0014-5793(97)00118-X; Maniatis T., 1982, MOL CLONING LAB MANU; MASON RW, 1986, BIOCHEM J, V233, P925, DOI 10.1042/bj2330925; MASON RW, 1985, BIOCHEM J, V226, P233, DOI 10.1042/bj2260233; Mathur PP, 1997, BIOCHEM MOL BIOL INT, V42, P217; MCINTYRE GF, 1994, J BIOL CHEM, V269, P567; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; Newsham IF, 1998, AM J PATHOL, V153, P5, DOI 10.1016/S0002-9440(10)65538-1; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PARIS A, 1995, FEBS LETT, V369, P326, DOI 10.1016/0014-5793(95)00777-7; PENDAS AM, 1994, CYTOGENET CELL GENET, V66, P263, DOI 10.1159/000133708; PETANCESKA S, 1992, J BIOL CHEM, V267, P26038; Rao NV, 1997, J BIOL CHEM, V272, P10260; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; RITONJA A, 1988, FEBS LETT, V228, P341, DOI 10.1016/0014-5793(88)80028-0; Rood JA, 1997, GENOMICS, V41, P169, DOI 10.1006/geno.1997.4614; Santamaria I, 1998, CANCER RES, V58, P1624; Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816; Santamaria I, 1998, GENOMICS, V53, P231, DOI 10.1006/geno.1997.5180; SHI GP, 1992, J BIOL CHEM, V267, P7258; SHI GP, 1994, J BIOL CHEM, V269, P11530; Sloane B F, 1990, Semin Cancer Biol, V1, P137; TAKEDA A, 1992, BIOCHEM J, V288, P643, DOI 10.1042/bj2880643; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; TEZUKA K, 1994, J BIOL CHEM, V269, P1106; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; VELASCO G, 1994, J BIOL CHEM, V269, P27136; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000; WANG X, 1987, CYTOGENET CELL GENET, V46, P710; Wex T, 1998, BIOCHEM BIOPH RES CO, V248, P255, DOI 10.1006/bbrc.1998.8954; WIEDERANDERS B, 1992, J BIOL CHEM, V267, P13708	65	72	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13800	13809		10.1074/jbc.274.20.13800	http://dx.doi.org/10.1074/jbc.274.20.13800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318784	hybrid			2022-12-27	WOS:000080322200013
J	Vilk, G; Saulnier, RB; St Pierre, R; Litchfield, DW				Vilk, G; Saulnier, RB; St Pierre, R; Litchfield, DW			Inducible expression of protein kinase CK2 in mammalian cells - Evidence for functional specialization of CK2 isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; SACCHAROMYCES-CEREVISIAE; CASEIN KINASE-2; DNA-BINDING; II-ALPHA; CELLULAR-REGULATION; CYCLE PROGRESSION; BETA-SUBUNIT; GENE CSNK2A1; PHOSPHORYLATION	Protein kinase CK2 (formerly casein kinase II) exhibits elevated expression in a variety of cancers, induces lymphocyte transformation in transgenic mice, and collaborates with Ha-Ras in fibroblast transformation. To systematically examine the cellular functions of CK2, human osteosarcoma U2-OS cells constitutively expressing a tetracycline-regulated transactivator were stably transfected with a bidirectional plasmid encoding either catalytic isoform. of CK2 (i.e, CK2 alpha or CK2 alpha') together with the regulatory CK2 beta subunit in order to increase the cellular levels of either CK2 isoform. To interfere with either CK2 isoform, cells were also transfected with kinase-inactive CK2 alpha or CK2 alpha' (i.e. GK2 alpha (K68M) or CK2 alpha' (K69M)) together with CK2 beta. In these cells, removal of tetracycline from the growth medium stimulated coordinate expression of catalytic and regulatory CK2 subunits. Increased expression of active forms of CK2 alpha or CK2 alpha' resulted in modest decreases in cell proliferation, suggesting that optimal levels of CK2 are required for optimal proliferation. By comparison, the effects of induced expression of kinase-inactive CK2 alpha differed significantly from the effects of induced expression of kinase-inactive CK2 alpha'. Of particular interest is the dramatic attenuation of proliferation that is observed following induction of CK2 alpha'(K69M), but not following induction of CK2 alpha(K68M). These results provide evidence for functional specialization of CK2 isoforms in mammalian cells. Moreover, cell lines exhibiting regulatable expression of CK2 will facilitate efforts to systematically elucidate its cellular functions.	Univ Western Ontario, Hlth Sci Ctr, Dept Biochem, London, ON N6A 5C1, Canada	London Health Sciences Centre; University of Manitoba; Children's Hospital Research Institute of Manitoba; Western University (University of Western Ontario)	Litchfield, DW (corresponding author), Univ Western Ontario, Hlth Sci Ctr, Dept Biochem, London, ON N6A 5C1, Canada.	litchfi@julian.uwo.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620				ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Cosmelli D, 1997, FEBS LETT, V410, P391, DOI 10.1016/S0014-5793(97)00625-X; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FRIEDRICH TD, 1989, BIOCHIM BIOPHYS ACTA, V992, P41, DOI 10.1016/0304-4165(89)90048-2; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; KIKKAWA U, 1992, MOL CELL BIOL, V12, P5711, DOI 10.1128/MCB.12.12.5711; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LITCHFIELD DW, 1994, CELL MOL BIOL RES, V40, P373; LITCHFIELD DW, 1993, MOL CELL BIOCHEM, V128, P187, DOI 10.1007/BF01076770; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LORENZ P, 1993, J BIOL CHEM, V268, P2733; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MARIDOR G, 1991, J BIOL CHEM, V266, P2362; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MILNE DM, 1992, NUCLEIC ACIDS RES, V20, P5565, DOI 10.1093/nar/20.21.5565; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; OELGESCHLAGER M, 1995, MOL CELL BIOL, V15, P5966; OLEMOIYOI OK, 1993, EMBO J, V12, P1621, DOI 10.1002/j.1460-2075.1993.tb05807.x; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Penner CG, 1997, J CELL BIOCHEM, V64, P525; PEPPERKOK R, 1991, EXP CELL RES, V197, P245, DOI 10.1016/0014-4827(91)90429-X; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Resnitzky D, 1997, MOL CELL BIOL, V17, P5640, DOI 10.1128/MCB.17.9.5640; Rethinaswamy A, 1998, J BIOL CHEM, V273, P5869, DOI 10.1074/jbc.273.10.5869; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEITZ G, 1989, BIOCHEM BIOPH RES CO, V163, P635, DOI 10.1016/0006-291X(89)92184-0; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WIRKNER U, 1994, GENOMICS, V19, P257, DOI 10.1006/geno.1994.1056; YANGFENG TL, 1994, GENOMICS, V19, P173, DOI 10.1006/geno.1994.1032; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; YU IJ, 1991, J CELL BIOL, V114, P1217, DOI 10.1083/jcb.114.6.1217	60	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14406	14414		10.1074/jbc.274.20.14406	http://dx.doi.org/10.1074/jbc.274.20.14406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318865	hybrid			2022-12-27	WOS:000080322200094
J	Zhao, LY; Helms, JB; Brunner, J; Wieland, FT				Zhao, LY; Helms, JB; Brunner, J; Wieland, FT			GTP-dependent binding of ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine retrieval motifs and p23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI MEMBRANES; GUANINE-NUCLEOTIDE; TRANSPORT VESICLES; EXCHANGE FACTOR; BREFELDIN-A; SECRETORY PATHWAY; COATED VESICLES; PROTEIN COMPLEX; PHOSPHOLIPASE-D; ARF PROTEIN	A site-directed photocross-linking approach was employed to determine components that act downstream of ADP-ribosylation factor (ARF). To this end, a photolabile phenylalanine analog was incorporated at various positions of the putative effector region of the ARF molecule. Depending on the position of incorporation, we find specific and GTP-dependent interactions of ARF with two subunits of the coatomer complex, beta-COP and gamma-COP, as well as an interaction with a cytosolic protein (similar to 185 kDa). In addition, we observe homodimer formation of ARF molecules at the Golgi membrane. These data suggest that the binding site of ARF to coatomer is at the interface of its beta- and gamma-subunits, and this is in close proximity to the second site of interaction of coatomer with the Golgi membrane, the binding site within gamma-COP for cytosolic dibasic/diphenylalanine motifs.	Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; Swiss Fed Inst Technol, Biochem Lab, CH-8092 Zurich, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helms, JB (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	helms@urz.uni-heidelberg.de						AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Bauerfeind R, 1993, CURR OPIN CELL BIOL, V5, P628, DOI 10.1016/0955-0674(93)90132-A; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; BECKERS CJM, 1992, METHOD ENZYMOL, V219, P5; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BRUNNER J, 1993, CHEM SOC REV, V22, P183, DOI 10.1039/cs9932200183; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Duden R, 1991, Trends Cell Biol, V1, P14, DOI 10.1016/0962-8924(91)90064-G; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; HARTER C, 1993, FEBS LETT, V332, P71, DOI 10.1016/0014-5793(93)80487-F; Harter C, 1996, BBA-REV BIOMEMBRANES, V1286, P75, DOI 10.1016/0304-4157(96)00003-2; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; Roos J, 1997, TRENDS CELL BIOL, V7, P257, DOI 10.1016/S0962-8924(97)01068-4; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Traub LM, 1997, TRENDS CELL BIOL, V7, P43, DOI 10.1016/S0962-8924(96)20042-X; TSAI SC, 1992, P NATL ACAD SCI USA, V89, P9272, DOI 10.1073/pnas.89.19.9272; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEISS O, 1989, J BIOL CHEM, V264, P21066; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	52	69	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14198	14203		10.1074/jbc.274.20.14198	http://dx.doi.org/10.1074/jbc.274.20.14198			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318838	hybrid			2022-12-27	WOS:000080322200067
J	Cox, GA; Johnson, RB; Cook, JA; Wakulchik, M; Johnson, MG; Villarreal, EC; Wang, QM				Cox, GA; Johnson, RB; Cook, JA; Wakulchik, M; Johnson, MG; Villarreal, EC; Wang, QM			Identification and characterization of human rhinovirus-14 3C protease deamidation isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; VIRUS-REPLICATION; RNA-BINDING; POLIOVIRUS; INHIBITION; TRANSCRIPTION; POLYPROTEIN; CLEAVAGE; PROTEINS; 3C(PRO)	A purified recombinant human rhinovirus-14 3C protease preparation contained only similar to 50% active enzyme as titrated using specifically designed irreversible 3C protease inhibitors. Analysis of the purified 3C protein by isoelectric focusing showed differently charged 3C isoforms that had isoelectric points (pI) of 8.3 (55%) and 9.0 (45%), with the latter one being consistent with the predicted pi of the human rhinovirus-14 3C protein. Further analysis indicated that the pi 8.3 protein was the deamidated form of 3C, and it displayed similar to 10-fold reduced cleavage activity relative to the original 3C protease sample. Peptide mapping followed by sequence analysis revealed that a single asparagine, Asn-164, was deamidated to aspartic acid in the pi 8.3 isoform, Converting Asn-164 to Asp by site-directed mutagenesis resulted in a mutated 3C protease with extremely low activity, as seen with the pi 8.3 isoform, indicating a role of Asn-164 in substrate recognition and binding, In addition, the deamidated 3C protease was found to be present in vivo, and its abundance was related to the viral replication cycle, Moreover, mutant virus carrying Asp-164 showed reduced viability in infected cells. Taken together, our data suggest that 3C protein deamidation plays a role in the regulation of its enzymatic activity.	Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Villarreal, EC (corresponding author), Eli Lilly & Co, Lilly Res Labs, Drop Code 0438, Indianapolis, IN 46285 USA.							BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; BECKER GW, 1988, BIOTECHNOL APPL BIOC, V10, P326; BIRCH GM, 1995, PROTEIN EXPRES PURIF, V6, P609, DOI 10.1006/prep.1995.1080; CLARK ME, 1991, EMBO J, V10, P2941, DOI 10.1002/j.1460-2075.1991.tb07844.x; CORDINGLEY MG, 1989, J VIROL, V63, P5037, DOI 10.1128/JVI.63.12.5037-5045.1989; Couch RB, 1996, VIROLOGY, P713; DIDONATO A, 1993, J BIOL CHEM, V268, P4745; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; HEINZ BA, 1995, J VIROL, V69, P4189, DOI 10.1128/JVI.69.7.4189-4197.1995; Higuchi R., 1989, PCR TECHNOLOGY, P61; JOHNSON WC, 1985, METHOD BIOCHEM ANAL, V31, P61, DOI 10.1002/9780470110522.ch2; Kong JS, 1998, J MED CHEM, V41, P2579, DOI 10.1021/jm980114+; LEONG LEC, 1993, J BIOL CHEM, V268, P25735; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; ORR DC, 1989, J GEN VIROL, V70, P2931, DOI 10.1099/0022-1317-70-11-2931; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SELVESEN G, 1993, PROTEOLYTIC ENZYMES, P83; Wang QM, 1998, EXPERT OPIN THER PAT, V8, P1151, DOI 10.1517/13543776.8.9.1151; Wang QM, 1997, ANAL BIOCHEM, V252, P238, DOI 10.1006/abio.1997.2315; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997	24	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13211	13216		10.1074/jbc.274.19.13211	http://dx.doi.org/10.1074/jbc.274.19.13211			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224078	hybrid			2022-12-27	WOS:000080200400040
J	Gibson, MA; Leavesley, DI; Ashman, LK				Gibson, MA; Leavesley, DI; Ashman, LK			Microfibril-associated glycoprotein-2 specifically interacts with a range of bovine and human cell types via alpha(v)beta(3) integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTIN-ASSOCIATED MICROFIBRILS; FIBRILLIN-CONTAINING MICROFIBRILS; MOLECULAR-CLONING; EXTRACELLULAR MICROFIBRILS; DEVELOPMENTAL EXPRESSION; VITRONECTIN RECEPTOR; PROTEIN-COMPONENTS; FIBER MICROFIBRILS; B-CELL; ADHESION	Microfibril-associated glycoprotein (MAGP)-1 and MAGP-2 are small structurally related glycoproteins that are specifically associated with fibrillin-containing microfibrils, MAGP-2, unlike MAGP-1, contains an RGD motif with potential for integrin binding. To determine if the RGD sequence is active, a series of cell binding assays was performed. MAGP-2 was shown to promote the attachment and spreading of bovine nuchal ligament fibroblasts when coated onto plastic wells in molar quantities similar to those of fibronectin, In contrast, similar to 10-fold more MAGP-1 was required to support comparable levels of cell adhesion. The fibroblast binding to MAGP-2 was completely inhibited if the peptide GRGDSP or the MAGP-2-specific peptide GVSGQRGDDVTTVTSET was added to the reaction medium at a 10 mu M final concentration. The control peptide GRGESP had no effect on the interaction. These findings indicate that the cell interaction with MAGP-2 is an RGD-mediated event. A monoclonal antibody to human alpha(V)beta(3) integrin (LM609) almost completely blocked cell attachment to MAGP-2 when added to the medium at 0.5 mu g/ml, whereas two monoclonal antibodies specific for the human beta(1) integrin subunit, 4B4 (blocking) and QE2.E5 (activating), had no effect even at 10 mu g/ml. Fetal bovine aortic smooth muscle cells, ear cartilage chondrocytes, and arterial endothelial cells and human skin fibroblasts and osteoblasts were also observed to adhere strongly to MAGP-2. In addition, each cell type was able to spread on MAGP-2 substrate, with the exception of the endothelial cells, which remained spherical after 2 h of incubation. The binding of each cell type was blocked when the anti-alpha(V)beta(3) integrin antibody was included in the assay, indicating that alpha(V)beta(3) integrin is the major receptor for MAGP-2 on several cell types. Thus, MAGP-2 may mediate interactions between fibrillin-containing microfibrils and cell surfaces during the development of a variety of tissues.	Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia; Royal Adelaide Hosp, Renal Unit, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia	University of Adelaide; Royal Adelaide Hospital; Institute Medical & Veterinary Science Australia	Gibson, MA (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA 5005, Australia.		ASHMAN, LEONIE/G-7631-2013; Leavesley, David/C-9532-2009	ASHMAN, LEONIE/0000-0003-3559-3611; Leavesley, David/0000-0002-1033-5459				ABRAMS WR, 1995, GENOMICS, V26, P47, DOI 10.1016/0888-7543(95)80081-V; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; BRIZZI MF, 1990, BRIT J HAEMATOL, V76, P203, DOI 10.1111/j.1365-2141.1990.tb07872.x; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Cleary E. G., 1996, EXTRACELLULAR MATRIX, V2, P95; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; D'Arrigo C, 1998, CONNECT TISSUE RES, V37, P29, DOI 10.3109/03008209809028898; DAVIS LS, 1990, J IMMUNOL, V145, P785; DIETZ HC, 1994, ADV HUM GENET, V22, P153; Faull RJ, 1996, J BIOL CHEM, V271, P25099, DOI 10.1074/jbc.271.41.25099; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; GIBSON MA, 1991, J BIOL CHEM, V266, P7596; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Gibson MA, 1998, EUR J BIOCHEM, V256, P221, DOI 10.1046/j.1432-1327.1998.2560221.x; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JOSHI P, 1993, J CELL SCI, V106, P389; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; KIELTY CM, 1995, INT J BIOCHEM CELL B, V27, P747, DOI 10.1016/1357-2725(95)00028-N; KUMARATILAKE JS, 1989, EUR J CELL BIOL, V50, P117; LaFlamme SE, 1997, MATRIX BIOL, V16, P153, DOI 10.1016/S0945-053X(97)90003-2; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; MARIENCHECK MC, 1995, CONNECT TISSUE RES, V31, P87, DOI 10.3109/03008209509028396; MECHAM RP, 1988, BIOCHEM BIOPH RES CO, V151, P822, DOI 10.1016/S0006-291X(88)80355-3; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; MINOWADA J, 1977, CANCER RES, V37, P3096; MIYOSHI I, 1977, NATURE, V267, P843, DOI 10.1038/267843a0; MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; RUBIN K, 1996, EXTRACELLULAR MATRIX, V2, P262; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; WALL RT, 1978, J CELL PHYSIOL, V96, P203, DOI 10.1002/jcp.1040960209; YEH H, 1994, GENOMICS, V23, P443, DOI 10.1006/geno.1994.1521; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855; ZHAO Z, 1995, HUM MOL GENET, V4, P58	56	57	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13060	13065		10.1074/jbc.274.19.13060	http://dx.doi.org/10.1074/jbc.274.19.13060			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224057	hybrid			2022-12-27	WOS:000080200400019
J	Kennedy, HJ; Pouli, AE; Ainscow, EK; Jouaville, LS; Rizzuto, R; Rutter, GA				Kennedy, HJ; Pouli, AE; Ainscow, EK; Jouaville, LS; Rizzuto, R; Rutter, GA			Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells - Potential role for strategically located mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETING CELLS; GLYCEROL-PHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; MOUSE PANCREATIC-ISLETS; RAT-HEART MITOCHONDRIA; SENSITIVE K+ CHANNELS; FIREFLY LUCIFERASE; ADENINE-NUCLEOTIDES; INTACT-CELLS; LACTATE-DEHYDROGENASE	Increases in the concentration of free ATP within the islet beta-cell may couple elevations in blood glucose to insulin release by closing ATP sensitive K+ (K-ATP) channels and activating Ca2+ influx. Here, we use recombinant targeted luciferases and photon counting imaging to monitor changes in free [ATP] in subdomains of single living MING and primary beta-cells. Resting [ATP] in the cytosol ([ATP](c)), in the mitochondrial matrix ([ATP](m)), and beneath the plasma membrane ([ATP](pm)) were similar (similar to 1 mM). Elevations in extracellular glucose concentration (3-30 mM) increased free [ATP] in each domain with distinct kinetics. Thus, sustained increases in [ATP](m) and [ATP](pm) were observed, but only a transient increase in [ATP](c). However, detectable increases in [ATP](c) and [ATP](pm), but not [ATP](m), required extracellular Ca2+. Enhancement of glucose-induced Ca2+ influx with high [K+] had little effect on the apparent [ATP](c) and [ATP](m) increases but augmented the [ATP](pm) increase. Underlying these changes, glucose increased the mitochondrial proton motive force, an effect mimicked by high [K+]. These data support a model in which glucose increases [ATP](m) both through enhanced substrate supply and by progressive Ca2+ dependent activation of mitochondrial enzymes. This may then lead to a privileged elevation of [ATP](pm), which may be essential for the sustained closure of K-ATP channels. Luciferase imaging would appear to be a useful new tool for dynamic in vivo imaging of free ATP concentration.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Padua, Dept Biomed Sci, I-35121 Padua 17, Italy; Univ Padua, CNR, Ctr Study Biol Membranes, I-35121 Padua 17, Italy	University of Bristol; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Rutter, GA (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.		Rizzuto, Rosario/B-6312-2008	Rizzuto, Rosario/0000-0001-7044-5097; Rutter, Guy/0000-0001-6360-0343	Telethon [850] Funding Source: Medline	Telethon(Fondazione Telethon)		ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BOWERS KC, 1992, J MOL CELL CARDIOL, V24, P213, DOI 10.1016/0022-2828(92)93159-H; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Civelek VN, 1996, BIOCHEM J, V315, P1015, DOI 10.1042/bj3151015; Cobbold PH, 1991, CELLULAR CALCIUM PRA, P55; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; CRAIG FF, 1991, BIOCHEM J, V276, P637, DOI 10.1042/bj2760637; DELUCA M, 1979, ANAL BIOCHEM, V95, P194, DOI 10.1016/0003-2697(79)90204-5; DENTON RM, 1980, FEBS LETT, V119, P1, DOI 10.1016/0014-5793(80)80986-0; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; FORD SR, 1995, BBA-PROTEIN STRUCT M, V1252, P180, DOI 10.1016/0167-4838(95)00150-S; Gribble FM, 1998, DIABETOLOGIA, V41, pA13; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HALESTRAP AP, 1982, BIOCHEM J, V204, P37, DOI 10.1042/bj2040037; HESS DT, 1992, J NEUROSCI, V12, P4634; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Kennedy HJ, 1997, J BIOL CHEM, V272, P20636, DOI 10.1074/jbc.272.33.20636; KENNEDY HJ, 1997, DIABETIC MED, V14, pS8; KLINGENBERG M, 1979, TRENDS BIOCHEM SCI, V4, P249, DOI 10.1016/0968-0004(79)90215-9; KOOP A, 1993, BIOCHEM J, V295, P165, DOI 10.1042/bj2950165; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; LEMASTERS JJ, 1977, BIOCHEMISTRY-US, V16, P445, DOI 10.1021/bi00622a016; LIANG Y, 1991, DIABETES, V40, P327, DOI 10.2337/diabetes.40.3.327; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MEGLASSON MD, 1989, METABOLISM, V38, P1188, DOI 10.1016/0026-0495(89)90158-3; MEGLASSON MD, 1989, AM J PHYSIOL, V256, pE173, DOI 10.1152/ajpendo.1989.256.1.E173; Nakazaki M, 1998, DIABETOLOGIA, V41, P279, DOI 10.1007/s001250050904; Nicholls D.G., 1982, BIOENERGETICS INTRO; OHTA M, 1993, J PHARMACOL EXP THER, V264, P35; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; PANTEN U, 1982, ENDOCRINOLOGY, V111, P1595, DOI 10.1210/endo-111-5-1595; Panten U., 1988, ENERGETICS SECRETION, P109; Pfanner N, 1997, CURR BIOL, V7, pR100, DOI 10.1016/S0960-9822(06)00048-0; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Pouli AE, 1998, BIOCHEM J, V330, P1399; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Prentki M, 1997, DIABETOLOGIA, V40, pS32, DOI 10.1007/s001250051395; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robb-Gaspers LD, 1998, BBA-BIOENERGETICS, V1366, P17, DOI 10.1016/S0005-2728(98)00118-2; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; RUTTER GA, 1988, BIOCHEM J, V252, P181, DOI 10.1042/bj2520181; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; RUTTER GA, 1990, INT J BIOCHEM, V22, P1081, DOI 10.1016/0020-711X(90)90105-C; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; RUTTER GA, 1994, CELL CALCIUM, V16, P71, DOI 10.1016/0143-4160(94)90002-7; RUTTER GA, 1990, BIOCHEM J, V271, P627, DOI 10.1042/bj2710627; RUTTER GA, 1999, IMAGING LIVING CELLS, P286; SCHOLZ TD, 1995, AM J PHYSIOL-HEART C, V268, pH82, DOI 10.1152/ajpheart.1995.268.1.H82; SEKINE N, 1994, J BIOL CHEM, V269, P4895; SENER A, 1992, J BIOL CHEM, V267, P13251; Sherf BA, 1994, PROMEGA NOTES, V49, P14; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Szewczyk A, 1998, BBA-BIOENERGETICS, V1365, P333, DOI 10.1016/S0005-2728(98)00094-2; Tagaya M, 1996, FEBS LETT, V394, P83, DOI 10.1016/0014-5793(96)00932-5; Wang X, 1996, AM J PHYSIOL-HEART C, V270, pH476, DOI 10.1152/ajpheart.1996.270.2.H476; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEISS J, 1985, J CLIN INVEST, V75, P436, DOI 10.1172/JCI111718; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; WOODWARD RH, 1972, STAT METHODS RES PRO, P178; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	84	265	269	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13281	13291		10.1074/jbc.274.19.13281	http://dx.doi.org/10.1074/jbc.274.19.13281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224088	hybrid			2022-12-27	WOS:000080200400050
J	Qiu, DM; Zhao, GH; Aoki, Y; Shi, LF; Uyei, A; Nazarian, S; Ng, JCH; Kao, PN				Qiu, DM; Zhao, GH; Aoki, Y; Shi, LF; Uyei, A; Nazarian, S; Ng, JCH; Kao, PN			Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappa B transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE HERBAL REMEDY; TUMOR-NECROSIS-FACTOR; WILFORDII HOOK-F; TRIPTERYGIUM-WILFORDII; GENE-EXPRESSION; NUCLEAR FACTOR; IMMUNE-SYSTEM; P65 SUBUNIT; DNA-BINDING; LYMPHOCYTE	PG490 (triptolide) is a diterpene triepoxide with potent immunosuppressive and antiinflammatory properties. PG490 inhibits interleukin(IL)-2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12-myristate 13-acetate (PMA) and antibody to CD3 (IC50 of 10 ng/ml), and with PMA and ionomycin (Iono, IC50 of 40 ng/ml). In Jurkat T-cells, PG490 inhibits PMA/Iono-stimulated IL-2 transcription. PG490 inhibits the induction of DNA binding activity at the purine-box/antigen receptor response element (ARRE)/nuclear factor of activated T-cells (NF-AT) target sequence but not at the NF-kappa B site. PG490 can completely inhibit transcriptional activation at the purine-box/ARRE/NF-AT and NF-kappa B target DNA sequences triggered by all stimuli examined (PMA, PMA/Iono, tumor necrosis factor-alpha). PG490 also inhibits PMA-stimulated activation of a chimeric transcription factor in which the C-terminal TA1 transactivation domain of NF-kappa B p65 is fused to the DNA binding domain of GAL4. In 16HBE human bronchial epithelial cells, IL-8 expression is regulated predominantly by NF-kappa B, and PG490 but not cyclosporin A can completely inhibit expression of IL-8. The mechanism of PG490 inhibition of cytokine gene expression differs from cyclosporin A and involves nuclear inhibition of transcriptional activation of NF-kappa B and the purine-box regulator operating at the ARRE/NF-AT site at a step after specific DNA binding.	Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Kao, PN (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.				NIAID NIH HHS [R01-AI39624] Funding Source: Medline; PHS HHS [K04-01147] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039624] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki Y, 1998, AM J PHYSIOL-LUNG C, V275, pL1164, DOI 10.1152/ajplung.1998.275.6.L1164; Aoki Y, 1997, BIOCHEM BIOPH RES CO, V234, P424, DOI 10.1006/bbrc.1997.6658; AOKI Y, 1997, AM J PHYSIOL, V272, pL272; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kincaid RL, 1995, J ALLERGY CLIN IMMUN, V96, P1170, DOI 10.1016/S0091-6749(95)70202-4; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; KUPCHAN SM, 1974, SCIENCE, V185, P791, DOI 10.1126/science.185.4153.791; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; LOS M, 1995, EMBO J, V14, P3731, DOI 10.1002/j.1460-2075.1995.tb00043.x; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; SCHMITZ ML, 1995, IMMUNOBIOLOGY, V193, P116, DOI 10.1016/S0171-2985(11)80534-6; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; TAO XL, 1989, CHINESE MED J-PEKING, V102, P327; TAO XL, 1995, J PHARMACOL EXP THER, V272, P1305; Tao XL, 1996, J PHARMACOL EXP THER, V276, P316; TAO XL, 1991, ARTHRITIS RHEUM, V34, P1274, DOI 10.1002/art.1780341011; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; WEI YS, 1991, ACTA PHARM SINIC, V12, P406; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2; YANG SX, 1994, INT J IMMUNOPHARMACO, V16, P895, DOI 10.1016/0192-0561(94)90044-2; Yang YL, 1998, IMMUNOPHARMACOLOGY, V40, P139, DOI 10.1016/S0162-3109(98)00036-8; ZHENG JR, 1987, CHUNG KUO I HSUEH KO, V9, P317; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	46	247	277	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13443	13450		10.1074/jbc.274.19.13443	http://dx.doi.org/10.1074/jbc.274.19.13443			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224109	hybrid			2022-12-27	WOS:000080200400071
J	Ramos-DeSimone, N; Hahn-Dantona, E; Sipley, J; Nagase, H; French, DL; Quigley, JP				Ramos-DeSimone, N; Hahn-Dantona, E; Sipley, J; Nagase, H; French, DL; Quigley, JP			Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE; TISSUE INHIBITOR; INTERSTITIAL COLLAGENASE; EXTRACELLULAR-MATRIX; PROGELATINASE-B; GELATINASE-B; 4-AMINOPHENYLMERCURIC ACETATE; 92-KDA GELATINASE; TERMINAL DOMAIN; PLASMIN SYSTEM	Matrix metalloproteinase-g (MMP-9) may play a critical catalytic role in tissue remodeling in vivo, but it is secreted by cells as a stable, inactive zymogen, pro MMP-9, and requires activation for catalytic function. A number of proteolytic enzymes activate pro-MIMP-9 in vitro, but the natural activator(s) of MMP-9 is unknown. To examine MMP-9 activation in a cellular setting we employed cultures of human tumor cells (MDA-MB-231 breast carcinoma cells) that were induced to produce MMP-9 over a 200-fold concentration range (0.03-8.1 nM). The levels of tissue inhibitors of metalloproteinase (TIMPs) in the induced cultures remain relatively constant at 1-4 nM. Quantitation of the zymogen/active enzyme status of MMP-9 in the MDA-MB-231 cultures indicates that even in the presence of potential activators, the molar ratio of endogenous MMP-9 to TIMP dictates whether pro-MMP-9 activation can progress. When the MMP-9/TIMP ratio exceeds 1.0, MMP-9 activation progresses, but through an interacting protease cascade involving plasmin and stromelysin 1 (MMP-3). Plasmin, generated by the endogenous urokinase-type plasminogen activator, is not an efficient activator of pro-MMP-9, neither the secreted pro-MMP-9 nor the very low levels of pro-MMP-9 associated with intact cells. Although plasmin can proteolytically process pro-MMP-9, this limited action does not yield an enzymatically active MMP-9, nor does it cause the MMP-9 to be more susceptible to activation. Plasmin, however, is very efficient at generating active MMP-3 (stromelysin-l) from exogenously added pro-MMP-3. The activated MMP-3 becomes a potent activator of the 92-kDa pro-MMP-9, yielding an 82-kDa species that is enzymatically active in solution and represents up to 50-75% conversion of the zymogen, The activated MMP-9 enhances the invasive phenotype of the cultured cells as their ability to both degrade extracellular matrix and transverse basement membrane is significantly increased following zymogen activation. That this enhanced tissue remodelling capability is due to the activation of MMP-9 is demonstrated through the use of a specific anti-MMP-9 blocking monoclonal antibody.	SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai; University of Kansas; University of Kansas Medical Center	Quigley, JP (corresponding author), Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [R01CA055852, R01CA076039] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA76039, R01CA55852] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrens D, 1996, ARTHRITIS RHEUM, V39, P1576, DOI 10.1002/art.1780390919; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Aimes RT, 1998, J CELL PHYSIOL, V174, P342, DOI 10.1002/(SICI)1097-4652(199803)174:3<342::AID-JCP8>3.3.CO;2-K; Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Benbow U, 1996, J BIOL CHEM, V271, P10715, DOI 10.1074/jbc.271.18.10715; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BROWN PD, 1990, CANCER RES, V50, P6184; Corcoran ML, 1996, ENZYME PROTEIN, V49, P7, DOI 10.1159/000468613; CRAWFORD HC, 1994, INVAS METAST, V14, P234; DeClerck YA, 1996, ENZYME PROTEIN, V49, P72, DOI 10.1159/000468617; DESRIVIERES S, 1993, J CELL PHYSIOL, V157, P587, DOI 10.1002/jcp.1041570319; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; FRIDMAN R, 1995, CANCER RES, V55, P2548; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; Heppner KJ, 1996, AM J PATHOL, V149, P273; Hewitt R, 1996, ENZYME PROTEIN, V49, P163, DOI 10.1159/000468623; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; HIMELSTEIN BP, 1994, INVAS METAST, V14, P246; Hua J, 1996, CANCER RES, V56, P5279; JONES PA, 1979, P NATL ACAD SCI USA, V76, P353, DOI 10.1073/pnas.76.1.353; JUAREZ J, 1993, INT J CANCER, V55, P10, DOI 10.1002/ijc.2910550104; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Kondapaka SB, 1997, INT J CANCER, V70, P722, DOI 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.3.CO;2-5; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Lijnen HR, 1998, BLOOD, V91, P2045, DOI 10.1182/blood.V91.6.2045.2045_2045_2053; LOWELL S, 1998, BIOCHEM J, V331, P453; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MOLL UM, 1990, CANCER RES, V50, P6162; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; MOOKHTIAR KA, 1986, ANAL BIOCHEM, V158, P322, DOI 10.1016/0003-2697(86)90557-9; NAGASE H, 1994, J BIOL CHEM, V269, P20952; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nguyen M, 1998, J BIOL CHEM, V273, P5400, DOI 10.1074/jbc.273.9.5400; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; OKADA Y, 1995, LAB INVEST, V72, P311; Partridge CA, 1997, AM J PHYSIOL-LUNG C, V272, pL813, DOI 10.1152/ajplung.1997.272.5.L813; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Sipley JD, 1997, P NATL ACAD SCI USA, V94, P2933, DOI 10.1073/pnas.94.7.2933; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Toth M, 1997, CANCER RES, V57, P3159; UNEMORI EN, 1991, J CLIN INVEST, V88, P1656, DOI 10.1172/JCI115480; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WISEN JF, 1996, ENZYME PROTEIN, V49, P174; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	63	477	497	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13066	13076		10.1074/jbc.274.19.13066	http://dx.doi.org/10.1074/jbc.274.19.13066			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224058	hybrid			2022-12-27	WOS:000080200400020
J	Richardson, M; Robishaw, JD				Richardson, M; Robishaw, JD			The alpha(2A)-adrenergic receptor discriminates between G(i) heterotrimers of different beta gamma subunit composition in Sf9 insect cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(1) ADENOSINE RECEPTORS; RECOMBINANT G-PROTEINS; RHODOPSIN; RECONSTITUTION; PURIFICATION; SPECIFICITY; INHIBITION; PHOSPHORYLATION; PRENYLATION; EXPRESSION	In view of the expanding roles of the beta gamma subunits of the G proteins in signaling, the possibility was raised that the rich diversity of beta gamma subunit combinations might contribute to the specificity of signaling at the level of the receptor. To test this possibility, Sf9 cell membranes expressing the recombinant alpha(2A)-adrenergic receptor were used to assess the contribution of the beta gamma subunit composition. Reconstituted coupling between the receptor and heterotrimeric G(i) protein was assayed by high affinity, guanine nucleotide-sensitive binding of the alpha(2)-adrenergic agonist, [H-3]UK-14,304. Supporting this hypothesis, the present study showed clear differences in the abilities of the various beta gamma dimers, including those containing the beta(3) subtype and the newly described gamma(4), gamma(10), and gamma(11) subtypes, to promote interaction of the same alpha(i) subunit with the alpha(2A)-adrenergic receptor.	Penn State Univ, Coll Med, Weis Ctr Res, Henry Hood Res Program, Danville, PA 17822 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Robishaw, JD (corresponding author), Penn State Univ, Coll Med, Weis Ctr Res, Henry Hood Res Program, Danville, PA 17822 USA.				NIGMS NIH HHS [GM39867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039867, R29GM039867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; Figler RA, 1997, BIOCHEMISTRY-US, V36, P16288, DOI 10.1021/bi972000q; Figler RA, 1996, MOL PHARMACOL, V50, P1587; GRABER SG, 1992, J BIOL CHEM, V267, P13123; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JANSSON CC, 1995, EUR J PHARM-MOLEC PH, V290, P75, DOI 10.1016/0922-4106(95)90019-5; KALMAN VK, 1995, J BIOL CHEM, V270, P14835, DOI 10.1074/jbc.270.24.14835; KELLEHER DJ, 1988, MOL PHARMACOL, V34, P452; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; LIMBIRD L, 1988, ALPHA 2 ADRENERGIC R, P22; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; PARKER EM, 1991, J BIOL CHEM, V266, P519; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; Ray K, 1996, TRENDS CARDIOVAS MED, V6, P115, DOI 10.1016/1050-1738(96)00021-7; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; ROBISHAW JD, 1993, ANAL BIOCHEM, V208, P283, DOI 10.1006/abio.1993.1047; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Taylor JM, 1996, J BIOL CHEM, V271, P3336; UEDA N, 1994, J BIOL CHEM, V269, P4388; Wang Q, 1997, J BIOL CHEM, V272, P26040, DOI 10.1074/jbc.272.41.26040; Yasuda H, 1996, J BIOL CHEM, V271, P18588, DOI 10.1074/jbc.271.31.18588	35	69	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13525	13533		10.1074/jbc.274.19.13525	http://dx.doi.org/10.1074/jbc.274.19.13525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224121	hybrid			2022-12-27	WOS:000080200400083
J	Saint-Pol, A; Codogno, P; Moore, SEH				Saint-Pol, A; Codogno, P; Moore, SEH			Cytosol-to-lysosome transport of free polymannose-type oligosaccharides - Kinetic and specificity studies using rat liver lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THY-1-NEGATIVE MUTANT LYMPHOMAS; LIPID-LINKED OLIGOSACCHARIDES; ALPHA-D-MANNOSIDASE; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN-BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; GLYCOPEPTIDE EXPORT; DIPHOSPHO-DOLICHOL; CATABOLIC PATHWAY; SIALIC-ACID	In hepatocellular carcinoma HepG2 cells, free polymannose-type oligosaccharides appearing in the cytosol during the biosynthesis and quality control of glycoproteins are rapidly translocated into lysosomes by an as yet pearly defined process (Saint-Pol, A., Bauvy, C., Codogno, P., and Moore, S. E. H. (1997) J. Cell Biol. 136, 45-59), Here, we demonstrate an ATP-dependent association of [2-H-3]mannose-labeled Man(5)GlcNAc with isolated rat liver lysosomes, This association was only observed in the presence of swainsonine, a mannosidase inhibitor, which was required for the protection of sedimentable, but not nonsedimentable, Man(5)GlcNAc from degradation, indicating that oligosaccharides were transported into lysosomes, Saturable high affinity transport (K-uptake, 22.3 mu M, V-max, 7.1 fmol/min/unit of P hexosaminidase) was dependent upon the hydrolysis of ATP but independent of vacuolar H+/ATPase activity. Transport. was inhibited strongly by NEM and weakly by vanadate but not by sodium azide, and, in addition, the sugar transport inhibitors phloretin, phloridzin, and cytochalasin B were without effect on transport. Oligosaccharide import did not show absolute specificity but was selective toward partially demannosylated and dephosphorylated oligosaccharides, and, furthermore, inhibition studies revealed that the free reducing GlcNAc residue of the oligosaccharide was of critical importance for its interaction with the transporter. These results demonstrate the presence of a novel lysosomal free oligosaccharide transporter that must work in concert with cytosolic hydrolases in order to clear the cytosol of endoplasmic reticulum-generated free oligosaccharides.	Fac Med Xavier Bichat, INSERM U410, Unite Neuroendocrinol & Biol Cellulaire Digest, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moore, SEH (corresponding author), Fac Med Xavier Bichat, INSERM U410, Unite Neuroendocrinol & Biol Cellulaire Digest, 16 Rue Henri Huchard, F-75018 Paris, France.		Moore, Stuart/AAF-3920-2021; Codogno, Patrice/G-1384-2013	Moore, Stuart/0000-0002-1020-2242; Codogno, Patrice/0000-0002-5492-3180				ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ALLEN AK, 1973, BIOCHEM J, V131, P155, DOI 10.1042/bj1310155; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BARRUECO JR, 1991, J BIOL CHEM, V266, P11732; BAUR H, 1977, EUR J BIOCHEM, V74, P397, DOI 10.1111/j.1432-1033.1977.tb11404.x; BEINTEMA JJ, 1994, FEBS LETT, V350, P159, DOI 10.1016/0014-5793(94)00753-5; BELARD M, 1988, BIOCHEM J, V255, P235; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; CACAN R, 1987, EUR J BIOCHEM, V166, P469, DOI 10.1111/j.1432-1033.1987.tb13539.x; Cacan R, 1997, TRENDS GLYCOSCI GLYC, V9, P365, DOI 10.4052/tigg.9.365; CACAN R, 1989, EUR J BIOCHEM, V185, P173, DOI 10.1111/j.1432-1033.1989.tb15099.x; CHAPMAN A, 1979, CELL, V17, P509, DOI 10.1016/0092-8674(79)90259-9; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; Chou HF, 1997, BIOCHEM J, V327, P781, DOI 10.1042/bj3270781; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FOHR KJ, 1989, BIOCHEM J, V262, P83; HAEUW JF, 1991, EUR J BIOCHEM, V202, P1257, DOI 10.1111/j.1432-1033.1991.tb16498.x; JONAS AJ, 1989, J BIOL CHEM, V264, P4953; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Lee RT, 1998, GLYCOCONJUGATE J, V15, P649, DOI 10.1023/A:1006976129458; LEE WS, 1994, J BIOL CHEM, V269, P12032; Lloyd J B, 1996, Subcell Biochem, V27, P361; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1990, J BIOL CHEM, V265, P12380; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982, DOI 10.1093/oxfordjournals.jbchem.a123700; OPHEIM DJ, 1977, J BIOL CHEM, V252, P739; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PIERCE RJ, 1979, BIOCHEM J, V180, P673, DOI 10.1042/bj1800673; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; RIJNBOUTT S, 1992, J BIOL CHEM, V267, P15665; ROMISCH K, 1992, P NATL ACAD SCI USA, V89, P7227, DOI 10.1073/pnas.89.15.7227; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; Smythe E, 1996, Subcell Biochem, V27, P51; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; STRECKER G, 1976, BIOCHIMIE, V58, P579, DOI 10.1016/S0300-9084(76)80227-1; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; SUZUKI T, 1994, GLYCOCONJUGATE J, V11, P469, DOI 10.1007/BF00731283; TIETZE F, 1989, J BIOL CHEM, V264, P15316; TROWBRIDGE IS, 1979, CELL, V17, P503, DOI 10.1016/0092-8674(79)90258-7; Varki A, 1996, P NATL ACAD SCI USA, V93, P4523, DOI 10.1073/pnas.93.10.4523; VILLERS C, 1994, BIOCHEM J, V298, P135, DOI 10.1042/bj2980135; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WOO JT, 1992, J ANTIBIOT, V45, P1108, DOI 10.7164/antibiotics.45.1108; YAMASHITA K, 1980, J BIOL CHEM, V255, P5126	56	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13547	13555		10.1074/jbc.274.19.13547	http://dx.doi.org/10.1074/jbc.274.19.13547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224124	hybrid			2022-12-27	WOS:000080200400086
J	Todd, JL; Tanner, KG; Denu, JM				Todd, JL; Tanner, KG; Denu, JM			Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR - A novel role in down-regulating the ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; MAP KINASE; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; IN-VIVO; REDOX REGULATION; PC12 CELLS; REVERSIBLE INACTIVATION; VACCINIA VIRUS	The mammalian dual-specificity protein-tyrosine phosphatase VHR (for VH1-related) has been identified as a novel regulator of extracellular regulated kinases (ERKs), To identify potential cellular substrates of VHR, covalently immobilized mutant VHR protein was employed as an affinity trap. A tyrosine-phosphorylated protein(s) of similar to 42 kDa was specifically adsorbed by the affinity column and identified as ERK1 and ERK2. Subsequent kinetic analyses and transfection studies demonstrated that VHR specifically dephosphorylates and inactivates ERK1 and ERK2 in vitro and in vivo, Only the native structure of phosphorylated ERK was recognized by VHR and was inactivated with a second-order rate constant of 40,000 M-1 s(-1). VHR was found to dephosphorylate endogenous ERK, but not p38 and JNK, Immunodepletion of endogenous VHR eliminated the dephosphorylation of cellular ERK. Transfection studies in COS-l cells demonstrated that in vivo phosphorylation of epidermal growth factor-stimulated ERK depended on VHR protein levels. Overexpression above endogenous levels of VHR led to accelerated ERK inactivation, but did not alter the normal activation of ERK. Unique among reported mitogen activated protein kinase phosphatases, VHR is constitutively expressed, localized to the nucleus, and tyrosine-specific. This study is the first to report the identification of authentic substrates of dual-specificity phosphatases utilizing affinity absorbents and is the first to identify a nuclear, constitutively expressed, and tyrosine-specific ERK phosphatase. The data strongly suggest that VHR is responsible for the rapid inactivation of ERK following stimulation and for its repression in quiescent cells.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol L224, Portland, OR 97201 USA	Oregon Health & Science University	Denu, JM (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							Abe MK, 1998, AM J RESP CELL MOL, V18, P562, DOI 10.1165/ajrcmb.18.4.2958; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Boglari G, 1998, EUR J CELL BIOL, V75, P54, DOI 10.1016/S0171-9335(98)80046-0; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Branch AD, 1998, TRENDS BIOCHEM SCI, V23, P45, DOI 10.1016/S0968-0004(97)01155-9; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chajry N, 1996, EUR J BIOCHEM, V235, P97, DOI 10.1111/j.1432-1033.1996.00097.x; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; DENU JM, 1995, BIOCHEMISTRY-US, V34, P3396, DOI 10.1021/bi00010a031; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Dorfman K, 1996, ONCOGENE, V13, P925; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Gopalbhai K, 1998, J CELL PHYSIOL, V174, P35, DOI 10.1002/(SICI)1097-4652(199801)174:1<35::AID-JCP5>3.0.CO;2-H; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; Keyse SM, 1998, SEMIN CELL DEV BIOL, V9, P143, DOI 10.1006/scdb.1997.0219; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; Leclerc P, 1997, FREE RADICAL BIO MED, V22, P643, DOI 10.1016/S0891-5849(96)00379-6; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; MAHADEVAN LC, 1991, NATURE, V349, P747, DOI 10.1038/349747c0; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Muller JM, 1997, EUR J BIOCHEM, V244, P45, DOI 10.1111/j.1432-1033.1997.00045.x; Osborn MT, 1996, J BIOL CHEM, V271, P30950, DOI 10.1074/jbc.271.48.30950; Pende M, 1997, J NEUROSCI, V17, P1291; PERALDI P, 1993, EUR J BIOCHEM, V218, P815, DOI 10.1111/j.1432-1033.1993.tb18436.x; PERALDI P, 1993, ENDOCRINOLOGY, V132, P2578, DOI 10.1210/en.132.6.2578; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Rao GN, 1996, ONCOGENE, V13, P713; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Schramek H, 1996, AM J PHYSIOL-RENAL, V271, pF423, DOI 10.1152/ajprenal.1996.271.2.F423; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; SULLIVAN SG, 1994, FREE RADICAL BIO MED, V16, P399, DOI 10.1016/0891-5849(94)90042-6; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; URICH M, 1995, J BIOL CHEM, V270, P29286, DOI 10.1074/jbc.270.49.29286; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Watson RWG, 1996, SURGERY, V120, P150; Wiland AM, 1996, J BIOL CHEM, V271, P33486, DOI 10.1074/jbc.271.52.33486; WNG X, 1998, J BIOL CHEM, V273, P9973; WU J, 1994, FEBS LETT, V353, P9, DOI 10.1016/0014-5793(94)01000-5; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHANG WY, 1995, J CELL PHYSIOL, V162, P348, DOI 10.1002/jcp.1041620307; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	75	142	148	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13271	13280		10.1074/jbc.274.19.13271	http://dx.doi.org/10.1074/jbc.274.19.13271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224087	hybrid			2022-12-27	WOS:000080200400049
J	Vig, E; Green, M; Liu, YW; Donner, DB; Mukaida, N; Goebl, MG; Harrington, MA				Vig, E; Green, M; Liu, YW; Donner, DB; Mukaida, N; Goebl, MG; Harrington, MA			Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappa B activity by mPLK IRAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; ACCESSORY PROTEIN; DEATH DOMAIN; CELL-DEATH; TNF; IL-1; COMPLEX; FAMILY	The innate immune response is an important defense against pathogenic agents. A component of this response is the NF-kappa B-dependent activation of genes encoding inflammatory cytokines such as interleukin-8 (IL-8) and cell adhesion molecules like E-selectin. Members of the serine/threonine innate immune kinase family of proteins have been proposed to mediate the innate immune response. One serine/threonine innate immune kinase family member, the mouse Pelle-like kinase/human interleukin-l receptor-associated kinase (mPLK/IRAK), has been proposed to play an obligate role in promoting IL-l-mediated inflammation. However, it is currently unknown whether mPLK/IRAK catalytic activity is required for IL-l-dependent NF-kappa B activation. The present study demonstrates that mPLK/IRAK catalytic activity is not required for IL-l-mediated activation of an NF-kappa B-dependent signal. Intriguingly, catalytically inactive mPLK/IRAK inhibits type 1 tumor necrosis factor (TNF) receptor-dependent NF-kappa B activation, The pathway through which mPLK/IRAK mediates this TNF response is TRADD- and TRAF2-independent. Our data suggest that in addition to its role in IL-1 signaling, mPLK/IRAK is a component of a novel signal transduction pathway through which TNF R1 activates NF-kappa B-dependent gene expression.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Canc Inst, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Kanazawa Univ, Canc Res Inst, Dept Pharmacol, Kanazawa 920, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Kanazawa University	Harrington, MA (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 1044 W Walnut St, Indianapolis, IN 46202 USA.		Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851	NCI NIH HHS [CA67891, CA73023] Funding Source: Medline; NIAID NIH HHS [AI42798] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA067891, R01CA067891, R01CA073023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042798] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chun KT, 1997, MOL GEN GENET, V256, P365, DOI 10.1007/s004380050580; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; Hedin KE, 1997, J IMMUNOL, V159, P5431; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Kalb A, 1996, J BIOL CHEM, V271, P28097, DOI 10.1074/jbc.271.45.28097; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Natoli G, 1997, J BIOL CHEM, V272, P26079, DOI 10.1074/jbc.272.42.26079; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Trofimova M, 1996, J BIOL CHEM, V271, P17609, DOI 10.1074/jbc.271.30.17609; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Volpe F, 1997, FEBS LETT, V419, P41, DOI 10.1016/S0014-5793(97)01426-9; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; YANG L, 1994, J BIOL CHEM, V269, P32732; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	50	51	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13077	13084		10.1074/jbc.274.19.13077	http://dx.doi.org/10.1074/jbc.274.19.13077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224059	hybrid			2022-12-27	WOS:000080200400021
J	Eliopoulos, AG; Gallagher, NJ; Blake, SMS; Dawson, CW; Young, LS				Eliopoulos, AG; Gallagher, NJ; Blake, SMS; Dawson, CW; Young, LS			Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; C-JUN; TERMINAL KINASE; FACTOR-ALPHA; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; TNF RECEPTOR-1; CELL-DEATH; LYMPHOCYTE TRANSFORMATION	The Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) is a pleiotropic protein the activities of which include effects on gene expression and cell transformation, growth, and death. LMP1 has been shown to induce nuclear factor (NF)-kappa B and c-Jun NH2-terminal kinase/AP-1 activities in target cells, and in this study we demonstrate that LMP1 also engages the p38 mitogen-activated protein kinase cascade, leading to activation of the transcription factor ATF2. Mutational analysis of the LMP1 cytoplasmic COOH terminus revealed that p38 activation occurs from both the tumor necrosis factor receptor-associated factor (TRAF)-interacting, membrane proximal COOH-terminal activating region (CTAR)1 domain (amino acids 186-231) and the extreme tumor necrosis factor receptor-associated death domain (TRADD) binding CTAR2 region (amino acids 351-386), Because LMP1 also engages signaling on the NF-kappa B axis through CTAR1 and CTAR2, we have examined whether these two pathways are overlapping or independent. We have found that inhibition of p58 by the highly specific inhibitor SB203580 did not affect NF-kappa B binding activity. Conversely, although the metabolic inhibitor D609 Mocked NF-kappa B activation, it did not impair the ability of LMP1 to signal on the p38 axis, suggesting that these two LMP1-mediated pathways are primarily independent. Divergence of signals must, however, occur downstream of TRAF2 as a dominant negative TRAF2 mutant that blocks LMP1-induced NF-kappa B activation also inhibited p38 signaling, In addition, we have found that p38 inhibition significantly impaired LMP1-mediated interleukin-g and -8 expression. Thus, p38 may play a significant cooperative role in regulating at least some of the pleiotropic activities of LMP1.	Univ Birmingham, Canc Res Campaign, Inst Canc Studies, Sch Med, Birmingham B15 2TA, W Midlands, England	University of Birmingham	Young, LS (corresponding author), Univ Birmingham, Canc Res Campaign, Inst Canc Studies, Sch Med, Birmingham B15 2TA, W Midlands, England.	L.S.Young@bham.ac.uk	Young, Lawrence S/B-7213-2009; ELIOPOULOS, ARISTIDES/R-9449-2018; ELIOPOULOS, ARISTIDES/ABI-6632-2020	Young, Lawrence S/0000-0003-3919-4298; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761				BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAICHWAL VR, 1988, ONCOGENE, V2, P461; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Craxton A, 1998, J IMMUNOL, V161, P3225; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; DECESARE D, 1995, ONCOGENE, V11, P365; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Eliopoulos AG, 1999, J VIROL, V73, P1023, DOI 10.1128/JVI.73.2.1023-1035.1999; Eliopoulos AG, 1998, CURR BIOL, V8, pR196, DOI 10.1016/S0960-9822(98)70123-X; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; FAHRAEUS R, 1990, NATURE, V345, P447, DOI 10.1038/345447a0; Floettmann JE, 1997, ONCOGENE, V15, P1851, DOI 10.1038/sj.onc.1201359; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HUEN DS, 1995, ONCOGENE, V10, P549; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; KAYE KM, 1995, J VIROL, V69, P675, DOI 10.1128/JVI.69.2.675-683.1995; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; NAKAGOMI H, 1994, INT J CANCER, V57, P240, DOI 10.1002/ijc.2910570218; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; ROWE M, 1987, J GEN VIROL, V68, P1575, DOI 10.1099/0022-1317-68-6-1575; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Wu GD, 1997, J BIOL CHEM, V272, P2396; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Young LS, 1997, BRIT MED BULL, V53, P509; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531	57	285	291	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16085	16096		10.1074/jbc.274.23.16085	http://dx.doi.org/10.1074/jbc.274.23.16085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347160	hybrid			2022-12-27	WOS:000080668600020
J	Gloe, T; Riedmayr, S; Sohn, HY; Pohl, U				Gloe, T; Riedmayr, S; Sohn, HY; Pohl, U			The 67-kDa laminin-binding protein is involved in shear stress-dependent endothelial nitric-oxide synthase expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; SIGNAL-TRANSDUCTION; CELL-ADHESION; FLOW; RECEPTOR; FORCES; MODEL; DIFFERENTIATION	It has been suggested that the mechanical forces acting on endothelial cells may be sensed in part by cell-matrix connections. We therefore studied the role of different matrix proteins, in particular laminin I, on a shear stress-dependent endothelial response, namely nitric-oxide synthase (eNOS) expression. Primary porcine aortic endothelial cells were seeded onto glass plates either noncoated (NC cells) or precoated with fibronectin (FN cells), laminin (LN cells), or collagen I (CN cells). Western blots were used to detect differences in the final matrix composition of these cells. A shear stress of 16 dyn/cm(2) was applied for 6 h, Only LN cells showed detectable amounts of laminin I in their underlying matrix when they reached confluence. They reacted with a a-fold increase of eNOS expression (n = 16, p < 0.001) to the exposure of shear stress, which went along with enhanced eNOS protein and NO release. In contrast, neither FN cells (n = 9) nor NC cells (n = 13) showed a significant increase of eNOS expression under shear stress, The increase in CN cells was borderline (1.4-fold; n = 9, p < 0.05) and was not associated with an increase of eNOS protein. The shear-induced increase in eNOS expression of LN cells was abolished by the peptide YIGSR, which blocks the cellular binding to laminin I via a 67-kDa laminin-binding protein, whereas a control peptide (YIGSK) had no effect. The induction of eNOS expression by shear stress is stimulated by an interaction of endothelial cells with laminin which is, at least in part, mediated by a 67-kDa laminin-binding protein.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Gloe, T (corresponding author), Univ Munich, Inst Physiol, Schillerstr 44, D-80336 Munich, Germany.							ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Ardini E, 1997, J BIOL CHEM, V272, P2342; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; BALLERMANN BJ, 1995, BLOOD PURIFICAT, V13, P125, DOI 10.1159/000170195; Black SM, 1997, J CLIN INVEST, V100, P1448, DOI 10.1172/JCI119665; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197; Golledge J, 1997, J CLIN INVEST, V99, P2719, DOI 10.1172/JCI119461; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; GUPTE A, 1990, IN VITRO CELL DEV B, V26, P57; Halatsch ME, 1997, CANCER LETT, V118, P7, DOI 10.1016/S0304-3835(97)00217-6; IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059; JIANG B, 1994, J CELL SCI, V107, P2499; KOLPAKOV V, 1995, CIRC RES, V77, P823, DOI 10.1161/01.RES.77.4.823; KOSLOW AR, 1986, J BIOMECH ENG-T ASME, V108, P338, DOI 10.1115/1.3138625; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MALEK AM, 1994, J HYPERTENS, V12, P989; MASSIA SP, 1993, J BIOL CHEM, V268, P8053; MECHAM RP, 1991, FASEB J, V5, P2538, DOI 10.1096/fasebj.5.11.1651264; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Muller JM, 1997, CIRC RES, V80, P320, DOI 10.1161/01.RES.80.3.320; Nadaud S, 1996, CIRC RES, V79, P857, DOI 10.1161/01.RES.79.4.857; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; NORIS M, 1995, CIRC RES, V76, P536, DOI 10.1161/01.RES.76.4.536; Ott MJ, 1995, ENDOTHELIUM, V3, P21; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; REDMOND EM, 1995, IN VITRO CELL DEV-AN, V31, P601; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Rosenthal AM, 1990, CELL CULTURE TECHNIQ, P117; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; THOUMINE O, 1995, LAB INVEST, V73, P565; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; Xiao ZS, 1997, J CELL PHYSIOL, V171, P205, DOI 10.1002/(SICI)1097-4652(199705)171:2<205::AID-JCP11>3.3.CO;2-3; ZAMAN Z, 1979, ANAL BIOCHEM, V100, P64, DOI 10.1016/0003-2697(79)90110-6	38	59	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15996	16002		10.1074/jbc.274.23.15996	http://dx.doi.org/10.1074/jbc.274.23.15996			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347148	hybrid			2022-12-27	WOS:000080668600008
J	Jiang, HL; Kruger, N; Lahiri, DR; Wang, DR; Vatele, JM; Balazy, M				Jiang, HL; Kruger, N; Lahiri, DR; Wang, DR; Vatele, JM; Balazy, M			Nitrogen dioxide induces cis-trans-isomerization of arachidonic acid within cellular phospholipids - Detection of trans-arachidonic acids in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; LIPID-PEROXIDATION; MASS-SPECTROMETRY; NITRIC-OXIDE; DERIVATIVES; METABOLISM; OXIDATION; PLATELET; PRODUCTS; RISK	Oxygen free radicals oxidize arachidonic acid to a complex mixture of metabolites termed isoeicosanoids that share structural similarity to enzymatically derived eicosanoids. However, little is known about oxidations of arachidonic acid mediated by reactive radical nitrogen oxides. We have studied the reaction of arachidonic acid with NO2, a free radical generated by nitric oxide and nitrite oxidations, A major group of products appeared to be a mixture of arachidonic acid isomers having one trans-bond and three cis-double bonds, We have termed these new products trans-arachidonic acids, These isomers were chromatographically distinct from arachidonic acid and produced mass spectra that were nearly identical with mass spectra of arachidonic acid. The lack of ultraviolet absorbance above 205 nm and the similarity of mass spectra of dimethyloxazoline derivatives suggested that the trans-bond was not conjugated with any of the cis-bonds, and the C=C bonds were located at carbons 5, 8, 11, and 14, Further identification was based on comparison of chromatographic properties with synthetic standards and revealed that NO2 generated 14-trans-eicosatetraenoic acid and a mixture containing 11-trans-, 8-trans, and 5-trans-eieosatetraenoic acids. Exposure of human platelets to submicromolar levels of NO2 resulted in a dose-dependent formation of 14-trans-eicosatetraenoic acid and other isomers within platelet glycerophospholipids. Using a sensitive isotopic dilution assay we detected trans-arachidonic acids in human plasma (50.3 +/- 10 ng/ml) and urine (122 +/- 50 pg/ml), We proposed a mechanism of arachidonic acid isomerization that involves a reversible attachment of NO2 to a double bond with formation of a nitroarachidonyl radical. Thus, free radical processes mediated by NO2 lead to generation of trans-arachidonic acid isomers, including biologically active 14-trans-eicosatetraenoic acid, within membrane phospholipids from which they can be released and excreted into urine.	New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; Univ Lyon 1, Lab Chim Organ 1, F-69622 Villeurbanne, France	New York Medical College; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Balazy, M (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	michael_balazy@nymc.edu		Balazy, Ph.D., Michael/0000-0003-0218-8820	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012993] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NCRR NIH HHS [SO1 RR 12993] Funding Source: Medline; NHLBI NIH HHS [P01 HL034300, HL 34300] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALAZY M, 1989, BIOMED ENVIRON MASS, V18, P328, DOI 10.1002/bms.1200180508; BALAZY M, 1991, J BIOL CHEM, V266, P23561; BALAZY M, 1986, ANAL CHEM, V58, P1098, DOI 10.1021/ac00297a026; Berdeaux O, 1996, J LIPID RES, V37, P2244; BERDEAUX O, 1995, CHEM PHYS LIPIDS, V78, P71, DOI 10.1016/0009-3084(95)02486-3; Feldman EB, 1996, AM J CLIN NUTR, V63, P663; GALLON AA, 1994, LIPIDS, V29, P171, DOI 10.1007/BF02536725; GIBSON TW, 1976, J ORG CHEM, V41, P791, DOI 10.1021/jo00867a009; HARRISON KA, 1995, J BIOL CHEM, V270, P17273, DOI 10.1074/jbc.270.29.17273; Jiang HL, 1998, NITRIC OXIDE-BIOL CH, V2, P350, DOI 10.1006/niox.1998.0196; KICE JL, 1962, J AM CHEM SOC, V84, P605, DOI 10.1021/ja00863a021; Kritchevsky D, 1997, PROSTAG LEUKOTR ESS, V57, P399, DOI 10.1016/S0952-3278(97)90418-X; LI YD, 1994, TOXICOL APPL PHARM, V129, P114, DOI 10.1006/taap.1994.1234; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Morrow JD, 1997, PROG LIPID RES, V36, P1, DOI 10.1016/S0163-7827(97)00001-5; Nelson GJ, 1998, NUTR REV, V56, P250, DOI 10.1111/j.1753-4887.1998.tb01758.x; PATEL JM, 1986, AM REV RESPIR DIS, V134, P1196; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; RATNAYAKE WMN, 1994, LIPIDS, V29, P707, DOI 10.1007/BF02538915; Reilly MP, 1998, J NUTR, V128, p434S, DOI 10.1093/jn/128.2.434S; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SAMUELSSON B, 1991, Z RHEUMATOL, V50, P3; SNYDER JM, 1982, J AM OIL CHEM SOC, V59, P469, DOI 10.1007/BF02636144; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; WITTIG G, 1955, CHEM BER-RECL, V88, P1654, DOI 10.1002/cber.19550881110; World Health Organization (WHO), 1997, ENV HLTH CRIT, V188; ZHANG JY, 1988, BIOMED ENVIRON MASS, V15, P33, DOI 10.1002/bms.1200150106	28	91	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16235	16241		10.1074/jbc.274.23.16235	http://dx.doi.org/10.1074/jbc.274.23.16235			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347179	hybrid			2022-12-27	WOS:000080668600039
J	Nakae, J; Park, BC; Accili, D				Nakae, J; Park, BC; Accili, D			Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through wortmannin-sensitive pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; INDUCED GLUCOSE-TRANSPORT; CAENORHABDITIS-ELEGANS; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; SER/THR KINASE; RAT ADIPOCYTES; POTENTIAL ROLE; FAMILY MEMBER; LONGEVITY	In the nematode Caenorhabditis elegans, mutations of the insulin/insulin-like growth factor-1 receptor homologue Daf-a gene cause developmental arrest at the dauer stage. The effect of Daf-2 mutations is counteracted by mutations in the Daf-16 gene, suggesting that Daf-16 is required for signaling by Daf-2. Daf-16 encodes a forkhead transcription factor. Based on sequence similarity, the FKHR genes are the likeliest mammalian Daf-16 homologues, FKHR proteins contain potential sites for phosphorylation by the serine/threonine kinase Akt. Because Akt is phosphorylated in response to insulin and has been implicated in a variety of insulin effects, we investigated whether insulin affects phosphorylation of FKHR. Insulin stimulated phosphorylation of endogenous FKHR and of a recombinant c-Myc/FKHR fusion protein transiently expressed in murine SV40-transformed hepatocytes. The effect of insulin was inhibited by wortmannin treatment, suggesting that PI S-kinase activity is required for FKHR phosphorylation. Mutation of serine 253, located in a consensus Akt phosphorylation site at the carboxyl-terminal end of the forkhead domain, abolished the effect of insulin on FKHR phosphorylation. In contrast, mutation of two additional Akt phosphorylation sites, at amino acids threonine 24 or serine 316, did not abolish insulin-induced phosphorylation. These data indicate that FKHR may represent a distal effector of insulin action.	NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Accili, D (corresponding author), NICHD, Dev Endocrinol Branch, NIH, Bldg 10,Rm 10D18, Bethesda, MD 20892 USA.		Nakae, Jun/Q-6141-2019					Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Barr FG, 1997, CURR TOP MICROBIOL, V220, P113; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OKADA T, 1994, J BIOL CHEM, V269, P3568; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Salvatore P, 1998, J BIOL CHEM, V273, P6989, DOI 10.1074/jbc.273.12.6989; SHIMIZU Y, 1994, BIOCHEM BIOPH RES CO, V202, P660, DOI 10.1006/bbrc.1994.1981; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Tissenbaum HA, 1998, GENETICS, V148, P703; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOMIZAWA M, 1999, IN PRESS DIABETES, V48; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619	28	391	400	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15982	15985		10.1074/jbc.274.23.15982	http://dx.doi.org/10.1074/jbc.274.23.15982			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347145	hybrid			2022-12-27	WOS:000080668600005
J	de Saro, FJL; Yoshikawa, N; Helmann, JD				de Saro, FJL; Yoshikawa, N; Helmann, JD			Expression, abundance, and RNA polymerase binding properties of the delta factor of Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-FACTOR; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; PROMOTER; DNA; INITIATION; SUBUNIT; PURIFICATION; CORE; TRANSCRIPTION	The delta protein is a dispensable subunit of Bacillus subtilis RNA polymerase (RNAP) that has major effects on the biochemical properties of the purified enzyme. In the presence of delta, RNAP displays an increased specificity of transcription, a decreased affinity for nucleic acids, and an increased efficiency of RNA synthesis because of enhanced recycling. Despite these profound effects, a strain containing a deletion of the delta gene (rpoE) is viable and shows no major alterations in gene expression, Quantitative immunoblotting experiments demonstrate that delta is present in molar excess relative to RNAP in both vegetative cells and spores. Expression of rpoE initiates from a single, sigma(A)-dependent promoter and is maximal in transition phase. A rpoE mutant strain has an altered morphology and is delayed in the exit from stationary phase. For biochemical analyses we have created derivatives of delta and sigma(A) that can be radiolabeled with protein kinase A. Using electrophoretic mobility shift assays, we demonstrate that delta binds core RNAP with an apparent affinity of 2.5 x 10(6) M-1, but we are unable to demonstrate the formation of a ternary complex containing core enzyme, delta, and sigma(A).	Cornell Univ, Microbiol Sect, Ithaca, NY 14853 USA	Cornell University	Helmann, JD (corresponding author), Cornell Univ, Microbiol Sect, Ithaca, NY 14853 USA.			Helmann, John/0000-0002-3832-3249	NIGMS NIH HHS [GM-47446] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047446] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHBERGER EC, 1982, J BACTERIOL, V150, P977, DOI 10.1128/JB.150.2.977-980.1982; ACHBERGER EC, 1982, NUCLEIC ACIDS RES, V10, P2893, DOI 10.1093/nar/10.9.2893; ACHBERGER EC, 1981, J BIOL CHEM, V256, P7424; ALTMANN CR, 1994, P NATL ACAD SCI USA, V91, P3784, DOI 10.1073/pnas.91.9.3784; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CHANG BY, 1990, J BACTERIOL, V172, P3257, DOI 10.1128/jb.172.6.3257-3263.1990; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; DEORA R, 1995, BIOCHEM BIOPH RES CO, V208, P610, DOI 10.1006/bbrc.1995.1382; DESARO FJL, 1995, J MOL BIOL, V252, P189, DOI 10.1006/jmbi.1995.0487; DICKEL CD, 1980, BIOCHEM BIOPH RES CO, V95, P1789, DOI 10.1016/S0006-291X(80)80106-9; DOBINSON KF, 1987, BIOCHEMISTRY-US, V26, P8206, DOI 10.1021/bi00399a028; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; HYDE EI, 1986, J BIOL CHEM, V261, P6565; JUANG YL, 1995, BIOCHEMISTRY-US, V34, P8465, DOI 10.1021/bi00026a030; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; KENNEY TJ, 1991, J BACTERIOL, V173, P3282, DOI 10.1128/jb.173.11.3282-3290.1991; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LAMPE M, 1988, GENE, V67, P13, DOI 10.1016/0378-1119(88)90003-0; Mendelson NH, 1996, J BACTERIOL, V178, P1980, DOI 10.1128/jb.178.7.1980-1989.1996; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; PERO J, 1975, P NATL ACAD SCI USA, V72, P1589, DOI 10.1073/pnas.72.4.1589; Rudner R, 1998, MOL MICROBIOL, V27, P687, DOI 10.1046/j.1365-2958.1998.00717.x; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; SLACK FJ, 1993, J BACTERIOL, V175, P4605, DOI 10.1128/JB.175.15.4605-4614.1993; SPIEGELMAN GB, 1978, J BIOL CHEM, V253, P1756; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Watson SP, 1998, MICROBIOL-UK, V144, P3159, DOI 10.1099/00221287-144-11-3159; WIGGS JL, 1981, P NATL ACAD SCI-BIOL, V78, P2762, DOI 10.1073/pnas.78.5.2762; ZUBER P, 1987, J BACTERIOL, V169, P2223, DOI 10.1128/jb.169.5.2223-2230.1987	37	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15953	15958		10.1074/jbc.274.22.15953	http://dx.doi.org/10.1074/jbc.274.22.15953			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336502	hybrid			2022-12-27	WOS:000080560100091
J	Ito, T; Yang, ML; May, WS				Ito, T; Yang, ML; May, WS			RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; TRANSLATIONAL CONTROL; INTERFERON; PKR; PHOSPHORYLATION; INITIATION; IDENTIFICATION; INTERLEUKIN-3; EXPRESSION; APOPTOSIS	The double-stranded (ds) RNA-dependent protein kinase (PKR) regulates protein synthesis by phosphorylating the alpha subunit of eukaryotic initiation factor-2, PKR is activated by viral induced dsRNA and thought to be involved in the host antiviral defense mechanism. PKR is also activated by various nonviral stresses such as growth factor deprivation, although the mechanism is unknown. By screening a mouse cDNA expression library, we have identified an ubiquitously expressed PKR-associated protein, RAX, RAX has a high sequence homology to human PACT, which activates PKR in the absence of dsRNA. Although RAX also can directly activate PKR in vitro, overexpression of RAX does not induce PKR activation or inhibit growth of interleukin-3 (IL-3)-dependent cells in the presence of IL-3. However, IL-3 deprivation as well as diverse cell stress treatments including arsenite, thapsigargin, and H2O2, which are known to inhibit protein synthesis, induce the rapid phosphorylation of RAX followed by RAX-PKR association and activation of PKR, Therefore, cellular RAX may be a stress-activated, physiologic activator of PKR that couples transmembrane stress signals and protein synthesis.	Univ Texas, Med Branch, Dept Internal Med, Sealy Ctr Oncol & Hematol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Ito, T (corresponding author), Univ Texas, Med Branch, Dept Internal Med, Sealy Ctr Oncol & Hematol, Galveston, TX 77555 USA.	tito@utmb.edu		Yang, Mingli/0000-0002-4781-690X	NATIONAL CANCER INSTITUTE [R01CA044649] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054083] Funding Source: NIH RePORTER; NCI NIH HHS [CA44649] Funding Source: Medline; NHLBI NIH HHS [HL54083] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOSWELL HS, 1990, EXP HEMATOL, V18, P794; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Clemens MJ, 1996, TRANSLATIONAL CONTRO, P139; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; Eckmann CR, 1997, J CELL BIOL, V138, P239, DOI 10.1083/jcb.138.2.239; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harlow E., 1988, ANTIBODIES LAB MANUA; ICELY PL, 1991, J BIOL CHEM, V266, P16073; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; ITO T, 1994, P NATL ACAD SCI USA, V91, P7455, DOI 10.1073/pnas.91.16.7455; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lee K, 1996, MOL CELL BIOL, V16, P3023; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; MATHEWS MB, 1996, TRANSLATIONAL CONTRO, P505; MAURIDES PA, 1989, ANAL BIOCHEM, V183, P144, DOI 10.1016/0003-2697(89)90182-6; Merrick WC., 1996, TRANSLATION CONTROL, P31; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; PROSTKO CR, 1995, J BIOL CHEM, V270, P6211, DOI 10.1074/jbc.270.11.6211; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Wu SY, 1998, BIOCHEMISTRY-US, V37, P13816, DOI 10.1021/bi981472h; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	37	186	189	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15427	15432		10.1074/jbc.274.22.15427	http://dx.doi.org/10.1074/jbc.274.22.15427			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336432	hybrid			2022-12-27	WOS:000080560100021
J	Osterlund, T; Beussman, DJ; Julenius, K; Poon, PH; Linse, S; Shabanowitz, J; Hunt, DF; Schotz, MC; Derewenda, ZS; Holm, C				Osterlund, T; Beussman, DJ; Julenius, K; Poon, PH; Linse, S; Shabanowitz, J; Hunt, DF; Schotz, MC; Derewenda, ZS; Holm, C			Domain identification of hormone-sensitive lipase by circular dichroism and fluorescence spectroscopy, limited proteolysis, and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORESIS; SEPARATION; CHARACTER; PROTEIN	Structure-function relationship analyses of hormone-sensitive lipase (HSL) have suggested that this metabolically important enzyme consists of several functional and at least two structural domains (Osterlund, T., Danielsson, B., Degerman, E., Contreras, J. A., Edgren, G., Davis, R. C., Schotz, M. C., and Helm, C. (1996) Bio-chem. J. 319, 411-420; Contreras, J. A., Karlsson, M., Osterlund, T., Laurell, H., Svensson, A, and Helm, C. (1996) J. Biol. Chem. 271, 31426-31430). To analyze the structural domain composition of HSL in more detail, we applied biophysical methods. Denaturation of HSL was followed by circular dichroism measurements and fluorescence spectroscopy, revealing that the unfolding of HSL is a two-step event. Using limited proteolysis in combination with mass spectrometry, several proteolytic fragments of HSL were identified, including one corresponding exactly to the proposed N-terminal domain. Major cleavage sites were found in the predicted hinge region between the two domains and in the regulatory module of the C-terminal, catalytic domain. Analyses of a hinge region cleavage mutant and calculations of the hydropathic pattern of HSL further suggest that the hinge region and regulatory module are exposed parts of HSL. Together, these data support our previous hypothesis that HSL consists of two major structural domains, encoded by exons 1-4 and 5-9, respectively, of which the latter contains an exposed regulatory module outside the catalytic alpha/beta-hydrolase fold core.	Univ Lund, Dept Cell & Mol Biol, Sect Mol Signalling, S-22100 Lund, Sweden; Univ Lund, Dept Phys Chem 2, S-22100 Lund, Sweden; Univ Virginia, Dept Chem, Charlottesville, VA 22906 USA; Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; W Los Angeles Vet Affairs Med Ctr, Lipid Res Lab, Los Angeles, CA 90073 USA	Lund University; Lund University; University of Virginia; University of Virginia; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Holm, C (corresponding author), Univ Lund, Dept Cell & Mol Biol, Sect Mol Signalling, S-22100 Lund, Sweden.		Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Linse, Sara/0000-0001-9629-7109; Osterlund, Torben/0000-0002-2047-767X				Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Contreras JA, 1996, J BIOL CHEM, V271, P31426, DOI 10.1074/jbc.271.49.31426; Degerman E, 1997, J BIOL CHEM, V272, P6823, DOI 10.1074/jbc.272.11.6823; DEREWENDA ZS, 1994, ADV PROTEIN CHEM, V45, P1; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; HOLM C, 1986, J BIOL CHEM, V261, P5659; Holm C, 1997, METHOD ENZYMOL, V286, P45; HOLM C, 1994, FEBS LETT, V344, P234, DOI 10.1016/0014-5793(94)00403-X; HOLM C, 1990, LIPIDS, V25, P254, DOI 10.1007/BF02544384; Holm C, 1997, METHOD ENZYMOL, V284, P272; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Osterlund T, 1997, FEBS LETT, V403, P259, DOI 10.1016/S0014-5793(97)00063-X; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smith GM, 1996, FEBS LETT, V396, P90, DOI 10.1016/0014-5793(96)01076-9; STRALFORS P, 1987, ENZYMES B, V18, P147; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4	19	29	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15382	15388		10.1074/jbc.274.22.15382	http://dx.doi.org/10.1074/jbc.274.22.15382			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336425	hybrid			2022-12-27	WOS:000080560100014
J	Qi, C; Zhu, YJ; Pan, J; Usuda, N; Maeda, N; Yeldandi, AV; Rao, MS; Hashimoto, T; Reddy, JK				Qi, C; Zhu, YJ; Pan, J; Usuda, N; Maeda, N; Yeldandi, AV; Rao, MS; Hashimoto, T; Reddy, JK			Absence of spontaneous peroxisome proliferation in Enoyl-CoA hydratase/L-3-Hydroxyacyl-CoA dehydrogenase-deficient mouse liver - Further support for the role of fatty acyl CoA oxidase in PPAR alpha ligand metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; STEROL CARRIER PROTEIN-2; MICE LACKING; RAT-LIVER; GENE; CLOFIBRATE; CLONING	Peroxisomes contain a classical L-hydroxy-specific peroxisome proliferator-inducible beta-oxidation system and also a second noninducible D-hydroxy-specific beta-oxidation system. We previously generated mice lacking fatty acyl-CoA oxidase (AOX), the first enzyme of the L-hydroxy-specific classical beta-oxidation system; these AOX(-/-) mice exhibited sustained activation of peroxisome proliferator-activated receptor alpha (PPAR alpha), resulting in profound spontaneous peroxisome proliferation liver cells. These observations implied that AOX is responsible for the metabolic degradation of PPAR alpha ligands, In this study, the function of enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase (L-PBE), the second enzyme of this peroxisomal beta-oxidation system, was investigated by disrupting its gene. Mutant mice (L-PBE-/-) were viable and fertile and exhibited no detectable gross phenotypic defects. L-PBE-/- mice showed no hepatic steatosis and manifested no spontaneous peroxisome proliferation, unlike that encountered in livers of mice deficient in AOX. These results indicate that disruption of classical peroxisomal fatty acid beta-oxidation system distal to AOX step does not interfere with the inactivation of endogenous ligands of PPAR alpha, further confirming that the AOX gene is indispensable for the physiological regulation of this receptor. The absence of appreciable changes in lipid metabolism also indicates that enoyl-CoAs, generated in the classical system in L-PBE-/- mice are diverted to D-hydroxy-specific system for metabolism by D-PBE, When challenged with a peroxisome proliferator, L-PBE-/- mice showed increases in the levels of hepatic mRNAs and proteins that are regulated by PPAR alpha except for appreciable blunting of peroxisome proliferative response as compared with that observed in hepatocytes of wild type mice similarly treated. This blunting of peroxisome proliferative response is attributed to the absence of L-PBE protein in L-PBE-/- mouse liver, because all other proteins are induced essentially to the same extent in both wild type and L-PBE-/- mice.	Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA	Northwestern University; University of North Carolina; University of North Carolina Chapel Hill	Reddy, JK (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.				NIGMS NIH HHS [GM 23750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023750, R01GM023750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baumgart E, 1996, P NATL ACAD SCI USA, V93, P13748, DOI 10.1073/pnas.93.24.13748; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; FORMAN BM, 1997, P NATL ACAD SCI USA, V89, P4653; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; HASHIMOTO T, 1999, IN PRESS NEUROCHEM R; ISHII N, 1987, J BIOL CHEM, V262, P8144; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; RAO MS, 1987, CARCINOGENESIS, V8, P631; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; REDDY JK, 1977, BIOCHEM BIOPH RES CO, V77, P824, DOI 10.1016/S0006-291X(77)80052-1; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Usuda N, 1996, ANN NY ACAD SCI, V804, P297, DOI 10.1111/j.1749-6632.1996.tb18624.x	22	81	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15775	15780		10.1074/jbc.274.22.15775	http://dx.doi.org/10.1074/jbc.274.22.15775			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336479	hybrid			2022-12-27	WOS:000080560100068
J	Sugawara, H; Yamamoto, H; Shihata, N; Inoue, T; Okada, S; Miyake, C; Yokota, A; Kai, Y				Sugawara, H; Yamamoto, H; Shihata, N; Inoue, T; Okada, S; Miyake, C; Yokota, A; Kai, Y			Crystal structure of carboxylase reaction-oriented ribulose 1,5-bisphosphate carboxylase oxygenase from a thermophilic red alga, Galdieria partita	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SPINACH RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; SUBSTRATE-SPECIFICITY FACTOR; RIBULOSEBISPHOSPHATE CARBOXYLASE; ACTIVE-SITE; PYLAIELLA-LITTORALIS; PYROCOCCUS-FURIOSUS; CARBON-DIOXIDE; SMALL SUBUNITS; BISPHOSPHATE	Ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco, EC 4.1.1.39) obtained from a thermophilic red alga Galdieria partita has the highest specificity factor of 238 among the Rubiscos hitherto reported. Crystal structure of activated Rubisco from G. partita complexed with the reaction intermediate analogue, 2-carboxyarabinitol 1,5-bisphosphate (P-CABP) has been determined at 2.4-Angstrom resolution. Compared with other Rubiscos, different amino residues bring the structural differences in active site, which are marked around the binding sites of P-2 phosphate of 2-CABP. Especially, side chains of His-327 and Arg-295 show the significant differences from those of spinach Rubisco. Moreover, the side chains of Asn-123 and His-294 which are reported to bind the substrate, ribulose 1,5-bisphosphate, form hydrogen bonds characteristic of Galdieria Rubisco. Small subunits of Galdieria Rubisco have more than 30 extra amino acid residues on the C terminus, which make up a hairpin-loop structure to form many interactions with the neighboring small subunits. When the structures of Galdieria and spinach Rubiscos are superimposed, the hairpin region of the neighboring small subunit in Galdieria enzyme and apical portion of insertion residues 52-63 characteristic of small subunits in higher plant enzymes are almost overlapped to each other.	Osaka Univ, Grad Sch Engn, Dept Chem Mat, Suita, Osaka 5650871, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Osaka University; Nara Institute of Science & Technology	Kai, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Chem Mat, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.		Shibata, Naoki/AFK-9971-2022	Shibata, Naoki/0000-0002-5096-1104				Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ASSALI NE, 1990, PLANT MOL BIOL, V15, P307, DOI 10.1007/BF00036916; ASSALI NE, 1991, PLANT MOL BIOL, V17, P853, DOI 10.1007/BF00037066; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; CURMI PMG, 1992, J BIOL CHEM, V267, P16980; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; HAINING RL, 1990, J BIOL CHEM, V265, P5434; Harpel MR, 1996, BIOCHEMISTRY-US, V35, P13865, DOI 10.1021/bi962184t; HARPEL MR, 1991, J BIOL CHEM, V266, P24734; HARTMAN FC, 1985, J BIOL CHEM, V260, P3968; HARTMAN FC, 1987, J BIOL CHEM, V262, P3496; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; HUANG CC, 1991, J MOL GRAPHICS, V9, P230, DOI 10.1016/0263-7855(91)80016-S; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRECKL W, 1989, J BIOL CHEM, V264, P10982; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE EH, 1993, J BIOL CHEM, V268, P26583; LEE GJ, 1992, BIOCHEMISTRY-US, V31, P2304, DOI 10.1021/bi00123a014; LIANG WA, 1974, PLANT PHYSIOL, V54, P678; LORIMER GH, 1981, BIOCHEMISTRY-US, V20, P1236, DOI 10.1021/bi00508a028; LUNDQVIST T, 1991, J BIOL CHEM, V266, P12604; LUNDQVIST T, 1989, J BIOL CHEM, V264, P7078; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1982, PREPARATION ANAL PRO, P96; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORDEN CW, 1991, J MOL EVOL, V32, P379, DOI 10.1007/BF02101278; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; NIYOGI SK, 1986, J BIOL CHEM, V261, P87; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; PORTIS AR, 1990, BIOCHIM BIOPHYS ACTA, V1015, P15, DOI 10.1016/0005-2728(90)90211-L; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; READ BA, 1992, BIOCHEMISTRY-US, V31, P519, DOI 10.1021/bi00117a031; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; SAVER BG, 1982, BIOCHEMISTRY-US, V21, P5398, DOI 10.1021/bi00265a003; SCHREUDER HA, 1993, PROTEIN SCI, V2, P1136, DOI 10.1002/pro.5560020708; Shibata N, 1996, J BIOL CHEM, V271, P26449, DOI 10.1074/jbc.271.43.26449; Shibata N, 1996, J BIOCHEM-TOKYO, V120, P1064; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; TAPIA O, 1995, THEOCHEM-J MOL STRUC, V342, P131; Taylor TC, 1997, BIOCHEMISTRY-US, V36, P4041, DOI 10.1021/bi962818w; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Taylor TC, 1997, J MOL BIOL, V265, P432, DOI 10.1006/jmbi.1996.0738; Uemura K, 1996, PLANT CELL PHYSIOL, V37, P325, DOI 10.1093/oxfordjournals.pcp.a028949; VONCAEMMERER S, 1991, J PLANT PHYSL, V18, P287; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; ZELITCH I, 1975, SCIENCE, V188, P626, DOI 10.1126/science.188.4188.626	59	50	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15655	15661		10.1074/jbc.274.22.15655	http://dx.doi.org/10.1074/jbc.274.22.15655			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336462	hybrid			2022-12-27	WOS:000080560100051
J	Uehara, T; Matsuno, J; Kaneko, M; Nishiya, T; Fujimuro, M; Yokosawa, H; Nomura, Y				Uehara, T; Matsuno, J; Kaneko, M; Nishiya, T; Fujimuro, M; Yokosawa, H; Nomura, Y			Transient nuclear factor kappa B (NF-kappa B) activation stimulated by interleukin-1 beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the I kappa B alpha molecule, in C6 glioma cells - Regulation of NF-kappa B linked to chemokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; CASEIN KINASE-II; MEDIATED PROTEOLYSIS; 26-S PROTEASOME; DEGRADATION; SUFFICIENT; COMPONENT; INDUCTION; REQUIRES; PATHWAY	We previously reported that several stresses can induce cytokine-induced neutrophil chemoattractant expression in a nuclear factor kappa B (NF-kappa B)-dependent manner. In this study, we focused further on the regulation of NF-kappa B, The activation of NF-kappa B and the subsequent cytokine-induced neutrophil chemoattractant induction in response to interleukin-1 beta (IL-1 beta) were inhibited by proteasome inhibitors, MG132 and proteasome inhibitor I. Translocation of NF-kappa B into nuclei occurs by the phosphorylation, multi-ubiquitination, and degradation of I kappa B alpha, a regulatory protein of NF-kappa B, Nascent I kappa B alpha began to degrade 5 min after treatment with IL-1 beta and disappeared completely after 15 min. However, I kappa B alpha returned to basal levels after 45-60 min. Interestingly, resynthesized I kappa B alpha was already phosphorylated at Ser-32, These results suggest that 1) the upstream signals are still activated, although the translocation of NF-kappa B peaks at 15 min; and 2) the regulated protein(s) acts downstream of I kappa B alpha phosphorylation, Western blotting showed that the resynthesized and phosphorylated I kappa B molecules were also upward-shifted by multi-ubiquitination in response to IL-1 beta treatment. On the other hand, ATP-dependent Leu-Leu-Val-Tyr cleaving activity transiently increased, peaked at 15 min, and then decreased to basal levels at 60 min. Furthermore, the cytosolic fraction that was stimulated by IL-1 beta for 15 min, but not for 0 and 60 min, could degrade phosphorylated and multi-ubiquitinated I kappa B alpha, These results indicate that the transient translocation of NF-kappa B in response to IL-1 beta may be partly dependent on transient proteasome activation.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan	Hokkaido University; Hokkaido University	Nomura, Y (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan.	nomura@pharm.hokudai.ac.jp	Kaneko, Masayuki/F-9302-2011; Fujimuro, Masahiro/AAC-4727-2020	Kaneko, Masayuki/0000-0002-0477-0171; Fujimuro, Masahiro/0000-0002-5165-0789; Uehara, Takashi/0000-0002-8545-4006				Aizawa H, 1996, BIOCHEM BIOPH RES CO, V218, P224, DOI 10.1006/bbrc.1996.0039; ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Castano JG, 1996, BIOCHEMISTRY-US, V35, P3782, DOI 10.1021/bi952540s; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Ciechanover A, 1996, NAT MED, V2, P1188, DOI 10.1038/nm1196-1188; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DONALD R, 1995, J BIOL CHEM, V270, P9, DOI 10.1074/jbc.270.1.9; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; ETLINGER JD, 1993, ENZYME PROTEIN, V47, P325, DOI 10.1159/000468690; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; KAWAHARA H, 1992, FEBS LETT, V310, P119, DOI 10.1016/0014-5793(92)81310-I; KENNETH NL, 1996, BIOCHEM BIOPH RES CO, V225, P855; LUDEMANN R, 1993, J BIOL CHEM, V268, P17413; MA CP, 1994, J BIOL CHEM, V269, P3539; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; NISHIYA T, 1995, FEBS LETT, V371, P333, DOI 10.1016/0014-5793(95)00933-Z; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; PETERS JM, 1994, J BIOL CHEM, V269, P7709; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; SAWADA H, 1993, FEBS LETT, V335, P207, DOI 10.1016/0014-5793(93)80731-9; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; Uehara T, 1999, J NEUROCHEM, V72, P196, DOI 10.1046/j.1471-4159.1999.0720196.x; Uehara T, 1998, BRAIN RES, V790, P284, DOI 10.1016/S0006-8993(98)00080-8; WEITMAN D, 1992, J BIOL CHEM, V267, P6977; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050	44	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15875	15882		10.1074/jbc.274.22.15875	http://dx.doi.org/10.1074/jbc.274.22.15875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336492	hybrid			2022-12-27	WOS:000080560100081
J	Yang, YJ; Keeney, D; Tang, XJ; Canfield, N; Rasmussen, BA				Yang, YJ; Keeney, D; Tang, XJ; Canfield, N; Rasmussen, BA			Kinetic properties and metal content of the metallo-beta-lactamase CcrA harboring selective amino acid substitutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; BACTEROIDES-FRAGILIS; ESCHERICHIA-COLI; AEROMONAS-HYDROPHILA; SERRATIA-MARCESCENS; GENE; PURIFICATION; SPECIFICITY; EXPRESSION; RESISTANCE	The crystal structure of the metallo-beta-lactamase CcrA3 indicates that the active site of this enzyme contains a binuclear zinc center. To aid in assessing the involvement of specific residues in beta-lactam hydrolysis and susceptibility to inhibitors, individual substitutions of selected amino acids were generated. Substitution of the zinc-ligating residue Cys(181) with Ser (C181S) resulted in a significant reduction in hydrolytic activity; k(cat) values decreased 2-4 orders of magnitude for all substrates. Replacement of His(99) with Asn (H99N) significantly reduced the hydrolytic activity for penicillin and imipenem, Replacement of Asp(103) with Asn (D103N) showed reduced hydrolytic activity for cephaloridine and imipenem, Deletion of amino acids 46-51 dramatically reduced both the hydrolytic activity and affinity for all beta-lactams, The metal binding capacity of each mutant enzyme was examined using nondenaturing electrospray ionization mass spectrometry, Two zinc ions were observed for the wild-type enzyme and most of the mutant enzymes. However, for the H99N, C181S, and D103N enzymes, three different zinc content patterns were observed. These enzymes contained two zinc molecules, one zinc molecule, and a mixture of one or two zinc molecules/enzyme molecule, respectively. Two enzymes with substitutions of Cys(104) Or Cys(104) and Cys(155) were also composed of mixed enzyme populations.	Wyeth Ayerst Res, Pearl River, NY 10965 USA	Pfizer	Rasmussen, BA (corresponding author), Wyeth Ayerst Res, 401 N Middletown Rd, Pearl River, NY 10965 USA.							Alksne LE, 1996, J BACTERIOL, V178, P4306; BANDOH K, 1991, ANTIMICROB AGENTS CH, V35, P371, DOI 10.1128/AAC.35.2.371; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crowder MW, 1996, BIOCHEMISTRY-US, V35, P12126, DOI 10.1021/bi960976h; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; FELICI A, 1995, ANTIMICROB AGENTS CH, V39, P192, DOI 10.1128/AAC.39.1.192; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; GANEM B, 1991, J AM CHEM SOC, V113, P6294, DOI 10.1021/ja00016a069; HUSSAIN M, 1985, J BACTERIOL, V164, P223, DOI 10.1128/JB.164.1.223-229.1985; Li Z, 1999, PROTEIN SCI, V8, P249; MARUMO K, 1995, MICROBIOL IMMUNOL, V39, P27, DOI 10.1111/j.1348-0421.1995.tb02164.x; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; RASMUSSEN BA, 1991, MOL MICROBIOL, V5, P1211, DOI 10.1111/j.1365-2958.1991.tb01895.x; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; RASMUSSEN BA, 1994, ANTIMICROB AGENTS CH, V38, P2116, DOI 10.1128/AAC.38.9.2116; Sambrook J., 2002, MOL CLONING LAB MANU; SEGATORE B, 1993, ANTIMICROB AGENTS CH, V37, P1324, DOI 10.1128/AAC.37.6.1324; SMITH RD, 1993, BIOL MASS SPECTROM, V22, P493, DOI 10.1002/bms.1200220902; Wang F, 1996, BIOCHEMISTRY-US, V35, P4069, DOI 10.1021/bi9521304; YANG YJ, 1992, ANTIMICROB AGENTS CH, V36, P1155, DOI 10.1128/AAC.36.5.1155	23	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15706	15711		10.1074/jbc.274.22.15706	http://dx.doi.org/10.1074/jbc.274.22.15706			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336469	hybrid			2022-12-27	WOS:000080560100058
J	Hoffmann, C; Moro, S; Nicholas, RA; Harden, TK; Jacobson, KA				Hoffmann, C; Moro, S; Nicholas, RA; Harden, TK; Jacobson, KA			The role of amino acids in extracellular loops of the human P2Y(1) receptor in surface expression and activation processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; ANGIOTENSIN-II; ANTAGONIST BINDING; PEPTIDE BINDING; LIGAND-BINDING; P-2Y-PURINOCEPTOR AGONISTS; MUTATIONAL ANALYSIS; RESIDUES	The P2Y(1) receptor is a membrane-bound G protein-coupled receptor stimulated by adenine nucleotides, Using alanine scanning mutagenesis, the role in receptor activation of charged amino acids (Asp, Glu, Lys, and Arg) and cysteines in the extracellular loops (EL) of the human P2Y(1) receptor has been investigated. The mutant receptors were expressed in COS-7 cells and measured for stimulation of phospholipase C induced by the potent agonist 2-methylthioadenosine-5'-diphosphate (2-MeSADP), In addition to single point mutations, all receptors carried the hemagglutinin epitope at the N-terminus for detection of cell-surface expression. The C124A and C202A mutations, located near the exofacial end of transmembrane helix 3 and in EL2, respectively, ablated phospholipase C stimulation by less than or equal to 100 mu M 2-MeSADP, Surface enzyme-linked immunosorbent assay detection of both mutant receptors showed <10% expression, suggesting that a critical disulfide bridge between EL2 and the upper part of transmembrane 3, as found in many other G protein coupled receptors, is required for proper trafficking of the P2Y(1) receptor to the cell surface. In contrast, the C42A and C296A mutant receptors (located in the N-terminal domain and EL3) were activated by 2-MeSADP, but the EC50 values were > 1000-fold greater than for the wild-type receptor. The double mutant receptor C42A/C296A exhibited no additive shift in the concentration-response curve for 2-MeSADP, These data suggest that Cys(42) and Cys(296) form another disulfide bridge in the extracellular region, which is critical for activation. Replacement of charged amino acids produced only minor changes in receptor activation, with two remarkable exceptions. The E209A mutant receptor (EL2) exhibited a >1000-fold shift in EC,,, However, if Glu(209) were substituted with amino acids capable of hydrogen bonding (Asp, Gin, or Arg), the mutant receptors responded like the wild-type receptor. Arg(287) in EL3 was impaired similarly to Glu(209) when substituted by alanine. Substitution of Arg287 by lysine, another positively charged residue, failed to fully restore wild-type activity.	NIDDK, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jacobson, KA (corresponding author), NIDDK, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bldg 8A,Rm B1A-17, Bethesda, MD 20892 USA.		Jacobson, Kenneth Alan/A-1530-2009; Moro, Stefano/A-2979-2012	Jacobson, Kenneth Alan/0000-0001-8104-1493; Moro, Stefano/0000-0002-7514-3802	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031116, Z01DK031117, Z01DK031115] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DK999999, Z01 DK031116-20] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; AKENSON M, 1997, J BIOL CHEM, V272, P17405; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Berthold M, 1997, NEUROCHEM RES, V22, P1023, DOI 10.1023/A:1022483027858; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; Boyer JL, 1996, BRIT J PHARMACOL, V118, P1959, DOI 10.1111/j.1476-5381.1996.tb15630.x; Burnstock G, 1996, DRUG DEVELOP RES, V38, P67, DOI 10.1002/(SICI)1098-2299(199605)38:1<67::AID-DDR9>3.0.CO;2-J; Camaioni E, 1998, J MED CHEM, V41, P183, DOI 10.1021/jm970433l; Cook JVF, 1996, ENDOCRINOLOGY, V137, P2851, DOI 10.1210/en.137.7.2851; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; ERB L, 1995, J BIOL CHEM, V270, P4185, DOI 10.1074/jbc.270.9.4185; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Filtz Theresa M., 1997, P39; FISCHER B, 1993, J MED CHEM, V36, P3937, DOI 10.1021/jm00076a023; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; HAN BM, 1995, MOL ENDOCRINOL, V9, P1708, DOI 10.1210/me.9.12.1708; HARDEN TK, 1988, BIOCHEM J, V252, P583, DOI 10.1042/bj2520583; Heerding JN, 1997, REGUL PEPTIDES, V72, P97, DOI 10.1016/S0167-0115(97)01042-2; Higuchi R., 1989, PCR TECHNOLOGY, P61; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HUANG RRC, 1994, MOL PHARMACOL, V45, P690; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Jakubik J, 1999, J BIOL CHEM, V274, P1349, DOI 10.1074/jbc.274.3.1349; Jiang QL, 1997, MOL PHARMACOL, V52, P499, DOI 10.1124/mol.52.3.499; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kim JH, 1996, MOL PHARMACOL, V49, P683; LeGouill C, 1997, FEBS LETT, V402, P203, DOI 10.1016/S0014-5793(96)01531-1; LEONG SR, 1994, J BIOL CHEM, V269, P19343; LUI J, 1995, P NATL ACAD SCI USA, V92, P11642; Moro S, 1998, J MED CHEM, V41, P1456, DOI 10.1021/jm970684u; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; NOVOTNY EA, 1994, BIOCHEM BIOPH RES CO, V201, P523, DOI 10.1006/bbrc.1994.1733; OHYAMA K, 1995, REGUL PEPTIDES, V57, P141, DOI 10.1016/0167-0115(95)00030-F; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schachter JB, 1997, BRIT J PHARMACOL, V121, P338, DOI 10.1038/sj.bjp.0701136; Silvente-Poirot S, 1998, MOL PHARMACOL, V54, P364, DOI 10.1124/mol.54.2.364; Van Rhee A M, 1995, Drug Des Discov, V13, P133; vanRhee AM, 1996, DRUG DEVELOP RES, V37, P1, DOI 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S; WALKER P, 1994, J BIOL CHEM, V269, P2863; Zhao MM, 1996, MOL PHARMACOL, V50, P1118	45	120	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14639	14647		10.1074/jbc.274.21.14639	http://dx.doi.org/10.1074/jbc.274.21.14639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329657	Green Submitted, hybrid, Green Accepted			2022-12-27	WOS:000081965200022
J	Wang, HP; Huang, W; Fei, YJ; Xia, H; Yang-Feng, TL; Leibach, FH; Devoe, LD; Ganapathy, V; Prasad, PD				Wang, HP; Huang, W; Fei, YJ; Xia, H; Yang-Feng, TL; Leibach, FH; Devoe, LD; Ganapathy, V; Prasad, PD			Human placental Na+-dependent multivitamin transporter - Cloning, functional expression, gene structure, and chromosomal localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; PROTEIN-KINASE-C; MULTIPLE CARBOXYLASE DEFICIENCY; CHORIOCARCINOMA CELL-LINE; BIOTIN TRANSPORT; INTESTINAL-ABSORPTION; TAURINE TRANSPORTER; PANTOTHENIC-ACID; KIDNEY CORTEX; RAT-KIDNEY	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR), The cDNA codes for a protein of 635 amino acids with 12 transmembrane domains and 4 putative sites for N-linked glycosylation, The human SMVT exhibits a high degree of homology (84% identity and 89% similarity) to the rat counterpart. When expressed in HRPE cells, the cDNA-induced transport process is obligatorily dependent on Na+ and accepts pantothenate, biotin, and lipoate as substrates, The relationship between the cDNA-specific uptake rate of pantothenate or biotin and Naf concentration is sigmoidal with a Na+:vitamin stoichiometry of 2:1, The human SMVT, when expressed in Xenopus laevis oocytes, induces inward currents in the presence of pantothenate, biotin, and lipoate in a Na+-, concentration-, and potential dependent manner. We also report here on the structural organization and chromosomal localization of the human SMVT gene. The SMVT gene is similar to 14 kilobase pairs in length and consists of 17 exons, The SMVT gene is located on chromosome 2p23 as evidenced by somatic cell hybrid analysis and fluorescence in situ hybridization.	Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Yale University	Prasad, PD (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.				NICHD NIH HHS [HD 33347] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033347] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARBARAT B, 1986, J BIOL CHEM, V261, P4455; BARBARAT B, 1991, J PHYSIOL-LONDON, V443, P79, DOI 10.1113/jphysiol.1991.sp018823; BAUMGARTNER R, 1982, HELV PAEDIATR ACTA, V37, P499; BAUR B, 1993, PFLUG ARCH EUR J PHY, V422, P499, DOI 10.1007/BF00375078; BAUR B, 1990, AM J PHYSIOL, V258, pF840, DOI 10.1152/ajprenal.1990.258.4.F840; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; FENSTERMACHER DK, 1986, AM J PHYSIOL, V250, pG155, DOI 10.1152/ajpgi.1986.250.2.G155; GANAPATHY V, 1995, CURR EYE RES, V14, P843, DOI 10.3109/02713689508995807; GRASSL SM, 1992, J BIOL CHEM, V267, P22902; GRASSL SM, 1992, J BIOL CHEM, V267, P17760; KARNITZ LM, 1984, BIOCHIM BIOPHYS ACTA, V769, P486, DOI 10.1016/0005-2736(84)90334-1; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KULANTHAIVEL P, 1991, BIOCHEM J, V277, P53, DOI 10.1042/bj2770053; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; Mackenzie B, 1996, BBA-BIOMEMBRANES, V1284, P125, DOI 10.1016/S0005-2736(96)00170-8; MUNNICH A, 1981, LANCET, V2, P263; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; PODEVIN RA, 1986, BIOCHIM BIOPHYS ACTA, V856, P471, DOI 10.1016/0005-2736(86)90138-0; Prasad PD, 1997, PLACENTA, V18, P527, DOI 10.1016/0143-4004(77)90006-6; Prasad PD, 1998, J NEUROCHEM, V70, P443; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; RAMAMOORTHY S, 1994, CURR EYE RES, V13, P523, DOI 10.3109/02713689408999884; SAID HM, 1987, AM J PHYSIOL, V253, pG631, DOI 10.1152/ajpgi.1987.253.5.G631; SAID HM, 1987, AM J PHYSIOL, V252, pG52, DOI 10.1152/ajpgi.1987.252.1.G52; SAID HM, 1992, BIOCHIM BIOPHYS ACTA, V1107, P238, DOI 10.1016/0005-2736(92)90410-N; SHAPER NL, 1992, GENOMICS, V12, P613, DOI 10.1016/0888-7543(92)90458-5; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; THOENE JG, 1983, NEW ENGL J MED, V308, P639, DOI 10.1056/NEJM198303173081107; THOENE JG, 1983, NEW ENGL J MED, V304, P817; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776	37	115	119	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14875	14883		10.1074/jbc.274.21.14875	http://dx.doi.org/10.1074/jbc.274.21.14875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329687	hybrid			2022-12-27	WOS:000081965200052
J	Yamashita, H; Avraham, S; Jiang, SX; Dikic, I; Avraham, H				Yamashita, H; Avraham, S; Jiang, SX; Dikic, I; Avraham, H			The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SIGNAL-TRANSDUCTION PATHWAYS; FAMILY TYROSINE KINASES; BREAST-CANCER CELLS; NEURONAL DIFFERENTIATION; PROTOONCOGENE PRODUCT; MOLECULAR-CLONING; BINDING-SITES; C-KIT; IDENTIFICATION	Csk homologous kinase (CHK), a member of the Csk regulatory tyrosine kinase family, is expressed primarily in brain and hematopoietic cells. The role of CHK in the nervous system is as yet unknown. Using PC12 cells as a model system of neuronal cells, we show that CHK participates in signaling mediated by TrkA receptors, CHK was found to be associated with tyrosine phosphorylated TrkA receptors in PC12 cells upon stimulation with NGF. Binding assays and far Western blotting analysis, using glutathione S-transferase fusion proteins containing the Src homology 2 (SH2) and SH3 domains of CHK, demonstrate that the SH2 domain of CHK binds directly to the tyrosine-phosphorylated TrkA receptors. Site-directed mutagenesis of TrkA cDNA, as well as phosphopeptide inhibition of the in vitro interaction of the CHK-SH2 domain or native CHK with TrkA receptors, indicated that the residue Tyr-785 on TrkA is required for its binding to the CHK-SH2 domain upon NGF stimulation. In addition, overexpression of CHK resulted in enhanced activation of the mitogen-activated protein kinase pathway upon NGF stimulation, and microinjection of anti-CHK antibodies, but not anti-Csk antibodies, inhibited neurite outgrowth of PC12 cells in response to NGF. Thus, CHK is a novel signaling molecule that participates in TrkA signaling, associates directly with TrkA receptors upon NGF stimulation, and is involved in neurite outgrowth of PC12 cells in response to NGF.	Beth Israel Deaconess Med Ctr, Div Expt Med, Harvard Inst Med, Harvard Med Sch, Boston, MA 02115 USA; Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Institute for Cancer Research	Avraham, H (corresponding author), Beth Israel Deaconess Med Ctr, Div Expt Med, Harvard Inst Med, Harvard Med Sch, 4 Blackfan Circle, Boston, MA 02115 USA.		Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511; Avraham, Hava/0000-0002-7545-3640	NCI NIH HHS [CA 76226] Funding Source: Medline; NHLBI NIH HHS [HL51456-02, HL55445] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055445, R01HL051456] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; AVRAHAM S, 1995, J BIOL CHEM, V270, P1833, DOI 10.1074/jbc.270.4.1833; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; BRINKLEY PM, 1995, GENE, V163, P179, DOI 10.1016/0378-1119(95)00352-7; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; JHUN BH, 1995, J BIOL CHEM, V270, P9661, DOI 10.1074/jbc.270.16.9661; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Keegan K, 1993, Curr Opin Neurobiol, V3, P14, DOI 10.1016/0959-4388(93)90029-X; Kita Y, 1998, J CELL SCI, V111, P907; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kuo SS, 1997, EUR J NEUROSCI, V9, P2383, DOI 10.1111/j.1460-9568.1997.tb01655.x; KUO SS, 1994, J NEUROSCI RES, V38, P705, DOI 10.1002/jnr.490380613; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MCVICAR DW, 1994, ONCOGENE, V9, P2037; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; SAKANO S, 1994, ONCOGENE, V9, P1155; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P4055, DOI 10.1073/pnas.74.9.4055; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zrihan-Licht S, 1998, J BIOL CHEM, V273, P4065, DOI 10.1074/jbc.273.7.4065; ZrihanLicht S, 1997, J BIOL CHEM, V272, P1856, DOI 10.1074/jbc.272.3.1856	41	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15059	15065		10.1074/jbc.274.21.15059	http://dx.doi.org/10.1074/jbc.274.21.15059			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329710	hybrid			2022-12-27	WOS:000081965200075
J	Middleton, SA; Barbone, FP; Johnson, DL; Thurmond, RL; You, Y; McMahon, FJ; Jin, RZ; Livnah, O; Tullai, J; Farrell, FX; Goldsmith, MA; Wilson, IA; Jolliffe, LK				Middleton, SA; Barbone, FP; Johnson, DL; Thurmond, RL; You, Y; McMahon, FJ; Jin, RZ; Livnah, O; Tullai, J; Farrell, FX; Goldsmith, MA; Wilson, IA; Jolliffe, LK			Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; GROWTH-HORMONE RECEPTOR; HUMAN TISSUE FACTOR; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; LIGAND-BINDING; HIGH-AFFINITY; HEMATOPOIETIC RECEPTORS; ANGSTROM RESOLUTION; PROTEIN HORMONE	We have shown previously that Phe(93) in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO. Substitution of Phe(93) with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells. Remarkably, Phe(93) forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (EMP1), suggesting that Phe(93) is also important for EMP1 binding. We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding. The three largest hydrophobic contacts at Phe(93) Met(150), and Phe(205) and a hydrogen bonding interaction at Thr(151) were examined. Our results indicate that Phe(93) and Phe(205) are important for both EPO and EMP1 binding, Met(150) is not important for EPO binding but is critical for EMP1 binding, and Thr(151) is not important for binding either ligand. Thus, Phe(93) and Phe(205) are important binding determinants for both EPO and EMP1, even though these ligands share no sequence or structural homology, suggesting that these residues mag represent a minimum epitope on the EPOR for productive ligand binding.	RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA; Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Johnson & Johnson; Johnson & Johnson USA; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Scripps Research Institute; Scripps Research Institute	Middleton, SA (corresponding author), RW Johnson Pharmaceut Res Inst, 1000 Route 202,POB 300, Raritan, NJ 08869 USA.	smiddlet@prius.jnj.com	McMahon, Francis J/A-7290-2009	McMahon, Francis J/0000-0002-9469-305X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049497, R01GM054351] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54351, GM49497] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbone FP, 1997, J BIOL CHEM, V272, P4985, DOI 10.1074/jbc.272.8.4985; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DONG YJ, 1993, EXP HEMATOL, V21, P483; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; HERMINE O, 1994, BLOOD, V84, P811; Horsten U, 1997, J BIOL CHEM, V272, P23748, DOI 10.1074/jbc.272.38.23748; Johnson DL, 1998, BIOCHEMISTRY-US, V37, P3699, DOI 10.1021/bi971956y; Johnson DL, 1996, PROTEIN EXPRES PURIF, V7, P104, DOI 10.1006/prep.1996.0014; JONES SS, 1990, BLOOD, V76, P31; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Klein BK, 1997, J BIOL CHEM, V272, P22630, DOI 10.1074/jbc.272.36.22630; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; KRANTZ SB, 1991, BLOOD, V77, P419; Layton JE, 1997, J BIOL CHEM, V272, P29735, DOI 10.1074/jbc.272.47.29735; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Middleton SA, 1996, J BIOL CHEM, V271, P14045, DOI 10.1074/jbc.271.24.14045; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Muller YA, 1996, J MOL BIOL, V256, P144, DOI 10.1006/jmbi.1996.0073; NAGAO M, 1993, BLOOD, V81, P2503; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Rajotte D, 1997, J EXP MED, V185, P1939, DOI 10.1084/jem.185.11.1939; SAWADA K, 1988, J CELL PHYSIOL, V137, P337, DOI 10.1002/jcp.1041370218; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; WARD WHJ, 1990, TRENDS PHARMACOL SCI, V11, P280, DOI 10.1016/0165-6147(90)90009-W; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; WELLS JA, 1995, BIO-TECHNOL, V13, P647, DOI 10.1038/nbt0795-647; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Yamasaki K, 1997, NAT STRUCT BIOL, V4, P498, DOI 10.1038/nsb0697-498; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001	47	43	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14163	14169		10.1074/jbc.274.20.14163	http://dx.doi.org/10.1074/jbc.274.20.14163			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318834	hybrid			2022-12-27	WOS:000080322200063
J	Pullen, SS; Dang, TTA; Crute, JJ; Kehry, MR				Pullen, SS; Dang, TTA; Crute, JJ; Kehry, MR			CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs) - Binding site specificity and activation of downstream pathways by distinct TRAFs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CROSS-LINKING CD40; TERMINAL KINASE; PROTEIN-KINASES; CELL-DEATH; P38 MAPK; IDENTIFICATION; DOMAIN; PROLIFERATION; INDUCTION	Tumor necrosis factor receptor-associated factors (TRAFs) associate with the CD40 cytoplasmic domain and initiate signaling after CD40 receptor multimerization by its ligand. We used saturating peptide-based mutational analyses of the TRAF1/TRAF2/TRAF3 and TRAF6 binding sequences in CD40 to finely map residues involved in CD40-TRAF interactions, The core binding site for TRAF1, TRAF2, and TRAF3 in CD40 could be minimally substituted. The TRAF6 binding site demonstrated more amino acid sequence flexibility and could be optimized. Point mutations that eliminated or enhanced binding of TRAFs to one or both sites were made in CD40 and tested in quantitative CD40-TRAF binding assays. Sequences flanking the core TRAF binding sites were found to modulate TRAF binding, and the two TRAF binding sites were not independent. Cloned stable transfectants of human embryonic kidney 293 cells that expressed wild type CD40 or individual CD40 mutations were used to demonstrate that both TRAF binding sites were required for optimal NF-kappa B and c-Jun N-terminal kinase activation. in contrast, p38 mitogen-activated protein kinase activation was primarily dependent upon TRAF6 binding, These studies suggest a role in CD40 signaling for competitive TRAF binding and imply that CD40 responses reflect an integration of signals from individual TRAFs.	Boehringer Ingelheim Pharmaceut Inc, Dept Biol, Ridgefield, CT 06877 USA	Boehringer Ingelheim	Kehry, MR (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Biol, 900 Ridgebury Rd,POB 368,Mail Code R6-5, Ridgefield, CT 06877 USA.							Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpentier I, 1998, FEBS LETT, V425, P195, DOI 10.1016/S0014-5793(98)00226-9; CHENG C, 1996, GENE DEV, V10, P963; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Craxton A, 1998, J IMMUNOL, V161, P3225; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; DRACHEVA S, 1995, J BIOL CHEM, V270, P14148, DOI 10.1074/jbc.270.23.14148; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Franken M, 1996, J VIROL, V70, P7819, DOI 10.1128/JVI.70.11.7819-7826.1996; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldstein MD, 1996, J IMMUNOL, V157, P2837; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARDY RR, 1986, HDB EXPT IMMUNOLOGY, V13, P1; HODGKIN PD, 1990, J IMMUNOL, V145, P2025; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hsing Y, 1997, J IMMUNOL, V159, P4898; HU HM, 1994, J BIOL CHEM, V269, P30069; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; JACKSON S, 1982, J IMMUNOL METHODS, V48, P299, DOI 10.1016/0022-1759(82)90331-3; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kehry MR, 1996, J IMMUNOL, V156, P2345; Kramer Achim, 1994, Methods (Orlando), V6, P388, DOI 10.1006/meth.1994.1039; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Purkerson JM, 1998, J IMMUNOL, V160, P2121; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Salmon RA, 1997, J IMMUNOL, V159, P5309; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Sutherland CL, 1996, J IMMUNOL, V157, P3381; vanKooten C, 1997, INT ARCH ALLERGY IMM, V113, P393, DOI 10.1159/000237614; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	46	147	165	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14246	14254		10.1074/jbc.274.20.14246	http://dx.doi.org/10.1074/jbc.274.20.14246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318845	hybrid			2022-12-27	WOS:000080322200074
J	Webb, Y; Zhou, XB; Ngo, L; Cornish, V; Stahl, J; Erdjument-Bromage, H; Tempst, P; Rifkind, RA; Marks, PA; Breslow, R; Richon, VM				Webb, Y; Zhou, XB; Ngo, L; Cornish, V; Stahl, J; Erdjument-Bromage, H; Tempst, P; Rifkind, RA; Marks, PA; Breslow, R; Richon, VM			Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMED-CELL DIFFERENTIATION; MURINE ERYTHROLEUKEMIA-CELLS; SEQUENCE DATABASES; RAT-LIVER; DNA; INDUCERS; SUBUNIT; CROSSLINKING; SUPPRESSION; CONTAINS	The ability of a novel class of hybrid polar compounds (HPCs) to induce differentiation and consequent cessation of proliferation of transformed cells has led to their development as potential chemotherapeutic agents in the treatment of cancer. Suberoylanilide hydroxamic acid (SAHA) is a prototype of a family of hydroxamic acid based compounds (SAHA-like HPCs) that can, at micromolar concentrations, induce a variety of transformed cell lines to differentiate. The mechanism of action of the HPCs is not entirely understood. Searching for a cellular target of the SAHA-like HPCs, we synthesized a photoaffinity labeling reagent structurally based on SAHA, and probed for SAHA-binding proteins in murine erythroleukemia (MEL) cells. Photoaffinity labeling in cell free extracts identified a 32-kDa protein (p32) that was specifically labeled by the photoaffinity reagent. Cell fractionation assays localized p32 to the P100 fraction, p32 was partially purified and identified by mass spectrometry as the 40 S ribosomal protein S3. Expression of epitope-tagged S3 in bacterial lysates followed by photoaffinity labeling confirmed its specific labeling. Identification of a cytodifferentiation agent target may shed light on the mechanism by which the SAHA-like HPCs exert their antitumor effects.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Memorial Sloan Kettering Cancer Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Memorial Sloan Kettering Cancer Center; Columbia University	Richon, VM (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.			Erdjument-Bromage, Hediye/0000-0003-0224-3594; Zhou, Xianbo/0000-0003-3544-7497	NCI NIH HHS [CA-0974823, P30 CA08748] Funding Source: Medline; NIGMS NIH HHS [GM18754-35A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018754, R37GM018754] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FA, 1998, CURRENT PROTOCALS MO; Bayley H, 1983, LAB TECHNIQUES BIOCH, V12; BOMMER UA, 1991, BIOCHIMIE, V73, P1007, DOI 10.1016/0300-9084(91)90142-N; BRESLOW R, 1991, P NATL ACAD SCI USA, V88, P5542, DOI 10.1073/pnas.88.13.5542; CHEN ZX, 1982, P NATL ACAD SCI-BIOL, V79, P471, DOI 10.1073/pnas.79.2.471; COREY EJ, 1977, TETRAHEDRON LETT, P3529; Deutsch WA, 1997, J BIOL CHEM, V272, P32857, DOI 10.1074/jbc.272.52.32857; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1996, ANAL CHEM, V68, pA721, DOI 10.1021/ac9621579; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Geromanos S, 1998, RAPID COMMUN MASS SP, V12, P551, DOI 10.1002/(SICI)1097-0231(19980515)12:9<551::AID-RCM198>3.3.CO;2-P; GRABOWSKI DT, 1991, NUCLEIC ACIDS RES, V19, P4297, DOI 10.1093/nar/19.15.4297; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; LUTSCH G, 1990, EUR J CELL BIOL, V51, P140; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; MARKS PA, 1989, P NATL ACAD SCI USA, V86, P6358, DOI 10.1073/pnas.86.16.6358; Marks PA, 1996, INT J HEMATOL, V63, P1; MARKS PA, 1992, CONCISE REV CLIN EXP, P91; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; NOMURA S, 1986, CELL, V44, P663, DOI 10.1016/0092-8674(86)90275-8; PALAI S, 1988, CHEM FUNCTIONAL GROU; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; REUBEN RC, 1978, J BIOL CHEM, V253, P4214; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; RICHON V, 1992, MOL CELLULAR APPROAC, P243; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; RICHON VM, 1994, CELL BIOL LAB HDB, V1, P213; Rifkind RA, 1996, PHARMACOL THERAPEUT, V69, P97, DOI 10.1016/0163-7258(95)02044-6; Sandigursky M, 1997, J BIOL CHEM, V272, P17480, DOI 10.1074/jbc.272.28.17480; SAUDIN RB, 1943, ORG SYN, V2, P196; TOLAN DR, 1983, BIOCHIMIE, V65, P427, DOI 10.1016/S0300-9084(83)80062-5; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; WESTERMANN P, 1979, FEBS LETT, V97, P101, DOI 10.1016/0014-5793(79)80061-7; WILLGERODT C, 1904, CHEM BERICHTE, V3351; WILSON DM, 1994, J BIOL CHEM, V269, P25359; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101	43	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14280	14287		10.1074/jbc.274.20.14280	http://dx.doi.org/10.1074/jbc.274.20.14280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318849	hybrid			2022-12-27	WOS:000080322200078
J	Chutkow, WA; Makielski, JC; Nelson, DJ; Burant, CF; Fan, Z				Chutkow, WA; Makielski, JC; Nelson, DJ; Burant, CF; Fan, Z			Alternative splicing of sur2 exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PIG VENTRICULAR MYOCYTES; HEART CELL-MEMBRANE; PANCREATIC B-CELLS; K+ CHANNEL; SULFONYLUREA RECEPTOR; SKELETAL-MUSCLE; SMOOTH-MUSCLE; FUNCTIONAL SIMILARITIES; DISTINCT FUNCTIONS	ATP-sensitive potassium channels (K-ATP) are implicated in a diverse array of physiological functions. Previous work has shown that alternative usage of exons 14, 39, and 40 of the muscle-specific K-ATP channel regulatory subunit,, sur2, occurs in tissue-specific patterns. Here, we show that exon 17 of the first nucleotide binding fold of sur2 is also alternatively spliced. RNase protection demonstrates that SUR2(Delta 17) predominates in skeletal muscle and gut and is also expressed in bladder, fat, heart, lung, liver, and kidney. Polymerase chain reaction and restriction digest analysis of sur2 cDNA demonstrate the existence of at least five sur2 splice variants as follows: SUR2(39), SUR2(40), SUR2(Delta 17/39), SUR2(Delta 17/40), and SUR2(Delta 14/39). Electrophysiological recordings of excised, inside-out patches from COS cells cotransfected with Kir6.2 and the sur2 variants demonstrated that exon 17 splicing alters KATP sensitivity to ATP block, by a;fold hom;approximate to 40 to approximate to 90 mu M for exon 17 and Delta 17, respectively. Single channel kinetic analysis of SUR2(39) and SUR2(Delta 17/39) demonstrated that both exhibited characteristic K-ATP kinetics but that SUR2(Delta 17/39) exhibited longer mean burst durations and shorter mean interburst dwell times. In sum, alternative splicing of sur2 enhances the observed diversity of K-ATP and may contribute to tissue-specific modulation of ATP sensitivity.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Univ Wisconsin, Dept Med, Madison, WI 53792 USA	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Burant, CF (corresponding author), Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.		Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058133, R01HL057414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002170] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL58133-01, R01-HL57414] Funding Source: Medline; NIDDK NIH HHS [DK-K08-02170] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Akao M, 1997, J CLIN INVEST, V100, P3053, DOI 10.1172/JCI119860; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; Alekseev AE, 1997, J MEMBRANE BIOL, V159, P161, DOI 10.1007/s002329900279; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEECH DJ, 1993, BRIT J PHARMACOL, V110, P573, DOI 10.1111/j.1476-5381.1993.tb13849.x; BLEICH M, 1990, PFLUG ARCH EUR J PHY, V415, P449, DOI 10.1007/BF00373623; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Carson MR, 1995, BIOPHYS J, V69, P2443, DOI 10.1016/S0006-3495(95)80113-X; Chutkow WA, 1996, DIABETES, V45, P1439, DOI 10.2337/diabetes.45.10.1439; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; FAN Z, 1990, PFLUG ARCH EUR J PHY, V415, P387, DOI 10.1007/BF00373613; FAN Z, 1990, J PHYSIOL-LONDON, V430, P273, DOI 10.1113/jphysiol.1990.sp018291; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HIRAOKA M, 1989, J PHARMACOL EXP THER, V250, P278; HIRAOKA M, 1993, CARDIOVASC DRUG THER, V7, P593, DOI 10.1007/BF00877625; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; KAJIOKA S, 1991, J PHYSIOL-LONDON, V444, P397, DOI 10.1113/jphysiol.1991.sp018885; KO YH, 1995, J BIOL CHEM, V270, P22093, DOI 10.1074/jbc.270.38.22093; MANAVALAN P, 1995, FEBS LETT, V366, P87, DOI 10.1016/0014-5793(95)00463-J; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Quast U, 1996, N-S ARCH PHARMACOL, V354, P213; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P659, DOI 10.1113/jphysiol.1984.sp015089; Sambrook J., 1989, MOL CLONING; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; SPRUCE AE, 1987, J PHYSIOL-LONDON, V382, P213, DOI 10.1113/jphysiol.1987.sp016364; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Tokuyama Y, 1996, BIOCHEM BIOPH RES CO, V220, P532, DOI 10.1006/bbrc.1996.0439; TRUBE G, 1984, PFLUG ARCH EUR J PHY, V401, P178, DOI 10.1007/BF00583879; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; YOSHIDA M, 1995, FEBS LETT, V359, P1, DOI 10.1016/0014-5793(94)01438-7	54	81	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13656	13665		10.1074/jbc.274.19.13656	http://dx.doi.org/10.1074/jbc.274.19.13656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224138	hybrid			2022-12-27	WOS:000080200400100
J	Holinger, EP; Chittenden, T; Lutz, RJ				Holinger, EP; Chittenden, T; Lutz, RJ			Bak BH3 peptides antagonize Bcl-x(L) function and induce apoptosis through cytochrome c-independent activation of caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; INDUCED CELL-DEATH; SURVIVAL-PROMOTING PROTEINS; POLY(ADP-RIBOSE) POLYMERASE; PERMEABILITY TRANSITION; FAMILY PROTEINS; ION-CHANNEL; HETERODIMERIZATION; INHIBITION; DOMAIN	The Bcl-2 homology 3 (BH3) domain is crucial for the death-inducing and dimerization properties of pro-apoptotic members of the Bcl-2 protein family, including Bak, Bar, and Bad. Here we report that synthetic peptides corresponding to the BH3 domain of Bak bind to Bcl-x(L), antagonize its anti-apoptotic function, and rapidly induce apoptosis when delivered into intact cells via fusion to the Antennapedia homeoprotein internalization domain. Treatment of HeLa cells with the Antennapedia-BH3 fusion peptide resulted in peptide internalization and induction of apoptosis within 2-3 h, as indicated by caspase activation and subsequent poly(ADP-ribose) polymerase cleavage, as well as morphological characteristics of apoptosis, A point mutation within the BH3 peptide that blocks its ability to bind to Bcl-x(L) abolished its apoptotic activity, suggesting that interaction of the BH3 peptide with Eel-a-related death suppressors, such as Bcl-x(L), may be critical for its activity in cells. While overexpression of Bcl-x(L) can block BH3-induced apoptosis, treatment with BH3 peptides resensitized Bcl-x(L)-expressing cells to Fas-mediated apoptosis, BH3-induced apoptosis was blocked by caspase inhibitors, demonstrating a dependence on caspase activation, but was not accompanied by a dramatic early loss of mitochondrial membrane potential or detectable translocation of cytochrome c from mitochondria to cytosol, These findings demonstrate that the BH3 domain itself is capable of inducing apoptosis in whole cells, possibly by antagonizing the function of Eel-a-related death suppressors.	Apoptosis Technol Inc, Cambridge, MA 02139 USA		Lutz, RJ (corresponding author), Apoptosis Technol Inc, 148 Sidney St, Cambridge, MA 02139 USA.							Adachi S, 1998, J BIOL CHEM, V273, P19892, DOI 10.1074/jbc.273.31.19892; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BALL KL, 1996, CURR BIOL, V7, P71; Bonfanti M, 1997, CANCER RES, V57, P1442; BOYD JM, 1995, ONCOGENE, V11, P1921; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Chauhan D, 1997, J BIOL CHEM, V272, P29995, DOI 10.1074/jbc.272.48.29995; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Diaz JL, 1997, J BIOL CHEM, V272, P11350; Fahraeus R, 1996, CURR BIOL, V6, P84, DOI 10.1016/S0960-9822(02)00425-6; Hall H, 1996, CURR BIOL, V6, P580, DOI 10.1016/S0960-9822(02)00544-4; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; Hegde R, 1998, J BIOL CHEM, V273, P7783, DOI 10.1074/jbc.273.14.7783; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kitanaka C, 1997, ONCOGENE, V15, P1763, DOI 10.1038/sj.onc.1201349; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; LABEZNIK YA, 1994, NATURE, V371, P346; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ottilie S, 1997, J BIOL CHEM, V272, P30866, DOI 10.1074/jbc.272.49.30866; Ottilie S, 1997, CELL DEATH DIFFER, V4, P526, DOI 10.1038/sj.cdd.4400288; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Simonian PL, 1996, J BIOL CHEM, V271, P22764, DOI 10.1074/jbc.271.37.22764; Simonian PL, 1997, ONCOGENE, V15, P1871, DOI 10.1038/sj.onc.1201350; Strasser A, 1997, BBA-REV CANCER, V1333, pF151, DOI 10.1016/S0304-419X(97)00019-X; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THEODORE L, 1995, J NEUROSCI, V15, P7158; Williams EJ, 1997, J BIOL CHEM, V272, P22349, DOI 10.1074/jbc.272.35.22349; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1997, J BIOL CHEM, V272, P31482, DOI 10.1074/jbc.272.50.31482; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	59	235	280	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13298	13304		10.1074/jbc.274.19.13298	http://dx.doi.org/10.1074/jbc.274.19.13298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224090	hybrid			2022-12-27	WOS:000080200400052
J	Kondejewski, LH; Jelokhani-Niaraki, M; Farmer, SW; Lix, B; Kay, CM; Sykes, BD; Hancock, REW; Hodges, RS				Kondejewski, LH; Jelokhani-Niaraki, M; Farmer, SW; Lix, B; Kay, CM; Sykes, BD; Hancock, REW; Hodges, RS			Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PROTEIN SECONDARY STRUCTURE; ALPHA-HELICAL PEPTIDES; GRAMICIDIN-S ANALOGS; PSEUDOMONAS-AERUGINOSA; BETA-SHEET; HYDROPHOBIC MOMENT; CIRCULAR-DICHROISM; LIPID BILAYERS; OUTER-MEMBRANE	We have investigated the role of amphipathicity in a homologous series of head-to-tail cyclic antimicrobial peptides in efforts to delineate features resulting in high antimicrobial activity coupled with low hemolytic activity (Le. a high therapeutic index). The peptide GS14, cyclo(VKLKVd-YPLKVKLd-YP), designed on the basis of gramicidin S (GS), exists in a preformed highly amphipathic beta-sheet conformation and was used as the base compound for this study. Fourteen diastereomers of GS14 were synthesized; each contained a different single enantiomeric substitution within the framework of GS14, The beta-sheet structure of all GS14 diastereomers was disrupted as determined by CD and NMR spectroscopy under aqueous conditions; however, all diastereomers exhibited differential structure inducibility in hydrophobic environments. Because the diastereomers all have the same composition, sequence, and intrinsic hydrophobicity, the amphipathicity of the diastereomers could be ranked based upon retention time from reversed-phase high performance liquid chromatography, There was a clear correlation showing that high amphipathicity resulted in high hemolytic activity and low antimicrobial activity in the diastereomers, The latter may be the result of increased affinity of highly amphipathic peptides to outer membrane components of Gram-negative microorganisms. The diastereomers possessing the most favorable therapeutic indices possessed some of the lowest amphipathicities, although there was a threshold value below which antimicrobial activity decreased. The best diastereomer exhibited 130-fold less hemolytic activity compared with GS14, as well as greatly increased antimicrobial activities, resulting in improvement in therapeutic indices of between 1,000- and 10,000 fold for a number of microorganisms. The therapeutic indices of this peptide were between 16- and 32-fold greater than GS for Gram-negative microorganisms and represents a significant improvement in specificity over GS, Our findings show that a highly amphipathic nature is not desirable in the design of constrained cyclic antimicrobial peptides and that an optimum amphipathicity can be defined by systematic enantiomeric substitutions.	Univ Alberta, Ctr Excellence, Prot Engn Network, Edmonton, AB T6G 2S2, Canada; Univ British Columbia, Canadian Bacterial Dis Network, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Microbiol, Vancouver, BC V6T 1Z3, Canada	University of Alberta; University of British Columbia; University of British Columbia	Hodges, RS (corresponding author), Univ Alberta, Ctr Excellence, Prot Engn Network, Edmonton, AB T6G 2S2, Canada.		Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Farmer, Susan/0000-0002-6712-7810				BLANCO FJ, 1994, BIOCHEMISTRY-US, V33, P6004, DOI 10.1021/bi00185a041; BLONDELLE SE, 1992, BIOCHEMISTRY-US, V31, P12688, DOI 10.1021/bi00165a020; CAGAS PM, 1995, PROT STRUCT FUNCT GE, V21, P141; CREIGHTON TE, 1984, PROTEINS STRUCTURES, P171; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Gause GF, 1944, NATURE, V154, P703, DOI 10.1038/154703a0; Gibbs AC, 1998, NAT STRUCT BIOL, V5, P284, DOI 10.1038/nsb0498-284; GUO DC, 1986, J CHROMATOGR, V359, P499, DOI 10.1016/0021-9673(86)80102-9; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; HULL SE, 1978, NATURE, V275, P206, DOI 10.1038/275206a0; IZUMIYA N, 1979, SYNTHETIC ASPECTS BI, P49; KATAYAMA T, 1994, J PHARM SCI, V83, P1357, DOI 10.1002/jps.2600830930; Kondejewski LH, 1996, J BIOL CHEM, V271, P25261, DOI 10.1074/jbc.271.41.25261; Krause E, 1996, INT J PEPT PROT RES, V48, P559; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Mant CT, 1998, J CHROMATOGR A, V816, P65, DOI 10.1016/S0021-9673(98)00507-X; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; NICAS TI, 1983, J GEN MICROBIOL, V129, P509; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; OVCHINNIKOV YA, 1975, TETRAHEDRON, V31, P2177, DOI 10.1016/0040-4020(75)80216-X; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PATHAK N, 1995, PROTEINS, V22, P182, DOI 10.1002/prot.340220210; Prenner EJ, 1997, BIOCHEMISTRY-US, V36, P7906, DOI 10.1021/bi962785k; RACKOVSKY S, 1980, P NATL ACAD SCI USA, V77, P6965, DOI 10.1073/pnas.77.12.6965; Rothemund S, 1996, PEPTIDE RES, V9, P79; SEREDA TJ, 1994, J CHROMATOGR A, V676, P139, DOI 10.1016/0021-9673(94)00371-8; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; TAMAKI M, 1987, J CHROMATOGR-BIOMED, V413, P287, DOI 10.1016/0378-4347(87)80241-4; TRAVIS J, 1994, SCIENCE, V264, P360, DOI 10.1126/science.8153615; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wishart DS, 1996, LETT PEPT SCI, V3, P53, DOI 10.1007/BF00131086; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; ZHOU N E, 1990, Peptide Research, V3, P8	41	228	239	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13181	13192		10.1074/jbc.274.19.13181	http://dx.doi.org/10.1074/jbc.274.19.13181			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224074	hybrid			2022-12-27	WOS:000080200400036
J	Munz, B; Wiedmann, M; Lochmuller, H; Werner, S				Munz, B; Wiedmann, M; Lochmuller, H; Werner, S			Cloning of novel injury-regulated genes - Implications for an important role of the muscle-specific protein skNAC in muscle repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGENERATING SKELETAL-MUSCLE; SATELLITE CELLS; ENDOPLASMIC-RETICULUM; MYOGENIN; COMPLEX; GROWTH; MOUSE; EXPRESSION; ACTIN; MYOD	To gain insight into the molecular mechanisms underlying the wound repair process, we searched for genes that are regulated by skin injury. Using the differential display reverse transcription-polymerase chain reaction technique, we identified a gene that was strongly induced as early as 12 h after wounding. Sequence analysis revealed the identity of the corresponding protein with skeletal muscle nascent polypeptide-associated complex (skNAC), a recently identified muscle-specific transcription factor. By in situ hybridization and immunohistochemistry, we demonstrated the specific expression of skNAC in skeletal muscle cells of the panniculus carnosus at the wound edge. Furthermore, in vitro studies with cultured myoblasts revealed expression of skNAC in differentiating and differentiated, but not in proliferating, nondifferentiated cells. Differentiation of cultured myoblasts was accompanied by simultaneous expression of skNAC and the muscle-specific transcription factor myogenin. Our results provide the first evidence for a role of skNAC in muscle repair processes. Furthermore, they demonstrate the usefulness of our approach in identifying new players in wound repair.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Univ Munich, Genzentrum, D-81377 Munich, Germany; Univ Munich, Friedrich Baur Inst, D-80336 Munich, Germany	Max Planck Society; Memorial Sloan Kettering Cancer Center; University of Munich; University of Munich	Werner, S (corresponding author), ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.			Werner, Sabine/0000-0001-7397-8710; Lochmuller, Hanns/0000-0003-2324-8001				ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BAUER D, 1994, PCR METH APPL, V4, P97; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK RAF, 1996, MOL CELLULAR BIOL WO, P8; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Franke WW, 1996, DIFFERENTIATION, V60, P245, DOI 10.1046/j.1432-0436.1996.6040245.x; FUCHTBAUER EM, 1992, DEV DYNAM, V193, P34; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; HAM RG, 1988, IN VITRO CELL DEV B, V24, P833; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; LAURING B, 1995, P NATL ACAD SCI USA, V92, P9435, DOI 10.1073/pnas.92.21.9435; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; ROSENTHAL A, 1987, EMBO J, V6, P3641, DOI 10.1002/j.1460-2075.1987.tb02696.x; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763	19	27	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13305	13310		10.1074/jbc.274.19.13305	http://dx.doi.org/10.1074/jbc.274.19.13305			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224091	hybrid			2022-12-27	WOS:000080200400053
J	Spiridonov, NA; Wilson, DB				Spiridonov, NA; Wilson, DB			Characterization and cloning of CelR, a transcriptional regulator of cellulase genes from Thermomonospora fusca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-LIVIDANS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; LAC REPRESSORS; DNA-SEQUENCES; PROTEIN; EXPRESSION; IDENTIFICATION; ENDOGLUCANASE; AVICELASE	CelR, a protein that regulates transcription of cellulase genes in Thermomonospora fusca (Actinomycetaceae) was purified to homogeneity. A B-kilobase NotI-SacI fragment of T. fusca DNA containing the celR gene was cloned into Esherichia coli and sequenced. The celR gene encodes a 340-residue polypeptide that is highly homologous to members of the GalR-LacI family of bacterial transcriptional regulators. CelR specifically binds to a Ii-base pair inverted repeat, which has sequence similarity to the binding sites of other family members. This site is present in regions upstream of all six cellulase genes in T. fusca. The binding of CelR to the celE promoter is inhibited specifically by low concentrations of cellobiose (0.2-0.5 mM), the major end product of cellulases. The other sugars tested did not affect binding at equivalent or 50-fold higher concentrations. The results suggest that CelR may act as a repressor, and that the mechanism of induction involves a direct interaction of CelR with cellobiose.	Cornell Univ, Biochem Mol & Cell Biol Sect, Ithaca, NY 14853 USA	Cornell University	Wilson, DB (corresponding author), Cornell Univ, Biochem Mol & Cell Biol Sect, 458 Biotechnol Bldg,, Ithaca, NY 14853 USA.	dbw3@cornell.edu	Spiridonov, Nikolay/B-6287-2014					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; FERNANDEZABALOS JM, 1992, J BACTERIOL, V174, P6368; GLASS DB, 1986, J BIOL CHEM, V261, P2987; HAGERDAL BGR, 1978, APPL ENVIRON MICROB, V36, P606; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; JUNG ED, 1993, APPL ENVIRON MICROB, V59, P3032, DOI 10.1128/AEM.59.9.3032-3043.1993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAO G, 1991, J BACTERIOL, V173, P3397, DOI 10.1128/jb.173.11.3397-3407.1991; LIN E, 1987, APPL ENVIRON MICROB, V53, P1352, DOI 10.1128/AEM.53.6.1352-1357.1987; LIN E, 1988, J BACTERIOL, V170, P3843, DOI 10.1128/jb.170.9.3843-3846.1988; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; NAKAI R, 1988, GENE, V65, P229; Nguyen J, 1997, J BACTERIOL, V179, P6383, DOI 10.1128/jb.179.20.6383-6390.1997; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Saloheimo A., 1998, CARBOHYDRASES TRICHO, P267; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLOCHTERMEIER A, 1992, MOL MICROBIOL, V6, P3611, DOI 10.1111/j.1365-2958.1992.tb01797.x; Spiridonov NA, 1998, J BACTERIOL, V180, P3529, DOI 10.1128/JB.180.14.3529-3532.1998; THEBERGE M, 1992, APPL ENVIRON MICROB, V58, P815; Walter S, 1996, MOL GEN GENET, V251, P186, DOI 10.1007/s004380050156; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WILSON DB, 1992, CRIT REV BIOTECHNOL, V12, P45, DOI 10.3109/07388559209069187; WILSON DB, 1999, IN PRESS RECENT PROG; ZHANG S, 1995, BIOCHEMISTRY-US, V34, P3386, DOI 10.1021/bi00010a030	30	50	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13127	13132		10.1074/jbc.274.19.13127	http://dx.doi.org/10.1074/jbc.274.19.13127			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224066	hybrid			2022-12-27	WOS:000080200400028
J	Huete-Perez, JA; Engel, JC; Brinen, LS; Mottram, JC; McKerrow, JH				Huete-Perez, JA; Engel, JC; Brinen, LS; Mottram, JC; McKerrow, JH			Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI; CYSTEINE PROTEINASE; PROCATHEPSIN-L; LEISHMANIA-MEXICANA; AMINO-ACID; CATHEPSIN-L; GENES; SEQUENCE; PROPEPTIDE; EXPRESSION	Trypanosome protozoa, an early lineage of eukaryotic cells, have proteases homologous to mammalian lysosomal cathepsins, but the precursor proteins lack mannose 6-phosphate. Utilizing green fluorescent protein as a reporter, we demonstrate that the carbohydrate-free prodomain of a trypanosome cathepsin L is necessary and sufficient for directing green fluorescent protein to the lysosome/endosome compartment. A proper prodomain/catalytic domain processing site sequence is also required to free the mature protease for delivery to the lysosome/endosome compartment. A nine-amino acid prodomain loop motif, implicated in prodomain-receptor interactions in mammalian cells, is conserved in the protozoa, Site-directed mutagenesis now confirms the importance of this loop to protease trafficking and suggests that a protein motif targeting signal for lysosomal proteases arose early in eukaryotic cell evolution.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94121 USA; Univ Glasgow, Anderson Coll, Wellcome Unit Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Glasgow	McKerrow, JH (corresponding author), Univ Calif San Francisco, Dept Pathol, VAMC-113B,4150 Clement St, San Francisco, CA 94121 USA.		Huete-Perez, Jorge/AAJ-9840-2021	Huete-Perez, Jorge A./0000-0001-5259-8428; Mottram, Jeremy/0000-0001-5574-3766	NIAID NIH HHS [AI35707] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BART G, 1995, MOL BIOCHEM PARASIT, V73, P271, DOI 10.1016/0166-6851(95)00113-F; CAZZULO JJ, 1990, MOL BIOCHEM PARASIT, V38, P41, DOI 10.1016/0166-6851(90)90203-X; CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X; Cazzulo JJ, 1996, CELL MOL BIOL, V42, P691; CONNER GE, 1992, J BIOL CHEM, V267, P21738; Coombs GH, 1997, PARASITOLOGY, V114, pS61, DOI 10.1017/S003118209700111X; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; DelNery E, 1997, J BIOL CHEM, V272, P25713, DOI 10.1074/jbc.272.41.25713; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Drenth J, 1971, Adv Protein Chem, V25, P79, DOI 10.1016/S0065-3233(08)60279-X; DUBOISE SM, 1994, MOL BIOCHEM PARASIT, V68, P119, DOI 10.1016/0166-6851(94)00157-X; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Engel JC, 1998, J CELL SCI, V111, P597; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HARIHARAN S, 1993, MOL BIOCHEM PARASIT, V57, P15, DOI 10.1016/0166-6851(93)90240-X; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; KENDALL G, 1990, EMBO J, V9, P2751, DOI 10.1002/j.1460-2075.1990.tb07462.x; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MACH L, 1994, J BIOL CHEM, V269, P13030; MCINTYRE GF, 1991, J BIOL CHEM, V266, P15438; MCINTYRE GF, 1994, J BIOL CHEM, V269, P567; MCINTYRE GF, 1993, P NATL ACAD SCI USA, V90, P10588, DOI 10.1073/pnas.90.22.10588; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; PIPER J, 1995, CYTOMETRY, V19, P10, DOI 10.1002/cyto.990190104; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Sack J. S., 1988, J MOL GRAPHICS, V6, P244; Sakanari JA, 1997, EXP PARASITOL, V85, P63, DOI 10.1006/expr.1996.4116; SOUZA AE, 1992, FEBS LETT, V311, P124, DOI 10.1016/0014-5793(92)81382-V; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; TRAUBCSEKO YM, 1993, MOL BIOCHEM PARASIT, V57, P101, DOI 10.1016/0166-6851(93)90248-V	34	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16249	16256		10.1074/jbc.274.23.16249	http://dx.doi.org/10.1074/jbc.274.23.16249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347181	hybrid			2022-12-27	WOS:000080668600041
J	Lee, YF; Young, WJ; Lin, WJ; Shyr, CR; Chang, CS				Lee, YF; Young, WJ; Lin, WJ; Shyr, CR; Chang, CS			Differential regulation of direct repeat 3 vitamin D-3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; D-RESPONSIVE ELEMENTS; MAJOR LATE PROMOTER; STEROID-RECEPTOR; GENE-EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; 24-HYDROXYLASE GENE; X-RECEPTOR; MOLECULAR MECHANISMS; COUP-TF	In situ hybridization analysis demonstrated that abundant testicular orphan receptor (TR4) transcripts were detected in kidney, intestine, and bone, which are vitamin D-3 target organs. Cell transfection studies also demonstrated that the expression of the vitamin D-3 target gene, 25-hydroxyvitamin D-3 24-hydroxylase, can be repressed by TR4 through high affinity binding (K-d = 1.32 nM) to the direct repeat 3 vitamin D-3 receptor response element (DR3VDRE). This TR4-mediated repression of DR3VDRE is in contrast to our earlier report that TR4 could induce thyroid hormone target genes containing a direct repeat 4 thyroid hormone response element (DR4T(3)RE). Electrophoretic mobility shift assay using several TR4 monoclonal antibodies when combined with either TR4-DR3VDRE or TR4-DR4T(3)RE showed a distinct supershifted pattern, and proteolytic analysis further demonstrated distinct digested peptides with either TR4-DR3VDRE or TR4-DR4T(3)RE, These results may therefore suggest that TR4 can adapt to different conformations once bound to DR3VDRE or DR4T(3)RE. The consequence of these different conformations of TR4-DR3VDRE and TR4-DR4T(3)RE may allow each of them to recruit different coregulators. The differential repression of TR4-mediated DR3VDRE and DR4T(3)RE transactivation by the receptor interacting protein 140, a TR4 coregulator, further strengthens our hypothesis that the specificity of gene regulation by TR4 can be modulated by protein-DNA and protein-protein interactions.	Univ Rochester, Med Ctr, Dept Pathol Urol Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol Urol Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	chang@pathology.rochester.edu	Lin, Wen-Jye/D-1028-2016		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047258] Funding Source: NIH RePORTER; NCI NIH HHS [CA68568, CA71570] Funding Source: Medline; NIDDK NIH HHS [DK47258] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BROMMAGE R, 1985, ENDOCR REV, V6, P491, DOI 10.1210/edrv-6-4-491; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; CHANG C, 1989, BIOCHEM BIOPH RES CO, V165, P735, DOI 10.1016/S0006-291X(89)80028-2; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; Davideau JL, 1996, ENDOCRINOLOGY, V137, P3577, DOI 10.1210/en.137.8.3577; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; HAUSSLER MR, 1998, RECENT PROG HORM RES, V44, P263; Johnson JA, 1996, J BONE MINER RES, V11, P56; Kerry DM, 1996, J BIOL CHEM, V271, P29715, DOI 10.1074/jbc.271.47.29715; KUMAR R, 1994, AM J PHYSIOL, V266, pF477, DOI 10.1152/ajprenal.1994.266.3.F477; LEE HJ, 1995, J BIOL CHEM, V270, P5434, DOI 10.1074/jbc.270.10.5434; LEE HJ, 1995, J BIOL CHEM, V270, P30129; Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437; Lee YF, 1997, J BIOL CHEM, V272, P12215, DOI 10.1074/jbc.272.18.12215; Leng X, 1996, MOL CELL BIOL, V16, P2332; LIN TM, 1995, J BIOL CHEM, V270, P30121; LIU LT, 1994, J AM SOC NEPHROL, V5, P1251; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; MINGHETTI PP, 1988, FASEB J, V2, P3043, DOI 10.1096/fasebj.2.15.2847948; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; OHYAMA Y, 1991, J BIOL CHEM, V266, P8690; OMALLEY BW, 1992, MOL ENDOCRINOL, V6, P1359, DOI 10.1210/me.6.9.1359; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; PIKE JW, 1989, ANNU REV NUTR, V11, P189; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; Roy S, 1996, ENDOCRINOLOGY, V137, P2938, DOI 10.1210/en.137.7.2938; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Young WJ, 1998, J BIOL CHEM, V273, P20877, DOI 10.1074/jbc.273.33.20877; Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; ZHONG K, 1994, AM J RESP CELL MOL, V11, P480, DOI 10.1165/ajrcmb.11.4.7917316	43	38	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16198	16205		10.1074/jbc.274.23.16198	http://dx.doi.org/10.1074/jbc.274.23.16198			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347174	hybrid			2022-12-27	WOS:000080668600034
J	Bhattacharyya, J; Das, KP				Bhattacharyya, J; Das, KP			Molecular chaperone-like properties of an unfolded protein, alpha(s)-casein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ALPHA-CRYSTALLIN; BETA-LACTOGLOBULIN; 1,1'-BI(4-ANILINO)NAPHTHALENE-5,5'-DISULFONIC ACID; FUNCTIONAL-PROPERTIES; ESCHERICHIA-COLI; WHEY PROTEINS; RIBOSOMAL-RNA; GROEL; LACTALBUMIN; CASEIN	All molecular chaperones known to date are well organized, folded protein molecules whose three-dimensional structure are believed to play a key role in the mechanism of substrate recognition and subsequent assistance to folding. A common feature of all protein and nonprotein molecular chaperones is the propensity to form aggregates very similar to the micellar aggregates. In this paper we show that alpha(s)-casein, abundant in mammalian milk, which has no well defined secondary and tertiary structure but exits in nature as a micellar aggregate, can prevent a variety of unrelated proteins/enzymes against thermal-, chemical-, or light-induced aggregation. It also prevents aggregation of its natural substrates, the whey proteins. alpha(s)-Casein interacts with partially unfolded proteins through its solvent-exposed hydrophobic surfaces. The absence of disulfide bridge or free thiol groups in its sequence plays important role in preventing thermal aggregation of whey proteins caused by thiol-disulfide interchange reactions. Our results indicate that alpha(s)-casein not only prevents the formation of huge insoluble aggregates but it can also inhibit accumulation of soluble aggregates of appreciable size. Unlike other molecular chaperones, this protein can solubilize hydrophobically aggregated proteins. This protein seems to have some characteristics of cold shock protein, and its chaperone-like activity increases with decrease of temperature.	Bose Inst, Dept Chem, Prot Chem Lab, Calcutta 700009, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das, KP (corresponding author), Bose Inst, Dept Chem, Prot Chem Lab, Main Campus,93-1 APC Rd, Calcutta 700009, W Bengal, India.			Das, Kali/0000-0001-7686-9077				Bhattacharyya J, 1998, BIOCHEM MOL BIOL INT, V46, P249; BIGELOW CC, 1967, J THEOR BIOL, V16, P187, DOI 10.1016/0022-5193(67)90004-5; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; Dalgleish DG, 1997, J AGR FOOD CHEM, V45, P4806, DOI 10.1021/jf970524r; Dalgleish DG, 1997, J AGR FOOD CHEM, V45, P3459, DOI 10.1021/jf970113a; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; DEWIT JN, 1983, NETH MILK DAIRY J, V37, P37; Doi N, 1998, FEBS LETT, V430, P150, DOI 10.1016/S0014-5793(98)00674-7; Ellis RJ, 1996, SCIENCE, V272, P1448; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; GETHING MJ, 1997, GUIDEBOOK MOL CHAPAR; Gezimati J, 1996, ACS SYM SER, V650, P113; Graumann P, 1996, ARCH MICROBIOL, V166, P293, DOI 10.1007/s002030050386; Guha S, 1998, J BIOL CHEM, V273, P30077, DOI 10.1074/jbc.273.46.30077; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; JENNESS R, 1970, MILK PROTEINS CHEMIS, V1, P17; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; KENKARE DB, 1964, J DAIRY SCI, V47, P947, DOI 10.3168/jds.S0022-0302(64)88817-2; KINSELLA JE, 1984, CRC CR REV FOOD SCI, V21, P197, DOI 10.1080/10408398409527401; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LALIGANT A, 1991, J AGR FOOD CHEM, V39, P2147, DOI 10.1021/jf00012a009; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCMEEKIN TL, 1949, ADV PROTEIN CHEM, V5, P201, DOI 10.1016/S0065-3233(08)60586-0; MERCIER JC, 1971, EUR J BIOCHEM, V23, P41, DOI 10.1111/j.1432-1033.1971.tb01590.x; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MORR CV, 1968, J DAIRY SCI, V51, P1349, DOI 10.3168/jds.S0022-0302(68)87193-0; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Reid KL, 1998, PROTEIN SCI, V7, P470; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; RUEGG M, 1977, J DAIRY RES, V44, P509, DOI 10.1017/S002202990002046X; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Smulders RHPH, 1998, INT J BIOL MACROMOL, V22, P187, DOI 10.1016/S0141-8130(98)00016-6; SUSI H, 1967, J BIOL CHEM, V242, P5460; WALSH MT, 1991, J BIOL CHEM, V266, P20079; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; WANG KY, 1994, J BIOL CHEM, V269, P13601; Waugh D. F., 1971, MILK PROTEINS CHEM B, V2, P3; XIANG YL, 1992, J AGR FOOD CHEM, V40, P380	49	154	157	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15505	15509		10.1074/jbc.274.22.15505	http://dx.doi.org/10.1074/jbc.274.22.15505			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336443	hybrid			2022-12-27	WOS:000080560100032
J	Efrati, E; Tocco, G; Eritja, R; Wilson, SH; Goodman, MF				Efrati, E; Tocco, G; Eritja, R; Wilson, SH; Goodman, MF			"Action-at-a-distance" mutagenesis - 8-oxo-7,8-dihydro-2 '-deoxyguanosine causes base substitution errors at neighboring template sites when copied by DNA polymerase beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; NUCLEOSIDE TRIPHOSPHATASE; MUTT PROTEIN; REPLICATION; INSERTION; FIDELITY; EXCISION; LESION; REPAIR	8-Oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a common oxidative DNA lesion, favors a syn-conformation in DNA, enabling formation of stable 8-oxo-dG A base mispairs resulting in G.C --> T.A transversion mutations. When human DNA polymerase (pol) beta was used to copy a short single-stranded gap containing a site-directed 8-oxo-dG lesion, incorporation of dAMP opposite 8-oxo-dG was slightly favored over dCMP depending on "downstream" sequence context. Unexpectedly, however, a significant increase in dCMP A and dGMP A mispairs was also observed at the "upstream" 3'-template site adjacent to the lesion. Errors at these undamaged template sites occurred in four sequence contexts with both gapped and primed single-stranded DNA templates, but not when pol alpha replaced pol beta. Error rates at sites adjacent to 8-oxo-dG were roughly 1% of the values opposite 8-oxo-dG:, potentially generating tandem mutations during in vivo short-gap repair synthesis by pol beta, When 8-oxo-dG was replaced with 8-bromo-2'-deoxyguanosine, incorporation of dCMP was strongly favored by both enzymes, with no detectable misincorporation occurring at neighboring template sites.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; European Mol Biol Org, D-69012 Heidelberg, Germany; NIEHS, Res Triangle Pk, NC 27709 USA	University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.		Eritja, Ramon/B-5613-2008; Wilson, Samuel H/E-6644-2019	Eritja, Ramon/0000-0001-5383-9334; Wilson, Samuel H/0000-0002-1702-5293	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; BHATNAGAR SK, 1988, J BIOL CHEM, V263, P8953; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; Efrati E, 1997, J BIOL CHEM, V272, P2559; FEIG DI, 1994, J MOL BIOL, V235, P33, DOI 10.1016/S0022-2836(05)80009-9; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hashim MF, 1997, J BIOL CHEM, V272, P20205, DOI 10.1074/jbc.272.32.20205; Hatahet Z, 1998, P NATL ACAD SCI USA, V95, P8556, DOI 10.1073/pnas.95.15.8556; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KOIZUME S, 1994, NUCLEOS NUCLEOT, V13, P1517, DOI 10.1080/15257779408012168; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SOBEL RW, 1996, NATURE, V379, P183; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	31	60	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15920	15926		10.1074/jbc.274.22.15920	http://dx.doi.org/10.1074/jbc.274.22.15920			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336498	hybrid			2022-12-27	WOS:000080560100087
J	Enghild, JJ; Thogersen, IB; Oury, TD; Valnickova, Z; Hojrup, P; Crapo, JD				Enghild, JJ; Thogersen, IB; Oury, TD; Valnickova, Z; Hojrup, P; Crapo, JD			The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; HUMAN LUNG; IMMUNOCYTOCHEMICAL LOCALIZATION; PRECURSOR PROTEINS; HEPATOCYTES; AFFINITY	Extracellular superoxide dismutase (EC-SOD) is the only known extracellular enzyme designed to scavenge the superoxide anion. The purified enzyme exists in two forms when visualized by reduced SDS-polyacrylamide gel electrophoresis: (i) intact EC-SOD (Trp(1)-Ala(222)) containing the C-terminal heparin-binding domain and (ii) cleaved EC-SOD (Trp(1)-Glu(209)) without the C-terminal heparin-binding domain. The proteolytic event(s) leading to proteolysis at Glu(209)-Arg(210) and removal of the heparin-binding domain are not known, but may represent an important regulatory mechanism. Removal of the heparin-binding domain affects both the affinity of EC-SOD for and its distribution to the extracellular matrix, in which it is secreted. During the purification of human EC-SOD, the intact/cleaved ratio remains constant, suggesting that proteolytic removal of the heparin-binding domain does not occur during purification (Oury, T. D., Crape, J. D., Valnickova, Z., and Enghild, J. J. (1996) Biochem. J. 317, 51-57). This was supported by the finding that fresh mouse tissue contains both intact and cleaved EC-SOD. To study other possible mechanisms leading to the formation of cleaved EC-SOD, we examined biosynthesis in cultured rat L2 epithelial-like cells using a pulse-chase protocol. The results of these studies suggest that the heparin-binding domain is removed intracellularly just prior to secretion. In addition, the intact/cleaved EC-SOD ratio appears to be tissue-dependent, implying that the intracellular processing event is regulated in a tissue-specific manner. The existence of this intracellular processing pathway may thus represent a novel regulatory pathway for affecting the distribution and effect of EC-SOD.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; Odense Univ, DK-5230 Odense, Denmark; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern Denmark; National Jewish Health	Enghild, JJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, POB 3712, Durham, NC 27710 USA.	enghi001@mc.duke.edu	Højrup, Peter/ABG-8477-2020	Enghild, Jan Johannes/0000-0001-9292-9172; Hojrup, Peter/0000-0002-7838-6180	NHLBI NIH HHS [HL31992, HL49542, HL42444] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031992, P01HL042444, R01HL049542] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI T, 1989, J BIOL CHEM, V264, P8537; BRATT T, 1993, BIOCHIM BIOPHYS ACTA, V1157, P147, DOI 10.1016/0304-4165(93)90058-G; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Folz RJ, 1997, AM J RESP CELL MOL, V17, P393, DOI 10.1165/ajrcmb.17.4.2826; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; KARLSSON K, 1993, BIOCHEM J, V290, P623, DOI 10.1042/bj2900623; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; OURY TD, 1994, LAB INVEST, V70, P889; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; OURY TD, 1993, AM REV RESPIR DIS, V147, pA444; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; Salvesen G, 1989, PROTEOLYTIC ENZYMES, P83; SANDSTROM J, 1992, J BIOL CHEM, V267, P18205; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; SJOBERG EM, 1992, ARCH BIOCHEM BIOPHYS, V295, P217, DOI 10.1016/0003-9861(92)90509-U; STRALIN P, 1995, ARTERIOSCL THROM VAS, V15, P2032, DOI 10.1161/01.ATV.15.11.2032; Su WY, 1997, AM J RESP CELL MOL, V16, P162, DOI 10.1165/ajrcmb.16.2.9032123; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700	22	84	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14818	14822		10.1074/jbc.274.21.14818	http://dx.doi.org/10.1074/jbc.274.21.14818			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329680	hybrid			2022-12-27	WOS:000081965200045
J	Huang, CS; Ma, WY; Li, JX; Goranson, A; Dong, ZG				Huang, CS; Ma, WY; Li, JX; Goranson, A; Dong, ZG			Requirement of Erk, but not JNK, for arsenite-induced cell transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATOR PROTEIN-1 ACTIVITY; NIH 3T3 CELLS; AP-1 ACTIVITY; MALIGNANT TRANSFORMATION; MOLECULAR MECHANISMS; TERMINAL KINASE; SODIUM ARSENITE; EMBRYO CELLS; HA-RAS	Trivalent arsenic (arsenite, As3+) is a human carcinogen, which is associated with cancers of skin, lung, liver, and bladder. However, the mechanism by which arsenite causes cancer is not well understood, In this study, we found that exposure of Cl 41 cells, a well characterized mouse epidermal cell model for tumor promotion, to a low concentration of arsenite (<25 mu M) induces cell transformation. Interestingly, arsenite induces Erk phosphorylation and increased Erk activity at doses ranging from 0.8 to 200 mu M, while higher doses (more than 50 mu M) are required for activation of JNK. Arsenite-induced Erk activation was markedly inhibited by introduction of dominant negative Erk2 into cells, while expression of dominant negative Erk2 did not show inhibition of JNK and MEK1/2. Furthermore, arsenite-induced cell transformation was blocked in cells expressing the dominant negative Erk2, In contrast, overexpression of dominant negative JNK1 was shown to increase cell transformation even though it inhibits arsenite induced JNK activation. Our results not only show that arsenite induces Erk activation, but also for the first time demonstrates that activation of Erk, but not JNK, by arsenite is required for its effects on cell transformation.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16Th Ave NE, Austin, MN 55912 USA.			Huang, Chuanshu/0000-0003-4133-5096	NCI NIH HHS [CA74916] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA074916] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALANI R, 1991, MOL CELL BIOL, V11, P6286, DOI 10.1128/MCB.11.12.6286; BETTLEY FR, 1975, BRIT J DERMATOL, V92, P563; Brown JL, 1996, CANCER LETT, V98, P227; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; COBO JM, 1995, TOXICOL IN VITRO, V9, P459, DOI 10.1016/0887-2333(95)00038-A; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOMANN FE, 1994, CELL GROWTH DIFFER, V5, P9; DONG ZG, 1995, CARCINOGENESIS, V16, P749, DOI 10.1093/carcin/16.4.749; Dong ZG, 1997, J BIOL CHEM, V272, P9962; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dong ZG, 1998, ONCOGENE, V17, P1845, DOI 10.1038/sj.onc.1202084; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; EVANS S, 1977, BRIT J DERMATOL, V97, P13, DOI 10.1111/j.1365-2133.1977.tb14294.x; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Goyer R.A., 1986, CASARETT DOULLS TOXI, P582; HERTZPICCIOTTO I, 1993, SCAND J WORK ENV HEA, V19, P217, DOI 10.5271/sjweh.1480; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 1997, J BIOL CHEM, V272, P26325, DOI 10.1074/jbc.272.42.26325; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; *IARC, 1980, IARC MON EV CARC RIS, V23, P37; JHA AN, 1992, MUTAT RES, V284, P215, DOI 10.1016/0027-5107(92)90005-M; LANDOLPH JR, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.2307/3431774; LANSDOWN ABG, 1995, CRIT REV TOXICOL, V25, P397, DOI 10.3109/10408449509049339; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LUCHTRATH H, 1983, J CANCER RES CLIN, V105, P173, DOI 10.1007/BF00406929; Ludwig S, 1998, J BIOL CHEM, V273, P1917, DOI 10.1074/jbc.273.4.1917; LUI YC, 1997, J CELL BIOCHEM, V64, P423; Martinez JD, 1997, ONCOGENE, V14, P2511, DOI 10.1038/sj.onc.1201095; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; NAKAMURO K, 1981, MUTAT RES, V88, P73, DOI 10.1016/0165-1218(81)90091-4; NORDBERG GF, 1981, ENVIRON HEALTH PERSP, V40, P65, DOI 10.2307/3429221; PERSHAGEN G, 1981, ENVIRON HEALTH PERSP, V40, P93, DOI 10.2307/3429223; Philipp R, 1985, Rev Environ Health, V5, P27; RAPP UR, 1994, ONCOGENE, V9, P3493; Rincon M, 1996, MOL CELL BIOL, V16, P1074; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; TSENG WP, 1968, J NATL CANCER I, V40, P453; VHTER M, 1987, TOXICOL LETT, V37, P41; WAALKES MP, 1995, METAL TOXICOLOGY, P54; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907	50	142	145	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14595	14601		10.1074/jbc.274.21.14595	http://dx.doi.org/10.1074/jbc.274.21.14595			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329651	hybrid			2022-12-27	WOS:000081965200016
J	Gupta, D; Wang, QL; Vinson, C; Dziarski, R				Gupta, D; Wang, QL; Vinson, C; Dziarski, R			Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB ATF and AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-REGULATED KINASE; LPS-BINDING-PROTEIN; LIPOPOLYSACCHARIDE LPS; SOLUBLE PEPTIDOGLYCAN; MONOCYTIC CELLS; CROSS-LINKING; C-JUN; CD14; GENE	Peptidoglycan (PGN), the major cell wall component of Gram-positive bacteria, induces secretion of cytokines in macrophages through CD14, the pattern recognition receptor that binds lipopolysaccharide and other microbial products. To begin to elucidate the mechanisms that regulate the transcription of cytokine genes, we wanted to determine which transcription factors are activated by PGN in mouse RAW264.7 and human THP-1 macrophage cells. Our results demonstrated that: (i) PGN induced phosphorylation of the transcription factors ATF-1 and CREB; (ii) ATF-1 and CREB bound DNA asa dimer and induced transcriptional activation of a CRE reporter plasmid, which was inhibited by dominant negative CREB and ATF-1; (iii) PGN induced phosphorylation of c-Jun, protein synthesis of JunB and c-Fos, and transcriptional activation of the AP-1 reporter plasmid, which was inhibited by dominant negative c-Fos; and (iv) PGN-induced activation of CREB/ATF and AP-1 was mediated through CD14. This is the first study to demonstrate activation of CREB/ATF and AP-1 transcription factors by PGN or by any other component of Gram-positive bacteria.	Indiana Univ, Sch Med, NW Ctr Med Educ, Gary, IN 46408 USA; NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Indiana University System; Indiana University Northwest; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gupta, D (corresponding author), Indiana Univ, Sch Med, NW Ctr Med Educ, 3400 Broadway, Gary, IN 46408 USA.				NIAID NIH HHS [AI28797] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028797] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, V3; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; CAMHI SL, 1995, AM J RESP CELL MOL, V13, P387, DOI 10.1165/ajrcmb.13.4.7546768; CHANDRA G, 1995, J IMMUNOL, V155, P4535; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DENT T, 1993, GENE DEV, V7, P479; DZIARSKI R, 1991, J BIOL CHEM, V266, P4713; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Dziarski R, 1996, J INFECT DIS, V174, P777, DOI 10.1093/infdis/174.4.777; DZIARSKI R, 1999, GLYCOMICROBIOLOGY; FUJIHARA M, 1993, J BIOL CHEM, V268, P14898; GRAY JG, 1993, MOL CELL BIOL, V13, P6678, DOI 10.1128/MCB.13.11.6678; GUPTA D, 1995, J IMMUNOL, V155, P2620; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Heymer B., 1985, IMMUNOLOGY BACTERIAL, P11; Jin YP, 1998, J INFECT DIS, V177, P1629, DOI 10.1086/515318; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; PROFFITT J, 1995, GENE, V152, P173, DOI 10.1016/0378-1119(94)00701-S; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; ULEVITCH RJ, 1994, CURR OPIN IMMUNOL, V6, P125, DOI 10.1016/0952-7915(94)90043-4; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; WEIDEMANN B, 1994, INFECT IMMUN, V62, P4709, DOI 10.1128/IAI.62.11.4709-4715.1994; Weidemann B, 1997, INFECT IMMUN, V65, P858, DOI 10.1128/IAI.65.3.858-864.1997; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	39	62	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14012	14020		10.1074/jbc.274.20.14012	http://dx.doi.org/10.1074/jbc.274.20.14012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318814	hybrid			2022-12-27	WOS:000080322200043
J	Kraichely, DM; Collins, JJ; DeLisle, RK; MacDonald, PN				Kraichely, DM; Collins, JJ; DeLisle, RK; MacDonald, PN			The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ESTROGEN-RECEPTOR; LIGAND-BINDING DOMAIN; THYROID-HORMONE RECEPTOR; D-MEDIATED TRANSCRIPTION; NUCLEAR RECEPTORS; RETINOIC ACID; CRYSTAL-STRUCTURE; CONSERVED REGION; DNA-BINDING; FACTOR IIB	A ligand-inducible transactivation function (AF-2) exists in the extreme carboxyl terminus of the vitamin D receptor (VDR) that is essential for 1 alpha,25-dihydroxyvitamin D-3 (1,25-(OH)(2)D-3)-activated transcription and p160 coactivator interaction. Crystallographic data of related nuclear receptors suggest that binding of 1,26-(OH)(2)D-3 by VDR induces conformational changes in the ligand-binding domain (LBD), the most striking of which is a packing of the AF-2 helix onto the LED adjacent to helices H3 and H4. In this study, a panel of VDR helix H3 mutants was generated, and residues in helix H3 that are important for ligand-activated transcription by the full-length VDR were identified. In particular, one mutant (VDR (Y236A)) exhibited normal ligand binding and heterodimerization with the retinoid X receptor (RXR) but was transcriptionally inactive. Yeast two-hybrid studies and in vitro protein interaction assays demonstrated that VDR (Y236A) was selectively impaired in interaction with AF-2-interacting coactivator proteins such as SRC-1 and GRIP-1. These data indicate an importance of helix H3 in the mechanism of VDR-mediated transcription, and they support the concept that helix HS functions in concert with the AF-2 domain to form a transactivation surface for binding the p160 class of nuclear receptor coactivators.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, Hlth Sci Ctr, St Louis, MO 63104 USA	Saint Louis University	MacDonald, PN (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, Hlth Sci Ctr, 1402 S Grand Blvd, St Louis, MO 63104 USA.	macdonal@slu.edu			NIDDK NIH HHS [R01DK50348] Funding Source: Medline; NIGMS NIH HHS [T32-GM08306] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FAGAN R, 1994, CELL, V78, P799, DOI 10.1016/S0092-8674(94)90522-3; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FOLKERS GE, 1993, MOL ENDOCRINOL, V7, P616, DOI 10.1210/me.7.4.616; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; Jeyakumar M, 1997, MOL ENDOCRINOL, V11, P755, DOI 10.1210/me.11.6.755; Jurutka PW, 1997, J BIOL CHEM, V272, P14592, DOI 10.1074/jbc.272.23.14592; Kraichely Dennis M., 1998, Frontiers in Bioscience, V3, pD821; MACDONALD PN, 1994, SEMIN NEPHROL, V14, P101; MACDONALD PN, 1993, MOL CELL BIOL, V13, P5907, DOI 10.1128/MCB.13.9.5907; Masuyama H, 1997, MOL ENDOCRINOL, V11, P218, DOI 10.1210/me.11.2.218; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; NAKAJIMA S, 1993, BIOCHEM BIOPH RES CO, V197, P478, DOI 10.1006/bbrc.1993.2504; Norris JD, 1997, MOL ENDOCRINOL, V11, P747, DOI 10.1210/me.11.6.747; ONATE SA, 1995, SCIENCE, V270, P1354; PHAM TA, 1992, MOL ENDOCRINOL, V6, P1043, DOI 10.1210/me.6.7.1043; PIERRAT B, 1994, GENE, V143, P193, DOI 10.1016/0378-1119(94)90096-5; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; WURTZ JM, 1997, VITAMIN D CHEM BIOL, P165	39	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14352	14358		10.1074/jbc.274.20.14352	http://dx.doi.org/10.1074/jbc.274.20.14352			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318858	hybrid			2022-12-27	WOS:000080322200087
J	Rosenblat, M; Belinky, P; Vaya, J; Levy, R; Hayek, T; Coleman, R; Merchav, S; Aviram, M				Rosenblat, M; Belinky, P; Vaya, J; Levy, R; Hayek, T; Coleman, R; Merchav, S; Aviram, M			Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein - A possible role for protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; CHRONIC GRANULOMATOUS-DISEASE; LIPID-PEROXIDATION; HUMAN-NEUTROPHILS; RESPIRATORY BURST; HUMAN-MONOCYTES; LDL OXIDATION; IN-VITRO; ANTIOXIDANT ACTIVITY; STRUCTURAL ASPECTS	Macrophage-mediated oxidation of low density lipoprotein (LDL) is considered to be of major importance in early atherogenesis; therefore, intervention means to inhibit this process are being extensively studied. In the present study, we questioned the ability of the isoflavan glabridin (from licorice) to accumulate in macrophages and to affect cell-mediated oxidation of LDL, We first performed in vitro studies, using mouse peritoneal macrophages (MPMs) and the J-774 A.1 macrophage-like cell line. Both cells accumulated up to 1.5 mu g of glabridin/mg of cell protein after 2 h of incubation, and this process was time- and glabridin dose-dependent. In parallel, in glabridin-enriched cells, macrophage-mediated oxidation of LDL was inhibited by up to 80% in comparison with control cells. Glabridin inhibited superoxide release from MPMs in response to phorbol 12-myristate 13-acetate, or to LDL when added together with copper ions, by up to 60%, Translocation of P-47, a cytosolic component of NADPH oxidase to the plasma membrane was substantially inhibited, In glabridin-enriched macrophages, protein kinase C activity reduced by similar to 70%. All of the above effects of glabridin required the presence of the two hydroxyl groups on the flavonoid's B phenol ring, In order to assess the physiological significance of these results, we next performed in vivo studies, using the atherosclerotic apolipoprotein E-deficient (E-0) mice. MPMs harvested from glabridin-treated E-0 mice (20 mu g/mouse/day for a period of 6 weeks) demonstrated reduced capability to oxidize LDL by 80% in comparison with placebo-treated mice. This latter phenomenon was associated with a reduction in the lesion oxysterols and a 50% reduction in the aortic lesion size. We thus conclude that glabridin accumulation in macrophages is associated with reduced cell-mediated oxidation of LDL and decreased activation of the NADPH oxidase system. These phenomena could be responsible for the attenuation of atherosclerosis in E-0 mice, induced by glabridin.	Rambam Med Ctr, Lipid Res Lab, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Lipid Res Lab, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Dept Anat & Cell Biol,Haemopoiesis Unit, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Div Morphol Sci, Haifa, Israel; Galilee Technol Ctr, Lab Nat Cpds Med Use, Kiryat Shmona, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Infect Dis Lab, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Aviram, M (corresponding author), Rambam Med Ctr, Lipid Res Lab, Haifa, Israel.	aviram@tx.technion.ac.il						AEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43; Agullo G, 1997, BIOCHEM PHARMACOL, V53, P1649, DOI 10.1016/S0006-2952(97)82453-7; Aviram M, 1998, MOL CELL BIOCHEM, V188, P149, DOI 10.1023/A:1006841011201; AVIRAM M, 1993, ANN NUTR METAB, V37, P75, DOI 10.1159/000177753; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599; Aviram M, 1996, METABOLISM, V45, P1069, DOI 10.1016/S0026-0495(96)90005-0; Aviram M, 1998, ATHEROSCLEROSIS, V137, pS45, DOI 10.1016/S0021-9150(97)00306-7; AVIRAM M, 1989, ARTERIOSCLEROSIS, V9, P67, DOI 10.1161/01.ATV.9.1.67; AVIRAM M, 1992, J BIOL CHEM, V267, P218; AVIRAM M, 1994, J LIPID RES, V35, P385; AVIRAM M, 1999, CURR INT CARDIOL REP, V1, P66; Baoutina A, 1998, J LIPID RES, V39, P114; Belinky PA, 1998, ATHEROSCLEROSIS, V137, P49, DOI 10.1016/S0021-9150(97)00251-7; Belinky PA, 1998, FREE RADICAL BIO MED, V24, P1419, DOI 10.1016/S0891-5849(98)00006-9; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Buege J A, 1978, Methods Enzymol, V52, P302; CATHCART MK, 1989, J IMMUNOL, V142, P1963; CHANG WS, 1993, ANTICANCER RES, V13, P2165; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; DARLEYUSMAR VM, 1992, FREE RADICAL RES COM, V17, P9, DOI 10.3109/10715769209061085; DEWHALLEY CV, 1990, BIOCHEM PHARMACOL, V39, P1743, DOI 10.1016/0006-2952(90)90120-A; DUSI S, 1993, BIOCHEM J, V290, P173, DOI 10.1042/bj2900173; ELLIOTT AJ, 1992, BIOCHEM PHARMACOL, V44, P1603, DOI 10.1016/0006-2952(92)90478-2; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; FUHRMAN B, 1995, AM J CLIN NUTR, V61, P549, DOI 10.1093/ajcn/61.3.549; Fuhrman B, 1997, AM J CLIN NUTR, V66, P267, DOI 10.1093/ajcn/66.2.267; GOCKE N, 1996, J CARDIOVASC RISK, V3, P352; HATANO T, 1991, YAKUGAKU ZASSHI, V111, P311, DOI 10.1248/yakushi1947.111.6_311; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; HEYWORTH PG, 1990, BIOCHIM BIOPHYS ACTA, V1052, P299, DOI 10.1016/0167-4889(90)90225-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIRAMATSU K, 1987, ARTERIOSCLEROSIS, V7, P55, DOI 10.1161/01.ATV.7.1.55; Jaiswal AS, 1996, INDIAN J BIOCHEM BIO, V33, P116; JARVIS WD, 1994, CANCER RES, V54, P1707; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; LEVY R, 1994, BBA-MOL CELL RES, V1220, P253, DOI 10.1016/0167-4889(94)90146-5; LEVY R, 1991, J IMMUNOL, V147, P3066; LEVY R, 1990, J IMMUNOL, V145, P2595; LI Q, 1994, J BIOL CHEM, V269, P17508; LIMASSET B, 1993, BIOCHEM PHARMACOL, V46, P1257, DOI 10.1016/0006-2952(93)90476-D; LINDAHL M, 1993, INFLAMMATION, V17, P573, DOI 10.1007/BF00914195; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANGIAPANE H, 1992, BIOCHEM PHARMACOL, V43, P445, DOI 10.1016/0006-2952(92)90562-W; Muldoon MF, 1996, BRIT MED J, V312, P458, DOI 10.1136/bmj.312.7029.458; NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483; PAGONIS C, 1986, BIOCHEM PHARMACOL, V35, P237, DOI 10.1016/0006-2952(86)90520-4; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; PARK JW, 1995, BIOCHEM BIOPH RES CO, V211, P410, DOI 10.1006/bbrc.1995.1829; PARTHASARATHY S, 1992, CURR OPIN LIPIDOL, V3, P313; Pearson DA, 1997, J AGR FOOD CHEM, V45, P578, DOI 10.1021/jf9603893; Pierpoint W S, 1986, Prog Clin Biol Res, V213, P125; PINCEMAIL J, 1987, EXPERIENTIA, V43, P181, DOI 10.1007/BF01942843; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; ROBAK J, 1988, POL J PHARMACOL PHAR, V40, P451; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; Rosenblat M, 1998, FREE RADICAL BIO MED, V24, P305, DOI 10.1016/S0891-5849(97)00231-1; SUZUKAWA M, 1994, ATHEROSCLEROSIS, V110, P77, DOI 10.1016/0021-9150(94)90070-1; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; Vaya J, 1997, FREE RADICAL BIO MED, V23, P302, DOI 10.1016/S0891-5849(97)00089-0; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	69	103	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13790	13799		10.1074/jbc.274.20.13790	http://dx.doi.org/10.1074/jbc.274.20.13790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318783	hybrid			2022-12-27	WOS:000080322200012
J	Thoidis, G; Kupriyanova, T; Cunningham, JM; Chen, P; Cadel, S; Foulon, T; Cohen, P; Fine, RE; Kandror, KV				Thoidis, G; Kupriyanova, T; Cunningham, JM; Chen, P; Cadel, S; Foulon, T; Cohen, P; Fine, RE; Kandror, KV			Glucose transporter Glut3 is targeted to secretory vesicles in neurons and PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOPEPTIDASE-B; HUMAN PLATELETS; INSULIN; TRANSLOCATION; MEMBRANE; PROTEINS; TISSUE; BRAIN	In rat brain and cultured neuroendocrine PC12 cells, Glut3 is localized at the cell surface and, also, in a distinct population of homogenous synaptic-like vesicles. Glut3-containing vesicles co-purify with "classical" synaptic vesicles, but can be separated from the latter by sucrose gradient centrifugation. Unlike classical synaptic vesicles, Glut3-containing vesicles possess a high level of aminopeptidase activity, which has been identified as aminopeptidase B. This enzyme has recently been shown to be a marker of the secretory pathway in PC12 cells (Balogh, A., Cadel, S., Foulon, T., Picart, R., Der Garabedian, A., Rousselet, A., Tougard, C., and Cohen, P. (1998) J. Cell Sci. 111, 161-169). We, therefore, conclude that Glut3 is targeted to secretory vesicles in both neurons and PC12 cells.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Edith Nourse Rodgers Mem Vet Hosp, Bedford, MA 01730 USA; Univ Paris 06, CNRS, UMR 7631, F-75006 Paris, France	Boston University; Boston University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K121,715 Albany St, Boston, MA 02118 USA.			Kandror, Konstantin/0000-0002-8601-9313	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201, R01DK052057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG005894] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG-05894] Funding Source: Medline; NIDDK NIH HHS [T32DK07201, R01DK52057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balogh A, 1998, J CELL SCI, V111, P161; BILAN PJ, 1992, BIOCHEM BIOPH RES CO, V186, P1129, DOI 10.1016/0006-291X(92)90864-H; Cadel S, 1997, P NATL ACAD SCI USA, V94, P2963, DOI 10.1073/pnas.94.7.2963; CADEL S, 1995, MOL CELL ENDOCRINOL, V110, P149, DOI 10.1016/0303-7207(95)03529-G; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; Heijnen HFG, 1997, J CELL BIOL, V138, P323, DOI 10.1083/jcb.138.2.323; HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; KANDROR KV, 1995, BIOCHEM J, V307, P383, DOI 10.1042/bj3070383; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Sorbara LR, 1997, BIOCHEM J, V328, P511; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183	19	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14062	14066		10.1074/jbc.274.20.14062	http://dx.doi.org/10.1074/jbc.274.20.14062			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318820	hybrid			2022-12-27	WOS:000080322200049
J	Cai, H; Clarke, S				Cai, H; Clarke, S			A novel methyltransferase catalyzes the methyl esterification of trans-aconitate in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR METHYLTRANSFERASE; STATIONARY-PHASE; RUMINAL FERMENTATION; RNA-POLYMERASE; SURVIVAL; COMMON; IDENTIFICATION; ACCUMULATION; EXPRESSION; RESISTANCE	We have identified a new type of S-adenosyl-L-methionine-dependent methyltransferase in the cytosol of Escherichia coli that is expressed in early stationary phase under the control of the RpoS a factor. This enzyme catalyzes the monomethyl esterification of trans-aconitate at high affinity (K-m = 0.32 mat) and cis-aconitate, isocitrate, and citrate at lower velocities and affinities. We have purified the enzyme to homogeneity by gel-filtration, anion-exchange, and hydrophobic chromatography, The N-terminal amino acid sequence was found to match that expected for the o252 open reading frame at 34.57 min on the E. coli genomic sequence whose deduced amino acid sequence contains the signature sequence motifs of the major class of S-adenosyl-L-methionine-dependent methyltransferases, Overexpression of the o252 gene resulted in an overexpression of the methyltransferase activity, and we have now designated it tom for trans-aconitate methyltransferase. We have generated a knock-out strain off. coli lacking this activity, and we find that its growth and stationary phase survival are similar to that of the parent strain. We demonstrate the endogenous formation of trans-aconitate methyl ester in extracts of wild type but not tam(-) mutant cells indicating that trans-aconitate is present in E. coli, Since trans-aconitate does not appear to be a metabolic intermediate in these cells but forms spontaneously from the key citric acid cycle intermediate cis-aconitate, we suggest that its methylation may limit its potential interference in normal metabolic pathways. We have detected trans-aconitate methyltransferase activity in extracts of the yeast Saccharomyces cerevisiae, whereas no activity has been found in extracts of Caenorhabditis elegans or mouse brain.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, S (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Box 951570, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM26020] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMBLER JA, 1948, J ORG CHEM, V13, P399, DOI 10.1021/jo01161a013; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORCHARDT RT, 1980, J MED CHEM, V23, P347, DOI 10.1021/jm00178a001; BURAU R, 1965, SCIENCE, V150, P766, DOI 10.1126/science.150.3697.766; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CLARKE S, 1999, S ADENOSYLMETHIONINE; COIC Y., 1961, ANN INST NATL RECH AGRON SER A ANN PHYSIOL VEG, V3, P87; COOK GM, 1994, APPL ENVIRON MICROB, V60, P2533, DOI 10.1128/AEM.60.7.2533-2537.1994; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; GAWRON O, 1977, BIOCHIM BIOPHYS ACTA, V484, P453, DOI 10.1016/0005-2744(77)90101-2; GUSSOW D, 1989, NUCLEIC ACIDS RES, V17, P4000; HALL BG, 1982, J BACTERIOL, V151, P269, DOI 10.1128/JB.151.1.269-273.1982; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; KIM E, 1997, P NATL ACAD SCI USA, V94, P3132; Krebs HA, 1944, BIOCHEM J, V38, P426, DOI 10.1042/bj0380426; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; LI C, 1992, P NATL ACAD SCI USA, V89, P9885, DOI 10.1073/pnas.89.20.9885; LOEWEN PC, 1994, ANNU REV MICROBIOL, V48, P53, DOI 10.1146/annurev.mi.48.100194.000413; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malachowski R, 1928, BER DTSCH CHEM GES, V61, P2521, DOI 10.1002/cber.19280611119; MATIN A, 1991, MOL MICROBIOL, V5, P3, DOI 10.1111/j.1365-2958.1991.tb01819.x; OTTEN JG, 1970, ANAL BIOCHEM, V35, P302, DOI 10.1016/0003-2697(70)90041-2; REBHOLZ KL, 1994, ARCH BIOCHEM BIOPHYS, V312, P227, DOI 10.1006/abbi.1994.1303; ROSE IA, 1993, BIOCHEMISTRY-US, V32, P8504, DOI 10.1021/bi00084a016; RUSSELL JB, 1984, APPL ENVIRON MICROB, V47, P155, DOI 10.1128/AEM.47.1.155-159.1984; Sambrook J., 2002, MOL CLONING LAB MANU; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; STOUT PR, 1967, AGRON J, V59, P21, DOI 10.2134/agronj1967.00021962005900010006x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THOMPSON JF, 1990, ANAL BIOCHEM, V184, P39, DOI 10.1016/0003-2697(90)90008-W; Visick JE, 1998, FEMS MICROBIOL LETT, V167, P19, DOI 10.1111/j.1574-6968.1998.tb13202.x; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Watanabe K, 1997, CURR MICROBIOL, V35, P97, DOI 10.1007/s002849900219; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985	42	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13470	13479		10.1074/jbc.274.19.13470	http://dx.doi.org/10.1074/jbc.274.19.13470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224113	hybrid			2022-12-27	WOS:000080200400075
J	Lin, KI; Pasinelli, P; Brown, RH; Hardwick, JM; Ratan, RR				Lin, KI; Pasinelli, P; Brown, RH; Hardwick, JM; Ratan, RR			Decreased intracellular superoxide levels activate Sindbis virus-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRAMMED CELL-DEATH; ALPHAVIRUS-INDUCED APOPTOSIS; NF-KAPPA-B; OXIDATIVE STRESS; NEURONAL APOPTOSIS; HYDROGEN-PEROXIDE; TRANSGENIC MICE; MAMMALIAN-CELLS; INFECTED-CELLS	Infection of many cultured cell types with Sindbis virus (SV), an alphavirus, triggers apoptosis through a commonly utilized caspase activation pathway. However, the upstream signals by which SV activates downstream apoptotic effecters, including caspases, remain unclear. Here we report that in AT-3 prostate carcinoma cells, SV infection decreases superoxide (O-radical anion) levels within minutes of infection as monitored by an aconitase activity assay. This SV-induced decrease in O-radical anion levels appears to activate or modulate cell death, as a recombinant SV expressing the O-radical anion scavenging enzyme, copper/zinc superoxide dismutase (SOD), potentiates SV-induced apoptosis. A recombinant SV expressing a mutant form of SOD, which has reduced SOD activity, has no effect. The potentiation of SV-induced apoptosis by wild type SOD is because of its ability to scavenge intracellular OX rather than its ability to promote the generation of hydrogen peroxide. Pyruvate, a peroxide scavenger, does not affect the ability of wild type SOD to potentiate cell death; and increasing the intracellular catalase activity via a recombinant SV vector has no effect on SV-induced apoptosis, Moreover, increasing intracellular O-radical anion by treatment of 3T3 cells with paraquat protects them from SV-induced death. Altogether, our results suggest that SV may activate apoptosis by reducing intracellular superoxide levels and define a novel redox signaling pathway by which viruses can trigger cell death.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02129 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Johns Hopkins University	Ratan, RR (corresponding author), Harvard Univ, Sch Med, Dept Neurol, 77 Ave Louis Pasteur,Rm 857, Boston, MA 02115 USA.	rratan@caregroup.harvard.edu		Pasinelli, Piera/0000-0002-3385-2707	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034943, K08NS001951] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEBI H, 1984, METHOD ENZYMOL, V105, P121; AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024; BarPeled O, 1996, P NATL ACAD SCI USA, V93, P8530, DOI 10.1073/pnas.93.16.8530; BISHAI WR, 1994, J BACTERIOL, V176, P2914, DOI 10.1128/JB.176.10.2914-2921.1994; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; Desagher S, 1997, J NEUROSCI, V17, P9060; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; Esch F, 1998, J NEUROSCI, V18, P4083; ESOLEN LM, 1995, J VIROL, V69, P3955, DOI 10.1128/JVI.69.6.3955-3958.1995; Fariello R G, 1988, Funct Neurol, V3, P407; FERRARI G, 1995, J NEUROSCI, V15, P2857; FREEMAN BA, 1982, LAB INVEST, V47, P412; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; GRIFFIN DE, 1994, ARCH VIROL, P31; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; KAWANISHI M, 1993, J VIROL, V67, P7654, DOI 10.1128/JVI.67.12.7654-7658.1993; KELNER MJ, 1990, J BIOL CHEM, V265, P10872; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Levine B, 1996, P NATL ACAD SCI USA, V93, P4810, DOI 10.1073/pnas.93.10.4810; Lewis J, 1996, J VIROL, V70, P1828, DOI 10.1128/JVI.70.3.1828-1835.1996; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lin KI, 1998, J CELL BIOL, V141, P1479, DOI 10.1083/jcb.141.7.1479; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MCCORD JM, 1988, OXYRADICALS MOL BIOL, P27; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MOREY AL, 1993, J PATHOL, V169, P213, DOI 10.1002/path.1711690207; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Nava VE, 1998, J VIROL, V72, P452, DOI 10.1128/JVI.72.1.452-459.1998; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PELEDKAMAR M, 1995, EMBO J, V14, P4985, DOI 10.1002/j.1460-2075.1995.tb00181.x; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; PORTERACALLIAU C, 1995, J NEUROSCI, V13, P3669; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RATAN RR, 1994, J NEUROSCI, V14, P4385; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SHEN YQ, 1995, CURR OPIN GENET DEV, V5, P105, DOI 10.1016/S0959-437X(95)90061-6; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOLSKAYA EA, 1995, J VIROL, V69, P1181, DOI 10.1128/JVI.69.2.1181-1189.1995; TSUDA T, 1994, NEURON, V13, P727, DOI 10.1016/0896-6273(94)90039-6; Tucker PC, 1996, J VIROL, V70, P3972, DOI 10.1128/JVI.70.6.3972-3977.1996; Wang JF, 1996, FREE RADICAL BIO MED, V20, P533, DOI 10.1016/0891-5849(95)02085-3; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533	63	30	31	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13650	13655		10.1074/jbc.274.19.13650	http://dx.doi.org/10.1074/jbc.274.19.13650			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224137	hybrid			2022-12-27	WOS:000080200400099
J	Nierras, CR; Warner, JR				Nierras, CR; Warner, JR			Protein kinase C enables the regulatory circuit that connects membrane synthesis to ribosome synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; SECRETORY PATHWAY; TRANSMEMBRANE PROTEIN; GENE-TRANSCRIPTION; ESCHERICHIA-COLI; S-CEREVISIAE; CELL-GROWTH; YEAST-CELLS; CYCLIC-AMP; EXPRESSION	The balanced growth of a cell requires the integration of major systems such as DNA replication, membrane biosynthesis, and ribosome formation. An example of such integration is evident from our recent finding that, in Saccharomyces cerevisiae, any failure in the secretory pathway leads to severe repression of transcription of both rRNA and ribosomal protein genes. We have attempted to determine the regulatory circuit(s) that connects the secretory pathway with the transcription of ribosomal genes. Experiments show that repression does not occur through the circuit that responds to misfolded proteins in the endoplasmic reticulum, nor does it occur through circuits known to regulate ribosome synthesis, e.g. the stringent response, or the cAMP pathway. Rather, it appears to depend on a stress response at the plasma membrane that is transduced through protein kinase C (PKC), Deletion of PKC1 relieves the repression of both ribosomal protein and rRNA genes that occurs in response to a defect in the secretory pathway. We propose that failure of the secretory pathway prevents the synthesis of new plasma membrane. As protein synthesis continues, stress develops in the plasma membrane. This stress is monitored by Pkc1p, which initiates a signal transduction pathway that leads to repression of transcription of the rRNA and ribosomal protein genes. The importance of the transcription of the 137 ribosomal protein genes to the economy of the cell is apparent from the existence of at least three distinct pathways that can effect the repression of this set of genes.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Warner, JR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	warner@aecom.yu.edu			NCI NIH HHS [CA13330] Funding Source: Medline; NIGMS NIH HHS [GM25532] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025532] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BREWSTER JL, 1994, YEAST, V10, P425, DOI 10.1002/yea.320100402; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; GRIFFIOEN G, 1994, FEMS MICROBIOL LETT, V123, P137, DOI 10.1111/j.1574-6968.1994.tb07213.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HAMIL KG, 1988, MOL CELL BIOL, V8, P4328, DOI 10.1128/MCB.8.10.4328; Helliwell SB, 1998, GENETICS, V148, P99; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HERRUER MH, 1989, NUCLEIC ACIDS RES, V17, P7427, DOI 10.1093/nar/17.18.7427; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; KIM CH, 1983, MOL CELL BIOL, V3, P457, DOI 10.1128/MCB.3.3.457; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; KRAAKMAN LS, 1993, MOL GEN GENET, V239, P196, DOI 10.1007/BF00281618; Ktistakis NT, 1998, BIOESSAYS, V20, P495; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Meyuhas Oded, 1996, V30, P363; Mizuta K, 1998, NUCLEIC ACIDS RES, V26, P1063, DOI 10.1093/nar/26.4.1063; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Mori K, 1998, J BIOL CHEM, V273, P9912, DOI 10.1074/jbc.273.16.9912; MORI K, 1993, CELL, V74, P743; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Planta RJ, 1997, YEAST, V13, P1505, DOI 10.1002/(SICI)1097-0061(199712)13:16<1505::AID-YEA229>3.0.CO;2-I; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rose MD., 1990, METHODS YEAST GENETI; ROTENBERG MO, 1986, MOL CELL BIOL, V6, P674, DOI 10.1128/MCB.6.2.674; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHWINDINGER WF, 1987, J BIOL CHEM, V262, P5690; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shamu CE, 1998, CURR BIOL, V8, pR121, DOI 10.1016/S0960-9822(98)70986-8; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WARNER JR, 1977, CELL, V11, P201, DOI 10.1016/0092-8674(77)90331-2; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; WARNER JR, 1978, NATURE, V275, P338, DOI 10.1038/275338a0; WARNER JR, 1976, J BACTERIOL, V125, P887, DOI 10.1128/JB.125.3.887-891.1976; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1	78	77	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13235	13241		10.1074/jbc.274.19.13235	http://dx.doi.org/10.1074/jbc.274.19.13235			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224082	hybrid			2022-12-27	WOS:000080200400044
J	Zhang, LJ; Kim, M; Choi, YH; Goemans, B; Yeung, C; Hu, ZY; Zhan, SL; Seth, P; Helman, LJ				Zhang, LJ; Kim, M; Choi, YH; Goemans, B; Yeung, C; Hu, ZY; Zhan, SL; Seth, P; Helman, LJ			Diminished G(1) checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR P21 GENE; NIH 3T3 CELLS; P53-INDEPENDENT EXPRESSION; DEPENDENT KINASES; PHASE-TRANSITION; PROTEIN-KINASES; CANCER CELLS; D1; PROGRESSION; DIFFERENTIATION	High levels of insulin-like growth factor II (IGFII) mRNA expression are detected in many human tumors of different origins including rhabdomyosarcoma, a tumor of skeletal muscle origin. To investigate the role of IGFII in tumorigenesis, we have compared the mouse myoblast cell line C2C12-2.7, which was stably transfected with human IGFII cDNA and expressed high and constant amounts of IGFII, to a control cell line C2C12-1.1, A rhabdomyosarcoma cell line, RH30, which expresses high levels of IGFII and contains mutated p53, was also used in these studies. IGFII overexpression in mouse myoblast C2C12 cells causes a reduced cycling time and higher growth rate. After gamma-irradiation treatment, C2C12-1.1 cells were arrested mainly in G(0)/G(1) phase. However, C2C12-2.7 and RH30 cells went through a very short G(1) phase and then were arrested in an extended G(2)/M phase. To verify further the effect of IGFII on the cell cycle, we developed a Chinese hamster ovary (CHO) cell line with tetracycline-controlled IGFII expression. We found that CHO cells with high expression of IGFII have a shortened cycling time and a diminished G(1) checkpoint after treatment with methylmethane sulfonate (MMS), a DNA base-damaging agent, when compared with CHO cells with very low IGFII expression, It was also found that IGFII overexpression in C2C12 cells was associated with increases in cyclin D1, p21, and p53 protein levels, as well as mitogen-activated protein kinase activity, These studies suggest that IGFII overexpression shortens cell cycling time and diminishes the G(1) checkpoint after DNA damage despite an intact p53/p21 induction. In addition, IGFII overexpression is also associated with multiple changes in the levels and activities of cell cycle regulatory components following gamma-irradiation, Taken together, these changes may contribute to the high growth rate and genetic alterations that occur during tumorigenesis.	NCI, Mol Oncol Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; NCI, Med Breast Canc Sect, NIH, Bethesda, MD 20892 USA; NCI, Cell Signalling & Oncogenesis Sect, NIH, Bethesda, MD 20892 USA; NIDDK, Liver Dis Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Helman, LJ (corresponding author), NCI, Mol Oncol Sect, Pediat Oncol Branch, NIH, Bldg 10,Rm 13N240, Bethesda, MD 20892 USA.							BHATAVDEKAR JM, 1994, NEOPLASMA, V41, P101; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELBADRY OM, 1989, J CLIN INVEST, V84, P829, DOI 10.1172/JCI114243; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; FIORENTINO M, 1994, DIAGN MOL PATHOL, V3, P59, DOI 10.1097/00019606-199403010-00010; FURLANETTO RW, 1994, MOL ENDOCRINOL, V8, P510, DOI 10.1210/me.8.4.510; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hiyama H, 1998, ONCOGENE, V16, P1513, DOI 10.1038/sj.onc.1201667; Hiyama H, 1997, ONCOGENE, V14, P2533, DOI 10.1038/sj.onc.1201080; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; JIANG HP, 1994, ONCOGENE, V9, P3397; JIANG W, 1993, ONCOGENE, V8, P3447; JIANG W, 1992, CANCER RES, V52, P2980; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LAHM H, 1994, INT J CANCER, V58, P452, DOI 10.1002/ijc.2910580325; LAMMIE GA, 1991, ONCOGENE, V6, P439; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Liu Y, 1996, CANCER RES, V56, P31; LOVEC H, 1994, ONCOGENE, V9, P323; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Marchetti A, 1996, ONCOGENE, V12, P1319; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MINNITI CP, 1995, CELL GROWTH DIFFER, V6, P263; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MURRAY A, 1993, CELL CYCLE, P3; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SCHUURING E, 1992, ONCOGENE, V7, P355; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Smith Martin L., 1995, Current Opinion in Oncology, V7, P69; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133; Winston JT, 1996, ONCOGENE, V12, P127; Xu FH, 1997, BRIT J HAEMATOL, V97, P429, DOI 10.1046/j.1365-2141.1997.592708.x; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	57	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13118	13126		10.1074/jbc.274.19.13118	http://dx.doi.org/10.1074/jbc.274.19.13118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224065	hybrid			2022-12-27	WOS:000080200400027
J	Sakahira, H; Enari, M; Nagata, S				Sakahira, H; Enari, M; Nagata, S			Functional differences of two forms of the inhibitor of caspase-activated DNase, ICAD-L, and ICAD-S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MOLECULAR CHAPERONES; PROLYL 4-HYDROXYLASE; APOPTOSIS; PROTEIN; FRAGMENTATION; SPECIFICITIES; RECEPTOR; SUBUNIT; FAMILY	Caspase-activated DNase (CAD) is responsible for the DNA fragmentation that occurs during apoptosis. CAD is complexed with an inhibitor of CAD (ICAD) in non-apoptotic, growing cells. Here, we report that mouse WR19L and human Jurkat T lymphoma cells express two alternative forms of ICAD, ICAD-L and ICAD-S, at similar levels. CAD was predominantly associated with ICAD-L in these cell lines. When CAD was expressed alone in Sf9 cells, it was found in insoluble fractions. However, when CAD was co-expressed with ICAD-L and ICAD-S, it was recovered as a soluble protein complexed predominantly with ICAD-L. In vitro transcription and translation of CAD cDNA did not produce a functional protein. Addition of ICAD-L but not ICAD-S to the assay mixture resulted in the synthesis of functional CAD. These results indicated that ICAD-L but not ICAD-S works as a specific chaperone for CAD, facilitating its correct folding during synthesis. Recombinant CAD, as a complex with ICAD-L, was then produced in Sf9 cells. The complex was treated with caspase 3, and CAD was purified to homogeneity. The purified CAD had DNase activity with a high specific activity.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, B-3,2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	nagata@genetic.med.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019; Enari, Masato/E-5507-2014	Nagata, Shigekazu/0000-0001-9758-8426; Enari, Masato/0000-0003-4293-3848				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; JAKOB U, 1993, J BIOL CHEM, V268, P1517; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; SMULDERS RHPH, 1995, J BIOL CHEM, V270, P13916, DOI 10.1074/jbc.270.23.13916; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YOSHIKAWA A, 1995, EMBO J, V14, P5288, DOI 10.1002/j.1460-2075.1995.tb00213.x; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	30	89	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15740	15744		10.1074/jbc.274.22.15740	http://dx.doi.org/10.1074/jbc.274.22.15740			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336474	hybrid			2022-12-27	WOS:000080560100063
J	Xin, HB; Rogers, K; Qi, Y; Kanematsu, T; Fleischer, S				Xin, HB; Rogers, K; Qi, Y; Kanematsu, T; Fleischer, S			Three amino acid residues determine selective binding of FK506-binding protein 12.6 to the cardiac ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; FK-506-BINDING PROTEIN; FK506; CALCINEURIN; COMPLEX; FKBP; TRANSPLANTATION; FKBP-FK506	FK506-binding protein (FKBP12) has been found to be associated with the skeletal muscle ryanodine receptor (RyR1) (calcium release channel), whereas FKBP12.6, a novel isoform of FKBP, is selectively associated with the cardiac ryanodine receptor (RyR2), For both RyRs, the stoichiometry is 4 FKBP/RyR. Although FKBP12.6 differs from FKBP12 by only 18 of 108 amino acids, FKBP12.6 selectively binds to RyR2 and exchanges with bound FKBP12.6 of RyR2, whereas both FKBP isoforms bind to RyR1 and exchange with bound FKBP12 of RyR1. To assess the amino acid residues of FKBP12.6 that are critical for selective binding to RyR2, the residues of FKBP12.6 that differ with FKBP12 were mutated to the respective residues of FKBP12. RyR2 of cardiac sarcoplasmic reticulum, prelabeled by exchange with [S-35]FKBP12.6, was used as assay system for binding/ exchange with the mutants. The triple mutant (Q31E/ N32D/F59W) of FKBP12.6 was found to lack selective binding to the cardiac RyR2, comparable with that of FKBP12.0. In complementary studies, mutations of FKBP12 to the three critical amino acids of FKBP12.6, conferred selective binding to RyR2, Each of the FKBP12.6 and FKBP12 mutants retained binding to the skeletal muscle RyR1, We conclude that three amino acid residues (Gln(31), Asn(32), and Phe(59)) of human FKBP12.6 account for the selective binding to cardiac RyR2.	Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA	Vanderbilt University	Fleischer, S (corresponding author), Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032711] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32711] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; MOORE JM, 1991, NATURE, V351, P248, DOI 10.1038/351248a0; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; OCHIAI T, 1987, TRANSPLANTATION, V44, P734, DOI 10.1097/00007890-198712000-00002; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SEWELL TJ, 1994, J BIOL CHEM, V269, P21094; STANDAERT RF, 1990, NATURE, V346, P671, DOI 10.1038/346671a0; STERZL TE, 1995, LANCET, V346, P1346; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; TIMERMAN AP, 1994, BIOCHEM BIOPH RES CO, V198, P701, DOI 10.1006/bbrc.1994.1101; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; TODO S, 1989, SURGERY, V106, P444; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wagenknecht T, 1996, BIOPHYS J, V70, P1709, DOI 10.1016/S0006-3495(96)79733-3; WINKLER M, 1995, DRUG SAFETY, V12, P348, DOI 10.2165/00002018-199512050-00006; XIN HB, 1995, BIOCHEM BIOPH RES CO, V214, P263, DOI 10.1006/bbrc.1995.2283	34	62	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15315	15319		10.1074/jbc.274.22.15315	http://dx.doi.org/10.1074/jbc.274.22.15315			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336416	hybrid			2022-12-27	WOS:000080560100005
J	Benachour, A; Sipos, G; Flury, I; Reggiori, F; Canivenc-Gansel, E; Vionnet, C; Conzelmann, A; Benghezal, M				Benachour, A; Sipos, G; Flury, I; Reggiori, F; Canivenc-Gansel, E; Vionnet, C; Conzelmann, A; Benghezal, M			Deletion of GPI7, a yeast gene required for addition of a side chain to the glycosylphosphatidylinositol (GPI) core structure, affects GPI protein transport, remodeling, and cell wall integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYL-PHOSPHATIDYLINOSITOL ANCHOR; HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; GLYCOINOSITOL PHOSPHOLIPID ANCHOR; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MEMBRANE ANCHOR; INOSITOL-ACYLATION; PLASMA-MEMBRANE; FIRST STEP; CLASS-H	Gpi7 was isolated by screening for mutants defective in the surface expression of glycosylphosphatidylinositol (GPI) proteins. Gpi7 mutants are deficient in YJL062w, herein named GP17. GPI7 is not essential, but its deletion renders cells hypersensitive to Calcofluor White, indicating cell wall fragility. Several aspects of GPI biosynthesis are disturbed in Delta gpi7. The extent of anchor remodeling, i.e. replacement of the primary lipid moiety of GPI anchors by ceramide, is significantly reduced, and the transport of GPI proteins to the Golgi is delayed, Gpi7p is a highly glycosylated integral membrane protein with 9-11 predicted transmembrane domains in the C-terminal part and a large, hydrophilic N-terminal ectodomain. The bulk of Gpi7p is located at the plasma membrane, but a small amount is found in the endoplasmic reticulum. GP17 has homologues in Saccharomyces cerevisiae, Caenorhabditis elegans, and man, but the precise biochemical function of this protein family is unknown. Based on the analysis of M4, an abnormal GPI lipid accumulating in gpi7, we propose that Gpi7p adds a side chain onto the GPI core structure. Indeed, when compared with complete GPI lipids, M4 lacks a previously unrecognized phosphodiester-linked side chain, possibly an ethanolamine phosphate. Gpi7p contains significant homology with phosphodiesterases suggesting that Gpi7p itself is the transferase adding a side chain to the alpha 1,6-linked mannose of the GPI core structure.	Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland	University of Fribourg	Conzelmann, A (corresponding author), Univ Fribourg, Inst Biochem, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch	Sipos, György/AAC-8267-2019; Sipos, Gyorgy/D-9287-2011; Reggiori, Fulvio/U-8327-2019	Sipos, György/0000-0002-6666-1384; Reggiori, Fulvio/0000-0003-2652-2686				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AZZOUZ N, 1995, EMBO J, V14, P4422, DOI 10.1002/j.1460-2075.1995.tb00121.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; BENGHEZAL M, 1995, J CELL BIOL, V130, P1333, DOI 10.1083/jcb.130.6.1333; Benghezal M, 1996, EMBO J, V15, P6575, DOI 10.1002/j.1460-2075.1996.tb01048.x; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; Canivenc-Gansel E, 1998, GLYCOBIOLOGY, V8, P761, DOI 10.1093/glycob/8.8.761; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; Chen R, 1996, P NATL ACAD SCI USA, V93, P2280, DOI 10.1073/pnas.93.6.2280; CONZELMANN A, 1992, EMBO J, V11, P457, DOI 10.1002/j.1460-2075.1992.tb05075.x; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; De Nobel Hans, 1994, Trends in Cell Biology, V4, P42, DOI 10.1016/0962-8924(94)90003-5; DEEG MA, 1992, J BIOL CHEM, V267, P18573; FANKHAUSER C, 1991, EUR J BIOCHEM, V195, P439, DOI 10.1111/j.1432-1033.1991.tb15723.x; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; FRANZUSOFF A, 1991, METHOD ENZYMOL, V194, P662; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GUTHER MLS, 1994, J BIOL CHEM, V269, P18694; HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629; HARLOW E, 1988, ANTIBODIES LAB MANUA, P541; HEESEN ST, 1991, EUR J CELL BIOL, V56, P8; HILL JE, 1993, YEAST, V2, p1Y63; HIROSE S, 1992, J BIOL CHEM, V267, P16968; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; INOUE N, 1993, J BIOL CHEM, V268, P6882; KAMITANI T, 1993, J BIOL CHEM, V268, P20733; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; LEIDICH SD, 1995, J BIOL CHEM, V270, P13029, DOI 10.1074/jbc.270.22.13029; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Mondesert G, 1997, GENETICS, V147, P421; Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1111/j.1574-6976.1997.tb00347.x; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; PUOTI A, 1993, J BIOL CHEM, V268, P7215; PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515; PUOTI A, 1992, J BIOL CHEM, V267, P22673; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Ramalingam S, 1996, P NATL ACAD SCI USA, V93, P7528, DOI 10.1073/pnas.93.15.7528; REDMAN CA, 1994, BIOCHEM J, V302, P861, DOI 10.1042/bj3020861; Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955; SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x; Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; Takahashi M, 1996, EMBO J, V15, P4254, DOI 10.1002/j.1460-2075.1996.tb00800.x; TAKEDA J, 1995, TRENDS BIOCHEM SCI, V20, P367, DOI 10.1016/S0968-0004(00)89078-7; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; UEDA E, 1993, J BIOL CHEM, V268, P9998; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yu JL, 1997, P NATL ACAD SCI USA, V94, P12580, DOI 10.1073/pnas.94.23.12580	64	102	106	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15251	15261		10.1074/jbc.274.21.15251	http://dx.doi.org/10.1074/jbc.274.21.15251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329735	hybrid, Green Published			2022-12-27	WOS:000081965200100
J	Longland, CL; Mezna, M; Michelangeli, F				Longland, CL; Mezna, M; Michelangeli, F			The mechanism of inhibition of the Ca2+-ATPase by mastoparan - Mastoparan abolishes cooperative Ca2+ binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA-2+-ATPASE; GASTRIC (H+; ADENOSINE 5'-TRIPHOSPHATE; BOUND CONFORMATION; ATPASE; MELITTIN; CALCIUM; PEPTIDE; (CA2+-MG2+)-ATPASE; VESICLES	The amphiphilic peptide mastoparan, isolated from wasp venom, is a potent inhibitor of the sarcoplasmic reticulum Ca2+-ATPase. At pH 7.2, ATPase activity is inhibited with an inhibitory constant (K-i) of 1 +/- 0.13 mu M. Mastoparan shifts the E2-E1 equilibrium toward El and may affect the regulatory ATP binding site. The peptide also decreases the affinity of the ATPase for Ca2+ and abolishes the cooperativity of Ca2+ binding. In the presence of mastoparan, the two Ca2+ ions bind independently of one another. Our results appear to support the model that describes the relationship between the two Ca2+ binding sites as "side-by-side," because this model allows the possibility of independent Ca2+ entry to the two sites. Mastoparan shifts the steady-state equilibrium between E1'Ca-2 and E1'Ca-2. P toward E1'Ca-2. P, by possibly affecting the conformational change that follows ATP binding. The peptide also causes a reduction in the levels of phosphoenzyme formed from [P-32]P-i. Some analogues of mastoparan were also tested and were found to cause inhibition of the Ca2+-ATPase in the range of 2-4 mu M. The inhibitory action of mastoparan and its analogues appears dependent on their ability to form alpha-helices in membranes.	Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Michelangeli, F (corresponding author), Univ Birmingham, Sch Biochem, POB 363, Birmingham B15 2TT, W Midlands, England.							BAKER KJ, 1995, BIOCHEMISTRY-US, V34, P3596, DOI 10.1021/bi00011a014; BAKER KJ, 1995, BIOCHEM J, V307, P571, DOI 10.1042/bj3070571; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; COLL RJ, 1986, BIOCHEM BIOPH RES CO, V138, P652, DOI 10.1016/S0006-291X(86)80546-0; CUPPOLETTI J, 1990, ARCH BIOCHEM BIOPHYS, V283, P249, DOI 10.1016/0003-9861(90)90639-G; CUPPOLETTI J, 1989, ARCH BIOCHEM BIOPHYS, V275, P263, DOI 10.1016/0003-9861(89)90372-X; CUPPOLETTI J, 1992, MOL CELL BIOCHEM, V114, P57; CUPPOLETTI J, 1990, ARCH BIOCHEM BIOPHYS, V278, P409, DOI 10.1016/0003-9861(90)90278-7; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DUPONT Y, 1985, J BIOL CHEM, V260, P7241; DUPONT Y, 1982, BIOCHEM BIOPH RES CO, V106, P1272, DOI 10.1016/0006-291X(82)91250-5; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FROUD RJ, 1986, BIOCHEM J, V237, P197, DOI 10.1042/bj2370197; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HIRAI Y, 1980, BIOMED RES-TOKYO, V1, P185, DOI 10.2220/biomedres.1.185; HIRAI Y, 1979, CHEM PHARM BULL, V27, P1942; INESI G, 1980, J BIOL CHEM, V255, P3025; KOSKKOSICKA D, 1983, BIOCHEMISTRY-US, V22, P2559, DOI 10.1021/bi00279a037; Langel U, 1996, REGUL PEPTIDES, V62, P47, DOI 10.1016/0167-0115(96)00002-X; Longland CL, 1998, CELL CALCIUM, V24, P27, DOI 10.1016/S0143-4160(98)90086-0; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MAHANEY JE, 1991, BIOCHEMISTRY-US, V30, P7171, DOI 10.1021/bi00243a019; MICHELANGELI F, 1991, ANAL BIOCHEM, V194, P231, DOI 10.1016/0003-2697(91)90223-G; MICHELANGELI F, 1990, BIOCHEMISTRY-US, V29, P8307, DOI 10.1021/bi00488a015; MICHELANGELI F, 1990, BIOCHEMISTRY-US, V29, P3090; PETITHORY JR, 1986, BIOCHEMISTRY-US, V25, P4493, DOI 10.1021/bi00364a006; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; SUKUMAR M, 1992, J BIOL CHEM, V267, P21421; WAKABAYASHI S, 1990, J BIOCHEM-TOKYO, V107, P563, DOI 10.1093/oxfordjournals.jbchem.a123087; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P5654, DOI 10.1021/bi00139a032; WATANABE T, 1982, J BIOL CHEM, V257, P1510; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C	35	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14799	14805		10.1074/jbc.274.21.14799	http://dx.doi.org/10.1074/jbc.274.21.14799			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329678	hybrid			2022-12-27	WOS:000081965200043
J	Nurizzo, D; Cutruzzola, F; Arese, M; Bourgeois, D; Brunori, M; Cambillau, C; Tegoni, M				Nurizzo, D; Cutruzzola, F; Arese, M; Bourgeois, D; Brunori, M; Cambillau, C; Tegoni, M			Does the reduction of c heme trigger the conformational change of crystalline nitrite reductase?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; PSEUDOMONAS-AERUGINOSA; CYTOCHROME-OXIDASE; ARM EXCHANGE; MUTAGENESIS; CATALYSIS; DOMAIN; ENZYME; CD(1)	The structures of nitrite reductase from Paracoccus denitrificans GB17 (NiR-Pd) and Pseudomonas aeruginosa (NiR-Pa) have been described for the oxidized and reduced state (Fulop, V., Moir, J. W. B., Ferguson, S. J., and Hajdu, J. (1995) Cell 81, 369-377; Nurizzo, D., Silvestrini, M. C., Mathieu, M., Cutruzzola, F., Bourgeois, D., Fulop, V., Hajdu, J., Brunori, M., Tegoni, M., and Cambillau, C. (1997) Structure 5, 1157-1171; Nurizzo, D., Cutruzzola F., Arese, M., Bourgeois, D., Brunori, M., Cambillau, C., and Tegoni, M. (1998) Biochemistry 37, 13987-13996). Major conformational rearrangements are observed in the extreme states although they are more substantial in NiR-Pd. The four structures differ significantly in the c heme domains. Upon reduction, a His(17)/ Met(106) heme-ligand switch is observed in NiR-Pd together with concerted movements of the Tyr in the distal site of the d(1) heme (Tyr(10) in NiR-Pa, Tyr(25) in NiR-Pd) and of a loop of the c heme domain (56-62 in NiR-Pa, 99-116 in NiR-Pd). Whether the reduction of the c heme, which undergoes the major rearrangements, is the trigger of these movements is the question addressed by our study. This conformational reorganization is not observed in the partially reduced species, in which the c heme is partially or largely (15-90%) reduced but the d(1) heme is still oxidized. These results suggest that the d(1) heme reduction is likely to be responsible of the movements. We speculate about the mechanistic explanation as to why the opening of the d(1) heme distal pocket only occurs upon electron transfer to the d(1) heme itself, to allow binding of the physiological substrate NO2- exclusively to the reduced metal center.	IBSM, UPR9039, CNRS, Marseille 20, France; Univ Rome La Sapienza, CNR, Dipartimento Sci Biochim, I-00185 Rome, Italy; Univ Rome La Sapienza, CNR, Ctr Biol Mol, I-00185 Rome, Italy; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; European Synchrotron Radiation Facility (ESRF)	Cambillau, C (corresponding author), IBSM, UPR9039, CNRS, 31 Ch Joseph Aiguier, Marseille 20, France.		Cutruzzola', Francesca/G-4052-2011; , Bourgeois/AAI-2337-2020	Cutruzzola', Francesca/0000-0002-4621-2135; ARESE, Marzia/0000-0002-6140-2287; Brunori, Maurizio/0000-0002-7795-1635				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; BLATT Y, 1979, BIOCHEMISTRY-US, V18, P2917, DOI 10.1021/bi00580a037; Bourgeois D, 1998, J APPL CRYSTALLOGR, V31, P22, DOI 10.1107/S0021889897006730; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1996, X PLOR MANUAL; Cutruzzola F, 1997, FEBS LETT, V412, P365, DOI 10.1016/S0014-5793(97)00583-8; EGEBERG KD, 1990, BIOCHEMISTRY-US, V29, P9783, DOI 10.1021/bi00494a004; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; GREENWOOD C, 1978, BIOCHEM J, V173, P11, DOI 10.1042/bj1730011; HOLMES MA, 1991, J MOL BIOL, V218, P583, DOI 10.1016/0022-2836(91)90703-9; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0; Nurizzo D, 1998, BIOCHEMISTRY-US, V37, P13987, DOI 10.1021/bi981348y; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PARR SR, 1977, BIOCHEM J, V167, P447, DOI 10.1042/bj1670447; PARR SR, 1976, BIOCHEM J, V157, P423, DOI 10.1042/bj1570423; PIN S, 1994, BIOCHEMISTRY-US, V33, P11618, DOI 10.1021/bi00204a024; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Roussel A, 1991, SILICON GRAPHICS GEO, P86; SCHICHMAN SA, 1981, J AM CHEM SOC, V103, P7794, DOI 10.1021/ja00416a020; SHIMADA H, 1976, J BIOCHEM-TOKYO, V80, P135, DOI 10.1093/oxfordjournals.jbchem.a131245; SILVESTRINI MC, 1979, BIOCHEM J, V183, P701, DOI 10.1042/bj1830701; SILVESTRINI MC, 1990, J BIOL CHEM, V265, P11783; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	30	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14997	15004		10.1074/jbc.274.21.14997	http://dx.doi.org/10.1074/jbc.274.21.14997			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329702	hybrid			2022-12-27	WOS:000081965200067
J	Smirnova, E; Shurland, DL; Newman-Smith, ED; Pishvaee, B; van der Bliek, AM				Smirnova, E; Shurland, DL; Newman-Smith, ED; Pishvaee, B; van der Bliek, AM			A model for dynamin self-assembly based on binding between three different protein domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL CHANGE; PLECKSTRIN HOMOLOGY DOMAINS; COATED VESICLE FORMATION; GTPASE ACTIVITY; SH3 DOMAINS; DROSOPHILA; ENDOCYTOSIS; SHIBIRE; OLIGOMERIZATION; MICROTUBULES	Dynamin is a 100-kDa GTPase that assembles into multimeric spirals at the necks of budding clathrin-coated vesicles. We describe three different intramolecular binding interactions that may account for the process of dynamin self-assembly. The first binding interaction is the dimerization of a 100-amino acid segment in the C-terminal half of dynamin. We call this segment the assembly domain, because it appears to be critical for multimerization. The second binding interaction occurs between the assembly domain and the N-terminal GTPase domain The strength of this interaction is controlled by the nucleotide-bound state of the GTPase domain, as shown with mutations in GTP binding motifs and in vitro binding experiments. The third binding interaction occurs between the assembly domain and a segment that we call the middle domain. This is the segment between the N-terminal GTPase domain and the pleckstrin homology domain The three different binding interactions suggest a model in which dynamin molecules first dimerize. The dimers are then linked into a chain by a second binding reaction. The third binding interaction might connect adjacent rungs of the spiral.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	van der Bliek, AM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, POB 951737, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM51866] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051866] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artalejo CR, 1997, EMBO J, V16, P1565, DOI 10.1093/emboj/16.7.1565; Ausubel FM, 1988, MOL REPROD DEV; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fancy DA, 1996, CHEM BIOL, V3, P551, DOI 10.1016/S1074-5521(96)90146-5; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Grant D, 1998, GENETICS, V149, P1019; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MELEN K, 1992, J BIOL CHEM, V267, P25898; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; POULLET P, 1995, EUR J BIOCHEM, V227, P537, DOI 10.1111/j.1432-1033.1995.tb20421.x; Roos J, 1997, TRENDS CELL BIOL, V7, P257, DOI 10.1016/S0962-8924(97)01068-4; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310	36	114	116	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14942	14947		10.1074/jbc.274.21.14942	http://dx.doi.org/10.1074/jbc.274.21.14942			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329695	hybrid			2022-12-27	WOS:000081965200060
J	Su, KH; Roos, MD; Yang, XY; Han, I; Paterson, AJ; Kudlow, JE				Su, KH; Roos, MD; Yang, XY; Han, I; Paterson, AJ; Kudlow, JE			An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; LACTACYSTIN BETA-LACTONE; EPIDERMAL GROWTH-FACTOR; 67-KDA POLYPEPTIDE P67; DNA-BINDING ACTIVITY; KAPPA-B-ALPHA; PROTEIN-DEGRADATION; O-GLYCOSYLATION; END RULE; C-JUN	The transcription factor Spl is important for the expression of many cellular genes. Previously, it was shown that reduced O-glycosylation of Spl is associated with increased proteasome susceptibility. Spl undergoes proteasome-dependent degradation in cells stressed with glucose deprivation and adenylate cyclase activation, and this process is blocked in cells treated with glucosamine. In this study, using a reconstituted in vitro system, we identified the principal structural determinant in Spl that targets Spl for proteasome-dependent degradation. We found by using deletion analysis that the N-terminal 54 amino acids of Spl is required for Spl degradation. This element can act as an independent processing signal by directing degradation of an unrelated protein Recognition of this Spl element by the proteasome-dependent system is saturable, and ubiquitination of this element is not required for recognition. Time course experiments revealed that Spl degradation is a two-step process. First, a discrete endoproteolytic cleavage occurs downstream of the target region immediately C-terminal to Leu(56). The Spl sequence C-terminal to the cleavage site is subsequently degraded, whereas the N-terminal peptide remains intact. The identification of this Spl degradation-targeting signal will facilitate the identification of the critical proteins involved in the control of Spl proteasome-dependent degradation and the role of O-GlcNAc in this process.	Univ Alabama, Dept Med, Div Endocrinol & Metab, Birmingham, AL 35294 USA; Univ Alabama, Dept Cell Biol, Div Endocrinol & Metab, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kudlow, JE (corresponding author), Univ Alabama, Dept Med, Div Endocrinol & Metab, Birmingham, AL 35294 USA.							Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; DATTA B, 1989, J BIOL CHEM, V264, P20620; DATTA B, 1988, P NATL ACAD SCI USA, V85, P3324, DOI 10.1073/pnas.85.10.3324; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Dick LR, 1997, J BIOL CHEM, V272, P182; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1994, P NATL ACAD SCI USA, V91, P3358, DOI 10.1073/pnas.91.8.3358; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1992, MOL CELL BIOL, V12, P2178, DOI 10.1128/MCB.12.5.2178; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JANE SM, 1993, MOL CELL BIOL, V13, P3272, DOI 10.1128/MCB.13.6.3272; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P200; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Li XQ, 1996, J BIOL CHEM, V271, P4447; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin RT, 1996, MOL CELL BIOL, V16, P1401; LUCA FC, 1991, EMBO J, V10, P4311, DOI 10.1002/j.1460-2075.1991.tb05009.x; Moriyama T, 1998, J BIOL CHEM, V273, P22037, DOI 10.1074/jbc.273.34.22037; Mortensen ER, 1997, J BIOL CHEM, V272, P16540, DOI 10.1074/jbc.272.26.16540; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURATA Y, 1994, J BIOL CHEM, V269, P20674; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PARTHUN MR, 1992, MOL CELL BIOL, V12, P4981, DOI 10.1128/MCB.12.11.4981; Piedrafita FJ, 1997, MOL CELL BIOL, V17, P6348, DOI 10.1128/MCB.17.11.6348; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; RAY MK, 1992, P NATL ACAD SCI USA, V89, P539, DOI 10.1073/pnas.89.2.539; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; SHIN TH, 1992, MOL CELL BIOL, V12, P3998, DOI 10.1128/MCB.12.9.3998; Sijts AJAM, 1997, J BIOL CHEM, V272, P19261, DOI 10.1074/jbc.272.31.19261; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Weil R, 1997, J BIOL CHEM, V272, P9942; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997	75	92	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15194	15202		10.1074/jbc.274.21.15194	http://dx.doi.org/10.1074/jbc.274.21.15194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329728	hybrid			2022-12-27	WOS:000081965200093
J	Kitagawa, H; Shimakawa, H; Sugahara, K				Kitagawa, H; Shimakawa, H; Sugahara, K			The tumor suppressor EXT-like gene EXTL2 encodes an alpha 1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region - The key enzyme for the chain initiation of heparan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MULTIPLE EXOSTOSES; IN-VITRO; IDENTIFICATION; BIOSYNTHESIS; FAMILY; CHROMOSOME-11; EXPRESSION; GLYCOSYLTRANSFERASES; TETRASACCHARIDES; HETEROZYGOSITY	We previously demonstrated a unique alpha-N-acetylgalactosaminyltransferase that transferred N-acetylgalactosamine (GalNAc) to the tetrasaccharide-serine, GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser (GlcA represents glucuronic acid), derived from the common glycosaminoglycan-protein linkage region, through an alpha 1,4-linkage. In this study, we purified the enzyme from the serum-free culture medium of a human sarcoma cell line. Peptide sequence analysis of the purified enzyme revealed 100% identity to the multiple exostoses-like gene EXTL2/EXTR1, a member of the hereditary multiple exostoses (EXT) gene family of tumor suppressors. The expression of a soluble recombinant form of the protein produced an active enzyme, which transferred alpha-GalNAc from UDP-[H-3]GalNAc to various acceptor substrates including GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser. Interestingly, the enzyme also catalyzed the transfer of N-acetylglucosamine (GlcNAc) from UDP-[H-3]GlcNAc to GlcA beta 1-3Gal beta 1-O-naphthalenemethanol, which was the acceptor substrate for the previously described GlcNAc transferase I involved in the biosynthetic initiation of heparan sulfate. The GlcNAc transferase reaction product was sensitive to the action of heparitinase I, establishing the identity of the enzyme to be alpha 1,4-GlcNAc transferase. These results altogether indicate that EXTL2/EXTR2 encodes the alpha 1,4-N-acetylhexosaminyl-transferase that transfers GalNAc/GlcNAc to the tetrasaccharide representing the common glycosaminoglycan-protein linkage region and that is most likely the critical enzyme that determines and initiates the heparin/heparan sulfate synthesis, separating it from the chondroitin sulfate/dermatan sulfate synthesis.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita-machi, Kobe, Hyogo 6588558, Japan.	k-sugar@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Binari RC, 1997, DEVELOPMENT, V124, P2623; COOK A, 1993, AM J HUM GENET, V53, P71; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Fritz TA, 1997, GLYCOBIOLOGY, V7, P587, DOI 10.1093/glycob/7.5.587-c; GOTO F, 1993, PURE APPL CHEM, V65, P793, DOI 10.1351/pac199365040793; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITAGAWA H, 1999, IN PRESS GLYCOBIOLOG, V9; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; Lidholt K, 1997, GLYCOCONJUGATE J, V14, P737, DOI 10.1023/A:1018525602197; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lindahl U., 1972, GLYCOPROTEINS THEIR, P491; Miura Y, 1998, GLYCOBIOLOGY, V8, P813, DOI 10.1093/glycob/8.8.813; Murch SH, 1996, LANCET, V347, P1299, DOI 10.1016/S0140-6736(96)90941-1; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Van Hul W, 1998, GENOMICS, V47, P230, DOI 10.1006/geno.1997.5101; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796	30	161	169	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13933	13937		10.1074/jbc.274.20.13933	http://dx.doi.org/10.1074/jbc.274.20.13933			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318803	hybrid			2022-12-27	WOS:000080322200032
J	Liu, RY; Fan, C; Olashaw, NE; Wang, X; Zuckerman, KS				Liu, RY; Fan, C; Olashaw, NE; Wang, X; Zuckerman, KS			Tumor necrosis factor-alpha-induced proliferation of human Mo7e leukemic cells occurs via activation of nuclear factor kappa B transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-KINASE ACTIVATION; BREAST-CANCER CELLS; TNF-ALPHA; INDUCED APOPTOSIS; LYMPHOMA PATIENTS; U937 CELLS; HEL CELLS; LINE; INHIBITION	Tumor necrosis factor-alpha (TNF-alpha) stimulates proliferation of Mo7e, CMK, HU-3, and M-MOK human leukemic cell lines. We report here the signal transduction pathway involved in TNF-alpha-induced Mo7e cell proliferation. Mo7e cells spontaneously die in the absence of growth factors, but treating the cells with interleukin (IL)-3, IL-6, thrombopoietin, granulocyte/macrophage colony-stimulating factor, or TNF-alpha promotes their survival and proliferation. Although most of these factors activate MAP kinase and Jun NH2-terminal kinase/signal transducer and activators of transcription signaling pathways, TNF-alpha fails to activate either pathway. When Mo7e cells were treated with TNF-alpha, nuclear factor kappa B (NF-kappa B) was activated transiently. The activated NF-kappa B consisted of heterodimers of p65 and p50 subunits. The degradation of I kappa B alpha coincided with activation of NF-kappa B in TNF-alpha-treated cells. To investigate the role of activated NF-kappa B in TNF-alpha-induced Mo7e proliferation, a cell-permeable peptide (SN50) carrying the nuclear localization sequence of p50 NF-KB was used to block nuclear translocation of activated NF-kappa B, Pretreating Mo7e cells with SN50 blocked TNF-alpha-induced nuclear translocation of NF-kappa B and inhibited TNF-alpha-induced Mo7e cell survival and proliferation. A mutant SN50 peptide did not affect TNF-alpha-induced Mo7e cell growth. SN50 had no effects on IL-3- or granulocyte/macrophage colony-stimulating factor-induced Mo7e cell proliferation. The results indicate that activation of NF-kappa B is involved in TNF-alpha-induced Mo7e cell survival and proliferation.	Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol & Med Oncol, Tampa, FL 33612 USA; Univ S Florida, Dept Biochem Mol Biol, Tampa, FL 33612 USA; Univ S Florida, Dept Anat, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liu, RY (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol & Med Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.				NATIONAL CANCER INSTITUTE [R01CA056072, P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [CA56072, P30 CA76292] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAMSSON J, 1993, AM J PEDIAT HEMATOL, V15, P364; ADERKA D, 1993, BLOOD, V81, P2076; AKIYAMA Y, 1992, JPN J CANCER RES, V83, P989, DOI 10.1111/j.1349-7006.1992.tb02012.x; AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Blagosklonny MV, 1998, INT J CANCER, V78, P511, DOI 10.1002/(SICI)1097-0215(19981109)78:4<511::AID-IJC19>3.0.CO;2-8; BRACH MA, 1993, LEUKEMIA, V7, pS22; BRASS LF, 1992, BIOCHEM J, V281, P73, DOI 10.1042/bj2810073; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CIMINO G, 1991, LEUKEMIA, V5, P32; DIGEL W, 1989, BLOOD, V73, P1242; Drexler HG, 1997, LEUKEMIA, V11, P701, DOI 10.1038/sj.leu.2400633; Flury N, 1997, EUR J BIOCHEM, V249, P421, DOI 10.1111/j.1432-1033.1997.00421.x; GREENBERG SM, 1988, BLOOD, V72, P1968; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Holmstrom TH, 1998, J IMMUNOL, V160, P2626; ISHII E, 1991, INT J HEMATOL, V54, P79; KALMANTI M, 1993, INT J HEMATOL, V57, P147; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu RY, 1999, BLOOD, V93, P2369, DOI 10.1182/blood.V93.7.2369.407k18_2369_2379; Liu RY, 1998, CANCER RES, V58, P2217; LIU RY, 1992, CANCER RES, V52, P3667; Liu XY, 1996, P NATL ACAD SCI USA, V93, P11819, DOI 10.1073/pnas.93.21.11819; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lu G, 1997, NEUROCHEM INT, V30, P401, DOI 10.1016/S0197-0186(96)00075-7; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MIURA K, 1992, LEUKEMIA RES, V16, P281, DOI 10.1016/0145-2126(92)90066-G; MUNKER R, 1993, ACTA HAEMATOL-BASEL, V90, P77; OGURA M, 1985, BLOOD, V66, P1384; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Olashaw NE, 1996, J BIOL CHEM, V271, P30307; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Ozaki K, 1997, FEBS LETT, V410, P297, DOI 10.1016/S0014-5793(97)00653-4; Qin ZH, 1998, MOL PHARMACOL, V53, P33, DOI 10.1124/mol.53.1.33; SAARINEN UM, 1990, CANCER RES, V50, P592; Salles G, 1996, BRIT J HAEMATOL, V93, P352, DOI 10.1046/j.1365-2141.1996.5181059.x; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wadhwa M, 1996, CYTOKINE, V8, P900, DOI 10.1006/cyto.1996.0121; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Warzocha K, 1997, J CLIN ONCOL, V15, P499, DOI 10.1200/JCO.1997.15.2.499; Warzocha Krzysztof, 1997, Leukemia (Basingstoke), V11, P441; Watabe M, 1996, J BIOL CHEM, V271, P14067, DOI 10.1074/jbc.271.24.14067; Watabe M, 1997, CANCER RES, V57, P3097; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614	48	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13877	13885		10.1074/jbc.274.20.13877	http://dx.doi.org/10.1074/jbc.274.20.13877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318796	hybrid			2022-12-27	WOS:000080322200025
J	Norris, JL; Baldwin, AS				Norris, JL; Baldwin, AS			Oncogenic Ras enhances NF-kappa B transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CELLULAR-TRANSFORMATION; GENE-EXPRESSION; REQUIRES RAF-1; FACTOR-ALPHA; HA-RAS; C-JUN; CASCADES; STRESS; PHOSPHORYLATION	Tumors frequently contain mutations in ras genes, resulting in constitutive activation of Ras-activated signaling pathways. The ultimate targets of these signal transduction cascades are transcription factors required for cellular proliferation. Understanding how constitutive activation of Ras contributes to tumorigenesis requires an understanding of both the signaling pathways that Ras activates and how these pathways in turn regulate gene expression. Gene expression from kappa B sites is enhanced in cells transformed with activated Ras and NF-kappa B activity is required for oncogenic Ras to transform NIH-3T3 and Rat-1 fibroblasts. Both dominant negative and constitutively active components of signaling pathways have been tested for their ability to regulate NF-kappa B. These experiments show that Ras utilizes Raf-dependent and Raf-independent pathways to activate NF-kappa B transcriptional activity, both of which require the stress-activated kinase p38 or a related kinase. In the case of Raf, activation of NF-kappa B by an autocrine factor stimulates kappa B-dependent transcriptional activity.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.				NATIONAL CANCER INSTITUTE [R01CA073756, F32CA073487] Funding Source: NIH RePORTER; NCI NIH HHS [CA73756, 5F32 CA73487] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Cogswell PC, 1997, J EXP MED, V185, P491, DOI 10.1084/jem.185.3.491; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; FINCO TS, 1993, J BIOL CHEM, V268, P17676; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOEDERT M, 1997, EMBO J, V16, P3663; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; OLSEN MF, 1995, SCIENCE, V269, P1270; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SAMUELS ML, 1994, MOL CELL BIOL, V14, P7855, DOI 10.1128/MCB.14.12.7855; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TROPPMAIR J, 1997, ONCOGENE, V17, P4454; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	41	110	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13841	13846		10.1074/jbc.274.20.13841	http://dx.doi.org/10.1074/jbc.274.20.13841			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318790	hybrid			2022-12-27	WOS:000080322200019
J	Qi, JH; Ito, N; Claesson-Welsh, L				Qi, JH; Ito, N; Claesson-Welsh, L			Tyrosine phosphatase SHP-2 is involved in regulation of platelet-derived growth factor-induced migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; FACTOR RECEPTOR-BETA; SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; PDGF RECEPTOR; CDNA CLONING; BINDING-SITE; PROTEIN; PHOSPHORYLATION; ACTIVATION; CHEMOTAXIS	SHP-2 is a ubiquitously expressed Src homology-2-containing cytosolic tyrosine phosphatase that binds to and becomes tyrosine-phosphorylated by the activated platelet-derived growth factor receptor-beta (PDGFR-beta). Removal of the binding site on the receptor, by mutation of Tyr(1009) to Phe(1009) (denoted Y1009F), led to loss of PDGF-stimulated phosphatase activity in cells expressing the mutated receptor, and these cells failed to form membrane edge ruffles and to migrate toward PDGF. Furthermore, treatment with phosphatase inhibitors phenylarsine oxide (PAO) and orthovanadate led to loss of PDGF-stimulated phosphatase activity and attenuated PDGF-stimulated migration of wild type PDGFR-beta cells. Treatment of wild type PDGFR-beta cells with combinations of PAO or orthovanadate and phosphatidylinositol 3-kinase inhibitors wortmannin or LY294002 resulted in a synergistic inhibition of PDGFR-beta-mediated cell migration. PDGF stimulation of wild type PDGFR-beta cells led to induction of p125 focal adhesion kinase (FAK) activity at low concentrations of the growth factor and a decrease at higher concentrations. In the mutant Y1009F cells and in wild type PDGFR-beta cells treated with PAO and orthovanadate, FAK activity was not increased in response to PDGF. These results suggest that SHP-2 activity is involved in regulation of FAK activity and thereby of cell migration through PDGFR-beta, independently of phosphatidylinositol 3-kinase.	Univ Uppsala, Dept Med Biochem & Microbiol, Ctr Biomed, S-75123 Uppsala, Sweden	Uppsala University	Claesson-Welsh, L (corresponding author), Univ Uppsala, Dept Med Biochem & Microbiol, Ctr Biomed, Box 575, S-75123 Uppsala, Sweden.							AUERBACH R, 1991, PHARMACOL THERAPEUT, V51, P1, DOI 10.1016/0163-7258(91)90038-N; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BRISCOE CP, 1995, BIOCHEM J, V306, P115, DOI 10.1042/bj3060115; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; DEFILIPPI P, 1995, EXP CELL RES, V221, P141, DOI 10.1006/excr.1995.1361; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ouwens DM, 1996, BIOCHEM J, V318, P609, DOI 10.1042/bj3180609; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RANKIN S, 1994, J BIOL CHEM, V269, P704; Rankin S, 1996, J BIOL CHEM, V271, P7829, DOI 10.1074/jbc.271.13.7829; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Stokes C L, 1992, EXS, V61, P118; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WENNSTROM S, 1994, ONCOGENE, V9, P651; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	37	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14455	14463		10.1074/jbc.274.20.14455	http://dx.doi.org/10.1074/jbc.274.20.14455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318871	hybrid			2022-12-27	WOS:000080322200100
J	Rehault, S; Brillard-Bourdet, M; Juliano, MA; Juliano, L; Gauthier, F; Moreau, T				Rehault, S; Brillard-Bourdet, M; Juliano, MA; Juliano, L; Gauthier, F; Moreau, T			New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; CHYMOTRYPSIN-LIKE ENZYMES; PROTEINASE-INHIBITORS; CRYSTAL-STRUCTURE; HUMAN CHYMASE; PEPTIDE; ELASTASE; LEUKOCYTE; PROTEASES; TISSUE	Cathepsin G has both trypsin- and chymotrypsin-like activity, but studies on its enzymatic properties have been limited by a lack of sensitive synthetic substrates. Cathepsin G activity is physiologically controlled by the fast acting serpin inhibitors alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor, in which the reactive site loops are cleaved during interaction with their target enzymes. We therefore synthesized a series of intramolecularly quenched fluorogenic peptides based on the sequence of various serpin loops. Those peptides were assayed as substrates for cathepsin G and other chymotrypsin-like enzymes including chymotrypsin and chymase. Peptide substrates derived from the alpha(1)-antichymotrypsin loop were the most sensitive for cathepsin G; with k(cat)/K-m values of 5-20 mM(-1) s(-1). Substitutions were introduced at positions P-1 and P-2 in alpha(1)-antichymotrypsin-derived substrates to tentatively improve their sensitivity. Replacement of Leu-Leu in ortho-aminobenzoyl (Abz)-Thr-Leu-Leu-Ser-Ala-Leu-Gln-N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) by Pro-Phe in Abz-Thr-Pro-Phe-Ser-Ala-Leu-Gln-EDDnp produced the most sensitive substrate of cathepsin G ever reported. It was cleaved with a specificity constant k(cat)/K-m of 150 mM(-1) s(-1). Analysis by molecular modeling of a peptide substrate bound into the cathepsin G active site revealed that, in addition to the protease S-1 subsite, subsites S-1' and S-2' significantly contribute to the definition of the substrate specificity of cathepsin G.	Univ Tours, Enzymol & Prot Chem Lab, F-37032 Tours, France; Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04044020 Sao Paulo, Brazil	Universite de Tours; Universidade Federal de Sao Paulo (UNIFESP)	Moreau, T (corresponding author), Univ Tours, Enzymol & Prot Chem Lab, 2bis Blvd Tonnelle, F-37032 Tours, France.		REHAULT-GODBERT, Sophie/Y-3890-2019; Juliano, Luiz/D-7204-2012	Juliano, Luiz/0000-0002-5589-2822; Rehault-Godbert, Sophie/0000-0003-2800-3417				ALLEN DH, 1995, J BIOL CHEM, V270, P1408, DOI 10.1074/jbc.270.3.1408; AVRIL LE, 1995, FEBS LETT, V367, P251, DOI 10.1016/0014-5793(95)00571-P; BAGGIOLINI M, 1978, AGENTS ACTIONS, V8, P3, DOI 10.1007/BF01972395; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; BAUER CA, 1976, BIOCHEMISTRY-US, V15, P1291, DOI 10.1021/bi00651a019; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BIETH JG, 1986, BIOL EXTRACELLULAR M, V1, P217; Bourgeois L, 1997, J BIOL CHEM, V272, P29590, DOI 10.1074/jbc.272.47.29590; CHAGAS JR, 1991, ANAL BIOCHEM, V192, P419, DOI 10.1016/0003-2697(91)90558-B; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Duranton J, 1998, BIOCHEMISTRY-US, V37, P11239, DOI 10.1021/bi980223q; ERMOLIEFF J, 1994, J BIOL CHEM, V269, P29502; Fersht A, 1985, ENZYME STRUCTURE MEC, P105; Fitzpatrick PA, 1996, PROTEIN ENG, V9, P585, DOI 10.1093/protein/9.7.585; HARPER JW, 1981, ANAL BIOCHEM, V118, P382, DOI 10.1016/0003-2697(81)90597-2; HARVIMA IT, 1994, ARCH DERMATOL RES, V287, P61, DOI 10.1007/BF00370720; Hayem A, 1988, Adv Exp Med Biol, V240, P97; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; LAROSA CA, 1994, J VASC SURG, V19, P306, DOI 10.1016/S0741-5214(94)70106-7; LEVY H, 1979, BIOCHIM BIOPHYS ACTA, V567, P35, DOI 10.1016/0005-2744(79)90169-4; LOMAS DA, 1995, J BIOL CHEM, V270, P23437, DOI 10.1074/jbc.270.40.23437; MAISON CM, 1991, J IMMUNOL, V147, P921; McGrath ME, 1997, BIOCHEMISTRY-US, V36, P14318, DOI 10.1021/bi971403n; MCRAE B, 1980, BIOCHEMISTRY-US, V19, P3973, DOI 10.1021/bi00558a013; OLIVEIRA MCF, 1992, ANAL BIOCHEM, V203, P39, DOI 10.1016/0003-2697(92)90040-E; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHECHTER NM, 1993, J BIOL CHEM, V268, P23626; SCHECHTER NM, 1989, J BIOL CHEM, V264, P21308; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SENIOR RM, 1984, J IMMUNOL, V132, P2547; SHAFER WM, 1991, J BIOL CHEM, V266, P112; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; TANAKA T, 1985, BIOCHEMISTRY-US, V24, P2040, DOI 10.1021/bi00329a036; Tsu CA, 1997, BIOCHEMISTRY-US, V36, P5393, DOI 10.1021/bi961753u; WANG MC, 1979, INVEST UROL, V17, P159; Watorek W, 1988, Adv Exp Med Biol, V240, P23; Yamazaki T, 1998, IMMUNOLOGY, V93, P115	46	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13810	13817		10.1074/jbc.274.20.13810	http://dx.doi.org/10.1074/jbc.274.20.13810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318785	hybrid			2022-12-27	WOS:000080322200014
J	Tomura, H; Nishigori, H; Sho, K; Yamagata, K; Inoue, I; Takeda, J				Tomura, H; Nishigori, H; Sho, K; Yamagata, K; Inoue, I; Takeda, J			Loss-of-function and dominant-negative mechanisms associated with hepatocyte nuclear factor-1 beta mutations in familial type 2 diabetes mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEINS; GLUCOSE-TRANSPORTER; GENE; TRANSCRIPTION; HOMEOPROTEIN; MODY; HETERODIMERS; MEMBER; GLUT2; CELL	Hepatocyte nuclear factor (HNF)-1 beta, a homeodomain-containing transcription factor, regulates gene expression in a dimerized form in pancreas, liver, and some other tissues. Recent genetic studies have identified two HNF-1 beta mutations, R177X and A263fsinsGG, in subjects with a monogenic form of type 2 diabetes. Despite the defects being in the same gene, diverse severities of disease are observed in the affected subjects. To investigate the molecular mechanism by which mutations might cause various phenotypic features, wild type and mutant proteins were transiently expressed in insulin-producing (MIN6) and hepatic (HepG2) cells. Luciferase reporter assay showed that both mutations resulted in a marked reduction of transactivation activity. Because their dimerization activity was found to be intact by the yeast two-hybrid system, it was possible that they were dominant-negative to wild type activity. When co-expressed with wild type, both of the mutants significantly decreased wild type activity in HepG2 cells. In contrast, although A263fsinsGG functioned similarly in MIN6 cells, R177X failed to affect wild type activity in this cell line. Immunohistochemical analysis of the mutants suggests that this functional divergence might be generated by the modification of nuclear localization. These results suggest that HNF-1 beta mutations may impair pancreatic beta-cell function by loss-of-function and dominant-negative mechanisms.	Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gumma 3718512, Japan; Osaka Univ, Sch Med, Dept Internal Med 2, Osaka 5650871, Japan	Gunma University; Osaka University	Takeda, J (corresponding author), Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Mol Genet Lab, 3-39-15 Showa Machi, Maebashi, Gumma 3718512, Japan.							BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; DESIMONE V, 1991, EMBO J, V10, P1435, DOI 10.1002/j.1460-2075.1991.tb07664.x; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Nishigori H, 1998, DIABETES, V47, P1354, DOI 10.2337/diabetes.47.8.1354; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; TAKEDA J, 1993, DIABETES, V42, P773, DOI 10.2337/diabetes.42.5.773; TREISMAN J, 1989, CELL, V59, P553; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Yamada S, 1999, DIABETES, V48, P645, DOI 10.2337/diabetes.48.3.645; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	20	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12975	12978		10.1074/jbc.274.19.12975	http://dx.doi.org/10.1074/jbc.274.19.12975			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224045	hybrid			2022-12-27	WOS:000080200400007
J	Xue, HH; Fujie, M; Sakaguchi, T; Oda, T; Ogawa, H; Kneer, NM; Lardy, HA; Ichiyama, A				Xue, HH; Fujie, M; Sakaguchi, T; Oda, T; Ogawa, H; Kneer, NM; Lardy, HA; Ichiyama, A			Flux of the L-serine metabolism in rat liver - The predominant contribution of serine dehydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE AMINOTRANSFERASE; GLYOXYLATE AMINOTRANSFERASE; SUBCELLULAR-DISTRIBUTION; GLYCINE CATABOLISM; HEPATIC ALANINE; MITOCHONDRIA; GENE; GLUCONEOGENESIS; LOCALIZATION; EXPRESSION	L-Serine metabolism in rat liver was investigated, focusing on the relative contributions of the three pathways, one initiated by L-serine dehydratase (SDR), another by serine: pyruvate/alanine:glyoxylate aminotransferase (SPT/AGT), and the other involving serine hydroxymethyltransferase and the mitochondrial glycine cleavage enzyme system (GCS). Because serine hydroxymethyltransferase is responsible for the interconversion between serine and glycine, SDH, SPT/AGT, and GCS were considered to be the metabolic exits of the serine-glycine pool. In vitro, flux through SDH was predominant in both 24-h starved and glucagon-treated rats. Flux through SPT/AGT was enhanced by glucagon administration, but even after the induction, its contribution under quasi-physiological conditions (1 mM L-serine and 0.25 mM pyruvate) was about 1/10 of that through SDH. Flux through GCS accounted for only several percent of the amount of L-serine metabolized. Relative contributions of SDH and SPT/AGT to gluconeogenesis from L-serine were evaluated in vivo based on the principle that H-3 at the 3 position of L-serine is mostly removed in the SDH pathway, whereas it is largely retained in the SPT/AGT pathway. The results showed that SPT/AGT contributed only 10-20% even after the enhancement of its activity by glucagon. These results suggested that SDH is the major metabolic exit of L-serine in rat liver.	Hamamatsu Univ Sch Med, Dept Biochem 1, Shizuoka 4313192, Japan; Hamamatsu Univ Sch Med, Equipment Ctr, Shizuoka 4313192, Japan; Hamamatsu Univ Sch Med, Dept Surg 2, Shizuoka 4313192, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Biochem, Toyama 9300194, Japan; Univ Wisconsin, Inst Enzyme Res, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Toyama; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ichiyama, A (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, 3600 Handa Cho, Shizuoka 4313192, Japan.			Xue, Hai-Hui/0000-0002-9163-7669				AIKAWA T, 1972, BIOCHIM BIOPHYS ACTA, V279, P234, DOI 10.1016/0304-4165(72)90139-0; AIKAWA T, 1973, J BIOCHEM, V74, P1003; BELIVEAU GP, 1982, J NUTR, V112, P686, DOI 10.1093/jn/112.4.686; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BHATIA SC, 1975, LIFE SCI, V17, P267, DOI 10.1016/0024-3205(75)90514-7; CHAN TM, 1971, BIOCHIM BIOPHYS ACTA, V237, P99, DOI 10.1016/0304-4165(71)90034-1; Cowin GJ, 1996, BBA-MOL CELL RES, V1310, P41, DOI 10.1016/0167-4889(95)00141-7; CYBULSKI RL, 1976, BIOCHEMISTRY-US, V15, P3183, DOI 10.1021/bi00660a004; DANPURE CJ, 1990, J CELL SCI, V97, P669; DANPURE CJ, 1995, METABOLIC MOL BASES, V2, P2385; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; EXON JH, 1970, RECENT PROG HORM RES, V26, P411; FREEDLAND RA, 1964, J BIOL CHEM, V239, P3357; GELLER AM, 1989, ANAL BIOCHEM, V180, P120, DOI 10.1016/0003-2697(89)90098-5; HEDRICK JL, 1961, J BIOL CHEM, V236, P1867; HEDRICK JL, 1964, ARCH BIOCHEM BIOPHYS, V105, P261, DOI 10.1016/0003-9861(64)90007-4; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; ICHIYAMA A, 1970, J BIOL CHEM, V245, P1699; ICHIYAMA A, 1985, J BIOCHEM-TOKYO, V98, P1375, DOI 10.1093/oxfordjournals.jbchem.a135405; JOIS M, 1992, BIOCHEM J, V283, P435, DOI 10.1042/bj2830435; JOIS M, 1990, J BIOL CHEM, V265, P1246; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KITAGAWA Y, 1979, BIOCHIM BIOPHYS ACTA, V582, P276, DOI 10.1016/0304-4165(79)90390-8; LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410; LARDY HA, 1969, FEBS S, V19, P55; MALLETTE LE, 1969, J BIOL CHEM, V244, P5713; MENDESMOURAO J, 1975, FEBS LETT, V53, P29, DOI 10.1016/0014-5793(75)80674-0; METZ T, 1972, H-S Z PHYSIOL CHEM, V353, P1496; NAKAGAWA H, 1967, BIOCHEM BIOPH RES CO, V28, P359, DOI 10.1016/0006-291X(67)90318-X; NOGUCHI T, 1978, J BIOL CHEM, V253, P7598; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; ODA T, 1989, J BIOCHEM-TOKYO, V106, P460, DOI 10.1093/oxfordjournals.jbchem.a122874; ODA T, 1982, J BIOCHEM, V91, P219, DOI 10.1093/oxfordjournals.jbchem.a133679; ODA T, 1990, J BIOL CHEM, V265, P7513; OGAWA H, 1995, HISTOCHEM J, V27, P380, DOI 10.1007/BF02389024; PANDE SV, 1978, J BIOL CHEM, V253, P1565; REMESY C, 1983, J NUTR, V113, P28, DOI 10.1093/jn/113.1.28; ROWSELL EV, 1979, COMP BIOCHEM PHYS B, V63, P543, DOI 10.1016/0305-0491(79)90061-0; RYAN WL, 1966, NATURE, V212, P292, DOI 10.1038/212292a0; SALLACH HJ, 1972, ENDOCRINOLOGY, V91, P1054, DOI 10.1210/endo-91-4-1054; SANDOVAL IV, 1974, EUR J BIOCHEM, V43, P609, DOI 10.1111/j.1432-1033.1974.tb03448.x; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1974, BIOCHEM J, V142, P433, DOI 10.1042/bj1420433; TAKADA Y, 1982, COMP BIOCHEM PHYS B, V72, P597, DOI 10.1016/0305-0491(82)90512-0; UCHIDA C, 1994, J BIOL CHEM, V269, P8849; VARNER JE, 1957, METHOD ENZYMOL, V3, P397, DOI 10.1016/S0076-6879(57)03404-7; VENEZIAL.CM, 1967, BIOCHEMISTRY-US, V6, P2129, DOI 10.1021/bi00859a034; YOSHIDA T, 1969, BIOCHEM BIOPH RES CO, V35, P577, DOI 10.1016/0006-291X(69)90387-8; YOSHIDA T, 1970, ARCH BIOCHEM BIOPHYS, V139, P380, DOI 10.1016/0003-9861(70)90490-X; YOSHIDA T, 1972, J BIOCHEM, V72, P1503, DOI 10.1093/oxfordjournals.jbchem.a130042	50	37	39	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16020	16027		10.1074/jbc.274.23.16020	http://dx.doi.org/10.1074/jbc.274.23.16020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347151	hybrid			2022-12-27	WOS:000080668600011
J	Dowell, P; Ishmael, JE; Avram, D; Peterson, VJ; Nevrivy, DJ; Leid, M				Dowell, P; Ishmael, JE; Avram, D; Peterson, VJ; Nevrivy, DJ; Leid, M			Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAIN; HORMONE RECEPTORS; PPAR-GAMMA; HISTONE ACETYLTRANSFERASE; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; ESTROGEN-RECEPTOR; RESPONSE ELEMENT; CO-REPRESSOR	Nuclear receptor corepressor (NCoR) was demonstrated to interact strongly with peroxisome proliferator-activated receptor alpha (PPAR alpha), and PPAR alpha ligands suppressed this interaction. In contrast to the interaction of PPAR alpha with the coactivator protein, p300, association of the receptor with NCoR did not require any part of the PPAR alpha ligand binding domain. NCoR was found to suppress PPAR alpha-dependent transcriptional activation in the context of a PPAR alpha.retinoid X receptor alpha (RXR alpha) heterodimeric complex bound to a peroxisome proliferator-responsive element in human embryonic kidney 293 cells. This repression was reversed agonists of either receptor demonstrating a functional interaction between NCoR and PPAR alpha.RXR alpha heterodimeric complexes in mammalian cells. NCoR appears to influence PPARa signaling pathways and, therefore, may modulate tissue responsiveness to peroxisome proliferators.	Oregon State Univ, Coll Pharm, Mol Pharmacol Lab, Corvallis, OR 97331 USA; Oregon State Univ, Coll Pharm, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Leid, M (corresponding author), Oregon State Univ, Coll Pharm, Mol Pharmacol Lab, Corvallis, OR 97331 USA.				NIEHS NIH HHS [ES00040] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES000040] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Avram D, 1999, J BIOL CHEM, V274, P14331, DOI 10.1074/jbc.274.20.14331; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Green S, 1995, MUTAT RES-FUND MOL M, V333, P101, DOI 10.1016/0027-5107(95)00136-0; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, BIOCHIMIE, V75, P251, DOI 10.1016/0300-9084(93)90084-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LAKE BG, 1995, ANNU REV PHARMACOL, V35, P483, DOI 10.1146/annurev.pa.35.040195.002411; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEDOUARIN B, 1995, NUCLEIC ACIDS RES, V23, P876, DOI 10.1093/nar/23.5.876; LEID M, 1994, J BIOL CHEM, V269, P14175; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OMALLEY BW, 1992, BIOL REPROD, V46, P163, DOI 10.1095/biolreprod46.2.163; ONATE SA, 1995, SCIENCE, V270, P1354; PIERRAT B, 1992, GENE, V119, P237, DOI 10.1016/0378-1119(92)90277-V; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhu YJ, 1996, GENE EXPRESSION, V6, P185; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	57	108	112	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15901	15907		10.1074/jbc.274.22.15901	http://dx.doi.org/10.1074/jbc.274.22.15901			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336495	hybrid			2022-12-27	WOS:000080560100084
J	Lievremont, JP; Sciorati, C; Morandi, E; Paolucci, C; Bunone, G; Della Valle, G; Meldolesi, J; Clementi, E				Lievremont, JP; Sciorati, C; Morandi, E; Paolucci, C; Bunone, G; Della Valle, G; Meldolesi, J; Clementi, E			The p75(NTR)-induced apoptotic program develops through a ceramide-caspase pathway negatively regulated by nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; NF-KAPPA-B; CELL-DEATH; INTRACELLULAR DOMAIN; NEURONAL APOPTOSIS; FAMILY PROTEASES; T-LYMPHOCYTES; SYSTEM	SK-N-BE neuroblastoma cell clones transfected with p75(NTR) and lacking Trk neurotrophin receptors, previously reported to undergo extensive spontaneous apoptosis and to be protected by nerve growth factor (NGF) (Bunone, G., Mariotti, A., Compagni, A., Morandi, E., and Della Valle, G:. (1997) Oncogene 14, 1463-1470), are shown to exhibit (i) increased levels of the pro-apoptotic lipid metabolite ceramide and (ii) high activity of caspases, the proteases of the cell death cascade. In the p75(NTR) expressing cells, these parameters were partially normalized by prolonged NGF treatment, which, in addition, decreased apoptosis, similar to caspase blockers. Conversely, exogenous ceramide increased caspase activity and apoptosis in both wild-type and p75(NTR)-expressing cells. A new p75(NTR)-expressing clone characterized by low spontaneous apoptosis exhibited high endogenous ceramide and low caspase levels. A marked difference between the apoptotic and resistant clones concerned the very low and high activities of nitric-oxide (NO) synthase, respectively. Protection from apoptosis by NO was confirmed by results with the NO donor S-nitrosoacetylpenicillamine and the NO-trapping agent hemoglobin, We conclude that the p75NTR receptor, while free of NGF, triggers a cascade leading to apoptosis; the cascade includes generation of ceramide and increased caspase activity; and the protective role of NO occurs at step(s) in between the latter events.	San Raffaele Sci Inst, Dept Neurosci, DIBIT, I-20132 Milan, Italy; Univ Milan, Consiglio Nazl Ric, Ctr Mol & Cellular Pharmacol, Dept Pharmacol, I-20132 Milan, Italy; Univ Milan, Consiglio Nazl Ric, Ctr Mol & Cellular Pharmacol, Bruno Ceccarelli Ctr, I-20132 Milan, Italy; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Natl Canc Inst, I-20129 Milan, Italy; Univ Bologna, Dept Biol, I-40126 Bologna, Italy; Univ Calabria, Sch Pharm, Dept Pharmacol, I-87036 Arcavacata, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Pavia; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Bologna; University of Calabria	Meldolesi, J (corresponding author), San Raffaele Sci Inst, Dept Neurosci, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		sciorati, clara/K-4823-2016	sciorati, clara/0000-0003-2030-9366				Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bredesen DE, 1997, TRENDS NEUROSCI, V20, P287, DOI 10.1016/S0166-2236(96)01049-1; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Bunone G, 1997, ONCOGENE, V14, P1463, DOI 10.1038/sj.onc.1200972; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Farschon DM, 1997, J CELL BIOL, V137, P1117, DOI 10.1083/jcb.137.5.1117; FERRARINI M, 1995, J IMMUNOL, V154, P3704; Frade JM, 1996, NATURE, V383, P166; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Hebestreit H, 1998, J EXP MED, V187, P415, DOI 10.1084/jem.187.3.415; Hehner SP, 1998, J BIOL CHEM, V273, P18117, DOI 10.1074/jbc.273.29.18117; Henderson Z, 1996, PROG NEUROBIOL, V48, P219, DOI 10.1016/0301-0082(95)00041-0; Heumann Rolf, 1994, Current Opinion in Neurobiology, V4, P668, DOI 10.1016/0959-4388(94)90008-6; Ladiwala U, 1998, J NEUROSCI, V18, P1297; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LIPTON SA, 1993, NATURE, V364, P577; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Majdan M, 1997, J NEUROSCI, V17, P6988; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Miller FD, 1998, CELL DEATH DIFFER, V5, P343, DOI 10.1038/sj.cdd.4400385; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rooney E, 1996, J BIOL CHEM, V271, P29304, DOI 10.1074/jbc.271.46.29304; ROSKAMS AJ, 1994, NEURON, V13, P289; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Samdani AF, 1997, J NEUROSCI, V17, P4633; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Srinivasan A, 1996, J NEUROSCI, V16, P5654; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WILLIAMS CV, 1994, J NEUROSCI, V14, P1746, DOI 10.1523/JNEUROSCI.14-03-01746.1994; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Yun HY, 1996, CRIT REV NEUROBIOL, V10, P291, DOI 10.1615/CritRevNeurobiol.v10.i3-4.20; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213	46	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15466	15472		10.1074/jbc.274.22.15466	http://dx.doi.org/10.1074/jbc.274.22.15466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336437	hybrid			2022-12-27	WOS:000080560100026
J	Webb, BL; Cox, MM; Inman, RB				Webb, BL; Cox, MM; Inman, RB			ATP hydrolysis and DNA binding by the Escherichia coli RecF protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENETIC-RECOMBINATION; POSTREPLICATION REPAIR; EXCISION REPAIR; PURIFICATION; MUTATIONS; FILAMENTS; PATHWAY; K-12; TRIPHOSPHATE	The Escherichia coli RecF protein possesses a weak ATP hydrolytic activity. ATP hydrolysis leads to RecF dissociation from double-stranded (ds)DNA, The RecF protein is subject to precipitation and an accompanying inactivation in vitro when not bound to DNA. A mutant RecF protein that can bind but cannot hydrolyze ATP (RecF K36R) does not readily dissociate from dsDNA in the presence of ATP. This is in contrast to the limited dsDNA binding observed for wild-type RecF protein in the presence of ATP but is similar to dsDNA binding by wild-type RecF binding in the presence of the nonhydrolyzable ATP analog, adenosine 5'-O-(3-thio)triphosphate (ATPyS). In addition, wild-type RecF protein binds tightly to dsDNA in the presence of ATP at low pH where its ATPase activity is blocked. A transfer of RecF protein from labeled to unlabeled dsDNA is observed in the presence of ATP but not ATP gamma S. The transfer is slowed considerably when the RecR protein is also present. In competition experiments, RecF protein appears to bind at random locations on dsDNA and exhibits no special affinity for single strand/double strand junctions when bound to gapped DNA. Possible roles for the ATPase activity of RecF in the regulation of recombinational DNA repair are discussed.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM014711, R01GM052725] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52725, GM14711] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayora S, 1997, NUCLEIC ACIDS RES, V25, P2766, DOI 10.1093/nar/25.14.2766; Bjornson KP, 1996, J MOL BIOL, V263, P411, DOI 10.1006/jmbi.1996.0585; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARK AJ, 1994, CRIT REV MICROBIOL, V20, P125, DOI 10.3109/10408419409113552; COHEN A, 1983, MOL GEN GENET, V189, P471, DOI 10.1007/BF00325911; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Cox MM, 1998, GENES CELLS, V3, P65, DOI 10.1046/j.1365-2443.1998.00175.x; GRIFFIN TJ, 1990, J BACTERIOL, V172, P6291, DOI 10.1128/jb.172.11.6291-6299.1990; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Huang LC, 1997, J BACTERIOL, V179, P6076, DOI 10.1128/jb.179.19.6076-6083.1997; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; LINDSLEY JE, 1990, J BIOL CHEM, V265, P10164; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; MADIRAJU MVVS, 1992, J BACTERIOL, V174, P7705, DOI 10.1128/JB.174.23.7705-7710.1992; MADIRAJU MVVS, 1991, NUCLEIC ACIDS RES, V19, P6295, DOI 10.1093/nar/19.22.6295; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; ROTHMAN RH, 1977, MOL GEN GENET, V155, P279, DOI 10.1007/BF00272806; Sandler SJ, 1996, MOL MICROBIOL, V19, P871, DOI 10.1046/j.1365-2958.1996.429959.x; SANDLER SJ, 1993, GENETICS, V135, P643; SANDLER SJ, 1992, NUCLEIC ACIDS RES, V20, P839, DOI 10.1093/nar/20.4.839; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; TSENG YC, 1994, MUTAT RES, V315, P1; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680	34	33	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15367	15374		10.1074/jbc.274.22.15367	http://dx.doi.org/10.1074/jbc.274.22.15367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336423	hybrid			2022-12-27	WOS:000080560100012
J	Bakker, BM; Michels, PAM; Opperdoes, FR; Westerhoff, HV				Bakker, BM; Michels, PAM; Opperdoes, FR; Westerhoff, HV			What controls glycolysis in bloodstream form Trypanosoma brucei?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORM; GLYCOSOMAL GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PYRUVATE-KINASE; FRUCTOSE 2,6-BISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; KINETIC CHARACTERIZATION; CARBOHYDRATE-METABOLISM; GLUCOSE TRANSPORTERS; ENZYMES; PHOSPHOFRUCTOKINASE	On the basis of the experimentally determined kinetic properties of the trypanosomal enzymes, the question is addressed of which step limits the glycolytic flux in bloodstream form Trypanosoma brucei. There appeared to be no single answer; in the physiological range, control shifted between the glucose transporter on the one hand and aldolase (ALD), glyceraldehyde-3-phosphate dehydrogenase (GAPBH), phosphoglycerate kinase (PGK), and glycerol-3-phosphate dehydrogenase (GDH) on the other hand. The other kinases, which are often thought to control glycolysis, exerted little control; so did the utilization of ATP. We identified potential targets for anti-trypanosomal drugs by calculating which steps need the least inhibition to achieve a certain inhibition of the glycolytic flux in these parasites. The glucose transporter appeared to be the most promising target, followed by ALD, GDH, GAPDH, and PGK, By contrast, in erythrocytes more than 95% deficiencies of PGK, GAPDH, or ALD did not cause any clinical symptoms (Schuster, R. and Holzhutter, H.-G. (1995) fur. J. Biochem. 229, 403-418), Therefore, the selectivity of drugs inhibiting these enzymes may be much higher than expected from their molecular effects alone, Quite unexpectedly trypanosomes seem to possess a substantial overcapacity of hexokinase, phosphofructokinase, and pyruvate kinase, making these "irreversible" enzymes mediocre drug targets.	Free Univ Amsterdam, BioCtr Amsterdam, NL-1081 HV Amsterdam, Netherlands; Univ Amsterdam, EC Slater Inst Biochem Res, BioCtr Amsterdam, NL-1018 TV Amsterdam, Netherlands; Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Trop Dis Res Unit, B-1200 Brussels, Belgium; Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Universite Catholique Louvain; Universite Catholique Louvain	Westerhoff, HV (corresponding author), Free Univ Amsterdam, BioCtr Amsterdam, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	hw@bio.vu.nl	Opperdoes, Frederik R/C-8897-2018; Westerhoff, Hans V/I-5762-2012; Michels, Paul A/A-5637-2009; Opperdoes, Fred/N-9922-2019	Opperdoes, Frederik R/0000-0003-1984-3764; Westerhoff, Hans V/0000-0002-0443-6114; Michels, Paul A/0000-0003-3726-6104; Opperdoes, Fred/0000-0003-1984-3764; Bakker, Barbara/0000-0001-6274-3633				Bakker BM, 1995, J BIOENERG BIOMEMBR, V27, P513, DOI 10.1007/BF02110191; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Bakker BM, 1996, BIOTHERMOKINETICS LI, P136; BARNARD JP, 1988, MOL BIOCHEM PARASIT, V31, P141, DOI 10.1016/0166-6851(88)90165-X; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; CALLENS M, 1992, MOL BIOCHEM PARASIT, V50, P235, DOI 10.1016/0166-6851(92)90220-E; Colowick SP., 1973, ENZYMES, V9, P1, DOI DOI 10.1016/S1874-6047(08)60113-4; CRONIN CN, 1985, BIOCHEM J, V227, P113, DOI 10.1042/bj2270113; CRONIN CN, 1987, BIOCHEM J, V245, P13, DOI 10.1042/bj2450013; DAVIES SEC, 1992, BIOCHEMISTRY-US, V31, P4729, DOI 10.1021/bi00134a028; EISENTHAL R, 1985, FEBS LETT, V181, P23, DOI 10.1016/0014-5793(85)81106-6; EISENTHAL R, 1989, BIOCHIM BIOPHYS ACTA, V985, P81, DOI 10.1016/0005-2736(89)90107-7; FAIRLAMB AH, 1977, NATURE, V265, P270, DOI 10.1038/265270a0; Fell D., 1997, UNDERSTANDING CONTRO; FRANKEL S, 1963, GRADWOHLS CLIN LAB M, V1; GIFFIN BF, 1989, AM J TROP MED HYG, V40, P487, DOI 10.4269/ajtmh.1989.40.487; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; GROEN AK, 1982, J BIOL CHEM, V257, P2754; GRUENBERG J, 1978, EUR J BIOCHEM, V89, P461, DOI 10.1111/j.1432-1033.1978.tb12549.x; HAMMOND DJ, 1980, MOL BIOCHEM PARASIT, V2, P77, DOI 10.1016/0166-6851(80)90033-X; HAMMOND DJ, 1985, J BIOL CHEM, V260, P5646; HAMMOND DJ, 1980, MOL BIOCHEM PARASIT, V2, P63, DOI 10.1016/0166-6851(80)90032-8; HANNAERT V, 1994, J BIOENERG BIOMEMBR, V26, P205, DOI 10.1007/BF00763069; HENRY RJ, 1974, CLIN CHEM PRINCIPLES; HOFMEYR JHS, 1991, EUR J BIOCHEM, V200, P223, DOI 10.1111/j.1432-1033.1991.tb21071.x; JENSEN PR, 1993, EMBO J, V12, P1277, DOI 10.1002/j.1460-2075.1993.tb05772.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; KHOLODENKO BN, 1995, BIOPHYS CHEM, V56, P215, DOI 10.1016/0301-4622(95)00039-Z; Kholodenko BN, 1996, BIOCHEM J, V314, P753, DOI 10.1042/bj3140753; KIAIRA JK, 1994, BIOTECHNOL APPL BIOC, V20, P347, DOI 10.1111/j.1470-8744.1994.tb00322.x; KIM HD, 1995, BIOCHEMISTRY-US, V34, P14975, DOI 10.1021/bi00046a004; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; KRUPKA RM, 1980, BIOCHIM BIOPHYS ACTA, V598, P134, DOI 10.1016/0005-2736(80)90271-0; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHELS PAM, 1994, J BIOENERG BIOMEMBR, V26, P213, DOI 10.1007/BF00763070; MICHELS PAM, 1988, BIOL CELL, V64, P157, DOI 10.1016/0248-4900(88)90075-5; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; NWAGWU M, 1982, ACTA TROP, V39, P61; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; PERIE J, 1993, PHARMACOL THERAPEUT, V60, P347, DOI 10.1016/0163-7258(93)90016-7; POOLMAN B, 1987, J BACTERIOL, V169, P5887, DOI 10.1128/jb.169.12.5887-5890.1987; RAPOPORT TA, 1974, EUR J BIOCHEM, V42, P107, DOI 10.1111/j.1432-1033.1974.tb03320.x; Rohwer JM, 1996, J THEOR BIOL, V179, P213, DOI 10.1006/jtbi.1996.0062; RUIJTER GJG, 1991, J BACTERIOL, V173, P6184; SAURO HM, 1991, MATH COMPUT MODEL, V15, P15, DOI 10.1016/0895-7177(91)90038-9; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; SCHUSTER R, 1995, EUR J BIOCHEM, V229, P403, DOI 10.1111/j.1432-1033.1995.0403k.x; SCHUSTER S, 1993, BIOPHYS CHEM, V48, P1, DOI 10.1016/0301-4622(93)80037-J; SEYFANG A, 1991, EUR J BIOCHEM, V202, P191, DOI 10.1111/j.1432-1033.1991.tb16362.x; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; Snoep JL, 1996, BIOTECHNOL BIOENG, V51, P190, DOI 10.1002/(SICI)1097-0290(19960720)51:2<190::AID-BIT8>3.0.CO;2-E; STANBURY JB, 1993, METABOLIC BASIS INHE; TERKUILE BH, 1991, J BIOL CHEM, V266, P857; VANCALENBERGH S, 1995, J MED CHEM, V38, P3838, DOI 10.1021/jm00019a014; VANSCHAFTINGEN E, 1985, EUR J BIOCHEM, V153, P403, DOI 10.1111/j.1432-1033.1985.tb09316.x; VANSCHAFTINGEN E, 1987, EUR J BIOCHEM, V166, P653; VELLIEUX FMD, 1993, P NATL ACAD SCI USA, V90, P2355, DOI 10.1073/pnas.90.6.2355; VERLINDE CLMJ, 1994, J MED CHEM, V37, P3605, DOI 10.1021/jm00047a017; VISSER N, 1981, EUR J BIOCHEM, V118, P521, DOI 10.1111/j.1432-1033.1981.tb05550.x; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; Westerhoff H., 1987, THERMODYNAMICS CONTR; WILLSON M, 1994, BIOCHEMISTRY-US, V33, P214, DOI 10.1021/bi00167a028	69	145	150	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14551	14559		10.1074/jbc.274.21.14551	http://dx.doi.org/10.1074/jbc.274.21.14551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329645	hybrid, Green Published			2022-12-27	WOS:000081965200010
J	Manthey, D; Bukauskas, F; Lee, CG; Kozak, CA; Willecke, K				Manthey, D; Bukauskas, F; Lee, CG; Kozak, CA; Willecke, K			Molecular cloning and functional expression of the mouse gap junction gene connexin-57 in human HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL ASSIGNMENTS; CHANNELS; PROTEINS; FAMILY; PH; HYBRIDIZATION; SEQUENCE; PAIRS; BRAIN; CDNA	A new mouse connexin gene has been isolated that codes for a connexin protein of 505 amino acid residues. Based on the predicted molecular mass of 57.115 kDa, it has been designated connexin-57. Similar to most other mouse connexin genes, the coding region of connexin-57 is not interrupted by introns and exists in the mouse genome as a single-copy gene. Within the connexin family, this new gene shows highest sequence identity to porcine connexin-60 in the Lu group of connexins. The connexin-57 gene was mapped to a position on mouse chromosome 4, 30 centimorgans proximal to a cluster of previously mapped connexin genes. Low levels of connexin-57 mRNA were detected in skin, heart, kidney, testis, ovary, intestine, and in the mouse embryo after 8 days post coitum, but expression was not detected in brain, sciatic nerve or liver. In order to analyze gene function, the connexin-57 coding region was expressed by transfection in human HeLa cells, where it restored homotypic intercellular transfer of microinjected neurobiotin. Heterotypic transfer was observed between HeLa connexin-57 transfectants and HeLa cells, expressing murine connexin-83, -37, or -30.3. Double whole-cell voltage clamp analyses revealed that HeLa-connexin-57 transfectants expressed about 10 times more channels than parental HeLa cells. Voltage gating by transjunctional and transmembrane voltages as well as unitary conductance (similar to 27 picosiemens) were different from intrinsic connexin channels in parental HeLa cells.	Univ Bonn, Genet Inst, D-53117 Bonn, Germany; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Kaunas Med Univ, Lab Excitable Struct, Kaunas, Lithuania; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	University of Bonn; Yeshiva University; Albert Einstein College of Medicine; Lithuanian University of Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Willecke, K (corresponding author), Univ Bonn, Genet Inst, Romerstr 164, D-53117 Bonn, Germany.	genetik@uni-bonn.de			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000301] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMSON MC, 1991, VIROLOGY, V183, P778, DOI 10.1016/0042-6822(91)91010-E; Barrio LC, 1997, BIOPHYS J, V73, P757, DOI 10.1016/S0006-3495(97)78108-6; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; BEYER EC, 1988, INT REV CYTOL C, V137, P231; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUKAUSKAS F, 1992, J PHYSIOL-LONDON, V448, P321, DOI 10.1113/jphysiol.1992.sp019044; BUKAUSKAS FF, 1995, BIOPHYS J, V68, P2289, DOI 10.1016/S0006-3495(95)80411-X; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Dahl E, 1996, J BIOL CHEM, V271, P17903, DOI 10.1074/jbc.271.30.17903; Delmar M, 1998, GAP JUNCTIONS, P8; ECKERT R, 1993, PFLUG ARCH EUR J PHY, V424, P335, DOI 10.1007/BF00384361; EK JF, 1994, CIRC RES, V74, P1058, DOI 10.1161/01.RES.74.6.1058; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Fusenig N E, 1985, Carcinog Compr Surv, V9, P293; FUSENIG NE, 1983, J INVEST DERMATOL, V81, pS168, DOI 10.1111/1523-1747.ep12541032; GIMLICH RL, 1990, J CELL BIOL, V110, P597, DOI 10.1083/jcb.110.3.597; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HENNEMANN H, 1992, EUR J CELL BIOL, V57, P51; HENNEMANN H, 1992, EUR J CELL BIOL, V58, P81; HENNEMANN H, 1992, J CELL BIOL, V117, P1299, DOI 10.1083/jcb.117.6.1299; HORST M, 1991, J BIOL CHEM, V266, P13914; Itahana K, 1998, ENDOCRINOLOGY, V139, P320, DOI 10.1210/en.139.1.320; Itahana K, 1996, ENDOCRINOLOGY, V137, P5036, DOI 10.1210/en.137.11.5036; Jiang JX, 1996, P NATL ACAD SCI USA, V93, P1287, DOI 10.1073/pnas.93.3.1287; KOZAK CA, 1990, GENOMICS, V8, P519, DOI 10.1016/0888-7543(90)90039-W; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAIRD DW, 1990, J CELL SCI, V97, P109; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; NEYTON J, 1985, NATURE, V317, P331, DOI 10.1038/317331a0; O'Brien J, 1998, J NEUROSCI, V18, P7625; OBAID AL, 1983, J MEMBRANE BIOL, V73, P69, DOI 10.1007/BF01870342; PAUL DL, 1995, CURR OPIN CELL BIOL, V7, P665, DOI 10.1016/0955-0674(95)80108-1; Peracchia C, 1997, BRAZ J MED BIOL RES, V30, P577, DOI 10.1590/S0100-879X1997000500003; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWARZ HJ, 1994, SOMAT CELL MOLEC GEN, V20, P243, DOI 10.1007/BF02254763; SCHWARZ HJ, 1992, SOMAT CELL MOLEC GEN, V18, P351, DOI 10.1007/BF01235758; SHAPER NL, 1990, CYTOGENET CELL GENET, V54, P172, DOI 10.1159/000132987; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; SOHL G, 1998, EUR J CELL BIOL, V69, P27; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; VERSELIS VK, 1991, BIOPHYS J, V59, P114, DOI 10.1016/S0006-3495(91)82204-4; WEINGART R, 1986, J PHYSIOL-LONDON, V370, P267, DOI 10.1113/jphysiol.1986.sp015934; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; Willecke K, 1999, NOVART FDN SYMP, V219, P76; WILLECKE K, 1991, J CELL BIOL, V114, P1049, DOI 10.1083/jcb.114.5.1049; Willecke K, 1996, J BIOENERG BIOMEMBR, V28, P319, DOI 10.1007/BF02110108; ZHANG JT, 1994, J MEMBRANE BIOL, V139, P15	53	82	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14716	14723		10.1074/jbc.274.21.14716	http://dx.doi.org/10.1074/jbc.274.21.14716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329667	hybrid			2022-12-27	WOS:000081965200032
J	Sakanaka, C; Williams, LT				Sakanaka, C; Williams, LT			Functional domains of axin - Importance of the C terminus as an oligomerization domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; ADENOMATOUS POLYPOSIS; NEGATIVE REGULATOR; XENOPUS EMBRYOS; TRANSCRIPTION; ACTIVATION; MUTATIONS; COMPLEX	To understand the mechanism of how Axin acts as an inhibitory molecule in the Wnt pathway, we generated a series of mutated forms of Axin. From the binding experiments, we defined the domains of Axin that bind glycogen synthase kinase-3 beta (GSK-3 beta) and beta-catenin. We also examined the ability of each Axin mutant to inhibit lymphoid enhancer factor-1 (Lef-1) reporter activity in a cell line expressing high levels of beta-catenin. Axin mutants that did not bind GSK-3 beta or beta-catenin were ineffective in suppressing Lef-1 reporter activity. Binding GSK-3 beta and beta-catenin was not sufficient for this inhibitory effect of Axin. Axin mutants with C-terminal truncations lacked the ability to inhibit Lef-1 reporter activity, even though they bound GSH-3 beta and beta-catenin. The C-terminal region was required for binding to Axin itself. Substitution of the C-terminal, region with an unrelated dimerizing molecule, the retinoid X receptor restored its inhibitory effect on Lef-1-dependent, transcription. The oligomerization of Axin through its C terminus is important for its function in regulation of beta-catenin-mediated response.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Chiron Corp, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Novartis	Williams, LT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.							Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MCMAHON AP, 1992, TRENDS GENET, V8, P236, DOI 10.1016/0168-9525(92)90122-K; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Vasicek TJ, 1997, GENETICS, V147, P777; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	23	61	63	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14090	14093		10.1074/jbc.274.20.14090	http://dx.doi.org/10.1074/jbc.274.20.14090			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318824	hybrid			2022-12-27	WOS:000080322200053
J	Brame, CJ; Salomon, RG; Morrow, JD; Roberts, LJ				Brame, CJ; Salomon, RG; Morrow, JD; Roberts, LJ			Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; PROSTAGLANDIN ENDOPEROXIDES; GENERATION; F-2-ISOPROSTANES; LEVUGLANDIN-E2; FRAGMENTATION; GLUTATHIONE; DISEASE; HEXANE; VITRO	Isoprostanes are prostaglandin-like compounds produced by non enzymatic peroxidation of arachidonic acid. The cyclooxygenase-derived endoperoxide, prostaglandin H-2, can undergo rearrangement to highly reactive gamma-ketoaldehyde secoprostanoids (levuglandin E-2 and D-2), We explored whether isoprostane endoperoxide intermediates also rearrange to levuglandin-like compounds (isolevuglandins), Formation of a series of isolevuglandins during oxidation of arachidonic acid in vitro was established utilizing a number of mass spectrometric analyses. However, these compounds could not be detected in free form in protein-containing biological systems, which we hypothesized was due to extremely rapid adduction to amines. This was supported by the finding that >60% of levuglandin E-2 adducted to albumin within 20 s, whereas -50% of 4-hydroxynonenal still remained unadducted after 1 h. By utilizing electro spray tandem mass spectrometry, we established that these compounds form oxidized pyrrole adducts (lactams and hydroxylactams) with lysine, Formation of isolevuglandin-lysine adducts on apolipoprotein B was readily detected during oxidation of low density lipoprotein following enzymatic digestion of the protein to single amino acids, These studies identify a novel series of extremely reactive products of the isoprostane pathway that rapidly form covalent adducts with lysine residues on proteins. This provides the basis to explore the formation of isolevuglandins in vivo to investigate the potential biological ramifications of their formation in settings of oxidant injury.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Vanderbilt University; Vanderbilt University; Case Western Reserve University	Roberts, LJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.		Salomon, Robert G/C-3463-2008	Salomon, Robert/0000-0001-9456-3557	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042056, R37GM042056, P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 48831] Funding Source: Medline; NIGMS NIH HHS [GM 15431, GM 42056] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CURZIO M, 1986, BIOL CHEM H-S, V367, P321, DOI 10.1515/bchm3.1986.367.1.321; DECAPRIO AP, 1982, TOXICOL APPL PHARM, V65, P440, DOI 10.1016/0041-008X(82)90389-1; DEMKOWICZDOBRZANSKI K, 1992, CARCINOGENESIS, V13, P1447, DOI 10.1093/carcin/13.8.1447; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HAMBERG M, 1966, J AM CHEM SOC, V88, P2349, DOI 10.1021/ja00962a068; IYER RS, 1994, J ORG CHEM, V59, P6038, DOI 10.1021/jo00099a039; IYER RS, 1989, PROSTAGLANDINS, V37, P471, DOI 10.1016/0090-6980(89)90096-8; IYER RS, 1990, J ORG CHEM, V55, P3171; LYNCH SM, 1994, J CLIN INVEST, V93, P998, DOI 10.1172/JCI117107; MILLER DB, 1990, J ORG CHEM, V55, P3164, DOI 10.1021/jo00297a036; MILLS GL, 1984, GUIDEBOOK LIPOPROTEI, P87; Montine TJ, 1998, ANN NEUROL, V44, P410, DOI 10.1002/ana.410440322; Morrow JD, 1998, ARCH BIOCHEM BIOPHYS, V353, P160, DOI 10.1006/abbi.1998.0645; Morrow JD, 1996, J BIOL CHEM, V271, P23185, DOI 10.1074/jbc.271.38.23185; MORROW JD, 1994, J BIOL CHEM, V269, P4317; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9883; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; SALOMON RG, 1984, J AM CHEM SOC, V106, P6049, DOI 10.1021/ja00332a049; SMITH EB, 1967, J ORG CHEM, V32, P3330, DOI 10.1021/jo01286a012; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; ZIRROLLI JA, 1990, J AM SOC MASS SPECTR, V1, P325, DOI 10.1016/1044-0305(90)85009-B	24	144	153	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13139	13146		10.1074/jbc.274.19.13139	http://dx.doi.org/10.1074/jbc.274.19.13139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224068	hybrid			2022-12-27	WOS:000080200400030
J	Kusuhara, H; Sekine, T; Utsunomiya-Tate, N; Tsuda, M; Kojima, R; Cha, SH; Sugiyama, Y; Kanai, Y; Endou, H				Kusuhara, H; Sekine, T; Utsunomiya-Tate, N; Tsuda, M; Kojima, R; Cha, SH; Sugiyama, Y; Kanai, Y; Endou, H			Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOROID-PLEXUS INVITRO; CATION TRANSPORTER; EXPRESSION CLONING; BARRIER; PROTEIN; KIDNEY; LIVER; CIMETIDINE; MECHANISMS; CELLS	A cDNA encoding the new member of the multispecific organic anion transporter family, OAT3, was isolated by the reverse transcription polymerase chain reaction cloning method. Degenerate primers were designed based on the sequences conserved among OAT1, OAT2, and organic cation transporter 1 (OCT1), and reverse transcription-polymerase chain reaction was performed using rat brain poly(A)(+) RNA. The 536-amino acid protein sequence encoded by OAT3 showed 49, 39, and 36% identity to those of OAT1, OAT2, and OCT1, respectively. Northern blot analysis revealed that rat OAT3 mRNA is expressed in the liver, brain, kidney, and eye. When expressed in Xenopus laevis oocytes, OAT3 mediated the uptake of organic anions, such asp-aminohippurate (K-m = 65 mu M), ochratoxin A (K-m = 0.74 Emr), and estrone sulfate (K-m = 2.3 mu M) and a cationic compound, cimetidine. OAT3-mediated uptake of [H-3]estrone sulfate was sodium-independent. para-Aminohippuric acid, estrone sulfate or ochratoxin A did not show any trans-stimulatory effect on either influx or efflux of [H-3]estrone sulfate via OAT3. Organic anions such as sulfobromophthalein, probenecid, indocyanine green, bumetanide, piroxicam, furosemide, azidodeoxythymidine, 4,4'-diisothiocyanostilbene-3,3'-disulfonic acid, and benzylpenicillin inhibited OAT3-mediated estrone sulfate uptake, while ouabain and digoxin did not. Organic cations such as tetraethylammonium, guanidine, verapamil, and quinidine did not interact with OAT3, Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3, These results suggest an important role of OAT3 in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Tokyo 1130033, Japan; Meijo Univ, Fac Pharm, Dept Pharmacol, Tempaku Ku, Nagoya, Tokyo 4688503, Japan	Kyorin University; University of Tokyo; Meijo University	Endou, H (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	endouh@kyorin-u.ac.jp						Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; BOOM SPA, 1993, J PHARMACOL EXP THER, V267, P1039; Bradbury MWB, 1979, CONCEPT BLOOD BRAIN; CORNFORD EM, 1985, J NEUROCHEM, V44, P1541, DOI 10.1111/j.1471-4159.1985.tb08793.x; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Hakvoort A, 1998, BRAIN RES, V795, P247, DOI 10.1016/S0006-8993(98)00284-4; Heaney C, 1998, HUM MOL GENET, V7, P1407, DOI 10.1093/hmg/7.9.1407; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kakee A, 1997, J PHARMACOL EXP THER, V283, P1018; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEININGER B, 1991, J NEUROCHEM, V56, P1163, DOI 10.1111/j.1471-4159.1991.tb11406.x; MASEREEUW R, 1994, PHARMACEUT RES, V11, P324, DOI 10.1023/A:1018932213953; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801, DOI 10.1152/ajpgi.1995.269.6.G801; Moller J. V., 1983, PHARMACOL REV, V34, P315; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; Pardridge WM., 1991, PEPTIDE DRUG DELIVER; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Rapoport SI, 1976, BLOOD BRAIN BARRIER; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; SIMONSON GD, 1994, J CELL SCI, V107, P1065; SUZUKI H, 1987, J PHARMACOL EXP THER, V242, P660; SUZUKI H, 1986, J PHARMACOL EXP THER, V239, P927; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Takasawa K, 1997, BIOPHARM DRUG DISPOS, V18, P611, DOI 10.1002/(SICI)1099-081X(199710)18:7<611::AID-BDD45>3.0.CO;2-2; ULLRICH KJ, 1993, CLIN INVESTIGATOR, V71, P843; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P280, DOI 10.1007/BF00374179	31	406	416	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13675	13680		10.1074/jbc.274.19.13675	http://dx.doi.org/10.1074/jbc.274.19.13675			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224140	hybrid			2022-12-27	WOS:000080200400102
J	Linnemann, T; Geyer, M; Jaitner, BK; Block, C; Kalbitzer, HR; Wittinghofer, A; Herrmann, C				Linnemann, T; Geyer, M; Jaitner, BK; Block, C; Kalbitzer, HR; Wittinghofer, A; Herrmann, C			Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; SIGNALING PATHWAY; STRUCTURAL BASIS; IN-VITRO; R-RAS; PROTEIN; TRANSFORMATION; EFFECTORS; YEAST; IDENTIFICATION	Cellular signaling downstream of Ras is highly diversified and may involve many different effector molecules. A potential candidate is AF6 which was originally identified as a fusion to ALL-1 in acute myeloid leukemia. In the present work the interaction between Ras and AF6 is characterized and compared with other effecters. The binding characteristics are quite similar to Raf and RalGEF, i.e. nucleotide dissociation as well as GTPase-activating protein activity are inhibited, whereas the intrinsic GTPase activity of Ras is unperturbed by AF6 binding. Particularly, the dynamics of interaction are similar to Raf and RalGEF with a lifetime of the Ras.AF6 complex in the millisecond range. As probed by P-31 NMR spectroscopy one of two major conformational states of Ras is stabilized by the interaction with AF6, Looking at the affinities of AF6 to a number of Pas mutants in the effector region, a specificity profile emerges distinct from that of other effector molecules. This finding may be useful in defining the biological function of AF6 by selectively switching off other pathways downstream of Ras using the appropriate effector mutant. Notably, among the Ras-related proteins AF6 binds most tightly to Rap1A which could imply a role of Rap1A in AF6 regulation.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44026 Dortmund, Germany; Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany	Max Planck Society; University of Regensburg	Herrmann, C (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Postfach 102664, D-44026 Dortmund, Germany.			Geyer, Matthias/0000-0002-7718-5002; Kalbitzer, Hans Robert/0000-0002-6514-2355				Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bork P, 1997, TRENDS BIOCHEM SCI, V22, P296, DOI 10.1016/S0968-0004(97)01084-0; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; COX AD, 1994, ONCOGENE, V9, P3281; Daub M, 1998, MOL CELL BIOL, V18, P6698, DOI 10.1128/MCB.18.11.6698; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; GRAHAM SM, 1994, MOL CELL BIOL, V14, P4108, DOI 10.1128/MCB.14.6.4108; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ito S, 1997, MOL GEN GENET, V255, P429, DOI 10.1007/s004380050515; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; MCCABE PC, 1992, MOL CELL BIOL, V12, P4084, DOI 10.1128/MCB.12.9.4084; MIYAMOTO H, 1995, GENE DEV, V9, P612, DOI 10.1101/gad.9.5.612; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; PRASAD R, 1993, CANCER RES, V53, P5624; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Rebstein PJ, 1997, EXP CELL RES, V231, P276, DOI 10.1006/excr.1996.3466; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; SHIROUZU M, 1994, ONCOGENE, V9, P2153; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; VANAELST L, 1994, COLD SPRING HARB SYM, V59, P181, DOI 10.1101/SQB.1994.059.01.022; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407	55	117	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13556	13562		10.1074/jbc.274.19.13556	http://dx.doi.org/10.1074/jbc.274.19.13556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224125	hybrid			2022-12-27	WOS:000080200400087
J	Loechel, F; Overgaard, MT; Oxvig, C; Albrechtsen, R; Wewer, UM				Loechel, F; Overgaard, MT; Oxvig, C; Albrechtsen, R; Wewer, UM			Regulation of human ADAM 12 protease by the prodomain - Evidence for a functional, cysteine switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN FIBROBLAST COLLAGENASE; ACTIVE-SITE; TISSUE INHIBITORS; MUTATIONAL ANALYSIS; CONVERTING-ENZYME; CATALYTIC DOMAIN; LYTIC PROTEASE; MELTRIN-ALPHA; IN-VIVO	The ADAMs (a disintegrin and metalloprotease) are a family of multidomain proteins that are believed to play key roles in cell-cell and cell-matrix interactions, We have shown recently that human ADAM 12-S (meltrin alpha) is an active metalloprotease. It is synthesized as a zymogen, with the prodomain maintaining the protease in a latent form. We now provide evidence that the latency mechanism of ADAM 12 can be explained by the cysteine switch model, in which coordination of Zn2+ in the active site of the catalytic domain by a cysteine residue in the prodomain is critical for inhibition of the protease. Replacing Cys(179) with other amino acids results in an ADAM 12 preform that is proteolytically active, but latency can be restored by placing cysteine at other positions in the propeptide, None of the amino acids adjacent to the crucial cysteine residue is essential for blocking activity of the protease domain. In addition to its latency function, the prodomain is required for exit of ADAM 12 protease from the endoplasmic reticulum, Tissue inhibitor of metalloprotease-l, -2, and -3 were not found to block proteolytic activity of ADAM 12, hence a physiological inhibitor of ADAM 12 protease in the extracellular environment remains to be identified.	Univ Copenhagen, Inst Mol Pathol, DK-2100 Copenhagen, Denmark; Aarhus Univ, Dept Mol & Struct Biol, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University	Wewer, UM (corresponding author), Univ Copenhagen, Inst Mol Pathol, Frederik Vs Vej 11, DK-2100 Copenhagen, Denmark.		Overgaard, Michael Toft/E-1354-2011	Overgaard, Michael Toft/0000-0002-1423-2481; Oxvig, Claus/0000-0002-4715-9719; Albrechtsen, Reidar/0000-0003-4180-1827				Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; BJARNASON JB, 1995, METHOD ENZYMOL, V248, P345; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; CHEN LC, 1993, BIOCHEMISTRY-US, V32, P10289, DOI 10.1021/bi00090a003; DOLMER K, 1995, FEBS LETT, V372, P93, DOI 10.1016/0014-5793(95)00960-H; FEINMAN RD, 1994, ANN NY ACAD SCI, V737, P245, DOI 10.1111/j.1749-6632.1994.tb44316.x; FOX JW, 1996, ZINC METALLOPROTEINA, P47; FREIMARK BD, 1994, J BIOL CHEM, V269, P26982; Galazka G, 1996, BIOCHEMISTRY-US, V35, P11221, DOI 10.1021/bi960618e; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Khan AR, 1998, PROTEIN SCI, V7, P815; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; NAGASE H, 1994, ANN NY ACAD SCI, V732, P294, DOI 10.1111/j.1749-6632.1994.tb24744.x; Nagase H, 1996, ZINC METALLOPROTEASE, P153; PARK AJ, 1991, J BIOL CHEM, V266, P1584; Peters RJ, 1998, BIOCHEMISTRY-US, V37, P12058, DOI 10.1021/bi980883v; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; RAMOS C, 1994, J BIOL CHEM, V269, P7006; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Sambrook J., 2002, MOL CLONING LAB MANU; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; Sohl JL, 1997, BIOCHEMISTRY-US, V36, P3894, DOI 10.1021/bi962341o; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STOCKER W, 1995, PROTEIN SCI, V4, P823; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; WINDSOR LJ, 1991, BIOCHEMISTRY-US, V30, P641, DOI 10.1021/bi00217a008; WINDSOR LJ, 1994, J BIOL CHEM, V269, P26201; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313	36	118	124	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13427	13433		10.1074/jbc.274.19.13427	http://dx.doi.org/10.1074/jbc.274.19.13427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224107	hybrid			2022-12-27	WOS:000080200400069
J	Weston, WM; LeClair, EE; Trzyna, W; McHugh, KM; Nugent, P; Lafferty, CM; Ma, L; Tuan, RS; Greene, RM				Weston, WM; LeClair, EE; Trzyna, W; McHugh, KM; Nugent, P; Lafferty, CM; Ma, L; Tuan, RS; Greene, RM			Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MESSENGER-RNA; SALIVARY PROTEIN; N-GLYCOSYLATION; LEUCINE ZIPPER; PEPTIDES; SITES	We have identified a novel gene transcript of approximately 1.1 kilobases in length that is expressed in the presumptive nasal epithelium of the mouse embryo. In situ hybridization analysis shows discrete regions of expression associated with the palate, nasal septum, and nasal conchae, This transcript is also expressed strongly in the trachea and bronchi of the adult lung, Screening of a mouse heart cDNA library yielded several overlapping clones to give a continuous sequence of 1113 bases, containing an open reading frame of 278 codons comprising the complete mRNA. No significant homologies with known genes were observed at the nucleotide level; limited amino acid homology with two salivary gland-specific proteins was noted. A search for functionally significant protein motifs revealed consensus sequences for N-glycosylation, protein kinase C and casein kinase phosphorylation, and a leucine zipper. Additionally, we observed a unique amino acid sequence pattern, consisting of the residues Gly-(Leu/Pro/Gln)-(Pro/Leu)-Leu-Pro-Leu, repeated four times near the amino-terminal portion of the protein with two amino acid residues separating the repeats. Based on these observations, we propose that we have identified a new gene, which we call plunc (for palate, lung, and nasal epithelium clone; GenBank(TM) accession number U69172).	Thomas Jefferson Univ, Orthopaed Res Lab, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Univ Louisville, Sch Dent, Dept Biol & Biophys Sci, Louisville, KY 40292 USA; Allegheny Univ Hlth Sci, Dept Pathol, Philadelphia, PA 19102 USA	Jefferson University; Jefferson University; University of Louisville; Drexel University	LeClair, EE (corresponding author), Thomas Jefferson Univ, Orthopaed Res Lab, 501 Curtis Bldg,1015 Walnut St, Philadelphia, PA 19107 USA.		McHugh, Kirk/E-3640-2011		NICHD NIH HHS [HD08368] Funding Source: Medline; NIDCR NIH HHS [DE05550, DE11176] Funding Source: Medline; NIDDK NIH HHS [R01 DK055791] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE011176, R01DE005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055791] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; GREENE RM, 1994, MASTERY PLASTIC RECO, P459; Kaufman M.H., 1992, ATLAS MOUSE DEV; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIANG P, 1995, METHOD ENZYMOL, V254, P304; MADSEN HO, 1985, NUCLEIC ACIDS RES, V13, P1, DOI 10.1093/nar/13.1.1; MIRELS L, 1992, J BIOL CHEM, V267, P2679; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PROVENZA DV, 1972, FUNDAMENTALS ORAL HI; Rajan GH, 1996, ANIM GENET, V27, P407, DOI 10.1111/j.1365-2052.1996.tb00507.x; RONIN C, 1978, FEBS LETT, V96, P179, DOI 10.1016/0014-5793(78)81089-8; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; WAWERSIK S, 1999, DEV BIOL PROTOCOLS; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x	23	109	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13698	13703		10.1074/jbc.274.19.13698	http://dx.doi.org/10.1074/jbc.274.19.13698			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224143	hybrid			2022-12-27	WOS:000080200400105
J	Cummins, PM; Pabon, A; Margulies, EH; Glucksman, MJ				Cummins, PM; Pabon, A; Margulies, EH; Glucksman, MJ			Zinc coordination and substrate catalysis within the neuropeptide processing enzyme endopeptidase EC 3.4.24.15 - Identification of active site histidine and glutamate residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELEASING HORMONE; ENKEPHALIN-CONTAINING PEPTIDES; ANGIOTENSIN-CONVERTING ENZYME; LUTEINIZING-HORMONE; RAT-BRAIN; SOLUBLE METALLOENDOPEPTIDASE; PSEUDOMONAS-AERUGINOSA; DIRECTED MUTAGENESIS; MOLECULAR-CLONING; NATURAL PEPTIDES	Endopeptidase EC 5.4.24.15 (EP24.15) is a zinc metalloendopeptidase that is broadly distributed within the brain, pituitary, and gonads. Its substrate specificity includes a number of physiologically important neuropeptides such as neurotensin, bradykinin, and gonadotropin-releasing hormone, the principal regulatory peptide for reproduction. In studying the structure and function of EP24.15, we have employed in. vitro mutagenesis and subsequent protein expression to genetically dissect the enzyme and allow us to glean insight into the mechanism of substrate binding and catalysis, Comparison of the sequence of EP24.15 with bacterial homologues previously solved by x-ray crystallography and used as models for mammalian metalloendopeptidases, indicates conserved residues. The active site of EP24.15 exhibits an HEXXH motif, a common feature of zinc metalloenzymes, Mutations have confirmed the importance, for binding and catalysis, of the residues (His(473), Glu(474), and His(477)) within this motif, A third putative metal ligand, presumed to coordinate directly to the active site zinc ion in concert with His(473) and His(477), has been identified as Glu(502). Conservative alterations to these residues drastically reduces enzymatic activity against both a putative physiological substrate and a synthetic quenched fluorescent substrate as well as binding of the specific active site-directed inhibitor, N-[1-(RS) -carboxy-3-phenylpropyl] -Ala-Ala-Tyr-p-aminobenzoate, the binding of which we have shown to be dependent upon the presence, and possibly coordination, of the active site zinc ion. These studies contribute to a more complete understanding of the catalytic mechanism of EP24.15 and will aid in rational design of inhibitors and pharmacological agents for this class of enzymes.	CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Glucksman, MJ (corresponding author), CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Box 1065,1425 Madison Ave, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135] Funding Source: NIH RePORTER; NIDA NIH HHS [2T32-DA7135-16] Funding Source: Medline; NIDDK NIH HHS [DK45493] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKER GR, 1987, J NEUROCHEM, V48, P284, DOI 10.1111/j.1471-4159.1987.tb13160.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN NL, 1988, EUR J PHARMACOL, V148, P79, DOI 10.1016/0014-2999(88)90456-6; BULL HG, 1985, J BIOL CHEM, V260, P2952; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CHU TG, 1985, ENDOCRINOLOGY, V116, P1418, DOI 10.1210/endo-116-4-1418; Creighton T. E., 1993, PROTEINS STRUCTURES; DAUCH P, 1995, J BIOL CHEM, V270, P27266, DOI 10.1074/jbc.270.45.27266; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Davis JP, 1997, BIOCHEM PHARMACOL, V54, P459, DOI 10.1016/S0006-2952(97)00197-4; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELMOUJAHED A, 1990, FEBS LETT, V265, P137, DOI 10.1016/0014-5793(90)80903-V; GLUCKSMAN MJ, 1992, BIOPHYS J, V62, P119, DOI 10.1016/S0006-3495(92)81798-8; GLUCKSMAN MJ, 1995, METH NEUROSCI, V23, P296; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; HEALY DP, 1992, BRAIN RES, V571, P121, DOI 10.1016/0006-8993(92)90517-D; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KAWAMOTO S, 1993, INFECT IMMUN, V61, P1400, DOI 10.1128/IAI.61.4.1400-1405.1993; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNUGI S, 1982, EUR J BIOCHEM, V124, P157, DOI 10.1111/j.1432-1033.1982.tb05919.x; LASDUN A, 1989, J PHARMACOL EXP THER, V251, P439; LASDUN A, 1990, J PHARMACOL EXP THER, V253, P1265; LEMOUAL H, 1991, J BIOL CHEM, V266, P15670; Lesburg CA, 1997, BIOCHEMISTRY-US, V36, P15780, DOI 10.1021/bi971296x; LEVY PL, 1975, P NATL ACAD SCI USA, V72, P4341, DOI 10.1073/pnas.72.11.4341; LEW RA, 1994, J BIOL CHEM, V269, P12626; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MATTHEWS BW, 1972, NATURE-NEW BIOL, V249, P8030; MCDERMOTT JR, 1992, BIOCHEM BIOPH RES CO, V185, P746, DOI 10.1016/0006-291X(92)91689-N; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOLINEAUX CJ, 1988, J NEUROCHEM, V51, P624, DOI 10.1111/j.1471-4159.1988.tb01084.x; MOLINEAUX CJ, 1990, J NEUROCHEM, V55, P611, DOI 10.1111/j.1471-4159.1990.tb04177.x; Montiel JL, 1997, J NEUROCHEM, V68, P354; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; ORLOWSKI M, 1988, BIOCHEMISTRY-US, V27, P597, DOI 10.1021/bi00402a015; ORLOWSKI M, 1989, BIOCHEM J, V261, P951, DOI 10.1042/bj2610951; Oyama K., 1981, J CHEM SOC P2, P356; PAPASTOITSIS G, 1994, BIOCHEMISTRY-US, V33, P192, DOI 10.1021/bi00167a025; PAUPTIT RA, 1988, J MOL BIOL, V199, P525, DOI 10.1016/0022-2836(88)90623-7; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; Ripellino James A., 1998, Society for Neuroscience Abstracts, V24, P1006; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; SMITH AI, 1994, BIOCHIMIE, V76, P288, DOI 10.1016/0300-9084(94)90160-0; STARK W, 1992, EUR J BIOCHEM, V207, P781, DOI 10.1111/j.1432-1033.1992.tb17109.x; THAYER MM, 1991, J BIOL CHEM, V266, P2864; TIPTON K F, 1992, P1; TISLJAR U, 1993, BIOL CHEM H-S, V374, P91; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; WEI L, 1992, J BIOL CHEM, V267, P13398; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Wu TJ, 1997, J NEUROENDOCRINOL, V9, P813, DOI 10.1046/j.1365-2826.1997.00637.x	62	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16003	16009		10.1074/jbc.274.23.16003	http://dx.doi.org/10.1074/jbc.274.23.16003			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347149	hybrid			2022-12-27	WOS:000080668600009
J	Gavigan, SA; Nguyen, T; Nguyen, N; Senear, DF				Gavigan, SA; Nguyen, T; Nguyen, N; Senear, DF			Role of multiple CytR binding sites on cooperativity, competition, and induction at the Escherichia coli udp promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; CRP ACTIVATOR PROTEIN; LAMBDA-CI REPRESSOR; DNA-BINDING; DEOP2 PROMOTER; TRANSCRIPTION ACTIVATION; PARAMETER-ESTIMATION; CRYSTAL-STRUCTURE; PURINE REPRESSOR; GENE-EXPRESSION	The CytR repressor fulfills dual roles as both a repressor of transcription from promoters of the Escherichia coli CytR regulon and a co-activator in some circumstances. Transcription is repressed by a three-protein complex (cAMP receptor protein (CRP)-CytR-CRP) that is stabilized by cooperative interactions between CRP and CytR, However, cooperativity also means that CytR can recruit CRP and, by doing so, can act as a co-activator, The central role of cooperativity in regulation is highlighted by the fact that binding of the inducer, cytidine, to CytR is coupled to CytR-CRP cooperativity; this underlies the mechanism for induction. Similar interactions at the different promoters of the CytR regulon coordinate expression of the transport proteins and enzymes required for nucleoside catabolism but also provide differential expression of these genes. A fundamental question in both prokaryotic and eukaryotic gene regulation is how combinatorial mechanisms of this sort regulate differential expression. Recently, we showed that CytR binds specifically to multiple sites in the E, coli deoP promoter, thereby providing competition for CRP binding to CRP operator site 1 (CRP1) and CRP2 as well as cooperativity, The effect of the competition at this promoter is to negate the role of CytR in recruiting CRP, Here, we have used quantitative footprint and mobility shift analysis to investigate CRP and CytR binding to the E, coli udp promoter. Here too, we find that CytR both cooperates and competes for CRP binding. However, consistent with both the distribution of CytR recognition motifs in the sequence of the promoter and the regulation of the promoter, the competition is limited to CRP2, When cytidine binds to CytR, the effect on cooperativity is very different at the udp promoter than at the deoP2 promoter. Cooperativity with CRP at CRP1 is nearly eliminated, but the effect on CytR-CRP2 cooperativity is negligible. These results are discussed in relation to the current structural model of CytR in which the core, inducer-binding domain is tethered to the helix-turn-helix, DNA-binding domain via flexible peptide linkers.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Senear, DF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.							ACKERS GK, 1983, J MOL BIOL, V170, P223, DOI 10.1016/S0022-2836(83)80234-4; Barbier CS, 1997, J BIOL CHEM, V272, P16962, DOI 10.1074/jbc.272.27.16962; BARBIER CS, 1992, J BACTERIOL, V174, P2881, DOI 10.1128/JB.174.9.2881-2890.1992; Belyaeva TA, 1998, J MOL BIOL, V277, P789, DOI 10.1006/jmbi.1998.1666; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; BRENOWITZ M, 1989, CURRENT PROTOCOLS MO, V2; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; FILES JG, 1976, J BIOL CHEM, V251, P3386; GRONENBORN AM, 1986, BIOCHEM J, V236, P643, DOI 10.1042/bj2360643; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; Jorgensen CI, 1998, MOL MICROBIOL, V27, P41, DOI 10.1046/j.1365-2958.1998.00655.x; Kallipolitis BH, 1997, CELL, V89, P1101, DOI 10.1016/S0092-8674(00)80297-4; Kristensen HH, 1997, J MOL BIOL, V266, P866, DOI 10.1006/jmbi.1996.0852; Kristensen HH, 1996, J MOL BIOL, V260, P113, DOI 10.1006/jmbi.1996.0385; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Maniatas T., 1989, MOL CLONING LAB MANU; MARTINUSSEN J, 1989, DNA PROTEIN INTERACT, P31; PEDERSEN H, 1991, J BIOL CHEM, V266, P17804; PEDERSEN H, 1995, MOL MICROBIOL, V17, P843, DOI 10.1111/j.1365-2958.1995.mmi_17050843.x; Pedersen H, 1997, EMBO J, V16, P2108, DOI 10.1093/emboj/16.8.2108; Perini LT, 1996, J BIOL CHEM, V271, P33242, DOI 10.1074/jbc.271.52.33242; RASMUSSEN PB, 1993, NUCLEIC ACIDS RES, V21, P879, DOI 10.1093/nar/21.4.879; Rasmussen PB, 1996, P NATL ACAD SCI USA, V93, P10151, DOI 10.1073/pnas.93.19.10151; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; SENEAR DF, 1990, BIOCHEMISTRY-US, V29, P6568, DOI 10.1021/bi00480a004; SENEAR DF, 1992, METHOD ENZYMOL, V210, P463; Senear DF, 1998, METHOD ENZYMOL, V295, P403; SENEAR DF, 1991, BIOCHEMISTRY-US, V30, P6677, DOI 10.1021/bi00241a007; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; WAXMAN E, 1993, ANAL BIOCHEM, V210, P425, DOI 10.1006/abio.1993.1220; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303	36	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16010	16019		10.1074/jbc.274.23.16010	http://dx.doi.org/10.1074/jbc.274.23.16010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347150	hybrid			2022-12-27	WOS:000080668600010
J	Hang, Q; Woods, L; Feiss, M; Catalano, CE				Hang, Q; Woods, L; Feiss, M; Catalano, CE			Cloning, expression, and biochemical characterization of hexahistidine-tagged terminase proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA TERMINASE; DNA PACKAGING ENZYME; INTEGRATION HOST FACTOR; GENE-PRODUCT-A; LARGE SUBUNIT; PHAGE-LAMBDA; ENDONUCLEASE ACTIVITY; PROHEAD BINDING; KINETIC CHARACTERIZATION; DOMAIN	The terminase enzyme from bacteriophage lambda is composed of two viral proteins (gpA, 73.2 kDa; gpNu1, 20.4 kDa) and is responsible for packaging viral DNA into the confines of an empty procapsid, We are interested in the genetic, biochemical, and biophysical properties of DNA packaging in phage lambda and, in particular, the nucleoprotein complexes involved in these processes. These studies require the routine purification of large quantities of wild-type and mutant proteins in order to probe the molecular mechanism of DNA packaging. Toward this end, we have constructed a hexahistidine (hexa-His)tagged terminase holoenzyme as well as hexa-His-tagged gpNu1 and gpA subunits. We present a simple, one-step purification scheme for the purification of large quantities of the holoenzyme and the individual subunits directly from the crude cell lysate, Importantly, we have developed a method to purify the highly insoluble gpNu1 subunit from inclusion bodies in a single step. Hexa-His terminase holoenzyme is functional in vise and possesses steady-state and single-turnover ATPase activity that is indistinguishable from wild-type enzyme. The nuclease activity of the modified holoenzyme is near wild type, but the reaction exhibits a greater dependence on Escherichia coli integration host factor, a result that is mirrored in vivo, These results suggest that the hexa-His-tagged holoenzyme possesses a mild DNA-binding defect that is masked, at least in part, by integration host factor. The mild defect in hexa-His terminase holoenzyme is more significant in the isolated gpA-hexa-His subunit that does not appear to bind DNA Moreover, whereas the hexa-His-tagged gpNul subunit may be reconstituted into a holoenzyme complex with wild-type catalytic activities, gpa-hexa-His is impaired in its interactions with the gpNu1 subunit of the enzyme. The results reported here underscore that a complete biochemical characterization of the effects of purification tags on enzyme function must be performed prior to their use in mechanistic studies.	Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Denver, CO 80262 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Iowa; University of Iowa	Catalano, CE (corresponding author), Univ Colorado, Hlth Sci Ctr, Program Mol Biol, 4200 E 9th Ave, Denver, CO 80262 USA.	carlos.catalano@uchsc.edu		Catalano, Carlos E./0000-0003-2349-5758	NIGMS NIH HHS [GM51611, GM50328-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050328, R01GM051611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Cai ZH, 1997, J BACTERIOL, V179, P2479, DOI 10.1128/jb.179.8.2479-2485.1997; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; CHOW S, 1987, GENE, V60, P277, DOI 10.1016/0378-1119(87)90236-8; CUE D, 1992, J MOL BIOL, V228, P58, DOI 10.1016/0022-2836(92)90491-2; DANIELS DL, 1983, LAMBDA, V2, P522; DAVIDSON AR, 1992, VIROLOGY, V189, P21, DOI 10.1016/0042-6822(92)90677-H; FEISS M, 1986, TRENDS GENET, V2, P100, DOI 10.1016/0168-9525(86)90193-9; FEISS M, 1983, P NATL ACAD SCI-BIOL, V80, P955, DOI 10.1073/pnas.80.4.955; FEISS M, 1982, GENE, V17, P123, DOI 10.1016/0378-1119(82)90064-6; FEISS M, 1983, LAMBDA, V2, P305; FRACKMAN S, 1984, J MOL BIOL, V180, P283, DOI 10.1016/S0022-2836(84)80005-4; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; GOLD M, 1983, J BIOL CHEM, V258, P4619; Hanagan A, 1998, INT J BIOL MACROMOL, V23, P37, DOI 10.1016/S0141-8130(98)00010-5; HOHN B, 1983, P NATL ACAD SCI-BIOL, V80, P7456, DOI 10.1073/pnas.80.24.7456; HOHN B, 1975, J MOL BIOL, V98, P93, DOI 10.1016/S0022-2836(75)80103-3; Hwang Y, 1996, BIOCHEMISTRY-US, V35, P2796, DOI 10.1021/bi952322z; HWANG Y, 1995, VIROLOGY, V211, P367, DOI 10.1006/viro.1995.1419; KYPR J, 1986, J MOL BIOL, V191, P139, DOI 10.1016/0022-2836(86)90430-4; MANIATIS T, 1982, MOL CLONING LABORATO, P440; Meyer JD, 1998, INT J BIOL MACROMOL, V23, P27, DOI 10.1016/S0141-8130(98)00009-9; MIWA T, 1983, GENE, V24, P199; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; PAL SK, 1988, J BACTERIOL, V172, P2819; PARRIS W, 1988, J BIOL CHEM, V263, P8413; PARRIS W, 1994, J BIOL CHEM, V269, P13564; RUBINCHIK S, 1994, J BIOL CHEM, V269, P13586; RUBINCHIK S, 1994, J BIOL CHEM, V269, P13575; SIPPY J, 1992, J BACTERIOL, V174, P850, DOI 10.1128/jb.174.3.850-856.1992; SIX EW, 1973, VIROLOGY, V51, P327, DOI 10.1016/0042-6822(73)90432-7; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TOMKA MA, 1993, BIOCHEMISTRY-US, V32, P11992, DOI 10.1021/bi00096a008; TOMKA MA, 1993, J BIOL CHEM, V268, P3056; Woods L, 1997, BIOCHEMISTRY-US, V36, P5777, DOI 10.1021/bi963044m; WU WF, 1988, GENETICS, V119, P477; XIN W, 1988, NUCLEIC ACIDS RES, V16, P2015, DOI 10.1093/nar/16.5.2015; XIN W, 1993, J MOL BIOL, V230, P492, DOI 10.1006/jmbi.1993.1166; Yang Q, 1999, BIOCHEMISTRY-US, V38, P465, DOI 10.1021/bi981271d; YEO A, 1995, J MOL BIOL, V245, P126; [No title captured]	43	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15305	15314		10.1074/jbc.274.22.15305	http://dx.doi.org/10.1074/jbc.274.22.15305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336415	hybrid			2022-12-27	WOS:000080560100004
J	Kottke, TJ; Blajeski, AL; Martins, LM; Mesner, PW; Davidson, NE; Earnshaw, WC; Armstrong, DK; Kaufmann, SH				Kottke, TJ; Blajeski, AL; Martins, LM; Mesner, PW; Davidson, NE; Earnshaw, WC; Armstrong, DK; Kaufmann, SH			Comparison of paclitaxel-, 5-fluoro-2 '-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis - Evidence for EGF-induced anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; RECEPTOR TYROSINE KINASE; DRUG-INDUCED APOPTOSIS; BREAST-CANCER-CELLS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CHEMOTHERAPY-INDUCED APOPTOSIS; ETOPOSIDE-INDUCED APOPTOSIS; CYTOCHROME-C ACCUMULATION; DAMAGE-INDUCED APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE	Epidermal growth factor (EGF), a hormone that stimulates proliferation of many cell types, induces apoptosis in some cell lines that overexpress the EGF receptor. To evaluate the mechanism of EGF-induced apoptosis, MDA-MB-468 breast cancer cells were examined by microscopy, flow cytometry, immunoblotting, enzyme assays, and affinity labeling after treatment with EGF, paclitaxel, or 5-fluoro-2'-deoxyuridine (5FUdR). Apoptosis induced by all three agents was accompanied by activation of caspases-3, -6, and -7, as indicated by disappearance of the corresponding zymogens from immunoblots, cleavage of substrate polypeptides in situ, and detection of active forms of these caspases in cytosol and nuclei using fluorogenic assays and affinity labeling. Further analysis indicated involvement of the cytochrome c/Apaf-1/caspase-9 pathway of caspase activation, but not the Fas/Fas ligand pathway. Interestingly, caspase activation was consistently lower after EGF treatment than after paclitaxel or 5FUdR treatment. Additional experiments revealed that the majority of cells detaching from the substratum after EGF (but not paclitaxel or 5FUdR) were morphologically normal and retained the capacity to readhere, suggesting that EGF-induced apoptosis involves cell detachment followed by anoikis, These observations not only indicate that EGF- and chemotherapy-induced apoptosis in this cell line involve the same downstream pathways but also suggest that detachment-induced apoptosis is responsible for the paradoxical antiproliferative effects of EGF.	Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Pharmacol, Rochester, MN 55905 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA	Mayo Clinic; Mayo Clinic; University of Edinburgh; Johns Hopkins University; Johns Hopkins Medicine	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, 1801 Guggenheim,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.Scott@Mayo.edu	Earnshaw, William/AAY-7438-2020	Earnshaw, William/0000-0002-7191-0621; Kaufmann, Scott/0000-0002-4900-7145	NATIONAL CANCER INSTITUTE [U01CA066084, R01CA069008] Funding Source: NIH RePORTER; NCI NIH HHS [UO1 CA66084, R01 CA69008, R01 CA069008] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; ARGILES A, 1992, CANCER RES, V52, P4356; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; ARMSTRONG DK, 1992, CANCER RES, V52, P3418; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bible KC, 1997, CANCER RES, V57, P3375; Blagosklonny MV, 1997, CANCER RES, V57, P130; Budihardjo II, 1998, CLIN CANCER RES, V4, P117; Chauhan D, 1997, J BIOL CHEM, V272, P29995, DOI 10.1074/jbc.272.48.29995; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V29, P29, DOI 10.1007/BF00666179; DONG XF, 1991, ANTICANCER RES, V11, P737; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; EASTMAN A, 1995, SEMIN CANCER BIOL, V6, P45, DOI 10.1006/scbi.1995.0006; Eischen C M, 1997, Adv Pharmacol, V41, P107, DOI 10.1016/S1054-3589(08)61056-X; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; ENNIS BW, 1989, MOL ENDOCRINOL, V3, P1830, DOI 10.1210/mend-3-11-1830; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Fang GF, 1998, CANCER RES, V58, P3202; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Fuchs EJ, 1997, CANCER RES, V57, P2550; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greenberg AH, 1996, ADV EXP MED BIOL, V406, P219; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; Houghton JA, 1997, P NATL ACAD SCI USA, V94, P8144, DOI 10.1073/pnas.94.15.8144; Ibrado AM, 1997, CANCER RES, V57, P1109; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karnes WE, 1998, GASTROENTEROLOGY, V114, P930, DOI 10.1016/S0016-5085(98)70312-9; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KAUFMANN SH, 1989, J BIOL CHEM, V264, P13946; Kelloff GJ, 1996, CANCER EPIDEM BIOMAR, V5, P657; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Khwaja A, 1997, J CELL BIOL, V139, P1017, DOI 10.1083/jcb.139.4.1017; Kim CN, 1997, CANCER RES, V57, P3115; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Konig A, 1997, BLOOD, V90, P4307; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEE K, 1987, EXP CELL RES, V173, P156, DOI 10.1016/0014-4827(87)90341-7; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Matthews DE, 1988, USING UNDERSTANDING, P178; May W S Jr, 1997, Adv Pharmacol, V41, P219; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; McCloskey DE, 1996, CLIN CANCER RES, V2, P847; Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7; MINKE JMHM, 1991, CANCER RES, V51, P4028; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NELSON J, 1995, CANCER RES, V55, P3772; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Park J R, 1996, Curr Opin Hematol, V3, P191; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; RUSCH V, 1996, CYTOKINE GROWTH F R, V71, P133; Sachs L, 1996, P NATL ACAD SCI USA, V93, P4742, DOI 10.1073/pnas.93.10.4742; Schaerli P, 1998, CELL MOL LIFE SCI, V54, P129, DOI 10.1007/s000180050132; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Srinivasan A, 1996, J NEUROSCI, V16, P5654; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tang DG, 1998, BIOCHEM BIOPH RES CO, V242, P380, DOI 10.1006/bbrc.1997.7969; Thornberry N A, 1997, Adv Pharmacol, V41, P155, DOI 10.1016/S1054-3589(08)61058-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ucker D S, 1997, Adv Pharmacol, V41, P179, DOI 10.1016/S1054-3589(08)61059-5; Villunger A, 1997, CANCER RES, V57, P3331; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; ZHAN QM, 1994, ONCOGENE, V9, P3743	95	80	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15927	15936		10.1074/jbc.274.22.15927	http://dx.doi.org/10.1074/jbc.274.22.15927			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336499	hybrid			2022-12-27	WOS:000080560100088
J	Liu, MS; Lee, BH; Mathews, MB				Liu, MS; Lee, BH; Mathews, MB			Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS E1A ONCOPROTEIN; DNA-BINDING PROTEINS; B VIRUS ENHANCER; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL DOMAINS; MOLECULAR-CLONING; AUXILIARY PROTEIN; POLYMERASE-DELTA; GENE; CYCLIN	The proliferating cell nuclear antigen (PCNA) is an essential eukaryotic DNA replication factor that is transcriptionally regulated by the adenovirus oncoprotein E1A 243B. Inducibility of the human PCNA promoter by E1A 243R is conferred by the cis-acting PCNA E1A-responsive element (PERE), which associates with the ATF-1, cAMP response element-binding protein (CREB), and RFX1 transcription factors and is modulated by cellular proteins such as the coactivator CREB-binding protein (CBP) and tumor suppressor p107 (Labrie, C., Lee, B. R, and Mathews, M. B. (1995) Nucleic Acids Res. 23, 3732-3741; Lee, B, H., and Mathews, M, B, (1997) Proc. Natl. Acad Sci. U.S, R 94, 4481-4486; Lee, B. H., Liu, M, and Mathews, M. B, (1998) J. ViroL 72, 1138-1145). RFX1 also forms a complex with sequences in the PCNA promoter of mouse and rat that share homology with the RFX1 consensus site. To explore the role of RFX1 in regulating the PCNA promoter, we examined the effects of mutations in the human PERE on RFX1 binding and gene expression. Mutations within the RFX1 consensus binding site reduced RFX1 binding, whereas mutations up-stream of the site, or on its border, increased RFX1 binding. These mutations also affected the transcriptional activity of PCNA-chloramphenicol acetyltransferase reporter constructs in transient expression assays. The relative transcriptional activity of mutant PCNA promoters, both in the presence and absence of E1A 243R, was inversely related to their ability to complex with RFX1. These findings suggest that the binding of RFX1 is influenced by sequences outside its consensus binding site and that this transcription factor plays an inhibitory role in the regulation of PCNA gene expression.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11790 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, MS (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	mathews@umdnj.edu			NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA 13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; LABRIE C, 1993, MOL CELL BIOL, V13, P1697, DOI 10.1128/MCB.13.3.1697; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; Lee BH, 1997, P NATL ACAD SCI USA, V94, P4481, DOI 10.1073/pnas.94.9.4481; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; MOORE KS, 1987, J BIOL CHEM, V262, P8447; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MORRIS GF, 1990, J BIOL CHEM, V265, P16116; MORRIS GF, 1994, MOL CELL BIOL, V14, P543, DOI 10.1128/MCB.14.1.543; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; MORRIS GF, 1991, J VIROL, V65, P6397, DOI 10.1128/JVI.65.12.6397-6406.1991; NEVINS JR, 1989, ADV VIRUS RES, V37, P35; OHASHI Y, 1992, BIOCHIM BIOPHYS ACTA, V1130, P175, DOI 10.1016/0167-4781(92)90525-5; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; SHENK T, 1991, ADV CANCER RES, V57, P47; SHIVAKUMAR CV, 1995, MOL CELL BIOL, V15, P6785; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; TAN CK, 1986, J BIOL CHEM, V261, P2310; TRAVALI S, 1989, J BIOL CHEM, V264, P7466; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WOLD MS, 1987, CANCER CELL, P133; YAMAGUCHI M, 1991, NUCLEIC ACIDS RES, V19, P2403, DOI 10.1093/nar/19.9.2403; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821	36	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15433	15439		10.1074/jbc.274.22.15433	http://dx.doi.org/10.1074/jbc.274.22.15433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336433	hybrid			2022-12-27	WOS:000080560100022
J	Yang, JP; Hori, M; Sanda, T; Okamoto, T				Yang, JP; Hori, M; Sanda, T; Okamoto, T			Identification of a novel inhibitor of nuclear factor-kappa B RelA-associated inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; IN-VITRO; ACTIVATION; ALPHA; SEQUENCES; PROTEINS; TRANSCRIPTION; ANKYRIN; KINASE; 53BP2	Here we report the identification and characterization of a novel protein, RelA-associated inhibitor (RAI), that binds to the NF-kappa B subunit p65 (RelA) and inhibits its transcriptional activity. RAI gene was isolated in a yeast two-hybrid screen using the central region of p65 as bait. We confirmed the physical interaction in vitro using recombinant proteins as well as in vivo by immunoprecipitation/Western blot assay. RAI gene encodes a protein with homology to the C-terminal region of 53BP2 containing four consecutive ankyrin repeats and an Src homology 3 domain. RAI mRNA was preferentially expressed in human heart, placenta, and prostate. Despite its similarity to 53BP2, RAI did not interact with p53 in a yeast two-hybrid assay. RAI inhibited the action of NF-kappa B p65 but not that of p53 in transient luciferase gene expression assays. Similarly, RAI inhibited the endogenous NF-kappa B activity induced by tumor necrosis factor-alpha. RAI specifically inhibited the DNA binding activity of p65 when co-transfected in 293 cells. RAI protein appeared to be located in the nucleus and colocalized with NF-kappa B p65 that was activated by TNF-alpha. These observations indicate that RAI is another inhibitor of NF-kappa B in addition to I kappa B proteins and may confer an alternative mechanism of regulation.	Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.							Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Brown K, 1997, MOL CELL BIOL, V17, P3021, DOI 10.1128/MCB.17.6.3021; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lamerdin JE, 1996, GENOMICS, V34, P399, DOI 10.1006/geno.1996.0303; Liu ZQ, 1996, FEBS LETT, V385, P109, DOI 10.1016/0014-5793(96)00360-2; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Min W, 1996, MOL CELL BIOL, V16, P359; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; OKAMOTO T, 1990, VIROLOGY, V177, P606, DOI 10.1016/0042-6822(90)90526-W; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Okamoto T, 1998, CYTOGENET CELL GENET, V82, P105, DOI 10.1159/000015077; OKAMOTO T, 1989, AIDS RES HUM RETROV, V5, P131, DOI 10.1089/aid.1989.5.131; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Sakurada S, 1996, INT IMMUNOL, V8, P1483, DOI 10.1093/intimm/8.10.1483; Sambrook J., 2002, MOL CLONING LAB MANU; Sato T, 1998, AIDS RES HUM RETROV, V14, P293, DOI 10.1089/aid.1998.14.293; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; SIEBENLIST U, 1995, NF KAPPAB MEDIATOR P, V1, P93; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Suyang H, 1996, MOL CELL BIOL, V16, P5444; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; THUKRAL SK, 1994, MOL CELL BIOL, V14, P8315, DOI 10.1128/MCB.14.12.8315; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; YANG JP, 1995, FEBS LETT, V361, P89, DOI 10.1016/0014-5793(95)00157-5	40	137	151	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15662	15670		10.1074/jbc.274.22.15662	http://dx.doi.org/10.1074/jbc.274.22.15662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336463	hybrid			2022-12-27	WOS:000080560100052
J	Lee, MG; Choi, JY; Luo, X; Strickland, E; Thomas, PJ; Muallem, S				Lee, MG; Choi, JY; Luo, X; Strickland, E; Thomas, PJ; Muallem, S			Cystic fibrosis transmembrane conductance regulator regulates luminal Cl-/HCO3- exchange in mouse submandibular and pancreatic ducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG PANCREAS; BICARBONATE SECRETION; INTERLOBULAR DUCTS; AIRWAY EPITHELIA; MEMBRANE LOCALIZATION; CHLORIDE CHANNELS; SALIVARY DUCTS; ION CHANNELS; CFTR; TRANSPORT	We have demonstrated previously the regulation of Cl-/HCO3- exchange activity by the cystic fibrosis transmembrane conductance regulator (CFTR) in model systems of cells stably or transiently transfected with CFTR (Lee, M. G., Wigley, W. C., Zeng, W., Noel, L. E., Marino, C, R,, Thomas, P. J., and Muallem, S, (1999) J. Biol. Chem. 274, 3414-3421), In the present work we examine the significance of this regulation in cells naturally expressing CFTR. These include the human colonic T84 cell line and the mouse submandibular gland and pancreatic ducts, tissues that express high levels of CFTR in the luminal membrane. As in heterologous expression systems, stimulation of T84 cells with forskolin increased the Cl-/HCO3- exchange activity independently of CFTR Cl- channel activity. Freshly isolated submandibular gland ducts from wild type mice showed variable Cl-/HCO3- exchange activity. Measurement of [Cl-](i) revealed that this was largely the result of variable steady-state [Cl-](i). Membrane depolarization with 5 mM Ba2+ or 100 mM K+ increased and stabilized [Cl-](i). Under depolarized conditions wild type and Delta F/Delta F mice had comparable basal Cl-/HCO3- exchange activity. Notably, stimulation with forskolin increased Cl-/HCO3- exchange activity in submandibular gland ducts from wild type but not Delta F/Delta F mice. Microperfusion of the main pancreatic duct showed Cl-/HCO3- exchange activity in both the basolateral and luminal membranes. Stimulation of ducts from wild type animals with forskolin had no effect on basolateral but markedly stimulated luminal Cl-/HCO3- exchange activity. By contrast, forskolin had no effect on either basolateral or luminal Cl-/HCO3- exchange activity of ducts from Delta F/Delta F animals. We conclude that CFTR regulates luminal Cl-/HCO3- exchange activity in CFTR-expressing cells, and we discuss the possible physiological significance of these findings regarding cystic fibrosis.	Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Program Mol Biophys, Dallas, TX 75235 USA	Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.	mlee@yumc.yonsei.ac.kr	Thomas, Philip J/F-7115-2012; Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X	NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK49835, DK38938] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938, R01DK049835, R37DK049835] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ARGENT BE, 1994, PHYSL GASTROINTESTIN, P1478; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Barrett KE, 1997, AM J PHYSIOL-CELL PH, V272, pC1069, DOI 10.1152/ajpcell.1997.272.4.C1069; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; Chaturapanich G, 1997, J PHYSIOL-LONDON, V503, P583, DOI 10.1111/j.1469-7793.1997.583bg.x; Cheng HS, 1998, J MEMBRANE BIOL, V164, P155, DOI 10.1007/s002329900401; Cook D. I., 1994, P1061; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; GRAY MA, 1989, AM J PHYSIOL, V257, pC240, DOI 10.1152/ajpcell.1989.257.2.C240; Gray MA, 1995, BIOSCIENCE REP, V15, P531, DOI 10.1007/BF01204355; Greger R, 1996, J MOL MED-JMM, V74, P527; GRUBB BR, 1995, AM J PHYSIOL-GASTR L, V268, pG505, DOI 10.1152/ajpgi.1995.268.3.G505; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Hogan DL, 1997, GASTROENTEROLOGY, V113, P533, DOI 10.1053/gast.1997.v113.pm9247473; Illek B, 1997, AM J PHYSIOL-LUNG C, V272, pL752, DOI 10.1152/ajplung.1997.272.4.L752; Illek B, 1996, AM J PHYSIOL-CELL PH, V270, pC265, DOI 10.1152/ajpcell.1996.270.1.C265; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P169, DOI 10.1113/jphysiol.1996.sp021582; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P179, DOI 10.1113/jphysiol.1996.sp021583; LAU KR, 1994, PFLUG ARCH EUR J PHY, V427, P24, DOI 10.1007/BF00585938; Lee MC, 1998, AM J PHYSIOL-LUNG C, V274, pL450, DOI 10.1152/ajplung.1998.274.3.L450; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 1998, J PHYSIOL-LONDON, V513, P341, DOI 10.1111/j.1469-7793.1998.341bb.x; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 1999, CYSTIC FIBROSIS IN ADULTS, P419, DOI 10.1111/b.9780631213284.1999.00056.x; REDDY MM, 1993, PEDIATR PULM S, V9, P208; SCHULTZ SG, 1972, GASTROENTEROLOGY, V63, P161; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; XU X, 1995, J BIOL CHEM, V270, P19606, DOI 10.1074/jbc.270.33.19606; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zeng WZ, 1997, J BIOL CHEM, V272, P32956, DOI 10.1074/jbc.272.52.32956; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57; ZHAO H, 1995, J BIOL CHEM, V270, P19599, DOI 10.1074/jbc.270.33.19599	47	143	147	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14670	14677		10.1074/jbc.274.21.14670	http://dx.doi.org/10.1074/jbc.274.21.14670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329661	Green Published, hybrid			2022-12-27	WOS:000081965200026
J	Nueda, A; Hudson, F; Mivechi, NF; Dynan, WS				Nueda, A; Hudson, F; Mivechi, NF; Dynan, WS			DNA-dependent protein kinase protects against heat-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK-REPAIR; SHOCK TRANSCRIPTION FACTOR-1; STRESS-INDUCED APOPTOSIS; RNA-POLYMERASE-II; MOUSE-CELL LINES; CATALYTIC SUBUNIT; KU AUTOANTIGEN; CHO CELLS; HYPERTHERMIC RADIOSENSITIZATION; NONSENSE MUTATION	Purified heat shock transcription factor 1 (HSF1) binds to both the regulatory and catalytic components of the DNA-dependent protein kinase (DNA-PK). This observation suggests that DNA-PK may have a physiological role in the heat shock response. To investigate this possibility, we performed a comparison of cell lines that were deficient in either the Ku protein or the DNA-PK catalytic subunit versus the same cell lines that had been rescued by the introduction of a functional gene. DNA-PK-negative cell lines were up to 10-fold more sensitive to heat-induced apoptosis than matched DNA-PK-positive cell lines. There may be a regulatory interaction between DNA-PK and HSF1 in vivo, because constitutive overexpression of HSF1 sensitized the DNA-PK-positive cells to heat but had no effect in DNA-PK-negative cells. The initial burst of hsp70 mRNA expression was similar in DNA-PK-negative and -positive cell lines, but the DNA-PK-negative cells showed an attenuated rate of mRNA synthesis at later times and, in some cases, lower heat shock protein expression. These findings provide evidence for an antiapoptotic function of DNA-PK that is experimentally separable from its mechanical role in DNA double strand break repair.	Med Coll Georgia, Inst Mol Med & Genet, Program Gene Regulat, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Dynan, WS (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Program Gene Regulat, 1120 15th St, Augusta, GA 30912 USA.			Dynan, William/0000-0002-4045-5662; Nueda, Arsenio/0000-0001-8373-500X	NCI NIH HHS [CA 62130] Funding Source: Medline; NIGMS NIH HHS [GM 35866] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA062130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035866] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN DJ, 1986, SCAN ELECTRON MICROS, V1986, P1121; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; BELLON T, 1994, EUR J IMMUNOL, V24, P41, DOI 10.1002/eji.1830240107; BENHUR E, 1974, RADIAT RES, V58, P38, DOI 10.2307/3573947; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BROWN T, 1997, CURRENT PROTOCOLS MO, V1; BURGMAN P, 1997, CANCER RES, V57, P2874; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Chen FQ, 1996, MUTAT RES-DNA REPAIR, V362, P9, DOI 10.1016/0921-8777(95)00026-7; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Danska JS, 1996, MOL CELL BIOL, V16, P5507; DUKE RC, 1986, J IMMUNOL, V137, P1442; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; DYSON JED, 1986, CELL TISSUE KINET, V19, P311, DOI 10.1111/j.1365-2184.1986.tb00683.x; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; GORZOWSKI JJ, 1995, J BIOL CHEM, V270, P26940, DOI 10.1074/jbc.270.45.26940; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GREENBERG ME, 1997, CURRENT PROTOCOLS MO, V1; HARMON BV, 1991, INT J RADIAT BIOL, V59, P489, DOI 10.1080/09553009114550441; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; HENLE KJ, 1976, RADIAT RES, V66, P505, DOI 10.2307/3574455; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; HUNT C, 1990, GENE, V87, P199, DOI 10.1016/0378-1119(90)90302-8; ILIAKIS G, 1990, INT J HYPERTHER, V6, P801, DOI 10.3109/02656739009140827; JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; JORRITSMA JBM, 1986, RADIAT RES, V106, P89, DOI 10.2307/3576564; JORRITSMA JBM, 1984, RADIAT RES, V98, P198, DOI 10.2307/3576063; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KIM D, 1995, J BIOL CHEM, V270, P15277, DOI 10.1074/jbc.270.25.15277; Kim Y, 1997, J CELL BIOCHEM, V67, P43, DOI 10.1002/(SICI)1097-4644(19971001)67:1<43::AID-JCB5>3.0.CO;2-W; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; KURIMASA A, 1994, HUM GENET, V93, P21; LASZLO, 1992, CELL PROLIFERATION, V25, P59; LI GC, 1995, P NATL ACAD SCI USA, V92, P4512, DOI 10.1073/pnas.92.10.4512; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu L, 1998, MOL CELL BIOL, V18, P4221, DOI 10.1128/MCB.18.7.4221; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; MIMORI T, 1986, J BIOL CHEM, V261, P2274; MIVECHI NF, 1995, J CELL BIOCHEM, V59, P266, DOI 10.1002/jcb.240590215; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; OHARA MD, 1995, INT J RADIAT ONCOL, V31, P905, DOI 10.1016/0360-3016(94)00435-8; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; PETERSON SR, 1995, J BIOL CHEM, V270, P1449, DOI 10.1074/jbc.270.3.1449; ROBINSON JE, 1974, ACTA RADIOL THER PHY, V13, P241, DOI 10.3109/02841867409129880; Romero F, 1996, MOL CELL BIOL, V16, P37; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SELLINS KS, 1991, RADIAT RES, V126, P88, DOI 10.2307/3578175; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; Tsukamoto Y, 1998, GENES CELLS, V3, P135, DOI 10.1046/j.1365-2443.1998.00180.x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WARTERS RL, 1985, J CELL PHYSIOL, V124, P481, DOI 10.1002/jcp.1041240318; WONG RSL, 1995, INT J RADIAT BIOL, V68, P141, DOI 10.1080/09553009514551041; Yang SH, 1996, MOL CELL BIOL, V16, P3799, DOI 10.1128/mcb.16.7.3799; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	69	34	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14988	14996		10.1074/jbc.274.21.14988	http://dx.doi.org/10.1074/jbc.274.21.14988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329701	hybrid			2022-12-27	WOS:000081965200066
J	Schwartz, BS; Espana, F				Schwartz, BS; Espana, F			Two distinct urokinase-serpin interactions regulate the initiation of cell surface-associated plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN UROKINASE; PROTEIN-C INHIBITOR; ENZYMATIC-ACTIVITY; PLASMA; RECEPTOR; MONOCYTES; COMPLEXES; PURIFICATION; TYPE-1	Single-chain urokinase-type plasminogen activator (scu-PA) possesses enzymatic activity that increases by 2-3 orders of magnitude upon binding to its cellular cofactor, the u-PA receptor (u-PAR), hence activating an enzymatic cascade initially composed of zymogens. The present study demonstrates that plasminogen activator inhibitor type 3 (PAI-3) reversibly inhibits scu-PA in solution, maintaining the system "off." Because the scu-PA/PAT-3 interaction is reversible, cellular expression of u-PAR allows partitioning of scu-PA from PAI-3 to u-PAR with resultant expression of full enzymatic activity. PAI-3 that was originally complexed to scu-PA remains in solution, retaining its functional activity. Importantly, the scu-PA on cell surface u-PAR is protected from PAI-3 inhibition, remaining an effective activator in a PAI-rich environment. Plasmin formed as a result of scu-PA activity then cleaves scu-PA to the mature protease, two-chain u-PA (tcu-PA), which is efficiently and irreversibly inhibited by PAI-3 via the standard serpin mechanism, even on u-PAR. This data generates a new hypothesis which in contrast to the previous paradigm, holds that receptor bound scu-PA is the initiating enzyme and that tcu-PA is generated not to augment enzymatic activity but rather to allow for inhibition and therefore appropriate regulation of the process.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Hosp La Fe, Ctr Invest, E-46009 Valencia, Spain	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Hospital Universitari i Politecnic La Fe	Schwartz, BS (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.		España, Francisco/A-7286-2008		NHLBI NIH HHS [HL43506] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043506] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BACHMAN F, 1994, HEMOSTASIS THROMBOSI, P1605; Bachmann F., 1994, HEMOSTASIS THROMBOSI, V3rd, P1592; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1993, THROMB HAEMOSTASIS, V70, P989; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HIGAZI AA, 1995, J BIOL CHEM, V270, P17375, DOI 10.1074/jbc.270.29.17375; Koshland DE, 1998, SCIENCE, V280, P852, DOI 10.1126/science.280.5365.852; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; MANCHANDA N, 1995, J BIOL CHEM, V270, P20032, DOI 10.1074/jbc.270.34.20032; MANCHANDA N, 1991, J BIOL CHEM, V266, P14580; MANCHANDA N, 1990, J IMMUNOL, V145, P4174; MUSSONI L, 1984, THROMB RES, V34, P241, DOI 10.1016/0049-3848(84)90008-2; NYKIAER A, 1992, J BIOL CHEM, V267, P14543; PANNELL R, 1987, BLOOD, V69, P22; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Tachias K, 1997, J BIOL CHEM, V272, P28; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; WUN TC, 1982, J BIOL CHEM, V257, P7262	28	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15278	15283		10.1074/jbc.274.21.15278	http://dx.doi.org/10.1074/jbc.274.21.15278			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329738	hybrid			2022-12-27	WOS:000081965200103
J	Ueno, T; Ishidoh, K; Mineki, R; Tanida, I; Murayama, K; Kadowaki, M; Kominami, E				Ueno, T; Ishidoh, K; Mineki, R; Tanida, I; Murayama, K; Kadowaki, M; Kominami, E			Autolysosomal membrane-associated betaine homocysteine methyltransferase - Limited degradation fragment of a sequestered cytosolic enzyme monitoring autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; GTP-BINDING-PROTEINS; LEUPEPTIN TREATMENT; AUTO-LYSOSOMES; CELL-LINE; LIVER; MECHANISMS; FUSION; VACUOLE; ACID	We compared the membrane proteins of autolysosomes isolated from leupeptin-administered rat Liver with those of lysosomes. In addition to many polypeptides common to the two membranes, the autolysosomal membranes were found to be more enriched in endoplasmic reticulum lumenal proteins (protein-disulfide isomerase, calreticulin, ER60, BiP) and endosome/Golgi markers (cation-independent mannose g-phosphate receptor, transferrin receptor, Golgi 58-kDa protein) than lysosomal membranes. The autolysosomal membrane proteins include three polypeptides (44, 35, and 32 kDa) whose amino-terminal sequences have not yet been reported. Combining immunoblotting and reverse transcriptase-polymerase chain reaction analyses, we identified the 44-kDa peptide as the intact subunit of betaine homocysteine methyltransferase and the 35- and 32-kDa peptides as two proteolytic fragments. Pronase digestion of autolysosomes revealed that the 44-kDa and 32-kDa peptides are present in the lumen, whereas the 35-kDa peptide is not. In primary hepatocyte cultures, the starvation-induced accumulation of the 32-kDa peptide occurs in the presence of E64d, showing that the 32-kDa peptide is formed from the sequestered 44-kDa peptide during autophagy. The accumulation is induced by rapamycin but completely inhibited by wortmannin, 3-methyladenine, and bafilomycin. Thus, detection of the 32-kDa peptide by immunoblotting can be used as a streamlined assay for monitoring autophagy.	Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; Juntendo Univ, Sch Med, Cent Lab Med Sci, Bunkyo Ku, Tokyo 1138421, Japan; Niigata Univ, Fac Agr, Dept Appl Biochem, Niigata 95021, Japan	Juntendo University; Juntendo University; Niigata University	Kominami, E (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Bldg 9,Rm 913, Tokyo 1138421, Japan.		Tanida, Isei/C-8277-2009; Kominami, Eiki/D-3802-2009	Tanida, Isei/0000-0001-8999-3990				BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; BERON W, 1995, ARCH BIOCHEM BIOPHYS, V317, P337, DOI 10.1006/abbi.1995.1172; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FURUNO K, 1982, J BIOCHEM-TOKYO, V91, P1485, DOI 10.1093/oxfordjournals.jbchem.a133840; FURUNO K, 1984, J BIOCHEM, V95, P671, DOI 10.1093/oxfordjournals.jbchem.a134656; FURUNO K, 1982, J BIOCHEM-TOKYO, V91, P1943, DOI 10.1093/oxfordjournals.jbchem.a133888; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; KOBAYASHI R, 1989, ANAL BIOCHEM, V183, P9, DOI 10.1016/0003-2697(89)90162-0; KOMINAMI E, 1983, J BIOL CHEM, V258, P6093; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LIU FT, 1979, BIOCHEMISTRY-US, V18, P690, DOI 10.1021/bi00571a022; LUSIS AJ, 1976, J BIOL CHEM, V251, P7753; MAIER O, 1995, BIOCHEM BIOPH RES CO, V208, P135, DOI 10.1006/bbrc.1995.1315; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; MUNO D, 1993, ARCH BIOCHEM BIOPHYS, V306, P103, DOI 10.1006/abbi.1993.1486; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5; SEGLEN PO, 1987, LYSOSOMES THEIR ROLE, P371; SKIBA WE, 1987, METHOD ENZYMOL, V143, P384; TANAKA K, 1978, J BIOCHEM-TOKYO, V84, P937, DOI 10.1093/oxfordjournals.jbchem.a132207; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UENO T, 1991, J BIOL CHEM, V266, P18995; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ward DM, 1997, J CELL BIOL, V139, P665, DOI 10.1083/jcb.139.3.665; WHITE S, 1992, BIOCHIM BIOPHYS ACTA, V1136, P28, DOI 10.1016/0167-4889(92)90081-L; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P573, DOI 10.1177/38.4.2319125; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P1571, DOI 10.1177/38.11.2212617	46	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15222	15229		10.1074/jbc.274.21.15222	http://dx.doi.org/10.1074/jbc.274.21.15222			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329731	hybrid			2022-12-27	WOS:000081965200096
J	van Endert, PM				van Endert, PM			Role of nucleotides and peptide substrate for stability and functional state of the human ABC family transporters associated with antigen processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING CASSETTE TRANSPORTER; RECONSTITUTED P-GLYCOPROTEIN; ATPASE ACTIVITY; ENCODED TRANSPORTER; ESCHERICHIA-COLI; TAP; PROTEIN; CFTR; DOMAINS	The transporters associated with antigen processing (TAP) belong to the family of ATP-binding cassette (ABC) transporters which share structural organization and use energy provided by ATP to translocate a large variety of solutes across cellular membranes. TAP is thought to hydrolyze ATP in order to deliver peptides to the endoplasmic reticulum where they can assemble with major histocompatibility complex class I molecules. However, initial binding of peptide substrates to TAP has been suggested to be ATP-independent. In this study, the effect of temperature, energetic nucleotides, and peptide on conformation and functional capacity of TAP proteins was examined. Incubation of insect cell microsomes overexpressing human TAP complexes or of human B cell microsomes at 37 degrees C induced a rapid and irreversible structural change that reduced dramatically TAP reactivity with antibodies to transmembrane and nucleotide-binding domains and abolished peptide binding and transport by TAP. These alterations were inhibited almost completely by di- or trinucleotides, and partially by high affinity peptides, suggesting that complete nucleotide dissociation inactivates TAP complexes. Experiments with isolated TAP subunits and fragments suggested that TAP complex stabilization by nucleotides may depend on their binding to the TAP1 subunit. Thus, the cellular level of functional TAP complexes may be regulated by nucleotide concentrations. It is speculated that this regulation may serve to prevent induction of autoimmunity by stressed cells with low energy levels.	Hop Necker Enfants Malad, INSERM, U25, F-75743 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	van Endert, PM (corresponding author), INSERM, U25, 161 Rue Sevres, F-75743 Paris 15, France.		van Endert, Peter/R-4606-2017	van Endert, Peter/0000-0003-3782-0750				Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chang XB, 1998, J BIOL CHEM, V273, P23844, DOI 10.1074/jbc.273.37.23844; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; KORONAKIS V, 1993, MOL MICROBIOL, V8, P1163, DOI 10.1111/j.1365-2958.1993.tb01661.x; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; MULLER KM, 1994, J BIOL CHEM, V269, P14032; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; SCHNEIDER E, 1994, J BIOL CHEM, V269, P20456; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Sonveaux N, 1996, J BIOL CHEM, V271, P24617, DOI 10.1074/jbc.271.40.24617; Stephens DB, 1997, FEBS LETT, V416, P353, DOI 10.1016/S0014-5793(97)01221-0; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Uebel S, 1997, FEBS LETT, V416, P359, DOI 10.1016/S0014-5793(97)01222-2; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WANG K, 1994, FEBS LETT, V350, P337, DOI 10.1016/0014-5793(94)00806-X	33	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14632	14638		10.1074/jbc.274.21.14632	http://dx.doi.org/10.1074/jbc.274.21.14632			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329656	hybrid			2022-12-27	WOS:000081965200021
J	Djellas, Y; Manganello, JM; Antonakis, K; Le Breton, GC				Djellas, Y; Manganello, JM; Antonakis, K; Le Breton, GC			Identification of G alpha(13) as one of the G-proteins that couple to human platelet thromboxane A(2) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE BINDING-PROTEIN; STIMULATE PHOSPHOLIPASE-C; HUMAN-BLOOD PLATELETS; PORTAL-VEIN MYOCYTES; ALPHA-SUBUNITS; ADENYLYL-CYCLASE; G13 PROTEINS; P115 RHOGEF; EXCHANGE; PURIFICATION	Previous studies have shown that ligand or immunoaffinity chromatography can be used to purify the human platelet thromboxane A(2) (TXA(2)) receptor-G alpha(q) complex. The same principle of co-elution was used to identify another G-protein associated with platelet TXA(2) receptors, It was found that in addition to G alpha(q), purification of TXA(2) receptors by ligand (SQ31,491)-affinity chromatography resulted in the co-purification of a member of the G(12) family, Using an antipeptide antibody specific for the human G(13) alpha-subunit, this G-protein was identified as G alpha(13). In separate experiments, it was found that the TXA(2) receptor agonist U46619 stimulated [S-35]guanosine 5'-O-(3-thiotriphosphate) incorporation into G(13) alpha-subunit. Further evidence for functional coupling of G(13) to TXA(2) receptors was provided in studies where solubilized platelet membranes were subjected to immunoaffinity chromatography using an antibody raised against native TXA(2) receptor protein. It was found that U46619 induced a significant decrease in G alpha(q) and G alpha(13) association with the receptor protein. These results indicate that both G alpha(q) and G alpha(13) are functionally coupled to TXA(2) receptors and dissociate upon agonist activation. Furthermore, this agonist effect was specifically blocked by pretreatment with the TXA(2) receptor antagonist, BM13.505. Taken collectively, these data provide direct evidence that endogenous G alpha(13) is a TXA(2) receptor-coupled G-protein, as: 1) its alpha-subunit can be co-purified with the receptor protein using both ligand and immunoaffinity chromatography, 2) TXA(2) receptor activation stimulates GTP gamma S binding to G alpha(13), and 3) G alpha(13) affinity for the TXA(2) receptor can be modulated by agonist-receptor activation.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; CNRS, Inst Rech Sci Canc, Chim Organ Biol & Spect UMR 133, F-94802 Villejuif, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centre National de la Recherche Scientifique (CNRS)	Le Breton, GC (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,M-C 868, Chicago, IL 60612 USA.				NHLBI NIH HHS [HL-24530, T32 HL07692] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024530, T32HL007692] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan CJ, 1996, J PHARMACOL EXP THER, V277, P1132; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; BALDASSARE JJ, 1993, BIOCHEM J, V291, P235, DOI 10.1042/bj2910235; Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; BORG C, 1993, BIOCHEM PHARMACOL, V45, P2071, DOI 10.1016/0006-2952(93)90018-R; BORG C, 1994, J BIOL CHEM, V269, P6109; BRACE LD, 1985, AM J PHYSIOL, V249, pH1, DOI 10.1152/ajpheart.1985.249.1.H1; BRASS LF, 1988, J BIOL CHEM, V263, P5348; BRASS LF, 1987, J CLIN INVEST, V79, P1269, DOI 10.1172/JCI112947; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; COLEMAN RA, 1979, BRIT J PHARMACOL, V68, pP127; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; Djellas Y, 1998, P NATL ACAD SCI USA, V95, P10944, DOI 10.1073/pnas.95.18.10944; DORN GW, 1990, CIRCULATION, V81, P212, DOI 10.1161/01.CIR.81.1.212; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hooley R, 1996, J BIOL CHEM, V271, P6152, DOI 10.1074/jbc.271.11.6152; KABOURIDIS PS, 1995, MOL CELL BIOCHEM, V144, P45, DOI 10.1007/BF00926739; KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313; Kitamura K, 1996, J BIOL CHEM, V271, P7412, DOI 10.1074/jbc.271.13.7412; KITAMURA K, 1995, AM J PHYSIOL-CELL PH, V268, pC101, DOI 10.1152/ajpcell.1995.268.1.C101; KNEZEVIC I, 1993, J BIOL CHEM, V268, P26011; KNEZEVIC I, 1992, J PHARMACOL EXP THER, V260, P947; Kozasa T, 1996, J BIOL CHEM, V271, P12562, DOI 10.1074/jbc.271.21.12562; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin X, 1996, J BIOL CHEM, V271, P22604, DOI 10.1074/jbc.271.37.22604; Macrez N, 1997, J BIOL CHEM, V272, P23180, DOI 10.1074/jbc.272.37.23180; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; MILLIGAN G, 1992, FEBS LETT, V297, P186, DOI 10.1016/0014-5793(92)80357-M; NEEDLEMAN P, 1976, SCIENCE, V193, P163, DOI 10.1126/science.945611; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; PATSCHEKE H, 1987, THROMB HAEMOSTASIS, V58, P182; PATSCHEKE H, 1984, THROMB RES, V33, P277, DOI 10.1016/0049-3848(84)90163-4; PATSCHEKE H, 1984, BIOMED BIOCHIM ACTA, V43, P312; Plonk SG, 1998, J BIOL CHEM, V273, P4823, DOI 10.1074/jbc.273.9.4823; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIESS W, 1985, BLOOD, V65, P1141; SIFFERT W, 1990, J BIOL CHEM, V265, P719; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; STRATHMANN M, 1989, P NATL ACAD SCI USA, V88, P5582; STRYER L, 1985, BIOPOLYMERS, V24, P29, DOI 10.1002/bip.360240105; SWEATT JD, 1986, J BIOL CHEM, V261, P8667; SWEATT JD, 1986, J BIOL CHEM, V261, P8660; Tosun M, 1998, J PHARMACOL EXP THER, V284, P921; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; USHIKUBI F, 1989, J BIOL CHEM, V264, P16496; USHIKUBI F, 1987, THROMB HAEMOSTASIS, V57, P158; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; WU KK, 1981, J CLIN INVEST, V67, P1801, DOI 10.1172/JCI110221; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744	62	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14325	14330		10.1074/jbc.274.20.14325	http://dx.doi.org/10.1074/jbc.274.20.14325			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318854	hybrid			2022-12-27	WOS:000080322200083
J	Jonas, JC; Sharma, A; Hasenkamp, W; Ilkova, H; Patane, G; Laybutt, R; Bonner-Weir, S; Weir, GC				Jonas, JC; Sharma, A; Hasenkamp, W; Ilkova, H; Patane, G; Laybutt, R; Bonner-Weir, S; Weir, GC			Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL PHOSPHATE DEHYDROGENASE; INSULIN GENE-TRANSCRIPTION; LACTATE-DEHYDROGENASE; FATTY RATS; PANCREATECTOMIZED RATS; ISOLATED ISLETS; GLUCOSE; EXPRESSION; SECRETION; GLUCOKINASE	Differentiated pancreatic beta cells are unique in their ability to secrete insulin in response to a rise in plasma glucose. We have proposed that the unique constellation of genes they express may be lost in diabetes due to the deleterious effect of chronic hyperglycemia. To test this hypothesis, Sprague-Dawley rats were submitted to a 85-95% pancreatectomy or sham pancreatectomy. One week later, the animals developed mild to severe chronic hyperglycemia that was stable for the next 3 weeks, without significant alteration of plasma nonesterified fatty acid levels. Expression of many genes important for glucose-induced insulin release decreased progressively with increasing hyperglycemia, in parallel with a reduction of several islet transcription factors involved in beta cell development and differentiation. In contrast, genes barely expressed in sham islets (lactate dehydrogenase A and hexokinase I) were markedly increased, in parallel with an increase in the transcription factor c-Myc, a potent stimulator of cell growth. These abnormalities were accompanied by beta cell hypertrophy. Changes in gene expression were fully developed 2 weeks after pancreatectomy. Correction of blood glucose by phlorizin for the next 2 weeks normalized islet gene expression and beta cell volume without affecting plasma nonesterified fatty acid levels, strongly suggesting Chat hyperglycemia triggers these abnormalities. In conclusion, chronic hyperglycemia leads to beta cell hypertrophy and loss of beta cell differentiation that is correlated with changes in c-Myc and other key transcription factors. A similar change in beta cell differentiation could contribute to the profound derangement of insulin secretion in human diabetes.	Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.	Weir, GC (corresponding author), Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, 1 Joslin Pl,Rm 535, Boston, MA 02215 USA.	weirg@joslab.harvard.edu	Jonas, Jean-Christophe/C-6766-2011	Jonas, Jean-Christophe/0000-0001-9882-5438; Bonner-Weir, Susan/0000-0003-4682-0656	NIDDK NIH HHS [DK-44523, DK-36836, DK-35449] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK035449, R01DK044523] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BarreraHernandez G, 1996, DIABETES, V45, P1217, DOI 10.2337/diabetes.45.9.1217; Baumgart E, 1996, J BIOL CHEM, V271, P3846; BECKER TC, 1994, J BIOL CHEM, V269, P21234; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; BROCKENBROUGH JS, 1988, DIABETES, V37, P232, DOI 10.2337/diabetes.37.2.232; Cockburn BN, 1997, DIABETES, V46, P1434, DOI 10.2337/diabetes.46.9.1434; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; EFRAT S, 1994, P NATL ACAD SCI USA, V91, P2051, DOI 10.1073/pnas.91.6.2051; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Fleischer N, 1998, DIABETES, V47, P1419, DOI 10.2337/diabetes.47.9.1419; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GIROIX MH, 1993, DIABETOLOGIA, V36, P305, DOI 10.1007/BF00400232; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; HENQUIN JC, 1994, JOSLINS DIABETES MEL, P56; HOSOKAWA H, 1995, DIABETES, V44, P1328, DOI 10.2337/diabetes.44.11.1328; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; Leahy Jack L., 1996, P103; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; Madsen OD, 1997, HORM METAB RES, V29, P265, DOI 10.1055/s-2007-979035; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; PHILIPPE J, 1987, MOL CELL BIOL, V7, P560, DOI 10.1128/MCB.7.1.560; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Roche E, 1998, DIABETOLOGIA, V41, pA130; ROE MW, 1994, J BIOL CHEM, V269, P18279; Roe MW, 1996, AM J PHYSIOL-ENDOC M, V270, pE133, DOI 10.1152/ajpendo.1996.270.1.E133; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Susini S, 1998, FASEB J, V12, P1173, DOI 10.1096/fasebj.12.12.1173; Tokuyama Y, 1996, BIOCHEM BIOPH RES CO, V220, P532, DOI 10.1006/bbrc.1996.0439; TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; VALERA A, 1994, J BIOL CHEM, V269, P28543; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Weir GC, 1997, ACTA DIABETOL, V34, P177, DOI 10.1007/s005920050071; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; YAMASHITA S, 1988, ENDOCRINOLOGY, V123, P1825, DOI 10.1210/endo-123-4-1825; ZAMBON A, 1993, J LIPID RES, V34, P1021; Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	54	451	481	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14112	14121		10.1074/jbc.274.20.14112	http://dx.doi.org/10.1074/jbc.274.20.14112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318828	hybrid			2022-12-27	WOS:000080322200057
J	Le Bonniec, S; Deregnaucourt, C; Redeker, V; Banerjee, R; Grellier, P; Goldberg, DE; Schrevel, J				Le Bonniec, S; Deregnaucourt, C; Redeker, V; Banerjee, R; Grellier, P; Goldberg, DE; Schrevel, J			Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTIC PROTEINASE; PROTEASES; PURIFICATION; DEGRADATION; EXPRESSION; SEPARATION; SPECTRIN; PATHWAY; CULTURE; CELLS	Plasmepsin II, an aspartic protease from the human intraerythrocytic parasite Plasmodium falciparum, is involved in degradation of the host cell hemoglobin within the acidic food vacuole of the parasite. Previous characterization of enzymatic activities from Plasmodium soluble extracts, responsible for in vitro hydrolysis of erythrocyte spectrin, had shown that the hydrolysis process occurred at pH 5.0 and involved aspartic protease(s) cleaving mainly within the SH3 motif of the spectrin alpha-subunit. Therefore, we used a recombinant construct of the erythroid SH3 motif as substrate to investigate the involvement of plasmepsins in spectrin hydrolysis, Using specific anti-plasmepsin II antibodies in Western blotting experiments, plasmepsin II was detected in chromatographic fractions enriched in the parasite SH3 hydrolase activity. Involvement of plasmepsin II in hydrolysis was demonstrated by mass spectrometry identification of cleavage sites in the SH3 motif, upon hydrolysis by Plasmodium extract enzymatic activity, and by recombinant plasmepsin II, Furthermore, recombinant plasmepsin II digested native spectrin at pH 6.8, either purified or situated in erythrocyte ghosts, Additional degradation of actin and protein 4.1 from ghosts was observed. Specific antibodies were used in confocal imaging of schizont-infected erythrocytes to localize plasmepsin II in mature stages of the parasite development cycle; antibodies clearly labeled the periphery of the parasites. Taken together, these results strongly suggest that, in addition to hemoglobin degradation, plasmepsin II might be involved in cytoskeleton cleavage of infected erythrocytes.	Museum Natl Hist Nat, Lab Biol Parasitaire, CNRS, F-75231 Paris 05, France; Ecole Super Phys & Chim Ind Ville Paris, Neurobiol Lab, CNRS, UMR 7637, F-75231 Paris, France; Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Deregnaucourt, C (corresponding author), Museum Natl Hist Nat, Lab Biol Parasitaire, CNRS, EP 1790,61 Rue Buffon, F-75231 Paris 05, France.		Redeker, Virginie/L-8929-2018; Schrevel, Joseph/AAG-7085-2020	Redeker, Virginie/0000-0003-2694-8388; 	NIAID NIH HHS [AI31615] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031615] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DAME JB, 1994, MOL BIOCHEM PARASIT, V64, P177, DOI 10.1016/0166-6851(94)90024-8; DEGUERCY A, 1990, MOL BIOCHEM PARASIT, V38, P233, DOI 10.1016/0166-6851(90)90026-I; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; GRELLIER P, 1994, BIOL CELL, V82, P129, DOI 10.1016/S0248-4900(94)80015-4; HILL J, 1994, FEBS LETT, V352, P155, DOI 10.1016/0014-5793(94)00940-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LeBonniec S, 1996, CR ACAD SCI III-VIE, V319, P1011; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; MORROW JS, 1980, P NATL ACAD SCI-BIOL, V77, P6592, DOI 10.1073/pnas.77.11.6592; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; ROSENTHAL PJ, 1989, MOL BIOCHEM PARASIT, V35, P177, DOI 10.1016/0166-6851(89)90120-5; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREVEL J, 1990, BLOOD CELLS, V16, P563; SHERMAN IW, 1983, MOL BIOCHEM PARASIT, V8, P207, DOI 10.1016/0166-6851(83)90044-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WEIDEKAMM E, 1973, BIOCHIM BIOPHYS ACTA, V323, P539, DOI 10.1016/0005-2736(73)90162-4	24	85	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14218	14223		10.1074/jbc.274.20.14218	http://dx.doi.org/10.1074/jbc.274.20.14218			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318841	hybrid			2022-12-27	WOS:000080322200070
J	Pelkmans, L; Helenius, A				Pelkmans, L; Helenius, A			Expression of antibody interferes with disulfide bond formation and intracellular transport of antigen in the secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; PROTEIN; CALNEXIN; CELL; IMMUNIZATION; NETWORK	To determine whether antibodies would interfere with the folding of glycoprotein antigens in the endoplasmic reticulum lumen of living cells, hybridoma cells producing monoclonal anti-hemagglutinin (HA) antibodies were infected with influenza virus. The fate of the newly synthesized HA was determined using an established pulse-chase approach. When the monoclonal antibodies were against epitopes present on early folding intermediates, folding and intracellular transport of HA to the Golgi complex were severely disturbed. On the other hand, when the antibodies were specific for the native HA trimers, immune complexes were formed, but folding or transport of HA was not affected. The use of antibodies in this way provided in situ information about the protein folding process inside the endoplasmic reticulum lumen of cells without external perturbation of the folding chains or the folding compartment.	ETH Zurich, Biochem Lab, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH Zurich, Biochem Lab, Swiss Fed Inst Technol, Univ Str 16, CH-8092 Zurich, Switzerland.			Pelkmans, Lucas/0000-0002-6754-9730				Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BURKE B, 1984, CELL, V36, P847, DOI 10.1016/0092-8674(84)90034-5; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREBER UF, 1992, J CELL BIOL, V116, P15, DOI 10.1083/jcb.116.1.15; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LODISH HF, 1993, J BIOL CHEM, V268, P20598; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Persic L, 1997, GENE, V187, P1, DOI 10.1016/S0378-1119(96)00627-0; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; TSOU CL, 1988, BIOCHEMISTRY-US, V27, P1809, DOI 10.1021/bi00406a001; Zhou P, 1998, J IMMUNOL, V160, P1489	24	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14495	14499		10.1074/jbc.274.20.14495	http://dx.doi.org/10.1074/jbc.274.20.14495			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318876	hybrid, Green Published			2022-12-27	WOS:000080322200105
J	Bennett, MK; Ngo, TT; Athanikar, JN; Rosenfeld, JM; Osborne, TF				Bennett, MK; Ngo, TT; Athanikar, JN; Rosenfeld, JM; Osborne, TF			Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; SERUM RESPONSE FACTOR; CHOLESTEROL-SYNTHESIS; SYNTHASE PROMOTER; FATTY-ACIDS; EXPRESSION; REPRESSION; LIVER; CELLS; SITES	Sterol regulation of gene expression in mammalian cells is mediated by an interaction between the cholesterol-sensitive sterol regulatory element-binding proteins (SREBPs) and promoter-specific but generic co-regulatory transcription factors such as Spl and NF-Y/CBF, Thus, sterol-regulated promoters that require different co-regulatory factors could be regulated independently through targeting the specific interaction between the SREBPs and the individual co-regulatory proteins. In the present studies we demonstrate that transiently expressed yin yang 1 protein (YY1) inhibits the SREBP-mediated activation of the low density lipoprotein (LDL) receptor in a sensitive and dose dependent manner. The inhibition is independent of YY1 binding directly to the LDL receptor promoter, and we show that the same region of YY1 that interacts in solution with Spl also interacts with SREBP. Furthermore, other SREBP-regulated genes that are not co-regulated by Spl are either not affected at all or are not as sensitive to the repression. Thus, the specific interaction that occurs between SREBPs and Spl to stimulate the LDL receptor promoter is a specific target for inhibition by the YY1 protein, and we provide evidence that the mechanism can be at least partially explained by the ability of YY1 to inhibit the interaction between SREBP and Spl in solution in vitro, The LDL receptor is the key gene of cholesterol uptake, and the rate-controlling genes of cholesterol synthesis are stimulated by the concerted action of SREBPs along with coregulators that are distinct from Spl, Therefore, repression of gene expression through specifically targeting the interaction between SREBP and Spl would provide a molecular mechanism to explain how cholesterol uptake can be regulated independently from cholesterol biosynthesis in mammalian cells.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Osborne, TF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 19172 Jamboree Rd, Irvine, CA 92697 USA.				NHLBI NIH HHS [HL48044] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048044] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; AUWERX JH, 1989, MOL CELL BIOL, V9, P2298, DOI 10.1128/MCB.9.6.2298; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; DIETSCHY JM, 1983, BIOCHEM SOC T, V11, P639, DOI 10.1042/bst0110639; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Guan GM, 1997, J BIOL CHEM, V272, P10295; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; MILLINDERVALLET.S, 1996, J BIOL CHEM, V271, P12247; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Osborne TF, 1998, METHODS, V16, P42, DOI 10.1006/meth.1998.0643; OSBORNE TF, 1992, J BIOL CHEM, V267, P18973; Osborne TF, 1997, CURR BIOL, V7, pR172, DOI 10.1016/S0960-9822(97)70081-2; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; SODOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; SPADY DK, 1985, J LIPID RES, V26, P465; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; TURLEY SD, 1981, J LIPID RES, V22, P551; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Yokoyama C., 1993, CELL, V75, P185; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995	40	63	75	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13025	13032		10.1074/jbc.274.19.13025	http://dx.doi.org/10.1074/jbc.274.19.13025			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224053	hybrid			2022-12-27	WOS:000080200400015
J	Renard, S; Olivier, A; Granger, P; Avenet, P; Graham, D; Sevrin, M; George, P; Besnard, F				Renard, S; Olivier, A; Granger, P; Avenet, P; Graham, D; Sevrin, M; George, P; Besnard, F			Structural elements of the gamma-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; BINDING-SITE; ALPHA-SUBUNIT; A RECEPTOR; POINT MUTATION; PHARMACOLOGY; MODULATION; AFFINITY	gamma-aminobutyric acid type A (GABA(A)) receptors comprise a subfamily of ligand-gated ion channels whose activity can be modulated by ligands acting at the benzodiazepine binding site on the receptor. The benzodiazepine binding site was characterized using a site-directed mutagenesis strategy in which amino acids of the alpha(5) subunit were substituted by their corresponding alpha(1) residues. Given the high affinity and selectivity of alpha(1)-containing compared with alpha(5)-containing GABA(A) receptors for zolpidem, mutated alpha(5) subunits were co-expressed with beta(2) and gamma(2) subunits, and the affinity of recombinant receptors for zolpidem was measured. One alpha(5) mutant (bearing P162T, E200G, and T204S) exhibited properties similar to that of the alpha(1) subunit, notably high affinity zolpidem binding and potentiation by zolpidem of GABA-induced chloride current. Two of these mutations, alpha(5)P162T and alpha(5)E200G, might alter binding pocket conformation, whereas alpha(5)T204S probably permits formation of a hydrogen bond with a proton acceptor in zolpidem, These three amino acid substitutions also influenced receptor affinity for CL218872, Our data thus suggest that corresponding amino acids of the alpha(1) subunit, particularly alpha(1)-Ser(204), are the crucial residues influencing ligand selectivity at the binding pocket of alpha(1)-containing receptors, and a model of this binding pocket is presented.	Synthelabo, Dept Genom Biol, F-92500 Rueil Malmaison, France; CNS Res Dept, F-92225 Bagneux, France	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Besnard, F (corresponding author), Synthelabo, Dept Genom Biol, 10 Rue Carrieres, F-92500 Rueil Malmaison, France.			Renard, Stephane/0000-0002-1374-4960				Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Besnard F, 1997, J RECEPT SIGNAL TR R, V17, P99, DOI 10.3109/10799899709036596; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Buhr A, 1996, MOL PHARMACOL, V49, P1080; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DUCIC I, 1995, J PHARMACOL EXP THER, V272, P438; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; FAUREHALLEY C, 1993, EUR J PHARM-MOLEC PH, V246, P283, DOI 10.1016/0922-4106(93)90043-9; GARDNER CR, 1992, PROG NEURO-PSYCHOPH, V16, P755, DOI 10.1016/0278-5846(92)90099-Z; Graham D, 1996, EUR NEUROPSYCHOPHARM, V6, P119, DOI 10.1016/0924-977X(95)00072-W; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; LANGER SZ, 1988, FUND CLIN PHARMACOL, V2, P159, DOI 10.1111/j.1472-8206.1988.tb00629.x; McKernan RM, 1998, MOL PHARMACOL, V54, P33, DOI 10.1124/mol.54.1.33; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Olivier A, 1997, BIOORG MED CHEM LETT, V7, P2277, DOI 10.1016/S0960-894X(97)00404-6; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; Schaerer MT, 1998, EUR J PHARMACOL, V354, P283, DOI 10.1016/S0014-2999(98)00456-7; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; STEPHENSON FA, 1995, BIOCHEM J, V310, P1; WIELAND HA, 1994, J MED CHEM, V37, P4576, DOI 10.1021/jm00052a019; WIELAND HA, 1992, J BIOL CHEM, V267, P1426	26	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13370	13374		10.1074/jbc.274.19.13370	http://dx.doi.org/10.1074/jbc.274.19.13370			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224099	hybrid			2022-12-27	WOS:000080200400061
J	Bohrmann, B; Tjernberg, L; Kuner, P; Poli, S; Levet-Trafit, B; Naslund, J; Richards, G; Huber, W; Dobeli, H; Nordstedt, C				Bohrmann, B; Tjernberg, L; Kuner, P; Poli, S; Levet-Trafit, B; Naslund, J; Richards, G; Huber, W; Dobeli, H; Nordstedt, C			Endogenous proteins controlling amyloid beta-peptide polymerization - Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PRECURSOR PROTEIN; FIBRIL FORMATION; HUMAN PLASMA; P COMPONENT; ALPHA-2-MACROGLOBULIN; DEPOSITION; TERMINUS; INVITRO	We report that certain plasma proteins, at physiological concentrations, are potent inhibitors of amyloid beta-peptide (A beta) polymerization. These proteins are also present in cerebrospinal fluid, but at low concentrations having little or no effect on A beta. Thirteen proteins representing more than 90% of the protein content in plasma and cerebrospinal fluid were studied. Quantitatively, albumin was the most important protein, representing 60% of the total amyloid inhibitory activity, followed by alpha(1)-antitrypsin and immunoglobulins A and G, Albumin suppressed amyloid formation by binding to the oligomeric or polymeric A beta, blocking a further addition of peptide. This effect was also observed when the incorporation of labeled A beta into genuine beta-amyloid in tissue section was studied. The A beta and the anti-diabetic drug tolbutamide apparently bind to the same site on albumin. Tolbutamide displaces A beta from albumin, increasing its free concentration and enhancing amyloid formation. The present results suggest that several endogenous proteins are negative regulators of amyloid formation. Plasma contains at least 300 times more amyloid inhibitory activity than cerebrospinal fluid. These findings may provide one explanation as to why beta-amyloid deposits are not found in peripheral tissues but are only found in the central nervous system. Moreover, the data suggest that some drugs that display an affinity for albumin may enhance beta-amyloid formation and promote the development of Alzheimer's disease.	F Hoffmann La Roche AG, Div Pharma, Preclin Res, CH-4070 Basel, Switzerland; Karolinska Hosp, Lab Biochem & Mol Pharmacol, Sect Drug Dependence Res, Dept Clin Neurosci, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, S-14186 Huddinge, Sweden	Roche Holding; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Nordstedt, C (corresponding author), F Hoffmann La Roche AG, Div Pharma, Preclin Res, CH-4070 Basel, Switzerland.			Kuner, Pascal/0000-0001-6513-5414				Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; Burtis C.A., 1994, TXB CLIN CHEM, V2nd, P1715; DOOLITTLE DF, 1994, MOL BASIS BLOOD DIS, P701; ERIKSSON S, 1995, P NATL ACAD SCI USA, V92, P2313, DOI 10.1073/pnas.92.6.2313; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Goodman Gilman G, 1996, GOODMAN GILMANS PHAR, V9th, P3; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hardman J. G., 1996, GOODMAN GILMANS PHAR; HAWKINS PN, 1994, BIOCHEM BIOPH RES CO, V201, P722, DOI 10.1006/bbrc.1994.1760; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KISILEVSKY R, 1988, PATHOLOGY, P1178; KOUDINOV A, 1994, BIOCHEM BIOPH RES CO, V205, P1164, DOI 10.1006/bbrc.1994.2788; LANNFELT L, 1995, NEUROSCI LETT, V199, P203, DOI 10.1016/0304-3940(95)12059-D; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Orgel LE, 1996, CHEM BIOL, V3, P413, DOI 10.1016/S1074-5521(96)90087-3; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SELKOE DJ, 1989, ANN MED, V21, P73, DOI 10.3109/07853898909149187; SMITH MD, 1976, J IMMUNOL METHODS, V9, P373, DOI 10.1016/0022-1759(76)90212-X; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VASILEVA TG, 1989, VOP MED KHIM, V35, P48; VATASSERY GT, 1991, CLIN CHIM ACTA, V197, P19, DOI 10.1016/0009-8981(91)90344-C; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190; WISNIEWSKI T, 1993, ANN NEUROL, V34, P631, DOI 10.1002/ana.410340422; WRIGLEY NG, 1968, J ULTRA MOL STRUCT R, V24, P454, DOI 10.1016/S0022-5320(68)80048-6	41	131	138	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15990	15995		10.1074/jbc.274.23.15990	http://dx.doi.org/10.1074/jbc.274.23.15990			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347147	hybrid			2022-12-27	WOS:000080668600007
J	Feinmesser, RL; Wicks, SJ; Taverner, CJ; Chantry, A				Feinmesser, RL; Wicks, SJ; Taverner, CJ; Chantry, A			Ca2+/calmodulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serine 744 within the kinase domain to regulate signal generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TYROSINE KINASE; EGF RECEPTOR; SELF-PHOSPHORYLATION; V-ERBB; ACTIVATION; THREONINE; CELLS; TRANSFORMATION; TRANSDUCTION	Down-regulation of receptor tyrosine kinase activity plays an essential role in coordinating and controlling cellular growth/differentiation. Ca2+/calmodulin-dependent kinase II (CaM kinase II)-mediated phosphorylation of threonine 1172 in the cytoplasmic tail of HER2/c-erbB2 can modulate tyrosine kinase activity and consensus phosphorylation sites are also found at serines 1046/1047 in the structurally related epidermal growth factor receptor (EGFR). We show that serines 1046/1047 are sites for CaM kinase II phosphorylation, although there is a preference for serine 1047, which resides within the consensus -R-X-X-S-, In addition, we have identified major phosphorylation sites at serine 1142 and serine 1057, which lie within a novel -S-X-D-consensus. Mutation of serines 1046/1047 in full-length EGFR enhanced both fibroblast transformation and tyrosine autokinase activity that was significantly potentiated by additional mutation of serines 1057 and 1142. A single CaM kinase II site was also identified at serine 744 within sub-kinase domain III, and autokinase activity was significantly affected by mutation of this serine to an aspartic acid making this site appear constitutively phosphorylated, We have addressed the mechanism by which CaM kinase II phosphorylation of the EGFR might regulate receptor autokinase activity and show that this modification can hinder association of the cytoplasmic tail with the kinase domain to prevent an enzyme-substrate interaction. We postulate that the location and greater number of CaM kinase II phosphorylation sites in the EGFR compared with HER-2/c-erbB2, leading to differential regulation of autokinase activity, contributes to differences in the strength of downstream signaling events and may explain the higher relative transforming potential of HER-2/c-erbB2.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Canc Med, London W6 8RP, England	Imperial College London	Chantry, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Canc Med, Charing Cross Campus,Fulham Palace Rd, London W6 8RP, England.							ADAM MA, 1991, J VIROL, V65, P4985, DOI 10.1128/JVI.65.9.4985-4990.1991; ANDO S, 1991, BIOCHEM BIOPH RES CO, V175, P955, DOI 10.1016/0006-291X(91)91658-Y; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Feinmesser RL, 1996, ONCOGENE, V12, P2725; FRIEDMAN B, 1989, P NATL ACAD SCI USA, V86, P812, DOI 10.1073/pnas.86.3.812; Groenen LC, 1997, BIOCHEMISTRY-US, V36, P3826, DOI 10.1021/bi9614141; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HILL SC, 1996, CELL, V80, P199; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; KHAZAIE K, 1988, EMBO J, V7, P3061, DOI 10.1002/j.1460-2075.1988.tb03171.x; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; LEE EB, 1993, ONCOGENE, V8, P1317; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASSOGLIA S, 1990, MOL CELL BIOL, V10, P3048, DOI 10.1128/MCB.10.6.3048; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; MORRISON P, 1993, J BIOL CHEM, V268, P15536; NORTHWOOD IC, 1989, J BIOL CHEM, V264, P5746; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PANAYOTOU G, 1993, BIOESSAYS, V15, P171, DOI 10.1002/bies.950150305; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHU HKG, 1991, J VIROL, V65, P6173, DOI 10.1128/JVI.65.11.6173-6180.1991; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THEROUX SJ, 1992, J BIOL CHEM, V267, P7967; Tinhofer I, 1996, J BIOL CHEM, V271, P30505, DOI 10.1074/jbc.271.48.30505; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WALTON GM, 1990, J BIOL CHEM, V265, P1750; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	44	62	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16168	16173		10.1074/jbc.274.23.16168	http://dx.doi.org/10.1074/jbc.274.23.16168			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347170	hybrid			2022-12-27	WOS:000080668600030
J	Galigniana, MD; Housley, PR; DeFranco, DB; Pratt, WB				Galigniana, MD; Housley, PR; DeFranco, DB; Pratt, WB			Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; PROGESTERONE-RECEPTOR; STEROID-RECEPTORS; IN-VIVO; NUCLEUS; BINDING; CELLS; PHOSPHORYLATION; GELDANAMYCIN; CYTOPLASM	It has been shown previously that glucocorticoid receptors (GRs) that have undergone hormone-dependent translocation to the nucleus and have subsequently exited the nucleus upon hormone withdrawal are unable to recycle into the nucleus if cells are treated during hormone withdrawal with okadaic acid, a cell-permeable inhibitor of certain serine/threonine protein phosphatases. Using a green fluorescent protein (GFP) GR chimera (GFP-GR), we report here that okadaic acid inhibition of steroid-dependent receptor recycling to the nucleus is abrogated in cells treated for 1 h with colcemid to eliminate microtubule networks prior to steroid addition. After withdrawal of colcemid, normal cytoskeletal architecture is restored and okadaic acid inhibition of steroid-dependent GFP-GR nuclear recycling is restored. When okadaic acid is present during hormone withdrawal, GR that is recycled to the cytoplasm becomes complexed with hsp90 and binds steroid, but it does not undergo the normal agonist-dependent dissociation from hsp90 upon retreatment with steroid. However, when the cytoskeleton is disrupted by colcemid, the GR in okadaic acid-treated cells recycles from the cytoplasm to the nucleus in an agonist-dependent manner without dissociating from hsp90, This suggests that under physiological conditions where the cytoskeleton is intact, a dephosphorylation event is required for loss of high affinity binding to hsp90 that is required for receptor translocation through the cytoplasm to the nucleus along cytoskeletal tracts.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ S Carolina, Sch Med, Dept Pharmacol, Columbia, SC 29208 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Michigan System; University of Michigan; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pratt, WB (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.			GALIGNIANA, MARIO/0000-0002-9130-8574	NCI NIH HHS [CA43037, CA28010] Funding Source: Medline; NIDDK NIH HHS [DK47951] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028010, R01CA043037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047951] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODWELL JE, 1991, J BIOL CHEM, V266, P7549; CHANDRAN UR, 1992, MOL ENDOCRINOL, V6, P837, DOI 10.1210/me.6.5.837; Czar MJ, 1997, BIOCHEMISTRY-US, V36, P7776, DOI 10.1021/bi970648x; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DeFranco DB, 1995, VITAM HORM, V51, P315, DOI 10.1016/S0083-6729(08)61043-2; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; GUICHONMANTEL A, 1991, EMBO J, V10, P3851; HOECK W, 1989, J BIOL CHEM, V264, P14396; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; ORTI E, 1992, ENDOCR REV, V13, P105, DOI 10.1210/er.13.1.105; ORTI E, 1989, J BIOL CHEM, V264, P9728; PERROTAPPLANAT M, 1992, J CELL BIOL, V119, P337, DOI 10.1083/jcb.119.2.337; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; QI M, 1990, MOL ENDOCRINOL, V4, P455, DOI 10.1210/mend-4-3-455; QI M, 1989, MOL ENDOCRINOL, V3, P1279, DOI 10.1210/mend-3-8-1279; RAAKA BM, 1985, J BIOL CHEM, V260, P4009; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SZAPARY D, 1994, J STEROID BIOCHEM, V51, P143, DOI 10.1016/0960-0760(94)90087-6; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; WILSON L, 1970, BIOCHEMISTRY-US, V9, P4999, DOI 10.1021/bi00827a026; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3	28	73	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16222	16227		10.1074/jbc.274.23.16222	http://dx.doi.org/10.1074/jbc.274.23.16222			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347177	hybrid			2022-12-27	WOS:000080668600037
J	Bolhuis, A; Tjalsma, H; Stephenson, K; Harwood, CR; Venema, G; Bron, S; van Dijl, JM				Bolhuis, A; Tjalsma, H; Stephenson, K; Harwood, CR; Venema, G; Bron, S; van Dijl, JM			Different mechanisms for thermal inactivation of Bacillus subtilis signal peptidase mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORALLY CONTROLLED EXPRESSION; WALL-ASSOCIATED PROTEASE; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; DEGRADATION; IDENTIFICATION; SIPS; GENE; SITE	The type I signal peptidase SipS of Bacillus subtilis is of major importance for the processing of secretory precursor proteins. In the present studies, we have investigated possible mechanisms of thermal inactivation of five temperature-sensitive SipS mutants. The results demonstrate that two of these mutants, L74A and Y81A, are structurally stable but strongly impaired in catalytic activity at 48 degrees C, showing the (unprecedented) involvement of the conserved leucine 74 and tyrosine 81 residues in the catalytic reaction of type I signal peptidases. This conclusion is supported by the crystal structure of the homologous signal peptidase of Escherichia coli (Paetzel, M., Dalbey, R. E., and Strynadka, N, C, J, (1998) Nature 396, 188-190), In contrast, the SipS mutant proteins R84A, R84H, and D146A were inactivated by proteolytic degradation, indicating that the conserved arginine 84 and aspartic acid 146 residues are required to obtain a protease-resistant conformation. The cell wall-bound protease WprA was shown to be involved in the degradation of SipS D146A, which is in accord with the fact that SipS has a large extracytoplasmic domain. As WprA was not involved in the degradation of the SipS mutant proteins R84A and R84H, we conclude that multiple proteases are responsible for the thermal inactivation of temperature-sensitive SipS mutants.	Groningen Biomol Sci & Biotechnol Inst, Dept Genet, NL-9751 NN Haren, Netherlands; Univ Newcastle Upon Tyne, Sch Med, Sch Microbiol Immunol & Virol Sci, Newcastle Upon Tyne NE4 4HH, Tyne & Wear, England	University of Groningen; Newcastle University - UK	van Dijl, JM (corresponding author), Univ Groningen, Dept Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.		Harwood, Colin/AGF-0120-2022; Tjalsma, Harold/I-7146-2012; van Dijl, Jan Maarten/G-1205-2013; Bolhuis, Albert/E-9932-2010	Bolhuis, Albert/0000-0001-9307-0515; Harwood, Colin/0000-0002-3624-0001				Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bolhuis A, 1996, MOL MICROBIOL, V22, P605, DOI 10.1046/j.1365-2958.1996.d01-4676.x; DALBEY RE, 1997, PROTEIN SCI, V17, P474; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437; MULLINS C, 1995, J BIOL CHEM, V270, P17139, DOI 10.1074/jbc.270.29.17139; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; ROLAND KL, 1990, J BIOL CHEM, V265, P12828; Stephenson K, 1998, APPL ENVIRON MICROB, V64, P2875; Tjalsma H, 1997, J BIOL CHEM, V272, P25983, DOI 10.1074/jbc.272.41.25983; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; VANDIJL JM, 1992, EMBO J, V11, P2819, DOI 10.1002/j.1460-2075.1992.tb05349.x; VANDIJL JM, 1995, J BIOL CHEM, V270, P3611, DOI 10.1074/jbc.270.8.3611; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; VANDIJL JM, 1998, HDB PROTEOLITIC ENZY, P451; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	25	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15865	15868		10.1074/jbc.274.22.15865	http://dx.doi.org/10.1074/jbc.274.22.15865			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336490	hybrid			2022-12-27	WOS:000080560100079
J	Li, Y; Hashimoto, Y; Agadir, A; Kagechika, H; Zhang, XK				Li, Y; Hashimoto, Y; Agadir, A; Kagechika, H; Zhang, XK			Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG-CANCER; ESTROGEN RESPONSE ELEMENT; LIGAND-BINDING DOMAIN; X-RECEPTOR; NUCLEAR RECEPTORS; TRANSCRIPTIONAL ACTIVATION; RETINOBENZOIC ACIDS; CRYSTAL-STRUCTURE; THYROID-HORMONE; RAR	Four candidate retinoid antagonists (LE135, LE511, LE540, and LE550) were designed on the basis of the ligand superfamily concept and synthesized. Analysis of these related retinoids by transient transfection assay demonstrated that LE135, LE540, and LE550 are effective retinoic acid receptor (RAR) antagonists, whereas LE511 selectively induced RAR beta transcriptional activity. Both LE135 and LE540 inhibited retinoic acid (RA)induced transcriptional activation of RAR beta, but not RAR alpha, RAR gamma or retinoid X receptor alpha (RXR alpha), on a variety of RA response elements. The retinoid antagonists also inhibited all-trans-RA-induced transcriptional activation of RAR beta/RXR alpha heterodimers, although they did not show any effect on transactivation activity of RXR/ RXR homodimers, In ZR-75-1 human breast cancer cells, cotreatment of LE135 and LE540 with all-trans-RA inhibited all-trans-RA-induced apoptosis of the cells, further demonstrating that RAR beta plays a role in RA-induced apoptosis of breast cancer cells. We also evaluated the effect of these retinoids on AP-1 activity. Our data showed that LE135 and LE540 strongly repressed 12-O-tetradecanoylphorbol-13-acetate-induced AP-1 activity in the presence of RAR beta and RXR alpha, Interestingly, LE550 induced AP-1 activity when RAR beta and RXR alpha were expressed in HeLa cells but not in breast cancer cells. These results demonstrate that LE135 and LE540 were a novel class of RAR beta-selective antagonists and anti-AP-1 retinoids and should be useful tools for studying the role of retinoids and their receptors.	La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst, La Jolla, CA 92037 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 113, Japan; Univ Tokyo, Fac Pharmaceut Sci, Tokyo 113, Japan	Sanford Burnham Prebys Medical Discovery Institute; University of Tokyo; University of Tokyo	Zhang, XK (corresponding author), La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Kagechika, Hiroyuki/0000-0002-6747-1013				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; BENBROOK D, 1998, NATURE, V333, P624; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; DEJEAN A, 1986, NATURE, V322, P70, DOI 10.1038/322070a0; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; EYROLLES L, 1994, J MED CHEM, V37, P1508, DOI 10.1021/jm00036a017; Eyrolles L., 1992, MED CHEM RES, V2, P361; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Fanjul AN, 1996, CANCER RES, V56, P1571; GEBERT JF, 1991, ONCOGENE, V6, P1859; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GUDAS LJ, 1996, RETINOIDS, P443; HAMADA K, 1989, P NATL ACAD SCI USA, V86, P8289, DOI 10.1073/pnas.86.21.8289; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1734; HOULE B, 1991, EXP CELL RES, V195, P163; JONG L, 1993, J MED CHEM, V36, P2605, DOI 10.1021/jm00070a003; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KANEKO S, 1991, MED CHEM RES, V1, P220; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LEE MO, 1995, MOL CELL BIOL, V15, P4194; LEHMANN JM, 1991, CANCER RES, V51, P4804; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li JJ, 1996, CANCER RES, V56, P483; Li Y, 1998, INT J CANCER, V75, P88, DOI 10.1002/(SICI)1097-0215(19980105)75:1<88::AID-IJC14>3.0.CO;2-9; Liu Y, 1996, MOL CELL BIOL, V16, P1138; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; LOTAN R, 1987, CANC TREAT REP, V71, P493; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; NAGPAL S, 1995, J BIOL CHEM, V270, P923, DOI 10.1074/jbc.270.2.923; NERVI C, 1991, EXP CELL RES, V195, P163, DOI 10.1016/0014-4827(91)90512-S; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; ROBERTS AB, 1984, RETINOIDS, V2, P209; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; VANDERLEEDE BJM, 1993, MOL CARCINOGEN, V8, P112, DOI 10.1002/mc.2940080208; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; YANGYEN HF, 1991, NEW BIOL, V3, P1206; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1994, CANCER RES, V54, P5663; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	53	93	95	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15360	15366		10.1074/jbc.274.22.15360	http://dx.doi.org/10.1074/jbc.274.22.15360			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336422	hybrid			2022-12-27	WOS:000080560100011
J	Nishimura, N; Bannykh, S; Slabough, S; Matteson, J; Altschuler, Y; Hahn, K; Balch, WE				Nishimura, N; Bannykh, S; Slabough, S; Matteson, J; Altschuler, Y; Hahn, K; Balch, WE			A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; COATED VESICLE FORMATION; SEMI-INTACT CELLS; GOLGI TRANSPORT; INTRACELLULAR-TRANSPORT; SUBUNIT INTERACTIONS; PROTEIN-TRANSPORT; SECRETORY PATHWAY; COPII VESICLES; PRE-GOLGI	Efficient export of vesicular stomatitis virus glycoprotein (Vm-G), a type I transmembrane protein, from the endoplasmic reticulum requires a di-acidic code (DXE) located in the cytosolic carboxyl-terminal tail (Nishimura, N,, and Balch, W, E, (1997) Science 277, 558-558), Mutation of the DXE code by mutation to AXA did not prevent VSV-G recruitment to pre-budding complexes formed in the presence of the activated form of the Sari and the Sec23/24 complex, components of the COPII budding machinery. However, the signal was required at a subsequent concentration step preceding vesicle fission. By using green fluorescence protein-tagged VSV-G to image movement in a single cell, we found that VSV-G lacking the DXE code fails to be concentrated into COPII vesicles. As a result, the normal 5-10-fold increase in the steady-state concentration of VSV-G in downstream pre-Golgi intermediates and Golgi compartments was lost. These results demonstrate for the first time that inactivation of the DXE signal uncouples early cargo selection steps from concentration into COPII. vesicles. We propose that two sequential steps are required for efficient export from the endoplasmic reticulum.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Hahn, Klaus/0000-0002-1970-7562	NCI NIH HHS [CA 58689] Funding Source: Medline; NIGMS NIH HHS [GM 42336] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Aridor M, 1996, TRENDS CELL BIOL, V6, P315, DOI 10.1016/0962-8924(96)10027-1; Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Bonifacino JS, 1996, P ASSOC AM PHYSICIAN, V108, P285; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Campbell JL, 1997, P NATL ACAD SCI USA, V94, P837, DOI 10.1073/pnas.94.3.837; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; Dascher C, 1996, J BIOL CHEM, V271, P15866, DOI 10.1074/jbc.271.27.15866; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; HELM R, 1995, NATURE, V373, P663; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LAFAY F, 1974, J VIROL, V14, P1220, DOI 10.1128/JVI.14.5.1220-1228.1974; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1991, J CELL SCI, V100, P415; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377	52	132	133	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15937	15946		10.1074/jbc.274.22.15937	http://dx.doi.org/10.1074/jbc.274.22.15937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336500	hybrid			2022-12-27	WOS:000080560100089
J	Sakai, T; de la Pena, JM; Mosher, DF				Sakai, T; de la Pena, JM; Mosher, DF			Synergism among lysophosphatidic acid, beta(1)A integrins, and epidermal growth factor or platelet-derived growth factor in mediation of cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SMOOTH-MUSCLE CELLS; ACTIN STRESS FIBERS; SPHINGOSINE 1-PHOSPHATE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; EGF RECEPTOR; DEPENDENT MECHANISM; RHO; FIBRONECTIN	GD25 cells lacking the beta(1) integrin subunit or expressing beta(1)A with certain cytoplasmic mutations have poor directed cell migration to platelet derived growth factor (PDGF) or epidermal growth factor (EGF), ligands of receptor tyrosine kinases, or to lysophosphatidic acid (LPA), a ligand of G-protein-coupled receptors (Sakai, T., Zhang, Q., Fassler, R., and Mosher, D. F. (1998) J. Cell Biol, 141, 527-538 and Sakai, T,, Peyruchaud, O,, Fassler, R,, and Mosher, D, F, (1998) J, Biol, Chem, 273, 19378-19382), We demonstrate here that LPA synergizes with signals induced by beta(1)A integrins and ligated EGF or PDGF receptors to modulate migration. When LPA was mixed with EGF or PDGF, migration was greater than with EGF or PDGF alone. The enhancement was greater for beta(1)A-expressing cells than for beta(1)-null cells. Cells expressing beta(1)A with mutations of prolines or tyrosines in conserved cytoplasmic NPXY motifs had blunted migratory responses to mixtures of LPA and EG:F or PDGF, The major effects on beta(1)A-expressing cells of LPA when combined with EC:F or PDGF were to sensitize cells so that maximal responses were obtained with >10-fold lower concentrations of growth factor and increase the chemokinetic component of migration. Sensitization by LPA was lost when cells were preincubated with pertussis toxin or C3 exotransferase. There was no evidence for transactivation or sensitization of receptors for EGF or PDGF by LPA. EGF or PDGF and LPA caused activation of mitogen-activated protein kinase by pertussis toxin-insensitive and -sensitive pathways respectively, but activation was not additive. These findings indicate that signaling pathways initiated by the cytoplasmic domains of ligated beta(1)A integrins and tyrosine kinase receptors interact with signaling pathways initiated by LPA to facilitate directed cell migration.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Lund, Dept Expt Pathol, S-22185 Lund, Sweden	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Lund University	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 1300 Univ Ave, Madison, WI 53706 USA.				NHLBI NIH HHS [HL56396, HL21644] Funding Source: Medline; NIGMS NIH HHS [T32 GM07215] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396, R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; AnandApte B, 1997, STEM CELLS, V15, P259, DOI 10.1002/stem.150259; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; CHECOVICH WJ, 1993, ARTERIOSCLER THROMB, V13, P1662, DOI 10.1161/01.ATV.13.11.1662; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Imamura F, 1996, INT J CANCER, V65, P627, DOI 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Kiss Z, 1997, FEBS LETT, V412, P197, DOI 10.1016/S0014-5793(97)00776-X; KUNDRA V, 1995, J CELL BIOL, V130, P725, DOI 10.1083/jcb.130.3.725; LaFlamme SE, 1997, MATRIX BIOL, V16, P153, DOI 10.1016/S0945-053X(97)90003-2; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Panetti TS, 1997, J LAB CLIN MED, V129, P208, DOI 10.1016/S0022-2143(97)90141-4; Pietruck F, 1997, N-S ARCH PHARMACOL, V355, P1; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; SAKAI T, 1995, INT J CANCER, V63, P720, DOI 10.1002/ijc.2910630519; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 1998, J BIOL CHEM, V273, P19378, DOI 10.1074/jbc.273.31.19378; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; STOKES CL, 1991, J THEOR BIOL, V152, P377, DOI 10.1016/S0022-5193(05)80201-2; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Ware MF, 1998, J CELL SCI, V111, P2423; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Woodard AS, 1998, J CELL SCI, V111, P469; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; ZETTER BR, 1990, NEW ENGL J MED, V322, P605; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	60	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15480	15486		10.1074/jbc.274.22.15480	http://dx.doi.org/10.1074/jbc.274.22.15480			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336439	hybrid			2022-12-27	WOS:000080560100028
J	Strobeck, MW; Okuda, M; Yamaguchi, H; Schwartz, A; Fukasawa, K				Strobeck, MW; Okuda, M; Yamaguchi, H; Schwartz, A; Fukasawa, K			Morphological transformation induced by activation of the mitogen-activated protein kinase pathway requires suppression of the T-type Ca2+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEINS; NUCLEOTIDE DISSOCIATION STIMULATOR; MAP KINASE; CALCIUM CHANNELS; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR CHARACTERIZATION; INCREASING COMPLEXITY; SIGNAL-TRANSDUCTION; CELL MORPHOLOGY; RAS INTERACTS	Transformation of fibroblasts by various oncogenes, including ras, mos, and src accompanies with characteristic morphological changes from flat to round (or spindle) shapes, Such morphological change is believed to play an important role in establishing malignant characteristics of cancer cells. Activation of the mitogen-activated protein kinase (MAPR) pathway is a converging downstream event of transforming activities of many oncogene products commonly found in human cancers. Intracellular calcium is known to regulate cellular morphology, In fibroblasts, Ca2+ influx is primarily controlled by two types of Ca2+ channels (T- and L-types), Here, we report that the T-type current was specifically inhibited in cells expressing oncogenically activated Ras as well as gain-of-function mutant MEK (MAPK/extracellular signal-regulated kinase (ERK) kinase, a direct activator of MAPK), whereas treatment of ras-transformed cells with a MEK-specific inhibitor restored T-type Ca2+ channel activity. Using a T-type Ca2+ channel antagonist, we further found that suppression of the T-type Ca2+ channel by the activated MAPK pathway is a prerequisite event for the induction and/or maintenance of transformation-associated morphological changes.	Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Fukasawa, K (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol, POB 670521, Cincinnati, OH 45267 USA.			Okuda, Masaru/0000-0003-4690-8244	NHLBI NIH HHS [P01 HL22619-19] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022619] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andersson P, 1980, Adv Cancer Res, V33, P109, DOI 10.1016/S0065-230X(08)60670-3; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bean BP, 1998, NEURON, V20, P825, DOI 10.1016/S0896-6273(00)80463-8; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; Chik CL, 1996, FASEB J, V10, P1310, DOI 10.1096/fasebj.10.11.8836045; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRANCK Z, 1990, J CELL BIOL, V111, P2475, DOI 10.1083/jcb.111.6.2475; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; GALIZZI JP, 1987, J BIOL CHEM, V262, P6947; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HELL JW, 1994, J BIOL CHEM, V269, P7390; HICKS GG, 1991, MOL CELL BIOL, V11, P1344, DOI 10.1128/MCB.11.3.1344; Hille B., 1992, IONIC CHANNELS EXCIT; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Jones SW, 1998, J BIOENERG BIOMEMBR, V30, P299, DOI 10.1023/A:1021977304001; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Louvard D, 1989, CURR OPIN CELL BIOL, V1, P51, DOI 10.1016/S0955-0674(89)80036-5; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MOODIE SA, 1994, TRENDS GENET, V10, P14; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; OKADA Y, 1977, J MEMBRANE BIOL, V35, P319, DOI 10.1007/BF01869957; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PERES A, 1988, PFLUG ARCH EUR J PHY, V411, P554, DOI 10.1007/BF00582377; Perez-Reyes E, 1998, J BIOENERG BIOMEMBR, V30, P313, DOI 10.1023/A:1021981420839; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; RASMUSSEN CD, 1992, CELL MOTIL CYTOSKEL, V21, P45, DOI 10.1002/cm.970210106; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; UEDA S, 1986, J MEMBRANE BIOL, V91, P65, DOI 10.1007/BF01870215; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VARADI G, 1995, TRENDS PHARMACOL SCI, V16, P43, DOI 10.1016/S0165-6147(00)88977-4; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEEDS A, 1982, NATURE, V296, P811, DOI 10.1038/296811a0; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; YIN HL, 1980, J BIOL CHEM, V255, P9494; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	76	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15694	15700		10.1074/jbc.274.22.15694	http://dx.doi.org/10.1074/jbc.274.22.15694			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336467	hybrid			2022-12-27	WOS:000080560100056
J	Bhattacharya, SK; Dubey, AK				Bhattacharya, SK; Dubey, AK			Kinetic mechanism of cytosine DNA ethyltransferase MspI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC PROPERTIES; ESCHERICHIA-COLI; METHYLTRANSFERASE; SUBSTRATE; METHYLATION; BINDING	A kinetic analysis of MspI DNA methyltransferase (M.MspI) is presented. The enzyme catalyzes methylation of A-DNA, a 50-kilobase pair linear molecule with multiple M.MspI-specific sites, with a specificity constant (k(cat)/K-M) of 0.9 x 10(8) M-1 s(-1). But the values of the specificity constants for the smaller DNA substrates (121 and 1459 base pairs (bp)) with single methylation target or with multiple targets (sonicated A-DNA) were less by an order of magnitude. Product inhibition of the M.MspI-catalyzed methylation reaction by methylated DNA is competitive with respect to DNA and noncompetitive with respect to S-adenosylmethionine (AdoMet). The S-adenosylhomocysteine inhibition of the methylation reaction is competitive with respect to AdoMet and uncompetitive with respect to DNA. The presteady state kinetic analysis showed a burst of product formation when AdoMet was added to the enzyme preincubated with the substrate DNA. The burst is followed by a constant rate of product formation (0.06 mol per mol of enzyme s(-1)) which is similar to catalytic constants (k(cat) = similar to 0.056 s(-1)) measured under steady state conditions. The isotope exchange in chasing the labeled methyltransferase-DNA complex with unlabeled DNA and AdoMet leads to a reduced burst as compared with the one involving chase with labeled DNA and AdoMet. The enzyme is capable of exchanging tritium at C-5 of target cytosine in the substrate DNA in the absence of cofactor AdoMet. The kinetic data are consistent with an ordered Bi Bi mechanism for the M.MspI-catalyzed DNA methylation where DNA binds first.	Indian Inst Technol, Dept Biochem Engn & Biotechnol, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Bhattacharya, SK (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol NB20, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Bhattacharya, Sanjoy K/B-2001-2008					BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P3167, DOI 10.1093/nar/20.12.3167; Dubey AK, 1997, NUCLEIC ACIDS RES, V25, P2025, DOI 10.1093/nar/25.10.2025; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; FEDOROFF NV, 1989, CELL, V77, P473; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GUNTHERT U, 1981, J BIOL CHEM, V256, P9346; HANCK T, 1993, NUCLEIC ACIDS RES, V21, P303, DOI 10.1093/nar/21.2.303; Hiromi K., 1979, KINETICS FAST ENZYME; IVANETICH KM, 1992, PROG NUCLEIC ACID RE, V42, P127, DOI 10.1016/S0079-6603(08)60575-9; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MATSUO K, 1994, NUCLEIC ACIDS RES, V22, P5354, DOI 10.1093/nar/22.24.5354; MI S, 1992, NUCLEIC ACIDS RES, V20, P4811, DOI 10.1093/nar/20.18.4811; NARDONE G, 1986, J BIOL CHEM, V261, P2128; Orsi B A, 1979, Methods Enzymol, V63, P159; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Sambrook J., 2002, MOL CLONING LAB MANU; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; SZILAK L, 1994, NUCLEIC ACIDS RES, V22, P2876, DOI 10.1093/nar/22.15.2876; TAYLOR C, 1993, BIOCHEM J, V291, P493, DOI 10.1042/bj2910493; TIMINSKAS A, 1995, GENE, V157, P3, DOI 10.1016/0378-1119(94)00783-O; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; WU JC, 1987, J BIOL CHEM, V262, P4778; ZWIEB C, 1991, LAB GUIDE IN VITRO S, P245	30	39	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14743	14749		10.1074/jbc.274.21.14743	http://dx.doi.org/10.1074/jbc.274.21.14743			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329670	hybrid			2022-12-27	WOS:000081965200035
J	Giet, R; Uzbekov, R; Cubizolles, F; Le Guellec, K; Prigent, C				Giet, R; Uzbekov, R; Cubizolles, F; Le Guellec, K; Prigent, C			The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME SEGREGATION REGULATORS; CYCLE-DEPENDENT EXPRESSION; MITOTIC SPINDLE; CENTROSOME SEPARATION; MICROTUBULE DYNAMICS; CYTOPLASMIC DYNEIN; DROSOPHILA-AURORA; BIPOLAR SPINDLE; FISSION YEAST; EGG EXTRACTS	We have previously reported on the cloning of XlEg5, a Xenopus laevis kinesin-related protein from the bimC family (Le Guellec, R., Paris, J., Couturier, A., Roghi, C., and Philippe, M. (1991) Mol. Cell. Biol. 11, 3395-3408) as well as pEg2, an Aurora-related serine/threonine kinase (Roghi, C., Giet, R., Uzbekov, R., Morin, N., Chartrain, I., Le Guellec, R., Couturier, A., Doree, M., Philippe, M., and Prigent, C. (1998) J. Cell Sci. 111, 557-572). Inhibition of either XlEg5 or pEg2 activity during mitosis in Xenopus egg extract led to monopolar spindle formation. Here, we report that in Xenopus XL2 cells, pEg2 and XlEg5 are both confined to separated centrosomes in prophase, and then to the microtubule spindle poles. We also show that pEg2 co-immunoprecipitates with XlEg5 from egg extracts and XL2 cell lysates. Both proteins can directly interact in vitro, but also through the two-hybrid system. Furthermore immunoprecipitated pEg2 were found to remain active when bound to the beads and phosphorylate XlEg5 present in the precipitate. Two-dimensional mapping of XlEg5 tryptic peptides phosphorylated in vivo first confirmed that XlEg5 was phosphorylated by p34(cdc2) and next revealed that in vitro pEg2 kinase phosphorylated XlEg5 on the same stalk domain serine residue that was phosphorylated in metabolically labeled XL2 cells. The kinesin-related XlEg5 is to our knowledge the first in vivo substrate ever reported for an Aurora-related kinase.	CNRS, UPR 41, Biol & Genet Dev Lab, Fac Med,Grp Cycle Cellulaire, F-35043 Rennes, France; CNRS, UPR 41, Biol & Genet Dev Lab, Fac Med,Grp Struct Dynam Chromatine, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Prigent, C (corresponding author), CNRS, UPR 41, Biol & Genet Dev Lab, Fac Med,Grp Cycle Cellulaire, F-35043 Rennes, France.	claude.prigent@univ-rennes1.fr	Uzbekov, Rustem/J-8922-2012	Cubizolles, Fabien/0000-0002-9822-4074				AIZAWA H, 1991, BIOCHEM BIOPH RES CO, V179, P1620, DOI 10.1016/0006-291X(91)91760-A; Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; ANIZET MP, 1981, IN VITRO CELL DEV B, V17, P267; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BARTON NR, 1995, MOL BIOL CELL, V6, P1563, DOI 10.1091/mbc.6.11.1563; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; COLE DG, 1994, J BIOL CHEM, V269, P22913; Drummond DR, 1998, J CELL SCI, V111, P853; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Frolova L, 1996, RNA, V2, P334; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Giet R, 1998, EXP CELL RES, V244, P470, DOI 10.1006/excr.1998.4218; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KS, 1995, MOL CELL BIOL, V15, P7143; LEGUELLEC R, 1991, MOL CELL BIOL, V11, P3395, DOI 10.1128/MCB.11.6.3395; LOHKA MJ, 1988, EXP CELL RES, V179, P303, DOI 10.1016/0014-4827(88)90370-9; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Niwa H, 1996, GENE, V169, P197, DOI 10.1016/0378-1119(95)00809-8; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; PARIS J, 1988, GENE, V72, P169, DOI 10.1016/0378-1119(88)90139-4; PRIGENT C, 1998, SILICO BIOL; Roghi C, 1998, J CELL SCI, V111, P557; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shindo M, 1998, BIOCHEM BIOPH RES CO, V244, P285, DOI 10.1006/bbrc.1998.8250; Tatsuka M, 1998, CANCER RES, V58, P4811; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; Uzbekov R, 1998, EXP CELL RES, V242, P60, DOI 10.1006/excr.1998.4097; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yanai A, 1997, ONCOGENE, V14, P2943, DOI 10.1038/sj.onc.1201144; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	61	180	192	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15005	15013		10.1074/jbc.274.21.15005	http://dx.doi.org/10.1074/jbc.274.21.15005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329703	hybrid			2022-12-27	WOS:000081965200068
J	Zenser, TV; Lakshmi, VM; Hsu, FF; Davis, BB				Zenser, TV; Lakshmi, VM; Hsu, FF; Davis, BB			Peroxygenase metabolism of N-acetylbenzidine by prostaglandin H synthase - Formation of an N-hydroxylamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOGEN 2-AMINO-4-(5-NITRO-2-FURYL)-THIAZOLE ANFT; DNA-ADDUCTS; HORSERADISH-PEROXIDASE; ENDOPEROXIDE SYNTHETASE; EXPOSED WORKERS; OXYGEN-TRANSFER; BENZIDINE; OXIDATION; MECHANISM; ACTIVATION	Synthesis of prostaglandin H-2 by prostaglandin H synthase (PHS) results in a two electron oxidation of the enzyme. An active reduced enzyme is regenerated by reducing cofactors, which become oxidized. This report examines the mechanism by which PHS from ram seminal vesicle microsomes catalyzes the oxidation of the reducing cofactor N-acetylbenzidine (ABZ). During the conversion of 0.06 mM ABZ to its final end product, 4'-nitro-4-acetylaminobiphenyl, a new metabolite was observed when 1 mM ascorbic acid was present. Similar results were observed whether 0.2 mM arachidonic acid or 0.5 mM H2O2 was used as the substrate. This metabolite co-eluted with synthetic N'-hydroxy-N-acetylbenzidine (N'HA), but not with N-hydroxy-N-acetylbenzidine. The new metabolite was identified as N'HA by electrospray ionization/MS/MS. N'HA represented as much as 10% of the total radioactivity recovered by high pressure liquid chromatography. When N'HA was substituted for ABZ, PHS metabolized N'HA to 4'-nitro-4-acetylaminobiphenyl. Inhibitor studies demonstrated that metabolism was due to PHS, not cytochrome P-450. The lack of effect of 5,5-dimethyl-1-pyrroline N-oxide, mannitol, and superoxide dismutase suggests the lack of involvement of one-electron transfer reactions and suggests that hydroxyl radicals and superoxide are not sources of oxygen or oxidants. Oxygen uptake studies did not demonstrate a requirement for molecular oxygen. When [O-18]H2O2 was used as the substrate, O-18 enrichment was observed for 4'-nitro-4-acetylaminobiphenyl, but not for N'HA. A 97% enrichment was observed for one atom of O-18, and a 17 +/- 7% enrichment was observed for two O-18 atoms. The rapid exchange of O-18-N'HA with water was suggested to explain the lack of enrichment of N'HA and the low enrichment of two O-18 atoms into 4'-nitro-4-acetylaminobiphenyl. Results demonstrate a peroxygenase oxidation of ABZ and N'HA by PHS and suggest a stepwise oxidation of ABZ to N'-hydroxy, 4'-nitroso, and 4'-nitro products.	Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Div Geriatr Med, St Louis, MO 63125 USA; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63125 USA; Washington Univ, Dept Med, St Louis, MO 63125 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Saint Louis University; Washington University (WUSTL)	Zenser, TV (corresponding author), Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Div Geriatr Med, 11G-JB, St Louis, MO 63125 USA.			Hsu, Fong-Fu/0000-0001-5368-0183	NCI NIH HHS [CA72613] Funding Source: Medline; NCRR NIH HHS [RR-00954] Funding Source: Medline; NIADDK NIH HHS [AM-20579] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM020579] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA072613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ATOR MA, 1987, J BIOL CHEM, V262, P1542; Babu SR, 1995, CARCINOGENESIS, V16, P3069, DOI 10.1093/carcin/16.12.3069; BELAND FA, 1983, ENVIRON HEALTH PERSP, V49, P125, DOI 10.2307/3429589; BOYD JA, 1983, J BIOL CHEM, V258, P8246; CORBETT MD, 1985, BIOCHEM ARCH, V1, P115; CORBETT MD, 1980, BIOCHEM J, V187, P893, DOI 10.1042/bj1870893; Correia MA, 1995, CYTOCHROME P450 STRU, P607; DANON A, 1986, CANCER RES, V46, P5676; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; DOERGE DR, 1991, BIOCHEMISTRY-US, V30, P8960, DOI 10.1021/bi00101a007; DOERGE DR, 1991, CHEM RES TOXICOL, V4, P556, DOI 10.1021/tx00023a011; EGAN RW, 1980, J BIOL CHEM, V255, P323; ELING TE, 1990, ANNU REV PHARMACOL, V30, P1, DOI 10.1146/annurev.pa.30.040190.000245; FLAMMANG TJ, 1989, CANCER RES, V49, P1977; FOX TR, 1990, CANCER RES, V50, P4014; FREDERICK CB, 1985, CARCINOGENESIS, V6, P959, DOI 10.1093/carcin/6.7.959; HARRIS RZ, 1993, J BIOL CHEM, V268, P1637; HATCHER JF, 1995, CARCINOGENESIS, V16, P2149, DOI 10.1093/carcin/16.9.2149; HEFLICH RH, 1986, MUTAGENESIS, V1, P201, DOI 10.1093/mutage/1.3.201; Hsu FF, 1996, ANAL BIOCHEM, V234, P183, DOI 10.1006/abio.1996.0070; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; JOSEPHY PD, 1983, MOL PHARMACOL, V23, P766; KRAEMER SA, 1992, ARCH BIOCHEM BIOPHYS, V293, P391, DOI 10.1016/0003-9861(92)90411-O; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; Lakshmi VM, 1997, DRUG METAB DISPOS, V25, P481; LAKSHMI VM, 1994, TOXICOL APPL PHARM, V125, P256, DOI 10.1006/taap.1994.1071; LAKSHMI VM, 1990, CARCINOGENESIS, V11, P139, DOI 10.1093/carcin/11.1.139; LAKSHMI VM, 1992, CARCINOGENESIS, V13, P2087, DOI 10.1093/carcin/13.11.2087; LAKSHMI VM, 1993, J PHARMACOL EXP THER, V266, P81; LAKSHMI VM, 1990, CARCINOGENESIS, V11, P1965, DOI 10.1093/carcin/11.11.1965; Lakshmi VM, 1998, CARCINOGENESIS, V19, P911, DOI 10.1093/carcin/19.5.911; LAMBEIR AM, 1985, J BIOL CHEM, V260, P4894; LASKER JM, 1981, J BIOL CHEM, V256, P7764; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; MARNETT LJ, 1977, BIOCHEM BIOPH RES CO, V79, P569, DOI 10.1016/0006-291X(77)90195-4; MARNETT LJ, 1979, FEBS LETT, V106, P13, DOI 10.1016/0014-5793(79)80684-5; MARNETT LJ, 1980, ADV PROSTAGLANDIN TH, P149; MARTIN CN, 1982, CANCER RES, V42, P2678; MELCHIOR WB, 1994, CARCINOGENESIS, V15, P889, DOI 10.1093/carcin/15.5.889; MORRISON LD, 1993, MUTAT RES, V302, P45, DOI 10.1016/0165-7992(93)90089-E; MOTTLEY C, 1989, BIOL MAGN RESON, V8, P489; MULDER GJ, 1982, CHEM-BIOL INTERACT, V39, P111, DOI 10.1016/0009-2797(82)90010-2; NOVAK M, 1993, J AM CHEM SOC, V115, P9453, DOI 10.1021/ja00074a010; OHKI S, 1979, J BIOL CHEM, V254, P829; OLDFIELD LF, 1951, J PHYS COLLOID CHEM, V55, P1255, DOI 10.1021/j150490a016; PAGELS WR, 1983, J BIOL CHEM, V258, P6517; PLE P, 1989, J BIOL CHEM, V264, P13983; RIFI MR, 1969, TETRAHEDRON LETT, V58, P5089; Rothman N, 1997, CANCER EPIDEM BIOMAR, V6, P1039; Rothman N, 1996, P NATL ACAD SCI USA, V93, P5084, DOI 10.1073/pnas.93.10.5084; Schulte PA, 1988, CARCINOGENIC MUTAGEN, P23; SESARDIC D, 1990, BRIT J CLIN PHARMACO, V29, P651, DOI 10.1111/j.1365-2125.1990.tb03686.x; SMITH BJ, 1992, CHEM RES TOXICOL, V5, P431, DOI 10.1021/tx00027a018; WISE RW, 1985, CARCINOGENESIS, V6, P579, DOI 10.1093/carcin/6.4.579; WISE RW, 1983, CARCINOGENESIS, V4, P285, DOI 10.1093/carcin/4.3.285; WISE RW, 1984, CANCER RES, V44, P1893; ZENSER TV, 1978, J PHARMACOL EXP THER, V207, P719; ZENSER TV, 1983, J PHARMACOL EXP THER, V227, P545	58	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14850	14856		10.1074/jbc.274.21.14850	http://dx.doi.org/10.1074/jbc.274.21.14850			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329684	hybrid			2022-12-27	WOS:000081965200049
J	Gardner, TG; Kearse, KP				Gardner, TG; Kearse, KP			Modification of the T cell antigen-receptor (TCR) complex by UDP-glucose : glycoprotein glucosyltransferase - TCR folding is finalized convergent with formation of alpha beta delta epsilon gamma epsilon complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; LINKED OLIGOSACCHARIDES; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR CHAPERONE; INITIAL STEP; CLASS-I; CALNEXIN; PROTEINS; DEGRADATION; CHAINS	Most T lymphocytes express on their surfaces a multisubunit receptor complex, the T cell antigen receptor (TCR) containing alpha, beta, gamma, delta, epsilon, and zeta molecules, that has been widely studied as a model system for protein quality control. Although the parameters of TCR assembly are relatively well established, little information exists regarding the stage(s) of TCR oligomerization where folding of TCR proteins is completed. Here we evaluated the modification of TCR glycoproteins by the endoplasmic reticulum folding sensor enzyme UDP-glucose:glycoprotein glucosyltransferase (GT) as a unique and sensitive indicator of how TCR subunits assembled into multisubunit; complexes are perceived by the endoplasmic reticulum quality control system. These results demonstrate that all TCR subunits containing N-glycan were modified by GT and that TCR proteins were differentially reglucosylated during their assembly with partner TCR chains. importantly, these data show that GT modification of most TCR subunits persisted until as; sembly of CD3 alpha beta chains and formation of CD3-associated, disulfide-linked alpha beta heterodimers. These studies provide a novel evaluation of the folding status of TCR glycoproteins during their assembly into multisubunit complexes and are consistent with the concept that TCR folding is finalized convergent with formation of alpha beta delta epsilon gamma epsilon complexes.	E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27848 USA	University of North Carolina; East Carolina University	Kearse, KP (corresponding author), E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27848 USA.			Gardner, Terrence/0000-0002-6018-2083	NIAID NIH HHS [R29 AI42104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI042104] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balow JP, 1996, J IMMUNOL METHODS, V189, P251, DOI 10.1016/0022-1759(95)00255-3; BONIFACINO JS, 1988, P NATL ACAD SCI USA, V85, P6929, DOI 10.1073/pnas.85.18.6929; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DESSEN A, 1995, BIOCHEMISTRY-US, V34, P4933, DOI 10.1021/bi00015a004; Dietrich J, 1998, J BIOL CHEM, V273, P26281, DOI 10.1074/jbc.273.41.26281; Dietrich J, 1996, J CELL BIOL, V132, P299, DOI 10.1083/jcb.132.3.299; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Exley M, 1991, Semin Immunol, V3, P283; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1998, EMBO J, V17, P5877, DOI 10.1093/emboj/17.20.5877; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; GANNAN S, 1991, BIOCHEMISTRY-US, V30, P3098; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; HUBBARD SC, 1979, J BIOL CHEM, V254, P4568; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KEARSE KP, 1995, IMMUNITY, V2, P391; KEARSE KP, 1993, P NATL ACAD SCI USA, V90, P2348; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEE O, 1987, P NATL ACAD SCI USA, V84, P1374; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; SAMELSON LE, 1986, J IMMUNOL, V137, P3254; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; Solheim JC, 1997, J IMMUNOL, V158, P541; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; SUH KS, 1989, J CELL BIOL, V108, P811, DOI 10.1083/jcb.108.3.811; SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520; VanLeeuwen JEM, 1997, J BIOL CHEM, V272, P4179, DOI 10.1074/jbc.272.7.4179; vanLeeuwen JEM, 1996, J BIOL CHEM, V271, P9660, DOI 10.1074/jbc.271.16.9660; VARKI A, 1994, METHOD ENZYMOL, V230, P16; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; WENG SA, 1993, J BIOL CHEM, V268, P25656; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	44	17	17	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14094	14099		10.1074/jbc.274.20.14094	http://dx.doi.org/10.1074/jbc.274.20.14094			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318825	hybrid			2022-12-27	WOS:000080322200054
J	Ichiba, T; Hashimoto, Y; Nakaya, M; Kuraishi, Y; Tanaka, S; Kurata, T; Mochizuki, N; Matsuda, M				Ichiba, T; Hashimoto, Y; Nakaya, M; Kuraishi, Y; Tanaka, S; Kurata, T; Mochizuki, N; Matsuda, M			Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; DEPENDENT ACTIVATION; GDP/GTP EXCHANGE; PROTEIN C3G; SH3 DOMAIN; MAP KINASE; CRK; BINDING; ONCOGENE; PRODUCT	C3G is a guanine nucleotide exchange factor fbr Rap1 and is activated by the expression of Crk adaptor proteins, We found that expression of CrkI in COS cells induced significant tyrosine phosphorylation of C3G. To understand the mechanism by which C3G is phosphorylated and activated by Crk, we constructed a series of deletion mutants. Deletion of the amino terminus of C3G to amino acid 61 did not remarkably affect either tyrosine phosphorylation or Crk-dependent activation of C3G. When C3G was truncated to amino acid 390, C3G was still phosphorylated on tyrosine but was not effectively activated by CrkI, Deletion of the amino terminus of C3G to amino acid 579 significantly reduced the Crk-dependent tyrosine phosphorylation of C3G and increased GTP-bound Rap1 irrespective of the presence of CrkI. We substituted all seven tyrosine residues in this region, amino acids 391-579, for phenylalanine for identification of the phosphorylation site. Among the substitution mutants, the C3G-Y504F mutant, in which tyrosine 504 was substituted by phenylalanine, was remarkably less activated and phosphorylated than the wild type, All the other substitution mutants were activated and tyrosyl-phosphorylated by the expression of CrkI. Thus, CrkI activates C3G by the phosphorylation of tyrosine 504, which represses the cis-acting negative regulatory domain outside the catalytic region.	Int Med Ctr Japan, Res Inst, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; Jikei Univ, Sch Med, Dept Internal Med 3, Minato Ku, Tokyo 1058461, Japan; Hokkaido Univ, Sch Med, Dept Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Jikei University; Hokkaido University	Matsuda, M (corresponding author), Int Med Ctr Japan, Res Inst, Dept Pathol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.		Tanaka, Shinya/D-3586-2011	Matsuda, Michiyuki/0000-0002-5876-9969				Baouz S, 1997, J BIOL CHEM, V272, P6671, DOI 10.1074/jbc.272.10.6671; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; FRANKE B, 1997, AMBO J, V15, P252; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; HAMAGUCHI M, 1990, MOL CELL BIOL, V10, P830, DOI 10.1128/MCB.10.2.830; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kiyokawa E, 1997, CRIT REV ONCOGENESIS, V8, P329, DOI 10.1615/CritRevOncog.v8.i4.30; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MUROYA K, 1992, ONCOGENE, V7, P277; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Qian XL, 1998, MOL CELL BIOL, V18, P771, DOI 10.1128/MCB.18.2.771; Tanaka S, 1998, J BIOL CHEM, V273, P1281, DOI 10.1074/jbc.273.3.1281; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	33	94	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14376	14381		10.1074/jbc.274.20.14376	http://dx.doi.org/10.1074/jbc.274.20.14376			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318861	hybrid			2022-12-27	WOS:000080322200090
J	Quinn, JM; Nakamoto, SS; Merchant, S				Quinn, JM; Nakamoto, SS; Merchant, S			Induction of coproporphyrinogen oxidase in Chlamydomonas chloroplasts occurs via transcriptional regulation of Cpx1 mediated by copper response elements and increased translation from a copper-deficiency-specific form of the transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL BIOSYNTHETIC ENZYME; PLASTIDIC CYTOCHROME-C; MESSENGER-RNA; GENE-EXPRESSION; CARBOXYLASE-OXYGENASE; COMPLEMENTARY-DNA; HEME ATTACHMENT; 2 GENES; REINHARDTII; PLASTOCYANIN	Coproporphyrinogen III oxidase, encoded by a single nuclear gene in Chlamydomonas reinhardtii, produces three distinct transcripts. One of these transcripts is greatly induced in copper-deficient cells by transcriptional activation, whereas the other forms are copper-insensitive. The induced form of the transcript was expressed coordinately with the cytochrome c(6)-encoding (Cyc6) gene, which is known to be transcriptionally regulated in copper-deficient cells. The sequence GTAC, which forms the care of a copper response element associated with the Cyc6 gene, is also essential for induction of the Cpx1 gene, suggesting that both are targets of the same signal transduction pathway. The constitutive and induced Cpx1 transcripts have the same half-lives in vivo and all encode the same polypeptide with a chloroplast-targeting transit sequence, but the shortest one representing the induced form is a 2-4-fold better template for translation than are either of the constitutive forms. The enzyme remains localized to a soluble compartment in the chloroplast even in induced cells, and its abundance is not affected when the tetrapyrrole pathway is manipulated either genetically or by gabaculine treatment.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Merchant, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu			NIGMS NIH HHS [GM07185, GM42143] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM042143, R01GM042143, R37GM042143] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], MOL BIOL CHLOROPLAST; BCALE SI, 1993, MOL BIOL CYANOBACTER, P519; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chow KS, 1997, J BIOL CHEM, V272, P27565, DOI 10.1074/jbc.272.44.27565; Chow KS, 1998, PLANT J, V15, P531, DOI 10.1046/j.1365-313X.1998.00235.x; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DAVIES JP, 1994, MOL CELL BIOL, V14, P5165, DOI 10.1128/MCB.14.8.5165; DEHOSTOS EL, 1989, MOL GEN GENET, V218, P229, DOI 10.1007/BF00331273; DROPPA M, 1990, CRIT REV PLANT SCI, V9, P111, DOI 10.1080/07352689009382284; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; FALVEY E, 1995, EMBO J, V14, P4307, DOI 10.1002/j.1460-2075.1995.tb00105.x; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOLDSCHMIDTCLERMONT M, 1986, PLANT MOL BIOL, V6, P13, DOI 10.1007/BF00021302; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; HE ZH, 1994, PLANT PHYSIOL, V106, P537, DOI 10.1104/pp.106.2.537; HILL KL, 1991, J BIOL CHEM, V266, P15060; Hill KL, 1996, PLANT PHYSIOL, V112, P697, DOI 10.1104/pp.112.2.697; HILL KL, 1995, EMBO J, V14, P857, DOI 10.1002/j.1460-2075.1995.tb07067.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOWE G, 1994, J BIOL CHEM, V269, P5824; HOWE G, 1995, MOL GEN GENET, V246, P156, DOI 10.1007/BF00294678; Ishikawa N, 1997, J BIOL CHEM, V272, P3289, DOI 10.1074/jbc.272.6.3289; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; KOHNO H, 1993, J BIOL CHEM, V268, P21359; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lermontova I, 1997, P NATL ACAD SCI USA, V94, P8895, DOI 10.1073/pnas.94.16.8895; LI HH, 1995, J BIOL CHEM, V270, P23504, DOI 10.1074/jbc.270.40.23504; Li HH, 1996, J BIOL CHEM, V271, P31283, DOI 10.1074/jbc.271.49.31283; LI HH, 1992, J BIOL CHEM, V267, P9368; LUMBRERAS V, 1995, PLANT J, V8, P541, DOI 10.1046/j.1365-313X.1995.8040541.x; Luo MZ, 1997, PLANT MOL BIOL, V33, P709, DOI 10.1023/A:1005798207693; MADSEN O, 1993, PLANT MOL BIOL, V23, P35, DOI 10.1007/BF00021417; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Marston F. A. O., 1987, DNA CLONING, P59; MATTERS GL, 1994, PLANT MOL BIOL, V24, P617, DOI 10.1007/BF00023558; MATTERS GL, 1995, PLANT MOL BIOL, V27, P607, DOI 10.1007/BF00019326; MAYER M, 1997, PLANT PHYSL S, V114, P180; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; MERCHANT S, 1987, EMBO J, V6, P2531, DOI 10.1002/j.1460-2075.1987.tb02540.x; Merchant S, 1997, CH MICROBIOL SER, P450; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; MERCHANT S, 1990, J BIOL CHEM, V265, P12372; MERCHANT S, 1987, J BIOL CHEM, V262, P9062; MERCHANT S, 1986, J BIOL CHEM, V261, P5850; MERCHANT S, 1998, MOL BIOL CHLAMYDOMON, V7, P597; MORAND LZ, 1994, MOL BIOL CYANOBACTER, P243; Owen CA., 1981, COPPER DEFICIENCY TO, V1st; Peck SC, 1998, PLANT J, V14, P573, DOI 10.1046/j.1365-313X.1998.00156.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; Randolph-Anderson BL, 1998, PLANT MOL BIOL, V38, P839, DOI 10.1023/A:1006085026294; REDINBO MR, 1994, J BIOENERG BIOMEMBR, V26, P49, DOI 10.1007/BF00763219; SANDMANN G, 1986, ARCH MICROBIOL, V145, P76, DOI 10.1007/BF00413030; SANDMANN G, 1983, ARCH MICROBIOL, V134, P23, DOI 10.1007/BF00429401; SANDMANN G, 1987, PHOTOSYNTH RES, V11, P37, DOI 10.1007/BF00117672; Sharp P A, 1980, Methods Enzymol, V65, P750; Sigfridsson K, 1998, PHOTOSYNTH RES, V57, P1, DOI 10.1023/A:1006067631076; SMITH AG, 1993, BIOCHEM J, V292, P503, DOI 10.1042/bj2920503; TAMAOKI M, 1995, PLANT J, V7, P927, DOI 10.1046/j.1365-313X.1995.07060927.x; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; Xie ZY, 1996, J BIOL CHEM, V271, P4632; ZAGOREC M, 1986, J BIOL CHEM, V261, P2506; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718	65	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14444	14454		10.1074/jbc.274.20.14444	http://dx.doi.org/10.1074/jbc.274.20.14444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318870	hybrid			2022-12-27	WOS:000080322200099
J	Abuin, G; Freitas, LHG; Colli, W; Alves, MJM; Schenkman, S				Abuin, G; Freitas, LHG; Colli, W; Alves, MJM; Schenkman, S			Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INVASION; MESSENGER-RNA; SURFACE PROTEIN; BLOOD-STREAM; CYCLIC-AMP; DEVELOPMENTAL REGULATION; 3'-UNTRANSLATED REGION; TRYPOMASTIGOTE FORMS; SIGNAL-TRANSDUCTION; ADHESION MOLECULE	To adapt to different environments, Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, expresses a different set of proteins during development, To bean to understand the mechanism that controls this differential gene expression, we have analyzed the levels of amastin and trans-sialidase mRNAs and the mRNAs encoding members of the 85-kDa glycoprotein gene family, which are differentially expressed in the T, cruzi stages found in the mammalian host. Amastin mRNA is expressed predominantly in intracellular and proliferative amastigotes. trans-Sialidase mRNAs are found mostly in forms undergoing transformation from amastigotes to trypomastigotes inside infected cells, whereas mRNAs encoding the 85-kDa glycoproteins appear only in the infective trypomastigotes released from the cells. The genes coding for these mRNA species are constitutively transcribed in all stages of T, cruzi cells, suggesting that expression is controlled post-transcriptionally during differentiation. Inhibition of transcription by actinomycin D revealed that each mRNA species has a relatively long half-life in stages where it accumulates. In the case of the trans-sialidase and 85-kDa glycoprotein genes, mRNA accumulation was induced by treatment with the protein synthesis inhibitor cycloheximide at the stages that preceded the normal accumulation. Therefore, mRNA stabilization may account for mRNA accumulation. mRNA degradation could be promoted by proteins with high turnover, or stabilization could be promoted by forming a complex with the translational machinery at defined times in development. Identification of the factors that induce mRNA degradation or stabilization is essential to the understanding of control of gene expression in these organisms.	Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05599970 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Schenkman, S (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Rua Botucatu 862 8 A, BR-04023062 Sao Paulo, Brazil.	sergio@ecb.epm.br	Schenkman, Sergio/A-9227-2013; Freitas-Junior, Lucio H/C-8677-2011; Alves, Maria Julia/K-8976-2012; Colli, Walter/ABA-5440-2021; Colli, Walter/G-1188-2012; Colli, Walter/AAW-7649-2021	Schenkman, Sergio/0000-0001-9353-8480; Freitas-Junior, Lucio H/0000-0002-8904-7897; Alves, Maria Julia/0000-0001-7211-9631; Colli, Walter/0000-0001-7305-4673				ABUIN G, 1989, MOL BIOCHEM PARASIT, V35, P229, DOI 10.1016/0166-6851(89)90209-0; ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; AMORIM MI, 1993, ACTA TROP, V53, P99, DOI 10.1016/0001-706X(93)90022-4; ATWATER JA, 1990, ANNU REV GENET, V24, P519; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; BORDA ES, 1991, MOL BIOCHEM PARASIT, V47, P91, DOI 10.1016/0166-6851(91)90151-U; BOSCHETTI MA, 1987, MOL BIOCHEM PARASIT, V24, P175, DOI 10.1016/0166-6851(87)90104-6; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUENKOVA M, 1995, J EXP MED, V181, P1693, DOI 10.1084/jem.181.5.1693; CLAYTON C, 1992, PROG NUCLEIC ACID RE, V43, P37, DOI 10.1016/S0079-6603(08)61043-0; COSO OA, 1992, BIOCHEM J, V287, P443, DOI 10.1042/bj2870443; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; DACRUZ MQ, 1991, EXPERIENTIA, V47, P89, DOI 10.1007/BF02041263; DIETRICH P, 1993, GENE, V125, P103, DOI 10.1016/0378-1119(93)90753-P; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; DOCAMPO R, 1993, MOL BIOCHEM PARASIT, V59, P305, DOI 10.1016/0166-6851(93)90228-P; Egima CM, 1996, MOL BIOCHEM PARASIT, V77, P115, DOI 10.1016/0166-6851(96)02582-0; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Garcia ES, 1995, EXP PARASITOL, V81, P255, DOI 10.1006/expr.1995.1116; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; GONZALESPERDOMO M, 1988, EXP PARASITOL, V66, P205, DOI 10.1016/0014-4894(88)90092-6; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; GRAHAM SV, 1995, MOL CELL BIOL, V15, P5945; Graham SV, 1996, MOL BIOCHEM PARASIT, V80, P179, DOI 10.1016/0166-6851(96)02674-6; HALL BF, 1992, J EXP MED, V176, P313, DOI 10.1084/jem.176.2.313; HEATH S, 1990, MOL BIOCHEM PARASIT, V43, P133, DOI 10.1016/0166-6851(90)90138-C; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; LEGUIZAMON MS, 1994, INFECT IMMUN, V62, P3441; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; MORRIS SA, 1992, EXP PARASITOL, V74, P69, DOI 10.1016/0014-4894(92)90140-6; Nozaki T, 1995, MOL BIOCHEM PARASIT, V75, P55, DOI 10.1016/0166-6851(95)02512-X; OCHATT CM, 1993, MOL BIOCHEM PARASIT, V57, P73, DOI 10.1016/0166-6851(93)90245-S; OLIVEIRA MM, 1993, MOL CELL BIOCHEM, V124, P91, DOI 10.1007/BF00929200; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; PEREIRA IS, 1982, ACTA TROP, V39, P275; Pereira M. E. A., 1990, Modern parasite biology: cellular, immunological, and molecular aspects., P64; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Ribeirao M, 1997, GLYCOBIOLOGY, V7, P1237, DOI 10.1093/glycob/7.8.1237; ROLIN S, 1993, MOL BIOCHEM PARASIT, V61, P115, DOI 10.1016/0166-6851(93)90164-S; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A; Silva LHP, 1953, FOLIA CLIN BIOL, V20, P191; Stojdl DF, 1996, EXP PARASITOL, V83, P134, DOI 10.1006/expr.1996.0057; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; TSCHUDI C, 1994, INFECT AGENT DIS, V3, P181; TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x; UEMURA H, 1992, EMBO J, V11, P3837, DOI 10.1002/j.1460-2075.1992.tb05476.x; ULLU E, 1990, NUCLEIC ACIDS RES, V18, P3319, DOI 10.1093/nar/18.11.3319; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; WILSON ME, 1993, J BIOL CHEM, V268, P15731; ZINGALES B, 1987, MOL BIOCHEM PARASIT, V26, P135, DOI 10.1016/0166-6851(87)90137-X	62	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13041	13047		10.1074/jbc.274.19.13041	http://dx.doi.org/10.1074/jbc.274.19.13041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224055	hybrid			2022-12-27	WOS:000080200400017
J	DeLuca, C; Petropoulos, L; Zmeureanu, D; Hiscott, J				DeLuca, C; Petropoulos, L; Zmeureanu, D; Hiscott, J			Nuclear I kappa B beta maintains persistent NF-kappa B activation in HIV-1-infected myeloid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TUMOR-NECROSIS-FACTOR; PERIPHERAL-BLOOD MONOCYTES; CYTOKINE GENE-EXPRESSION; KINASE COMPLEX; MYELOMONOBLASTIC CELLS; TRANSCRIPTION FACTOR; ALPHA DEGRADATION; INDUCED APOPTOSIS; DNA-BINDING	Monocytic cells exhibit constitutive NF-kappa B activation upon infection with human immunodeficiency virus-1 (HIV-1). Because I kappa B beta has been implicated in maintaining NF-kappa B DNA binding, we sought to investigate whether I kappa B beta was involved in maintaining persistent NF-kappa B activation in HN-l-infected monocytic cell lines. I kappa B beta was present in the nucleus of HIV-l-infected cells and participated in the ternary complex formation with NF-kappa B and DNA. In contrast to uninfected cells, the addition of recombinant glutathione S-transferase-I kappa B alpha protein to preformed NF-kappa B DNA complexes from HIV-1-infected cell extracts did not completely dissociate the complexes, suggesting that I kappa B beta may protect NF-kappa B complexes from I kappa B alpha-mediated dissociation. Immunodepletion of I kappa B beta resulted in an NF-kappa B.DNA binding complex that was sensitive to I kappa B alpha-mediated dissociation, thus demonstrating the protective role of I kappa B beta. In addition, co-transfection studies with an NF-kappa B-dependent reporter construct demonstrated that I kappa B beta co-expression partially alleviated inhibition of NF-kappa B-mediated gene expression by I kappa B alpha, implying that I kappa B beta can maintain transcriptionally active NF-kappa B.DNA complexes. Furthermore, constitutive phosphorylation of I kappa B alpha was observed. Immunoprecipitation of the I kappa B kinase (IKK) complex followed by in vitro analysis of kinase activity demonstrated that IKK was constitutively activated in HIV-1-infected myeloid cells. Thus, virus-induced constitutive IKK activation, coupled with the maintenance of a ternary NF-kappa B.DNA complex by I kappa B beta, maintains persistent NF-kappa B activity in HN-l-infected myeloid cells.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Hiscott, J (corresponding author), Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.							ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Attar RM, 1998, MOL CELL BIOL, V18, P477, DOI 10.1128/MCB.18.1.477; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; CROWE SM, 1994, J LEUKOCYTE BIOL, V56, P215, DOI 10.1002/jlb.56.3.215; DADDARIO M, 1992, J IMMUNOL, V148, P1222; DADDARIO M, 1990, J VIROL, V64, P6080, DOI 10.1128/JVI.64.12.6080-6089.1990; DeLuca C, 1998, VIROLOGY, V244, P27, DOI 10.1006/viro.1998.9085; DeLuca C, 1996, J VIROL, V70, P5183, DOI 10.1128/JVI.70.8.5183-5193.1996; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; Good LF, 1996, J VIROL, V70, P2730, DOI 10.1128/JVI.70.5.2730-2735.1996; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Hirano F, 1998, MOL CELL BIOL, V18, P2596, DOI 10.1128/MCB.18.5.2596; JAFFRAY E, 1995, MOL CELL BIOL, V15, P2166; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Johnson DR, 1996, J BIOL CHEM, V271, P16317, DOI 10.1074/jbc.271.27.16317; KORNBLUTH RS, 1994, J LEUKOCYTE BIOL, V56, P247, DOI 10.1002/jlb.56.3.247; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; McKinsey TA, 1997, J BIOL CHEM, V272, P22377, DOI 10.1074/jbc.272.36.22377; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MOLINA JM, 1990, J INFECT DIS, V161, P888, DOI 10.1093/infdis/161.5.888; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Perno CF, 1997, J LEUKOCYTE BIOL, V62, P1; PETERS AMJ, 1991, CLIN IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0090-1229(05)80006-6; Phillips RJ, 1997, MOL CELL BIOL, V17, P4390, DOI 10.1128/MCB.17.8.4390; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; ROULSTON A, 1992, J EXP MED, V175, P751, DOI 10.1084/jem.175.3.751; ROULSTON A, 1993, J VIROL, V67, P5235, DOI 10.1128/JVI.67.9.5235-5246.1993; STAAL FJT, 1992, LANCET, V339, P909, DOI 10.1016/0140-6736(92)90939-Z; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	54	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13010	13016		10.1074/jbc.274.19.13010	http://dx.doi.org/10.1074/jbc.274.19.13010			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224051	hybrid			2022-12-27	WOS:000080200400013
J	Tanaka, K; Nigg, EA				Tanaka, K; Nigg, EA			Cloning and characterization of the murine Nek3 protein kinase, a novel member of the NIMA family of putative cell cycle regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; CHROMATIN CONDENSATION; MITOTIC REGULATOR; PHOSPHORYLATION SITES; EXPRESSION PATTERN; VERTEBRATE CELLS; P34CDC2 KINASE; ACTIVATION; MITOSIS; GENE	We have cloned and characterized murine Nek3 (NIMA-related kinase 3), a novel mammalian gene product structurally related to the cell cycle-regulatory kinase NIMA of Aspergillus nidulans. By RNase protection, low levels of Nek3 expression could be detected in all organs examined, regardless of proliferative index. In contrast to Nek1 and Nek2, Nek3 levels were not particularly elevated in either the male or the female germ line. Nek3 levels showed at most marginal variations through the cell cycle, but they were elevated in G(0)-arrested, quiescent fibroblasts. Furthermore, no cell cycle-dependent changes in Nek3 activity could be detected, and no effects upon cell cycle progression could be observed upon antibody microinjection or overexpression of either wild-type or catalytically inactive Nek3. Finally, Nek3 was found to be a predominantly cytoplasmic enzyme. These data indicate that Nek3 differs from previously characterized Neks with regard to all parameters investigated, including organ specificity of expression, cell cycle dependence of expression and activity, and subcellular localization. Hence, the structural similarity between mammalian Neks may not necessarily be indicative of a common function, and it is possible that some members of this kinase family may perform functions that are not directly related to cell cycle control.	Univ Geneva, Dept Mol Biol Sci 2, CH-1211 Geneva 4, Switzerland	University of Geneva	Nigg, EA (corresponding author), Univ Geneva, Dept Mol Biol Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.			nigg, erich/0000-0003-4835-5719; Tanaka, Kayoko/0000-0002-2905-3603				Arama E, 1998, ONCOGENE, V16, P1813, DOI 10.1038/sj.onc.1201710; BERGEN LG, 1984, J BACTERIOL, V159, P114, DOI 10.1128/JB.159.1.114-119.1984; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fry AM, 1997, METHOD ENZYMOL, V283, P270; FRY AM, 1995, CURR BIOL, V5, P1122, DOI 10.1016/S0960-9822(95)00227-2; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GRAYSON J, 1995, MOL CELL BIOL, V15, P1870; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; JONES DGL, 1990, GENE, V90, P87, DOI 10.1016/0378-1119(90)90442-T; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Krien MJE, 1998, J CELL SCI, V111, P967; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; LEVEDAKOU EN, 1994, ONCOGENE, V9, P1977; Lu K P, 1995, Prog Cell Cycle Res, V1, P187; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; LU KP, 1993, J BIOL CHEM, V268, P8769; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nigg EA, 1996, CURR OPIN CELL BIOL, V8, P312, DOI 10.1016/S0955-0674(96)80003-2; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; OCONNELL MJ, 1994, EMBO J, V13, P4926, DOI 10.1002/j.1460-2075.1994.tb06820.x; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OSMANI AH, 1991, EMBO J, V10, P2669, DOI 10.1002/j.1460-2075.1991.tb07810.x; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; PU RT, 1995, J BIOL CHEM, V270, P18110, DOI 10.1074/jbc.270.30.18110; REUTER R, 1986, FEBS LETT, V201, P25, DOI 10.1016/0014-5793(86)80564-6; Rhee K, 1997, DEVELOPMENT, V124, P2167; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; SCHWEITZER B, 1992, MOL GEN GENET, V234, P164, DOI 10.1007/BF00272358; Tanaka K, 1997, EXP CELL RES, V237, P264, DOI 10.1006/excr.1997.3788; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Ye X S, 1997, Prog Cell Cycle Res, V3, P221; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	42	32	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13491	13497		10.1074/jbc.274.19.13491	http://dx.doi.org/10.1074/jbc.274.19.13491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224116	Green Published, hybrid			2022-12-27	WOS:000080200400078
J	Thomas, F; Serratrice, G; Beguin, C; Saint Aman, E; Pierre, JL; Fontecave, M; Laulhere, JP				Thomas, F; Serratrice, G; Beguin, C; Saint Aman, E; Pierre, JL; Fontecave, M; Laulhere, JP			Calcein as a fluorescent probe for ferric iron - Application to iron nutrition in plant cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOMATO MUTANT CHLORONERVA; MAMMALIAN-CELLS; K562 CELLS; POOL; NICOTIANAMINE; TRANSFERRIN; CHELATORS; SOYBEANS; CATIONS; ANALOGS	The recent use of calcein (CA) as a fluorescent probe for cellular iron has been shown to reflect the nutritional status of iron in mammalian cells (Breuer, W, Epsztejn, S,, and Cabantchik, Z, I. (1995) J, Biol. Chem. 270, 24209-24215), CA was claimed to be a chemosensor for iron(II), to measure the labile iron pool and the concentration of cellular free iron(II), We first study here the thermodynamic and kinetic properties of iron binding by CA. Chelation of a first iron(III) involves one aminodiacetic arm and a phenol. The overall stability constant log beta(111) of Fe(III)CAH is 33.9, The free metal ion concentration is pFe(III) = 20.3, A (Fe-III)(2) CA complex can be formed, A reversible iron(III) exchange from Fe(III)CAH to citrate and nitrilotriacetic acid is evidenced when these ligands are present in large excess. The kinetics of iron(III) exchange by CA is compatible with metabolic studies. The low reduction potential of Fe(III)CAH shows that the ferric form is highly stabilized. CA fluorescence is quenched by 85% after Fe-III chelation but by only 20% using Fe-II. Real time iron nutrition by Arabidopsis thaliana cells has been measured by fluorimetry, and the iron buffer Fe(III)CAH + CA was used as source of iron. As a siderophore, Fe(III)CAH promotes cell growth and regreening of iron-deficient cells more rapidly than Fe(III)EDTA. We conclude that CA is a good chemosensor for iron(III) in cells and biological fluids, but not for Fe(II), We discuss the interest of quantifying iron buffers in biochemical studies of iron, in vitro as well as in cells.	Univ Grenoble 1, EP 1087 CNRS, CEA, Lab Chim & Biochim,Ctr Redox Biol, F-38054 Grenoble 9, France; Univ Grenoble 1, Lab Electrochim Organ & Photochim Redox, UMR 5630, F-38041 Grenoble 9, France; Univ Grenoble 1, UMR CNRS 5616, Lab Chim Biomimet, F-38041 Grenoble 9, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Laulhere, JP (corresponding author), Univ Grenoble 1, EP 1087 CNRS, CEA, Lab Chim & Biochim,Ctr Redox Biol, 17 Rue Martyrs, F-38054 Grenoble 9, France.	laulhere@cbcrb.ceng.cea.fr	fabrice, thomas/H-3789-2011					BARNESS E, 1992, PLANT PHYSIOL, V99, P1329, DOI 10.1104/pp.99.4.1329; BASTIAN R, 1956, ANAL CHEM, V28, P459, DOI 10.1021/ac50161a014; BECKER R, 1995, PLANT PHYSIOL, V108, P269, DOI 10.1104/pp.108.1.269; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Breuer W, 1996, FEBS LETT, V382, P304, DOI 10.1016/0014-5793(96)00190-1; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Breuer W, 1997, FEBS LETT, V403, P213, DOI 10.1016/S0014-5793(97)00056-2; BROWN JC, 1971, PLANT PHYSIOL, V47, P836, DOI 10.1104/pp.47.6.836; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; Caris C, 1995, BIOCHEM J, V312, P879, DOI 10.1042/bj3120879; CHABEREK S, 1959, ORGANIC SEQUESTERING, P174; CRICHTON R, 1991, INORGANIC BIOCH IRON, P131; CRUMBLISS AL, 1991, HDB MICROBIAL IRON C, P177; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Fages F, 1996, J ORG CHEM, V61, P3956, DOI 10.1021/jo960191h; FONTECAVE M, 1991, BIOL MET, V4, P133, DOI 10.1007/BF01141302; GANS P, 1985, J CHEM SOC DALTON, P1195, DOI 10.1039/dt9850001195; Glickstein H, 1996, BLOOD, V87, P4871, DOI 10.1182/blood.V87.11.4871.bloodjournal87114871; HARRIS WR, 1981, J AM CHEM SOC, V103, P2667, DOI 10.1021/ja00400a030; LAULHERE JP, 1969, PHYSIOL VEG, V7, P277; LAULHERE JP, 1972, PHYSIOL VEG, V10, P589; LONGNECKER N, 1990, PLANT PHYSIOL, V92, P17, DOI 10.1104/pp.92.1.17; Martell A. E., 1974, CRITICAL STABILITY C; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nudelman R, 1998, J MED CHEM, V41, P1671, DOI 10.1021/jm970581b; PICH A, 1991, J EXP BOT, V42, P1517, DOI 10.1093/jxb/42.12.1517; PRICE CA, 1968, ANN REV PLANT PHYSIO, V19, P239, DOI 10.1146/annurev.pp.19.060168.001323; Ringbom A., 1963, COMPLEXATION ANAL CH; SAARI LA, 1984, ANAL CHEM, V56, P810, DOI 10.1021/ac00268a051; SCHUBERT J, 1963, IR MET INT S BERL, P467; STEPHAN UW, 1995, J EXP BOT, V46, P531, DOI 10.1093/jxb/46.5.531; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Weizman H, 1996, J AM CHEM SOC, V118, P12368, DOI 10.1021/ja9610646; WILLIAMS RJP, 1982, FEBS LETT, V140, P3, DOI 10.1016/0014-5793(82)80508-5; ZHANG FS, 1991, PLANT PHYSIOL, V97, P1302, DOI 10.1104/pp.97.4.1302	35	101	103	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13375	13383		10.1074/jbc.274.19.13375	http://dx.doi.org/10.1074/jbc.274.19.13375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224100	hybrid			2022-12-27	WOS:000080200400062
J	Hu, W; Jans, DA				Hu, W; Jans, DA			Efficiency of importin alpha/beta-mediated nuclear localization sequence recognition and nuclear import - Differential role of NTF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; TRANSPORT FACTOR-2 NTF2; PROTEIN IMPORT; PORE COMPLEX; FACTOR P97; FACTOR P10; IN-VIVO; BINDING; IDENTIFICATION; SITE	Little quantitative, kinetic information is available with respect to the process of nuclear import of conventional nuclear localization sequence (NLS)-containing proteins, which initially involves recognition and docking at the nuclear pore by importin alpha/beta. This study compares the binding and nuclear import properties of mouse (m) and yeast (y) importin (IMP) subunits with respect to the NLSs from the SV40 large tumor antigen (T-ag), and the Xenopus laevis phosphoprotein N1N2. m- and y-IMP alpha recognized both NLSs, with y-IMP alpha exhibiting higher affinity. m-IMP beta greatly enhanced the binding of m-IMP alpha to the T-ag and N1N2 NLSs, but y-IMP beta did not significantly affect the affinity of y-IMP alpha for the T-ag NLS. In contrast, y-IMP beta enhanced y-IMP alpha binding to the NLS of N1N2, but to a lesser extent than the enhancement of m-IMP alpha binding by m-IMP beta. NLS dependent nuclear import was reconstituted in vitro using the different importin subunits together with the transport factors Ran and NTF2. Whereas T-ag NLS-mediated nuclear import did not exhibit an absolute requirement for NTF2, N1N2 NLS-mediated transport strictly required NTF2. High levels of NTF2 inhibited nuclear accumulation conferred by both NLSs. We conclude that different NLSs possess distinct nuclear import properties due to differences in recognition by importin and requirements for NTF2.	Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Nucl Signalling Lab, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Jans, DA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Nucl Signalling Lab, Canberra, ACT 2601, Australia.	David.Jans@anu.edu.au						ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Feldherr C, 1998, J CELL SCI, V111, P1889; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; HUBNER S, 1999, UNPUB J BIOL CHEM; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605, DOI 10.1002/j.1460-2075.1988.tb02986.x; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Paschal BM, 1997, J BIOL CHEM, V272, P21534, DOI 10.1074/jbc.272.34.21534; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Tachibana T, 1996, FEBS LETT, V397, P177, DOI 10.1016/S0014-5793(96)01180-5; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451	49	86	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15820	15827		10.1074/jbc.274.22.15820	http://dx.doi.org/10.1074/jbc.274.22.15820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336485	hybrid			2022-12-27	WOS:000080560100074
J	Communi, D; Dewaste, V; Erneux, C				Communi, D; Dewaste, V; Erneux, C			Calcium-calmodulin-dependent protein kinase II and protein kinase C-mediated phosphorylation and activation of D-myo-inositol 1,4,5-trisphosphate 3-kinase B in astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR PURKINJE-CELLS; RAT-BRAIN; MOLECULAR-CLONING; CULTURED ASTROCYTES; DENDRITIC SPINES; EXPRESSION; RECEPTOR; PURIFICATION; LOCALIZATION; MESSENGER	D-myo-Inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3) 3-kinase catalyzes the production of D-myo-inositol 1,3,4,5-tetrakisphosphate from the second messenger Ins (1,4,5)P-3. Transient and okadaic acid-sensitive activation of Ins(1,4,5)P-3 3-kinase by 8-10-fold is observed in homogenates prepared from rat cortical astrocytes after incubation with either carbachol or UTP. 12-O-Tetradecanoylphorbol-13-acetate provokes the activation of Ins(1,4,5)P-3 3-kinase by a-fold in both cell systems. The kinase was purified by calmodulin-Sepharose from the two cell systems. Enzyme activity corresponding to the silver-stained 88-kDa protein could be regenerated after SDS-polyacrylamide gel electrophoresis. Antibodies to two distinct peptides chosen in the primary structure of human Ins(1,4,5)P-3 3-kinase B recognized the astrocytic native isoform. In [P-32]orthophosphate-preincubated cells, a major phosphorylated 88-kDa enzyme could be purified and identified in cells in response to receptor activation or 12-O-tetradecanoylphorbol-13-acetate treatment. Calmodulin kinase II inhibitors (i.e. KN-93 and KN-62) and a protein kinase C inhibitor (i.e. calphostin C) prevented the phosphorylation of the 88-kDa isoenzyme. In addition to enzyme activation, a redistribution of Ins(1,4,5)P-3 3-kinase from soluble to particulate fraction of astrocytes was observed. In vitro phosphorylation of the purified enzyme by calmodulin kinase II and protein kinase C added together resulted in a maximal 60-70-fold activation.	Free Univ Brussels, Inst Interdisciplinary Res, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Communi, D (corresponding author), Free Univ Brussels, Inst Interdisciplinary Res, 808 Route Lennik,Campus Erasme,Bldg C, B-1070 Brussels, Belgium.	dcommuni@ulb.ac.be						BABA H, 1995, J NEUROSCI RES, V41, P846, DOI 10.1002/jnr.490410615; BABCOCKATKINSON E, 1989, GLIA, V2, P112, DOI 10.1002/glia.440020207; BARNES GN, 1995, J NEUROCHEM, V64, P340; BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRONSTEIN J, 1988, J NEUROCHEM, V50, P45, DOI 10.1111/j.1471-4159.1988.tb13227.x; CHALLISS RAJ, 1990, J NEUROCHEM, V54, P2138, DOI 10.1111/j.1471-4159.1990.tb04920.x; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; Collin T, 1998, NEUROSCI LETT, V255, P67, DOI 10.1016/S0304-3940(98)00699-5; COMMUNI D, 1994, BIOCHEM J, V298, P669, DOI 10.1042/bj2980669; Communi D, 1997, EMBO J, V16, P1943, DOI 10.1093/emboj/16.8.1943; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Easom RA, 1998, BIOCHEM J, V329, P283; GO M, 1993, NEUROSCI LETT, V158, P135, DOI 10.1016/0304-3940(93)90247-I; Inagaki N, 1997, J BIOL CHEM, V272, P25195, DOI 10.1074/jbc.272.40.25195; IRVINE RF, 1991, BIOESSAYS, V13, P419, DOI 10.1002/bies.950130810; Ismailov II, 1996, P NATL ACAD SCI USA, V93, P10505, DOI 10.1073/pnas.93.19.10505; King BF, 1996, NEUROSCIENCE, V74, P1187, DOI 10.1016/0306-4522(96)00209-6; Loomis-Husselbee JW, 1998, BIOCHEM J, V331, P947, DOI 10.1042/bj3310947; LU CY, 1989, J MEMBRANE BIOL, V109, P85, DOI 10.1007/BF01870793; MAILLEUX P, 1992, NEUROSCI LETT, V137, P69, DOI 10.1016/0304-3940(92)90300-V; MAILLEUX P, 1991, BRAIN RES, V539, P203, DOI 10.1016/0006-8993(91)91622-8; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MURPHY JA, 1993, NEUROCHEM INT, V23, P87, DOI 10.1016/0197-0186(93)90147-W; NAKAHATA N, 1987, BIOCHEM J, V241, P337, DOI 10.1042/bj2410337; NEARY JT, 1988, J NEUROCHEM, V50, P1179, DOI 10.1111/j.1471-4159.1988.tb10590.x; Oliva AM, 1997, BIOCHEM PHARMACOL, V54, P1243, DOI 10.1016/S0006-2952(97)00329-8; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; ROISIN MP, 1995, BRAIN RES, V701, P297, DOI 10.1016/0006-8993(95)01126-7; ROSKOSKI R, 1979, METHOD ENZYMOL, V99, P3; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; SIM SS, 1990, J BIOL CHEM, V265, P10367; SMITH PM, 1998, J PHYSL P, V509, pP145; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; Soriano S, 1997, BIOCHEM J, V324, P579, DOI 10.1042/bj3240579; TAKAZAWA K, 1990, BIOCHEM J, V268, P213, DOI 10.1042/bj2680213; TAKAZAWA K, 1990, BIOCHEM J, V272, P107, DOI 10.1042/bj2720107; TAKAZAWA K, 1991, BIOCHEM J, V278, P883, DOI 10.1042/bj2780883; TAKAZAWA K, 1991, BIOCHEM BIOPH RES CO, V174, P529, DOI 10.1016/0006-291X(91)91449-M; TAKAZAWA K, 1988, BIOPHYS RES COMMUN, V158, P632; THOMAS S, 1994, BBA-MOL CELL RES, V1220, P219, DOI 10.1016/0167-4889(94)90139-2; Tsubokawa H, 1996, J PHYSIOL-LONDON, V497, P67, DOI 10.1113/jphysiol.1996.sp021750; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; Xie WW, 1998, J PHYSIOL-LONDON, V510, P661, DOI 10.1111/j.1469-7793.1998.661bj.x; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; YAMAMOTOHINO M, 1995, NEUROREPORT, V6, P273, DOI 10.1097/00001756-199501000-00012	49	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14734	14742		10.1074/jbc.274.21.14734	http://dx.doi.org/10.1074/jbc.274.21.14734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329669	hybrid			2022-12-27	WOS:000081965200034
J	Dhar, G; Bhaduri, A				Dhar, G; Bhaduri, A			Synthesis and characterization of stacked and quenched uridine nucleotide fluorophores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AROMATIC-AROMATIC INTERACTIONS; MOLECULAR RECOGNITION; BENZENE DIMER; FLUORESCENCE; SYSTEMS; 1,8-DIARYLNAPHTHALENES; MECHANISM; POLAR/PI; SITES; BOND	Intramolecular aromatic interactions in aqueous solution often lead to stacked conformation for model organic molecules. This designing principle was used to develop stacked and folded uridine nucleotide analogs that showed highly quenched fluoroscence in aqueous solution by attaching the fluorophore 1-aminonaphthalene-5-sulfonate (AmNS) to the terminal phosphate via a phosphoramidate bond. Severalfold enhancement of fluorescence could be observed by destacking the molecules in organic solvents, such as isopropanol and dimethylsulfoxide or by enzymatic cleavage of the pyrophosphate bond. Stacking and destacking were confirmed by H1- NMR spectroscopy. The extent of quenching of the uridine derivatives correlated very well with the extent of stacking. Taking 5-H as the monitor, temperature-variable NMR studies demonstrated the presence of a rapid interconversionary equilibrium between the stacked and open forms for uridine-5'-diphosphoro-beta-1-(5-sulfonic acid) naphthylamidate (UDPAmNS) in aqueous solution. Delta H was calculated to be -2.3 Kcal/mol, with 43-50% of the population in stacked conformation. Fluorescence lifetime for UDPAmNS in water was determined to be 2.5 ns as against 11 ns in dimethyl sulfoxide or 15 ns for the pyrophosphate adduct of AmNS in water. Such a greatly reduced lifetime for UDPAmNS in water suggests collisional interaction between the pyrimidine and the fluorophore moieties to be responsible for quenching. The potential usefulness of such stacked and quenched nucleotide fluorophores as probes for protein-ligand interaction studies has been briefly discussed.	Indian Inst Chem Biol, Calcutta 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhaduri, A (corresponding author), Indian Inst Chem Biol, 4 Raja Sc Mullick Rd, Calcutta 700032, W Bengal, India.							AMABILINO DB, 1995, J AM CHEM SOC, V117, P1271, DOI 10.1021/ja00109a011; BARRIO JR, 1973, FEBS LETT, V29, P215, DOI 10.1016/0014-5793(73)80022-5; Bhattacharyya U, 1999, J BIOL CHEM, V274, P14573, DOI 10.1074/jbc.274.21.14573; BORNSEN KO, 1986, J CHEM PHYS, V85, P1726, DOI 10.1063/1.451173; BRENNAN JS, 1974, J CHEM SOC FARAD T 1, V70, P1965, DOI 10.1039/f19747001965; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chatterji D, 1996, METHOD ENZYMOL, V274, P456; CONSTANT JF, 1988, BIOCHEMISTRY-US, V27, P3997, DOI 10.1021/bi00411a016; COZZI F, 1992, J AM CHEM SOC, V114, P5729, DOI 10.1021/ja00040a036; COZZI F, 1993, J AM CHEM SOC, V115, P5330, DOI 10.1021/ja00065a069; COZZI F, 1995, ANGEW CHEM INT EDIT, V34, P1019, DOI 10.1002/anie.199510191; EVANS DA, 1987, ANGEW CHEM INT EDIT, V26, P1184, DOI 10.1002/anie.198711841; GROVER JR, 1987, J PHYS CHEM-US, V91, P3233, DOI 10.1021/j100296a026; GRUBER BA, 1975, P NATL ACAD SCI USA, V72, P3966, DOI 10.1073/pnas.72.10.3966; HENIS YI, 1980, P NATL ACAD SCI-BIOL, V77, P5055, DOI 10.1073/pnas.77.9.5055; JARDETZK.O, 1966, J BIOL CHEM, V241, P85; JORGENSEN WL, 1990, J AM CHEM SOC, V112, P4768, DOI 10.1021/ja00168a022; KELLY TR, 1990, J AM CHEM SOC, V112, P8024, DOI 10.1021/ja00178a027; LAATIKAINEN R, 1995, J AM CHEM SOC, V117, P11006, DOI 10.1021/ja00149a025; Lakowicz J. R., 1982, PRINCIPLES FLUORESCE; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299; Liljas A., 1974, ANNU REV BIOCHEM, V43, P475; MILES DW, 1968, J BIOL CHEM, V243, P4181; MURAKAMI Y, 1982, J AM CHEM SOC, V104, P5189, DOI 10.1021/ja00383a033; NEWCOMB LF, 1994, J AM CHEM SOC, V116, P4993, DOI 10.1021/ja00090a057; Saenger W., 1984, PRINCIPLES NUCL ACID; SCHLAGECK JG, 1979, J BIOL CHEM, V254, P2074; SECRIST JA, 1972, SCIENCE, V175, P646, DOI 10.1126/science.175.4022.646; SIJBESMA RP, 1992, J AM CHEM SOC, V114, P9807, DOI 10.1021/ja00051a013; Spencer R. D., 1972, STRUCTURE FUNCTION O, P393; TSO P, 1974, BASIC PRINCIPLES NUC, V1; UEDA H, 1988, BIOCHEM BIOPH RES CO, V154, P199, DOI 10.1016/0006-291X(88)90670-5; WEBER G, 1954, BIOCHEM J, V56, pP31; WINTNER EA, 1994, J AM CHEM SOC, V116, P8877, DOI 10.1021/ja00099a003; YARBROUGH LR, 1978, BIOCHEM BIOPH RES CO, V81, P35, DOI 10.1016/0006-291X(78)91627-3; YARBROUGH LR, 1979, J BIOL CHEM, V254, P2069	37	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14568	14572		10.1074/jbc.274.21.14568	http://dx.doi.org/10.1074/jbc.274.21.14568			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329647	hybrid			2022-12-27	WOS:000081965200012
J	Grover, A; Houlden, H; Baker, M; Adamson, J; Lewis, J; Prihar, G; Pickering-Brown, S; Duff, K; Hutton, M				Grover, A; Houlden, H; Baker, M; Adamson, J; Lewis, J; Prihar, G; Pickering-Brown, S; Duff, K; Hutton, M			5 ' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SECONDARY STRUCTURE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; GENE; CHROMOSOME-17; LOCALIZATION; SEQUENCES; IDENTIFICATION	Missense and splice site mutations in the microtubule-associated protein tau gene were recently found associated with fronto-temporal dementia and parkinsonism linked to chromosome 17 (Poorkaj et al. (1998) Ann. Neurol. 43, 815-825; Hutton et al. (1998) Nature 393, 702-705; Spillantini et al. (1998) Proc. Natl Acad Sci. U.S.A 95, 7737-7741). The mutations in the 5' splice site of exon 10 were shown to increase the ratio of tau mRNAs containing exon 10 and thus the proportion of Tau protein isoforms with 4 microtubule binding repeat domains, although how this increase leads to neurodegeneration is presently unclear. The mechanism by which these mutations increase tau exon 10 splicing was not determined, although the mutations were predicted to disrupt a potential stem-loop structure that was likely involved in the regulation of exon 10 alternative splicing. Here we describe in vitro splicing assays and RNA structural analysis that demonstrate that the mutations do indeed act through disruption of the stem-loop structure and that the stability of this secondary structure feature at least partially determines the ratio of tau exon 10+/- transcripts. In addition, we provide evidence that the stability of the stem-loop structure underlies the alternative splicing of this exon in other species.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Univ Manchester, Sch Biol Sci, Div Neurosci, Manchester M13 9PT, Lancs, England; Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Mayo Clinic; University of Manchester; Nathan Kline Institute for Psychiatric Research	Hutton, M (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.		Pickering-Brown, Stuart/D-4008-2009; Houlden, Henry J/C-1532-2008	Pickering-Brown, Stuart/0000-0003-1561-6054; Houlden, Henry J/0000-0002-2866-7777; Duff, Karen/0000-0002-6177-868X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037143] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS37143-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; ANIELLO F, 1991, P NATL ACAD SCI USA, V88, P4035, DOI 10.1073/pnas.88.9.4035; CHEBLI K, 1989, MOL CELL BIOL, V9, P4852, DOI 10.1128/MCB.9.11.4852; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Delacourte A, 1997, INT REV CYTOL, V171, P167; Dickson DW, 1997, ANN NEUROL, V42, P541, DOI 10.1002/ana.410420403; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; DORVAL BC, 1991, SCIENCE, V252, P1823, DOI 10.1126/science.2063195; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOGUEL V, 1993, MOL CELL BIOL, V13, P6841, DOI 10.1128/MCB.13.11.6841; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	28	239	251	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15134	15143		10.1074/jbc.274.21.15134	http://dx.doi.org/10.1074/jbc.274.21.15134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329720	hybrid			2022-12-27	WOS:000081965200085
J	Lin, HJ; Wing, SS				Lin, HJ; Wing, SS			Identification of rabbit reticulocyte E2(17K) as a UBC7 homologue and functional characterization of its core domain loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; CELL-CYCLE; CARRIER PROTEIN; DNA-REPAIR; DEPENDENT PROTEOLYSIS; MOLECULAR-CLONING; CDC34 UBC3; IN-VIVO; DEGRADATION; SYSTEM	The structural basis by which ubiquitin (Ub)-conjugating enzymes (E2s) determine substrate specificity remains unclear. We cloned rabbit reticulocyte E2(17K) because unlike the similarly sized class I E2s, E2(14K) and UBC4, it is unable to support ubiquitin-protein ligase (E3)-dependent conjugation to endogenous proteins. RNA analysis revealed that this E2 was expressed in all tissues tested, with higher levels in the testis, Analysis of testis RNA from rats of different ages showed that E2(17K) mRNA was induced from days 15 to 30, The predicted amino acid sequence indicates that E2(17K) is a 19.5-kDa class I E2 but differs from other class I enzymes in possessing an insertion of 13 amino acids distal to the active site cysteine, E2(17K) shows 74% amino acid identity with Saccharomyces cerevisiae UBC7, and therefore, we rename it mammalian UBC7, Yeast UBC7 crystal structure indicates that this insertion forms a loop out of the otherwise conserved folding structure. Sequence analysis of E2s had previously suggested that this loop is a hypervariable region and may play a role in substrate specificity. We created mutant UBC7 lacking the loop (ubc7 Delta loop) and a mutant E2(17K) with an inserted loop (E2(14k)+loop) and characterized their biochemical functions. Ubc7 Delta loop had higher affinity for the E1-Ub thiol ester than native UBC7 and permitted conjugation of Ub to selected proteins in the testis but did not permit the broad spectrum E3-dependent conjugation to endogenous reticulocyte proteins. Surprisingly, E2(14k)+loop was unable to accept Ub from ubiquitin-activating enzyme (E1) but was able to accept NEDDS from E1. E2(14k)+loop was able to support conjugation of NEDD8 to endogenous reticulocyte proteins but with much lower efficiency than E2(14k). Thus, the loop can influence interactions of the E2 with charged El as well as with E3s or substrates, but the exact nature of these interactions depends on divergent sequences in the remaining conserved core domain.	McGill Univ, Polypeptide Lab, Dept Med, Montreal, PQ H3A 2B2, Canada	McGill University	Wing, SS (corresponding author), McGill Univ, Polypeptide Lab, Dept Med, 3640 Univ St,Strathcona Anat & Dent Bldg,Rm W-315, Montreal, PQ H3A 2B2, Canada.			Lin, Haijiang/0000-0003-2931-468X				Ausabel FM, 1993, CURRENT PROTOCOLS MO; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; CHARBONNEAU H, 1989, PRACTICAL GUIDE PROT, P17; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; COOK W, 1997, BIOCHEMISTRY-US, V36, P1521; COOK WJ, 1992, J BIOL CHEM, V267, P15116; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; GIROD PA, 1993, J BIOL CHEM, V268, P955; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; MORI S, 1992, J BIOL CHEM, V267, P6429; Oughtred R, 1998, J BIOL CHEM, V273, P18435, DOI 10.1074/jbc.273.29.18435; PICKART CM, 1985, J BIOL CHEM, V260, P1573; REISS Y, 1989, J BIOL CHEM, V264, P10378; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Townsley FM, 1998, TRENDS CELL BIOL, V8, P238, DOI 10.1016/S0962-8924(98)01268-9; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Watanabe TK, 1996, CYTOGENET CELL GENET, V74, P146, DOI 10.1159/000134403; Wing SS, 1996, MOL CELL BIOL, V16, P4064; WING SS, 1995, BIOCHEM J, V305, P125, DOI 10.1042/bj3050125; WING SS, 1992, J BIOL CHEM, V267, P6495; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	43	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14685	14691		10.1074/jbc.274.21.14685	http://dx.doi.org/10.1074/jbc.274.21.14685			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329663	hybrid			2022-12-27	WOS:000081965200028
J	Miller, RT; Martasek, P; Raman, CS; Masters, BSS				Miller, RT; Martasek, P; Raman, CS; Masters, BSS			Zinc content of Escherichia coli-expressed constitutive isoforms of nitric-oxide synthase - Enzymatic activity and effect of pterin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELAXING FACTOR; BRAIN; HEME; PURIFICATION; HEMOPROTEIN; STABILITY; CATALYSIS; PROTEIN; RELEASE; SUBUNIT	Recently, we obtained x-ray crystallographic data showing the presence of a ZnS4 center in the structure of Escherichia coli-expressed bovine endothelial nitric-oxide synthase (eNOS) and rat neuronal nitric oxide synthase (nNOS), The zinc atom is coordinated by two CXXXXC motifs, one motif being contributed by each NOS monomer (cysteine 326 through cysteine 331 in rat nNOS), Mutation of the nNOS cysteine 331 to alanine (C331A) results in the loss of NO. synthetic activity and also results in an inability to bind zinc efficiently. Although prolonged incubation of the C331A mutant of nNOS with high concentrations of L-arginine results in a catalytically active enzyme, zinc binding is not restored. In this study, we investigate the zinc stoichiometry in wild-type nNOS and eNOS, as well as in the C331A-mutated nNOS, using a chelation assay and electrothermal vaporization-inductively coupled plasma-mass spectrometry. The data reveal an approximate 2:1 stoichiometry of heme to zinc in (6R)-5,6,7,8-tetrahydro-L-biopterin-replete, wild-type nNOS and eNOS and show that the reactivated C331A mutant of nNOS has a limited ability to bind zinc. The present study substantiates that the zinc in NOS is structural rather than catalytic and is important for maintaining optimally functional, enzymatically active, constitutive NOSs.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA; Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California Irvine	Masters, BSS (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA.		; Martasek, Pavel/G-6622-2017	Raman, C. S./0000-0002-1036-3193; Martasek, Pavel/0000-0001-6165-4444	NHLBI NIH HHS [HL07350-19] Funding Source: Medline; NIGMS NIH HHS [GM52419] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLAKE PR, 1992, PROTEIN SCI, V1, P1522, DOI 10.1002/pro.5560011113; CHEN PF, 1995, BIOCHEM BIOPH RES CO, V215, P1119, DOI 10.1006/bbrc.1995.2579; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crow JP, 1997, J NEUROCHEM, V69, P1936; EIDNESS MK, 1992, PROTEIN ENG, V5, P367; FISCHMANN TO, 1999, NAT STRUCT BIOL, V5, P602; FURCHGOTT R F, 1988, P401; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KLATT P, 1992, BIOCHEM J, V288, P15, DOI 10.1042/bj2880015; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; NISHIMURA JS, 1995, BIOCHEM BIOPH RES CO, V210, P288, DOI 10.1006/bbrc.1995.1659; Olsson MHM, 1998, J BIOL INORG CHEM, V3, P109, DOI 10.1007/s007750050212; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Perry JM, 1998, P NATL ACAD SCI USA, V95, P11101, DOI 10.1073/pnas.95.19.11101; PERSECHINI A, 1995, BIOCHEMISTRY-US, V34, P15091, DOI 10.1021/bi00046a015; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; RodriguezCrespo I, 1997, BIOCHEMISTRY-US, V36, P8530, DOI 10.1021/bi970192j; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; SHETA EA, 1994, J BIOL CHEM, V269, P15147; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001	30	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14537	14540		10.1074/jbc.274.21.14537	http://dx.doi.org/10.1074/jbc.274.21.14537			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329642	hybrid			2022-12-27	WOS:000081965200007
J	Ortiz, L; Aza-Blanc, P; Zannini, M; Cato, ACB; Santisteban, P				Ortiz, L; Aza-Blanc, P; Zannini, M; Cato, ACB; Santisteban, P			The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-I; MAMMARY-TUMOR VIRUS; GROWTH-FACTOR-I; ADENOVIRUS DNA-REPLICATION; MAMMALIAN-CELLS; BINDING PROTEIN; THYROGLOBULIN PROMOTER; DOWN-REGULATION; RAT-LIVER; EXPRESSION	The forkhead thyroid-specific transcription factor TTF-2 is the main mediator of thyrotropin and insulin regulation of thyroperoxidase (TPO) gene expression. This function depends on multimerization and specific orientation of its DNA-binding site, suggesting that TTF-S is part of a complex interaction network within the TPO promoter, This was confirmed by transfection experiments and by protein-DNA interaction studies, which demonstrated that CTF/NF1 proteins bind 10 base pairs upstream of the TTF-a-binding site to enhance its action in hormone-induced expression of the TPO gene. GST pull-down assays showed that TTF-S physically interacts with CTF/NF1 proteins. In addition, we demonstrate that increasing the distance between both transcription factors binding sites by base pair insertion results in loss of promoter activity and in a drastic decrease on the ability of the promoter to respond to the hormones. CTF/NF1 is a family of transcription factors that contributes to constitutive and cell-type specific gene expression. Originally identified as factors implicated in the replication of adenovirus, this group of proteins (CTF/NF1-A, -B, -C, and -X) is now known to be involved in the regulation of several genes. In contrast to other reports regarding the involvement of these proteins in inducible gene expression, we show here that members of this family of transcription factors are regulated by hormones. With the use of specific CTF/NF1 DNA probes and antibodies we demonstrate that CTF/NF1-C is a thyrotropin-, cAMP-, and insulin-inducible protein. Thus CTF/NF1 proteins do not only mediate hormone-induced gene expression cooperating with TTF-2, but are themselves hormonally regulated. All these findings are clearly of important value in understanding the mechanisms governing the transcription regulation of RNA polymerase II promoters, which often contain binding sites for multiple transcription factors.	Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Naples Federico II; Helmholtz Association; Karlsruhe Institute of Technology	Santisteban, P (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.		Zannini, Mariastella/I-1735-2012; Cato, Andrew C. B./H-2071-2013; Santisteban, Pilar/E-7829-2016	Cato, Andrew C. B./0000-0001-8508-3834; Santisteban, Pilar/0000-0002-2758-796X; Ortiz Hernandez, Lourdes/0000-0001-6084-3411				AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANNWEILER A, 1991, NUCLEIC ACIDS RES, V19, P3750, DOI 10.1093/nar/19.13.3750; AZABLANC P, 1993, MOL ENDOCRINOL, V7, P1297, DOI 10.1210/me.7.10.1297; Bachurski CJ, 1997, J BIOL CHEM, V272, P32759, DOI 10.1074/jbc.272.52.32759; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; CARDINAUX JR, 1994, J BIOL CHEM, V269, P32947; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU HM, 1991, NUCLEIC ACIDS RES, V19, P2721, DOI 10.1093/nar/19.10.2721; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DAMANTE G, 1994, BBA-GENE STRUCT EXPR, V1218, P255, DOI 10.1016/0167-4781(94)90176-7; DEGROOT LJ, 1977, METABOLISM, V26, P665, DOI 10.1016/0026-0495(77)90088-9; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; Gao B, 1996, MOL CELL BIOL, V16, P5997; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; GREWAL T, 1992, MOL CELL BIOL, V12, P2339, DOI 10.1128/MCB.12.5.2339; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; ISOZAKI O, 1989, MOL ENDOCRINOL, V3, P1681, DOI 10.1210/mend-3-11-1681; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; JACKSON PD, 1989, GENE DEV, V3, P1860, DOI 10.1101/gad.3.12a.1860; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu YC, 1997, J BIOL CHEM, V272, P10739; LU GH, 1992, INT J BIOCHEM, V24, P455, DOI 10.1016/0020-711X(92)90039-4; MEISTERERNST M, 1989, BIOCHEMISTRY-US, V28, P8191, DOI 10.1021/bi00446a034; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; NEBL G, 1994, J BIOL CHEM, V269, P7371; NEBL G, 1995, CELL MOL BIOL RES, V41, P85; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; Ortiz L, 1997, J BIOL CHEM, V272, P23334, DOI 10.1074/jbc.272.37.23334; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Pugh BF, 1996, CURR OPIN CELL BIOL, V8, P303, DOI 10.1016/S0955-0674(96)80002-0; Puzianowska-Kuznicka M, 1996, J BIOL CHEM, V271, P6273, DOI 10.1074/jbc.271.11.6273; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; SALMINEN M, 1995, J MOL BIOL, V253, P17, DOI 10.1006/jmbi.1995.0532; SALVATORE G, 1980, THYROID GLAND, P443; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; SANTISTEBAN P, 1987, J BIOL CHEM, V262, P4048; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Sato K, 1996, BIOCHEM BIOPH RES CO, V220, P86, DOI 10.1006/bbrc.1996.0361; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Taurog A., 1996, WERNER INGBARS THYRO, V7th, P47; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465	64	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15213	15221		10.1074/jbc.274.21.15213	http://dx.doi.org/10.1074/jbc.274.21.15213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329730	hybrid			2022-12-27	WOS:000081965200095
J	Berrocal-Tito, G; Sametz-Baron, L; Eichenberg, K; Horwitz, BA; Herrera-Estrella, A				Berrocal-Tito, G; Sametz-Baron, L; Eichenberg, K; Horwitz, BA; Herrera-Estrella, A			Rapid blue light regulation of a Trichoderma harzianum photolyase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED FISH CELLS; PYRIMIDINE DIMER PHOTOLYASE; GOLDFISH CARASSIUS-AURATUS; HIGH-LEVEL EXPRESSION; MOLECULAR CHARACTERIZATION; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; DNA PHOTOLYASE; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS	Photolyases and blue light receptors belong to a superfamily of flavoproteins that make use of blue and UVA light either to catalyze DNA repair or to control development. We have isolated a DNA photolyase gene (phr1) from Trichoderma harzianum, a common soil fungus that is of interest as a biocontrol agent against soil-borne plant pathogens and as a model for the study of light-dependent development. The sequence of phr1 is similar to other Class I Type I eukaryotic photolyase genes. Low fluences of blue light rapidly induced phr1 expression both in vegetative mycelia, which lack photoprotective pigments, and, to a greater extent, in conidiophores. Thus, visible light induces the development of pigmented, resistant spores as well as the expression of phr1, perhaps announcing in this way the imminent exposure to the more damaging short wavelengths of sunlight. Light induction of phr1 in nonsporulating mutants shows that a complete sporulation pathway is not required for photoregulation. The light requirements for photoinduction of phr1 were not altered in dimY photoperception mutants. This suggests that photoinduction of sporulation and of photolyase expression is distinct in their photoreceptor system or in the transduction of the blue light signal.	Inst Politecn Nacl, Unidad Irapuato, Ctr Invest & Estudios Avanzados, Dept Plant Genet Engn, Guanajuato 36500, Mexico; Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Technion Israel Institute of Technology	Herrera-Estrella, A (corresponding author), Inst Politecn Nacl, Unidad Irapuato, Ctr Invest & Estudios Avanzados, Dept Plant Genet Engn, Apartado Posta 629, Guanajuato 36500, Mexico.		Herrera-Estrella, Alfredo/F-3185-2011; Horwitz, Benjamin A/I-5056-2013; Herrera-Estrella, Alfredo/J-8210-2019	Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; BETINA V, 1984, INT J MICROBIOL, V2, P55; CARATTOLI A, 1994, MOL MICROBIOL, V13, P787, DOI 10.1111/j.1365-2958.1994.tb00471.x; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; CORROCHANO LM, 1995, DEV BIOL, V167, P190, DOI 10.1006/dbio.1995.1016; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; FOX ME, 1994, MOL CELL BIOL, V14, P8071, DOI 10.1128/MCB.14.12.8071; GALLAND P, 1996, MICROBIOL RES, V151, P1; GEREMIA RA, 1993, MOL MICROBIOL, V8, P603, DOI 10.1111/j.1365-2958.1993.tb01604.x; GOLDMAN GH, 1992, MOL MICROBIOL, V6, P1231, DOI 10.1111/j.1365-2958.1992.tb01562.x; GRESSEL J, 1967, DEV BIOL, V15, P575, DOI 10.1016/0012-1606(67)90054-1; GRESSEL J, 1983, ENCY PLANT PHYSL, V16, P603; GRESSEL JB, 1968, PLANTA, V79, P271, DOI 10.1007/BF00396034; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Horwitz BA, 1997, BOT ACTA, V110, P360, DOI 10.1111/j.1438-8677.1997.tb00651.x; HORWITZ BA, 1985, CURR GENET, V9, P605, DOI 10.1007/BF00381174; IHARA M, 1987, MOL GEN GENET, V209, P200, DOI 10.1007/BF00329860; Jang YK, 1996, MOL GEN GENET, V251, P167; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Lin C., 1996, PLANT PHYSIOL, V110, P1047; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MATHIEU M, 1994, EMBO J, V13, P4022, DOI 10.1002/j.1460-2075.1994.tb06718.x; Mitani H, 1996, PHOTOCHEM PHOTOBIOL, V64, P943, DOI 10.1111/j.1751-1097.1996.tb01859.x; MITANI H, 1995, PHOTOCHEM PHOTOBIOL, V61, P373, DOI 10.1111/j.1751-1097.1995.tb08625.x; MITANI H, 1983, MUTAT RES, V107, P279, DOI 10.1016/0027-5107(83)90169-0; PANG QS, 1991, PLANT PHYSIOL, V95, P536, DOI 10.1104/pp.95.2.536; PAPAVIZAS GC, 1985, ANNU REV PHYTOPATHOL, V23, P23, DOI 10.1146/annurev.py.23.090185.000323; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Puyesky M, 1997, MICROBIOL-UK, V143, P3157, DOI 10.1099/00221287-143-10-3157; Sambrook J., 2002, MOL CLONING LAB MANU; SametzBaron L, 1997, PHOTOCHEM PHOTOBIOL, V65, P849, DOI 10.1111/j.1751-1097.1997.tb01933.x; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SANCAR GB, 1985, NUCLEIC ACIDS RES, V13, P8231, DOI 10.1093/nar/13.22.8231; SEBASTIAN J, 1990, MOL CELL BIOL, V10, P4630, DOI 10.1128/MCB.10.9.4630; TODO T, 1994, MUTAT RES-DNA REPAIR, V315, P213, DOI 10.1016/0921-8777(94)90033-7; YAJIMA H, 1991, NUCLEIC ACIDS RES, V19, P5359, DOI 10.1093/nar/19.19.5359; YASUHIRA S, 1991, PHOTOCHEM PHOTOBIOL, V53, P211, DOI 10.1111/j.1751-1097.1991.tb03925.x; YASUHIRA S, 1992, J BIOL CHEM, V267, P25644; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; YASUI A, 1992, MUTAT RES, V273, P231, DOI 10.1016/0921-8777(92)90084-G	44	69	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14288	14294		10.1074/jbc.274.20.14288	http://dx.doi.org/10.1074/jbc.274.20.14288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318850	hybrid			2022-12-27	WOS:000080322200079
J	Cho, SW; Yoon, HY				Cho, SW; Yoon, HY			Photoaffinity labeling of brain glutamate dehydrogenase isoproteins with an azido-ADP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; AMINO-ACID SEQUENCE; BOVINE LIVER; CLOSTRIDIUM-SYMBIOSUM; NUCLEOTIDE ANALOG; REGULATORY SITE; IDENTIFICATION; PEPTIDES; DOMAIN; 5'-TRIPHOSPHATE	The ADP binding site within two types of bovine brain glutamate dehydrogenase isoproteins (GDH I and GDH II) was identified using photoaffinity labeling with [alpha-P-32]8-azidoadenosine 5'-diphosphate (8N(3)ADP), 8N(3)ADP, without photolysis, mimicked the activatory properties of ADP on GDH I and GDH II activities, although maximal activity with 8N(3)ADP was about 75% of maximal ADP-stimulated activity. Saturation of photoinsertion with [alpha-P-32]8N(3)ADP occurred at around 40 similar to 50 mu M photoprobe with apparent K-d values near 25 and 40 mu M for GDH I and GDH Il, respectively. Photoinsertion of [alpha-P-32]8N(3)ADP was decreased best by ADP in comparison with other nucleotides. With the combination of immobilized aluminum affinity chromatography and reversed-phase high performance liquid chromatography, photolabel-containing peptides generated by tryptic digestion were isolated. This identified a portion of the adenine ring binding domain of GDH isoproteins as in the region containing the sequence, EMSWIADT-YASTIGHYDIN. Photolabeling of the peptide was prevented over 90% by the presence of 1 mM ADP during photolysis, while other nucleotides could not reduce the amount of photoinsertion as effectively as ADP. These results demonstrate selectivity of the photoprobe for the ADP binding site and suggest that the photolabeled peptide with the residues Glu(179)-Asn(197) is within the ADP binding domain of the brain GDH isoproteins.	Univ Ulsan, Coll Med, Dept Biochem, Seoul 138736, South Korea; Yonsei Univ, Coll Hlth Sci, Dept Med Technol, Wonju 222701, South Korea	University of Ulsan; Yonsei University	Cho, SW (corresponding author), Univ Ulsan, Coll Med, Dept Biochem, 388-1 Poongnap-Dong,Songpa-Ku, Seoul 138736, South Korea.	swcho@www.amc.seoul.kr						ANDERSSON L, 1991, J CHROMATOGR, V539, P327, DOI 10.1016/S0021-9673(01)83941-8; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BATRA SP, 1986, J BIOL CHEM, V261, P5565; Bringaud F, 1997, MOL CELL BIOL, V17, P3915, DOI 10.1128/MCB.17.7.3915; Brusilow SW HA., 1995, METABOLIC MOL BASES, P1187; CAMPBELL S, 1990, P NATL ACAD SCI USA, V87, P1243, DOI 10.1073/pnas.87.3.1243; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Cho SW, 1996, BIOCHIMIE, V78, P817, DOI 10.1016/S0300-9084(97)84333-7; Cho SW, 1998, J BIOL CHEM, V273, P31125, DOI 10.1074/jbc.273.47.31125; Cho SW, 1998, FEBS LETT, V426, P196, DOI 10.1016/S0014-5793(98)00335-4; Cho SW, 1996, BIOCHEMISTRY-US, V35, P13907, DOI 10.1021/bi9618575; CHO SW, 1995, EUR J BIOCHEM, V233, P340, DOI 10.1111/j.1432-1033.1995.340_1.x; CIONI P, 1989, J MOL BIOL, V207, P237, DOI 10.1016/0022-2836(89)90453-1; CROSS DG, 1970, J BIOL CHEM, V245, P2612; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; FISHER HF, 1985, METHOD ENZYMOL, V113, P16; HUSSAIN MM, 1989, J BIOL CHEM, V264, P20730; JACOBSON MA, 1982, BIOCHEMISTRY-US, V21, P2177, DOI 10.1021/bi00538a029; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; KIM H, 1991, BIOCONJUGATE CHEM, V2, P142, DOI 10.1021/bc00009a002; Kim SW, 1997, J NEUROCHEM, V69, P418; KOBERSTEIN R, 1976, FEBS LETT, V64, P176, DOI 10.1016/0014-5793(76)80277-3; MAK AS, 1978, ANAL BIOCHEM, V84, P432, DOI 10.1016/0003-2697(78)90061-1; NAKATANI Y, 1987, BIOCHEM BIOPH RES CO, V149, P405, DOI 10.1016/0006-291X(87)90381-0; OLCOTT MC, 1994, BIOCHEMISTRY-US, V33, P11935, DOI 10.1021/bi00205a032; OZTURK DH, 1992, BIOCHEMISTRY-US, V31, P10544, DOI 10.1021/bi00158a018; OZTURK DH, 1991, BIOCHEMISTRY-US, V30, P7126, DOI 10.1021/bi00243a013; Peterson PE, 1997, J STRUCT BIOL, V120, P73, DOI 10.1006/jsbi.1997.3899; Plaitakis A, 1993, Can J Neurol Sci, V20 Suppl 3, pS109; PLAITAKIS A, 1982, SCIENCE, V216, P193, DOI 10.1126/science.6121377; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; PREISS T, 1993, J BIOL CHEM, V268, P24523; Rajas F, 1996, J BIOL CHEM, V271, P29882, DOI 10.1074/jbc.271.47.29882; SALVUCCI ME, 1992, BIOCHEMISTRY-US, V31, P4479, DOI 10.1021/bi00133a014; SCHMIDT JA, 1984, J BIOL CHEM, V259, P4515; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; SHOEMAKER MT, 1993, BIOCHEMISTRY-US, V32, P1883, DOI 10.1021/bi00058a023; Shoemaker MT, 1996, BIOCONJUGATE CHEM, V7, P302, DOI 10.1021/bc960014n; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STILLMAN TJ, 1992, J MOL BIOL, V224, P1181, DOI 10.1016/0022-2836(92)90481-X; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; TZIMAGIORGIS G, 1991, BIOCHIM BIOPHYS ACTA, V1089, P250, DOI 10.1016/0167-4781(91)90017-G; VAILLANCOURT RR, 1995, BIOCHEM J, V311, P987, DOI 10.1042/bj3110987; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WRZESZCZYNSKI KO, 1994, BIOCHEMISTRY-US, V33, P11544, DOI 10.1021/bi00204a017; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Zammarchi E, 1996, METABOLISM, V45, P957, DOI 10.1016/S0026-0495(96)90262-0	47	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13948	13953		10.1074/jbc.274.20.13948	http://dx.doi.org/10.1074/jbc.274.20.13948			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318805	hybrid			2022-12-27	WOS:000080322200034
J	Liang, XQ; Zhu, D; Schulz, H				Liang, XQ; Zhu, D; Schulz, H			Delta(3,5,7),Delta(2,4,6)-trienoyl-CoA isomerase, a novel enzyme that functions in the beta-oxidation of polyunsaturated fatty acids with conjugated double bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE-DEPENDENT PATHWAY; RAT-LIVER; DELTA(3,5),DELTA(2,4)-DIENOYL-COA ISOMERASE; 3-HYDROXYACYL-COA DEHYDROGENASE; MITOCHONDRIAL METABOLISM; PEROXISOMES; PURIFICATION; HYDRATASE; PROTEIN	The mitochondrial metabolism of unsaturated fatty acids with conjugated double bonds at odd-numbered positions, e.g. 9-cis,11-trans-octadecadienoic acid, was investigated. These fatty acids are substrates of beta-oxidation in isolated rat liver mitochondria and hence are expected to yield 5,7-dienoyl-CoA intermediates. 5,7-Decadienoyl-CoA was used to study the degradation of these intermediates. After introduction of a 2-trans-double bond by acyl-CoA dehydrogenase or acyl-CoA oxidase, the resultant 2,5,7-decatrienoyl-CoA can either continue its pass through the beta-oxidation cycle or be converted by Delta(3),Delta(2)-enoyl-CoA isomerase to 3,5,7-decatrienoyl-CoA. The latter compound was isomerized by a novel enzyme, named Delta(3,5,7),Delta(2,4,6)-trienoyl-CoA isomerase, to 2,4,6-decadrienoyl-CoA, which is a substrate of 2,4-dienoyl-CoA reductase (Wang, H.-Y. and Schulz, I-I. (1989) Biochem, J. 264, 47-52) and hence can be completely degraded via beta-oxidation. Delta(3,5,7),Delta(2,4,6)-Trienoyl-CoA isomerase was purified from pig heart to apparent homogeneity and found to be a component enzyme of Delta(3,5),Delta(2,4)-dienoyl-CoA isomerase. Although the direct beta-oxidation of 2,5,7-decatrienoyl-CoA seems to be the major pathway, the degradation via 2,4,6-trienoyl-CoA makes a significant contribution to the total beta-oxidation of this intermediate.	CUNY City Coll, Dept Chem, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Schulz, H (corresponding author), CUNY City Coll, Dept Chem, Convent Ave & 138th St, New York, NY 10031 USA.				NCRR NIH HHS [RR 03060] Funding Source: Medline; NHLBI NIH HHS [HL 30847] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030847] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw R A, 1975, Methods Enzymol, V35, P122, DOI 10.1016/0076-6879(75)35147-1; CHEN LS, 1994, BIOCHEMISTRY-US, V33, P10527, DOI 10.1021/bi00200a039; DUTTON HJ, 1979, GEOMETRICAL POSITION, P1; Ellman GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI DOI 10.1016/0003-9861(59)90090-6.PMID:13650640; Filppula SA, 1998, J BIOL CHEM, V273, P349, DOI 10.1074/jbc.273.1.349; Fong J C, 1981, Methods Enzymol, V71 Pt C, P390; HE XY, 1995, BIOCHEM BIOPH RES CO, V215, P15, DOI 10.1006/bbrc.1995.2428; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LUO MJ, 1994, J BIOL CHEM, V269, P2384; MARTIN JC, 1998, T FATTY ACIDS HUMAN, P261; MARYANOFF BE, 1985, J AM CHEM SOC, V107, P217, DOI 10.1021/ja00287a040; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Nedergaard J, 1979, Methods Enzymol, V55, P3; OSUMI T, 1979, BIOCHEM BIOPH RES CO, V89, P580, DOI 10.1016/0006-291X(79)90669-7; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; Shoukry K, 1998, J BIOL CHEM, V273, P6892, DOI 10.1074/jbc.273.12.6892; SMELAND TE, 1992, P NATL ACAD SCI USA, V89, P6673, DOI 10.1073/pnas.89.15.6673; Steinman H M, 1975, Methods Enzymol, V35, P136, DOI 10.1016/0076-6879(75)35149-5; WANG HY, 1989, BIOCHEM J, V264, P47, DOI 10.1042/bj2640047; YANG SY, 1986, J BIOL CHEM, V261, P5390	22	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13830	13835		10.1074/jbc.274.20.13830	http://dx.doi.org/10.1074/jbc.274.20.13830			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318788	hybrid			2022-12-27	WOS:000080322200017
J	Kang, SS; Kwon, T; Kwon, DY; Do, SI				Kang, SS; Kwon, T; Kwon, DY; Do, SI			Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; SIGNAL-TRANSDUCTION; CATALYTIC SUBUNIT; MOLECULAR-CLONING; SURVIVAL SIGNALS; TRANSFORMATION; IDENTIFICATION; AMPLIFICATION; INHIBITION; 3-KINASE	With the amino acid sequences of all reported Akt kinase physiological substrates, the possible Akt kinase substrate specificity has been suggested. The serine/threonine residue to be phosphorylated in these proteins is placed within stretches of amino acids with homology, and the arginine residues on the -5 and -3 positions and a hydrophobic amino acid on the +2 position are conserved relative to those of serine/threonine residues (XXRXRXYS/TXX). We noticed two putative Akt kinase phosphorylation sites ((220)GARRRGGSAS(229)) and ((817)AVRIRGKSYV(826)) in human telomerase reverse transcriptase (hTERT) subunit, To demonstrate that hTERT is an Akt kinase substrate protein, we performed the nonradioactive protein kinase assay with the fluorescein hTERT peptide ((817)AVRIRGKSYV(826)). We observed the phosphorylation of hTERT peptide by the human melanoma cell lysate or the activated recombinant Akt kinase proteins in vitro. With the treatment of the growth factor deprivation or okadaic acid, we also observed the up-regulation of both hTERT peptide phosphorylation and the telomerase activity. We noticed that Wortmannin down-regulates hTERT peptide phosphorylation and telomerase activity together. In addition, we observed the enhancement of telomerase activity with the pretreatment of Akt kinase in vitro. Thus, these observations suggest that Akt kinase enhances human telomerase activity through phosphorylation of hTERT subunit as one of its substrate proteins.	Shin Dong Bang R&D Ctr, Seocho Gu, Seoul 137132, South Korea; Korea Adv Inst Sci & Technol, Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kang, SS (corresponding author), Shin Dong Bang R&D Ctr, Seocho Gu, 363,Yangjae 2 Dong, Seoul 137132, South Korea.			Kwon, Taegun/0000-0002-0205-8535				Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Barthel A, 1998, BIOCHEM BIOPH RES CO, V243, P509, DOI 10.1006/bbrc.1998.8134; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Kang SS, 1998, J BIOCHEM MOL BIOL, V31, P339; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Ku WC, 1997, BIOCHEM BIOPH RES CO, V241, P730, DOI 10.1006/bbrc.1997.7874; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Li H, 1997, J BIOL CHEM, V272, P16729, DOI 10.1074/jbc.272.27.16729; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; RAY P, 1995, J BIOL CHEM, V270, P10680, DOI 10.1074/jbc.270.18.10680; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Ulrich E, 1998, ONCOGENE, V16, P825, DOI 10.1038/sj.onc.1201842	34	402	433	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13085	13090		10.1074/jbc.274.19.13085	http://dx.doi.org/10.1074/jbc.274.19.13085			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224060	hybrid			2022-12-27	WOS:000080200400022
J	Torti, M; Bertoni, A; Canobbio, I; Sinigaglia, F; Lapetina, EG; Balduini, C				Torti, M; Bertoni, A; Canobbio, I; Sinigaglia, F; Lapetina, EG; Balduini, C			Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves Fc gamma II receptor-mediated protein tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; IX-V COMPLEX; HUMAN-PLATELETS; GLYCOPROTEIN-IB; SIGNALING PROTEIN; ACTIVATION; ASSOCIATION; INTEGRIN; KINASE; CAMP	Stimulation of human platelets with von Willebrand factor (vWF) induced the translocation of the small GTPases Rap1B and Rap2B to the cytoskeleton. This effect was specifically prevented by an anti-glycoprotein Ib monoclonal antibody or by the omission of stirring, but was not affected by the peptide RGDS, which antagonizes binding of adhesive proteins to platelet integrins. Association of Rap2B with the cytoskeleton was very rapid, while translocation of Rap1B occurred in a later phase of platelet activation and was totally inhibited by cytochalasin D. vWF also induced the rapid tyrosine phosphorylation of several proteins that was prevented by the tyrosine kinases inhibitor genistein and by cAMP-increasing agents. Under these conditions, also the association of Rap1B and Rap2B with the cytoskeleton was prevented. Translocation of Rap proteins to the cytoskeleton induced by vWF, but not by thrombin, was inhibited by a monoclonal antibody against the Fc gamma II receptor. The same antibody inhibited vWF-induced tyrosine phosphorylation of selected substrates with molecular masses of about 75, 95, and 150 kDa. Three of these substrates were identified as the tyrosine kinase pp72(syk), the phospholipase C gamma 2, and the inositol 5-phosphatase SHIP. Our results indicate that translocation of Rap1B and Rap2B to the cytoskeleton is regulated by tyrosine kinases and suggest a novel role for the Fc gamma II receptor in the mechanism of platelet activation by vWF.	Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; Univ Genoa, Inst Biol Chem, I-16132 Genoa, Italy; Case Western Reserve Univ, Sch Med, Mol Cardiovasc Res Ctr, Cleveland, OH 44106 USA	University of Pavia; University of Genoa; Case Western Reserve University	Torti, M (corresponding author), Univ Pavia, Dept Biochem, Via Bassi 21, I-27100 Pavia, Italy.		Canobbio, Ilaria/L-7414-2013	Canobbio, Ilaria/0000-0002-9643-3403				Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; Asazuma N, 1997, BLOOD, V90, P4789, DOI 10.1182/blood.V90.12.4789.4789_4789_4798; BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9; Calverley DC, 1998, BLOOD, V91, P1295, DOI 10.1182/blood.V91.4.1295; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; Clemetson KJ, 1997, THROMB HAEMOSTASIS, V78, P266; FISCHER TH, 1990, J BIOL CHEM, V265, P19405; FISCHER TH, 1994, J BIOL CHEM, V269, P17257; FOX JEB, 1993, THROMB HAEMOSTASIS, V70, P884; FOX JEB, 1987, J BIOL CHEM, V262, P12627; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; JACKSON SP, 1994, J BIOL CHEM, V269, P27093; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; KROLL MH, 1991, J CLIN INVEST, V88, P1568, DOI 10.1172/JCI115468; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; OHMSTEDE CA, 1990, P NATL ACAD SCI USA, V87, P6527, DOI 10.1073/pnas.87.17.6527; OZAKI Y, 1995, BBA-GEN SUBJECTS, V1243, P482, DOI 10.1016/0304-4165(94)00178-Z; RAMASCHI G, 1994, BBA-GEN SUBJECTS, V1199, P20, DOI 10.1016/0304-4165(94)90091-4; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; TORTI M, 1992, P NATL ACAD SCI USA, V89, P7796, DOI 10.1073/pnas.89.16.7796; Torti M, 1996, THROMB HAEMOSTASIS, V76, P444; TORTI M, 1994, THROMB HAEMOSTASIS, V71, P533; TORTI M, 1994, P NATL ACAD SCI USA, V91, P4239, DOI 10.1073/pnas.91.10.4239; TORTI M, 1993, P NATL ACAD SCI USA, V90, P7553, DOI 10.1073/pnas.90.16.7553; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; WINEGAR DA, 1991, J BIOL CHEM, V266, P4381	29	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13690	13697		10.1074/jbc.274.19.13690	http://dx.doi.org/10.1074/jbc.274.19.13690			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224142	hybrid			2022-12-27	WOS:000080200400104
J	Zhou, GS; Lee, SC; Yao, ZB; Tan, TH				Zhou, GS; Lee, SC; Yao, ZB; Tan, TH			Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL CENTER KINASE; BREAST-CANCER CELLS; PROTEIN-KINASE; NH2-TERMINAL KINASE; ADAPTER PROTEINS; GAMMA-RADIATION; JNK PATHWAY; KAPPA-B; ACTIVATION; TRANSDUCTION	The c-Jun N-terminal kinase (JNK) signaling pathway is involved in transforming growth factor beta (TGF-beta) signaling in a variety of cell systems, We report here that hematopoietic progenitor kinase 1 (HPK1), a novel Ste20-like protein serine/threonine kinase, serves as an upstream mediator for the TGF-beta-activated JNK1 cas cede in 293T cells. TGF-beta treatment resulted in a time-dependent activation of HPK1, which was accompanied by similar kinetics of JNK1 activation. The activation of JNK1 by TGF-beta was abrogated by a kinase-defective HPK1 mutant but not by a kinase-defective mutant of kinase homologous to Ste20/Sps1, This result indicates that HPK1 is specifically required for TGF-beta-induced activation of JNK1. We also found that TGF-beta-induced JNK1 activation was blocked by a kinase-defective mutant of TGF-beta-activated kinase 1 (TAK1), In addition, interaction between HPK1 and TAK1 was observed in transient transfection assays, and this interaction was enhanced by TGF-beta treatment. Both stress-activated protein kinase/extracellular signal-regulated kinase kinase (SEK) and mitogen-activated protein kinase kinase 7 (MKK7) are immediate upstream activators of JNK1. Although SEK and MKK7 acted downstream of TAK1, only a kinase-defective SEK mutant blocked TGF-beta-induced activation of JNK1, indicating that the TGF-beta signal is relayed solely through SEK, but not MKK7, in vivo. Furthermore, TGF-beta-induced activating protein 1 activation was blocked by a HPK1 mutant, as well as by TAK1 and SEK mutants. Taken together, these studies establish a potential cascade of TGF-beta-activated interacting kinases beginning with HPK1, a Ste20 homolog, and ending in JNK1 activation: HPK1 --> TAK1 --> SEK --> JNK1.	Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Amgen Inc, Boulder, CO 80301 USA	Baylor College of Medicine; Amgen	Tan, TH (corresponding author), Baylor Coll Med, Dept Microbiol & Immunol, M929 1 Baylor Plaza, Houston, TX 77030 USA.	ttan@bcm.tmc.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170	NIAID NIH HHS [R01-AI38649, R01-AI42532] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532, R01AI038649] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Axmann A, 1998, BIOCHEM BIOPH RES CO, V249, P456, DOI 10.1006/bbrc.1998.9188; Chakrabarty S, 1998, LAB INVEST, V78, P413; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Frey RS, 1997, CANCER RES, V57, P628; HATZ P, 1994, J BIOL CHEM, V269, P16802; Hirai S, 1996, ONCOGENE, V12, P641; Hirai S, 1998, J BIOL CHEM, V273, P7406, DOI 10.1074/jbc.273.13.7406; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; LAI JH, 1995, MOL CELL BIOL, V15, P4260; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Ling P, 1999, MOL CELL BIOL, V19, P1359; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; WANG L, 1996, J BIOL CHEM, V273, P8522; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130	45	71	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13133	13138		10.1074/jbc.274.19.13133	http://dx.doi.org/10.1074/jbc.274.19.13133			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224067	hybrid			2022-12-27	WOS:000080200400029
J	Greene, B; King, J				Greene, B; King, J			Folding and stability of mutant scaffolding proteins defective in P22 capsid assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-SPIKE PROTEIN; TEMPERATURE-SENSITIVE MUTATIONS; PHAGE-P22 COAT PROTEIN; POLYPEPTIDE-CHAINS; BACTERIOPHAGE P22; TAILSPIKE PROTEIN; INCLUSION; VIRUS; PURIFICATION; SUBUNITS	Bacteriophage P22 scaffolding subunits are elongated molecules that interact through their C termini with coat subunits to direct icosahedral capsid assembly. The soluble state of the subunit exhibits a partially folded intermediate during equilibrium unfolding experiments, whose C-terminal domain is unfolded (Greene, B., and King, J. (1999) J. Biol. Chem. 274, 16135-16140). Four mutant scaffolding proteins exhibiting temperature-sensitive defects in different stages of particle assembly were purified. The purified mutant proteins adopted a similar conformation to wild type, but all were destabilized with respect to wild type. Analysis of the thermal melting transitions showed that the mutants S242F and Y214W further destabilized the C-terminal domain, whereas substitutions near the N terminus either destabilized a different domain or affected interactions between domains, Two mutant proteins carried an additional cysteine residue, which formed disulfide cross-links but did not affect the denaturation transition. These mutants differed both from temperature-sensitive folding mutants found in other P22 structural proteins and from the thermolabile temperature-sensitive mutants described for T4 lysozyme, The results suggest that the defects in these mutants are due to destabilization of domains affecting the weak subunit-subunit interactions important in the assembly and function of the virus precursor shell.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Greene, B (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017980, R37GM017980] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM17980] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; BAZINET C, 1988, BIOCHEMISTRY-US, V27, P1849, DOI 10.1021/bi00406a009; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; CASJENS S, 1991, GENETICS, V127, P637; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Desai P, 1996, VIROLOGY, V220, P516, DOI 10.1006/viro.1996.0341; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; GALISTEO ML, 1995, J BIOL CHEM, V270, P16595, DOI 10.1074/jbc.270.28.16595; GOLDENBERG DP, 1981, J MOL BIOL, V145, P633, DOI 10.1016/0022-2836(81)90307-7; GOLDENBERG DP, 1983, P NATL ACAD SCI-BIOL, V80, P7060, DOI 10.1073/pnas.80.23.7060; GORDON CL, 1993, J BIOL CHEM, V268, P9358; Greene B, 1996, VIROLOGY, V225, P82, DOI 10.1006/viro.1996.0577; Greene B, 1999, J BIOL CHEM, V274, P16135, DOI 10.1074/jbc.274.23.16135; HaasePettingell C, 1997, J MOL BIOL, V267, P88, DOI 10.1006/jmbi.1996.0841; KING J, 1978, CELL, V15, P551, DOI 10.1016/0092-8674(78)90023-5; King J, 1996, FASEB J, V10, P57, DOI 10.1096/fasebj.10.1.8566549; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P279; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Parker MH, 1997, PROTEIN SCI, V6, P1583, DOI 10.1002/pro.5560060722; Parker MH, 1997, J MOL BIOL, V268, P655, DOI 10.1006/jmbi.1997.0995; Pelletier A, 1997, J VIROL, V71, P5197, DOI 10.1128/JVI.71.7.5197-5208.1997; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; SMITH DH, 1980, GENETICS, V96, P331; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; SPEED MA, 1995, PROTEIN SCI, V4, P900; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; STURTEVANT JM, 1989, J BIOL CHEM, V264, P10693; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10658, DOI 10.1021/bi00091a016; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; THOMAS GJ, 1990, BIOCHEMISTRY-US, V29, P4181, DOI 10.1021/bi00469a022; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Tuma R, 1998, J MOL BIOL, V281, P81, DOI 10.1006/jmbi.1998.1916; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; Wood LJ, 1997, J VIROL, V71, P179, DOI 10.1128/JVI.71.1.179-190.1997; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	37	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16141	16146		10.1074/jbc.274.23.16141	http://dx.doi.org/10.1074/jbc.274.23.16141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347166	hybrid			2022-12-27	WOS:000080668600026
J	Fry, CJ; Pearson, A; Malinowski, E; Bartley, SM; Greenblatt, J; Farnham, PJ				Fry, CJ; Pearson, A; Malinowski, E; Bartley, SM; Greenblatt, J; Farnham, PJ			Activation of the murine dihydrofolate reductase promoter by E2F1 - A requirement for CBP recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; TRANSCRIPTIONAL COACTIVATORS P300; HYDROPHOBIC AMINO-ACIDS; HISTONE DEACETYLASE; TRANSACTIVATION DOMAIN; COMPLEX-FORMATION; GROWTH-REGULATION; TERMINAL DOMAIN; FACTOR-TFIIB	The E2F family of heterodimeric transcription factors plays an important role in the regulation of gene expression at the G(1)/S phase transition of the mammalian cell cycle. Previously, we have demonstrated that cell cycle regulation of murine dihydrofolate reductase (dhfr) expression requires E2F-mediated activation of the dhfr promoter in S phase. To investigate the mechanism by which E2F activates an authentic E2F-regulated promoter, we precisely replaced the E2F binding site in the dhfr promoter with a Gal4 binding site. Using Gal4-E2F1 derivatives, we found that E2F1 amino acids 409-437 contain a potent core transactivation domain. Functional analysis of the E2F1 core domain demonstrated that replacement of phenylalanine residues 413, 425, and 429 with alanine reduces both transcriptional activation of the dhfr promoter and protein-protein interactions with CBP, transcription factor (TF) IIH, and TATA-binding protein (TBP), However, additional amino acid substitutions for phenylalanine 429 demonstrated a strong correlation between activation of the dhfr promoter and binding of CBP, but not TFIIH or TBP, Finally, transactivator bypass experiments indicated that direct recruitment of CBP is sufficient for activation of the dhfr promoter. Therefore, we suggest that recruitment of CBP is one mechanism by which E2F activates the dhfr promoter.	Univ Wisconsin, Sch Med, Mcardle Lab Canc Res, Madison, WI 53706 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Toronto	Farnham, PJ (corresponding author), Univ Wisconsin, Sch Med, Mcardle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.			Pearson, Angela/0000-0002-5997-2846; Farnham, Peggy/0000-0003-4469-7914	NCI NIH HHS [CA07175, CA45240, CA09135] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009135, R29CA045240, R01CA045240, P30CA007175] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Blau J, 1996, MOL CELL BIOL, V16, P2044; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chiang YC, 1996, J BIOL CHEM, V271, P32359, DOI 10.1074/jbc.271.50.32359; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; DAS G, 1995, NATURE, V374, P657, DOI 10.1038/374657a0; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; FISCHER L, 1992, SCIENCE, V257, P1392, DOI 10.1126/science.1529339; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fry CJ, 1997, MOL CELL BIOL, V17, P1966, DOI 10.1128/MCB.17.4.1966; FUJII H, 1992, FEBS LETT, V314, P33, DOI 10.1016/0014-5793(92)81455-U; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; Ichinose H, 1997, GENE, V188, P95, DOI 10.1016/S0378-1119(96)00785-8; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Johnson DG, 1998, FRONT BIOSCI, V3, pd447; Kobayashi N, 1998, MOL CELL BIOL, V18, P4023, DOI 10.1128/MCB.18.7.4023; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Majello B, 1998, J BIOL CHEM, V273, P16509, DOI 10.1074/jbc.273.26.16509; Maniatis T., 1982, MOL CLONING LAB MANU; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Parker D, 1996, MOL CELL BIOL, V16, P694; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHILLING LJ, 1995, CELL GROWTH DIFFER, V6, P541; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; SLANSKY J, 1995, THESIS U WISCONSIN M; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Snowden AW, 1998, BIOCHEM PHARMACOL, V55, P1947, DOI 10.1016/S0006-2952(98)00020-3; SRUHL K, 1998, GENE DEV, V12, P599; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wells J, 1996, MOL CELL BIOL, V16, P634; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Xiao H, 1997, MOL CELL BIOL, V17, P6898, DOI 10.1128/MCB.17.12.6898; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; ZHU H, 1994, J BIOL CHEM, V269, P3489	81	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15883	15891		10.1074/jbc.274.22.15883	http://dx.doi.org/10.1074/jbc.274.22.15883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336493	hybrid			2022-12-27	WOS:000080560100082
J	Lo Surdo, P; Bottomley, MJ; Arcaro, A; Siegal, G; Panayotou, G; Sankar, A; Gaffney, PRJ; Riley, AM; Potter, BVL; Waterfield, MD; Driscoll, PC				Lo Surdo, P; Bottomley, MJ; Arcaro, A; Siegal, G; Panayotou, G; Sankar, A; Gaffney, PRJ; Riley, AM; Potter, BVL; Waterfield, MD; Driscoll, PC			Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85 alpha src homology 2 domains with phosphoinositides and inositol polyphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL SH2 DOMAIN; PROTEIN-KINASE-B; RECEPTOR TYROSINE KINASES; PHOSPHOLIPASE C-GAMMA; ESCHERICHIA-COLI; NMR TECHNIQUES; BINDING; ACTIVATION; 3,4,5-TRISPHOSPHATE; SPECIFICITY	Src homology 2 (SH2) domains exist in many intracellular proteins and have well characterized roles in signal transduction. SH2 domains bind to phosphotyrosine (Tyr(P))-containing proteins. Although tyrosine phosphorylation is essential for protein-SHE domain interactions, the binding specificity also derives from sequences C-terminal to the Tyr(P) residue. The high affinity and specificity of this interaction is critical for precluding aberrant cross-talk between signaling pathways. The p85 alpha subunit of phosphoinositide S-kinase (PI 3-kinase) contains two SH2 domains, and it has been proposed that in competition with Tyr(P) binding they may also mediate membrane attachment via interactions with phosphoinositide products of PI 3-kinase. We used nuclear magnetic resonance spectroscopy and biosensor experiments to investigate interactions between the p85 alpha SH2 domains and phosphoinositides or inositol polyphosphates. We reported previously a similar approach when demonstrating that some pleckstrin homology domains show binding specificity for distinct phosphoinositides (Salim, K., Bottomley, M. J., Querfurth, E., Zvelebil, M. J., Gout, I., Scaife, R., Margolis, R. L., Gigg, R., Smith, C. I., Driscoll, P. C., Waterfield, M. D., and Panayotou, G. (1996) EMBO J. 15, 6241-6250). However, neither SH2 domain exhibited binding specificity for phosphoinositides in phospholipid bilayers. We show that the p85 alpha SH2 domain Tyr(P) binding pockets indiscriminately accommodate phosphoinositides and inositol polyphosphates. Binding of the SH2 domains to Tyr(P) peptides was only poorly competed for by phosphoinositides or inositol polyphosphates. We conclude that these ligands do not bind p85 alpha SH2 domains with high affinity or specificity. Moreover, we observed that although wortmannin blocks PI S-kinase activity in vivo, it does not affect the ability of tyrosine-phosphorylated proteins to bind to p85 alpha. Consequently phosphoinositide prodcts of PI 3 kinase are unlikely to regulate signaling through p85 alpha SH2 domains.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Univ London Univ Coll, Dept Chem, London WC1H 0AJ, England; Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; Ludwig Inst Canc Res, London W1P 8BT, England	University of London; University College London; University of London; University College London; University of Bath; Ludwig Institute for Cancer Research	Driscoll, PC (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	driscoll@biochem.ucl.ac.uk	Driscoll, Paul C/B-8007-2010; Riley, Andrew M/F-3526-2013; Arcaro, Alexandre/G-1711-2010; Potter, Barry/AAX-4781-2020; Potter, Barry VL/A-1845-2012	Driscoll, Paul C/0000-0002-4124-6950; Riley, Andrew M/0000-0001-9003-3540; Arcaro, Alexandre/0000-0001-9107-2947; Siegal, Gregg/0000-0003-3806-4811				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Billeter M, 1995, J BIOMOL NMR, V5, P1; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Breeze AL, 1996, EMBO J, V15, P3579, DOI 10.1002/j.1460-2075.1996.tb00727.x; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DESAI T, 1996, SYNTHESIS LIPID CHEM, P67; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Gaffney PRJ, 1997, BIOORG MED CHEM LETT, V7, P3171, DOI 10.1016/S0960-894X(97)10166-4; Gunther UL, 1996, BIOCHEMISTRY-US, V35, P15570, DOI 10.1021/bi961783x; HENSMANN M, 1994, PROTEIN SCI, V3, P1020, DOI 10.1002/pro.5560030704; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; OTTING G, 1993, CURR OPIN STRUC BIOL, V3, P760, DOI 10.1016/0959-440X(93)90061-O; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; PANAYOTOU G, 1993, BIOESSAYS, V15, P171, DOI 10.1002/bies.950150305; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; POTTER BVL, 1995, ANGEW CHEM INT EDIT, V34, P1933, DOI 10.1002/anie.199519331; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Riley AM, 1997, ANGEW CHEM INT EDIT, V36, P1472, DOI 10.1002/anie.199714721; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Siegal G, 1998, J MOL BIOL, V276, P461, DOI 10.1006/jmbi.1997.1562; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; VANNULAND NAJ, 1993, FEBS LETT, V315, P11, DOI 10.1016/0014-5793(93)81122-G; Wang DS, 1998, J ORG CHEM, V63, P5430, DOI 10.1021/jo980356h; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	49	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15678	15685		10.1074/jbc.274.22.15678	http://dx.doi.org/10.1074/jbc.274.22.15678			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336465	Green Published, hybrid			2022-12-27	WOS:000080560100054
J	Makino, Y; Kanemaki, M; Kurokawa, Y; Koji, T; Tamura, TA				Makino, Y; Kanemaki, M; Kurokawa, Y; Koji, T; Tamura, TA			A rat RuvB-like protein, TIP49a, is a germ cell-enriched novel DNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II HOLOENZYME; RNA-POLYMERASE; MEIOTIC CHROMOSOMES; STRAND EXCHANGE; MOUSE TESTIS; RECOMBINATION; REPAIR; RECA; EXPRESSION; COMPLEX	We have isolated a novel nuclear protein with a molecular mass of 49 kDa (TIP49a) from rat liver. The rat TIP49a showed structural resemblance to several bacterial RuvBs and also displayed Walker A and B motifs, We overproduced the recombinant TIP49a in Escherichia coli and purified it to near homogeneity. Biochemical investigations demonstrated that TIP49a possessed ATPase activity that was stimulated by single-stranded DNA but neither by double-stranded DNA nor by any forms of RNA polymers tested. Moreover, a UV cross-linking assay indicated TIP49a specifically interacted with ATP, Interestingly, we found that DNA duplex was unwound by the recombinant TIP49a in the presence of ATP or dATP. Optimal concentrations of ATP and Mg2+ for the helicase activity were 1-2 mM and 0.25-1 mM, respectively. Displacement of the DNA strand occurred in the 3' to 5' direction with respect to the single-stranded DNA flanking the duplex. Western blot analysis revealed that TIP49a was abundantly expressed in testes and moderately in spleen, thymus, and lung. In mouse seminiferous tubules, the protein was restrictively observed in germ lineages from late pachytene spermatocytes to round spermatids. From these observations, we propose that TIP49a is a novel DNA helicase and may play a role in nuclear processes such as recombination and transcription.	Chiba Univ, Fac Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; Nagasaki Univ, Sch Med, Dept Histol & Cell Biol, Nagasaki 8528523, Japan; CREST Japan Sci & Technol Corp, Kawaguchi 3320012, Japan	Chiba University; Nagasaki University; Japan Science & Technology Agency (JST)	Tamura, TA (corresponding author), Chiba Univ, Fac Sci, Dept Biol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	btamura@nature.s.chiba-u.ac.jp						Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; ARMON T, 1990, J BIOL CHEM, V265, P20723; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GOTO M, 1990, EXP CELL RES, V186, P273, DOI 10.1016/0014-4827(90)90306-U; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holzmann K, 1998, BIOCHEM BIOPH RES CO, V252, P39, DOI 10.1006/bbrc.1998.9604; Ikeya T, 1996, GENES CELLS, V1, P379, DOI 10.1046/j.1365-2443.1996.d01-249.x; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; KOJI T, 1992, CELL BIOCHEM FUNCT, V10, P273, DOI 10.1002/cbf.290100411; Kurokawa Y, 1999, DNA SEQUENCE, V10, P37, DOI 10.3109/10425179909033934; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Makino Y, 1998, BIOCHEM BIOPH RES CO, V245, P819, DOI 10.1006/bbrc.1998.8504; Makino Y, 1997, J BIOL CHEM, V272, P23201, DOI 10.1074/jbc.272.37.23201; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; TUTEJA N, 1991, NUCLEIC ACIDS RES, V19, P3613, DOI 10.1093/nar/19.13.3613; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173	33	70	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15329	15335		10.1074/jbc.274.22.15329	http://dx.doi.org/10.1074/jbc.274.22.15329			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336418	hybrid			2022-12-27	WOS:000080560100007
J	Treuner, K; Findeisen, M; Strausfeld, U; Knippers, R				Treuner, K; Findeisen, M; Strausfeld, U; Knippers, R			Phosphorylation of replication protein a middle subunit (RPA32) leads to a disassembly of the RPA heterotrimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; NUCLEOTIDE EXCISION-REPAIR; A PHOSPHORYLATION; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; P34 SUBUNIT; IN-VITRO; S-PHASE; KINASE; CDC2	Replication protein A (RPA), the major eukaryotic single-strand specific DNA binding protein, consists of three subunits, RPA70, RPA32, and RPA14. The middle subunit, RPA32, is phosphorylated in a cell cycle-dependent manner. RPA occurs in two nuclear compartments, bound to chromatin or free in the nucleosol, We show here that the chromatin-associated fraction of RPA contains the phosphorylated forms of RPA32, Treatment of chromatin with 0.4 hr NaCl releases bound RPA and causes a separation of the large and the phosphorylated middle RPA subunit, Unmodified RPA in the nucleosolic fraction remains perfectly stable under identical conditions. Phosphorylation is most likely an important determinant of RPA desintegration because dialysis from 0.4 to 0.1 NaCl causes the reformation of trimeric RPA only under dephosphorylating conditions, Biochemical studies with isolated Cyclin-dependent protein kinases showed that cyclin A/CDK1 and cyclin B/CDK1, but not cyclin E/CDK2, can phosphorylate human recombinant RPA in vitro, However, only a small fraction of in vitro phosphorylated RPA desintegrated, suggesting that phosphorylation may be one, but probably not the only, determinant affecting subunit interaction. We speculate that phosphorylation and changes in subunit interaction are required for the proposed role of RPA during the polymerase switch at replication forks.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Knippers, R (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	rolf.knippers@uni-konstanz.de						ADAM SA, 1992, METHOD ENZYMOL, V219, P97; Blackwell LJ, 1996, MOL CELL BIOL, V16, P4798; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BOUBNOV NV, 1995, MOL CELL BIOL, V15, P5700; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FANG F, 1993, J CELL SCI, V106, P983; Fried LM, 1996, P NATL ACAD SCI USA, V93, P13825, DOI 10.1073/pnas.93.24.13825; HANCOCK R, 1974, J MOL BIOL, V86, P649, DOI 10.1016/0022-2836(74)90187-9; Harlow E., 1988, ANTIBODIES LAB MANUA; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Henricksen LA, 1996, NUCLEIC ACIDS RES, V24, P3107, DOI 10.1093/nar/24.15.3107; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Mass G, 1998, MOL CELL BIOL, V18, P6399, DOI 10.1128/MCB.18.11.6399; MOORE SP, 1991, P NATL ACAD SCI USA, V88, P9067, DOI 10.1073/pnas.88.20.9067; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Schwab BL, 1998, EXP CELL RES, V238, P415, DOI 10.1006/excr.1997.3850; SEROUSSI E, 1993, J BIOL CHEM, V268, P7147; SINGH KK, 1995, P NATL ACAD SCI USA, V92, P4907, DOI 10.1073/pnas.92.11.4907; Strausfeld UP, 1996, J CELL SCI, V109, P1555; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treuner K, 1999, NUCLEIC ACIDS RES, V27, P1499, DOI 10.1093/nar/27.6.1499; Treuner K, 1998, J BIOL CHEM, V273, P31744, DOI 10.1074/jbc.273.48.31744; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	46	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15556	15561		10.1074/jbc.274.22.15556	http://dx.doi.org/10.1074/jbc.274.22.15556			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336450	hybrid			2022-12-27	WOS:000080560100039
J	Hama, H; Tall, GG; Horazdovsky, BF				Hama, H; Tall, GG; Horazdovsky, BF			Vps9p is a guanine nucleotide exchange factor involved in vesicle-mediated vacuolar protein transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GDP-DISSOCIATION INHIBITOR; LYSOSOME-LIKE VACUOLE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; RAB-GTPASES; GDP/GTP EXCHANGE; MEMBRANE ASSOCIATION; ACTIVATING PROTEIN; SORTING RECEPTOR	Vacuolar protein sorting (vps) mutants of Saccharomyces cerevisiae missort and secrete vacuolar hydrolases, The gene affected in one of these mutants, VPS21, encodes a member of the Sec4/Ypt/Rab family of small GTPases. Rab proteins play an essential role in vesicle-mediated protein transport. Using both yeast two-hybrid assays and chemical cross-linking, we have identified another VPS gene product, Vps9p, that preferentially interacts with a mutant form of Vps21p-S21N that binds GDP but not GTP. In vitro purified Vps9p was found to stimulate GDP release hom Vps21p in a dose-dependent manner, Vps9p also stimulated GTP association as a result of facilitated GDP release. How ever Vps9p did not stimulate guanine nucleotide exchange of GTP-bound Vps21p or GTP hydrolysis. me tested the ability of Vps9p to stimulate the intrinsic guanine nucleotide exchange activity of Rab5, which is a mammalian sequence homologue of Vps21p, and Ypt7p, which is another yeast Rab protein involved in vacuolar protein transport, Rab5, but not Ypt7p was responsive to Vps9p, which indicates that Vps9p recognizes sequence variation among Rab proteins. We conclude that Vps9p is a novel guanine nucleotide exchange factor that is specific for Vps21p/Rab5. Since there are no obvious Vps9p sequence homologues in yeast, Vps9p may also possess unique regulatory functions required for vacuolar protein transport.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Horazdovsky, BF (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA.				NIGMS NIH HHS [GM-55301] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BANROQUES J, 1986, CELL, V46, P837, DOI 10.1016/0092-8674(86)90065-6; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; Chen YJ, 1996, EUR J CELL BIOL, V70, P289; Collins RN, 1997, J BIOL CHEM, V272, P18281, DOI 10.1074/jbc.272.29.18281; COWLES CR, 1994, J CELL SCI, V107, P3449; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; HORAZDOVSKY BF, 1995, CURR OPIN CELL BIOL, V7, P544, DOI 10.1016/0955-0674(95)80012-3; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; HORAZDOVSKY BF, 1989, J BACTERIOL, V171, P3053, DOI 10.1128/jb.171.6.3053-3059.1989; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Miller J.H., 1972, EXPT MOL GENETICS; MOYA M, 1993, NATURE, V361, P460, DOI 10.1038/361460a0; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; PIPER RC, 1994, EUR J CELL BIOL, V65, P305; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROMERO G, 1985, J BIOL CHEM, V260, P6167; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Sherman F, 1979, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5	58	110	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15284	15291		10.1074/jbc.274.21.15284	http://dx.doi.org/10.1074/jbc.274.21.15284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329739	hybrid			2022-12-27	WOS:000081965200104
J	Holz, B; Dank, N; Eickhoff, JE; Lipps, G; Krauss, G; Weinhold, E				Holz, B; Dank, N; Eickhoff, JE; Lipps, G; Krauss, G; Weinhold, E			Identification of the binding site for the extrahelical target base in N-6-adenine DNA methyltransferases by photo-cross-linking with duplex oligodeoxyribonucleotides containing 5-iodouracil at the target position	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA METHYLTRANSFERASE; CRYSTAL-STRUCTURE; ANTIBIOTIC-RESISTANCE; S-ADENOSYLMETHIONINE; TAQ-I; PROTEINS; COMPLEX; DOMAIN; RESTRICTION; MISMATCHES	DNA methyltransferases flip their target bases out of the DNA double helix for catalysis. Base flipping of C-5-cytosine DNA methyltransferases was directly observed in the protein-DNA cocrystal structures of M.HhaI and M.HaeIII. Indirect structural evidence for base flipping of N-6-adenine and N-4-cytosine DNA methyltransferases was obtained by modeling DNA into the three-dimensional structures of M.TaqI and M.PvuII in complex with the cofactor. In addition, biochemical evidence of base flipping was reported for different N-6-adenine DNA methyltransferases. As no protein-DNA cocrystal structure for the related N-6-adenine and N-4-cytosine DNA methyltransferases is available, we used light-induced photochemical cross-linking to identify the binding site of the extrahelical target bases, The N-6-adenine DNA methyltransferases M.TaqI and M.CviBIII, which both methylate adenine within the double-stranded 5'-TCGA-3' DNA sequence, were photo cross-linked to duplex oligodeoxyribonucleotides containing 5-iodouracil at the target position in 50-60% and almost quantitative yield, respectively. Proteolytic fragmentation of the M.CviBIII-DNA complex followed by Edman degradation and electrospray ionization mass spectrometry indicates photo-cross-linking to tyrosine 122. In addition, the mutant methyltransferases M.TaqI/Y108A and MTaqI/F196A were photo-cross-linked with 6-fold and 2-fold reduced efficiency, respectively, which suggests that tyrosine 108 is the primary site of modification in M.TaqI. Our results indicate a close proximity between the extrahelical target base and tyrosine 122 in M.CviBIII or tyrosine 108 in M.TaqI. As both residues belong to the conserved motif IV ((N/D/S)(P/I)P(Y/F/W)) found in all N-6-adenine and N-4-cytosine DNA as well as in N-6-adenine RNA methyltransferases, a similar spatial relationship between the target bases and the aromatic amino acid residue within motif IV is expected for all these methyltransferases.	Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany; Univ Bayreuth, Biochem Lab, D-95440 Bayreuth, Germany	Max Planck Society; University of Bayreuth	Weinhold, E (corresponding author), Max Planck Inst Mol Physiol, Phys Biochem Abt, Otto Hahn Str 11, D-44227 Dortmund, Germany.							ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ADAMS RLP, 1985, MOL BIOL DNA METHYLA, P3; Allan BW, 1998, J BIOL CHEM, V273, P2368, DOI 10.1074/jbc.273.4.2368; Allan BW, 1996, BIOCHEMISTRY-US, V35, P14757, DOI 10.1021/bi9615708; BARANY F, 1992, GENE, V112, P91, DOI 10.1016/0378-1119(92)90307-B; BARRAS F, 1989, TRENDS GENET, V5, P139, DOI 10.1016/0168-9525(89)90054-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussiere DE, 1998, BIOCHEMISTRY-US, V37, P7103, DOI 10.1021/bi973113c; Cal S, 1997, J BIOL CHEM, V272, P490; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Ferrer E, 1997, BIOCONJUGATE CHEM, V8, P757, DOI 10.1021/bc970042l; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; Heitman J, 1993, Genet Eng (N Y), V15, P57; Holz B, 1998, NUCLEIC ACIDS RES, V26, P1076, DOI 10.1093/nar/26.4.1076; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOST JP, 1993, DNA METHYLATION MOL; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; LeCuyer KA, 1996, EMBO J, V15, P6847, DOI 10.1002/j.1460-2075.1996.tb01076.x; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; NARVA KE, 1987, NUCLEIC ACIDS RES, V15, P9807, DOI 10.1093/nar/15.23.9807; NARVA KE, 1988, GENE, V74, P253, DOI 10.1016/0378-1119(88)90298-3; Norris CL, 1996, J AM CHEM SOC, V118, P5796, DOI 10.1021/ja9607852; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLUCKEBIER G, 1995, GENE, V157, P131, DOI 10.1016/0378-1119(94)00690-T; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; SLATKO BE, 1987, NUCLEIC ACIDS RES, V15, P9781, DOI 10.1093/nar/15.23.9781; STUMP WT, 1995, RNA, V1, P55; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; WILLIAMS KR, 1991, METHOD ENZYMOL, V208, P516; WILLIS MC, 1993, SCIENCE, V262, P1255, DOI 10.1126/science.7694369; Wong DL, 1998, NUCLEIC ACIDS RES, V26, P645, DOI 10.1093/nar/26.2.645; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; Yu LP, 1997, NAT STRUCT BIOL, V4, P483, DOI 10.1038/nsb0697-483	42	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15066	15072		10.1074/jbc.274.21.15066	http://dx.doi.org/10.1074/jbc.274.21.15066			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329711	hybrid			2022-12-27	WOS:000081965200076
J	Khanna, R; Chang, MC; Joiner, WJ; Kaczmarek, LK; Schlichter, LC				Khanna, R; Chang, MC; Joiner, WJ; Kaczmarek, LK; Schlichter, LC			hSK4/hIK1, a calmodulin-binding K-Ca channel in human T lymphocytes - Roles in proliferation and volume regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; PROTEIN-KINASE; KV1.3 CHANNELS; CELL-VOLUME; CALCIUM; ANTAGONISTS; INHIBITION; EXPRESSION; MECHANISMS	Human T lymphocytes express a Ca2+-activated K+ current (IK), whose roles and regulation are poorly understood. We amplified hSK4 cDNA hom human T lymphoblasts, and we showed that its biophysical and pharmacological properties when stably expressed in Chinese hamster ovary cells were essentially identical to the native IK current. In activated lymphoblasts, hSK4 mRNA increased 14.6-fold (Kv1.3 mRNA increased 1.3-fold), with functional consequences. Proliferation was inhibited when Kv1.3 and IK were blocked in naive T cells, but IK block alone inhibited re-stimulated lymphoblasts. IK and Kv1.3 were involved in volume regulation, but IK was more important, particularly in lymphoblasts. hSK4 lacks known Ca2+-binding sites; however, we mapped a Ca2+-dependent calmodulin (CaM)-binding site to the proximal C terminus (Ct1) of hSK4. Full-length hSK4 produced a highly negative membrane potential (V-m) in Chinese hamster ovary cells, whereas the channels did not function when either Ctl or the distal C terminus was deleted (V-m similar to 0 mV). Native IK (but not expressed hSK4) current was inhibited by CaM and CaM kinase antagonists at physiological V-m values, suggesting modulation by an accessory molecule in native cells. Our results provide evidence for increased roles for IK/hSK4 in activated T cell functions; thus hSK4 may be a promising therapeutic target for disorders involving the secondary immune response.	Toronto Western Hosp, Univ Hlth Network, Playfair Neurosci Unit, Toronto, ON M5T 2S8, Canada; Toronto Western Hosp, Dept Physiol, Toronto, ON M5T 2S8, Canada; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University	Schlichter, LC (corresponding author), Toronto Western Hosp, Univ Hlth Network, Playfair Neurosci Unit, MC 11-417,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	schlicht@playfair.utoronto.ca	Chang, Martin/J-2329-2016	Khanna, Rajesh/0000-0002-9066-2969	NIDCD NIH HHS [DC01919] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chang M. C., 1996, Society for Neuroscience Abstracts, V22, P1444; Chapin SJ, 1996, J BIOL CHEM, V271, P1336, DOI 10.1074/jbc.271.3.1336; CHEUNG RK, 1983, J IMMUNOL, V131, P2291; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung I, 1997, J MEMBRANE BIOL, V156, P73, DOI 10.1007/s002329900189; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; DEUTSCH C, 1993, P NATL ACAD SCI USA, V90, P10036, DOI 10.1073/pnas.90.21.10036; GIETZEN K, 1981, BIOCHEM BIOPH RES CO, V101, P418, DOI 10.1016/0006-291X(81)91276-6; GRINSTEIN S, 1982, J GEN PHYSIOL, V79, P849, DOI 10.1085/jgp.79.5.849; GRINSTEIN S, 1990, ANNU REV PHYSIOL, V52, P399; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Khanna R, 1998, BIOPHYS J, V74, pA35; KIHIRA M, 1990, BRIT J PHARMACOL, V100, P353, DOI 10.1111/j.1476-5381.1990.tb15808.x; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Koo GC, 1997, J IMMUNOL, V158, P5120; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P1, DOI 10.1159/000016269; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; LINSE S, 1991, J BIOL CHEM, V266, P8050; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MAHAUT-SMITH M P, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS164, DOI 10.1007/BF00582284; MAHAUTSMITH MP, 1989, J PHYSIOL-LONDON, V415, P69, DOI 10.1113/jphysiol.1989.sp017712; MCCANN JD, 1987, J GEN PHYSIOL, V89, P339, DOI 10.1085/jgp.89.2.339; MCGANN LE, 1988, CYTOMETRY, V9, P33, DOI 10.1002/cyto.990090106; NAKABAYASHI H, 1992, BIOL CELL, V75, P55, DOI 10.1016/0248-4900(92)90124-J; PAHAPILL PA, 1990, J PHYSIOL-LONDON, V422, P103, DOI 10.1113/jphysiol.1990.sp017975; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; REES RC, 1987, BIOSCIENCE REP, V7, P771, DOI 10.1007/BF01116749; SARKADI B, 1991, BIOCHIM BIOPHYS ACTA, V1071, P407, DOI 10.1016/0304-4157(91)90005-H; SCHLICHTER LC, 1993, RECEPTOR CHANNEL, V1, P201; SCHLICHTER LC, 1994, EXP CELL RES, V215, P211, DOI 10.1006/excr.1994.1334; Schlichter LC, 1997, CELL PHYSIOL BIOCHEM, V7, P159, DOI 10.1159/000154871; SCHLICHTER LC, 1992, PFLUG ARCH EUR J PHY, V421, P400, DOI 10.1007/BF00374232; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SCHUMACHER PA, 1995, J MEMBRANE BIOL, V145, P217; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; TANAKA T, 1982, MOL PHARMACOL, V22, P408; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Verheugen JAH, 1997, CELL PHYSIOL BIOCHEM, V7, P188, DOI 10.1159/000154874; VERHEUGEN JAH, 1995, CELL CALCIUM, V17, P287, DOI 10.1016/0143-4160(95)90075-6; Wadsworth JDF, 1997, ARCH BIOCHEM BIOPHYS, V346, P151, DOI 10.1006/abbi.1997.0280; WALSH M P, 1985, Reviews in Clinical and Basic Pharmacology, V5, P35; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Weiss B, 1980, Ann N Y Acad Sci, V356, P319, DOI 10.1111/j.1749-6632.1980.tb29621.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	56	199	209	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14838	14849		10.1074/jbc.274.21.14838	http://dx.doi.org/10.1074/jbc.274.21.14838			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329683	hybrid			2022-12-27	WOS:000081965200048
J	Koppaka, V; Silvestro, L; Engler, JA; Brouillette, CG; Axelsen, PH				Koppaka, V; Silvestro, L; Engler, JA; Brouillette, CG; Axelsen, PH			The structure of human lipoprotein A-I - Evidence for the "belt" model"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; LIPID-FREE STRUCTURE; INFRARED-SPECTROSCOPY; TERMINAL DELETIONS; CONFORMATION; FLUORESCENCE; MEMBRANES; RECEPTOR; GENE	The two main competing models for the structure of discoidal lipoprotein A-I complexes both presume that the protein component is helical and situated around the perimeter of a lipid bilayer disc. However, the more popular "picket fence" model orients the protein helices perpendicular to the surface of the lipid bilayer, while the alternative "belt" model orients them parallel to the bilayer surface. To distinguish between these models, we have investigated the structure of human lipoprotein A-I using a novel form of polarized internal reflection infrared spectroscopy that can characterize the relative orientation of protein and lipid components in the lipoprotein complexes under native conditions. Our results verify lipid bilayer structure in the complexes and point unambiguously to the belt model.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Infect Dis Sect, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Johnson Fdn Mol Biophys, Philadelphia, PA 19104 USA; Univ Alabama, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Med Ctr, Dept Physiol Opt, Ctr Macromol Crystallog, Birmingham, AL 35294 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Axelsen, PH (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.							Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ANDREWS AL, 1976, EUR J BIOCHEM, V64, P549, DOI 10.1111/j.1432-1033.1976.tb10335.x; AXELSEN PH, 1995, APPL SPECTROSC, V49, P526, DOI 10.1366/0003702953964273; Axelsen PH, 1995, BIOPHYS J, V69, P2770, DOI 10.1016/S0006-3495(95)80150-5; AXELSEN PH, 1997, PROG BIOPHYS MOL BIO, V66, P227; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; CHEUNG P, 1983, NUCLEIC ACIDS RES, V11, P3703, DOI 10.1093/nar/11.11.3703; Citra MJ, 1996, BIOPHYS J, V71, P1796, DOI 10.1016/S0006-3495(96)79380-3; FIELDING CJ, 1995, J LIPID RES, V36, P211; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P1055, DOI 10.1021/bi00534a036; HUGHES TA, 1988, J LIPID RES, V29, P363; JONAS A, 1987, PLASMA LIPOPROTEINS; MILLER NE, 1989, HIGH DENSITY LIPOPRO; Picard F, 1999, BIOPHYS J, V76, P539, DOI 10.1016/S0006-3495(99)77222-X; RHOADS GG, 1976, NEW ENGL J MED, V294, P293, DOI 10.1056/NEJM197602052940601; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; SEGREST JP, 1992, J LIPID RES, V33, P141; Silvestro L, 1999, BIOCHEMISTRY-US, V38, P113, DOI 10.1021/bi981289o; Silvestro L, 1998, CHEM PHYS LIPIDS, V96, P69, DOI 10.1016/S0009-3084(98)00081-4; VANLOO B, 1995, J LIPID RES, V36, P1686; WALD JH, 1990, J BIOL CHEM, V265, P20044; White S. H., 1995, PERMEABILITY STABILI, P1; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640	33	124	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14541	14544		10.1074/jbc.274.21.14541	http://dx.doi.org/10.1074/jbc.274.21.14541			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329643	hybrid			2022-12-27	WOS:000081965200008
J	Russo, N; Shapiro, R				Russo, N; Shapiro, R			Potent inhibition of mammalian ribonucleases by 3 ',5 '-pyrophosphate-linked nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCE; HUMAN ANGIOGENIN; 5'-DIPHOSPHOADENOSINE 3'-PHOSPHATE; RIBONUCLEOLYTIC ACTIVITY; PANCREATIC-TYPE; HUMAN-URINE; HUMAN-LIVER; URIDINE	Molecular modeling based on the crystal structure of the complex of bovine pancreatic RNase A with the inhibitor 5'-diphosphoadenosine 3'-phosphate (ppAp) (Leonidas, D. D., Shapiro, R., Irons, L. I., Russo, N., and Acharya, K. R. (1997) Biochemistry 36, 5578-5588) was used to design new inhibitors that extend into unoccupied regions of the enzyme active site. These compounds are dinucleotides that contain an unusual 3',5'-pyrophosphate Linkage and were synthesized in solution by a combined chemical and enzymatic procedure. The most potent of them, 5'-phospho-2'-deoxyuridine S'-pyrophosphate, P' --> 5'-ester with adenosine 3'-phosphate (pdUppAp), binds to RNase A with K-i values of 27 and 220 nM at pH 5.9 and 7, respectively. These values are 6-9-fold lower than those for ppAp and 50-fold lower than that for the transition state analogue, uridine vanadate. pdUppAp has broad specificity; it is an effective inhibitor of at least two other members of the pancreatic RNase superfamily, human RNase-a (eosinophil-derived neurotoxin) and RNase-4, which share only 36-44% sequence identity with the pancreatic enzyme. The potency of pdUppAp and the other inhibitors described here depends critically on the extended internucleotide linkage; the pyrophosphate group enhances dinucleotide binding to the three RNases by 2.1-2.9 orders of magnitude, as compared with a monophosphate. These data give further insight into the organization of the catalytic centers of the various RNases. Moreover, the new class of inhibitors provides a useful means by which to probe the biological actions of these and other related enzymes.	Harvard Univ, Sch Med, Ctr Biochem & Biophys Sci & Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shapiro, R (corresponding author), Harvard Univ, Sch Med, Ctr Biochem & Biophys Sci & Med, Seeley G Mudd Bldg,250 Longwood Ave, Boston, MA 02115 USA.	shapiro@ferret.med.harvard.edu		Russo, Aniello/0000-0001-5421-3552				ANDERSON DG, 1968, BIOCHEMISTRY-US, V7, P1637, DOI 10.1021/bi00845a004; Beaven G.H., 1955, NUCL ACIDS, V1, P493, DOI DOI 10.1002/JPS.3030440720; BEINTEMA JJ, 1988, BIOCHEMISTRY-US, V27, P4530, DOI 10.1021/bi00412a046; BEINTEMA JJ, 1986, MOL BIOL EVOL, V3, P262; BEINTEMA JJ, 1989, FEBS LETT, V254, P1, DOI 10.1016/0014-5793(89)80996-2; BORAH B, 1985, BIOCHEMISTRY-US, V24, P2058, DOI 10.1021/bi00329a038; BORKAKOTI N, 1982, ACTA CRYSTALLOGR B, V38, P2210, DOI 10.1107/S0567740882008346; D'Alessio Giuseppe, 1993, Trends in Cell Biology, V3, P106, DOI 10.1016/0962-8924(93)90166-X; DALESSIO G, 1991, TRENDS BIOCHEM SCI, V16, P104, DOI 10.1016/0968-0004(91)90042-T; DELROSAR.EJ, 1969, BIOCHEMISTRY-US, V8, P1884, DOI 10.1021/bi00833a017; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; HOFSTEENGE J, 1989, BIOCHEMISTRY-US, V28, P9806, DOI 10.1021/bi00451a040; Hofsteenge J, 1998, BIOCHEMISTRY-US, V37, P9250, DOI 10.1021/bi9803832; HOSOYA K, 1990, J BIOCHEM-TOKYO, V107, P613, DOI 10.1093/oxfordjournals.jbchem.a123095; IRIE M, 1984, J BIOCHEM-TOKYO, V95, P751, DOI 10.1093/oxfordjournals.jbchem.a134666; IWAHASHI K, 1981, J BIOCHEM-TOKYO, V90, P1685, DOI 10.1093/oxfordjournals.jbchem.a133644; IWAMA M, 1981, J BIOCHEM-TOKYO, V89, P1005; KING TV, 1991, J BONE JOINT SURG BR, V73, P587, DOI 10.1302/0301-620X.73B4.1712788; Leonidas DD, 1997, BIOCHEMISTRY-US, V36, P5578, DOI 10.1021/bi9700330; LINDQUIST RN, 1973, J AM CHEM SOC, V95, P8762, DOI 10.1021/ja00807a043; MOFFATT JG, 1961, J AM CHEM SOC, V83, P663, DOI 10.1021/ja01464a036; Mosimann SC, 1996, J MOL BIOL, V260, P540, DOI 10.1006/jmbi.1996.0420; NOGUES MV, 1995, BBA-PROTEIN STRUCT M, V1253, P16, DOI 10.1016/0167-4838(95)00138-K; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; RICHARDS FM, 1971, ENZYMES, V4, P647; RUSSO N, 1994, P NATL ACAD SCI USA, V91, P2920, DOI 10.1073/pnas.91.8.2920; Russo N, 1997, BIOCHEM BIOPH RES CO, V231, P671, DOI 10.1006/bbrc.1997.6167; SATO S, 1966, ARCH BIOCHEM BIOPHYS, V115, P48, DOI 10.1016/S0003-9861(66)81036-6; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V24, P229, DOI 10.1016/0006-3002(57)90186-5; SHAPIRO R, 1991, BIOCHEMISTRY-US, V30, P2246, DOI 10.1021/bi00222a030; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P3527, DOI 10.1021/bi00360a008; SHAPIRO R, 1987, BIOCHEMISTRY-US, V26, P5141, DOI 10.1021/bi00390a037; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P7255, DOI 10.1021/bi00371a002; SORRENTINO S, 1988, J BIOL CHEM, V263, P16125; SORRENTINO S, 1992, J BIOL CHEM, V267, P14859; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Vicentini AM, 1996, BIOCHEMISTRY-US, V35, P9128, DOI 10.1021/bi960457e; WITZEL H, 1962, BIOCHEM BIOPH RES CO, V7, P295, DOI 10.1016/0006-291X(62)90194-8; ZHOU HM, 1993, EUR J BIOCHEM, V217, P401, DOI 10.1111/j.1432-1033.1993.tb18259.x	44	47	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14902	14908		10.1074/jbc.274.21.14902	http://dx.doi.org/10.1074/jbc.274.21.14902			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329690	hybrid			2022-12-27	WOS:000081965200055
J	Truschel, ST; Ruiz, WG; Shulman, T; Pilewski, J; Sun, TT; Zeidel, ML; Apodaca, G				Truschel, ST; Ruiz, WG; Shulman, T; Pilewski, J; Sun, TT; Zeidel, ML; Apodaca, G			Primary uroepithelial cultures - A model system to analyze umbrella cell barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN URINARY-BLADDER; TRANSITIONAL EPITHELIAL-CELLS; EPIDERMAL GROWTH-FACTOR; HUMAN UROTHELIAL CELLS; SERUM-FREE MEDIUM; IN-VITRO; APICAL MEMBRANE; STROMAL INTERACTIONS; COLLECTING DUCT; TISSUE-CULTURE	Despite almost 25 years of effort, the development of a highly differentiated and functionally equivalent cell culture model of uroepithelial cells has eluded investigators. We have developed a primary cell culture model of rabbit uroepithelium that consists of an underlying cell layer that interacts with a collagen substratum, an intermediate cell layer, and an upper cell layer of large (25-100 mu m) superficial cells. When examined at the ultrastructural level, the superficial cells formed junctional complexes and had an asymmetric unit membrane, a hallmark of terminal differentiation in bladder umbrella cells. These cultured "umbrella" cells expressed uroplakins and a 27-kDa uroepithelial specific antigen that assembled into detergent-resistant asymmetric unit membrane particles, The cultures had low diffusive permeabilities for water (2.8 x 10(-4) cm/s) and urea (3.0 x 10(-7) cm/s) and high transepithelial resistance (>8000 Ohm cm(2)) was achieved when 1 mM CaCl2 was included in the culture medium. The cell cultures expressed an amiloride-sensitive sodium transport pathway and increases in apical membrane capacitance were observed when the cultures were osmotically stretched, The described primary rabbit cell culture model mimics many of the characteristics of uroepithelium found in vivo and should serve as a useful tool to explore normal uroepithelial function as well as dysfunction as a result of disease.	Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Lab Epithelial Cell Biol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Div Pulm, Pittsburgh, PA 15261 USA; NYU, Sch Med, Dept Dermatol, Epithelial Biol Unit, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, Epithelial Biol Unit, New York, NY 10016 USA; NYU, Sch Med, Dept Urol, Epithelial Biol Unit, New York, NY 10016 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; New York University; New York University	Apodaca, G (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 982 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	gla8@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Pilewski, Joseph/AAF-5149-2021; Sun, Tung-Tien/J-4425-2015	Sun, Tung-Tien/0000-0002-6841-1063; Truschel, Steven/0000-0003-3394-6006	NIDDK NIH HHS [DK 49469, DK 48217, R01DK51970-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048217, R37DK048217, R01DK049469, R01DK051970] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN LE, 1990, CANCER RES, V50, P1897; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; CHLAPOWSKI FJ, 1979, J CELL BIOL, V83, P605, DOI 10.1083/jcb.83.3.605; CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9; DEBOER WI, 1994, J HISTOCHEM CYTOCHEM, V42, P277, DOI 10.1177/42.2.7507144; DUBEAU L, 1987, CANCER RES, V47, P2107; ELLIOTT AY, 1975, IN VITRO CELL DEV B, V11, P251, DOI 10.1007/BF02615635; FELIX JS, 1979, INT REV CYTOL      S, V10, P11; FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0; GUHE C, 1994, AM J PHYSIOL, V266, pF298, DOI 10.1152/ajprenal.1994.266.2.F298; HANG A, 1994, AM J PHYSIOL, V267, pC1483; HERZ F, 1979, P SOC EXP BIOL MED, V161, P153; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; HODGES GM, 1977, CANCER RES, V37, P3720; HOEHN H, 1975, HUMANGENETIK, V29, P285, DOI 10.1007/BF00394190; HOWLETT AR, 1986, DEV BIOL, V118, P403, DOI 10.1016/0012-1606(86)90011-4; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; KATO T, 1978, TOHOKU J EXP MED, V124, P339, DOI 10.1620/tjem.124.339; KIRK D, 1985, IN VITRO CELL DEV B, V21, P165; KOSS LG, 1969, LAB INVEST, V21, P154; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LEWIS SA, 1976, J MEMBRANE BIOL, V28, P1, DOI 10.1007/BF01869689; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; LEWIS SA, 1990, METHOD ENZYMOL, V192, P632; LEWIS SA, 1976, J MEMBRANE BIOL, V28, P41, DOI 10.1007/BF01869690; LIEBERT M, 1990, J UROLOGY, V144, P1288, DOI 10.1016/S0022-5347(17)39721-5; LOGOTHETOURELLA H, 1988, EUR UROL, V15, P259; LORETZ LJ, 1988, IN VITRO CELL DEV B, V24, P333; MARTIN BF, 1972, J ANAT, V112, P433; MESSING EM, 1987, J UROLOGY, V138, P1329, DOI 10.1016/S0022-5347(17)43593-2; MESSING EM, 1987, CANCER RES, V47, P2230; MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685; MOLL R, 1995, AM J PATHOL, V147, P1383; MORITA T, 1995, UROL RES, V23, P143, DOI 10.1007/BF00389565; MURRAY JC, 1979, J CELL BIOL, V80, P197, DOI 10.1083/jcb.80.1.197; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; PARSONS CL, 1990, J UROLOGY, V143, P139; PEEHL DM, 1980, IN VITRO CELL DEV B, V16, P516; Perrone RD, 1996, AM J PHYSIOL-RENAL, V270, pF148, DOI 10.1152/ajprenal.1996.270.1.F148; PORTER KR, 1967, PROTOPLASMA, V63, P262, DOI 10.1007/BF01248042; PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002; RASHEED S, 1977, J NATL CANCER I, V58, P881, DOI 10.1093/jnci/58.4.881; REZNIKOFF CA, 1987, J CELL PHYSIOL, V131, P285, DOI 10.1002/jcp.1041310302; REZNIKOFF CA, 1983, IN VITRO CELL DEV B, V19, P326; RHEINWALD JG, 1985, ANN NY ACAD SCI, V455, P259, DOI 10.1111/j.1749-6632.1985.tb50416.x; RUSSELL PJ, 1988, INT J CANCER, V41, P74, DOI 10.1002/ijc.2910410115; SANDS JM, 1987, AM J PHYSIOL, V253, pF823, DOI 10.1152/ajprenal.1987.253.5.F823; SARIKAS SN, 1986, CELL TISSUE RES, V246, P109; Schaefer BM, 1998, J UROLOGY, V159, P284, DOI 10.1016/S0022-5347(01)64083-7; SCHMIDT WW, 1984, J UROLOGY, V132, P1262, DOI 10.1016/S0022-5347(17)50119-6; SHOKRITABIBZADEH S, 1982, VIRCHOWS ARCH B, V39, P41, DOI 10.1007/BF02892835; Smith PR, 1998, AM J PHYSIOL-RENAL, V274, pF91, DOI 10.1152/ajprenal.1998.274.1.F91; SOUTHGATE J, 1994, LAB INVEST, V71, P583; STRANGE K, 1987, J MEMBRANE BIOL, V96, P27, DOI 10.1007/BF01869332; SURYA B, 1990, J CELL SCI, V97, P419; SUTHERLAND GR, 1972, NATURE, V239, P231, DOI 10.1038/239231a0; TRIFILLIS AL, 1995, J UROLOGY, V153, P243, DOI 10.1097/00005392-199501000-00085; TSAO MC, 1982, J CELL PHYSIOL, V110, P219, DOI 10.1002/jcp.1041100217; WILLE JJ, 1992, J CELL PHYSIOL, V150, P52, DOI 10.1002/jcp.1041500108; WILLIAMS RD, 1980, INVEST UROL, V17, P359; WOODCOCKMITCHELL J, 1982, J CELL BIOL, V95, P580, DOI 10.1083/jcb.95.2.580; Wu RL, 1998, CANCER RES, V58, P1291; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207	72	93	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15020	15029		10.1074/jbc.274.21.15020	http://dx.doi.org/10.1074/jbc.274.21.15020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329705	hybrid			2022-12-27	WOS:000081965200070
J	Avram, D; Ishmael, JE; Nevrivy, DJ; Peterson, VJ; Lee, SH; Dowell, P; Leid, M				Avram, D; Ishmael, JE; Nevrivy, DJ; Peterson, VJ; Lee, SH; Dowell, P; Leid, M			Heterodimeric interactions between chicken ovalbumin upstream promoter-transcription factor family members ARP1 and Ear2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ORPHAN RECEPTORS; RETINOIC ACID RECEPTORS; OXYTOCIN GENE PROMOTER; COUP-TF; RESPONSE ELEMENTS; ESTROGEN-RECEPTOR; THYROID-HORMONE; EXPRESSION PATTERNS; MOLECULAR-CLONING; BINDING-SITES	Members of the chicken ovalbumin upstream promoter-transcription factor (COUP-TF) subfamily of orphan nuclear receptors, which minimally includes COUP-TFI and ARP1, are highly expressed in brain and are generally considered to be constitutive repressors of transcription. We have used a yeast two-hybrid system to isolate proteins expressed in brain that interact with ARP1. One of the proteins isolated in this screen was Ear2, another orphan receptor that has been suggested to be a member of the COUP-TF subfamily. Here we demonstrate that ARP1 and Ear2 form heterodimers in solution and on directly repeated response elements with high efficiency and a specificity differing from that of homodimeric complexes composed of either receptor. ARP1 and Ear2 were observed to interact in mammalian cells, and the tissue distribution of Ear2 transcripts was found to overlap precisely with the expression pattern of ARP1 in several mouse tissues and embryonal carcinoma cell lines. Heterodimeric interactions between ARP1 and Ear2 may define a distinct pathway of orphan receptor signaling.	Oregon State Univ, Coll Pharm, Mol Pharmacol Lab, Corvallis, OR 97331 USA; Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Leid, M (corresponding author), Oregon State Univ, Coll Pharm, Mol Pharmacol Lab, Corvallis, OR 97331 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES000210, P30 ES000210-35] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Avram D, 1996, GENETICS, V144, P511; Bailey PJ, 1997, J STEROID BIOCHEM, V63, P165, DOI 10.1016/S0960-0760(97)00079-4; Chu K, 1998, MOL CELL ENDOCRINOL, V137, P145, DOI 10.1016/S0303-7207(97)00241-4; Chu K, 1997, J MOL ENDOCRINOL, V19, P163, DOI 10.1677/jme.0.0190163; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; DASILVA SL, 1995, MOL BRAIN RES, V30, P131, DOI 10.1016/0169-328X(94)00289-Q; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; FJOSE A, 1993, EMBO J, V12, P1403, DOI 10.1002/j.1460-2075.1993.tb05784.x; HWUNG YP, 1988, J BIOL CHEM, V263, P13470; ISLAM TC, 1994, BIOCHEM BIOPH RES CO, V203, P545, DOI 10.1006/bbrc.1994.2217; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; KRONCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LEDOUARIN B, 1995, NUCLEIC ACIDS RES, V23, P876, DOI 10.1093/nar/23.5.876; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Leng X, 1996, MOL CELL BIOL, V16, P2332; LU XP, 1994, MOL ENDOCRINOL, V8, P1774, DOI 10.1210/me.8.12.1774; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1798; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; PASTORCIC M, 1989, NUCLEIC ACIDS RES, V17, P6693, DOI 10.1093/nar/17.16.6693; PASTORCIC M, 1986, MOL CELL BIOL, V6, P2784, DOI 10.1128/MCB.6.8.2784; PIERRAT B, 1992, GENE, V119, P237, DOI 10.1016/0378-1119(92)90277-V; POWER RF, 1991, SCIENCE, V252, P1546, DOI 10.1126/science.2047861; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Schrader M, 1996, J BIOL CHEM, V271, P19732, DOI 10.1074/jbc.271.33.19732; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Shigeta H, 1996, MOL REPROD DEV, V45, P21, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;21::AID-MRD3&gt;3.0.CO;2-U; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; vanderWees J, 1996, MECH DEVELOP, V54, P173, DOI 10.1016/0925-4773(95)00471-8; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1987, J BIOL CHEM, V262, P16080; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656	50	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14331	14336		10.1074/jbc.274.20.14331	http://dx.doi.org/10.1074/jbc.274.20.14331			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318855	Green Accepted, hybrid			2022-12-27	WOS:000080322200084
J	Dianov, GL; Prasad, R; Wilson, SH; Bohr, VA				Dianov, GL; Prasad, R; Wilson, SH; Bohr, VA			Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; BOVINE TESTIS; SITE REPAIR; PATHWAY; REQUIREMENT; BINDING; EXTRACT	The two base excision repair (BER) subpathways in mammalian cells are characterized by the number of nucleotides synthesized into the excision patch. They are the "single-nucleotide" BER pathway and the "long patch" (several nucleotides incorporated) BER pathway. Both of these subpathways involve excision of a damaged base and/or nearby nucleotides and DNA synthesis to fill the excision gap Whereas DNA polymerase beta (pol beta) is known to participate in the single-nucleotide BER pathway, the identity of polymerases involved in long patch BER has remained unclear. By analyzing products of long patch excision generated during BER of a uracil-containing DNA substrate in mammalian cell extracts we find that long patch excision depends on pol beta. We show that the excision of the characteristic 5'-deoxyribose phosphate containing oligonucleotide (dRP-oligo) is deficient in extracts from pol beta null cells and is rescued by addition of purified pol beta. Also, pol beta-neutralizing antibody inhibits release of the dRP-oligo in wild-type cell extracts, and the addition of pol beta after inhibition with antibody completely restores the excision reaction. The results indicate that pol beta plays an essential role in long patch BER by conducting strand displacement synthesis and controlling the size of the excised flap.	NIA, NIH, Baltimore, MD 21224 USA; NIEHS, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dianov, GL (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.		Bohr, Vilhelm/AAP-5931-2020; Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, J BIOL CHEM, V265, P2124; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	22	198	206	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13741	13743		10.1074/jbc.274.20.13741	http://dx.doi.org/10.1074/jbc.274.20.13741			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318775	hybrid			2022-12-27	WOS:000080322200004
J	Iivanainen, A; Morita, T; Tryggvason, K				Iivanainen, A; Morita, T; Tryggvason, K			Molecular cloning and tissue-specific expression of a novel murine laminin gamma 3 chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; NIDOGEN BINDING-SITE; BASEMENT-MEMBRANES; MULTIDOMAIN PROTEIN; COLLAGEN-IV; S-LAMININ; B2 CHAIN; A-CHAIN; DEVELOPMENTAL EXPRESSION; NEUROMUSCULAR-JUNCTION	A novel laminin gamma 3 chain was identified from the expressed sequence tag data base at the National Center for Biotechnology Information. A complete cDNA-derived peptide sequence reveals a 1592-amino acid-long primary translation product, including a tentative 33-amino acid-long signal peptide. Comparison with the laminin gamma 1 chain predicts that the two polypeptides have equal spatial dimensions. In addition, the well conserved domains VI and III(LE4) predict that gamma 3 containing laminins are able to integrate to the laminin network and also via nidogen connect to other protein networks in the basement membranes. Combination of Northern analysis and in situ hybridization experiments indicate that expression of the gamma 3 chain is highly tissue- and cell-specific, being significantly strong in capillaries and arterioles of kidney as well as in interstitial Leydig cells of testis.	Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; Univ Helsinki, Dept Vet Basic Sci, Div Anat, FIN-00014 Helsinki, Finland	Karolinska Institutet; University of Helsinki	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.	karl.tryggvason@mbb.ki.se						ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ABERDAM D, 1994, CELL ADHES COMMUN, V2, P115, DOI 10.3109/15419069409004431; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIROCH A, 1997, NOMENCLATURE EXTRACE; Baumgartner R, 1996, J MOL BIOL, V257, P658, DOI 10.1006/jmbi.1996.0192; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Braissant O, 1998, BIOCHEMICA, V1, P10; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; CHUNG AE, 1979, CELL, V16, P277, DOI 10.1016/0092-8674(79)90005-9; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; GERECKE DR, 1994, J BIOL CHEM, V269, P11073; GREEN TL, 1992, J BIOL CHEM, V267, P2014; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; IIVANAINEN A, 1995, FEBS LETT, V365, P183, DOI 10.1016/0014-5793(95)00462-I; Iivanainen A, 1997, J BIOL CHEM, V272, P27862, DOI 10.1074/jbc.272.44.27862; IIVANAINEN A, 1995, MATRIX BIOL, V14, P489, DOI 10.1016/0945-053X(95)90006-3; INOUE S, 1989, INT REV CYTOL, V117, P57; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; KALLUNKI T, 1991, J BIOL CHEM, V266, P221; KLEIN G, 1990, DEVELOPMENT, V110, P823; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARRA M, 1996, WASHUHHMI MOUSE EST; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Nielsen H, 1996, PROTEINS, V24, P165, DOI 10.1002/(SICI)1097-0134(199602)24:2<165::AID-PROT4>3.0.CO;2-I; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PIKKARAINEN T, 1988, J BIOL CHEM, V263, P6751; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; RICHARDS AJ, 1994, GENOMICS, V22, P237, DOI 10.1006/geno.1994.1372; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; SUGIYAMA S, 1995, EUR J BIOCHEM, V228, P120, DOI 10.1111/j.1432-1033.1995.0120o.x; THOMAS T, 1993, EXP CELL RES, V208, P54, DOI 10.1006/excr.1993.1222; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; VERRANDO P, 1988, BIOCHIM BIOPHYS ACTA, V942, P45, DOI 10.1016/0005-2736(88)90273-8; Virtanen I, 1997, AM J PATHOL, V150, P1421; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; [No title captured]	69	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14107	14111		10.1074/jbc.274.20.14107	http://dx.doi.org/10.1074/jbc.274.20.14107			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318827	hybrid			2022-12-27	WOS:000080322200056
J	Ingalls, RR; Monks, BG; Golenbock, DT				Ingalls, RR; Monks, BG; Golenbock, DT			Membrane expression of soluble endotoxin-binding proteins permits lipopolysaccharide signaling in Chinese hamster ovary fibroblasts independently of CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PERMEABILITY-INCREASING PROTEIN; DECAY-ACCELERATING FACTOR; DIPHOSPHORYL LIPID-A; CD14-DEPENDENT MECHANISM; (LPS)-BINDING PROTEIN; LPS; CELLS; RECOGNITION; ACTIVATION	The activation of phagocytes by lipopolysaccharide (LPS) has been implicated in the pathogenesis of Gramnegative sepsis. Although the interaction between CD14 and LPS is a key event in the signaling cascade, the molecular mechanism by which cellular activation occurs remains obscure. We hypothesized that the main function of CD14 was to bind LPS and transfer it to a second receptor, which then initiates the subsequent signal for cellular activation. Thus, surface binding of LPS to the cell membrane would be the critical step that CD14 carries out. To test this hypothesis, we examined the activity of two other proteins known to bind LPS, lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein. We found that when these normally soluble proteins were expressed in Chinese hamster ovary-gl fibroblasts as glycosylphosphatidylinositol-anchored proteins, both could substitute for CD14 in initiating LPS signaling. Pharmacological studies with synthetic lipid A analogues demonstrated that these surface expressed LPS-binding proteins had characteristics that were qualitatively identical to membrane CD14. These data support the hypothesis that a receptor distinct from CD14 functions as the actual signal transducer and suggest that surface binding of LPS to the cell membrane is the crucial first step for initiating downstream signaling events.	Boston Med Ctr, Maxwell Finland Lab Infect Dis, Boston, MA 02118 USA	Boston Medical Center	Ingalls, RR (corresponding author), Boston Med Ctr, Maxwell Finland Lab Infect Dis, 774 Albany St, Boston, MA 02118 USA.		Monks, Brian/B-8362-2015	Monks, Brian/0000-0003-4008-3093; Ingalls, Robin/0000-0003-2197-7198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI038515, K08AI001476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; NIAID NIH HHS [AI01476, AI38515] Funding Source: Medline; NIGMS NIH HHS [GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahamson SL, 1997, J BIOL CHEM, V272, P2149; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; CHRIST WJ, 1994, J AM CHEM SOC, V116, P3637, DOI 10.1021/ja00087a075; DELUDE RL, 1994, J BIOL CHEM, V269, P22253; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; Elsbach P, 1994, Prog Clin Biol Res, V388, P41; Flaherty SF, 1997, J SURG RES, V73, P85, DOI 10.1006/jsre.1997.5195; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; GRAY PW, 1993, GENOMICS, V15, P188, DOI 10.1006/geno.1993.1030; GRAY PW, 1989, J BIOL CHEM, V264, P9505; Grunwald U, 1996, J IMMUNOL, V157, P4119; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAZIOT A, 1988, J IMMUNOL, V141, P547; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Ingalls RR, 1997, J IMMUNOL, V159, P433; Ingalls RR, 1998, J IMMUNOL, V161, P5413; KIRKLAND TN, 1991, INFECT IMMUN, V59, P131, DOI 10.1128/IAI.59.1.131-136.1991; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KOVACH NL, 1990, J EXP MED, V172, P77, DOI 10.1084/jem.172.1.77; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MARRA MN, 1992, J IMMUNOL, V148, P532; MATHISON JC, 1992, J IMMUNOL, V149, P200; MEDOF ME, 1986, BIOCHEMISTRY-US, V25, P6740, DOI 10.1021/bi00370a003; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; NICHOLSONWELLER A, 1985, BLOOD, V65, P1237; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1988, COLD SPRING HARB SYM, V53, P973, DOI 10.1101/SQB.1988.053.01.112; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; TAKAYAMA K, 1989, INFECT IMMUN, V57, P1336, DOI 10.1128/IAI.57.4.1336-1338.1989; TALL A, 1995, ANNU REV BIOCHEM, V64, P235; Thieblemont N, 1998, IMMUNITY, V8, P771, DOI 10.1016/S1074-7613(00)80582-8; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel M M, 1995, Prog Clin Biol Res, V392, P287; Wurfel MM, 1997, J IMMUNOL, V158, P3925; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yu B, 1996, J BIOL CHEM, V271, P4100	52	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13993	13998		10.1074/jbc.274.20.13993	http://dx.doi.org/10.1074/jbc.274.20.13993			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318811	hybrid			2022-12-27	WOS:000080322200040
J	Kirkman, HN; Rolfo, M; Ferraris, AM; Gaetani, GF				Kirkman, HN; Rolfo, M; Ferraris, AM; Gaetani, GF			Mechanisms of protection of catalase by NADPH - Kinetics and stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON OXIDATION; BOVINE LIVER CATALASE; COMPOUND-II FORMATION; PROTEUS-MIRABILIS PR; HYDROGEN-PEROXIDE; HUMAN ERYTHROCYTES; BOUND NADPH; SUPEROXIDE; DISPOSAL; RADICALS	NADPH is known to be tightly bound to mammalian catalase and to offset the ability of the substrate of catalase (H2O2) to convert the enzyme to an inactive state (compound II), In the process, the bound NADPH becomes NADP(+) and is replaced by another molecule of NADPH. This protection is believed to occur through electron tunneling between NADPH on the surface of the catalase and the heme group within the enzyme. The present study provided additional support for the concept of an intermediate state of catalase, through which NADPH serves to prevent the formation (rather than increase the removal) of compound II. In contrast, the superoxide radical seemed to bypass the intermediate state since NADPH had very little ability to prevent the superoxide radical from converting catalase to compound II. Moreover, the rate of NADPH oxidation was several times the rate of compound II formation (in the absence of NADPH) under a variety of conditions. Very little NADPH oxidation occurred when NADPH was exposed to catalase, H2O2, or the superoxide radical separately. That the ratio exceeds 1 suggests that NADPH may protect catalase from oxidative damage through actions broader than merely preventing the formation of compound II.	Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ Genoa, Dipartimento Oncol Clin & Sperimentale, I-16132 Genoa, Italy; Ist Nazl Ric Canc, Div Hematol Oncol, I-16132 Genoa, Italy	University of North Carolina; University of North Carolina Chapel Hill; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Kirkman, HN (corresponding author), Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA.							AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALMARSSON O, 1993, J AM CHEM SOC, V115, P7093, DOI 10.1021/ja00069a005; BICOUT DJ, 1995, BBA-PROTEIN STRUCT M, V1252, P172, DOI 10.1016/0167-4838(95)00123-C; BIELSKI BHJ, 1968, J PHYS CHEM-US, V72, P3836, DOI 10.1021/j100857a024; CHANCE B, 1950, BIOCHEM J, V46, P387, DOI 10.1042/bj0460387; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V41, P404, DOI 10.1016/0003-9861(52)90469-4; COHEN G, 1961, SCIENCE, V134, P1756, DOI 10.1126/science.134.3492.1756; Eaton J W, 1972, Adv Exp Med Biol, V28, P121; FITA I, 1985, P NATL ACAD SCI USA, V82, P1604, DOI 10.1073/pnas.82.6.1604; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GAETANI GD, 1974, P NATL ACAD SCI USA, V71, P3584, DOI 10.1073/pnas.71.9.3584; GAETANI GF, 1994, BLOOD, V84, P325; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; GEBICKA L, 1989, INT J RADIAT BIOL, V55, P45, DOI 10.1080/09553008914550051; GOUET P, 1995, J MOL BIOL, V249, P933, DOI 10.1006/jmbi.1995.0350; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HILLAR A, 1992, FEBS LETT, V314, P179, DOI 10.1016/0014-5793(92)80969-N; HILLAR A, 1994, BIOCHEM J, V300, P531, DOI 10.1042/bj3000531; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; JACOB HS, 1965, J CLIN INVEST, V44, P1187, DOI 10.1172/JCI105225; JOUVE HM, 1986, ARCH BIOCHEM BIOPHYS, V248, P71, DOI 10.1016/0003-9861(86)90402-9; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; KONO Y, 1982, J BIOL CHEM, V257, P5751; LARDINOIS OM, 1995, FREE RADICAL RES, V22, P251, DOI 10.3109/10715769509147544; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nicholls P., 1963, ENZYMES, V8, P147; OLSON LP, 1995, BIOCHEMISTRY-US, V34, P7335, DOI 10.1021/bi00022a006; SAWADA Y, 1973, BIOCHIM BIOPHYS ACTA, V327, P257, DOI 10.1016/0005-2744(73)90408-7; SCOTT MD, 1991, J LAB CLIN MED, V118, P7; SCOTT MD, 1993, BIOCHIM BIOPHYS ACTA, V1181, P163, DOI 10.1016/0925-4439(93)90106-B; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59	36	196	202	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13908	13914		10.1074/jbc.274.20.13908	http://dx.doi.org/10.1074/jbc.274.20.13908			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318800	hybrid			2022-12-27	WOS:000080322200029
J	Kwak, YG; Hu, NN; Wei, J; George, AL; Grobaski, TD; Tamkun, MM; Murray, KT				Kwak, YG; Hu, NN; Wei, J; George, AL; Grobaski, TD; Tamkun, MM; Murray, KT			Protein kinase A phosphorylation alters Kv beta 1.3 subunit-mediated inactivation of the Kv1.5 potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATRIAL MYOCYTES; RECTIFIER K+ CURRENT; BETA-SUBUNIT; MOLECULAR-CLONING; ALPHA-SUBUNIT; MODULATION; CYTOSKELETON; EXPRESSION; BINDING; DOMAIN	The human Kv1.5 potassium channel forms the I-Kur current in atrial myocytes and is functionally altered by coexpression with Kv beta subunits. To explore the role of protein kinase A (PKA) phosphorylation in beta-subunit function, we examined the effect of PKA stimulation on Kv1.5 current following coexpression with either Kv beta 1.2 or Kv beta 1.3, both of which coassemble with Kv1.5 and induce fast inactivation. In Xenopus oocytes expressing Kv1.5 and Kv beta 1.3, activation of PKA reduced macroscopic inactivation with an increase in K+ current. Similar results were obtained using HEK 293 cells which lack endogenous K+ channel subunits. These effects did not occur whom Kv1.5 was coexpressed with either KV beta 1.2 or Kv beta 1.3 lacking the amino terminus,suggesting involvement of this region of Kv beta 1.3. Removal of a consensus PKA phosphorylation site on the Kv beta 1.3 NH2 terminus (serine 24), but not alternative sites in either Kv beta 1.3 or Kv1.5, resulted in loss of the functional effects of kinase activation. The effects of phosphorylation appeared to be electrostatic, as replacement of serine 24 with a negatively charged amino acid reduced beta-mediated inactivation, while substitution with a positively charged residue enhanced it. These results indicate that Kv beta 1.3-induced inactivation is reduced by PKA activation, and that phosphorylation of serine 24 in the subunit NH2 terminus is responsible.	Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Colorado State Univ, Dept Physiol, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Vanderbilt University; Vanderbilt University; Colorado State University; Colorado State University	Murray, KT (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Rm 559,Med Res Bldg II,23rd Ave S & Pierce Ave, Nashville, TN 37232 USA.				NHLBI NIH HHS [HL49330, HL46681] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049330, P01HL046681] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIELLO EA, 1995, AM J PHYSIOL-HEART C, V268, pH926, DOI 10.1152/ajpheart.1995.268.2.H926; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; Cole WC, 1996, BIOCHEM CELL BIOL, V74, P439, DOI 10.1139/o96-048; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; Deal KK, 1996, PHYSIOL REV, V76, P49, DOI 10.1152/physrev.1996.76.1.49; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jing J, 1997, J BIOL CHEM, V272, P14021, DOI 10.1074/jbc.272.22.14021; KASS RS, 1993, TRENDS CARDIOVAS MED, V3, P149, DOI 10.1016/1050-1738(93)90016-Y; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; Morales MJ, 1996, P NATL ACAD SCI USA, V93, P15119, DOI 10.1073/pnas.93.26.15119; MURRAY KT, 1994, CIRC RES, V75, P999, DOI 10.1161/01.RES.75.6.999; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; OVERTURF KE, 1994, AM J PHYSIOL-CELL PH, V267, pC1231, DOI 10.1152/ajpcell.1994.267.5.C1231; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; TAMKUN MM, 1991, FASEB J, V5, P331, DOI 10.1096/fasebj.5.3.2001794; UEBELE VN, 1994, FEBS LETT, V340, P104, DOI 10.1016/0014-5793(94)80181-9; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; Wang ZG, 1996, J BIOL CHEM, V271, P28311, DOI 10.1074/jbc.271.45.28311; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8	29	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13928	13932		10.1074/jbc.274.20.13928	http://dx.doi.org/10.1074/jbc.274.20.13928			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318802	hybrid			2022-12-27	WOS:000080322200031
J	Yu, KY; Kwon, B; Ni, J; Zhai, YF; Ebner, R; Kwon, BS				Yu, KY; Kwon, B; Ni, J; Zhai, YF; Ebner, R; Kwon, BS			A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPESVIRUS ENTRY MEDIATOR; LYMPHOTOXIN BETA-RECEPTOR; TNF RECEPTOR; FAS LIGAND; T-CELLS; FAMILY; PROLIFERATION; INVOLVEMENT; ACTIVATION; PROTEINS	TR6 (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family. TR6 mRNA is expressed in lung tissues and colon adenocarcinoma, SW480. In addition, the expression of TR6 mRNA was shown in the endothelial cell line and induced by phorbol 12-myristate 13-acetate/ionomycin in Jurkat T leukemia cells. The open reading frame of TR6 encodes 300 amino acids with a 29-residue signal sequence but no transmembrane region. Using histidine-tagged recombinant TR6, we screened soluble forms of TNF-ligand proteins with immunoprecipitation. Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/CD95L). These bindings were confirmed with HEK 293 EBNA cells transfected with LIGHT cDNA by flow cytometry. TR6 inhibited LIGHT-induced cytotoxicity in HT29 cells. It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LT beta R) and HVEM/TR2 receptors. Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/TR2 and LT beta R, thereby suppressing LIGHT-mediated HT29 cell death. Thus, TR6 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46202 USA; Human Genome Sci, Rockville, MD 20850 USA; Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute; GlaxoSmithKline; Human Genome Sciences Inc; University of Ulsan; University of Ulsan	Kwon, BS (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.				NIAID NIH HHS [AI28125] Funding Source: Medline; NIDCR NIH HHS [DE12156] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI028125, R43AI028125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Desbarats J, 1998, NAT MED, V4, P1377, DOI 10.1038/3965; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Harrop JA, 1998, J IMMUNOL, V161, P1786; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SIMMONET WS, 1997, CELL, V89, P309; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; Tewari M, 1996, CURR OPIN GENET DEV, V6, P39, DOI 10.1016/S0959-437X(96)90008-8; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	20	331	380	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13733	13736		10.1074/jbc.274.20.13733	http://dx.doi.org/10.1074/jbc.274.20.13733			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318773	hybrid			2022-12-27	WOS:000080322200002
J	Anrather, J; Csizmadia, V; Soares, MP; Winkler, H				Anrather, J; Csizmadia, V; Soares, MP; Winkler, H			Regulation of NF-kappa B RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase C zeta in primary endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; E-SELECTIN EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; IN-VIVO; CELLULAR-TRANSFORMATION; COMPLEX-FORMATION; GENE-EXPRESSION; REQUIRES RAF-1; POTENTIAL ROLE	The activity of the transcription factor NF-kappa B is thought to be regulated mainly through cytoplasmic retention by I kappa B molecules. Here we present evidence of a second mechanism of regulation acting on NF-kappa B after release from I kappa B. In endothelial cells this mechanism involves phosphorylation of the RelA subunit of NF-kappa B through a pathway involving activation of protein kinase C zeta (PKC zeta) and p21(ras). We show that transcriptional activity of RelA is dependent on phosphorylation of the N-terminal Rel homology domain but not the C-terminal transactivation domain. Inhibition of phosphorylation by dominant negative mutants of PKC zeta or p21(ras) results in loss of RelA transcriptional activity without interfering with DNA binding. Raf/MEK, small GTPases, phosphatidylinositol 3-kinase, and stress-activated protein kinase pathways are not involved in this mechanism of regulation.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Immunobiol Res Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Anrather, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Immunobiol Res Ctr, 99 Brookline Ave, Boston, MA 02115 USA.	janrathe@caregroup.harvard.edu		Soares, Miguel/0000-0002-9314-4833	NHLBI NIH HHS [1RO1HL59476] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059476] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anrather J, 1997, J CLIN INVEST, V99, P763, DOI 10.1172/JCI119222; Baldassarre F, 1995, J BIOL CHEM, V270, P31244, DOI 10.1074/jbc.270.52.31244; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; BOULIKAS T, 1995, CRIT REV EUKAR GENE, V5, P1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brostjan C, 1997, J IMMUNOL, V158, P3836; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CHENG Q, 1994, J BIOL CHEM, V269, P13551; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; FINCO TS, 1993, J BIOL CHEM, V268, P17676; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; GEPPERT TD, 1994, MOL MED, V1, P93; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gomez J, 1997, J IMMUNOL, V158, P1516; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kannabiran C, 1997, MOL CELL BIOL, V17, P1, DOI 10.1128/MCB.17.1.1; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; LOZANO J, 1994, J BIOL CHEM, V269, P19200; MARSHALL M, 1995, MOL REPROD DEV, V42, P493, DOI 10.1002/mrd.1080420418; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Min W, 1997, J IMMUNOL, V159, P3508; Min W, 1996, MOL CELL BIOL, V16, P359; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Rzymkiewicz DM, 1996, J BIOL CHEM, V271, P17241, DOI 10.1074/jbc.271.29.17241; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trent JC, 1996, EMBO J, V15, P4497, DOI 10.1002/j.1460-2075.1996.tb00827.x; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yoza BK, 1996, J BIOL CHEM, V271, P18306, DOI 10.1074/jbc.271.31.18306; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	59	171	175	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13594	13603		10.1074/jbc.274.19.13594	http://dx.doi.org/10.1074/jbc.274.19.13594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224130	hybrid			2022-12-27	WOS:000080200400092
J	Maldonado, E				Maldonado, E			Transcriptional functions of a new mammalian TATA-binding protein-related factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATION; COMPLEX; INITIATION; DOMAIN; SRB	A mammalian protein highly homologous to TATA-binding protein (TBP) has been identified and cloned. The recombinant mammalian TBP-related factor binds to the TATA box of the Ad-MLP and forms stable complexes with TFIIB on the promoter DNA. The mammalian TBP-related factor is able to substitute for TBP in supporting transcription by RNA polymerase II in an in vitro reconstituted system.	Univ Chile, Fac Med, ICBM, Program Biol Celular & Mol, Santiago 7, Chile	Universidad de Chile	Maldonado, E (corresponding author), Univ Chile, Fac Med, ICBM, Program Biol Celular & Mol, Santiago 7, Chile.	emaldona@machi.med.uchile.cl						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buratowski S, 1997, CELL, V91, P13, DOI 10.1016/S0092-8674(01)80004-0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burley SK, 1996, CURR OPIN STRUC BIOL, V6, P69, DOI 10.1016/S0959-440X(96)80097-2; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; Hori R, 1998, CURR BIOL, V8, pR124, DOI 10.1016/S0960-9822(98)70987-X; IMBALZANO AN, 1994, J BIOL CHEM, V269, P8280; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5	20	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12963	12966		10.1074/jbc.274.19.12963	http://dx.doi.org/10.1074/jbc.274.19.12963			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224042	hybrid			2022-12-27	WOS:000080200400004
J	Costa, MCR; Mani, F; Santoro, W; Espreafico, EM; Larson, RE				Costa, MCR; Mani, F; Santoro, W; Espreafico, EM; Larson, RE			Brain myosin-V, a calmodulin-carrying myosin, binds to calmodulin-dependent protein kinase II and activates its kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY PROTEIN; UNCONVENTIONAL MYOSIN; SACCHAROMYCES-CEREVISIAE; LIGHT-CHAINS; GROWTH CONES; CELL-GROWTH; SYNAPSIN-I; RAT-BRAIN; LOCALIZATION; COMPLEX	Myosin-V, an unconventional myosin, has two notable structural features: (i) a regulatory neck domain having six IQ motifs that bind calmodulin and light chains, and (ii) a structurally distinct tail domain likely responsible for its specific intracellular interactions. Myosin-V copurifies with synaptic vesicles via its tail domain, which also is a substrate for calmodulin-dependent protein kinase II, We demonstrate here that myosin-V coimmunoprecipitates with CaM-kinase II from a Triton X-100-solubilized fraction of isolated nerve terminals, The purified proteins also coimmunoprecipitate from dilute solutions and bind in overlay experiments on Western blots. The binding region on myosin-V was mapped to its proximal and medial tail domains. Autophosphorylated CaM-kinase II binds to the tail domain of myosin-V with an apparent K-d of 7.7 nM. Surprisingly, myosin-V activates CaM-kinase II activity in a Ca2+-dependent manner, without the need for additional CaM, The apparent activation constants for the autophosphorylation of CaM-kinase II were 10 and 26 nM, respectively, for myo sin-V versus CaM. The maximum incorporation of P-32 into CaM-kinase II activated by myosin-V was twice that for CaM, suggesting that myosin-V binding to CaM-kinase II entails alterations in kinetic and/or phosphorylation site parameters. These data suggest that myosin-V, a calmodulin-carrying myosin, binds to and delivers CaM to CaM-kinase II, a calmodulin-dependent enzyme.	Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, BR-14049900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Morphol, BR-14049900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Larson, RE (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.	relarson@fmrp.usp.br	Espreafico, Enilza/O-3053-2016; Espreafico, Enilza/AAW-4658-2021	Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234				ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; Benfenati F, 1996, MOL BRAIN RES, V40, P297, DOI 10.1016/0169-328X(96)00053-8; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROCKERHOFF SE, 1992, J CELL BIOL, V118, P619, DOI 10.1083/jcb.118.3.619; BROCKERHOFF SE, 1994, J CELL BIOL, V124, P315, DOI 10.1083/jcb.124.3.315; Cameron LC, 1998, ARCH BIOCHEM BIOPHYS, V355, P35, DOI 10.1006/abbi.1998.0700; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COELHO MV, 1993, BRAZ J MED BIOL RES, V26, P465; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans LL, 1997, J CELL SCI, V110, P439; Evans LL, 1998, J CELL SCI, V111, P2055; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GOLDENRING JR, 1983, J BIOL CHEM, V258, P2632; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Grab D J, 1980, Ann N Y Acad Sci, V356, P55, DOI 10.1111/j.1749-6632.1980.tb29599.x; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HOSKINS B, 1986, J NEUROCHEM, V46, P303, DOI 10.1111/j.1471-4159.1986.tb12964.x; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LARSON RE, 1986, J NEUROSCI METH, V16, P47, DOI 10.1016/0165-0270(86)90007-5; Larson RE, 1996, BRAZ J MED BIOL RES, V29, P309; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; OHTA Y, 1986, FEBS LETT, V208, P423, DOI 10.1016/0014-5793(86)81061-4; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schlamp CL, 1996, EXP EYE RES, V63, P613, DOI 10.1006/exer.1996.0155; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Titus MA, 1997, CURR BIOL, V7, pR301, DOI 10.1016/S0960-9822(06)00143-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; WELSH MJ, 1978, P NATL ACAD SCI USA, V75, P1867, DOI 10.1073/pnas.75.4.1867; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	54	70	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15811	15819		10.1074/jbc.274.22.15811	http://dx.doi.org/10.1074/jbc.274.22.15811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336484	hybrid			2022-12-27	WOS:000080560100073
J	Kan, M; Wu, XC; Wang, F; McKeehan, WL				Kan, M; Wu, XC; Wang, F; McKeehan, WL			Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-AFFINITY BINDING; FACTOR FAMILY; CELL; IDENTIFICATION; ECTODOMAIN; EXPRESSION; SEQUENCE; FGF-2	A divalent cation-dependent association between heparin or heparan sulfate and the ectodomain of the FGF receptor kinase (FGFR) restricts FGF-independent trans-phosphorylation and supports the binding of activating FGF to self-associated FGFR, Here we show that in contrast to heparin, cellular heparan sulfate forms a binary complex with FGFR that discriminates between FGF-I and FGF-2. FGFR type 4 (FGFR4) in liver parenchymal cells binds only FGF-1, whereas FGFR1 binds FGF-I and FGF-2 equally. cell-free complexes of heparin and recombinant FGFR4 bound FGF-1 and FGF-2 equally. However, in contrast to FGFR1, when recombinant FGFR4 was expressed back in epithelial cells by transfection, it failed to bind FGF-2 unless heparan sulfate was depressed by chlorate or heparinase treatment, Isolated heparan sulfate proteoglycan (HSPG) from liver cells in cell-free complexes with FGFR4 restored the specificity for FGF-1 and supported the binding of both FGF-1 and FGF-S when complexed with FGFR1. In contrast, FGF-2 bound equally well to complexes of both FGFR1 and FGFR4 formed with endothelial cell-derived HSPG, but the endothelial HSPG was deficient for the binding of FGF-1 to both FGFR complexes. These data suggest that a heparan sulfate subunit is a cell type- and FGFR-specific determinant of the selectivity of the FGFR signaling complex for FGF. In a physiological context, the heparan sulfate subunit may limit the redundancy among the current 18 FGF polypeptides for the 4 known FGFR.	Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc Biol & Nutr, Houston, TX 77030 USA; Texas A&M Univ, Dept Biochem & Biophys, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System	McKeehan, WL (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc Biol & Nutr, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	wmckeeha@ibt.tamu.edu			NATIONAL CANCER INSTITUTE [R01CA059971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040739, R01DK035310] Funding Source: NIH RePORTER; NCI NIH HHS [CA59971] Funding Source: Medline; NIDDK NIH HHS [DK35310, DK40739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Feng SJ, 1996, BBA-MOL CELL RES, V1310, P67, DOI 10.1016/0167-4889(95)00146-8; Friedl A, 1997, AM J PATHOL, V150, P1443; Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382; HOSHI H, 1988, IN VITRO CELL DEV B, V24, P309; Jang JH, 1997, IN VITRO CELL DEV-AN, V33, P819; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN M, 1988, J BIOL CHEM, V263, P11306; KAN M, 1992, IN VITRO CELL DEV-AN, V28A, P515; KAN M, 1991, METHOD ENZYMOL, V198, P158; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Luo YD, 1996, J BIOL CHEM, V271, P26876, DOI 10.1074/jbc.271.43.26876; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; McKeehan WL, 1997, IN VITRO CELL DEV-AN, V33, P727, DOI 10.1007/s11626-997-0146-7; Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; Pye DA, 1998, BIOCHEM BIOPH RES CO, V248, P889, DOI 10.1006/bbrc.1998.9081; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; REICHSLOTKY R, 1994, J BIOL CHEM, V269, P32279; RON D, 1993, J BIOL CHEM, V268, P5388; VAINIKKA S, 1992, EMBO J, V11, P4273, DOI 10.1002/j.1460-2075.1992.tb05526.x; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; XU JM, 1992, J BIOL CHEM, V267, P17792	30	125	132	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15947	15952		10.1074/jbc.274.22.15947	http://dx.doi.org/10.1074/jbc.274.22.15947			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336501	hybrid			2022-12-27	WOS:000080560100090
J	Ollmann, MM; Barsh, GS				Ollmann, MM; Barsh, GS			Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING-HORMONE; PROOPIOMELANOCORTIN MESSENGER-RNA; IN-VITRO; ALPHA-MELANOTROPIN; PROCESSING ENZYME; MOLECULAR-CLONING; TRANSGENIC MICE; KEX2 PROTEASE; INSECT CELLS; YELLOW MICE	Agouti protein and Agouti-related protein (Agrp) regulate pigmentation and body weight, respectively, by antagonizing melanocortin receptor signaling. A carboxyl-terminal fragment of Agouti protein, Ser(73)-Cys(131) is sufficient for melanocortin receptor antagonism, but Western blot analysis of skin extracts reveals that the electrophoretic mobility of native Agouti protein corresponds to the mature full-length form, His(23)-Cys(131), TO investigate the potential role of the amino-terminal residues, we compared the function of full-length and carboxyl-terminal fragments of Agrp and Agouti protein in a sensitive bioassay based on pigment dispersion in Xenopus melanophores. We find that carboxyl-terminal Agouti protein, and all forms of Agrp tested, act solely by competitive antagonism of melanocortin action. However, full-length Agouti protein acts by an additional mechanism that is time- and temperature-dependent, depresses maximal levels of pigment dispersion, and is therefore likely to be mediated by receptor down-regulation. Apparent down-regulation is not observed for a mixture of amino-terminal and carboxyl-terminal fragments. We propose that the phenotypic effects of Agouti in vivo represent a bipartite mechanism: competitive antagonism of agonist binding by the carboxyl-terminal portion of Agouti protein and down-regulation of melanocortin receptor signaling by an unknown mechanism that requires residues in the amino terminus of the Agouti protein.	Stanford Univ, Beckman Ctr, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Ollmann, MM (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Pediat, B271A, Stanford, CA 94305 USA.				NIDDK NIH HHS [DK28506] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1998, CURRENT PROTOCOLS MO; BLANCHARD SG, 1995, BIOCHEMISTRY-US, V34, P10406, DOI 10.1021/bi00033a012; BRENNER C, 1992, P NATL ACAD SCI USA, V89, P922, DOI 10.1073/pnas.89.3.922; BRENNER C, 1994, METHOD ENZYMOL, V244, P152; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; EBERLE AN, 1988, MELANTROPINS CHEM PH; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; HUNT G, 1995, J ENDOCRINOL, V147, pR1, DOI 10.1677/joe.0.147R001; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JAYAWICKREME CK, 1994, J BIOL CHEM, V269, P29846; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V270, pE192, DOI 10.1152/ajpendo.1996.270.1.E192; KENAKIN T, 1995, BIOCHEM PHARMACOL, V50, P17, DOI 10.1016/0006-2952(95)00137-O; KENAKIN TP, 1982, CAN J PHYSIOL PHARM, V60, P249, DOI 10.1139/y82-036; Kiefer LL, 1998, BIOCHEMISTRY-US, V37, P991, DOI 10.1021/bi971913h; Kiefer LL, 1997, BIOCHEMISTRY-US, V36, P2084, DOI 10.1021/bi962647v; Kijas J M, 1998, Chromosome Res, V6, P243, DOI 10.1023/A:1009248432412; Kim JH, 1996, FASEB J, V10, P1646, DOI 10.1096/fasebj.10.14.9002558; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; LEFKOWITZ RJ, 1993, ADV SEC MESS PHOSPH, V28, P1; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MISRAHI M, 1994, EUR J BIOCHEM, V222, P711, DOI 10.1111/j.1432-1033.1994.tb18916.x; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mynatt RL, 1997, P NATL ACAD SCI USA, V94, P919, DOI 10.1073/pnas.94.3.919; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; OLSON MF, 1991, ENDOCR RES, V17, P19, DOI 10.1080/07435809109027187; Perry WL, 1996, GENETICS, V144, P255; PERRY WL, 1994, BIOESSAYS, V16, P705, DOI 10.1002/bies.950161002; POTENZA MN, 1992, PIGM CELL RES, V5, P372, DOI 10.1111/j.1600-0749.1992.tb00565.x; QUISTAD GB, 1994, J BIOL CHEM, V269, P11098; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Searle A.G., 1968, COMP GENETICS COAT C; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Siegrist W, 1996, BIOCHEM BIOPH RES CO, V218, P171, DOI 10.1006/bbrc.1996.0030; Siegrist W, 1997, J RECEPT SIGNAL TR R, V17, P75, DOI 10.3109/10799899709036595; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wang W, 1997, PEPTIDES, V18, P1295, DOI 10.1016/S0196-9781(97)00206-4; WILLARD DH, 1995, BIOCHEMISTRY-US, V34, P12341, DOI 10.1021/bi00038a030; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; ZEMEL MB, 1995, P NATL ACAD SCI USA, V92, P4733, DOI 10.1073/pnas.92.11.4733	55	29	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15837	15846		10.1074/jbc.274.22.15837	http://dx.doi.org/10.1074/jbc.274.22.15837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336487	hybrid			2022-12-27	WOS:000080560100076
J	Rasmussen, M; Muller, HP; Bjorck, L				Rasmussen, M; Muller, HP; Bjorck, L			Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; GROUP-A STREPTOCOCCI; NATIVE ALPHA(2)-MACROGLOBULIN; IGG-BINDING; FC-RECEPTOR; ALPHA-2-MACROGLOBULIN; ACTIVATION; DYSGALACTIAE; MODULATION; COMPLEXES	In the molecular interplay between pathogenic microorganisms and their host, proteolytic mechanisms are believed to play a crucial role. Here we find that the important human pathogen Streptococcus pyogenes (group A Streptococcus) expresses a surface protein with high affinity (K-alpha = 2.0 x 10(8) M-1) for alpha(2)-macroglobulin (alpha(2)M), the dominating proteinase inhibitor of human plasma. The immunoglobulin-binding protein G of group C and G streptococci also contains an alpha(2)M-binding domain and a gene encoding protein GRAB (protein G-related alpha(2)M-binding protein) was identified in the S. pyogenes Genome Sequencing data base. The grab gene is present in most S, pyogenes strains and is well conserved. Protein GRAB has typical features of a surface-attached protein of Gram-positive bacteria. It also contains a region homologous to parts of the alpha(2)M-binding domain of protein G and a variable number of a unique 28-amino acid-long repeat. Using Escherichia coli-produced protein GRAB and synthetic GRAB peptides, the alpha(2)M-binding region was mapped to the NH2-terminal part of protein GRAB, which is the region with homology to protein G, An isogenic S. pyogenes mutant lacking surface-associated protein GRAB showed no alpha(2)M-binding activity and was attenuated in virulence when injected intraperitoneally in mice. Finally, alpha(2)M bound to the bacterial surface via protein GRAB was found to entrap and inhibit the activity of both S. pyogenes and host proteinases, thereby protecting important virulence determinants from proteolytic degradation. This regulation of proteolytic activity at the bacterial surface should affect the host-microbe relation during S. pyogenes infections.	Univ Lund, Dept Cell & Mol Biol, Sect Mol Pathogenesis, S-22100 Lund, Sweden; Univ Greifswald, Dept Immunol & Transfus Med, D-17487 Greifswald, Germany	Lund University; Ernst Moritz Arndt Universitat Greifswald	Bjorck, L (corresponding author), Univ Lund, Dept Cell & Mol Biol, Sect Mol Pathogenesis, POB 94, S-22100 Lund, Sweden.			Rasmussen, Magnus/0000-0003-1588-5473				AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; BENNASR A, 1995, BIOCHEM J, V305, P173, DOI 10.1042/bj3050173; Berge A, 1997, J BIOL CHEM, V272, P20774, DOI 10.1074/jbc.272.33.20774; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; CHHATWAL GS, 1987, J BACTERIOL, V169, P3691, DOI 10.1128/jb.169.8.3691-3695.1987; CHU CT, 1994, ANN NY ACAD SCI, V737, P291, DOI 10.1111/j.1749-6632.1994.tb44319.x; ELLIOTT SD, 1945, J EXP MED, V81, P573, DOI 10.1084/jem.81.6.573; FEINMAN RD, 1994, ANN NY ACAD SCI, V737, P245, DOI 10.1111/j.1749-6632.1994.tb44316.x; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; GUSS B, 1986, EMBO J, V5, P1657; HANSKI E, 1995, METHOD ENZYMOL, V253, P269; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; HOFFMAN MR, 1987, J IMMUNOL, V139, P1885; HOLM SE, 1992, J INFECT DIS, V166, P31, DOI 10.1093/infdis/166.1.31; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; IKAI A, 1994, ANN NY ACAD SCI, V737, P339, DOI 10.1111/j.1749-6632.1994.tb44322.x; JONSSON H, 1994, EUR J BIOCHEM, V220, P819, DOI 10.1111/j.1432-1033.1994.tb18684.x; JONSSON H, 1994, GENE, V143, P85, DOI 10.1016/0378-1119(94)90609-2; JONSSON H, 1995, INFECT IMMUN, V63, P2968, DOI 10.1128/IAI.63.8.2968-2975.1995; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Lancefield RC, 1928, J EXP MED, V47, P91, DOI 10.1084/jem.47.1.91; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; MULLER HP, 1995, INFECT IMMUN, V63, P2833; MULLER HP, 1985, RECENT ADV STREPTOCO, P96; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; REIS KJ, 1984, J IMMUNOL, V132, P3091; SAMBROOK J, 1989, MOL CLONING LAB MANA; SCOTT BJ, 1983, CLIN CHEM, V29, P629; SJOBRING U, 1989, J IMMUNOL, V143, P2948; SOTTRUPJENSEN L, 1994, BIOL ALPHA2 MACROGLO, V737, P173; STOOPS JK, 1994, ANN NY ACAD SCI, V737, P212, DOI 10.1111/j.1749-6632.1994.tb44314.x; Suvorov AN, 1996, J BACTERIOL, V178, P5546, DOI 10.1128/jb.178.18.5546-5549.1996; THERN A, 1995, J IMMUNOL, V154, P375; VANLEUVEN F, 1982, TRENDS BIOCHEM SCI, V7, P185, DOI 10.1016/0968-0004(82)90135-9; WHITNACK E, 1985, J BACTERIOL, V164, P350, DOI 10.1128/JB.164.1.350-358.1985; WILLIAMS SE, 1994, ANN NY ACAD SCI, V737, P1, DOI 10.1111/j.1749-6632.1994.tb44297.x	48	104	109	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15336	15344		10.1074/jbc.274.22.15336	http://dx.doi.org/10.1074/jbc.274.22.15336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336419	hybrid			2022-12-27	WOS:000080560100008
J	Yamaguchi, T; Mukasa, T; Uchida, E; Kanayasu-Toyoda, T; Hayakawa, T				Yamaguchi, T; Mukasa, T; Uchida, E; Kanayasu-Toyoda, T; Hayakawa, T			The role of STAT3 in granulocyte colony-stimulating factor-induced enhancement of neutrophilic differentiation of Me2SO-treated HL-60 cells - GM-CSF inhibits the nuclear translocation of tyrosine-phosphorylated STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTOR SUPERFAMILY; PROMYELOCYTIC LEUKEMIA-CELLS; TERMINAL DIFFERENTIATION; SERINE PHOSPHORYLATION; RAPID ACTIVATION; RETINOIC ACID; INDUCTION; PATHWAYS; TRANSCRIPTION; INTERLEUKIN-3	The role of granulocyte colony-stimulating factor (G-CSF) on neutrophilic differentiation of Me2SO-treated HL-60 cells was studied. G-CSF augmented the functional maturation of Me2SO-treated HL-60 cells in terms of both O-2(radical anion)-generating ability and expression of the formyl-methionyl-leucyl-phenylalanine receptor. G-CSF induced enhancement of cell growth in Me2SO-treated HL-60 cells. These results indicate that G-CSF is a potent enhancer for the differentiation and proliferation of Me2SO-treated HL-60 cells. G-CSF caused the activation of p70 S6 kinase but not mitogen-activated protein (MAP) kinase. On the other hand, G-CSF rapidly induced tyrosine phosphorylation of signal transducers and activators of transcription-3 (STAT3), but did not induce serine727 phosphorylation, From the analysis of confocal laser scanning fluorescence microscopy and differential centrifugation, it was clearly demonstrated that G-CSF induced nuclear translocation of tyrosine-phosphorylated STATE. The G-CSF-dependent enhancement of neutrophilic differentiation in Me2SO-HL-60 cells was reversely inhibited by granulocyte-macrophage colony-stimulating factor (GMCSF), Notably, in the presence of GM-CSF, G-CSF induced the tyrosine phosphorylation of STATE but failed to induce the nuclear translocation of tyrosine-phosphorylated STATE, GM-CSF induced activation of not only p70 S6 kinase, but also of MAP kinase, Furthermore, GM-CSF caused the rapid serine727 phosphorylation of STAT3, both in the presence and absence of G-CSF, PD98059, an MEK1 inhibitor, inhibited the G-CSF-dependent serine727 phosphorylation of STAT3 and blocked the inhibitory effect of GM-CSF on G-CSF-dependent nuclear translocation of STAT3, These results suggest that G-CSF-dependent nuclear translocation of STAT3 coordinates with the promotion of neutrophilic differentiation in Me2SO-treated HL-60 cells.	Natl Inst Hlth Sci, Dept Biol Chem & Biol, Setagaya Ku, Tokyo 158, Japan	National Institute of Health Sciences - Japan	Yamaguchi, T (corresponding author), Natl Inst Hlth Sci, Dept Biol Chem & Biol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 158, Japan.							Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; BARSHAVIT Z, 1983, P NATL ACAD SCI-BIOL, V80, P5907, DOI 10.1073/pnas.80.19.5907; BASHEY A, 1994, BLOOD, V83, P949, DOI 10.1182/blood.V83.4.949.bloodjournal834949; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOLLAG W, 1991, BRIT J HAEMATOL, V79, P87, DOI 10.1111/j.1365-2141.1991.tb08129.x; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; DEMETRI GD, 1991, BLOOD, V78, P2791; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; KAKINUMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P50, DOI 10.1016/0304-4165(78)90251-9; KAKINUMA K, 1979, J BIOCHEM-TOKYO, V86, P87; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEONARD EJ, 1990, J IMMUNOL, V144, P1323; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; NICOLA NA, 1987, INT J CELL CLONING, V5, P1, DOI 10.1002/stem.5530050102; OKUDA K, 1992, BLOOD, V79, P2880; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; SAKAMAKI K, 1994, FEBS LETT, V353, P133, DOI 10.1016/0014-5793(94)01024-2; SAKAMAKI T, 1992, ANTICANCER RES, V12, P1331; SAKASHITA A, 1991, LEUKEMIA, V5, P26; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHWARTZ EL, 1988, CANCER RES, V48, P2683; Sengupta TK, 1996, P NATL ACAD SCI USA, V93, P9499, DOI 10.1073/pnas.93.18.9499; SONADA Y, 1988, P NATL ACAD SCI USA, V85, P4360; TIAN SS, 1994, BLOOD, V84, P1760; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VAN EDE, 1990, J IMMUNOL, V144, P1062; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamaguchi T, 1997, BIOL PHARM BULL, V20, P943; Yamaguchi T, 1998, ARCH BIOCHEM BIOPHYS, V353, P93, DOI 10.1006/abbi.1998.0622; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	41	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15575	15581		10.1074/jbc.274.22.15575	http://dx.doi.org/10.1074/jbc.274.22.15575			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336453	hybrid			2022-12-27	WOS:000080560100042
J	Patrick, SM; Turchi, JJ				Patrick, SM; Turchi, JJ			Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II); MOBILITY GROUP-1 PROTEIN; MAJOR ADDUCT; CROSS-LINKS; RECOGNITION; RECONSTITUTION; CHEMOTHERAPY; XPF-ERCC1; NUCLEASES	Replication protein A (RPA) is a heterotrimeric protein composed of 70-, 34-, and 14-kDa subunits that has been shown to be required for DNA replication, repair, and homologous recombination. We have previously shown preferential binding of recombinant human RPA (rhRPA) to duplex cisplatin-damaged DNA compared with the control undamaged DNA (Patrick, S. M., and Turchi, J. J. (1998) Biochemistry 37, 8808-8815), Here we assess the binding of rhRPA to DNA containing site-specific cisplatin-DNA adducts. rhRPA is shown to bind 1.5-2-fold better to a duplex 30-base pair substrate containing a single 1,3d(GpXpG) compared with a 1,2d(GpG) cisplatin-DNA intrastrand adduct, consistent with the difference in thermal stability of DNA containing each adduct. Consistent with these data, a 21-base pair DNA substrate containing a centrally located single interstrand cisplatin cross-link resulted in less binding than to the undamaged control DNA. A series of experiments measuring rhRPA binding and concurrent DNA denaturation revealed that rhRPA binds duplex cisplatin-damaged DNA via the generation of single-stranded DNA. Single-strand DNA binding experiments show that rhRPA binds 3-4-fold better to an undamaged 24-base DNA compared with the same substrate containing a single 1,2d(GpG) cisplatin-DNA adduct. These data are consistent with a low affinity interaction of rhRPA with duplex-damaged DNA followed by the generation of single-stranded DNA and then high affinity binding to the undamaged DNA strand.	Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Turchi, JJ (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.		Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992	NATIONAL CANCER INSTITUTE [R29CA064374] Funding Source: NIH RePORTER; NCI NIH HHS [CA64374] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; ANIN MF, 1990, NUCLEIC ACIDS RES, V18, P4395, DOI 10.1093/nar/18.15.4395; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BRABEC V, 1990, BIOPHYS CHEM, V35, P129, DOI 10.1016/0301-4622(90)80003-P; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; CHU G, 1994, J BIOL CHEM, V269, P787; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Eastman A, 1991, Cancer Treat Res, V57, P233; Evans E, 1997, EMBO J, V16, P625, DOI 10.1093/emboj/16.3.625; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Iftode C, 1997, MOL CELL BIOL, V17, P3876, DOI 10.1128/MCB.17.7.3876; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; LI L, 1995, MOL CELL BIOL, V15, P5396; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Patrick SM, 1997, BBA-GENE STRUCT EXPR, V1354, P279, DOI 10.1016/S0167-4781(97)00136-X; Patrick SM, 1998, BIOCHEMISTRY-US, V37, P8808, DOI 10.1021/bi9730590; PEREZ RP, 1993, CANCER, V71, P1571, DOI 10.1002/cncr.2820710424; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Stigger E, 1998, J BIOL CHEM, V273, P9337, DOI 10.1074/jbc.273.15.9337; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; TURCHI JJ, 1993, J BIOL CHEM, V268, P15136; Turchi JJ, 1997, BIOCHEMISTRY-US, V36, P7586, DOI 10.1021/bi963124q; Turchi JJ, 1996, BIOCHEMISTRY-US, V35, P2992, DOI 10.1021/bi951843j; VANGARDEREN CJ, 1994, EUR J BIOCHEM, V225, P1169; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Xu YC, 1997, NUCLEIC ACIDS RES, V25, P4067, DOI 10.1093/nar/25.20.4067; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	41	85	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14972	14978		10.1074/jbc.274.21.14972	http://dx.doi.org/10.1074/jbc.274.21.14972			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329699	hybrid			2022-12-27	WOS:000081965200064
J	Quitterer, U; Zaki, E; AbdAlla, S				Quitterer, U; Zaki, E; AbdAlla, S			Investigation of the extracellular accessibility of the connecting loop between membrane domains I and II of the bradykinin B-2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE TOPOLOGY; ODORANT RECEPTORS; AGONIST BINDING; PROTEINS; CLONING; EXPRESSION; ADJACENT; AFFINITY; RESIDUES; SITE	In analogy to the structure of rhodopsin, the seven hydrophobic segments of G-protein-coupled receptors are supposed to form seven membrane spanning alpha-helices. To analyze the topology of the bradykinin B-2 receptor, we raised site-directed antibodies to peptides corresponding to the loop regions and the amino and carboxyl terminus of this receptor. We found that a segment with predicted intracellular orientation according to the rhodopsin model, the connecting loop between membrane domains I and II of the bradykinin B-2 receptor, was accessible to site-directed antibodies on intact fibroblasts, A431 cells, or COS cells expressing human B-2 receptors, Extracellular orientation of this loop was further confirmed by the substituted cysteine accessibility method which showed that exchange of cysteine 94 for serine on this loop by point mutagenesis suppressed the effect of thiol modification by a membrane impermeant maleimide, In addition, this segment seemed to be involved in B-2 receptor activation, since (i) thiol modification of cysteine 94 partially suppressed B-2 receptor activation, and (ii) site-directed antibodies to the connecting loop between membrane domains I and II were agonists, The agonistic activity of the antibodies was suppressed by the B-2 antagonist HOE140 confirming the B-2 specificity of the antibody-generated signal. The extracellular orientation of the connecting loop between membrane domains I and II suggests a topology of the B-2 receptor different from rhodopsin, consisting of five (instead of seven) transmembrane domains and two hydrophobic segments with both ends facing the extracellular side.	Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany; Genet Engn & Biotechnol Res Inst, GEBRI, Alexandria, Egypt	University of Wurzburg	Quitterer, U (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.		Zaki, Essam/K-8456-2015	Zaki, Essam/0000-0002-3906-623X				Abd Alla S., 1996, J BIOL CHEM, V271, P1748; AbdAlla S, 1996, BIOCHEMISTRY-US, V35, P7514, DOI 10.1021/bi9601060; AbdAlla S, 1996, J BIOL CHEM, V271, P27382, DOI 10.1074/jbc.271.44.27382; ABDALLA S, 1993, J BIOL CHEM, V268, P17277; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; HERZIG MCS, 1995, J BIOL CHEM, V270, P20591, DOI 10.1074/jbc.270.35.20591; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LACATENA RM, 1994, P NATL ACAD SCI USA, V91, P10521, DOI 10.1073/pnas.91.22.10521; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; NARDONE J, 1994, P NATL ACAD SCI USA, V91, P4417, DOI 10.1073/pnas.91.10.4417; NOVOTNY EA, 1994, BIOCHEM BIOPH RES CO, V201, P523, DOI 10.1006/bbrc.1994.1733; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; QUITTERER U, 1995, J BIOL CHEM, V270, P1992, DOI 10.1074/jbc.270.5.1992; Quitterer U, 1996, BIOCHEMISTRY-US, V35, P13368, DOI 10.1021/bi961163w; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; ROSCHER AA, 1983, J CLIN INVEST, V72, P626, DOI 10.1172/JCI111012; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; WANG HY, 1989, J BIOL CHEM, V264, P14424	30	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14773	14778		10.1074/jbc.274.21.14773	http://dx.doi.org/10.1074/jbc.274.21.14773			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329674	hybrid			2022-12-27	WOS:000081965200039
J	Wadhwa, R; Sugihara, T; Yoshida, A; Duncan, EL; Hardeman, EC; Nomura, H; Reddel, RR; Kaul, SC				Wadhwa, R; Sugihara, T; Yoshida, A; Duncan, EL; Hardeman, EC; Nomura, H; Reddel, RR; Kaul, SC			Cloning and characterization of a novel gene, striamin, that interacts with the tumor suppressor protein p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; MYOBLAST DIFFERENTIATION; MOUSE MYOBLASTS; ALPHA-SKELETAL; EXPRESSION; CELLS; MYOD; ACTIN	Expression analysis of a novel cDNA isolated from immortal murine fibroblasts revealed a single transcript of 3.0 kilobase pairs that was highly expressed in mouse and human striated muscle and in mouse heart. The gene has therefore been named striamin. Its expression was confined to skeletal muscle types with a fast glycolytic (2B) contractile phenotype. It was also detected in C2C12 mouse myoblasts and was down-regulated during in vitro myogenesis. The cDNA has a single open reading frame encoding a predicted 16.8-kDa protein of 149 amino acids with no homology to known proteins. Microinjection and transfection of green fluorescence protein-tagged striamin demonstrated that it localizes to the nucleus. Coimmunoprecipitations revealed that it can interact with p53 (a positive marker for myoblast differentiation) in vivo and in vitro. Furthermore, it repressed p53 activity in p53-mediated reporter assays. Fluorescence in situ hybridization with a mouse P1 genomic clone localized the gene to chromosome 12C3, which is syntenic to human chromosome 14q21-22.	Chugai Res Inst Mol Med, Niihari, Ibaraki 30041, Japan; Childrens Med Res Inst, Westmead, NSW 2145, Australia; Natl Inst Biosci & Human Technol, Agcy Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	Children's Medical Research Institute - Australia; National Institute of Advanced Industrial Science & Technology (AIST)	Wadhwa, R (corresponding author), Chugai Res Inst Mol Med, 153-2 Nagai, Niihari, Ibaraki 30041, Japan.	renu@cimmed.com	Reddel, Roger R/A-6635-2014; Hardeman, Edna C/F-8872-2012; Wadhwa, Renu/L-8898-2018; Duncan, Emma L/L-1224-2013; Kaul, Sunil C/L-8671-2018	Reddel, Roger R/0000-0002-6302-6107; Wadhwa, Renu/0000-0001-8248-5192; Duncan, Emma L/0000-0002-8143-4403; Kaul, Sunil C/0000-0002-0046-3916; Hardeman, Edna/0000-0003-1649-7712				ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; ANTONIO J, 1993, MED SCI SPORT EXER, V25, P1333; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BOHELER KR, 1991, J CLIN INVEST, V88, P323, DOI 10.1172/JCI115295; COLBERT MC, 1992, DEV BIOL, V149, P66, DOI 10.1016/0012-1606(92)90264-H; DICKSON G, 1990, NATURE, V344, P348, DOI 10.1038/344348a0; Emerson CP, 1993, CURR OPIN CELL BIOL, V5, P1057, DOI 10.1016/0955-0674(93)90092-5; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085; GOBLET C, 1995, DEV BIOL, V170, P262, DOI 10.1006/dbio.1995.1213; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; GUNNING P, 1983, MOL CELL BIOL, V3, P1985, DOI 10.1128/MCB.3.11.1985; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Inada M, 1996, BIOCHEM BIOPH RES CO, V222, P317, DOI 10.1006/bbrc.1996.0742; KIESS M, 1995, ONCOGENE, V10, P159; KNUDSEN KA, 1990, DEV BIOL, V138, P159, DOI 10.1016/0012-1606(90)90185-L; KOSTROMINOVA TY, 1995, J CELL BIOCHEM, V58, P527, DOI 10.1002/jcb.240580416; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEFEROVICH JM, 1995, J NEUROSCI, V15, P596; LEWIS DM, 1982, J PHYSIOL-LONDON, V325, P393, DOI 10.1113/jphysiol.1982.sp014157; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; PROKOCIMER M, 1994, BLOOD, V84, P2391; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Shiio Y, 1996, ONCOGENE, V12, P1837; Soddu S, 1996, J CELL BIOL, V134, P193, DOI 10.1083/jcb.134.1.193; SODDU S, 1994, BLOOD, V83, P2230, DOI 10.1182/blood.V83.8.2230.bloodjournal8382230; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; WADHWA R, 1991, MUTAT RES, V256, P243, DOI 10.1016/0921-8734(91)90015-4; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wang J, 1997, CANCER RES, V57, P351; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; ZARDINI DM, 1994, MUSCLE NERVE, V17, P1308, DOI 10.1002/mus.880171110	45	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14948	14955		10.1074/jbc.274.21.14948	http://dx.doi.org/10.1074/jbc.274.21.14948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329696	hybrid			2022-12-27	WOS:000081965200061
J	Yan, W; Sheng, N; Seto, M; Morser, J; Wu, QY				Yan, W; Sheng, N; Seto, M; Morser, J; Wu, QY			Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MACROPHAGE SCAVENGER RECEPTORS; AMINO-ACID SEQUENCE; 4 TANDEM REPEATS; DROSOPHILA-MELANOGASTER; PLASMA PREKALLIKREIN; INDIAN HEDGEHOG; GENE ENCODES; CRD DOMAIN; POLARITY	A novel cDNA has been identified from human heart that encodes an unusual mosaic serine protease, designated corin. Corin has a predicted structure of a type II transmembrane protein and contains two frizzled-like cysteine-rich motifs, seven low density Lipoprotein receptor repeats, a macrophage scavenger receptor-like domain, and a trypsin-like protease domain in the extracellular region. Northern analysis showed that corin mRNA was highly expressed in the human heart. In mice, corin mRNA was detected by in situ hybridization in the cardiac myocytes of the embryonic heart as early as embryonic day (E) 9.5. By E11.5-13.5, corin mRNA was most abundant in the primary atrial septum and the trabecular ventricular compartment. Expression in the heart was maintained through the adult. In addition, mouse corin mRNA was also detected in the prehypertrophic chrondrocytes in developing bones. By fluorescent in situ hybridization analysis, the human corin gene was mapped to 4p12-13 where a congenital heart disease locus, total anomalous pulmonary venous return, had been previously localized. The unique domain structure and specific embryonic expression pattern suggest that corin may have a function in cell differentiation during development. The chromosomal localization of the human corin gene makes it an attractive candidate gene for total anomalous pulmonary venous return.	Berlex Biosci, Dept Cardiovasc Res, Richmond, CA 94804 USA; Berlex Biosci, Dept Biophys, Richmond, CA 94804 USA		Wu, QY (corresponding author), Berlex Biosci, Dept Cardiovasc Res, 15049 San Pablo Ave, Richmond, CA 94804 USA.			Wu, Qingyu/0000-0003-0561-9315				ANDERSON KV, 1992, COLD SPRING HARB SYM, V57, P409, DOI 10.1101/SQB.1992.057.01.046; APPEL LF, 1993, P NATL ACAD SCI USA, V90, P4937, DOI 10.1073/pnas.90.11.4937; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BLEYL S, 1995, AM J HUM GENET, V56, P408; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; CATTERALL CF, 1987, BIOCHEM J, V242, P849, DOI 10.1042/bj2420849; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; DANGOTT LJ, 1989, P NATL ACAD SCI USA, V86, P2128, DOI 10.1073/pnas.86.7.2128; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; GILBERT SF, 1994, DEV BIOL; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HONG CC, 1995, CELL, V82, P785, DOI 10.1016/0092-8674(95)90475-1; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Konrad KD, 1998, P NATL ACAD SCI USA, V95, P6819, DOI 10.1073/pnas.95.12.6819; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LeMosy EK, 1998, DEVELOPMENT, V125, P4045; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; Saldanha J, 1998, PROTEIN SCI, V7, P1632, DOI 10.1002/pro.5560070718; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Song LX, 1997, J BIOL CHEM, V272, P10543; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; THORPE DS, 1989, J BIOL CHEM, V264, P6545; TORRESROSADO A, 1993, P NATL ACAD SCI USA, V90, P7181, DOI 10.1073/pnas.90.15.7181; TSUJI A, 1991, J BIOL CHEM, V266, P16948; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	55	213	240	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14926	14935		10.1074/jbc.274.21.14926	http://dx.doi.org/10.1074/jbc.274.21.14926			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329693	hybrid			2022-12-27	WOS:000081965200058
J	Diverse-Pierluissi, MA; Fischer, T; Jordan, JD; Schiff, M; Ortiz, DF; Farquhar, MG; De Vries, L				Diverse-Pierluissi, MA; Fischer, T; Jordan, JD; Schiff, M; Ortiz, DF; Farquhar, MG; De Vries, L			Regulators of G protein signaling proteins as determinants of the rate of desensitization of presynaptic calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; GTPASE-ACTIVATING PROTEINS; RGS PROTEINS; MAMMALIAN-CELLS; ALPHA-SUBUNITS; CURRENTS; FAMILY; GAIP; LOCALIZATION; MECHANISMS	Norepinephrine inhibits omega-conotoxin GVIA-sensitive presynaptic Ca2+ channels in chick dorsal root ganglion neurons through two pathways, one mediated by G(o) and the other by G(i). These pathways desensitize at different rates. We have found that recombinant G alpha interacting protein (GAIP) and regulators of G protein signaling (RGS)4 selectively accelerate the rate of desensitization of G(o)- and G(i)-mediated pathways, respectively. Blockade of endogenous RGS proteins using antibodies raised against G alpha interacting protein and RGS4 slows the rate of desensitization of these pathways in a selective manner. These results demonstrate that different RGS proteins may interact with G(i) and G(o) selectively, giving rise to distinct time courses of transmitter-mediated effects.	CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Cellular & Mol Med, La Jolla, CA 92093 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Tufts University; University of California System; University of California San Diego; University of California System; University of California San Diego	Diverse-Pierluissi, MA (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol, 1 Gustave Levy Pl, New York, NY 10029 USA.			Jordan, Dedrick/0000-0002-0706-9583; Fischer, Thierry/0000-0002-9542-322X	NIDA NIH HHS [DA05798] Funding Source: Medline; NIDDK NIH HHS [DK17780] Funding Source: Medline; NINDS NIH HHS [NS37443] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017780, R01DK017780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA005798] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Saugstad JA, 1998, J NEUROSCI, V18, P905; Shuey DJ, 1998, J NEUROCHEM, V70, P1964; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Snow BE, 1998, GENE, V206, P247, DOI 10.1016/S0378-1119(97)00593-3; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	28	59	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14490	14494		10.1074/jbc.274.20.14490	http://dx.doi.org/10.1074/jbc.274.20.14490			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318875	hybrid			2022-12-27	WOS:000080322200104
J	Taupin, JL; Miossec, V; Pitard, V; Blanchard, F; Daburon, S; Raher, S; Jacques, Y; Godard, A; Moreau, JF				Taupin, JL; Miossec, V; Pitard, V; Blanchard, F; Daburon, S; Raher, S; Jacques, Y; Godard, A; Moreau, JF			Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; IL-6 SIGNAL TRANSDUCER; IMMUNOGLOBULIN-LIKE DOMAIN; GROWTH-HORMONE RECEPTOR; AMINO-ACID-RESIDUES; FACTOR GM-CSF; MONOCLONAL-ANTIBODIES; EXPRESSION CLONING; LIGAND-BINDING; MUTATIONAL ANALYSIS	The gp190 transmembrane protein,the low affinity receptor for the leukemia inhibitory factor (LIF), belongs to the hematopoietin family of receptors characterized by the cytokine binding domain (CBD). gp190 is one of the very few members of this family to contain two such domains. The membrane-proximal CBD (herein called D2) is separated from the membrane-distal one (called D1) by an immunoglobulin-like (Ig) domain and is followed by three fibronectin type III repeats. We used truncated gp190 mutants and a blocking anti-gp190 monoclonal antibody to study the role of these repeats in low affinity receptor function. Our results showed that the D1Ig region was involved in LIF binding, while D2 appeared to be crucial for the proper folding of D1, suggesting functionally important interactions between the two CBDs in the wild-type protein. In addition, point mutation in the carboxyl terminus of the Ig region strongly impaired ligand binding. These findings suggest that at least two distinct sites, both located within the D1Ig region, are involved in LIF binding to gp190, and more generally, that Ligand binding sites on these receptors may well be located outside the canonical CBDs.	Univ Bordeaux 2, CNRS, UMR 5540, F-33076 Bordeaux, France; INSERM, U463, Inst Biol, F-44035 Nantes, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Taupin, JL (corresponding author), Univ Bordeaux 2, CNRS, UMR 5540, Batiment 1B,146 Rue Leo Saignat, F-33076 Bordeaux, France.		Blanchard, Frederic/AAS-1930-2021; Blanchard, Frederic/K-8018-2015	Blanchard, Frederic/0000-0003-1055-2573; Blanchard, Frederic/0000-0003-1055-2573				Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; CHUA AO, 1994, J IMMUNOL, V153, P128; DAndrea RJ, 1996, BLOOD, V87, P2641, DOI 10.1182/blood.V87.7.2641.bloodjournal8772641; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; GEARING DP, 1992, NEW BIOL, V4, P61; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GODARD A, 1992, J BIOL CHEM, V267, P3214; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hilton DJ, 1996, J BIOL CHEM, V271, P4699; HILTON DJ, 1992, J BIOL CHEM, V267, P10238; HIRAOKA O, 1994, J BIOL CHEM, V269, P22412; HIRAOKA O, 1995, J BIOL CHEM, V270, P25928, DOI 10.1074/jbc.270.43.25928; HORSTEN U, 1995, FEBS LETT, V360, P43, DOI 10.1016/0014-5793(95)00053-C; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; IMLER JL, 1992, EMBO J, V11, P2047, DOI 10.1002/j.1460-2075.1992.tb05262.x; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; LARSEN A, 1990, J EXP MED, V172, P1559, DOI 10.1084/jem.172.6.1559; LAYTON MJ, 1994, J BIOL CHEM, V269, P29891; LAYTON MJ, 1994, J BIOL CHEM, V269, P17048; Liautard J, 1997, CYTOKINE, V9, P233, DOI 10.1006/cyto.1996.0159; MIYAZAKI T, 1991, EMBO J, V10, P3191, DOI 10.1002/j.1460-2075.1991.tb04881.x; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Owczarek CM, 1997, J BIOL CHEM, V272, P23976, DOI 10.1074/jbc.272.38.23976; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pitard V, 1997, J IMMUNOL METHODS, V205, P177, DOI 10.1016/S0022-1759(97)00074-4; Pitard V, 1998, EUR CYTOKINE NETW, V9, P599; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; ROZAKISADCOCK M, 1991, J BIOL CHEM, V266, P16472; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Starr R, 1997, J BIOL CHEM, V272, P19982, DOI 10.1074/jbc.272.32.19982; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TAUPIN JL, 1993, SCAND J IMMUNOL, V38, P293, DOI 10.1111/j.1365-3083.1993.tb01728.x; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Tomida M, 1996, J BIOCHEM-TOKYO, V120, P201; Vignon I, 1992, P NATL ACAD SCI USA, V89, P5640; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x	48	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14482	14489		10.1074/jbc.274.20.14482	http://dx.doi.org/10.1074/jbc.274.20.14482			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318874	hybrid			2022-12-27	WOS:000080322200103
J	Chen, LL; Whitty, A; Lobb, RR; Adams, SP; Pepinsky, RB				Chen, LL; Whitty, A; Lobb, RR; Adams, SP; Pepinsky, RB			Multiple activation states of integrin alpha(4)beta(1) detected through their different affinities for a small molecule ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; LEUKOCYTE ADHESION; ALPHA-4 INTEGRINS; CRYSTAL-STRUCTURE; DIVALENT-CATIONS; BINDING REGION; CROSS-LINKING; T-CELLS	We have used the highly specific alpha(4)beta(1) inhibitor 4-((N'-2-methylphenyl)ureido)- phenylacetyl-leucine-aspartic acid-valine-proline (BIO1211) as a model LDV-containing ligand to study integrin-ligand interactions on Jurkat cells under diverse conditions that affect the activation state of alpha(4)beta(1). Observed K-D values for BIO1211 binding ranged from a value of 20-40 NM in the nonactivated state of the integrin that exists in 1 mM Mg2+, I mM Ca2+ to 100 pM in the activated state seen in 2 mM Mn2+ to 18 pM when binding was measured after coactivation by 2 mM Mn2+ plus 10 mu g/ml of the integrin-activating monoclonal antibody TS2/16. The large range in RD values was governed almost exclusively by differences in the dissociation rates of the integrin-BIO1211 complex, which ranged from 0.17 x 10(-4) s(-1) to >140 x 10(-4) s(-1). Association rate constants varied only slightly under the same conditions, all falling in the narrow range from 0.9 to 2.7 x 10(6) M-1 s(-1). The further increase in affinity observed upon co-activation by divalent cations and TS2/16 compared with that observed at saturating concentrations of metal ions or TS2/16 alone indicates that the mechanism by which these factors bring about activation are distinct and identified a previously unrecognized high affinity state on alpha(4)beta(1) that had not been detected by conventional assay methods. Similar changes in affinity were observed when the binding properties of vascular cell adhesion molecule-1 and CS1 to alpha(4)beta(1) were studied, indicating that the different affinity states detected with BIO1211 are an inherent property of the integrin.	Biogen Inc, Cambridge, MA 02142 USA	Biogen	Pepinsky, RB (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.							ANWAR ARE, 1994, IMMUNOLOGY, V82, P222; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; CHAN BMC, 1991, J IMMUNOL, V147, P398; Chen LL, 1998, BIOCHEMISTRY-US, V37, P8743, DOI 10.1021/bi980311a; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; DAMLE NK, 1991, P NATL ACAD SCI USA, V88, P6403, DOI 10.1073/pnas.88.15.6403; DSOUZA SE, 1994, CELL, V79, P659, DOI 10.1016/0092-8674(94)90551-7; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; FERGUSON TA, 1991, P NATL ACAD SCI USA, V88, P8072, DOI 10.1073/pnas.88.18.8072; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GULINO D, 1992, J BIOL CHEM, V267, P1001; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Irie A, 1997, P NATL ACAD SCI USA, V94, P7198, DOI 10.1073/pnas.94.14.7198; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; JAKUBOWSKI A, 1995, CELL ADHES COMMUN, V3, P131, DOI 10.3109/15419069509081282; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; LOBB R, 1991, BIOCHEM BIOPH RES CO, V178, P1498, DOI 10.1016/0006-291X(91)91063-I; Lobb RR, 1995, CELL ADHES COMMUN, V3, P385, DOI 10.3109/15419069509081293; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MOLOSSI S, 1995, J CLIN INVEST, V95, P2601, DOI 10.1172/JCI117962; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Newham P, 1998, J IMMUNOL, V160, P4508; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PERELSON AS, 1980, MATH BIOSCI, V48, P71, DOI 10.1016/0025-5564(80)90017-6; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Tuckwell DS, 1997, FEBS LETT, V400, P297, DOI 10.1016/S0014-5793(96)01368-3; Udagawa T, 1996, J IMMUNOL, V157, P1965; WAHL SM, 1994, J CLIN INVEST, V94, P655, DOI 10.1172/JCI117382; WANG JH, 1995, P NATL ACAD SCI USA, V92, P5714, DOI 10.1073/pnas.92.12.5714; WAYER EA, 1992, J CELL BIOL, V116, P489; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Yoshikawa H, 1996, J IMMUNOL, V156, P1832	41	67	68	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13167	13175		10.1074/jbc.274.19.13167	http://dx.doi.org/10.1074/jbc.274.19.13167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224072	hybrid			2022-12-27	WOS:000080200400034
J	Liu, Y; Thor, A; Shtivelman, E; Cao, YH; Tu, GH; Heath, TD; Debs, RJ				Liu, Y; Thor, A; Shtivelman, E; Cao, YH; Tu, GH; Heath, TD; Debs, RJ			Systemic gene delivery expands the repertoire of effective antiangiogenic agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TUMOR ANGIOGENESIS; IN-VIVO; LUNG-CARCINOMA; CANCER; METASTASIS; THERAPY; GROWTH; SUPPRESSION; ANGIOSTATIN	Cationic liposome-DNA complex (CLDC)-based intravenous gene delivery targets gene expression to vascular endothelial cells, macrophages and tumor cells. We used systemic gene delivery to identify anti-angiogenic gene products effective against metastatic spread in tumor-bearing mice, Specifically, CLDC-based intravenous delivery of the p53 and GM-CSF genes were each as effective as the potent antiangiogenic gene, angiostatin, in reducing both tumor metastasis and tumor angiogenesis, Combined delivery of these genes did not increase anti-tumor activity, further suggesting that each gene appeared to produce its antimetastatic activity through a common antiangiogenic pathway. CLDC-based intravenous delivery of the human wild type p53 gene transfected up to 80% of tumor cells metastatic to lung. Furthermore, it specifically induced the expression of the potent antiangiogenic gene, thrombospondin-l, indicating that p53 gene delivery in vivo may inhibit angiogenesis by inducing endogenous thrombospondin-l expression. CLDC-based delivery also identified a novel antitumor activity for the metastasis suppressor gene CC3, Thus, CLDC-based intravenous gene delivery can produce systemic antiangiogenic gene therapy using a variety of different genes and may be used to assess potential synergy of combined anti-tumor gene delivery and to identify novel activities for existing anti-tumor genes.	Calif Pacific Med Ctr, Res Inst, Geraldine Brush Canc Res Inst, San Francisco, CA 94115 USA; Northwestern Univ, Sch Med, Dept Pathol, Evanston, IL 60201 USA; Karolinska Inst, Lab Angiogenesis Res, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; Northwestern University; Karolinska Institutet; University of Wisconsin System; University of Wisconsin Madison	Debs, RJ (corresponding author), Calif Pacific Med Ctr, Res Inst, Geraldine Brush Canc Res Inst, 2330 Clay St,Stern Bldg, San Francisco, CA 94115 USA.				NATIONAL CANCER INSTITUTE [R01CA058914, P50CA058207, R01CA071422] Funding Source: NIH RePORTER; NCI NIH HHS [CA58914, CA58207, CA71422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIKFALVI A, 1994, LEUKEMIA, V8, P523; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Cao YH, 1998, J CLIN INVEST, V101, P1055, DOI 10.1172/JCI1558; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; CRAFT PS, 1994, ANN ONCOL, V5, P305, DOI 10.1093/oxfordjournals.annonc.a058829; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; HEIDENREICH O, 1995, MOL MED TODAY, V1, P128, DOI 10.1016/S1357-4310(95)80090-5; Hong KL, 1997, FEBS LETT, V400, P233, DOI 10.1016/S0014-5793(96)01397-X; Kijima H, 1995, PHARMACOL THERAPEUT, V68, P247, DOI 10.1016/0163-7258(95)02008-X; LESOONWOOD LA, 1995, HUM GENE THER, V6, P395, DOI 10.1089/hum.1995.6.4-395; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; LIOTTA LA, 1993, PRINCIPLES MOL CELL, P134; LIU Y, 1995, J BIOL CHEM, V270, P24864, DOI 10.1074/jbc.270.42.24864; Liu Y, 1997, NAT BIOTECHNOL, V15, P167, DOI 10.1038/nbt0297-167; McLean JW, 1997, AM J PHYSIOL-HEART C, V273, pH387, DOI 10.1152/ajpheart.1997.273.1.H387; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Rak J, 1995, CANCER METAST REV, V14, P263, DOI 10.1007/BF00690598; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Soldi R, 1997, BLOOD, V89, P863, DOI 10.1182/blood.V89.3.863; Song YK, 1997, HUM GENE THER, V8, P1585, DOI 10.1089/hum.1997.8.13-1585; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; THOR AD, 1992, JNCI-J NATL CANCER I, V84, P845, DOI 10.1093/jnci/84.11.845; TSUIMOTO Y, 1987, P NATL ACAD SCI USA, V83, P5214; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; VOLPERT OV, 1995, BREAST CANCER RES TR, V36, P119, DOI 10.1007/BF00666034; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu M, 1997, HUM GENE THER, V8, P177, DOI 10.1089/hum.1997.8.2-177	36	76	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13338	13344		10.1074/jbc.274.19.13338	http://dx.doi.org/10.1074/jbc.274.19.13338			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224095	hybrid			2022-12-27	WOS:000080200400057
J	Nakamura, T; Takeuchi, K; Muraoka, S; Takezoe, H; Takahashi, N; Mori, N				Nakamura, T; Takeuchi, K; Muraoka, S; Takezoe, H; Takahashi, N; Mori, N			A neurally enriched coronin-like protein, ClipinC, is a novel candidate for an actin cytoskeleton-cortical membrane-linking protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; FOCAL ADHESIONS; BETA-1 INTEGRIN; CELL MOTILITY; STRESS FIBERS; GROWTH CONES; WD-REPEAT; DICTYOSTELIUM; FILOPODIA; SUBUNIT	Brain-enriched human FC96 protein shows a close sequence similarity to the Dictyostelium actin-binding protein coronin, which has been implicated in cell motility, cytokinesis, and phagocytosis, A phylogenetic tree analysis revealed that FC96 and two other mammalian molecules (p57 and IR10) form a new protein family, the coronin-like protein (Clipin) family; thus hereafter we refer to FC96 as ClipinC, A WD domain and a succeeding cu-helical region are conserved among coronin and Clipin family members. ClipinC is predominantly expressed in the brain, and discrete areas in the mouse brain were intensely labeled with anti-ClipinC antibodies. ClipinC was also shown to bind directly to F-actin in vitro. Immunocytochemical analysis revealed that ClipinC accumulated at focal adhesions as well as at neurite tips and stress fibers. Furthermore, ClipinC was associated with vinculin, which is a major component of focal contacts. These results indicate that ClipinC is also a component part of the cross-bridge between the actin cytoskeleton and the plasma membrane. These findings and the previously reported function of coronin suggest that ClipinC may play specific roles in the reorganization of neuronal actin structure, a change that has been implicated in both cell motility and growth cone advance.	Sumitomo Elect Ind Ltd, Biomed R&D Dept, Sakae Ku, Yokohama, Kanagawa 2448588, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Ikoma, Nara 6300101, Japan; Sci & Technol Corp Japan, PRESTO, Inheritance & Variat Grp, Kyoto 61902, Japan; Sci & Technol Corp Japan, CREST, Program Protecting Brain, Oobu, Aichi 4748522, Japan; Natl Inst Longev Sci, Dept Mol Genet Res, Oobu, Aichi 4748522, Japan	Sumitomo Electric Industries; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nakamura, T (corresponding author), Sumitomo Elect Ind Ltd, Biomed R&D Dept, Sakae Ku, Yokohama, Kanagawa 2448588, Japan.		Takeuchi, Kosei/AAV-3577-2021	Takeuchi, Kosei/0000-0001-6397-2243				Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; GARRITSEN A, 1994, J BIOL CHEM, V269, P24418; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grogan A, 1997, J CELL SCI, V110, P3071; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Nakamura T, 1996, ONCOGENE, V13, P1111; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; PUMIGLIA KM, 1995, J BIOL CHEM, V270, P14251, DOI 10.1074/jbc.270.24.14251; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sasaki Y F, 1994, DNA Res, V1, P91, DOI 10.1093/dnares/1.2.91; SCHMIDT CE, 1995, J NEUROSCI, V15, P3400; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; TANABE Y, 1988, MOL CELL BIOL, V8, P466; VARNUMFINNEY B, 1994, J CELL BIOL, V127, P1071, DOI 10.1083/jcb.127.4.1071; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; Wu DY, 1996, J NEUROSCI, V16, P1470; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; ZAPHIROPOULOS PG, 1996, DNA CELL BIOL, V15	33	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13322	13327		10.1074/jbc.274.19.13322	http://dx.doi.org/10.1074/jbc.274.19.13322			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224093	hybrid			2022-12-27	WOS:000080200400055
J	Spiegelberg, BD; Xiong, JP; Smith, JJ; Gu, RF; York, JD				Spiegelberg, BD; Xiong, JP; Smith, JJ; Gu, RF; York, JD			Cloning and characterization of a mammalian lithium-sensitive bisphosphate 3 '-nucleotidase inhibited by inositol 1,4-bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE 1-PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE; PAPS TRANSLOCASE; SALT TOLERANCE; YEAST; GENE; FRUCTOSE-1,6-BISPHOSPHATASE; MONOPHOSPHATASE; IDENTIFICATION	Discovery of a structurally conserved metal-dependent lithium-inhibited phosphomonoesterase protein family has identified several potential cellular targets of lithium as used to treat manic depression. Here we describe identification of a novel family member using a "computer cloning" strategy, Human and murine cDNA clones encoded proteins sharing 92% identity and were highly expressed in kidney. Native and recombinant protein harbored intrinsic magnesium-dependent bisphosphate nucleotidase activity (BPntase), which removed the S'-phosphate from 3'-5' bisphosphate nucleosides and 3'-phosphoadenosine 5'-phosphosulfate with K-m and V-max values of 0.5 mu M and 40 mu mol/min/mg. Lithium uncompetitively inhibited activity with a K-i of 157 mu M interestingly, BPntase was competitively inhibited by inositol 1,4-bisphosphate with a K-i of 15 mu M Expression of mammalian BPntase complemented defects in hal2/met22 mutant yeast. These data suggest that BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The presence of high levels of BPntase in the kidney are provocative in Light of the roles of bisphosphorylated nucleotides in regulating salt tolerance, sulfur assimilation, detoxification, and lithium toxicity. We propose that inhibition of human BPntase may account for Lithium-induced nephrotoxicity, which may be overcome by supplementation of current therapeutic regimes with inhibitors of nucleotide biosynthesis, such as methionine.	Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA.				NHLBI NIH HHS [R01-HL 55672] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEREST H, 1971, Journal of Bacteriology, V106, P758; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; INHORN RC, 1987, J BIOL CHEM, V262, P15946; INHORN RC, 1987, P NATL ACAD SCI USA, V84, P2170, DOI 10.1073/pnas.84.8.2170; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moore DD, 1995, GLOB MOB SURV; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3695, DOI 10.1021/bi951303m; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3685, DOI 10.1021/bi951302u; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; POLLACK SJ, 1993, EUR J BIOCHEM, V217, P281, DOI 10.1111/j.1432-1033.1993.tb18244.x; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; RAMASWAMY SG, 1987, J BIOL CHEM, V262, P10044; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER SS, 1979, ANAL BIOCHEM, V96, P34, DOI 10.1016/0003-2697(79)90550-5; Stolz LE, 1998, GENETICS, V148, P1715; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P8916, DOI 10.1073/pnas.92.19.8916; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; YORK JD, 1994, BIOCHEMISTRY-US, V33, P13164, DOI 10.1021/bi00249a002; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i	34	72	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13619	13628		10.1074/jbc.274.19.13619	http://dx.doi.org/10.1074/jbc.274.19.13619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224133	hybrid			2022-12-27	WOS:000080200400095
J	Lin, FT; Miller, WE; Luttrell, LM; Lefkowitz, RJ				Lin, FT; Miller, WE; Luttrell, LM; Lefkowitz, RJ			Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; FACTOR-I RECEPTOR; COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; TYROSINE PHOSPHORYLATION; INSULIN; ARRESTIN; INTERNALIZATION	The functions of beta-arrestin1 to facilitate clathrin-mediated endocytosis of the beta(2)-adrenergic receptor and to promote agonist-induced activation of extracellular signal-regulated kinases (ERK) are regulated by its phosphorylation/dephosphorylation at Ser-412. Cytoplasmic beta-arrestin1 is almost stoichiometrically phosphorylated at Ser-412. Dephosphorylation of beta-arrestin1 at the plasma membrane is required for targeting a signaling complex that includes the agonist-occupied receptors to the clathrin-coated pits. Here we demonstrate that beta-arrestin1 phosphorylation and function are modulated by an ERK-dependent negative feedback mechanism, ERK1 and ERK2 phosphorylate beta-arrestin1 at Ser-412 in vitro. Inhibition of ERK activity by a dominant-negative MEK1 mutant significantly attenuates beta-arrestin1 phosphorylation, thereby increasing the concentration of dephosphorylated beta-arrestin1. Under such conditions, beta-arrestin1-mediated beta(2)-adrenergic receptor internalization is enhanced as is its ability to bind clathrin. In contrast, if ERK-mediated phosphorylation is increased by transfection of a constitutively active MEK1 mutant, receptor internalization is inhibited. Our results suggest that dephosphorylated beta-arrestin1 mediates endocytosis-dependent ERK activation. Following activation, ERKs phosphorylate beta-arrestin1, thereby exerting an inhibitory feedback control of its function.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Box 3821, Durham, NC 27710 USA.	lefko001@mc.duke.edu	Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; LEE RM, 1992, J BIOL CHEM, V267, P1088; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; SEGER R, 1994, J BIOL CHEM, V269, P25699; UEKI K, 1994, J BIOL CHEM, V269, P15756; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086	27	115	119	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15971	15974		10.1074/jbc.274.23.15971	http://dx.doi.org/10.1074/jbc.274.23.15971			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347142	hybrid			2022-12-27	WOS:000080668600002
J	Herrmann, A; Davies, JR; Lindell, G; Martensson, S; Packer, NH; Swallow, DM; Carlstedt, I				Herrmann, A; Davies, JR; Lindell, G; Martensson, S; Packer, NH; Swallow, DM; Carlstedt, I			Studies on the "insoluble" glycoprotein complex from human colon - Identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SMALL-INTESTINE; MOLECULAR-CLONING; 6M-GUANIDINIUM CHLORIDE; MUCINS; REGION; GENE; CDNA; GLYCOSYLATION; BIOSYNTHESIS; POLYMORPHISM	The "insoluble" glycoprotein complex was isolated from human colonic tissue and mucin subunits were prepared following reduction, Antibodies raised against peptide sequences within MUC2 revealed that virtually all of this mucin occurs in the insoluble glycoprotein complex. In addition, reduction released a 120-kDa C-terminal MUC2 fragment, showing that proteolytic cleavage in this domain may occur and leave the fragment attached to the complex via disulfide bonds. The variable number tandem repeat region and the irregular repeat domain were isolated after trypsin digestion and shown to have molecular weights of 930,000 and 180,000, respectively, suggesting a molecular weight for the entire MUC2 monomer of approximately 1.5 million. Gel chromatography and agarose gel electrophoresis revealed several populations of MUGS subunits, and analytical ultracentrifugation showed that these have molecular weights on the order of 2 million, 4 million, and 5 million, corresponding to monomers, dimers, and trimers, respectively, Agarose gel electrophoresis of subunits from individuals expressing both a "long" and a "short" MUC2 allele revealed a larger number of populations, consistent with the presence of short and long monomers and oligomers arising from permutations of the two types of monomers. In addition to disulfide bonds, MUGS monomers are apparently joined by a "novel," reduction-insensitive bond.	Lund Univ, Dept Cell & Mol Biol, Mucosal Biol Grp, Sect Mol Pathogenesis, S-22100 Lund, Sweden; Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Urol, S-22185 Lund, Sweden; Macquarie Univ, Ctr Analyt Biotechnol, Sydney, NSW 2019, Australia; UCL, Human Biochem Genet Unit, London NW1 2HE, England	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Macquarie University; University of London; University College London	Carlstedt, I (corresponding author), Lund Univ, Dept Cell & Mol Biol, Mucosal Biol Grp, Sect Mol Pathogenesis, POB 94, S-22100 Lund, Sweden.	Ingemar.Carlstedt@medkem.lu.se	Packer, Nicolle/Q-8929-2019; Davies, Julia R/H-4194-2011	Davies, Julia R/0000-0001-5888-664X; Packer, Nicolle/0000-0002-7532-4021				Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; ASKER N, 1995, BIOCHEM J, V308, P873, DOI 10.1042/bj3080873; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; CARLSTEDT I, 1984, CIBA F SYMP, V109, P157, DOI 10.1002/9780470720905.ch11; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; Carlstedt I, 1995, BIOCHEM SOC T, V23, P845, DOI 10.1042/bst0230845; CREETH JM, 1982, J BIOCHEM BIOPH METH, V7, P25, DOI 10.1016/0165-022X(82)90033-1; Davies JR, 1996, BIOCHEM J, V313, P431, DOI 10.1042/bj3130431; DEVINE PL, 1992, BIOTECHNIQUES, V12, P160; FAHIM REF, 1983, BIOCHEM J, V209, P117, DOI 10.1042/bj2090117; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; GUM JR, 1992, J BIOL CHEM, V267, P21375; GUM JR, 1994, J BIOL CHEM, V269, P2440; HANSSON GC, 1994, BIOCHEM BIOPH RES CO, V198, P181, DOI 10.1006/bbrc.1994.1026; Herrmann A, 1995, BIOCHEM SOC T, V23, pS535, DOI 10.1042/bst023535s; HERRMANN A, 1996, 4 INT WORKSH CARC AS, P133; Khatri IA, 1998, BIOCHEM J, V331, P323, DOI 10.1042/bj3310323; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANSSON W, 1990, J UROLOGY, V144, P1359, DOI 10.1016/S0022-5347(17)39740-9; MANTLE M, 1984, BIOCHEM J, V224, P345, DOI 10.1042/bj2240345; MARTENSSON S, 1988, SCAND J CLIN LAB INV, V48, P633, DOI 10.3109/00365518809085783; OHMORI H, 1994, J BIOL CHEM, V269, P17833; Ou KL, 1996, J CHROMATOGR A, V723, P219, DOI 10.1016/0021-9673(95)00879-9; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; Sheehan JK, 1996, BIOCHEM J, V315, P1055, DOI 10.1042/bj3151055; SHEEHAN JK, 1984, BIOCHEM J, V221, P499, DOI 10.1042/bj2210499; SHEEHAN JK, 1984, BIOCHEM J, V217, P93, DOI 10.1042/bj2170093; THORNTON DJ, 1989, ANAL BIOCHEM, V182, P160, DOI 10.1016/0003-2697(89)90735-5; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; TORIBARA NW, 1991, J CLIN INVEST, V88, P1005, DOI 10.1172/JCI115360; van Klinken BJW, 1998, AM J PHYSIOL-GASTR L, V274, pG871, DOI 10.1152/ajpgi.1998.274.5.G871; van Klinken BJW, 1998, GLYCOBIOLOGY, V8, P67, DOI 10.1093/glycob/8.1.67; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; XU G, 1992, BIOCHEM BIOPH RES CO, V183, P821, DOI 10.1016/0006-291X(92)90557-2; XU GQ, 1992, J BIOL CHEM, V267, P5401; ZIMM BH, 1948, J CHEM PHYS, V16, P1099, DOI 10.1063/1.1746740	38	121	123	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15828	15836		10.1074/jbc.274.22.15828	http://dx.doi.org/10.1074/jbc.274.22.15828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336486	hybrid			2022-12-27	WOS:000080560100075
J	Liu, J; Razani, B; Tang, SQ; Terman, BI; Ware, JA; Lisanti, MP				Liu, J; Razani, B; Tang, SQ; Terman, BI; Ware, JA; Lisanti, MP			Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells - Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE CASCADE; PROTEIN-KINASE; TUMOR-GROWTH; IN-VIVO; SIGNAL-TRANSDUCTION; TYROSINE KINASE; MEMBRANE; CANCER; ANGIOSTATIN; METASTASIS	Angiogenesis is the process by which new blood vessels are formed via proliferation of vascular endothelial cells. A variety of angiogenesis inhibitors that antagonize the effects of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) have recently been identified. However, the mechanism by which these diverse angiogenesis inhibitors exert their common effects remains largely unknown. Caveolin-1 and -2 are known to be highly expressed in vascular endothelial cells both in vitro and in vivo, Here, we examine the potential role of caveolins in the angiogenic response, For this purpose, we used the well established human umbilical vein endothelial cell line, ECV 304, Treatment of ECV 304 cells with known angiogenic growth factors (VEGF, bFGF, or hepatocyte growth factor/scatter factor), resulted in a dramatic reduction in the expression of caveolin-1, This down-regulation event was selective for caveolin-1, as caveolin-2 levels remained constant under these conditions of growth factor stimulation. VEGF-induced down-regulation of caveolin-1 expression also resulted in the morphological loss of cell surface caveolae organelles as seen by trans mission electron microscopy, A variety of well characterized angiogenesis inhibitors (including angiostatin, fumagillin, 2-methoxy estradiol, transforming growth factor-A and thalidomide) effectively blocked VEGF-induced down-regulation of caveolin-1 as seen by immunoblotting and immunofluorescence microscopy, However, treatment with angiogenesis inhibitors alone did not significantly affect the expression of caveolin-1. PD98059, a specific inhibitor of mitogen-activated protein kinase and a known angiogenesis inhibitor, also blocked the observed VEGF-induced down-regulation of caveolin-1. Furthermore, we show that caveoliln-1 can function as a negative regulator of VEGF-R (KDR) signal transduction in vivo, Thus, down-regulation of caveolin-1 may be an important step along the pathway toward endothelial cell proliferation.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Canc Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University	Lisanti, MP (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lisanti@aecom.yu.edu	Lisanti, Michael P/C-6866-2013; Ware, Joseph/AAC-2843-2022; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Razani, Babak/0000-0002-7172-9240	NATIONAL CANCER INSTITUTE [R01CA080250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA-80250] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIRD A, 1986, BIOCHEM BIOPH RES CO, V138, P476, DOI 10.1016/0006-291X(86)90305-0; BATTEGAY EJ, 1995, J MOL MED, V73, P333; BICKNELL R, 1994, ANN ONCOL, V5, pS45, DOI 10.1093/annonc/5.suppl_4.S45; Bicknell Roy, 1996, Current Opinion in Oncology, V8, P60, DOI 10.1097/00001622-199601000-00011; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Engelman JA, 1998, J BIOL CHEM, V273, P20448, DOI 10.1074/jbc.273.32.20448; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOTIS T, 1994, NATURE, V368, P237; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GUERIN C, 1992, BIOCHEM BIOPH RES CO, V188, P740, DOI 10.1016/0006-291X(92)91118-A; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Jones MK, 1998, BIOCHEM BIOPH RES CO, V249, P118, DOI 10.1006/bbrc.1998.9095; Kalebic T, 1996, INT J CANCER, V68, P596; Kenyon BM, 1997, EXP EYE RES, V64, P971, DOI 10.1006/exer.1997.0292; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rosen EM, 1997, CIBA F SYMP, V212, P215; Saphir A, 1997, J NATL CANCER I, V89, P1658; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; TAKAHASHI H, 1992, ELECTRON LETT, V28, P380, DOI 10.1049/el:19920238; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; TAKAHASHI K, 1991, IN VITRO CELL DEV B, V27, P766; TAMARGO RJ, 1991, CANCER RES, V51, P672; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; TERMAN BI, 1991, ONCOGENE, V6, P1677; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; YAMAOKA M, 1993, CANCER RES, V53, P4262; Yue TL, 1997, MOL PHARMACOL, V51, P951, DOI 10.1124/mol.51.6.951; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	54	148	169	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15781	15785		10.1074/jbc.274.22.15781	http://dx.doi.org/10.1074/jbc.274.22.15781			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336480	hybrid			2022-12-27	WOS:000080560100069
J	Farr, CL; Wang, YX; Kaguni, LS				Farr, CL; Wang, YX; Kaguni, LS			Functional interactions of mitochondrial DNA polymerase and single-stranded DNA-binding protein - Template-primer DNA binding and initiation and elongation of DNA strand synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; REPLICATION; SSB; HOLOENZYME; EMBRYOS; BACTERIOPHAGE-T7; PURIFICATION; PROCESSIVITY	Functional interactions between mitochondrial DNA polymerase (pol gamma) and mitochondrial single stranded DNA-binding protein (mtSSB) from Drosophila embryos have been evaluated with regard to the overall activity of poli gamma and in partial reactions involving template-primer binding and initiation and idling in DNA strand synthesis. Both the 5' --> 3' DNA polymerase and 3' --> 5' exonuclease in pol gamma are stimulated 15-20-fold on oligonucleotide-primed single-stranded DNA by native and recombinant forms of mtSSB. That the extent of stimulation is similar for both enzyme activities over a broad range of KCI concentrations suggests their functional coordination and a similar mechanism of stimulation by mtSSB. At the same time, the high mispair specificity of pol gamma in exonucleolytic hydrolysis is maintained, indicating that enhancement of pol gamma catalytic efficiency is likely not accompanied by increased nucleotide turnover. DNase I footprinting of pol gamma DNA complexes and initial rate measurements show that mtSSB enhances primer recognition and binding and stimulates 30-fold the rate of initiation of DNA strands. Dissociation studies show that productive complexes of the native pol gamma heterodimer with template-primer DNA are formed and remain stable in the absence of replication accessory proteins.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	Michigan State University	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; CHA TA, 1988, CANCER CELL, V6, P1; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; GHRIR R, 1991, ARCH BIOCHEM BIOPHYS, V291, P395, DOI 10.1016/0003-9861(91)90152-9; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; HACKER KJ, 1994, J BIOL CHEM, V269, P24209; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KIM YT, 1992, J BIOL CHEM, V267, P15032; Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331; KUNKEL TA, 1983, BIOCHEMISTRY-US, V22, P2378, DOI 10.1021/bi00279a012; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MIGNOTTE B, 1985, NUCLEIC ACIDS RES, V13, P1703, DOI 10.1093/nar/13.5.1703; Mikhailov VS, 1996, J BIOL CHEM, V271, P18939, DOI 10.1074/jbc.271.31.18939; PAVCO PA, 1985, J CELL BIOL, V100, P258, DOI 10.1083/jcb.100.1.258; REEMS JA, 1994, J BIOL CHEM, V269, P33091; REUBEN RC, 1974, J BIOL CHEM, V249, P3843; RIGLER MN, 1995, J BIOL CHEM, V270, P8910, DOI 10.1074/jbc.270.15.8910; SHERMAN LA, 1976, J MOL BIOL, V103, P61, DOI 10.1016/0022-2836(76)90052-8; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; STROUMBAKIS ND, 1994, GENE, V143, P171, DOI 10.1016/0378-1119(94)90093-0; TABOR S, 1987, J BIOL CHEM, V262, P16212; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251; WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153	36	80	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14779	14785		10.1074/jbc.274.21.14779	http://dx.doi.org/10.1074/jbc.274.21.14779			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329675	hybrid			2022-12-27	WOS:000081965200040
J	Herold, J; Siddell, SG; Gorbalenya, AE				Herold, J; Siddell, SG; Gorbalenya, AE			A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; HEPATITIS-C VIRUS; INFECTIOUS-BRONCHITIS VIRUS; ZINC-CONTAINING ENZYME; P-28 CLEAVAGE SITE; CRYSTAL-STRUCTURE; MURINE CORONAVIRUS; BLEOMYCIN HYDROLASE; SECONDARY STRUCTURE; BINDING SITE	A cysteine proteinase, papain-like proteinase (PL1pro), of the human coronavirus 229E (HCoV) regulates the expression of the replicase polyproteins, pp1a and ppa1ab, by cleavage between Gly(111) and Asn(112), far upstream of its own catalytic residue Cys(1054). In this report, using bioinformatics tools, we predict that, unlike its distant cellular homologues, HCoV PL1pro and its coronaviral relatives have a poorly conserved Zn2+ finger connecting the left and right hand domains of a papain-like fold. Optical emission spectrometry has been used to confirm the presence of Zn2+ in a purified and proteolytically active form of the HCoV PL1pro fused with the Escherichia coli maltose-binding protein. In denaturation/renaturation experiments using the recombinant protein, its activity was shown to be strongly dependent upon Zn2+, which could be partly substituted by Co2+ during renaturation, The reconstituted, Zn2+-containing PL1pro was not sensitive to 1,10-phenanthroline, and the Zn2+-depleted protein was not reactivated by adding Zn2+ after renaturation. Consistent with the proposed essential structural role of Zn2+, PL1pro was selectively inactivated by mutations in the Zn2+ finger including replacements of any of four conserved Cys residues predicted to co-ordinate Zn2+. The unique domain organization of HCoV PL1pro provides a potential framework for regulatory processes and may be indicative of a nonproteolytic activity of this enzyme.	NCI, Frederick Canc Res & Dev Ctr, Adv Biomed Comp Ctr, SAIC,NIH, Frederick, MD 21702 USA; Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany; Leiden Univ, Ctr Med, NL-2300 RC Leiden, Netherlands; Russian Acad Med Sci, Inst Poliomyelitis & Viral Encephalitis, Moscow 142782, Russia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Wurzburg; Leiden University; Leiden University - Excl LUMC; Russian Academy of Medical Sciences	Gorbalenya, AE (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Adv Biomed Comp Ctr, SAIC,NIH, 430 Miller Dr,Rm 235, Frederick, MD 21702 USA.		Gorbalenya, Alexander E/J-4818-2012	Gorbalenya, Alexander E/0000-0002-4967-7341	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandrov N N, 1996, Pac Symp Biocomput, P53; Alexandrov NN, 1996, PROTEINS, V25, P354, DOI 10.1002/(SICI)1097-0134(199607)25:3<354::AID-PROT7>3.3.CO;2-W; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; ALTMAN RB, 1995, J MOL GRAPH MODEL, V13, P142, DOI 10.1016/0263-7855(95)00002-N; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; Aurora R, 1998, P NATL ACAD SCI USA, V95, P2818, DOI 10.1073/pnas.95.6.2818; BAKER EN, 1980, J MOL BIOL, V141, P441, DOI 10.1016/0022-2836(80)90255-7; BAKER SC, 1993, J VIROL, V67, P6056, DOI 10.1128/JVI.67.10.6056-6063.1993; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BONILLA PJ, 1995, VIROLOGY, V209, P489, DOI 10.1006/viro.1995.1281; BONILLA PJ, 1994, VIROLOGY, V198, P736, DOI 10.1006/viro.1994.1088; Bonilla PJ, 1997, J VIROL, V71, P900, DOI 10.1128/JVI.71.2.900-909.1997; BOURSNELL MEG, 1987, J GEN VIROL, V68, P57, DOI 10.1099/0022-1317-68-1-57; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; DeFrancesco R, 1996, BIOCHEMISTRY-US, V35, P13282, DOI 10.1021/bi9616458; DONG SH, 1994, VIROLOGY, V204, P541, DOI 10.1006/viro.1994.1567; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; ELEOUET JF, 1995, VIROLOGY, V206, P817, DOI 10.1006/viro.1995.1004; Gerstein M, 1995, COMPUT APPL BIOSCI, V11, P633; Gorbalenya A.E., 1993, SOV SCI REV D, V11, P1; GORBALENYA AE, 1991, FEBS LETT, V288, P201, DOI 10.1016/0014-5793(91)81034-6; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4847, DOI 10.1093/nar/17.12.4847; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Gorbalenya AE, 1996, PERSPECT DRUG DISCOV, V6, P64, DOI 10.1007/BF02174046; GORBALENYA AE, 1986, FEBS LETT, V194, P253, DOI 10.1016/0014-5793(86)80095-3; Guarne A, 1998, EMBO J, V17, P7469, DOI 10.1093/emboj/17.24.7469; HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989; HARRIS GW, 1992, ACTA CRYSTALLOGR B, V48, P67, DOI 10.1107/S0108768191006663; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Henikoff S, 1998, NUCLEIC ACIDS RES, V26, P309, DOI 10.1093/nar/26.1.309; Herold J, 1996, METHOD ENZYMOL, V275, P68; Herold J, 1998, J VIROL, V72, P910, DOI 10.1128/JVI.72.2.910-918.1998; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; HUGHES SA, 1995, J VIROL, V69, P809, DOI 10.1128/JVI.69.2.809-813.1995; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMPHUIS IG, 1985, J MOL BIOL, V182, P317, DOI 10.1016/0022-2836(85)90348-1; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LEE HJ, 1991, VIROLOGY, V180, P567, DOI 10.1016/0042-6822(91)90071-I; Lim KP, 1998, VIROLOGY, V245, P303, DOI 10.1006/viro.1998.9164; Liu X, 1998, J VIROL, V72, P4463, DOI 10.1128/JVI.72.5.4463-4466.1998; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Maes D, 1996, BIOCHEMISTRY-US, V35, P16292, DOI 10.1021/bi961491w; Mangel WF, 1997, TRENDS BIOCHEM SCI, V22, P393, DOI 10.1016/S0968-0004(97)01123-7; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; MCGRATH ME, 1995, J MOL BIOL, V247, P251, DOI 10.1006/jmbi.1994.0137; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; OH CS, 1989, VIROLOGY, V173, P692, DOI 10.1016/0042-6822(89)90582-5; OHARA BP, 1995, BIOCHEMISTRY-US, V34, P13190, DOI 10.1021/bi00040a034; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PICKERSGILL RW, 1991, ACTA CRYSTALLOGR B, V47, P766, DOI 10.1107/S0108768191003191; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; RITONJA A, 1989, FEBS LETT, V247, P419, DOI 10.1016/0014-5793(89)81383-3; Rost B, 1996, METHOD ENZYMOL, V266, P525; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Skern T, 1998, J GEN VIROL, V79, P301, DOI 10.1099/0022-1317-79-2-301; SOMMERGRUBER W, 1994, VIROLOGY, V204, P815, DOI 10.1006/viro.1994.1599; Sommergruber W, 1997, VIROLOGY, V234, P203, DOI 10.1006/viro.1997.8595; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113; XU HE, 1994, J BIOL CHEM, V269, P21177; YU SYF, 1992, VIROLOGY, V186, P725, DOI 10.1016/0042-6822(92)90039-R; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	86	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14918	14925		10.1074/jbc.274.21.14918	http://dx.doi.org/10.1074/jbc.274.21.14918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329692	hybrid, Green Published			2022-12-27	WOS:000081965200057
J	Wang, KL; Roufogalis, BD				Wang, KL; Roufogalis, BD			Ca2+/calmodulin stimulates GTP binding to the Ras-related protein Ral-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSOCIATION STIMULATOR; SYNAPTIC VESICLES; EXCHANGE FACTOR; HUMAN-PLATELETS; KINASE-II; CALMODULIN; ACTIVATION; GROWTH; CELLS; IDENTIFICATION	Ral-A is a Ras-related GTP-binding protein that has been suggested to be the downstream target of Ras proteins and is involved in the tyrosine kinase-mediated, Ras-dependent activation of phospholipase D. We reported recently that Ral-A purified from human erythrocyte membrane binds to calmodulin in a Ca2+-dependent manner at a calmodulin binding domain identified near its C-terminal region (Wang, K. L., Khan, M. T., and Roufogalis, B. D. (1997) J. Biol. Chem. 272, 16002-16009). In this study we show the enhancement of GTP binding to Ral-A by Ca2+/calmodulin. The stimulation up to 3-fold by calmodulin was Ca2+-dependent, with half-maximum activation occurring at 180 nM calmodulin and 80 nM free Ca2+ concentration. The present work supports a regulatory role of Ca2+/calnodulin for the activation of Ral-A and suggests a possible direct link between signal transduction pathways of Ca2+/calmodulin and Ral-A proteins.	Univ Sydney, Dept Pharm, Sydney, NSW 2006, Australia	University of Sydney	Roufogalis, BD (corresponding author), Univ Sydney, Dept Pharm, A15, Sydney, NSW 2006, Australia.	basilr@pharm.usyd.edu.au		Roufogalis, Basil/0000-0001-9123-5478				Bhullar RP, 1996, BBA-MOL CELL RES, V1311, P181, DOI 10.1016/0167-4889(96)00002-X; BIELINSKI DF, 1993, BIOCHIM BIOPHYS ACTA, V1151, P246, DOI 10.1016/0005-2736(93)90109-D; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Cohen P, 1988, CALMODULIN; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3450; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hinoi T, 1996, J BIOL CHEM, V271, P19710, DOI 10.1074/jbc.271.33.19710; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Lee CHJ, 1996, J NEUROSCI, V16, P6784; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Peppelenbosch MP, 1996, J BIOL CHEM, V271, P7883, DOI 10.1074/jbc.271.14.7883; POLAKIS PG, 1989, J BIOL CHEM, V264, P16383; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; VOGEL HJ, 1995, MOL CELL BIOCHEM, V149, P3, DOI 10.1007/BF01076558; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; VOLKNANDT W, 1993, FEBS LETT, V317, P53, DOI 10.1016/0014-5793(93)81490-Q; WALSH MP, 1994, MOL CELL BIOCHEM, V135, P21, DOI 10.1007/BF00925958; WANG KKW, 1988, ARCH BIOCHEM BIOPHYS, V267, P317, DOI 10.1016/0003-9861(88)90037-9; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486	38	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14525	14528		10.1074/jbc.274.21.14525	http://dx.doi.org/10.1074/jbc.274.21.14525			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329639	hybrid			2022-12-27	WOS:000081965200004
J	Yarwood, SJ; Steele, MR; Scotland, G; Houslay, MD; Bolger, GB				Yarwood, SJ; Steele, MR; Scotland, G; Houslay, MD; Bolger, GB			The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP-SPECIFIC PHOSPHODIESTERASE; N-TERMINAL DOMAIN; KINASE-C; BETA-SUBUNIT; INTRACELLULAR RECEPTOR; MEMBRANE ASSOCIATION; MOLECULAR-CLONING; RPDE-6 RNPDE4A5; COS7 CELLS; GENE	The WD-repeat protein receptor for activated C-kinase (RACK1) was identified by its interaction with the cyclic AMP-specific phosphodiesterase (PDE4) isoform PDE4D5 in a yeast two-hybrid screen. The interaction was confirmed by co-immunoprecipitation of native RACK1 and PDE4D5 from COS7, HEK293, 3T3-F442A, and SK-N-SH cell lines. The interaction was unaffected by stimulation of the cells with the phorbol ester phorbol S-myristate S-acetate. PDE4D5 did not interact with two other WD-repeat proteins, beta'-coatomer protein and G(s)beta, in two-hybrid tests. RACK1 did not interact with other PDE4D isoforms or with known PDE4A, PDE4B, and PDE4C isoforms, PDE4D5 and RACK1 interacted with high affinity (K-a approximately 7 pM) when they were expressed and purified from Escherichia coli, demonstrating that the interaction does not require intermediate proteins, The binding of the E. coli-expressed proteins did not alter the kinetics of cAMP hydrolysis by PDE4D5 but caused a 3-4-fold change in its sensitivity to inhibition by the PDE4 selective inhibitor rolipram. The subcellular distributions of RACK1 and PDE4D5 were extremely similar, with the major amount of both proteins (70%) in the high speed supernatant (S2) fraction. Analysis of constructs with specific deletions or single amino acid mutations in PDE4D5 demonstrated that a small cluster of amino acids in the unique amino terminal region of PDE4D5 was necessary for its interaction with RACK1. We suggest that RACK1 may act as a scaffold protein to recruit PDE4D5 and other proteins into a signaling complex.	Univ Utah, Dept Med Hematol Oncol, Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; Univ Utah, Dept Oncol Sci, Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biol & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; University of Glasgow	Bolger, GB (corresponding author), Univ Utah, Dept Med Hematol Oncol, Vet Affairs Med Ctr, 500 Foothills Blvd, Salt Lake City, UT 84148 USA.	Graeme.Bolger@m.cc.utah.edu	Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011	Yarwood, Stephen/0000-0001-9489-9253; Houslay, Miles/0000-0002-3826-8091				ALVAREZ R, 1995, MOL PHARMACOL, V48, P616; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 1997, BIOCHEM J, V328, P539; Bolger GB, 1996, J BIOL CHEM, V271, P1065, DOI 10.1074/jbc.271.2.1065; Bolger GB, 1998, METH MOL B, V88, P101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; GUAN C, 1988, GENE, V67, P21; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HARLOW E, 1990, ANTIBODIES LAB MANUA, P474; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Huston E, 1997, BIOCHEM J, V328, P549, DOI 10.1042/bj3280549; Huston E, 1996, J BIOL CHEM, V271, P31334, DOI 10.1074/jbc.271.49.31334; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; MCPHEE I, 1995, BIOCHEM J, V310, P965, DOI 10.1042/bj3100965; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nemoz G, 1996, FEBS LETT, V384, P97, DOI 10.1016/0014-5793(96)00300-6; OConnell JC, 1996, BIOCHEM J, V318, P255, DOI 10.1042/bj3180255; Owens RJ, 1997, CELL SIGNAL, V9, P575, DOI 10.1016/S0898-6568(97)00072-7; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SCOTLAND G, 1995, BIOCHEM J, V308, P673, DOI 10.1042/bj3080673; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; SETTE C, 1994, J BIOL CHEM, V269, P18271; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; SHAKUR Y, 1995, BIOCHEM J, V306, P801, DOI 10.1042/bj3060801; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	49	249	257	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14909	14917		10.1074/jbc.274.21.14909	http://dx.doi.org/10.1074/jbc.274.21.14909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329691	hybrid			2022-12-27	WOS:000081965200056
J	Zhao, T; Eissenberg, JC				Zhao, T; Eissenberg, JC			Phosphorylation of heterochromatin protein 1 by casein kinase II is required for efficient heterochromatin binding in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; ORIGIN RECOGNITION COMPLEX; DNA-BINDING; CHROMOSOMAL PROTEIN; CHROMATIN STRUCTURE; GENE-EXPRESSION; HP1; MELANOGASTER; DOMAIN; TRANSCRIPTION	Heterochromatin-associated protein 1 (HP1) is a nonhistone chromosomal protein with a dose-dependent effect on heterochromatin mediated position-effect silencing. It is multiply phosphorylated in vivo. Hyperphosphorylation of HP1 is correlated with heterochromatin assembly. We report here that HP1 is phosphorylated by casein kinase II in vivo at three serine residues located at the N and C termini of the protein. Alanine substitution mutations in the casein kinase II target phosphorylation sites dramatically reduce the heterochromatin binding activity of HP1, whereas glutamate substitution mutations, which mimic the charge contributions of phosphorylated serine, have apparently wild-type binding activity. We propose that phosphorylation of HP1 promotes protein-protein interaction between HP1 and target binding proteins in heterochromatin.	St Louis Univ, Hlth Sci Ctr, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Eissenberg, JC (corresponding author), St Louis Univ, Hlth Sci Ctr, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.							ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BIRNBAUM MJ, 1992, PROTEIN EXPRES PURIF, V3, P142, DOI 10.1016/S1046-5928(05)80098-1; BLUMENFELD M, 1978, P NATL ACAD SCI USA, V75, P866, DOI 10.1073/pnas.75.2.866; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; DADD CA, 1993, BIOTECHNIQUES, V14, P266; EISSENBERG JC, 1992, GENETICS, V131, P345; EISSENBERG JC, 1994, J BIOL CHEM, V269, P21315; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; FRIDELL YWC, 1991, NUCLEIC ACIDS RES, V19, P5082, DOI 10.1093/nar/19.18.5082; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; HARLOW E, 1988, ANTIBODIES LABORATOR, P505; Heitz E., 1928, JB WISS BOT, V69, P728; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; Huang DW, 1998, J CELL BIOL, V142, P307, DOI 10.1083/jcb.142.2.307; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KELLUM R, 1995, J CELL SCI, V108, P1407; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Leroy D, 1997, BIOCHEMISTRY-US, V36, P1242, DOI 10.1021/bi961949u; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; LOCKE J, 1988, GENETICS, V120, P181; MARTIN P, 1986, DEV BIOL, V117, P574, DOI 10.1016/0012-1606(86)90326-X; Massimi P, 1996, ONCOGENE, V12, P2325; MEEK DW, 1992, BIOCHEM J, V287, P1; ODA Y, 1993, J BIOL CHEM, V268, P27318; OReilly D, 1997, EMBO J, V16, P2420, DOI 10.1093/emboj/16.9.2420; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; PIMPINELLI S, 1986, TRENDS GENET, V2, P17, DOI 10.1016/0168-9525(86)90163-0; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; POWERS JA, 1993, J CELL BIOL, V120, P291, DOI 10.1083/jcb.120.2.291; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; SHORE EM, 1987, GENE DEV, V1, P829, DOI 10.1101/gad.1.8.829; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; Sweet MT, 1997, J BIOL CHEM, V272, P916, DOI 10.1074/jbc.272.2.916; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653	53	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15095	15100		10.1074/jbc.274.21.15095	http://dx.doi.org/10.1074/jbc.274.21.15095			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329715	hybrid			2022-12-27	WOS:000081965200080
J	Blomgren, K; Hallin, U; Andersson, AL; Puka-Sundvall, M; Bahr, BA; McRae, A; Saido, TC; Kawashima, S; Hagberg, H				Blomgren, K; Hallin, U; Andersson, AL; Puka-Sundvall, M; Bahr, BA; McRae, A; Saido, TC; Kawashima, S; Hagberg, H			Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED NEUTRAL PROTEASE; RAT-BRAIN; SUBCELLULAR-DISTRIBUTION; POSTISCHEMIC HIPPOCAMPUS; CALCIUM ACCUMULATION; MOLECULAR DIVERSITY; FODRIN PROTEOLYSIS; SPATIAL-RESOLUTION; NEURONAL DAMAGE; APOPTOTIC CELLS	In a model of cerebral hypoxia-ischemia in the immature rat, widespread brain injury is produced in the ipsilateral hemisphere, whereas the contralateral hemisphere is left undamaged. Previously, we found that calpains were equally translocated to cellular membranes (a prerequisite for protease activation) in the ipsilateral and contralateral hemispheres. However, activation, as judged by degradation of fodrin, occurred only in the ipsilateral hemisphere. In this study we demonstrate that calpastatin, the specific, endogenous inhibitor protein to calpain, is up-regulated in response to hypoxia and may be responsible for the halted calpain activation in the contralateral hemisphere. Concomitantly, extensive degradation of calpastatin occurred in the ipsilateral hemisphere, as demonstrated by the appearance of a membrane-bound 50-kDa calpastatin breakdown produce. The calpastatin breakdown product accumulated in the synaptosomal fraction, displaying a peak 24 h post-insult, but was not detectable in the cytosolic fraction. The degradation of calpastatin was blocked by administration of CX295, a calpain inhibitor, indicating that calpastatin acts as a suicide substrate to calpain during hypoxia-ischemia. In summary, calpastatin was up-regulated in areas that remain undamaged and degraded in areas where excessive activation of calpains and infarction occurs.	Univ Gothenburg, Perinatal Ctr, Inst Physiol & Pharmacol, SE-40530 Gothenburg, Sweden; Sahlgrens Univ Hosp, Perinatal Ctr, Dept Pediat, SE-41685 Gothenburg, Sweden; Univ Gothenburg, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden; Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; Univ Connecticut, Neurosci Program, Storrs, CT 06269 USA; Cortex Pharmaceut Inc, Irvine, CA 92618 USA; Univ W Indies, Dept Anat & Cell Biol, St Augustine, Trinidad Tobago; RIKEN, Proteolyt Neurosci Lab, Wako, Saitama 35101, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Biol, Bunkyo Ku, Tokyo 113, Japan; Sahlgrens Univ Hosp, Dept Obstet Gynecol, Perinatal Ctr, SE-41685 Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Connecticut; University of Connecticut; University West Indies Mona Jamaica; University West Indies Saint Augustine; RIKEN; Tokyo Metropolitan Institute of Medical Science; Sahlgrenska University Hospital	Blomgren, K (corresponding author), Univ Gothenburg, Perinatal Ctr, Inst Physiol & Pharmacol, POB 432, SE-40530 Gothenburg, Sweden.	klas.blomgren@fysiologi.gu.se	Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; Blomgren, Klas/0000-0002-0476-7271; Hagberg, Henrik/0000-0003-3962-1448				ADACHI Y, 1991, J BIOL CHEM, V266, P3968; BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; BLOMGREN K, 1995, BRAIN RES, V684, P136, DOI 10.1016/0006-8993(95)00398-A; BLOMGREN K, 1995, BRAIN RES, V684, P143, DOI 10.1016/0006-8993(95)00399-B; BLOMGREN K, 1989, NEUROCHEM RES, V14, P1149, DOI 10.1007/BF00965622; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cong M, 1998, J BIOL CHEM, V273, P660, DOI 10.1074/jbc.273.1.660; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DELUCA CI, 1993, BIOCHIM BIOPHYS ACTA, V1216, P81, DOI 10.1016/0167-4781(93)90040-K; DEMARTINO GN, 1984, ARCH BIOCHEM BIOPHYS, V232, P713, DOI 10.1016/0003-9861(84)90592-7; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; ETO A, 1995, J BIOL CHEM, V270, P25115, DOI 10.1074/jbc.270.42.25115; Hagberg B, 1993, RECENT ADV PAEDIATRI, P67; HAGBERG H, 1994, BIOL NEONATE, V66, P205; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; HU BR, 1994, J NEUROCHEM, V62, P1357; INOMATA M, 1989, J BIOL CHEM, V264, P18838; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; KARLSSON JO, 1994, ANAL BIOCHEM, V219, P144, DOI 10.1006/abio.1994.1243; KASAI Y, 1986, J BIOCHEM-TOKYO, V100, P183, DOI 10.1093/oxfordjournals.jbchem.a121691; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LEE WJ, 1992, J BIOL CHEM, V267, P8437; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; MAKI M, 1987, BIOCHEM BIOPH RES CO, V143, P300, DOI 10.1016/0006-291X(87)90665-6; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; MELLGREN RL, 1993, J BIOL CHEM, V268, P653; MELLGREN RL, 1986, ARCH BIOCHEM BIOPHYS, V246, P233, DOI 10.1016/0003-9861(86)90468-6; MELLGREN RL, 1988, BIOCHEM BIOPH RES CO, V150, P170, DOI 10.1016/0006-291X(88)90501-3; Melloni E, 1998, FEBS LETT, V431, P55, DOI 10.1016/S0014-5793(98)00724-8; NAGAO S, 1994, J BIOCHEM, V115, P1178, DOI 10.1093/oxfordjournals.jbchem.a124476; NAKAMURA M, 1989, BIOCHEMISTRY-US, V28, P449, DOI 10.1021/bi00428a007; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; OSTWALD K, 1994, J NEUROCHEM, V63, P1069; OSTWALD K, 1993, BRAIN RES, V630, P289, DOI 10.1016/0006-8993(93)90668-D; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; PUKASUNDVALL M, 1994, DEV BRAIN RES, V77, P146, DOI 10.1016/0165-3806(94)90223-2; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saido TC, 1997, NEUROSCI LETT, V227, P75, DOI 10.1016/S0304-3940(97)00309-1; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; SAIDO TC, 1991, BIOMED BIOCHIM ACTA, V50, P485; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SAITO Y, 1994, FEBS LETT, V353, P327, DOI 10.1016/0014-5793(94)01075-7; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; STEIN DT, 1988, J CEREBR BLOOD F MET, V8, P834, DOI 10.1038/jcbfm.1988.140; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; VANNUCCI RC, 1989, MANAGEMENT LABOR, P186; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P314; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748	61	98	100	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14046	14052		10.1074/jbc.274.20.14046	http://dx.doi.org/10.1074/jbc.274.20.14046			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318818	hybrid			2022-12-27	WOS:000080322200047
J	Heidenreich, O; Neininger, A; Schratt, G; Zinck, R; Cahill, MA; Engel, K; Kotlyarov, A; Kraft, R; Kostka, S; Gaestel, M; Nordheim, A				Heidenreich, O; Neininger, A; Schratt, G; Zinck, R; Cahill, MA; Engel, K; Kotlyarov, A; Kraft, R; Kostka, S; Gaestel, M; Nordheim, A			MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; C-FOS PROMOTER; TERNARY COMPLEX-FORMATION; GROWTH-FACTOR; TRANSCRIPTION FACTOR; TERMINAL PHOSPHORYLATION; CELLULAR STRESSES; NUCLEAR EXPORT; SAP KINASES; ELEMENT	Several growth factor- and calcium-regulated kinases such as pp90(rsk) or CaM kinase TV can phosphorylate the transcription factor serum response factor (SRF) at serine 103 (Ser-103). However, it is unknown whether stress-regulated kinases can also phosphorylate SRF. We show that treatment of cells with anisomycin, arsenite, sodium fluoride, or tetrafluoroaluminate induces phosphorylation of SRF at Ser-103 in both HeLa and NIH3T3 cells. This phosphorylation is dependent on the kinase p38/SAPK2 and correlates with the activation of MAPKAP kinase 2 (MK2). MK2 phosphorylates SRF in vitro at Ser-103 with similar efficiency as the small heat shock protein Hsp25 and significantly better than CREB, Comparison of wild type murine fibroblasts with those derived from MK2-deficient mice (Mk(-/-)) reveals MK2 as the major SRF kinase induced by arsenite. These results demonstrate that SRF is targeted by several signal transduction pathways within cells and establishes SRF as a nuclear target for MAPKAP kinase 2.	Univ Tubingen, Inst Zellbiol, Mol Biol Abt, D-72076 Tubingen, Germany; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Med Hsch Hannover, Inst Klin Chem, D-30623 Hannover, Germany; Univ Halle Wittenberg, Innovationskolleg Zellspezialisierung, D-06120 Halle, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hannover Medical School; Martin Luther University Halle Wittenberg	Nordheim, A (corresponding author), Univ Tubingen, Inst Zellbiol, Mol Biol Abt, Morgenstelle 15, D-72076 Tubingen, Germany.		Heidenreich, Olaf/AAP-5045-2021; Gaestel, Matthias/A-6560-2013; CAHILL, Michael/J-8035-2012	Heidenreich, Olaf/0000-0001-5404-6483; Gaestel, Matthias/0000-0002-4944-4652; CAHILL, Michael/0000-0002-8593-8844				Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Cano E, 1996, ONCOGENE, V12, P805; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; GAUTHIERROUVIERE C, 1995, MOL CELL BIOL, V15, P433, DOI 10.1128/MCB.15.1.433; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; GUTMAN A, 1991, MOL CELL BIOL, V11, P5381, DOI 10.1128/MCB.11.10.5381; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; JANKNECHT R, 1993, EUR J BIOCHEM, V216, P469, DOI 10.1111/j.1432-1033.1993.tb18165.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KRACHT M, 1994, J EXP MED, V180, P2017, DOI 10.1084/jem.180.6.2017; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Ludwig S, 1998, J BIOL CHEM, V273, P1917, DOI 10.1074/jbc.273.4.1917; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; Schultz H, 1997, J CELL PHYSIOL, V173, P310, DOI 10.1002/(SICI)1097-4652(199712)173:3<310::AID-JCP2>3.0.CO;2-Q; Sealy L, 1997, MOL CELL BIOL, V17, P1744, DOI 10.1128/MCB.17.3.1744; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VELCICH A, 1990, MOL CELL BIOL, V10, P6273, DOI 10.1128/MCB.10.12.6273; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; ZINCK R, 1995, MOL CELL BIOL, V15, P4930	58	144	150	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14434	14443		10.1074/jbc.274.20.14434	http://dx.doi.org/10.1074/jbc.274.20.14434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318869	hybrid			2022-12-27	WOS:000080322200098
J	Ogris, E; Du, XX; Nelson, KC; Mak, EK; Yu, XX; Lane, WS; Pallas, DC				Ogris, E; Du, XX; Nelson, KC; Mak, EK; Yu, XX; Lane, WS; Pallas, DC			A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYOMAVIRUS MIDDLE-T; BACTERIAL CHEMOTAXIS; CATALYTIC SUBUNIT; BOVINE BRAIN; TYROSINE PHOSPHORYLATION; METHYL ESTERIFICATION; POLYACRYLAMIDE GELS; MUTATIONAL ANALYSIS; CELLULAR PROTEINS; OKADAIC ACID	Carboxymethylation of proteins is a highly conserved means of regulation in eukaryotic: cells. The protein phosphatase 2A (PP2A) catalytic (C) subunit is reversibly methylated at its carboxyl terminus by specific methyltransferase and methylesterase enzymes which have been purified, but not cloned. Carboxymethylation affects PP2A activity and varies during the cell cycle. Here, we report that substitution of glutamine for either of two putative active site histidines in the PP2A C subunit results in inactivation of PP2A and formation of stable complexes between PP2A and several cellular proteins. One of these cellular proteins, herein named protein phosphatase methylesterase-1 (PME-1), was purified and microsequenced, and its cDNA was cloned. PME-1 is conserved from yeast to human and contains a motif found in lipases having a catalytic triad-activated serine as their active site nucleophile. Bacterially expressed PME-1 demethylated PP2A C subunit in vitro, and okadaic acid, a known inhibitor of the PP2A methylesterase, inhibited this reaction. To our knowledge, PME-1 represents the first mammalian protein methylesterase to be cloned. Several lines of evidence indicate that, although there appears to be a role for C subunit carboxyl-terminal amino acids in PME-1 binding, amino acids other than those at the extreme carboxyl terminus of the C subunit also play an important role in PME-1 binding to a catalytically inactive mutant.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA; Harvard Univ, Biol Labs, Harvard Microchem Facil, Cambridge, MA 02138 USA; Univ Vienna, Inst Mol Biol, A-1030 Vienna, Austria; Dana Farber Canc Inst, Div Cellular & Mol Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Emory University; Emory University; Harvard University; University of Vienna; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Ogris, Egon/0000-0001-5950-9264	NATIONAL CANCER INSTITUTE [R01CA057327] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057327, CA57327] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ansai T, 1996, J BIOL CHEM, V271, P24401, DOI 10.1074/jbc.271.40.24401; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHERINGTON V, 1986, P NATL ACAD SCI USA, V83, P4307, DOI 10.1073/pnas.83.12.4307; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Gelderloos JA, 1996, ONCOGENE, V13, P2367; GLENN GM, 1995, J VIROL, V69, P3729, DOI 10.1128/JVI.69.6.3729-3736.1995; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GRUSSENMEYER T, 1987, J VIROL, V61, P3902, DOI 10.1128/JVI.61.12.3902-3909.1987; Harlow E., 1988, ANTIBODIES LAB MANUA; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; JAKES S, 1986, BIOCHIM BIOPHYS ACTA, V888, P135, DOI 10.1016/0167-4889(86)90079-0; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; KRUEGER JK, 1992, BIOCHIM BIOPHYS ACTA, V1119, P322, DOI 10.1016/0167-4838(92)90220-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE WS, 1991, J PROTEIN CHEM, V10, P151, DOI 10.1007/BF01024778; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; PALLAS D, 1982, CELL, V30, P407, DOI 10.1016/0092-8674(82)90238-0; PALLAS DC, 1986, J VIROL, V60, P1075, DOI 10.1128/JVI.60.3.1075-1084.1986; PALLAS DC, 1988, J VIROL, V62, P3934, DOI 10.1128/JVI.62.11.3934-3940.1988; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; RUNDELL K, 1987, J VIROL, V61, P1240, DOI 10.1128/JVI.61.4.1240-1243.1987; Sambrook J., 2002, MOL CLONING LAB MANU; SIM ATR, 1994, J NEUROCHEM, V62, P1552; SIMMS SA, 1987, J BIOL CHEM, V262, P29; SNYDER MA, 1984, METHOD ENZYMOL, V106, P321; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; ULUG ET, 1992, J VIROL, V66, P1458, DOI 10.1128/JVI.66.3.1458-1467.1992; USUI H, 1988, J BIOL CHEM, V263, P3752; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WYLIE D, 1988, BIOCHEM BIOPH RES CO, V151, P891, DOI 10.1016/S0006-291X(88)80365-6; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1994, J BIOL CHEM, V269, P1981; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	54	147	159	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14382	14391		10.1074/jbc.274.20.14382	http://dx.doi.org/10.1074/jbc.274.20.14382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318862	Green Accepted, hybrid			2022-12-27	WOS:000080322200091
J	Wadgaonkar, R; Collins, T				Wadgaonkar, R; Collins, T			Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL COACTIVATORS; P300/CBP-ASSOCIATED FACTOR; SYNERGISTIC ACTIVATION; ONCOPROTEIN MDM2; TERMINAL DOMAIN; P53 PROTEIN; WILD-TYPE; REPRESSION	The ability of the p53 tumor suppressor to induce cell cycle arrest and cell death is closely regulated under normal conditions. The transcriptional activity of p53 is negatively controlled by murine double minute (MDM2). p53 requires the coactivator CREB-binding protein (CBP), or its structural homolog, p300, to stimulate transcription of responsive genes. Here we find that the transactivation domain of p53 selectively interacts with the N- and C-terminal regions of CBP/p300. A mutant CBP lacking the N terminus failed to stimulate p53-dependent transactivation. In both p53 null Saos2 cells, and in UV-irradiated MCF7 cells, we observed that MDM2 associates with the N-terminal region of CBP/p300. Because p53 interacts with both MDM2 and CBP/p300 through its trans-activation domain, we examined the role of MDM2 in p53-coactivator interactions. MDM2 blocked CBP/p300 recruitment in vitro and inhibited the interaction of the transactivating region of p53 with both the N- or C-terminal regions of CBP/p300 in a mammalian two-hybrid assay. These observations suggest that MDM2 may be inhibiting p53 trans-activation by shielding its activation domain from the coactivators, a new mechanism for the inhibition of p53-dependent gene expression.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Collins, T (corresponding author), Brigham & Womens Hosp, Dept Pathol, 221 Longwood Ave, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035716, P01HL036028, R37HL035716] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 36028, HL 45462, HL 35716] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDIERY WS, 1993, CELL, V75, P817; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lee JS, 1996, J BIOL CHEM, V271, P17666, DOI 10.1074/jbc.271.30.17666; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; LUNA RMD, 1995, NATURE, V378, P203; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; Scolnick DM, 1997, CANCER RES, V57, P3693; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	39	85	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13760	13767		10.1074/jbc.274.20.13760	http://dx.doi.org/10.1074/jbc.274.20.13760			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318779	hybrid			2022-12-27	WOS:000080322200008
J	Ishii, T; Matsunaga, T; Pellerin, P; O'Neill, MA; Darvill, A; Albersheim, P				Ishii, T; Matsunaga, T; Pellerin, P; O'Neill, MA; Darvill, A; Albersheim, P			The plant cell wall polysaccharide rhamnogalacturonan II self-assembles into a covalently cross-linked dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PECTIC POLYSACCHARIDE; BORON REQUIREMENT; STRUCTURAL ROLE; SUGAR-BEET; COMPLEX; OLIGOSACCHARIDES; HYDROLYSIS; COMPONENT; TOBACCO; ESTER	The location of the 1:2 borate-diol ester cross-link in the dimer of the plant cell wall polysaccharide rhamnogalacturonan II (RG-II) has been determined. The ester cross-links the apiofuranosyl residue of the 2-O-methyl-D-xylose-containing side chains in each of the subunits of the dimer. The apiofuranosyl residue in each of the two aceric acid-containing side chains is not esterified. The site of borate esterification is identical in naturally occurring and in in vitro synthesized dimer. Pb2+, La3+, and Ca2+ increase dimer formation in vitro in a concentration- and pH-dependent manner. Pb2+ is the most effective cation. The dimer accounts for 55% of the RG-II when the monomer (0.5 mM) is treated for 5 min at pH 3.5 with boric acid (1 mM) and Pb2+ (0.5 mM); at pH 5 the rate of conversion is somewhat slower. Hg2+ does not increase the rate of dimer formation. A cation's charge density and its ability to form a coordination complex with RG-II, in addition to steric factors, may regulate the rate and stability of dimer formation in vitro. Our data provide evidence that the structure of RG-II itself determines which apiofuranosyl residues are esterified with borate and that in the presence of boric acid and certain cations, two RG-II monomers self-assemble to form a dimer.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; Kyushu Natl Agr Expt Stn, Kumamoto 8611192, Japan; INRA, Inst Produits de la Vigne, Unite Rech Biopolymeres & Aromes, F-34060 Montpellier, France	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Forestry & Forest Products Research Institute - Japan; National Agriculture & Food Research Organization - Japan; INRAE	O'Neill, MA (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.							[Anonymous], 1997, PLANT NUTR SUSTAINAB; Brown PH, 1997, PLANT SOIL, V196, P211, DOI 10.1023/A:1004245823080; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Findeklee P, 1996, BOT ACTA, V109, P463, DOI 10.1111/j.1438-8677.1996.tb00599.x; Fleischer A, 1998, PLANT PHYSIOL, V117, P1401, DOI 10.1104/pp.117.4.1401; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; HIRSCH AM, 1980, CAN J BOT, V58, P856, DOI 10.1139/b80-110; HU HI, 1994, PLANT PHYSIOL, V105, P681, DOI 10.1104/pp.105.2.681; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Ishii T, 1996, CARBOHYD RES, V284, P1, DOI 10.1016/0008-6215(96)00010-9; Ishii T, 1997, PLANT PHYSIOL, V113, P1265, DOI 10.1104/pp.113.4.1265; Ishii T, 1998, PHYTOCHEMISTRY, V49, P1195, DOI 10.1016/S0031-9422(98)00119-8; JARVIS MC, 1992, PLANT CELL ENVIRON, V15, P1, DOI 10.1111/j.1365-3040.1992.tb01452.x; Kaneko S, 1997, PHYTOCHEMISTRY, V44, P243, DOI 10.1016/S0031-9422(96)00539-0; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kobayashi M, 1997, PLANT CELL PHYSIOL, V38, P676, DOI 10.1093/oxfordjournals.pcp.a029220; Kouchi H., 1975, Soil Science and Plant Nutrition, V21, P137, DOI 10.1080/00380768.1975.10432630; LOOMIS WD, 1992, BIOFACTORS, V3, P229; MACDOUGALL AJ, 1995, PLANT PHYSIOL, V108, P1679, DOI 10.1104/pp.108.4.1679; Matoh T, 1997, PLANT SOIL, V193, P59, DOI 10.1023/A:1004207824251; Matoh T, 1996, PLANT CELL PHYSIOL, V37, P636, DOI 10.1093/oxfordjournals.pcp.a028992; MCNEIL M, 1982, METHOD ENZYMOL, V83, P3; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pellerin P, 1996, CARBOHYD RES, V290, P183, DOI 10.1016/0008-6215(96)00139-5; Pellerin  P, 1998, ANALUSIS, V26, pM32; Shin KS, 1998, CARBOHYD RES, V307, P97, DOI 10.1016/S0008-6215(98)00016-0; STEVENSON TT, 1988, CARBOHYD RES, V179, P269, DOI 10.1016/0008-6215(88)84124-7; VANDUIN M, 1987, CARBOHYD RES, V162, P65, DOI 10.1016/0008-6215(87)80201-X; WEAST RC, 1983, CRC HDB CHEM PHYSICS, pF170; WHITCOMBE AJ, 1995, CARBOHYD RES, V271, P15, DOI 10.1016/0008-6215(94)00002-W; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9	32	148	154	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13098	13104		10.1074/jbc.274.19.13098	http://dx.doi.org/10.1074/jbc.274.19.13098			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224062	hybrid			2022-12-27	WOS:000080200400024
J	Jang, MH; Basran, J; Scrutton, NS; Hille, R				Jang, MH; Basran, J; Scrutton, NS; Hille, R			The reaction of trimethylamine dehydrogenase with trimethylamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; COVALENTLY BOUND COENZYME; MONOAMINE-OXIDASE; BACTERIUM W3A1; DIMETHYLAMINE DEHYDROGENASE; METHYLOTROPHIC BACTERIUM; PROSTHETIC GROUPS; FLAVOPROTEIN; SUBSTRATE; CATALYSIS	The reductive half-reaction of trimethylamine dehydrogenase with its physiological substrate trimethylamine has been examined by stopped-flow spectroscopy over the pH range 6.0-11.0, with attention focusing on the fastest of the three kinetic phases of the reaction, the flavin reduction/substrate oxidation process. As in previous work with the slow substrate diethylmethylamine, the reaction is found to consist of three well resolved kinetic phases. The observed rate constant for the fast phase exhibits hyperbolic dependence on the substrate concentration with an extrapolated limiting rate constant (k(lim)) greater than 1000 s(-1) at pH above 8.5, 10 degrees C, The kinetic parameter k(lim)/K-d for the fast phase exhibits a bell-shaped pH dependence, with two pK(a) values of 9.3 +/- 0.1 and 10.0 +/- 0.1 attributed to a basic residue in the enzyme active site and the ionization of the free substrate, respectively. The sigmoidal pH profile for k(lim) gives a single pK(a) value of 7.1 +/- 0.2. The observed rate constants for both the intermediate and slow phases are found to decrease as the substrate concentration is increased. The steady-state kinetic behavior of trimethylamine dehydrogenase with trimethylamine has also been examined, and is found to be adequately described without invoking a second, inhibitory substrate-binding site. The present results demonstrate that: (a) substrate must be protonated in order to bind to the enzyme; (b) an ionization group on the enzyme is involved in substrate binding; (c) an active site general base is involved, but not strictly required, in the oxidation of substrate; (d) the fast phase of the reaction with native enzyme is considerably faster than observed with enzyme isolated from Methylophilus methylotrophus that has been grown up on dimethylamine; and (e) a discrete inhibitory substrate-binding site is not required to account for excess substrate inhibition, the kinetic behavior of trimethylamine dehydrogenase can be readily explained in the context of the known properties of the enzyme.	Ohio State Univ, Dept Med Biochem, Columbus, OH 43210 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University System of Ohio; Ohio State University; University of Leicester	Hille, R (corresponding author), Ohio State Univ, Dept Med Biochem, Columbus, OH 43210 USA.							ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; Basran J, 1999, J BIOL CHEM, V274, P13155, DOI 10.1074/jbc.274.19.13155; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; BELLAMY HD, 1989, J BIOL CHEM, V264, P11887; COLBY J, 1974, BIOCHEM J, V143, P555, DOI 10.1042/bj1430555; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; EDMONDSON DE, 1995, XENOBIOTICA, V25, P735, DOI 10.3109/00498259509061889; Falzon L, 1996, BIOCHEMISTRY-US, V35, P2445, DOI 10.1021/bi951550q; HILL CL, 1977, P NATL ACAD SCI USA, V74, P547, DOI 10.1073/pnas.74.2.547; HILLE R, 1984, J BIOL CHEM, V259, P1570; KASPRZAK AA, 1983, BIOCHEM J, V211, P535, DOI 10.1042/bj2110535; KIM JM, 1993, J AM CHEM SOC, V115, P10591, DOI 10.1021/ja00076a017; LIM LW, 1988, J BIOL CHEM, V263, P3075; LIM LW, 1986, J BIOL CHEM, V261, P5140; ROHLFS RJ, 1995, J BIOL CHEM, V270, P22196, DOI 10.1074/jbc.270.38.22196; ROHLFS RJ, 1991, J BIOL CHEM, V266, P15244; SILVERMAN RB, 1995, ACCOUNTS CHEM RES, V28, P335, DOI 10.1021/ar00056a003; SINGER TP, 1980, FLAVINS FLAVOPROTEIN, P277; STANKOVICH MT, 1987, FLAVINS FLAVOPROTEIN, P687; STEENKAMP DJ, 1982, BIOCHEM J, V207, P233, DOI 10.1042/bj2070233; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; STEENKAMP DJ, 1978, BIOCHEM J, V169, P361, DOI 10.1042/bj1690361; STEENKAMP DJ, 1976, BIOCHEM BIOPH RES CO, V71, P1289, DOI 10.1016/0006-291X(76)90794-4; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2812; STEENKAMP DJ, 1976, BIOCHIM BIOPHYS ACTA, V429, P705, DOI 10.1016/0005-2744(76)90319-3; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P4086; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; STEENKAMP DJ, 1985, BIOCHEM BIOPH RES CO, V132, P352, DOI 10.1016/0006-291X(85)91029-0; STEENKAMP DJ, 1978, MECHANISMS OXIDIZING, P127; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; WEAST RC, 1968, HDB CHEM PHYSICS, pD89	31	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13147	13154		10.1074/jbc.274.19.13147	http://dx.doi.org/10.1074/jbc.274.19.13147			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224069	hybrid			2022-12-27	WOS:000080200400031
J	Mukhopadhyay, A; Ni, J; Zhai, YF; Yu, GL; Aggarwal, BB				Mukhopadhyay, A; Ni, J; Zhai, YF; Yu, GL; Aggarwal, BB			Identification and characterization of a novel cytokine, THANK, a (T)under-barNF (H)under-baromologue that activates (A)under-barpoptosis, nuclear factor-kappa B, and c-Jun NH2-terminal (K)under-barinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TNF RECEPTOR; CELL-GROWTH; HUMAN LYMPHOTOXIN; FACTOR FAMILY; LIGAND; APOPTOSIS; DEATH; PURIFICATION; SUPERFAMILY	By using the amino acid sequence motif of tumor necrosis factor (TNF), we searched the expressed sequence tag data base and identified a novel full-length cDNA encoding 285 amino acid residues and named it THANK. THANK is a type II transmembrane protein with 15-20% overall amino acid sequence homology to TNF, LT-alpha, Fast, and LIGHT, all members of the TNF family. The mRNA for THANK was expressed at high levels by peripheral blood leukocytes, lymph node, spleen, and thymus and at low levels by small intestine, pancreas, placenta, and lungs. THANK was also prominently expressed in hematopoietic cell lines. The recombinant purified protein expressed in the baculovirus system had an approximate molecular size 20 kDa with amino-terminal sequence of AVQGP. Treatment of human myeloid U937 cells with purified THANK activated nuclear transcription factor-kappa B (NF-kappa B) consisting of p50 and p65. Activation was time- and dose-dependent, beginning with as little as a 1 pM amount of the cytokines and as early as 15 min. Under the same conditions, THANK also activated c-jun NH2-terminal kinase (JNK) in U937 cells. THANK also strongly suppressed the growth of tumor cell lines and activated caspase-3. Although THANK had all the activities and potency of TNF, it did not bind to the TNF receptors. Thus our results indicate that THANK is a novel cytokine that belongs to the TNF family and activates apoptosis, NF-kappa B, and JNK through a distinct receptor.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Oncol, Cytokine Res Lab, Houston, TX 77030 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	University of Texas System; UTMD Anderson Cancer Center; GlaxoSmithKline; Human Genome Sciences Inc	Aggarwal, BB (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Oncol, Cytokine Res Lab, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aggarwal@utmdacc.mda.uth.tmc.edu	Aggarwal, Bharat B/G-3388-2013					AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; AGGARWAL BB, 1984, J BIOL CHEM, V259, P686; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; GRAY PW, 1984, NATURE, V312, P721, DOI 10.1038/312721a0; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Haridas V, 1998, J IMMUNOL, V160, P3152; HIGUCHI M, 1992, ANAL BIOCHEM, V204, P53, DOI 10.1016/0003-2697(92)90138-W; Kumar A, 1999, METHOD ENZYMOL, V300, P339; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Ni J, 1997, J BIOL CHEM, V272, P10853; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Singh A, 1998, J INTERF CYTOK RES, V18, P439, DOI 10.1089/jir.1998.18.439; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181	25	276	379	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15978	15981		10.1074/jbc.274.23.15978	http://dx.doi.org/10.1074/jbc.274.23.15978			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347144	hybrid			2022-12-27	WOS:000080668600004
J	Allen, RM; Roll, JT; Rangaraj, P; Shah, VK; Roberts, GP; Ludden, PW				Allen, RM; Roll, JT; Rangaraj, P; Shah, VK; Roberts, GP; Ludden, PW			Incorporation of molybdenum into the iron-molybdenum cofactor of nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII STRAINS; IN-VITRO SYNTHESIS; KLEBSIELLA-PNEUMONIAE; GENE-PRODUCT; DINITROGENASE REDUCTASE; NUCLEOTIDE-SEQUENCE; INVITRO SYNTHESIS; NIFB COFACTOR; PROTEIN; PURIFICATION	The biosynthesis of the iron-molybdenum cofactor (FeMo-co) of dinitrogenase was investigated using Mo-99 to follow the incorporation of Mo into precursors. Mo-99 label accumulates on dinitrogenase only when all known components of the FeMo-co synthesis system, NfH, NifNE, NifB-cofactor, homocitrate, MgATP, and reductant, are present. Furthermore, Mo-99 label accumulates only on the gamma protein, which has been shown to serve as a chaperone/insertase for the maturation of apodinitrogenase when all known components are present, It appears that only completed FeMo-co can accumulate on the gamma protein. Very little FeMo-co synthesis was observed when all known components are used in purified forms, indicating that additional factors are required for optimal FeMo-co synthesis. Mo-99 did not accumulate on NifNE under any conditions tested, suggesting that Mo enters the pathway at some other step, although it remains possible that a MO-containing precursor of FeMo-co that is not sufficiently stable to persist during gel electrophoresis occurs but is not observed. Mo-99 accumulates on several unidentified species, which may be the additional components required for FeMo-co synthesis. The molybdenum storage protein was observed and the accumulation of Mo-99 on this protein required nucleotide.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Ctr Study Nitrogen Fixat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ludden, PW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ludden@biochem.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035332, R01GM035332] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35332] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RM, 1993, J BIOL CHEM, V268, P23670; Allen RM, 1996, J BIOL CHEM, V271, P4256; ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; BISHOP PE, 1986, SCIENCE, V232, P92, DOI 10.1126/science.232.4746.92; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BRIGLE KE, 1985, GENE, V37, P37, DOI 10.1016/0378-1119(85)90255-0; CARRELL CJ, 1988, J AM CHEM SOC, V110, P8651, DOI 10.1021/ja00234a011; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Chatterjee R, 1997, J BIOL CHEM, V272, P21604, DOI 10.1074/jbc.272.34.21604; EMERICH DW, 1978, BIOCHIM BIOPHYS ACTA, V527, P359, DOI 10.1016/0005-2744(78)90350-9; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; GLUSKER JP, 1980, ACCOUNTS CHEM RES, V13, P345, DOI 10.1021/ar50154a002; HAWKES TR, 1983, BIOCHEM J, V209, P43, DOI 10.1042/bj2090043; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; HOOVER TR, 1988, BIOCHEMISTRY-US, V27, P3647, DOI 10.1021/bi00410a019; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; IMPERIAL J, 1989, BIOCHEMISTRY-US, V28, P7796, DOI 10.1021/bi00445a040; IMPERIAL J, 1984, J BACTERIOL, V158, P187, DOI 10.1128/JB.158.1.187-194.1984; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; MCLEAN PA, 1983, BIOCHEM J, V211, P589, DOI 10.1042/bj2110589; Mouncey NJ, 1996, MICROBIOL-SGM, V142, P1997, DOI 10.1099/13500872-142-8-1997; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; PIENKOS PT, 1981, J BACTERIOL, V145, P743, DOI 10.1128/JB.145.2.743-751.1981; ROBERTS GP, 1980, J BACTERIOL, V144, P210, DOI 10.1128/JB.144.1.210-216.1980; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; ROLL JT, 1995, J BIOL CHEM, V270, P4432, DOI 10.1074/jbc.270.9.4432; ROSENTEL JK, 1995, J BACTERIOL, V177, P4857, DOI 10.1128/jb.177.17.4857-4864.1995; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1986, P NATL ACAD SCI USA, V83, P1636, DOI 10.1073/pnas.83.6.1636; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; UGALDE RA, 1984, J BACTERIOL, V159, P888, DOI 10.1128/JB.159.3.888-893.1984; WAUGH SI, 1995, J BACTERIOL, V177, P1505, DOI 10.1128/jb.177.6.1505-1510.1995; Wright DW, 1996, J BIOL INORG CHEM, V1, P143, DOI 10.1007/s007750050033	39	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15869	15874		10.1074/jbc.274.22.15869	http://dx.doi.org/10.1074/jbc.274.22.15869			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336491	hybrid			2022-12-27	WOS:000080560100080
J	Baranski, TJ; Herzmark, P; Lichtarge, O; Gerber, BO; Trueheart, J; Meng, EC; Iiri, T; Sheikh, SP; Bourne, HR				Baranski, TJ; Herzmark, P; Lichtarge, O; Gerber, BO; Trueheart, J; Meng, EC; Iiri, T; Sheikh, SP; Bourne, HR			C5a receptor activation - Genetic identification of critical residues in four transmembrane helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; PHEROMONE RESPONSE PATHWAY; MEMBRANE-SPANNING SEGMENT; SITE-DIRECTED MUTAGENESIS; SCHIFF-BASE COUNTERION; DOPAMINE D2 RECEPTOR; ACID SIDE-CHAINS; BOVINE RHODOPSIN; LIGAND-BINDING; CONFORMATIONAL-CHANGES	Hormones and sensory stimuli activate serpentine receptors, transmembrane switches that relay signals to heterotrimeric guanine nucleotide-binding proteins (G proteins). To understand the switch mechanism, we subjected 93 amino acids in transmembrane helices III, V, VI, and VII of the human chemoattractant C5a receptor to random saturation mutagenesis. A yeast selection identified 121 functioning mutant receptors, containing a total of 523 amino acid substitutions. Conserved hydrophobic residues are located on helix surfaces that face other helices in a modeled seven-helix bundle (Baldwin, J. M., Schertler, G. F., and Unger, V. M. (1997) J. Mol. Biol. 272, 144-164), whereas surfaces predicted to contact the surrounding lipid tolerate many substitutions. Our analysis identified 25 amino acid positions resistant to nonconservative substitutions. These appear to comprise two distinct components of the receptor switch, a surface at or near the extracellular membrane interface and a core cluster in the cytoplasmic half of the bundle. Twenty-one of the 121 mutant receptors exhibit constitutive activity, Amino acids substitutions in these activated receptors predominate in helices III and VI; other activating mutations truncate the receptor near the extracellular end of helix VI. These results identify key elements of a general mechanism for the serpentine receptor switch.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Cadus Pharmaceut Corp, Tarrytown, NY 10591 USA	University of California System; University of California San Francisco	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Box 0450,513 Parnassus Ave, San Francisco, CA 94143 USA.				NIGMS NIH HHS [GM-27800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027800, R01GM027800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Chen ZG, 1998, J BIOL CHEM, V273, P10411, DOI 10.1074/jbc.273.17.10411; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; FARAHBAKHSH ZT, 1993, SCIENCE, V262, P1416, DOI 10.1126/science.8248781; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; FONG TM, 1992, J BIOL CHEM, V267, P25668; Fu DY, 1996, BIOCHEMISTRY-US, V35, P11278, DOI 10.1021/bi960928x; GERARD C, 1985, J BIOL CHEM, V260, P2613; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HASHIMOTO K, 1995, J CLIN ENDOCR METAB, V80, P2933, DOI 10.1210/jc.80.10.2933; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HILL DE, 1987, METHOD ENZYMOL, V155, P558; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; HO BY, 1992, FEBS LETT, V312, P259, DOI 10.1016/0014-5793(92)80948-G; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; JIANG MS, 1995, EXP EYE RES, V60, P401, DOI 10.1016/S0014-4835(05)80096-X; Leberer E, 1997, CURR OPIN GENET DEV, V7, P59, DOI 10.1016/S0959-437X(97)80110-4; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Lin ZL, 1997, PROTEIN ENG, V10, P501, DOI 10.1093/protein/10.5.501; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MATTEUCCI MD, 1983, NUCLEIC ACIDS RES, V11, P3113, DOI 10.1093/nar/11.10.3113; MERY L, 1994, J BIOL CHEM, V269, P3457; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; PHILLIPS WJ, 1994, BIOCHEM J, V299, P351, DOI 10.1042/bj2990351; Price LA, 1996, MOL PHARMACOL, V50, P829; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Raffetseder U, 1996, EUR J BIOCHEM, V235, P82, DOI 10.1111/j.1432-1033.1996.00082.x; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheer A, 1997, J RECEPT SIGNAL TR R, V17, P57, DOI 10.3109/10799899709036594; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shyu JF, 1996, J BIOL CHEM, V271, P31127, DOI 10.1074/jbc.271.49.31127; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Silversides DW, 1997, J MOL ENDOCRINOL, V18, P101, DOI 10.1677/jme.0.0180101; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; vanRhee AM, 1996, DRUG DEVELOP RES, V37, P1, DOI 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wittenberg C, 1996, CURR OPIN CELL BIOL, V8, P223, DOI 10.1016/S0955-0674(96)80069-X; WONG SKF, 1990, J BIOL CHEM, V265, P6219; Zhang XL, 1997, PROTEINS, V28, P261, DOI 10.1002/(SICI)1097-0134(199706)28:2<261::AID-PROT13>3.0.CO;2-G; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	71	118	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15757	15765		10.1074/jbc.274.22.15757	http://dx.doi.org/10.1074/jbc.274.22.15757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336477	hybrid			2022-12-27	WOS:000080560100066
J	Szameit, C; Miech, C; Balleininger, M; Schmidt, B; von Figura, K; Dierks, T				Szameit, C; Miech, C; Balleininger, M; Schmidt, B; von Figura, K; Dierks, T			The iron sulfur protein AtsB is required for posttranslational formation of formylglycine in the Klebsiella sulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; ENDOPLASMIC-RETICULUM; MONOAMINE REGULON; GENE-CLUSTER; ARYLSULFATASE; CYSTEINE; BIOSYNTHESIS; CONVERSION; AEROGENES; REGULATOR	The catalytic residue of eukaryotic and prokaryotic sulfatases is a alpha-formylglycine. In the sulfatase of Klebsiella pneumoniae the formylglycine is generated by posttranslational oxidation of serine 72, We cloned the atsBA operon of K. pneumoniae and found that the sulfatase was expressed in inactive form in Escherichia coli transformed with the structural gene (atsA), Coexpression of the atsB gene, however, led to production of high sulfatase activity, indicating that the atsB gene product plays a posttranslational role that is essential for the sulfatase to gain its catalytic activity. This was verified after purification of the sulfatase from the periplasm of the cells. Peptide analysis of the protein expressed in the presence of AtsB revealed that half of the polypeptides carried the formylglycine at position 72, while the remaining polypeptides carried the encoded serine. The inactive sulfatase expressed in the absence of AtsB carried exclusively serine 72, demonstrating that the atsB gene is required for formylglycine modification. This gene encodes a 395-amino acid residue iron sulfur protein that has a cytosolic localization and is supposed to directly or indirectly catalyze the oxidation of the serine to formylglycine.	Univ Gottingen, Inst Biochem & Mol Zellbiol, Abt Biochem 2, D-37073 Gottingen, Germany	University of Gottingen	Dierks, T (corresponding author), Univ Gottingen, Inst Biochem & Mol Zellbiol, Abt Biochem 2, Gosslerstr 12D, D-37073 Gottingen, Germany.	dierks@ukb2-00.uni-be.gwdg.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339				Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; AZAKAMI H, 1993, J BACTERIOL, V175, P6287, DOI 10.1128/JB.175.19.6287-6292.1993; AZAKAMI H, 1995, GENE, V164, P89, DOI 10.1016/0378-1119(95)00400-Z; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURLAND V, 1993, GENOMICS, V16, P551, DOI 10.1006/geno.1993.1230; CHENG Q, 1992, J BACTERIOL, V174, P7185, DOI 10.1128/jb.174.22.7185-7193.1992; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dodgson K.S., 1982, SULFATASES MICROBIAL; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; GOOSEN N, 1989, J BACTERIOL, V171, P447, DOI 10.1128/jb.171.1.447-455.1989; Kawasaki S, 1997, J BACTERIOL, V179, P235, DOI 10.1128/jb.179.1.235-242.1997; KLETZIN A, 1995, J BACTERIOL, V177, P4817, DOI 10.1128/jb.177.16.4817-4819.1995; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lovry O.H., 1951, J BIOL CHEM, V193, P265; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; MULLIGAN ME, 1989, J BIOL CHEM, V264, P19200; MUROOKA Y, 1990, J BACTERIOL, V172, P2131, DOI 10.1128/jb.172.4.2131-2140.1990; Neubauer H, 1998, FEMS MICROBIOL LETT, V164, P55, DOI 10.1016/S0378-1097(98)00196-7; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Recksiek R, 1998, J BIOL CHEM, V273, P6096, DOI 10.1074/jbc.273.11.6096; Schirmer A, 1998, CHEM BIOL, V5, pR181, DOI 10.1016/S1074-5521(98)90154-5; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284	33	62	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15375	15381		10.1074/jbc.274.22.15375	http://dx.doi.org/10.1074/jbc.274.22.15375			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336424	hybrid			2022-12-27	WOS:000080560100013
J	Mehta, AD; Rief, M; Spudich, JA				Mehta, AD; Rief, M; Spudich, JA			Biomechanics, one molecule at a time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SINGLE KINESIN MOLECULES; ATOMIC-FORCE MICROSCOPY; MUSCLE PROTEIN TITIN; OPTICAL TWEEZERS; RNA-POLYMERASE; MYOSIN MOLECULE; ACTIN FILAMENT; LASER TRAP; MOTOR; MOVEMENT		Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA.							BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gautel M, 1996, FEBS LETT, V385, P11, DOI 10.1016/0014-5793(96)00338-9; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Ishijima A, 1996, BIOPHYS J, V70, P383, DOI 10.1016/S0006-3495(96)79582-6; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; MARUYAMA K, 1977, J BIOCHEM, V82, P317; Mehta AD, 1998, METHOD CELL BIOL, V55, P47; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sheetz M.P., 1998, LASER TWEEZERS CELL, V55; Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Warshaw DM, 1998, P NATL ACAD SCI USA, V95, P8034, DOI 10.1073/pnas.95.14.8034; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	60	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14517	14520		10.1074/jbc.274.21.14517	http://dx.doi.org/10.1074/jbc.274.21.14517			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329637	hybrid			2022-12-27	WOS:000081965200002
J	Tian, JM; Karin, M				Tian, JM; Karin, M			Stimulation of Elk1 transcriptional activity by mitogen-activated protein kinases is negatively regulated by protein phosphatase 2B (calcineurin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; C-FOS PROMOTER; JUN NH2-TERMINAL KINASE; SERUM RESPONSE ELEMENT; MAP KINASE; T-LYMPHOCYTES; DEPENDENT TRANSCRIPTION; SELECTIVE ACTIVATION; MOLECULAR-CLONING; GENE-EXPRESSION	Cellular calcium (Ca2+) and the Ca2+-binding protein calmodulin (CaM) regulate the activities of Ca2+/CaM-dependent protein kinases and protein phosphatase 2B (calcineurin). Functional interactions between CaM kinases and mitogen-activated protein (MAP) kinases were described. In this report, we describe crosstalk, between calcineurin and mitogen-activated protein kinase signaling. Calcineurin was found to specifically down-regulate the transcriptional activity of transcription factor Elk1, following stimulation of this activity by the ERK, Jun N-terminal kinase, or p38 MAP kinase pathways. Expression of constitutively activated calcineurin or activation of endogenous calcineurin by Ca2+ ionophore decreased the phosphorylation of Elk1 at sites that positively regulate its transcriptional activity. Calcineurin specifically dephosphorylates Elk1 at phosphoserine 383, a site whose phosphorylation by MAP kinases makes a critical contribution to the enhanced transcriptional activity of Elk1. The cross-talk between calcineurin and MAP kinases is of physiological significance as low doses of Ca2+ ionophore which by themselves are insufficient for c-fos induction can actually inhibit induction of c-fos expression by activators of MAP kinases. Thus through the effect of calcineurin on Elk1 phosphorylation, Ca2+ can have a negative effect on expression of Elk1 target genes. This mechanism explains why different levels of intracellular Ca2+ can result in very different effects on gene expression.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.							ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bading H, 1997, BIOCHEM BIOPH RES CO, V236, P541, DOI 10.1006/bbrc.1997.7037; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Cantrell DA, 1996, CANCER SURV, V27, P165; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; DAERIJARD B, 1995, SCIENCE, V267, P682; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Finch A, 1997, FEBS LETT, V418, P144, DOI 10.1016/S0014-5793(97)01364-1; FREODIN M, 1995, J BIOL CHEM, V270, P7882; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; GonzalezCuadrado S, 1996, CLIN EXP IMMUNOL, V106, P518, DOI 10.1046/j.1365-2249.1996.d01-864.x; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; JANKNECHT R, 1995, IMMUNOBIOLOGY, V193, P137, DOI 10.1016/S0171-2985(11)80536-X; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; LALLI E, 1994, J BIOL CHEM, V269, P17359; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LOHSE DL, 1995, STRUCTURE, V3, P987, DOI 10.1016/S0969-2126(01)00234-9; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MARUMO T, 1995, HYPERTENSION, V25, P764, DOI 10.1161/01.HYP.25.4.764; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Pende M, 1997, J NEUROSCI, V17, P1291; Resing KA, 1998, BIOCHEMISTRY-US, V37, P463, DOI 10.1021/bi971750x; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Shapiro PS, 1998, J BIOL CHEM, V273, P1788, DOI 10.1074/jbc.273.3.1788; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; Stoddard BL, 1996, CURR OPIN STRUC BIOL, V6, P770, DOI 10.1016/S0959-440X(96)80006-6; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Villafranca JE, 1996, CURR OPIN BIOTECH, V7, P397; VOGEL HJ, 1995, MOL CELL BIOCHEM, V149, P3, DOI 10.1007/BF01076558; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; XIE HJ, 1995, J IMMUNOL, V154, P1717; ZINCK R, 1993, EMBO J, V12, P2377, DOI 10.1002/j.1460-2075.1993.tb05892.x	82	88	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15173	15180		10.1074/jbc.274.21.15173	http://dx.doi.org/10.1074/jbc.274.21.15173			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329725	hybrid			2022-12-27	WOS:000081965200090
J	Yamashita, H; Xu, J; Erwin, RA; Larner, AC; Rui, H				Yamashita, H; Xu, J; Erwin, RA; Larner, AC; Rui, H			A lymphoma growth inhibitor blocks some but not all prolactin-stimulated signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN BREAST-CANCER; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; NB2 LYMPHOMA; MAP KINASE; CELL-LINES; C-FOS; RECEPTOR; STAT5	Cytokines and hormones activate a network of intracellular signaling pathways to regulate cell division, survival and differentiation. In parallel, a series of growth inhibitory mechanisms critically restrict cell population sizes. For example, mitogens can be opposed in crowded cell cultures through contact-inhibition or by autocrine release of antiproliferative substances. Here, we characterize a small, heat-stable growth inhibitor secreted by a rat T lymphoma line when cultured at high cell density. Short term incubation (<60 min) of prolactin-responsive Nb2 lymphoma cells at high density selectively blocked prolactin stimulation of p42/p44 mitogen-activated protein kinases and transcription factors Stat1 and Stat3 but not prolactin activation of Stat5 or the tyrosine kinase Jak2. The selective effects of cell density on prolactin signaling were reversible. Furthermore, exposure of cells at low density to conditioned media from cells incubated at high density had the same inhibitory effects on prolactin signaling. This selective inhibition of discrete prolactin signals was mimicked by short term preincubation of cells at low density with staurosporine or genistein but not with bis-indoleyl maleimide, cyclic nucleotide analogs, calcium ionophore A23187, or phorbol 12-myristate 13-acetate. A heat-stable, proteinase K-resistant, low molecular weight factor with these characteristics was recovered from high density culture medium, The partially purified inhibitor suppressed Nb2 cell growth with a sigmoidal concentration response consistent with a saturable, receptor-mediated process.	Uniformed Serv Univ Hlth Sci, Dept Pathol, Sch Med, Bethesda, MD 20814 USA; Univ Texas, Dept Integrat Biol Pharmacol & Physiol, Houston, TX 77030 USA; Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA	Uniformed Services University of the Health Sciences - USA; University of Texas System; Cleveland Clinic Foundation	Rui, H (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	hrui@usuhs.mil	Yamashita, Hiroko/D-5102-2012	Yamashita, Hiroko/0000-0003-4281-8727	NIDDK NIH HHS [R01 DK52013-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052013] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALI S, 1991, J BIOL CHEM, V266, P20110; Barahmand-Pour F, 1998, J BIOL CHEM, V273, P12567, DOI 10.1074/jbc.273.20.12567; Berlanga JJ, 1997, J BIOL CHEM, V272, P2050; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; BUCKLEY AR, 1994, BIOCHEM BIOPH RES CO, V204, P1158, DOI 10.1006/bbrc.1994.2584; CAREY GB, 1995, ARCH BIOCHEM BIOPHYS, V316, P179, DOI 10.1006/abbi.1995.1026; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; CLEVENGER CV, 1994, J BIOL CHEM, V269, P5559; COULDWELL WT, 1992, J NEUROL SCI, V110, P178, DOI 10.1016/0022-510X(92)90026-H; DASILVA L, 1994, J BIOL CHEM, V269, P18267; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; Edwards GM, 1998, J BIOL CHEM, V273, P9495, DOI 10.1074/jbc.273.16.9495; EINHORN S, 1993, MED ONCOL TUMOR PHAR, V10, P25; ERWIN RA, 1995, ENDOCRINOLOGY, V136, P3512, DOI 10.1210/en.136.8.3512; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; FORSCHUNG B, 1974, EUR J BIOCHEM, V47, P91; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Gong TWL, 1998, ENDOCRINOLOGY, V139, P1863, DOI 10.1210/en.139.4.1863; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GOUT PW, 1980, CANCER RES, V40, P2433; HAREL L, 1984, J CELL PHYSIOL, V119, P101, DOI 10.1002/jcp.1041190117; JOHNSON TC, 1994, PHARMACOL THERAPEUT, V62, P247, DOI 10.1016/0163-7258(94)90013-2; Kirken RA, 1997, J BIOL CHEM, V272, P14098, DOI 10.1074/jbc.272.22.14098; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; MARNETT LJ, 1992, CANCER RES, V52, P5575; RAO YP, 1995, J CELL PHYSIOL, V163, P266, DOI 10.1002/jcp.1041630207; RAO YP, 1995, CELL GROWTH DIFFER, V6, P1235; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; RUI H, 1994, J BIOL CHEM, V269, P5364; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Rui H, 1998, J BIOL CHEM, V273, P28, DOI 10.1074/jbc.273.1.28; Schaber JD, 1998, CANCER RES, V58, P1914; Shao RG, 1997, CANCER RES, V57, P4029; SIDIS Y, 1994, ENDOCRINOLOGY, V134, P1979, DOI 10.1210/en.134.4.1979; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Smith WL, 1997, ADV EXP MED BIOL, V400, P989; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; VANGIJN R, 1995, J CHROMATOGR B, V667, P269, DOI 10.1016/0378-4347(95)00037-J; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; YuLee LY, 1997, P SOC EXP BIOL MED, V215, P35, DOI 10.3181/00379727-215-44111	43	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14699	14705		10.1074/jbc.274.21.14699	http://dx.doi.org/10.1074/jbc.274.21.14699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329665	hybrid			2022-12-27	WOS:000081965200030
J	Gabrielli, BG; Sarcevic, B; Sinnamon, J; Walker, G; Castellano, M; Wang, XQ; Ellem, KAO				Gabrielli, BG; Sarcevic, B; Sinnamon, J; Walker, G; Castellano, M; Wang, XQ; Ellem, KAO			A cyclin D-Cdk4 activity required for G(2) phase cell cycle progression is inhibited in ultraviolet radiation-induced G(2) phase delay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-CDK COMPLEXES; DEPENDENT KINASES; RETINOBLASTOMA-PROTEIN; DNA-DAMAGE; HUMAN KERATINOCYTES; HUMAN FIBROBLASTS; G1 ARREST; P16; PHOSPHORYLATION; P53	Cyclin D-Cdk4 complexes have a demonstrated role in G(1) phase, regulating the function of the retinoblastoma susceptibility gene product (Rb). Previously, we have shown that following treatment with low doses of UV radiation, cell lines that express wild-type pie and Cdk4 responded with a Gz phase cell. cycle delay. The UV-responsive lines contained elevated levels of p16 posttreatment, and the accumulation of pie correlated with the G(2) delay, Here we report that in UV-irradiated HeLa and A2058 cells, pie bound Cdk4 and Cdk6 complexes with increased avidity and inhibited a cyclin D3-Cdk4 compiler normally activated in late S/early G(2) phase. Activation of this complex was correlated with the caffeine-induced release from the UV-induced G(2) delay and a decrease in the level of pie bound to Cdk4, Finally, overexpression of a dominant-negative mutant of Cdk4 blocked cells in G(2) phase. These data indicate that the cyclin D3-Cdk4 activity is necessary for cell cycle progression through G(2) phase into mitosis and that the increased binding of p16 blocks this activity and G(2), phase progression after UV exposure.	Univ Queensland, Queensland Inst Med Res, Queensland Canc Fund Res Unit, Brisbane, Qld 4029, Australia; Univ Queensland, Joint Expt Oncol Program, Brisbane, Qld 4029, Australia; St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Gabrielli, BG (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	brianG@qimr.edu.au	Gabrielli, Brian G/B-3655-2011; Wang, Xue-Qing/F-1758-2010	Gabrielli, Brian G/0000-0003-3933-1651; Sarcevic, Boris/0000-0002-8063-1050				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; APRELIKOVA O, 1995, J BIOL CHEM, V270, P18195, DOI 10.1074/jbc.270.31.18195; BATES S, 1994, ONCOGENE, V9, P1633; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Castellano M, 1997, CANCER RES, V57, P4868; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; DellaRagione F, 1996, J BIOL CHEM, V271, P15942, DOI 10.1074/jbc.271.27.15942; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Foulkes WD, 1997, MOL MED, V3, P5, DOI 10.1007/BF03401664; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HERZINGER T, 1995, ONCOGENE, V11, P2151; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KASTAN MB, 1991, CANCER RES, V51, P6304; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; LI Y, 1994, ONCOGENE, V9, P2261; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Milligan A, 1998, MUTAT RES-FUND MOL M, V422, P43, DOI 10.1016/S0027-5107(98)00174-2; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x; Petrocelli T, 1996, ONCOGENE, V12, P1387; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; TAM SW, 1994, CANCER RES, V54, P5816; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; Wang XQ, 1996, CANCER RES, V56, P2510; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weller EM, 1996, INT J RADIAT BIOL, V69, P371, DOI 10.1080/095530096145931	45	63	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13961	13969		10.1074/jbc.274.20.13961	http://dx.doi.org/10.1074/jbc.274.20.13961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318807	hybrid			2022-12-27	WOS:000080322200036
J	Hawkes, NA; Roberts, SGE				Hawkes, NA; Roberts, SGE			The role of human TFIIB in transcription start site selection in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; N-TERMINAL REGION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL DOMAINS; LARGEST SUBUNIT; DNA-BINDING; YEAST; MUTATIONS; ACTIVATOR	The general transcription factor TFIIB plays a crucial role in selecting the transcription initiation site in yeast. We have analyzed the human homologs of TFIIB mutants that have previously been shown to affect transcription start site selection in the yeast Saccharomyces cerevisiae. Despite the distinct mechanisms of transcription start site selection observed in S. cerevisiae and humans, the role of TFIIB in this process is similar. However, unlike their yeast counterparts, the human mutants do not show a severe defect in supporting either basal transcription or transcription stimulated by an acidic activator in vitro. Transient transfection analysis revealed that, in addition to a role in transcription start site selection, human TFIIB residue Arg-66 performs a critical function in vivo that is bypassed in vitro. Furthermore, although correct transcription start site selection is dependent upon an arginine residue at position 66 in human TFIIB, innate function in vivo is determined by the charge of the residue alone. Our observations raise questions as to the evolutionary conservation of TFIIB and uncover an additional function for TFIIB that is required in vivo but can be bypassed in vitro.	Univ Dundee, Dept Biochem, Div Gene Express, Dundee DD1 5EH, Scotland	University of Dundee	Roberts, SGE (corresponding author), Univ Dundee, Dept Biochem, Div Gene Express, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland.	sgeroberts@bad.dundee.ac.uk	Roberts, Stefan GE/R-5537-2016	Roberts, Stefan GE/0000-0002-7535-6365				BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; BERROTERAN RW, 1994, MOL CELL BIOL, V14, P226, DOI 10.1128/MCB.14.1.226; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Fang SM, 1996, J BIOL CHEM, V271, P11703, DOI 10.1074/jbc.271.20.11703; FURTERGRAVES EM, 1994, NUCLEIC ACIDS RES, V22, P4932, DOI 10.1093/nar/22.23.4932; Ge H, 1996, METHOD ENZYMOL, V274, P57; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PINTO I, 1994, J BIOL CHEM, V269, P30569; Qureshi SA, 1998, MOL CELL, V1, P389, DOI 10.1016/S1097-2765(00)80039-8; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; Shaw SP, 1996, MOL CELL BIOL, V16, P3651; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	34	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14337	14343		10.1074/jbc.274.20.14337	http://dx.doi.org/10.1074/jbc.274.20.14337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318856	hybrid			2022-12-27	WOS:000080322200085
J	Hsieh, CM; Yet, SF; Layne, MD; Watanabe, M; Hong, AM; Perrella, MA; Lee, ME				Hsieh, CM; Yet, SF; Layne, MD; Watanabe, M; Hong, AM; Perrella, MA; Lee, ME			Genomic cloning and promoter analysis of aortic preferentially expressed gene-1 - Identification of a vascular smooth muscle-specific promoter mediated by an E box motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTOR; MESSENGER-RNA; TRANSGENIC MICE; MYC PROTEINS; DNA-BINDING; IN-VIVO; CELLS; DIFFERENTIATION; ELEMENT; SM22-ALPHA	Aortic preferentially expressed gene-1 (APEG-1) was originally identified as a 1.4-kilobase (kb) transcript preferentially expressed in differentiated vascular smooth muscle cells (VSMC). Its expression is markedly down-regulated in de-differentiated VSMC, suggesting a role for APEG-1 in VSMC differentiation. We have now determined that APEG-1 is a single-copy gene in the human, rat, and mouse genomes and have mapped human APEG-1 to chromosome 2q34. To study the molecular mechanisms regulating its expression, we characterized the genomic organization and promoter of mouse APEG-1. APEG-1 spans 4.5 kb in the mouse genome and is composed of five exons. Using reporter gene transfection analysis, we found that a 2.7-kb APEG-1 5'-flanking sequence directed a high level of promoter activity only in VSMC. Its activity was minimal in five other cell types. A repressor region located within an upstream 685-base pair sequence suppressed the activity of this 2.7-kb promoter. Further deletion and mutation analyses identified an E box motif as a positive regulatory element, which was bound by nuclear protein prepared from VSMC. In conjunction with its flanking. sequence, this E box moth confers VSMC-specific enhancer activity to a heterologous SV40 promoter, To our knowledge, this is the first demonstration of an E box motif that mediates gene expression restricted to VSMC.	Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lee, ME (corresponding author), Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, 677 Huntington Ave, Boston, MA 02115 USA.		Yet, Shaw-Fang/B-1067-2010; Yet, Shaw-Fang/O-8583-2019	Calderwood, Audrey/0000-0001-7486-8310; Yet, Shaw-Fang/0000-0001-9097-3962; Layne, Matthew/0000-0003-0007-4870	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003194, F32HL010113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32-HL10113, KO8-HL03194] Funding Source: Medline; NIGMS NIH HHS [R01-GM53249] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMROLIA PJ, 1995, J BIOL CHEM, V270, P12892, DOI 10.1074/jbc.270.21.12892; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; GRECO A, 1994, J GEN VIROL, V75, P1693, DOI 10.1099/0022-1317-75-7-1693; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Herring BP, 1997, AM J PHYSIOL-CELL PH, V272, pC1394, DOI 10.1152/ajpcell.1997.272.4.C1394; Hsieh CM, 1996, J BIOL CHEM, V271, P17354, DOI 10.1074/jbc.271.29.17354; JACOBS Y, 1993, MOL CELL BIOL, V13, P7321, DOI 10.1128/MCB.13.12.7321; Jain MK, 1998, J BIOL CHEM, V273, P5993, DOI 10.1074/jbc.273.11.5993; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; LEE ME, 1990, J BIOL CHEM, V265, P10446; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; LIBBY P, 1991, LAB INVEST, V64, P5; Madsen CS, 1997, J BIOL CHEM, V272, P6332, DOI 10.1074/jbc.272.10.6332; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NELSEN B, 1992, INT REV CYTOL, V133, P121, DOI 10.1016/S0074-7696(08)61859-8; NOMURA M, 1995, J BIOL CHEM, V270, P7453, DOI 10.1074/jbc.270.13.7453; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; OWENS GK, 1995, PHYSIOL REV, V75, P487; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWARTZ SM, 1990, PHYSIOL REV, V70, P1177, DOI 10.1152/physrev.1990.70.4.1177; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tsai JC, 1996, J CLIN INVEST, V97, P146, DOI 10.1172/JCI118383; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; WINDER SJ, 1991, ADV EXP MED BIOL, V304, P37; YANO H, 1995, J BIOL CHEM, V270, P23661, DOI 10.1074/jbc.270.40.23661; Yet SF, 1998, J BIOL CHEM, V273, P10530, DOI 10.1074/jbc.273.17.10530; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918	48	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14344	14351		10.1074/jbc.274.20.14344	http://dx.doi.org/10.1074/jbc.274.20.14344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318857	hybrid			2022-12-27	WOS:000080322200086
J	Oh, H; Park, Y; Park, C				Oh, H; Park, Y; Park, C			A mutated PtsG, the glucose transporter, allows uptake of D-ribose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRANSCRIPTIONAL ACTIVATOR; PHOSPHOTRANSFERASE SYSTEM; PHOSPHORYLATION; GENE; EXPRESSION; CLONING; OPERON; OVEREXPRESSION; PURIFICATION	Mutations arose from an Escherichia coli strain defective in the high (Rbs/ribose) and low (Als/allose and Xyl/xylose) affinity D-ribose transporters, which allow cells to grow on D-ribose. Genetic tagging and mapping of the mutations revealed that two loci in the E. coli linkage map are involved in creating a novel ribose transport mechanism. One mutation was found in ptsG, the glucose-specific transporter of phosphoenolpyruvate:carbohydrate phosphotransferase system and the other in mlc, recently reported to be involved in the regulation of ptsG. Five different mutations in ptsG were characterized, whose growth on D-ribose medium was about 80% that of the high affinity system (Rbs(+)). Two of them were found in the predicted periplasmic loops, whereas three others are in the transmembrane region. Ribose uptakes in the mutants, competitively inhibited by D-glucose, D-xylose, or D-allose, were much lower than that of the high affinity transporter but higher than those of the Als and Xyl systems. Further analyses of the mutants revealed that the rbsK (ribokinase) and rbsD (function unknown) genes are involved in the ribose transport through PtsG, indicating that the phosphorylation of ribose is not mediated by PtsG and that some unknown metabolic function mediated by RbsD is-required. It was also found that D-xylose, another sugar not involved in phosphorylation, was efficiently transported through the wild-type or mutant PtsG in mlc-negative background, The efficiencies of xylose add glucose transports are variable in the PtsG mutants, depending on their locations, either in the periplasm or in the membrane. In an extreme case of the transmembrane change (I283T), xylose transport is virtually abolished, indicating that the residue is directly involved in determining sugar specificity. We propose that there are at least two domains for substrate specificity in PtsG with slightly altered recognition properties.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Behav Genet, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Park, C (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Behav Genet, Dept Biol Sci, Yusong-Ku, Taejon 305701, South Korea.		Park, Chankyu/C-1936-2011					AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Begley GS, 1996, J BACTERIOL, V178, P940, DOI 10.1128/jb.178.3.940-942.1996; BUHR A, 1993, J BIOL CHEM, V268, P11599; BUHR A, 1992, J BIOL CHEM, V267, P3847; BUHR A, 1994, J BIOL CHEM, V269, P23437; CURTIS SJ, 1975, J BACTERIOL, V122, P1189, DOI 10.1128/JB.122.3.1189-1199.1975; DAVIS EO, 1987, J BIOL CHEM, V262, P13928; Decker K, 1998, MOL MICROBIOL, V27, P381, DOI 10.1046/j.1365-2958.1998.00694.x; Declan D. A., 1998, SCIENCE, V280, P69; DORSCHUG M, 1984, EUR J BIOCHEM, V144, P113, DOI 10.1111/j.1432-1033.1984.tb08438.x; HALL MN, 1981, J MOL BIOL, V151, P1, DOI 10.1016/0022-2836(81)90218-7; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HOPE JN, 1986, J BIOL CHEM, V261, P7663; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Kim CH, 1997, J BACTERIOL, V179, P7631, DOI 10.1128/jb.179.24.7631-7637.1997; Kimata K, 1998, MOL MICROBIOL, V29, P1509, DOI 10.1046/j.1365-2958.1998.01035.x; LOPILATO JE, 1984, J BACTERIOL, V158, P665, DOI 10.1128/JB.158.2.665-673.1984; MEINS M, 1993, J BIOL CHEM, V268, P11604; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Miller J.H., 1972, EXPT MOL GENETICS; MOWBRAY SL, 1992, J MOL BIOL, V225, P693; PARK C, 1986, J BACTERIOL, V167, P101, DOI 10.1128/jb.167.1.101-109.1986; Plumbridge J, 1998, MOL MICROBIOL, V29, P1053, DOI 10.1046/j.1365-2958.1998.00991.x; Plumbridge J, 1998, MOL MICROBIOL, V27, P369, DOI 10.1046/j.1365-2958.1998.00685.x; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; RIEDL J, 1991, J BACTERIOL, V173, P4862; RUIJTER GJG, 1992, J BACTERIOL, V174, P2843, DOI 10.1128/JB.174.9.2843-2850.1992; Sambrook J., 2002, MOL CLONING LAB MANU; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song SG, 1998, FEMS MICROBIOL LETT, V163, P255, DOI 10.1111/j.1574-6968.1998.tb13054.x; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; WILEMSRIESENBER.MR, 1992, J BACTERIOL, V174, P4558	33	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14006	14011		10.1074/jbc.274.20.14006	http://dx.doi.org/10.1074/jbc.274.20.14006			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318813	hybrid			2022-12-27	WOS:000080322200042
J	Yang, YK; Dickinson, CJ; Zeng, Q; Li, JY; Thompson, DK; Gantz, I				Yang, YK; Dickinson, CJ; Zeng, Q; Li, JY; Thompson, DK; Gantz, I			Contribution of melanocortin receptor exoloops to Agouti-related protein binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING-HORMONE RECEPTOR; MOLECULAR-CLONING; COUPLED RECEPTORS; LIGAND-BINDING; EXPRESSION; ANTAGONISM; OBESITY; FAMILY; MICE; ART	Agouti-related protein (AGRP) is an endogenous antagonist of melanocortin action that functions in the hypothalamic control of feeding behavior. Although previous studies have shown that AGRP binds three of the five known subtypes of melanocortin receptor, the receptor domains participating in binding and the molecular interactions involved are presently unknown, The present studies were designed to examine the contribution of extracytoplasmic domains of the melanocortin-4 receptor (MC4R) to AGRP binding by making chimerical receptor constructs of the human melanocortin-1 receptor (MC1R; a receptor that is not inhibited by AGRP) and the human MC4R (a receptor that is potently inhibited by AGRP). Substitutions of the extracytoplasmic NH2 terminus and the first extracytoplasmic: loop (exoloop) of the MC4R, with homologous domains of the MC1R had no effect on AGRP (87-132) binding affinity or inhibitory activity (the ability to inhibit melanocortin-stimulated cAMP generation). In contrast, cassette substitutions of exoloops 2 and 3 of the MC4R with the homologous exoloops of the MC1R resulted in a substantial loss of AGRP binding affinity and inhibitory activity. Conversely, the exchange of exoloops 2 land 3 of the MC1R with the homologous exoloops of the MC4R was found to confer AGRP binding and inhibitory activity to the basic structure of the MC1R. Importantly, these substitutions did not affect the ability of the alpha-melanocyte stimulating: hormone analogue [Nle(4),D-Phe(7)] melanocyte stimulating hormone to bind or activate the chimeric receptors. These data indicate that exoloops 2 and 3 of the melanocortin receptors are important for AGRP binding.	Univ Michigan, Sch Med, Dept Gen Surg, Ann Arbor, MI 48109 USA; Ann Arbor Vet Adm Hosp, Dept Gen Surg, Ann Arbor, MI 48109 USA; Gryphon Sci, S San Francisco, CA 94080 USA; Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gantz, I (corresponding author), 6504 MSRB I,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.			Thompson, Darren/0000-0002-3725-7112	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK054032, R01DK047398] Funding Source: NIH RePORTER; NIDDK NIH HHS [1RO1 DK54032-01, P30DK34933, R01 DK47398] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BLANCHARD SG, 1995, BIOCHEMISTRY-US, V34, P10406, DOI 10.1021/bi00033a012; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chhajlani V, 1996, BIOCHEM BIOPH RES CO, V219, P521, DOI 10.1006/bbrc.1996.0266; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; EBERLE AN, 1988, MELANOTROPINS CHEM P, P210; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Haskell-Luevano C, 1996, Drug Des Discov, V14, P197; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schioth HB, 1996, BIOCHEM BIOPH RES CO, V229, P687, DOI 10.1006/bbrc.1996.1866; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Tatro JB, 1996, NEUROIMMUNOMODULAT, V3, P259, DOI 10.1159/000097281; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148	23	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14100	14106		10.1074/jbc.274.20.14100	http://dx.doi.org/10.1074/jbc.274.20.14100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318826	hybrid			2022-12-27	WOS:000080322200055
J	Bochar, DA; Pan, ZQ; Knights, R; Fisher, RP; Shilatifard, A; Shiekhattar, R				Bochar, DA; Pan, ZQ; Knights, R; Fisher, RP; Shilatifard, A; Shiekhattar, R			Inhibition of transcription by the trimeric cyclin-dependent kinase 7 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-ACTIVATING KINASE; RNA-POLYMERASE-II; RING FINGER PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; EXCISION-REPAIR; FACTOR TFIIH; IN-VITRO; CAK	Cyclin-dependent kinase 7 (CDK7) can be isolated as a subunit of a trimeric kinase complex functional in activation of the mitotic promoting factor. In this study, we demonstrate that the trimeric cdk-activating kinase (CAK) acts as a transcriptional repressor of class II promoters and show that repression results from CAK impeding the entry of RNA polymerase II and basal transcription factor IIF into a competent preinitiation complex. This repression is independent of CDK7 kinase activity. We find that the p36/mAT1 subunit of CAK, is required for transcriptional repression and the repression is independent of the promoter used. Our results demonstrate a central role for CAK in regulation of messenger RNA synthesis by either inhibition of RNA polymerase II-catalyzed transcription or stimulation of transcription through association with basal transcription repair factor IIH.	Wistar Inst, Philadelphia, PA 19104 USA; CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	The Wistar Institute; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Saint Louis University	Shiekhattar, R (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Bochar, Daniel A/A-9224-2009		NIGMS NIH HHS [GM55059] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; FEAVER WJ, 1991, J BIOL CHEM, V266, P19000; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; Fisher RP, 1997, METHOD ENZYMOL, V283, P256; FLORES O, 1992, J BIOL CHEM, V267, P2786; GERARD M, 1991, J BIOL CHEM, V266, P20940; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; Kaldis P, 1996, CELL, V86, P553, DOI 10.1016/S0092-8674(00)80129-4; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; SUN P, 1992, MOL ENDOCRINOL, V11, P1858; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; WANG ZG, 1995, MOL CELL BIOL, V15, P2288	31	9	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13162	13166		10.1074/jbc.274.19.13162	http://dx.doi.org/10.1074/jbc.274.19.13162			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224071	hybrid			2022-12-27	WOS:000080200400033
J	Devine, JH; Eubank, DW; Clouthier, DE; Tontonoz, P; Spiegelman, BM; Hammer, RE; Beale, EG				Devine, JH; Eubank, DW; Clouthier, DE; Tontonoz, P; Spiegelman, BM; Hammer, RE; Beale, EG			Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC EXPRESSION; HUMAN GROWTH-HORMONE; GENE-EXPRESSION; TRANSGENIC MICE; PPAR-GAMMA; COUP-TF; GTP; TRANSCRIPTION; UPSTREAM; PATHWAY	A putative adipocyte-specific enhancer has been mapped to approximately 1 kilobase pair upstream of the cytosolic phosphoenolpyruvate carboxykinase (PEPCK) gene, In the present study, we used transgenic mice to identify and characterize the 413-base pair (bp) region between -1242 and -828 bp as a bona fide adipocyte-specific enhancer in vivo. This enhancer functioned most efficiently in the context of the PEPCK promoter. The nuclear receptors peroxisome proliferator-activated receptor gamma (PPAR gamma) and g-cis-retinoic acid receptor (RXR) are required for enhancer function in vivo because: 1) a 3-bp mutation in the PPAR gamma-/RXR-binding element centered at -992 bp, PCK2, completely abolished transgene expression in adipose tissue; and 2) electrophoretic mobility supershift experiments with specific antibodies indicated that PPAR gamma and RXR are the only factors in adipocyte nuclear extracts which bind PCK2, In contrast, a second PPAR gamma/RXR-binding element centered at -446 bp, PCK1, is not involved in adipocyte specificity because inactivation of this site did not affect transgene expression, Moreover, electrophoretic mobility shift experiments indicated that, unlike PCK2, PCK1 is not selective for PPAR gamma/RXR-binding. To characterize the enhancer further, the rat and human PEPCK 5'-flanking DNA sequences were compared by computer and found to have significant similarities in the enhancer region. This high level of conservation suggests that additional transcription factors are probably involved in enhancer function. A putative human PCK2 element was identified by this sequence comparison. The human and rat PCK2 elements bound PPAR gamma/RXR with the same affinities. This work provides the first in vivo evidence that the binding of PPAR gamma to its target sequences is absolutely required for adipocyte-specific gene expression.	Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; Univ Texas, SW Med Ctr, Dept Biochem, Howard Hughes Med Inst, Dallas, TX 75235 USA; Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Beale, EG (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA.	bioegb@ttusc.edu	Beale, Elmus/GNM-8181-2022	Hammer, Robert E./0000-0001-5487-7551; Beale, Elmus/0000-0002-7758-0600	NIGMS NIH HHS [R01GM39895] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039895] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTRASFERRY J, 1994, BIOCHEM BIOPH RES CO, V203, P385, DOI 10.1006/bbrc.1994.2194; BEALE EG, 1985, J BIOL CHEM, V260, P748; BEALE EG, 1992, FASEB J, V6, P3330, DOI 10.1096/fasebj.6.15.1281456; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHEYETTE TE, 1992, NUCLEIC ACIDS RES, V20, P3427, DOI 10.1093/nar/20.13.3427; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; Ghosh D, 1999, NUCLEIC ACIDS RES, V27, P315, DOI 10.1093/nar/27.1.315; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HANSON RW, 1973, AM J CLIN NUTR, V26, P55, DOI 10.1093/ajcn/26.1.55; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; IDZERDA RL, 1989, MOL CELL BIOL, V9, P5154, DOI 10.1128/MCB.9.11.5154; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IP YT, 1990, MOL CELL BIOL, V10, P3770, DOI 10.1128/MCB.10.7.3770; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; MCGRANE MM, 1990, J BIOL CHEM, V265, P22371; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHORT MK, 1992, MOL CELL BIOL, V12, P1007, DOI 10.1128/MCB.12.3.1007; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703	36	75	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13604	13612		10.1074/jbc.274.19.13604	http://dx.doi.org/10.1074/jbc.274.19.13604			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224131	hybrid			2022-12-27	WOS:000080200400093
J	Friesen, JA; Campbell, HA; Kent, C				Friesen, JA; Campbell, HA; Kent, C			Enzymatic and cellular characterization of a catalytic fragment of CTP : phosphocholine cytidylyltransferase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; RAT-LIVER; DOMAIN; IDENTIFICATION; EXPRESSION; SITES	To probe the mechanism of lipid activation of CTP: phosphocholine cytidylyltransferase (CCT alpha), we have characterized a catalytic fragment of the enzyme that lacks the membrane-binding segment. The kinetic properties of the purified fragment, CCT alpha 236, were characterized, as well as the effects of expressing the fragment in cultured cells. CCT alpha 236 was truncated after residue 236, which corresponds to the end of the highly conserved catalytic domain. The activity of purified CCT alpha 236 was independent of lipids and about 50-fold higher than the activity of wild-type CCT alpha assayed in the absence of lipids, supporting a model in which the membrane-binding segment functions as an inhibitor of the catalytic domain. The k(cat)/K-m values for CCT alpha 236 were only slightly lower than those for lipid-activated CCT alpha. The importance of the membrane-binding segment in vivo was tested by expression of CCT alpha 236 in CHO58 cells, a cell line that is temperature-sensitive for growth and CCT alpha activity. Expression of wild-type CCT alpha in these cells complemented the defective growth phenotype when the cells were cultured in complete or delipidated fetal bovine serum. Expression of CCT alpha 236, however, did not complement the growth phenotype in the absence of serum lipids. These cells were capable of making phosphatidylcholine in the delipidated medium, so the inability of the cells to grow was not due to defective phosphatidylcholine synthesis. Supplementation of the delipidated medium with an unsaturated fatty acid allowed growth of CHO58 cells expressing CCT alpha 236, These results indicate that the membrane-binding segment of CCT alpha has an important role in cellular lipid metabolism.	Univ Michigan, Dept Biol Chem, Sch Med, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kent, C (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, Med Ctr, 4417 Med Sci 1, Ann Arbor, MI 48109 USA.			Adams, Heidi/0000-0001-7563-3126	NATIONAL CANCER INSTITUTE [R01CA064159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019286] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA64159] Funding Source: Medline; NIDDK NIH HHS [5P60DK-20572] Funding Source: Medline; NIGMS NIH HHS [1 F32 GM19286-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CORNELL R, 1989, J BIOL CHEM, V264, P9077; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; ESKO JD, 1981, J BIOL CHEM, V256, P7388; FELDMAN DA, 1987, J BIOL CHEM, V262, P9075; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; KYTE J, 1995, MECH PROTEIN CHEM, P149; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; PARK YS, 1993, J BIOL CHEM, V268, P16648; PLESNER IW, 1986, BIOCHEM J, V239, P175, DOI 10.1042/bj2390175; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1995, J BIOL CHEM, V270, P17843, DOI 10.1074/jbc.270.30.17843; WEINHOLD PA, 1992, METHOD ENZYMOL, V209, P248; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951; [No title captured]	19	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13384	13389		10.1074/jbc.274.19.13384	http://dx.doi.org/10.1074/jbc.274.19.13384			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224101	hybrid			2022-12-27	WOS:000080200400063
J	Ishisaki, A; Yamato, K; Hashimoto, S; Nakao, A; Tamaki, K; Nonaka, K; ten Dijke, P; Sugino, H; Nishihara, T				Ishisaki, A; Yamato, K; Hashimoto, S; Nakao, A; Tamaki, K; Nonaka, K; ten Dijke, P; Sugino, H; Nishihara, T			Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA FAMILY MEMBERS; MAD-RELATED PROTEIN; RECEPTOR SERINE KINASE; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; XENOPUS SMAD7; ACTIVATION; ANTAGONIST; INDUCTION; GENE	Smad6 and Smad7 prevent ligand-induced activation of signal-transducing Smad proteins in the transforming growth factor-p family. Here we demonstrate that both Smad6 and Smad7 are human bone morphogenetic protein-2 (hBMP-2)-inducible antagonists of hBMP-2-induced growth arrest and apoptosis in mouse B cell hybridoma HS-72 cells. Moreover, we confirmed that the ectopic expressions of Smad6 and Smad7 inhibited the hBMP-2-induced Smad1/Smad5 phosphorylation. We previously reported that Smad7 is an activin A-inducible antagonist of activin A-induced growth arrest and apoptosis in HS-72 cells. Interestingly, although mRNA expression of Smad6 was induced by activin A in HS-72 cells, Smad6 showed no antagonistic effect on activin A-induced growth arrest and apoptosis, Moreover, we found that the ectopic expression of Smad7, but not Smad6, inhibited the activin A-induced Smad2 phosphorylation in HS-72 cells. Thus, Smad6 and Smad7 exhibit differential inhibitory effects in bone morphogenetic protein-2- and activin A-mediated signaling in B lineage cells.	Nstl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Med & Dent Univ, Fac Dent, Dept Mol Cellular Oncol Microbiol, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, Fac Dent, Dept Oral & Maxillofacial Surg 1, Bunkyo Ku, Tokyo 1138549, Japan; Chiba Univ, Sch Med, Dept Med, Chuo Ku, Chiba 2600856, Japan; Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan; Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Chiba University; Tokushima University; Ludwig Institute for Cancer Research	Nishihara, T (corresponding author), Nstl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.		Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; Ishisaki, Akira/0000-0001-6704-4436; Nishihara, Tatsuji/0000-0001-7075-9678				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Bhushan A, 1998, DEV BIOL, V200, P260, DOI 10.1006/dbio.1998.8965; Casellas R, 1998, DEV BIOL, V198, P1; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 1997, P NATL ACAD SCI USA, V94, P12938, DOI 10.1073/pnas.94.24.12938; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1998, J BIOL CHEM, V273, P24293, DOI 10.1074/jbc.273.38.24293; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nakayama T, 1998, GENES CELLS, V3, P387, DOI 10.1046/j.1365-2443.1998.00196.x; Nakayama T, 1998, DEVELOPMENT, V125, P857; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; NISHIHARA T, 1995, J INTERF CYTOK RES, V15, P509, DOI 10.1089/jir.1995.15.509; PERANDONES CE, 1993, J IMMUNOL, V151, P3521; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; SUGITO S, 1991, INT J CANCER, V49, P880, DOI 10.1002/ijc.2910490614; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Watanabe TK, 1997, GENOMICS, V42, P446, DOI 10.1006/geno.1997.4753; Yamato K, 1997, MOL ENDOCRINOL, V11, P1044, DOI 10.1210/me.11.8.1044; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	43	196	209	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13637	13642		10.1074/jbc.274.19.13637	http://dx.doi.org/10.1074/jbc.274.19.13637			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224135	hybrid			2022-12-27	WOS:000080200400097
J	Goldshleger, R; Karlish, SJD				Goldshleger, R; Karlish, SJD			The energy transduction mechanism of Na,K-ATPase studied with iron-catalyzed oxidative cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT ADENOSINE-TRIPHOSPHATASE; SITE-DIRECTED MUTAGENESIS; MEMBRANE H+-ATPASE; (NA+ + K+)-ATPASE; ALPHA-SUBUNIT; BINDING-SITE; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; NA+/K+-ATPASE; AMINO-ACID	This paper extends our recent report on specific iron-catalyzed oxidative cleavages of renal Na,K-ATPase and effects of E-1 <----> E-2 conformational transitions (Goldshleger, R., and Karlish, S. J. D. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 9596-9601). The experiments indicate that only peptide bonds close to a bound Fe2+ ion are cleaved, and provide evidence on proximity of the different cleavage positions in the native enzyme. A sequence HFIH near trans-membrane segment M3 appears to be involved in Fe2+ binding, Previously we hypothesized that E-2 and E-1 conformations are characterized by formation or relaxation of interactions within the alpha subunit at or near highly conserved sequences, TGES in the minor cytoplasmic loop and CSDK, MVTGD, and VNDSPALKK in the major cytoplasmic loop. This concept has been tested by examining iron-catalyzed cleavage in both non-phosphorylated and phosphorylated conformations and effects of phosphate, vanadate, and ouabain. The results imply that both E-1 <----> E-2 and E1P <----> E2P transitions are indeed associated with formation and relaxation of interactions between cytoplasmic domains, comprising the minor loop plus N-terminal tail leading into M1 and major loop, respectively. Furthermore, it appears that either non-covalently or covalently bound phosphate bind near CSDK and MVTGD, and Mg2+ ions may bind to residues within TGES and VNDSPALKK and to bound phosphate, Thus cytoplasmic domain interactions seem to occur within or near the active site. We discuss the relationship between structural changes in the cytoplasmic domain and movements of trans-membrane segments that lead to cation transport. Presumably conformation-dependent formation and relaxation of domain interactions underlie energy transduction in all P-type pumps.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.							ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ASKARI A, 1983, J BIOL CHEM, V258, P3453; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bar Shimon M, 1998, J BIOL CHEM, V273, P34190, DOI 10.1074/jbc.273.51.34190; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; Cornelius F, 1998, BIOCHEMISTRY-US, V37, P16686, DOI 10.1021/bi981571v; Daly SE, 1997, J BIOL CHEM, V272, P6341, DOI 10.1074/jbc.272.10.6341; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; FAHN S, 1966, J BIOL CHEM, V241, P1882; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; Fedosova NU, 1998, BIOCHEMISTRY-US, V37, P13634, DOI 10.1021/bi980703h; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; FUKUSHIMA Y, 1978, J BIOL CHEM, V253, P6853; GIRARDET JL, 1993, EUR J BIOCHEM, V217, P225, DOI 10.1111/j.1432-1033.1993.tb18237.x; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; GREEN NM, 1992, ACTA PHYSIOL SCAND, V146, P59; HARLOW E, 1988, ANTIBODIES LAB MANUA, P509; HARRIS SL, 1991, J BIOL CHEM, V266, P24439; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Jorgensen PL, 1997, ANN NY ACAD SCI, V834, P161, DOI 10.1111/j.1749-6632.1997.tb52248.x; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1985, BIOCHIM BIOPHYS ACTA, V821, P319, DOI 10.1016/0005-2736(85)90102-6; Karlish SJD, 1997, ANN NY ACAD SCI, V834, P30, DOI 10.1111/j.1749-6632.1997.tb52223.x; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; KARLISH SJD, 1998, ACTA PHYSL SCAND, V163, P89; KOSO VN, 1997, BIOCHEMISTRY-US, V36, P8045; MAUNSBACH AB, 1991, SOC GEN PHY, V46, P159; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; OHTA T, 1986, P NATL ACAD SCI USA, V83, P2071, DOI 10.1073/pnas.83.7.2071; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P111, DOI 10.1016/0014-5793(87)81253-X; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; PLATIS IE, 1993, BIOCHEMISTRY-US, V32, P12761, DOI 10.1021/bi00210a027; POST RL, 1975, J BIOL CHEM, V250, P691; RANA TM, 1991, P NATL ACAD SCI USA, V88, P10578, DOI 10.1073/pnas.88.23.10578; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Smirnova IN, 1998, FEBS LETT, V431, P309, DOI 10.1016/S0014-5793(98)00760-1; Stokes DL, 1998, ACTA PHYSIOL SCAND, V163, P35; SWEADNER KJ, 1988, METHOD ENZYMOL, V156, P65; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TRAN CM, 1994, J BIOL CHEM, V269, P6558; TRAN CM, 1994, BIOCHEMISTRY-US, V33, P4140, DOI 10.1021/bi00180a006; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	53	40	40	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16213	16221		10.1074/jbc.274.23.16213	http://dx.doi.org/10.1074/jbc.274.23.16213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347176	hybrid			2022-12-27	WOS:000080668600036
J	Sarafova, S; Siu, G				Sarafova, S; Siu, G			A potential role for Elf-1 in CD4 promoter function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DEVELOPMENT; TRANSGENIC MICE; DNA-BINDING; TRANSCRIPTION FACTOR; POSITIVE SELECTION; ANTIGEN RECEPTOR; LYMPHOCYTE DEVELOPMENT; NEGATIVE SELECTION; LINEAGE COMMITMENT; GENE-EXPRESSION	The control of CD4 gene expression is believed to be linked directly to the signaling events that mediate T cell development and is directly dependent on the CD4 promoter. We have previously determined that this promoter contains four factor-binding sites important for its function. One of these sites, referred to as the P4 site, contains an Ets consensus recognition sequence. Using functional and biochemical analyses, we determine that Elf-1 binds to this site and specifically activates the CD4 promoter, indicating that Elf-1 is playing an important role in CD4 promoter function. In addition, a second nuclear factor binds to this region. Although there are consensus recognition sites for other factors, we demonstrate that none of these factors binds to the P4 site, nor do other known members of the Ets family. Thus, a novel transcription factor may bind to the CD4 promoter and help mediate its function.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University	Siu, G (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	siu@cusiu3.cpmc.columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034925] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI34925] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BOSSELUT R, 1993, NUCLEIC ACIDS RES, V21, P5184, DOI 10.1093/nar/21.22.5184; Bruniquel D, 1997, IMMUNOGENETICS, V47, P96, DOI 10.1007/s002510050332; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Davis JN, 1996, GENE, V171, P265, DOI 10.1016/0378-1119(96)00013-3; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; GEGONNE A, 1992, NEW BIOL, V4, P512; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; GOYAL N, 1990, MOL CELL BIOL, V10, P1041, DOI 10.1128/MCB.10.3.1041; HUARD B, 1994, IMMUNOGENETICS, V39, P213; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KRUISBEEK AM, 1985, J EXP MED, V161, P1029, DOI 10.1084/jem.161.5.1029; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANCKI DW, 1983, J EXP MED, V157, P921, DOI 10.1084/jem.157.3.921; LEIDEN JM, 1992, IMMUNOL TODAY, V13, P22, DOI 10.1016/0167-5699(92)90200-Q; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.iy.05.040187.003021; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; ManzanoWinkler B, 1996, J BIOL CHEM, V271, P12076, DOI 10.1074/jbc.271.20.12076; Miyazaki Y, 1996, ONCOGENE, V13, P1721; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Oettgen P, 1996, MOL CELL BIOL, V16, P5091; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERLMUTTER RM, 1993, CLIN IMMUNOL IMMUNOP, V67, pS44, DOI 10.1006/clin.1993.1083; PERLMUTTER RM, 1989, BIOCHIM BIOPHYS ACTA, V948, P245, DOI 10.1016/0304-419X(89)90001-2; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SALMON P, 1993, P NATL ACAD SCI USA, V90, P7739, DOI 10.1073/pnas.90.16.7739; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WATERMAN M L, 1990, New Biologist, V2, P621; Wilkinson DA, 1997, LEUKEMIA, V11, P86, DOI 10.1038/sj.leu.2400516; WURSTER AL, 1994, MOL CELL BIOL, V14, P6452, DOI 10.1128/MCB.14.10.6452; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	64	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16126	16134		10.1074/jbc.274.23.16126	http://dx.doi.org/10.1074/jbc.274.23.16126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347164	hybrid			2022-12-27	WOS:000080668600024
J	Hipfner, DR; Mao, QC; Qiu, W; Leslie, EM; Gao, M; Deeley, RG; Cole, SPC				Hipfner, DR; Mao, QC; Qiu, W; Leslie, EM; Gao, M; Deeley, RG; Cole, SPC			Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP - Localization of their epitopes to the nucleotide-binding domains of the protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-TUMOR-CELLS; MOUSE P-GLYCOPROTEIN; HUMAN LUNG-CANCER; LEUKOTRIENE C-4; VINCRISTINE TRANSPORT; CASSETTE TRANSPORTER; MEMBRANE-VESICLES; EXPORT PUMP; EFFLUX PUMP; ATP	Multidrug resistance in tumor cells is often accompanied by overexpression of multidrug resistance protein (MRP), a 190-kDa transmembrane protein that belongs to the ATP-binding cassette superfamily of transport proteins. MRP mediates ATP-dependent transport of a variety of conjugated organic anions and can also transport several unmodified xenobiotics in a glutathione-dependent manner. To facilitate structure-function studies of MRP, we have generated a panel of MRP-specific monoclonal antibodies (mAbs), Four of these mAbs, QCRL-2, -3, -4, and -6, bind intracellular conformation-dependent epitopes, and we have shown that they can inhibit the transport of several MRP substrates, Binding competition and immunoprecipitation assays indicated that mAbs QCRL-4 and -6 probably recognize the same detergent-sensitive epitope in MRP, whereas mAbs QCRL-2, -3, and -4 each bind distinct, non-overlapping epitopes, Fab fragments inhibit transport as effectively as the intact mAbs, suggesting that inhibition results from direct interactions of the mAbs with MRP, Immunodot blot and immunoprecipitation analyses revealed that the minimal regions of MRP sufficient for full reactivity of mAbs QCRL-2 and -3 are amino acids 617-858 and 617-932, respectively, which encompass the NH2-proximal nucleotide-binding domain (NBD), In contrast, the epitope bound by mAb QCRL-4 localized to amino acids 1294-1531, a region that contains the COOH-proximal NBD. However, none of the mAbs inhibited photo-labeling of intact MRP with 8-azido-[alpha-P-32]ATP. This suggests that rather than preventing nucleotide binding, the mAbs inhibit transport by interfering with substrate binding or by trapping MRP in a conformation that does not allow transport to occur. Our results also demonstrate for the first time that the NBDs of MRP can be expressed as soluble polypeptides that retain a native conformation.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall, Kingston, ON K7L 3N6, Canada.		Cole, Susan P.C./I-6389-2017; Deeley, Roger/J-4828-2012	Cole, Susan P.C./0000-0001-6571-6884; Leslie, Elaine/0000-0003-1825-348X				Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; ALMQUIST KC, 1995, CANCER RES, V55, P102; ARCECI RJ, 1993, CANCER RES, V53, P310; Barnouin K, 1998, BRIT J CANCER, V77, P201, DOI 10.1038/bjc.1998.34; BAUBICHONCORTAY H, 1994, J BIOL CHEM, V269, P22983; Chan HSL, 1997, J LAB CLIN MED, V130, P297, DOI 10.1016/S0022-2143(97)90025-1; Chan HSL, 1997, CANCER RES, V57, P2325; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; Dayan G, 1996, J BIOL CHEM, V271, P11652, DOI 10.1074/jbc.271.20.11652; DEELEY RG, 1997, MOL GENETICS DRUG RE, P247; Filipits M, 1997, BRIT J CANCER, V75, P208, DOI 10.1038/bjc.1997.35; Filipits M, 1997, CLIN CANCER RES, V3, P1419; FLENS MJ, 1994, CANCER RES, V54, P4557; Flens MJ, 1996, AM J PATHOL, V148, P1237; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; GEORGES E, 1991, J CELL PHYSIOL, V148, P479, DOI 10.1002/jcp.1041480321; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; GRANT CE, 1994, CANCER RES, V54, P357; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; HIPFNER DR, 1994, CANCER RES, V54, P5788; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Ito K, 1998, ONCOL RES, V10, P99; Jedlitschky G, 1996, CANCER RES, V56, P988; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KO YH, 1995, J BIOL CHEM, V270, P22093, DOI 10.1074/jbc.270.38.22093; Kokubu N, 1997, BIOCHEM BIOPH RES CO, V230, P398, DOI 10.1006/bbrc.1996.5970; LEIER I, 1994, EUR J BIOCHEM, V220, P599, DOI 10.1111/j.1432-1033.1994.tb18661.x; LEIER I, 1994, J BIOL CHEM, V269, P27807; LINCKE CR, 1990, CANCER RES, V50, P1779; Loe DW, 1997, MOL PHARMACOL, V51, P1034, DOI 10.1124/mol.51.6.1034; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; MEYERS MB, 1989, CANCER RES, V49, P3209; MIRSKI SEL, 1987, CANCER RES, V47, P2594; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; SHARMA S, 1995, J BIOL CHEM, V270, P14085, DOI 10.1074/jbc.270.23.14085; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Stride BD, 1996, MOL PHARMACOL, V49, P962; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wright SR, 1998, CLIN CANCER RES, V4, P2279; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822	55	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15420	15426		10.1074/jbc.274.22.15420	http://dx.doi.org/10.1074/jbc.274.22.15420			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336431	hybrid			2022-12-27	WOS:000080560100020
J	Mori, K; Ogawa, Y; Ebihara, K; Tamura, N; Tashiro, K; Kuwahara, T; Mukoyama, M; Sugawara, A; Ozaki, S; Tanaka, I; Nakao, K				Mori, K; Ogawa, Y; Ebihara, K; Tamura, N; Tashiro, K; Kuwahara, T; Mukoyama, M; Sugawara, A; Ozaki, S; Tanaka, I; Nakao, K			Isolation and characterization of CA XIV, a novel membrane-bound carbonic anhydrase from mouse kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL SEQUENCE TRAP; MOLECULAR-CLONING; II DEFICIENCY; CDNA CLONING; EXPRESSION; RECEPTOR; PROTEIN; LOCALIZATION; IV; EFFICIENT	Carbonic anhydrase (CA) is involved in various physiological processes such as acid-base balance and transport of carbon dioxide and ions. In this study, we have succeeded in the isolation of a novel CA from the mouse kidney by use of the signal sequence trap method. It is a 337-amino acid polypeptide with a calculated molecular mass of 37.5 kDa, consisting of a putative amino-terminal signal sequence, a CA domain, a transmembrane domain, and a short hydrophilic carboxyl terminus, which we designated CA XIV.(1) The CA domain of CA XIV is highly homologous with those of known CAs, especially extracellular CAs including CA XII, IX, VI, and IV. The expression study of an epitope-tagged protein has suggested that CA XIV is located on the plasma membrane. When expressed in COS-7 cells, CA XIV exhibits CA activity that is predominantly associated with the membrane fraction. By Northern blot analysis, the gene expression of CA XIV is most abundant in the kidney and heart, followed by the skeletal muscle, brain, lung, and liver. In situ hybridization has revealed that, in the kidney, the gene is expressed intensely in the proximal convoluted tubule, which is the major segment for bicarbonate reabsorption and also in the outer border of the inner stripe of the outer medulla. In conclusion, we have cloned a functional cDNA encoding a novel membrane-bound CA. This study will bring new insights into our understanding of carbon dioxide metabolism and acid-base balance.	Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto, Japan; Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068057, Japan; Saiseikai Nakatsu Hosp, Dept Nephrol, Kita Ku, Osaka 5300012, Japan	Kyoto University; Kyoto University	Ogawa, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, 54 Shogoin Kawahara cho, Kyoto, Japan.	ogawa@kuhp.kyoto-u.ac.jp	Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351; Ogawa, Yoshihiro/0000-0002-0834-2836				ALPERN RJ, 1996, BRENNER RECTORS KIDN, P408; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; BROWN D, 1983, AM J PHYSIOL, V245, pF110, DOI 10.1152/ajprenal.1983.245.1.F110; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOBYAN DC, 1982, ANAT REC, V204, P185, DOI 10.1002/ar.1092040303; FERNLEY RT, 1988, BIOCHEMISTRY-US, V27, P2815, DOI 10.1021/bi00408a023; FLEMING RE, 1993, AM J PHYSIOL, V265, pL627, DOI 10.1152/ajplung.1993.265.6.L627; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mori K, 1997, FEBS LETT, V401, P218, DOI 10.1016/S0014-5793(96)01473-1; Mori K, 1997, FEBS LETT, V417, P371, DOI 10.1016/S0014-5793(97)01325-2; NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872; Nei M., 1987, MOL EVOLUT GENET, P293; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OKUYAMA T, 1992, P NATL ACAD SCI USA, V89, P1315, DOI 10.1073/pnas.89.4.1315; PASTOREK J, 1994, ONCOGENE, V9, P2877; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; RIDDERSTRALE Y, 1992, J HISTOCHEM CYTOCHEM, V40, P1665, DOI 10.1177/40.11.1431055; SCHWARTZ MM, 1974, KIDNEY INT, V6, pA93, DOI 10.1038/ki.1974.101; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; SPICER SS, 1979, J HISTOCHEM CYTOCHEM, V27, P820, DOI 10.1177/27.4.109495; SUGIMOTO Y, 1994, AM J PHYSIOL, V266, pF823, DOI 10.1152/ajprenal.1994.266.5.F823; SUNDARAM V, 1986, AM J HUM GENET, V38, P125; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TASHIAN RE, 1992, ADV GENET, V30, P321, DOI 10.1016/S0065-2660(08)60323-5; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tashiro K, 1997, Methods Mol Biol, V69, P203; Tsuruoka S, 1998, AM J PHYSIOL-RENAL, V274, pF259, DOI 10.1152/ajprenal.1998.274.2.F259; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; ZHU XL, 1990, J BIOL CHEM, V265, P8795	43	106	110	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15701	15705		10.1074/jbc.274.22.15701	http://dx.doi.org/10.1074/jbc.274.22.15701			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336468	hybrid			2022-12-27	WOS:000080560100057
J	Shimamoto, N				Shimamoto, N			One-dimensional diffusion of proteins along DNA - Its biological and chemical significance revealed by single-molecule measurements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							REPRESSOR-OPERATOR INTERACTION; COLI RNA-POLYMERASE; RESTRICTION-ENDONUCLEASE ECORI; IRRADIATED ESCHERICHIA-COLI; INITIATED EXCISION REPAIR; LAC REPRESSOR; LINEAR DIFFUSION; FACILITATED DIFFUSION; ASSOCIATION KINETICS; DRIVEN MECHANISMS	Evidence for sliding of proteins along DNA has been provided by many kinetic studies, but single-molecule-based measurements have uncovered distinct problems, the solutions of which may lead us to an understanding of new mechanisms for gene regulation. Furthermore, they reveal a deep problem lying between chemistry and physics regarding the seemingly simple binding between DNA and protein. Single-molecule dynamics provides a tool to solve this problem without prejudgments or unsound assumptions.	Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Shimamoto, N (corresponding author), Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan.		Shimamoto, Nobuo/AAJ-4999-2020	Shimamoto, Nobuo/0000-0001-7579-0084				BARKLEY MD, 1981, BIOCHEMISTRY-US, V20, P3833, DOI 10.1021/bi00516a026; BELINTSEV BN, 1980, NUCLEIC ACIDS RES, V8, P1391, DOI 10.1093/nar/8.6.1391; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1978, BIOPHYS CHEM, V8, P271, DOI 10.1016/0301-4622(78)80010-6; BERG OG, 1982, BIOPHYS CHEM, V15, P41, DOI 10.1016/0301-4622(82)87015-4; Berkhout B, 1996, J BIOL CHEM, V271, P1837, DOI 10.1074/jbc.271.4.1837; EHBRECHT HJ, 1985, J BIOL CHEM, V260, P6160; FICKERT R, 1992, J MOL BIOL, V226, P59, DOI 10.1016/0022-2836(92)90124-3; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GRUSKIN EA, 1988, J BIOL CHEM, V263, P12738; GRUSKIN EA, 1988, J BIOL CHEM, V263, P12728; Hsieh M, 1997, J BIOL CHEM, V272, P22092, DOI 10.1074/jbc.272.35.22092; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; JELTSCH A, 1994, BIOCHEMISTRY-US, V33, P10215, DOI 10.1021/bi00200a001; Jeltsch A, 1996, EMBO J, V15, P5104, DOI 10.1002/j.1460-2075.1996.tb00891.x; JELTSCH A, 1993, ANAL BIOCHEM, V213, P234, DOI 10.1006/abio.1993.1415; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; KHOURY AM, 1990, BIOCHIM BIOPHYS ACTA, V1087, P55, DOI 10.1016/0167-4781(90)90120-Q; KIM JG, 1987, J MOL BIOL, V196, P149, DOI 10.1016/0022-2836(87)90517-1; LANGOWSKI J, 1983, NUCLEIC ACIDS RES, V11, P501, DOI 10.1093/nar/11.2.501; LEE SP, 1995, BIOCHEMISTRY-US, V34, P10215, DOI 10.1021/bi00032a015; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; LLOYD RS, 1980, NUCLEIC ACIDS RES, V8, P5113, DOI 10.1093/nar/8.21.5113; LOHMAN TM, 1978, BIOPHYS CHEM, V8, P281, DOI 10.1016/0301-4622(78)80011-8; NARDONE G, 1986, J BIOL CHEM, V261, P2128; PARK CS, 1982, J BIOL CHEM, V257, P6944; RICCHETTI M, 1988, P NATL ACAD SCI USA, V85, P4610, DOI 10.1073/pnas.85.13.4610; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; SCHUCK P, 1997, ANNU REV BIOPH BIOM, V26, P539; SHIMAMOTO N, 1992, STRUCTURAL TOOLS ANA, P241; SINGER P, 1987, J BIOL CHEM, V262, P14178; SINGER PT, 1988, J BIOL CHEM, V263, P4208; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2209, DOI 10.1021/bi951884f; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; van Noort SJT, 1998, BIOPHYS J, V74, P2840, DOI 10.1016/S0006-3495(98)77991-3; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WASHIZU M, 1995, IEEE T IND APPL, V31, P447, DOI 10.1109/28.382102; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Yang SW, 1995, EMBO J, V14, P6292, DOI 10.1002/j.1460-2075.1995.tb00319.x	44	138	139	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15293	15296		10.1074/jbc.274.22.15293	http://dx.doi.org/10.1074/jbc.274.22.15293			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336412	hybrid			2022-12-27	WOS:000080560100001
J	Budhram-Mahadeo, V; Morris, PJ; Smith, MD; Midgley, CA; Boxer, LM; Latchman, DS				Budhram-Mahadeo, V; Morris, PJ; Smith, MD; Midgley, CA; Boxer, LM; Latchman, DS			p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NEURONAL CELLS; FUNCTIONAL-ANALYSIS; HUMAN NEUROBLASTOMA; ESTROGEN-RECEPTOR; RESPONSE ELEMENT; ALPHA-INTERNEXIN; CELLULAR DEATH; APOPTOSIS; GROWTH	The Brn-3a POU family transcription factor has been shown to strongly activate expression of the Bcl-2 protooncogene and thereby protect neuronal cells from programmed cell death (apoptosis), This activation of the Bcl-2 promoter by Brn-3a is strongly inhibited by the p53 anti-oncogene protein. This inhibitory effect of p53 on Brn-3a-mediated transactivation is observed with nonoverlapping gene fragments containing either the Bcl-2 pi or p2 promoters but is not observed with other Brn-3a-activated promoters such as in the gene encoding alpha-internexin or with an isolated Bm-Sa binding site from the Bcl-2 promoter linked to a heterologous promoter. In contrast, p53 mutants, which are incapable of binding to DNA, do not affect Brn-3a-mediated activation of the Bcl-2 pi and p2 promoters. Moreover, Brn-3a and p53 have been shown to bind to adjacent sites in the p2 promoter and to directly interact with one another, both in vitro and in vivo, with this interaction being mediated by the POU domain of Brn-3a and the DNA binding domain of p53, The significance of these effects is discussed in terms of the antagonistic effects of Bcl-2 and p53 on the rate of apoptosis and the overexpression of Brn-3a in specific tumor cell types.	UCL, Sch Med, Windeyer Inst Med Sci, Dept Mol Pathol, London W1P 6DB, England; Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland; Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA	University of London; University College London; UCL Medical School; University of Dundee; Stanford University	Latchman, DS (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Dept Mol Pathol, Windeyer Bldg,46 Cleveland St, London W1P 6DB, England.	windinst@ucl.ac.uk						Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; BANIAHMAD C, 1995, MOL ENDOCRINOL, V9, P34, DOI 10.1210/me.9.1.34; Budhram-Mahadeo V, 1998, MOL CELL BIOL, V18, P1029, DOI 10.1128/MCB.18.2.1029; BUDHRAMMAHADEO V, 1995, J BIOL CHEM, V270, P2853, DOI 10.1074/jbc.270.6.2853; CHEN HM, 1995, MOL CELL BIOL, V15, P3840; CHING GY, 1991, J BIOL CHEM, V266, P19459; CHIOU SK, 1994, MOL CELL BIOL, V14, P2556, DOI 10.1128/MCB.14.4.2556; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; GORMAN CM, 1985, DNA CLONING PRACTICA, P143; Harn HJ, 1996, HISTOPATHOLOGY, V28, P317, DOI 10.1046/j.1365-2559.1996.d01-431.x; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hoehner JC, 1997, BRIT J CANCER, V75, P1185, DOI 10.1038/bjc.1997.203; HOEHNER JC, 1995, INT J CANCER, V62, P19, DOI 10.1002/ijc.2910620106; Ibrahim AP, 1997, BBA-GENE STRUCT EXPR, V1350, P306, DOI 10.1016/S0167-4781(96)00170-4; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Latchman DS, 1997, INT J ONCOL, V10, P1133; LeblondFrancillard M, 1997, J CLIN ENDOCR METAB, V82, P89, DOI 10.1210/jc.82.1.89; Lee WY, 1996, ANTICANCER RES, V16, P3007; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LILLYCROP KA, 1992, NUCLEIC ACIDS RES, V20, P5093, DOI 10.1093/nar/20.19.5093; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; MORRIS PJ, 1994, MOL CELL BIOL, V14, P6907, DOI 10.1128/MCB.14.10.6907; Ndisdang D, 1998, J CLIN INVEST, V101, P1687, DOI 10.1172/JCI1089; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Oue T, 1996, J PEDIATR SURG, V31, P251, DOI 10.1016/S0022-3468(96)90009-3; PARK DJ, 1994, ONCOGENE, V9, P1899; REED JC, 1991, CANCER RES, V51, P6529; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Smith MD, 1996, INT J CANCER, V67, P653; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Smith MD, 1998, NUCLEIC ACIDS RES, V26, P4100, DOI 10.1093/nar/26.18.4100; THEIL T, 1993, NUCLEIC ACIDS RES, V21, P5921, DOI 10.1093/nar/21.25.5921; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Wang TTY, 1997, CANCER LETT, V116, P61, DOI 10.1016/S0304-3835(97)00175-4; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084	40	128	128	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15237	15244		10.1074/jbc.274.21.15237	http://dx.doi.org/10.1074/jbc.274.21.15237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329733	hybrid			2022-12-27	WOS:000081965200098
J	He, GP; Kim, SW; Ro, HS				He, GP; Kim, SW; Ro, HS			Cloning and characterization of a novel zinc finger transcriptional repressor - A direct role of the zinc finger motif in repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER BINDING-PROTEIN; GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; FACTOR EGR-1; P2 GENE; KRUPPEL; CELLS; DOMAINS; DNA; YY1	We have identified a novel transcriptional repressor, AEBP2, that binds to a regulatory sequence (termed AE-1) located in the proximal promoter region of the aP2 gene that encodes the adipose fatty acid-binding protein. Sequence analysis of AEBP2 cDNA revealed that it encodes a protein containing three Gli-Kruppel (Cys(2)-His(2))-type zinc fingers. Northern blot analysis revealed two transcripts (4.5 and 3.5 kilobases) which were ubiquitously expressed in every mouse tissue examined. In co-transfection assays, AEBP2 repressed transcription from the homologous aP2 promoter containing multiple copies of the AE-1 sequence. Moreover, a chimeric construct encoding a fusion AEBP2 protein with the Gal4 DNA-binding domain was able to repress the transcriptional activity of a heterologous promoter containing the Gal4-binding sequence. The transcriptional repression function of AEBP2 was completely abolished when one of the conserved histidine residues and a flanking serine residue in the middle zinc finger were replaced with an arginine residue. The defective transcriptional repression function of the mutant derivative was due neither to lack of expression nor to a failure to localize to the nucleus. Moreover, both the wild-type and mutant derivative of either the histidine-tagged recombinant AEBP2 proteins or the in vitro translated Gal4-AEBP2 fusion proteins were equally able to bind to the target DNA. These results suggest that a portion of the zinc finger structure may play a direct role in transcriptional repression function, but not in DNA binding.	Dalhousie Univ, Fac Med, Dept Biochem, Halifax, NS B3H 4H7, Canada	Dalhousie University	Ro, HS (corresponding author), Dalhousie Univ, Fac Med, Dept Biochem, Sir Charles Tupper Med Bldg, Halifax, NS B3H 4H7, Canada.			Ro, Hyo-Sung/0000-0003-4411-0386				BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jiang SW, 1996, J BIOL CHEM, V271, P9510, DOI 10.1074/jbc.271.16.9510; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ostling J, 1996, MOL CELL BIOL, V16, P753; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; RO HS, 1991, MOL CELL BIOL, V11, P2303, DOI 10.1128/MCB.11.4.2303; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Seyfert VL, 1996, ONCOGENE, V12, P2331; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P22143, DOI 10.1074/jbc.270.38.22143; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; XU L, 1994, NUCLEIC ACIDS RES, V22, P646, DOI 10.1093/nar/22.4.646; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	34	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14678	14684		10.1074/jbc.274.21.14678	http://dx.doi.org/10.1074/jbc.274.21.14678			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329662	hybrid			2022-12-27	WOS:000081965200027
J	Varlamov, O; Eng, FJ; Novikova, EG; Fricker, LD				Varlamov, O; Eng, FJ; Novikova, EG; Fricker, LD			Localization of metallocarboxypeptidase D in AtT-20 cells - Potential, role in prohormone processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B VIRUS-PARTICLES; IMMATURE SECRETORY GRANULES; TRANS-GOLGI NETWORK; OBESE FAT/FAT MICE; CARBOXYPEPTIDASE-E; INTRACELLULAR TRAFFICKING; MEMBRANE-PROTEIN; ENZYME-ACTIVITY; FAT MUTATION; VESICLES	Carboxypeptidase D (CPD) is a recently discovered metallocarboxypeptidase that is predominantly located in the trans-Golgi network (TGN), and also cycles between the cell surface and the TGN. In the present study, the intracellular distribution of CPD was examined in AtT-20 cells, a mouse anterior pituitary-derived corticotroph. CPD-containing compartments were isolated using antibodies to the CPD cytosolic tail. The immunopurified vesicles contained TGN proteins (TGN38, furin, syntaxin 6) but not lysosomal or plasma membrane proteins. The CPD containing vesicles also contained neuropeptide-processing enzymes and adrenocorticotropic hormone, a product of proopiomelanocortin proteolysis. Electron microscopic analysis revealed that CPD is present within the TGN and immature secretory granules but is virtually absent from mature granules, suggesting that CPD is actively removed from the regulated pathway during the process of granule maturation. A second major finding of the present study is that a soluble truncated form of CPD is secreted mainly via the constitutive pathway in AtT-20 cells, indicating that the lumenal domain does not contain signals for the sorting of CPD to mature secretory granules. Taken together, these data are consistent with the proposal that CPD participates in the processing of proteins within the TGN and immature secretory vesicles.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000194] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA-00194] Funding Source: Medline; NIDDK NIH HHS [R01 DK-51271] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cain BM, 1997, ENDOCRINOLOGY, V138, P4034, DOI 10.1210/en.138.9.4034; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; DOCHERTY K, 1983, FEBS LETT, V162, P137, DOI 10.1016/0014-5793(83)81065-5; Dong W, 1999, NEUROSCIENCE, V89, P1301, DOI 10.1016/S0306-4522(98)00381-9; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; Fan XM, 1999, DNA CELL BIOL, V18, P121, DOI 10.1089/104454999315501; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; Fricker LD, 1996, J BIOL CHEM, V271, P30619, DOI 10.1074/jbc.271.48.30619; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; FRICKER LD, 1991, PEPTIDE BIOSYNTHESIS, P199; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; GUEST PC, 1991, ENDOCRINOLOGY, V129, P734, DOI 10.1210/endo-129-2-734; Hohl I, 1996, J CELL SCI, V109, P2539; HOOK VYH, 1984, P NATL ACAD SCI-BIOL, V81, P2776, DOI 10.1073/pnas.81.9.2776; HORNBY PJ, 1993, NEUROENDOCRINOLOGY, V58, P555, DOI 10.1159/000126590; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; KOEDAM JA, 1992, J CELL BIOL, V116, P617, DOI 10.1083/jcb.116.3.617; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; KUROKI K, 1994, J VIROL, V68, P2091, DOI 10.1128/JVI.68.4.2091-2096.1994; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MATSUUCHI L, 1988, J CELL BIOL, V106, P239, DOI 10.1083/jcb.106.2.239; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILGRAM SL, 1994, J CELL SCI, V107, P737; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; Rovere C, 1996, ENDOCRINOLOGY, V137, P2954, DOI 10.1210/en.137.7.2954; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SETTLE SH, 1995, P NATL ACAD SCI USA, V92, P9470, DOI 10.1073/pnas.92.21.9470; SHENNAN KIJ, 1995, J BIOL CHEM, V270, P1402, DOI 10.1074/jbc.270.3.1402; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Song LX, 1996, J BIOL CHEM, V271, P28884, DOI 10.1074/jbc.271.46.28884; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Thorens B, 1996, J CELL SCI, V109, P1311; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Udupi V, 1997, ENDOCRINOLOGY, V138, P1959, DOI 10.1210/en.138.5.1959; Varlamov O, 1998, J CELL SCI, V111, P877; Varlamov O, 1996, J BIOL CHEM, V271, P13981, DOI 10.1074/jbc.271.24.13981; Xin XN, 1997, DNA CELL BIOL, V16, P897, DOI 10.1089/dna.1997.16.897; ZHOU A, 1993, J BIOL CHEM, V268, P1763	49	67	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14759	14767		10.1074/jbc.274.21.14759	http://dx.doi.org/10.1074/jbc.274.21.14759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329672	hybrid			2022-12-27	WOS:000081965200037
J	Grossberger, R; Gieffers, C; Zachariae, W; Podtelejnikova, AV; Schleiffer, A; Nasmyth, K; Mann, M; Peters, JM				Grossberger, R; Gieffers, C; Zachariae, W; Podtelejnikova, AV; Schleiffer, A; Nasmyth, K; Mann, M; Peters, JM			Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; END RULE PATHWAY; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; RECOGNITION COMPONENT; MEDIATES ASSOCIATION; POLYACRYLAMIDE GELS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MITOTIC SPINDLE	The anaphase-promoting complex/cyclosome (APC) is a ubiquitin-protein ligase whose activity is essential for progression through mitosis. The vertebrate APC is thought to be composed of 8 subunits, whereas in budding yeast several additional APC-associated proteins have been identified, including a 33-kDa protein called Doc1 or Apc10, Here, we show that Doc1/Apc10 is a subunit of the yeast APC throughout the cell cycle. Mutation of Doc1/Apc10 inactivates the APC without destabilizing the complex, An ortholog of Doc1/Apc10, which we call APC10, is associated with the APC in different vertebrates, including humans and frogs. Biochemical fractionation experiments and mass spectrometric analysis of a component of the purified human APC show that APC10 is a genuine APC subunit whose cellular levels or association with the APC are not cell cycle-regulated, We have further identified an APC10 homology region, which we propose to call the DOC domain, in several protein sequences that also contain either cullin or HECT domains. Cullins are present in several ubiquitination complexes including the APC, whereas HECT domains represent the catalytic core of a different type of ubiquitin-protein ligase, DOC domains may therefore be important for reactions catalyzed by several types of ubiquitin-protein ligases.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Odense Univ, Univ So Denmark, Prot Interact Lab, DK-5230 Odense M, Denmark	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Southern Denmark	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799; Nasmyth, Kim/0000-0001-7030-4403; Schleiffer, Alexander/0000-0001-6251-2747				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; HUIBREGTSE JM, 1998, UBIQUITIN BIOL CELL, P323; Hwang LH, 1997, MOL BIOL CELL, V8, P1877, DOI 10.1091/mbc.8.10.1877; IMIGER S, 1995, CELL, V81, P269; IRNIGER S, 1998, CELL, V93; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kominami K, 1998, EMBO J, V17, P5388, DOI 10.1093/emboj/17.18.5388; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Varshavsky A., 1998, UBIQUITIN BIOL CELL, P223; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Yamada H, 1997, J CELL SCI, V110, P1793; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	62	78	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14500	14507		10.1074/jbc.274.20.14500	http://dx.doi.org/10.1074/jbc.274.20.14500			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318877	hybrid			2022-12-27	WOS:000080322200106
J	Kelm, RJ; Cogan, JG; Elder, PK; Strauch, AR; Getz, MJ				Kelm, RJ; Cogan, JG; Elder, PK; Strauch, AR; Getz, MJ			Molecular interactions between single-stranded DNA-binding proteins associated with all essential MCAT element in the mouse smooth muscle alpha-actin promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN GENE PROMOTER; FAR UPSTREAM ELEMENT; PUR-ALPHA; MESSENGER-RNA; GLIAL-CELLS; Y-BOX; TRANSCRIPTIONAL REGULATION; STIMULATES TRANSCRIPTION; SEQUENCE; YB-1	Transcriptional activity of the mouse vascular smooth muscle alpha-actin gene in fibroblasts is regulated, in part, by a 30-base pair asymmetric polypurine-polypyrimidine tract containing an essential MCAT enhancer motif. The double-stranded form of this sequence serves as a binding site for a transcription enhancer factor 1-related protein while the separated single strands interact with two distinct DNA binding activities termed VACssBF1 and 2 (Cogan, J. G., Sun, S., Stoflet, E. S., Schmidt, L. J., Getz, M. J., and Strauch, A. R. (1995) J, Biol. Chem. 270, 11310-11321; Sun, S., Stoflet, E. S., Cogan, J. G., Strauch, A. R., and Getz, M. J. (1995) Mol.. Cell. Biol. 15, 2429-2936), VACssBF2 has been recently cloned and shown to consist of two closely related proteins, Pur alpha and Pur beta (Kelm, R. J., Elder, P. K., Strauch, A. R., and Getz, M. J, (1997) J. Biol. Chem. 272, 26727-26733). In this study, we demonstrate that Pur alpha and Pur beta interact with each other via highly specific protein-protein interactions and bind to the purine-rich strand of the MCAT enhancer in the form of both homo- and heteromeric complexes. Moreover, both Pur proteins interact with MSY1, a VACssBF1-like protein cloned by virtue of its affinity for the pyrimidine-rich strand of the enhancer. Interactions between Pur alpha, Pur beta, and MSY1 do not require the participation of DNA, Combinatorial interactions between these three single-stranded DNA-binding proteins may be important in regulating activity of the smooth muscle alpha-actin MCAT enhancer in fibroblasts.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Ohio State Univ, Coll Med, Dept Physiol, Columbus, OH 43210 USA	Mayo Clinic; University System of Ohio; Ohio State University	Getz, MJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.				NHLBI NIH HHS [R01 HL54281] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054281] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIOK S, 1993, MOL CELL BIOL, V13, P7303, DOI 10.1128/MCB.13.12.7303; ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; CLOWES AW, 1988, J CELL BIOL, V107, P1939, DOI 10.1083/jcb.107.5.1939; Cogan J. G., 1994, Molecular Biology of the Cell, V5, p164A; COGAN JG, 1995, J BIOL CHEM, V270, P11310, DOI 10.1074/jbc.270.19.11310; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; GROSSMANN ME, 1995, J BIOL CHEM, V270, P10968, DOI 10.1074/jbc.270.18.10968; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; HERAULT Y, 1993, CELL MOL BIOL RES, V39, P717; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Jurk M, 1996, NUCLEIC ACIDS RES, V24, P2799, DOI 10.1093/nar/24.14.2799; Kelm RJ, 1996, J BIOL CHEM, V271, P24278, DOI 10.1074/jbc.271.39.24278; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; MA ZW, 1994, GENE, V149, P311, DOI 10.1016/0378-1119(94)90167-8; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; OZER J, 1990, J BIOL CHEM, V265, P22143; Saito H, 1996, J BIOL CHEM, V271, P8911, DOI 10.1074/jbc.271.15.8911; SAKURA H, 1988, GENE, V73, P499; STOFLET ES, 1992, MOL BIOL CELL, V3, P1073, DOI 10.1091/mbc.3.10.1073; SUN SQ, 1995, MOL CELL BIOL, V15, P2429; TAFURI SR, 1993, J BIOL CHEM, V268, P12213; TAFURI SR, 1992, NEW BIOL, V4, P349; TANUMA Y, 1995, MOL CELL BIOL, V15, P517, DOI 10.1128/MCB.15.1.517; Thatikunta P, 1997, J CELL BIOCHEM, V67, P466, DOI 10.1002/(SICI)1097-4644(19971215)67:4<466::AID-JCB5>3.0.CO;2-Q; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293; ZOU YM, 1995, MOL CELL BIOL, V15, P2972	40	74	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14238	14245		10.1074/jbc.274.20.14238	http://dx.doi.org/10.1074/jbc.274.20.14238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318844	hybrid			2022-12-27	WOS:000080322200073
J	Pigazzi, A; Heydrick, S; Folli, F; Benoit, S; Michelson, A; Loscalzo, J				Pigazzi, A; Heydrick, S; Folli, F; Benoit, S; Michelson, A; Loscalzo, J			Nitric oxide inhibits thrombin-receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BETA-GAMMA-SUBUNITS; LYN TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; P85 SUBUNIT; PI 3-KINASE; INTEGRIN; TRANSLOCATION; ASSOCIATION; BINDING	Although nitric oxide (NO) has potent antiplatelet actions, the signaling pathways affected by NO in the platelet are poorly understood. Since NO can induce platelet disaggregation and phosphoinositide a-kinase (PI3-kinase) activation renders aggregation irreversible, we tested the hypothesis that NO exerts its antiplatelet effects at least in part by inhibiting PI3-kinase; The results demonstrate that the NO donor S-nitrosoglutathione (S-NO-glutathione) inhibits the stimulation of PI3-kinase associated with tyrosine-phosphorylated proteins and of p85/PI3-kinase associated with the SRC family kinase member LYN following the exposure of platelets to thrombin receptor-activating peptide. The activation of LYN-associated PI3-kinase was unrelated to changes in the amount of PI3-kinase physically associated with LYN signaling complexes but did require the activation of LYN and other tyrosine kinases. The cyclic GMP-dependent kinase activator 8-bromo-cyclic GMP had similar effects on PI3-kinase activity, consistent with a model in which the cyclic nucleotide mediates the effects of NO. Additional studies showed that wortmannin and S-NO-glutathione have additive inhibitory effects on thrombin receptor-activating peptide-induced platelet aggregation and the surface expression of platelet activation markers. These data provide evidence of a distinct and novel mechanism for the inhibitory effects of NO on platelet function.	Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; HS Raffaele, Unit Metab Dis, Milan, Italy	Boston University; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Loscalzo, J (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 700 Albany St, Boston, MA 02118 USA.		Michelson, Alan/ABE-8487-2021; Loscalzo, Joseph/ABD-8980-2021; folli, franco/J-2795-2018	Michelson, Alan/0000-0002-1746-4819; folli, franco/0000-0001-9824-5222	NHLBI NIH HHS [HL55993, HL53919, HL48976] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055993, R01HL053919] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; DORAHY DJ, 1995, BIOCHEM J, V309, P481, DOI 10.1042/bj3090481; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; Dorahy DJ, 1996, BIOCHEM BIOPH RES CO, V218, P575, DOI 10.1006/bbrc.1996.0102; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GEIGER J, 1992, P NATL ACAD SCI USA, V89, P1031, DOI 10.1073/pnas.89.3.1031; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; Hazeki O, 1998, LIFE SCI, V62, P1555, DOI 10.1016/S0024-3205(98)00106-4; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; LAM K, 1994, J BIOL CHEM, V269, P20648; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640, DOI 10.1152/ajpheart.1996.270.5.H1640; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; SOTIRELLIS N, 1995, J BIOL CHEM, V270, P29773; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; THOMASON PA, 1994, J BIOL CHEM, V269, P16525; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; YANAGI S, 1994, EUR J BIOCHEM, V224, P329, DOI 10.1111/j.1432-1033.1994.00329.x; YATOMI Y, 1992, BIOCHEM J, V285, P745, DOI 10.1042/bj2850745; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265; ZHANG J, 1992, J BIOL CHEM, V267, P4686	43	71	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14368	14375		10.1074/jbc.274.20.14368	http://dx.doi.org/10.1074/jbc.274.20.14368			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318860	hybrid			2022-12-27	WOS:000080322200089
J	Shifrin, VI; Anderson, P				Shifrin, VI; Anderson, P			Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-II EVALUATION; CANCER STUDY-GROUP; MAMMALIAN-CELLS; POLY(ADP-RIBOSE) POLYMERASE; SIGNALING PATHWAY; T-2 TOXIN; DNA FRAGMENTATION; MAPKAP KINASE-2; INHIBITION; BINDING	The trichothecene family of mycotoxins inhibit protein synthesis by binding to the ribosomal peptidyltransferase site. Inhibitors of the peptidyltransferase reaction (e.g. anisomycin) can trigger a ribotoxic stress response that activates c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinases, components of a signaling cascade that regulates cell survival in response to stress. We have found that selected trichothecenes strongly activate JNK/p38 kinases and induce rapid apoptosis in Jurkat T cells. Although the ability of individual trichothecenes to inhibit protein synthesis and activate JNK/p38 kinases are dissociable, both effects contribute to the induction of apoptosis. Among trichothecenes that strongly activate JNK/p38 kinases, induction of apoptosis increases linearly with inhibition of protein synthesis. Among trichothecenes that strongly inhibit protein synthesis, induction of apoptosis increases linearly with activation of JNK/p38 kinases. Trichothecenes that inhibit protein synthesis without activating JNK/p38 kinases inhibit the function (i.e. activation of JNK/p38 kinases and induction of apoptosis) of apoptotic trichothecenes and anisomycin. Harringtonine, a structurally unrelated protein synthesis inhibitor that competes with trichothecenes (and anisomycin) for ribosome binding, also inhibits the activation of JNK/p38 kinases and induction of apoptosis by trichothecenes and anisomycin. Taken together,these results implicate the peptidyltransferase site as a regulator of both JNK/p38 kinase activation and apoptosis.	Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Anderson, P (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA067929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033660] Funding Source: NIH RePORTER; NCI NIH HHS [CA 67929] Funding Source: Medline; NIAID NIH HHS [AI 33660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER SS, 1984, CANCER TREAT REP, V68, P423; Anderson P, 1997, MICROBIOL MOL BIOL R, V61, P33, DOI 10.1128/.61.1.33-46.1997; Ausbel F.M., 1995, CURRENT PROTOCOLS MO; BALLESTRA J, 1991, TRANSLATION EUKARYOT; Budihardjo II, 1998, MOL CELL BIOCHEM, V178, P245, DOI 10.1023/A:1006808001462; BUKOWSKI R, 1982, CANCER TREAT REP, V66, P381; Cahill MA, 1996, ONCOGENE, V13, P2087; CANNON M, 1976, BIOCHEM J, V160, P137, DOI 10.1042/bj1600137; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Cano E, 1996, ONCOGENE, V12, P805; CARTER CJ, 1976, BIOCHEM J, V154, P171, DOI 10.1042/bj1540171; CASHEL M, 1987, ESCHERICHIA COLI SAL, V2, P1410; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; CROW T, 1990, P NATL ACAD SCI USA, V87, P4490, DOI 10.1073/pnas.87.12.4490; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DESIMONE PA, 1986, AM J CLIN ONCOL-CANC, V9, P187, DOI 10.1097/00000421-198606000-00002; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; GOODWIN JW, 1983, CANCER TREAT REP, V67, P285; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harlow E., 1988, ANTIBODIES LAB MANUA; HOBDEN AN, 1980, BIOCHEM J, V190, P765, DOI 10.1042/bj1900765; Iordanov MS, 1998, J BIOL CHEM, V273, P15794, DOI 10.1074/jbc.273.25.15794; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Iordanov MS, 1998, J BIOL CHEM, V273, P3528, DOI 10.1074/jbc.273.6.3528; JIMENEZ A, 1975, EUR J BIOCHEM, V54, P483, DOI 10.1111/j.1432-1033.1975.tb04160.x; JIMENEZ A, 1975, BIOCHIM BIOPHYS ACTA, V383, P427, DOI 10.1016/0005-2787(75)90312-3; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KOCHI SK, 1993, EXP CELL RES, V208, P296, DOI 10.1006/excr.1993.1249; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEATHERMAN DL, 1993, J PHARMACOL EXP THER, V266, P741; LEATHERMAN DL, 1993, J PHARMACOL EXP THER, V266, P732; LEIST M, 1994, J IMMUNOL, V153, P1778; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Li L., 1994, Yaoxue Xuebao, V29, P667; MIDDLEBROOK JL, 1989, BIOCHEM PHARMACOL, V38, P3103, DOI 10.1016/0006-2952(89)90021-X; MIDDLEBROOK JL, 1989, J PHARMACOL EXP THER, V250, P860; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rudel T, 1998, J IMMUNOL, V160, P7; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Shifrin VI, 1997, J BIOL CHEM, V272, P2957, DOI 10.1074/jbc.272.5.2957; SUGITA M, 1995, ZOOL SCI, V12, P419, DOI 10.2108/zsj.12.419; SYNETOS D, 1986, BIOCHIM BIOPHYS ACTA, V868, P249, DOI 10.1016/0167-4781(86)90061-8; TEJEDOR F, 1985, BIOCHEMISTRY-US, V24, P3667, DOI 10.1021/bi00335a040; THIGPEN JT, 1981, CANCER TREAT REP, V65, P881; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu WP, 1998, MOL CARCINOGEN, V22, P247, DOI 10.1002/(SICI)1098-2744(199808)22:4<247::AID-MC6>3.3.CO;2-P	56	344	358	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13985	13992		10.1074/jbc.274.20.13985	http://dx.doi.org/10.1074/jbc.274.20.13985			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318810	hybrid			2022-12-27	WOS:000080322200039
J	Galvez, T; Parmentier, ML; Joly, C; Malitschek, B; Kaupmann, K; Kuhn, R; Bittiger, H; Froestl, W; Bettler, B; Pin, JP				Galvez, T; Parmentier, ML; Joly, C; Malitschek, B; Kaupmann, K; Kuhn, R; Bittiger, H; Froestl, W; Bettler, B; Pin, JP			Mutagenesis and modeling of the GABA(B) receptor extracellular domain support a Venus flytrap mechanism for ligand binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PUTATIVE PHEROMONE RECEPTORS; AGONIST SELECTIVITY; PROTEIN-STRUCTURE; MULTIGENE FAMILY; PHOSPHOLIPASE-C; ACTIVATION; SPECIFICITY; LEUCINE; SITE	The gamma-aminobutyric acid type B (GABA(B)) receptor is distantly related to the metabotropic glutamate receptor-like family of G-protein-coupled receptors (family 3), Sequence comparison revealed that, like metabotropic glutamate receptors, the extracellular domain of the two GABA(B) receptor splice variants possesses an identical region homologous to the bacterial periplasmic leucine-binding protein (LBP), but lacks the cysteine-rich region common to all other family 3 receptors. A three dimensional model of the LBP-like domain of the GABA(B) receptor was constructed based on the known structure of LBP, This model predicts that four of the five cysteine residues found in this GABA(B) receptor domain are important for its correct folding. This conclusion is supported by analysis of mutations of these Cys residues and a decrease in the thermostability of the binding site after dithiothreitol treatment. Additionally, Ser-246 was found to be critical for CGP64213 binding. Interestingly, this residue aligns with Ser-79 of LBP, which forms a hydrogen bond with the ligand, The mutation of Ser-269 was found to differently affect the affinity of various ligands, indicating that this residue is involved in the selectivity of recognition of GABA(B) re ceptor ligands, Finally, the mutation of two residues, Ser-247 and Gln-312, was found to increase the affinity for agonists and to decrease the affinity for antagonists. Such an effect of point mutations can be explained by the Venus flytrap model for receptor activation. This model proposes that the initial step in the activation of the receptor by agonist results from the closure of the two lobes of the binding domain.	CNRS UPR 9023, INSERM, Ctr Pharmacol Endocrinol Mecanismes Mol Commun Ce, F-34094 Montpellier 5, France; Novartis Pharma AG, Therapuet Area, Nervous Syst, CH-4002 Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Novartis	Pin, JP (corresponding author), CNRS UPR 9023, INSERM, Ctr Pharmacol Endocrinol Mecanismes Mol Commun Ce, 141 Rue Cardonille, F-34094 Montpellier 5, France.		bettler, bernhard/AAO-8018-2020; Parmentier, Marie-Laure/N-9915-2017; Pin, Jean-Philippe/Y-6668-2019	Parmentier, Marie-Laure/0000-0001-6133-3413; Pin, Jean-Philippe/0000-0002-1423-345X; Kaupmann, Klemens/0000-0001-8903-2508; Bettler, Bernhard/0000-0003-0842-8207				BITTIGER H, 1993, TRENDS PHARMACOL SCI, V14, P391, DOI 10.1016/0165-6147(93)90056-P; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; FROESTL W, 1995, J MED CHEM, V38, P3297, DOI 10.1021/jm00017a015; Gomeza J, 1996, MOL PHARMACOL, V50, P923; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; MAO B, 1982, J BIOL CHEM, V257, P1131; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OH BH, 1994, J BIOL CHEM, V269, P4135; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; OLAH GA, 1993, J BIOL CHEM, V268, P16241; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Parmentier ML, 1998, MOL PHARMACOL, V53, P778, DOI 10.1124/mol.53.4.778; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tones MA, 1995, NEUROREPORT, V7, P117, DOI 10.1097/00001756-199512290-00028; WALMSLEY AR, 1992, BIOCHEMISTRY-US, V31, P11175, DOI 10.1021/bi00160a031; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241; WOLF A, 1994, J BIOL CHEM, V269, P23051; WOLF A, 1995, J BIOL CHEM, V270, P16097, DOI 10.1074/jbc.270.27.16097; Wolf A, 1996, J BIOL CHEM, V271, P21243, DOI 10.1074/jbc.271.35.21243	43	166	171	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13362	13369		10.1074/jbc.274.19.13362	http://dx.doi.org/10.1074/jbc.274.19.13362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224098	hybrid			2022-12-27	WOS:000080200400060
J	Lum, L; Wong, BR; Josien, R; Becherer, JD; Erdjument-Bromage, H; Schlondorff, J; Tempst, P; Choi, Y; Blobel, CP				Lum, L; Wong, BR; Josien, R; Becherer, JD; Erdjument-Bromage, H; Schlondorff, J; Tempst, P; Choi, Y; Blobel, CP			Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY FACTOR; T-CELLS; LIGAND; OSTEOPROTEGERIN; DISINTEGRIN; METALLOPROTEINASE; CYTOKINE; DIFFERENTIATION; ACTIVATION; PRECURSOR	Tumor necrosis factor (TNF)-related activation-induced cytokine (TRANCE), a member of the TNF family, is a dendritic cell survival factor and is essential for osteoclastogenesis and osteoclast activation. In this report we demonstrate (i) that TRANCE, like TNF-a, is made as a membrane-anchored precursor, which is released from the plasma membrane by a metalloprotease; (ii) that soluble TRANCE has potent dendritic cell survival and osteoclastogenic activity; (iii) that the metalloprotease-disintegrin TNF-alpha convertase (TACE) can cleave immunoprecipitated TRANCE in vitro in a fashion that mimics the cleavage observed in tissue culture cells; and (iv) that in vitro cleavage of a TRANCE ectodomain/CD8 fusion protein and of a peptide corresponding to the TRANCE cleavage site by TACE occurs at the same site that is used when TRANCE is shed from cells into the supernatant. We propose that the TRANCE ectodomain is released from cells by TACE or a related metalloprotease-disintegrin, and that this release is an important component of the function of TRANCE in bone and immune homeostasis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Tri Inst Cornell Rockefeller Univ, Mem Sloan Kettering Canc Ctr, MD PHD Training Program, New York, NY USA; Glaxo Wellcome Res & Dev Ltd, Dept Mol Biochem, Res Triangle Pk, NC 27709 USA; Rockefeller Univ, Immunobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; GlaxoSmithKline; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Blobel, CP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, 1275 York Ave,Box 368, New York, NY 10021 USA.		Josien, Regis/L-7468-2015; Josien, Regis/U-4405-2019	Josien, Regis/0000-0001-7900-7413; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Schlondorff, Johannes/0000-0002-9973-9731	NIAID NIH HHS [AI44264] Funding Source: Medline; NIGMS NIH HHS [5T32GM07739-17] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BECHERER JD, 1991, J CELL BIOCH G S, V15, P139; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Botos I, 1996, P NATL ACAD SCI USA, V93, P2749, DOI 10.1073/pnas.93.7.2749; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	29	339	356	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13613	13618		10.1074/jbc.274.19.13613	http://dx.doi.org/10.1074/jbc.274.19.13613			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224132	hybrid			2022-12-27	WOS:000080200400094
J	Walker, KW; Bradshaw, RA				Walker, KW; Bradshaw, RA			Yeast methionine aminopeptidase I - Alteration of substrate specificity by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; MYCOBACTERIUM-LEPRAE; AMINO-ACID; PROTEIN; GENE; CLONING; TRANSFORMATION; ORGANIZATION	In eukaryotes, two isozymes (I and II) of methionine aminopeptidase (MetAP) catalyze the removal of the initiator methionine if the penultimate residue has a small radius of gyration (glycine, alanine, serine, threonine, proline, valine, and cysteine), Using site-directed mutagenesis, recombinant yeast MetAP I derivatives that are able to cleave N-terminal methionine from substrates that have larger penultimate residues have been expressed. A Met to Ala change at 329 (Met(206) in Escherichia coli enzyme) produces an average catalytic efficiency Id-fold higher than the native enzyme on normal substrates and cleaves substrates containing penultimate asparagine, glutamine, isoleucine, leucine, methionine, and phenylalanine, Interestingly, the native enzyme also has significant activity with the asparagine peptide not previously identified as a substrate. Mutation of Gln(356) (Gln(233) in E coli MetAP) to alanine results in a catalytic efficiency about one-third that of native with normal substrates but which can cleave methionine from substrates with penultimate histidine, asparagine, glutamine, leucine, methionine, phenylalanine, and tryptophan. Mutation of Ser(195) to alanine had no effect on substrate specificity. None of the altered enzymes produced cleaved substrates with a fully charged residue (lysine, arginine, aspartic acid, or glutamic acid) or tyrosine in the penultimate position.	Univ Calif Irvine, Dept Physiol & Biophys, Coll Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Anat & Neurobiol, Coll Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Bradshaw, RA (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Coll Med, Irvine, CA 92697 USA.		Bradshaw, Ralph A/K-1515-2013		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032465] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32465] Funding Source: Medline; NIGMS NIH HHS [GM18940] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARFIN SM, 1995, P NATL ACAD SCI USA, V92, P7714, DOI 10.1073/pnas.92.17.7714; BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; CHANG YH, 1990, J BIOL CHEM, V265, P19892; CHANG YH, 1992, J BIOL CHEM, V267, P8007; EIGLMEIER K, 1993, MOL MICROBIOL, V7, P197, DOI 10.1111/j.1365-2958.1993.tb01111.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hilbert H, 1996, NUCLEIC ACIDS RES, V24, P628, DOI 10.1093/nar/24.4.628; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KENDALL RL, 1992, J BIOL CHEM, V267, P20667; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Klinkenberg M, 1997, ARCH BIOCHEM BIOPHYS, V347, P193, DOI 10.1006/abbi.1997.0345; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lowther WT, 1998, P NATL ACAD SCI USA, V95, P12153, DOI 10.1073/pnas.95.21.12153; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; MOVVA NR, 1990, MOL GEN GENET, V223, P345; Newton DL, 1998, BIOCHEMISTRY-US, V37, P5173, DOI 10.1021/bi972147h; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; Sensen CW, 1996, MOL MICROBIOL, V22, P175, DOI 10.1111/j.1365-2958.1996.tb02666.x; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Suh JW, 1996, GENE, V169, P17, DOI 10.1016/0378-1119(95)00757-1; Tahirov TH, 1998, J STRUCT BIOL, V121, P68, DOI 10.1006/jsbi.1997.3940; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TSUNASAWA S, 1985, J BIOL CHEM, V260, P5382; Walker KW, 1998, PROTEIN SCI, V7, P2684, DOI 10.1002/pro.5560071224; Walker KW, 1999, BIOTECHNOL APPL BIOC, V29, P157; WU SY, 1993, J BIOL CHEM, V268, P10796; ZUO SL, 1995, MOL GEN GENET, V246, P247, DOI 10.1007/BF00294688	41	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13403	13409		10.1074/jbc.274.19.13403	http://dx.doi.org/10.1074/jbc.274.19.13403			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224104	hybrid			2022-12-27	WOS:000080200400066
J	Bowers, J; Sokolsky, T; Quach, T; Alani, E				Bowers, J; Sokolsky, T; Quach, T; Alani, E			A mutation in the MSH6 subunit of the Saccharomyces cerevisiae MSH2-MSH6 complex disrupts mismatch recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BASE PAIRS; DUPLEX OLIGONUCLEOTIDES; TRANSLOCATION MECHANISM; SPECIFICALLY BINDS; HETERODUPLEX DNA; GENE-PRODUCT; HMUTS-ALPHA; PROTEIN; REPAIR; HETERODIMER	In yeast, MSH2 interacts with MSH6 to repair base pair mismatches and single nucleotide insertion/deletion mismatches and with MSH3 to recognize small loop insertion/deletion mismatches. We identified a msh6 mutation (msh6-F337A) that when overexpressed in wild type strains conferred a defect in both MSH2-MSH6- and MSH2-MSH3-dependent mismatch repair pathways. Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering MSH2 and preventing it from interacting with MSH3 and MSH6. In UV cross-linking, filter binding, and gel retardation assays, the MSH2-msh6-F337A complex displayed a mismatch recognition defect. These observations, in conjunction with ATPase and dissociation rate analysis, suggested that MSH2-msh6-F337A formed an unproductive complex that was unable to stably bind to mismatch DNA.	Cornell Univ, Genet & Dev Sect, Ithaca, NY 14853 USA	Cornell University	Alani, E (corresponding author), Cornell Univ, Genet & Dev Sect, 459 Biotechnol Bldg, Ithaca, NY 14853 USA.	eea3@cornell.edu			NIGMS NIH HHS [GM53085, R01 GM053085] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053085] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Alani E, 1996, MOL CELL BIOL, V16, P5604; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; AU KG, 1992, J BIOL CHEM, V267, P12142; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CROUSE GF, 1996, DNA DAMAGE REPAIR BI, P411; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iaccarino I, 1996, CURR BIOL, V6, P484, DOI 10.1016/S0960-9822(02)00516-X; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Maniatis T., 1982, MOL CLONING; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; REENAN RAG, 1992, GENETICS, V132, P975; Rose MD., 1990, METHODS YEAST GENETI; STRAND M, 1995, P NATL ACAD SCI USA, V92, P10418, DOI 10.1073/pnas.92.22.10418; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; WELSH KM, 1987, J BIOL CHEM, V262, P15624; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985	41	77	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16115	16125		10.1074/jbc.274.23.16115	http://dx.doi.org/10.1074/jbc.274.23.16115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347163	hybrid			2022-12-27	WOS:000080668600023
J	Johnson, RE; Prakash, S; Prakash, L				Johnson, RE; Prakash, S; Prakash, L			Requirement of DNA polymerase activity of yeast Rad30 protein for its biological function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE REPETITIVE SEQUENCES; ESCHERICHIA-COLI DINB; GROUP-D GENE; SACCHAROMYCES-CEREVISIAE; REPAIR; HELICASE; MUTAGENESIS; RECONSTITUTION; MECHANISM; MUTATIONS	The RAD30 gene of Saccharomyces cerevisiae encodes a DNA polymerase, Pol eta, The Rad30 protein shares homology with the yeast Rev1 and the Escherichia coli DinB and UmuC proteins. Although these proteins contain several highly conserved motifs, only Rad30 has been shown to possess a DNA polymerase activity. To determine whether the DNA polymerase activity of Rad30 was essential for its biological function, we made a mutation in the highly conserved SIDE sequence in Rad30, in which the aspartate and glutamate residues have each been changed to alanine. The mutant Rad30 protein lacks the DNA polymerase activity, and the mutant gene does not complement the rad30 Delta mutation. These findings indicate that DNA polymerase activity is indispensable for the biological function of RAD30.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Med Res Bldg,11th & Mechan St, Galveston, TX 77555 USA.		Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	NIGMS NIH HHS [GM19261] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019261] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; GUZDER SN, 1995, J BIOL CHEM, V270, P17660, DOI 10.1074/jbc.270.30.17660; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; McDonald JP, 1997, GENETICS, V147, P1557; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Roush AA, 1998, MOL GEN GENET, V257, P686; Smith BT, 1998, GENETICS, V148, P1599; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755	20	105	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					15975	15977		10.1074/jbc.274.23.15975	http://dx.doi.org/10.1074/jbc.274.23.15975			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347143	hybrid			2022-12-27	WOS:000080668600003
J	Beattie, BK; Merrill, AR				Beattie, BK; Merrill, AR			A fluorescence investigation of the active site of Pseudomonas aeruginosa exotoxin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; HYDROCHLORIDE-INDUCED DENATURATION; E1 CHANNEL PEPTIDE; DIPHTHERIA-TOXIN; TRYPTOPHAN RESIDUES; CRYSTAL-STRUCTURE; ADP-RIBOSYLATION; DOMAIN-III; TRANSLOCATION; RESOLUTION	Single tryptophan mutant proteins of a catalytically active domain III recombinant protein (PE24) from Pseudomonas aeruginosa exotoxin A were prepared by site-directed mutagenesis, The binding of the dinucleotide substrate, NAD(+), to the PE24 active site was studied by exploiting intrinsic tryptophan fluorescence for the wild-type, single Trp, and tryptophan-deficient mutant proteins. Various approaches were used to study the substrate binding process, including dynamic quenching, CD spectroscopy, steady-state fluorescence emission analysis, NAD(+)-glycohydrolase activity, NAD(+) binding analysis, protein denaturation experiments, fluorescence lifetime analysis, steady-state anisotropy measurement, stopped flow fluorescence spectroscopy, and quantum yield determination, It was found that the conservative replacement of tryptophan residues with phenylalanine had little or no effect on the folded stability and enzyme activity of the PE24 protein. Dynamic quenching experiments indicated that when bound to the active site of the enzyme, the NAD(+) substrate protected Trp-558 from solvent to a large extent but had no effect on the degree of solvent exposure for tryptophans 417 and 466, Also, upon substrate binding, the anisotropy of the Trp-417(W466F/W558F) protein showed the largest increase, followed by Trp-466(W417F/W558F), and there was no effect on Trp-558(W417F/W466F). Furthermore, the intrinsic tryptophan fluorescence exhibited the highest degree of substrate-induced quenching for the wild-type protein, followed in decreasing order by Trp-417(W466F/W558F), Trp-558(W417F/W466F), and Trp-466(W417F/W558F). These data provide evidence for a structural rearrangement in the enzyme domain near Trp-417 invoked by the binding of the NAD(+) substrate.	Univ Guelph, Dept Chem & Biochem, Guelph Waterloo Ctr Grad Work Chem, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Waterloo; Guelph-Waterloo Centre for Graduate Work in Chemistry & Biochemistry	Merrill, AR (corresponding author), Univ Guelph, Dept Chem & Biochem, Guelph Waterloo Ctr Grad Work Chem, Guelph, ON N1G 2W1, Canada.		Merrill, Rod/M-8313-2014					ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P9042, DOI 10.1021/bi960396k; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Bell CE, 1997, PROTEIN SCI, V6, P2084; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; BOPP LH, 1991, INFECT IMMUN, V59, P708, DOI 10.1128/IAI.59.2.708-711.1991; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; DOMENIGHINI M, 1991, MOL MICROBIOL, V5, P23, DOI 10.1111/j.1365-2958.1991.tb01822.x; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977; JINNO Y, 1989, J BIOL CHEM, V264, P15953; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; LI M, 1995, P NATL ACAD SCI USA, V92, P9308, DOI 10.1073/pnas.92.20.9308; MERRILL AR, 1993, BIOCHEMISTRY-US, V32, P6974, DOI 10.1021/bi00078a023; Merrill AR, 1997, BIOCHEMISTRY-US, V36, P6874, DOI 10.1021/bi970222i; OPPENHEIMER NJ, 1981, J BIOL CHEM, V256, P8579; Parker C. A., 1968, PHOTOLUMINESCENCE SO, P220; Permyakov EA, 1993, LUMINESCENT SPECTROS; Steer BA, 1997, BIOCHEMISTRY-US, V36, P3037, DOI 10.1021/bi961926f; STEER BA, 1995, BIOCHEMISTRY-US, V34, P7225, DOI 10.1021/bi00021a038; TORY MC, 1998, BIOPHYS J, V74, pM135; WILSON BA, 1992, CURR TOP MICROBIOL I, V175, P1	23	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15646	15654		10.1074/jbc.274.22.15646	http://dx.doi.org/10.1074/jbc.274.22.15646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336461	hybrid			2022-12-27	WOS:000080560100050
J	Grasberger, H; Buettner, C; Janssen, OE				Grasberger, H; Buettner, C; Janssen, OE			Modularity of serpins - A bifunctional chimera possessing alpha(1)-proteinase inhibitor and thyroxine-binding globulin properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-INHIBITORS; 3-DIMENSIONAL STRUCTURE; ALPHA-LACTALBUMIN; FOLDING UNITS; MECHANISM; LOOP; GENE; ALPHA-1-ANTITRYPSIN; POLYMERIZATION; EVOLUTION	An exciting application of protein engineering is the creation of proteins with novel functions by the retrofitting of native proteins. Such attempts might be facilitated by the idea of a mosaic architecture of proteins out of structural units. Even though numerous theoretical concepts deal with the delineation of structural "modules," their potential in the design of proteins has not yet been sufficiently exploited. To address this question we used a gain of function approach by designing modular chimeric molecules out of two structurally homologous but functionally diverse members of the superfamily of serine-proteinase inhibitors, alpha(1)-proteinase inhibitor and thyroxine-binding globulin, Substitution of two of four alpha(1)-proteinase inhibitor modules (Lys(222) to Leu(288) and Pro(362) to Lys(394), respectively), identified by cu-backbone distance analysis, with their thyroxine-binding globulin homologues resulted in a bifunctional chimera with inhibition of human leukocyte elastase and high affinity thyroxine binding. To our knowledge, this is the first report on a bifunctional chimera engineered from modules of homologous globular proteins. Our results demonstrate how a modular concept can facilitate the design of new functional proteins by swapping structural units chosen from members of a protein superfamily.	Univ Munich, Med Klin, Klinikum Innenstadt, Dept Med, D-80336 Munich, Germany	University of Munich	Janssen, OE (corresponding author), Univ Munich, Med Klin, Klinikum Innenstadt, Dept Med, Ziemssenstr 1, D-80336 Munich, Germany.		Grasberger, Helmut/C-4148-2015	Grasberger, Helmut/0000-0002-4065-4418				Bottomley SP, 1997, BIOCHEM BIOPH RES CO, V241, P264, DOI 10.1006/bbrc.1997.7805; BRUCH M, 1988, J BIOL CHEM, V263, P16626; Campbell RK, 1997, NAT BIOTECHNOL, V15, P439, DOI 10.1038/nbt0597-439; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Carrell RW, 1996, BIOL CHEM H-S, V377, P1; Chang WSW, 1997, PROTEIN SCI, V6, P89; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; CRIPPEN GM, 1978, J MOL BIOL, V126, P315, DOI 10.1016/0022-2836(78)90043-8; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; HOLM L, 1994, PROTEINS, V19, P256, DOI 10.1002/prot.340190309; Hopfner KP, 1998, P NATL ACAD SCI USA, V95, P9813, DOI 10.1073/pnas.95.17.9813; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; JANSSEN OE, 1992, J BIOL CHEM, V267, P13998; KAHN MS, 1977, J BIOL CHEM, V252, P1895; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KORCEK L, 1976, J BIOL CHEM, V251, P3558; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; LEVIN EG, 1987, BLOOD, V70, P1090; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; MURATA Y, 1985, J ENDOCRINOL INVEST, V8, P225, DOI 10.1007/BF03348482; MURZIN AG, 1993, TRENDS BIOCHEM SCI, V18, P403, DOI 10.1016/0968-0004(93)90132-7; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; NEMETHY G, 1979, P NATL ACAD SCI USA, V76, P6050, DOI 10.1073/pnas.76.12.6050; NITTA K, 1989, EUR J BIOCHEM, V182, P111, DOI 10.1111/j.1432-1033.1989.tb14806.x; Nixon AE, 1997, P NATL ACAD SCI USA, V94, P1069, DOI 10.1073/pnas.94.4.1069; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PATSTON PA, 1995, FEBS LETT, V368, P401, DOI 10.1016/0014-5793(95)00694-5; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; QASBA PK, 1984, NATURE, V308, P377, DOI 10.1038/308377a0; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RASHIN AA, 1981, NATURE, V291, P85, DOI 10.1038/291085a0; REFETOFF S, 1994, ENDOCRINE REV MONOGR, V3, P162; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULZE AJ, 1992, BIOCHEMISTRY-US, V31, P7560, DOI 10.1021/bi00148a017; SNYDER SM, 1976, J BIOL CHEM, V251, P6489; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; TABACHNICK M, 1987, BIOCHEM INT, V15, P409; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WAKASUGI K, 1994, J BIOL CHEM, V269, P18750; WEBB AC, 1991, BIOTECHNIQUES, V11, P512; WETLAUFER DB, 1973, ANNU REV BIOCHEM, V42, P135, DOI 10.1146/annurev.bi.42.070173.001031; Whisstock J, 1998, TRENDS BIOCHEM SCI, V23, P63, DOI 10.1016/S0968-0004(97)01172-9; WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K; Zehfus MH, 1997, PROTEIN SCI, V6, P1210, DOI 10.1002/pro.5560060609	56	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15046	15051		10.1074/jbc.274.21.15046	http://dx.doi.org/10.1074/jbc.274.21.15046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329708	hybrid			2022-12-27	WOS:000081965200073
J	Pochampally, R; Fodera, B; Chen, LH; Lu, WG; Chen, JD				Pochampally, R; Fodera, B; Chen, LH; Lu, WG; Chen, JD			Activation of an MDM2-specific caspase by p53 in the absence of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; CYTOCHROME-C; MDM2 ONCOPROTEIN; TRANSCRIPTIONAL ACTIVATION; PROTEOLYTIC CLEAVAGE; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; DEATH RECEPTORS; CELLS	Cells undergoing p53-mediated apoptosis activate caspase 3-like activities, resulting in the cleavage of the MDM2 oncoprotein and other apoptotic substrates such as poly(ADP-ribose) polymerase, To investigate the mechanism of p53-mediated apoptosis and to determine whether cleavage of MDM2 has a potential role in regulating p53, we examined caspase activation and cleavage of MDM2 in a cell line undergoing p53-mediated growth arrest and delayed apoptosis, We found that in H1299 cells expressing a temperature-sensitive human p53, a distinct caspase activity specific for the MDM2 cleavage site DVPD is induced by p53 prior to the onset of apoptosis and loss of viability. This is accompanied by the cleavage of MDM2 but not the apoptotic substrate poly(ADP-ribose) polymerase. The cleaved MDM2 loses the ability to promote p53 degradation and may potentially function in a dominant-negative fashion to stabilize p53, These results suggest that p53 activation may induce a positive feedback effect by cleavage of MDM2 through a unique caspase.	Louisiana State Univ, Med Ctr, Dept Microbiol, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System	Chen, JD (corresponding author), Louisiana State Univ, Med Ctr, Dept Microbiol, Stanley S Scott Canc Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.			Pochampally, Radhika/0000-0002-4263-0364	NATIONAL CANCER INSTITUTE [R01CA072915] Funding Source: NIH RePORTER; NCI NIH HHS [CA72915] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Attardi LD, 1996, EMBO J, V15, P3693, DOI 10.1002/j.1460-2075.1996.tb00739.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen JD, 1996, MOL CELL BIOL, V16, P2445; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 1998, P NATL ACAD SCI USA, V95, P195, DOI 10.1073/pnas.95.1.195; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Erhardt P, 1997, J BIOL CHEM, V272, P15049, DOI 10.1074/jbc.272.24.15049; Gottlieb E, 1998, EMBO J, V17, P3587, DOI 10.1093/emboj/17.13.3587; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LUNA RMD, 1995, NATURE, V378, P203; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pochampally R, 1998, ONCOGENE, V17, P2629, DOI 10.1038/sj.onc.1202206; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; SABBATINI P, 1995, GENE DEV, V9, P2184, DOI 10.1101/gad.9.17.2184; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	52	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15271	15277		10.1074/jbc.274.21.15271	http://dx.doi.org/10.1074/jbc.274.21.15271			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329737	hybrid			2022-12-27	WOS:000081965200102
J	Stock, MF; Guerrero, J; Cobb, B; Eggers, CT; Huang, TG; Li, X; Hackney, DD				Stock, MF; Guerrero, J; Cobb, B; Eggers, CT; Huang, TG; Li, X; Hackney, DD			Formation of the compact confomer of kinesin requires a COOH-terminal heavy chain domain and inhibits microtubule-stimulated ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE BRAIN KINESIN; HELICAL COILED-COIL; DROSOPHILA KINESIN; CONVENTIONAL KINESIN; ENZYMATIC-PROPERTIES; ESCHERICHIA-COLI; DIMERIC KINESIN; SMOOTH-MUSCLE; NECK REGION; MOTOR	Full-length Drosophila kinesin heavy chain from position 1 to 975 was expressed in Escherichia coli (DKH975) and is a dimer, The sedimentation coefficient of DKH975 shifts from 5.4 S at 1 M NaCl to similar to 6.9 S at <0.2 Rr NaCl, This transition of DKH975 between extended and compact conformations is essentially identical to that for the heavy chain dimer of bovine kinesin (Hackney, D. D., Levitt, J. D., and Suhan, J. (1992) J. Biol. Chem, 267, 8696-8701), Thus the capacity for undergoing the 7 S/5 S transition is an intrinsic property of the heavy chains and requires neither light chains nor eukaryotic post-translational modification. DKH960 undergoes a similar transition, indicating that the extreme COOH-terminal region is not required. More extensive deletions from the COOH-terminal (DKH945 and DKH937) result in a shift in the midpoint for the transition to lower salt concentrations. DKH927 and shorter constructs remaining extended even in the absence of added salt. Thus the COOH-terminal similar to 50 amino acids are required for the formation of the compact conformation. Separately expressed COOH-terminal tail segments and NH2-terminal head/neck segments interact in a salt-dependent manner that is consistent with the compact conformer being produced by the interaction of domains from these regions of the heavy chain dimer, The microtubule-stimulated ATPase rate of DKH975 in the compact conformer is strongly inhibited compared with the rate of extended DKH894 (4 s(-1) and 35 s(-1), respectively, for k(cat) at saturating microtubules).	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Hackney, DD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	ddh+@andrew.cmu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028562] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28562] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; Coy D. L., 1996, Biophysical Journal, V70, pA36; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; HACKNEY DD, 1991, METHOD ENZYMOL, V196, P175; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HISANAGA S, 1989, CELL MOTIL CYTOSKEL, V12, P264, DOI 10.1002/cm.970120407; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HUANG TG, 1994, J BIOL CHEM, V269, P16502; IKEBE M, 1983, BIOCHEMISTRY-US, V22, P4580, DOI 10.1021/bi00288a036; JIANG MY, 1995, BIOPHYS J, V68, pS283; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; KUZNETSOV SA, 1989, J BIOL CHEM, V264, P589; KUZNETSOV SA, 1988, EMBO J, V7, P353, DOI 10.1002/j.1460-2075.1988.tb02820.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MACKNIGHT AE, 1994, DIVERSITY MYOSIN LIK; Moraga D. E., 1997, Molecular Biology of the Cell, V8, p258A; Morii H, 1997, BIOCHEMISTRY-US, V36, P1933, DOI 10.1021/bi962392l; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; STEINBERG G, 1995, MOL BIOL CELL, V6, P1605, DOI 10.1091/mbc.6.11.1605; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Tripet B, 1997, J BIOL CHEM, V272, P8946; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; URRUTIA R, 1991, P NATL ACAD SCI USA, V88, P6701, DOI 10.1073/pnas.88.15.6701; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	38	119	120	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14617	14623		10.1074/jbc.274.21.14617	http://dx.doi.org/10.1074/jbc.274.21.14617			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329654	hybrid			2022-12-27	WOS:000081965200019
J	Xu, P; Jacobs, AR; Taylor, SI				Xu, P; Jacobs, AR; Taylor, SI			Interaction of insulin receptor substrate 3 with insulin receptor, insulin receptor-related receptor, insulin-like growth factor-1 receptor, and downstream signaling proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-DEPENDENT INTERACTION; PLECKSTRIN HOMOLOGY DOMAIN; TANDEM SH2 DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; HEPATOMA-CELLS; SH2-CONTAINING PROTEIN; TYROSINE-PHOSPHATASE; DOCKING PROTEIN; 2-HYBRID SYSTEM; RAT ADIPOCYTES	Insulin receptor substrates (IRS) mediate biological actions of insulin, growth factors, and cytokines. All four mammalian IRS proteins contain pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains at their N termini. However, the molecules diverge in their C-terminal sequences. IRS3 is considerably shorter than IRS1, IRS2, and IRS4, and is predicted to interact with a distinct group of downstream signaling molecules. In the present study, we investigated interactions of IRS3 with various signaling molecules. The PTB domain of mIRS3 is necessary and sufficient for binding to the juxtamembrane NPXpY motif of the insulin receptor in the yeast two-hybrid system. This interaction is stronger if the PH domain or the C-terminal phosphorylation domain is retained in the construct. As determined in a modified yeast two-hybrid system, mIRS3 bound strongly to the p85 subunit of phosphatidylinositol 3-kinase. Although high affinity interaction required the presence of at least two of the four YXXM motifs in mIRS3, there was not a requirement for specific YXXM motifs. mIRS3 also bound to SHP2, Grb2, Nck, and Shc, but less strongly than to p85. Studies in COS-7 cells demonstrated that deletion of either the PH or the PTB domain abolished insulin-stimulated phosphorylation of mIRS3. Insulin stimulation promoted the association of mIRS3 with p85, SHP2, Nck, and Shc. Despite weak association between mIRS3 and Grb2, this interaction was not increased by insulin, and may not be mediated by the SH2 domain of Grb2. Thus, in contrast to other IRS proteins, mIRS3 appears to have greater specificity for activation of the phosphatidylinositol 3-kinase pathway rather than the Grb2/Ras pathway.	NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; George Washington Univ, Grad Program Genet, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); George Washington University	Taylor, SI (corresponding author), NIDDK, Diabet Branch, NIH, Bldg 10,Rm 9S-213, Bethesda, MD 20892 USA.	simeon_taylor@nih.gov						Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Burks DJ, 1997, J BIOL CHEM, V272, P27716, DOI 10.1074/jbc.272.44.27716; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; HERBST JJ, 1994, BIOCHEMISTRY-US, V33, P9376, DOI 10.1021/bi00198a002; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Keegan K, 1996, ONCOGENE, V12, P1537; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAVAN BE, 1993, J BIOL CHEM, V268, P5921; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; MILARSKI KL, 1995, BIOCHEM J, V308, P579, DOI 10.1042/bj3080579; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PERROTTI N, 1987, P NATL ACAD SCI USA, V84, P3137, DOI 10.1073/pnas.84.10.3137; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Ross SA, 1998, BIOCHEM BIOPH RES CO, V247, P487, DOI 10.1006/bbrc.1998.8821; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; SawkaVerhelle D, 1997, J BIOL CHEM, V272, P16414, DOI 10.1074/jbc.272.26.16414; Sciacchitano S, 1997, ENDOCRINOLOGY, V138, P4931, DOI 10.1210/en.138.11.4931; SmithHall J, 1997, BIOCHEMISTRY-US, V36, P8304, DOI 10.1021/bi9630974; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Tirode F, 1997, J BIOL CHEM, V272, P22995, DOI 10.1074/jbc.272.37.22995; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zhang J, 1996, ANAL BIOCHEM, V242, P68, DOI 10.1006/abio.1996.0429; ZhangSun G, 1996, ENDOCRINOLOGY, V137, P2649, DOI 10.1210/en.137.7.2649; Zhou LX, 1997, J BIOL CHEM, V272, P29829, DOI 10.1074/jbc.272.47.29829; Zhou LX, 1999, MOL ENDOCRINOL, V13, P505, DOI 10.1210/me.13.3.505; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	49	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15262	15270		10.1074/jbc.274.21.15262	http://dx.doi.org/10.1074/jbc.274.21.15262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329736	hybrid			2022-12-27	WOS:000081965200101
J	Murdock, DG; Boone, BE; Esposito, LA; Wallace, DC				Murdock, DG; Boone, BE; Esposito, LA; Wallace, DC			Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart muscle isoform of the adenine nucleotide translocator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE CHAIN-REACTION; CYTOCHROME-C-OXIDASE; DIFFERENTIAL DISPLAY; SEQUENCE-ANALYSIS; IDENTIFICATION; EXPRESSION; SUBUNIT; CLONING; MUTANT; CDNA	Mice deficient in the heart/muscle specific isoform of the adenine nucleotide translocator (ANT1) exhibit many of the hallmarks of human oxidative phosphorylation (OXPHOS) disease, including a dramatic proliferation of skeletal muscle mitochondria, Because many of the genes necessary for mitochondrial biosynthesis, OXPHOS function, and response to OXPHOS disease might be expected to be up-regulated in the Ant1(-/-)mouse, we used differential display reverse transcription-polymerase chain reaction techniques in an effort to identify these genes. 17 genes were identified as upregulated in Ant1-deficient mice, and they fall into four categories: 1) nuclear and mitochondrial genes encoding OXPHOS components, 2) mitochondrial tRNA and rRNA genes, 3) genes involved in intermediary metabolism, and 4) an eclectic group of other genes. Among the latter genes, we identified the gene encoding anti-apoptotic Mcl-1, the Skd3 gene, and the WS-3 gene, which were previously unknown to be related to mitochondrial function. These results indicate that identification of genes up-regulated in the skeletal muscle of the Ant1-deficient mouse provides a novel method for identifying mammalian genes required for mitochondrial biogenesis.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA	Emory University	Wallace, DC (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.		Murdock, Deborah/C-3483-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG13154] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASU A, 1990, BIOCHIM BIOPHYS ACTA, V1087, P98, DOI 10.1016/0167-4781(90)90128-O; Buess M, 1997, NUCLEIC ACIDS RES, V25, P2233, DOI 10.1093/nar/25.11.2233; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; HEDDI A, 1994, BBA-MOL BASIS DIS, V1226, P206, DOI 10.1016/0925-4439(94)90030-2; HEDDI A, 1993, J BIOL CHEM, V268, P12156; HIRVAS L, 1991, EMBO J, V10, P1017, DOI 10.1002/j.1460-2075.1991.tb08036.x; HOOD DA, 1994, CAN J APPL PHYSIOL, V19, P12, DOI 10.1139/h94-002; HUDSON JW, 1993, BIOCHIM BIOPHYS ACTA, V1164, P197, DOI 10.1016/0167-4838(93)90248-P; Ichikawa K, 1997, GENE, V189, P277, DOI 10.1016/S0378-1119(96)00863-3; JOH T, 1987, J BIOL CHEM, V262, P15127; KELLY TM, 1993, J BIOL CHEM, V268, P19866; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MOCZKO M, 1995, J MOL BIOL, V254, P538, DOI 10.1006/jmbi.1995.0636; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NIELSEN PJ, 1989, NUCLEIC ACIDS RES, V17, P6723, DOI 10.1093/nar/17.16.6723; PERIER F, 1995, GENE, V152, P157, DOI 10.1016/0378-1119(94)00697-Q; Schmitt M, 1996, J CELL BIOL, V134, P1375, DOI 10.1083/jcb.134.6.1375; Schneider R, 1997, FEBS LETT, V407, P249, DOI 10.1016/S0014-5793(97)00360-8; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; Wallace D. C., 1996, P1280; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173	24	70	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14429	14433		10.1074/jbc.274.20.14429	http://dx.doi.org/10.1074/jbc.274.20.14429			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318868	hybrid			2022-12-27	WOS:000080322200097
J	Pelosi, M; Di Bartolo, V; Mounier, V; Mege, D; Pascussi, JM; Dufour, E; Blondel, A; Acuto, O				Pelosi, M; Di Bartolo, V; Mounier, V; Mege, D; Pascussi, JM; Dufour, E; Blondel, A; Acuto, O			Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; KINASE-ACTIVITY; SH2 DOMAIN; SIGNAL-TRANSDUCTION; FAMILY; PHOSPHORYLATION; ACTIVATION; SYK; IDENTIFICATION; PROTEINS	T-cell antigen receptor-induced signaling requires both ZAP-70 and Lck protein-tyrosine kinases, One essential function of Lck in this process is to phosphorylate ZAP-70 and up-regulate its catalytic activity. We have previously shown that after T-cell antigen receptor stimulation, Lck binds to ZAP-70 via its Src homology 2 (SH2) domain (LckSH2) and, more recently, that Tyr(319) of ZAP-70 is phosphorylated in vivo and plays a positive regulatory role. Here, we investigated the possibility that Tyr(319) mediates the SH2-dependent interaction between Lck and ZAP-70. We show that a phosphopeptide encompassing the motif harboring Tyr(319), YSDP, interacted with LckSH2, although with a lower affinity compared with a phosphopeptide containing the optimal binding motif, YEEI. Moreover, mutation of Tyr(319) to phenylalanine prevented the interaction of ZAP-70 with LckSH2. Based on these results, a gain-of-function mutant of ZAP-70 was generated by changing the sequence (YSDP)-S-319 into (YEEI)-E-319. As a result of its increased ability to bind LckSH2, this mutant induced a dramatic increase in NFAT activity in Jurkat T-cells, was hyperphosphorylated, and displayed a higher catalytic activity compared with wild-type ZAP-70. Collectively, our findings indicate that Tyr(319)-mediated binding of the SH2 domain of Lck is crucial for ZAP-70 activation and consequently for the propagation of the signaling cascade leading to T-cell activation.	Inst Pasteur, Dept Immunol, Mol Immunol Unit, F-75724 Paris 15, France; Inst Pasteur, Cellular Biochem Unit, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Acuto, O (corresponding author), Inst Pasteur, Dept Immunol, Mol Immunol Unit, 25 Rue Docteur Roux, F-75724 Paris 15, France.	oacuto@pasteur.fr	pascussi, jean marc/F-9311-2013; Di Bartolo, Vincenzo/AAL-6834-2020	pascussi, jean marc/0000-0002-5168-5383; Di Bartolo, Vincenzo/0000-0002-5453-947X				Afar DEH, 1996, MOL CELL BIOL, V16, P3465; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Kong GH, 1996, MOL CELL BIOL, V16, P5026; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LUO K, 1990, ONCOGENE, V5, P921; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhao QH, 1996, MOL CELL BIOL, V16, P6765; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	44	103	107	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14229	14237		10.1074/jbc.274.20.14229	http://dx.doi.org/10.1074/jbc.274.20.14229			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318843	hybrid			2022-12-27	WOS:000080322200072
J	Qu, ZQ; Zhu, GY; Yang, ZJ; Cui, NR; Li, YJ; Chanchevalap, S; Sulaiman, S; Haynie, H; Jiang, C				Qu, ZQ; Zhu, GY; Yang, ZJ; Cui, NR; Li, YJ; Chanchevalap, S; Sulaiman, S; Haynie, H; Jiang, C			Identification of a critical motif responsible for gating of Kir2.3 channel by intracellular protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-RAT MEDULLA; CENTRAL CHEMOSENSITIVITY; POTASSIUM CHANNELS; CULTIVATED NEURONS; K(IR)1.1 CHANNELS; CARBON-DIOXIDE; PH; SENSITIVITY; K+; CURRENTS	Protons are involved in gating Kir2.3. To identify the molecular motif in the Kir2.3 channel protein that is responsible for this process, experiments were performed using wild-type and mutated Kir2.3 and Kir2.1. CO2 and low pH(i) strongly inhibited wild-type Kir2.3 but not Kir2.1 in whole cell voltage clamp and excised inside-out patches, This CO2/pH sensitivity was completely eliminated in a mutant Kir2.3 in which the N terminus was substituted with that in Kir2.1, whereas a similar replacement of its C terminus had no effect. Site-specific mutations of all titratable residues in the N terminus, however, did not change the CO2/pH sensitivity. Using several chimeras generated systematically in the N terminus, a 10-residue motif near the M1 region was identified in which only three amino acids are different between Kir2.3 and Kir2.1. Mutations of these residues, especially Thr(53), dramatically reduced the pH sensitivity of Kir2.3. Introducing these residues or even a single threonine to the corresponding positions of Kir2.1 made the mutant channel pH-sensitive. Thus, a critical motif responsible for gating Kir2.3 by protons was identified in the N terminus, which contained about 10 residues centered by Thr(53).	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 24 Peachtree Cent Ave, Atlanta, GA 30303 USA.	biocjj@panther.gsu.edu		Yang, Zhenjiang/0000-0002-9315-154X	NHLBI NIH HHS [R01 HL058410, HL58410-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058410] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bukauskas FF, 1997, BIOPHYS J, V72, P2137, DOI 10.1016/S0006-3495(97)78856-8; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; DEAN JB, 1990, NEUROSCIENCE, V36, P207, DOI 10.1016/0306-4522(90)90363-9; Doi T, 1996, J BIOL CHEM, V271, P17261, DOI 10.1074/jbc.271.29.17261; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; FELDMAN JL, 1986, HDB PHYSL 1, V4, P463; Fitzherald RS, 1986, HDB PHYSL 3, P313; HAYASHI F, 1992, ABSTR SOC NEUR, V18; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; JIANG C, 1994, J NEUROSCI, V14, P5590; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; JIANG C, 1997, ABSTR SOC NEUR, V23; JIANG C, 1996, TISSUE OXYGEN DEPRIV, P595; Karschin C, 1997, MOL CELL NEUROSCI, V10, P131, DOI 10.1006/mcne.1997.0655; Krishek BJ, 1996, J PHYSIOL-LONDON, V492, P431, DOI 10.1113/jphysiol.1996.sp021319; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; MITCHELL RA, 1975, AM REV RESPIR DIS, V111, P206; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Scheid P, 1998, FASEB J, V12, pA50; Schlaefke M E, 1981, Rev Physiol Biochem Pharmacol, V90, P171, DOI 10.1007/BFb0034080; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Wellner-Kienitz MC, 1998, NEUROSCIENCE, V87, P109, DOI 10.1016/S0306-4522(98)00159-6; Wellner-Kienitz MC, 1998, J NEUROPHYSIOL, V79, P2885, DOI 10.1152/jn.1998.79.6.2885; Widdicombe J.G., 1986, HDB PHYS, P1; XU HX, 1998, ABSTR SOC NEUR, V24; Zhu GY, 1999, J BIOL CHEM, V274, P11643, DOI 10.1074/jbc.274.17.11643; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3; Zhu GY, 1999, J PHYSIOL-LONDON, V516, P699, DOI 10.1111/j.1469-7793.1999.0699u.x	34	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13783	13789		10.1074/jbc.274.20.13783	http://dx.doi.org/10.1074/jbc.274.20.13783			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318782	hybrid			2022-12-27	WOS:000080322200011
J	Ma, YS; Cunningham, ME; Wang, XM; Ghosh, I; Regan, L; Longley, BJ				Ma, YS; Cunningham, ME; Wang, XM; Ghosh, I; Regan, L; Longley, BJ			Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOONCOGENE C-KIT; STEM-CELL FACTOR; TYROSINE KINASE; SIGNAL TRANSDUCTION; FUNCTION MUTATIONS; ACTIVATION; LIGAND; IDENTIFICATION; DIMERIZATION; MASTOCYTOSIS	KIT receptor kinase activity is repressed, prior to stem cell factor binding, by unknown structural constraints. Using site-directed mutagenesis, we examined the role of KIT intracellular juxtamembrane residues Met-552 through Ile-563 in controlling receptor autophosphorylation, Alanine substitution for Tyr-553, Trp-557, Val-559, or Val-560, all sitting along the hydrophobic side of an amphipathic alpha-helix (Tyr-553-Ile-563) predicted by the Chou-Fasman algorithm, resulted in substantially increased spontaneous receptor phosphorylation, revealing inhibitory roles for these residues Alanine substitution for other residues, most of which are on the hydrophilic side of the helix, caused no or slightly increased basal receptor phosphorylation, Converting Tyr-553 or Trp-557 to phenylalanine generated slight or no elevation, respectively, in basal KIT phosphorylation, indicating that the phenyl ring of Tyr-553 and the hydrophobicity of Trp-557 are critical for the inhibition. Although alanine substitution for Lys-558 had no effect on receptor phosphorylation, its substitution with proline produced high spontaneous receptor phosphorylation, suggesting that the predicted alpha-helical conformation is involved in the inhibition. A synthetic peptide comprising Tyr-553 through Ile-563 showed circular dichroism spectra characteristic of alpha-helix, supporting the structural prediction. Thus, the KIT intracellular juxtamembrane region contains important residues which, in a putative alpha-helical conformation, exert inhibitory control on the kinase activity of ligand-unoccupied receptor.	Columbia Univ Coll Phys & Surg, Dept Dermatol, Sect Dermatopathol, Vanderbilt Clin, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Columbia University; Vanderbilt University; Columbia University; Yale University	Longley, BJ (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, Sect Dermatopathol, Vanderbilt Clin, 630 W 168th St,15-221, New York, NY 10032 USA.		Cunningham, Matthew/AAA-4994-2022	Cunningham, Matthew/0000-0003-3723-062X	NIAMS NIH HHS [R01 AR43356, AR44535] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, R01AR043356] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; LEV S, 1992, J BIOL CHEM, V267, P15970; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Ma YS, 1999, J INVEST DERMATOL, V112, P165, DOI 10.1046/j.1523-1747.1999.00488.x; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1991, EMBO J, V10, P2451, DOI 10.1002/j.1460-2075.1991.tb07784.x; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZHANG MJ, 1994, BIOCHEMISTRY-US, V33, P1163, DOI 10.1021/bi00171a016	20	105	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13399	13402		10.1074/jbc.274.19.13399	http://dx.doi.org/10.1074/jbc.274.19.13399			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224103	hybrid			2022-12-27	WOS:000080200400065
J	Paul-Soto, R; Bauer, R; Frere, JM; Galleni, M; Meyer-Klaucke, W; Nolting, H; Rossolini, GM; de Seny, D; Hernandez-Valladares, M; Zeppezauer, M; Adolph, HW				Paul-Soto, R; Bauer, R; Frere, JM; Galleni, M; Meyer-Klaucke, W; Nolting, H; Rossolini, GM; de Seny, D; Hernandez-Valladares, M; Zeppezauer, M; Adolph, HW			Mono- and binuclear Zn2+-beta-lactamase - Role of the conserved cysteine in the catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLO-BETA-LACTAMASE; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; BINDING; SITES	When expressed by pathogenic bacteria, Zn2+-beta-lactamases induce resistance to most beta-lactam antibiotics. A possible strategy to fight these bacteria would be a combined therapy with non-toxic inhibitors of Zn2+-beta-lactamases together with standard antibiotics. For this purpose, it is important to verify that the inhibitor is effective under all clinical conditions. We have investigated the correlation between the number of zinc ions bound to the Zn2+-beta-lactamase from Bacillus cereus and hydrolysis of benzylpenicillin and nitrocefin for the wild type and a mutant where cysteine 168 is replaced by alanine. It is shown that both the mono-Zn2+ (mononuclear) and di-Zn2+ (binuclear) Zn2+-beta-lactamases are catalytically active but with different kinetic properties, The mono-Zn2+-beta-lactamase requires the conserved cysteine residue for hydrolysis of the beta-lactam ring in contrast to the binuclear enzyme where the cysteine residue is not essential. Substrate affinity is not significantly affected by the mutation for the mononuclear enzyme but is decreased for the binuclear enzyme. These results were derived from kinetic studies on two wild types and the mutant enzyme with benzylpenicillin and nitrocefin as substrates. Thus, targeting drug design to modify this residue might represent an efficient strategy, the more so if it also interferes with the formation of the binuclear enzyme.	Univ Saarlandes, Fachrichtung Biochem 12 4, D-66041 Saarbrucken, Germany; Univ Liege, Inst Chim B6, Ctr Ingn Prot, B-4000 Liege, Belgium; DESY, EMBL, Outstn Hamburg, D-22603 Hamburg, Germany; Royal Vet & Agr Univ, Dept Phys, DK-1871 Frederiksberg, Denmark; Univ Siena, Dipartimento Biol Mol, Sez Microbiol, I-53100 Siena, Italy	Saarland University; University of Liege; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Copenhagen; University of Siena	Adolph, HW (corresponding author), Univ Saarlandes, Fachrichtung Biochem 12 4, D-66041 Saarbrucken, Germany.		Meyer-Klaucke, Wolfram/G-1148-2010; Hernandez-Valladares, Maria del Carmen/GXF-7320-2022; Adolph, Hans W/A-2104-2008	Hernandez-Valladares, Maria del Carmen/0000-0001-9347-7841; ROSSOLINI, Gian Maria/0000-0002-9386-0434				AULD DS, 1988, METHOD ENZYMOL, V158, P1; BALDWIN GS, 1978, BIOCHEM J, V175, P441, DOI 10.1042/bj1750441; BALDWIN GS, 1980, J INORG BIOCHEM, V13, P189, DOI 10.1016/S0162-0134(00)80068-9; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crowder MW, 1996, BIOCHEMISTRY-US, V35, P12126, DOI 10.1021/bi960976h; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; DEMEESTER F, 1987, BIOCHEM PHARMACOL, V36, P2393, DOI 10.1016/0006-2952(87)90609-5; FEITERS MC, 1990, COMMENTS INORG CHEM, V11, P131; FEITERS MC, 1986, J PHYS, P1169; HERMES C, 1984, NUCL INSTRUM METH A, V222, P207, DOI 10.1016/0167-5087(84)90532-5; MeyerKlaucke W, 1996, EUR J BIOCHEM, V241, P432, DOI 10.1111/j.1432-1033.1996.00432.x; PAYNE DJ, 1993, J MED MICROBIOL, V39, P93, DOI 10.1099/00222615-39-2-93; Shaw R W, 1991, Protein Expr Purif, V2, P151, DOI 10.1016/1046-5928(91)90064-P; SOTO RP, 1998, FEBS LETT, V438, P137; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; Wang ZG, 1998, J BIOL CHEM, V273, P22402, DOI 10.1074/jbc.273.35.22402	21	117	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13242	13249		10.1074/jbc.274.19.13242	http://dx.doi.org/10.1074/jbc.274.19.13242			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224083	hybrid			2022-12-27	WOS:000080200400045
J	van de Water, B; Nagelkerke, JF; Stevens, JL				van de Water, B; Nagelkerke, JF; Stevens, JL			Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; PROXIMAL TUBULAR CELLS; RAT-KIDNEY; PHOSPHATIDYLINOSITOL 3-KINASE; C-MYC; POLY(ADP-RIBOSE) POLYMERASE; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; PP125(FAK); ACTIVATION	The relationship between focal adhesion protein (FAK) activity and loss of cell-matrix contact during apoptosis is not entirely clear nor has the role of FAK in chemically induced apoptosis been studied. We investigated the status of FAK phosphorylation and cleavage in renal epithelial cells during apoptosis caused by the nephrotoxicant dichlorovinylcysteine (DCVC). DCVC treatment caused a loss of cell-matrix contact which was preceded by a dissociation of FAK from the focal adhesions and tyrosine dephosphorylation of FAK. Paxillin was also dephosphorylated at tyrosine. DCVC treatment activated caspase-3 which was associated with cleavage of FAK. However, FAK cleavage occurred after cells had already lost focal adhesions indicating that cleavage of FAK by caspases is not responsible for loss of FAK from focal adhesions. Accordingly, although inhibition of caspase activity with zVAD-fmk blocked activation of caspase-3, FAK cleavage, and apoptosis, it neither affected dephosphorylation nor translocation of FAK or paxillin, However, zVAD-fmk completely blocked the cell detachment caused by DCVC treatment. Orthovanadate prevented DCVC-induced tyrosine dephosphorylation of both FAK and paxillin; however, it did not inhibit DCVC-induced apoptosis and actually potentiated focal adhesion disorganization and cell detachment. Thus, FAK dephosphorylation and loss of focal adhesions are not due to caspase activation; however, caspases are required for FAK proteolysis and cell detachment.	Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA	Leiden University; Leiden University - Excl LUMC; University of Vermont	van de Water, B (corresponding author), Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, POB 9503, NL-2300 RA Leiden, Netherlands.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007847] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46267] Funding Source: Medline; NIEHS NIH HHS [ES07847] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; BOOGAARD PJ, 1989, TOXICOL APPL PHARM, V101, P135, DOI 10.1016/0041-008X(89)90219-6; Brady H.R., 1996, KIDNEY, P1200; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Caponigro F, 1997, ANTI-CANCER DRUG, V8, P26, DOI 10.1097/00001813-199701000-00003; CHAN PY, 1994, J BIOL CHEM, V269, P20567; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; CHEN Q, 1990, J BIOL CHEM, V265, P21603; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Crouch DH, 1996, ONCOGENE, V12, P2689; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEPESO L, 1997, SCIENCE, V278, P687; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GAILIT J, 1993, AM J PHYSIOL, V264, pF149, DOI 10.1152/ajprenal.1993.264.1.F149; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; GOLDSTEIN RS, 1996, TOXICOLOGY, P417; GOLIGORSKY MS, 1993, AM J PHYSIOL, V264, pF1, DOI 10.1152/ajprenal.1993.264.1.F1; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; HATZINGER PB, 1989, IN VITRO CELL DEV B, V25, P205; HAYDEN PJ, 1990, MOL PHARMACOL, V37, P468; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic D, 1997, J CELL SCI, V110, P401; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kruidering M, 1998, CELL DEATH DIFFER, V5, P601, DOI 10.1038/sj.cdd.4400392; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; Maravei DV, 1997, CELL DEATH DIFFER, V4, P707, DOI 10.1038/sj.cdd.4400311; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; OSBORNE BA, 1995, SEMIN CANCER BIOL, V6, P27, DOI 10.1006/scbi.1995.0004; RACUSEN LC, 1991, LAB INVEST, V64, P546; RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Sanders EJ, 1995, INT REV CYTOL, V163, P105, DOI 10.1016/S0074-7696(08)62210-X; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Sonoda Y, 1997, BIOCHEM BIOPH RES CO, V241, P769, DOI 10.1006/bbrc.1997.7895; STEVENS JL, 1986, J BIOL CHEM, V261, P5529; VANDEWATER B, 1994, AM J PHYSIOL-RENAL, V267, pF888, DOI 10.1152/ajprenal.1994.267.5.F888; VANDEWATER B, 1994, J BIOL CHEM, V269, P14546; VanDeWater B, 1996, AM J PHYSIOL-RENAL, V270, pF593, DOI 10.1152/ajprenal.1996.270.4.F593; VUORI K, 1993, J BIOL CHEM, V268, P21459; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; YU KF, 1994, J CELL PHYSIOL, V161, P303, DOI 10.1002/jcp.1041610215; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; Zhan Y, 1997, MOL CELL BIOL, V17, P6755, DOI 10.1128/MCB.17.11.6755; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	68	125	125	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13328	13337		10.1074/jbc.274.19.13328	http://dx.doi.org/10.1074/jbc.274.19.13328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224094	hybrid, Green Published			2022-12-27	WOS:000080200400056
J	Le, KT; Boue-Grabot, E; Archambault, V; Seguela, P				Le, KT; Boue-Grabot, E; Archambault, V; Seguela, P			Functional and biochemical evidence for heteromeric ATP-gated channels composed of P2X(1) and P2X(5) subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION CHANNELS; SENSORY NEURONS; P-2X RECEPTOR; EXTRACELLULAR ATP; STRUCTURAL MOTIF; RAT; PURINOCEPTOR; EXPRESSION; CLONING; FAMILY	The mammalian P2X receptor gene family encodes two-transmembrane domain nonselective cation channels gated by extracellular ATP, Anatomical localization data obtained by in situ hybridization and immunocytochemistry have shown that neuronal P2X subunits are expressed in specific but overlapping distribution patterns, Therefore, the native ionotropic ATP receptors diversity most likely arises from interactions between different P2X subunits that generate hetero-multimers phenotypically distinct from homomeric channels, Rat P2X(1) and P2X(5) mRNAs are localized within common subsets of peripheral and central sensory neurons as well as spinal motoneurons. The present study demonstrates a functional association between P2X(1) and P2X(5) subunits giving rise to hybrid ATP-gated channels endowed with the pharmacology of P2X(1) and the kinetics of P2X(5). When expressed in Xenopus oocytes, hetero-oligomeric: P2X(1+5) ATP receptors were characterized by slowly desensitizing currents highly sensitive to the agonist alpha,beta-methylene ATP (EC50 = 1.1 mu M) and to the antagonist trinitrophenyl ATP (IC50 = 64 nM), observed with neither P2X(1) nor P2X(5) alone. Direct physical evidence for P2X(1+5) co-assembly was provided by reciprocal subunit-specific co-purifications between epitope-tagged P2X(1) and P2X(5) subunits transfected in HEK-293A cells.	McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Cell Biol Excitable Tissue Grp, Montreal, PQ H3A 2B4, Canada	McGill University	Seguela, P (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Cell Biol Excitable Tissue Grp, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.		Boué-Grabot, Eric/AAQ-2061-2020	Boué-Grabot, Eric/0000-0003-2187-9037				BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chow YW, 1998, J NEUROCHEM, V70, P2606; Collo G, 1996, J NEUROSCI, V16, P2495; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Funk GD, 1997, J NEUROSCI, V17, P6325; GarciaGuzman M, 1996, FEBS LETT, V388, P123, DOI 10.1016/0014-5793(96)00499-1; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Le KT, 1998, J NEUROSCI, V18, P7152; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; Radford KM, 1997, J NEUROSCI, V17, P6529; Seguela P, 1996, J NEUROSCI, V16, P448; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Thomas S, 1998, J PHYSIOL-LONDON, V509, P411, DOI 10.1111/j.1469-7793.1998.411bn.x; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Virginio C, 1998, MOL PHARMACOL, V53, P969; Vulchanova L, 1997, NEUROPHARMACOLOGY, V36, P1229, DOI 10.1016/S0028-3908(97)00126-3; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; WANG C, 1996, BIOCHEM BIOPH RES CO, V230, P8063	25	79	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15415	15419		10.1074/jbc.274.22.15415	http://dx.doi.org/10.1074/jbc.274.22.15415			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336430	Green Published, hybrid			2022-12-27	WOS:000080560100019
J	Mani, SS; Besharse, JC; Knox, BE				Mani, SS; Besharse, JC; Knox, BE			Immediate upstream sequence of arrestin directs rod-specific expression in Xenopus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DARK CYCLE; MOUSE S-ANTIGEN; PINEAL-GLAND; G-PROTEIN; DEVELOPMENTAL EXPRESSION; PHOTORECEPTOR CELLS; 48-KDA PROTEIN; MESSENGER-RNAS; BETA-ARRESTIN; BOVINE RETINA	Arrestins are a family of proteins that modulate G protein-coupled receptor responses with distinct arrestin genes expressed in rods and cones. To understand the regulatory mechanisms controlling rod-specific expression, the abundant Xenopus rod arrestin cDNA and a partial genomic clone, containing the immediate upstream region and amino terminus of the polypeptide, have been characterized. The deduced polypeptide has similar to 69% identity to other vertebrate rod arrestins. Southern blot analysis and polymerase chain reaction of intronic sequences demonstrated multiple alleles for rod arrestin. DNase I footprinting with retinal proteins revealed four major DNA binding sites in the proximal promoter, coinciding with consensus sequences reported in mammalian promoters. Purified bovine Crx homeodomain and mouse Nrl proteins protected a number of these sites. A dual approach of transient embryo transfections and transgenesis was used to locate transcriptional control sequences essential for rod-specific expression in Xenopus. Constructs containing -1287/+113 of 5' upstream sequence with or without intron 1 directed high level expression, specifically in rods. A construct containing only -287/+113 directed expression of green fluorescent protein solely in rod cells. These results suggest that the Crx and Nrl binding sites in the proximal promoter are the primary cis-acting sequences regulating arrestin gene expression in rods.	SUNY Hlth Sci Ctr, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; SUNY Hlth Sci Ctr, Ctr Vis Res, Dept Ophthalmol, Syracuse, NY 13210 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Medical College of Wisconsin	Knox, BE (corresponding author), SUNY Hlth Sci Ctr, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	knoxb@hscsyr.edu			NATIONAL EYE INSTITUTE [R01EY009409, R55EY009409, R01EY002414] Funding Source: NIH RePORTER; NEI NIH HHS [EY02414, R01 EY002414, EY09409] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABDULAEVA G, 1995, EUR J BIOCHEM, V234, P437, DOI 10.1111/j.1432-1033.1995.437_b.x; ABE T, 1990, EXP EYE RES, V51, P111, DOI 10.1016/0014-4835(90)90178-W; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; BATNI S, 1999, IN PRESS METHODS ENZ; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Boatright JH, 1997, EXP EYE RES, V64, P269, DOI 10.1006/exer.1996.0222; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BREITMAN ML, 1991, J BIOL CHEM, V266, P15505; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAFT CM, 1995, FEBS LETT, V362, P247, DOI 10.1016/0014-5793(95)00213-S; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; FARBER DB, 1991, EXP EYE RES, V53, P781, DOI 10.1016/0014-4835(91)90114-T; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GRAF JD, 1991, METHOD CELL BIOL, V36, P19; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Hisatomi O, 1997, FEBS LETT, V411, P12, DOI 10.1016/S0014-5793(97)00640-6; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; KERPPOLA TK, 1994, ONCOGENE, V9, P675; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; KIKUCHI T, 1995, INVEST OPHTH VIS SCI, V36, pS772; Kimura A., 1998, IOVS, V39, pS47; KISELEV A, 1994, SCIENCE, V266, P1369, DOI 10.1126/science.7973725; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; KORF B, 1989, CELL TISSUE RES, V258, P319; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LU XP, 1994, MOL ENDOCRINOL, V8, P1774, DOI 10.1210/me.8.12.1774; MCGINNIS JF, 1992, J NEUROSCI RES, V31, P584, DOI 10.1002/jnr.490310325; NEIUWKOOP P, 1994, NORMAL TABLE XENOPUS, P53; Palczewski K, 1997, CURR OPIN NEUROBIOL, V7, P500, DOI 10.1016/S0959-4388(97)80029-3; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P1355, DOI 10.1002/pro.5560030901; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAXEN L, 1995, ANN ACAD SCI A4, V23, P1; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SHINOHARA T, 1988, PROGR RETINAL RES, V8, P51; Singh AK, 1996, EXP EYE RES, V62, P299, DOI 10.1006/exer.1996.0036; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMITH WC, 1995, J NEUROCHEM, V64, P1; STIEMKE MM, 1994, DEV BIOL, V162, P169, DOI 10.1006/dbio.1994.1076; Swofford D., 1998, PAUP PHYLOGENETIC AN; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TIMMERS AM, 1993, EXP EYE RES, V56, P257, DOI 10.1006/exer.1993.1034; TSUDA M, 1988, GENE, V73, P11, DOI 10.1016/0378-1119(88)90308-3; TSUDA M, 1991, EUR J BIOCHEM, V200, P95, DOI 10.1111/j.1432-1033.1991.tb21053.x; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YAMAKI K, 1987, BIOCHEM BIOPH RES CO, V142, P904, DOI 10.1016/0006-291X(87)91499-9; YAMAKI K, 1990, J BIOL CHEM, V265, P20757; ZHANG J, 1994, VISUAL NEUROSCI, V11, P1185, DOI 10.1017/S0952523800006982	60	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15590	15597		10.1074/jbc.274.22.15590	http://dx.doi.org/10.1074/jbc.274.22.15590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336455	hybrid			2022-12-27	WOS:000080560100044
J	Bhattacharyya, U; Dhar, G; Bhaduri, A				Bhattacharyya, U; Dhar, G; Bhaduri, A			An arginine residue is essential for stretching and binding of the substrate on UDP-glucose-4-epimerase from Escherichia coli - Use of a stacked and quenched uridine nucleotide fluorophore as probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GALACTOSE 4-EPIMERASE; UDPGLUCOSE 4-EPIMERASE; KLUYVEROMYCES-FRAGILIS; MOLECULAR-STRUCTURE; MECHANISM; REDUCTION; ENZYME; SITE	In the previous paper we demonstrated that uridine-5'-beta-1-(5-sulfonic acid) naphthylamidate (UDPAmNS) is a stacked and quenched fluorophore that shows severalfold enhancement of fluorescence in a stretched conformation. UDPAnNS was found to be a powerful competitive inhibitor (K-i = 0.2 mM) for UDP-glucose-4-epimerase from Escherichia coli, This active site-directed fluorophore assumed a stretched conformation on the enzyme surface, as was evidenced by full enhancement of fluorescence in saturating enzyme concentration. Complete displacement of the fluorophore by UDP suggested it to bind to the substrate binding site of the active site. Analysis of inactivation kinetics in presence of alpha,beta-diones such as phenylglyoxal, cyclohaxanedione, and a,3-butadione suggested involvement of the essential arginine residue in the overall catalytic process. From spectral analysis, loss of activity could also be directly correlated with modification of only one arginine residue. Protection experiments with UDP showed the arginine residue to be located in the uridyl phosphate binding subsite, Unlike the native enzyme, the modified enzyme failed to show any enhancement of fluorescence with UDPAmNS clearly demonstrating the role of the essential arginine residue in stretching and binding of the substrate. The potential usefulness of such stacked and quenched nucleotide fluorophores has been discussed.	Indian Inst Chem Biol, Calcutta 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhaduri, A (corresponding author), Indian Inst Chem Biol, 4 Raja Sc Mullick Rd, Calcutta 700032, W Bengal, India.							ADAIR WL, 1973, J BIOL CHEM, V248, P4635; BAUER AJ, 1992, PROTEINS, V12, P372, DOI 10.1002/prot.340120409; BHATTACHARJEE H, 1992, J BIOL CHEM, V267, P11714; Dhar G, 1999, J BIOL CHEM, V274, P14568, DOI 10.1074/jbc.274.21.14568; FLENTKE GR, 1990, BIOCHEMISTRY-US, V29, P2430, DOI 10.1021/bi00461a029; Frey P. A., 1987, PYRIDINE NUCLEOTID B, V2B, P462; GABRIEL O, 1975, SUBUNIT ENZYMES BIOC, P85; HAYMAN S, 1978, BIOCHEMISTRY-US, V17, P4161, DOI 10.1021/bi00613a009; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; LEVY HM, 1963, J BIOL CHEM, V238, P3654; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAITRA US, 1971, P NATL ACAD SCI USA, V68, P2660, DOI 10.1073/pnas.68.11.2660; MANIATIS J, 1982, MOL CLONING LAB MANU, P466; MAS MT, 1985, BIOCHEMISTRY-US, V24, P1634, DOI 10.1021/bi00328a011; MUKHERJI S, 1986, J BIOL CHEM, V261, P4519; MUKHERJI S, 1992, J BIOL CHEM, V267, P11709; NELSESTU.GL, 1971, J BIOL CHEM, V246, P7533; PAL DK, 1971, BIOCHIM BIOPHYS ACTA, V250, P588, DOI 10.1016/0005-2744(71)90259-2; PATTHY L, 1975, J BIOL CHEM, V250, P557; RAY M, 1975, J BIOL CHEM, V250, P4373; RAY M, 1980, J BIOL CHEM, V255, P782; RIOIDAN JF, 1973, BIOCHEMISTRY-US, V12, P3915; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; TAKAHASHI K, 1977, J BIOCHEM-TOKYO, V81, P403, DOI 10.1093/oxfordjournals.jbchem.a131472; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; VANHOOKE JL, 1994, J BIOL CHEM, V269, P31496; WEE TG, 1973, J BIOL CHEM, V248, P33; WILSON DB, 1964, J BIOL CHEM, V239, P2469; WONG SS, 1977, BIOCHEMISTRY-US, V16, P298, DOI 10.1021/bi00621a022; WONG SS, 1978, BIOCHEMISTRY-US, V18, P3551; WONG YHH, 1979, BIOCHEMISTRY-US, V18, P5337, DOI 10.1021/bi00591a012	33	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14573	14578		10.1074/jbc.274.21.14573	http://dx.doi.org/10.1074/jbc.274.21.14573			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329648	hybrid			2022-12-27	WOS:000081965200013
J	Brown, RA; Domino, J; Arcaro, A; Waterfield, MD; Shepherd, PR				Brown, RA; Domino, J; Arcaro, A; Waterfield, MD; Shepherd, PR			Insulin activates the alpha isoform of class II phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; C2 DOMAIN; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; GROWTH-FACTOR; CLONING; FAMILY; CALCIUM; IRS-1	The novel class II phosphoinositide (PI) S-kinases are characterized by the presence of a C-terminal C2 domain, but little is known about their regulation, We find insulin causes a rapid 2-3-fold increase in the activity of PI S-kinase C2 alpha (PI3K-C2 alpha) in CHO-IR cells, 3T3-L1 adipocytes, and fully differentiated L5L6 myotubes. No insulin-induced activation of PI3K-C2 alpha was observed in cell types known to have low responsiveness to insulin including HEK 293 cells, 3T3-L1 preadipocytes, and undifferentiated L5L6 myoblasts, The mechanism of activation of PI3K-C2a by insulin differs from that of class Ia PI S-kinases in that insulin stimulation did not cause PI3K-C2a to associate with IRS-1 or insulin receptor, PI3K-C2a existed as a doublet, and insulin stimulation caused a redistribution from the lower molecular weight band to the higher molecular weight band, suggesting phosphorylation-induced bandshift. Consistent with this, in vitro phosphatase treatment reduced the intensity of the upper band back to that seen in unstimulated cells, This suggests that insulin-induced phosphorylation could play a role in regulation of the activity of PI3K-C2 alpha. The finding that insulin activates PI3K-C2 alpha in cell types known to possess a wide range of responses to insulin suggests that PI3K-C2 alpha is a novel component of insulin-stimulated signaling cascades.	Univ London Univ Coll, Dept Biochem & Mol Biol, London WC1E 6BT, England; Ludwig Inst Canc Res, London W1P 8BT, England	University of London; University College London; Ludwig Institute for Cancer Research	Shepherd, PR (corresponding author), Univ London Univ Coll, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.		Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947				Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Brown RA, 1997, BIOCHEM BIOPH RES CO, V233, P537, DOI 10.1006/bbrc.1997.6495; CHEUNG JY, 1987, AM J PHYSIOL, V252, pC163, DOI 10.1152/ajpcell.1987.252.2.C163; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; HERBST JJ, 1994, BIOCHEMISTRY-US, V33, P9376, DOI 10.1021/bi00198a002; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KLIP A, 1984, AM J PHYSIOL, V247, pE297, DOI 10.1152/ajpendo.1984.247.3.E297; KLIP A, 1987, J BIOL CHEM, V262, P9141; Macdougall LK, 1995, CURR BIOL, V5, P1404, DOI 10.1016/S0960-9822(95)00278-8; Misawa H, 1998, BIOCHEM BIOPH RES CO, V244, P531, DOI 10.1006/bbrc.1998.8294; Molz L, 1996, J BIOL CHEM, V271, P13892, DOI 10.1074/jbc.271.23.13892; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; Zhang J, 1998, J BIOL CHEM, V273, P14081, DOI 10.1074/jbc.273.23.14081	24	109	111	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14529	14532		10.1074/jbc.274.21.14529	http://dx.doi.org/10.1074/jbc.274.21.14529			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329640	hybrid			2022-12-27	WOS:000081965200005
J	Mihara, H; Maeda, M; Fujii, T; Kurihara, T; Hata, Y; Esaki, N				Mihara, H; Maeda, M; Fujii, T; Kurihara, T; Hata, Y; Esaki, N			A nifS-like gene, csdB, encodes an Escherichia coli counterpart of mammalian selenocysteine lyase - Gene cloning, purification, characterization and preliminary x-ray crystallographic studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPHOSPHATE SYNTHETASE; NUCLEOTIDE-SEQUENCE; AZOTOBACTER-VINELANDII; PHYSICAL MAP; PROTEIN; ENZYME; MECHANISM; SELENIUM; IDENTIFICATION; BIOSYNTHESIS	Selenocysteine lyase is a pyridoxal 5'-phosphate (PLP)-dependent enzyme that catalyzes the exclusive decomposition of L-selenocysteine to L-alanine and elemental selenium. An open reading frame, named csdB, from Escherichia coli encodes a putative protein that is similar to selenocysteine lyase of pig Liver and cysteine desulfurase (NifS) of Azotobacter vinelandii. In this study, the csdB gene was cloned and expressed in E. coli cells. The gene product was a homodimer with the subunit M-r of 44,439, contained 1 mol of PLP as a cofactor per mol of subunit, and catalyzed the release of Se, SO2, and S from L-selenocysteine, L-cysteine sulfinic acid, and L-cysteine, respectively, to yield L-alanine; the reactivity of the substrates decreased in this order. Although the enzyme was not specific for L-selenocysteine, the high specific activity for L-selenocysteine (5.5 units/mg compared with 0.019 units/mg for L-cysteine) supports the view that the enzyme can be regarded as an E. coli counterpart of mammalian selenocysteine lyase. me crystallized CsdB, the csdB gene product, by the hanging drop vapor diffusion method. The crystals were of suitable quality for x-ray crystallography and belonged to the tetragonal space group P4(3)2(1)2 with unit cell dimensions of a = b = 128.1 Angstrom and c = 137.0 Angstrom. Consideration of the Matthews parameter V-m (3.19 Angstrom(3)/Da) accounts for the presence of a single dimer in the crystallographic asymmetric unit. A native diffraction dataset up to 2.8 Angstrom resolution was collected. This is the first crystallographic analysis of a protein of NifS/selenocysteine lyase family.	Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Kyoto University	Esaki, N (corresponding author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.		Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403				Adams E, 1979, Methods Enzymol, V62, P407; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ESAKI N, 1985, ARCH BIOCHEM BIOPHYS, V238, P418, DOI 10.1016/0003-9861(85)90182-1; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Flint DH, 1996, J BIOL CHEM, V271, P16068; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HEIDER J, 1993, ADV MICROB PHYSIOL, V35, P71, DOI 10.1016/S0065-2911(08)60097-1; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOLMAN C, 1993, J BACTERIOL, V175, P1433, DOI 10.1128/JB.175.5.1433-1442.1993; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1989, J BIOL CHEM, V264, P9720; LEINWEBER FJ, 1987, METHOD ENZYMOL, V143, P15; Liu SY, 1997, ARCH BIOCHEM BIOPHYS, V341, P353, DOI 10.1006/abbi.1997.9990; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mullins LS, 1997, J AM CHEM SOC, V119, P6684, DOI 10.1021/ja971074m; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Neuhierl B, 1996, EUR J BIOCHEM, V239, P235, DOI 10.1111/j.1432-1033.1996.0235u.x; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Rudd KE, 1998, MICROBIOL MOL BIOL R, V62, P985, DOI 10.1128/MMBR.62.3.985-1019.1998; SLIWKOWSKI MX, 1985, J BIOL CHEM, V260, P3140; Soda K, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P1; Stadtman T C, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P1; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; SUN DX, 1993, J BACTERIOL, V175, P1423, DOI 10.1128/JB.175.5.1423-1432.1993; TANAKA H, 1987, METHOD ENZYMOL, V143, P240; TATE SS, 1971, ADV ENZYMOL RAMB, V35, P503; VERES Z, 1994, J BIOL CHEM, V269, P10597; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	36	100	108	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14768	14772		10.1074/jbc.274.21.14768	http://dx.doi.org/10.1074/jbc.274.21.14768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329673	hybrid			2022-12-27	WOS:000081965200038
J	Svetek, J; Yadav, MP; Nothnagel, EA				Svetek, J; Yadav, MP; Nothnagel, EA			Presence of a glycosylphosphatidylinositol lipid anchor on rose arabinogalactan proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYL YARIV REAGENT; CELL-WALL; GLYCOSYL-PHOSPHATIDYLINOSITOL; SOMATIC EMBRYOGENESIS; REGULATED EXPRESSION; MEMBRANE ANCHORS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; NICOTIANA-ALATA; TOBACCO-LEAVES	Arabinogalactan proteins constitute a class of plant cell surface proteoglycans with widespread occurrence and suggested functions in various aspects of plant growth and development, including cell proliferation, expansion, marking, and death. Previous investigations of subcellular fractions from suspension-cultured cells of "Paul's Scarlet" rose (Rosa sp.) have revealed extensive structural similarity between some soluble arabinogalactan proteins from the cell wall space and some plasma membrane-associated arabinogalactan proteins, thus inspiring the present investigation of the mechanism through which these inherently water-soluble molecules are held on the plasma membrane. Several lines of evidence gained through a combination of methods including reversed-phase chromatography, treatment with phosphatidylinositol-specific phospholipase C, and chemical structural analysis now show that some rose arabinogalactan proteins carry a ceramide class glycosylphosphatidylinositol Lipid anchor. The predominant form of the ceramide is composed of tetracosanoic acid and 4-hydroxysphinganine. Plasma membrane vesicles readily shed arabinogalactan proteins by an inherent mechanism that appears to involve a phospholipase. This finding has significance toward understanding the biosynthesis, localization, and function of arabinogalactan proteins and toward stimulating other studies that may expand the currently very short List of higher plant proteins found to carry such membrane lipid anchors.	Univ Calif Riverside, Dept Bot & Plant Sci 072, Riverside, CA 92521 USA	University of California System; University of California Riverside	Nothnagel, EA (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci 072, Riverside, CA 92521 USA.	eugene.nothnagel@ucr.edu						BUTIKOFER P, 1993, J BIOL CHEM, V268, P17794; CAMPBELL AS, 1992, BIOORG MED CHEM LETT, V2, P655; CARTER HE, 1969, J LIPID RES, V10, P356; CARTER HE, 1969, BIOCHEMISTRY-US, V8, P383, DOI 10.1021/bi00829a053; CARTER HE, 1969, J LIPID RES, V10, P363; Casero PJ, 1998, PLANTA, V204, P252, DOI 10.1007/s004250050254; Cheung AY, 1996, P NATL ACAD SCI USA, V93, P3853, DOI 10.1073/pnas.93.9.3853; Ding L, 1997, PLANTA, V203, P289, DOI 10.1007/s004250050194; Du H, 1996, TRENDS CELL BIOL, V6, P411, DOI 10.1016/S0962-8924(96)20036-4; Fan JQ, 1997, J BIOL CHEM, V272, P27058, DOI 10.1074/jbc.272.43.27058; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRIFFITH OH, 1991, METHOD ENZYMOL, V197, P493, DOI DOI 10.1016/0076-6879(91)97175-X; HAMMARST.S, 1970, J LIPID RES, V11, P175; HSIEH TCY, 1978, BIOCHEMISTRY-US, V17, P3575, DOI 10.1021/bi00610a024; Ikezawa H, 1981, METHODS ENZYMOLOGY C, P731, DOI [10.1016/0076-6879(81)71086-3, DOI 10.1016/0076-6879(81)71086-3]; Jones DR, 1998, INT J BIOCHEM CELL B, V30, P313, DOI 10.1016/S1357-2725(97)00144-1; KAUL K, 1978, BIOCHEMISTRY-US, V17, P3569, DOI 10.1021/bi00610a023; Knox JP, 1996, MEMBRANES SPECIALIZE, P93; KOMALAVILAS P, 1991, J BIOL CHEM, V266, P15956; KREUGER M, 1995, PLANTA, V197, P135, DOI 10.1007/BF00239949; Kunze M, 1997, PLANT PHYSIOL BIOCH, V35, P507; Langan KJ, 1997, PROTOPLASMA, V196, P87, DOI 10.1007/BF01281062; Li SX, 1996, PLANT MOL BIOL, V32, P641, DOI 10.1007/BF00020205; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; McCabe PF, 1997, PLANT CELL, V9, P2225, DOI 10.1105/tpc.9.12.2225; MENON AK, 1994, METHOD ENZYMOL, V230, P418; Morita N, 1996, BBA-GEN SUBJECTS, V1290, P53, DOI 10.1016/0304-4165(95)00185-9; MURPHY RC, 1993, HDB LIPID RES, V7, P71; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; PROUDFOOT L, 1995, BIOCHEM J, V308, P45, DOI 10.1042/bj3080045; Roy S, 1998, PLANTA, V204, P450, DOI 10.1007/s004250050279; SERPE MD, 1995, PLANT PHYSIOL, V109, P1007, DOI 10.1104/pp.109.3.1007; SERPE MD, 1994, PLANTA, V193, P542, DOI 10.1007/BF02411560; Serpe MD, 1996, PLANT PHYSIOL, V112, P1261, DOI 10.1104/pp.112.3.1261; SommerKnudsen J, 1996, PLANT J, V9, P71, DOI 10.1046/j.1365-313X.1996.09010071.x; SommerKnudsen J, 1997, SEX PLANT REPROD, V10, P253, DOI 10.1007/s004970050095; Svetek J, 1996, MOL BIOL CELL, V7, P1762; Takos AM, 1997, FEBS LETT, V405, P1, DOI 10.1016/S0014-5793(97)00064-1; TARENTINO AL, 1982, J BIOL CHEM, V257, P776; Thompson HJM, 1998, PLANTA, V205, P32, DOI 10.1007/s004250050293; Toonen MAJ, 1997, PLANTA, V203, P188, DOI 10.1007/s004250050181; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; WANG H, 1993, PLANT CELL, V5, P1639, DOI 10.1105/tpc.5.11.1639; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Youl JJ, 1998, P NATL ACAD SCI USA, V95, P7921, DOI 10.1073/pnas.95.14.7921	47	121	125	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14724	14733		10.1074/jbc.274.21.14724	http://dx.doi.org/10.1074/jbc.274.21.14724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329668	hybrid			2022-12-27	WOS:000081965200033
J	Parolini, I; Topa, S; Sorice, M; Pace, A; Ceddia, P; Montesoro, E; Pavan, A; Lisanti, MP; Peschle, C; Sargiacomo, M				Parolini, I; Topa, S; Sorice, M; Pace, A; Ceddia, P; Montesoro, E; Pavan, A; Lisanti, MP; Peschle, C; Sargiacomo, M			Phorbol ester-induced disruption of the CD4-Lck complex occurs within a detergent-resistant microdomain of the plasma membrane - Involvement of the translocation of activated protein kinase C isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; TYROSINE KINASE; SIGNAL-TRANSDUCTION; LYMPHOCYTES-T; MYRISTATE ACETATE; ANCHORED PROTEINS; CD4 RECEPTOR; COATED PITS; CAVEOLAE; DOMAINS	Recent studies have highlighted the existence of discrete microdomains at the cell surface that are distinct from caveolae. The function of these microdomains remains unknown. However, recent evidence suggests that they may participate in a subset of transmembrane signaling events. In hematopoietic cells, these low density Triton-insoluble (LDTI) microdomains (also called caveolae-related domains) are dramatically enriched in signaling molecules, such as cell surface receptors (CD4 and CD55), Src family tyrosine kinases (Lyn, Lck, Hck, and Fyn), heterotrimeric G proteins, and gangliosides (GM(1) and GM(3)). Human T lymphocytes have become a well established model system for studying the process of phorbol ester-induced down-regulation of CD4. Here, we present evidence that phorbol 12-myristate 13-acetate (PMA)-induced down-regulation of the cell surface pool of CD4 occurs within the LDTI microdomains of T cells. Localization of CD4 in LDTI microdomains was confirmed by immunoelectron microscopy,PMA-induced disruption of the CD4-Lck complex was rapid (within 5 min), and this disruption occurred within LDTI microdomains, Because PMA is an activator of protein kinase C (PKC), we next evaluated the possible roles of different PKC isoforms in this process. Our results indicate that PMA induced the rapid translocation of cytosolic PKCs to LDTI microdomains. We identified PKC alpha as the major isoform involved in this translocation event. Taken together, our results support the hypothesis that LDTI microdomains represent a functionally important plasma membrane compartment in T cells.	Ist Super Sanita, Dept Hematol Oncol, I-00161 Rome, Italy; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; Univ La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Istituto Superiore di Sanita (ISS); University of L'Aquila; Sapienza University Rome; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Jefferson University	Sargiacomo, M (corresponding author), Ist Super Sanita, Dept Hematol Oncol, Viale Regina Elena 299, I-00161 Rome, Italy.		Sorice, Maurizio/Q-5079-2019; Sousa, Maria/HCI-9642-2022; Lisanti, Michael P/C-6866-2013; parolini, Isabella/J-9955-2016; Lisanti, Michael/B-6131-2018	parolini, Isabella/0000-0001-9863-1051; Lisanti, Michael/0000-0003-2034-1382; Sorice, Maurizio/0000-0003-3534-1502; Sargiacomo, Massimo/0000-0003-4040-706X	NCI NIH HHS [R01-CA-80250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080250] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; ALEXANDER DR, 1989, IMMUNOL TODAY, V10, P200, DOI 10.1016/0167-5699(89)90325-3; BAIER G, 1994, EUR J BIOCHEM, V225, P195, DOI 10.1111/j.1432-1033.1994.00195.x; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; BERRY N, 1989, J IMMUNOL, V143, P1407; BIJLMAKERS MJ, 1997, J CELL BIOL, V137, P1019; BLUE ML, 1987, J IMMUNOL, V139, P3949; BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Chow L M, 1995, Semin Immunol, V7, P207, DOI 10.1006/smim.1995.0026; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DOYLE C, 1989, IMMUNOL REV, V109, P17, DOI 10.1111/j.1600-065X.1989.tb00018.x; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; FRA AM, 1994, J BIOL CHEM, V269, P30745; GAY D, 1988, P NATL ACAD SCI USA, V85, P5629, DOI 10.1073/pnas.85.15.5629; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; GUPTA S, 1994, ADV EXP MED BIOL, V365, P143; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HOESSLI DC, 1983, P NATL ACAD SCI-BIOL, V80, P439, DOI 10.1073/pnas.80.2.439; HOESSLI DC, 1996, CURR OPIN CELL BIOL, V8, P168; HOXIE JA, 1986, J IMMUNOL, V137, P1194; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; KIGUCHI K, 1990, J BIOCHEM-TOKYO, V107, P8, DOI 10.1093/oxfordjournals.jbchem.a123016; KISHORE K, 1998, CELL, V94, P625; LEHEL C, 1994, J BIOL CHEM, V269, P4761; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; LUCAS S, 1990, FEBS LETT, V260, P53, DOI 10.1016/0014-5793(90)80064-P; MARTH JD, 1989, J IMMUNOL, V142, P2430; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; MISCHAK H, 1991, J IMMUNOL, V147, P3981; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MOLDOVAN NI, 1995, EXP CELL RES, V219, P309, DOI 10.1006/excr.1995.1233; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PELCHENMATTHEWS A, 1991, J EXP MED, V173, P575, DOI 10.1084/jem.173.3.575; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; PETERSEN CM, 1992, EXP CELL RES, V201, P160, DOI 10.1016/0014-4827(92)90360-K; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; SHIN JY, 1991, J BIOL CHEM, V266, P10658; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; Sorice M, 1997, J LIPID RES, V38, P969; SORICE M, 1995, SCAND J IMMUNOL, V41, P148, DOI 10.1111/j.1365-3083.1995.tb03547.x; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; STRULOVICI B, 1991, J BIOL CHEM, V266, P168; TSUTSUMI A, 1993, J IMMUNOL, V150, P1746; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554	65	77	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14176	14187		10.1074/jbc.274.20.14176	http://dx.doi.org/10.1074/jbc.274.20.14176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318836	hybrid			2022-12-27	WOS:000080322200065
J	Guo, SL; Stolz, LE; Lemrow, SM; York, JD				Guo, SL; Stolz, LE; Lemrow, SM; York, JD			SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; PHOSPHOLIPASE-D ACTIVITY; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; VACUOLE; FAB1P; PHOSPHOINOSITIDES; IDENTIFICATION; 2ND-MESSENGER; PURIFICATION	The SAC1 gene product has been implicated in the regulation of actin cytoskeleton, secretion from the Golgi, and microsomal ATP transport; yet its function is unknown. Within SAC1 is an evolutionarily conserved 300-amino acid region, designated a SAC1-like domain, that is also present at the amino termini of the inositol polyphosphate 5-phosphatases, mammalian synaptojanin, and certain yeast INP5 gene products. Here we report that SAC1-like domains have intrinsic enzymatic activity that defines a new class of polyphosphoinositide phosphatase (PPIPase), Purified recombinant SAC1-like domains convert yeast lipids phosphatidylinositol (PI) S-phosphate, PI 4-phosphate, and PI 3,5-bisphosphate to PI, whereas PI 4,5-bisphosphate is not a substrate. Yeast lacking Sac1p exhibit 10-, 2.5-, and a-fold increases in the cellular levels of PI 4-phosphate, PI 3,5-bisphosphate, and PI 3-phosphate, respectively. The 5-phosphatase domains of synaptojanin, Inp52p, and Inp53p are also catalytic, thus representing the first examples of an inositol signaling protein with two distinct lipid phosphatase active sites within a single polypeptide chain. Together, our data provide a long sought mechanism as to how defects in Sac1p overcome certain actin mutants and bypass the requirement for yeast phosphatidylinositol/phosphatidylcholine transfer protein, Sec14p. We demonstrate that PPIPase activity is a key regulator of membrane trafficking and actin cytoskeleton organization and suggest signaling roles for phosphoinositides other than PI 4,5-bisphosphate in these processes. Additionally, the tethering of PPIPase and B-phosphatase activities indicate a novel mechanism by which concerted phosphoinositide hydrolysis participates in membrane trafficking.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL 55672] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSUBEL FA, 1995, CURRENT PROTOCOLS MO, V2; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; ERNEUX G, 1998, BIOCHIM BIOPHYS ACTA, V1436, P185; ESTEVEZ F, 1994, BIOCHEM J, V302, P709, DOI 10.1042/bj3020709; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Hinchliffe KA, 1998, BBA-MOL CELL BIOL L, V1436, P87, DOI 10.1016/S0005-2760(98)00140-4; HOPE HMR, 1994, J BIOL CHEM, V269, P23648; Kandzari D E, 1996, Subcell Biochem, V26, P97; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; MAYINGER P, 1995, J CELL BIOL, V131, P1377, DOI 10.1083/jcb.131.6.1377; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; NOVICK P, 1989, GENETICS, V121, P659; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PIGNATARO OP, 1990, J BIOL CHEM, V265, P1718; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Srinivasan S, 1997, EUR J CELL BIOL, V74, P350; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Stolz LE, 1998, GENETICS, V148, P1715; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; Whiteford CC, 1997, BIOCHEM J, V323, P597, DOI 10.1042/bj3230597; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	38	296	304	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12990	12995		10.1074/jbc.274.19.12990	http://dx.doi.org/10.1074/jbc.274.19.12990			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224048	hybrid			2022-12-27	WOS:000080200400010
J	Mukherjee, S; Palczewski, K; Gurevich, VV; Hunzicker-Dunn, M				Mukherjee, S; Palczewski, K; Gurevich, VV; Hunzicker-Dunn, M			beta-arrestin-dependent desensitization of luteinizing hormone choriogonadotropin receptor is prevented by a synthetic peptide corresponding to the third intracellular loop of the receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN ADENYLATE-CYCLASE; HUMAN BETA-2-ADRENERGIC RECEPTOR; LUTROPIN/CHORIOGONADOTROPIN RECEPTOR; GONADOTROPIN RECEPTOR; CYTOPLASMIC DOMAINS; GRANULOSA-CELLS; LIGAND-BINDING; CORPUS-LUTEUM; LH RECEPTORS; ACTIVATE GS	Desensitization is a ubiquitous response of guanine nucleotide-binding protein-coupled receptors (GPCRs) characterized by the waning of effector activity despite continued presence of agonist, Binding of an arrestin to the activated, often phosphorylated GPCR triggers desensitization. We reported for the luteinizing hormone/choriogonadotropin receptor (LH/CG R) that beta-arrestin tightly bound to porcine ovarian follicular membranes mediates agonist-dependent desensitization of LH/CG R-stimulated adenylyl cyclase (AC) activity (Mukherjee, S,, Palczewski, K,, Gurevich, V, V., Benovic, J, L,, Banga, J, P., and Hunzicker-Dunn, M. (1999) Proc. Natl, Acad, Sci. U, S, A. 96, 493-498). We now show that addition of a synthetic peptide corresponding to the entire third intracellular loop (3i) of the LH/CG R completely and specifically reverses desensitization of AC activity, with an ED50 of 10 mu M but does not modulate basal, hCG-stimulated, or forskolin-stimulated AC activities. beta-Arrestin binds selectively to the 3i peptide coupled to activated Sepharose, Desensitization of LH/CG R-stimulated AC activity is rescued when the 3i peptide is preincubated with exogenous beta-arrestin, These results show that endogenous beta-arrestin participates in cell-free desensitization of agonist-dependent LH/CG R-stimulated AC activity in follicular membranes by interacting directly with the 3i loop of the receptor, thereby preventing G(s) activation.	Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Washington, Sch Med, Dept Ophthalmol Pharmacol & Chem, Seattle, WA 98195 USA; Sun Hlth Res Inst, Ralph & Muriel Roberts Lab Vis Res, Sun City, AZ 85372 USA	Northwestern University; University of Washington; University of Washington Seattle; Banner Research; Banner Health; Banner Sun Health Research Institute	Hunzicker-Dunn, M (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.		Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NEI NIH HHS [R01 EY 09339, R01 EY 11500] Funding Source: Medline; NICHD NIH HHS [P01 HD 21921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500, R01EY009339] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abell AN, 1997, J BIOL CHEM, V272, P14586, DOI 10.1074/jbc.272.23.14586; Abell AN, 1998, MOL ENDOCRINOL, V12, P1857, DOI 10.1210/me.12.12.1857; AMSTERDAM A, 1980, P NATL ACAD SCI-BIOL, V77, P3440, DOI 10.1073/pnas.77.6.3440; Beau I, 1998, J BIOL CHEM, V273, P18610, DOI 10.1074/jbc.273.29.18610; BENDER FE, 1982, STAT METHODS FOOD AG; BOCKAERT J, 1976, J BIOL CHEM, V251, P2653; Chan WY, 1998, MOL GENET METAB, V63, P75, DOI 10.1006/mgme.1997.2650; CONTI M, 1976, J BIOL CHEM, V251, P7729; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; EKSTROM RC, 1989, ENDOCRINOLOGY, V125, P2470, DOI 10.1210/endo-125-5-2470; EKSTROM RC, 1992, J BIOL CHEM, V267, P22183; EKSTROM RC, 1990, ENDOCRINOLOGY, V127, P2578, DOI 10.1210/endo-127-5-2578; EKSTROM RC, 1990, ENDOCRINOLOGY, V126, P1191, DOI 10.1210/endo-126-2-1191; EKSTROM RC, 1989, ENDOCRINOLOGY, V124, P956, DOI 10.1210/endo-124-2-956; EZRA E, 1980, J BIOL CHEM, V255, P653; EZRA E, 1981, J BIOL CHEM, V256, P5377; FERGUSON SSG, 1996, CAN J PHYSL PHARM, V74, P1094; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HUNZICKERDUNN M, 1981, BIOL REPROD, V24, P279, DOI 10.1095/biolreprod24.2.279; HUNZICKERDUNN M, 1981, ENDOCRINOLOGY, V109, P345, DOI 10.1210/endo-109-2-345; HUNZICKERDUNN M, 1976, ENDOCRINOLOGY, V99, P185, DOI 10.1210/endo-99-1-185; HUNZICKERDUNN M, 1976, ENDOCRINOLOGY, V99, P198, DOI 10.1210/endo-99-1-198; JONASSEN JA, 1980, ENDOCRINOLOGY, V106, P1786, DOI 10.1210/endo-106-6-1786; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kosugi S, 1996, J BIOL CHEM, V271, P31813, DOI 10.1074/jbc.271.50.31813; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; LAMM MLG, 1994, ENDOCRINOLOGY, V134, P1745, DOI 10.1210/en.134.4.1745; LAMM MLG, 1994, MOL ENDOCRINOL, V8, P1537, DOI 10.1210/me.8.11.1537; LAMPRECHT SA, 1977, J CYCLIC NUCL PROT, V3, P69; LAMPRECHT SA, 1973, J ENDOCRINOL, V57, P217, DOI 10.1677/joe.0.0570217; LIGGETT SB, 1991, J BIOL CHEM, V266, P4816; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSH JM, 1973, BIOCHIM BIOPHYS ACTA, V304, P197, DOI 10.1016/0304-4165(73)90128-1; MARSH JM, 1970, J BIOL CHEM, V245, P1596; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Meduri G, 1996, J ENDOCRINOL, V148, P435, DOI 10.1677/joe.0.1480435; Mukherjee S, 1999, P NATL ACAD SCI USA, V96, P493, DOI 10.1073/pnas.96.2.493; NAKATA H, 1994, EUR J BIOCHEM, V220, P29, DOI 10.1111/j.1432-1033.1994.tb18595.x; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P4201; Rajagopalan-Gupta RM, 1999, ENDOCRINOLOGY, V140, P1612, DOI 10.1210/en.140.4.1612; RAO MC, 1977, ENDOCRINOLOGY, V101, P512, DOI 10.1210/endo-101-2-512; SCHWALL RH, 1984, ENDOCRINOLOGY, V114, P1114, DOI 10.1210/endo-114-4-1114; Tsuga H, 1998, J BIOL CHEM, V273, P5323, DOI 10.1074/jbc.273.9.5323; Wang Z, 1997, MOL ENDOCRINOL, V11, P183, DOI 10.1210/me.11.2.183; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WONG SKF, 1990, J BIOL CHEM, V265, P6219; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; ZOR U, 1976, BIOCHIM BIOPHYS ACTA, V428, P761, DOI 10.1016/0304-4165(76)90206-3	54	41	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12984	12989		10.1074/jbc.274.19.12984	http://dx.doi.org/10.1074/jbc.274.19.12984			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224047	hybrid			2022-12-27	WOS:000080200400009
J	Prezeau, L; Richman, JG; Edwards, SW; Limbird, LE				Prezeau, L; Richman, JG; Edwards, SW; Limbird, LE			The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha(2)-adrenergic receptor subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; AGONIST-PROMOTED DESENSITIZATION; CANINE KIDNEY-CELLS; ADRENERGIC-RECEPTOR; ALPHA(2A)-ADRENERGIC RECEPTOR; ALPHA-2-ADRENERGIC RECEPTORS; BASOLATERAL MEMBRANE; COUPLED RECEPTORS; BINDING PROTEINS; NA+/H+ EXCHANGE	The alpha(2)-adrenergic receptors (alpha(2)ARs) are localized to and function on the basolateral surface in polarized renal epithelial cells via a mechanism involving the third cytoplasmic loop. To identify proteins that may contribute to this retention, [S-35]Met-labeled Gen10 fusion proteins with the 3i loops of the alpha(2A)AR (Val(217)-Ala(377)), alpha(2B)AR (Lys(210)-Trp(354)) and alpha(2C)AR (Arg(248)-Val(363)) were used as ligands in gel overlay assays. A protein doublet of similar to 30 kDa in Madin-Darby canine kidney cells or pig brain cytosol (alpha(2B) greater than or equal to alpha(2C) >> alpha(2A)) was identified. The interacting protein was purified by sequential DEAE and size exclusion chromatography, and subsequent microsequencing revealed that they are the zeta isoform of 14-3-3 proteins. [S-35]Met-14-3-3 zeta binds to all three native alpha(2)AR subtypes, assessed using a solid phase binding assay (alpha(2A) greater than or equal to alpha(2B) > alpha(2C)), and this binding depends on the presence of the 3i loops. Attenuation of the alpha(2)AR-14-3-3 interactions in the presence of a phosphorylated Raf-l peptide corresponding to its 14-3-3 interacting domain (residues 251-266), but not by its non-phosphorylated counterpart, provides evidence for the functional specificity of these interactions and suggests one potential interface for the alpha(2)AR and 14-3-3 interactions. These studies represent the first evidence for G protein-coupled receptor interactions with 14-3-3 proteins and may provide a mechanism for receptor localization and/or coordination of signal transduction.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Limbird, LE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Rm 468, Nashville, TN 37232 USA.	Lee.Limbird@mcmail.vanderbilt.edu		Edwards, Stephen/0000-0002-7985-111X	NIDDK NIH HHS [DK13499, DK15658, DK 43185] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013499, R01DK015658, R13DK043185, R01DK013499] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; EASON MG, 1995, J BIOL CHEM, V270, P4681, DOI 10.1074/jbc.270.9.4681; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; EASON MG, 1992, J BIOL CHEM, V267, P25473; Eason MG, 1996, J BIOL CHEM, V271, P12826, DOI 10.1074/jbc.271.22.12826; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; FLORDELLIS CS, 1995, J BIOL CHEM, V270, P3491, DOI 10.1074/jbc.270.8.3491; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GUYER CA, 1990, J BIOL CHEM, V265, P17307; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; HERTEL C, 1990, J BIOL CHEM, V265, P17988; JEWELLMOTZ EA, 1995, BIOCHEMISTRY-US, V34, P11946, DOI 10.1021/bi00037a036; Jinsi A, 1996, EUR J PHARMACOL, V302, P183, DOI 10.1016/0014-2999(96)00049-0; JONES SB, 1990, J PHARMACOL EXP THER, V254, P294; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KUROSE H, 1994, J BIOL CHEM, V269, P10093; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACNULTY EE, 1992, J BIOL CHEM, V267, P2149; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; NUNNARI JM, 1987, J BIOL CHEM, V262, P12387; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; PARKER EM, 1995, J BIOL CHEM, V270, P6482, DOI 10.1074/jbc.270.12.6482; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Reuther GW, 1996, VITAM HORM, V52, P149, DOI 10.1016/S0083-6729(08)60410-0; RICHMAN JG, 1998, AM J PHYSIOL, V43, pC654; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wade SM, 1996, MOL PHARMACOL, V50, P351; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	57	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13462	13469		10.1074/jbc.274.19.13462	http://dx.doi.org/10.1074/jbc.274.19.13462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224112	hybrid			2022-12-27	WOS:000080200400074
J	Goldberg, ME; Schaeffer, F; Guillou, Y; Djavadi-Ohaniance, L				Goldberg, ME; Schaeffer, F; Guillou, Y; Djavadi-Ohaniance, L			Pseudo-native motifs in the noncovalent heme-apocytochrome c complex - Evidence from antibody binding studies by enzyme-linked immunosorbent assay and microcalorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; CYTOCHROME-C; LIGAND-BINDING; MONOCLONAL-ANTIBODIES; P21(H-RAS) PROTEIN; SELF-ORGANIZATION; MECHANISM; EQUILIBRIUM; RESOLUTION; CONSTANT	When beef heart apocytochrome c is unfolded, it folds upon noncovalent heme binding (Dumont, M. E., Corin, A. F., and Campbell, G.A. (1994) Biochemistry, 33, 7368-7378), Here, the conformation of the heme-apocytochrome noncovalent complex is compared with that of holocytochrome c, A purification method was designed for obtaining in large amounts apocytochrome c that was shown by amino acid analysis and mass spectroscopy to be chemically intact. The apoprotein and its noncovalent complex were characterized by absorption, fluorescence, circular dichroism, and sedimentation velocity, confirming previous reports. Sedimentation-diffusion equilibrium showed that the apoprotein and its noncovalent complex with heme were monomeric, Surprisingly, whereas apocytochrome c was quite soluble, the noncovalent complex slowly formed heavy aggregates, thus precluding experiments at the concentrations needed for structural studies. Two monoclonal antibodies that bind strongly to distinct antigenic sites on native holocytochrome were used to probe the noncovalent complex conformation. For both antibodies, the affinity for the noncovalent complex was only about 5-10fold smaller than that for native holocytochrome c, and about 50-100-fold larger than that for apocytochrome c, These results indicate that the noncovalent complex, although not entirely native, carries some pseudo-native structural motifs.	Inst Pasteur, Unite Biochim Cellulaire, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 1129, Lab Resonance Magnet Nucl, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Goldberg, ME (corresponding author), Inst Pasteur, Unite Biochim Cellulaire, 28 Rue Dr Roux, F-75724 Paris 15, France.							ALLEN MJ, 1994, BIOCHEMISTRY-US, V33, P3967, DOI 10.1021/bi00179a024; CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; CREIGHTON TE, 1988, BIOPHYS CHEM, V31, P155, DOI 10.1016/0301-4622(88)80021-8; DAMASCHUN G, 1991, INT J BIOL MACROMOL, V13, P217, DOI 10.1016/0141-8130(91)90062-Y; DJAVADIOHANIANCE L, 1986, BIOCHEMISTRY-US, V25, P2502, DOI 10.1021/bi00357a033; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; FISHER WR, 1973, J BIOL CHEM, V248, P3188; FRIGUET B, 1989, RES IMMUNOL, V140, P355, DOI 10.1016/0923-2494(89)90142-9; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; FRIGUET B, 1989, PROTEIN STRUCTURE PR, P287; FURIE B, 1975, J MOL BIOL, V92, P497, DOI 10.1016/0022-2836(75)90305-8; GOLDBERG ME, 1994, PROTEIN SCI, V3, P883; GOSHORN SC, 1991, J BIOL CHEM, V266, P2134; Jaenicke R, 1998, BIOL CHEM, V379, P237; LARVOR MP, 1994, J IMMUNOL METHODS, V170, P167, DOI 10.1016/0022-1759(94)90392-1; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MILES EW, 1970, J BIOL CHEM, V245, P6016; Onoue K, 1965, Immunochemistry, V2, P401, DOI 10.1016/0019-2791(65)90039-X; PAUL KG, 1950, ACTA CHEM SCAND, V4, P239, DOI 10.3891/acta.chem.scand.04-0239; PTITSYN OB, 1973, DOKL AKAD NAUK SSSR+, V210, P1213; RAMAN CS, 1992, BIOCHEMISTRY-US, V31, P10370, DOI 10.1021/bi00157a027; RAMAN CS, 1995, BIOCHEMISTRY-US, V34, P5831, DOI 10.1021/bi00017a015; Roux P, 1997, J BIOL CHEM, V272, P24843, DOI 10.1074/jbc.272.40.24843; STELLWAGEN E, 1972, J BIOL CHEM, V247, P8074; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; TAKANO T, 1973, J BIOL CHEM, V248, P5234; Tsai CJ, 1998, FOLD DES, V3, pR71, DOI 10.1016/S1359-0278(98)00032-7; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zhang J, 1998, BIOCHEMISTRY-US, V37, P14891, DOI 10.1021/bi981116z; Zhang J, 1998, BIOCHEMISTRY-US, V37, P14881, DOI 10.1021/bi9811157	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16052	16061		10.1074/jbc.274.23.16052	http://dx.doi.org/10.1074/jbc.274.23.16052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347156	hybrid			2022-12-27	WOS:000080668600016
J	Zhang, LX; Paakkarinen, V; van Wijk, KJ; Aro, EM				Zhang, LX; Paakkarinen, V; van Wijk, KJ; Aro, EM			Co-translational assembly of the D1 protein into photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; ENDOPLASMIC-RETICULUM; THYLAKOID MEMBRANES; IN-VITRO; INTEGRATION; CHLOROPLAST; IDENTIFICATION; LIGHT; TRANSLOCATION; ORGANIZATION	Assembly of multi-subunit membrane protein complexes is poorly understood, In this study, we present direct evidence that the D1 protein, a multiple membrane spanning protein, assembles co-translationally into the large membrane-bound complex, photosystem II. During pulse-chase studies in intact chloroplasts, incorporation of the D1 protein occurred without transient accumulation of free labeled protein in the thylakoid membrane, and photosystem II subcomplexes contained nascent D1 intermediates of 17, 22, and 25 kDa, These N-terminal D1 intermediates could be coimmunoprecipitated with antiserum directed against the D2 protein, suggesting co-translational assembly of the D1 protein into PS II complexes. Further evidence for a co-translational assembly of the D1 protein into photosystem II was obtained by analyzing ribosome nascent chain complexes liberated from the thylakoid membrane after a short pulse labeling. Radiolabeled D1 intermediates could be immunoprecipitated under nondenaturing conditions with antisera raised against the D1 and D2 protein as well as CP47, However, when the ribosome pellets were solubilized with SDS, the interaction of these intermediates with CP47 was completely lost, but strong interaction of a 25-kDa D1 intermediate with the D2 protein still remained. Taken together, our results indicate that during the repair of photosystem II, the assembly of the newly synthesized D1 protein into photosystem II occurs co-translationally involving direct interaction of the nascent D1 chains with the D2 protein.	Univ Turku, Dept Biol, Lab Plant Physiol, FIN-20520 Turku, Finland; Univ Stockholm, Dept Biochem, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden	University of Turku; Stockholm University	Aro, EM (corresponding author), Univ Turku, Dept Biol, Lab Plant Physiol, Biocity A,6th Floor, FIN-20520 Turku, Finland.		Aro, Eva-Mari/Q-8664-2017	Aro, Eva-Mari/0000-0002-2922-1435				ADIR N, 1990, J BIOL CHEM, V265, P12563; ANDERSSON B, 1994, ADV MOL CEL, V10, P1; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; BARBATO R, 1995, EUR J BIOCHEM, V234, P459, DOI 10.1111/j.1432-1033.1995.459_b.x; BARBATO R, 1992, J CELL BIOL, V119, P315; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; DINER BA, 1996, OXYGENIC PHOTOSYNTHE, P213; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; ESHAGHI S, 1998, PHOTOSYNTHESIS MECH, V2, P695; GHIRARDI ML, 1989, CURRENT RES PHOTOSYN, V2, P733; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; ISAACS WB, 1987, P NATL ACAD SCI USA, V84, P6174, DOI 10.1073/pnas.84.17.6174; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; JAGENDORF AT, 1990, PLANT SCI, V71, P137, DOI 10.1016/0168-9452(90)90001-5; Kepes F, 1996, J MOL BIOL, V262, P77, DOI 10.1006/jmbi.1996.0500; KIM JM, 1991, J BIOL CHEM, V266, P14931; KLEIN RR, 1988, J CELL BIOL, V106, P289, DOI 10.1083/jcb.106.2.289; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; MATTOO AK, 1981, P NATL ACAD SCI-BIOL, V78, P1572, DOI 10.1073/pnas.78.3.1572; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; MULLET JE, 1986, EUR J BIOCHEM, V155, P331, DOI 10.1111/j.1432-1033.1986.tb09495.x; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Rhee KH, 1997, NATURE, V389, P522, DOI 10.1038/39103; SATOH K, 1993, PHOTOSYNTHETIC REACT, V1, P289; vanWijk KJ, 1996, J BIOL CHEM, V271, P9627, DOI 10.1074/jbc.271.16.9627; vanWijk KJ, 1997, BIOCHEMISTRY-US, V36, P6178, DOI 10.1021/bi962921l; vanWijk KJ, 1996, FEBS LETT, V388, P89, DOI 10.1016/0014-5793(96)00540-6; VANWIJK KJ, 1995, J BIOL CHEM, V270, P25685, DOI 10.1074/jbc.270.43.25685; Xiong J, 1998, PHOTOSYNTH RES, V56, P229, DOI 10.1023/A:1006061918025; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x	35	168	177	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16062	16067		10.1074/jbc.274.23.16062	http://dx.doi.org/10.1074/jbc.274.23.16062			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347157	hybrid			2022-12-27	WOS:000080668600017
J	Boffelli, D; Zajchowski, DA; Yang, ZY; Lawn, RM				Boffelli, D; Zajchowski, DA; Yang, ZY; Lawn, RM			Estrogen modulation of apolipoprotein(a) expression - Identification of a regulatory element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA LIPOPROTEIN(A) LEVELS; CORONARY HEART-DISEASE; TRANSGENIC MICE; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; TISSUE-SPECIFICITY; HUMAN PLASMINOGEN; DNA-BINDING; I GENE; RECEPTOR	Elevated plasma levels of the lipoprotein particle Lp(a) are a major risk factor for cardiovascular disease, Lp(a) plasma levels are determined by the level of expression of its characteristic protein component, apo(a), Apo(a) expression is modulated by several hormones, of which estrogens are the best known, The chromosomal region responsible for estrogen response was identified within an apo(a) enhancer located at similar to 26 kilobases from the apo(a) promoter. Although the estrogen-responsive unit contains a potential estrogen response element, binding of estrogen receptor-cu to DNA was not necessary. The receptor, activated by bound estradiol, interacts through its transactivation domains with a transcription factor necessary for the function of the enhancer, preventing its binding to DNA.	Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Stanford, CA 94305 USA; Berlex Biosci, Dept Canc Res, Richmond, CA 94804 USA	Stanford University	Lawn, RM (corresponding author), CV Therapeut, 3172 Porter Dr, Palo Alto, CA 94304 USA.				NHLBI NIH HHS [HL50590] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050590] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Blobel GA, 1996, MOL CELL BIOL, V16, P1687, DOI 10.1128/mcb.16.4.1687; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; BYRNE CD, 1994, ARTERIOSCLER THROMB, V14, P534, DOI 10.1161/01.ATV.14.4.534; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; Craig WY, 1998, CLIN CHEM, V44, P2301; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FARISH E, 1991, BRIT MED J, V303, P694, DOI 10.1136/bmj.303.6804.694; FEDOR M J, 1992, Current Opinion in Cell Biology, V4, P436, DOI 10.1016/0955-0674(92)90009-2; FRAZER KA, 1995, NAT GENET, V9, P424, DOI 10.1038/ng0495-424; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; Harnish DC, 1998, J BIOL CHEM, V273, P9270, DOI 10.1074/jbc.273.15.9270; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JENNER JL, 1993, CIRCULATION, V87, P1135, DOI 10.1161/01.CIR.87.4.1135; KIM CJ, 1994, ARTERIOSCLER THROMB, V14, P275, DOI 10.1161/01.ATV.14.2.275; KRAFT HG, 1992, HUM GENET, V90, P220; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LATCHMAN DS, 1995, EUKARYOTIC TRANSCRIP, P78; Lou XJ, 1998, P NATL ACAD SCI USA, V95, P12591, DOI 10.1073/pnas.95.21.12591; MAGNAGHI P, 1994, BIOCHEM BIOPH RES CO, V205, P930, DOI 10.1006/bbrc.1994.2754; MAGNAGHI P, 1994, HUM MOL GENET, V3, P437, DOI 10.1093/hmg/3.3.437; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Meroni G, 1996, EUR J BIOCHEM, V236, P373, DOI 10.1111/j.1432-1033.1996.00373.x; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; Ramharack R, 1997, BIOCHEM BIOPH RES CO, V238, P48, DOI 10.1006/bbrc.1997.7240; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; RYMER J, 1993, ACTA ENDOCRINOL-COP, V128, P259, DOI 10.1530/acta.0.1280259; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SOMA MR, 1993, ARCH INTERN MED, V153, P1462, DOI 10.1001/archinte.153.12.1462; Stein JH, 1997, ARCH INTERN MED, V157, P1170, DOI 10.1001/archinte.157.11.1170; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; UTTERMANN G, 1989, SCIENCE, V246, P904; von Lindern M, 1998, MOL ENDOCRINOL, V12, P263, DOI 10.1210/me.12.2.263; WADE DP, 1994, J BIOL CHEM, V269, P19757; Wade DP, 1997, J BIOL CHEM, V272, P30387, DOI 10.1074/jbc.272.48.30387; WALSH A, 1993, J LIPID RES, V34, P617; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; ZAJCHOWSKI DA, 1991, MOL ENDOCRINOL, V5, P1613, DOI 10.1210/mend-5-11-1613; Zysow BR, 1997, ARTERIOSCL THROM VAS, V17, P1741, DOI 10.1161/01.ATV.17.9.1741	55	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15569	15574		10.1074/jbc.274.22.15569	http://dx.doi.org/10.1074/jbc.274.22.15569			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336452	hybrid			2022-12-27	WOS:000080560100041
J	Cases, I; Perez-Martin, J; de Lorenzo, V				Cases, I; Perez-Martin, J; de Lorenzo, V			The IIA(Ntr) (PtsN) protein of Pseudomonas putida mediates the C source inhibition of the sigma(54)-dependent Pu promoter of the TOL plasmid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE REPRESSION CONTROL; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; FUNCTIONAL DOMAINS; RNA-POLYMERASE; SIGMA-FACTOR; RPON OPERON; GENE; EXPRESSION; XYLR	The gene cluster adjacent to the sequence of rpoN (encoding sigma factor sigma(54)) of Pseudomonas putida has been studied with respect to the C source regulation of the Pu promoter of the upper TOL (toluene catabolism) operon. The region includes four open reading frames (ORFs), two of which (named ptsN and ptsO genes) encode proteins similar to components of the phosphoenolpyruvate:sugar phosphotransferase system. Each of the four genes was disrupted with a nonpolar insertion, and the effects in the inhibition caused by glucose on Pu activity were inspected with a lacZ reporter system. Although cells lacking ORF102, ORF284, and ptsO did not display any evident phenotype under the conditions tested, the loss of ptsN, which encodes the IIA(Ntr) protein, made Pu unresponsive to repression by glucose. The ptsN mutant had rates of glucose/gluconate consumption identical to those of the wild type, thus ruling out indirect effects mediated by the transport of the carbohydrate, A site-directed ptsN mutant in which the conserved phospho-acceptor site His(68) Of IIANtr was replaced by an aspartic acid residue made Pu blind to the presence or absence of glucose, thus supporting the notion that phosphorylation of IIA(Ntr) mediates the C source inhibition of the promoter. These data substantiate the existence of a molecular pathway for co-regulation of some sigma(54) promoters in which IIA(Ntr) is a key protein intermediate.	Ctr Nacl Biotecnol Consejo Super Invest Cient, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de Lorenzo, V (corresponding author), Ctr Nacl Biotecnol Consejo Super Invest Cient, Campus Cantoblanco, Madrid 28049, Spain.	vdlorenzo@cnb.uam.es	Perez-Martin, Jose/K-5117-2014; Cases, Ildefonso/C-2998-2008	Perez-Martin, Jose/0000-0001-9849-7382; Cases, Ildefonso/0000-0002-8784-5174; de Lorenzo, Victor/0000-0002-6041-2731				Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; ASSINDER SJ, 1990, ADV MICROB PHYSIOL, V31, P1; BEGLEY GS, 1994, FEMS MICROBIOL LETT, V119, P389; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; Cases I, 1996, MOL MICROBIOL, V19, P7, DOI 10.1046/j.1365-2958.1996.345873.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; DELORENZO V, 1994, TRENDS BIOTECHNOL, V12, P365, DOI 10.1016/0167-7799(94)90037-X; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Du Y, 1996, RES MICROBIOL, V147, P129, DOI 10.1016/0923-2508(96)80212-9; Duetz WA, 1996, APPL ENVIRON MICROB, V62, P601, DOI 10.1128/AEM.62.2.601-606.1996; DUETZ WA, 1994, J BACTERIOL, V176, P2354, DOI 10.1128/JB.176.8.2354-2361.1994; EHRT S, 1994, J BACTERIOL, V176, P3493, DOI 10.1128/JB.176.12.3493-3499.1994; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; HOLTEL A, 1994, J BACTERIOL, V176, P1773, DOI 10.1128/jb.176.6.1773-1776.1994; HUGOUVIEUXCOTTEPATTAT N, 1990, J BACTERIOL, V172, P6651, DOI 10.1128/jb.172.12.6651-6660.1990; Janakiraman RS, 1997, J BACTERIOL, V179, P5138, DOI 10.1128/jb.179.16.5138-5147.1997; JIN SG, 1994, J BACTERIOL, V176, P1316, DOI 10.1128/jb.176.5.1316-1322.1994; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; KANIGA K, 1991, GENE, V103, P137; KOHLER T, 1989, NUCLEIC ACIDS RES, V17, P10125, DOI 10.1093/nar/17.23.10125; KOHLER T, 1989, J BACTERIOL, V171, P4326; KOHLER T, 1994, FEMS MICROBIOL LETT, V115, P177, DOI 10.1016/0378-1097(94)90010-8; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; MARQUES S, 1994, J BACTERIOL, V176, P2517; MERRICK MJ, 1989, MOL MICROBIOL, V3, P1765, DOI 10.1111/j.1365-2958.1989.tb00162.x; MERRICK MJ, 1995, NITROGEN FIXATION FU; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; PerezMartin J, 1996, GENE, V172, P81, DOI 10.1016/0378-1119(96)00193-X; PEREZMARTIN J, 1995, P NATL ACAD SCI USA, V92, P9392, DOI 10.1073/pnas.92.20.9392; PerezMartin J, 1996, J MOL BIOL, V258, P575, DOI 10.1006/jmbi.1996.0270; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; RunyenJanecky LJ, 1997, J BACTERIOL, V179, P2802, DOI 10.1128/jb.179.9.2802-2809.1997; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Saier MH, 1996, FEMS MICROBIOL LETT, V138, P97; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Romero JM, 1998, APPL ENVIRON MICROB, V64, P4040; SAWYER MH, 1977, ARCH MICROBIOL, V112, P49, DOI 10.1007/BF00446653; Schleissner C, 1997, MICROBIOL-SGM, V143, P1595, DOI 10.1099/00221287-143-5-1595; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; VICENTE M, 1973, J BACTERIOL, V116, P908, DOI 10.1128/JB.116.2.908-914.1973; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005	54	88	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15562	15568		10.1074/jbc.274.22.15562	http://dx.doi.org/10.1074/jbc.274.22.15562			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336451	hybrid			2022-12-27	WOS:000080560100040
J	Cross, AR; Erickson, RW; Curnutte, JT				Cross, AR; Erickson, RW; Curnutte, JT			Simultaneous presence of p47(phox) and flavocytochrome b(-245), are required for the activation of NADPH oxidase by anionic amphiphiles - Evidence for an intermediate state of oxidase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; SUPEROXIDE-GENERATING SYSTEM; CELL-FREE SYSTEM; HUMAN-NEUTROPHILS; CYTOCHROME-B; CYTOSOLIC COMPONENT; INDEPENDENT ACTIVATION; CONFORMATIONAL-CHANGES; ELECTRON FLOW; TRANSLOCATION	We have examined the kinetics of NADPH oxidase activation induced by arachidonic acid or SDS in a cell-free system using mixtures of recombinant Phox proteins and purified flavocytochrome b(-245). Activation of oxidase activity required the simultaneous presence of p47(phox), flavocytochrome b(-245), and the anionic amphiphile. The activation of electron transfer reactions was much more rapid when iodonitrotetrazolium violet was used as electron acceptor than when oxygen alone was the acceptor. We propose that this difference represents an intermediate activation state of NADPH oxidase in which electron flow can proceed hom NADPH to enzyme flavin (and hence to iodonitrotetrazolium violet) but not from flavin to heme (or not between the hemes). A model for NADPH oxidase activation is presented that is consistent with these observations.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Scripps Research Institute; Roche Holding; Genentech	Cross, AR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM-241,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NIAID NIH HHS [AI24838] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBRUSO DR, 1990, J BIOL CHEM, V265, P924; BABIOR BM, 1988, J BIOL CHEM, V263, P1713; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BELLAVITE P, 1983, BIOCHIM BIOPHYS ACTA, V746, P40, DOI 10.1016/0167-4838(83)90008-0; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CROSS AR, 1984, BIOCHEM J, V223, P337, DOI 10.1042/bj2230337; Cross AR, 1999, BIOCHEM J, V338, P229, DOI 10.1042/0264-6021:3380229; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CROSS AR, 1995, J BIOL CHEM, V270, P6543, DOI 10.1074/jbc.270.12.6543; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; CROSS AR, 1994, J BIOL CHEM, V269, P21448; CROSS AR, 1984, P 8 INT S FLAV FLAV; ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; FUJIMOTO S, 1989, J BIOL CHEM, V264, P21629; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; KLEINBERG ME, 1990, J BIOL CHEM, V265, P15577; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Koshkin V, 1995, BBA-BIOENERGETICS, V1232, P225, DOI 10.1016/0005-2728(95)00123-9; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; OHTSUKA T, 1990, J BIOCHEM-TOKYO, V108, P169, DOI 10.1093/oxfordjournals.jbchem.a123177; Park HS, 1998, BBA-PROTEIN STRUCT M, V1387, P406, DOI 10.1016/S0167-4838(98)00152-6; QUINN MT, 1993, J BIOL CHEM, V268, P20983; QUINN MT, 1992, J BIOL CHEM, V267, P7303; ROOS D, 1997, PRIMARY IMMUNODEFICI, P318; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Swain SD, 1997, J BIOL CHEM, V272, P29502, DOI 10.1074/jbc.272.47.29502; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; UHLINGER DJ, 1994, J BIOL CHEM, V269, P22095; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; YOSHIDA LS, 1992, BIOCHIM BIOPHYS ACTA, V1135, P245	35	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15519	15525		10.1074/jbc.274.22.15519	http://dx.doi.org/10.1074/jbc.274.22.15519			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336445	hybrid			2022-12-27	WOS:000080560100034
J	Patel, RP; Hogg, N; Spencer, NY; Kalyanaraman, B; Matalon, S; Darley-Usmar, VM				Patel, RP; Hogg, N; Spencer, NY; Kalyanaraman, B; Matalon, S; Darley-Usmar, VM			Biochemical characterization of human S-nitrosohemoglobin - Effects on oxygen binding and transnitrosation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MASS-SPECTROMETRY; NITROGEN-OXIDES; HEMOGLOBIN; NITROSOGLUTATHIONE; NITROSYLATION; ACTIVATION; RECEPTOR; PROTEINS; THIOLS	S-Nitrosation of cysteine beta 93 in hemoglobin (S-nitrosohemoglobin (SNO-Hb)) occurs in vivo, and transnitrosation reactions of deoxygenated SNO-Hb are proposed as a mechanism leading to release of NO and control of blood flow. However, little is known of the oxygen binding properties of SNO-Hb or the effects of oxygen on transnitrosation between SNO-Hb and the dominant low molecular weight thiol in the red blood cell, GSH, These data are important as they would provide a biochemical framework to assess the physiological function of SNO-Hb, Our results demonstrate that SNO-Hb has a higher affinity for oxygen than native Hb, This implies that NO transfer from SNO-Hb in vivo would be limited to regions of extremely low oxygen tension if this were to occur from deoxygenated SNO-Hb. Furthermore, the kinetics of the transnitrosation reactions between GSH and SNO-Hb are relatively slow, making transfer of NO+ from SNO-Hb to GSH less likely as a mechanism to elicit vessel relaxation under conditions of low oxygen tension and over the circulatory lifetime of a given red blood cell. These data suggest that the reported oxygen-dependent promotion of S-nitrosation from SNO-Hb involves biochemical mechanisms that are not intrinsic to the Hb molecule.	Univ Alabama Birmingham, Dept Pathol, Mol & Cellular Div, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Anesthesiol Physiol & Biophys, Birmingham, AL 35294 USA; Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical College of Wisconsin	Darley-Usmar, VM (corresponding author), Univ Alabama Birmingham, Dept Pathol, Mol & Cellular Div, Volker Hall,Rm GO19,1670 Univ Blvd, Birmingham, AL 35294 USA.	darley@path.uab.edu	Spencer, Netanya/AAS-7999-2020; Darley-Usmar, Victor/F-7656-2010	Spencer, Netanya/0000-0003-1010-5458; Patel, Rakesh/0000-0002-1526-4303; Darley-Usmar, Victor/0000-0001-8921-7086	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031197, R01HL031197, R01HL051173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055792, R01GM055792] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL51173, HL31197] Funding Source: Medline; NIGMS NIH HHS [GM55792] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HAEMOGLOBIN MYOGLOBI; BENESCH R, 1969, NATURE, V221, P618, DOI 10.1038/221618a0; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; CRAESCU CT, 1986, J BIOL CHEM, V261, P4710; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Feelisch M., 1996, METHODS NITRIC OXIDE; Ferranti P, 1997, FEBS LETT, V400, P19, DOI 10.1016/S0014-5793(96)01258-6; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Funai EF, 1997, BIOCHEM BIOPH RES CO, V239, P875, DOI 10.1006/bbrc.1997.7565; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HARANO K, 1984, FEBS LETT, V173, P45, DOI 10.1016/0014-5793(84)81014-5; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KILMARTIN IV, 1976, BR MED B, V32, P209; KILMARTIN JV, 1973, P NATL ACAD SCI USA, V70, P1246, DOI 10.1073/pnas.70.4.1246; Kluge I, 1997, J NEUROCHEM, V69, P2599; Kosaka H, 1996, BIOCHEM BIOPH RES CO, V218, P749, DOI 10.1006/bbrc.1996.0133; KULCHAN MJ, 1994, AM J PHYSIOL, V267, pC753; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LIU X, 1988, J BIOL CHEM, V273, P1870; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pawloski JR, 1998, CIRCULATION, V97, P263, DOI 10.1161/01.CIR.97.3.263; RIGGS A, 1961, J BIOL CHEM, V236, P1948; Rossi R, 1997, ANAL BIOCHEM, V254, P215, DOI 10.1006/abio.1997.2424; SCHARFSTEIN JS, 1994, J CLIN INVEST, V94, P1432, DOI 10.1172/JCI117480; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; Tsai AG, 1998, P NATL ACAD SCI USA, V95, P6590, DOI 10.1073/pnas.95.12.6590; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	35	122	124	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15487	15492		10.1074/jbc.274.22.15487	http://dx.doi.org/10.1074/jbc.274.22.15487			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336440	hybrid			2022-12-27	WOS:000080560100029
J	Rozwarski, DA; Vilcheze, C; Sugantino, M; Bittman, R; Sacchettini, JC				Rozwarski, DA; Vilcheze, C; Sugantino, M; Bittman, R; Sacchettini, JC			Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD(+) and a C16 fatty acyl substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN REDUCTASE; MYCOLIC ACID BIOSYNTHESIS; ESCHERICHIA-COLI; ISONIAZID TARGET; BRASSICA-NAPUS; 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE; DRUG-RESISTANCE; CELL-WALL; GENE; FABI	Enoyl-ACP reductases participate in fatty acid biosynthesis by utilizing NADH to reduce the trans double bond between positions C2 and C3 of a fatty acyl chain linked to the acyl carrier protein. The enoyl-ACP reductase from My. cobacterium tuberculosis, known as InhA, is a member of an unusual FAS-II system that prefers longer chain fatty acyl substrates for the purpose of synthesizing mycolic acids, a major component of mycobacterial cell walls. The crystal structure of InhA in complex with NAD(+) and a C16 fatty acyl substrate, trans-2-hexadecenoyl-(N-acetylcysteamine)-thioester, reveals that the substrate binds in a general "U-shaped" conformation, with the trans double bond positioned directly adjacent to the nicotinamide ring of NAD(+). The side chain of Tyr(158) directly interacts with the thioester carbonyl oxygen of the C16 fatty acyl substrate and therefore could help stabilize the enolate intermediate, proposed to form during substrate catalysis, Hydrophobic residues, primarily from the substrate binding loop (residues 196-219), engulf the fatty acyl chain portion of the substrate. The substrate binding loop of InhA is longer than that of other enoyl-ACP reductases and creates a deeper substrate binding crevice, consistent with the ability of InhA to recognize longer chain fatty acyl substrates.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	Texas A&M University System; Texas A&M University College Station; Yeshiva University; Albert Einstein College of Medicine; City University of New York (CUNY) System; Queens College NY (CUNY)	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI036849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045859] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36849] Funding Source: Medline; NIGMS NIH HHS [GM45859] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER ME, 1995, BIOCHEM J, V309, P1029, DOI 10.1042/bj3091029; Baldock C, 1996, SCIENCE, V274, P2107, DOI 10.1126/science.274.5295.2107; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Basso LA, 1996, J AM CHEM SOC, V118, P11301, DOI 10.1021/ja962035y; Bergler H, 1996, EUR J BIOCHEM, V242, P689, DOI 10.1111/j.1432-1033.1996.0689r.x; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Blanchard JS, 1996, ANNU REV BIOCHEM, V65, P215, DOI 10.1146/annurev.bi.65.070196.001243; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CHRISTOPHER JA, 1998, SPOCK SOFTWARE VERSI; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DAVIDSON LA, 1979, ANTIMICROB AGENTS CH, V16, P104, DOI 10.1128/AAC.16.1.104; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1; FAWCETT T, 1994, PLANT MOL BIOL, V26, P155, DOI 10.1007/BF00039528; FULCO AJ, 1983, PROG LIPID RES, V22, P133, DOI 10.1016/0163-7827(83)90005-X; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; HEYM B, 1994, LANCET, V344, P293, DOI 10.1016/S0140-6736(94)91338-2; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KATER MM, 1994, PLANT MOL BIOL, V25, P771, DOI 10.1007/BF00028873; KATER MM, 1991, PLANT MOL BIOL, V17, P895, DOI 10.1007/BF00037070; KIKUCHI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P318, DOI 10.1016/0003-9861(92)90524-Z; Kleerebezem M, 1996, RES MICROBIOL, V147, P609, DOI 10.1016/0923-2508(96)84016-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LACAVE C, 1990, BIOCHIM BIOPHYS ACTA, V1045, P58, DOI 10.1016/0005-2760(90)90203-A; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; LOPEZMARIN LM, 1991, BIOCHIM BIOPHYS ACTA, V1086, P22, DOI 10.1016/0005-2760(91)90150-G; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Musser JM, 1996, J INFECT DIS, V173, P196, DOI 10.1093/infdis/173.1.196; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Quemard A, 1996, J AM CHEM SOC, V118, P1561, DOI 10.1021/ja950998b; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; QURESHI N, 1984, J BACTERIOL, V157, P46, DOI 10.1128/JB.157.1.46-52.1984; RAFFERTY JB, 1995, STRUCTURE, V3, P927, DOI 10.1016/S0969-2126(01)00227-1; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; ROUSE DA, 1995, ANTIMICROB AGENTS CH, V39, P2472, DOI 10.1128/AAC.39.11.2472; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Sacchettini JC, 1996, RES MICROBIOL, V147, P36, DOI 10.1016/0923-2508(96)80201-4; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; TAKAYAMA K, 1975, J LIPID RES, V16, P308; TAKAYAMA K, 1972, ANTIMICROB AGENTS CH, V2, P29, DOI 10.1128/AAC.2.1.29; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wheeler PR, 1996, BIOCHEM J, V318, P451, DOI 10.1042/bj3180451; WHEELER PR, 1993, BIOCHIM BIOPHYS ACTA, V1167, P182, DOI 10.1016/0005-2760(93)90160-B; WINDER F G, 1970, Journal of General Microbiology, V63, P41; YOSHIMOTO T, 1991, J BACTERIOL, V173, P2173, DOI 10.1128/JB.173.7.2173-2179.1991; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6; YOUNG DB, 1994, CURR BIOL, V4, P351, DOI 10.1016/S0960-9822(00)00077-4; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731	56	224	230	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15582	15589		10.1074/jbc.274.22.15582	http://dx.doi.org/10.1074/jbc.274.22.15582			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336454	hybrid			2022-12-27	WOS:000080560100043
J	Wallin, JJ; Rinkenberger, JL; Rao, S; Gackstetter, ER; Koshland, ME; Zwollo, P				Wallin, JJ; Rinkenberger, JL; Rao, S; Gackstetter, ER; Koshland, ME; Zwollo, P			B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'ALPHA ENHANCER; GENE-EXPRESSION; BSAP; TRANSCRIPTION; DNA; DIFFERENTIATION; REPRESSOR; SEQUENCE; ELEMENT	The immunoglobulin J chain gene is inducibly transcribed in mature B cells upon antigen recognition and a signal from interleubin-2 (IL-2). B cell-specific activator protein (BSAP), a transcription factor that silences J chain transcription, has been identified as a nuclear target of the IL-2 signal, The levels of BSAP progressively decrease in response to IL-2 and this change correlates with the differentiation of B cells into antibody secreting plasma cells. Here we report the binding of the upstream stimulatory factor (USF) to an E-box motif immediately upstream from the BSAP site on the J chain promoter. Mutations in the USF binding motif significantly decrease J chain promoter activity in J chain expressing B cell lines. We also show that a functional relationship exists between USF and a second J chain positive-regulating factor, B-MEF2, using co-immunoprecipitation assays and transfections. Finally, we provide evidence that the binding of BSAP prevents USF and B-IMEF2 from interacting with the J chain promoter during the antigen-independent stages of B cell development. It is not until the levels of BSAP decrease during the antigen-driven stages of B cell development that both USF and B-IMEF2 are able to bind to their respective promoter elements and activate J chain transcription.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	William & Mary; University of California System; University of California Berkeley	Zwollo, P (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	Pxzwol@facstaff.wm.edu		Wallin, Jeffrey/0000-0002-5952-3813	NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NCI NIH HHS [CA09179] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BUSSLINGER M, 1995, CURR OPIN GENET DEV, V5, P595, DOI 10.1016/0959-437X(95)80028-X; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; HALLE JP, 1995, J BIOL CHEM, V270, P21307, DOI 10.1074/jbc.270.36.21307; KOKUBO T, 1993, J BIOL CHEM, V268, P17554; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; LANSFORD RD, 1992, P NATL ACAD SCI USA, V89, P5966, DOI 10.1073/pnas.89.13.5966; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; MCFADDEN HJ, 1991, P NATL ACAD SCI USA, V88, P11027, DOI 10.1073/pnas.88.24.11027; Michaelson JS, 1996, J IMMUNOL, V156, P2349; MINIE ME, 1986, MOL CELL BIOL, V6, P4031, DOI 10.1128/MCB.6.11.4031; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; NEURATH MF, 1995, IMMUNOL TODAY, V16, P564, DOI 10.1016/0167-5699(95)80078-6; NEURATH MF, 1994, J IMMUNOL, V153, P730; PETERSON CL, 1986, MOL CELL BIOL, V6, P4168, DOI 10.1128/MCB.6.12.4168; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Rao S, 1998, J BIOL CHEM, V273, P26123, DOI 10.1074/jbc.273.40.26123; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961	30	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15959	15965		10.1074/jbc.274.22.15959	http://dx.doi.org/10.1074/jbc.274.22.15959			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336503	hybrid			2022-12-27	WOS:000080560100092
J	Blaukat, A; Ivankovic-Dikic, I; Gronroos, E; Dolfi, F; Tokiwa, G; Vuori, K; Dikic, I				Blaukat, A; Ivankovic-Dikic, I; Gronroos, E; Dolfi, F; Tokiwa, G; Vuori, K; Dikic, I			Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SRC FAMILY KINASES; TYROSINE KINASE; CELL-ADHESION; SIGNALING PATHWAY; IN-VIVO; SH3 DOMAINS; V-CRK; RECEPTOR; PHOSPHORYLATION	The protein tyrosine kinase Pyk2 acts as an upstream regulator of mitogen-activated protein (MAP) kinase cascades in response to numerous extracellular signals. The precise molecular mechanisms by which Pyk2 activates distinct MAP kinase pathways are not yet fully understood. In this report, we provide evidence that the protein tyrosine kinase Src and adaptor proteins Grb2, Crk, and p130Cas act as downstream mediators of Pyk2 leading to the activation of extracellular signal-regulated kinase (ERK) and c-Jun amino-terminal kinase (JNK). Pyk2-induced activation of Src is necessary for phosphorylation of Shc and p130Cas and their association with Grb2 and Crk, respectively, and for the activation of ERK and JNK cascades. Expression of a Grb2 mutant with a deletion of the amino-terminal Src homology 3 domain or the carboxyl-terminal tail of Sos strongly reduced Pyk2-induced ERK activation, with no apparent effect on JNK activity. Grb2 with a deleted carboxyl-terminal Src homology 3 domain partially blocked Pyk2-induced ERK and JNK pathways, whereas expression of dominant interfering mutants of p130Cas or Crk specifically inhibited JNK but not ERK activation by Pyk2. Taken together, our data reveal specific pathways that couple Pyk2 with MAP kinases: the Grb2/Sos complex connects Pyk2 to the activation of ERK, whereas adaptor proteins p130Cas and Crk link Pyk2 with the JNK pathway.	Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA; Burnham Inst, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; New York University; Sanford Burnham Prebys Medical Discovery Institute	Dikic, I (corresponding author), Ludwig Inst Canc Res, Box 595,Husargatan 3, S-75124 Uppsala, Sweden.	Ivan.Dikic@licr.uu.se	Gronroos, Eva/E-9351-2013; Gronroos, Eva/P-6951-2015; Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511; Gronroos, Eva/0000-0001-8303-5409	NCI NIH HHS [CA71560] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071560] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Butler AA, 1997, J BIOL CHEM, V272, P27660, DOI 10.1074/jbc.272.44.27660; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Ganju RK, 1998, BLOOD, V91, P791, DOI 10.1182/blood.V91.3.791.791_791_797; GISHIZKY ML, 1995, P NATL ACAD SCI USA, V92, P10889, DOI 10.1073/pnas.92.24.10889; Gismondi A, 1997, J IMMUNOL, V159, P4729; Hatch WC, 1998, BLOOD, V91, P3967, DOI 10.1182/blood.V91.10.3967.3967_3967_3973; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kiyokawa E, 1997, CRIT REV ONCOGENESIS, V8, P329, DOI 10.1615/CritRevOncog.v8.i4.30; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; KIYOKAWA E, GENES DEV, V2, P3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lev S, 1999, MOL CELL BIOL, V19, P2278; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nakashima N, 1999, J BIOL CHEM, V274, P3001, DOI 10.1074/jbc.274.5.3001; Neet K, 1996, GENES CELLS, V1, P147, DOI 10.1046/j.1365-2443.1996.d01-234.x; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Ohba T, 1998, BIOCHEM J, V330, P1249, DOI 10.1042/bj3301249; Okazaki H, 1997, J BIOL CHEM, V272, P32443, DOI 10.1074/jbc.272.51.32443; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Pomerance M, 1998, J BIOL CHEM, V273, P24301, DOI 10.1074/jbc.273.38.24301; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; RAABE T, 1995, EMBO J, V14, P2509, DOI 10.1002/j.1460-2075.1995.tb07248.x; Raja S, 1997, J BIOL CHEM, V272, P10941; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SALGIA R, 1995, J BIOL CHEM, V270, P29145, DOI 10.1074/jbc.270.49.29145; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Xie YM, 1995, J BIOL CHEM, V270, P30717, DOI 10.1074/jbc.270.51.30717; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu T, 1998, J BIOL CHEM, V273, P33864, DOI 10.1074/jbc.273.50.33864	67	179	181	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14893	14901		10.1074/jbc.274.21.14893	http://dx.doi.org/10.1074/jbc.274.21.14893			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329689	hybrid			2022-12-27	WOS:000081965200054
J	Kasahara, M; Ohmori, M				Kasahara, M; Ohmori, M			Activation of a cyanobacterial adenylate cyclase, CyaC, by autophosphorylation and a subsequent phosphotransfer reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; SPIRULINA-PLATENSIS; ANABAENA-CYLINDRICA; DIFFERENTIAL ACTIVATION; BACTERIAL CHEMOTAXIS; MYXOCOCCUS-XANTHUS; ESCHERICHIA-COLI; RAS PROTEINS; GENE; PHOSPHORYLATION	The CyaC protein, a cyanobacterial adenylate cyclase, has a unique primary structure composed of the catalytic domain of adenylate cyclase and the conserved domains of bacterial two-component regulatory systems, one transmitter domain and two receiver domains. In the present work, CyaC was produced in Escherichia coli as a histidine-tagged recombinant protein and purified to homogeneity, CyaC showed ability to autophosphorylate in vitro with the gamma-phosphate of [gamma-P-32]ATP. CyaC derivatives were constructed by site-directed mutagenesis in which the highly conserved phosphorylation sites in the transmitter domain (His(572)) and receiver domains (Asp(60) or. Asp(895)) were replaced by glutamine and alanine residues, respectively. After autophosphorylation of the CyaC derivatives, the chemical stabilities of the phosphoryl groups bound to the derivatives were determined. It was found that His(572) is the initial phosphorylation site and that the phosphoryl group once bound to His(572) is transferred to Asp(895). The enzyme activities of the CyaC derivatives defective in His572 Or Asp(895) were considerably reduced. Asp(895) is phosphorylated by acetyl [P-32]phosphate, a small phosphoryl molecule, but Asp(60) is not. Acetyl phosphate stimulates adenylate cyclase activity only when Asp(895) is intact. These results suggest that the phosphorylation of Asp(895) is essential for the activation of adenylate cyclase and that Asp(60) functions differently from Asp(895) in regulating the enzyme activity.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 153, Japan	University of Tokyo	Ohmori, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 153, Japan.	cohmori@komaba.ecc.u-tokyo.ac.jp						BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; HOOD EE, 1979, BIOCHIM BIOPHYS ACTA, V588, P193, DOI 10.1016/0304-4165(79)90202-2; IGO MM, 1989, GENE DEV, V3, P598, DOI 10.1101/gad.3.5.598; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; Kaneko T, 1996, DNA Res, V3, P109; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; Katayama M, 1997, J BACTERIOL, V179, P3588, DOI 10.1128/jb.179.11.3588-3593.1997; KATAYAMA M, 1995, J BACTERIOL, V177, P3873, DOI 10.1128/jb.177.13.3873-3878.1995; KAWABE J, 1994, J BIOL CHEM, V269, P16554; KOSHLAND DE, 1952, J AM CHEM SOC, V74, P2286, DOI 10.1021/ja01129a035; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MCCLEARY WR, 1990, P NATL ACAD SCI USA, V87, P5898, DOI 10.1073/pnas.87.15.5898; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; OHMORI K, 1992, PLANT CELL PHYSIOL, V33, P21; OHMORI M, 1989, PLANT CELL PHYSIOL, V30, P911, DOI 10.1093/oxfordjournals.pcp.a077824; OHMORI M, 1988, ARCH MICROBIOL, V150, P203, DOI 10.1007/BF00425163; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; REDDY P, 1985, P NATL ACAD SCI USA, V82, P8300, DOI 10.1073/pnas.82.24.8300; RUSSO FD, 1993, J MOL BIOL, V231, P261, DOI 10.1006/jmbi.1993.1281; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Yashiro K, 1996, PLANT MOL BIOL, V31, P175, DOI 10.1007/BF00020618; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	38	36	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15167	15172		10.1074/jbc.274.21.15167	http://dx.doi.org/10.1074/jbc.274.21.15167			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329724	hybrid			2022-12-27	WOS:000081965200089
J	Zhang, YF; Pasparakis, M; Kollias, G; Simons, M				Zhang, YF; Pasparakis, M; Kollias, G; Simons, M			Myocyte-dependent regulation of endothelial cell syndecan-4 expression - Role of TNF-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; HEPARAN-SULFATE PROTEOGLYCANS; MOLECULAR-CLONING; GENE-EXPRESSION; PHOSPHORYLATION; ANGIOGENESIS; ISCHEMIA	Syndecan-4 is a unique member of the syndecan gene family that has the ability to bind and activate protein kinase C-alpha. Whereas increased syndecan-4 levels have been noted in ischemic hearts, little is known regarding the regulation of its expression. To investigate the role of cardiac myocytes in induction of syndecan-4 expression, human endothelial cells (ECV304) mere exposed to a medium conditioned by primary mouse cardiac myocytes or H9c2 cells. The medium conditioned by hypoxic but not normal myocytes was able to induce syndecan-4 expression in ECV cells. Western analysis of the conditioned medium demonstrated an increased presence of tumor necrosis factor-alpha (TNF-alpha) in the medium conditioned by hypoxic but not normal myoblasts. Primary cardiac myocytes collected from the wild type C57/129 but not the homozygous TNF-alpha(-/-) knockout mice were able to induce syndecan-4 expression in ECV cells when cultured under hypoxic conditions. In vitro studies demonstrated that TNF-alpha induced endothelial cell syndecan-4 expression by both increasing syndecan-4 gene expression in an NF-KB-dependent manner and by prolonging syndecan-4 mRNA half-life. We conclude that TNF-alpha is the principal factor produced by the ischemic myocytes that is responsible for induction of endothelial cell syndecan-4 expression and that this requires both transcriptional and posttranscriptional mechanisms.	Beth Israel Deaconess Med Ctr, Div Cardiovasc, Dept Med, Angiogenesis Res Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Hellen Pasteur Inst, Genet Mol Lab, Athens 11521, Greece	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Simons, M (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, Dept Med, Angiogenesis Res Ctr, 330 Brookline Ave, Boston, MA 02215 USA.		Kollias, George/A-7079-2012; Pasparakis, Manolis/H-9292-2017; Simons, Michael/G-8553-2014; Pasparakis, Manolis/N-4350-2019	Kollias, George/0000-0003-1867-3150; Pasparakis, Manolis/0000-0002-9870-0966; Simons, Michael/0000-0003-0348-7734; Pasparakis, Manolis/0000-0002-9870-0966	NHLBI NIH HHS [R01 HL53793, P50 HL56993] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793, P50HL056993] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carey DJ, 1997, BIOCHEM J, V327, P1; Chandrasekar B, 1997, CLIN EXP IMMUNOL, V108, P346, DOI 10.1046/j.1365-2249.1997.d01-1017.x; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Gurevitch J, 1996, J AM COLL CARDIOL, V28, P247, DOI 10.1016/0735-1097(96)00105-2; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; Li JA, 1997, CIRC RES, V81, P785; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; MONTRUCCHIO G, 1994, J EXP MED, V180, P377, DOI 10.1084/jem.180.1.377; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; Norrby K, 1996, MICROVASC RES, V52, P79, DOI 10.1006/mvre.1996.0045; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Tsuzuki S, 1997, J BIOCHEM-TOKYO, V122, P17; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058	20	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14786	14790		10.1074/jbc.274.21.14786	http://dx.doi.org/10.1074/jbc.274.21.14786			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329676	hybrid			2022-12-27	WOS:000081965200041
J	Shirane, M; Harumiya, Y; Ishida, N; Hirai, A; Miyamoto, C; Hatakeyama, S; Nakayama, K; Kitagawa, M				Shirane, M; Harumiya, Y; Ishida, N; Hirai, A; Miyamoto, C; Hatakeyama, S; Nakayama, K; Kitagawa, M			Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; NF-KAPPA-B; CELL-CYCLE; PROTEASOME PATHWAY; PROTEIN-DEGRADATION; BREAST-CANCER; FRTL-5 CELLS; MICE LACKING; S-PHASE; ACTIVATION	The intracellular level of p27(Kip1), a cyclin-dependent kinase (CDK) inhibitory protein, is rapidly reduced at the G(1)/S transition phase when the cell cycle pause ceases. In this study, we demonstrated that two posttranslational mechanisms were involved in p27(Kip1) breakdown: degradation via the ubiquitin (Ub)-proteasome pathway and proteolytic processing that rapidly eliminates the cyclin-binding domain. We confirmed that p27(Kip1) was ubiquitinated in vitro as well as in vivo. The p27(Kip1) -ubiquitination activity was higher at the G(1)/S boundary than during the G(0)/G(1) phase, and p27(Kip1) ubiquitination was reduced significantly when the lysine residues at positions 134, 153, and 165 were replaced by arginine, suggesting that these lysine residues are the targets for Ub conjugation. In parallel with its Uh-dependent degradation, p27(Kip1) was processed rapidly at its N terminus, reducing its molecular mass from 27 to 22 kDa, by a ubiquitination-independent but adenosine triphosphate (ATP)-dependent mechanism with higher activity during the S than the G(0)/G(1) phase. This 22-kDa intermediate had no cyclin-binding domain at its N terminus and virtually no CDK2 kinase inhibitory activity. These results suggest that p27(Kip1) is eliminated by two independent mechanisms, ubiquitin-mediated degradation and ubiquitin-independent processing, during progression from the G(1) to S phase.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Japanese Fdn Canc Res, Inst Canc, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Tokyo 1708455, Japan; Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 2600856, Japan; Chiba Prefectural Togane Hosp, Togane 2838588, Japan; Nippon Roche Res Ctr, Kamakura, Kanagawa 2470063, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Chiba University; Roche Holding	Nakayama, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	高, 雨莉/HGU-8187-2022; Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hirai A, 1997, J BIOL CHEM, V272, P13; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kawana H, 1998, AM J PATHOL, V153, P505, DOI 10.1016/S0002-9440(10)65593-9; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KITAGAWA M, 1994, ONCOGENE, V9, P2549; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Steeg PS, 1997, NAT MED, V3, P152, DOI 10.1038/nm0297-152; Tanaka T, 1998, J BIOL CHEM, V273, P26772, DOI 10.1074/jbc.273.41.26772; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tokumoto T, 1997, J CELL BIOL, V138, P1313, DOI 10.1083/jcb.138.6.1313; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Uren A, 1997, J BIOL CHEM, V272, P21669, DOI 10.1074/jbc.272.35.21669; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yamamoto K, 1996, ENDOCRINOLOGY, V137, P2036, DOI 10.1210/en.137.5.2036	47	214	221	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13886	13893		10.1074/jbc.274.20.13886	http://dx.doi.org/10.1074/jbc.274.20.13886			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318797	hybrid			2022-12-27	WOS:000080322200026
J	Abu-Elneel, K; Kapeller, I; Shlomai, J				Abu-Elneel, K; Kapeller, I; Shlomai, J			Universal minicircle sequence-binding protein, a sequence-specific DNA-binding protein that recognizes the two replication origins of the kinetoplast DNA minicircle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; CRITHIDIA-FASCICULATA; TRYPANOSOMA-EQUIPERDUM; GENOMIC ORGANIZATION; NETWORKS; DISCONTINUITIES; TRANSCRIPTION; PURIFICATION; SITES; GAP	Replication of the kinetoplast DNA minicircle lagging (heavy (H)) strand initiates at, or near, a unique hexameric sequence (5'-ACGCCC-3') that is conserved in the minicircles of trypanosomatid species. A protein from the trypanosomatid Crithidia fasciculata binds specifically a 14-mer sequence, consisting of the complementary strand hexamer and eight flanking nucleotides at the H-strand replication origin, This protein was identified as the previously described universal minicircle sequence (UMS)-binding protein (UMSBP) (Tzfati, Y,, Abeliovich, H,, Avrahami, D,, and Shlomai, J, (1995) J. Biol. Chem, 270, 21339-21345), This CCHC-type zinc finger protein binds the single-stranded form of both the 12-mer (UMS) and 14-mer sequences, at the replication origins of the minicircle L-strand and H-strand, respectively. The attribution of the two different DNA binding activities to the same protein relies on their co-purification from C, fasciculata cell extracts and on the high affinity of recombinant UMSBP to the two origin-associated sequences. Both the conserved H-strand hexamer and its nanking nucleotides at the replication origin are required for binding. Neither the hexameric sequence per se nor this sequence flanked by different sequences could support the generation of specific nucleoprotein complexes, Stoichiometry analysis indicates that each UMSBP molecule binds either of the two origin-associated sequences in the nucleoprotein complex but not both simultaneously.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Shlomai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, IL-91120 Jerusalem, Israel.							ABELIOVICH H, 1995, ANAL BIOCHEM, V228, P351, DOI 10.1006/abio.1995.1363; ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; BIRKENMEYER L, 1986, J BIOL CHEM, V261, P2362; BIRKENMEYER L, 1987, J BIOL CHEM, V262, P2384; BRACK C, 1972, P NATL ACAD SCI USA, V69, P1642, DOI 10.1073/pnas.69.6.1642; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEPAMPHILIS ML, 1996, DNA REPLICATION EUKA, P45; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; Englund Paul T., 1995, MBL (Marine Biology Laboratory) Lectures in Biology, V12, P147; ENGLUND PT, 1977, J BIOL CHEM, V252, P6208; ENGLUND PT, 1978, CELL, V14, P157, DOI 10.1016/0092-8674(78)90310-0; ENGLUND PT, 1982, ANNU REV BIOCHEM, V51, P695, DOI 10.1146/annurev.bi.51.070182.003403; ENGLUND PT, 1979, J BIOL CHEM, V254, P4895; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIED MG, 1984, J MOL BIOL, V172, P241, DOI 10.1016/S0022-2836(84)80025-X; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KITCHIN PA, 1985, J BIOL CHEM, V260, P3844; KITCHIN PA, 1986, J BIOL CHEM, V261, P1302; KORNBERG A, 1991, DNA REPLICATION, P511; LIUJOHNSON HN, 1986, CELL, V47, P995, DOI 10.1016/0092-8674(86)90814-7; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; NTAMBI JM, 1985, J BIOL CHEM, V260, P5574; NTAMBI JM, 1986, J BIOL CHEM, V261, P1890; PEREZMORGA D, 1993, J CELL BIOL, V123, P1069, DOI 10.1083/jcb.123.5.1069; PEREZMORGA DL, 1993, CELL, V74, P703, DOI 10.1016/0092-8674(93)90517-T; RAY DS, 1987, PLASMID, V17, P177, DOI 10.1016/0147-619X(87)90026-6; RYAN KA, 1989, J BIOL CHEM, V264, P823; RYAN KA, 1988, ANNU REV MICROBIOL, V42, P339, DOI 10.1146/annurev.mi.42.100188.002011; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SHELINE C, 1989, MOL BIOCHEM PARASIT, V37, P151, DOI 10.1016/0166-6851(89)90147-3; SHELINE C, 1989, MOL CELL BIOL, V9, P169, DOI 10.1128/MCB.9.1.169; SHLOMAI J, 1986, J BIOL CHEM, V261, P6219; SHLOMAI J, 1994, PARASITOL TODAY, V10, P341, DOI 10.1016/0169-4758(94)90244-5; SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; STUART K, 1992, INT REV CYTOL, V141, P65, DOI 10.1016/S0074-7696(08)62063-X; SUGISAKI H, 1987, MOL BIOCHEM PARASIT, V23, P253, DOI 10.1016/0166-6851(87)90032-6; TORRI AL, 1996, DNA REPLICATION EUKA, P1029; TZFATI Y, 1992, P NATL ACAD SCI USA, V89, P6891, DOI 10.1073/pnas.89.15.6891; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Tzfati Y, 1998, MOL BIOCHEM PARASIT, V94, P137, DOI 10.1016/S0166-6851(98)00052-8	45	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13419	13426		10.1074/jbc.274.19.13419	http://dx.doi.org/10.1074/jbc.274.19.13419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224106	hybrid			2022-12-27	WOS:000080200400068
J	Cho, WL; Tsao, SM; Hays, AR; Walter, R; Chen, JS; Snigirevskaya, ES; Raikhel, AS				Cho, WL; Tsao, SM; Hays, AR; Walter, R; Chen, JS; Snigirevskaya, ES; Raikhel, AS			Mosquito cathepsin B-like protease involved in embryonic degradation of vitellin is produced as a latent extraovarian precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							29-KDA HEMOCYTE PROTEINASE; AMINO-ACID-SEQUENCES; CYSTEINE PROTEINASE; FAT-BODY; YOLK DEGRADATION; AEDES-AEGYPTI; MOLECULAR-CLONING; PROCATHEPSIN-B; BOMBYX-MORI; HAEMONCHUS-CONTORTUS	Here we report identification of a novel member of the thiol protease superfamily in the yellow fever mosquito, Aedes aegypti. It is synthesized and secreted as a latent proenzyme in a sex-, stage-, and tissue-specific manner by the fat body, an insect metabolic tissue, of female mosquitoes during vitellogenesis in response to blood feeding. The secreted, hemolymph form of the enzyme is a large molecule, likely a hexamer, consisting of 44-kDa subunits. The deduced amino acid sequence of this 44-kDa precursor shares high similarity with cathepsin B but not with other mammalian cathepsins. We have named this mosquito enzyme vitellogenic cathepsin B (VCB). VCB decreases to 42 kDa after internalization by oocytes, In mature yolk bodies, VCB is located in the matrix surrounding the crystalline yolk protein, vitellin. At the onset of embryogenesis, VCB is further processed to 33 kDa. The embryo extract containing the 33-kDa VCB is active toward benzoyloxycarbonyl-Arg-Arg-para-nitroanilide, a cathepsin B-specific substrate, and degrades vitellogenin, the vitellin precursor. Both of these enzymatic activities are prevented by trans-epoxysuccinyl-L-leucylamido- (4-guanidino)butane (E-64), a thiol protease inhibitor. Furthermore, addition of the anti-VCB antibody to the embryonic extract prevented cleavage of vitellogenin, strongly indicating that the activated VCB is involved in embryonic degradation of vitellin.	Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; Natl Yang Ming Univ, Dept Parasitol, Taipei 112, Taiwan; Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; Russian Acad Sci, Inst Cytol, Electron Microscopy Lab, St Petersburg 194064, Russia	Michigan State University; National Yang Ming Chiao Tung University; Michigan State University; Michigan State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Raikhel, AS (corresponding author), Michigan State Univ, Dept Entomol, S-150 Plant Biol Bldg, E Lansing, MI 48824 USA.	araikhel@pilot.msu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032154, R37AI024716, R01AI024716] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-24716, AI-32154] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BECHET DM, 1991, J BIOL CHEM, V266, P14104; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; Brinke A, 1997, GENOMICS, V45, P105, DOI 10.1006/geno.1997.4902; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Chiou JY, 1998, J BIOMED SCI, V5, P120; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cho WL, 1997, INSECT BIOCHEM MOLEC, V27, P351, DOI 10.1016/S0965-1748(97)00017-9; CHO WL, 1992, J BIOL CHEM, V267, P21823; CHO WL, 1995, INSECT BIOCHEM MOLEC, V25, P19, DOI 10.1016/0965-1748(94)00045-J; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COX GN, 1990, MOL BIOCHEM PARASIT, V41, P25, DOI 10.1016/0166-6851(90)90093-2; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DEITSCH KW, 1995, INSECT BIOCHEM MOLEC, V25, P449, DOI 10.1016/0965-1748(94)00082-A; DHADIALLA TS, 1990, J BIOL CHEM, V265, P9924; FAGOTTO F, 1994, J CELL BIOL, V125, P1047, DOI 10.1083/jcb.125.5.1047; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P237, DOI 10.1002/arch.940140404; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P217, DOI 10.1002/arch.940140403; FELLEISEN R, 1990, EMBO J, V9, P371, DOI 10.1002/j.1460-2075.1990.tb08120.x; Giorgi F, 1997, TISSUE CELL, V29, P293, DOI 10.1016/S0040-8166(97)80005-5; HAGEDORN HH, 1977, J INSECT PHYSIOL, V23, P203, DOI 10.1016/0022-1910(77)90030-0; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; KAWOOYA JK, 1986, J BIOL CHEM, V261, P844; Khan A, 1998, MODERN PATHOL, V11, P704; Kim K, 1998, INT J CANCER, V79, P324, DOI 10.1002/(SICI)1097-0215(19980821)79:4<324::AID-IJC4>3.3.CO;2-N; KLINKERT MQ, 1989, MOL BIOCHEM PARASIT, V33, P113, DOI 10.1016/0166-6851(89)90025-X; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; KULAKOSKY PC, 1987, INSECT BIOCHEM, V19, P367; KURATA S, 1992, DEV BIOL, V153, P115, DOI 10.1016/0012-1606(92)90096-Y; KURATA S, 1992, EUR J BIOCHEM, V204, P911, DOI 10.1111/j.1432-1033.1992.tb16711.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XD, 1996, J BIOL CHEM, V271, P33344, DOI 10.1074/jbc.271.52.33344; Loukas A, 1998, MOL BIOCHEM PARASIT, V92, P275, DOI 10.1016/S0166-6851(97)00245-4; MACH L, 1994, J BIOL CHEM, V269, P13030; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; MACH L, 1992, BIOCHEM J, V282, P577, DOI 10.1042/bj2820577; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MEDINA M, 1989, DEV GROWTH DIFFER, V31, P241; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; MERCKELBACH A, 1994, TROP MED PARASITOL, V45, P193; MORT JS, 1986, BIOCHEM J, V233, P57, DOI 10.1042/bj2330057; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; POOLE AR, 1978, NATURE, V273, P545, DOI 10.1038/273545a0; PRATT D, 1992, MOL BIOCHEM PARASIT, V56, P39, DOI 10.1016/0166-6851(92)90152-A; PRATT D, 1990, MOL BIOCHEM PARASIT, V43, P181, DOI 10.1016/0166-6851(90)90143-A; QIAN F, 1991, DNA CELL BIOL, V10, P159, DOI 10.1089/dna.1991.10.159; Raikhel A. S., 1997, The molecular biology of insect disease vectors: a methods manual., P507; RAIKHEL AS, 1987, TISSUE CELL, V19, P515, DOI 10.1016/0040-8166(87)90045-0; RAIKHEL AS, 1991, TISSUE CELL, V23, P577, DOI 10.1016/0040-8166(91)90015-L; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; RIBOLLA PEM, 1993, INSECT BIOCHEM MOLEC, V23, P217, DOI 10.1016/0965-1748(93)90002-A; ROBERTSON CD, 1993, MOL BIOCHEM PARASIT, V62, P271, DOI 10.1016/0166-6851(93)90116-F; ROSENBERG K, 1989, NEW STATESMAN SOC, V2, P35; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sappington T. W., 1997, The molecular biology of insect disease vectors: a methods manual., P523; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SAPPINGTON TW, 1995, INSECT BIOCHEM MOLEC, V25, P807, DOI 10.1016/0965-1748(95)00016-O; Seroussi E, 1998, GENE, V212, P13, DOI 10.1016/S0378-1119(98)00098-5; SLOANE BF, 1981, SCIENCE, V212, P1151, DOI 10.1126/science.7233209; SLOANE BF, 1990, CANCER METAST REV, V9, P333, DOI 10.1007/BF00049523; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; STEPHENS H, 1982, J HISTOCHEM CYTOCHEM, V30, P605; TAKAHASHI N, 1993, FEBS LETT, V334, P153, DOI 10.1016/0014-5793(93)81702-2; TAKAHASHI SY, 1993, J BIOCHEM, V114, P267, DOI 10.1093/oxfordjournals.jbchem.a124165; TAKIO K, 1983, P NATL ACAD SCI-BIOL, V80, P3666, DOI 10.1073/pnas.80.12.3666; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; TERRA WR, 1988, INSECT BIOCHEM, V18, P423, DOI 10.1016/0020-1790(88)90058-3; WAHLI W, 1988, TRENDS GENET, V4, P227, DOI 10.1016/0168-9525(88)90155-2; Xing RY, 1998, BIOCHEM J, V332, P499, DOI 10.1042/bj3320499; YAMAMOTO Y, 1994, J BIOCHEM, V116, P1330, DOI 10.1093/oxfordjournals.jbchem.a124683; YAMAMOTO Y, 1993, COMP BIOCHEM PHYS B, V106, P35, DOI 10.1016/0305-0491(93)90004-O; YAMAMOTO Y, 1994, J INSECT PHYSIOL, V40, P447, DOI 10.1016/0022-1910(94)90163-5; Yoshizaki N, 1998, COMP BIOCHEM PHYS B, V119, P571, DOI 10.1016/S0305-0491(98)00030-3; Yu YL, 1998, FEBS LETT, V429, P9, DOI 10.1016/S0014-5793(98)00548-1; ZHU J, 1986, Biochimica et Biophysica Acta, V882, P427, DOI 10.1016/0304-4165(86)90267-9	83	161	177	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13311	13321		10.1074/jbc.274.19.13311	http://dx.doi.org/10.1074/jbc.274.19.13311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224092	hybrid			2022-12-27	WOS:000080200400054
J	Hajduch, E; Rencurel, F; Balendran, A; Batty, IH; Downes, CP; Hundal, HS				Hajduch, E; Rencurel, F; Balendran, A; Batty, IH; Downes, CP; Hundal, HS			Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; AMINO-ACID-TRANSPORT; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; DEVELOPMENTAL REGULATION; SUBCELLULAR-DISTRIBUTION; COUPLED RECEPTORS; 3T3-L1 CELLS	In this study we show that serotonin (5-hydroxytryptamine (5-HT)) causes a rapid stimulation in glucose uptake by similar to 50% in both L6 myotubes and isolated rat skeletal muscle. This activation is mediated via the 5-HT2A receptor, which is expressed in L6, rat, and human skeletal muscle. In L6 cells, expression of the 5-HT2A receptor is developmentally regulated based on the finding that receptor abundance increases by over 3-fold during differentiation from myoblasts to myotubes, Stimulation of the 5-HT2A receptor using methylserotonin (m-HT), a selective 5-HT2A agonist, increased muscle glucose uptake in a manner similar to that seen in response to 5-HT. The agonist-mediated stimulation in glucose uptake was attributable to an increase in the plasma membrane content of GLUT1, GLUT3, and GLUT4. The stimulatory effects of 5-HT and m-HT were suppressed in the presence of submicromolar concentrations of ketanserin (a selective 5-HT2A antagonist) providing further evidence that the increase in glucose uptake was specifically mediated via the 5-HT2A receptor. Treatment of L6 cells with insulin resulted in tyrosine phosphorylation of IRS1, increased cellular production of phosphatidylinositol 3,4,5-phosphate and a 41-fold activation in protein kinase B (PKB/Akt) activity. In contrast, m-HT did not modulate IRS1, phosphoinositide 3-kinase, or PKB activity. The present results indicate that rat and human skeletal muscle both express the 5-HT2A receptor and that 5-HT and specific 5-HT2A agonists can rapidly stimulate glucose uptake in skeletal muscle by a mechanism which does not depend upon components that participate in the insulin signaling pathway.	Univ Dundee, Dept Anat & Physiol, Dundee DD1 4HN, Scotland; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland; Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 4HN, Scotland	University of Dundee; University of Dundee; University of Dundee	Hundal, HS (corresponding author), Univ Dundee, Dept Anat & Physiol, Dundee DD1 4HN, Scotland.		Hundal, Hari/A-8990-2008; Hajduch, Eric/B-7332-2008	Hundal, Hari/0000-0002-7621-4932; Hajduch, Eric/0000-0002-0125-7751				Aledo JC, 1997, BIOCHEM J, V325, P727, DOI 10.1042/bj3250727; BILAN PJ, 1992, FEBS LETT, V298, P285, DOI 10.1016/0014-5793(92)80078-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; Coulie B, 1998, AM J PHYSIOL-ENDOC M, V274, pE317, DOI 10.1152/ajpendo.1998.274.2.E317; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; FISCHER Y, 1995, BIOCHEM J, V311, P575, DOI 10.1042/bj3110575; FURMAN BL, 1980, DIABETOLOGIA, V19, P386, DOI 10.1007/BF00280525; GuilletDeniau I, 1997, J BIOL CHEM, V272, P14825, DOI 10.1074/jbc.272.23.14825; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HOYER D, 1994, PHARMACOL REV, V46, P157; HUNDAL HS, 1994, MOL MEMBR BIOL, V11, P255, DOI 10.3109/09687689409160435; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; LUNDQUIST I, 1971, DIABETOLOGIA, V7, P414, DOI 10.1007/BF01212056; Martin F. J., 1995, Life Sciences, V56, P51; McDowell HE, 1997, EUR J BIOCHEM, V247, P306, DOI 10.1111/j.1432-1033.1997.00306.x; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; MONOPOLI A, 1990, CARDIOVASC DRUG THER, V4, P59, DOI 10.1007/BF00053428; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Newsholme EA, 1995, ADV EXP MED BIOL, V384, P315; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; PEROUTKA SJ, 1995, TRENDS NEUROSCI, V18, P68; SMITH SA, 1977, BIOCHEM J, V168, P495, DOI 10.1042/bj1680495; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; TECOTT L, 1995, MOL CELL NEUROSCI, V6, P43, DOI 10.1006/mcne.1995.1005; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; UvnasMoberg K, 1996, NEUROENDOCRINOLOGY, V63, P269, DOI 10.1159/000126970; VanEppsFung M, 1997, ENDOCRINOLOGY, V138, P5170, DOI 10.1210/en.138.12.5170; WILSON JP, 1974, AM J PHYSIOL, V227, P305, DOI 10.1152/ajplegacy.1974.227.2.305; WOZNIAK KM, 1991, LIFE SCI, V49, P101, DOI 10.1016/0024-3205(91)90023-5; YAMADA J, 1989, LIFE SCI, V45, P1931, DOI 10.1016/0024-3205(89)90547-X; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125	39	95	101	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13563	13568		10.1074/jbc.274.19.13563	http://dx.doi.org/10.1074/jbc.274.19.13563			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224126	hybrid			2022-12-27	WOS:000080200400088
J	Jacob, A; Cooney, D; Tridandapani, S; Kelley, T; Coggeshall, KM				Jacob, A; Cooney, D; Tridandapani, S; Kelley, T; Coggeshall, KM			Fc gamma RIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; SH2-CONTAINING INOSITOL PHOSPHATASE; PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; HEMATOPOIETIC-CELLS; NEGATIVE REGULATION; MULTIPLE CYTOKINES	We examined activation of the serine/threonine kinase Akt in the murine B cell line A20. Akt is activated in a phosphoinositide 3-kinase (PtdIns 3-kinase)-dependent manner upon stimulation of the antigen receptor, surface immunoglobulin (sIg). In contrast, Akt induction is reduced upon co-clustering of sig with the B cell IgG receptor, Fc gamma RIIb. Go-clustering of sIg-Fc gamma RIIb transmits a dominant negative signal and is associated with reduced accumulation of the PtdIns 3-kinase product phosphatidylinositol 3,4,5-trisphosphate (PtdIns 3,4,5-P-3), known to be a potent activator of Akt. PtdIns 3-kinase is activated to the same extent with and without Fc gamma RIIb co-ligation, indicating conditions supporting the generation of PtdIns 3,4,5-P-3. We hypothesized that the decreased Akt activity arises from the consumption of PtdIns 3,4,5-P-3 by the inositol-5-phosphatase Src homology 2-containing inositol B-phosphatase (SHIP), which has been shown by us to be tyrosine-phosphorylated and associated with Fc gamma RIIb when the latter is co-ligated. In direct support of this hypothesis, we report here that Akt induction is greatly reduced in fibroblasts expressing catalytically active but not inactive SHIP. Likewise, the reduction in Akt activity upon sIgFc gamma RIIb co-clustering is absent from avian B cells lacking expression of SHIP. These findings indicate that SHIP acts as a negative regulator of Akt activation.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Coggeshall, KM (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	coggeshall.1@osu.edu	Cooney, Damon/J-4762-2014; Tridandapani, Susheela/E-4209-2011	Cooney, Damon/0000-0002-2786-287X; 	NATIONAL CANCER INSTITUTE [R01CA064268, P30CA016058, R29CA064268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI041147] Funding Source: NIH RePORTER; NCI NIH HHS [CA64268, P30 CA16058] Funding Source: Medline; NIAID NIH HHS [AI41147] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Ashman RF, 1996, J IMMUNOL, V157, P5; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chacko GW, 1996, J IMMUNOL, V157, P2234; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Coggeshall KM, 1998, CURR OPIN IMMUNOL, V10, P306, DOI 10.1016/S0952-7915(98)80169-6; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; delPeso L, 1997, SCIENCE, V278, P687; DeuterReinhard M, 1997, MOL CELL BIOL, V17, P2559, DOI 10.1128/MCB.17.5.2559; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GOLD MR, 1994, J BIOL CHEM, V269, P5403; GOLD MR, 1994, J IMMUNOL, V152, P42; GOLD MR, 1992, J IMMUNOL, V148, P2012; Hippen KL, 1997, IMMUNITY, V7, P49, DOI 10.1016/S1074-7613(00)80509-9; Hunter MG, 1998, J IMMUNOL, V160, P4979; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kiener PA, 1997, J BIOL CHEM, V272, P3838, DOI 10.1074/jbc.272.6.3838; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu L, 1997, J BIOL CHEM, V272, P8983; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Sarkar S, 1996, J BIOL CHEM, V271, P20182, DOI 10.1074/jbc.271.33.20182; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tridandapani S, 1997, J IMMUNOL, V158, P1125; Tridandapani S, 1997, MOL CELL BIOL, V17, P4305, DOI 10.1128/MCB.17.8.4305; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wijkander J, 1997, J BIOL CHEM, V272, P21520, DOI 10.1074/jbc.272.34.21520; Yamashita Y, 1996, J EXP MED, V184, P113, DOI 10.1084/jem.184.1.113; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	56	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13704	13710		10.1074/jbc.274.19.13704	http://dx.doi.org/10.1074/jbc.274.19.13704			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224144	hybrid			2022-12-27	WOS:000080200400106
J	Kawasaki, H; Fujii, H; Gotoh, Y; Morooka, T; Shimohama, S; Nishida, E; Hirano, T				Kawasaki, H; Fujii, H; Gotoh, Y; Morooka, T; Shimohama, S; Nishida, E; Hirano, T			Requirement for mitogen-activated protein kinase in cerebellar long term depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; PHOSPHORYLATION SITES; PURKINJE-CELLS; OSMOTIC SHOCK; CALCIUM; POTENTIATION; CASCADE; RAS; INVOLVEMENT; MECHANISMS	The mitogen-activated protein kinase (MAPK) cascade has been shown to play an essential role in regulation of cell proliferation and cell differentiation. Although mammalian MAPKs are most abundantly expressed in postmitotic and terminally differentiated neuronal cells, their function in the central nervous system is still largely undefined. We present evidence here for a role of the MAPK cascade in cerebellar long term depression (LTD), which is a widely studied form of synaptic plasticity in mammalian brain. In cultured Purkinje cells, LTD is known to be induced by iontophoretic application of glutamate and depolarization of Purkinje cells. We found that MAPK was activated in Purkinje cells by treatment of primary cultures of rat embryonic cerebella with glutamate and a depolarization-inducing agent, KCl. Application of PD98059, a specific inhibitor of MAPK kinase (MAPKK/MEK), inhibited both the activation of MAPK and the induction of LTD in Purkinje cells. Furthermore, the induction of LTD was completely blocked by introduction into Purkinje cells of anti-active MAPK antibody, which was found to specifically and potently inhibit the activity of MAPK. These results suggest that postsynaptic activation of the MAPK cascade is essential for the induction of cerebellar LTD.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Inst Virus Res, Dept Genet & Mol Biol, Sakyo Ku, Kyoto 606, Japan; Japan Sci & Technol Corp, CRESt, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.		KAWASAKI, Hiroshi/L-3736-2015; Kawasaki, Hiroshi/C-4404-2015	Kawasaki, Hiroshi/0000-0002-2514-1497; Fujii, Hiroaki/0000-0002-0013-5891				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kawasaki H, 1996, EUR J BIOCHEM, V241, P315, DOI 10.1111/j.1432-1033.1996.00315.x; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1994, J NEUROPHYSIOL, V71, P1992, DOI 10.1152/jn.1994.71.5.1992; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MATSUDA S, 1995, J BIOL CHEM, V270, P12781, DOI 10.1074/jbc.270.21.12781; MORIGUCHI T, 1995, J BIOL CHEM, V270, P12969, DOI 10.1074/jbc.270.22.12969; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519	33	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13498	13502		10.1074/jbc.274.19.13498	http://dx.doi.org/10.1074/jbc.274.19.13498			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224117	hybrid			2022-12-27	WOS:000080200400079
J	Madge, LA; Sierra-Honigmann, MR; Pober, JS				Madge, LA; Sierra-Honigmann, MR; Pober, JS			Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1) - A nonpharmacological explanation for inhibition of TNF-mediated activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; PROTEIN-KINASE ACTIVATION; HUMAN ENDOTHELIAL-CELLS; SOLUBLE FORM; ALPHA PHOSPHORYLATION; FACTOR-BINDING; COMPLEX; CLEAVAGE; DEATH	Several chemical compounds not known to interact with tumor necrosis factor (TNF) signal transducing proteins inhibit TNF-mediated activation of vascular endothelial cells (EC), Four structurally diverse agents, arachidonyl trifluoromethylketone, staurosporine, sodium salicylate, and C-6-ceramide, were studied. All four agents caused EC apoptosis at concentrations that inhibited TNF-induced I kappa B alpha degradation. However, evidence of apoptosis was not evident until after several (e.g, 3-12) hours of treatment, whereas 2 h of treatment was sufficient to inhibit TNF responses. IL-l-induced I kappa B alpha degradation was unaffected by these treatments. Inhibition of TNF signaling could not be prevented with either of the broad spectrum caspase inhibitors zVADfmk or yVADcmk, The inhibition of p38 kinase with SB203580 prevented the inhibition of TNF signaling by all agents except arachidonyl trifluoromethylketone,No changes in the levels or molecular weights of the adaptor proteins TRADD (TNF receptor-associated death domain), RIP (receptor-interacting protein), or TRAF2 (TNF receptor-associated factor-alpha) were caused by apoptogenic drugs. However, TNF receptor 1 (TNFR1) surface expression was significantly reduced by all four agents, Furthermore, TNF-dependent recruitment of TRADD to surface TNFR1 was also inhibited. These data suggest that several putative inhibitors of TNF signaling work by triggering apoptosis and that an early event coincident with the initiation of apoptosis, preceding evidence of injury, is loss of TNFR1, Consistent with this hypothesis, cotreatment of EC with the metalloproteinase inhibitor Tapi (TNF-alpha proteinase inhibitor) blocked the reduction in surface TNFR1 by apoptogenic drugs and prevented inhibition of TNF-induced I kappa B alpha degradation without blocking apoptosis. TNFR1 loss could be a mechanism to limit inflammation in response to apoptotic cell death.	Yale Univ, Sch Med, Mol Cardiobiol Program, Boyer Ctr Mol Med, New Haven, CT 06536 USA	Yale University	Pober, JS (corresponding author), Yale Univ, Sch Med, Mol Cardiobiol Program, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06536 USA.				NHLBI NIH HHS [HL-36007] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Bjornberg F, 1998, BIOCHEM BIOPH RES CO, V244, P594, DOI 10.1006/bbrc.1998.8302; BRADLEY JR, 1995, AM J PATHOL, V146, P27; BRADLEY JR, 1993, AM J PATHOL, V142, P1598; BRAKEBUSCH C, 1992, EMBO J, V11, P943, DOI 10.1002/j.1460-2075.1992.tb05133.x; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COPE AP, 1992, ARTHRITIS RHEUM, V35, P1160, DOI 10.1002/art.1780351008; CROWE PD, 1993, J IMMUNOL, V151, P6882; DELUCA LG, 1994, J BIOL CHEM, V269, P19193; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GULLBERG U, 1992, EUR J CELL BIOL, V58, P307; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Haridas V, 1998, J IMMUNOL, V160, P3152; HIGUCHI M, 1993, J BIOL CHEM, V268, P5624; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE TA, 1990, BIOCHEM BIOPH RES CO, V172, P1273, DOI 10.1016/0006-291X(90)91587-I; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; LANTZ M, 1994, J IMMUNOL, V152, P1362; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Pierce JW, 1996, J IMMUNOL, V156, P3961; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; SLOWIK MR, 1993, AM J PATHOL, V143, P1724; Slowik MR, 1996, CIRC RES, V79, P736, DOI 10.1161/01.RES.79.4.736; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stuhlmeier KM, 1997, J BIOL CHEM, V272, P24679, DOI 10.1074/jbc.272.39.24679; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Wissing D, 1997, P NATL ACAD SCI USA, V94, P5073, DOI 10.1073/pnas.94.10.5073; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	61	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13643	13649		10.1074/jbc.274.19.13643	http://dx.doi.org/10.1074/jbc.274.19.13643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224136	hybrid			2022-12-27	WOS:000080200400098
J	Casse, C; Giannoni, F; Nguyen, VT; Dubois, MF; Bensaude, O				Casse, C; Giannoni, F; Nguyen, VT; Dubois, MF; Bensaude, O			The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase IIC-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; GENE-EXPRESSION; DNA-DAMAGE; IN-VIVO; LARGEST SUBUNIT; RIBOSOMAL-RNA; HISTONE ACETYLTRANSFERASE; TAT TRANSACTIVATION; PROTEIN-KINASE	Actinomycin D and alpha-amanitin are commonly used to inhibit transcription. Unexpectedly, however, the transcription of the human immunodeficiency virus (HIV-1) long terminal repeats (LTR) is shown to be activated at the level of elongation, in human and murine cells exposed to these drugs, whereas the Rous sarcoma virus LTR, the human cytomegalovirus immediate early gene (CMV), and the HSP70 promoters are repressed. Activation of the HIV LTR is independent of the NF kappa B and TAR sequences and coincides with an enhanced average phosphorylation of the C-terminal domain (CTD) from the largest subunit of RNA polymerase II. Both the HIV-1 LTR activation and the bulk CTD phosphorylation enhancement are prevented by several CTD kinase inhibitors, including 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole. The efficacies of the various compounds to block CTD phosphorylation and transcription in vivo correlate with their capacities to inhibit the CDK9/ PITALRE kinase in vitro. Hence, the positive transcription elongation factor, P-TEFb, is likely to contribute to the average CTD phosphorylation in vivo and to the activation of the HIV-1 LTR induced by actinomycin D.	Ecole Normale Super, Genet Mol Lab, F-75230 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Bensaude, O (corresponding author), Ecole Normale Super, Genet Mol Lab, 46 Rue Ulm, F-75230 Paris 05, France.		Giannoni, Federico/A-6577-2013	Giannoni, Federico/0000-0001-5521-512X; Bensaude, Olivier/0000-0002-0259-6608				ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Barbeau B, 1997, J BIOL CHEM, V272, P12968, DOI 10.1074/jbc.272.20.12968; Bates S, 1996, ONCOGENE, V13, P1103; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bentley D, 1998, NATURE, V395, P21, DOI 10.1038/25616; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; BROWN FL, 1993, MOL CELL BIOL, V13, P5245, DOI 10.1128/MCB.13.9.5245; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DEMERCOYROL L, 1989, BIOCHEM J, V258, P165, DOI 10.1042/bj2580165; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dubois MF, 1997, NUCLEIC ACIDS RES, V25, P694, DOI 10.1093/nar/25.4.694; DUBOIS MF, 1994, J BIOL CHEM, V269, P13331; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Dubois MF, 1999, NUCLEIC ACIDS RES, V27, P1338, DOI 10.1093/nar/27.5.1338; Dubois MF, 1998, CELL STRESS CHAPERON, V3, P147, DOI 10.1379/1466-1268(1998)003<0147:PORPIC>2.3.CO;2; EGYHAZI E, 1976, NATURE, V262, P319, DOI 10.1038/262319a0; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GARCIA JA, 1994, PROG NUCLEIC ACID RE, V49, P157; GEELEN JLMC, 1988, J GEN VIROL, V69, P2913, DOI 10.1099/0022-1317-69-11-2913; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; GUALBERTO A, 1995, MOL CELL BIOL, V15, P3450; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; HADJIOLOVA KV, 1995, EUR J BIOCHEM, V228, P605, DOI 10.1111/j.1432-1033.1995.tb20300.x; Harris W., 1991, Horticulture in New Zealand, V2, P2; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; JEANG KT, 1993, J BIOL CHEM, V268, P24940; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Keen NJ, 1997, EMBO J, V16, P5260, DOI 10.1093/emboj/16.17.5260; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; KIDDER GM, 1985, J EXP ZOOL, V233, P155, DOI 10.1002/jez.1402330123; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; KOLESKE AJ, 1995, TRENDS BIOCHEM SCI, V20, P113, DOI 10.1016/S0968-0004(00)88977-X; KONTERMANN RE, 1995, BIOL CHEM H-S, V376, P473, DOI 10.1515/bchm3.1995.376.8.473; KRETZREMY C, 1994, FEBS LETT, V351, P191, DOI 10.1016/S0014-5793(94)80103-7; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MACIASZEK JW, 1994, J VIROL, V68, P6598, DOI 10.1128/JVI.68.10.6598-6604.1994; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; Marshall NF, 1998, J BIOL CHEM, V273, P31726, DOI 10.1074/jbc.273.48.31726; MCCUNE JM, 1995, CELL, V82, P183, DOI 10.1016/0092-8674(95)90305-4; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARADA CA, 1995, J BIOL CHEM, V270, P2274, DOI 10.1074/jbc.270.5.2274; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Piret B, 1996, NUCLEIC ACIDS RES, V24, P4242, DOI 10.1093/nar/24.21.4242; RAYNAL F, 1984, FEBS LETT, V167, P263, DOI 10.1016/0014-5793(84)80139-8; SAKAGUCHI M, 1991, J VIROL, V65, P5448, DOI 10.1128/JVI.65.10.5448-5456.1991; Schafer H, 1998, ONCOGENE, V16, P2479, DOI 10.1038/sj.onc.1201788; SCHWARTZ O, 1990, GENE, V88, P197, DOI 10.1016/0378-1119(90)90032-M; SHELDON M, 1993, MOL CELL BIOL, V13, P1251, DOI 10.1128/MCB.13.2.1251; Shuman S, 1997, P NATL ACAD SCI USA, V94, P12758, DOI 10.1073/pnas.94.24.12758; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VLACH J, 1995, VIROLOGY, V208, P753, DOI 10.1006/viro.1995.1207; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Wright S, 1996, J MOL BIOL, V263, P1, DOI 10.1006/jmbi.1996.0551; Xiao H, 1997, MOL CELL BIOL, V17, P6898, DOI 10.1128/MCB.17.12.6898; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	88	83	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16097	16106		10.1074/jbc.274.23.16097	http://dx.doi.org/10.1074/jbc.274.23.16097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347161	hybrid			2022-12-27	WOS:000080668600021
J	Lu, GQ; Tsai, AL; Van Wart, HE; Kulmacz, RJ				Lu, GQ; Tsai, AL; Van Wart, HE; Kulmacz, RJ			Comparison of the peroxidase reaction kinetics of prostaglandin H synthase-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANO PROTOPORPHYRIN-IX; HIGHER OXIDATION-STATES; SELECTIVE-INHIBITION; REACTION-MECHANISMS; TYROSYL RADICALS; ARACHIDONIC-ACID; FATTY-ACIDS; BIOSYNTHESIS; CYCLOOXYGENASE; PURIFICATION	Prostaglandin H synthase isoforms 1 and 2 (PGHS-1 and -2) each have a peroxidase activity and also a cyclooxygenase activity that requires initiation by hydroperoxide, The hydroperoxide initiator requirement for PGHS-2 cyclooxygenase is about 10-fold lower than for PGHS-1 cyclooxygenase, and this difference may contribute to the distinct control of cellular prostanoid synthesis by the two isoforms. We compared the kinetics of the initial peroxidase steps in PGHS-1 and -2 to quantify mechanistic differences between the isoforms that might contribute to the difference in cyclooxygenase initiation efficiency, The kinetics of formation of Intermediate I (an Fe(IV) species with a porphyrin free radical) and Intermediate II (an Fe(IV) species with a tyrosyl free radical, thought to be the crucial oxidant in cyclooxygenase catalysis) were monitored at 4 degrees c by stopped flow spectrophotometry with several hydroperoxides as substrate. With 15-hydroperoxyeicosatetraenoic acid, the rate constant for Intermediate I formation (k(1)) was 2.3 x 10(7) M-1 s(-1) for PGHS-1 and 2.5 x 10(7) M-1 s(-1) for PGHS-2, indicating that the isoforms have similar initial reactivity with this lipid hydroperoxide, For PGHS-1, the rate of conversion of Intermediate I to Intermediate II (k(2)) became the limiting factor when the hydroperoxide level was increased, indicating a rate constant of 10(2)-10(3) s(-1) for the generation of the active cyclooxygenase species. For PGHS-2, however, the transition between Intermediates I and II was not rate-limiting even at the highest hydroperoxide concentrations tested, indicating that the k(2) value for PGHS-2 was much greater than that for PGHS-1. Computer modelling predicted that faster formation of the active cyclooxygenase species (Intermediate II) or increased stability of the active species increases the resistance of the cyclooxygenase to inhibition by the intracellular hydroperoxide scavenger; glutathione peroxidase, Kinetic differences between the PGHS isoforms in forming or stabilizing the active cyclooxygenase species can thus contribute to the difference in the regulation of their cellular activities.	Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA; Roche Biosci, Inflammatory Dis Unit, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Health Science Center Houston; Roche Holding	Kulmacz, RJ (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Internal Med, MSB5 284,6431 Fannin St, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052170] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 44911, GM 52170] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E; HEMLER ME, 1979, ARCH BIOCHEM BIOPHYS, V193, P340, DOI 10.1016/0003-9861(79)90038-9; HEMLER ME, 1978, BIOCHEM BIOPH RES CO, V85, P1325, DOI 10.1016/0006-291X(78)91148-8; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; HSUANYU YC, 1992, J BIOL CHEM, V267, P17649; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; KULMACZ RJ, 1987, J BIOL CHEM, V262, P10524; KULMACZ RJ, 1983, PROSTAGLANDINS, V25, P531, DOI 10.1016/0090-6980(83)90025-4; Kulmacz RJ, 1998, FEBS LETT, V430, P154, DOI 10.1016/S0014-5793(98)00657-7; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kulmacz RJ, 1987, PROSTAGLANDINS RELAT, P209; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LAMBEIR AM, 1985, J BIOL CHEM, V260, P4894; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; MARSHALL PJ, 1987, J BIOL CHEM, V262, P3510; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; PORTER NA, 1979, J ORG CHEM, V44, P3177, DOI 10.1021/jo01332a017; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; TSAI AL, 1994, J BIOL CHEM, V269, P5085; Tsai AL, 1998, J BIOL CHEM, V273, P3888, DOI 10.1074/jbc.273.7.3888; Tsai AL, 1997, J BIOL CHEM, V272, P8885; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; WEI CH, 1995, BIOCHEMISTRY-US, V34, P8499, DOI 10.1021/bi00026a034	30	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	1999	274	23					16162	16167		10.1074/jbc.274.23.16162	http://dx.doi.org/10.1074/jbc.274.23.16162			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202TQ	10347169	hybrid			2022-12-27	WOS:000080668600029
J	Mamiya, N; Worman, HJ				Mamiya, N; Worman, HJ			Hepatitis C virus core protein binds to a DEAD box RNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ERYTHROID-CELLS; NON-B-HEPATITIS; INTERNAL INITIATION; NON-A; TRANSLATION; SEQUENCE; GENOME; POLIOVIRUS; YEAST; IDENTIFICATION	Approximately 4 million Americans are infected with the hepatitis C virus (HCV), making it a major cause of chronic liver disease. Because of the lack of an efficient cell culture system, little is known about the interaction between HCV and host cells. We performed a yeast two-hybrid screen of a human liver cell cDNA library with HCV core protein as bait and isolated the DEAD box protein DBX. DBX has significant amino acid sequence identity to mouse PL10, an ATP-dependent RNA helicase. The binding of DBX to HCV core protein occurred in an in vitro binding assay in the presence of 1 M NaCl or detergent. When expressed in mammalian cells, HCV core protein and DBX were co-localized at the endoplasmic reticulum, In a mutant strain of Saccharomyces cerevisiae, DBX complemented the function of Ded1p, an essential DEAD box RNA helicase. HCV core protein inhibited the growth of DBX-complemented mutant yeast but not Ded1p-expressing yeast. HCV core protein also inhibited the in vitro translation of capped but not uncapped RNA. These findings demonstrate an interaction between HCV core protein and a host cell protein involved in RNA translation and suggest a mechanism by which HCV may inhibit host cell mRNA translation.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Worman, HJ (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St,10th Floor,Rm 508, New York, NY 10032 USA.				NCI NIH HHS [5 P30 CA13696] Funding Source: Medline; NCRR NIH HHS [1S10 RR10506] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010506] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; CHIEN C, 1991, P NATL ACAD SCI USA, V88, P9579; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Chung J, 1995, KOREAN J BIOCHEM, V27, P193; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fukushi S, 1997, J VIROL, V71, P1662, DOI 10.1128/JVI.71.2.1662-1666.1997; GEE SL, 1994, GENE, V140, P171, DOI 10.1016/0378-1119(94)90541-X; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; KIM DW, 1994, JPN J MED SCI BIOL, V47, P211, DOI 10.7883/yoken1952.47.211; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KNIPE DM, 1996, FIELDS VIROLOGY, P273; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; Liang TJ, 1998, NEW ENGL J MED, V339, P1549, DOI 10.1056/NEJM199811193392112; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MAMIYA N, 1997, CURR OPIN INFECT DIS, V10, P3990; MANSELL CJ, 1995, SEMIN LIVER DIS, V15, P15, DOI 10.1055/s-2007-1007260; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Ray RB, 1997, J BIOL CHEM, V272, P10983; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; ROSE JK, 1978, P NATL ACAD SCI USA, V75, P2732, DOI 10.1073/pnas.75.6.2732; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; TAKAMIZAWA A, 1991, J VIROL, V65, P1105, DOI 10.1128/JVI.65.3.1105-1113.1991; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998; 1997, HEPATOLOGY, V26, pS1	42	145	157	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15751	15756		10.1074/jbc.274.22.15751	http://dx.doi.org/10.1074/jbc.274.22.15751			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336476	hybrid			2022-12-27	WOS:000080560100065
J	Oh, H; Takagi, H; Suzuma, K; Otani, A; Matsumura, M; Honda, Y				Oh, H; Takagi, H; Suzuma, K; Otani, A; Matsumura, M; Honda, Y			Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; FACTOR MESSENGER-RNA; IN-VIVO; TIE2 RECEPTOR; RETINAL NEOVASCULARIZATION; GENE-TRANSCRIPTION; FACTOR EXPRESSION; FACTOR VEGF; ANGIOGENESIS	Recent studies have shown that the angiopoietin-Tie2 system is a predominant regulator of vascular integrity. In this study, we investigated the effect of two known angiogenic stimuli, hypoxia and vascular endothelial growth factor (VEGF), on these molecules. VEGF induced both a time- and concentration-dependent increase in angiopoietin-2 (Ang2) mRNA expression in bovine microvascular endothelial cells. This up-regulation was derived primarily from an increased transcription rate as evidenced by nuclear run-on assay and mRNA decay study. The increased Ang2 expression upon VEGF treatment was almost totally abolished by inhibition of tyrosine kinase or mitogen-activated protein kinase and partially by suppression of protein kinase C. Hypoxia also directly increased Ang2 mRNA expression. In contrast, Ang1 and Tie2 responded to neither of these stimuli. The enhanced Ang2 expression following VEGF stimulation and hypoxia was accompanied by de novo protein synthesis as detected by immunoprecipitation. In a mouse model of ischemia-induced retinal neovascularization, Ang2 mRNA was up-regulated in the ischemic inner retinal layer, and remarkable expression was observed in neovascular vessels. These data suggest that both hypoxia- and VEGF-induced neovascularization might be facilitated by selective induction of Ang2, which deteriorates the integrity of preexisting vasculature.	Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Takagi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shogoinkawara Cho, Kyoto 6068507, Japan.							Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; ASAHARA T, 1997, SCIENCE, V275, P965; ASHTON N, 1957, AM J OPHTHALMOL, V44, P7, DOI 10.1016/0002-9394(57)90426-9; BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; Barleon B, 1997, CANCER RES, V57, P5421; BERU N, 1986, MOL CELL BIOL, V6, P2571, DOI 10.1128/MCB.6.7.2571; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Couffinhal T, 1997, AM J PATHOL, V150, P1673; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GOLDBERG MA, 1991, BLOOD, V77, P271; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kukk E, 1997, BRIT J HAEMATOL, V98, P195, DOI 10.1046/j.1365-2141.1997.1732989.x; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; NOMURA M, 1995, J BIOL CHEM, V270, P28316; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; PAJUSOLA K, 1992, CANCER RES, V52, P5738; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; SABRI MN, 1991, AM HEART J, V121, P876, DOI 10.1016/0002-8703(91)90202-S; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Seymour LW, 1996, LAB INVEST, V75, P427; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takagi H, 1996, DIABETES, V45, P1016, DOI 10.2337/diabetes.45.8.1016; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; TERMAN BI, 1991, ONCOGENE, V6, P1677; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006	68	391	409	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15732	15739		10.1074/jbc.274.22.15732	http://dx.doi.org/10.1074/jbc.274.22.15732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336473	hybrid			2022-12-27	WOS:000080560100062
J	Spencer, JA; Baron, MH; Olson, EN				Spencer, JA; Baron, MH; Olson, EN			Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; FACTOR GENE; TINMAN HOMOLOG; MUSCLE-CELLS; BOX PROTEIN; IN-VITRO; EXPRESSION; ALPHA; PROMOTER; ELEMENT	Serum response factor (SRF) is a MADS box transcription factor that controls a wide range of genes involved in cell proliferation and differentiation. The MADS box mediates homodimerization and binding of SRF to the consensus sequence CC(APT)(6)GG, known as a CArG box, which is found in the control regions of numerous serum-inducible and muscle-specific genes, Using a modified yeast one-hybrid screen to identify potential SRF cofactors, we found that SRF interacts with the high mobility group factor SSRP1 (structure-specific recognition protein). This interaction, which occurs in yeast and mammalian cells, is mediated through the MADS box of SRF and a basic region of SSRP1 encompassing amino acids 489-542, immediately adjacent to the high mobility group domain. SSRP1 does not bind the CArG box, but interaction of SSRP1 with SRF dramatically increases the DNA binding activity of SRF, resulting in synergistic transcriptional activation of native and artificial SRF-dependent promoters. These results reveal an important role for SSRP1 as a coregulator of SRF-dependent transcription in mammalian cells.	Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75235 USA; SUNY, Mt Sinai Sch Med, New York, NY 10228 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; SUNY Community College; SUNY Maritime College; SUNY Optometry	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042413] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; BROWN SJ, 1993, SCIENCE, V261, P603, DOI 10.1126/science.8342024; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dyer MA, 1998, MOL CELL BIOL, V18, P2617, DOI 10.1128/MCB.18.5.2617; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; Groisman R, 1996, J BIOL CHEM, V271, P5258; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Hautmann MB, 1997, CIRC RES, V81, P600, DOI 10.1161/01.RES.81.4.600; Hertel L, 1997, BIOCHIMIE, V79, P717, DOI 10.1016/S0300-9084(97)86929-5; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; JOLIET V, 1995, NATURE, V373, P632, DOI 10.1038/373632a0; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; Molkentin JD, 1996, J MOL CELL CARDIOL, V28, P1211, DOI 10.1006/jmcc.1996.0112; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OWENS GK, 1995, PHYSIOL REV, V75, P487; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Treisman R, 1992, CURR OPIN GENET DEV, V2, P221, DOI 10.1016/S0959-437X(05)80277-1; VANDROMME M, 1992, J CELL BIOL, V118, P1489, DOI 10.1083/jcb.118.6.1489; WATT F, 1988, NUCLEIC ACIDS RES, V16, P1471, DOI 10.1093/nar/16.4.1471; Xiang YY, 1996, CANCER LETT, V106, P271, DOI 10.1016/0304-3835(96)04332-7; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	44	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15686	15693		10.1074/jbc.274.22.15686	http://dx.doi.org/10.1074/jbc.274.22.15686			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336466	hybrid			2022-12-27	WOS:000080560100055
J	Tokumitsu, H; Takahashi, N; Eto, K; Yano, S; Soderling, TR; Muramatsu, M				Tokumitsu, H; Takahashi, N; Eto, K; Yano, S; Soderling, TR; Muramatsu, M			Substrate recognition by Ca2+/calmodulin-dependent protein kinase kinase - Role of the Arg-Pro-rich insert domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; MOLECULAR-CLONING; IV KINASE; PHOSPHORYLASE-KINASE; RAT-BRAIN; ACTIVATION; CALMODULIN; CALCIUM; CASCADE; IDENTIFICATION	Mammalian Ca2+/CaM-dependent protein kinase kinase (CaM-KK) has been identified and cloned as an activator for two kinases, CaM kinase I (CaM-KI) and CaM kinase IV (CaM-KIV), and a recent report (Yano, S., Togumitsu, Il., and Soderling, T. R. (1998) Nature 396, 584-587) demonstrates that CaM-KH can also activate and phosphorylate protein kinase B (PKB), In this study, we identify a CaM-KK from Caenorhabditis elegans, and comparison of its sequence with the mammalian CaM-KK alpha and beta shows a unique Arg-Pro (RP)-rich insert in their catalytic domains relative to other protein kinases, Deletion of the RP-domain resulted in complete loss of CaM-KIV activation activity and physical interaction of CaM-KK with glutathione S-transferase-CaM-KIV (T196A). However, CaM-KK autophosphorylation and phosphorylation of a synthetic peptide substrate were normal in the RP-domain mutant. Site-directed mutagenesis of three conserved Arg in the RP-domain of CaM-KK confirmed that these positive charges are important for CaM-KIV activation. The RP-domain deletion mutant also failed to fully activate and phosphorylate CaM-KI, but this mutant was indistinguishable from wild-type CaM-KK for the phosphorylation and activation of PKB, These results indicate that the RP-domain in CaM-KK is critical for recognition of downstream CaM-kinases but not for its catalytic activity (i.e. autophosphorylation) and PKB activation.	Helix Res Inst Inc, Kisarazu, Chiba 2920812, Japan; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Tokyo Med & Dent Univ, Med Res Inst, Dept Biol Cybergenet, Bunkyo Ku, Tokyo 1138510, Japan	Oregon Health & Science University; Tokyo Medical & Dental University (TMDU)	Tokumitsu, H (corresponding author), Helix Res Inst Inc, 1532-3 Yana, Kisarazu, Chiba 2920812, Japan.		Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ALLETA JM, 1996, J BIOL CHEM, V271, P20930; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BUECHLER JA, 1990, BIOCHEMISTRY-US, V29, P1937, DOI 10.1021/bi00459a039; CHO FS, 1994, BBA-MOL CELL RES, V1224, P156, DOI 10.1016/0167-4889(94)90123-6; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LEE JSC, 1994, J BIOL CHEM, V269, P2158; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; OKUNO S, 1993, J BIOCHEM-TOKYO, V114, P167, DOI 10.1093/oxfordjournals.jbchem.a124149; OKUNO S, 1994, J BIOCHEM, V116, P923, DOI 10.1093/oxfordjournals.jbchem.a124617; Okuno S, 1997, J BIOCHEM, V122, P337; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; ROSKOSKI R, 1985, METHOD ENZYMOL, V99, P3; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; SHOJI S, 1979, J BIOL CHEM, V254, P6211; Soderling TR, 1996, BBA-PROTEIN STRUCT M, V1297, P131, DOI 10.1016/S0167-4838(96)00105-7; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TOMODA T, 1993, BIOCHIM BIOPHYS ACTA, V1175, P333, DOI 10.1016/0167-4889(93)90226-F; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALSH DA, 1971, J BIOL CHEM, V246, P1968; WEEKES J, 1994, EUR J BIOCHEM, V219, P751, DOI 10.1111/j.1432-1033.1994.tb18554.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	46	49	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	1999	274	22					15803	15810		10.1074/jbc.274.22.15803	http://dx.doi.org/10.1074/jbc.274.22.15803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	200VE	10336483	hybrid			2022-12-27	WOS:000080560100072
J	Kim, KS; Kim, KH; Storey, MK; Voelker, DR; Carman, GM				Kim, KS; Kim, KH; Storey, MK; Voelker, DR; Carman, GM			Isolation and characterization of the Saccharomyces cerevisiae EKI1 gene encoding ethanolamine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; MEMBRANE PHOSPHOLIPID-COMPOSITION; CDP-CHOLINE PATHWAY; TRANSFER PROTEIN; PHOSPHATIDYLSERINE DECARBOXYLASE; INOSITOL SYNTHESIS; ESCHERICHIA-COLI; NULL ALLELE; CKI GENE; YEAST	Ethanolamine kinase (ATP:ethanolamine O-phosphotransferase, EC 2.7.1.82) catalyzes the committed step of phosphatidylethanolamine synthesis via the CDP-ethanolamine pathway. The gene encoding ethanolamine kinase (EKI1) was identified from the Saccharomyces Genome Data Base (locus YDR147W) based on its homology to the Saccharomyces cerevisiae CKI1-encoded choline kinase, which also exhibits ethanolamine kinase activity. The EKI1 gene was isolated and used to construct eki1 Delta and eki1 Delta cki1 Delta mutants. A multicopy plasmid containing the EKI1 gene directed the overexpression of ethanolamine kinase activity in wild-type, eki1 Delta mutant, cki1 Delta mutant, and eki1 Delta cki1 Delta double mutant cells. The heterologous expression of the S. cerevisiae EKI1 gene in Sf-9 insect cells resulted in a 165,500-fold overexpression of ethanolamine kinase activity relative to control insect cells, The EKI1 gene product also exhibited choline kinase activity. Biochemical analyses of the enzyme expressed in insect cells, in eki1 Delta mutants, and in cki1 Delta mutants indicated that ethanolamine was the preferred substrate. The eki1 Delta mutant did not exhibit a growth phenotype, Biochemical analyses of eki1 Delta, cki1 Delta, and eki1 Delta cki1 Delta mutants showed that the EKI1 and CKI1 gene products encoded all of the ethanolamine kinase and choline kinase activities in S, cerevisiae, lit vivo labeling experiments showed that the EKI1 and CKI1 gene products had overlapping functions with respect to phospholipid synthesis. Whereas the EKI1 gene product was primarily responsible for phosphatidylethanolamine synthesis via the CDP-ethanolamine pathway, the CKI1 gene product was primarily responsible for phosphatidylcholine synthesis via the CDP-choline pathway. Unlike cki1 Delta mutants, eki1 Delta mutants did not suppress the essential function of Sec14p.	Rutgers State Univ, New Jersey Agr Expt Stn, Cook Coll, Dept Food Sci, New Brunswick, NJ 08901 USA; Natl Jewish Ctr Immunol & Resp Med, Lord & Taylor Lab Lung Biochem, Denver, CO 80206 USA; Natl Jewish Ctr Immunol & Resp Med, Anna Perahia Adatto Clin Res Ctr, Denver, CO 80206 USA	Rutgers State University New Brunswick; National Jewish Health; National Jewish Health	Carman, GM (corresponding author), Rutgers State Univ, New Jersey Agr Expt Stn, Cook Coll, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			NIGMS NIH HHS [GM-32453, GM-50679] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R01GM032453, R01GM050679] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JB, 1994, YEAST, V10, P1267, DOI 10.1002/yea.320101003; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; CULBERTSON MR, 1975, GENETICS, V80, P23; Elabbadi N, 1997, BIOCHEM J, V324, P435, DOI 10.1042/bj3240435; ESKO JD, 1980, J BIOL CHEM, V255, P4474; Fang M, 1998, BBA-MOL CELL RES, V1404, P85, DOI 10.1016/S0167-4889(98)00049-4; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Ishidate K, 1997, BBA-LIPID LIPID MET, V1348, P70, DOI 10.1016/S0005-2760(97)00118-5; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacq C, 1997, NATURE, V387, P75, DOI 10.1038/387s075; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCGRAW P, 1989, GENETICS, V122, P317; McMaster CR, 1997, BBA-LIPID LIPID MET, V1348, P117, DOI 10.1016/S0005-2760(97)00098-2; MinSeok R, 1996, J BIOCHEM, V120, P1040; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P109; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; REPETTO B, 1990, MOL CELL BIOL, V10, P4221, DOI 10.1128/MCB.10.8.4221; ROSENBERG M, 1990, MICROBIAL CELL SURFA, P1; ROTHSTEIN R, 1991, METHODS ENZYMOL, V194, P281; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; SUMMERS EF, 1988, GENETICS, V120, P909; TEEGARDEN D, 1990, J BIOL CHEM, V265, P6042; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; YAMASHITA S, 1997, BIOCHIM BIOPHYS ACTA, P63	59	67	70	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14857	14866		10.1074/jbc.274.21.14857	http://dx.doi.org/10.1074/jbc.274.21.14857			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329685	hybrid			2022-12-27	WOS:000081965200050
J	Pages, P; Benali, N; Saint-Laurent, N; Esteve, JP; Schally, AV; Tkaczuk, J; Vaysse, N; Susini, C; Buscail, L				Pages, P; Benali, N; Saint-Laurent, N; Esteve, JP; Schally, AV; Tkaczuk, J; Vaysse, N; Susini, C; Buscail, L			sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1) - Evidence for the role of SHP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; TYROSINE PHOSPHATASE SHP-1; MAMMARY EPITHELIAL-CELLS; CDK INHIBITOR; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; GROWTH ARREST; G(1) ARREST; MOTH-EATEN; TGF-BETA	Activation of the somatostatin receptor sst2 inhibits cell proliferation by a mechanism involving the stimulation of the protein-tyrosine phosphatase SHP-1, The cell cycle regulatory events leading to sst2-mediated growth arrest are not known. Here, we report that treatment of Chinese hamster ovary cells expressing sst2 with the somatostatin analogue, RC-160, led to G(1) cell cycle arrest and inhibition of insulin-induced S-phase entry through induction of the cyclin-dependent kinase inhibitor p27(Kip1). Consequently, a decrease of p27(Kip1)-cdk2 association, an inhibition of insulin-induced cyclin E-cdk2 kinase activity, and an accumulation of hypophosphorylated retinoblastoma gene product (Rb) were observed. However, RC-160 had no effect on the p21(Waf1/Cip1) When sst2 was coexpressed with a catalytically inactive mutant SHP-1 in Chinese hamster ovary cells, mutant SHP-1 induced entry into cell cycle and down-regulation of p27(Kip1) and prevented modulation by insulin and RC-160 of p27(Kip1) expression, p27(Kip1)-cdk2 association, cyclin E-cdk2 kinase activity, and the phosphorylation state of Rb. In mouse pancreatic acini, RC-160 reverted down-regulation of p27(Kip1) induced by a mitogen, and this effect did not occur in acini from viable motheaten (me(v)/me(v)) mice expressing a mutant SHP-1 with markedly deficient enzymes. These findings provide the first evidence that sst2 induces cell cycle arrest through the up-regulation of p27(Kip1) and demonstrate that SHP-1 is required for maintaining high inhibitory levels of p27(Kip1) and is a critical target of the insulin, and somatostatin signaling cascade, leading to the modulation of p27(Kip1).	CHU Rangueil, Inst Louis Bugnard, INSERM, U151, F-31403 Toulouse, France; Tulane Univ, Dept Med, New Orleans, LA 70112 USA; Vet Affairs Med Ctr, Sch Med, New Orleans, LA 70112 USA; CHU Rangueil, Immunol Lab, F-31403 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Tulane University; US Department of Veterans Affairs; Veterans Health Administration (VHA); CHU de Toulouse	Susini, C (corresponding author), CHU Rangueil, Inst Louis Bugnard, INSERM, U151, F-31403 Toulouse, France.		Nathalie, Saint-Laurent/G-5487-2017	Schally, Andrew/0000-0003-1273-6747				Akiyama T, 1997, CANCER RES, V57, P1495; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Bouchard C, 1997, J IMMUNOL, V159, P4155; Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; BUSCAIL L, 1995, P NATL ACAD SCI USA, V92, P1580, DOI 10.1073/pnas.92.5.1580; BUSCAIL L, 1994, P NATL ACAD SCI USA, V91, P2315, DOI 10.1073/pnas.91.6.2315; CAI RZ, 1986, P NATL ACAD SCI USA, V83, P1896, DOI 10.1073/pnas.83.6.1896; CHEUNG NW, 1995, ENDOCRINOLOGY, V136, P4174, DOI 10.1210/en.136.10.4174; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; HARPER JW, 1993, CELL, V75, P805; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KNUHTSEN S, 1990, J BIOL CHEM, V265, P1129; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Kwon TK, 1996, CELL GROWTH DIFFER, V7, P1305; Kwon TK, 1996, BIOCHEM BIOPH RES CO, V220, P703, DOI 10.1006/bbrc.1996.0468; LAMBERTS SWJ, 1991, ENDOCR REV, V12, P450, DOI 10.1210/edrv-12-4-450; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LEWIN MJM, 1992, ANNU REV PHYSIOL, V54, P455, DOI 10.1146/annurev.physiol.54.1.455; LIEBOW C, 1989, P NATL ACAD SCI USA, V86, P2003, DOI 10.1073/pnas.86.6.2003; LOGSDON CD, 1983, GASTROENTEROLOGY, V85, P339; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Mandal M, 1998, ONCOGENE, V16, P217, DOI 10.1038/sj.onc.1201529; Mann DJ, 1997, ONCOGENE, V14, P1759, DOI 10.1038/sj.onc.1201134; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PAGLIACCI MC, 1991, ENDOCRINOLOGY, V129, P2555, DOI 10.1210/endo-129-5-2555; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Sgambato A, 1998, CANCER RES, V58, P3448; Sharma K, 1996, MOL ENDOCRINOL, V10, P1688, DOI 10.1210/me.10.12.1688; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SRIKANT CB, 1995, BIOCHEM BIOPH RES CO, V209, P400, DOI 10.1006/bbrc.1995.1517; Sweeney KJ, 1998, ONCOGENE, V16, P2865, DOI 10.1038/sj.onc.1201814; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Wu XP, 1996, ONCOGENE, V12, P1397; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	51	110	119	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					15186	15193		10.1074/jbc.274.21.15186	http://dx.doi.org/10.1074/jbc.274.21.15186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329727	hybrid			2022-12-27	WOS:000081965200092
J	Ward, AC; Smith, L; de Koning, JP; van Aesch, Y; Touw, IP				Ward, AC; Smith, L; de Koning, JP; van Aesch, Y; Touw, IP			Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-CSF RECEPTOR; TYROSINE-PHOSPHATASE; EXPRESSION CLONING; RAPID ACTIVATION; IN-VIVO; PROTEIN; STAT3; DOMAINS; BINDING; GROWTH	Granulocyte colony-stimulating factor (G-CSF) regulates neutrophil production through activation of its cognate receptor, the G-CSF-R Previous studies with deletion mutants have shown that the membrane-proximal cytoplasmic domain of the receptor is sufficient for mitogenic signaling, whereas the membrane-distal domain is required for differentiation signaling. However, the function of the four cytoplasmic tyrosines of the G-CSF-R in the control of proliferation, differentiation, and survival has remained unclear. Here we investigated the role of these tyrosines by expressing a tyrosine "null" mutant and single tyrosine "add back" mutants in maturation-competent myeloid 32D cells. Clones expressing the null mutant showed only minimal proliferation and differentiation, with survival also reduced at low G-CSF concentrations. Analysis of clones expressing the add-back mutants revealed that multiple tyrosines contribute to proliferation, differentiation, and survival signals from the G-CSF-R. Analysis of signaling pathways downstream of these tyrosines suggested a positive role for STAT3 activation in both differentiation and survival signaling, whereas SHP-2, Grb2 and Shc appear important for proliferation signaling. In addition, we show that a tyrosine-independent "differentiation domain" in the membrane-distal region of the G-CSF-R appears necessary but not sufficient for mediating neutrophilic differentiation in these cells.	Erasmus Univ, Inst Hematol, NL-3000 DR Rotterdam, Netherlands; Dr Daniel Den Hoed Canc Ctr, Dept Hematol, NL-3008 AE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Ward, AC (corresponding author), Erasmus Univ, Inst Hematol, Room H EE 1314,POB 1738, NL-3000 DR Rotterdam, Netherlands.	ward@hema.fgg.eul.nl		Ward, Alister/0000-0001-7945-7975				Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Barge RMY, 1996, BLOOD, V87, P2148, DOI 10.1182/blood.V87.6.2148.bloodjournal8762148; BASHEY A, 1994, BLOOD, V83, P949, DOI 10.1182/blood.V83.4.949.bloodjournal834949; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Chakraborty A, 1999, BLOOD, V93, P15, DOI 10.1182/blood.V93.1.15.401a46_15_24; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Csar XF, 1997, BIOCHEM J, V322, P79, DOI 10.1042/bj3220079; de Koning JP, 1998, BLOOD, V91, P1924, DOI 10.1182/blood.V91.6.1924.1924_1924_1933; deKoning JP, 1996, BLOOD, V87, P132; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; DEMETRI GD, 1991, BLOOD, V78, P2791; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; FUKUNAGA R, 1990, CELL, V61, P341, DOI 10.1016/0092-8674(90)90814-U; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 1998, J IMMUNOL, V160, P4979; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Longmore GD, 1998, BLOOD, V91, P870, DOI 10.1182/blood.V91.3.870.870_870_878; Nicholson SE, 1996, J BIOL CHEM, V271, P26947, DOI 10.1074/jbc.271.43.26947; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; Novak U, 1996, GROWTH FACTORS, V13, P251, DOI 10.3109/08977199609003226; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAUCHI T, 1994, J BIOL CHEM, V269, P25206; Tian SS, 1996, BLOOD, V88, P4435, DOI 10.1182/blood.V88.12.4435.bloodjournal88124435; TIAN SS, 1994, BLOOD, V84, P1760; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; Vogel W, 1996, CELL GROWTH DIFFER, V7, P1589; Ward AC, 1998, BBA-MOL CELL RES, V1448, P70, DOI 10.1016/S0167-4889(98)00120-7; WARD AC, 1995, ARCH VIROL, V140, P2067, DOI 10.1007/BF01322693; Ward AC, 1998, BIOCHEM BIOPH RES CO, V251, P117, DOI 10.1006/bbrc.1998.9441; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; YOSHIKAWA A, 1995, EMBO J, V14, P5288, DOI 10.1002/j.1460-2075.1995.tb00213.x; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	105	105	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	1999	274	21					14956	14962		10.1074/jbc.274.21.14956	http://dx.doi.org/10.1074/jbc.274.21.14956			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	225MK	10329697	hybrid, Green Published			2022-12-27	WOS:000081965200062
J	Dorn, C; Ou, QL; Svaren, J; Crawford, PA; Sadovsky, Y				Dorn, C; Ou, QL; Svaren, J; Crawford, PA; Sadovsky, Y			Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL HYPOPLASIA CONGENITA; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; PROTEIN-KINASE-C; FACTOR-I SF-1; SUBUNIT GENE; TRANSGENIC MICE; DNA-BINDING; NGFI-A; GNRH RECEPTOR; DIFFERENTIAL REGULATION	We have previously shown that early growth response (Egr) 1-deficient mice exhibit female infertility, reflecting a luteinizing hormone (LH) beta deficiency. Egr-1 activates the LH beta gene in vitro through synergy with steroidogenic factor-1 (SF-1), a protein required for gonadotrope function, To test if this synergy is essential for gonadotropin-releasing hormone (GnRH) stimulation of LH beta, we examined the activity of the LH beta promoter in the gonadotrope cell line L beta T2. GnRH markedly stimulated the LH beta promoter (15-fold). Mutation of either Egr-1 or SF-1 elements within the LH beta promoter attenuated this stimulation, whereas mutation of both promoter elements abrogated GnRH induction of the LH beta promoter. Furthermore, GnRH stimulated Egr-1 but not SF-1 expression in L beta T2 cells. Importantly, overexpression of Egr-1 alone was sufficient to enhance LH beta expression. Although other Egr proteins are expressed in L beta T2 cells and are capable of interacting with SF-1, GnRH stimulation of Egr-1 was the most robust, We also found that the nuclear receptor DAX-1, a repressor of SF-1 activity, reduced Egr-1-SF-1 synergy and diminished GnRH stimulation of the LH beta promoter. We conclude that the synergy between Egr-1 and SF-1 is essential for GnRH stimulation of the LH beta gene and plays a central role in the dynamic regulation of LH beta expression.	Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sadovsky, Y (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, POB 8064,4911 Barnes Jewish Hosp Plaza, St Louis, MO 63110 USA.	sadovskyy@msnotes.wustl.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Crawford, Peter/0000-0001-8597-4426				Alarid ET, 1996, DEVELOPMENT, V122, P3319; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANDREWS WV, 1988, J BIOL CHEM, V263, P13755; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Brown P, 1997, INT J BIOCHEM CELL B, V29, P1513, DOI 10.1016/S1357-2725(97)00082-4; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLAYTON RN, 1991, MOL CELL ENDOCRINOL, V80, P193, DOI 10.1016/0303-7207(91)90156-M; Crawford PA, 1997, MOL ENDOCRINOL, V11, P1626, DOI 10.1210/me.11.11.1626; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Ehrengruber MU, 1998, METHOD ENZYMOL, V293, P483; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; GREEN ED, 1986, MOL CELL BIOCHEM, V72, P81; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Haisenleder DJ, 1996, ENDOCRINOLOGY, V137, P5719, DOI 10.1210/en.137.12.5719; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ikuyama S, 1998, CLIN ENDOCRINOL, V48, P647, DOI 10.1046/j.1365-2265.1998.00477.x; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Kaiser UB, 1998, J BIOL CHEM, V273, P12943, DOI 10.1074/jbc.273.21.12943; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; KERI RA, 1994, MOL ENDOCRINOL, V8, P1807, DOI 10.1210/me.8.12.1807; Lanctot C, 1997, DEVELOPMENT, V124, P2807; LeDrean Y, 1996, MOL ENDOCRINOL, V10, P217, DOI 10.1210/me.10.3.217; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Naor Z, 1998, FRONT NEUROENDOCRIN, V19, P1, DOI 10.1006/frne.1997.0162; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; SAADE G, 1989, ENDOCRINOLOGY, V124, P1744, DOI 10.1210/endo-124-4-1744; Sadovsky Y, 1998, J SOC GYNECOL INVEST, V5, P6, DOI 10.1016/S1071-5576(97)00096-8; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; SHUPNIK MA, 1991, J BIOL CHEM, V266, P17084; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; WATSON MA, 1990, DEVELOPMENT, V110, P173; Weck J, 1998, MOL ENDOCRINOL, V12, P451, DOI 10.1210/me.12.3.451; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899	65	151	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13870	13876		10.1074/jbc.274.20.13870	http://dx.doi.org/10.1074/jbc.274.20.13870			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318795	hybrid			2022-12-27	WOS:000080322200024
J	Hanlon, M; Sealy, L				Hanlon, M; Sealy, L			Ras regulates the association of serum response factor and CCAAT/enhancer-binding protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR PROTEIN; LONG TERMINAL REPEAT; C/EBP-BETA; FACTOR SRF; ELEMENT; FAMILY; SEQUENCE; COMPLEX; NF-IL6; MEMBER	The serum response element (SRE) is a promoter element essential for transcriptional activation of immediate early genes, such as c-fos and early growth response-1, by mitogenic signals, Several transcription factors bind the SRE, including the serum response factor (SRF), the ternary complex factor, and the CCAAT/enhancer-binding protein beta (C/EBP beta). The C/EBP beta mRNA encodes three translation products of 38, 35, and 20 kDa, p35-C/EBP beta activates transcription of the SRE in an SRF-dependent fashion, whereas p20-C/EBP beta, which initiates at an internal in-frame methionine, lacks a transactivation domain and inhibits transcription. We show that SRF and C/EBP beta interact in vivo through the DNA binding domain of SRF and the C terminus of C/EEP beta common to p35/38 and p20. Therefore, like the ternary complex factor, C/EBP beta may be recruited to the SRE not only by binding to the DNA, which is not a high affinity site, but also by protein-protein interactions with SRF, Strikingly, in both the mammalian two-hybrid assay and in vivo coimmunoprecipitations, the association of SRF and p35-C/EBP beta but not p20-C/EBP beta is dramatically stimulated by activated Ras, Furthermore, mutation of the threonine within a mitogen-activated protein kinase consensus motif in the C terminus of C/EBP beta eliminates the response to Ras, These results suggest a new mechanism by which mitogenic signals may influence transcription activity of the SRE by selectively promoting protein-protein interactions between SRF and the transactivator p35-C/EBP beta.	Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Vanderbilt University	Sealy, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.				NIGMS NIH HHS [GM29826, 5T32GM08554] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029826, T32GM008554] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BOULDEN AM, 1992, MOL CELL BIOL, V12, P4769, DOI 10.1128/MCB.12.10.4769; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; COHEN D R, 1989, Critical Reviews in Oncogenesis, V1, P65; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Mobley CM, 1998, J VIROL, V72, P6592, DOI 10.1128/JVI.72.8.6592-6601.1998; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pelech S L, 1995, Prog Cell Cycle Res, V1, P33; Sealy L, 1997, MOL CELL BIOL, V17, P1744, DOI 10.1128/MCB.17.3.1744; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; Treisman R, 1990, Semin Cancer Biol, V1, P47; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TRIESMAN R, 1987, EMBO J, V6, P2711; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	23	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14224	14228		10.1074/jbc.274.20.14224	http://dx.doi.org/10.1074/jbc.274.20.14224			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318842	hybrid			2022-12-27	WOS:000080322200071
J	Hirata, K; Dichek, HL; Cioffi, JA; Choi, SY; Leeper, NJ; Quintana, L; Kronmal, GS; Cooper, AD; Quertermous, T				Hirata, K; Dichek, HL; Cioffi, JA; Choi, SY; Leeper, NJ; Quintana, L; Kronmal, GS; Cooper, AD; Quertermous, T			Cloning of a unique lipase from endothelial cells extends the lipase gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY-LIKE STRUCTURES; LIPOPROTEIN-LIPASE; HEPATIC LIPASE; PANCREATIC LIPASE; DIFFERENTIATION; ANGIOGENESIS; ATHEROSCLEROSIS; HYBRIDIZATION; METABOLISM; RECEPTOR	A new lipoprotein lipase-like gene has been cloned from endothelial cells through a subtraction methodology aimed at characterizing genes that are expressed with in vitro differentiation of this cell type. The conceptual endothelial cell-derived lipase protein contains 500 amino acids, including an 18-amino acid hydrophobic signal sequence, and is 44% identical to lipoprotein lipase and 41% identical to hepatic lipase. Comparison of primary sequence to that of lipoprotein and hepatic lipase reveals conservation of the serine, aspartic acid, and histidine catalytic residues as well as the 10 cysteine residues involved in disulfide bond formation. Expression was identified in cultured human umbilical vein endothelial cells, human coronary artery endothelial cells, and murine endothelial-like yolk sac cells by Northern blot. In addition, Northern blot and in situ hybridization analysis revealed expression of the endothelial-derived lipase in placenta, liver, lung, ovary, thyroid gland, and testis. A c-Myc-tagged protein secreted from transfected COS7 cells had phospholipase Al activity but no triglyceride lipase activity. Its tissue-restricted pattern of expression and its ability to be expressed by endothelial cells, suggests that endothelial cell-derived lipase may have unique functions in lipoprotein metabolism and in vascular disease.	Stanford Univ, Sch Med, Div Cardiol, Stanford, CA 94305 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Progenitor Inc, Menlo Park, CA 94025 USA; Palo Alto Med Fdn, Palo Alto, CA 94301 USA; Stanford Univ, Sch Med, Div Gastroenterol, Stanford, CA 94305 USA	Stanford University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; Palo Alto Medical Foundation Research Institute; Stanford University	Quertermous, T (corresponding author), Stanford Univ, Sch Med, Div Cardiol, Falk Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.			Quertermous, Thomas/0000-0002-7645-9067	NHLBI NIH HHS [KO8 HL 03865 01] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BATENBURG JJ, 1992, AM J PHYSIOL, V262, P367; BELFRAGE P, 1969, J LIPID RES, V10, P341; BIEZENSKI JJ, 1969, AM J OBSTET GYNECOL, V104, P1177, DOI 10.1016/S0002-9378(16)34293-4; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Corn BJ, 1991, CLIN BIOTECHNOL, V3, P15; CRYER A, 1987, LIPOPROTEIN LIPASE; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DICHEK HL, 1993, J LIPID RES, V34, P1393; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; HIDE WA, 1992, J LIPID RES, V33, P167; HOGAN B, 1994, MANIPULATING MOUSE E, P325; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Mallampalli RK, 1997, J CLIN INVEST, V99, P2020, DOI 10.1172/JCI119370; OBRIEN KD, 1994, AM J PATHOL, V144, P538; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; QUINN DM, 1982, BIOCHEMISTRY-US, V21, P6872, DOI 10.1021/bi00269a038; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROONEY SA, 1985, AM REV RESPIR DIS, V131, P439; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; VONHEIJNE G, 1987, SEQUENCE ANAL MOL BI, P112; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; WEI YZ, 1995, STEM CELLS, V13, P541, DOI 10.1002/stem.5530130512; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	31	257	295	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14170	14175		10.1074/jbc.274.20.14170	http://dx.doi.org/10.1074/jbc.274.20.14170			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318835	hybrid			2022-12-27	WOS:000080322200064
J	Holz, GG; Leech, CA; Heller, RS; Castonguay, M; Habener, JF				Holz, GG; Leech, CA; Heller, RS; Castonguay, M; Habener, JF			cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells - A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; INOSITOL 1,4,5-TRISPHOSPHATE; RELEASE CHANNEL; PEPTIDE-I; SARCOPLASMIC-RETICULUM; PEPTIDE-1(7-36) AMIDE; PHOSPHOLIPASE-C; CALCIUM-RELEASE; SECRETING CELLS; CARDIAC-MUSCLE	Glucagon-like peptide-1 (GLP-1) is an intestinally derived insulinotropic hormone currently under investigation for use as a novel therapeutic agent in the treatment of type 2 diabetes mellitus, In vitro studies of pancreatic islets of Langerhans demonstrated that GLP-1 interacts with specific beta-cell G protein-coupled receptors, thereby facilitating insulin exocytosis by raising intracellular levels of cAMP and Ca2+. Here we report that the stimulatory influence of GLP-1 on Ca2+ signaling results, in part, from cAMP-dependent mobilization of ryanodine-sensitive Ca2+ stores. Studies of human, rat, and mouse beta-cells demonstrate that the binding of a fluorescent derivative of ryanodine (BODIPY FL-X ryanodine) to its receptors is specific, reversible, and of high affinity. Rat islets and BTC3 insulinoma cells are shown by reverse transcriptase polymerase chain reaction analyses to express mRNA corresponding to the type 2 isoform of ryanodine receptor-intracellular Ca2+ release channel (RYR2), Single-cell measurements of [Ca2+](i) using primary cultures of rat and human beta-cells indicate that GLP-1 facilitates Ca2+-induced Ca2+ release (CICR), whereby mobilization of Ca2+ stores is triggered by influx of Ca2+ through L-type Ca2+ channels, In these cells, GLP-1 is shown to interact with metabolism of D-glucose to produce a fast transient increase of [Ca2+](i). This effect is reproduced by 8-Br-cAMP, but is blocked by a GLP-1 receptor antagonist (exendin-(9-39)), a cAMP antagonist ((Rp)-cAMPS), an L-type Ca2+ channel antagonist (nimodipine), an antagonist of the sarco(endo)plasmic reticulum Ca2+ ATPase (thapsigargin), or by ryanodine, Characterization of the CICR mechanism by voltage clamp analysis also demonstrates a stimulation of Ca2+ release by caffeine. These findings provide new support for a model of beta-cell signal transduction whereby GLP-1 promotes CICR by sensitizing intracellular Ca2+ release channels to the stimulatory influence of cytosolic Ca2+.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Endocrinol Lab, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Holz, GG (corresponding author), NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA.		Holz, George G/A-3386-2012; Heller, R.Scott/A-7279-2008	Holz, George/0000-0002-1781-3580	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045817, R01DK052166, R01DK045817, R01DK030834] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-45817, R01 DK045817, DK-52166, DK-30834, R01 DK030834] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; AYABE T, 1995, DEVELOPMENT, V121, P2233; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; Chatton JY, 1998, BIOCHEM J, V330, P1411, DOI 10.1042/bj3301411; Chen TH, 1996, LIFE SCI, V58, P983, DOI 10.1016/0024-3205(96)00046-X; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; CULLINAN CA, 1994, CELL CALCIUM, V15, P391, DOI 10.1016/0143-4160(94)90014-0; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; FRIDOLF T, 1991, DIABETES RES CLIN EX, V16, P185; FRIDOLF T, 1993, MOL CELL ENDOCRINOL, V96, P85, DOI 10.1016/0303-7207(93)90098-5; GALIONE A, 1993, SCIENCE, V259, P325, DOI 10.1126/science.8380506; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; GRAPENGIESSER E, 1991, J BIOL CHEM, V266, P12207; Gromada J, 1998, FEBS LETT, V425, P277, DOI 10.1016/S0014-5793(98)00254-3; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Gromada J, 1998, DIABETES, V47, P57, DOI 10.2337/diabetes.47.1.57; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Gromada J, 1996, BRIT J PHARMACOL, V118, P769, DOI 10.1111/j.1476-5381.1996.tb15466.x; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; HOLZ GG, 1995, J BIOL CHEM, V270, P17749, DOI 10.1074/jbc.270.30.17749; ISLAM MS, 1992, FEBS LETT, V296, P287, DOI 10.1016/0014-5793(92)80306-2; ISLAM MS, 1995, BIOCHEM J, V306, P679, DOI 10.1042/bj3060679; Islam MS, 1997, DIABETOLOGIA, V40, P1480, DOI 10.1007/s001250050853; Islam MS, 1997, BIOCHEM J, V321, P347, DOI 10.1042/bj3210347; ISLAM MS, 1993, SCIENCE, V262, P584, DOI 10.1126/science.8211188; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Kato M, 1996, REGUL PEPTIDES, V62, P23, DOI 10.1016/0167-0115(95)00164-6; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; KOMATSU M, 1995, P NATL ACAD SCI USA, V92, P10728, DOI 10.1073/pnas.92.23.10728; KREYMANN B, 1987, LANCET, V2, P1300; LACY PE, 1967, DIABETES, V16, P335; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; Leech CA, 1996, ANN NY ACAD SCI, V805, P81; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Malaisse WJ, 1997, BIOCHEM BIOPH RES CO, V231, P546, DOI 10.1006/bbrc.1996.5715; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; NAKADE S, 1994, J BIOL CHEM, V269, P6735; NATHAN DM, 1992, DIABETES CARE, V15, P270, DOI 10.2337/diacare.15.2.270; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; Okamoto H, 1997, DIABETOLOGIA, V40, P1485, DOI 10.1007/s001250050854; OTSU K, 1990, J BIOL CHEM, V265, P13472; Ozawa T, 1998, BIOCHEM BIOPH RES CO, V246, P422, DOI 10.1006/bbrc.1998.8636; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; RAJAN AS, 1989, DIABETES, V38, P874, DOI 10.2337/diabetes.38.7.874; RUTTER GA, 1994, CELL CALCIUM, V16, P71, DOI 10.1016/0143-4160(94)90002-7; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TANIGUCHI T, 1996, ENDOCRINOL METAB, V3, P135; Tengholm A, 1998, DIABETES, V47, P1224, DOI 10.2337/diabetes.47.8.1224; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; WANG JL, 1993, J BIOL CHEM, V268, P7785; Webb DL, 1996, J BIOL CHEM, V271, P19074, DOI 10.1074/jbc.271.32.19074; WHEELER MB, 1993, ENDOCRINOLOGY, V133, P57, DOI 10.1210/en.133.1.57; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; WILLMOTT NJ, 1995, CELL CALCIUM, V18, P411, DOI 10.1016/0143-4160(95)90056-X; WOLF BA, 1985, BIOCHEM J, V227, P965, DOI 10.1042/bj2270965; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; YADA T, 1993, ENDOCRINOLOGY, V133, P1685, DOI 10.1210/en.133.4.1685; ZAWALICH WS, 1993, REGUL PEPTIDES, V44, P277, DOI 10.1016/0167-0115(93)90137-W	69	188	201	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14147	14156		10.1074/jbc.274.20.14147	http://dx.doi.org/10.1074/jbc.274.20.14147			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318832	Green Accepted, hybrid			2022-12-27	WOS:000080322200061
J	Huang, CYF; Chang, CPB; Huang, CL; Ferrell, JE				Huang, CYF; Chang, CPB; Huang, CL; Ferrell, JE			M phase phosphorylation of cytoplasmic dynein intermediate chain and p150(Glued)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-OOCYTE MATURATION; MAP KINASE CASCADE; MOS PROTO-ONCOGENE; CELL-CYCLE; MEIOTIC MATURATION; MITOTIC SPINDLE; IN-VIVO; TYROSINE PHOSPHORYLATION; MOTOR PROTEINS; CHROMOSOME SEGREGATION	To understand how the dramatic cell biological changes of oocyte maturation are brought about, we have begun to identify proteins whose phosphorylation state changes during Xenopus oocyte maturation. Here we have focused on one such protein, p83. We partially purified p83, obtained peptide sequence, and identified it as the intermediate chain of cytoplasmic dynein. During oocyte maturation, dynein intermediate chain became hyperphosphorylated at the time of germinal vesicle breakdown and remained hyperphosphorylated throughout the rest of meiosis and early embryogenesis. p150(Glued), a subunit of dynactin that has been shown to bind to dynein intermediate chain, underwent similar changes in its phosphorylation, Both dynein intermediate chain and p150(Glued) also became hyperphosphorylated during M phase in XTC-2 cells and HeLa cells. Thus, two components of the dynein-dynactin complex undergo coordinated phosphorylation changes at two G(2)/M transitions (maturation in oocytes and mitosis in cells in culture) but remain constitutively in their M phase forms during early embryogenesis. Dynein intermediate chain and p150(Glued) phosphorylation may positively regulate mitotic processes, such as spindle assembly or orientation, or negatively regulate interphase processes such as minus-end-directed organelle trafficking.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 115, Taiwan	Stanford University; National Health Research Institutes - Taiwan	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.	ferrell@cmgm.stanford.edu	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937	NIGMS NIH HHS [GM46383] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; DILLMAN JF, 1995, BIOPHYS J, V68, pS226; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Farshori P, 1997, BIOCHEM BIOPH RES CO, V232, P810, DOI 10.1006/bbrc.1997.6379; Faulkner NE, 1998, HUM MOL GENET, V7, P671, DOI 10.1093/hmg/7.4.671; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; HACCARD O, 1990, EUR J BIOCHEM, V192, P633, DOI 10.1111/j.1432-1033.1990.tb19270.x; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Huang CYF, 1996, EMBO J, V15, P2169, DOI 10.1002/j.1460-2075.1996.tb00570.x; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; JESSUS C, 1991, DEVELOPMENT, V111, P813; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; KOBAYASHI H, 1991, COLD SH Q B, V56, P437; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; Maller JL, 1991, CURR OPIN CELL BIOL, V3, P269; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Murray AW, 1998, CELL, V92, P157, DOI 10.1016/S0092-8674(00)80910-1; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Nigg EA, 1996, EXP CELL RES, V229, P174, DOI 10.1006/excr.1996.0356; NORBURY C, 1990, CIBA F SYMP, V150, P168; NORBURY C, 1990, CIBA F SYMP, V150, P177; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Saredi A, 1997, J CELL SCI, V110, P1287; SCHROER TA, 1994, CURR OPIN CELL BIOL, V6, P69, DOI 10.1016/0955-0674(94)90118-X; Skoufias DA, 1993, CURR OPIN CELL BIOL, V5, P95, DOI 10.1016/S0955-0674(05)80014-6; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	63	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					14262	14269		10.1074/jbc.274.20.14262	http://dx.doi.org/10.1074/jbc.274.20.14262			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318847	hybrid			2022-12-27	WOS:000080322200076
J	Matsumoto, T; Yokote, K; Tamura, K; Takemoto, M; Ueno, S; Saito, Y; Mori, S				Matsumoto, T; Yokote, K; Tamura, K; Takemoto, M; Ueno, S; Saito, Y; Mori, S			Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA-RECEPTOR; FACTOR BETA-RECEPTOR; SIGNAL-TRANSDUCTION PATHWAYS; LIGAND-MEDIATED ENDOCYTOSIS; HEAT-SHOCK PROTEIN-27; MAP KINASE; C-JUN; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; CDC42 GTPASES	Members of the mitogen activated protein (MAP) kinase family, extracellular signal-regulated kinase, stress-activated protein kinase 1/c-Jun NH2-terminal kinase, and p38, are central elements that transduce the signal generated by growth factors, cytokines, and stressing agents. It is well known that the plaleletrderived growth factor (PDGF) activates extracellular signal-regulated kinase, which leads to cellular mitogenic response. On the other hand, the role of the other MAP kinases in mediating the cellular function of PDGF remains unclear. In the present study, we have investigated the functional role of the other MAP kinases in PDGF-mediated cellular responses. We show that ligand stimulation of PDGF receptors leads to the activation of p38 but not stress-activated protein kinase-1/c-Jun NH2-terminal kinase. Experiments using a specific inhibitor of p38, SB203580, show that the activation of p38 is required for PDGF-induced cell motility responses such as cell migration and actin reorganization but not required for PDGF-stimulated DNA synthesis. Analyses of tyrosine residue-mutated PDGF receptors show that Src homology 2 domain-containing proteins including Src family kinases, phosphatidylinositol 3-kinase, the GTPase-activating protein of Ras, the Src homology 2 domain-containing phosphatase SHP-2, phospholipase C-gamma, and Crk do not play a major role in mediating the PDGF-induced activation of p38. Finally, the expression of dominant-negative Ras but not dominant-negative Rac inhibited p38 activation by PDGF, suggesting that Ras is a potent mediator in the p38 activation pathway downstream of PDGF receptors, Taken together, our present study proposes the existence of a Ras-dependent pathway for the activation of p38, which is important for cell motility responses elicited by PDGF stimulation.	Chiba Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Chiba 2600856, Japan; Kyushu Univ, Sch Med, Dept Cardiol, Mol Cardiol Unit,Higashi Ku, Fukuoka 8128582, Japan	Chiba University; Kyushu University	Matsumoto, T (corresponding author), Chiba Univ, Sch Med, Dept Internal Med 2, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.							ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; CANO E, 1995, J CELL SCI, V108, P3599; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; ERIKSSON A, 1995, J BIOL CHEM, V270, P7773, DOI 10.1074/jbc.270.13.7773; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Guay J, 1997, J CELL SCI, V110, P357; HELDIN CH, 1994, GUIDEBOOK CYTOKINES, P249; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Huot J, 1996, CANCER RES, V56, P273; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KUNDRA V, 1995, J CELL BIOL, V130, P725, DOI 10.1083/jcb.130.3.725; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MORI S, 1991, J BIOL CHEM, V266, P21158; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; MORI S, 1994, J BIOL CHEM, V269, P4917; NISTER M, 1988, CELL, V52, P791, DOI 10.1016/0092-8674(88)90421-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; RUPP E, 1994, EUR J BIOCHEM, V225, P29, DOI 10.1111/j.1432-1033.1994.00029.x; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519; STOKER M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P81, DOI 10.1016/0304-419X(91)90008-9; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Ueno H, 1997, ARTERIOSCL THROM VAS, V17, P898, DOI 10.1161/01.ATV.17.5.898; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WENNSTROM S, 1994, ONCOGENE, V9, P651; Yokote K, 1996, J BIOL CHEM, V271, P5101; Yokote K, 1998, ONCOGENE, V16, P1229, DOI 10.1038/sj.onc.1201641; YU JC, 1991, MOL CELL BIOL, V11, P3780, DOI 10.1128/MCB.11.7.3780; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	44	147	152	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13954	13960		10.1074/jbc.274.20.13954	http://dx.doi.org/10.1074/jbc.274.20.13954			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318806	hybrid			2022-12-27	WOS:000080322200035
J	Wang, YX; Dhulipala, PDK; Li, L; Benovic, JL; Kotlikoff, MI				Wang, YX; Dhulipala, PDK; Li, L; Benovic, JL; Kotlikoff, MI			Coupling of M-2 muscarinic receptors to membrane ion channels via phosphoinositide 3-kinase gamma and atypical protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; POTASSIUM CHANNEL; K+ CHANNEL; INTRACELLULAR CALCIUM; SYMPATHETIC NEURONS; SIGNAL-TRANSDUCTION; PLATELET CYTOSOL; INWARD CURRENT; ACTIVATION; IDENTIFICATION	We report a novel signaling pathway linking M-2 muscarinic receptors to metabotropic ion channels. Stimulation of heterologously expressed M-2 receptors, but not other G(i)/G(o)-associated receptors (M-4 or alpha(2c)), activates a calcium- and voltage-independent chloride current in Xenopus oocytes. We show that the stimulatory pathway linking M-2 receptors to these chloride channels consists of G beta gamma stimulation of phosphoinositide 3-kinase gamma (PI-3K gamma), formation of phosphatidylinositol 3,4,5-trisphosphate (PIP3), and activation of atypical protein kinase C (PKC). The chloride current is activated in the absence of M-2 receptor stimulation by the injection of PIP3, and PIP3 current activation is blocked by a pseudosubstrate inhibitory peptide of atypical PKC but not other PKCs. Moreover, the current is activated by injection of recombinant PKC zeta at concentrations as low as 1 mM. M-2 receptor-current coupling was disrupted by inhibiton of PI-3K and by injection of beta gamma binding peptides, but it was not affected by expression of dominant negative p85 cRNA. We also show that this pathway mediates M-2 receptor coupling to metabotropic nonselective cation channels in mammalian smooth muscle cells, thus demonstrating the broad relevance of this signaling cascade in neurotransmitter signaling.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Kotlikoff, MI (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.				NHLBI NIH HHS [HL41084, HL45239] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045239, R01HL041084, R29HL041084] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENHAM CD, 1985, NATURE, V316, P345, DOI 10.1038/316345a0; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BYRNE NG, 1987, BRIT J PHARMACOL, V92, P371, DOI 10.1111/j.1476-5381.1987.tb11333.x; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; COUPRY I, 1992, J BIOL CHEM, V267, P9852; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; FUKUDA K, 1987, NATURE, V327, P623, DOI 10.1038/327623a0; Gadbut AP, 1996, J BIOL CHEM, V271, P6398, DOI 10.1074/jbc.271.11.6398; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; HARE K, 1994, P NATL ACAD SCI USA, V91, P7415; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INOUE R, 1990, J PHYSIOL-LONDON, V424, P73, DOI 10.1113/jphysiol.1990.sp018056; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOZANO J, 1994, J BIOL CHEM, V269, P19200; MARSH SJ, 1995, NEURON, V15, P729, DOI 10.1016/0896-6273(95)90160-4; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MOCHIDA S, 1988, NEUROSCI LETT, V86, P201, DOI 10.1016/0304-3940(88)90571-X; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; PACAUD P, 1991, J PHYSIOL-LONDON, V441, P477, DOI 10.1113/jphysiol.1991.sp018763; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; THOMASON PA, 1994, J BIOL CHEM, V269, P16525; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; Wang YX, 1997, AM J PHYSIOL-CELL PH, V273, pC500, DOI 10.1152/ajpcell.1997.273.2.C500; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	41	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	1999	274	20					13859	13864		10.1074/jbc.274.20.13859	http://dx.doi.org/10.1074/jbc.274.20.13859			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	196RW	10318793	hybrid			2022-12-27	WOS:000080322200022
J	Ferrari, D; Stroh, C; Schulze-Osthoff, K				Ferrari, D; Stroh, C; Schulze-Osthoff, K			P2X(7)/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; NUCLEAR FACTOR; EXTRACELLULAR ATP; KAPPA-B; PURINERGIC RECEPTORS; PLASMA-MEMBRANE; NERVOUS-SYSTEM; CYCLOSPORINE-A; GENE FAMILY; CALCINEURIN	ATP is released from neurons and other cell types during several physiological and stress conditions under which it exerts various biological effects upon binding to purinoreceptors, A rather peculiar purinoreceptor called P2X(7)/P2Z is expressed on microglial and other myeloic cells. Although increasing evidence implicates an important role for P2Z in inflammatory processes, little information exists about underlying signaling pathways. Here, we report that in N9 microglial cells, extracellular ATP potently activates nuclear factor of activated T cells (NFAT), a central transcription factor involved in cytokine gene expression. ATP activated NFAT rapidly (within 1 min), whereas activation of nuclear factor kappa B was much delayed, with strikingly distinct kinetics, During ATP stimulation, both NFAT-1 and NFAT-2 were activated by a calcineurin dependent pathway that required the influx of extracellular calcium ions. Based on the pharmacological profile, NFAT activation was specifically mediated by P2Z and not by other purinoreceptors. Ne cells that lacked P2Z but still expressed P2Y purinoreceptors failed to respond to NFAT activation. We conclude that P2Z-mediated NFAT activation may represent a novel mechanism by which extracellular ATP can modulate early inflammatory gene expression within the nervous and immune system.	Univ Tubingen, Med Clin, Dept Internal Med 1, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schulze-Osthoff, K (corresponding author), Univ Tubingen, Med Clin, Dept Internal Med 1, Otfried Muller Str 10, D-72076 Tubingen, Germany.		Schulze-Osthoff, Klaus/N-9025-2013; Ferrari, Davide/F-5644-2015	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Ferrari, Davide/0000-0002-5727-9204				APASOV S, 1995, IMMUNOL REV, V146, P5, DOI 10.1111/j.1600-065X.1995.tb00680.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Brake AJ, 1996, ANNU REV CELL DEV BI, V12, P519, DOI 10.1146/annurev.cellbio.12.1.519; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; FERRARI D, 1997, J EXP MED, V185, P1; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HICKMAN SE, 1994, BLOOD, V84, P2452; HO AM, 1994, J BIOL CHEM, V269, P28181; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Humphreys BD, 1996, J IMMUNOL, V157, P5627; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MURGIA M, 1993, J BIOL CHEM, V268, P8199; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; Wesselborg S, 1996, J BIOL CHEM, V271, P1274, DOI 10.1074/jbc.271.3.1274; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	51	126	128	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13205	13210		10.1074/jbc.274.19.13205	http://dx.doi.org/10.1074/jbc.274.19.13205			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224077	hybrid			2022-12-27	WOS:000080200400039
J	Gradin, K; Toftgard, R; Poellinger, L; Berghard, A				Gradin, K; Toftgard, R; Poellinger, L; Berghard, A			Repression of dioxin signal transduction in fibroblasts - Identification of a putative repressor associated with Arnt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; AH-RECEPTOR; HISTONE ACETYLATION; TRANSCRIPTIONAL REPRESSION; CHROMATIN STRUCTURE; MESSENGER-RNA; GENE FAMILY; EXPRESSION; PROTEIN; RECRUITMENT	Heterodimeric complexes of basic helix-loop-helix/PAS transcription factors are involved in regulation of diverse physiological phenomena such as circadian rhythms, reaction to low oxygen tension, and detoxification, In fibroblasts, the basic helix-loop-helix/PAS heterodimer consisting of the ligand-inducible dioxin receptor and Arnt shows DNA-binding activity, and the receptor and Arnt are able to activate transcription when fused to a heterologous DNA-binding domain. However, fibroblasts are nonresponsive to dioxin with regard to induction mediated by the DNA response element recognized by the receptor and Arnt. Here we demonstrate that Arnt is associated with a fibroblast-specific factor, forming a complex that is capable of binding the dioxin response element. This factor may function as a repressor since negative regulation of target gene induction appears to be abolished by inhibition of histone deacetylase activity by trichostatin A. Finally, the negative regulatory function of this factor appears to be restricted for dioxin signaling since Ar-nt was able to mediate, together with hypoxia-inducible factor-la, transcriptional activation in hypoxic cells. Taken together, these data suggest that fibroblast-specific inhibition of dioxin responsiveness involves recruitment by Arnt of a cell type- and signaling pathway-specific corepressor associated with a histone deacetylase.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Ctr Nutr & Toxicol, S-14157 Huddinge, Sweden; Umea Univ, Dept Cell & Mol Biol, S-90187 Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University	Gradin, K (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	katarina.gradin@cmb.ki.se						AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; Basu A, 1997, J BIOL CHEM, V272, P5899, DOI 10.1074/jbc.272.9.5899; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Campbell SJ, 1996, J CELL SCI, V109, P2619; CHEN H, 1995, NAT GENET, V10, P9, DOI 10.1038/ng0595-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Ema M, 1996, MOL CELL BIOL, V16, P5865; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GRADIN K, 1994, J BIOL CHEM, V269, P23800; GRADIN K, 1993, J BIOL CHEM, V268, P4061; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Ko HP, 1997, MOL CELL BIOL, V17, P3497, DOI 10.1128/MCB.17.7.3497; Kobayashi A, 1997, J BIOCHEM, V122, P703; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LUSSKA A, 1992, J BIOL CHEM, V267, P15146; MASON GGF, 1994, J BIOL CHEM, V269, P4438; MORGAN JE, 1992, P NATL ACAD SCI USA, V89, P11622, DOI 10.1073/pnas.89.23.11622; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OMIECINSKI CJ, 1990, CANCER RES, V50, P4315; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; REICK M, 1994, MOL CELL BIOL, V14, P5653, DOI 10.1128/MCB.14.9.5653; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; STRUHL K, 1990, CURRENT PROTOCOLS S, V11; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wang G L, 1996, Curr Opin Hematol, V3, P156; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WATSON AJ, 1992, MOL CELL BIOL, V12, P2115, DOI 10.1128/MCB.12.5.2115; WHITELAW M, 1993, MOL CELL BIOL, V13, P2504, DOI 10.1128/MCB.13.4.2504; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	53	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13511	13518		10.1074/jbc.274.19.13511	http://dx.doi.org/10.1074/jbc.274.19.13511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224119	hybrid			2022-12-27	WOS:000080200400081
J	Pye, DA; Gallagher, JT				Pye, DA; Gallagher, JT			Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RECEPTOR-BINDING; MITOGENIC ACTIVITY; EXTRACELLULAR DOMAIN; BIOLOGICAL-ACTIVITY; FGF RECEPTORS; DIMERIZATION; AFFINITY; IDENTIFICATION; EXPRESSION	The interaction of basic fibroblast growth factor (bFGF) with heparan sulfate (HS)/heparin has been shown to strongly enhance the activity of the growth factor although the mechanism of activation is unclear. We have addressed the issue of the minimal stoichiometry of an active HS oligosaccharide bFGF complex by chemically cross-linking the two components to form novel covalent conjugates. The cross-linking procedure produced both monomeric and dimeric bFGF oligosaccharide complexes, which were purified to homogeneity. Dimer conjugates were shown to have been formed as a result of disulfide bridging of monomer conjugates. These monomer conjugates were subsequently found to be biologically active in a mitogenesis assay. We therefore conclude that a monomeric bFGF oligosaccharide complex is the minimal functional unit required for mitogenic stimulation.	Univ Manchester, Paterson Inst Canc Res, Dept Med Oncol, Canc Res Campaign,Christie Hosp, Manchester M20 4BX, Lancs, England; Univ Manchester, Paterson Inst Canc Res, Dept drug Dev & Imaging, Canc Res Campaign,Christie Hosp, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Manchester	Pye, DA (corresponding author), Univ Manchester, Paterson Inst Canc Res, Dept Med Oncol, Canc Res Campaign,Christie Hosp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.							ARAKAWA T, 1989, BIOCHEM BIOPH RES CO, V161, P335, DOI 10.1016/0006-291X(89)91601-X; AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P576; Coulier F, 1997, J MOL EVOL, V44, P43, DOI 10.1007/PL00006120; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOX GM, 1988, J BIOL CHEM, V263, P18452; GAMBARINI AG, 1993, MOL CELL BIOCHEM, V124, P121, DOI 10.1007/BF00929204; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; HEATH WF, 1991, BIOCHEMISTRY-US, V30, P5608, DOI 10.1021/bi00236a039; HEIDIN CH, 1995, CELL, V80, P213; Hoshikawa M, 1998, BIOCHEM BIOPH RES CO, V244, P187, DOI 10.1006/bbrc.1998.8239; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; Krufka A, 1996, BIOCHEMISTRY-US, V35, P11131, DOI 10.1021/bi960125+; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MACH H, 1993, BIOCHEMISTRY-US, V32, P5480, DOI 10.1021/bi00071a026; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; McWhirter JR, 1997, DEVELOPMENT, V124, P3221; Miao HQ, 1996, J BIOL CHEM, V271, P4879; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; MOSES MA, 1991, BIO-TECHNOL, V9, P630, DOI 10.1038/nbt0791-630; Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PRESTA M, 1992, BIOCHEM BIOPH RES CO, V185, P1098, DOI 10.1016/0006-291X(92)91739-D; PYE DA, 1995, BBA-MOL CELL RES, V1266, P235, DOI 10.1016/0167-4889(95)00012-H; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Pye DA, 1998, BIOCHEM BIOPH RES CO, V248, P889, DOI 10.1006/bbrc.1998.9081; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SENO M, 1988, BIOCHEM BIOPH RES CO, V151, P701, DOI 10.1016/S0006-291X(88)80337-1; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; UENO H, 1992, J BIOL CHEM, V267, P1470; Venkataraman G, 1996, P NATL ACAD SCI USA, V93, P845, DOI 10.1073/pnas.93.2.845; WALKER A, 1994, J BIOL CHEM, V269, P931; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	59	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					13456	13461		10.1074/jbc.274.19.13456	http://dx.doi.org/10.1074/jbc.274.19.13456			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224111	hybrid			2022-12-27	WOS:000080200400073
